Citrus Sinensis ID: 015406
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 407 | 2.2.26 [Sep-21-2011] | |||||||
| P42158 | 450 | Casein kinase I isoform d | no | no | 0.906 | 0.82 | 0.851 | 0.0 | |
| Q5ZLL1 | 416 | Casein kinase I isoform e | yes | no | 0.835 | 0.817 | 0.673 | 1e-145 | |
| Q9JMK2 | 416 | Casein kinase I isoform e | yes | no | 0.835 | 0.817 | 0.663 | 1e-144 | |
| P49674 | 416 | Casein kinase I isoform e | yes | no | 0.800 | 0.783 | 0.687 | 1e-144 | |
| Q06486 | 415 | Casein kinase I isoform d | no | no | 0.732 | 0.718 | 0.778 | 1e-144 | |
| Q9DC28 | 415 | Casein kinase I isoform d | no | no | 0.732 | 0.718 | 0.778 | 1e-144 | |
| P48730 | 415 | Casein kinase I isoform d | no | no | 0.732 | 0.718 | 0.778 | 1e-144 | |
| P35508 | 415 | Casein kinase I isoform d | yes | no | 0.732 | 0.718 | 0.778 | 1e-144 | |
| Q5BP74 | 415 | Casein kinase I isoform d | N/A | no | 0.732 | 0.718 | 0.775 | 1e-144 | |
| Q6P3K7 | 409 | Casein kinase I isoform d | yes | no | 0.847 | 0.843 | 0.659 | 1e-144 |
| >sp|P42158|KC1D_ARATH Casein kinase I isoform delta-like OS=Arabidopsis thaliana GN=At4g26100 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 670 bits (1729), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 327/384 (85%), Positives = 351/384 (91%), Gaps = 15/384 (3%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
MEPRVGNKFRLGRKIGSGSFGEIYLGTNI TNEE+AIKLENVKTKHPQLLYESKLYRILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIHTNEELAIKLENVKTKHPQLLYESKLYRILQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTG+PNV+WFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLK+VLMLADQMINRVEF H
Sbjct: 61 GGTGVPNVKWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKSVLMLADQMINRVEFFH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SKSFLHRD+KPDNFLMGLGRRANQVYIIDFGLAKKYRD++THQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDLKPDNFLMGLGRRANQVYIIDFGLAKKYRDSTTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
SMNTHLGIEQSRRDDLESLGY+LMYFL+GSLPWQGLKAGTKKQKYE+ISEKKVSTSIEAL
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYILMYFLKGSLPWQGLKAGTKKQKYERISEKKVSTSIEAL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
CRGYP+EFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL
Sbjct: 241 CRGYPSEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
Query: 301 ATPPARALVPGAGTSGA-PPAIASGDRQTGGGEEGRPAGLSSMDSSRRRMSGPVINSGSF 359
PP+RAL P GTS A PP I++ DR T G EEGRP M+SSRRR+SG + NSG+
Sbjct: 301 TAPPSRALNPAVGTSAALPPGISNIDRYT-GEEEGRP----HMESSRRRVSGALDNSGNI 355
Query: 360 SKQKSPVVNEPTMT--KDTMVSNS 381
S N+PT + +D+M+ +S
Sbjct: 356 S-------NQPTSSSARDSMIPSS 372
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. It can phosphorylate a large number of proteins. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q5ZLL1|KC1E_CHICK Casein kinase I isoform epsilon OS=Gallus gallus GN=CSNK1E PE=2 SV=2 | Back alignment and function description |
|---|
Score = 516 bits (1329), Expect = e-145, Method: Compositional matrix adjust.
Identities = 250/371 (67%), Positives = 296/371 (79%), Gaps = 31/371 (8%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
ME RVGNK+RLGRKIGSGSFG+IYLG NI T EEVAIKLE VKTKHPQL ESK Y+++Q
Sbjct: 1 MELRVGNKYRLGRKIGSGSFGDIYLGANIATGEEVAIKLECVKTKHPQLHIESKFYKMMQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GG GIP+++W G EGDYNV+VM+LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61 GGVGIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAKKYRD THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
S+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQS-- 298
C+GYP+EF++Y ++CRSLRFDDKPDY+YL+++FR+LF R+GF +DYVFDW +LK+ +
Sbjct: 241 CKGYPSEFSTYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAARN 300
Query: 299 ------------------QLATPPARALVPGAGTSGAPPAIASGDRQTGGGEEGRPAGLS 340
QL RAL PG PPA A+G+R E ++
Sbjct: 301 PEDMDRERREHEREERMGQLRGSATRALPPG------PPAGATGNRLRNVAEP-----MA 349
Query: 341 SMDSSRRRMSG 351
S +SR + SG
Sbjct: 350 STPTSRIQQSG 360
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Can phosphorylate a large number of proteins. Participates in Wnt signaling. Phosphorylates DVL1. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2. Retains PER1 in the cytoplasm. Gallus gallus (taxid: 9031) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9JMK2|KC1E_MOUSE Casein kinase I isoform epsilon OS=Mus musculus GN=Csnk1e PE=1 SV=2 | Back alignment and function description |
|---|
Score = 511 bits (1316), Expect = e-144, Method: Compositional matrix adjust.
Identities = 246/371 (66%), Positives = 294/371 (79%), Gaps = 31/371 (8%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
ME RVGNK+RLGRKIGSGSFG+IYLG NI + EEVAIKLE VKTKHPQL ESK Y+++Q
Sbjct: 1 MELRVGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQLHIESKFYKMMQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GG GIP+++W G EGDYNV+VM+LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61 GGVGIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAKKYRD THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
S+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQS-- 298
C+GYP+EF++Y ++CRSLRFDDKPDY+YL+++FR+LF R+GF +DYVFDW +LK+ +
Sbjct: 241 CKGYPSEFSTYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAARN 300
Query: 299 ------------------QLATPPARALVPGAGTSGAPPAIASGDRQTGGGEEGRPAGLS 340
QL RAL PG PP A+ +R E ++
Sbjct: 301 PEDVDRERREHEREERMGQLRGSATRALPPG------PPTGATANRLRSAAEP-----VA 349
Query: 341 SMDSSRRRMSG 351
S +SR + +G
Sbjct: 350 STPASRIQQTG 360
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Can phosphorylate a large number of proteins. Participates in Wnt signaling. Phosphorylates DVL1. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2. Retains PER1 in the cytoplasm. Inhibits cytokine-induced granuloytic differentiation. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P49674|KC1E_HUMAN Casein kinase I isoform epsilon OS=Homo sapiens GN=CSNK1E PE=1 SV=1 | Back alignment and function description |
|---|
Score = 511 bits (1315), Expect = e-144, Method: Compositional matrix adjust.
Identities = 242/352 (68%), Positives = 285/352 (80%), Gaps = 26/352 (7%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
ME RVGNK+RLGRKIGSGSFG+IYLG NI + EEVAIKLE VKTKHPQL ESK Y+++Q
Sbjct: 1 MELRVGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQLHIESKFYKMMQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GG GIP+++W G EGDYNV+VM+LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61 GGVGIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAKKYRD THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
S+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQS-- 298
C+GYP+EF++Y ++CRSLRFDDKPDY+YL+++FR+LF R+GF +DYVFDW +LK+ +
Sbjct: 241 CKGYPSEFSTYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAARN 300
Query: 299 ------------------QLATPPARALVPGAGTSGAPPAIASGDRQTGGGE 332
QL RAL PG PP A+ +R E
Sbjct: 301 PEDVDRERREHEREERMGQLRGSATRALPPG------PPTGATANRLRSAAE 346
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Can phosphorylate a large number of proteins. Participates in Wnt signaling. Phosphorylates DVL1. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2. Retains PER1 in the cytoplasm. Inhibits cytokine-induced granuloytic differentiation. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q06486|KC1D_RAT Casein kinase I isoform delta OS=Rattus norvegicus GN=Csnk1d PE=1 SV=2 | Back alignment and function description |
|---|
Score = 511 bits (1315), Expect = e-144, Method: Compositional matrix adjust.
Identities = 232/298 (77%), Positives = 271/298 (90%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
ME RVGN++RLGRKIGSGSFG+IYLGT+I EEVAIKLE VKTKHPQL ESK+Y+++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GG GIP +RW G EGDYNV+VM+LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAKKYRD THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
S+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQS 298
C+GYP+EFA+Y ++CRSLRFDDKPDY+YL+++FR+LF R+GF +DYVFDW +LK+ S
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAS 298
|
Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|Q9DC28|KC1D_MOUSE Casein kinase I isoform delta OS=Mus musculus GN=Csnk1d PE=1 SV=2 | Back alignment and function description |
|---|
Score = 511 bits (1315), Expect = e-144, Method: Compositional matrix adjust.
Identities = 232/298 (77%), Positives = 271/298 (90%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
ME RVGN++RLGRKIGSGSFG+IYLGT+I EEVAIKLE VKTKHPQL ESK+Y+++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GG GIP +RW G EGDYNV+VM+LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAKKYRD THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
S+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQS 298
C+GYP+EFA+Y ++CRSLRFDDKPDY+YL+++FR+LF R+GF +DYVFDW +LK+ S
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAS 298
|
Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|P48730|KC1D_HUMAN Casein kinase I isoform delta OS=Homo sapiens GN=CSNK1D PE=1 SV=2 | Back alignment and function description |
|---|
Score = 511 bits (1315), Expect = e-144, Method: Compositional matrix adjust.
Identities = 232/298 (77%), Positives = 271/298 (90%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
ME RVGN++RLGRKIGSGSFG+IYLGT+I EEVAIKLE VKTKHPQL ESK+Y+++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GG GIP +RW G EGDYNV+VM+LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAKKYRD THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
S+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQS 298
C+GYP+EFA+Y ++CRSLRFDDKPDY+YL+++FR+LF R+GF +DYVFDW +LK+ S
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAS 298
|
Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|P35508|KC1D_BOVIN Casein kinase I isoform delta OS=Bos taurus GN=CSNK1D PE=2 SV=2 | Back alignment and function description |
|---|
Score = 511 bits (1315), Expect = e-144, Method: Compositional matrix adjust.
Identities = 232/298 (77%), Positives = 271/298 (90%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
ME RVGN++RLGRKIGSGSFG+IYLGT+I EEVAIKLE VKTKHPQL ESK+Y+++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GG GIP +RW G EGDYNV+VM+LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAKKYRD THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
S+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQS 298
C+GYP+EFA+Y ++CRSLRFDDKPDY+YL+++FR+LF R+GF +DYVFDW +LK+ S
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAS 298
|
Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|Q5BP74|KC1D_XENLA Casein kinase I isoform delta OS=Xenopus laevis GN=csnk1d PE=1 SV=2 | Back alignment and function description |
|---|
Score = 510 bits (1314), Expect = e-144, Method: Compositional matrix adjust.
Identities = 231/298 (77%), Positives = 272/298 (91%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
ME RVGN++RLGRKIGSGSFG+IYLGT+I +EEVAIKLE VKTKHPQL ESK+Y+++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAASEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GG GIP ++W G EGDYNV+VM+LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61 GGVGIPTIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAKKYRD THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
S+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQS 298
C+GYP+EFA+Y ++CRSLRFDDKPDY+YL+++FR+LF R+GF +DYVFDW +LK+ S
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAS 298
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Isoform 1 can phosphorylate a large number of proteins. Isoform 2 has no kinase activity. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating per1 and per2, which may lead to their degradation. Participates in wnt signaling. Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6P3K7|KC1DB_DANRE Casein kinase I isoform delta-B OS=Danio rerio GN=csnk1db PE=2 SV=1 | Back alignment and function description |
|---|
Score = 510 bits (1314), Expect = e-144, Method: Compositional matrix adjust.
Identities = 244/370 (65%), Positives = 293/370 (79%), Gaps = 25/370 (6%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
ME RVGN++RLGRKIGSGSFG+IYLGT+I EEVAIKLE VKTKHPQL ESK+Y+++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDISVGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GG GIP ++W G EGDYNV+VM+LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61 GGVGIPTIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAKKYRD THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
S+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
C+GYP+EFA+Y ++CRSLRFDDKPDY+YL+++FR+LF R+GF +DYVFDW +LK+ ++
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGANRT 300
Query: 301 A------------------TPPARALVPGAG-----TSGAPPAIASGDRQTGGGEEGRPA 337
A P AR + +G GAPP + T RP
Sbjct: 301 AEEADRERRERDERMRHSRNPAARGIPAASGRPRPTQDGAPPTPLTPTSHTANTSSPRP- 359
Query: 338 GLSSMDSSRR 347
++ M+ R+
Sbjct: 360 -VTGMERERK 368
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating per1 and per2, which may lead to their degradation. Participates in wnt signaling. Danio rerio (taxid: 7955) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 407 | ||||||
| 224122454 | 475 | predicted protein [Populus trichocarpa] | 0.941 | 0.806 | 0.901 | 0.0 | |
| 359484471 | 474 | PREDICTED: casein kinase I isoform delta | 0.931 | 0.799 | 0.898 | 0.0 | |
| 356547889 | 483 | PREDICTED: casein kinase I isoform delta | 0.933 | 0.786 | 0.900 | 0.0 | |
| 359482807 | 471 | PREDICTED: casein kinase I isoform delta | 0.928 | 0.802 | 0.900 | 0.0 | |
| 224091248 | 475 | predicted protein [Populus trichocarpa] | 0.938 | 0.804 | 0.906 | 0.0 | |
| 449446600 | 479 | PREDICTED: casein kinase I isoform delta | 0.928 | 0.789 | 0.913 | 0.0 | |
| 413915514 | 479 | Caesin kinase I isoform delta like prote | 0.928 | 0.789 | 0.910 | 0.0 | |
| 449488044 | 480 | PREDICTED: casein kinase I isoform delta | 0.928 | 0.787 | 0.913 | 0.0 | |
| 356561895 | 466 | PREDICTED: casein kinase I isoform delta | 0.884 | 0.772 | 0.933 | 0.0 | |
| 255560729 | 472 | casein kinase, putative [Ricinus communi | 0.938 | 0.809 | 0.893 | 0.0 |
| >gi|224122454|ref|XP_002330485.1| predicted protein [Populus trichocarpa] gi|222872419|gb|EEF09550.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 724 bits (1868), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 346/384 (90%), Positives = 361/384 (94%), Gaps = 1/384 (0%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN+KTKHPQLLYESKLYRILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENIKTKHPQLLYESKLYRILQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLK+VLMLADQMINRVEFVH
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKSVLMLADQMINRVEFVH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD+STHQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDSSTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL
Sbjct: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
Query: 301 ATPPARALVPGAGTSGAPPAIASGDRQTGGGEEGRPAGLSSMDSSRRRMSGPVINSGSFS 360
A PP R + PG GTS P I S DRQTG GEEGR G SMDSSR R+SGP++N+GS+S
Sbjct: 301 ANPPTRGIGPGVGTSSGMPPIVSADRQTGSGEEGRAVG-QSMDSSRHRLSGPILNAGSYS 359
Query: 361 KQKSPVVNEPTMTKDTMVSNSYYL 384
KQKSPV N+ +TKD ++ +S +L
Sbjct: 360 KQKSPVANDYPITKDAVLPSSTFL 383
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359484471|ref|XP_002281345.2| PREDICTED: casein kinase I isoform delta-like [Vitis vinifera] gi|147859066|emb|CAN80417.1| hypothetical protein VITISV_024542 [Vitis vinifera] gi|297738643|emb|CBI27888.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 717 bits (1851), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 347/386 (89%), Positives = 365/386 (94%), Gaps = 7/386 (1%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTGIPNVRWFGVEG+YNVLVMDLLGPSLEDLFNFCSRKLSLK+VLMLADQMINRVEFVH
Sbjct: 61 GGTGIPNVRWFGVEGEYNVLVMDLLGPSLEDLFNFCSRKLSLKSVLMLADQMINRVEFVH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT+THQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTATHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE+KVSTSIE L
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISERKVSTSIEVL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL
Sbjct: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
Query: 301 ATPPARALVPGAGTSGA--PPAIASGDRQTGGGEEGRPAGLSSMDSSRRRMSGPVINSGS 358
ATPP+R L PGAGTS PPA+A+ DRQ+ GEEGRPAGLSSMD SRRR+SG + G
Sbjct: 301 ATPPSRVLGPGAGTSSGLPPPAVANADRQS--GEEGRPAGLSSMDPSRRRISG---DGGG 355
Query: 359 FSKQKSPVVNEPTMTKDTMVSNSYYL 384
SKQKSPV ++ ++KD M+S+S++L
Sbjct: 356 LSKQKSPVASDLAVSKDAMLSSSHFL 381
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356547889|ref|XP_003542337.1| PREDICTED: casein kinase I isoform delta-like isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 714 bits (1844), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 344/382 (90%), Positives = 358/382 (93%), Gaps = 2/382 (0%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF+H
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFIH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SKSFLHRDIKPDNFLMGLGRRANQVY IDFGLAKKYRD+STHQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYAIDFGLAKKYRDSSTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL
Sbjct: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
Query: 301 ATPPARALVPGAGT-SGAPPAIASGDRQTGGGEEGRPAGLSSMDSSRRRMSGPVINSGSF 359
ATPP RA+ P AGT SG PPA+ + DR T GGEEGRP L S+DSSRRRMSGP++N+ SF
Sbjct: 301 ATPPTRAIGPSAGTSSGMPPAVTNADRHT-GGEEGRPPALVSVDSSRRRMSGPILNTVSF 359
Query: 360 SKQKSPVVNEPTMTKDTMVSNS 381
SK K + N D+++S+S
Sbjct: 360 SKPKKLITNFSFTFSDSIISSS 381
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359482807|ref|XP_002277513.2| PREDICTED: casein kinase I isoform delta-like [Vitis vinifera] gi|297743045|emb|CBI35912.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 712 bits (1839), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 343/381 (90%), Positives = 361/381 (94%), Gaps = 3/381 (0%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLY+ILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYKILQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTGIPNV+WFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH
Sbjct: 61 GGTGIPNVKWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SKSFLHRDIKPDNFLMGLGRRANQVY+IDFGLAKKYRD+STHQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYVIDFGLAKKYRDSSTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQI 300
Query: 301 ATPPARALVPGAGTS-GAPPAIASGDRQTGGGEEGRPAGLSSMDSSRRRMSGPVINSGSF 359
+ PP+RAL PGAG S G PPA+A+ DRQ+ GGE+GRP+G SS D SRRR + P +N GS
Sbjct: 301 SGPPSRALGPGAGPSHGIPPAVANMDRQS-GGEDGRPSGWSSADPSRRRTTVPALNLGSL 359
Query: 360 SKQKSPVVNEPTMTKDTMVSN 380
KQKSPV N+ TM KD++ +N
Sbjct: 360 -KQKSPVANDSTMAKDSLSAN 379
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224091248|ref|XP_002309212.1| predicted protein [Populus trichocarpa] gi|222855188|gb|EEE92735.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 712 bits (1839), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 349/385 (90%), Positives = 359/385 (93%), Gaps = 3/385 (0%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLK+VLMLADQMINRVEFVH
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKSVLMLADQMINRVEFVH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD+STHQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDSSTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL
Sbjct: 241 SRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
Query: 301 ATPPARALVPGAGT-SGAPPAIASGDRQTGGGEEGRPAGLSSMDSSRRRMSGPVINSGSF 359
A PP R L G GT SG PP I S DRQT GGEE R AG +M+SSRRR+SG +IN+GS
Sbjct: 301 ANPPTRGLGLGVGTSSGMPPPIVSADRQT-GGEEVRAAG-QTMESSRRRLSGQIINAGSS 358
Query: 360 SKQKSPVVNEPTMTKDTMVSNSYYL 384
SKQKS V NE +TKD M+ NS +L
Sbjct: 359 SKQKSLVANESPITKDAMLPNSTFL 383
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449446600|ref|XP_004141059.1| PREDICTED: casein kinase I isoform delta-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 710 bits (1833), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 348/381 (91%), Positives = 360/381 (94%), Gaps = 3/381 (0%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD+STHQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDSSTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
CRGYP+EFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL
Sbjct: 241 CRGYPSEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
Query: 301 ATPPARALVPGAGT-SGAPPAIASGDRQTGGGEEGRPAGLSSMDSSRRRMSGPVINSGSF 359
ATPP RAL GAGT SG PP IA+ DRQT GGEE + AG+S MDSSRRR SG +NSG+F
Sbjct: 301 ATPPTRALGAGAGTSSGIPPGIANPDRQT-GGEEAQLAGMSLMDSSRRRASGLTMNSGTF 359
Query: 360 SKQKSPVVNE-PTMTKDTMVS 379
+KQKSP+ N+ + KD + S
Sbjct: 360 AKQKSPIANDTAAVPKDGVFS 380
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|413915514|emb|CCM43976.1| Caesin kinase I isoform delta like protein [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 709 bits (1831), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 347/381 (91%), Positives = 360/381 (94%), Gaps = 3/381 (0%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD+STHQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDSSTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
SMNTHLGIEQSRRDDLE+LGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL
Sbjct: 181 SMNTHLGIEQSRRDDLETLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
CRGYP+EFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL
Sbjct: 241 CRGYPSEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
Query: 301 ATPPARALVPGAGT-SGAPPAIASGDRQTGGGEEGRPAGLSSMDSSRRRMSGPVINSGSF 359
ATPP RAL GAGT SG PP IA+ DRQT GGEE + AG+S MDSSRRR SG +NSG+F
Sbjct: 301 ATPPTRALGAGAGTSSGIPPGIANPDRQT-GGEEAQLAGMSLMDSSRRRASGLTMNSGTF 359
Query: 360 SKQKSPVVNE-PTMTKDTMVS 379
+KQKSP+ N+ + KD + S
Sbjct: 360 AKQKSPIANDTAAVPKDGVFS 380
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449488044|ref|XP_004157925.1| PREDICTED: casein kinase I isoform delta-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 709 bits (1830), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 349/382 (91%), Positives = 361/382 (94%), Gaps = 4/382 (1%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD+STHQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDSSTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
CRGYP+EFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL
Sbjct: 241 CRGYPSEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
Query: 301 ATPPARALV-PGAGT-SGAPPAIASGDRQTGGGEEGRPAGLSSMDSSRRRMSGPVINSGS 358
ATPP RALV GAGT SG PP IA+ DRQT GGEE + AG+S MDSSRRR SG +NSG+
Sbjct: 301 ATPPTRALVRAGAGTSSGIPPGIANPDRQT-GGEEAQLAGMSLMDSSRRRASGLTMNSGT 359
Query: 359 FSKQKSPVVNE-PTMTKDTMVS 379
F+KQKSP+ N+ + KD + S
Sbjct: 360 FAKQKSPIANDTAAVPKDGVFS 381
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356561895|ref|XP_003549212.1| PREDICTED: casein kinase I isoform delta-like isoform 3 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 706 bits (1822), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 339/363 (93%), Positives = 348/363 (95%), Gaps = 3/363 (0%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF+H
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFIH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SKSFLHRDIKPDNFLMGLGRRANQVY IDFGLAKKYRD+STHQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYAIDFGLAKKYRDSSTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL
Sbjct: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
Query: 301 ATPPARALV--PGAGT-SGAPPAIASGDRQTGGGEEGRPAGLSSMDSSRRRMSGPVINSG 357
ATPP RA+V P AGT SG PPA+ + DR TG GEEGRP L S+DSSRRRMSGP++N+
Sbjct: 301 ATPPTRAIVSGPSAGTSSGMPPAVTNADRHTGRGEEGRPPALVSVDSSRRRMSGPILNTV 360
Query: 358 SFS 360
SFS
Sbjct: 361 SFS 363
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255560729|ref|XP_002521378.1| casein kinase, putative [Ricinus communis] gi|223539456|gb|EEF41046.1| casein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 706 bits (1822), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 344/385 (89%), Positives = 361/385 (93%), Gaps = 3/385 (0%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLY+ILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYKILQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR+FRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQI 300
Query: 301 ATPPARALVPGAG-TSGAPPAIASGDRQTGGGEEGRPAGLSSMDSSRRRMSGPVINSGSF 359
A PP RAL PGAG +SG PP+ A+ DRQ GGEEGRP SMD +RRR SGP+ +S +F
Sbjct: 301 ANPPTRALGPGAGPSSGMPPSGANIDRQP-GGEEGRPT-WPSMDPTRRRNSGPITSSVNF 358
Query: 360 SKQKSPVVNEPTMTKDTMVSNSYYL 384
SKQK PV N+ ++KD +S++ +L
Sbjct: 359 SKQKGPVANDLPLSKDAKLSSTNFL 383
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 407 | ||||||
| TAIR|locus:2030170 | 465 | CKL2 "casein kinase 1-like pro | 0.950 | 0.832 | 0.785 | 4.8e-165 | |
| TAIR|locus:2120765 | 450 | CK1 "casein kinase 1" [Arabido | 0.906 | 0.82 | 0.804 | 3.5e-162 | |
| TAIR|locus:504954933 | 435 | ckl12 "casein kinase I-like 12 | 0.889 | 0.832 | 0.802 | 6.1e-158 | |
| TAIR|locus:2050409 | 433 | ckl5 "casein kinase I-like 5" | 0.803 | 0.755 | 0.789 | 4.6e-144 | |
| TAIR|locus:2167634 | 476 | ckl7 "casein kinase I-like 7" | 0.729 | 0.623 | 0.791 | 1.4e-133 | |
| TAIR|locus:2024147 | 471 | ADK1 "dual specificity kinase | 0.729 | 0.630 | 0.787 | 1.3e-132 | |
| TAIR|locus:2090875 | 442 | ckl10 "casein kinase I-like 10 | 0.761 | 0.701 | 0.748 | 2.4e-131 | |
| TAIR|locus:2121338 | 479 | CKL6 "casein kinase I-like 6" | 0.732 | 0.622 | 0.755 | 1.8e-129 | |
| UNIPROTKB|Q6K9N1 | 463 | OJ1234_B11.27 "Os02g0622100 pr | 0.714 | 0.628 | 0.780 | 4e-129 | |
| TAIR|locus:2129640 | 457 | CKI1 "casein kinase I" [Arabid | 0.828 | 0.737 | 0.695 | 2.8e-128 |
| TAIR|locus:2030170 CKL2 "casein kinase 1-like protein 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1606 (570.4 bits), Expect = 4.8e-165, P = 4.8e-165
Identities = 308/392 (78%), Positives = 337/392 (85%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
MEPRVGNKFRLGRKIG GSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLY++LQ
Sbjct: 1 MEPRVGNKFRLGRKIGGGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYKVLQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTG+PNV+W+GVEGDYNVLV+DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR+EFVH
Sbjct: 61 GGTGVPNVKWYGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRIEFVH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
KSFLHRDIKPDNFLMGLGRRANQVY+IDFGLAKKYRD S HQHIPYRENKNLTGTARYA
Sbjct: 121 QKSFLHRDIKPDNFLMGLGRRANQVYVIDFGLAKKYRD-SNHQHIPYRENKNLTGTARYA 179
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 240
SMNTHLGIEQSRRDDLESLG+VLMYFL+GSLPWQGLKAG VSTSIEAL
Sbjct: 180 SMNTHLGIEQSRRDDLESLGFVLMYFLKGSLPWQGLKAGNKKQKYEKISEKKVSTSIEAL 239
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
CRGYP+EFASYFHYCRSLRFDDKPDYAYLKR+FRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 240 CRGYPSEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQI 299
Query: 301 ATPPARALVPGAGTSGA-PPAIASGDRQTGGGEEGRPAGLXXXXXXXXXXXGPVINSGSF 359
+TPP R P G S A PPAI S +R +GG +E RP+G G + NSGS
Sbjct: 300 STPPPRHHGPVVGPSSALPPAITSAERPSGG-DEARPSGWSSGIPRRNS--GQIFNSGSL 356
Query: 360 SKQKSPVVNEPTMTKDTMVSNSYYLFCPFSPR 391
+KQK+PV ++P ++KD ++S+S +L S R
Sbjct: 357 AKQKAPVSSDPAISKDVVLSSSSFLRATGSSR 388
|
|
| TAIR|locus:2120765 CK1 "casein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1579 (560.9 bits), Expect = 3.5e-162, P = 3.5e-162
Identities = 309/384 (80%), Positives = 330/384 (85%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
MEPRVGNKFRLGRKIGSGSFGEIYLGTNI TNEE+AIKLENVKTKHPQLLYESKLYRILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIHTNEELAIKLENVKTKHPQLLYESKLYRILQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTG+PNV+WFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLK+VLMLADQMINRVEF H
Sbjct: 61 GGTGVPNVKWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKSVLMLADQMINRVEFFH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SKSFLHRD+KPDNFLMGLGRRANQVYIIDFGLAKKYRD++THQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDLKPDNFLMGLGRRANQVYIIDFGLAKKYRDSTTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 240
SMNTHLGIEQSRRDDLESLGY+LMYFL+GSLPWQGLKAGT VSTSIEAL
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYILMYFLKGSLPWQGLKAGTKKQKYERISEKKVSTSIEAL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
CRGYP+EFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL
Sbjct: 241 CRGYPSEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
Query: 301 ATPPARALVPGAGTSGA-PPAIASGDRQTGGGEEGRPAGLXXXXXXXXXXXGPVINSGSF 359
PP+RAL P GTS A PP I++ DR TG EEGRP G + NSG+
Sbjct: 301 TAPPSRALNPAVGTSAALPPGISNIDRYTGE-EEGRP----HMESSRRRVSGALDNSGNI 355
Query: 360 SKQKSPVVNEPTMT--KDTMVSNS 381
S N+PT + +D+M+ +S
Sbjct: 356 S-------NQPTSSSARDSMIPSS 372
|
|
| TAIR|locus:504954933 ckl12 "casein kinase I-like 12" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1539 (546.8 bits), Expect = 6.1e-158, P = 6.1e-158
Identities = 296/369 (80%), Positives = 317/369 (85%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
MEPRVGNK+RLGRKIGSGSFGEIYLGT+IQTNEEVAIKLENVKTKHPQLLYESKLYRILQ
Sbjct: 1 MEPRVGNKYRLGRKIGSGSFGEIYLGTHIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTG+PN++WFGVEGDYN LVMDLLGPSLEDLFNFCSRKLSLK+VLMLADQMINRVE+ H
Sbjct: 61 GGTGVPNIKWFGVEGDYNTLVMDLLGPSLEDLFNFCSRKLSLKSVLMLADQMINRVEYFH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SKSFLHRD+KPDNFLMGLGRRANQV+IIDFGLAKKYRD +THQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDLKPDNFLMGLGRRANQVHIIDFGLAKKYRDNTTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 240
SMNTHLGIEQSRRDDLESLGY+LMYFL+GSLPWQGLKAGT VSTSIE+L
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYILMYFLKGSLPWQGLKAGTKKQKYERISEKKVSTSIESL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
CRGYP+EFASYFHYCRSLRFDDKPDY YLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL
Sbjct: 241 CRGYPSEFASYFHYCRSLRFDDKPDYGYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
Query: 301 ATPPARALV-PGAGTS-GAPPAIASGDRQTGGGEEGRPAGLXXXXXXXXXXXGPVINSGS 358
PP+R LV P GTS G PP + S DR G E GRP G + NSG+
Sbjct: 301 TAPPSRGLVSPAVGTSAGLPPGLTSIDRYGGEEEGGRPP----MDSSRRRMSGALENSGN 356
Query: 359 FSKQKSPVV 367
S + P++
Sbjct: 357 LSS-RGPMM 364
|
|
| TAIR|locus:2050409 ckl5 "casein kinase I-like 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1408 (500.7 bits), Expect = 4.6e-144, P = 4.6e-144
Identities = 259/328 (78%), Positives = 292/328 (89%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
MEPRVGNKFRLGRKIGSGSFGEIYLGT++QTNEEVAIKLE+VKT HPQL YES++YR+LQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTDVQTNEEVAIKLESVKTAHPQLSYESRIYRVLQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTGIPN++W+GVEGDYNVLVMDLLGPSLEDLF++C R+ SLKTVLMLADQMINR+EF+H
Sbjct: 61 GGTGIPNMKWYGVEGDYNVLVMDLLGPSLEDLFSYCKRQFSLKTVLMLADQMINRLEFIH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SKS+LHRDIKPDNFLMGLGRRANQVYIID+GLAKKYRD+STH+HIPYRENK+L GT RYA
Sbjct: 121 SKSYLHRDIKPDNFLMGLGRRANQVYIIDYGLAKKYRDSSTHRHIPYRENKSLIGTPRYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 240
S+NTHLGIEQSRRDD+ESLGY+LMYFL+GSLPWQGLKAG VSTSIE L
Sbjct: 181 SLNTHLGIEQSRRDDIESLGYILMYFLKGSLPWQGLKAGNKKQKYDKISEKKVSTSIETL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
CRG+PTEFASYFHYCRSLRFDDKPDYAYLKR+FR+LFIREGFQFD+VFDWT+ KYQQSQ
Sbjct: 241 CRGHPTEFASYFHYCRSLRFDDKPDYAYLKRLFRNLFIREGFQFDFVFDWTVYKYQQSQS 300
Query: 301 ATPPARALVPGAGTS-GAPPAIASGDRQ 327
P R G GTS G PA+ + +++
Sbjct: 301 GNPQPRPHDGGVGTSSGLNPAVGNSEKR 328
|
|
| TAIR|locus:2167634 ckl7 "casein kinase I-like 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1309 (465.8 bits), Expect = 1.4e-133, P = 1.4e-133
Identities = 235/297 (79%), Positives = 268/297 (90%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
M+ +G KF+LG+KIGSGSFGE+YLG N+QT EEVA+KLENVKTKHPQL YESKLY +LQ
Sbjct: 1 MDLVIGGKFKLGKKIGSGSFGELYLGVNVQTGEEVAVKLENVKTKHPQLHYESKLYMLLQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GG+GIPN++WFGVEGDY+V+V+DLLGPSLEDLFN+C+RKL+LKTVLMLADQ++NRVEF+H
Sbjct: 61 GGSGIPNIKWFGVEGDYSVMVIDLLGPSLEDLFNYCNRKLTLKTVLMLADQLLNRVEFMH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
++ FLHRDIKPDNFLMGLGR+ANQVYIIDFGL KKYRD TH+HIPYRENKNLTGTARYA
Sbjct: 121 TRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLGKKYRDLQTHKHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 240
S+NTHLG+EQSRRDDLESLGYVLMYFL+GSLPWQGLKAGT VST IE L
Sbjct: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLKGSLPWQGLKAGTKKQKYDRISEKKVSTPIEVL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQ 297
C+ P+EF SYFHYCRSLRFDDKPDY+YLKR+FRDLFIREG+QFDYVFDWT+LKY Q
Sbjct: 241 CKNQPSEFVSYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGYQFDYVFDWTVLKYPQ 297
|
|
| TAIR|locus:2024147 ADK1 "dual specificity kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1300 (462.7 bits), Expect = 1.3e-132, P = 1.3e-132
Identities = 234/297 (78%), Positives = 267/297 (89%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
M+ +G KF+LGRKIGSGSFGE+YLG N+QT EEVA+KLE+VKTKHPQL YESKLY +LQ
Sbjct: 1 MDLVIGGKFKLGRKIGSGSFGELYLGINVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTG+PN++W+GVEGDYNV+V+DLLGPSLEDLFN+C+RKLSLKTVLMLADQ+INRVEF+H
Sbjct: 61 GGTGVPNLKWYGVEGDYNVMVIDLLGPSLEDLFNYCNRKLSLKTVLMLADQLINRVEFMH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
++ FLHRDIKPDNFLMGLGR+ANQVYIIDFGL KKYRD TH+HIPYRENKNLTGTARYA
Sbjct: 121 TRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLGKKYRDLQTHRHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 240
S+NTHLG+EQSRRDDLE+LGYVLMYFL+GSLPWQGLKAGT V+T IE L
Sbjct: 181 SVNTHLGVEQSRRDDLEALGYVLMYFLKGSLPWQGLKAGTKKQKYDRISEKKVATPIEVL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQ 297
C+ P+EF SYF YCRSLRFDDKPDY+YLKR+FRDLFIREG+QFDYVFDWT+LKY Q
Sbjct: 241 CKNQPSEFVSYFRYCRSLRFDDKPDYSYLKRLFRDLFIREGYQFDYVFDWTVLKYPQ 297
|
|
| TAIR|locus:2090875 ckl10 "casein kinase I-like 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1288 (458.5 bits), Expect = 2.4e-131, P = 2.4e-131
Identities = 235/314 (74%), Positives = 272/314 (86%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
M+ +G KF+LGRKIGSGSFGE+Y+G N+QT EEVA+KLE VKTKHPQL YESK+Y +LQ
Sbjct: 1 MDHVIGGKFKLGRKIGSGSFGELYIGINVQTGEEVALKLEPVKTKHPQLHYESKVYMLLQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTG+P+++WFGVEG+YN + +DLLGPSLEDLFN+C+R SLKTVLMLADQ+INRVE++H
Sbjct: 61 GGTGVPHIKWFGVEGNYNCMAIDLLGPSLEDLFNYCTRSFSLKTVLMLADQLINRVEYMH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
S+ FLHRDIKPDNFLMGLGR+ANQVYIID+GLAKKYRD TH+HIPYRENKNLTGTARYA
Sbjct: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 240
S+NTHLGIEQSRRDDLESLGYVLMYF+RGSLPWQGLKAGT + T +E L
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFIRGSLPWQGLKAGTKKQKYEKISEKKMLTPVEVL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQS-Q 299
C+ YP+EF SYFHYCRSLRF+DKPDY+YLKR+FRDLFIREG+QFDYVFDWTILKY QS
Sbjct: 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQSGS 300
Query: 300 LATP---PARALVP 310
++ P P AL P
Sbjct: 301 ISKPRPNPKPALDP 314
|
|
| TAIR|locus:2121338 CKL6 "casein kinase I-like 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1251 (445.4 bits), Expect = 1.8e-129, Sum P(2) = 1.8e-129
Identities = 225/298 (75%), Positives = 261/298 (87%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
M+ +G KF+LGRKIG GSFGE++L ++QT EE A+KLE KTKHPQL YESK+Y +LQ
Sbjct: 5 MDNVIGGKFKLGRKIGGGSFGELFLAVSLQTGEEAAVKLEPAKTKHPQLHYESKIYMLLQ 64
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GG+GIP+++WFGV+GDYN +V+DLLGPSLEDLFN+C+R+L+LK VLMLADQ+I+RVE++H
Sbjct: 65 GGSGIPSLKWFGVQGDYNAMVIDLLGPSLEDLFNYCNRRLTLKAVLMLADQLISRVEYMH 124
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
S+ FLHRDIKPDNFLMGLGR+ANQVYIIDFGLAKKYRD TH+HIPYRENKNLTGTARYA
Sbjct: 125 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDLQTHRHIPYRENKNLTGTARYA 184
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 240
S+NTHLG+EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT VST IE L
Sbjct: 185 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDRISEKKVSTPIEVL 244
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQS 298
C+ YP EF SYF YCRSLRF+DKPDY+YLKR+FRDLFIREG+QFDYVFDWT LK+ QS
Sbjct: 245 CKSYPPEFVSYFQYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTALKHPQS 302
|
|
| UNIPROTKB|Q6K9N1 OJ1234_B11.27 "Os02g0622100 protein" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 1267 (451.1 bits), Expect = 4.0e-129, P = 4.0e-129
Identities = 227/291 (78%), Positives = 263/291 (90%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
ME +G KF+LGRKIGSGSFGE+YLG NIQ++EEVAIKLE+VK++HPQL YESKLY +LQ
Sbjct: 1 MEHVIGGKFKLGRKIGSGSFGELYLGVNIQSSEEVAIKLESVKSRHPQLHYESKLYMLLQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTGIP+++WFGVEG+YNV+V+DLLGPSLEDLFN+C+RK SLKTVLMLADQMINRVE++H
Sbjct: 61 GGTGIPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQMINRVEYMH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
++ FLHRDIKPDNFLMGLGR+A+QVY+ID+GLAKKYRD TH+HIPYRENKNLTGTARYA
Sbjct: 121 TRGFLHRDIKPDNFLMGLGRKASQVYVIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 240
S+NTHLG+EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT + T +E L
Sbjct: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPVEVL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWT 291
C+ YPTEF SYFHYCRSLRF+DKPDY+YLKR+FRDLFIREG+Q DY+FDWT
Sbjct: 241 CKSYPTEFISYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQLDYIFDWT 291
|
|
| TAIR|locus:2129640 CKI1 "casein kinase I" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1259 (448.2 bits), Expect = 2.8e-128, P = 2.8e-128
Identities = 235/338 (69%), Positives = 273/338 (80%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
M+ +G KF+LGRK+GSGSFGE+YLG NIQT EEVA+KLE VKT+HPQL YESK+Y LQ
Sbjct: 7 MDHVIGGKFKLGRKLGSGSFGELYLGINIQTGEEVAVKLEPVKTRHPQLQYESKIYMFLQ 66
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTG+P+++WFGVEG+Y+ +V+DLLGPSLEDLFN+C R SLK+VLMLADQ+I RVE++H
Sbjct: 67 GGTGVPHLKWFGVEGEYSCMVIDLLGPSLEDLFNYCKRIFSLKSVLMLADQLICRVEYMH 126
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
S+ FLHRDIKPDNFLMGLGRRANQVYIID+GLAKKY+D T +HIPYRENKNLTGTARYA
Sbjct: 127 SRGFLHRDIKPDNFLMGLGRRANQVYIIDYGLAKKYKDLQTQKHIPYRENKNLTGTARYA 186
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 240
S+NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT + TS+E L
Sbjct: 187 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTSVETL 246
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
C+ YP+EF SYFHYCRSLRF+DKPDY+YL+R+FRDLFIREG+Q DYVFDWTI KY Q
Sbjct: 247 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLRRLFRDLFIREGYQLDYVFDWTISKYPQIGS 306
Query: 301 ATPPARALVPGAGTSGAPPAIASGDRQTGGGEEGRPAG 338
++ P P G PPA + G GR G
Sbjct: 307 SSRPRPTPRPALDPPG-PPAERAEKPTVGQDLRGRFTG 343
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| P42158 | KC1D_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8515 | 0.9066 | 0.82 | no | no |
| Q556Y4 | KC1_DICDI | 2, ., 7, ., 1, 1, ., 1 | 0.7108 | 0.7223 | 0.6901 | yes | no |
| P49674 | KC1E_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.6875 | 0.8009 | 0.7836 | yes | no |
| Q6QNM1 | KC1_TOXGO | 2, ., 7, ., 1, 1, ., 1 | 0.7249 | 0.7592 | 0.9537 | N/A | no |
| P35508 | KC1D_BOVIN | 2, ., 7, ., 1, 1, ., 2, 6 | 0.7785 | 0.7321 | 0.7180 | yes | no |
| Q6P3K7 | KC1DB_DANRE | 2, ., 7, ., 1, 1, ., 1 | 0.6594 | 0.8476 | 0.8435 | yes | no |
| Q7RBX5 | KC1_PLAYO | 2, ., 7, ., 1, 1, ., 1 | 0.7010 | 0.7149 | 0.9009 | N/A | no |
| Q5RC72 | KC1D_PONAB | 2, ., 7, ., 1, 1, ., 2, 6 | 0.7718 | 0.7321 | 0.7180 | yes | no |
| P29295 | HRR25_YEAST | 2, ., 7, ., 1, 1, ., 1 | 0.6666 | 0.7371 | 0.6072 | yes | no |
| P40235 | HHP1_SCHPO | 2, ., 7, ., 1, 1, ., 1 | 0.7773 | 0.7174 | 0.8 | yes | no |
| O76324 | DCO_DROME | 2, ., 7, ., 1, 1, ., 1 | 0.7254 | 0.7248 | 0.6704 | yes | no |
| Q8IHZ9 | KC1_PLAF7 | 2, ., 7, ., 1, 1, ., 1 | 0.7010 | 0.7149 | 0.9009 | yes | no |
| Q5ZLL1 | KC1E_CHICK | 2, ., 7, ., 1, 1, ., 1 | 0.6738 | 0.8353 | 0.8173 | yes | no |
| Q20471 | KIN20_CAEEL | 2, ., 7, ., 1, 1, ., 1 | 0.7366 | 0.7346 | 0.6016 | yes | no |
| Q6QNL9 | KC1_EIMTE | 2, ., 7, ., 1, 1, ., 1 | 0.7372 | 0.7199 | 0.8746 | N/A | no |
| Q5BP74 | KC1D_XENLA | 2, ., 7, ., 1, 1, ., 1 | 0.7751 | 0.7321 | 0.7180 | N/A | no |
| Q9JMK2 | KC1E_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.6630 | 0.8353 | 0.8173 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| gw1.145.30.1 | hypothetical protein (475 aa) | ||||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 407 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-47 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-36 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-34 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-28 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 7e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-20 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 2e-20 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-19 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-19 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-16 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-14 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-14 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 6e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-13 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-13 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-13 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-13 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-13 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-13 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-12 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-12 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-11 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-11 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-11 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-11 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-11 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 9e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-10 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-10 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-10 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-10 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-10 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-10 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-10 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-09 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-09 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-09 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-09 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-09 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-09 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-09 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-09 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-09 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-09 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-09 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-08 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-08 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-08 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-08 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-08 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-08 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-08 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-08 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-08 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-08 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-08 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-08 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-08 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-08 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-08 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-08 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-08 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-07 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-07 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-07 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 1e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-07 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-07 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-07 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-07 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-07 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-07 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-07 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-07 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-07 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-07 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-07 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-07 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-07 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-06 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-06 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-06 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-06 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-06 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-06 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-06 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-06 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-06 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-06 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-06 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-06 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-06 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-06 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-06 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-06 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-06 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-06 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-06 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 8e-06 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-06 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 9e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 9e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 9e-06 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 9e-06 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-05 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-05 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-05 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-05 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-05 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-05 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-05 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-05 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-05 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-05 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-05 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-05 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-05 | |
| COG2112 | 201 | COG2112, COG2112, Predicted Ser/Thr protein kinase | 7e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-04 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-04 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 1e-04 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-04 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-04 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-04 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-04 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-04 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-04 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-04 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-04 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-04 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-04 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-04 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-04 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-04 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-04 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-04 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-04 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-04 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-04 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-04 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-04 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 6e-04 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-04 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-04 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 9e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 0.001 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 0.001 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 0.001 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 0.001 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 0.001 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 0.001 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 0.001 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 0.001 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 0.001 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 0.001 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.002 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 0.002 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 0.002 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.002 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 0.002 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 0.002 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 0.003 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 0.003 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 0.004 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 0.004 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 2e-47
Identities = 71/260 (27%), Positives = 109/260 (41%), Gaps = 23/260 (8%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY----ESKLYRILQGGTG 64
+ L RK+GSGSFG +Y + T + VA+K+ +++ + E ++ R L
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 65 IPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVHSK 122
+ + F + D+ LVM+ DLF++ SR LS +A Q++ +E++HS
Sbjct: 61 VRLIDAF-EDKDHLYLVMEYCEGG--DLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN 117
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASM 182
+HRD+KP+N L+ V I DFGLAKK GT Y +
Sbjct: 118 GIIHRDLKPENILLD---ENGVVKIADFGLAKK-------LLKSSSSLTTFVGTPWYMAP 167
Query: 183 NTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241
L G + D+ SLG +L L G P+ G + Q +I +
Sbjct: 168 EVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWS 227
Query: 242 RGYPTEFASYFHYCRSLRFD 261
G E C L D
Sbjct: 228 SGSE-EAKDLIKKC--LNKD 244
|
Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 136 bits (342), Expect = 2e-36
Identities = 78/238 (32%), Positives = 119/238 (50%), Gaps = 11/238 (4%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTN--EEVAIKLENVKTKHPQLLYESKLYRILQGGTGI 65
+R+ RK+G GSFGE+YL + + + +A KLE+ + + L E ++ L I
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60
Query: 66 PNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSK 122
+ F + LVM+ + G SLEDL R LS L + Q+++ +E++HSK
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK 120
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASM 182
+HRDIKP+N L L R V +IDFGLAK D + IP + ++ GT Y +
Sbjct: 121 GIIHRDIKPENIL--LDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSV-GTPGYMAP 177
Query: 183 NTHLGIEQ---SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237
LG+ S D+ SLG L L G P++G K + + KI + + S+
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235
|
Length = 384 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 3e-34
Identities = 65/201 (32%), Positives = 103/201 (51%), Gaps = 22/201 (10%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLLYESKLYRILQGGTGIPN-VRW 70
+G G FG +YL + +T ++VAIK E+ + +LL E ++ + L PN V+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNH----PNIVKL 56
Query: 71 FGV--EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHR 127
+GV + ++ LVM+ G SL+DL KLS +L + Q++ +E++HS +HR
Sbjct: 57 YGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHR 116
Query: 128 DIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG 187
D+KP+N L L +V + DFGL+K K + GT Y + LG
Sbjct: 117 DLKPENIL--LDSDNGKVKLADFGLSKLLTSDK-------SLLKTIVGTPAYMAPEVLLG 167
Query: 188 I-EQSRRDDLESLGYVLMYFL 207
S + D+ SLG V++Y L
Sbjct: 168 KGYYSEKSDIWSLG-VILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-28
Identities = 69/234 (29%), Positives = 111/234 (47%), Gaps = 27/234 (11%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLLYESKLYRILQGGTGI 65
+ + K+G GSFG++YL + +T + VAIK + +K ++L E K+ + L+
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKH---- 56
Query: 66 PN-VRWFGV--EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
PN VR + V + D LVM+ G L DL +LS Q+++ +E++HS
Sbjct: 57 PNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKR-GRLSEDEARFYLRQILSALEYLHS 115
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181
K +HRD+KP+N L+ V + DFGLA++ GT Y +
Sbjct: 116 KGIVHRDLKPENILLD---EDGHVKLADFGLARQLDPGEKL--------TTFVGTPEYMA 164
Query: 182 MNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYEKISEKKVS 234
LG + D+ SLG V++Y L G P+ G + ++KI + K
Sbjct: 165 PEVLLGKGYGKAVDIWSLG-VILYELLTGKPPFPG--DDQLLELFKKIGKPKPP 215
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 7e-22
Identities = 63/221 (28%), Positives = 108/221 (48%), Gaps = 24/221 (10%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTK-HPQLLYESKLYRILQGGT 63
+++ G KIG G+FG++Y N+ T E +A I++++ K ++ E K+ +L+
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKH-- 58
Query: 64 GIPN-VRWFGVE-GDYNVLV-MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
PN V+++GVE V + M+ G +LE+L R L + + Q++ + ++
Sbjct: 59 --PNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYL 115
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN-KNLTGTAR 178
HS +HRDIKP N + + + DFG A K ++ +T E ++L GT
Sbjct: 116 HSHGIVHRDIKPANIFLD---HNGVIKLGDFGCAVKLKNNTT----TMGEEVQSLAGTPA 168
Query: 179 YASMNTHLGIEQS---RRDDLESLGYVLMYFLRGSLPWQGL 216
Y + G + R D+ SLG V++ G PW L
Sbjct: 169 YMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 1e-20
Identities = 68/289 (23%), Positives = 115/289 (39%), Gaps = 50/289 (17%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLY------RILQ 60
+ F+ G+ IG GSF + L +TN+E AIK+ + + QL+ E K+ +L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKR----QLIKEKKVKYVKIEKEVLT 56
Query: 61 GGTGIPN-VRWFGVEGD----YNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMI 113
G P ++ + D Y V++ G L+ + + S L K A +++
Sbjct: 57 RLNGHPGIIKLYYTFQDEENLY--FVLEYAPNGELLQYIRKYGS--LDEKCTRFYAAEIL 112
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK-------------KYRDTS 160
+E++HSK +HRD+KP+N L+ + + I DFG AK +
Sbjct: 113 LALEYLHSKGIIHRDLKPENILLD---KDMHIKITDFGTAKVLDPNSSPESNKGDATNID 169
Query: 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 220
+ R + GTA Y S + DL +LG ++ L G P++G
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRG---SN 226
Query: 221 KKQKYEKISE----------KKVSTSIEALCRGYPTEFASYFHYCRSLR 259
+ ++KI + IE L P + L+
Sbjct: 227 EYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK 275
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 2e-20
Identities = 79/298 (26%), Positives = 138/298 (46%), Gaps = 45/298 (15%)
Query: 6 GNKFRLGRKIGSGSFGEIY---LGTNIQTNEEVAIKLENVK--TKHPQLLYESKLYRI-- 58
G ++++ + IG G FG +Y ++ N + K+EN++ T + L + +Y I
Sbjct: 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDK 70
Query: 59 LQGGTGIPNVRWFGVEGDYNV------------LVMDLLGPSLEDLFN--FCSRKLSLKT 104
+ I N+ G+ Y ++++ L + +++F C K +K
Sbjct: 71 IALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKN 130
Query: 105 VLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164
++ M+ +E++H H DIKP+N ++ R YIID+G+A + +H
Sbjct: 131 IMK---DMLTTLEYIHEHGISHGDIKPENIMVDGNNRG---YIIDYGIASHF--IIHGKH 182
Query: 165 IPY-RENKNL-TGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT-- 220
I Y +E K+L GT YA ++ H G +RR DLESLGY ++ + LPW+G
Sbjct: 183 IEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL 242
Query: 221 ----KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRS-LRFDDKPDYAYLKRIF 273
K +++ E K+ +F F C + L +++KPDY L +IF
Sbjct: 243 IHAAKCDFIKRLHEGKIKIK-------NANKFIYDFIECVTKLSYEEKPDYDALIKIF 293
|
Length = 294 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 1e-19
Identities = 51/180 (28%), Positives = 93/180 (51%), Gaps = 21/180 (11%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLLYESKLYRILQGGTGI 65
F + KIG G FGE+Y + +T +EVAIK+ K K +++ E ++ + +
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKH---- 56
Query: 66 PN-VRWFG--VEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
PN V+++G ++ D +VM+ G SL+DL ++ L+ + + +++ +E++HS
Sbjct: 57 PNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS 116
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181
+HRDIK N L+ +V +IDFGL+ + DT + + GT + +
Sbjct: 117 NGIIHRDIKAANILLT---SDGEVKLIDFGLSAQLSDT--------KARNTMVGTPYWMA 165
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (216), Expect = 2e-19
Identities = 60/218 (27%), Positives = 94/218 (43%), Gaps = 27/218 (12%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKLYRILQGGT 63
++ G +G GSFG +YL + T E +A+K + L E ++ LQ
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQH-- 58
Query: 64 GIPN-VRWFGVEGD-----YNVLVMDLL-GPSLEDLF-NFCSRKLSLKTVLMLADQMINR 115
PN VR++G E D N + ++ + G SL L F KL + Q++
Sbjct: 59 --PNIVRYYGSERDEEKNTLN-IFLEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEG 113
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175
+ ++HS +HRDIK N L+ + DFG AK+ D T + ++ G
Sbjct: 114 LAYLHSNGIVHRDIKGANILVDSDGVVK---LADFGCAKRLGDIETGE-----GTGSVRG 165
Query: 176 TARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
T + + G E R D+ SLG ++ G PW
Sbjct: 166 TPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPW 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 6e-19
Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 31/216 (14%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGT 63
++++ +IG G+ G ++ + +T E VA+K ++ Q L E K + Q
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQH-- 58
Query: 64 GIPN-VRWFGV--EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
P V+ V G VLVM+ + L ++ R L V ++ V ++H
Sbjct: 59 --PYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH 116
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY----RDTSTHQHIP--YRENKNLT 174
+ +HRD+KP N L+ + I DFGLA+ + +HQ YR + L
Sbjct: 117 ANGIMHRDLKPANLLIS---ADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLY 173
Query: 175 GTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
G +Y G+ DL ++G + L GS
Sbjct: 174 GARKYDP-----GV------DLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (201), Expect = 3e-17
Identities = 43/156 (27%), Positives = 71/156 (45%), Gaps = 14/156 (8%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQ-LLYESKLYRILQGGTG 64
+ K+G G++G +Y + +T E VA+K L+N + P L E L + L+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKH--- 57
Query: 65 IPN-VRWFGVEGDYN--VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
PN V+ V LV + L+ + LS + + Q++ + + HS
Sbjct: 58 -PNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS 116
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157
LHRD+KP N L+ R + + DFGLA+ +
Sbjct: 117 HRILHRDLKPQNILIN---RDGVLKLADFGLARAFG 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 1e-16
Identities = 48/177 (27%), Positives = 80/177 (45%), Gaps = 36/177 (20%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----------HPQLLYESKLY 56
++ G+K+G G++ +Y + +T VAIK K K + L E KL
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIK----KIKLGERKEAKDGINFTALREIKLL 56
Query: 57 RILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLAD------ 110
+ L+ I + FG + + N LV + + LE + VL AD
Sbjct: 57 QELKHPNIIGLLDVFGHKSNIN-LVFEFMETDLEKVIK------DKSIVLTPADIKSYML 109
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKYRDTS---THQ 163
+ +E++HS LHRD+KP+N L+ ++ + + DFGLA+ + + THQ
Sbjct: 110 MTLRGLEYLHSNWILHRDLKPNNLLIA----SDGVLKLADFGLARSFGSPNRKMTHQ 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 5e-15
Identities = 46/154 (29%), Positives = 77/154 (50%), Gaps = 30/154 (19%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY-ESKLYRILQGGTGIPN-VRWF 71
KIG G+ GE+Y T+ T +EVAIK ++ ++ +L+ E + + + PN V ++
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKH----PNIVDYY 81
Query: 72 G--VEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRV--------EFVH 120
+ GD +VM+ + G SL D+ +++ + I V E++H
Sbjct: 82 DSYLVGDELWVVMEYMDGGSLTDIITQNFVRMN--------EPQIAYVCREVLQGLEYLH 133
Query: 121 SKSFLHRDIKPDNFLMGL-GRRANQVYIIDFGLA 153
S++ +HRDIK DN L+ G V + DFG A
Sbjct: 134 SQNVIHRDIKSDNILLSKDGS----VKLADFGFA 163
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (182), Expect = 1e-14
Identities = 44/169 (26%), Positives = 73/169 (43%), Gaps = 39/169 (23%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--------------LENVK-----TKHPQL 49
+++ +++G G+FG +YL N +T E VAIK L VK +HP +
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNI 60
Query: 50 LYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLF-NFCSRKLSLKTVLML 108
+ KL + E D V + + +L L + + S + +
Sbjct: 61 V---KLKEVF-------------RENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSI 104
Query: 109 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157
Q++ + +H F HRD+KP+N L+ V I DFGLA++ R
Sbjct: 105 IYQILQGLAHIHKHGFFHRDLKPENLLV---SGPEVVKIADFGLAREIR 150
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (175), Expect = 5e-14
Identities = 65/254 (25%), Positives = 104/254 (40%), Gaps = 77/254 (30%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT--------KHP---QLLY 51
+G GSFG++ L T + A+K +E+ T HP +L Y
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 52 ----ESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSR--KLSLK 103
E KLY LV++ G +LF+ S+ + S +
Sbjct: 61 AFQTEEKLY-----------------------LVLEYAPGG----ELFSHLSKEGRFSEE 93
Query: 104 TVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK--YRDTST 161
A +++ +E++HS ++RD+KP+N L L + + + DFGLAK+ + T
Sbjct: 94 RARFYAAEIVLALEYLHSLGIIYRDLKPENIL--LDADGH-IKLTDFGLAKELSSEGSRT 150
Query: 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGT 220
+ GT Y + LG + D SLG VL+Y L G P+ A
Sbjct: 151 NT---------FCGTPEYLAPEVLLGKGYGKAVDWWSLG-VLLYEMLTGKPPFY---AED 197
Query: 221 KKQKYEKISEKKVS 234
+K+ YEKI + +
Sbjct: 198 RKEIYEKILKDPLR 211
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 71.0 bits (175), Expect = 6e-14
Identities = 54/174 (31%), Positives = 82/174 (47%), Gaps = 22/174 (12%)
Query: 10 RLGRKIGSGSFGEIYLGTNIQTN----EEVAIK--LENVKTKHPQLLY-ESKLYRILQGG 62
LG+K+G G+FGE+Y G EVA+K E+ + + E+++ R L
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDH- 60
Query: 63 TGIPN-VRWFGV--EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 118
PN V+ GV E + +VM+ + G L KLSL +L A Q+ +E+
Sbjct: 61 ---PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEY 117
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT----STHQHIPYR 168
+ SK+F+HRD+ N L+G V I DFGL++ D +P R
Sbjct: 118 LESKNFIHRDLAARNCLVGEN---LVVKISDFGLSRDLYDDDYYRKRGGKLPIR 168
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 6e-14
Identities = 68/255 (26%), Positives = 99/255 (38%), Gaps = 58/255 (22%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKTKHPQLL------YESK 54
+ I G+FG +YL T + AIK + NVK + ++ Y +K
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61
Query: 55 LYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMI 113
LY Q DY LVM+ L G L L +++
Sbjct: 62 LYYSFQ-------------SKDYLYLVMEYLNGGDCASLIKTLG-GLPEDWAKQYIAEVV 107
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNL 173
VE +H + +HRDIKP+N L+ + + + DFGL++ ENK
Sbjct: 108 LGVEDLHQRGIIHRDIKPENLLID---QTGHLKLTDFGLSRN-----------GLENKKF 153
Query: 174 TGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI----- 228
GT Y + T LG+ + D SLG V+ FL G P+ A T ++ I
Sbjct: 154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFH---AETPDAVFDNILSRRI 210
Query: 229 ---SEKKVSTSIEAL 240
E K S EA+
Sbjct: 211 NWPEEVKEFCSPEAV 225
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 75/270 (27%), Positives = 111/270 (41%), Gaps = 54/270 (20%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLLYESKLYRILQGGTGIPN 67
R IG G GE+YL + + VA+K L + L E+K+ L GI
Sbjct: 8 RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI-HPGIVP 66
Query: 68 VRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSL----------KTVLMLADQMINRV 116
V +GD M + G +L+ L +K SL L + ++ +
Sbjct: 67 VYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATI 126
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK------------KYRDTSTHQH 164
E+VHSK LHRD+KPDN L+GL +V I+D+G A + +
Sbjct: 127 EYVHSKGVLHRDLKPDNILLGL---FGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183
Query: 165 ---IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 221
IP + + GT Y + LG+ S D+ +LG +L L S P+ +
Sbjct: 184 SMTIPGK----IVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY-------R 232
Query: 222 KQKYEKISEKKVSTSIEALCRGYPTEFASY 251
++K KIS + V S P E A Y
Sbjct: 233 RKKGRKISYRDVILS--------PIEVAPY 254
|
Length = 932 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 3e-13
Identities = 43/156 (27%), Positives = 78/156 (50%), Gaps = 13/156 (8%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPN- 67
F + K+G GS+G +Y + +T + VAIK+ V+ ++ K IL+ P
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEI---IKEISILK-QCDSPYI 60
Query: 68 VRWFG---VEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
V+++G D +VM+ G S+ D+ ++ L+ + + + Q + +E++HS
Sbjct: 61 VKYYGSYFKNTDL-WIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK 119
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
+HRDIK N L+ Q + DFG++ + DT
Sbjct: 120 KIHRDIKAGNILLN---EEGQAKLADFGVSGQLTDT 152
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (169), Expect = 4e-13
Identities = 49/186 (26%), Positives = 79/186 (42%), Gaps = 27/186 (14%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKH-PQLLYESKLYRILQGGT 63
K+ + ++IG GSFG++YL + +K L N+ K L E K+ + L
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNH-- 58
Query: 64 GIPN-VRWFG--VEGDYNVLVMDLL-GPSLEDLF---NFCSRKLSLKTVLMLADQMINRV 116
PN ++++ E +VM+ G L + + +L Q+ +
Sbjct: 59 --PNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116
Query: 117 EFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175
+++HS+ LHRDIKP N FL V + DFG++K T K + G
Sbjct: 117 KYLHSRKILHRDIKPQNIFLT----SNGLVKLGDFGISKVLSSTVDL-------AKTVVG 165
Query: 176 TARYAS 181
T Y S
Sbjct: 166 TPYYLS 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 4e-13
Identities = 44/162 (27%), Positives = 68/162 (41%), Gaps = 19/162 (11%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYR---ILQ-----GGTG 64
KIG G++G +Y + T E VAIK +K + R +L+
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIK--KIKLRFESEGIPKTALREIKLLKELNHPNIIK 62
Query: 65 IPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
+ +V F +GD LV + + L L R L + Q++ + F HS
Sbjct: 63 LLDV--FRHKGDL-YLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI 119
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR---DTSTHQ 163
LHRD+KP+N L+ + + DFGLA+ + TH
Sbjct: 120 LHRDLKPENLLI---NTEGVLKLADFGLARSFGSPVRPYTHY 158
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (169), Expect = 4e-13
Identities = 75/282 (26%), Positives = 124/282 (43%), Gaps = 51/282 (18%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQL-LYESKLYRILQGGTGIPNV 68
+IG G++G++Y N +T E VA+K +EN K P + E KL + L+ PN+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLR----HPNI 60
Query: 69 -RWFGV---EGDYNV-LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
R + +G ++ +V + + L L + K + + Q++ ++++HS
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG 120
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP------YRENKNLTGTA 177
LHRDIK N L+ + + DFGLA+ Y ++ + YR + L G
Sbjct: 121 ILHRDIKGSNILIN---NDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGAT 177
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237
RY + D+ S+G +L G +QG T+ ++ EKI E
Sbjct: 178 RYGP-----EV------DMWSVGCILAELFLGKPIFQG---STELEQLEKIFE------- 216
Query: 238 EALCRGYPTEFASYFHYCRSLRF--DDKPDYAYLKRIFRDLF 277
LC G PT+ + L + + KP Y KR R+ F
Sbjct: 217 --LC-GSPTD--ENWPGVSKLPWFENLKPKKPY-KRRLREFF 252
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (167), Expect = 7e-13
Identities = 52/170 (30%), Positives = 83/170 (48%), Gaps = 26/170 (15%)
Query: 9 FRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKLENVKTKHPQ---LLYESKLYRILQG 61
LG+K+G G+FGE+Y GT T +VA+K + L E+ + + L
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 62 GTGIPN-VRWFGV--EGDYNVLVMDL--LGPSLEDLFNF---CSRKLSLKTVLMLADQMI 113
PN VR GV +G+ +V + G DL +F KL+LK +L +A Q+
Sbjct: 61 ----PNIVRLLGVCTQGEPLYIVTEYMPGG----DLLDFLRKHGEKLTLKDLLQMALQIA 112
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163
+E++ SK+F+HRD+ N L+ V I DFGL++ + ++
Sbjct: 113 KGMEYLESKNFVHRDLAARNCLVT---ENLVVKISDFGLSRDIYEDDYYR 159
|
Length = 258 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-12
Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 35/229 (15%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-------QLLYESKLYRIL 59
+R G+ +G G+FG +YL ++ T E+A+K P L E +L + L
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 60 QGGTGIPNVRWFGVEGDYNVL--VMDLL-GPSLED-------LFNFCSRKLSLKTVLMLA 109
Q V+++G D L M+ + G S++D L +RK +
Sbjct: 62 QHER---IVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR------- 111
Query: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRE 169
Q++ VE++HS +HRDIK N L A V + DFG +K+ + +
Sbjct: 112 -QILEGVEYLHSNMIVHRDIKGANILRDS---AGNVKLGDFGASKRLQTICSSG----TG 163
Query: 170 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218
K++TGT + S G R+ D+ S+G ++ L PW +A
Sbjct: 164 MKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 2e-12
Identities = 54/177 (30%), Positives = 87/177 (49%), Gaps = 27/177 (15%)
Query: 10 RLGRKIGSGSFGEIYLGTNIQTN----EEVAIK--LENVKTKHPQLLY-ESKLYRILQGG 62
LG+K+G G+FGE+Y GT EVA+K E+ + + E+++ R L
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDH- 60
Query: 63 TGIPN-VRWFGV--EGDYNVLVMDLLGPSLEDLFNFC----SRKLSLKTVLMLADQMINR 115
PN V+ GV E + ++VM+ + DL ++ ++LSL +L A Q+
Sbjct: 61 ---PNIVKLLGVCTEEEPLMIVMEYM--PGGDLLDYLRKNRPKELSLSDLLSFALQIARG 115
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD----TSTHQHIPYR 168
+E++ SK+F+HRD+ N L+G V I DFGL++ D +P R
Sbjct: 116 MEYLESKNFIHRDLAARNCLVGEN---LVVKISDFGLSRDLYDDDYYKVKGGKLPIR 169
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (156), Expect = 2e-11
Identities = 71/246 (28%), Positives = 104/246 (42%), Gaps = 55/246 (22%)
Query: 13 RKIGSGSFGEIYLGT---NIQTNEEVAIKLENVKTKHP-----QLLYESKLYRILQGGTG 64
+K+G G+FGE+Y G EVA+K +K L E+++ + L G
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKT--LKEDASEEERKDFLKEARVMKKL----G 54
Query: 65 IPN-VRWFGV--EGDYNVLVM------DLLG---PSLEDLFNFCSRKLSLKTVLMLADQM 112
PN VR GV E + LV+ DLL S + LSLK +L A Q+
Sbjct: 55 HPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQI 114
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK-----YRDTSTHQHIPY 167
+E++ SK F+HRD+ N L+G V I DFGL++ Y T +P
Sbjct: 115 AKGMEYLASKKFVHRDLAARNCLVG---EDLVVKISDFGLSRDVYDDDYYRKKTGGKLPI 171
Query: 168 R----ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTK 221
R E S+ + +S D+ S G VL++ F G+ P+ GL
Sbjct: 172 RWMAPE-----------SLKDGIFTSKS---DVWSFG-VLLWEIFTLGATPYPGLSNEEV 216
Query: 222 KQKYEK 227
+ K
Sbjct: 217 LEYLRK 222
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 2e-11
Identities = 60/222 (27%), Positives = 95/222 (42%), Gaps = 27/222 (12%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK---TKHPQLLYESKLYRILQGGTGI 65
+ +G GS G +Y + T + A+K +V QLL E K R
Sbjct: 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRS----CES 58
Query: 66 PN-VRWFGV---EGDYNVLV--MDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
P V+ +G EG+ ++++ MD G SL DL K+ + +A Q++ ++++
Sbjct: 59 PYVVKCYGAFYKEGEISIVLEYMD--GGSLADLLKKV-GKIPEPVLAYIARQILKGLDYL 115
Query: 120 HSKS-FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 178
H+K +HRDIKP N L+ +V I DFG++K +T + GT
Sbjct: 116 HTKRHIIHRDIKPSNLLIN---SKGEVKIADFGISKVLENTLD-------QCNTFVGTVT 165
Query: 179 YASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 220
Y S G S D+ SLG L+ G P+ +
Sbjct: 166 YMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 45/160 (28%), Positives = 77/160 (48%), Gaps = 21/160 (13%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNE-----EVAIKLENVKTKH--PQLLYESKLYRILQ 60
++R G +GSGSFG +Y G N+ + EV++ + + QL E L LQ
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 61 GGTGIPN-VRWFGV---EGDYNVLVMDLLGPSLEDLF-NFCSRKLSLKTVLMLADQMINR 115
PN V++ G E + + + + G SL L + S + + + Q++
Sbjct: 61 H----PNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPV--IRLYTRQILLG 114
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155
+E++H ++ +HRDIK N L+ V + DFG+AK+
Sbjct: 115 LEYLHDRNTVHRDIKGANILV---DTNGVVKLADFGMAKQ 151
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 4e-11
Identities = 64/229 (27%), Positives = 106/229 (46%), Gaps = 21/229 (9%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKH--PQLLYESKLYRILQGGTGIPNVR 69
I G++G ++L T + AIK+ ++ K+ Q+L E IL V+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERD---ILSQAQSPYVVK 57
Query: 70 WF-GVEGDYNV-LVMDLL-GPSLEDLF-NFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 125
+ +G N+ LVM+ L G L L N S L + +++ +E++HS +
Sbjct: 58 LYYSFQGKKNLYLVMEYLPGGDLASLLENVGS--LDEDVARIYIAEIVLALEYLHSNGII 115
Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKK-YRDTSTHQHIPYRENKNLTGTARYASMNT 184
HRD+KPDN L+ + + DFGL+K + + +E+K + GT Y +
Sbjct: 116 HRDLKPDNILID---SNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 185 HLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233
LG S+ D SLG +L FL G P+ G T ++ ++ I K+
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLVGIPPFHG---ETPEEIFQNILNGKI 218
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 5e-11
Identities = 48/168 (28%), Positives = 78/168 (46%), Gaps = 22/168 (13%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTK-HPQLLYESKLYRILQGGT 63
++LG IG G+FG +Y G N++T + VAIK LE +K + ++ E L + L+
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKH-- 58
Query: 64 GIPN-VRWFGV--EGDYNVLVMDL-LGPSLEDL---FNFCSRKLSLKTVLMLADQMINRV 116
PN V++ G D ++++ SL + F L V Q++ +
Sbjct: 59 --PNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVY----QVLQGL 112
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164
++H + +HRDIK N L + V + DFG+A K D S
Sbjct: 113 AYLHEQGVIHRDIKAANILTT---KDGVVKLADFGVATKLNDVSKDDA 157
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 8e-11
Identities = 48/159 (30%), Positives = 70/159 (44%), Gaps = 17/159 (10%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQ-LLYESKLYRILQGGTGIPN-VR 69
IG G++G +Y ++ T VA+K V P L E L + L+ PN VR
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLES-FEHPNIVR 65
Query: 70 WFGVEGDYNV-------LVMDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHS 121
V LV + + L + C + L +T+ L Q++ V+F+HS
Sbjct: 66 LLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS 125
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160
+HRD+KP N L+ QV I DFGLA+ Y
Sbjct: 126 HRIVHRDLKPQNILVT---SDGQVKIADFGLARIYSFEM 161
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 9e-11
Identities = 50/186 (26%), Positives = 80/186 (43%), Gaps = 35/186 (18%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGI----- 65
G +G G++G++ + T + VAIK K K ++ + R L G GI
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIK----KVKIIEISNDVTKDRQLVGMCGIHFTTL 68
Query: 66 -----------PNV---RWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 111
N+ VEGD+ LVMD++ L+ + + R L+ V + Q
Sbjct: 69 RELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIR-LTESQVKCILLQ 127
Query: 112 MINRVEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKKY------RDTSTHQH 164
++N + +H F+HRD+ P N F+ G I DFGLA++Y S +
Sbjct: 128 ILNGLNVLHKWYFMHRDLSPANIFINSKG----ICKIADFGLARRYGYPPYSDTLSKDET 183
Query: 165 IPYREN 170
+ RE
Sbjct: 184 MQRREE 189
|
Length = 335 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 63/264 (23%), Positives = 100/264 (37%), Gaps = 52/264 (19%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN----VKTKHPQLLYESKLYRILQGG 62
+ F + + IG G+FGE++L + T + A+K+ +K + + IL
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERD--ILA-- 56
Query: 63 TGIPNVRW-------FGVEGDYNVLVMDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMI 113
+ W F E ++ LVM+ + DL N RK +T +++
Sbjct: 57 --DADSPWIVKLYYSFQDE-EHLYLVMEYMPGG--DLMNLLIRKDVFPEETARFYIAELV 111
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD--------------- 158
++ VH F+HRDIKPDN L+ + + DFGL KK
Sbjct: 112 LALDSVHKLGFIHRDIKPDNILID---ADGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168
Query: 159 --TSTHQHIPYRENKN-----LTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGS 210
+ + + GT Y + G D SLG V++Y L G
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLG-VILYEMLYGF 227
Query: 211 LPWQGLKAGTKKQKYEKISEKKVS 234
P + T ++ Y KI K S
Sbjct: 228 PP---FYSDTLQETYNKIINWKES 248
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 17/202 (8%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQL--LYESKLYRILQGGT 63
K+ R +G G+FG ++L + V IK V+ TK +L E ++ ++L
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 64 GIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFN-FCSRKLSLKTVLMLADQMINRVEFVHS 121
I F +E ++VM+ G +L + C+ L T+L Q++ + VH+
Sbjct: 61 IIEYYENF-LEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT 119
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181
K LHRD+K N L+ + V I DFG++K S + + GT Y S
Sbjct: 120 KLILHRDLKTQNILL--DKHKMVVKIGDFGISKILSSKS--------KAYTVVGTPCYIS 169
Query: 182 MNTHLGIEQSRRDDLESLGYVL 203
G +++ D+ +LG VL
Sbjct: 170 PELCEGKPYNQKSDIWALGCVL 191
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 47/168 (27%), Positives = 81/168 (48%), Gaps = 15/168 (8%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPN 67
K+ KIG G+ G +Y ++ T +EVAIK N++ + + L +++ + + PN
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKH--PN 77
Query: 68 VRWF---GVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
+ + + GD +VM+ L G SL D+ + + + + + +EF+HS
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSNQ 135
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFG----LAKKYRDTSTHQHIPY 167
+HRDIK DN L+G+ V + DFG + + ST PY
Sbjct: 136 VIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPY 180
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 44/156 (28%), Positives = 76/156 (48%), Gaps = 21/156 (13%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGI-- 65
+ L ++IGSG++G++Y +I T E VAIK+ +K L + I+Q +
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKV--IK------LEPGDDFEIIQQEISMLK 55
Query: 66 ----PN-VRWFG--VEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
PN V +FG + D +VM+ G SL+D++ LS + + + + +
Sbjct: 56 ECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLA 115
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
++H +HRDIK N L+ V + DFG++
Sbjct: 116 YLHETGKIHRDIKGANILL---TEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 50/194 (25%), Positives = 78/194 (40%), Gaps = 37/194 (19%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHP-QLLYESKLYRILQGGTG 64
+ + K+G G+FGE+Y I+T VA+K + N K P L E K+ + L+
Sbjct: 10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNV 69
Query: 65 IPNVRWFGVEGD---------YNVL---VMDLLG----PSLEDLFNFCSRKLSLKTVLML 108
+P + D Y V DL G PS++ K +
Sbjct: 70 VPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK--LTESQIKCYML----- 122
Query: 109 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYR 168
Q++ + ++H LHRDIK N L+ + I DFGLA+ Y P
Sbjct: 123 --QLLEGINYLHENHILHRDIKAANILID---NQGILKIADFGLARPYDGP-----PPNP 172
Query: 169 ENKNLTGTARYASM 182
+ GT +Y ++
Sbjct: 173 KGGGGGGTRKYTNL 186
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 43/162 (26%), Positives = 81/162 (50%), Gaps = 20/162 (12%)
Query: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKLYRILQGGTG 64
F L IG G++G++Y + +T + VAIK ++ ++ + ++ E Y IL+ +
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEE---YNILRKYSN 61
Query: 65 IPNV-RWFGV--------EGDYNVLVMDLL-GPSLEDLFN---FCSRKLSLKTVLMLADQ 111
PN+ ++G D LVM+L G S+ DL ++L + + + +
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
+ + ++H +HRDIK N L L + A +V ++DFG++
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNIL--LTKNA-EVKLVDFGVS 160
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 4e-10
Identities = 63/219 (28%), Positives = 95/219 (43%), Gaps = 31/219 (14%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN----VKTKHPQLLYESKLYRILQGGTG 64
F L R IG G+FG++ + T + A+K N V+ + + + RILQ
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNER--RILQELNH 59
Query: 65 --IPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLK--TVLMLADQMINRVEFVH 120
+ N+ + + + LV+DLL DL S+K+ V +++ +E++H
Sbjct: 60 PFLVNLWYSFQDEENMYLVVDLLLGG--DLRYHLSQKVKFSEEQVKFWICEIVLALEYLH 117
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT---GTA 177
SK +HRDIKPDN L+ V+I DF +A K + T GT
Sbjct: 118 SKGIIHRDIKPDNILLD---EQGHVHITDFNIATKVTP-----------DTLTTSTSGTP 163
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQG 215
Y + S D SLG V Y LRG P++G
Sbjct: 164 GYMAPEVLCRQGYSVAVDWWSLG-VTAYECLRGKRPYRG 201
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 7e-10
Identities = 65/240 (27%), Positives = 111/240 (46%), Gaps = 37/240 (15%)
Query: 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKL-------ENVKTKHPQLL----YESKLYRILQ 60
G IGSGSFG +YLG N + E +A+K + K + +L E L + LQ
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 61 GGTGIPN-VRWFG--VEGDY-NVLVMDLLGPSLEDLFN-FCSRKLSLKTVLMLADQMINR 115
N V++ G ++ D+ N+ + + G S+ L N + + + +L V Q++
Sbjct: 65 H----ENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETL--VRNFVRQILKG 118
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR----DTSTHQHIPYRENK 171
+ ++H++ +HRDIK N L+ + I DFG++KK T T+ P
Sbjct: 119 LNYLHNRGIIHRDIKGANILVD---NKGGIKISDFGISKKLEANSLSTKTNGARP----- 170
Query: 172 NLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 231
+L G+ + + +R+ D+ SLG +++ L G P+ T+ Q KI E
Sbjct: 171 SLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC---TQLQAIFKIGEN 227
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 60/232 (25%), Positives = 105/232 (45%), Gaps = 26/232 (11%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN----VKTKHPQLLYESKLYRILQGGTG 64
+ +G+G+FG ++L + + A+K+ ++ K Q ++ K R+L+ +
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEK--RVLKEVSH 60
Query: 65 IPNVRWFGVEGDYNVLVMDLLGPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHSK 122
+R F E D L M + +LF++ S + S T L A +++ +E++HSK
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD-TSTHQHIPYRENKNLTGTARYAS 181
++RD+KP+N L+ + + + DFG AKK RD T T L GT Y +
Sbjct: 121 EIVYRDLKPENILLD---KEGHIKLTDFGFAKKLRDRTWT-----------LCGTPEYLA 166
Query: 182 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233
++ D +LG ++ L G P+ YEKI K+
Sbjct: 167 PEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD---DNPFGIYEKILAGKL 215
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 53/182 (29%), Positives = 86/182 (47%), Gaps = 21/182 (11%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTKHPQL-LYESKLYRILQGGTGIPNVR 69
KIG G++G +Y + TNE +A I+LE P + E L + +Q G VR
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN---IVR 65
Query: 70 WFGV-EGDYNV-LVMDLLGPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSF 124
V + + LV + L L+ + ++ L + Q++ + + HS
Sbjct: 66 LQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLY--QILRGIAYCHSHRV 123
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR---DTSTHQHIP--YRENKNLTGTARY 179
LHRD+KP N L + RR N + + DFGLA+ + T TH+ + YR + L G+ Y
Sbjct: 124 LHRDLKPQNLL--IDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHY 181
Query: 180 AS 181
++
Sbjct: 182 ST 183
|
Length = 294 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 2e-09
Identities = 38/151 (25%), Positives = 59/151 (39%), Gaps = 28/151 (18%)
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGL-GRRANQVYIIDFGLAKK-YRDTSTHQHIPYR 168
++ E++H++ ++RD+KP+N L+ G V ++DFG AKK T
Sbjct: 101 CVVLAFEYLHNRGIIYRDLKPENLLLDSNGY----VKLVDFGFAKKLKSGQKTW------ 150
Query: 169 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKA--------- 218
GT Y + L D SLG +L+Y L G P+
Sbjct: 151 ---TFCGTPEYVAPEIILNKGYDFSVDYWSLG-ILLYELLTGRPPFGEDDEDPMEIYNDI 206
Query: 219 --GTKKQKYEKISEKKVSTSIEALCRGYPTE 247
G K ++ +K I+ L R P E
Sbjct: 207 LKGNGKLEFPNYIDKAAKDLIKQLLRRNPEE 237
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 47/162 (29%), Positives = 73/162 (45%), Gaps = 15/162 (9%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKL-----ENVKTKHPQLLYESKLYRILQGGTGIPN- 67
+IG GSFG +Y TN TNE VA+K + K ++ E K + L+ PN
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKH----PNT 83
Query: 68 VRWFG--VEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 125
+ + G ++ LVM+ S DL + L + + + + ++HS + +
Sbjct: 84 IEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMI 143
Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPY 167
HRDIK N L+ QV + DFG A K ++ PY
Sbjct: 144 HRDIKAGNILL---TEPGQVKLADFGSASKSSPANSFVGTPY 182
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (141), Expect = 2e-09
Identities = 41/171 (23%), Positives = 73/171 (42%), Gaps = 44/171 (25%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKT------------------KHPQ 48
++ L + IGSG++G + + +T +VAIK + NV +H
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 49 LLYESKLYRILQGGTGIPNVRWFGVEGDYNVL--VMDLLGPSLEDLFNFCSRKLSLKTVL 106
++ L IL P D+N + V +L+ L + + L+ +
Sbjct: 61 II---GLLDIL-----RPPSP-----EDFNDVYIVTELMETDLHKVIK-SPQPLTDDHIQ 106
Query: 107 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN---QVYIIDFGLAK 154
Q++ ++++HS + +HRD+KP N L N + I DFGLA+
Sbjct: 107 YFLYQILRGLKYLHSANVIHRDLKPSNIL------VNSNCDLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 33/217 (15%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLLYESKLYRI----LQGG 62
++LG IG+GSFG +Y I T+E+VAIK L++ + K+ +LL L I L+
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDY 127
Query: 63 TGIPNVRWFGVEGDYNV---LVMDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRV 116
+ + + N+ +VM+ + ++ +R L L V + + Q+ +
Sbjct: 128 YYTECFK----KNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRAL 183
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY----RDTSTHQHIPYRENKN 172
++HSK HRD+KP N L + + + + DFG AK R S YR +
Sbjct: 184 AYIHSKFICHRDLKPQNLL--IDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPEL 241
Query: 173 LTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRG 209
+ G Y TH+ DL SLG ++ + G
Sbjct: 242 MLGATNYT---THI--------DLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 41/167 (24%), Positives = 75/167 (44%), Gaps = 26/167 (15%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHP----------QLLYES 53
+K+ KIG G+FGE++ + +T + VA+K +EN K P QLL
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHE 71
Query: 54 KLYRILQ----GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLA 109
+ +++ T + G + LV + L L + + K +L + +
Sbjct: 72 NVVNLIEICRTKATPYNRYK-----GSF-YLVFEFCEHDLAGLLSNKNVKFTLSEIKKVM 125
Query: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
++N + ++H LHRD+K N L+ + + + DFGLA+ +
Sbjct: 126 KMLLNGLYYIHRNKILHRDMKAANILI---TKDGILKLADFGLARAF 169
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 4e-09
Identities = 48/163 (29%), Positives = 85/163 (52%), Gaps = 18/163 (11%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT-NIQTNEEVAIKLENVKTKHPQ-LLYESKLYRILQ 60
PR +L RK+G+G FGE+++GT N T +VA+K T P+ L E+++ + L+
Sbjct: 4 PR--ESLKLERKLGAGQFGEVWMGTWNGTT--KVAVKTLKPGTMSPEAFLQEAQIMKKLR 59
Query: 61 GGTGIPN-VRWFGV--EGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
V+ + V E + +V + + G L+ L + +KL L ++ +A Q+
Sbjct: 60 H----DKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEG 115
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158
+ ++ S++++HRD+ N L+G I DFGLA+ D
Sbjct: 116 MAYLESRNYIHRDLAARNILVGEN---LVCKIADFGLARLIED 155
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 4e-09
Identities = 43/170 (25%), Positives = 77/170 (45%), Gaps = 22/170 (12%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQL--LYESKLYRILQGGTGI 65
+++ KIG G+F E+ + +T + AIK ++ Q+ L E + R L +
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRL---SPH 57
Query: 66 PNVRWFGVEGDYN------VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
PN+ +E ++ LV +L+ +L +L R L K V Q++ ++ +
Sbjct: 58 PNILRL-IEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHM 116
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRE 169
H HRDIKP+N L+ + + + + DFG + + PY E
Sbjct: 117 HRNGIFHRDIKPENILI----KDDILKLADFGSCR-----GIYSKPPYTE 157
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 4e-09
Identities = 52/211 (24%), Positives = 97/211 (45%), Gaps = 20/211 (9%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPN 67
K+ KIG G+ G +Y ++ T +EVAI+ N++ + + L +++ + + PN
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN--PN 78
Query: 68 VRWF---GVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
+ + + GD +VM+ L G SL D+ + + + + + +EF+HS
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN-LTGTARYASM 182
+HRDIK DN L+G+ V + DFG Q P + ++ + GT + +
Sbjct: 137 VIHRDIKSDNILLGMD---GSVKLTDFGFCA--------QITPEQSKRSTMVGTPYWMAP 185
Query: 183 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
+ D+ SLG + + + G P+
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 4e-09
Identities = 43/165 (26%), Positives = 76/165 (46%), Gaps = 22/165 (13%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLLYESKLYRILQGGT 63
F L IG GSFGE+Y + +TN+ VAIK LE + + + E + +
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCR--- 57
Query: 64 GIPNV-RWFG-VEGDYNV-LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
P + +++G + ++M+ G S DL KL + + +++ +E++
Sbjct: 58 -SPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLK--PGKLDETYIAFILREVLLGLEYL 114
Query: 120 HSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLAKKYRDTST 161
H + +HRDIK N L+ G V + DFG++ + T +
Sbjct: 115 HEEGKIHRDIKAANILLSEEG------DVKLADFGVSGQLTSTMS 153
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 5e-09
Identities = 66/281 (23%), Positives = 120/281 (42%), Gaps = 52/281 (18%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLLYESKLYRILQGGTGIP 66
F L RK+GSG FGE++ G + VAIK+ + K E + + L+ I
Sbjct: 8 FTLERKLGSGYFGEVWEGL-WKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI- 65
Query: 67 NVRWFGV--EGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
F V G+ ++ +L+ G L L + + L + +++ +A Q+ + ++ +
Sbjct: 66 --SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT--STHQH-IPYRENKNLTGTARY 179
+ +HRD+ N L+G + DFGLA+ ++ + IPY+ TA
Sbjct: 124 NSIHRDLAARNILVGEDLVCK---VADFGLARLIKEDVYLSSDKKIPYK------WTAPE 174
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237
A+ + S + D+ S G +L+Y F G +P+ G+ + Y++I+
Sbjct: 175 AASHGTF----STKSDVWSFG-ILLYEMFTYGQVPYPGM---NNHEVYDQIT-------- 218
Query: 238 EALCRGY--------PTEFASYFHYCRSLRFDDKPDYAYLK 270
GY P E C + +D+P + L+
Sbjct: 219 ----AGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALR 255
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 56.7 bits (136), Expect = 5e-09
Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ---LLYESKLYRILQGGTG 64
K+ KIG G+ G ++ ++ T +EVAIK N++ K P+ ++ E + + L+
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ-KQPKKELIINEILVMKELKN--- 75
Query: 65 IPNVRWF---GVEGDYNVLVMDLL-GPSLEDLFN-FCSRKLSLKTVLMLADQMINRVEFV 119
PN+ F + GD +VM+ L G SL D+ C + + V + + +EF+
Sbjct: 76 -PNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAV---CRECLQALEFL 131
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN-LTGTAR 178
H+ +HRDIK DN L+G+ V + DFG Q P + ++ + GT
Sbjct: 132 HANQVIHRDIKSDNVLLGM---DGSVKLTDFGFCA--------QITPEQSKRSTMVGTPY 180
Query: 179 YASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
+ + + D+ SLG + + + G P+
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 6e-09
Identities = 67/277 (24%), Positives = 118/277 (42%), Gaps = 25/277 (9%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LLYESKLYRILQG 61
PR RL K+G G FGE+++GT T + VAIK T P+ L E+++ + L+
Sbjct: 4 PR--ESLRLDVKLGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEAQIMKKLRH 60
Query: 62 GTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
+P E Y V G L+ L + L L ++ +A Q+ + + ++
Sbjct: 61 DKLVPLYAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER 120
Query: 122 KSFLHRDIKPDNFLMGLGRRANQV-YIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
+++HRD++ N L+G N V I DFGLA+ D Y + ++
Sbjct: 121 MNYIHRDLRAANILVG----DNLVCKIADFGLARLIEDNE------YTARQGAKFPIKWT 170
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239
+ L + + D+ S G +L + +G +P+ G+ ++ E +V
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM---VNREVLE-----QVERGYRM 222
Query: 240 LC-RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 275
C +G P C D++P + Y++ D
Sbjct: 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 6e-09
Identities = 43/149 (28%), Positives = 67/149 (44%), Gaps = 10/149 (6%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTKHP-QLLYESKLYRILQGGTGIPNVR 69
+I G++G +Y + +T E VA +K+E K P L E + LQ I V+
Sbjct: 12 RIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQH-PNIVTVK 70
Query: 70 --WFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHR 127
G D +VM+ + L+ L + V L Q+++ V +H LHR
Sbjct: 71 EVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHR 130
Query: 128 DIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
D+K N L+ + I DFGLA++Y
Sbjct: 131 DLKTSNLLL---NNRGILKICDFGLAREY 156
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 6e-09
Identities = 53/211 (25%), Positives = 97/211 (45%), Gaps = 20/211 (9%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPN 67
K+ KIG G+ G +Y +I T +EVAIK N++ + + L +++ + + PN
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKN--PN 77
Query: 68 VRWF---GVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
+ + + GD +VM+ L G SL D+ + + + + + ++F+HS
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALDFLHSNQ 135
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN-LTGTARYASM 182
+HRDIK DN L+G+ V + DFG Q P + ++ + GT + +
Sbjct: 136 VIHRDIKSDNILLGMD---GSVKLTDFGFCA--------QITPEQSKRSTMVGTPYWMAP 184
Query: 183 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
+ D+ SLG + + + G P+
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 7e-09
Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 21/209 (10%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFG- 72
+IG GSFGE+Y G + +T E VAIK+ +++ ++ + +L R++G
Sbjct: 11 RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70
Query: 73 -VEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 130
++G ++M+ L G S DL L + + +++ ++++HS+ +HRDIK
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLK--PGPLEETYIATILREILKGLDYLHSERKIHRDIK 128
Query: 131 PDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ 190
N L+ V + DFG+A + DT ++ GT + + I+Q
Sbjct: 129 AANVLLS---EQGDVKLADFGVAGQLTDTQIKRN-------TFVGTPFWMAPEV---IKQ 175
Query: 191 SRRD---DLESLGYVLMYFLRGSLPWQGL 216
S D D+ SLG + +G P L
Sbjct: 176 SAYDFKADIWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 8e-09
Identities = 45/155 (29%), Positives = 74/155 (47%), Gaps = 24/155 (15%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQ-------LLYESKLYRILQGGT 63
KIG G++G ++ N +T+E VA+K L++ P LL E K I
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI----- 61
Query: 64 GIPNVRWFGV-EGDYNV-LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
VR + V D + LV + L+ F+ C+ + + V Q++ + F HS
Sbjct: 62 ----VRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS 117
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
+ LHRD+KP N L+ + ++ + DFGLA+ +
Sbjct: 118 HNVLHRDLKPQNLLI---NKNGELKLADFGLARAF 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 43/160 (26%), Positives = 78/160 (48%), Gaps = 23/160 (14%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESK-----------LYRILQGGT 63
+GSG+FG +Y + N + + L+ + +P + + I++
Sbjct: 8 LGSGAFGCVY-KVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 64 GIPN-VRWFG--VEGDYNVLVMDLL-GPSLEDLFNFCSRK---LSLKTVLMLADQMINRV 116
PN VR++ +E D +VMDL+ G L + FN K + + + + QM+ +
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 117 EFVH-SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155
++H K +HRD+ P+N ++G ++V I DFGLAK+
Sbjct: 127 RYLHKEKRIVHRDLTPNNIMLG---EDDKVTITDFGLAKQ 163
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 54/198 (27%), Positives = 85/198 (42%), Gaps = 55/198 (27%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVA---IKLEN----------------VKTKHPQ------ 48
KIG G++G +Y G N +T + VA I+LE+ + +HP
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 49 -LLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLM 107
L+ ES+LY I + L MDL L+ L + + + V
Sbjct: 67 VLMQESRLYLI------------------FEFLSMDL-KKYLDSLPK--GQYMDAELVKS 105
Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR---DTSTHQH 164
Q++ + F HS+ LHRD+KP N L+ + + DFGLA+ + TH+
Sbjct: 106 YLYQILQGILFCHSRRVLHRDLKPQNLLID---NKGVIKLADFGLARAFGIPVRVYTHEV 162
Query: 165 IP--YRENKNLTGTARYA 180
+ YR + L G+ RY+
Sbjct: 163 VTLWYRAPEVLLGSPRYS 180
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 56/203 (27%), Positives = 87/203 (42%), Gaps = 44/203 (21%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHP-QLLYESKLYRILQGG 62
+KF + +IG G++G++Y + T E VA+K L+N K P + E K+ R L
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNH- 65
Query: 63 TGIPNV--------------------RWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSL 102
N+ F + +Y + DL+G L +F S
Sbjct: 66 ---RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEY--MDHDLMGLLESGLVHF-----SE 115
Query: 103 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS-- 160
+ Q++ + + H K+FLHRDIK N L+ Q+ + DFGLA+ Y
Sbjct: 116 DHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLN---NKGQIKLADFGLARLYNSEESR 172
Query: 161 --THQHIP--YRENKNLTGTARY 179
T++ I YR + L G RY
Sbjct: 173 PYTNKVITLWYRPPELLLGEERY 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 69/281 (24%), Positives = 116/281 (41%), Gaps = 28/281 (9%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----LENVKTKHPQ-LLYESKLYRILQGGT 63
F++ +KIG G F E+Y T + + VA+K E + K Q + E L + L
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 64 GIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSL---KTVLMLADQMINRVEFVH 120
I + F + + N+++ L + + ++ L +TV Q+ + VE +H
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 121 SKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
S+ +HRDIKP N F+ G V + D GL + + +T H +L GT Y
Sbjct: 124 SRRVMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAH-------SLVGTPYY 172
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG--TKKQKYEKISEKKVSTSI 237
S + + D+ SLG +L P+ G K + QK E+ + T
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPT-- 230
Query: 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278
Y + C D +PD Y+ +I + + +
Sbjct: 231 ----EHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMHV 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 49/200 (24%), Positives = 87/200 (43%), Gaps = 23/200 (11%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY----ESKLYRILQGGTGIPN- 67
R +G G+FGE L + + V K N+ + E + +LQ PN
Sbjct: 6 RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQH----PNI 61
Query: 68 VRWFGVEGDYNVLVMDLL---GPSLEDLFNFCSRKL-SLKTVLMLADQMINRVEFVHSKS 123
+ ++ D N L++++ G +L D +L + VL Q+++ V ++H
Sbjct: 62 IAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG 121
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMN 183
LHRDIK N + +A + + DFG++K + + + GT Y S
Sbjct: 122 ILHRDIKTLNIFL---TKAGLIKLGDFGISKILGSEYSMA-------ETVVGTPYYMSPE 171
Query: 184 THLGIEQSRRDDLESLGYVL 203
G++ + + D+ +LG VL
Sbjct: 172 LCQGVKYNFKSDIWALGCVL 191
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 43/155 (27%), Positives = 74/155 (47%), Gaps = 20/155 (12%)
Query: 13 RKIGSGSFGEIYLGT----NIQTNEEVAIKLENVKTKHPQ---LLYESKLYRILQGGTGI 65
+++G G FG++ L T E+VA+K N + E ++ R L
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDH---- 65
Query: 66 PN-VRWFGV-EGDYNV---LVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
N V++ GV E L+M+ L SL D +++LK +L+ + Q+ ++++
Sbjct: 66 ENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYL 125
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
S+ ++HRD+ N L+ + V I DFGLAK
Sbjct: 126 GSQRYIHRDLAARNILV---ESEDLVKISDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 2e-08
Identities = 43/162 (26%), Positives = 80/162 (49%), Gaps = 22/162 (13%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP--QLLYESKLYRIL--------QGG 62
+GSG++G + + + ++VA+K K P L++ + YR L +
Sbjct: 21 TPVGSGAYGSVCSAYDTRLRQKVAVK----KLSRPFQSLIHARRTYRELRLLKHMKHENV 76
Query: 63 TGIPNVRWFGVEG-DYN--VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
G+ +V ++N LV +L+G L ++ +KLS + V L Q++ ++++
Sbjct: 77 IGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYI 134
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161
HS +HRD+KP N + ++ I+DFGLA++ D T
Sbjct: 135 HSAGIIHRDLKPSNVAVN---EDCELRILDFGLARQADDEMT 173
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 3e-08
Identities = 44/159 (27%), Positives = 71/159 (44%), Gaps = 7/159 (4%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYES--KLYRILQGGTGIPNVRW 70
R+IG GSFG +Y +++TNE VAIK + K ++ K + LQ ++ +
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 71 FG--VEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRD 128
G + LVM+ S DL + L + + + + ++HS + +HRD
Sbjct: 91 KGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 150
Query: 129 IKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPY 167
IK N L+ QV + DFG A ++ PY
Sbjct: 151 IKAGNILL---TEPGQVKLADFGSASIASPANSFVGTPY 186
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 3e-08
Identities = 43/155 (27%), Positives = 70/155 (45%), Gaps = 14/155 (9%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-------ENVKTKHPQLLYESKLYRIL 59
NK+ + +G G++G + N T E VAIK E+VK L E K+ R L
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKT---ALREVKVLRQL 57
Query: 60 QGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
+ + F +G LV + + +L +L L V Q++ + +
Sbjct: 58 RHENIVNLKEAFRRKGRL-YLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYC 116
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
HS + +HRDIKP+N L+ + + + DFG A+
Sbjct: 117 HSHNIIHRDIKPENILV---SESGVLKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 3e-08
Identities = 53/182 (29%), Positives = 83/182 (45%), Gaps = 22/182 (12%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTKHPQL-LYESKLYRILQGGTGIPN-V 68
KIG G++G +Y + T E VA I+LE P + E L + L PN V
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNH----PNIV 61
Query: 69 RWFGV-EGDYNV-LVMDLLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSFL 125
R V + + LV + L L+ + L + Q++ + + HS L
Sbjct: 62 RLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVL 121
Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKY----RDTSTHQHIP--YRENKNLTGTARY 179
HRD+KP N L+ R + + DFGLA+ + R T TH+ + YR + L G+ +Y
Sbjct: 122 HRDLKPQNLLID---REGALKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEILLGSRQY 177
Query: 180 AS 181
++
Sbjct: 178 ST 179
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 74/276 (26%), Positives = 123/276 (44%), Gaps = 35/276 (12%)
Query: 13 RKIGSGSFGEIYLGTNIQTNE---EVAIKL---ENVKTKHPQLLYESKLYRILQGGTGIP 66
+++G G+FG + G + + EVA+K E++ + L E+ + L P
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDH----P 56
Query: 67 N-VRWFGV-EGDYNVLVMDL--LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
VR GV +G+ +LVM+L LGP L+ L R++ + + LA Q+ + ++ SK
Sbjct: 57 CIVRLIGVCKGEPLMLVMELAPLGPLLKYLKK--RREIPVSDLKELAHQVAMGMAYLESK 114
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR-YAS 181
F+HRD+ N L L R +Q I DFG+++ S + YR + YA
Sbjct: 115 HFVHRDLAARNVL--LVNR-HQAKISDFGMSRALGAGSDY----YRATTAGRWPLKWYAP 167
Query: 182 MNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239
+ G S + D+ S G V ++ F G+ P+ +K + + E
Sbjct: 168 ECINYGK-FSSKSDVWSYG-VTLWEAFSYGAKPYGEMKG----AEVIAMLESGERLPRPE 221
Query: 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 275
C P E S C R +D+P ++ L+ FR
Sbjct: 222 EC---PQEIYSIMLSCWKYRPEDRPTFSELESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 45/151 (29%), Positives = 73/151 (48%), Gaps = 15/151 (9%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKLYRILQGGTGIPN-V 68
LG IG G FG++ LG ++VA+K L++ T L E+ + L+ PN V
Sbjct: 10 LGATIGKGEFGDVMLGD--YRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRH----PNLV 63
Query: 69 RWFGV--EGDYNVLVMDLLGP-SLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSF 124
+ GV +G+ +V + + SL D R ++L L A + +E++ K+F
Sbjct: 64 QLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNF 123
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155
+HRD+ N L+ + DFGLAK+
Sbjct: 124 VHRDLAARNVLVS---EDLVAKVSDFGLAKE 151
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 4e-08
Identities = 64/236 (27%), Positives = 109/236 (46%), Gaps = 48/236 (20%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGI-----PN 67
KIG G+FG++Y G ++ N EVA+K ++ P L + LQ + PN
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVK--TCRSTLPPDLKR----KFLQEAEILKQYDHPN 53
Query: 68 -VRWFGVEGDYN--VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
V+ GV +VM+L+ G SL +L++K +L ++ +E++ SK+
Sbjct: 54 IVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN 113
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK-----YRDTSTHQHIPYR----ENKNLT 174
+HRD+ N L+G N + I DFG++++ Y + + IP + E N
Sbjct: 114 CIHRDLAARNCLVGEN---NVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALN-- 168
Query: 175 GTARYASMNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKI 228
RY S + D+ S G +L++ F G P+ G+ + +Q E+I
Sbjct: 169 -YGRYTSES-----------DVWSYG-ILLWETFSLGDTPYPGM---SNQQTRERI 208
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 4e-08
Identities = 47/218 (21%), Positives = 95/218 (43%), Gaps = 33/218 (15%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKT---------KHPQLLYESKLYRILQGGTGI 65
IG G++G +Y G ++ T VA+K+ N+ T + LL + + +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQ-------SQP 61
Query: 66 PNV-RWFG--VEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
PN+ +++G ++G ++M+ G S+ L + ++ K + ++ +++ ++++H
Sbjct: 62 PNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMK--AGPIAEKYISVIIREVLVALKYIHK 119
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181
+HRDIK N L+ V + DFG+A S + GT + +
Sbjct: 120 VGVIHRDIKAANILV---TNTGNVKLCDFGVAALLNQNS-------SKRSTFVGTPYWMA 169
Query: 182 MNTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218
G + D+ SLG + G+ P+ + A
Sbjct: 170 PEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA 207
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 53/182 (29%), Positives = 79/182 (43%), Gaps = 25/182 (13%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLLYESKLYRILQGGT 63
+ + L IG G+ +Y + NE+VAIK LE +T +L E +
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNH-- 58
Query: 64 GIPN-VRWFG--VEGDYNVLVMDLL-GPSLEDLFNFCSRK-----LSLKTVLMLADQMIN 114
PN V+++ V GD LVM L G SL D+ + + TVL +++
Sbjct: 59 --PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL---KEVLK 113
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174
+E++HS +HRDIK N L+G V I DFG++ D + K
Sbjct: 114 GLEYLHSNGQIHRDIKAGNILLG---EDGSVKIADFGVSASLADGGDRTR---KVRKTFV 167
Query: 175 GT 176
GT
Sbjct: 168 GT 169
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 4e-08
Identities = 56/230 (24%), Positives = 96/230 (41%), Gaps = 41/230 (17%)
Query: 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGI------ 65
G IG G++G +YL N+ T E +A+K + + P + R +
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVK----QVELPATIAGRHDSRQKDMVKALRSEIET 61
Query: 66 ------PN-VRWFGVEG---DYNVLVMDLLGPSLEDLFNFCSR---KLSLKTVLMLADQM 112
N V++ G E ++ + + G S+ C R + + V +Q+
Sbjct: 62 LKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGS----CLRTYGRFEEQLVRFFTEQV 117
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN 172
+ + ++HSK LHRD+K DN L+ I DFG++KK D + +N +
Sbjct: 118 LEGLAYLHSKGILHRDLKADNLLVDA---DGICKISDFGISKKSDDIYDND-----QNMS 169
Query: 173 LTGT----ARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218
+ G+ A + G S + D+ SLG V++ G PW +A
Sbjct: 170 MQGSVFWMAPEVIHSYSQGY--SAKVDIWSLGCVVLEMFAGRRPWSDEEA 217
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 6e-08
Identities = 53/219 (24%), Positives = 95/219 (43%), Gaps = 17/219 (7%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLY----RILQGGTG 64
+RLG+ +G G+FG +YL + T E+A+K + P+ E ++L+
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 65 IPNVRWFGV-----EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
V+++G E ++ + + G S++D L+ Q++ V ++
Sbjct: 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLK-SYGALTENVTRKYTRQILEGVSYL 122
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
HS +HRDIK N L V + DFG +K+ + + K++TGT +
Sbjct: 123 HSNMIVHRDIKGANILRD---SVGNVKLGDFGASKRLQTIC----LSGTGMKSVTGTPYW 175
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218
S G R+ D+ S+G ++ L PW +A
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 6e-08
Identities = 51/206 (24%), Positives = 98/206 (47%), Gaps = 23/206 (11%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFG- 72
+IG GSFGE++ G + +T + VAIK+ +++ ++ + +L +++G
Sbjct: 11 RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 73 -VEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 129
++G ++M+ L G +L+ L + + T+L +++ ++++HS+ +HRDI
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATML---KEILKGLDYLHSEKKIHRDI 127
Query: 130 KPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 189
K N L+ V + DFG+A + DT + GT + + I+
Sbjct: 128 KAANVLLS---EQGDVKLADFGVAGQLTDTQI-------KRNTFVGTPFWMAPEV---IQ 174
Query: 190 QSRRD---DLESLGYVLMYFLRGSLP 212
QS D D+ SLG + +G P
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 7e-08
Identities = 70/286 (24%), Positives = 118/286 (41%), Gaps = 39/286 (13%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LLYESKLYRILQG 61
PR RL K+G G FGE+++GT T VAIK T P+ L E+++ + L+
Sbjct: 4 PR--ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRH 60
Query: 62 GTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
+ E Y V G L+ L + L L ++ +A Q+ + + +V
Sbjct: 61 EKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 120
Query: 122 KSFLHRDIKPDNFLMGLGRRANQV-YIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
+++HRD++ N L+G N V + DFGLA+ D Y + ++
Sbjct: 121 MNYVHRDLRAANILVG----ENLVCKVADFGLARLIEDNE------YTARQGAKFPIKWT 170
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239
+ L + + D+ S G +L +G +P+ G+ ++V +E
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM------------VNREVLDQVE- 217
Query: 240 LCRGY----PTEFASYFH----YCRSLRFDDKPDYAYLKRIFRDLF 277
RGY P E H C +++P + YL+ D F
Sbjct: 218 --RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 51/181 (28%), Positives = 80/181 (44%), Gaps = 20/181 (11%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL----LYESKLYRILQGGTGIPN-V 68
KIG G++G +Y N T E VA+K + T+ + + E L + L PN V
Sbjct: 7 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH----PNIV 62
Query: 69 RWFGVEGDYN--VLVMDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFL 125
+ V N LV + L L+ + + L + Q++ + F HS L
Sbjct: 63 KLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVL 122
Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKY---RDTSTHQHIP--YRENKNLTGTARYA 180
HRD+KP N L+ + + DFGLA+ + T TH+ + YR + L G Y+
Sbjct: 123 HRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 179
Query: 181 S 181
+
Sbjct: 180 T 180
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 1e-07
Identities = 51/205 (24%), Positives = 96/205 (46%), Gaps = 21/205 (10%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFG- 72
KIG GSFGE++ G + +T + VAIK+ +++ ++ + +L +++G
Sbjct: 11 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 73 -VEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 130
++ ++M+ L G S DL L + + +++ ++++HS+ +HRDIK
Sbjct: 71 YLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIK 128
Query: 131 PDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ 190
N L+ +V + DFG+A + DT ++ GT + + I+Q
Sbjct: 129 AANVLLS---EHGEVKLADFGVAGQLTDTQIKRN-------TFVGTPFWMAPEV---IKQ 175
Query: 191 SRRD---DLESLGYVLMYFLRGSLP 212
S D D+ SLG + +G P
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (127), Expect = 1e-07
Identities = 65/242 (26%), Positives = 106/242 (43%), Gaps = 46/242 (19%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN----VKTKHPQLLYESKLYRILQGGTG 64
F + +G+GSFG + L + + + A+K+ + VK K + + K RILQ
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEK--RILQ---- 56
Query: 65 IPNVR-------WFGVEGDYNV-LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
++R + + D N+ LVM+ + G L + A Q++
Sbjct: 57 --SIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLA 113
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD-TSTHQHIPYRENKNLT 174
+E++HS ++RD+KP+N L+ + I DFG AK+ + T T L
Sbjct: 114 LEYLHSLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRVKGRTYT-----------LC 159
Query: 175 GTARYAS--MNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYEKISEK 231
GT Y + + G ++ D +LG +L+Y L G P+ Q YEKI E
Sbjct: 160 GTPEYLAPEIILSKGYGKAV--DWWALG-ILIYEMLAGYPPF---FDDNPIQIYEKILEG 213
Query: 232 KV 233
KV
Sbjct: 214 KV 215
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-07
Identities = 29/149 (19%), Positives = 60/149 (40%), Gaps = 18/149 (12%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQG-GTGIPNVRWF 71
+ + G +YL +E+ +K+ + K E + ++L G +P V
Sbjct: 4 KLLKGGLTNRVYLLGT--KDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLAS 61
Query: 72 GVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS---KSFLHR 127
G ++ L+M+ + G +L+ ++S + +A+Q+ + +H H
Sbjct: 62 GESDGWSYLLMEWIEGETLD--------EVSEEEKEDIAEQLAELLAKLHQLPLLVLCHG 113
Query: 128 DIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
D+ P N L+ + IID+ A
Sbjct: 114 DLHPGNILV---DDGKILGIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 74/288 (25%), Positives = 127/288 (44%), Gaps = 57/288 (19%)
Query: 14 KIGSGSFGEIYLG--TNIQTNEEVAIKLENVKTKHP----QLLYESKLYRILQGGTGIPN 67
++GSG+FG + G ++ + VA+K+ P +LL E+ + + L P
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDN----PY 57
Query: 68 -VRWFGV-EGDYNVLVMDL--LGPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHS 121
VR G+ E + +LVM+L LGP L F ++ ++ K + L Q+ ++++
Sbjct: 58 IVRMIGICEAESWMLVMELAELGP----LNKFLQKNKHVTEKNITELVHQVSMGMKYLEE 113
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVY--IIDFGLAK------KYRDTSTHQHIPYRENKNL 173
+F+HRD+ N L+ Q Y I DFGL+K Y TH P +
Sbjct: 114 TNFVHRDLAARNVLL-----VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVK----- 163
Query: 174 TGTARYAS--MNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKIS 229
YA MN + + S + D+ S G VLM+ F G P++G+K Q E
Sbjct: 164 ----WYAPECMNYY---KFSSKSDVWSFG-VLMWEAFSYGQKPYKGMKGNEVTQMIES-- 213
Query: 230 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277
+++ + P E C + D++P +A ++ R+ +
Sbjct: 214 GERMECP-----QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNYY 256
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 43/155 (27%), Positives = 71/155 (45%), Gaps = 15/155 (9%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL----LYESKLYRILQGGTGIPNVR 69
+IG G++G +Y + + VA+K V+T L + E L + L+ VR
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 70 WFGV----EGDYNVLVMDLLGPSLEDLFNFCSR----KLSLKTVLMLADQMINRVEFVHS 121
V D V + +DL + + L +T+ L Q + ++F+H+
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
+HRD+KP+N L+ G QV + DFGLA+ Y
Sbjct: 127 NCIVHRDLKPENILVTSG---GQVKLADFGLARIY 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 53/206 (25%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENV-KTKHPQLLY-ESKLYRILQGGTGIPN-VRW 70
KIG GS G + + T+ T +VA+K ++ K + +LL+ E + R Q PN V
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQH----PNIVEM 81
Query: 71 FG--VEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHR 127
+ + GD +VM+ L G +L D+ +++ + + + ++ + F+H++ +HR
Sbjct: 82 YSSYLVGDELWVVMEFLEGGALTDIVT--HTRMNEEQIATVCLAVLKALSFLHAQGVIHR 139
Query: 128 DIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG 187
DIK D+ L+ +V + DFG + + +P R K+L GT + +
Sbjct: 140 DIKSDSILL---TSDGRVKLSDFGFCAQ-----VSKEVPRR--KSLVGTPYWMAPEVISR 189
Query: 188 IEQSRRDDLESLGYVLMYFLRGSLPW 213
+ D+ SLG +++ + G P+
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 44/175 (25%), Positives = 85/175 (48%), Gaps = 26/175 (14%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----LENVKTKHPQLLYESKLYRIL 59
VG++++ IGSG++G + + ++ ++VAIK +V T + L E K+ R
Sbjct: 2 DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF 61
Query: 60 QGGTGIPNV-------RWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQM 112
+ N+ R G + +VMDL+ L + + L+ + + Q+
Sbjct: 62 KH----DNIIAIRDILRPPGADFKDVYVVMDLMESDLHHII-HSDQPLTEEHIRYFLYQL 116
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ---VYIIDFGLAKKYRDTSTHQH 164
+ ++++HS + +HRD+KP N L+ N+ + I DFG+A+ +S +H
Sbjct: 117 LRGLKYIHSANVIHRDLKPSNLLV------NEDCELRIGDFGMARGL-SSSPTEH 164
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 42/155 (27%), Positives = 80/155 (51%), Gaps = 10/155 (6%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPN- 67
F L ++IGSG++G++Y N+ T E AIK+ ++ + + ++ I+ N
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEI--IMMKDCKHSNI 68
Query: 68 VRWFG--VEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
V +FG + D + M+ G SL+D+++ + LS + ++ + + + ++HSK
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQDIYH-VTGPLSESQIAYVSRETLQGLYYLHSKGK 127
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
+HRDIK N L+ V + DFG++ + T
Sbjct: 128 MHRDIKGANILL---TDNGHVKLADFGVSAQITAT 159
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 41/159 (25%), Positives = 68/159 (42%), Gaps = 7/159 (4%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYES--KLYRILQGGTGIPNVRW 70
R+IG GSFG +Y +++ +E VAIK + K ++ K R LQ +++
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 71 FG--VEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRD 128
G + LVM+ S DL + L + + + + ++HS + +HRD
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140
Query: 129 IKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPY 167
+K N L+ V + DFG A + PY
Sbjct: 141 VKAGNILL---SEPGLVKLGDFGSASIMAPANXFVGTPY 176
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 59/228 (25%), Positives = 97/228 (42%), Gaps = 35/228 (15%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--------ENVKTKHP-----QLLYESKL 55
+RLG+ +G G+FGE+YL + T E+A+K E K + QLL +
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 56 YRILQGGTGIPNVRWFGV-----EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLAD 110
RI+Q ++G E ++ V + G S++D L+
Sbjct: 64 DRIVQ---------YYGCLRDPEEKKLSIFVEYMPGGSIKDQLK-AYGALTENVTRRYTR 113
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170
Q++ V ++HS +HRDIK N L A V + DFG +K+ + +
Sbjct: 114 QILQGVSYLHSNMIVHRDIKGANILRD---SAGNVKLGDFGASKRIQTI----CMSGTGI 166
Query: 171 KNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218
K++TGT + S G R+ D+ S+ ++ L PW +A
Sbjct: 167 KSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 42/151 (27%), Positives = 67/151 (44%), Gaps = 19/151 (12%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-----LLYESKLYRILQGGTGIPN 67
R+IG GSFG +Y +++TNE VAIK + K ++ E + + L+ PN
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH----PN 76
Query: 68 VRWFGVEGDY-----NVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
+ +G Y LVM+ S D+ + L + + + + ++HS
Sbjct: 77 TIEY--KGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH 134
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
+HRDIK N L+ V + DFG A
Sbjct: 135 ERIHRDIKAGNILL---TEPGTVKLADFGSA 162
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 47/167 (28%), Positives = 73/167 (43%), Gaps = 50/167 (29%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLLYESKLYRILQGGTGIPNVR 69
IG G++G + N +TNE+VAIK +N + + L E KL R L NV
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDN-RIDAKRTLREIKLLRHLDH----ENV- 66
Query: 70 WFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLAD------------------- 110
+ + D++ P + FN + + LM D
Sbjct: 67 ---------IAIKDIMPPPHREAFN----DVYIVYELMDTDLHQIIRSSQTLSDDHCQYF 113
Query: 111 --QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAK 154
Q++ ++++HS + LHRD+KP N L+ AN + I DFGLA+
Sbjct: 114 LYQLLRGLKYIHSANVLHRDLKPSNLLLN----ANCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 5e-07
Identities = 45/153 (29%), Positives = 74/153 (48%), Gaps = 18/153 (11%)
Query: 13 RKIGSGSFGEI----YLGTNIQTNEEVAIKLENVKTKHPQLLYES--KLYRILQGGTGIP 66
R +G G FG++ Y N T E VA+K +K + Q K IL+
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVK--TLKRECGQQNTSGWKKEINILKTLYHEN 67
Query: 67 NVRWFGV---EGDYNV-LVMDLLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHS 121
V++ G +G + L+M+ + L L ++ + KL+L +L+ A Q+ + ++HS
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYV--PLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHS 125
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+ ++HRD+ N L+ V I DFGLAK
Sbjct: 126 QHYIHRDLAARNVLL---DNDRLVKIGDFGLAK 155
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 5e-07
Identities = 65/283 (22%), Positives = 119/283 (42%), Gaps = 37/283 (13%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LLYESKLYRILQG 61
PR +L +K+G+G FGE+++GT N +VA+K T P+ L E+++ + L+
Sbjct: 4 PR--ESLQLIKKLGNGQFGEVWMGT-WNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRH 60
Query: 62 GTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
+ E Y V G L+ L + R L L ++ +A Q+ + ++
Sbjct: 61 DKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER 120
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181
+++HRD++ N L+G G I DFGLA+ D Y + ++ +
Sbjct: 121 MNYIHRDLRSANILVGDGLVCK---IADFGLARLIEDNE------YTARQGAKFPIKWTA 171
Query: 182 MNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
L + + D+ S G +L + +G +P+ G+ + ++V +E
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM------------NNREVLEQVE-- 217
Query: 241 CRGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 275
RGY P C +++P + YL+ D
Sbjct: 218 -RGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 5e-07
Identities = 45/161 (27%), Positives = 77/161 (47%), Gaps = 13/161 (8%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LLYESKLYRILQG 61
PR +L +K+G+G FGE+++G + +VAIK + P+ L E+ L + LQ
Sbjct: 4 PR--ETLKLVKKLGAGQFGEVWMGY-YNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQH 60
Query: 62 GTGIPNVRWFGV---EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 118
VR + V E Y + G ++ L KL++ ++ +A Q+ + F
Sbjct: 61 PR---LVRLYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAF 117
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
+ K+++HRD++ N L+ I DFGLA+ D
Sbjct: 118 IERKNYIHRDLRAANILVS---ETLCCKIADFGLARLIEDN 155
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 7e-07
Identities = 25/80 (31%), Positives = 42/80 (52%), Gaps = 8/80 (10%)
Query: 78 NVLVMDLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNF 134
+VL+MD + DLF+ KLS V + Q++ + +H + +H DIK +N
Sbjct: 84 HVLIMDYIKDG---DLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENV 140
Query: 135 LMGLGRRANQVYIIDFGLAK 154
L R +++Y+ D+GL K
Sbjct: 141 L--YDRAKDRIYLCDYGLCK 158
|
Length = 267 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 7e-07
Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 26/161 (16%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQ--LLYESKLYRILQGG 62
K+ +G GS+G + + +T + VAIK LE+ K + + E ++ + L+
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRH- 59
Query: 63 TGIPNV--------RWFGVEGDYNVLVMDLLGPS-LEDLFNFCSRKLSLKTVLMLADQMI 113
+ N+ R + LV + + + L+DL + + L V Q++
Sbjct: 60 ENLVNLIEVFRRKKRLY--------LVFEFVDHTVLDDLEKYPN-GLDESRVRKYLFQIL 110
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+EF HS + +HRDIKP+N L+ ++ V + DFG A+
Sbjct: 111 RGIEFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 9e-07
Identities = 50/202 (24%), Positives = 98/202 (48%), Gaps = 14/202 (6%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENV-KTKHPQLLY-ESKLYRILQGGTGIPNVRWF 71
KIG GS G + + + +VA+K+ ++ K + +LL+ E + R Q + + +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 72 GVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKP 131
V + VL+ L G +L D+ + +L+ + + + + ++ + ++HS+ +HRDIK
Sbjct: 88 LVGEELWVLMEFLQGGALTDIVS--QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKS 145
Query: 132 DNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQS 191
D+ L+ L R V + DFG + + +P R K+L GT + +
Sbjct: 146 DSILLTLDGR---VKLSDFGFCAQ-----ISKDVPKR--KSLVGTPYWMAPEVISRTPYG 195
Query: 192 RRDDLESLGYVLMYFLRGSLPW 213
D+ SLG +++ + G P+
Sbjct: 196 TEVDIWSLGIMVIEMVDGEPPY 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 9e-07
Identities = 39/154 (25%), Positives = 80/154 (51%), Gaps = 8/154 (5%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNV 68
+ L +++GSG++G++Y N+ T E A+K+ ++ L + +++ +++ V
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIF-MVKECKHCNIV 69
Query: 69 RWFG--VEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 125
+FG + + + M+ G SL+D+++ + LS + + + + + ++HSK +
Sbjct: 70 AYFGSYLSREKLWICMEYCGGGSLQDIYH-VTGPLSELQIAYVCRETLQGLAYLHSKGKM 128
Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
HRDIK N L+ V + DFG+A K T
Sbjct: 129 HRDIKGANILL---TDNGDVKLADFGVAAKITAT 159
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 44/155 (28%), Positives = 80/155 (51%), Gaps = 16/155 (10%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT-NIQTNEEVAIKLENVKTKHPQ-LLYESKLYRILQGGTG 64
+L RK+G+G FGE++ G N T VA+K T P+ L E+++ + L+
Sbjct: 6 TSIQLLRKLGAGQFGEVWEGLWNNTT--PVAVKTLKPGTMDPKDFLAEAQIMKKLRH--- 60
Query: 65 IPN-VRWFGV--EGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
P ++ + V + +V +L+ G LE L R L L ++ +A Q+ + + ++
Sbjct: 61 -PKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL 119
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+++++HRD+ N L+G N + DFGLA+
Sbjct: 120 EAQNYIHRDLAARNVLVG---ENNICKVADFGLAR 151
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 59/219 (26%), Positives = 92/219 (42%), Gaps = 22/219 (10%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLLYESKLYRILQGG 62
FR+ +KIG G F E+Y T + VA+K L + K + + E L + L
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARA-DCIKEIDLLKQLNHP 62
Query: 63 TGIPNVRWFGVEGDYNVLVMDLLGPSLEDL---FNFCSRKLSLKTVLMLADQMINRVEFV 119
I F + + N+++ L + F R + KTV Q+ + +E +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 120 HSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 178
HS+ +HRDIKP N F+ G V + D GL + + +T H +L GT
Sbjct: 123 HSRRVMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAH-------SLVGTPY 171
Query: 179 YASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 217
Y S + + D+ SLG +L P+ G K
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 28/167 (16%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP--QLLYESKLYRILQGG 62
V +++R +++GSG++G + + +T +VAIK K P L+ + YR L+
Sbjct: 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIK----KLYRPFQSELFAKRAYRELR-- 66
Query: 63 TGIPNVRWFGVEGDYNV--------------LVMDLLGPSLEDLFNFCSRKLSLKTVLML 108
+ +++ V G +V LVM +G L L KLS + L
Sbjct: 67 -LLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH--EKLSEDRIQFL 123
Query: 109 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155
QM+ ++++H+ +HRD+KP N + ++ I+DFGLA++
Sbjct: 124 VYQMLKGLKYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLARQ 167
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 46/161 (28%), Positives = 77/161 (47%), Gaps = 20/161 (12%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEE---VAIKL---ENVKTKHPQLLYESKLYRILQGGTG 64
LGR IG G FG++Y G + E VA+K + + L E+ + R
Sbjct: 10 LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDH--- 66
Query: 65 IPN-VRWFGVEGDYNV-LVMDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFV 119
P+ V+ GV + V +VM+L L +L ++ L L ++++ + Q+ + ++
Sbjct: 67 -PHIVKLIGVITENPVWIVMELA--PLGELRSYLQVNKYSLDLASLILYSYQLSTALAYL 123
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160
SK F+HRDI N L+ + V + DFGL++ D S
Sbjct: 124 ESKRFVHRDIAARNVLVS---SPDCVKLGDFGLSRYLEDES 161
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 68/274 (24%), Positives = 120/274 (43%), Gaps = 47/274 (17%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-----LLYESKLYRILQGGTGIPN-V 68
+G G+FGE++ GT ++ VA+K K PQ L E+++ + PN V
Sbjct: 3 LGKGNFGEVFKGT-LKDKTPVAVK--TCKEDLPQELKIKFLSEARILKQYDH----PNIV 55
Query: 69 RWFGV--EGDYNVLVMDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHSKS 123
+ GV + +VM+L+ D +F +K L K ++ A + ++ SK+
Sbjct: 56 KLIGVCTQRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN 113
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD----TSTHQHIPYR-ENKNLTGTAR 178
+HRD+ N L+G N + I DFG++++ D +S + IP + R
Sbjct: 114 CIHRDLAARNCLVG---ENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGR 170
Query: 179 YASMNTHLGIEQSRRDDLESLGYVLM-YFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237
Y+S D+ S G +L F G P+ G+ T +Q E++ EK S
Sbjct: 171 YSS-----------ESDVWSYGILLWETFSLGVCPYPGM---TNQQAREQV-EKGYRMSC 215
Query: 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271
C P + C + +++P ++ L++
Sbjct: 216 PQKC---PDDVYKVMQRCWDYKPENRPKFSELQK 246
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 54/203 (26%), Positives = 86/203 (42%), Gaps = 18/203 (8%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-----ENVKTKHPQLLYESKLYRILQG 61
NKF + +G G++G + + +T E VAIK EN + K L E K+ R L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTL-RELKMLRTLKQ 59
Query: 62 GTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
+ F G LV + + ++ +L + + V Q+I + + H
Sbjct: 60 ENIVELKEAFRRRGKL-YLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHK 118
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVY-IIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
+HRDIKP+N L+ N V + DFG A+ + S + Y T Y
Sbjct: 119 NDIVHRDIKPENLLIS----HNDVLKLCDFGFARNLSEGSNANYTEY------VATRWYR 168
Query: 181 SMNTHLGIEQSRRDDLESLGYVL 203
S LG + D+ S+G +L
Sbjct: 169 SPELLLGAPYGKAVDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 55/222 (24%), Positives = 96/222 (43%), Gaps = 23/222 (10%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-------LLYESKLYRILQG 61
+R G+ +G G+FG +YL ++ T E+A K + P+ L E +L + LQ
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH 63
Query: 62 GTGIPNVRWFGVEGDY-----NVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116
V+++G D + + + G S++D L+ Q++ +
Sbjct: 64 ER---IVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLK-AYGALTESVTRKYTRQILEGM 119
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGT 176
++HS +HRDIK N L A V + DFG +K+ + + +++TGT
Sbjct: 120 SYLHSNMIVHRDIKGANILRD---SAGNVKLGDFGASKRLQTIC----MSGTGIRSVTGT 172
Query: 177 ARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218
+ S G R+ D+ SLG ++ L PW +A
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 53/221 (23%), Positives = 88/221 (39%), Gaps = 33/221 (14%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-----QLLYESKLYRILQG 61
F++ ++G G +G+++L T E VA+K +L E IL
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERD---ILTT 57
Query: 62 GTGIPNVRW-----FGVEGDYNV-LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
W + + D + L M+ + G L N LS +M
Sbjct: 58 T----KSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLN-NLGVLSEDHARFYMAEMFE 112
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174
V+ +H ++HRD+KP+NFL+ + + + DFGL+K T+ + ++
Sbjct: 113 AVDALHELGYIHRDLKPENFLID---ASGHIKLTDFGLSK---GIVTYAN-------SVV 159
Query: 175 GTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
G+ Y + G D SLG +L FL G P+ G
Sbjct: 160 GSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG 200
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 21/49 (42%), Positives = 29/49 (59%), Gaps = 1/49 (2%)
Query: 111 QMINRVEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKKYRD 158
Q++N V ++HS LHRD+KP N +MG G V I D GLA+ +
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNA 164
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 59/202 (29%), Positives = 92/202 (45%), Gaps = 56/202 (27%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESK-LYRILQGGTGIPNVRW 70
R IG G+FG ++ T+ + + VA+K + NV Q L K ++R L+ + +
Sbjct: 6 RPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF----QNLVSCKRVFRELK------MLCF 55
Query: 71 FGVEGDYNVL-VMDLLGPSLEDLFNFCSRKLSLKTVLMLAD------------------- 110
F + NVL +D+L P D F ++ + T LM +D
Sbjct: 56 FKHD---NVLSALDILQPPHIDPF----EEIYVVTELMQSDLHKIIVSPQPLSSDHVKVF 108
Query: 111 --QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKYR-DTSTH---- 162
Q++ ++++HS LHRDIKP N L+ +N + I DFGLA+ D S H
Sbjct: 109 LYQILRGLKYLHSAGILHRDIKPGNLLVN----SNCVLKICDFGLARVEEPDESKHMTQE 164
Query: 163 ---QHIPYRENKNLTGTARYAS 181
Q+ YR + L G+ Y S
Sbjct: 165 VVTQY--YRAPEILMGSRHYTS 184
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 57/210 (27%), Positives = 87/210 (41%), Gaps = 28/210 (13%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----LENVKTKHPQ-LLYESKLYRILQG 61
F++ +KIG G F +Y + VA+K E + K Q L E L + L
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH 61
Query: 62 GTGIPNV-RWFGVEGDYNVLVMDLLGPSLEDL------FNFCSRKLSLKTVLMLADQMIN 114
PNV ++ + N L + L DL F R + +T+ Q+ +
Sbjct: 62 ----PNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS 117
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKYRDTSTHQHIPYRENKNL 173
+E +HSK +HRDIKP N + A V + D GL + + +T H +L
Sbjct: 118 ALEHMHSKRIMHRDIKPANVFIT----ATGVVKLGDLGLGRFFSSKTTAAH-------SL 166
Query: 174 TGTARYASMNTHLGIEQSRRDDLESLGYVL 203
GT Y S + + D+ SLG +L
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLL 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 44/170 (25%), Positives = 74/170 (43%), Gaps = 21/170 (12%)
Query: 14 KIGSGSFGEIYLGTNIQTNEE---VAIKL---ENVKTKHPQLLYESKLYRILQGGTGIPN 67
K+G GSFG + G + + VA+K + + L E+ + L N
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDH----EN 57
Query: 68 -VRWFGVEGDYNV-LVMDL--LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
+R +GV + + +V +L LG L+ L + T+ A Q+ N + ++ SK
Sbjct: 58 LIRLYGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNL 173
F+HRD+ N L+ ++V I DFGL + H Y ++L
Sbjct: 118 FIHRDLAARNILLA---SDDKVKIGDFGLMRALPQNEDH----YVMEEHL 160
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 37/169 (21%), Positives = 70/169 (41%), Gaps = 49/169 (28%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----------------KHPQLL------- 50
+G G+FG++Y + +T A K+ +++ KHP ++
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 51 YESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLAD 110
YE+KL+ +++ G G + ++++L E + R
Sbjct: 73 YENKLWILIEFCDG----------GALDSIMLELERGLTEPQIRYVCR------------ 110
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
QM+ + F+HS +HRD+K N L+ V + DFG++ K + T
Sbjct: 111 QMLEALNFLHSHKVIHRDLKAGNILL---TLDGDVKLADFGVSAKNKST 156
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 41/169 (24%), Positives = 70/169 (41%), Gaps = 43/169 (25%)
Query: 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVK----------------TKHPQLL 50
+L R IG G++G +Y + + E VA+K ++N + +HP ++
Sbjct: 11 KLNR-IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIV 69
Query: 51 YESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLAD 110
+L ++ G D LVM+ L L + S V L
Sbjct: 70 ---ELKEVVVGK-----------HLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLML 115
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLAKKY 156
Q++ ++++H +HRD+K N L+ G + I DFGLA+ Y
Sbjct: 116 QLLRGLQYLHENFIIHRDLKVSNLLLTDKGC------LKIADFGLARTY 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 46/179 (25%), Positives = 85/179 (47%), Gaps = 18/179 (10%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTKHPQLLYESKLYRILQGGTGIPNVRW 70
K+G G++ ++ G + T VA I+LE+ + + E L + L+ N+
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA----NIVT 68
Query: 71 FG--VEGDYNV-LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHR 127
V D ++ LV + L L+ + C +S+ V + Q++ + + H + LHR
Sbjct: 69 LHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHR 128
Query: 128 DIKPDNFLMGLGRRANQVYIIDFGLAK-KYRDTSTHQH----IPYRENKNLTGTARYAS 181
D+KP N L+ ++ + DFGLA+ K T T+ + + YR L G++ Y++
Sbjct: 129 DLKPQNLLIN---ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYST 184
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 44/176 (25%), Positives = 81/176 (46%), Gaps = 12/176 (6%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTKHPQLLYESKLYRILQGGTGIPNVRW 70
K+G G++ +Y G + T+ VA I+LE+ + + E L + L+ +
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 71 FGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 130
E LV + L L+ + C +++ V + Q++ + + H + LHRD+K
Sbjct: 73 IHTEKSLT-LVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLK 131
Query: 131 PDNFLMGLGRRANQVYIIDFGLAK-KYRDTSTHQH----IPYRENKNLTGTARYAS 181
P N L+ ++ + DFGLA+ K T T+ + + YR L G+ Y++
Sbjct: 132 PQNLLIN---ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYST 184
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 3e-06
Identities = 60/248 (24%), Positives = 89/248 (35%), Gaps = 53/248 (21%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHP-QLLYESKLYRILQGGTGIPN-V 68
IG GSFG + + + K N+ K QL+ E + R L+ PN V
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKH----PNIV 62
Query: 69 RWFGVEGD------YNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF---- 118
R++ D Y +VM+ DL + + + ++ I R+
Sbjct: 63 RYYDRIIDRSNQTLY--IVMEYCEGG--DLAQLIQKCKKERK--YIEEEFIWRILTQLLL 116
Query: 119 ---------VHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKKYRDTS--THQHIP 166
+ LHRD+KP N FL N V + DFGLAK S ++
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDA----NNNVKLGDFGLAKILGHDSSFAKTYV- 171
Query: 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE 226
GT Y S + + D+ SLG ++ S P+ A + Q
Sbjct: 172 --------GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT---ARNQLQLAS 220
Query: 227 KISEKKVS 234
KI E K
Sbjct: 221 KIKEGKFR 228
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 39/169 (23%), Positives = 72/169 (42%), Gaps = 27/169 (15%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP--QLLYESKLYRILQ-- 60
+G+++ R +G GS G ++ + ++ VA+K + L E K+ R L
Sbjct: 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHD 62
Query: 61 ---------GGTGIPNVRWFGVEGDYNVL--VMDLLGPSLEDLFNFCSRKLSLKTVLMLA 109
G +G G + N + V + + L ++ LS + +
Sbjct: 63 NIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLE--QGPLSEEHARLFM 120
Query: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ----VYIIDFGLAK 154
Q++ ++++HS + LHRD+KP N + N + I DFGLA+
Sbjct: 121 YQLLRGLKYIHSANVLHRDLKPANVFI------NTEDLVLKIGDFGLAR 163
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 4e-06
Identities = 58/218 (26%), Positives = 93/218 (42%), Gaps = 41/218 (18%)
Query: 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKL------ENVKTKHPQLLYESKLYRILQGGTGI 65
+IGSG+ G +Y + T A+K+ + V+ Q+ E ++ R
Sbjct: 79 VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRR---QICREIEILR----DVNH 131
Query: 66 PNV----RWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
PNV F G+ VL+ + G SLE + L+ +A Q+++ + ++H
Sbjct: 132 PNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA-----DVARQILSGIAYLHR 186
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181
+ +HRDIKP N L+ + V I DFG+++ T P + GT Y S
Sbjct: 187 RHIVHRDIKPSNLLINSAKN---VKIADFGVSRILAQTMD----PCNSS---VGTIAYMS 236
Query: 182 ---MNTHLGIEQSRRD----DLESLGYVLMYFLRGSLP 212
+NT L D D+ SLG ++ F G P
Sbjct: 237 PERINTDL--NHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 4e-06
Identities = 64/247 (25%), Positives = 100/247 (40%), Gaps = 40/247 (16%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPN 67
K LG IG G FG + G T ++VA+K L E+ + L
Sbjct: 7 KLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKN---L 61
Query: 68 VRWFGV---EGDYNVLVMDLLGPSLEDLFNFCSRK----LSLKTVLMLADQMINRVEFVH 120
VR GV G Y +VM+L+ S +L NF + +S+ +L + + +E++
Sbjct: 62 VRLLGVILHNGLY--IVMELM--SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE 117
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SK +HRD+ N L+ + DFGLA+ + +P + TA A
Sbjct: 118 SKKLVHRDLAARNILVS---EDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEA 168
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
+ S + D+ S G +L W+ G + Y K+S K+V +E
Sbjct: 169 LKHKKF----SSKSDVWSYGVLL---------WEVFSYG--RAPYPKMSLKEVKECVEKG 213
Query: 241 CRGYPTE 247
R P E
Sbjct: 214 YRMEPPE 220
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 41/155 (26%), Positives = 77/155 (49%), Gaps = 20/155 (12%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLLY-ESKLYRILQGGTGIP 66
+GSG++G++ + +T +VAIK ++ H + Y E +L + + I
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS--AIHAKRTYRELRLLKHMDHENVIG 78
Query: 67 NVRWF----GVEGDYNV-LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
+ F +E +V LV L+G L ++ +KLS + L Q++ ++++HS
Sbjct: 79 LLDVFTPASSLEDFQDVYLVTHLMGADLNNIVK--CQKLSDDHIQFLVYQILRGLKYIHS 136
Query: 122 KSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKK 155
+HRD+KP N + + ++ I+DFGLA+
Sbjct: 137 AGIIHRDLKPSN----IAVNEDCELKILDFGLARH 167
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 4e-06
Identities = 43/157 (27%), Positives = 82/157 (52%), Gaps = 14/157 (8%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKLYRILQGGTGIPN-VRWF 71
K+G G +GE+Y G + + VA+K L+ + + L E+ + + ++ PN V+
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH----PNLVQLL 68
Query: 72 GV---EGDYNVLVMDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFLHR 127
GV E + ++ + +L D C+R+ ++ +L +A Q+ + +E++ K+F+HR
Sbjct: 69 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 128
Query: 128 DIKPDNFLMGLGRRANQVYIIDFGLAKKYR-DTSTHQ 163
D+ N L+G + V + DFGL++ DT T
Sbjct: 129 DLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAH 162
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 4e-06
Identities = 47/180 (26%), Positives = 80/180 (44%), Gaps = 47/180 (26%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLLYESKLYRILQGG 62
++++ IG GS+G + + T E+VAIK E+V ++L E KL R+L+
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDAT-RILREIKLLRLLRH- 58
Query: 63 TGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFN-----FCSRKLSLKTVLMLAD------- 110
P++ V + ++ P F F + L V+ D
Sbjct: 59 ---PDI----------VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHH 105
Query: 111 -----QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN---QVYIIDFGLAK-KYRDTST 161
Q++ ++++H+ + HRD+KP N L AN ++ I DFGLA+ + DT T
Sbjct: 106 QFFLYQLLRALKYIHTANVFHRDLKPKNIL------ANADCKLKICDFGLARVAFNDTPT 159
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 4e-06
Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 23/153 (15%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP--QLLYESKLYRIL--------QGGTG 64
+GSG++G + + +T E+VAIK K P ++ + YR L + G
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIK----KLSRPFQSEIFAKRAYRELTLLKHMQHENVIG 78
Query: 65 IPNVRWFGVEGD--YNV-LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
+ +V V GD + LVM + DL LS V L QM+ ++++HS
Sbjct: 79 LLDVFTSAVSGDEFQDFYLVMPYM---QTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHS 135
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+HRD+KP N + ++ I+DFGLA+
Sbjct: 136 AGIIHRDLKPGNLAVN---EDCELKILDFGLAR 165
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 45/160 (28%), Positives = 76/160 (47%), Gaps = 18/160 (11%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEE--VAIK-LENVKTKH---PQLLYESKLYRILQGG 62
+ L +++G G++G + N +T+EE VAIK + NV +K + L E KL R +G
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61
Query: 63 TGIPN------VRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116
I V Y L +L+ L + + L+ Q++ +
Sbjct: 62 KNITCLYDMDIVFPGNFNELY--LYEELMEADLHQIIR-SGQPLTDAHFQSFIYQILCGL 118
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
+++HS + LHRD+KP N L+ ++ I DFGLA+ +
Sbjct: 119 KYIHSANVLHRDLKPGNLLVNAD---CELKICDFGLARGF 155
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 6e-06
Identities = 56/234 (23%), Positives = 95/234 (40%), Gaps = 22/234 (9%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN---VKTKHPQLLYESKLYRILQGGTGI 65
F + + IG G+FGE+ + ++ A+K+ N + + + + ++ G
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 66 PNVRWFGVEGDYNV-LVMDL-LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
+ + + N+ LVMD +G L L + +L +M+ ++ VH
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMN 183
++HRDIKPDN LM + + + DFG K + T Q + GT Y S
Sbjct: 123 YVHRDIKPDNILMDMN---GHIRLADFGSCLKLMEDGTVQ------SSVAVGTPDYISPE 173
Query: 184 THLGIEQSR-----RDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232
+E + D SLG + L G P+ A + + Y KI K
Sbjct: 174 ILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY---AESLVETYGKIMNHK 224
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 6e-06
Identities = 48/213 (22%), Positives = 96/213 (45%), Gaps = 20/213 (9%)
Query: 12 GRKIGSGSFGEIYLGTNIQTNEEVAIK----LENVKTKHPQLLYESKLYRI-LQGGTGIP 66
G+++G+G+F Y +++T +A+K + N ++ ++ E+ I L P
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEV-VEALRKEIRLMARLNHP 63
Query: 67 N-VRWFGV---EGDYNVLVMDLLGPSLEDLF-NFCSRKLSLKTVLMLADQMINRVEFVHS 121
+ +R G + +N+ V + G S+ L + + K ++ ++ +Q++ + ++H
Sbjct: 64 HIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAV--IINYTEQLLRGLSYLHE 121
Query: 122 KSFLHRDIKPDNFLM-GLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
+HRD+K N L+ G+R + I DFG A + T L GT +
Sbjct: 122 NQIIHRDVKGANLLIDSTGQR---LRIADFGAAARLAAKGTGAG---EFQGQLLGTIAFM 175
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
+ G + R D+ S+G V++ PW
Sbjct: 176 APEVLRGEQYGRSCDVWSVGCVIIEMATAKPPW 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 6e-06
Identities = 73/292 (25%), Positives = 118/292 (40%), Gaps = 69/292 (23%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LEN----VKTKHPQLL 50
++ L ++IGSG FG ++LG +VAIK +E +K HP+L+
Sbjct: 4 SELTLVQEIGSGQFGLVWLGY-WLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLV 62
Query: 51 YESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLAD 110
+LY + + I V F G L D K S +T+L +
Sbjct: 63 ---QLYGVCTERSPICLVFEFMEHG------------CLSDYLRAQRGKFSQETLLGMCL 107
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY-IIDFGLAKKYRD----TSTHQHI 165
+ + ++ S + +HRD+ N L+G NQV + DFG+ + D +ST
Sbjct: 108 DVCEGMAYLESSNVIHRDLAARNCLVG----ENQVVKVSDFGMTRFVLDDQYTSSTGTKF 163
Query: 166 PYR-ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK 224
P + + + ++Y+S + D+ S G VLM W+ G K
Sbjct: 164 PVKWSSPEVFSFSKYSS-----------KSDVWSFG-VLM--------WEVFSEG--KTP 201
Query: 225 YEKISEKKVSTSIEALCRGYPTEFAS-----YFHYCRSLRFDDKPDYAYLKR 271
YE S +V +I A R Y AS +C R +D+P ++ L
Sbjct: 202 YENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLH 253
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 7e-06
Identities = 44/179 (24%), Positives = 83/179 (46%), Gaps = 18/179 (10%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTKHPQLLYESKLYRILQGGTGIPNVRW 70
K+G G++ ++ G + T VA I+LE+ + + E L + L+ N+
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHA----NIVT 67
Query: 71 FG--VEGDYNV-LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHR 127
+ + + LV + L L+ + C +S+ V + Q++ + + H + LHR
Sbjct: 68 LHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHR 127
Query: 128 DIKPDNFLMGLGRRANQVYIIDFGLAK-KYRDTSTHQH----IPYRENKNLTGTARYAS 181
D+KP N L+ ++ + DFGLA+ K T T+ + + YR L G+ Y++
Sbjct: 128 DLKPQNLLIN---EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYST 183
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 7e-06
Identities = 45/168 (26%), Positives = 81/168 (48%), Gaps = 19/168 (11%)
Query: 80 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 139
LVM+L+ +L + + +L + + L QM+ ++ +HS +HRD+KP N ++
Sbjct: 103 LVMELMDANLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV--- 156
Query: 140 RRANQVYIIDFGLAKKYRDTSTH-QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLES 198
+ + I+DFGLA R T+ PY T Y + LG+ D+ S
Sbjct: 157 KSDCTLKILDFGLA---RTACTNFMMTPY------VVTRYYRAPEVILGMGYKENVDIWS 207
Query: 199 LGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 246
+G ++ ++GS+ +QG ++ K+ E+ + S E + R PT
Sbjct: 208 VGCIMGELVKGSVIFQGTD---HIDQWNKVIEQLGTPSAEFMNRLQPT 252
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 7e-06
Identities = 59/219 (26%), Positives = 91/219 (41%), Gaps = 26/219 (11%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPN 67
++ + +KIG GSFG+IYL +E IK ++ + SK IL PN
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 68 VRWFGVEGDYN---VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN-------RVE 117
+ F N +VM+ DL +R+ + VL DQ+++ ++
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGG--DLMKRINRQ---RGVLFSEDQILSWFVQISLGLK 115
Query: 118 FVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGT 176
+H + LHRDIK N FL G A + DFG+A++ D+ GT
Sbjct: 116 HIHDRKILHRDIKSQNIFLSKNGMVAK---LGDFGIARQLNDSMELA-------YTCVGT 165
Query: 177 ARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
Y S + + D+ SLG VL P++G
Sbjct: 166 PYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 8e-06
Identities = 55/238 (23%), Positives = 88/238 (36%), Gaps = 33/238 (13%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLY------RILQ 60
F + +G G FGE+ + T + A+K K LL + + IL
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMK----VMKKSVLLAQETVSFFEEERDILS 56
Query: 61 GGTG--IPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
IP +++ + D LVM+ G L L N + +++ +
Sbjct: 57 ISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIH 116
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY-RDTSTHQHIPYRENKNLTGT 176
VH ++HRDIKP+N L+ R + + DFG A + + + +P GT
Sbjct: 117 SVHQMGYVHRDIKPENVLID---RTGHIKLADFGSAARLTANKMVNSKLP-------VGT 166
Query: 177 ARY------ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228
Y +MN D SLG + + G P+ GT + Y I
Sbjct: 167 PDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH---EGTSAKTYNNI 221
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 8e-06
Identities = 48/218 (22%), Positives = 94/218 (43%), Gaps = 27/218 (12%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYES-KLYRILQGGTGIPN 67
F++ +K+G GS+G +Y + N+ A+K ++ + + ++ RIL PN
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNH-PN 60
Query: 68 VRWFG---VEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVL------MLADQMINRVEF 118
+ + ++G+ +VM+ DL S++ + ++ + Q++ ++
Sbjct: 61 IISYKEAFLDGNKLCIVMEY--APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQA 118
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYII-DFGLAKKYRDTSTHQHIPYRENKNLTGTA 177
+H + LHRD+K N L AN + I D G++K + K GT
Sbjct: 119 LHEQKILHRDLKSANIL----LVANDLVKIGDLGISKVLKKNMA---------KTQIGTP 165
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
Y + G S + D+ SLG +L + P++
Sbjct: 166 HYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEA 203
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 8e-06
Identities = 39/148 (26%), Positives = 75/148 (50%), Gaps = 12/148 (8%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYES-KLYRILQGGTGIPNVRWFG 72
+G G++G +Y ++ T +AIK + +++ Q L+E L+ L+ V++ G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN---IVQYLG 72
Query: 73 --VEGDYNVLVMDLL-GPSLEDLF--NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHR 127
E + + M+ + G SL L + K + +T++ Q++ ++++H +HR
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHR 132
Query: 128 DIKPDNFLMGLGRRANQVYIIDFGLAKK 155
DIK DN L + + V I DFG +K+
Sbjct: 133 DIKGDNVL--VNTYSGVVKISDFGTSKR 158
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 8e-06
Identities = 47/172 (27%), Positives = 74/172 (43%), Gaps = 35/172 (20%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKLENVK---TKHPQLLYESK 54
PR N G+ +G+G+FG++ T +VA+K+ ++ L+ E K
Sbjct: 33 PR--NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELK 90
Query: 55 LYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSL--------EDLFNFCSRK----LSL 102
+ L I N+ G GP L DL NF RK L+L
Sbjct: 91 IMSHLGNHENIVNLLGACTIG----------GPILVITEYCCYGDLLNFLRRKRESFLTL 140
Query: 103 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+ +L + Q+ + F+ SK+ +HRD+ N L+ G+ I DFGLA+
Sbjct: 141 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVK---ICDFGLAR 189
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 9e-06
Identities = 42/163 (25%), Positives = 77/163 (47%), Gaps = 28/163 (17%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP--QLLYESKLYRILQGGTGIPNVRWFG 72
+GSG++G + + +T VA+K K P +++ + YR L+ + +++
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRL---LKHMKHEN 77
Query: 73 VEGDYNV--------------LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 118
V G +V LV L+G L ++ +KL+ V L Q++ +++
Sbjct: 78 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKY 135
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161
+HS +HRD+KP N + ++ I+DFGLA+ D T
Sbjct: 136 IHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT 175
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 9e-06
Identities = 52/192 (27%), Positives = 83/192 (43%), Gaps = 32/192 (16%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVR 69
KIG G++G++Y + T + VA+K ++ P L E L ++L I VR
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYI--VR 65
Query: 70 WFGVE------GDYNV-LVMDLLGPSLEDLFNF----CSRKLSLKTVLMLADQMINRVEF 118
VE G ++ LV + L L+ + R L KT+ Q++ V
Sbjct: 66 LLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAH 125
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA-------KKYRDTSTHQHIP--YRE 169
H +HRD+KP N L + ++ + I D GL K Y TH+ + YR
Sbjct: 126 CHKHGVMHRDLKPQNLL--VDKQKGLLKIADLGLGRAFSIPVKSY----THEIVTLWYRA 179
Query: 170 NKNLTGTARYAS 181
+ L G+ Y++
Sbjct: 180 PEVLLGSTHYST 191
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 9e-06
Identities = 56/191 (29%), Positives = 78/191 (40%), Gaps = 47/191 (24%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKTKHPQLLYES------K 54
+ IG G+FGE+ L + TN A+K +VK + +L E+ K
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAER-DILAEADNEWVVK 65
Query: 55 LYRILQGGTGIPNVRWFGVEGDYNVLVMDLL---GPSLEDLFNFCSRKLSLKTVLMLADQ 111
LY Q + V + GD +M LL G EDL F +L+
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGD----MMSLLIRLGIFEEDLARFYIAELTCA-------- 113
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENK 171
+E VH F+HRDIKPDN L+ R + + DFGL +R TH Y++
Sbjct: 114 ----IESVHKMGFIHRDIKPDNILID---RDGHIKLTDFGLCTGFR--WTHDSKYYQKG- 163
Query: 172 NLTGTARYASM 182
R SM
Sbjct: 164 ---DHHRQDSM 171
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 9e-06
Identities = 58/228 (25%), Positives = 105/228 (46%), Gaps = 35/228 (15%)
Query: 11 LGRKIGSGSFGEIYLGT--NIQ-TNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPN 67
L R++G G+FG+++L N+ T +++ + ++ +K P L R + T + +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD--PTLAARKDFQREAELLTNLQH 66
Query: 68 ---VRWFGVEGDYNVLVM--------DL------LGPSLEDLFNFCSRK----LSLKTVL 106
V+++GV GD + L+M DL GP L + R+ L L +L
Sbjct: 67 EHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML 126
Query: 107 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166
+A Q+ + + ++ S+ F+HRD+ N L+G V I DFG++ RD + +
Sbjct: 127 HIASQIASGMVYLASQHFVHRDLATRNCLVGANL---LVKIGDFGMS---RDVYSTDY-- 178
Query: 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM-YFLRGSLPW 213
YR + R+ + + + + D+ S G +L F G PW
Sbjct: 179 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 75/288 (26%), Positives = 127/288 (44%), Gaps = 63/288 (21%)
Query: 14 KIGSGSFGEIYLGTNIQTNEE--VAIKL---ENVKTKHPQLLYESKLYRILQGGTGIPN- 67
++GSG+FG + G ++ VAIK+ EN K+ +++ E+++ L P
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDN----PYI 57
Query: 68 VRWFGV-EGDYNVLVMDLL--GPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHS 121
VR GV E + +LVM++ GP L F S K +++ V+ L Q+ ++++
Sbjct: 58 VRMIGVCEAEALMLVMEMASGGP----LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG 113
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVY--IIDFGLAK------KYRDTSTHQHIPYRENKNL 173
K+F+HRD+ N L+ NQ Y I DFGL+K Y + P +
Sbjct: 114 KNFVHRDLAARNVLL-----VNQHYAKISDFGLSKALGADDSYYKARSAGKWPLK----- 163
Query: 174 TGTARYAS--MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 231
YA +N + S R D+ S G + W+ G K Y+K+
Sbjct: 164 ----WYAPECINFR---KFSSRSDVWSYGITM---------WEAFSYGQK--PYKKMKGP 205
Query: 232 KVSTSIEALCR-----GYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 274
+V + IE R P E + C +++D+P++A ++ R
Sbjct: 206 EVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMR 253
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 50/211 (23%), Positives = 95/211 (45%), Gaps = 28/211 (13%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLLYESKLYRILQGGTGIPN-V 68
++G+G+ G + + T + +A+K LE + Q+L E IL P V
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRE---LDILHKCNS-PYIV 62
Query: 69 RWFG---VEGDYNVLV--MDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK- 122
++G GD ++ + MD G SL+ + ++ + + +A ++ + ++H K
Sbjct: 63 GFYGAFYNNGDISICMEYMD--GGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH 120
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASM 182
+HRD+KP N L+ Q+ + DFG++ + ++ K GT+ Y +
Sbjct: 121 KIIHRDVKPSNILVN---SRGQIKLCDFGVSGQLVNSLA---------KTFVGTSSYMAP 168
Query: 183 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
G + S + D+ SLG L+ G P+
Sbjct: 169 ERIQGNDYSVKSDIWSLGLSLIELATGRFPY 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 41/159 (25%), Positives = 65/159 (40%), Gaps = 37/159 (23%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIK-------LENVKTKHPQ----LLYES------KLYR 57
IG G+FGE+ L T A+K LE + H + +L E+ KLY
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYY 68
Query: 58 ILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINR 115
Q + +Y L+M+ L P D+ +K + + + I
Sbjct: 69 SFQ-------------DENYLYLIMEYL-PG-GDMMTLLMKKDTFTEEETRFYIAETILA 113
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
++ +H ++HRDIKPDN L+ + + DFGL
Sbjct: 114 IDSIHKLGYIHRDIKPDNLLL---DAKGHIKLSDFGLCT 149
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 63/242 (26%), Positives = 98/242 (40%), Gaps = 46/242 (19%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQ-LLYESKLYRILQGGT 63
F +G +G+GSFG + + + T E AIK E +K K Q + E + L
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 64 GIPNVRWFGVEGDYNVLVMDLLGPSL-----------EDLFNFCSRKLSLKTVLMLADQM 112
+ + F E L+ ++G L D+ F +L L
Sbjct: 80 IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA--------- 130
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD-TSTHQHIPYRENK 171
E++HSK ++RD+KP+N L L + + V + DFG AKK D T T
Sbjct: 131 ---FEYLHSKDIIYRDLKPENLL--LDNKGH-VKVTDFGFAKKVPDRTFT---------- 174
Query: 172 NLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 231
L GT Y + + D ++G +L F+ G P+ T + YEKI
Sbjct: 175 -LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD---DTPFRIYEKILAG 230
Query: 232 KV 233
++
Sbjct: 231 RL 232
|
Length = 329 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 44/157 (28%), Positives = 75/157 (47%), Gaps = 16/157 (10%)
Query: 13 RKIGSGSFGEIYL------GTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIP 66
R +G G FG++ L G N T E+VA+K ++ + K IL+
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDN--TGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 67
Query: 67 NVRWFGV---EGDYNV-LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
V++ G+ +G + L+M+ L SL++ K++LK L A Q+ ++++ S
Sbjct: 68 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS 127
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158
+ ++HRD+ N L+ +QV I DFGL K
Sbjct: 128 RQYVHRDLAARNVLV---ESEHQVKIGDFGLTKAIET 161
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 42/146 (28%), Positives = 67/146 (45%), Gaps = 9/146 (6%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTK--HPQLLYESKLYRILQGGTGIPNV 68
+ +G G+FG + + T + VAIK ++ T + E KL + L+ I
Sbjct: 16 QPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLS 75
Query: 69 RWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRD 128
F + V +LLG L L SR L + + Q++ +++VHS +HRD
Sbjct: 76 DIFISPLEDIYFVTELLGTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRD 133
Query: 129 IKPDNFLMGLGRRANQVYIIDFGLAK 154
+KP N L+ + I DFGLA+
Sbjct: 134 LKPSNILIN---ENCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 46/165 (27%), Positives = 70/165 (42%), Gaps = 35/165 (21%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKTKHPQLLYES------K 54
+ +G G+FGE+ L + T A+K + +VK + +L E+ +
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAER-DILAEADNEWVVR 65
Query: 55 LYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
LY Q + V + GD L++ + G EDL F ++
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRM-GIFPEDLARF------------YIAELTC 112
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
VE VH F+HRDIKPDN L+ R + + DFGL +R T
Sbjct: 113 AVESVHKMGFIHRDIKPDNILID---RDGHIKLTDFGLCTGFRWT 154
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 69/284 (24%), Positives = 117/284 (41%), Gaps = 48/284 (16%)
Query: 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LLYESKLYRILQGGTGIPNV 68
+L +K+G+G FGE+++G + +VA+K T Q L E+ L + LQ V
Sbjct: 9 KLVKKLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDK---LV 64
Query: 69 RWFGV----EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
R + V E Y + G L+ L + K+ L ++ + Q+ + ++ K++
Sbjct: 65 RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY 124
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN--LTGTARYASM 182
+HRD++ N L+ + I DFGLA+ D RE + TA A
Sbjct: 125 IHRDLRAANVLVS---ESLMCKIADFGLARVIED----NEYTAREGAKFPIKWTAPEAIN 177
Query: 183 NTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
I + D+ S G +L+Y G +P+ G+ S + AL
Sbjct: 178 FGSFTI----KSDVWSFG-ILLYEIVTYGKIPYPGMSN---------------SDVMSAL 217
Query: 241 CRGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276
RGY P E C + +++P + YL+ + D
Sbjct: 218 QRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 40/168 (23%), Positives = 63/168 (37%), Gaps = 49/168 (29%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKL-------------------------ENVKTKHPQ 48
K+G G++ +Y G N T E VA+K EN+ H
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV 66
Query: 49 LLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLML 108
+ E+KL + + ++ D MD G L TV
Sbjct: 67 IHTENKLMLVFEY-----------MDKDLKKY-MDTHGVR---------GALDPNTVKSF 105
Query: 109 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
Q++ + F H LHRD+KP N L+ + ++ + DFGLA+ +
Sbjct: 106 TYQLLKGIAFCHENRVLHRDLKPQNLLIN---KRGELKLADFGLARAF 150
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 52/215 (24%), Positives = 83/215 (38%), Gaps = 19/215 (8%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN----VKTKHPQLLYESKLYRILQGGTG 64
F + + IG G+FGE+ + T A+K+ N +K E + +
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 65 IPNVRWFGVEGDYNVLVMDL-LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
I + + + +Y LVMD +G L L + +L +M+ + +H
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMN 183
++HRDIKPDN L+ + + + DFG K T Q + GT Y S
Sbjct: 123 YVHRDIKPDNVLLDMN---GHIRLADFGSCLKMNQDGTVQ------SSVAVGTPDYISPE 173
Query: 184 THLGIEQSRRD-----DLESLGYVLMYFLRGSLPW 213
+E D SLG + L G P+
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 46/202 (22%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENV-KTKHPQLLYESKLYRILQGGTGIPNVRWFG 72
KIG GS G + + T T ++VA+K ++ K + +LL+ + + ++
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 73 VEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKP 131
+ GD +VM+ L G +L D+ +++ + + + ++ + ++H++ +HRDIK
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVT--HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKS 146
Query: 132 DNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQS 191
D+ L+ R + + DFG + + +P R K+L GT + + +
Sbjct: 147 DSILLTSDGR---IKLSDFGFCAQ-----VSKEVPKR--KSLVGTPYWMAPEVISRLPYG 196
Query: 192 RRDDLESLGYVLMYFLRGSLPW 213
D+ SLG +++ + G P+
Sbjct: 197 TEVDIWSLGIMVIEMIDGEPPY 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 59/227 (25%), Positives = 93/227 (40%), Gaps = 57/227 (25%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIK-------LEN--------------VKTKHPQLLYES 53
+G GSFG++ L TNE AIK LE+ + +HP L +
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFL---T 59
Query: 54 KLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNF-CSRKLSLKTVLMLADQ 111
L+ Q ++ VM+ L G L +F+ S + A +
Sbjct: 60 HLFCTFQ-------------TKEHLFFVMEYLNGGDL--MFHIQSSGRFDEARARFYAAE 104
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENK 171
+I ++F+H K ++RD+K DN L+ + + I DFG+ K +++ E K
Sbjct: 105 IICGLQFLHKKGIIYRDLKLDNVLLD---KDGHIKIADFGMCK--------ENM-NGEGK 152
Query: 172 NLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQG 215
T GT Y + G + + D S G VL+Y L G P+ G
Sbjct: 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFG-VLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 37/152 (24%), Positives = 69/152 (45%), Gaps = 10/152 (6%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLLYESKLYRILQGGTG 64
+ + + IG G+FGE+ L + T + A+KL E +K +E +
Sbjct: 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 65 IPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKS 123
+ + + + Y +VM+ + DL N S + K +++ ++ +HS
Sbjct: 105 VVQLFYAFQDDRYLYMVMEYMPGG--DLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMG 162
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155
F+HRD+KPDN L+ ++ + + DFG K
Sbjct: 163 FIHRDVKPDNMLLD---KSGHLKLADFGTCMK 191
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 40/170 (23%), Positives = 81/170 (47%), Gaps = 19/170 (11%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKLYRILQG 61
P + + + IG G++G+++ N + + A+K L+ + ++ E Y IL+
Sbjct: 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAE---YNILKA 70
Query: 62 GTGIPNV-RWFG-------VEGDYNVLVMDLL-GPSLEDLFN-FCSR--KLSLKTVLMLA 109
+ PNV +++G GD LV++L G S+ DL F R ++ + +
Sbjct: 71 LSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYIL 130
Query: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
+ + ++ +H +HRD+K +N L+ V ++DFG++ + T
Sbjct: 131 HEALMGLQHLHVNKTIHRDVKGNNILLTTE---GGVKLVDFGVSAQLTST 177
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 34/145 (23%), Positives = 70/145 (48%), Gaps = 7/145 (4%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGV 73
++G G+FG++Y N +T A K+ K++ Y ++ IL V+ G
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEI-EILATCNHPYIVKLLGA 77
Query: 74 ---EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 130
+G +++ G +++ + R L+ + ++ QM+ ++++HS +HRD+K
Sbjct: 78 FYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLK 137
Query: 131 PDNFLMGLGRRANQVYIIDFGLAKK 155
N L+ L + + DFG++ K
Sbjct: 138 AGNVLLTLD---GDIKLADFGVSAK 159
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 40/163 (24%), Positives = 65/163 (39%), Gaps = 44/163 (26%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIK---------------LENVKT----KHPQL--LYE 52
KIG GS+G ++ N +T + VAIK L ++ KHP L L E
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 53 S-KLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 111
+ R L LV + ++ + R + + + Q
Sbjct: 68 VFRRKRKLH-------------------LVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQ 108
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+ V F H + +HRD+KP+N L+ + Q+ + DFG A+
Sbjct: 109 TLQAVNFCHKHNCIHRDVKPENILI---TKQGQIKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 63/280 (22%), Positives = 113/280 (40%), Gaps = 39/280 (13%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LLYESKLYRILQGGTGIPN 67
+L +K+G+G FGE+++ T + +VA+K + + L E+ + + LQ +
Sbjct: 8 LKLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL 66
Query: 68 VRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHR 127
E Y + G L+ L + K L ++ + Q+ + F+ ++++HR
Sbjct: 67 HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHR 126
Query: 128 DIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN--LTGTARYASMNTH 185
D++ N L+ + I DFGLA+ D RE + TA A
Sbjct: 127 DLRAANILVS---ASLVCKIADFGLARVIED----NEYTAREGAKFPIKWTAPEAINFGS 179
Query: 186 LGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 244
I + D+ S G +LM + G +P+ G+ I AL RGY
Sbjct: 180 FTI----KSDVWSFGILLMEIVTYGRIPYPGMSN---------------PEVIRALERGY 220
Query: 245 --------PTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276
P E + C R +++P + Y++ + D
Sbjct: 221 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 4e-05
Identities = 30/113 (26%), Positives = 54/113 (47%), Gaps = 21/113 (18%)
Query: 116 VEFVHSKSFLHRDIKPDNFLM-GLGRRANQVYIIDFGLAK------------KYRDTSTH 162
+E++H+ +HRD+KPDN L+ +G + + DFGL+K + + T
Sbjct: 114 LEYLHNYGIVHRDLKPDNLLITSMG----HIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169
Query: 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
+ + +K + GT Y + L + D ++G +L FL G +P+ G
Sbjct: 170 EFL----DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 218
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 5e-05
Identities = 67/268 (25%), Positives = 111/268 (41%), Gaps = 39/268 (14%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL----LYESKLYRILQGGTGIPNVR 69
+IG G+FGE++ G N VA+K +T P L L E+ RIL+ + VR
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVK-SCRETLPPDLKAKFLQEA---RILKQYSHPNIVR 57
Query: 70 WFGV--EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 126
GV + +VM+L+ G +L +K ++ + + +E++ SK +H
Sbjct: 58 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIH 117
Query: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKK-----YRDTSTHQHIPYR-ENKNLTGTARYA 180
RD+ N L+ N + I DFG++++ Y T + IP + RY+
Sbjct: 118 RDLAARNCLV---TEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYS 174
Query: 181 SMNTHLGIEQSRRDDLESLGYVLM-YFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239
S D+ S G +L F G++P+ L + +Q E I E+ V
Sbjct: 175 S-----------ESDVWSFGILLWEAFSLGAVPYANL---SNQQTREAI-EQGVRLPCPE 219
Query: 240 LCRGYPTEFASYFHYCRSLRFDDKPDYA 267
LC P C +P ++
Sbjct: 220 LC---PDAVYRLMERCWEYDPGQRPSFS 244
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|225023 COG2112, COG2112, Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 7e-05
Identities = 42/193 (21%), Positives = 65/193 (33%), Gaps = 40/193 (20%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFG 72
+++ G+ +YLG EVA+K+ + L E+K+ IL G P V ++G
Sbjct: 28 KELAKGTTSVVYLGE--WRGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYG 85
Query: 73 VEGDYNVLVMD-LLGPSLEDLFNFCSRKLSLKTV---LMLADQMINRVEFVHSKSFLHRD 128
+ + M+ + G L L RK L+ + L I E +
Sbjct: 86 ----EDFIRMEYIDGRPLGKLEIGGDRKHLLRVLEKAYKLDRLGIEHGELSRPWKNV--- 138
Query: 129 IKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 188
+ D VYIIDF A + N+T L
Sbjct: 139 LVND----------RDVYIIDFDSATFKKKPR-----------NVTQALSL------LFR 171
Query: 189 EQSRRDDLESLGY 201
E R + GY
Sbjct: 172 EGLRIEKTILRGY 184
|
Length = 201 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 40/165 (24%), Positives = 76/165 (46%), Gaps = 37/165 (22%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL------------ENVKTKHPQL-LYESK- 54
F + + I G+FG++YLG ++ A+K+ V+ + L L +S
Sbjct: 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPF 65
Query: 55 ---LYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 111
LY LQ + V + + GD SL ++ + ++++K + +
Sbjct: 66 IVHLYYSLQSANNVYLVMEYLIGGDVK---------SLLHIYGYFDEEMAVKYI----SE 112
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI--IDFGLAK 154
+ ++++H +HRD+KPDN L+ +N+ +I DFGL+K
Sbjct: 113 VALALDYLHRHGIIHRDLKPDNMLI-----SNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 46/170 (27%), Positives = 73/170 (42%), Gaps = 35/170 (20%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKTKHPQLLYES------K 54
+ +G G+FGE+ L + T+ A+K + +VK + +L E+ K
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAER-DILAEADNEWVVK 65
Query: 55 LYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
LY Q + V + GD L++ + E L F +L+L
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRM-EVFPEVLARFYIAELTLA----------- 113
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164
+E VH F+HRDIKPDN L+ L + + DFGL +R T ++
Sbjct: 114 -IESVHKMGFIHRDIKPDNILIDLD---GHIKLTDFGLCTGFRWTHNSKY 159
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 1e-04
Identities = 49/173 (28%), Positives = 77/173 (44%), Gaps = 37/173 (21%)
Query: 9 FRLGRKIGSGSFG---EIYLGTNIQTNEEVAIKL----------------ENVKTK---H 46
F LGR +G G FG E L + + ++VA+K+ E K H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 47 PQL--LYESKLYRILQGGTGIPNVRW-FGVEGD-YNVLVMDLLGPSLEDLFNFCSRKLSL 102
P + L L +G IP V F GD + L+M +G E+ F L L
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIG---EEPFT-----LPL 112
Query: 103 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155
+T++ + + +E++ SK+F+HRD+ N ++ V + DFGL+KK
Sbjct: 113 QTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLN---ENMTVCVADFGLSKK 162
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 71/284 (25%), Positives = 119/284 (41%), Gaps = 61/284 (21%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPN-V 68
+++GSG FG ++LG + +VAIK+ + E+K+ L PN V
Sbjct: 8 FLKELGSGQFGVVHLG-KWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSH----PNLV 62
Query: 69 RWFGVEGDYN--VLVMDLLGPSLEDLFNFCSR---KLSLKTVLMLADQMINRVEFVHSKS 123
+ +GV +V + + + L N+ KL + +L + + +E++ S
Sbjct: 63 QLYGVCTKQRPIFIVTEYM--ANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG 120
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD---TSTHQHIPYRENKNLTGT---A 177
F+HRD+ N L+G N V + DFGLA+ D TS+ GT
Sbjct: 121 FIHRDLAARNCLVG---EDNVVKVSDFGLARYVLDDQYTSS------------QGTKFPV 165
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKISEKKVST 235
++A S + D+ S G VLM+ F G +P YE+ S +V
Sbjct: 166 KWAPPEVFDYSRFSSKSDVWSFG-VLMWEVFSEGKMP------------YERFSNSEV-- 210
Query: 236 SIEALCRGY--------PTEFASYFHYCRSLRFDDKPDYAYLKR 271
+E++ GY PTE + + C + +D+P + L
Sbjct: 211 -VESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLS 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 1e-04
Identities = 40/156 (25%), Positives = 72/156 (46%), Gaps = 25/156 (16%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLY---------ESK-LYRILQGGT 63
I G+ EIYLG + + IK K +HP+L E++ + R + G
Sbjct: 4 IKRGAEAEIYLGDFL--GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGV 61
Query: 64 GIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
+P V + E ++VM+ + G L+DL N S + + +++ ++ HS
Sbjct: 62 NVPAVYFVDPENF--IIVMEYIEGEPLKDLIN--SNGMEELELSREIGRLVGKL---HSA 114
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158
+H D+ N ++ ++Y+IDFGLA+ +D
Sbjct: 115 GIIHGDLTTSNMIL----SGGKIYLIDFGLAEFSKD 146
|
Length = 211 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 61/246 (24%), Positives = 94/246 (38%), Gaps = 62/246 (25%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT--NIQTNE---EVAIKLENVK---TKHPQLLYESKLYRI 58
K L R++G GSFG +Y G + E VAIK N + + L E+ +
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEAS---V 62
Query: 59 LQGGTGIPNVRWFGV--EGDYNVLVMDLLG-----------------------PSLEDLF 93
++ VR GV G ++VM+L+ P+L+
Sbjct: 63 MKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFI 122
Query: 94 NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
+ +AD M ++ +K F+HRD+ N ++ V I DFG+
Sbjct: 123 QMAAE---------IADGM----AYLAAKKFVHRDLAARNCMVA---EDLTVKIGDFGMT 166
Query: 154 KKYRDTSTHQHIPYR-ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL--MYFLRGS 210
RD + YR K L A + G+ + + D+ S G VL M L
Sbjct: 167 ---RDIYETDY--YRKGGKGLLPVRWMAPESLKDGVFTT-KSDVWSFGVVLWEMATL-AE 219
Query: 211 LPWQGL 216
P+QGL
Sbjct: 220 QPYQGL 225
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 38/156 (24%), Positives = 73/156 (46%), Gaps = 16/156 (10%)
Query: 14 KIGSGSFGEIYLGTNIQTNEE-VAIKLENVKTKHPQL----LYESKLYRILQGGTGIPNV 68
+IG G++G+++ +++ VA+K V+T + + E + R L+ V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 69 RWFGV----EGDYNVLVMDLLGPSLEDLFNFCSRK----LSLKTVLMLADQMINRVEFVH 120
R F V D + + +DL + + + +T+ + Q++ ++F+H
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
S +HRD+KP N L+ Q+ + DFGLA+ Y
Sbjct: 128 SHRVVHRDLKPQNILVTSS---GQIKLADFGLARIY 160
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 46/172 (26%), Positives = 76/172 (44%), Gaps = 33/172 (19%)
Query: 10 RLGRKIGSGSFGEIYLGTNIQTNEE-----VAIK-LENVKTKHPQL--LYESKLYRILQG 61
L R +G G+FGE+Y G + + VA+K L ++ + L E+ ++
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEA----LIMS 64
Query: 62 GTGIPN-VRWFGVEGDYN--VLVMDLLGPSLEDLFNFC---------SRKLSLKTVLMLA 109
N VR GV + ++++L+ DL +F L++K +L A
Sbjct: 65 KFNHQNIVRLIGVSFERLPRFILLELMAGG--DLKSFLRENRPRPERPSSLTMKDLLFCA 122
Query: 110 DQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLAKK-YR 157
+ +++ F+HRDI N L+ G GR A I DFG+A+ YR
Sbjct: 123 RDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAK---IADFGMARDIYR 171
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 50/191 (26%), Positives = 74/191 (38%), Gaps = 43/191 (22%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKTKHPQLLYES- 53
F + IG G+FGE+ L T + A+K L +VK + +L ES
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAER-DVLAESD 59
Query: 54 -----KLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVL 106
LY Q + Y L+M+ L G + L + S
Sbjct: 60 SPWVVSLYYSFQ-------------DAQYLYLIMEFLPGGDLMTMLIKY--DTFSEDVTR 104
Query: 107 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166
+ + +E VH F+HRDIKPDN L+ R + + DFGL+ + H
Sbjct: 105 FYMAECVLAIEAVHKLGFIHRDIKPDNILID---RGGHIKLSDFGLSTGFH--KQHDSAY 159
Query: 167 YRENKNLTGTA 177
Y+ K L G +
Sbjct: 160 YQ--KLLQGKS 168
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 50/154 (32%), Positives = 78/154 (50%), Gaps = 23/154 (14%)
Query: 15 IGSGSFGEI----Y--LGTNIQTNEEVAIK-LENVKTKHPQ-LLYESKLYRILQGGTGIP 66
+G G+FG + Y L N T E VA+K L++ +H + E ++ + LQ
Sbjct: 12 LGKGNFGSVELCRYDPLQDN--TGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDN--- 66
Query: 67 NVRWFGV---EGDYNV-LVMDLLGP--SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
V++ GV G N+ LVM+ L P SL D +L + +L+ A Q+ +E++
Sbjct: 67 IVKYKGVCYSAGRRNLRLVMEYL-PYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG 125
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
SK ++HRD+ N L+ N+V I DFGL K
Sbjct: 126 SKRYVHRDLATRNILV---ESENRVKIGDFGLTK 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 60/222 (27%), Positives = 93/222 (41%), Gaps = 23/222 (10%)
Query: 2 EPRVGNK-----FRLGRKIGSGSFGEIYLGTNIQTN-EEVAIK-LENVKT-KHPQLLYES 53
EP+ NK F R +G+GSFG + L T + VAIK E K K Q+ +
Sbjct: 20 EPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF 79
Query: 54 KLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVL--MLADQ 111
+IL V +G D + L + L + F F R + A Q
Sbjct: 80 SERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQ 139
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENK 171
++ E++ S + ++RD+KP+N L+ + + + DFG AK DT T+
Sbjct: 140 IVLIFEYLQSLNIVYRDLKPENLLLD---KDGFIKMTDFGFAKVV-DTRTY--------- 186
Query: 172 NLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
L GT Y + L + + D +LG + L G P+
Sbjct: 187 TLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 47/180 (26%), Positives = 81/180 (45%), Gaps = 40/180 (22%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLY--RILQGG 62
VG +++ IG G++G + T+ T +VAIK P +E + + R L+
Sbjct: 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIK-----KISP---FEHQTFCQRTLRE- 53
Query: 63 TGIPNVRWFGVEGDYNVL-VMDLLGPSLEDLFN----------------FCSRKLSLKTV 105
I +R F E N++ ++D++ P + FN ++ LS +
Sbjct: 54 --IKILRRFKHE---NIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHI 108
Query: 106 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKYRDTSTHQH 164
Q++ ++++HS + LHRD+KP N L+ N + I DFGLA+ H H
Sbjct: 109 QYFLYQILRGLKYIHSANVLHRDLKPSNLLLN----TNCDLKICDFGLARI--ADPEHDH 162
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 40/160 (25%), Positives = 69/160 (43%), Gaps = 8/160 (5%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN----VKTKHPQLLYESKLYRILQGGTG 64
F + + IG G+FGE+ + T + A+K+ N +K E + +
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW 62
Query: 65 IPNVRWFGVEGDYNVLVMDL-LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
I N+ + + + LVMD +G L L + +L +M+ ++ VH
Sbjct: 63 ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG 122
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163
++HRDIKPDN L+ + + + DFG + T Q
Sbjct: 123 YVHRDIKPDNVLLD---KNGHIRLADFGSCLRLLADGTVQ 159
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 2e-04
Identities = 39/169 (23%), Positives = 76/169 (44%), Gaps = 30/169 (17%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-------LLYESKLYR---- 57
F L +G+G++G++Y G +++T + AIK+ +V + +L + +R
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 58 -----ILQGGTGIPNVRWFGVEGDYNVLVMDLLGP-SLEDLF-NFCSRKLSLKTVLMLAD 110
I + G+ + W LVM+ G S+ DL N L + + +
Sbjct: 68 YYGAFIKKNPPGMDDQLW---------LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR 118
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
+++ + +H +HRDIK N L+ +V ++DFG++ + T
Sbjct: 119 EILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRT 164
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 30/109 (27%), Positives = 53/109 (48%), Gaps = 14/109 (12%)
Query: 109 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYR 168
A +++ ++F+HSK ++RD+K DN ++ R + I DFG+ K+ +
Sbjct: 102 AAEIVCGLQFLHSKGIIYRDLKLDNVMLD---RDGHIKIADFGMCKEN---------VFG 149
Query: 169 ENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
+N+ T GT Y + G++ + D S G +L L G P+ G
Sbjct: 150 DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 2e-04
Identities = 45/207 (21%), Positives = 88/207 (42%), Gaps = 13/207 (6%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGV 73
K+G GS+ +Y G + + VA+K+ ++ + + +L+G V +
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDI 71
Query: 74 --EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKP 131
+ LV + + L + L + V + Q++ + ++H + LHRD+KP
Sbjct: 72 IHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKP 131
Query: 132 DNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQ 190
N L+ ++ + DFGLA+ + +P N T Y + LG E
Sbjct: 132 QNLLIS---DTGELKLADFGLARA-------KSVPSHTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 191 SRRDDLESLGYVLMYFLRGSLPWQGLK 217
S D+ +G + + ++G + G+K
Sbjct: 182 STCLDMWGVGCIFVEMIQGVAAFPGMK 208
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 38/159 (23%), Positives = 69/159 (43%), Gaps = 35/159 (22%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLLYESKLYRILQGGTGIPNVRWF 71
IG G+FG + + + +A+K + + +LL + L +++ V+++
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMD--LDVVMRSSDCPYIVKFY 69
Query: 72 GV---EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR-------VEFVHS 121
G EGD + M+L+ SL+ + K V + +I V V +
Sbjct: 70 GALFREGDCWI-CMELMDISLDKFY---------KYVYEVLKSVIPEEILGKIAVATVKA 119
Query: 122 KSFL-------HRDIKPDNFLMGLGRRANQVYIIDFGLA 153
++L HRD+KP N L L R N + + DFG++
Sbjct: 120 LNYLKEELKIIHRDVKPSNIL--LDRNGN-IKLCDFGIS 155
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 3e-04
Identities = 51/227 (22%), Positives = 92/227 (40%), Gaps = 48/227 (21%)
Query: 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPN---- 67
G +G G++G +Y G TN+ I ++ V+ +L K Y LQ +
Sbjct: 5 GEVLGKGAYGTVYCGL---TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 68 ---VRWFGVEGDYNVL--------------VMDLLGPSLEDLFNFCSRKLSLKTVLMLAD 110
V++ G D N + +++ GP E +F ++
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK------------ 109
Query: 111 QMINRVEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKKYRDTS---THQHIP 166
Q+++ V ++H+ +HRDIK +N LM G + +IDFG A++ TH ++
Sbjct: 110 QILDGVAYLHNNCVVHRDIKGNNVMLMPNG----IIKLIDFGCARRLAWVGLHGTHSNML 165
Query: 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
K++ GT + + R+ D+ S+G + G P
Sbjct: 166 ----KSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 3e-04
Identities = 56/217 (25%), Positives = 88/217 (40%), Gaps = 24/217 (11%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLLYESKLYRILQGGTG----IPN 67
IG G FGE+Y T + A+K + +K K + L ++ + TG I
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 68 VRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVHSKSFL 125
+ + D ++DL+ DL S+ S + A ++I +E +H++ +
Sbjct: 62 MSYAFHTPDKLSFILDLMNGG--DLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVV 119
Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY-ASMNT 184
+RD+KP N L+ V I D GLA + H + GT Y A
Sbjct: 120 YRDLKPANILLD---EHGHVRISDLGLACDFSKKKPHASV---------GTHGYMAPEVL 167
Query: 185 HLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 221
G+ D SLG +L LRG P++ K K
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 56/225 (24%), Positives = 88/225 (39%), Gaps = 49/225 (21%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKL---------ENVKT------------KHPQLLY 51
+ +G GSFG+++L TN+ AIK ++V+ +HP L
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL-- 58
Query: 52 ESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLAD 110
+ LY Q + VM+ L G L C K L A
Sbjct: 59 -THLYCTFQTKENL-------------FFVMEYLNGGDLMFHIQSC-HKFDLPRATFYAA 103
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170
++I ++F+HSK ++RD+K DN L+ + I DFG+ K+ + +
Sbjct: 104 EIICGLQFLHSKGIVYRDLKLDNILLD---TDGHIKIADFGMCKE-------NMLGDAKT 153
Query: 171 KNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
GT Y + LG + + D S G +L L G P+ G
Sbjct: 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 41/158 (25%), Positives = 78/158 (49%), Gaps = 19/158 (12%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKLYRILQGGTGIPN-VRWFG 72
IG G++G++Y TN + A+K L+ + ++ E Y ILQ PN V+++G
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAE---YNILQSLPNHPNVVKFYG 86
Query: 73 V--EGDYNV-----LVMDLL-GPSLEDLFN---FCSRKLSLKTVLMLADQMINRVEFVHS 121
+ + D V LV++L G S+ +L C ++L + + + ++ +H+
Sbjct: 87 MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN 146
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
+HRD+K +N L+ V ++DFG++ + T
Sbjct: 147 NRIIHRDVKGNNILL---TTEGGVKLVDFGVSAQLTST 181
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 36/154 (23%), Positives = 71/154 (46%), Gaps = 11/154 (7%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNV----R 69
++G G+FG++Y N +T A K+ + TK + L + + + PN+
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKV--IDTKSEEELEDYMVEIDILASCDHPNIVKLLD 69
Query: 70 WFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 129
F E + +L+ G +++ + R L+ + ++ Q + + ++H +HRD+
Sbjct: 70 AFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDL 129
Query: 130 KPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163
K N L L + + DFG++ K +T T Q
Sbjct: 130 KAGNILFTLD---GDIKLADFGVSAK--NTRTIQ 158
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 30/110 (27%), Positives = 52/110 (47%), Gaps = 12/110 (10%)
Query: 103 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162
K + +A+ ++ + ++HS+ +HRDIKP N L+ R QV + DFG++ + ++
Sbjct: 105 KVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILL---TRKGQVKLCDFGVSGELVNSLA- 160
Query: 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
TGT+ Y + G S D+ SLG L+ + P
Sbjct: 161 --------GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 35/116 (30%), Positives = 55/116 (47%), Gaps = 22/116 (18%)
Query: 107 MLADQMINRVEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKKYRDT------ 159
+L Q++ ++ VHS+ +HRD+K N FLM G + + DFG +K+Y D+
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG----IIKLGDFGFSKQYSDSVSLDVA 228
Query: 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
S+ PY L RY S++ D+ SLG +L L P++G
Sbjct: 229 SSFCGTPYYLAPELWERKRY-----------SKKADMWSLGVILYELLTLHRPFKG 273
|
Length = 478 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 4e-04
Identities = 49/196 (25%), Positives = 87/196 (44%), Gaps = 32/196 (16%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIK-------LENVKTKHPQ----LLYESKLYRILQGGT 63
IG G+FGE+ L T A+K LE + H + +L E+ +++
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVK--- 65
Query: 64 GIPNVRWFGVEGDYNV-LVMDLLGPSLEDLFNFCSRKLSL---KTVLMLADQMINRVEFV 119
++ + N+ L+M+ L D+ +K +L +T +A+ ++ ++ +
Sbjct: 66 -----MFYSFQDKLNLYLIMEFLPGG--DMMTLLMKKDTLTEEETQFYIAETVL-AIDSI 117
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRE-NKNLTGTAR 178
H F+HRDIKPDN L+ V + DFGL + H+ YR N +L
Sbjct: 118 HQLGFIHRDIKPDNLLLD---SKGHVKLSDFGLCTGLK--KAHRTEFYRNLNHSLPSDFT 172
Query: 179 YASMNTHLGIEQSRRD 194
+ +MN+ E +R+
Sbjct: 173 FQNMNSKRKAETWKRN 188
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 4e-04
Identities = 56/219 (25%), Positives = 89/219 (40%), Gaps = 24/219 (10%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLLYESKLYRILQGGTG----IPN 67
IG G FGE+Y T + A+K + +K K + L ++ + TG I
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 68 VRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVHSKSFL 125
+ + D ++DL+ DL S+ S K + A ++I +E +H++ +
Sbjct: 62 MTYAFHTPDKLCFILDLMNGG--DLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVV 119
Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNT- 184
+RD+KP N L+ V I D GLA + H + GT Y +
Sbjct: 120 YRDLKPANILLD---EHGHVRISDLGLACDFSKKKPHASV---------GTHGYMAPEVL 167
Query: 185 HLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ 223
G D SLG +L LRG P++ K K +
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 5e-04
Identities = 38/162 (23%), Positives = 76/162 (46%), Gaps = 16/162 (9%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-KTKHPQLLYESKLYRILQGGTGIPN 67
F L +G+G++G++Y G +++T + AIK+ +V + + ++ E + + I
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 68 VRWFGV--------EGDYNVLVMDLLGP-SLEDLF-NFCSRKLSLKTVLMLADQMINRVE 117
++G D LVM+ G S+ DL N L + + +++ +
Sbjct: 78 --YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLA 135
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
+H+ +HRDIK N L+ +V ++DFG++ + T
Sbjct: 136 HLHAHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRT 174
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 5e-04
Identities = 57/228 (25%), Positives = 101/228 (44%), Gaps = 36/228 (15%)
Query: 14 KIGSGSFGEIYLG--TNIQTNEE---VAIKLENVKTKHPQLLY--ESKLYRILQGGTGIP 66
++G G+FG+++L N+ ++ VA+K ++ + + E++L +LQ
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQH--- 68
Query: 67 NVRWFGV--EGDYNVLVMDLL------------GPS---LEDLFNFCSRKLSLKTVLMLA 109
VR++GV EG ++V + + GP L + +L+L +L +A
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRE 169
Q+ + + ++ S F+HRD+ N L+G G V I DFG+++ T YR
Sbjct: 129 SQIASGMVYLASLHFVHRDLATRNCLVGQGL---VVKIGDFGMSRDIYSTDY-----YRV 180
Query: 170 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM-YFLRGSLPWQGL 216
R+ + L + + D+ S G VL F G PW L
Sbjct: 181 GGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL 228
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 6e-04
Identities = 34/100 (34%), Positives = 47/100 (47%), Gaps = 15/100 (15%)
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLAKKYRDTSTHQHIPY 167
Q++ V VHSK +HRDIK N L+ GL V + DFG +K Y T +
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGL------VKLGDFGFSKMYAATVSDD---- 200
Query: 168 RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL 207
+ GT Y + S++ D+ SLG VL+Y L
Sbjct: 201 -VGRTFCGTPYYVAPEIWRRKPYSKKADMFSLG-VLLYEL 238
|
Length = 496 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 6e-04
Identities = 42/157 (26%), Positives = 68/157 (43%), Gaps = 12/157 (7%)
Query: 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL--LYESKLYRILQGGTGIPNVR 69
G K+G G++G +Y +E L+ ++ + E L R L+ I +
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQK 65
Query: 70 WFGVEGDYNV-LVMDLLGPSLEDLFNF--CSR------KLSLKTVLMLADQMINRVEFVH 120
F D V L+ D L + F S+ +L V L Q+++ + ++H
Sbjct: 66 VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 121 SKSFLHRDIKPDNFL-MGLGRRANQVYIIDFGLAKKY 156
+ LHRD+KP N L MG G +V I D G A+ +
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 6e-04
Identities = 50/203 (24%), Positives = 96/203 (47%), Gaps = 16/203 (7%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENV-KTKHPQLLY-ESKLYRILQGGTGIPNVRWF 71
KIG GS G + + T + + VA+K ++ K + +LL+ E + R Q + +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 72 GVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 130
V GD +VM+ L G +L D+ +++ + + + ++ + +H++ +HRDIK
Sbjct: 87 LV-GDELWVVMEFLEGGALTDIVT--HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIK 143
Query: 131 PDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ 190
D+ L+ R V + DFG + + +P R K+L GT + + +
Sbjct: 144 SDSILLTHDGR---VKLSDFGFCAQ-----VSKEVPRR--KSLVGTPYWMAPELISRLPY 193
Query: 191 SRRDDLESLGYVLMYFLRGSLPW 213
D+ SLG +++ + G P+
Sbjct: 194 GPEVDIWSLGIMVIEMVDGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 7e-04
Identities = 41/159 (25%), Positives = 68/159 (42%), Gaps = 23/159 (14%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNE----EVAIKLENVKTKHPQ-----LLYESKLYRIL 59
+ +GSG+FG +Y G I E VAIK+ ++ + +L E+ +
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKV--LREETSPKANKEILDEAY----V 62
Query: 60 QGGTGIPN-VRWFGV-EGDYNVLVMDL--LGPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
P+ VR G+ L+ L LG L+ + N + + +L Q+
Sbjct: 63 MASVDHPHVVRLLGICLSSQVQLITQLMPLGCLLDYVRNHKDN-IGSQYLLNWCVQIAKG 121
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+ ++ K +HRD+ N L+ + V I DFGLAK
Sbjct: 122 MSYLEEKRLVHRDLAARNVLV---KTPQHVKITDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 9e-04
Identities = 55/221 (24%), Positives = 91/221 (41%), Gaps = 51/221 (23%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL------------ENVK-TKHPQLLYESK 54
++ L +++G GSFG +YL + + E +K+ E V+ + QLL SK
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLL--SK 58
Query: 55 LYRILQGGTGIPNVRWFG---VEGDYNVLVMDLL-GPSLEDLFNFCS---RKLSLKTVLM 107
L P + F +E D ++ + G L+ + LS V
Sbjct: 59 LDH--------PAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCE 110
Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR---DTSTHQH 164
Q++ V ++H + LHRD+K N + + N + I DFG+++ D +T
Sbjct: 111 WFIQLLLGVHYMHQRRILHRDLKAKNIFL----KNNLLKIGDFGVSRLLMGSCDLAT--- 163
Query: 165 IPYRENKNLTGTARYASMN--THLGIEQSRRDDLESLGYVL 203
TGT Y S H G + + D+ SLG +L
Sbjct: 164 -------TFTGTPYYMSPEALKHQGYDS--KSDIWSLGCIL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 41/154 (26%), Positives = 71/154 (46%), Gaps = 19/154 (12%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLLY-ESKLYRILQGGTGIP 66
+ IGSG+ G + + T + VAIK +NV H + Y E L +++ I
Sbjct: 22 KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVT--HAKRAYRELVLMKLVNHKNIIG 79
Query: 67 NVRWFGVEGDYN-----VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
+ F + LVM+L+ +L + L + + L QM+ ++ +HS
Sbjct: 80 LLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHS 136
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155
+HRD+KP N ++ + + I+DFGLA+
Sbjct: 137 AGIIHRDLKPSNIVV---KSDCTLKILDFGLART 167
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 62/268 (23%), Positives = 97/268 (36%), Gaps = 22/268 (8%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTK-HPQLLYESKLYRILQGGTG 64
F + KIG GSFG ++ A+K L + + + + E+++ L
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 65 IPNVRWFGVEGDYNVLVMDLLGPSLEDLFN-FCSRKLSLKTVLMLADQMINRVEFVHSKS 123
I F +G N+++ L L R L V Q++ + +HSK
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK 121
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMN 183
LHRDIK N + + V I D G+AK D + + GT Y S
Sbjct: 122 ILHRDIKSLNLFLDAY---DNVKIGDLGVAKLLSDNTNFA-------NTIVGTPYYLSPE 171
Query: 184 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243
+ + D+ +LG VL G P+ G K + VS +
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVS-------QM 224
Query: 244 YPTEFASYFHYCRSLRFDDKPDYAYLKR 271
Y + A C + + +PD L R
Sbjct: 225 YSQQLAQLIDQCLTKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 48/184 (26%), Positives = 80/184 (43%), Gaps = 41/184 (22%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYL------------GTNIQTNEE--VAIKL---ENVKTK 45
PR + RL K+G G FGE++L G + VA+K+ + KT
Sbjct: 3 PR--QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTA 60
Query: 46 HPQLLYESKLYRILQGGTGIPNV-RWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK----- 99
L E K+ L+ PN+ R GV + L M DL F S++
Sbjct: 61 RNDFLKEIKIMSRLKN----PNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIEST 116
Query: 100 ---------LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 150
+S+ +L +A Q+ + ++++ S +F+HRD+ N L+G + I DF
Sbjct: 117 FTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG---NHYTIKIADF 173
Query: 151 GLAK 154
G+++
Sbjct: 174 GMSR 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 35/140 (25%), Positives = 61/140 (43%), Gaps = 17/140 (12%)
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170
Q+I+ +E +H + ++RD+KP+N L+ V I D GLA + +D + +
Sbjct: 105 QIISGLEHLHQRRIIYRDLKPENVLLD---NDGNVRISDLGLAVELKDGQS-------KT 154
Query: 171 KNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL--RGSLPWQGLKAGTKKQKYEKI 228
K GT + + G E D +LG L + RG +G K K+ K +
Sbjct: 155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRIL 214
Query: 229 SE-----KKVSTSIEALCRG 243
++ K S + ++ C
Sbjct: 215 NDSVTYPDKFSPASKSFCEA 234
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 39/150 (26%), Positives = 65/150 (43%), Gaps = 10/150 (6%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLLYESKLYRILQGGTGIPNVRW 70
IG G+FGE+ L + + + A+KL E +K +E + I+ V+
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEER--DIMAFANSPWVVQL 108
Query: 71 FGVEGDYNVLVMDLLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDI 129
F D L M + DL N S + K +++ ++ +HS +HRD+
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDV 168
Query: 130 KPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
KPDN L+ + + + DFG K +T
Sbjct: 169 KPDNMLLD---KHGHLKLADFGTCMKMDET 195
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 42/158 (26%), Positives = 71/158 (44%), Gaps = 20/158 (12%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFG 72
+KIG GSFG+ L + + ++ IK N+ P+ ES+ + PN+ +
Sbjct: 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65
Query: 73 VEGDYN---VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN-------RVEFVHSK 122
+ N +VMD DL+ + + + VL DQ+++ ++ VH +
Sbjct: 66 ESFEENGNLYIVMDYCEGG--DLYKKINAQ---RGVLFPEDQILDWFVQICLALKHVHDR 120
Query: 123 SFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKKYRDT 159
LHRDIK N FL + + + DFG+A+ T
Sbjct: 121 KILHRDIKSQNIFLT----KDGTIKLGDFGIARVLNST 154
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 59/258 (22%), Positives = 98/258 (37%), Gaps = 79/258 (30%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEE-----VAIK-----------------LENVKT- 44
+ LG+ +G G+FG++ + + VA+K +E +K
Sbjct: 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMI 72
Query: 45 -KHPQLL-------YESKLYRIL----QGGTGIPNVRWF-----GVEGDYNVLVMDLLGP 87
KH ++ E LY ++ G N+R F +
Sbjct: 73 GKHKNIINLLGVCTQEGPLYVVVEYAAHG-----NLRDFLRARRPPGEYASPDDPRPPEE 127
Query: 88 SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI 147
L+ K ++ A Q+ +EF+ SK +HRD+ N L+ + + I
Sbjct: 128 -----------TLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED---HVMKI 173
Query: 148 IDFGLAKK------YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGY 201
DFGLA+ YR T T+ +P K + A + + TH QS D+ S G
Sbjct: 174 ADFGLARDIHHIDYYRKT-TNGRLPV---KWMAPEALFDRVYTH----QS---DVWSFG- 221
Query: 202 VLMY--FLRGSLPWQGLK 217
VL++ F G P+ G+
Sbjct: 222 VLLWEIFTLGGSPYPGIP 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 32/101 (31%), Positives = 51/101 (50%), Gaps = 12/101 (11%)
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175
++ +HS ++RD+KP+N L+ + + DFGL+K+ D H+ Y + G
Sbjct: 111 LDHLHSLGIIYRDLKPENILLD---EEGHIKLTDFGLSKESID---HEKKAY----SFCG 160
Query: 176 TARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQG 215
T Y + ++ D S G VLM+ L GSLP+QG
Sbjct: 161 TVEYMAPEVVNRRGHTQSADWWSFG-VLMFEMLTGSLPFQG 200
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 0.001
Identities = 16/44 (36%), Positives = 29/44 (65%), Gaps = 3/44 (6%)
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
Q++ ++++HS + +HRD+KP N L+ +V + DFGLA+
Sbjct: 115 QLLKALKYIHSGNVIHRDLKPSNILLN---SDCRVKLADFGLAR 155
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 17/152 (11%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEE----VAIKL--ENVKTK-HPQLLYESKLYRILQGGTGI 65
+ +GSG+FG +Y G I E VAIK+ EN K + ++L E+ + G G
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEA----YVMAGVGS 68
Query: 66 PNV-RWFGVEGDYNVLVMDLLGP--SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
P V R G+ V ++ L P L D ++ + +L Q+ + ++
Sbjct: 69 PYVCRLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV 128
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+HRD+ N L+ + N V I DFGLA+
Sbjct: 129 RLVHRDLAARNVLV---KSPNHVKITDFGLAR 157
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 15/49 (30%), Positives = 30/49 (61%), Gaps = 3/49 (6%)
Query: 91 DLFNFCSRK---LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 136
DL+ + + L L V +A Q+++ ++++H + +HRDIK +N L+
Sbjct: 245 DLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV 293
|
Length = 461 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 40/152 (26%), Positives = 72/152 (47%), Gaps = 9/152 (5%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPN 67
++ + R +G GSFG L ++ ++++ A+K E K + +S+ +L PN
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMK-EIRLPKSSSAVEDSRKEAVLLAKMKHPN 59
Query: 68 VRWF--GVEGDYNV-LVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
+ F E D ++ +VM+ G ++ + + T+L QM V+ +H K
Sbjct: 60 IVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK 119
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
LHRDIK N + + +V + DFG A+
Sbjct: 120 RVLHRDIKSKNIFL---TQNGKVKLGDFGSAR 148
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 40/173 (23%), Positives = 70/173 (40%), Gaps = 23/173 (13%)
Query: 80 LVMDLL-GPSLE-DLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 137
LVM L+ G L+ ++N + A Q+I +E +H + ++RD+KP+N L+
Sbjct: 70 LVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLD 129
Query: 138 LGRRANQVYIIDFGLAKKYRD-TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDL 196
V I D GLA + + GT Y + G D
Sbjct: 130 ---DHGNVRISDLGLAVELKGGKKIKGRA---------GTPGYMAPEVLQGEVYDFSVDW 177
Query: 197 ESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFA 249
+LG L + G P++ Q+ EK+ ++++ + YP +F+
Sbjct: 178 FALGCTLYEMIAGRSPFR--------QRKEKVEKEELKRRTLEMAVEYPDKFS 222
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.002
Identities = 41/157 (26%), Positives = 69/157 (43%), Gaps = 12/157 (7%)
Query: 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL--LYESKLYRILQGGTGIPNVR 69
G K+G G++G +Y ++ L+ ++ + E L R L+ I +
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQK 65
Query: 70 WFGVEGDYNV-LVMDLLGPSLEDLFNFC-SRKLSLKTVLM-------LADQMINRVEFVH 120
F D V L+ D L + F + K + K V + L Q+++ + ++H
Sbjct: 66 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125
Query: 121 SKSFLHRDIKPDNFL-MGLGRRANQVYIIDFGLAKKY 156
+ LHRD+KP N L MG G +V I D G A+ +
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 51/183 (27%), Positives = 73/183 (39%), Gaps = 55/183 (30%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEE---VAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVR 69
R IG G FG +Y GT I ++ + A+K L RI T + V
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVK---------------SLNRI----TDLEEVE 41
Query: 70 WFGVEG-------DYNVLVMDLLGPSLE---------------DLFNFC---SRKLSLKT 104
F EG NVL LLG L DL NF + ++K
Sbjct: 42 QFLKEGIIMKDFSHPNVL--SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKD 99
Query: 105 VLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT---ST 161
++ Q+ +E++ SK F+HRD+ N ++ + V + DFGLA+ D S
Sbjct: 100 LIGFGLQVAKGMEYLASKKFVHRDLAARNCMLD---ESFTVKVADFGLARDIYDKEYYSV 156
Query: 162 HQH 164
H H
Sbjct: 157 HNH 159
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.002
Identities = 57/228 (25%), Positives = 96/228 (42%), Gaps = 32/228 (14%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPN-- 67
L R++G G+FG+++L E L VKT K +R + T + +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 68 -VRWFGV--EGDYNVLVMDLLGPSLEDLFNFCS---------------RKLSLKTVLMLA 109
V+++GV EGD ++V + + DL F +L+ +L +A
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHG--DLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIA 126
Query: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRE 169
Q+ + ++ S+ F+HRD+ N L+G V I DFG+++ T YR
Sbjct: 127 QQIAAGMVYLASQHFVHRDLATRNCLVG---ENLLVKIGDFGMSRDVYSTDY-----YRV 178
Query: 170 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM-YFLRGSLPWQGL 216
+ R+ + + + + D+ SLG VL F G PW L
Sbjct: 179 GGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.003
Identities = 38/148 (25%), Positives = 69/148 (46%), Gaps = 10/148 (6%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLLYESKLYRILQGGTG 64
F + + IG G+FGE+ L + + + A+KL E +K +E +
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEW 104
Query: 65 IPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKS 123
I + + + Y +VM+ + P DL N S + K +++ ++ +HS
Sbjct: 105 IVQLHYAFQDDKYLYMVMEYM-PG-GDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMG 162
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFG 151
F+HRD+KPDN L+ ++ + + DFG
Sbjct: 163 FIHRDVKPDNMLLD---KSGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.003
Identities = 58/230 (25%), Positives = 101/230 (43%), Gaps = 36/230 (15%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGI----- 65
LG+ +G G FG + G Q N++ +I VKT + S++ L +
Sbjct: 3 LGKTLGEGEFGSVMEG---QLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDH 59
Query: 66 PNV-RWFGV-------EGDYNVLVMDLLGPSLEDLFNF--------CSRKLSLKTVLMLA 109
PNV R GV EG Y V+ L DL +F C + L + ++
Sbjct: 60 PNVMRLIGVCLQTVESEG-YPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFM 118
Query: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRE 169
+ + +E++ SKSF+HRD+ N ++ V + DFGL+KK + YR+
Sbjct: 119 TDIASGMEYLSSKSFIHRDLAARNCMLN---ENMNVCVADFGLSKKIYNGDY-----YRQ 170
Query: 170 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL--RGSLPWQGLK 217
+ ++ ++ + + + D+ S G V M+ + RG P+ G++
Sbjct: 171 GRIAKMPVKWIAIESLADRVYTTKSDVWSFG-VTMWEIATRGQTPYPGVE 219
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.004
Identities = 30/108 (27%), Positives = 53/108 (49%), Gaps = 8/108 (7%)
Query: 79 VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 138
LV + L L+ + C LS+ V + Q++ + + H + LHRD+KP N L+
Sbjct: 79 TLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLIS- 137
Query: 139 GRRANQVYIIDFGLAK-KYRDTSTHQH----IPYRENKNLTGTARYAS 181
++ + DFGLA+ K + T+ + + YR L G+ Y++
Sbjct: 138 --ERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYST 183
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.004
Identities = 34/136 (25%), Positives = 64/136 (47%), Gaps = 14/136 (10%)
Query: 80 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 139
LVM+L+ +L + +L + + L QM+ ++ +HS +HRD+KP N ++
Sbjct: 99 LVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV--- 152
Query: 140 RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESL 199
+ + I+DFGLA+ ++ PY T Y + LG+ D+ S+
Sbjct: 153 KSDCTLKILDFGLART--AGTSFMMTPY------VVTRYYRAPEVILGMGYKENVDIWSV 204
Query: 200 GYVLMYFLRGSLPWQG 215
G ++ +R + + G
Sbjct: 205 GCIMGEMVRHKILFPG 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 407 | |||
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.94 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.92 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.91 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.9 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.9 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.9 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.89 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.87 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.87 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.84 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.83 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.82 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.82 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.81 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.79 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.78 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.75 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.72 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.69 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.69 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.68 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.65 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.61 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.54 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.52 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.52 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.51 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.41 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.41 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.34 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.24 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.19 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.15 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.15 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.09 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.09 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.0 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.88 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.81 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.81 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.78 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.77 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.74 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.69 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.65 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.56 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.51 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.48 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.39 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.26 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.16 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.12 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.11 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.02 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.94 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.93 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.88 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.87 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.77 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.7 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.68 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.67 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.62 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.61 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.58 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.56 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.39 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.37 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.35 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.29 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.16 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.07 | |
| PLN02236 | 344 | choline kinase | 96.96 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.85 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.78 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.59 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.41 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.24 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.0 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.96 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.93 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.87 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.86 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.42 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.18 | |
| PTZ00296 | 442 | choline kinase; Provisional | 94.56 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 94.41 |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-57 Score=390.12 Aligned_cols=300 Identities=72% Similarity=1.234 Sum_probs=290.5
Q ss_pred CccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 3 ~~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
-.++++|+++++||+|+||.+|+|.+..+|+.||||+.+.+..++++..|.+++..|++...+|.+.+|+.+..+..+||
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 35789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 83 e~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
|++|.||+++++.|.+.++..+++.++.|++.-++|+|.+++|||||||+|+|++.+...+.+.|+|||+|+.+.+..+.
T Consensus 91 dLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~ 170 (341)
T KOG1163|consen 91 DLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTR 170 (341)
T ss_pred eccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccccc
Confidence 99999999999999999999999999999999999999999999999999999999989999999999999999999999
Q ss_pred cccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhc
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (407)
.|+||++.....||.+|++-..+.+.+++++.|+.|+|++|.++..|.+||++..+.+..+++++|.+++...+++.+|+
T Consensus 171 ~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~ 250 (341)
T KOG1163|consen 171 QHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCK 250 (341)
T ss_pred ccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchhhcccccC
Q 015406 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLAT 302 (407)
Q Consensus 243 ~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~~~~~~~~ 302 (407)
++|.||.-++..|....+++-|++..|.++|+-+|...+++.|..+||+.++++..+...
T Consensus 251 G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~lkqk~~q~~~ 310 (341)
T KOG1163|consen 251 GFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTMLKQKSQQSGR 310 (341)
T ss_pred CCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHHHHHHhhcccC
Confidence 999999999999999999999999999999999999999999999999999876544433
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-54 Score=411.13 Aligned_cols=276 Identities=23% Similarity=0.351 Sum_probs=238.6
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCC-----CCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeE
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 79 (407)
-..+|.+++.||.|+|++|++|+++.+++.||||++.++ ...+-+.+|..+|.+|.+|++|..++..+++....|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 357899999999999999999999999999999987653 334457889999999999999999999999999999
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 80 lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
+|+||+ +|+|.++|++. +.|++..++.++.||+.||+|||++|||||||||+|||| +.++++||+|||.|+.+..
T Consensus 151 FvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILL---d~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILL---DKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeE---cCCCcEEEeeccccccCCh
Confidence 999999 99999999974 689999999999999999999999999999999999999 7999999999999998866
Q ss_pred CCCCccc----CccC--CCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhc
Q 015406 159 TSTHQHI----PYRE--NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (407)
Q Consensus 159 ~~~~~~~----~~~~--~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (407)
....... .+.. ...++||..|.+||++.....+..+|||+||||||+|+.|.+||.+.+. ...+++|....
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne---yliFqkI~~l~ 303 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE---YLIFQKIQALD 303 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH---HHHHHHHHHhc
Confidence 5433111 1111 2569999999999999999999999999999999999999999987544 55666666544
Q ss_pred ccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchhhcccccC
Q 015406 233 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLAT 302 (407)
Q Consensus 233 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~~~~~~~~ 302 (407)
.. +.+++|+.+.+||.++|..||.+|++..+|++ ++|+..+||+.+.++..+.-.
T Consensus 304 y~-----fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~----------HpFF~~Vdw~nlw~~~PP~l~ 358 (604)
T KOG0592|consen 304 YE-----FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA----------HPFFEGVDWENLWQQTPPKLQ 358 (604)
T ss_pred cc-----CCCCCCHHHHHHHHHHHccCccccccHHHHhh----------CcccccCChhhhhhcCCCccc
Confidence 43 45779999999999999999999999877765 489999999998776644433
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-52 Score=377.47 Aligned_cols=292 Identities=60% Similarity=1.035 Sum_probs=282.9
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
.++-.|+++++||+|+||++++|++.-+++.||||....+...+++..|.+.++.|.+.++|+.+++|+.++.+..||||
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 56789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccC--CCCCceEEEEeccceeeeccCCC
Q 015406 84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL--GRRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 84 ~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~--~~~~~~~kL~DFGla~~~~~~~~ 161 (407)
++|.||+|+++.|+++|+.+++..++.|++.-++|+|++.+|.|||||+|+||+. ..+.+.+.|+|||+|+.+.+..+
T Consensus 105 LLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~T 184 (449)
T KOG1165|consen 105 LLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKT 184 (449)
T ss_pred hhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccc
Confidence 9999999999999999999999999999999999999999999999999999974 23457899999999999999999
Q ss_pred CcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHh
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (407)
.+|+||++.+...||.+||+-..+.|.+++++.|+.|||-+++++|.|.+||++.++.+.+++|++|.+.+..++++.+|
T Consensus 185 kqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc 264 (449)
T KOG1165|consen 185 KQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVLC 264 (449)
T ss_pred cccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchh
Q 015406 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKY 295 (407)
Q Consensus 242 ~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~ 295 (407)
.++|.+|...+.....+++++-|+++.+..+|.+++.+.|..+|+.+||..+..
T Consensus 265 ~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~ln~ 318 (449)
T KOG1165|consen 265 EGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMGLNN 318 (449)
T ss_pred hcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccccccccccCC
Confidence 999999999999999999999999999999999999999999999999998763
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-53 Score=388.49 Aligned_cols=273 Identities=21% Similarity=0.256 Sum_probs=230.6
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeE
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 79 (407)
-.++|+++++||+|+||+||+++.+.+++.||+|+++++. .......|..++..++| +.++.+.+.+++.+..|
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~h-PFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKH-PFIVKLIYSFQTEEKLY 101 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCC-CcEeeeEEecccCCeEE
Confidence 3578999999999999999999999999999999887653 23447889999999765 88999999999999999
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 80 lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
||+||+ ||.|...|++ ++.+++..+..++.+|+.||.|||++|||||||||+|||| +..|+++|+|||+|+..-.
T Consensus 102 lVld~~~GGeLf~hL~~-eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILL---d~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQR-EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILL---DEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EEEeccCCccHHHHHHh-cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeee---cCCCcEEEeccccchhccc
Confidence 999999 9999999986 5689999999999999999999999999999999999999 7999999999999996544
Q ss_pred CCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHH
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (407)
... ...+++||+.|||||++.+..|+..+|+||||+++|||++|..||.+ .+..+.+++|...+...
T Consensus 178 ~~~-------~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~---~~~~~~~~~I~~~k~~~--- 244 (357)
T KOG0598|consen 178 DGD-------ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA---EDVKKMYDKILKGKLPL--- 244 (357)
T ss_pred CCC-------ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC---ccHHHHHHHHhcCcCCC---
Confidence 332 24578999999999999999999999999999999999999999987 44567777777766322
Q ss_pred HHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchhhcccccC
Q 015406 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLAT 302 (407)
Q Consensus 239 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~~~~~~~~ 302 (407)
...-++.+.++++.++|..||++|... ..+...-..++++..+||+.+......++.
T Consensus 245 -~p~~ls~~ardll~~LL~rdp~~RLg~------~~d~~~ik~HpfF~~inW~~l~~k~l~PpF 301 (357)
T KOG0598|consen 245 -PPGYLSEEARDLLKKLLKRDPRQRLGG------PGDAEEIKRHPFFKGINWEKLLAKKLSPPF 301 (357)
T ss_pred -CCccCCHHHHHHHHHHhccCHHHhcCC------CCChHHhhcCcccccCCHHHHHhcCCCCCe
Confidence 123378999999999999999999631 111111345688999999988877655543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-52 Score=384.65 Aligned_cols=250 Identities=26% Similarity=0.364 Sum_probs=211.0
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeE
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 79 (407)
...++|.+.++||+|+||+||+|+++.++..||||.+..+. ..+.+..|+.+|+.++| ++|+.+..+....++.|
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H-~nIV~l~d~~~~~~~i~ 85 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKH-PNIVRLLDCIEDDDFIY 85 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCC-cceeeEEEEEecCCeEE
Confidence 45688999999999999999999999999999999887664 23447899999999995 88888889999999999
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCC---ceEEEEeccceee
Q 015406 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA---NQVYIIDFGLAKK 155 (407)
Q Consensus 80 lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~---~~~kL~DFGla~~ 155 (407)
|||||| ||+|.++++. .+.+++.+++.++.||+.||++||+++||||||||+||||+..... ..+||+|||+|+.
T Consensus 86 lVMEyC~gGDLs~yi~~-~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRR-RGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EEEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 999999 9999999997 4589999999999999999999999999999999999999765232 6899999999998
Q ss_pred eccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccc
Q 015406 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (407)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (407)
+..... ..+.+|++.|||||++....|+.|+|+||+|+|||+|++|+.||...+ ..+.+..+.....
T Consensus 165 L~~~~~--------a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t---~~eL~~~~~k~~~-- 231 (429)
T KOG0595|consen 165 LQPGSM--------AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET---PKELLLYIKKGNE-- 231 (429)
T ss_pred CCchhH--------HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC---HHHHHHHHhcccc--
Confidence 875443 568899999999999999999999999999999999999999997644 3454444433322
Q ss_pred cHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHH
Q 015406 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 268 (407)
Q Consensus 236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~ 268 (407)
.++.+...++..+.+++...+..++.+|-++.+
T Consensus 232 ~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~ 264 (429)
T KOG0595|consen 232 IVPVLPAELSNPLRELLISLLQRNPKDRISFED 264 (429)
T ss_pred ccCchhhhccCchhhhhhHHHhcCccccCchHH
Confidence 122223345667778999999999999987543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-52 Score=386.94 Aligned_cols=254 Identities=24% Similarity=0.323 Sum_probs=216.3
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC---------cchHHHHHHHHHHHcCCCCCCeeEEeeee
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---------HPQLLYESKLYRILQGGTGIPNVRWFGVE 74 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~ 74 (407)
.+.+.|.+.+.||+|+||.|-+|..+.+|+.||||+++.... .....+|+++|++|+| |+|+.+..+++.
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~H-P~IV~~~d~f~~ 247 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSH-PNIVRIKDFFEV 247 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCC-CCEEEEeeeeec
Confidence 467789999999999999999999999999999999875421 1235799999999997 788888899999
Q ss_pred CceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccce
Q 015406 75 GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (407)
Q Consensus 75 ~~~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla 153 (407)
.++.||||||+ ||.|.+.+-. ++.+.+..-..++.|++.||.|||++||+||||||+|||++.++.+..+||+|||+|
T Consensus 248 ~ds~YmVlE~v~GGeLfd~vv~-nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 248 PDSSYMVLEYVEGGELFDKVVA-NKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred CCceEEEEEEecCccHHHHHHh-ccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchh
Confidence 99999999999 9999999875 557899999999999999999999999999999999999987777899999999999
Q ss_pred eeeccCCCCcccCccCCCCccccccccccccccCCCC---ChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhh
Q 015406 154 KKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ---SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230 (407)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~---~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~ 230 (407)
+....... ..++|||+.|.|||++.++.+ ..++||||+||+||-+++|.+||.+.... ....+.|..
T Consensus 327 K~~g~~sf--------m~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~--~sl~eQI~~ 396 (475)
T KOG0615|consen 327 KVSGEGSF--------MKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD--PSLKEQILK 396 (475)
T ss_pred hcccccee--------hhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC--ccHHHHHhc
Confidence 98765433 468999999999999987653 45889999999999999999999875432 224555666
Q ss_pred hcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015406 231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 231 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
+.... .+..+..++++..+||.+||..||++||++++++
T Consensus 397 G~y~f-~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL 435 (475)
T KOG0615|consen 397 GRYAF-GPLQWDRISEEALDLINWMLVVDPENRPSADEAL 435 (475)
T ss_pred Ccccc-cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHh
Confidence 55543 2345677999999999999999999999976654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-51 Score=377.83 Aligned_cols=252 Identities=23% Similarity=0.337 Sum_probs=215.9
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC---CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCc-eeEEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGD-YNVLVM 82 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~-~~~lvm 82 (407)
.+.+.++.||+|..|+||+++++.+++.+|+|++.... ...++.+|+++++..+ +++|+.+++.+.... ...|+|
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~-spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQ-SPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC-CCCeeeEeEEEEeCCceEEeeh
Confidence 36778899999999999999999999999999884332 3456899999999995 577877777777777 599999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 83 e~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
||| +|||++++... +++++...-.|+.+|++||.|||+ ++||||||||+|||+ +..|.|||||||.++.+.+..
T Consensus 158 EYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLv---NskGeVKicDFGVS~~lvnS~ 233 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLV---NSKGEVKICDFGVSGILVNSI 233 (364)
T ss_pred hhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeee---ccCCCEEeccccccHHhhhhh
Confidence 999 99999999864 679999999999999999999995 999999999999999 689999999999999877652
Q ss_pred CCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCC--CcCchHHHHHHHhhhcccccHH
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL--KAGTKKQKYEKISEKKVSTSIE 238 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~--~~~~~~~~~~~i~~~~~~~~~~ 238 (407)
..+++||..|||||.+.+..|+.++||||||++++|+++|+.||... ......+.+..|.....+.
T Consensus 234 ---------a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~--- 301 (364)
T KOG0581|consen 234 ---------ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPR--- 301 (364)
T ss_pred ---------cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCC---
Confidence 46899999999999999999999999999999999999999999763 2345667777777654443
Q ss_pred HHhcC-CcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHH
Q 015406 239 ALCRG-YPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (407)
Q Consensus 239 ~~~~~-~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~ 279 (407)
++.+ ++++|+++|..||.+||.+||++.+| +++-|.+
T Consensus 302 -lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qL---l~Hpfi~ 339 (364)
T KOG0581|consen 302 -LPEGEFSPEFRSFVSCCLRKDPSERPSAKQL---LQHPFIK 339 (364)
T ss_pred -CCcccCCHHHHHHHHHHhcCCcccCCCHHHH---hcCHHHh
Confidence 3344 89999999999999999999996655 4555544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=390.90 Aligned_cols=252 Identities=25% Similarity=0.380 Sum_probs=221.8
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCC-----CCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
.+|..++.||+|||+.||++++..+|+.||+|++.++ ...+.+.+|++|.+.|+| ++|+.++.++++.++.|||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~H-pnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKH-PNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCC-CcEEeeeeEeecCCceEEE
Confidence 5699999999999999999999999999999988753 334568899999999997 8888999999999999999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 82 me~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
.|+| .++|..++++ .+.+++.+++.++.||+.||.|||+++|||||||..|+|| +++.++||+|||||..+..+.
T Consensus 97 LELC~~~sL~el~Kr-rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL---~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 97 LELCHRGSLMELLKR-RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFL---NENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EEecCCccHHHHHHh-cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheee---cCcCcEEecccceeeeecCcc
Confidence 9999 9999999984 6789999999999999999999999999999999999999 688999999999999887553
Q ss_pred CCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHH
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (407)
. ...+.+|||.|.|||++....++..+||||+|||||-||.|++||+. .+..+.|.+|.......
T Consensus 173 E-------rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet---k~vkety~~Ik~~~Y~~----- 237 (592)
T KOG0575|consen 173 E-------RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET---KTVKETYNKIKLNEYSM----- 237 (592)
T ss_pred c-------ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc---chHHHHHHHHHhcCccc-----
Confidence 2 24588999999999999999999999999999999999999999976 45677888887765542
Q ss_pred hcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcC
Q 015406 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREG 281 (407)
Q Consensus 241 ~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~ 281 (407)
+..++.+.++||.++|+.||.+||++++| |++-|-..|
T Consensus 238 P~~ls~~A~dLI~~lL~~~P~~Rpsl~~v---L~h~Ff~~g 275 (592)
T KOG0575|consen 238 PSHLSAEAKDLIRKLLRPNPSERPSLDEV---LDHPFFKSG 275 (592)
T ss_pred ccccCHHHHHHHHHHhcCCcccCCCHHHH---hcCHhhhCC
Confidence 24588999999999999999999996655 444444444
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-51 Score=361.07 Aligned_cols=272 Identities=20% Similarity=0.286 Sum_probs=235.6
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeE
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 79 (407)
-.++|++++.||.|+||.|.+++.+.+|..+|+|++++... .+....|..+|+.+.| +.+..+.+.+.+....|
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~-PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSH-PFLVKLYGTFKDNSNLY 120 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccC-ceeEEEEEeeccCCeEE
Confidence 45789999999999999999999999999999999876542 2336789999999984 88889999999999999
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 80 lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
|||||. ||.|..+++++ +++++..++.++.||+.||+|||+++|++|||||+|||| |..|.+||+|||+|+....
T Consensus 121 mvmeyv~GGElFS~Lrk~-~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLl---D~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKS-GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLL---DQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred EEEeccCCccHHHHHHhc-CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeee---ccCCcEEEEeccceEEecC
Confidence 999999 99999999974 579999999999999999999999999999999999999 7999999999999998866
Q ss_pred CCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHH
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (407)
.. -+.||||.|+|||++..++|+.++|.|||||++|||+.|.+||.+.+. .+.|++|...+..
T Consensus 197 rT----------~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~---~~iY~KI~~~~v~---- 259 (355)
T KOG0616|consen 197 RT----------WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP---IQIYEKILEGKVK---- 259 (355)
T ss_pred cE----------EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh---HHHHHHHHhCccc----
Confidence 42 378999999999999999999999999999999999999999987544 8889999988765
Q ss_pred HHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchhhcccccCCC
Q 015406 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATPP 304 (407)
Q Consensus 239 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~~~~~~~~~~ 304 (407)
+++.+++++++|+..+|+.|-.+|- ..+++-.++ -.+++|+..++|..+..+..+++..|
T Consensus 260 -fP~~fs~~~kdLl~~LL~vD~t~R~--gnlknG~~d---Ik~H~wF~~v~W~~i~~r~ie~P~~p 319 (355)
T KOG0616|consen 260 -FPSYFSSDAKDLLKKLLQVDLTKRF--GNLKNGVED---IKNHPWFKGVDWEAILQRKIEPPFEP 319 (355)
T ss_pred -CCcccCHHHHHHHHHHHhhhhHhhh--cCcCCCccc---cccCcccccccHHHHhhccccCCCCC
Confidence 3455889999999999999999982 222222222 24568888999999988876666554
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-51 Score=361.49 Aligned_cols=244 Identities=24% Similarity=0.330 Sum_probs=209.1
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC----CcchHHHHHHHHHHHcCCCCCCeeE-EeeeeCceeEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVR-WFGVEGDYNVLV 81 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~-~~~~~~~~~~lv 81 (407)
.+|+|.++||+|+||+||++++..+|..||.|-++... ..+....|+.+|++|+|+|++..+. .+..+....+||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 45999999999999999999999999999999776443 2345889999999999977776666 344455568999
Q ss_pred Eecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHh--CC--ceeccCCCCcccccCCCCCceEEEEeccce
Q 015406 82 MDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHS--KS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (407)
Q Consensus 82 me~~-g~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~--~~--ivHrDLKp~NILl~~~~~~~~~kL~DFGla 153 (407)
|||| +|+|.++++.. ++.+++.++|+++.|++.||..+|+ .+ |+||||||.||+| +.+|.+||+|||++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl---~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFL---TANGVVKLGDFGLG 175 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEE---cCCCceeeccchhH
Confidence 9999 99999999743 4569999999999999999999999 45 9999999999999 68899999999999
Q ss_pred eeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcc
Q 015406 154 KKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (407)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (407)
+.+...... ..+++|||.||+||.+.+.+|+.+|||||+||++|||+.-..||.+. ...+.-.+|.....
T Consensus 176 r~l~s~~tf-------A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~---n~~~L~~KI~qgd~ 245 (375)
T KOG0591|consen 176 RFLSSKTTF-------AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD---NLLSLCKKIEQGDY 245 (375)
T ss_pred hHhcchhHH-------HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc---cHHHHHHHHHcCCC
Confidence 988765542 45789999999999999999999999999999999999999999984 45666677777665
Q ss_pred cccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCH
Q 015406 234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 266 (407)
Q Consensus 234 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 266 (407)
++... ..++.++..||..|+..||+.||+.
T Consensus 246 ~~~p~---~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 246 PPLPD---EHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred CCCcH---HHhhhHHHHHHHHHccCCcccCCCc
Confidence 54332 3378999999999999999999984
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=378.28 Aligned_cols=270 Identities=22% Similarity=0.314 Sum_probs=221.9
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc-----chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
.++|++++.||+|+||.||+|+.+.||+.+|+|++++.... ..+..|..+|.. ...+.++.+++.+++.++.||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~-~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAE-VDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhh-cCCCcEEEEEEEecCCCeeEE
Confidence 57899999999999999999999999999999998875432 347788899888 556999999999999999999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 81 vme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
||||+ ||++..+|.+ .+.|++..++.++.+++.|++.||+.|+|||||||+|+|| |..|++||+|||||+.+...
T Consensus 219 iMEylPGGD~mTLL~~-~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLi---D~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMR-KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLI---DAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEEecCCccHHHHHHh-cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheee---cCCCCEeeccccccchhhhh
Confidence 99999 9999999986 5689999999999999999999999999999999999999 79999999999999744321
Q ss_pred CCC------------------cccCc----c------------------CCCCccccccccccccccCCCCChhhHHHHH
Q 015406 160 STH------------------QHIPY----R------------------ENKNLTGTARYASMNTHLGIEQSRRDDLESL 199 (407)
Q Consensus 160 ~~~------------------~~~~~----~------------------~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSl 199 (407)
... ...+. + .....+|||.|||||++.+..|+..+|+|||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 000 00010 0 1234689999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhc--ccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCC---HHHHHHHHH
Q 015406 200 GYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK--VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD---YAYLKRIFR 274 (407)
Q Consensus 200 G~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~~l~~~l~ 274 (407)
||||||||.|.+||.+.+. .+.+.+|..-. +..+.+ ..++++.++||.+|+. ||++|.. ++||+
T Consensus 375 G~ImyEmLvGyPPF~s~tp---~~T~rkI~nwr~~l~fP~~---~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK---- 443 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETP---QETYRKIVNWRETLKFPEE---VDLSDEAKDLITRLLC-DPENRLGSKGAEEIK---- 443 (550)
T ss_pred HHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhhhccCCCc---CcccHHHHHHHHHHhc-CHHHhcCcccHHHHh----
Confidence 9999999999999988554 55555555433 111111 2367999999999999 9999976 34443
Q ss_pred HHHHHcCCCCCCccccccchhhc
Q 015406 275 DLFIREGFQFDYVFDWTILKYQQ 297 (407)
Q Consensus 275 ~l~~~~~~~~~~~~dw~~~~~~~ 297 (407)
.++|+..+||+.+....
T Consensus 444 ------~HPfF~~v~W~~l~~~~ 460 (550)
T KOG0605|consen 444 ------KHPFFKGVDWDHLREMP 460 (550)
T ss_pred ------cCCccccCCcchhhcCC
Confidence 35899999999887754
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-49 Score=383.91 Aligned_cols=290 Identities=21% Similarity=0.268 Sum_probs=241.6
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeE
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 79 (407)
-.++|.++++||+|+||+|+++..+.+++.+|||++++.. ..+..+.|.+|+.....|+.+..++.+++..+..|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 3578999999999999999999999999999999987653 34558899999999998999999999999999999
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 80 lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
+||||+ ||++..+.+ .+.|++..+..|+.+|+.||+|||++||||||||.+|||| |..|++||+|||+++....
T Consensus 446 fvmey~~Ggdm~~~~~--~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLL---D~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIH--TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLL---DTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred EEEEecCCCcEEEEEe--cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEE---cccCcEEecccccccccCC
Confidence 999999 888444433 4689999999999999999999999999999999999999 7999999999999986432
Q ss_pred CCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHH
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (407)
... ...+++||+.|||||++.+..|+..+|+|||||+||||+.|..||.+. +..+.++.|.......
T Consensus 521 ~g~-------~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd---dEee~FdsI~~d~~~y--- 587 (694)
T KOG0694|consen 521 QGD-------RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD---DEEEVFDSIVNDEVRY--- 587 (694)
T ss_pred CCC-------ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHhcCCCCC---
Confidence 221 257899999999999999999999999999999999999999999874 4467777777665543
Q ss_pred HHhcCCcHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHHHHcCCCCCCccccccchhhcccccCCCCccCCCCCC
Q 015406 239 ALCRGYPTEFASYFHYCRSLRFDDKPDY-----AYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATPPARALVPGAG 313 (407)
Q Consensus 239 ~~~~~~~~~l~~li~~cl~~~p~~RPt~-----~~l~~~l~~l~~~~~~~~~~~~dw~~~~~~~~~~~~~~~~~~~~~~~ 313 (407)
+..++.+..+|++++|..+|++|... .+|+ .++|+..+||+.+.+.+..++.. |....+.+
T Consensus 588 --P~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~----------~hpFFr~i~w~~L~~r~i~PPf~--P~i~~~~D 653 (694)
T KOG0694|consen 588 --PRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIK----------KHPFFRSIDWDDLLNRRIKPPFV--PTIKGPED 653 (694)
T ss_pred --CCcccHHHHHHHHHHhccCcccccCCCCCCchhhh----------hCCccccCCHHHHhhccCCCCCC--cccCChhh
Confidence 34589999999999999999999865 3332 24788899999999988666554 34444445
Q ss_pred CCCCCCCCCCCCC
Q 015406 314 TSGAPPAIASGDR 326 (407)
Q Consensus 314 ~~~~~~~~~~~~~ 326 (407)
.+.......+..+
T Consensus 654 ~snFd~eFt~e~p 666 (694)
T KOG0694|consen 654 VSNFDEEFTSEKP 666 (694)
T ss_pred hcccchhhhcCCC
Confidence 5554444444333
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-48 Score=369.62 Aligned_cols=256 Identities=23% Similarity=0.364 Sum_probs=209.6
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeE-EEEEEecCCCC----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCc-eeEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE-VAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEGD-YNVL 80 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~-vAvK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~-~~~l 80 (407)
....+.+.||+|+||+||+|.+ .|.. ||||++..... ...+.+|+.++.+++| ++|+.+.++..+.. ..+|
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~H-pNIV~f~G~~~~~~~~~~i 117 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRH-PNIVQFYGACTSPPGSLCI 117 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCC-CCeeeEEEEEcCCCCceEE
Confidence 4456677899999999999995 4556 99998875432 2369999999999998 45555656555555 7899
Q ss_pred EEecc-CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeccCCCCcccccCCCCCc-eEEEEeccceeee
Q 015406 81 VMDLL-GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKS-FLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKY 156 (407)
Q Consensus 81 vme~~-g~sL~~~l~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~-ivHrDLKp~NILl~~~~~~~-~~kL~DFGla~~~ 156 (407)
||||+ +|+|.+++.. .+..+++..++.|+.||+.||+|||+++ ||||||||+|||+ +.+. ++||+|||+++..
T Consensus 118 VtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv---~~~~~~~KI~DFGlsr~~ 194 (362)
T KOG0192|consen 118 VTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILV---DLKGKTLKIADFGLSREK 194 (362)
T ss_pred EEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEE---cCCCCEEEECCCccceee
Confidence 99999 9999999987 3678999999999999999999999999 9999999999999 5775 9999999999876
Q ss_pred ccCCCCcccCccCCCCcccccccccccccc--CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhccc
Q 015406 157 RDTSTHQHIPYRENKNLTGTARYASMNTHL--GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (407)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (407)
..... ..+...||+.|||||++. ...|+.|+||||||++||||+||+.||.+... .+....+......
T Consensus 195 ~~~~~-------~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~---~~~~~~v~~~~~R 264 (362)
T KOG0192|consen 195 VISKT-------SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP---VQVASAVVVGGLR 264 (362)
T ss_pred ccccc-------cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhcCCC
Confidence 64321 123468999999999999 56899999999999999999999999998655 3333333332222
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcC
Q 015406 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREG 281 (407)
Q Consensus 235 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~ 281 (407)
+ .+...+++.+..+|..||..||+.||++.+|...|+.+.....
T Consensus 265 p---~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 265 P---PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred C---CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 2 2334489999999999999999999999999999998876543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-48 Score=370.23 Aligned_cols=246 Identities=26% Similarity=0.333 Sum_probs=212.8
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCC-------CCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCce
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-------TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 77 (407)
..++|.+++.||+|+||.|++|.+..+++.||+|+++.+ .....+.+|+.+++.+.+|++|..+..+......
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 457899999999999999999999999999999987664 1234566899999999977889888888888888
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCC-ceEEEEeccceee
Q 015406 78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA-NQVYIIDFGLAKK 155 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~-~~~kL~DFGla~~ 155 (407)
.|+||||+ ||+|.+++.. .+++.+..+..++.||+.|++|||++||+||||||+|||+ +.+ +.+||+|||++..
T Consensus 95 ~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENill---d~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILL---DGNEGNLKLSDFGLSAI 170 (370)
T ss_pred EEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEe---cCCCCCEEEeccccccc
Confidence 99999999 8999999997 7789999999999999999999999999999999999999 466 9999999999998
Q ss_pred ec-cCCCCcccCccCCCCccccccccccccccCCC-C-ChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhc
Q 015406 156 YR-DTSTHQHIPYRENKNLTGTARYASMNTHLGIE-Q-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (407)
Q Consensus 156 ~~-~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~-~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (407)
.. ... ...+.+||+.|+|||++.+.. | +.++||||+||+||.|++|..||.+. +....+.++....
T Consensus 171 ~~~~~~--------~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~---~~~~l~~ki~~~~ 239 (370)
T KOG0583|consen 171 SPGEDG--------LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS---NVPNLYRKIRKGE 239 (370)
T ss_pred cCCCCC--------cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc---cHHHHHHHHhcCC
Confidence 74 222 246889999999999999988 8 58999999999999999999999873 3345555555554
Q ss_pred ccccHHHHhcCC-cHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015406 233 VSTSIEALCRGY-PTEFASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 233 ~~~~~~~~~~~~-~~~l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
+. ++..+ ++++.+|+.+||..||.+|+++.+|.
T Consensus 240 ~~-----~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 240 FK-----IPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred cc-----CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 43 23445 89999999999999999999977776
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=346.62 Aligned_cols=253 Identities=21% Similarity=0.283 Sum_probs=208.7
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcc----hHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~----~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
++|+.+.++|+|+||.||+++++.||+.||||.+......+ -.++|++++++|+| ++++.+...+......+||+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH-~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKH-ENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhccc-chHHHHHHHHHhcceeEEEe
Confidence 57999999999999999999999999999999876554433 36899999999998 55666666667777889999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 83 e~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
|||.-++.+.+++....++...+..++.|++.|+.|+|++++|||||||+|||| ...+.+||||||+|+.+......
T Consensus 81 E~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILi---t~~gvvKLCDFGFAR~L~~pgd~ 157 (396)
T KOG0593|consen 81 EYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILI---TQNGVVKLCDFGFARTLSAPGDN 157 (396)
T ss_pred eecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEE---ecCCcEEeccchhhHhhcCCcch
Confidence 999888888888777789999999999999999999999999999999999999 58999999999999988753321
Q ss_pred cccCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhh----------
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK---------- 231 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~---------- 231 (407)
.+..+.|..|.|||.+.| .+|+..+||||+||++.||++|.+.|.+.++-+..-.+.+....
T Consensus 158 -------YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~ 230 (396)
T KOG0593|consen 158 -------YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFS 230 (396)
T ss_pred -------hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhc
Confidence 346788999999999998 78999999999999999999999999886553322222221111
Q ss_pred -------------cccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015406 232 -------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 232 -------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
.-..+.+...++++.-+.+++..||..||++|++-+++.
T Consensus 231 ~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll 282 (396)
T KOG0593|consen 231 SNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL 282 (396)
T ss_pred cCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence 112233333445667789999999999999999988876
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-48 Score=368.74 Aligned_cols=254 Identities=23% Similarity=0.362 Sum_probs=213.1
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc-chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~-~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~- 85 (407)
.+++++.||+|.||+||+|.+ .....||+|.++..... ..+.+|+++|++|+| ++++.+++++..++..||||||+
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~-~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H-~~lV~l~gV~~~~~piyIVtE~m~ 284 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKW-NGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRH-EKLVKLYGVCTKQEPIYIVTEYMP 284 (468)
T ss_pred HHHHHHHhcCCccceEEEEEE-cCCCcccceEEeccccChhHHHHHHHHHHhCcc-cCeEEEEEEEecCCceEEEEEecc
Confidence 356688999999999999996 33348999988875544 678999999999998 77777888888777899999999
Q ss_pred CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcc
Q 015406 86 GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164 (407)
Q Consensus 86 g~sL~~~l~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~ 164 (407)
.|+|.+++.. .+..+.....+.++.|||+|++||+++++|||||.++|||+ +++..+||+|||+|+...++..
T Consensus 285 ~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV---~~~~~vKIsDFGLAr~~~d~~Y--- 358 (468)
T KOG0197|consen 285 KGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILV---DEDLVVKISDFGLARLIGDDEY--- 358 (468)
T ss_pred cCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheee---ccCceEEEcccccccccCCCce---
Confidence 9999999986 45679999999999999999999999999999999999999 6889999999999995554432
Q ss_pred cCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcC
Q 015406 165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243 (407)
Q Consensus 165 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (407)
.......-...|.|||.+....++.|||||||||+||||+| |+.||.++...+ .++.+..+-..+ .+..
T Consensus 359 ---~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e---v~~~le~GyRlp----~P~~ 428 (468)
T KOG0197|consen 359 ---TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE---VLELLERGYRLP----RPEG 428 (468)
T ss_pred ---eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH---HHHHHhccCcCC----CCCC
Confidence 22223334678999999999999999999999999999999 999999876644 444443332221 2356
Q ss_pred CcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHH
Q 015406 244 YPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (407)
Q Consensus 244 ~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~ 279 (407)
||+++.++|..||..+|++||||+.+...|++++..
T Consensus 429 CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 429 CPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 999999999999999999999999999999988754
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=364.82 Aligned_cols=258 Identities=22% Similarity=0.282 Sum_probs=213.8
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc-c--hHHHHHHHHHHHcCCCCCCeeEEeeeeCc-eeE
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-P--QLLYESKLYRILQGGTGIPNVRWFGVEGD-YNV 79 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~-~--~~~~E~~~l~~l~~~~~i~~~~~~~~~~~-~~~ 79 (407)
.+-++|.++++||.|+||.||+|+.+.+++.||||.++.+-.. + .-++|++.|++|..|++|..+.....+.+ ..|
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 3567999999999999999999999999999999987765432 2 25789999999996677777777666666 899
Q ss_pred EEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 80 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 80 lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
+|||||..+|.++++..++.|++..++.|+.||++||+|+|.+|+.||||||+|||+ .....+||+|||+|+.....
T Consensus 87 fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi---~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 87 FVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILI---SGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred eeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEe---cccceeEecccccccccccC
Confidence 999999999999999878889999999999999999999999999999999999999 45889999999999987664
Q ss_pred CCCcccCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhh-------
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK------- 231 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~------- 231 (407)
.. .+..+.|..|.|||++.. .-|+.+.||||+|||++|+.+=++.|.+.+.-+..-++-.+...
T Consensus 164 pP--------YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 164 PP--------YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWP 235 (538)
T ss_pred CC--------cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccch
Confidence 43 346788999999998874 56899999999999999999999999885543222222111111
Q ss_pred ---------------cccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015406 232 ---------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRI 272 (407)
Q Consensus 232 ---------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~ 272 (407)
.....+..+.+..+.++.++|.+|+.+||++|||+.+.++.
T Consensus 236 eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 236 EGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 12234455666789999999999999999999998877653
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-48 Score=356.90 Aligned_cols=252 Identities=26% Similarity=0.386 Sum_probs=203.7
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC--cchHHHHHHHHHHHcCCCCCCeeEEeee-eCc-eeEEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGV-EGD-YNVLVM 82 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~-~~~-~~~lvm 82 (407)
.+|..++.||+|+||.||++.+..+|+..|||....... .+.+.+|+.+|.+|+ |++|+.+.+... ... .++|+|
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~-~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLN-HPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCC-CCCEEeeCCccccccCeeeEeee
Confidence 468899999999999999999999999999997655411 345899999999999 566666655433 333 789999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCC-CceEEEEeccceeeeccCC
Q 015406 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR-ANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 83 e~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~-~~~~kL~DFGla~~~~~~~ 160 (407)
||+ +|||.+++...+++|++..++.+..||++||.|||++|||||||||+|||+ +. ++.+||+|||+++......
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl---~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILL---DPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEE---eCCCCeEEeccCcccccccccc
Confidence 999 999999999866689999999999999999999999999999999999999 46 6899999999998776411
Q ss_pred CCcccCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHH
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (407)
.. ........||+.|||||++.+ ....+++|||||||++.||+||+.||... ......+..+.... ..+.
T Consensus 173 ~~----~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~~~~ig~~~---~~P~ 243 (313)
T KOG0198|consen 173 TK----SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEALLLIGRED---SLPE 243 (313)
T ss_pred cc----ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchHHHHHHHhccC---CCCC
Confidence 11 122346789999999999995 33456999999999999999999999874 22233333333332 2225
Q ss_pred HhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 240 ~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
++..++++.++++.+|+..||++|||++++++
T Consensus 244 ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~ 275 (313)
T KOG0198|consen 244 IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLE 275 (313)
T ss_pred CCcccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 66779999999999999999999999777654
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-47 Score=365.26 Aligned_cols=244 Identities=20% Similarity=0.291 Sum_probs=214.2
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
.+-|++++.||.|+.|.|-+|++..||+.+|||++..... ...+.+|+-+|+.+.| +++..++........+|+
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~H-pnVl~LydVwe~~~~lyl 89 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEH-PNVLRLYDVWENKQHLYL 89 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcC-CCeeeeeeeeccCceEEE
Confidence 4679999999999999999999999999999999876532 2348899999999987 566677777778888999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 81 vme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
|.||+ ||.|.+++-. ++++++.++.+++.||+.|+.|+|..+|+||||||+|+|| +..+.+||+|||+|..-...
T Consensus 90 vlEyv~gGELFdylv~-kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLL---d~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVR-KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLL---DVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EEEecCCchhHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhh---hcccCEeeeccceeecccCC
Confidence 99999 9999999986 5689999999999999999999999999999999999999 67777999999999865443
Q ss_pred CCCcccCccCCCCccccccccccccccCCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHH
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (407)
.- ..+.||++.|+|||++.|.+| +.++||||+|||||.||+|++||.+ +.....+.++..+.+.
T Consensus 166 kl--------LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD---dNir~LLlKV~~G~f~---- 230 (786)
T KOG0588|consen 166 KL--------LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD---DNIRVLLLKVQRGVFE---- 230 (786)
T ss_pred cc--------ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC---ccHHHHHHHHHcCccc----
Confidence 32 457899999999999999999 7999999999999999999999975 5567778888877664
Q ss_pred HHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015406 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 239 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
++..+|++.++||.+|+..||+.|.|.++|.
T Consensus 231 -MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~ 261 (786)
T KOG0588|consen 231 -MPSNISSEAQDLLRRMLDVDPSTRITTEEIL 261 (786)
T ss_pred -CCCcCCHHHHHHHHHHhccCccccccHHHHh
Confidence 4477999999999999999999999966654
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-47 Score=348.78 Aligned_cols=271 Identities=21% Similarity=0.324 Sum_probs=224.7
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
+.|++++.||.|.-|+||+++...++..+|+|++.+.. ...+...|.+||..++| +.++.++..++..++.|++
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDH-PFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDH-PFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCC-CccchhhheeeccceeEEE
Confidence 56889999999999999999999999999999987643 23457789999999986 9999999999999999999
Q ss_pred Eecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 82 MDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 82 me~~-g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
|||| ||+|..++++. ++.|++..++.++.+|+.||+|||-.|||+|||||+|||| .++|++.|+||.|+......
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILv---redGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILV---REDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEE---ecCCcEEeeeccccccCCCC
Confidence 9999 99999999864 3569999999999999999999999999999999999999 79999999999998643211
Q ss_pred CCCc------------------------------c------------------cC-ccCCCCccccccccccccccCCCC
Q 015406 160 STHQ------------------------------H------------------IP-YRENKNLTGTARYASMNTHLGIEQ 190 (407)
Q Consensus 160 ~~~~------------------------------~------------------~~-~~~~~~~~gt~~Y~aPE~~~~~~~ 190 (407)
.+.. . .| -.....++||-.|.|||++.|...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0000 0 00 012346899999999999999999
Q ss_pred ChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCC----H
Q 015406 191 SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD----Y 266 (407)
Q Consensus 191 ~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt----~ 266 (407)
+.++|+|+|||+||||+.|..||.+.+. .+.+.+|.......+-. ..++..+++||+++|.+||.+|.. +
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~---~~Tl~NIv~~~l~Fp~~---~~vs~~akDLIr~LLvKdP~kRlg~~rGA 386 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNN---KETLRNIVGQPLKFPEE---PEVSSAAKDLIRKLLVKDPSKRLGSKRGA 386 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCc---hhhHHHHhcCCCcCCCC---CcchhHHHHHHHHHhccChhhhhccccch
Confidence 9999999999999999999999988554 56666666554432221 246789999999999999999987 5
Q ss_pred HHHHHHHHHHHHHcCCCCCCccccccchhhc
Q 015406 267 AYLKRIFRDLFIREGFQFDYVFDWTILKYQQ 297 (407)
Q Consensus 267 ~~l~~~l~~l~~~~~~~~~~~~dw~~~~~~~ 297 (407)
.+|++ ++|+..++|...+...
T Consensus 387 ~eIK~----------HpFF~gVnWaLir~~~ 407 (459)
T KOG0610|consen 387 AEIKR----------HPFFEGVNWALIRCAR 407 (459)
T ss_pred HHhhc----------CccccCCChhheeccC
Confidence 66654 5899999999655543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-47 Score=356.03 Aligned_cols=259 Identities=23% Similarity=0.311 Sum_probs=213.5
Q ss_pred CccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcch----HHHHHHHHHHHcCCCCCCeeEEeeee-Cce
Q 015406 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ----LLYESKLYRILQGGTGIPNVRWFGVE-GDY 77 (407)
Q Consensus 3 ~~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~----~~~E~~~l~~l~~~~~i~~~~~~~~~-~~~ 77 (407)
++..+.|+.+++||+|.||.||+|++..+|+.||+|.+..+...+. ..+|+.||++|.|++++......... ...
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS 192 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence 4456789999999999999999999999999999998877664443 67999999999985555444444443 578
Q ss_pred eEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeec
Q 015406 78 NVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (407)
Q Consensus 78 ~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~ 157 (407)
+|||+|||..+|.-++....-+|++.++..|+.||+.||+|||++||+|||||.+|||| |.+|.+||+|||||+.+.
T Consensus 193 iYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLi---dn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 193 IYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILI---DNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEE---cCCCCEEeccccceeecc
Confidence 99999999999999998766789999999999999999999999999999999999999 799999999999999887
Q ss_pred cCCCCcccCccCCCCccccccccccccccCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhc----
Q 015406 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK---- 232 (407)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~---- 232 (407)
...... .+..+-|..|.|||.++|. .|+.+.|+||.||||.||++|++.|++.+.-+...++.++....
T Consensus 270 ~~~~~~------~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~ 343 (560)
T KOG0600|consen 270 PSGSAP------YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDY 343 (560)
T ss_pred CCCCcc------cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhc
Confidence 655321 3567889999999999985 58999999999999999999999999865544343333332211
Q ss_pred -----------------ccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015406 233 -----------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 233 -----------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
....+.+....+|....+|+..+|..||++|.|+.+.+
T Consensus 344 W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL 398 (560)
T KOG0600|consen 344 WPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSAL 398 (560)
T ss_pred cccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHh
Confidence 01222344567899999999999999999999987665
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=341.48 Aligned_cols=258 Identities=20% Similarity=0.287 Sum_probs=213.4
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
.-.+.|++.+.||.|..+.||+|+.+.+++.||||+++.+... ..+.+|+..+..+.| +||..++..+..+...|+
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~H-PNIv~~~~sFvv~~~LWv 101 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDH-PNIVTYHCSFVVDSELWV 101 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCC-CCcceEEEEEEecceeEE
Confidence 3467899999999999999999999999999999998876543 457889999988876 778888888888999999
Q ss_pred EEecc-CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 81 VMDLL-GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 81 vme~~-g~sL~~~l~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
||.|| +||+.++++. ....+++..+..|++++++||.|||.+|.||||||+.|||| +.+|.|||+|||.+..+..
T Consensus 102 VmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi---~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 102 VMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILI---DSDGTVKLADFGVSASLFD 178 (516)
T ss_pred eehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEE---cCCCcEEEcCceeeeeecc
Confidence 99999 9999999974 34569999999999999999999999999999999999999 6999999999999887766
Q ss_pred CCCCcccCccCCCCccccccccccccccC--CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhccc--
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS-- 234 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-- 234 (407)
...... ++. .+++||+.|||||++.. ..|+.|+||||||++..||.+|..||....+. +..+.++......
T Consensus 179 ~G~R~~--~rf-~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm--kvLl~tLqn~pp~~~ 253 (516)
T KOG0582|consen 179 SGDRQV--TRF-NTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM--KVLLLTLQNDPPTLL 253 (516)
T ss_pred cCceee--Eee-ccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH--HHHHHHhcCCCCCcc
Confidence 543221 222 78899999999999653 46899999999999999999999999886542 2333333332210
Q ss_pred --ccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015406 235 --TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 235 --~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
.....-.+.++..|.+++..||..||.+||++++++
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLl 291 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLL 291 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHh
Confidence 112233356788999999999999999999998875
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=347.31 Aligned_cols=268 Identities=18% Similarity=0.232 Sum_probs=211.8
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
.|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+.+|+.++..+.| +++..+..++.+.+..+++|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~-~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNS-RFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCC-CcEEEEEEEEccCCeEEEEE
Confidence 4889999999999999999999999999999876432 12246789999999987 55666666667778899999
Q ss_pred ecc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 83 DLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 83 e~~-g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
||+ +++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||+ ++++.++|+|||++.......
T Consensus 80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill---~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL---DDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeCCCcEEcCCCC
Confidence 999 899998876433 468999999999999999999999999999999999999 578899999999998754322
Q ss_pred CCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHH
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (407)
. .....||..|+|||++.+..++.++|||||||++|||++|+.||.........+.+..... .....+
T Consensus 157 ~--------~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~----~~~~~~ 224 (285)
T cd05631 157 T--------VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVK----EDQEEY 224 (285)
T ss_pred e--------ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhh----cccccC
Confidence 1 2245789999999999999999999999999999999999999987544322222222111 111223
Q ss_pred hcCCcHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHHHHcCCCCCCccccccchhhccccc
Q 015406 241 CRGYPTEFASYFHYCRSLRFDDKPD-----YAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLA 301 (407)
Q Consensus 241 ~~~~~~~l~~li~~cl~~~p~~RPt-----~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~~~~~~~ 301 (407)
...+++++.+|+.+||+.||++||+ ++++.+ +++...++|..++..+..++
T Consensus 225 ~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~----------h~~~~~~~~~~~~~~~~~~~ 280 (285)
T cd05631 225 SEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ----------HPIFKNINFKRLEANMLEPP 280 (285)
T ss_pred CccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc----------CHhhcCCCHHHHHhCcCCcC
Confidence 4568899999999999999999997 444432 34556678887776654433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=352.62 Aligned_cols=260 Identities=20% Similarity=0.286 Sum_probs=211.7
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
.++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+|+.+++.++| +++..+...+...+..|+
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSH-PFIVNMMCSFQDENRVYF 95 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCC-CCCCcEEEEEEcCCEEEE
Confidence 478999999999999999999999999999999876432 23457889999999986 566666677778889999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 81 vme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
+|||+ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 96 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 96 LLEFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLL---DNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred EEcCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE---CCCCCEEEeeccCceEcCCC
Confidence 99999 9999999985 4578999999999999999999999999999999999999 67889999999999876432
Q ss_pred CCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHH
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (407)
. ....||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ..+.+..+......
T Consensus 172 ~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~i~~~~~~----- 233 (329)
T PTZ00263 172 T----------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT---PFRIYEKILAGRLK----- 233 (329)
T ss_pred c----------ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC---HHHHHHHHhcCCcC-----
Confidence 2 24579999999999999999999999999999999999999997633 34455555444322
Q ss_pred HhcCCcHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHHHHcCCCCCCccccccchh
Q 015406 240 LCRGYPTEFASYFHYCRSLRFDDKPDY--AYLKRIFRDLFIREGFQFDYVFDWTILKY 295 (407)
Q Consensus 240 ~~~~~~~~l~~li~~cl~~~p~~RPt~--~~l~~~l~~l~~~~~~~~~~~~dw~~~~~ 295 (407)
+...++.++.+||.+||..||.+||+. ..+.+++. ++|....+|..+..
T Consensus 234 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~-------hp~f~~~~~~~~~~ 284 (329)
T PTZ00263 234 FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN-------HPYFHGANWDKLYA 284 (329)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc-------CCccCCCCHHHHHh
Confidence 234578899999999999999999973 11222222 25555667876544
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=347.90 Aligned_cols=255 Identities=22% Similarity=0.337 Sum_probs=209.6
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+|+.+++.+.| +++..+..+..+....|+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~lv 79 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH-PFIIRLFWTEHDQRFLYML 79 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCC-CcHhhhHhhhccCCeEEEE
Confidence 47999999999999999999999999999999876432 22347789999999987 5666666777778899999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 82 me~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
|||+ +++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 80 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli---~~~~~~kl~Dfg~~~~~~~~~ 155 (291)
T cd05612 80 MEYVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILL---DKEGHIKLTDFGFAKKLRDRT 155 (291)
T ss_pred EeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEEecCcchhccCCc
Confidence 9999 8999999975 4579999999999999999999999999999999999999 578899999999998654321
Q ss_pred CCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHH
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (407)
....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ..+.+..+...... +
T Consensus 156 ----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~---~~~~~~~i~~~~~~-----~ 217 (291)
T cd05612 156 ----------WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN---PFGIYEKILAGKLE-----F 217 (291)
T ss_pred ----------ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCcC-----C
Confidence 24578999999999999999999999999999999999999997743 34445554443322 2
Q ss_pred hcCCcHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHHHHcCCCCCCccccccch
Q 015406 241 CRGYPTEFASYFHYCRSLRFDDKPD-----YAYLKRIFRDLFIREGFQFDYVFDWTILK 294 (407)
Q Consensus 241 ~~~~~~~l~~li~~cl~~~p~~RPt-----~~~l~~~l~~l~~~~~~~~~~~~dw~~~~ 294 (407)
...+++.+.++|.+||+.||.+||+ ++++. .++|...++|....
T Consensus 218 ~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l----------~h~~~~~~~~~~~~ 266 (291)
T cd05612 218 PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVK----------NHRWFKSVDWDDVP 266 (291)
T ss_pred CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHh----------cCccccCCCHHHHh
Confidence 3457889999999999999999995 44443 23555667786433
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=354.77 Aligned_cols=261 Identities=18% Similarity=0.314 Sum_probs=205.5
Q ss_pred cCCceeEeccccccCceEEEEEEEc-----CCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeee-eC
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGV-EG 75 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~-----~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~-~~ 75 (407)
-.++|++.++||+|+||.||+|.+. .+++.||||++..... ...+..|+.++..+.+|++++.+..++. ..
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 3578999999999999999999752 3456899998864332 2357889999999965677776665544 45
Q ss_pred ceeEEEEecc-CCCHHHHHHHcC---------------------------------------------------------
Q 015406 76 DYNVLVMDLL-GPSLEDLFNFCS--------------------------------------------------------- 97 (407)
Q Consensus 76 ~~~~lvme~~-g~sL~~~l~~~~--------------------------------------------------------- 97 (407)
...+++|||+ +|+|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 5689999999 999999987421
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcccCccCCCCc
Q 015406 98 ----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNL 173 (407)
Q Consensus 98 ----~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~ 173 (407)
..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++........ ......
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~---~~~~~~kl~DfG~a~~~~~~~~~-----~~~~~~ 236 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDY-----VRKGSA 236 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEE---cCCCcEEEeecccccccccCcch-----hcccCC
Confidence 237788999999999999999999999999999999999 57889999999999865432211 112344
Q ss_pred cccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcHHHHHHH
Q 015406 174 TGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYF 252 (407)
Q Consensus 174 ~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li 252 (407)
.++..|+|||++.+..++.++|||||||+||||++ |..||.+..... .....+...... .....+++++.+++
T Consensus 237 ~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~~~~~~~~~~~----~~~~~~~~~l~~li 310 (338)
T cd05102 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EFCQRLKDGTRM----RAPENATPEIYRIM 310 (338)
T ss_pred CCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HHHHHHhcCCCC----CCCCCCCHHHHHHH
Confidence 56788999999999899999999999999999997 999998754321 222222222111 12346789999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHHHHHH
Q 015406 253 HYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (407)
Q Consensus 253 ~~cl~~~p~~RPt~~~l~~~l~~l~~~ 279 (407)
.+||+.||++||++.+|.+.|++++.+
T Consensus 311 ~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 311 LACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=357.05 Aligned_cols=247 Identities=22% Similarity=0.357 Sum_probs=207.5
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC--CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
...|....+||+|+.|.||.|+...+++.||||.++... ..+-++.|+.+|+.++|.+.+..+..|... +..|+|||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~-deLWVVME 350 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG-DELWVVME 350 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc-ceeEEEEe
Confidence 356888999999999999999999999999999877654 334588999999999986666666555544 77899999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 84 ~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
|+ ||+|.|++.. ..+++.++..|+++++.||+|||.+||+|||||.+|||+ ..++.+||+|||+|..+.....
T Consensus 351 ym~ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL---~~~g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 351 YMEGGSLTDVVTK--TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILL---TMDGSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred ecCCCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEe---ccCCcEEEeeeeeeeccccccC-
Confidence 99 9999999984 459999999999999999999999999999999999999 5888999999999998876553
Q ss_pred cccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhc
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (407)
...+.+||+.|||||+.....|+++.||||||++++||+.|.+||-..+ ..+.+..|.....+. -....
T Consensus 425 ------KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~---PlrAlyLIa~ng~P~--lk~~~ 493 (550)
T KOG0578|consen 425 ------KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN---PLRALYLIATNGTPK--LKNPE 493 (550)
T ss_pred ------ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC---hHHHHHHHhhcCCCC--cCCcc
Confidence 2468899999999999999999999999999999999999999997633 344443333322211 12235
Q ss_pred CCcHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015406 243 GYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 243 ~~~~~l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
.++++|++++.+||..|+++|+++.+|+
T Consensus 494 klS~~~kdFL~~cL~~dv~~RasA~eLL 521 (550)
T KOG0578|consen 494 KLSPELKDFLDRCLVVDVEQRASAKELL 521 (550)
T ss_pred ccCHHHHHHHHHHhhcchhcCCCHHHHh
Confidence 6899999999999999999999977765
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=351.67 Aligned_cols=244 Identities=23% Similarity=0.308 Sum_probs=209.7
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcc----hHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~----~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+....+ .+.+|++|++.|+|++ |..+...++.....++|.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpn-iv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPN-IVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcc-hhhHHHhhcccceEEEEe
Confidence 57999999999999999999999999999999887654332 4889999999999855 445555556667789999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 83 e~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
|||-|+|..++.. .++++++.+..|+.|++.||.|||+.+|+|||+||+|||+ +..+.+|+||||+|+.+......
T Consensus 81 e~a~g~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl---~~~~~~KlcdFg~Ar~m~~~t~v 156 (808)
T KOG0597|consen 81 EYAVGDLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILL---EKGGTLKLCDFGLARAMSTNTSV 156 (808)
T ss_pred hhhhhhHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeee---cCCCceeechhhhhhhcccCcee
Confidence 9996699999986 6689999999999999999999999999999999999999 68999999999999987653321
Q ss_pred cccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhc
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (407)
.....|||.|||||+..+.+|+..+|+||||||+|||++|++||.. ....+....|.......+.
T Consensus 157 -------ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a---~si~~Lv~~I~~d~v~~p~----- 221 (808)
T KOG0597|consen 157 -------LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA---RSITQLVKSILKDPVKPPS----- 221 (808)
T ss_pred -------eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH---HHHHHHHHHHhcCCCCCcc-----
Confidence 3466899999999999999999999999999999999999999975 4556777777666554433
Q ss_pred CCcHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015406 243 GYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 243 ~~~~~l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
..+..+.++++..|.+||.+|.+-.++.
T Consensus 222 ~~S~~f~nfl~gLL~kdP~~RltW~~Ll 249 (808)
T KOG0597|consen 222 TASSSFVNFLQGLLIKDPAQRLTWTDLL 249 (808)
T ss_pred cccHHHHHHHHHHhhcChhhcccHHHHh
Confidence 5789999999999999999999966553
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=349.72 Aligned_cols=265 Identities=21% Similarity=0.264 Sum_probs=214.3
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCC-----CCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
+|++.+.||+|+||.||+|++..+++.||||++... .....+..|.+++..+.|+++++.+..++...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 589999999999999999999999999999987643 122346788899999998888998888888888999999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCC
Q 015406 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 83 e~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~ 161 (407)
||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05587 81 EYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DAEGHIKIADFGMCKENIFGGK 156 (324)
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---cCCCCEEEeecCcceecCCCCC
Confidence 999 9999999875 4578999999999999999999999999999999999999 5788999999999875322111
Q ss_pred CcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHh
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (407)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.. ..+.+..+...... +.
T Consensus 157 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~---~~~~~~~i~~~~~~-----~~ 221 (324)
T cd05587 157 -------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED---EDELFQSIMEHNVS-----YP 221 (324)
T ss_pred -------ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCC-----CC
Confidence 1234579999999999999999999999999999999999999997643 34444444443321 23
Q ss_pred cCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchhh
Q 015406 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQ 296 (407)
Q Consensus 242 ~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~~ 296 (407)
..+++++.+++.+||..||.+|++.... ..+++ ..+++...++|......
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~--~~~~~---~~hp~~~~~~~~~~~~~ 271 (324)
T cd05587 222 KSLSKEAVSICKGLLTKHPAKRLGCGPT--GERDI---REHAFFRRIDWEKLERR 271 (324)
T ss_pred CCCCHHHHHHHHHHhhcCHHHcCCCCCC--CHHHH---hcCCCcCCCCHHHHHhC
Confidence 4688999999999999999999986310 01111 13366677889766544
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-45 Score=347.99 Aligned_cols=254 Identities=20% Similarity=0.280 Sum_probs=205.7
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEecCCC-----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-C
Q 015406 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (407)
Q Consensus 13 ~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~-g 86 (407)
+.||+|+||.||+|++..+++.||||++.... ....+..|+.+++.+.| +++..+...+...+..|+||||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-p~i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRH-PFLTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCC-CCCCCEEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999999999999999886432 12346788999999887 66777777778888999999999 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcccC
Q 015406 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166 (407)
Q Consensus 87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~ 166 (407)
++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DfG~a~~~~~~~~----- 150 (323)
T cd05571 80 GELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML---DKDGHIKITDFGLCKEGISDGA----- 150 (323)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEeeCCCCcccccCCC-----
Confidence 999999875 4579999999999999999999999999999999999999 6788999999999975322211
Q ss_pred ccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcH
Q 015406 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 246 (407)
Q Consensus 167 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 246 (407)
......||+.|+|||++.+..++.++|||||||++|||++|..||...+ ....+..+..... .+...+++
T Consensus 151 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~---~~~~~~~~~~~~~-----~~p~~~~~ 220 (323)
T cd05571 151 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEKLFELILMEEI-----RFPRTLSP 220 (323)
T ss_pred --cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC---HHHHHHHHHcCCC-----CCCCCCCH
Confidence 1235679999999999999999999999999999999999999997633 2333444433322 23356889
Q ss_pred HHHHHHHHHhCCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCccccccchhh
Q 015406 247 EFASYFHYCRSLRFDDKP-----DYAYLKRIFRDLFIREGFQFDYVFDWTILKYQ 296 (407)
Q Consensus 247 ~l~~li~~cl~~~p~~RP-----t~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~~ 296 (407)
++.++|.+||..||++|| ++.++++ ++|....+|......
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~ll~----------h~~f~~~~~~~~~~~ 265 (323)
T cd05571 221 EAKSLLAGLLKKDPKQRLGGGPEDAKEIME----------HRFFASINWQDVVQK 265 (323)
T ss_pred HHHHHHHHHccCCHHHcCCCCCCCHHHHHc----------CCCcCCCCHHHHHhC
Confidence 999999999999999999 6555542 356667788765543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=350.09 Aligned_cols=247 Identities=21% Similarity=0.304 Sum_probs=210.2
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcc---hHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP---QLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~---~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
-...|...+.||+|+||.||+|.+..+++.||+|+++.+.... .+..|+.++..+++ +++-.+++....+...+++
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~-~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDS-PNITEYYGSYLKGTKLWII 89 (467)
T ss_pred cccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCc-chHHhhhhheeecccHHHH
Confidence 3457888999999999999999999999999999998765443 47789999999887 6777777778889999999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 82 me~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
|||| ||++.++++. +..+++..+..++++++.||.|||.++.+|||||+.|||+. ..+.+||+|||.+..+....
T Consensus 90 Mey~~gGsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s---~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKS-GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLS---ESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred HHHhcCcchhhhhcc-CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEe---ccCcEEEEecceeeeeechh
Confidence 9999 9999999984 33458999999999999999999999999999999999995 66999999999998877654
Q ss_pred CCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHH
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (407)
. + ..+++||+.|||||++.+..|+.|+||||||++.+||++|.+||....+.... ........+.+
T Consensus 166 ~------r-r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl-------flIpk~~PP~L 231 (467)
T KOG0201|consen 166 K------R-RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL-------FLIPKSAPPRL 231 (467)
T ss_pred h------c-cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE-------EeccCCCCCcc
Confidence 3 2 36899999999999999999999999999999999999999999887663211 11112222334
Q ss_pred hcCCcHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015406 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 241 ~~~~~~~l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
...+++.++++|..||.+||+.||++.+|+
T Consensus 232 ~~~~S~~~kEFV~~CL~k~P~~RpsA~~LL 261 (467)
T KOG0201|consen 232 DGDFSPPFKEFVEACLDKNPEFRPSAKELL 261 (467)
T ss_pred ccccCHHHHHHHHHHhhcCcccCcCHHHHh
Confidence 456899999999999999999999988765
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=327.90 Aligned_cols=253 Identities=22% Similarity=0.283 Sum_probs=219.2
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeE
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 79 (407)
.+.+.|++.+.||+|.|+.||++.+..+|+.+|+|+++.+. ..+.+.+|++|.+.|+| ++|+.+.....+..+.|
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqH-P~IvrL~~ti~~~~~~y 86 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH-PNIVRLHDSIQEESFHY 86 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCC-CcEeehhhhhcccceeE
Confidence 46788999999999999999999999999999999887543 45678999999999997 77777777778888999
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 80 lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
||+|++ |++|..-|-. ..-+++..+-.++.||++||.|+|.+||||||+||+|+|+...+...-+||+|||+|..+..
T Consensus 87 lvFe~m~G~dl~~eIV~-R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~ 165 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVA-REFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND 165 (355)
T ss_pred EEEecccchHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence 999999 8888665543 24589999999999999999999999999999999999998777778899999999998874
Q ss_pred CCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHH
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (407)
... ...++|||.|||||++...+|+..+|||+.|||||-|+.|.+||.+ .+....|+.|.......+.
T Consensus 166 g~~--------~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~---~~~~rlye~I~~g~yd~~~- 233 (355)
T KOG0033|consen 166 GEA--------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD---EDQHRLYEQIKAGAYDYPS- 233 (355)
T ss_pred ccc--------cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC---ccHHHHHHHHhccccCCCC-
Confidence 322 4578999999999999999999999999999999999999999987 4456788888877665433
Q ss_pred HHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015406 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 239 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
..++.++++.++|+.+||..||.+|.|+.|.+
T Consensus 234 ~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 234 PEWDTVTPEAKSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred cccCcCCHHHHHHHHHHhccChhhhccHHHHh
Confidence 24577999999999999999999999976543
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=347.12 Aligned_cols=267 Identities=20% Similarity=0.262 Sum_probs=215.0
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
+|++.+.||+|+||.||+|++..+++.||||++..... ......|..++..+.+++++..+..++...+..|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 58999999999999999999999999999998865321 1235667888888888899998988888889999999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCC
Q 015406 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 83 e~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~ 161 (407)
||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kL~DfG~~~~~~~~~~ 156 (323)
T cd05616 81 EYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENMWDGV 156 (323)
T ss_pred cCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEE---CCCCcEEEccCCCceecCCCCC
Confidence 999 8999999875 4579999999999999999999999999999999999999 6888999999999975432221
Q ss_pred CcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHh
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (407)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ...+..+...... ++
T Consensus 157 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~~~~i~~~~~~-----~p 221 (323)
T cd05616 157 -------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQSIMEHNVA-----YP 221 (323)
T ss_pred -------ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCC-----CC
Confidence 12356799999999999999999999999999999999999999976433 4445555443322 23
Q ss_pred cCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchhhcc
Q 015406 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQS 298 (407)
Q Consensus 242 ~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~~~~ 298 (407)
..++.++.+++.+||+.+|++|++.... ...++ ..+++....||........
T Consensus 222 ~~~s~~~~~li~~~l~~~p~~R~~~~~~--~~~~i---~~h~~~~~~~~~~~~~~~~ 273 (323)
T cd05616 222 KSMSKEAVAICKGLMTKHPGKRLGCGPE--GERDI---KEHAFFRYIDWEKLERKEV 273 (323)
T ss_pred CcCCHHHHHHHHHHcccCHHhcCCCCCC--CHHHH---hcCCCcCCCCHHHHHhCCC
Confidence 4588999999999999999999985211 01111 1235666788987665543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=345.41 Aligned_cols=266 Identities=18% Similarity=0.258 Sum_probs=208.7
Q ss_pred ceeEeccccccCceEEEEEEEc---CCCeEEEEEEecCCC------CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCcee
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKT------KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~---~~~~~vAvK~~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 78 (407)
+|++.+.||+|+||.||++++. .+++.||+|++.... ....+..|+.+++.+.+++++..+..++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999864 478899999875421 1234678999999998889999998888888899
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeec
Q 015406 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~ 157 (407)
++||||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+.
T Consensus 81 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili---~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILL---DSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEE---CCCCCEEEeeCcCCcccc
Confidence 9999999 8999999875 4579999999999999999999999999999999999999 578899999999998654
Q ss_pred cCCCCcccCccCCCCccccccccccccccCCC-CChhhHHHHHHHHHHHHHhCCCCCCCCCcCchH-HHHHHHhhhcccc
Q 015406 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK-QKYEKISEKKVST 235 (407)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~-~~~~~i~~~~~~~ 235 (407)
..... ......||+.|+|||++.+.. ++.++|||||||++|||++|..||......... .....+.....
T Consensus 157 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-- 228 (332)
T cd05614 157 SEEKE------RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDP-- 228 (332)
T ss_pred ccCCC------ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCC--
Confidence 32221 123457999999999998754 789999999999999999999999754332222 22222222111
Q ss_pred cHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHHHHcCCCCCCccccccchh
Q 015406 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYA--YLKRIFRDLFIREGFQFDYVFDWTILKY 295 (407)
Q Consensus 236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~--~l~~~l~~l~~~~~~~~~~~~dw~~~~~ 295 (407)
.+...+++++.+++.+||..||++||++. .+.++++ ++|....+|.....
T Consensus 229 ---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~-------h~~~~~~~~~~~~~ 280 (332)
T cd05614 229 ---PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE-------HPFFKGLDWEALAL 280 (332)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc-------CCCcCCCCHHHHHh
Confidence 23345789999999999999999999543 2333332 25555667776544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=337.51 Aligned_cols=254 Identities=19% Similarity=0.266 Sum_probs=202.3
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC---CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
++|++.++||.|+||.||+|++..+++.||+|++.... ....+.+|+.+++.++| +++..+..++...+..++|||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKH-ANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCC-CCEeeEEEEEcCCCeEEEEEe
Confidence 57999999999999999999999999999999876432 23357789999999987 666677777777888999999
Q ss_pred ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCc
Q 015406 84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (407)
Q Consensus 84 ~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~ 163 (407)
|+.++|.+++......+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 84 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~DfG~~~~~~~~~~-- 158 (288)
T cd07871 84 YLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLI---NEKGELKLADFGLARAKSVPTK-- 158 (288)
T ss_pred CCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEECcCcceeeccCCCc--
Confidence 99879999998666668999999999999999999999999999999999999 5788999999999986543221
Q ss_pred ccCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcc---------
Q 015406 164 HIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV--------- 233 (407)
Q Consensus 164 ~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~--------- 233 (407)
......|++.|+|||++.+ ..++.++|||||||++|||++|+.||.+..................
T Consensus 159 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07871 159 -----TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS 233 (288)
T ss_pred -----cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcccc
Confidence 1234578999999999876 5689999999999999999999999977543222222211111000
Q ss_pred -------------cccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 234 -------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 234 -------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
..........+++++.++|.+||..||.+|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00111222456789999999999999999999888753
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=343.73 Aligned_cols=253 Identities=19% Similarity=0.288 Sum_probs=204.1
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEecCCC-----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-C
Q 015406 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (407)
Q Consensus 13 ~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~-g 86 (407)
+.||+|+||.||++++..+++.||+|++.... ....+.+|+.+++.+.| +++..+..++...+..|+||||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRH-PFLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC-CCCcceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999999999999999886432 22346788999998877 66777777778888999999999 9
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcccC
Q 015406 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166 (407)
Q Consensus 87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~ 166 (407)
++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~DfG~~~~~~~~~~----- 150 (328)
T cd05593 80 GELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML---DKDGHIKITDFGLCKEGITDAA----- 150 (328)
T ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEE---CCCCcEEEecCcCCccCCCccc-----
Confidence 999988875 4579999999999999999999999999999999999999 6788999999999875332211
Q ss_pred ccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcH
Q 015406 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 246 (407)
Q Consensus 167 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 246 (407)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...+. .+....+..... .+...+++
T Consensus 151 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~---~~~~~~~~~~~~-----~~p~~~~~ 220 (328)
T cd05593 151 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELILMEDI-----KFPRTLSA 220 (328)
T ss_pred --ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH---HHHHHHhccCCc-----cCCCCCCH
Confidence 12345799999999999998999999999999999999999999976432 333333322221 23356889
Q ss_pred HHHHHHHHHhCCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCccccccchh
Q 015406 247 EFASYFHYCRSLRFDDKP-----DYAYLKRIFRDLFIREGFQFDYVFDWTILKY 295 (407)
Q Consensus 247 ~l~~li~~cl~~~p~~RP-----t~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~ 295 (407)
++.++|.+||..||++|+ ++.++.+ +.|....+|.....
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~il~----------h~~~~~~~~~~~~~ 264 (328)
T cd05593 221 DAKSLLSGLLIKDPNKRLGGGPDDAKEIMR----------HSFFTGVNWQDVYD 264 (328)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCCCHHHHhc----------CCCcCCCCHHHHHh
Confidence 999999999999999997 6665543 25666778876544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=348.27 Aligned_cols=260 Identities=22% Similarity=0.334 Sum_probs=209.9
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
++|++.+.||+|+||.||+|++..+++.||||++.... ....+..|+.++..+.| ++++.+..++...+..|+|
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~iv~~~~~~~~~~~~~lv 79 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS-EWLVKLLYAFQDDEYLYLA 79 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCC-CCCccEEEEEEcCCEEEEE
Confidence 47999999999999999999999999999999886432 22347789999999985 6777777777888899999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 82 me~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
|||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 80 ~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kL~Dfg~a~~~~~~- 154 (333)
T cd05600 80 MEYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLI---DASGHIKLTDFGLSKGIVTY- 154 (333)
T ss_pred EeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEEEeCcCCcccccc-
Confidence 9999 9999999975 4578999999999999999999999999999999999999 57889999999999865431
Q ss_pred CCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcc---cccH
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV---STSI 237 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~---~~~~ 237 (407)
.....||+.|+|||++.+..++.++|||||||++|||++|..||..... .+.+..+..... .+..
T Consensus 155 ---------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~ 222 (333)
T cd05600 155 ---------ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP---NETWENLKYWKETLQRPVY 222 (333)
T ss_pred ---------cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH---HHHHHHHHhccccccCCCC
Confidence 2356799999999999999999999999999999999999999977443 333333322111 1111
Q ss_pred HHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccch
Q 015406 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILK 294 (407)
Q Consensus 238 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~dw~~~~ 294 (407)
......+++++.+++.+||..+|++||++.++.+ ++|...++|....
T Consensus 223 ~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~----------h~~~~~~~~~~~~ 269 (333)
T cd05600 223 DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKN----------HPFFKEVDWNELR 269 (333)
T ss_pred CccccccCHHHHHHHHHHhhChhhhcCCHHHHHh----------CcccCCCCHHHHh
Confidence 1011246899999999999999999999776654 2455556776544
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=343.43 Aligned_cols=266 Identities=20% Similarity=0.265 Sum_probs=215.6
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
+|++.+.||+|+||.||+|++..+++.||+|++.... ....+..|..++..+.|++++..+..++...+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4789999999999999999999999999999876432 22346778888888888899998988888888999999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCC
Q 015406 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 83 e~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~ 161 (407)
||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 Ey~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill---~~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 81 EYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML---DSEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeccccccccCCCCc
Confidence 999 9999999875 4579999999999999999999999999999999999999 5788999999999975432211
Q ss_pred CcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHh
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (407)
......||+.|+|||++.+..++.++|||||||++|||++|..||.+... ...+..+...... +.
T Consensus 157 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~~~i~~~~~~-----~p 221 (323)
T cd05615 157 -------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---DELFQSIMEHNVS-----YP 221 (323)
T ss_pred -------cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCC-----CC
Confidence 12345799999999999999999999999999999999999999977433 4444444443322 23
Q ss_pred cCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchhhc
Q 015406 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQ 297 (407)
Q Consensus 242 ~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~~~ 297 (407)
..++.++.+++.+||..+|.+|++..+. ..+++ ..+++...++|.......
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~R~~~~~~--~~~~i---~~h~~f~~~~~~~~~~~~ 272 (323)
T cd05615 222 KSLSKEAVSICKGLMTKHPSKRLGCGPE--GERDI---REHAFFRRIDWDKLENRE 272 (323)
T ss_pred ccCCHHHHHHHHHHcccCHhhCCCCCCC--CHHHH---hcCcccCCCCHHHHhcCC
Confidence 4578999999999999999999985321 11122 234667788998766554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=338.58 Aligned_cols=255 Identities=21% Similarity=0.285 Sum_probs=205.7
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEecCCC-----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-C
Q 015406 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (407)
Q Consensus 13 ~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~-g 86 (407)
+.||+|+||.||+|++..+++.||||+++... ....+..|..++..+.+|++++.+..++..++..|+||||+ |
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999886432 22335667777777667788888888888888999999999 9
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcccC
Q 015406 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166 (407)
Q Consensus 87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~ 166 (407)
++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~a~~~~~~~~----- 151 (316)
T cd05592 81 GDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEG----- 151 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEE---CCCCCEEEccCcCCeECCCCCC-----
Confidence 999999875 4579999999999999999999999999999999999999 5788999999999986433221
Q ss_pred ccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcH
Q 015406 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 246 (407)
Q Consensus 167 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 246 (407)
......||+.|+|||++.+..++.++|||||||++|||++|..||.+.+. .+.+..+..... .+...++.
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~---~~~~~~i~~~~~-----~~~~~~~~ 221 (316)
T cd05592 152 --KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE---DELFDSILNDRP-----HFPRWISK 221 (316)
T ss_pred --ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHcCCC-----CCCCCCCH
Confidence 12356799999999999999999999999999999999999999987443 344444433221 12345789
Q ss_pred HHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHHHHcCCCCCCccccccchhh
Q 015406 247 EFASYFHYCRSLRFDDKPDYA-YLKRIFRDLFIREGFQFDYVFDWTILKYQ 296 (407)
Q Consensus 247 ~l~~li~~cl~~~p~~RPt~~-~l~~~l~~l~~~~~~~~~~~~dw~~~~~~ 296 (407)
++.+++.+||+.||++||++. ++++ +++....+|......
T Consensus 222 ~~~~ll~~~l~~~P~~R~~~~~~l~~----------h~~~~~~~~~~~~~~ 262 (316)
T cd05592 222 EAKDCLSKLFERDPTKRLGVDGDIRQ----------HPFFRGIDWERLEKR 262 (316)
T ss_pred HHHHHHHHHccCCHHHcCCChHHHHc----------CcccCCCCHHHHHhC
Confidence 999999999999999999863 3322 355666788765544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=326.06 Aligned_cols=254 Identities=20% Similarity=0.234 Sum_probs=208.1
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcc----hHHHHHHHHHHHcCCCCCCeeEEe--eeeCceeE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKLYRILQGGTGIPNVRWF--GVEGDYNV 79 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~----~~~~E~~~l~~l~~~~~i~~~~~~--~~~~~~~~ 79 (407)
.+.|+.+.+|++|+||.||+|+++.+++.||+|.++.+.... .-++|+.++..++| ++|+.+..+ +..-+..|
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H-~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARH-PNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCC-CCeeeeEEEEeccccceee
Confidence 467999999999999999999999999999999988765443 36899999999985 777777554 44666799
Q ss_pred EEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 80 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 80 lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
||||||..+|..+++....+|...++..++.|++.||+|||.+.|+||||||+|+|+ .+.|.+||+|||+|+.+...
T Consensus 154 ~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm---~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 154 IVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLL---SHKGILKIADFGLAREYGSP 230 (419)
T ss_pred eeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheee---ccCCcEEecccchhhhhcCC
Confidence 999999999999999888899999999999999999999999999999999999999 58899999999999988775
Q ss_pred CCCcccCccCCCCccccccccccccccCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhc----c-
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK----V- 233 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~----~- 233 (407)
.. ..+..+-|..|.|||.+.|. .|+...|+||+|||+.||+++++-|.+...-+...++.+..... +
T Consensus 231 ~k-------~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwp 303 (419)
T KOG0663|consen 231 LK-------PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWP 303 (419)
T ss_pred cc-------cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCC
Confidence 32 23566789999999999975 58999999999999999999999999866544433333322111 0
Q ss_pred --------------cccHHHHh---cC--CcHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015406 234 --------------STSIEALC---RG--YPTEFASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 234 --------------~~~~~~~~---~~--~~~~l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
..+...+. .. +++.-.+|+..+|.+||.+|.|+++.+
T Consensus 304 g~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L 359 (419)
T KOG0663|consen 304 GYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGL 359 (419)
T ss_pred CccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhh
Confidence 00011111 11 357788999999999999999987654
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=346.10 Aligned_cols=259 Identities=21% Similarity=0.300 Sum_probs=211.8
Q ss_pred CCceeEeccccccCceEEEEEEEcCCC-eEEEEEEecCC-----CCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTN-EEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~-~~vAvK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 79 (407)
.++|++.+.||+|+||.||+|.+..++ ..||+|.+... .....+..|+.+++.+.| ++++.+..++.+....|
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH-PFCVNLYGSFKDESYLY 107 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCC-CCCcceEEEEEeCCEEE
Confidence 467999999999999999999876654 68999987532 223457789999999986 66777777778888999
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 80 lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
+||||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 108 lv~Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLL---DKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEecCCCCeecCC
Confidence 999999 9999999986 4579999999999999999999999999999999999999 5789999999999987543
Q ss_pred CCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHH
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (407)
. .....||+.|+|||++.+..++.++|||||||++|||++|..||.+.+ ....+..+......
T Consensus 184 ~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~---~~~~~~~i~~~~~~---- 246 (340)
T PTZ00426 184 R----------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE---PLLIYQKILEGIIY---- 246 (340)
T ss_pred C----------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC---HHHHHHHHhcCCCC----
Confidence 2 124579999999999999889999999999999999999999997643 23444555443321
Q ss_pred HHhcCCcHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCccccccchhhc
Q 015406 239 ALCRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQ 297 (407)
Q Consensus 239 ~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~~~ 297 (407)
+...+++++.++|.+||+.||++|+ ++++++ .++|...++|.......
T Consensus 247 -~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~----------~hp~f~~~~~~~~~~~~ 299 (340)
T PTZ00426 247 -FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVK----------EHPWFGNIDWVSLLHKN 299 (340)
T ss_pred -CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHH----------cCCCcCCCCHHHHHhCC
Confidence 2345788999999999999999996 555543 34677778897655443
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=315.61 Aligned_cols=251 Identities=20% Similarity=0.251 Sum_probs=208.3
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc----chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
.+|...++||+|.||.||+|++..+|+.||||.++..... ...++|++.|+.++| ++|..+.+.+...+..-||+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h-~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKH-PNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccC-cchhhhhhhccCCCceEEEE
Confidence 5799999999999999999999999999999988765433 357899999999996 66666666677777789999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 83 e~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
||+..+|+..++.....++..++..|+.+++.||+|||++.|+||||||.|+|| ..+|.+||+|||+|+.+......
T Consensus 81 Efm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLi---s~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 81 EFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLI---SSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred EeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEE---cCCCcEEeecccchhccCCCCcc
Confidence 999999999999877789999999999999999999999999999999999999 58999999999999988765542
Q ss_pred cccCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhc---------
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK--------- 232 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~--------- 232 (407)
. ...+-|..|.|||.+.| ..|+...||||.|||+.||+.|.+-|.+.++ .+.+..|....
T Consensus 158 ~-------~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD---idQL~~If~~LGTP~~~~WP 227 (318)
T KOG0659|consen 158 Q-------THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD---IDQLSKIFRALGTPTPDQWP 227 (318)
T ss_pred c-------ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch---HHHHHHHHHHcCCCCcccCc
Confidence 2 22367899999999987 4689999999999999999999988888554 33333332211
Q ss_pred --------------ccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 233 --------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 233 --------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.......+....+.+..+|+..||.+||.+|.++.|..+
T Consensus 228 ~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~ 280 (318)
T KOG0659|consen 228 EMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK 280 (318)
T ss_pred cccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence 111222344556788899999999999999999776654
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=340.59 Aligned_cols=262 Identities=19% Similarity=0.241 Sum_probs=208.4
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEecCCC-----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-C
Q 015406 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (407)
Q Consensus 13 ~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~-g 86 (407)
+.||+|+||.||+|++..+++.||||++.... ....+..|.+++..+.+|+++..+..++...+..|+||||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999999999999999876432 22346678888888877889999988888889999999999 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcccC
Q 015406 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166 (407)
Q Consensus 87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~ 166 (407)
++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill---~~~~~~kL~Dfg~~~~~~~~~~----- 151 (321)
T cd05591 81 GDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILL---DAEGHCKLADFGMCKEGILNGV----- 151 (321)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeecccceecccCCc-----
Confidence 999998875 4579999999999999999999999999999999999999 6788999999999986433221
Q ss_pred ccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcH
Q 015406 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 246 (407)
Q Consensus 167 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 246 (407)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+ ....+..+...... ....++.
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~---~~~~~~~i~~~~~~-----~p~~~~~ 221 (321)
T cd05591 152 --TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN---EDDLFESILHDDVL-----YPVWLSK 221 (321)
T ss_pred --cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC---HHHHHHHHHcCCCC-----CCCCCCH
Confidence 1235679999999999999999999999999999999999999997644 34445554443322 2234789
Q ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchhh
Q 015406 247 EFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQ 296 (407)
Q Consensus 247 ~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~~ 296 (407)
++.+++.+||..||++||+........++++ .++|...++|......
T Consensus 222 ~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~---~hp~~~~~~~~~~~~~ 268 (321)
T cd05591 222 EAVSILKAFMTKNPNKRLGCVASQGGEDAIK---QHPFFKEIDWVLLEQR 268 (321)
T ss_pred HHHHHHHHHhccCHHHcCCCCCCCCCHHHHh---cCCccCCCCHHHHHhC
Confidence 9999999999999999994322111111111 2356677889876543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=339.67 Aligned_cols=238 Identities=21% Similarity=0.273 Sum_probs=195.5
Q ss_pred eeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-----CcchHHHHHHHHHHHc--CCCCCCeeEEeeeeCceeEEE
Q 015406 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQ--GGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 9 y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~~l~~l~--~~~~i~~~~~~~~~~~~~~lv 81 (407)
|++.+.||+|+||.||+|.+..+++.||||+++... ....+..|++++..++ .|+++..+..++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 789999999999999999999999999999986432 2234667777765543 357777788888888899999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 82 me~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
|||+ +++|..++. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 81 ~E~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 81 MEYAAGGDLMMHIH--TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLL---DTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EcCCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCcEEeCcccCCccCCCCC
Confidence 9999 899988886 3579999999999999999999999999999999999999 678999999999987533221
Q ss_pred CCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHH
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (407)
. ......|++.|+|||++.+..++.++|||||||++|||++|..||.+... .+.+..+...... .
T Consensus 156 ~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~---~~~~~~i~~~~~~-----~ 220 (324)
T cd05589 156 D-------RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE---EEVFDSIVNDEVR-----Y 220 (324)
T ss_pred C-------cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCC-----C
Confidence 1 12356799999999999999999999999999999999999999976433 3444444333221 2
Q ss_pred hcCCcHHHHHHHHHHhCCCCCCCCCH
Q 015406 241 CRGYPTEFASYFHYCRSLRFDDKPDY 266 (407)
Q Consensus 241 ~~~~~~~l~~li~~cl~~~p~~RPt~ 266 (407)
...+++++.++|.+||..||++||+.
T Consensus 221 p~~~~~~~~~li~~~L~~dP~~R~~~ 246 (324)
T cd05589 221 PRFLSREAISIMRRLLRRNPERRLGS 246 (324)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCC
Confidence 34578999999999999999999964
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=339.56 Aligned_cols=262 Identities=19% Similarity=0.243 Sum_probs=209.8
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEecCCC-----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-C
Q 015406 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (407)
Q Consensus 13 ~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~-g 86 (407)
+.||+|+||.||+|++..+++.||||++.... ....+..|..++..+.+|++++.+..++...+..|+||||+ +
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999999999999999876431 22346678888888777788888888888889999999999 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcccC
Q 015406 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166 (407)
Q Consensus 87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~ 166 (407)
++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 g~L~~~i~~-~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli---~~~~~~kL~DfG~~~~~~~~~~----- 151 (320)
T cd05590 81 GDLMFHIQK-SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGIFNGK----- 151 (320)
T ss_pred chHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeeCCCCeecCcCCC-----
Confidence 999998875 4579999999999999999999999999999999999999 6788999999999875432211
Q ss_pred ccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcH
Q 015406 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 246 (407)
Q Consensus 167 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 246 (407)
......||+.|+|||++.+..++.++|||||||++|||++|..||.+.+ ..+.+..+...... +...++.
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~---~~~~~~~i~~~~~~-----~~~~~~~ 221 (320)
T cd05590 152 --TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN---EDDLFEAILNDEVV-----YPTWLSQ 221 (320)
T ss_pred --cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC---HHHHHHHHhcCCCC-----CCCCCCH
Confidence 1235679999999999999999999999999999999999999997643 34444544443221 2245789
Q ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchhhc
Q 015406 247 EFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQ 297 (407)
Q Consensus 247 ~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~~~ 297 (407)
++.+++.+||..||++||++.++ .-.+++ ..++|...++|+.....+
T Consensus 222 ~~~~li~~~L~~dP~~R~~~~~~-~~~~~~---~~h~~f~~~~~~~~~~~~ 268 (320)
T cd05590 222 DAVDILKAFMTKNPTMRLGSLTL-GGEEAI---LRHPFFKELDWEKLNRRQ 268 (320)
T ss_pred HHHHHHHHHcccCHHHCCCCCCC-CCHHHH---HcCCCcCCCCHHHHHhCC
Confidence 99999999999999999997443 111111 234666778888665443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=334.91 Aligned_cols=255 Identities=20% Similarity=0.234 Sum_probs=198.8
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+|+.+++.++| +++..+..++...+..++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQ-ENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCC-ccccchhhhEecCCEEEEEE
Confidence 479999999999999999999999999999998765422 2357789999999987 55556666667778899999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 83 e~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
||+.+++.+.+......+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||+++........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLI---SHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccCcccccccccc
Confidence 999555555555445679999999999999999999999999999999999999 57889999999999876432211
Q ss_pred cccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcc---------
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV--------- 233 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~--------- 233 (407)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.+............+.....
T Consensus 157 ------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07848 157 ------NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS 230 (287)
T ss_pred ------cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhc
Confidence 12345789999999999998999999999999999999999999987543222211111110000
Q ss_pred ---------------cccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 234 ---------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 234 ---------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
..........++.++.+++.+||+.||++||+++++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00001112346888999999999999999999887653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=338.14 Aligned_cols=261 Identities=18% Similarity=0.263 Sum_probs=201.4
Q ss_pred cCCceeEeccccccCceEEEEEEEcC----------------CCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCC
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQ----------------TNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGI 65 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~----------------~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i 65 (407)
..++|++.++||+|+||.||+|.+.. ++..||+|++..... ...+.+|++++..++| +++
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~ni 81 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKD-PNI 81 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCC-CCe
Confidence 35789999999999999999998532 345799998875432 2357889999999976 666
Q ss_pred CeeEEeeeeCceeEEEEecc-CCCHHHHHHHcC------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 015406 66 PNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS------------------RKLSLKTVLMLADQMINRVEFVHSKSFLH 126 (407)
Q Consensus 66 ~~~~~~~~~~~~~~lvme~~-g~sL~~~l~~~~------------------~~l~~~~~~~i~~qi~~aL~yLH~~~ivH 126 (407)
..+..++...+..+++|||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+|
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 67777777778899999999 999999986421 23678899999999999999999999999
Q ss_pred ccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHH
Q 015406 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYF 206 (407)
Q Consensus 127 rDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~el 206 (407)
|||||+|||+ +.++.+||+|||+++....... ........++..|+|||++.+..++.++||||||+++|||
T Consensus 162 ~dlkp~Nill---~~~~~~kl~DfG~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el 233 (304)
T cd05096 162 RDLATRNCLV---GENLTIKIADFGMSRNLYAGDY-----YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEI 233 (304)
T ss_pred cCcchhheEE---cCCccEEECCCccceecccCce-----eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHH
Confidence 9999999999 5788999999999986543321 1112334567899999999988999999999999999999
Q ss_pred Hh--CCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015406 207 LR--GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 274 (407)
Q Consensus 207 lt--G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~ 274 (407)
++ +..||..............................+|..+.+++.+||+.+|++||++.+|.+.|+
T Consensus 234 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 234 LMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred HHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 86 678887754432222221111111111111122457899999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=344.18 Aligned_cols=270 Identities=19% Similarity=0.274 Sum_probs=208.8
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
++|++.+.||+|+||.||+|++..+++.||||++.... ....+..|+.++..++| ++++.+...+.+....|+|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~-~~iv~~~~~~~~~~~~~lv 79 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS-LWVVKMFYSFQDKLNLYLI 79 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCC-CCcceEEEEEecCCeEEEE
Confidence 47999999999999999999999999999999986432 12346778999998876 6677777777788899999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 82 me~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
|||+ |++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.+....
T Consensus 80 ~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi---~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 80 MEFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLL---DSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred EcCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCCEEEeeccCcccccccc
Confidence 9999 9999999986 4579999999999999999999999999999999999999 578899999999997653211
Q ss_pred CCc-------cc---------------------CccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCC
Q 015406 161 THQ-------HI---------------------PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212 (407)
Q Consensus 161 ~~~-------~~---------------------~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~P 212 (407)
... .. ........+||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 000 00 00001245799999999999999999999999999999999999999
Q ss_pred CCCCCcCchHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCC---CCCHHHHHHHHHHHHHHcCCCCCCccc
Q 015406 213 WQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDD---KPDYAYLKRIFRDLFIREGFQFDYVFD 289 (407)
Q Consensus 213 f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~---RPt~~~l~~~l~~l~~~~~~~~~~~~d 289 (407)
|.+.. ..+.+.++.........+. ...+++++.++|.+++. +|++ ||++++|++ ++|...++
T Consensus 236 f~~~~---~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~----------hp~f~~~~ 300 (363)
T cd05628 236 FCSET---PQETYKKVMNWKETLIFPP-EVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKT----------NPFFEGVD 300 (363)
T ss_pred CCCCC---HHHHHHHHHcCcCcccCCC-cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhC----------CCCCCCCC
Confidence 97643 3444554443221111110 12367899999998765 4444 578776643 47788889
Q ss_pred cccchhh
Q 015406 290 WTILKYQ 296 (407)
Q Consensus 290 w~~~~~~ 296 (407)
|......
T Consensus 301 ~~~~~~~ 307 (363)
T cd05628 301 WEHIRER 307 (363)
T ss_pred HHHHHhC
Confidence 9876543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=342.50 Aligned_cols=253 Identities=21% Similarity=0.287 Sum_probs=203.9
Q ss_pred ccccCceEEEEEEEcCCCeEEEEEEecCCC-----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-CCC
Q 015406 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPS 88 (407)
Q Consensus 15 iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~-g~s 88 (407)
||+|+||.||+|++..+++.||+|++.... ....+..|+.+++.++| ++++.+..++...+..|+||||+ +++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNC-PFIVPLKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC-CcEeceeeEEecCCeEEEEEcCCCCCc
Confidence 799999999999999999999999876421 22346789999999976 55666666677788899999999 999
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcccCcc
Q 015406 89 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYR 168 (407)
Q Consensus 89 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 168 (407)
|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~------- 148 (312)
T cd05585 80 LFHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL---DYQGHIALCDFGLCKLNMKDDD------- 148 (312)
T ss_pred HHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEE---CCCCcEEEEECcccccCccCCC-------
Confidence 9999975 4579999999999999999999999999999999999999 6788999999999975432221
Q ss_pred CCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcHHH
Q 015406 169 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEF 248 (407)
Q Consensus 169 ~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l 248 (407)
......||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ..+.+..+..... .+...+++++
T Consensus 149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~---~~~~~~~~~~~~~-----~~~~~~~~~~ 220 (312)
T cd05585 149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN---VNEMYRKILQEPL-----RFPDGFDRDA 220 (312)
T ss_pred ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC---HHHHHHHHHcCCC-----CCCCcCCHHH
Confidence 1235679999999999999999999999999999999999999997643 3344444443322 2335688999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccch
Q 015406 249 ASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILK 294 (407)
Q Consensus 249 ~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~dw~~~~ 294 (407)
.+++.+||..||++||++..+.++|.+ +|....+|....
T Consensus 221 ~~li~~~L~~dp~~R~~~~~~~e~l~h-------p~~~~~~~~~~~ 259 (312)
T cd05585 221 KDLLIGLLSRDPTRRLGYNGAQEIKNH-------PFFSQLSWKKLL 259 (312)
T ss_pred HHHHHHHcCCCHHHcCCCCCHHHHHcC-------CCcCCCCHHHHH
Confidence 999999999999999987666666554 344445665443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=339.08 Aligned_cols=253 Identities=20% Similarity=0.290 Sum_probs=203.0
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEecCCC-----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-C
Q 015406 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (407)
Q Consensus 13 ~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~-g 86 (407)
+.||+|+||.||++++..+++.||+|++.... ....+..|+++++.++| +++..+..++...+..|+||||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH-PFLTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCC-CCCcceeeEEecCCEEEEEEeCCCC
Confidence 46899999999999999999999999876432 22346678999999976 66777777777888999999999 9
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcccC
Q 015406 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166 (407)
Q Consensus 87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~ 166 (407)
++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~----- 150 (323)
T cd05595 80 GELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGA----- 150 (323)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---cCCCCEEecccHHhccccCCCC-----
Confidence 999988875 4579999999999999999999999999999999999999 5788999999999875322211
Q ss_pred ccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcH
Q 015406 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 246 (407)
Q Consensus 167 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 246 (407)
......||+.|+|||++.+..++.++|||||||++|||++|..||...+. ...+..+...... +...+++
T Consensus 151 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~---~~~~~~~~~~~~~-----~p~~~~~ 220 (323)
T cd05595 151 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLFELILMEEIR-----FPRTLSP 220 (323)
T ss_pred --ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHhcCCCC-----CCCCCCH
Confidence 12345799999999999999999999999999999999999999976433 3333333322221 2356889
Q ss_pred HHHHHHHHHhCCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCccccccchh
Q 015406 247 EFASYFHYCRSLRFDDKP-----DYAYLKRIFRDLFIREGFQFDYVFDWTILKY 295 (407)
Q Consensus 247 ~l~~li~~cl~~~p~~RP-----t~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~ 295 (407)
++.++|.+||..||++|| ++.++.+ ++|...++|.....
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~~l~----------h~~~~~~~~~~~~~ 264 (323)
T cd05595 221 EAKSLLAGLLKKDPKQRLGGGPSDAKEVME----------HRFFLSINWQDVVQ 264 (323)
T ss_pred HHHHHHHHHccCCHHHhCCCCCCCHHHHHc----------CCCcCCCCHHHHHh
Confidence 999999999999999998 5554433 35666677875543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=334.53 Aligned_cols=252 Identities=19% Similarity=0.267 Sum_probs=199.4
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
.++|++.++||+|+||.||+|++..+++.||||++..... ...+.+|+.+++.++| +++..+..+.......++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKH-ANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCC-CCcCeEEEEEecCCeEEEEE
Confidence 4789999999999999999999999999999998865432 2346789999999987 56667777777888899999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 83 e~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
||++++|.+++......+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~- 158 (303)
T cd07869 83 EYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLI---SDTGELKLADFGLARAKSVPSH- 158 (303)
T ss_pred ECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECCCCcceeccCCCc-
Confidence 999889999888666679999999999999999999999999999999999999 5788999999999975433221
Q ss_pred cccCccCCCCccccccccccccccCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcc--------
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-------- 233 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-------- 233 (407)
......||+.|+|||++.+. .++.++|||||||++|||++|..||.+... ....+..+.....
T Consensus 159 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~ 230 (303)
T cd07869 159 ------TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD--IQDQLERIFLVLGTPNEDTWP 230 (303)
T ss_pred ------cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHHhCCCChhhcc
Confidence 12345689999999998764 579999999999999999999999987533 1222222211000
Q ss_pred -----------------cccHHHHh--cCCcHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015406 234 -----------------STSIEALC--RGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 234 -----------------~~~~~~~~--~~~~~~l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
........ ..+++++.+++.+||+.||++|||+.+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l 286 (303)
T cd07869 231 GVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAAL 286 (303)
T ss_pred chhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHh
Confidence 00000001 12457889999999999999999977665
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=339.19 Aligned_cols=254 Identities=20% Similarity=0.259 Sum_probs=203.9
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc----------------chHHHHHHHHHHHcCCCCCCe
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----------------PQLLYESKLYRILQGGTGIPN 67 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----------------~~~~~E~~~l~~l~~~~~i~~ 67 (407)
...++|++++.||+|.||.|-+|++..+++.||||++.+.... +...+|+.+|++|.| ++++.
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H-~nVV~ 172 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHH-PNVVK 172 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCC-cCeeE
Confidence 3468899999999999999999999999999999987654311 247889999999998 56666
Q ss_pred eEEeee--eCceeEEEEecc-CCCHHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCc
Q 015406 68 VRWFGV--EGDYNVLVMDLL-GPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN 143 (407)
Q Consensus 68 ~~~~~~--~~~~~~lvme~~-g~sL~~~l~~~~~~-l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~ 143 (407)
+..+-. ..+..|||+||| .|.+...-. ... +++.+++.|+.+++.||+|||.+|||||||||+|+|| +.++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~--d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl---~~~g 247 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPP--DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLL---SSDG 247 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCC--CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEE---cCCC
Confidence 555443 567889999999 665543322 234 8999999999999999999999999999999999999 5789
Q ss_pred eEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCC---C-ChhhHHHHHHHHHHHHHhCCCCCCCCCcC
Q 015406 144 QVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE---Q-SRRDDLESLGYVLMYFLRGSLPWQGLKAG 219 (407)
Q Consensus 144 ~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~-~~~sDIwSlG~il~elltG~~Pf~~~~~~ 219 (407)
++||+|||.+..+........ .......+|||.|+|||...+.. + +.+.||||+||+||.|+.|+.||.+ .
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~--d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~---~ 322 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGS--DDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD---D 322 (576)
T ss_pred cEEeeccceeeecccCCcccc--HHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc---c
Confidence 999999999987643321110 01123468999999999988732 3 6889999999999999999999976 4
Q ss_pred chHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 220 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 220 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
...+.+.+|....+..+.. +.+.+.+++||.+||.+||++|.+..+|+.
T Consensus 323 ~~~~l~~KIvn~pL~fP~~---pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 323 FELELFDKIVNDPLEFPEN---PEINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred hHHHHHHHHhcCcccCCCc---ccccHHHHHHHHHHhhcChhheeehhhhee
Confidence 5678888888776654332 246789999999999999999999777754
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=339.77 Aligned_cols=255 Identities=21% Similarity=0.292 Sum_probs=205.4
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEecCC-----CCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-C
Q 015406 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (407)
Q Consensus 13 ~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~-g 86 (407)
+.||+|+||.||+|++..+++.||+|+++.. ........|..++..+.+++++..+..++...+..|+||||+ +
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4799999999999999999999999988643 223346678888877766788888888888889999999999 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcccC
Q 015406 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166 (407)
Q Consensus 87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~ 166 (407)
++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~----- 151 (316)
T cd05620 81 GDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML---DRDGHIKIADFGMCKENVFGDN----- 151 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEeCccCCCeecccCCC-----
Confidence 999999875 4579999999999999999999999999999999999999 5788999999999875322111
Q ss_pred ccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcH
Q 015406 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 246 (407)
Q Consensus 167 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 246 (407)
......||+.|+|||++.+..++.++|||||||++|||++|..||.+.+. .+.+..+..... .+...++.
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~---~~~~~~~~~~~~-----~~~~~~~~ 221 (316)
T cd05620 152 --RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE---DELFESIRVDTP-----HYPRWITK 221 (316)
T ss_pred --ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCC-----CCCCCCCH
Confidence 12356799999999999999999999999999999999999999976433 333443332221 12345789
Q ss_pred HHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHHHHcCCCCCCccccccchhh
Q 015406 247 EFASYFHYCRSLRFDDKPDYA-YLKRIFRDLFIREGFQFDYVFDWTILKYQ 296 (407)
Q Consensus 247 ~l~~li~~cl~~~p~~RPt~~-~l~~~l~~l~~~~~~~~~~~~dw~~~~~~ 296 (407)
++.+++.+||+.||++||++. +++ .++|....+|......
T Consensus 222 ~~~~li~~~l~~dP~~R~~~~~~~~----------~h~~f~~~~~~~~~~~ 262 (316)
T cd05620 222 ESKDILEKLFERDPTRRLGVVGNIR----------GHPFFKTINWTALEKR 262 (316)
T ss_pred HHHHHHHHHccCCHHHcCCChHHHH----------cCCCcCCCCHHHHHhC
Confidence 999999999999999999963 332 2366667788765443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=332.91 Aligned_cols=251 Identities=19% Similarity=0.269 Sum_probs=198.6
Q ss_pred CceeEeccccccCceEEEEEEEcC-CCeEEEEEEecCCCC----cchHHHHHHHHHHHc--CCCCCCeeEEeee-----e
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQ-TNEEVAIKLENVKTK----HPQLLYESKLYRILQ--GGTGIPNVRWFGV-----E 74 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~-~~~~vAvK~~~~~~~----~~~~~~E~~~l~~l~--~~~~i~~~~~~~~-----~ 74 (407)
++|++.+.||+|+||.||+|++.. +++.||+|.+..... ...+.+|+.+++.+. .|++++.+..++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 479999999999999999999854 468899998765432 234677888888775 3466666655443 3
Q ss_pred CceeEEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccce
Q 015406 75 GDYNVLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (407)
Q Consensus 75 ~~~~~lvme~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla 153 (407)
....++||||++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~---~~~~~~kl~Dfg~~ 157 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLA 157 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---cCCCCEEEccccce
Confidence 45689999999889999997533 458999999999999999999999999999999999999 57889999999999
Q ss_pred eeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhc-
Q 015406 154 KKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK- 232 (407)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~- 232 (407)
+....... .....||+.|+|||++.+..++.++|||||||++|||++|..||.+.... +.+..+....
T Consensus 158 ~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~---~~~~~i~~~~~ 226 (290)
T cd07862 158 RIYSFQMA--------LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKILDVIG 226 (290)
T ss_pred EeccCCcc--------cccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH---HHHHHHHHHhC
Confidence 87643321 23557899999999999989999999999999999999999999875432 2222222110
Q ss_pred ---------------------ccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 233 ---------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 233 ---------------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.......+.+.+++.+.+++.+||+.||++||++.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 227 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred CCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 111233344567889999999999999999999887763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=338.67 Aligned_cols=265 Identities=22% Similarity=0.270 Sum_probs=206.8
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCC-----CCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
++|++.+.||+|+||.||++++..+++.||+|++... .....+..|..++..+.| ++++.+..++...+..|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv 79 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR-RWITNLHYAFQDENNLYLV 79 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCC-CCCCceEEEEecCCeEEEE
Confidence 5799999999999999999999999999999987642 122346778888887765 7777788888888899999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 82 me~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
|||+ |++|.+++......+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++..+....
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEE---CCCCCEEEEECCceeecCCCC
Confidence 9999 999999998666679999999999999999999999999999999999999 578899999999998765432
Q ss_pred CCcccCccCCCCccccccccccccccC-----CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccc
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHLG-----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (407)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.. ..+.+..+.......
T Consensus 157 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~---~~~~~~~i~~~~~~~ 227 (331)
T cd05597 157 TV------QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES---LVETYGKIMNHKEHF 227 (331)
T ss_pred Cc------cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC---HHHHHHHHHcCCCcc
Confidence 21 1123469999999999873 357889999999999999999999997643 234444444322211
Q ss_pred cHHHHhcCCcHHHHHHHHHHhCCCCCC--CCCHHHHHHHHHHHHHHcCCCCCCccccccch
Q 015406 236 SIEALCRGYPTEFASYFHYCRSLRFDD--KPDYAYLKRIFRDLFIREGFQFDYVFDWTILK 294 (407)
Q Consensus 236 ~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~~l~~~l~~l~~~~~~~~~~~~dw~~~~ 294 (407)
........+++++.+++.+|+..+++. |+++.++++ ++|....+|....
T Consensus 228 ~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~----------hp~~~~~~~~~~~ 278 (331)
T cd05597 228 QFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKD----------HPFFEGIDWDNIR 278 (331)
T ss_pred cCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhc----------CCCCCCCCHHHHh
Confidence 222223457899999999998753332 566554443 3666778887654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=339.33 Aligned_cols=259 Identities=20% Similarity=0.285 Sum_probs=203.0
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEecCCC-----CcchHHHHHHH-HHHHcCCCCCCeeEEeeeeCceeEEEEecc-
Q 015406 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKL-YRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (407)
Q Consensus 13 ~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~~-l~~l~~~~~i~~~~~~~~~~~~~~lvme~~- 85 (407)
+.||+|+||.||+|++..+++.||||++.... ....+..|... ++.++| +++..+...+...+..|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~h-p~iv~~~~~~~~~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKH-PFLVGLHYSFQTADKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCC-CCCCCeeEEEEeCCEEEEEEcCCC
Confidence 46899999999999999999999999876432 12234455544 345555 67777777778888999999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCccc
Q 015406 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165 (407)
Q Consensus 86 g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~ 165 (407)
+++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 ~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll---~~~~~~kl~Dfg~~~~~~~~~~---- 151 (323)
T cd05575 80 GGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGIEHSK---- 151 (323)
T ss_pred CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeccCCCcccccCCC----
Confidence 9999998875 4579999999999999999999999999999999999999 6788999999999875332211
Q ss_pred CccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCc
Q 015406 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 245 (407)
Q Consensus 166 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 245 (407)
......||+.|+|||++.+..++.++|||||||++|||++|..||...+ ..+.+..+...... +...++
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~-----~~~~~~ 220 (323)
T cd05575 152 ---TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD---TAEMYDNILNKPLR-----LKPNIS 220 (323)
T ss_pred ---ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC---HHHHHHHHHcCCCC-----CCCCCC
Confidence 1235679999999999999999999999999999999999999997643 34445555443322 335679
Q ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchhhc
Q 015406 246 TEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQ 297 (407)
Q Consensus 246 ~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~~~ 297 (407)
+++.++|.+||+.||++||++.+ .+.+++ .++|...++|..+....
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~~---~~~~il---~~~~~~~~~~~~~~~~~ 266 (323)
T cd05575 221 VSARHLLEGLLQKDRTKRLGAKD---DFLEIK---NHVFFSSINWDDLVNKK 266 (323)
T ss_pred HHHHHHHHHHhhcCHHhCCCCCC---CHHHHH---cCCCcCCCCHHHHhhcc
Confidence 99999999999999999999742 222222 34566677887655433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=333.83 Aligned_cols=264 Identities=19% Similarity=0.225 Sum_probs=208.7
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
.|++.++||+|+||.||++.+..+++.||||++..... ...+.+|+.+++.++| ++++.+...+..++..++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS-RFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCC-CCEeeeeeeecCCCeEEEEE
Confidence 48999999999999999999999999999998764321 2346789999999976 55666666667778899999
Q ss_pred ecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 83 DLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 83 e~~-g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
||+ +++|.+++... ...+++..+..++.|++.||.|||++||+||||||+||++ ++++.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL---DDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEE---CCCCCEEEeeCCCceecCCCC
Confidence 999 89999888653 3469999999999999999999999999999999999999 577899999999998754322
Q ss_pred CCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHH
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (407)
. .....|+..|+|||++.+..++.++|||||||++|||++|..||.+.......+.+...... .....
T Consensus 157 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~----~~~~~ 224 (285)
T cd05605 157 T--------IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKE----DQEEY 224 (285)
T ss_pred c--------cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhh----ccccc
Confidence 1 12457899999999999989999999999999999999999999875433222222211111 11123
Q ss_pred hcCCcHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCccccccchhhc
Q 015406 241 CRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQ 297 (407)
Q Consensus 241 ~~~~~~~l~~li~~cl~~~p~~RP-----t~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~~~ 297 (407)
...+++.+.+++.+||..||++|| +++++++ +++....+|...+..+
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~----------~~~~~~~~~~~~~~~~ 276 (285)
T cd05605 225 SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA----------HPFFRTANFKRLEAGM 276 (285)
T ss_pred CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc----------CcCccCCCHHHHhhCC
Confidence 345789999999999999999999 5555433 2566667888766544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-45 Score=349.49 Aligned_cols=257 Identities=23% Similarity=0.344 Sum_probs=211.6
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcc----hHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~----~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
.++..+...||+|.||+||+|++-. .||||+++.+...+ .|..|+.++++-+| .||..+.+++..... .||
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH-~NIlLFMG~~~~p~~-AIi 465 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRH-ENILLFMGACMNPPL-AII 465 (678)
T ss_pred HHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcch-hhheeeehhhcCCce-eee
Confidence 4567789999999999999999643 49999998876543 48889999999887 556666666666666 899
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 82 me~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
..+| |.+|+.+++-...+|.....+.|+.||++|+.|||.++|||||||..||++ .+++.|||+|||++..-..-.
T Consensus 466 TqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl---~~~~kVkIgDFGLatvk~~w~ 542 (678)
T KOG0193|consen 466 TQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFL---HEDLKVKIGDFGLATVKTRWS 542 (678)
T ss_pred ehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEE---ccCCcEEEecccceeeeeeec
Confidence 9999 889999998767789999999999999999999999999999999999999 577999999999997543221
Q ss_pred CCcccCccCCCCccccccccccccccC---CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccH
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHLG---IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (407)
... ......|...|||||+++. .+|++.+||||||+++|||++|.+||... ...+.+..+..+-..+..
T Consensus 543 g~~-----q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~---~~dqIifmVGrG~l~pd~ 614 (678)
T KOG0193|consen 543 GEQ-----QLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ---NRDQIIFMVGRGYLMPDL 614 (678)
T ss_pred ccc-----ccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC---ChhheEEEecccccCccc
Confidence 111 1234568899999999874 46899999999999999999999999843 334555555555555555
Q ss_pred HHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Q 015406 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (407)
Q Consensus 238 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~ 278 (407)
.....++|.++++|+..||.+++++||.+.+|...|+.++.
T Consensus 615 s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 615 SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 66677899999999999999999999999999998887754
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=346.51 Aligned_cols=258 Identities=20% Similarity=0.337 Sum_probs=205.2
Q ss_pred CCceeEeccccccCceEEEEEEEcCC-----CeEEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeeeCce
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQT-----NEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~-----~~~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 77 (407)
.++|++.+.||+|+||.||+|++... +..||||++...... ..+.+|+.+++.+..|++++.+..++...+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 35699999999999999999986543 357999998654322 3477899999999666888888888888889
Q ss_pred eEEEEecc-CCCHHHHHHHcC-----------------------------------------------------------
Q 015406 78 NVLVMDLL-GPSLEDLFNFCS----------------------------------------------------------- 97 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~~~~----------------------------------------------------------- 97 (407)
.++||||+ +++|.+++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 99999999 999999986421
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcccCc
Q 015406 98 ----------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPY 167 (407)
Q Consensus 98 ----------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~~ 167 (407)
..+++..++.|+.||+.||.|||++||+||||||+|||+ ++++.+||+|||+++........
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~---~~~~~~kL~DfGla~~~~~~~~~----- 268 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLL---TDGRVAKICDFGLARDIMNDSNY----- 268 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEE---eCCCeEEEeeceeeeeccCCcce-----
Confidence 237888999999999999999999999999999999999 57889999999999865443211
Q ss_pred cCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcH
Q 015406 168 RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 246 (407)
Q Consensus 168 ~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 246 (407)
.......++..|||||++.+..++.++|||||||++|||++ |+.||....... .+.......... .....+|+
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~---~~~~~~~~~~~~---~~~~~~~~ 342 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS---KFYKMVKRGYQM---SRPDFAPP 342 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH---HHHHHHHcccCc---cCCCCCCH
Confidence 11223345678999999998899999999999999999997 999997654321 122222211111 11234689
Q ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHH
Q 015406 247 EFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (407)
Q Consensus 247 ~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~ 277 (407)
++.+++.+||+.||++||++.+|.+.|++++
T Consensus 343 ~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 343 EIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 9999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-45 Score=345.23 Aligned_cols=250 Identities=22% Similarity=0.268 Sum_probs=215.2
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc----chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
.++|..++++|+|+||.+++++++..+..|++|.++..... .....|+.++.+++|++++.....+..++.+.+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 47899999999999999999999999999999988765432 34788999999988865555555555566669999
Q ss_pred Eecc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 82 MDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 82 me~~-g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
|+|| ||+|.+.+.+.+ ..++++.++.|+.|++.|++|||+++|+|||||+.||++ .+++.|+|.|||+|+.+...
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifl---tk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFL---TKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhc---cccCceeecchhhhhhcCCc
Confidence 9999 999999998755 569999999999999999999999999999999999999 58888899999999988765
Q ss_pred CCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHH
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (407)
.. ...+.+||+.||+||++.+.+|+.|+|||||||++|||++-+.+|... +......+|...... .
T Consensus 160 ~~-------~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~---~m~~Li~ki~~~~~~----P 225 (426)
T KOG0589|consen 160 DS-------LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS---NMSELILKINRGLYS----P 225 (426)
T ss_pred hh-------hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc---chHHHHHHHhhccCC----C
Confidence 42 245789999999999999999999999999999999999999999774 445666666665532 3
Q ss_pred HhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015406 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRI 272 (407)
Q Consensus 240 ~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~ 272 (407)
+...++.++..+|..|+..+|..||++.+|+..
T Consensus 226 lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 226 LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 456789999999999999999999999988754
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=340.00 Aligned_cols=255 Identities=20% Similarity=0.275 Sum_probs=196.2
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC----CcchHHHHHHHHHHHcCCCCCCeeEEeee-----eCcee
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGV-----EGDYN 78 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~-----~~~~~ 78 (407)
+|++.++||+|+||.||+|++..+++.||||.+.... ....+.+|+.+++.++|++ +..+..+.. .....
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD-IVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCC-EeeecceEeccCCCCCceE
Confidence 6999999999999999999999999999999876422 2234788999999998754 444433332 22357
Q ss_pred EEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 79 VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 79 ~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
|+||||++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 80 ~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 80 YVVFELMESDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEEecCCCCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEccCcccccccc
Confidence 99999999899999875 4469999999999999999999999999999999999999 6889999999999986533
Q ss_pred CCCCcccCccCCCCccccccccccccccC--CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHH---------
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK--------- 227 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~--------- 227 (407)
..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+..
T Consensus 156 ~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 231 (338)
T cd07859 156 DTPTA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET 231 (338)
T ss_pred ccCcc----ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 22111 11234579999999999876 5789999999999999999999999976443211111110
Q ss_pred ---H-----------hhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 228 ---I-----------SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 228 ---i-----------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
+ .............+.+++++.+++.+||+.||++||+++++++
T Consensus 232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0 0111112222333567889999999999999999999887764
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=339.72 Aligned_cols=266 Identities=19% Similarity=0.263 Sum_probs=211.0
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEecCCCC-----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-C
Q 015406 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (407)
Q Consensus 13 ~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~-g 86 (407)
+.||+|+||.||+|++..+++.||+|++..... ...+..|..++..+.+++++..+..++......|+||||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 479999999999999999999999999875321 2336788999999988899999988888889999999999 9
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcccC
Q 015406 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166 (407)
Q Consensus 87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~ 166 (407)
++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~----- 151 (327)
T cd05617 81 GDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLL---DADGHIKLTDYGMCKEGLGPGD----- 151 (327)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---eCCCCEEEeccccceeccCCCC-----
Confidence 999998875 4579999999999999999999999999999999999999 5788999999999975332211
Q ss_pred ccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcC----chHHHHHHHhhhcccccHHHHhc
Q 015406 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG----TKKQKYEKISEKKVSTSIEALCR 242 (407)
Q Consensus 167 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~----~~~~~~~~i~~~~~~~~~~~~~~ 242 (407)
......||+.|+|||++.+..++.++|||||||+||||++|..||...... .....+..+..... .++.
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----~~p~ 224 (327)
T cd05617 152 --TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI-----RIPR 224 (327)
T ss_pred --ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC-----CCCC
Confidence 123567999999999999999999999999999999999999999643221 11222333322221 1334
Q ss_pred CCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchhhcc
Q 015406 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQS 298 (407)
Q Consensus 243 ~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~~~~ 298 (407)
.++.++.+++.+||..||++|+++... ..+.++ ..++|...++|+.....+.
T Consensus 225 ~~~~~~~~li~~~L~~dP~~R~~~~~~-~~~~~i---~~h~~f~~~~~~~~~~~~~ 276 (327)
T cd05617 225 FLSVKASHVLKGFLNKDPKERLGCQPQ-TGFSDI---KSHTFFRSIDWDLLEKKQV 276 (327)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCCCC-CCHHHH---HcCCCCCCCCHHHHHhCCC
Confidence 578999999999999999999985421 111111 2457777889987765543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=345.29 Aligned_cols=270 Identities=20% Similarity=0.291 Sum_probs=208.5
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+|+.++..+.| ++++.+...+..++..|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h-~~iv~~~~~~~~~~~~~lv 79 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN-PWVVKLYYSFQDENYLYLI 79 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC-CCCcceEEEEEcCCeEEEE
Confidence 47999999999999999999999999999999886432 12346779999999975 7777777788888999999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 82 me~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
|||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.++|+|||+++.+....
T Consensus 80 ~E~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 80 MEYLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLL---DAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred ECCCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEeecccceeccccc
Confidence 9999 9999999875 4579999999999999999999999999999999999999 688999999999998653321
Q ss_pred CCccc-----------------C---------c-----cCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhC
Q 015406 161 THQHI-----------------P---------Y-----RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRG 209 (407)
Q Consensus 161 ~~~~~-----------------~---------~-----~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG 209 (407)
..... + + ......+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 10000 0 0 001134799999999999999999999999999999999999
Q ss_pred CCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccc
Q 015406 210 SLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFD 289 (407)
Q Consensus 210 ~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~d 289 (407)
..||..... .+.+..+.........+ ....+++++.++|.+|+. +|.+|++...+.+++. ++|...++
T Consensus 236 ~~Pf~~~~~---~~~~~~i~~~~~~~~~~-~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~-------h~~~~~~~ 303 (364)
T cd05599 236 YPPFCSDNP---QETYRKIINWKETLQFP-DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS-------HPFFKGVD 303 (364)
T ss_pred CCCCCCCCH---HHHHHHHHcCCCccCCC-CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc-------CCCcCCCC
Confidence 999976443 33344443221111111 012468999999999996 9999998333333333 25666778
Q ss_pred cccc
Q 015406 290 WTIL 293 (407)
Q Consensus 290 w~~~ 293 (407)
|...
T Consensus 304 ~~~~ 307 (364)
T cd05599 304 WEHI 307 (364)
T ss_pred HHHH
Confidence 8754
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=348.89 Aligned_cols=268 Identities=22% Similarity=0.264 Sum_probs=206.0
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCC-----CCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
++|++++.||+|+||.||+|++..+++.||||++... .....+.+|+++++.+.| ++++.+...+.+++..|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h-~~iv~~~~~~~~~~~~~lv 79 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADN-EWVVKLYYSFQDKDNLYFV 79 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCC-CCcceEEEEEEcCCEEEEE
Confidence 4799999999999999999999999999999987542 123447789999999987 5666677777788899999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 82 me~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
|||+ +++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|..+....
T Consensus 80 ~E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 80 MDYIPGGDMMSLLIR-LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEE---CCCCCEEEEeCCCCccccccc
Confidence 9999 9999999976 4568999999999999999999999999999999999999 678899999999986432110
Q ss_pred CCc------------------------------------ccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHH
Q 015406 161 THQ------------------------------------HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 204 (407)
Q Consensus 161 ~~~------------------------------------~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ 204 (407)
... ..........+||+.|+|||++.+..++.++|||||||+||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 000 00000112457999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHHHHHHcC
Q 015406 205 YFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP---DYAYLKRIFRDLFIREG 281 (407)
Q Consensus 205 elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP---t~~~l~~~l~~l~~~~~ 281 (407)
||++|+.||.+... .+....+......... .....+++++.++|.+|+ .+|.+|+ ++.++++
T Consensus 236 ell~G~~Pf~~~~~---~~~~~~i~~~~~~~~~-~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~---------- 300 (376)
T cd05598 236 EMLVGQPPFLADTP---AETQLKVINWETTLHI-PSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA---------- 300 (376)
T ss_pred ehhhCCCCCCCCCH---HHHHHHHhccCccccC-CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC----------
Confidence 99999999987443 2222222221111110 112357889999999977 5999999 6555542
Q ss_pred CCCCCccccccch
Q 015406 282 FQFDYVFDWTILK 294 (407)
Q Consensus 282 ~~~~~~~dw~~~~ 294 (407)
++|...++|....
T Consensus 301 h~~~~~~~~~~~~ 313 (376)
T cd05598 301 HPFFKGIDFASLI 313 (376)
T ss_pred CCCcCCCCHHHHh
Confidence 3566667776654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=347.31 Aligned_cols=267 Identities=21% Similarity=0.233 Sum_probs=205.2
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
.|++++.||+|+||.||+|++..+++.||||++.... ....+..|+.+++.++| ++++.+..++.+.+..|+||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h-~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADN-EWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCC-CCeeeeEEEEecCCEEEEEE
Confidence 6899999999999999999999999999999886532 12347789999999876 67777777778888999999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCC
Q 015406 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 83 e~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~ 161 (407)
||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||| +.++.+||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili---~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 81 DYIPGGDMMSLLIR-MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILI---DLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred ecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEE---CCCCCEEEeeCcCCcccccccc
Confidence 999 9999999975 4569999999999999999999999999999999999999 5788999999999864421110
Q ss_pred Ccc----------------------------------------cCccCCCCccccccccccccccCCCCChhhHHHHHHH
Q 015406 162 HQH----------------------------------------IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGY 201 (407)
Q Consensus 162 ~~~----------------------------------------~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~ 201 (407)
... .........+||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 000 0000112457999999999999989999999999999
Q ss_pred HHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHh--CCCCCCCCCHHHHHHHHHHHHHH
Q 015406 202 VLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCR--SLRFDDKPDYAYLKRIFRDLFIR 279 (407)
Q Consensus 202 il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl--~~~p~~RPt~~~l~~~l~~l~~~ 279 (407)
++|||++|..||..... .+....+.........+ ....+++++.++|.+|+ ..++..||+++++++
T Consensus 237 il~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~~~-~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~-------- 304 (381)
T cd05626 237 ILFEMLVGQPPFLAPTP---TETQLKVINWENTLHIP-PQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA-------- 304 (381)
T ss_pred HHHHHHhCCCCCcCCCH---HHHHHHHHccccccCCC-CCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc--------
Confidence 99999999999976443 22222222211100010 11247899999999955 455556999887764
Q ss_pred cCCCCCCccccccc
Q 015406 280 EGFQFDYVFDWTIL 293 (407)
Q Consensus 280 ~~~~~~~~~dw~~~ 293 (407)
++|...++|...
T Consensus 305 --hp~f~~~~~~~~ 316 (381)
T cd05626 305 --HPFFSEVDFSSD 316 (381)
T ss_pred --CcccCCCChhHH
Confidence 366667788753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=336.65 Aligned_cols=259 Identities=21% Similarity=0.266 Sum_probs=207.0
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEecCCC-----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-C
Q 015406 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (407)
Q Consensus 13 ~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~-g 86 (407)
+.||+|+||.||+|++..+++.||||++.... ....+..|..++..+.+|+++..+..++...+..|+||||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999886432 22346778888888877789998888888888999999999 9
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcccC
Q 015406 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166 (407)
Q Consensus 87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~ 166 (407)
++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~----- 151 (318)
T cd05570 81 GDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL---DSEGHIKIADFGMCKEGILGGV----- 151 (318)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEE---CCCCcEEecccCCCeecCcCCC-----
Confidence 999998875 4579999999999999999999999999999999999999 5788999999999975322211
Q ss_pred ccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcH
Q 015406 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 246 (407)
Q Consensus 167 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 246 (407)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ....+..+...... +...++.
T Consensus 152 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~---~~~~~~~i~~~~~~-----~~~~~~~ 221 (318)
T cd05570 152 --TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD---EDELFQSILEDEVR-----YPRWLSK 221 (318)
T ss_pred --cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC---HHHHHHHHHcCCCC-----CCCcCCH
Confidence 1234578999999999999999999999999999999999999997643 23444444333221 2345789
Q ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchh
Q 015406 247 EFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKY 295 (407)
Q Consensus 247 ~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~ 295 (407)
++.++|.+||..||++||++.+ ..+.+++ .++|....+|.....
T Consensus 222 ~~~~li~~~l~~dP~~R~s~~~--~~~~~ll---~~~~~~~~~~~~~~~ 265 (318)
T cd05570 222 EAKSILKSFLTKNPEKRLGCLP--TGEQDIK---GHPFFREIDWDKLER 265 (318)
T ss_pred HHHHHHHHHccCCHHHcCCCCC--CCHHHHh---cCCCcCCCCHHHHHh
Confidence 9999999999999999999832 1112222 235555678875543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=339.75 Aligned_cols=265 Identities=22% Similarity=0.274 Sum_probs=206.8
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
++|++.+.||+|+||.||++++..+++.||+|++.... ....+..|..++..+.| +++..+..++...+..|+|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~l~~~~~~~~~~~lv 79 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC-QWITTLHYAFQDENYLYLV 79 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEcCCEEEEE
Confidence 57999999999999999999999999999999876421 12235667777777665 7788888888888999999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 82 me~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
|||+ |++|.+++......+++..+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEE---cCCCCEEEEeccceeeccCCC
Confidence 9999 999999998756679999999999999999999999999999999999999 578899999999998765432
Q ss_pred CCcccCccCCCCccccccccccccccC-----CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccc
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHLG-----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (407)
.. ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||.... ..+.+..+.......
T Consensus 157 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~---~~~~~~~i~~~~~~~ 227 (331)
T cd05624 157 TV------QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES---LVETYGKIMNHEERF 227 (331)
T ss_pred ce------eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC---HHHHHHHHHcCCCcc
Confidence 21 1234579999999999876 457889999999999999999999997643 344454444332211
Q ss_pred cHHHHhcCCcHHHHHHHHHHhCCCCCC--CCCHHHHHHHHHHHHHHcCCCCCCccccccch
Q 015406 236 SIEALCRGYPTEFASYFHYCRSLRFDD--KPDYAYLKRIFRDLFIREGFQFDYVFDWTILK 294 (407)
Q Consensus 236 ~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~~l~~~l~~l~~~~~~~~~~~~dw~~~~ 294 (407)
..+.....+++++.+++.+|+..++++ |+++++++ .++|...++|+...
T Consensus 228 ~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~----------~h~~f~~~~~~~~~ 278 (331)
T cd05624 228 QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFK----------KHAFFEGIDWENIR 278 (331)
T ss_pred cCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHh----------cCCCcCCCCHHHHh
Confidence 122223457899999999999865533 23444332 23566678898654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=344.56 Aligned_cols=268 Identities=23% Similarity=0.312 Sum_probs=212.7
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
++|++.+.||+|+||.||+|++..+++.||||++.... ....+..|+.++..+.| ++++.+...+.+++..|+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv 79 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS-PWIVKLYYSFQDEEHLYLV 79 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCC-CCccchhhheecCCeEEEE
Confidence 57999999999999999999999999999999886432 22347788999998875 6666777777788899999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 82 me~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
|||+ +++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 80 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 80 MEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILI---DADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred EcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEeecCCCCccCcccC
Confidence 9999 99999999864 579999999999999999999999999999999999999 688999999999998665433
Q ss_pred CCc----------------------ccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015406 161 THQ----------------------HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218 (407)
Q Consensus 161 ~~~----------------------~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~ 218 (407)
... ...........||+.|+|||++.+..++.++|||||||+||||++|..||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 000 0000112355799999999999999999999999999999999999999987543
Q ss_pred CchHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHHHHcCCCCCCccccccch
Q 015406 219 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD-YAYLKRIFRDLFIREGFQFDYVFDWTILK 294 (407)
Q Consensus 219 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~~l~~~l~~l~~~~~~~~~~~~dw~~~~ 294 (407)
...+.++.........+ ....+++++.++|.+||. +|.+||+ ++++++ ++|...++|....
T Consensus 236 ---~~~~~~i~~~~~~~~~p-~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~----------hp~~~~~~~~~~~ 297 (350)
T cd05573 236 ---QETYNKIINWKESLRFP-PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS----------HPFFKGIDWENLR 297 (350)
T ss_pred ---HHHHHHHhccCCcccCC-CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc----------CCCcCCCCHHHHh
Confidence 33344443311111111 112368999999999997 9999999 888764 3666678887544
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=340.38 Aligned_cols=264 Identities=18% Similarity=0.260 Sum_probs=207.2
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEecCCCC-----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-C
Q 015406 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (407)
Q Consensus 13 ~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~-g 86 (407)
+.||+|+||.||+|++..+++.||||+++.... ...+..|..++..+.+|++++.+..++......|+||||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 468999999999999999999999999875321 2336788999999977888888888888889999999999 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcccC
Q 015406 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166 (407)
Q Consensus 87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~ 166 (407)
++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~~~----- 151 (329)
T cd05588 81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGIRPGD----- 151 (329)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEECcCccccccccCCC-----
Confidence 999988875 4579999999999999999999999999999999999999 5788999999999975322111
Q ss_pred ccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCc------hHHHHHHHhhhcccccHHHH
Q 015406 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT------KKQKYEKISEKKVSTSIEAL 240 (407)
Q Consensus 167 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~------~~~~~~~i~~~~~~~~~~~~ 240 (407)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .......+..... .+
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~ 224 (329)
T cd05588 152 --TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI-----RI 224 (329)
T ss_pred --ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC-----CC
Confidence 1235679999999999999999999999999999999999999996432111 1122233332222 23
Q ss_pred hcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchhh
Q 015406 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQ 296 (407)
Q Consensus 241 ~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~~ 296 (407)
+..++.++.+++.+||..||.+|+++... ..+++++ .++|...++|......
T Consensus 225 p~~~~~~~~~li~~~L~~dP~~R~~~~~~-~~~~~i~---~hp~~~~~~~~~~~~~ 276 (329)
T cd05588 225 PRSLSVKASSVLKGFLNKDPKERLGCHPQ-TGFRDIK---SHPFFRNIDWDLLEQK 276 (329)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCC-CCHHHHh---cCCCCCCCCHHHHHhC
Confidence 35678999999999999999999984321 1122221 3456667889866543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=332.59 Aligned_cols=245 Identities=22% Similarity=0.347 Sum_probs=213.1
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcc-----hHHHHHHHHHHHcCCCCCCeeEEeeeeCceeE
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-----QLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~-----~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 79 (407)
...+|++.+.||+|.||.|-+|+....|+.||||.++++.... .+.+|++||..|+| ++|..++.+++..+..+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNH-PhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNH-PHIIQIYEVFENKDKIV 129 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCC-CceeehhhhhcCCceEE
Confidence 3467999999999999999999999999999999887654332 26789999999998 56666777778888899
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 80 lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
|||||. +|.|+||+.++ +.|++.++++|++||+.|+.|+|.++++|||||.+|||+ |.++.+||+|||++..+.+
T Consensus 130 ivMEYaS~GeLYDYiSer-~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILL---D~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISER-GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILL---DQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEEEecCCccHHHHHHHh-ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheee---cCCCCeeeeccchhhhhcc
Confidence 999999 99999999974 579999999999999999999999999999999999999 7999999999999988876
Q ss_pred CCCCcccCccCCCCccccccccccccccCCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccH
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (407)
... ..+++|++.|++||++.|.+| ++.+|-|||||+||-|+.|..||.+. +......+|..+....
T Consensus 206 ~kf--------LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~---Dhk~lvrQIs~GaYrE-- 272 (668)
T KOG0611|consen 206 KKF--------LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR---DHKRLVRQISRGAYRE-- 272 (668)
T ss_pred ccH--------HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc---hHHHHHHHhhcccccC--
Confidence 554 458999999999999999999 79999999999999999999999884 4456666666655433
Q ss_pred HHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 238 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
+.-|....-||..||..||++|.|+.+|..
T Consensus 273 ----P~~PSdA~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 273 ----PETPSDASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred ----CCCCchHHHHHHHHHhcCcccchhHHHHhh
Confidence 335778999999999999999999777654
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=337.96 Aligned_cols=258 Identities=19% Similarity=0.265 Sum_probs=202.7
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEecCCC-----CcchHHHHHHH-HHHHcCCCCCCeeEEeeeeCceeEEEEecc-
Q 015406 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKL-YRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (407)
Q Consensus 13 ~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~~-l~~l~~~~~i~~~~~~~~~~~~~~lvme~~- 85 (407)
+.||+|+||.||+|++..+++.||+|++.... ....+..|... ++.+.| +++..+...+...+..|+||||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h-~~Iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH-PFLVGLHFSFQTADKLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCC-CCCCceeEEEEcCCeEEEEEeCCC
Confidence 47999999999999999999999999876432 11234444443 444554 67777777888888999999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCccc
Q 015406 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165 (407)
Q Consensus 86 g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~ 165 (407)
+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 ~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili---~~~~~~kl~DfG~a~~~~~~~~---- 151 (325)
T cd05602 80 GGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENIEHNG---- 151 (325)
T ss_pred CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEEccCCCCcccccCCC----
Confidence 8999999875 4568999999999999999999999999999999999999 5788999999999975432221
Q ss_pred CccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCc
Q 015406 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 245 (407)
Q Consensus 166 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 245 (407)
......||+.|+|||++.+..++.++|||||||++|||++|..||.+... .+.+..+...... +...++
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~-----~~~~~~ 220 (325)
T cd05602 152 ---TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT---AEMYDNILNKPLQ-----LKPNIT 220 (325)
T ss_pred ---CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH---HHHHHHHHhCCcC-----CCCCCC
Confidence 12356799999999999999999999999999999999999999976433 3444444433221 234688
Q ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchhh
Q 015406 246 TEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQ 296 (407)
Q Consensus 246 ~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~~ 296 (407)
.++.+++.+||+.+|.+||++.+.. .++. .+.+...++|+.+...
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~~~~---~~i~---~~~~~~~~~~~~~~~~ 265 (325)
T cd05602 221 NSARHLLEGLLQKDRTKRLGAKDDF---MEIK---NHIFFSPINWDDLINK 265 (325)
T ss_pred HHHHHHHHHHcccCHHHCCCCCCCH---HHHh---cCcccCCCCHHHHHhC
Confidence 9999999999999999999975432 2222 3456667899876543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=328.70 Aligned_cols=254 Identities=13% Similarity=0.231 Sum_probs=205.3
Q ss_pred CCceeEeccccccCceEEEEEEEc---CCCeEEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~---~~~~~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 79 (407)
.++|++.+.||+|+||.||+|.+. ..+..||+|.++..... ..+.+|+.+++.++| +++..+.+++..++..+
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDH-SNIVRLEGVITRGNTMM 82 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCC-CCcCeEEEEEecCCCcE
Confidence 457999999999999999999865 44678999987754322 347789999998876 67777777778888899
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 80 lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
+||||+ +++|.+++......+++..++.++.||+.||+|||++|++||||||+|||+ +.++.++|+|||.+.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili---~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLV---NSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEE---cCCCcEEECCCcccccccc
Confidence 999999 889999998655679999999999999999999999999999999999999 5788999999998765322
Q ss_pred CCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccH
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (407)
... .......++..|+|||.+.+..++.++|||||||++||+++ |..||.+... ......+......
T Consensus 160 ~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~---~~~~~~~~~~~~~--- 227 (266)
T cd05064 160 EAI------YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG---QDVIKAVEDGFRL--- 227 (266)
T ss_pred cch------hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HHHHHHHHCCCCC---
Confidence 211 01123345678999999999999999999999999999875 9999987543 2333333332211
Q ss_pred HHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 015406 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (407)
Q Consensus 238 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l 276 (407)
.....+|..+.+++.+||+.+|++||++.+|.+.|+.+
T Consensus 228 -~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 -PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 12356899999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=346.43 Aligned_cols=268 Identities=21% Similarity=0.281 Sum_probs=205.7
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
++|+++++||+|+||.||+|++..+++.||||++.... ....+.+|+++++.+.| ++++.+..++.+....|+|
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~h-p~iv~~~~~~~~~~~~~lv 79 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS-PWVVSLYYSFQDAQYLYLI 79 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCC-CCcceEEEEEEcCCeeEEE
Confidence 47999999999999999999999999999999875422 12346779999998876 6777777888888899999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 82 me~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
|||+ |++|.+++.. .+.+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++.+....
T Consensus 80 ~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll---~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 80 MEFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILI---DRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEEeeccccccccccc
Confidence 9999 9999999975 4579999999999999999999999999999999999999 578899999999997432211
Q ss_pred CCc-----------ccC-----------------------------ccCCCCccccccccccccccCCCCChhhHHHHHH
Q 015406 161 THQ-----------HIP-----------------------------YRENKNLTGTARYASMNTHLGIEQSRRDDLESLG 200 (407)
Q Consensus 161 ~~~-----------~~~-----------------------------~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG 200 (407)
... ..+ .......+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 000 000 0001135799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHHHH
Q 015406 201 YVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP---DYAYLKRIFRDLF 277 (407)
Q Consensus 201 ~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP---t~~~l~~~l~~l~ 277 (407)
|+||||++|..||.+... .+.+..+.........+ -...++.++.++|.+|+. +|.+|+ ++.++++
T Consensus 236 vil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~~p-~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~------ 304 (377)
T cd05629 236 AIMFECLIGWPPFCSENS---HETYRKIINWRETLYFP-DDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKS------ 304 (377)
T ss_pred hhhhhhhcCCCCCCCCCH---HHHHHHHHccCCccCCC-CCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhc------
Confidence 999999999999976433 33344433211111000 012468899999999997 777765 6655543
Q ss_pred HHcCCCCCCccccccch
Q 015406 278 IREGFQFDYVFDWTILK 294 (407)
Q Consensus 278 ~~~~~~~~~~~dw~~~~ 294 (407)
++|...++|+.+.
T Consensus 305 ----hp~~~~~~~~~~~ 317 (377)
T cd05629 305 ----HPFFRGVDWDTIR 317 (377)
T ss_pred ----CCCcCCCCHHHHc
Confidence 3566677887653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=337.62 Aligned_cols=266 Identities=22% Similarity=0.276 Sum_probs=208.9
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
++|++.++||+|+||.||++++..+++.||+|++.... ....+..|+.++..+.| +++..+..++...+..|+|
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv 79 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN-QWITTLHYAFQDENNLYLV 79 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCC-CCEeeEEEEEecCCEEEEE
Confidence 57999999999999999999999999999999875321 12236677778777765 6777777788888899999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 82 me~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
|||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili---~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEeecchheecccCC
Confidence 9999 999999998756679999999999999999999999999999999999999 578899999999997654332
Q ss_pred CCcccCccCCCCcccccccccccccc-----CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccc
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (407)
.. ......||+.|+|||++. ...++.++|||||||+||||++|+.||.... ..+.+.++.......
T Consensus 157 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~---~~~~~~~i~~~~~~~ 227 (332)
T cd05623 157 TV------QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES---LVETYGKIMNHKERF 227 (332)
T ss_pred cc------eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC---HHHHHHHHhCCCccc
Confidence 21 123457999999999986 3457899999999999999999999997643 345555554433222
Q ss_pred cHHHHhcCCcHHHHHHHHHHhCCCCCC--CCCHHHHHHHHHHHHHHcCCCCCCccccccchh
Q 015406 236 SIEALCRGYPTEFASYFHYCRSLRFDD--KPDYAYLKRIFRDLFIREGFQFDYVFDWTILKY 295 (407)
Q Consensus 236 ~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~ 295 (407)
..+.....+++++.+++.+|+..+++. |+++.++++ ++|...++|+....
T Consensus 228 ~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~----------h~~f~~~~~~~~~~ 279 (332)
T cd05623 228 QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQ----------HPFFTGIDWDNIRN 279 (332)
T ss_pred cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhC----------CCCcCCCCHHHHhh
Confidence 222233467899999999999765544 567555542 36777788876543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=341.84 Aligned_cols=263 Identities=21% Similarity=0.290 Sum_probs=209.1
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
++|++.+.||+|+||.||+|++..+++.||+|+++.... ...+..|+.+++.+.| ++++.+..++.+.+..|+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~-~~i~~~~~~~~~~~~~~lv 79 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS-PWIPQLQYAFQDKDNLYLV 79 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC-CCCcceeeEEecCCeEEEE
Confidence 479999999999999999999999999999998875322 2346678888877665 6777777777788889999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 82 me~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
|||+ +++|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI---DRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEE---CCCCCEEeccCCCCeECCCCC
Confidence 9999 999999998765689999999999999999999999999999999999999 688999999999998765432
Q ss_pred CCcccCccCCCCcccccccccccccc------CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhccc
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHL------GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (407)
.. ......||+.|+|||++. +..++.++|||||||++|||++|..||..... ...+..+......
T Consensus 157 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~---~~~~~~i~~~~~~ 227 (330)
T cd05601 157 MV------NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS---AKTYNNIMNFQRF 227 (330)
T ss_pred ce------eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH---HHHHHHHHcCCCc
Confidence 21 122347899999999987 45678999999999999999999999976433 3334444332111
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccch
Q 015406 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILK 294 (407)
Q Consensus 235 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~dw~~~~ 294 (407)
...+ ....+++++.+|+..||. +|++||++.++.+ ++|....+|....
T Consensus 228 ~~~~-~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~----------h~~~~~~~~~~~~ 275 (330)
T cd05601 228 LKFP-EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC----------HPFFSKIDWNNIR 275 (330)
T ss_pred cCCC-CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC----------CCCcCCCCHHHHh
Confidence 1000 113478999999999998 9999999877642 3566667887544
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=339.44 Aligned_cols=254 Identities=24% Similarity=0.328 Sum_probs=221.4
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc-----chHHHHHHHHHHHcCCCCCCeeEEeeeeCcee
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 78 (407)
.+...|++.+.||.|.||.||+++.+.+|+.+|+|++.+.... ..+.+|+.+|+.+.+|++++.+...++.....
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 3567899999999999999999999999999999998765432 46899999999999889999999999999999
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCC-CceEEEEeccceeee
Q 015406 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR-ANQVYIIDFGLAKKY 156 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~-~~~~kL~DFGla~~~ 156 (407)
++|||+| ||.|.+.+... .+++..+..++.|++.++.|||+.||+||||||+|+|+...+. ++.+|++|||++...
T Consensus 112 ~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 9999999 99999999864 3999999999999999999999999999999999999975443 458999999999987
Q ss_pred ccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhccccc
Q 015406 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (407)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (407)
..... ....+||+.|+|||++.+..|+..+||||+|+++|.|++|..||.+... .....++....+. .
T Consensus 190 ~~~~~--------~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~---~~~~~~i~~~~~~-f 257 (382)
T KOG0032|consen 190 KPGER--------LHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETE---FEIFLAILRGDFD-F 257 (382)
T ss_pred cCCce--------EeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCCh---hHHHHHHHcCCCC-C
Confidence 76222 4577999999999999999999999999999999999999999988543 4555566666653 3
Q ss_pred HHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 237 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
....+..++..++++|..|+..||..|+++.++++
T Consensus 258 ~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 258 TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred CCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 33455778999999999999999999999877765
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=335.13 Aligned_cols=255 Identities=22% Similarity=0.298 Sum_probs=205.0
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEecCC-----CCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-C
Q 015406 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (407)
Q Consensus 13 ~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~-g 86 (407)
+.||+|+||.||+|++..+++.||||++... ........|..++..+.+|++++.+..++.+.+..|+||||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999987653 223346678888877666788888888888889999999999 9
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcccC
Q 015406 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166 (407)
Q Consensus 87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~ 166 (407)
++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~----- 151 (316)
T cd05619 81 GDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILL---DTDGHIKIADFGMCKENMLGDA----- 151 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEccCCcceECCCCCC-----
Confidence 999999975 3578999999999999999999999999999999999999 5788999999999975432211
Q ss_pred ccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcH
Q 015406 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 246 (407)
Q Consensus 167 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 246 (407)
......||+.|+|||++.+..++.++|||||||++|||++|..||.+.+. .+.+..+...... +...++.
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---~~~~~~i~~~~~~-----~~~~~~~ 221 (316)
T cd05619 152 --KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE---EELFQSIRMDNPC-----YPRWLTR 221 (316)
T ss_pred --ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCC-----CCccCCH
Confidence 12345789999999999999999999999999999999999999976433 3334433322211 2234788
Q ss_pred HHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHHHHcCCCCCCccccccchhh
Q 015406 247 EFASYFHYCRSLRFDDKPDYA-YLKRIFRDLFIREGFQFDYVFDWTILKYQ 296 (407)
Q Consensus 247 ~l~~li~~cl~~~p~~RPt~~-~l~~~l~~l~~~~~~~~~~~~dw~~~~~~ 296 (407)
++.+++.+||..||++||++. +++ .+++....+|......
T Consensus 222 ~~~~li~~~l~~~P~~R~~~~~~l~----------~h~~~~~~~~~~~~~~ 262 (316)
T cd05619 222 EAKDILVKLFVREPERRLGVKGDIR----------QHPFFREIDWSALEER 262 (316)
T ss_pred HHHHHHHHHhccCHhhcCCChHHHH----------cCcccCCCCHHHHHhC
Confidence 999999999999999999975 332 2356666788755443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=348.02 Aligned_cols=254 Identities=20% Similarity=0.267 Sum_probs=194.3
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeee-------eCce
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGV-------EGDY 77 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~-------~~~~ 77 (407)
..++|++.+.||+|+||.||+|.+..+++.||||.+... .....+|+.+++.++|++.+.....+.. ...+
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~--~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD--PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC--cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 356899999999999999999999999999999987543 2345679999999988655554443322 1235
Q ss_pred eEEEEeccCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEecccee
Q 015406 78 NVLVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (407)
Q Consensus 78 ~~lvme~~g~sL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~ 154 (407)
.++||||++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++ ...+.+||+|||+|+
T Consensus 142 l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~--~~~~~vkL~DFGla~ 219 (440)
T PTZ00036 142 LNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLID--PNTHTLKLCDFGSAK 219 (440)
T ss_pred EEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEc--CCCCceeeeccccch
Confidence 679999998899887753 245699999999999999999999999999999999999994 234579999999998
Q ss_pred eeccCCCCcccCccCCCCccccccccccccccCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhc-
Q 015406 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK- 232 (407)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~- 232 (407)
.+..... .....||+.|+|||++.+. .++.++|||||||+||||++|.+||.+.........+.......
T Consensus 220 ~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~ 291 (440)
T PTZ00036 220 NLLAGQR--------SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPT 291 (440)
T ss_pred hccCCCC--------cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 6644322 2345789999999998764 68999999999999999999999998754322211111111000
Q ss_pred ---------------c-----cccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015406 233 ---------------V-----STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 233 ---------------~-----~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
+ ......++...|+++.+||.+||..||.+||++.+++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l 349 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEAL 349 (440)
T ss_pred HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 0 0001122345688999999999999999999988775
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=338.77 Aligned_cols=265 Identities=18% Similarity=0.274 Sum_probs=207.4
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEecCCCC-----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-C
Q 015406 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (407)
Q Consensus 13 ~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~-g 86 (407)
+.||+|+||.||+|++..+++.||+|++..... ...+..|..++..+.+|++++.+..++...+..|+||||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999998875321 1236678888888877788888888888889999999999 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcccC
Q 015406 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166 (407)
Q Consensus 87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~ 166 (407)
++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili---~~~~~~kL~DfG~~~~~~~~~~----- 151 (329)
T cd05618 81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGD----- 151 (329)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCCEEEeeCCccccccCCCC-----
Confidence 999988875 4579999999999999999999999999999999999999 6788999999999975332211
Q ss_pred ccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcC------chHHHHHHHhhhcccccHHHH
Q 015406 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG------TKKQKYEKISEKKVSTSIEAL 240 (407)
Q Consensus 167 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~------~~~~~~~~i~~~~~~~~~~~~ 240 (407)
......||+.|+|||++.+..++.++|||||||++|||++|..||...... ........+..... .+
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-----~~ 224 (329)
T cd05618 152 --TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-----RI 224 (329)
T ss_pred --ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC-----CC
Confidence 123567999999999999999999999999999999999999999632211 11122233322222 23
Q ss_pred hcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchhhc
Q 015406 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQ 297 (407)
Q Consensus 241 ~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~~~ 297 (407)
+..++.++.+++.+||..||++||++.... .+.++ ..++|...++|......+
T Consensus 225 p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~-~~~~i---~~hp~f~~~~~~~~~~~~ 277 (329)
T cd05618 225 PRSLSVKAASVLKSFLNKDPKERLGCHPQT-GFADI---QGHPFFRNVDWDLMEQKQ 277 (329)
T ss_pred CCCCCHHHHHHHHHHhcCCHHHcCCCCCCC-CHHHH---hcCCCCCCCCHHHHHcCC
Confidence 356789999999999999999999842110 01111 235777788998766544
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=344.09 Aligned_cols=256 Identities=21% Similarity=0.319 Sum_probs=204.4
Q ss_pred CceeEeccccccCceEEEEEEE-----cCCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCcee
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTN-----IQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~-----~~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 78 (407)
++|++.++||+|+||.||+|++ ..++..||||+++.... ...+.+|+.++..+.+|++++.+.+++..++..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 4799999999999999999974 34567899998864332 235788999999997678888888888888899
Q ss_pred EEEEecc-CCCHHHHHHHcC------------------------------------------------------------
Q 015406 79 VLVMDLL-GPSLEDLFNFCS------------------------------------------------------------ 97 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~~~------------------------------------------------------------ 97 (407)
++||||+ +|+|.+++....
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 9999999 999999986422
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCc
Q 015406 98 --------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (407)
Q Consensus 98 --------------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~ 163 (407)
..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~~- 270 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIRNDSNY- 270 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEE---ECCCcEEEecCccceeccCcccc-
Confidence 147888999999999999999999999999999999999 56788999999999876443221
Q ss_pred ccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHHhc
Q 015406 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (407)
Q Consensus 164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (407)
.......++..|+|||++.+..++.++|||||||++|||++ |..||....... .....+.... .. ....
T Consensus 271 ----~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~~~~~~-~~---~~~~ 340 (375)
T cd05104 271 ----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKMIKEGY-RM---LSPE 340 (375)
T ss_pred ----cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHHHHhCc-cC---CCCC
Confidence 11223345678999999999999999999999999999998 899997654321 2222222211 11 1123
Q ss_pred CCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 015406 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (407)
Q Consensus 243 ~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l 276 (407)
..+.++.+|+.+||+.||++||++.+|.+.|++.
T Consensus 341 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 341 CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 4688999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=343.52 Aligned_cols=251 Identities=16% Similarity=0.185 Sum_probs=197.6
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~ 85 (407)
.++|++.+.||+|+||.||+|++..+++.||+|... ...+.+|+++++.|+| ++|+.+..++......+++||++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~----~~~~~~E~~il~~l~H-pnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ----RGGTATEAHILRAINH-PSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh----hhhhHHHHHHHHhCCC-CCCCCEeEEEEECCeeEEEEecC
Confidence 367999999999999999999999999999999643 3457899999999987 66667777777888899999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCccc
Q 015406 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165 (407)
Q Consensus 86 g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~ 165 (407)
+++|.+++.. ...+++..++.|+.||+.||.|||++|||||||||+|||+ +..+.+||+|||+|+.......
T Consensus 166 ~~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll---~~~~~vkL~DFG~a~~~~~~~~---- 237 (391)
T PHA03212 166 KTDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFI---NHPGDVCLGDFGAACFPVDINA---- 237 (391)
T ss_pred CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEE---cCCCCEEEEeCCcccccccccc----
Confidence 8899998875 4579999999999999999999999999999999999999 5778999999999975432211
Q ss_pred CccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcC----chHHHHHHHhhhc---------
Q 015406 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG----TKKQKYEKISEKK--------- 232 (407)
Q Consensus 166 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~----~~~~~~~~i~~~~--------- 232 (407)
.......||+.|+|||++.+..++.++|||||||++|||++|..||...... .....+..+....
T Consensus 238 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 238 --NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred --cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 1123467999999999999999999999999999999999999887543210 0011111111000
Q ss_pred -----------------c----cccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 233 -----------------V----STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 233 -----------------~----~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
. ..........+|.++.+||.+||+.||++|||+.++++
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0 00000111235778999999999999999999887764
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=337.15 Aligned_cols=253 Identities=20% Similarity=0.278 Sum_probs=202.2
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEecCCC-----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-C
Q 015406 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (407)
Q Consensus 13 ~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~-g 86 (407)
+.||+|+||.||++++..+++.||+|++.... ....+..|+++++.+.| ++++.+..++...+..|+||||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~h-p~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH-PFLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC-CCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999999999999999886432 12345678888888876 67777777788888999999999 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCccc
Q 015406 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165 (407)
Q Consensus 87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~ 165 (407)
++|.+++.. .+.+++..++.++.||+.||.|||+ +||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 ~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll---~~~~~~kL~Dfg~~~~~~~~~~---- 151 (325)
T cd05594 80 GELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGA---- 151 (325)
T ss_pred CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEE---CCCCCEEEecCCCCeecCCCCc----
Confidence 999988875 4579999999999999999999997 899999999999999 6788999999999975432221
Q ss_pred CccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCc
Q 015406 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 245 (407)
Q Consensus 166 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 245 (407)
......||+.|+|||++.+..++.++|||||||+||||++|..||.+... ......+..... .+...++
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~---~~~~~~i~~~~~-----~~p~~~~ 220 (325)
T cd05594 152 ---TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELILMEEI-----RFPRTLS 220 (325)
T ss_pred ---ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH---HHHHHHHhcCCC-----CCCCCCC
Confidence 12345799999999999999999999999999999999999999976433 333333332222 1235588
Q ss_pred HHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCccccccchh
Q 015406 246 TEFASYFHYCRSLRFDDKP-----DYAYLKRIFRDLFIREGFQFDYVFDWTILKY 295 (407)
Q Consensus 246 ~~l~~li~~cl~~~p~~RP-----t~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~ 295 (407)
+++.+++.+||+.||++|+ ++.++.+ ++|....+|.....
T Consensus 221 ~~~~~li~~~L~~dP~~R~~~~~~~~~~il~----------h~~~~~~~~~~~~~ 265 (325)
T cd05594 221 PEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ----------HKFFAGIVWQDVYE 265 (325)
T ss_pred HHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc----------CCCcCCCCHHHHHh
Confidence 9999999999999999997 6665543 35556677765443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=323.43 Aligned_cols=272 Identities=20% Similarity=0.282 Sum_probs=225.4
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
-++|+.+++||+|.||.|-+++.+.+++.||+|+++++-. ...-+.|-++|+..+| +.+..+.+.++..+..|+
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~H-PFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRH-PFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccC-cHHHHhhhhhccCceEEE
Confidence 4689999999999999999999999999999998876432 2235668888888776 777778888999999999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 81 vme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
||||. ||.|.-.+.+ .+.+++..++.+..+|+.||.|||+++||.||||.+|+|+ |++|++||+|||+++.-...
T Consensus 246 VMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlL---DkDGHIKitDFGLCKE~I~~ 321 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLL---DKDGHIKITDFGLCKEEIKY 321 (516)
T ss_pred EEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhee---ccCCceEeeecccchhcccc
Confidence 99999 9999888876 4579999999999999999999999999999999999999 79999999999999853222
Q ss_pred CCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHH
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (407)
. ...++++|||.|+|||++....|+.++|+|.+||+||||++|++||...+. ...++-|....+.
T Consensus 322 g-------~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh---~kLFeLIl~ed~k----- 386 (516)
T KOG0690|consen 322 G-------DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH---EKLFELILMEDLK----- 386 (516)
T ss_pred c-------ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch---hHHHHHHHhhhcc-----
Confidence 1 235689999999999999999999999999999999999999999987443 3444444433332
Q ss_pred HhcCCcHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHHHHcCCCCCCccccccchhhcccccCCC
Q 015406 240 LCRGYPTEFASYFHYCRSLRFDDKPD--YAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATPP 304 (407)
Q Consensus 240 ~~~~~~~~l~~li~~cl~~~p~~RPt--~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~~~~~~~~~~ 304 (407)
++..++++.+.|+..+|.+||.+|.. .++.+++.++ .|+..+||+........++..|
T Consensus 387 FPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h-------~FF~~v~W~~~~~Kki~PPfKP 446 (516)
T KOG0690|consen 387 FPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH-------RFFASVDWEATYRKKIEPPFKP 446 (516)
T ss_pred CCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh-------hhhccCCHHHHHHhccCCCCCC
Confidence 34668999999999999999999974 3566665554 5677899998777665554443
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=321.67 Aligned_cols=251 Identities=19% Similarity=0.246 Sum_probs=205.3
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCc------e
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEGD------Y 77 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~------~ 77 (407)
.|+.+++||+|+||+||+|+++.+|+.||+|.++.+.. .....+|+.+++.|+|.++++.+..+..... .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 47888999999999999999999999999998876644 2347999999999999887777777766555 7
Q ss_pred eEEEEeccCCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEecccee
Q 015406 78 NVLVMDLLGPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (407)
Q Consensus 78 ~~lvme~~g~sL~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~ 154 (407)
.++|+||+..+|.+++.... ..++...+..++.||+.||+|||+++|+||||||+|||| ++.+.+||+|||+|+
T Consensus 92 l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi---~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 92 LYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLI---SSSGVLKLADFGLAR 168 (323)
T ss_pred EEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEE---CCCCcEeeeccchHH
Confidence 89999999999999999766 358889999999999999999999999999999999999 579999999999999
Q ss_pred eeccCCCCcccCccCCCCccccccccccccccCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcc
Q 015406 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (407)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (407)
.+.-+ .+.....++|..|.|||++.|. .|+...||||+|||+.||++++.-|.+... .+.+.+|....-
T Consensus 169 a~~ip-------~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se---~~ql~~If~~lG 238 (323)
T KOG0594|consen 169 AFSIP-------MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE---IDQLFRIFRLLG 238 (323)
T ss_pred HhcCC-------cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH---HHHHHHHHHHcC
Confidence 65432 2335577899999999999987 689999999999999999999999988655 333333322110
Q ss_pred -------------------------cccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 234 -------------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 234 -------------------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
........+...+...+++.+||+.+|.+|.+++...+
T Consensus 239 tP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~ 301 (323)
T KOG0594|consen 239 TPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALT 301 (323)
T ss_pred CCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhc
Confidence 01111112233458999999999999999999776543
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=346.00 Aligned_cols=204 Identities=25% Similarity=0.344 Sum_probs=178.1
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-cchHHHHHHHHHHHc-----CCCCCCeeEEeeeeCcee
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQ-----GGTGIPNVRWFGVEGDYN 78 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~E~~~l~~l~-----~~~~i~~~~~~~~~~~~~ 78 (407)
+..+|.|.+.||+|+||.|.+|.+..|++.||||+++.+.. ..+...|+.+|..|+ +..+++.+..++...+..
T Consensus 184 i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 184 IAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred eEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 44589999999999999999999999999999999976543 455778999999998 235777888899999999
Q ss_pred EEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeec
Q 015406 79 VLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (407)
Q Consensus 79 ~lvme~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~ 157 (407)
|||+|++..+|.++++..+ ..|+...++.|+.||+.||.+||+.||||+||||+||||..- ....+||+|||.|....
T Consensus 264 ciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~-~r~~vKVIDFGSSc~~~ 342 (586)
T KOG0667|consen 264 CIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDP-KRSRIKVIDFGSSCFES 342 (586)
T ss_pred eeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccC-CcCceeEEecccccccC
Confidence 9999999999999998643 459999999999999999999999999999999999999543 23489999999998765
Q ss_pred cCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcC
Q 015406 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 219 (407)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~ 219 (407)
... .+..-+..|.|||++.|.+|+.+.||||||||+.||++|.+.|.+.+..
T Consensus 343 q~v----------ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~ 394 (586)
T KOG0667|consen 343 QRV----------YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEY 394 (586)
T ss_pred Ccc----------eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHH
Confidence 432 2567788999999999999999999999999999999999889875543
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=334.90 Aligned_cols=256 Identities=22% Similarity=0.276 Sum_probs=200.4
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEecCCC-----CcchHHHHHH-HHHHHcCCCCCCeeEEeeeeCceeEEEEecc-
Q 015406 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESK-LYRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (407)
Q Consensus 13 ~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~-~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~- 85 (407)
+.||+|+||.||+|++..+++.||+|++.... ....+..|.. +++.++| ++++.+...+...+..|+||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h-~~iv~~~~~~~~~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKH-PFLVGLHYSFQTAEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCC-CCccceeeEEEcCCEEEEEEcCCC
Confidence 47999999999999999999999999876432 1223455554 4555655 67777777778888999999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCccc
Q 015406 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165 (407)
Q Consensus 86 g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~ 165 (407)
+++|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 ~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~---- 151 (321)
T cd05603 80 GGELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGVEPEE---- 151 (321)
T ss_pred CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEccCCCCccCCCCCC----
Confidence 8999888875 4578999999999999999999999999999999999999 6788999999999875322211
Q ss_pred CccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCc
Q 015406 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 245 (407)
Q Consensus 166 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 245 (407)
......||+.|+|||++.+..++.++|||||||++|||++|..||...+ ..+.+..+...... +....+
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~~~~~-----~~~~~~ 220 (321)
T cd05603 152 ---TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD---VSQMYDNILHKPLQ-----LPGGKT 220 (321)
T ss_pred ---ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC---HHHHHHHHhcCCCC-----CCCCCC
Confidence 1235679999999999999899999999999999999999999997643 34445554443221 234578
Q ss_pred HHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHHHHcCCCCCCccccccchh
Q 015406 246 TEFASYFHYCRSLRFDDKPDYA-YLKRIFRDLFIREGFQFDYVFDWTILKY 295 (407)
Q Consensus 246 ~~l~~li~~cl~~~p~~RPt~~-~l~~~l~~l~~~~~~~~~~~~dw~~~~~ 295 (407)
.++.+++.+||+.+|.+||+.. ++.+.+ .+.+....+|..+..
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~~~~~~~~-------~~~~~~~~~~~~~~~ 264 (321)
T cd05603 221 VAACDLLVGLLHKDQRRRLGAKADFLEIK-------NHVFFSPINWDDLYH 264 (321)
T ss_pred HHHHHHHHHHccCCHhhcCCCCCCHHHHh-------CCCCcCCCCHHHHhc
Confidence 8999999999999999999853 233322 335556677876543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=323.09 Aligned_cols=256 Identities=21% Similarity=0.251 Sum_probs=205.1
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecC----CCCcchHHHHHHHHHHHcCCCCCCeeEEeee----eCc
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV----KTKHPQLLYESKLYRILQGGTGIPNVRWFGV----EGD 76 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~----~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~----~~~ 76 (407)
+...|..++.||.|+||.|+.+.++.+|+.||||.+.. ....++..+|+++++.++|.+.+..+..+.. .-.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 45677778999999999999999999999999997652 2234567899999999997666655555543 345
Q ss_pred eeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeee
Q 015406 77 YNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (407)
Q Consensus 77 ~~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~ 156 (407)
..|+|+|+|+.+|.++++. +..++...+..++.||++||.|+|+.+|+||||||.|+|+ +.+..+||+|||+|+..
T Consensus 100 DvYiV~elMetDL~~iik~-~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~---n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 100 DVYLVFELMETDLHQIIKS-QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLL---NADCDLKICDFGLARYL 175 (359)
T ss_pred eeEEehhHHhhHHHHHHHc-CccccHHHHHHHHHHHHHhcchhhcccccccccchhheee---ccCCCEEeccccceeec
Confidence 6799999999999999985 4459999999999999999999999999999999999999 67888999999999987
Q ss_pred ccCCCCcccCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHH----------
Q 015406 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY---------- 225 (407)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~---------- 225 (407)
...... ...+..+-|..|.|||++.. ..|+.+.||||.||||.||++|++-|.+.+.-...+.+
T Consensus 176 ~~~~~~-----~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e 250 (359)
T KOG0660|consen 176 DKFFED-----GFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE 250 (359)
T ss_pred cccCcc-----cchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence 643110 11356788999999998764 67999999999999999999999999885543222211
Q ss_pred --HHHh-----------hhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHH
Q 015406 226 --EKIS-----------EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 269 (407)
Q Consensus 226 --~~i~-----------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l 269 (407)
..+. ......+...+.++.++...+|+++||..||.+|+|+++.
T Consensus 251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eA 307 (359)
T KOG0660|consen 251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEA 307 (359)
T ss_pred HHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHH
Confidence 1111 1122344456667889999999999999999999996654
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=326.77 Aligned_cols=258 Identities=26% Similarity=0.485 Sum_probs=191.7
Q ss_pred CccCCceeEeccccccCceEEEEEEEcCC---CeEEEEEEecCCCCcchHHHH------------HHH---HHHHcCCCC
Q 015406 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKTKHPQLLYE------------SKL---YRILQGGTG 64 (407)
Q Consensus 3 ~~~~~~y~i~~~iG~G~~g~Vy~~~~~~~---~~~vAvK~~~~~~~~~~~~~E------------~~~---l~~l~~~~~ 64 (407)
...+++|++.++||+|+||.||+|.+..+ +..+|+|+....... +..| +.. +..+. +.+
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~--~~~e~~~~~~~~~~~~~~~~~~~~~~~-h~~ 84 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENET--IVMETLVYNNIYDIDKIALWKNIHNID-HLG 84 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCc--hhhHHHHHHhhhhHHHHHHHHHhccCC-CCC
Confidence 34578999999999999999999998777 677888875433221 1111 112 22223 355
Q ss_pred CCeeEEeeeeC----ceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCC
Q 015406 65 IPNVRWFGVEG----DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 140 (407)
Q Consensus 65 i~~~~~~~~~~----~~~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~ 140 (407)
++.+..++... .+.+++|+++..++.+++... ...++..++.++.|++.||+|||+++|+||||||+|||+ +
T Consensus 85 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill---~ 160 (294)
T PHA02882 85 IPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMV---D 160 (294)
T ss_pred CCcEEEeeeEecCCceEEEEEEehhccCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---c
Confidence 55555544432 255889999988888888753 346888999999999999999999999999999999999 5
Q ss_pred CCceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCc
Q 015406 141 RANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 220 (407)
Q Consensus 141 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~ 220 (407)
.++.++|+|||+|+.+..................||+.|+|||++.+..++.++|||||||+||||++|..||.+.....
T Consensus 161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~ 240 (294)
T PHA02882 161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG 240 (294)
T ss_pred CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence 77899999999998775432211111111234579999999999999999999999999999999999999998764322
Q ss_pred hHH------HHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 015406 221 KKQ------KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIF 273 (407)
Q Consensus 221 ~~~------~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l 273 (407)
... .+..+.... .....+|+++.+++..||..+|++||++.+|++.|
T Consensus 241 ~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 241 NLIHAAKCDFIKRLHEGK------IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHHhHHHHHHHhhhhh------hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 111 111111111 12345789999999999999999999999999876
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=326.76 Aligned_cols=259 Identities=20% Similarity=0.229 Sum_probs=202.1
Q ss_pred ccccCceEEEEEEEcCCCeEEEEEEecCCC-----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-CCC
Q 015406 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPS 88 (407)
Q Consensus 15 iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~-g~s 88 (407)
||+|+||.||++++..+|+.||+|.+..+. ....+..|+++++.++| +++..+...+..+...+++|||+ |++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~h-p~i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNS-PFIVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCC-CcEEEEEEEEecCCeEEEEEecCCCCC
Confidence 799999999999999999999999875422 12335679999999976 66667777777788899999999 999
Q ss_pred HHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcccCc
Q 015406 89 LEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPY 167 (407)
Q Consensus 89 L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~~ 167 (407)
|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.++|+|||++........
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~~l~Dfg~~~~~~~~~~------ 150 (277)
T cd05607 80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKT------ 150 (277)
T ss_pred HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEE---cCCCCEEEeeceeeeecCCCce------
Confidence 998886433 358999999999999999999999999999999999999 5788999999999987654321
Q ss_pred cCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCch-HHHHHHHhhhcccccHHHHhcCCcH
Q 015406 168 RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYEKISEKKVSTSIEALCRGYPT 246 (407)
Q Consensus 168 ~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~ 246 (407)
.....|+..|+|||++.+..++.++|||||||++|||++|..||........ .+.......... ......+++
T Consensus 151 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ 224 (277)
T cd05607 151 --ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEV----KFEHQNFTE 224 (277)
T ss_pred --eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccc----ccccccCCH
Confidence 1234689999999999998999999999999999999999999976433211 122222222111 111245789
Q ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchh
Q 015406 247 EFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKY 295 (407)
Q Consensus 247 ~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~ 295 (407)
++.+++.+||+.||++||++.++.+.+ + .++|+..++|...+.
T Consensus 225 ~~~~li~~~L~~~P~~R~~~~~~~~~~---~---~h~~f~~~~~~~~~~ 267 (277)
T cd05607 225 ESKDICRLFLAKKPEDRLGSREKNDDP---R---KHEFFKTINFPRLEA 267 (277)
T ss_pred HHHHHHHHHhccCHhhCCCCccchhhh---h---cChhhcCCCHHHHhc
Confidence 999999999999999999987654222 1 245666678865544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=336.48 Aligned_cols=257 Identities=21% Similarity=0.270 Sum_probs=200.7
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEecCCC-----CcchHHHHHHH-HHHHcCCCCCCeeEEeeeeCceeEEEEecc-
Q 015406 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKL-YRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (407)
Q Consensus 13 ~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~~-l~~l~~~~~i~~~~~~~~~~~~~~lvme~~- 85 (407)
+.||+|+||.||+|++..+++.||+|++.... ....+..|..+ ++.++| +++..+...+...+..|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h-p~iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKH-PFLVGLHYSFQTTEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCC-CCCccEEEEEecCCEEEEEEcCCC
Confidence 46999999999999999999999999876432 12234555554 344554 67777777778888999999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCccc
Q 015406 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165 (407)
Q Consensus 86 g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~ 165 (407)
+++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 ~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~---- 151 (325)
T cd05604 80 GGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILL---DSQGHVVLTDFGLCKEGIAQSD---- 151 (325)
T ss_pred CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEeecCCcccCCCCCC----
Confidence 8999988875 4579999999999999999999999999999999999999 5788999999999875322111
Q ss_pred CccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCc
Q 015406 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 245 (407)
Q Consensus 166 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 245 (407)
......||+.|+|||++.+..++.++|||||||++|||++|..||...+ ..+.+..+...... +...++
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~---~~~~~~~~~~~~~~-----~~~~~~ 220 (325)
T cd05604 152 ---TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD---VAEMYDNILHKPLV-----LRPGAS 220 (325)
T ss_pred ---CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC---HHHHHHHHHcCCcc-----CCCCCC
Confidence 1235679999999999999999999999999999999999999997643 33444444433221 234578
Q ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchh
Q 015406 246 TEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKY 295 (407)
Q Consensus 246 ~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~ 295 (407)
.++.+++.+||..+|.+||++.+. +.+++ .++|...++|.....
T Consensus 221 ~~~~~ll~~ll~~~p~~R~~~~~~---~~~i~---~h~~f~~~~~~~~~~ 264 (325)
T cd05604 221 LTAWSILEELLEKDRQRRLGAKED---FLEIQ---EHPFFESLSWTDLEQ 264 (325)
T ss_pred HHHHHHHHHHhccCHHhcCCCCCC---HHHHh---cCCCcCCCCHHHHHh
Confidence 999999999999999999996432 22222 235566677876544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=334.00 Aligned_cols=253 Identities=18% Similarity=0.281 Sum_probs=200.4
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
..++|++.+.||+|+||.||++++..++..||+|++..... ...+.+|+++++.++| +++..+..+....+..++|
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNS-PYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCC-CCCCeEEEEEEECCEEEEE
Confidence 35789999999999999999999999999999998875432 2358889999999986 5666676777778889999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 82 me~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
|||+ +++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||+ +.++.+||+|||++......
T Consensus 82 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 82 MEHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred eecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEE---cCCCcEEEccCccccccccc
Confidence 9999 8999999986 34689999999999999999999986 69999999999999 57889999999999765432
Q ss_pred CCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHH------------
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK------------ 227 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~------------ 227 (407)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+..
T Consensus 158 ~---------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (331)
T cd06649 158 M---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHS 228 (331)
T ss_pred c---------cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccc
Confidence 2 2345789999999999999999999999999999999999999975432111111000
Q ss_pred ---------------------------HhhhcccccHHHH-hcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 228 ---------------------------ISEKKVSTSIEAL-CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 228 ---------------------------i~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
..........+.. ...+++++.+||.+||..||++||++.+|.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~ 300 (331)
T cd06649 229 ISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMN 300 (331)
T ss_pred cCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000000 1236789999999999999999999777653
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=326.85 Aligned_cols=258 Identities=19% Similarity=0.236 Sum_probs=199.8
Q ss_pred ccccCceEEEEEEEcCCCeEEEEEEecCCCC-----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-CCC
Q 015406 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPS 88 (407)
Q Consensus 15 iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~-g~s 88 (407)
||+|+||+||++.+..+++.||+|.+..... ...+..|+++++.+.| +++..+..++......++||||+ +++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~-~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHS-RFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCC-CcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 7999999999999999999999998764321 1345679999998865 67777777777788899999999 999
Q ss_pred HHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCccc
Q 015406 89 LEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165 (407)
Q Consensus 89 L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~ 165 (407)
|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++..+.....
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~---- 152 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQS---- 152 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCccceecCCCCc----
Confidence 9988753 23468999999999999999999999999999999999999 5788999999999987654322
Q ss_pred CccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchH-HHHHHHhhhcccccHHHHhcCC
Q 015406 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK-QKYEKISEKKVSTSIEALCRGY 244 (407)
Q Consensus 166 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~ 244 (407)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .....+.... ..+...+
T Consensus 153 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-----~~~~~~~ 224 (280)
T cd05608 153 ---KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDS-----VTYPDKF 224 (280)
T ss_pred ---cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccC-----CCCcccC
Confidence 123457899999999999999999999999999999999999999764332211 1122221111 1223458
Q ss_pred cHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHHHHcCCCCCCccccccchh
Q 015406 245 PTEFASYFHYCRSLRFDDKPDYAY--LKRIFRDLFIREGFQFDYVFDWTILKY 295 (407)
Q Consensus 245 ~~~l~~li~~cl~~~p~~RPt~~~--l~~~l~~l~~~~~~~~~~~~dw~~~~~ 295 (407)
++++.+++.+||+.||++||++++ +.++++ ++|...++|..+..
T Consensus 225 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~-------h~~~~~~~~~~~~~ 270 (280)
T cd05608 225 SPASKSFCEALLAKDPEKRLGFRDGNCDGLRT-------HPLFRDLNWRQLEA 270 (280)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc-------ChhhhcCCHhHHhh
Confidence 899999999999999999995432 222332 24445567775433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=333.93 Aligned_cols=270 Identities=19% Similarity=0.281 Sum_probs=207.1
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
..++|++.++||+|+||.||++++..++..+|+|++..... ...+.+|+++++.++| ++++.+..++...+..++|
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNS-PYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCC-CcccceeEEEEECCEEEEE
Confidence 35789999999999999999999999999999998765432 2357899999999986 6677777777788899999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 82 me~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
|||+ +++|.+++.. .+.+++..+..++.|++.||.|||++ +|+||||||+|||+ +.++.+||+|||++..+...
T Consensus 82 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 82 MEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEE---cCCCCEEEeeCCcchhhhhh
Confidence 9999 8999999986 44689999999999999999999975 79999999999999 57788999999999765332
Q ss_pred CCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHH-------------
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE------------- 226 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~------------- 226 (407)
. .....||..|+|||++.+..++.++|||||||++|+|++|+.||...........+.
T Consensus 158 ~---------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (333)
T cd06650 158 M---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETS 228 (333)
T ss_pred c---------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccC
Confidence 1 134578999999999999889999999999999999999999997543211111000
Q ss_pred ------------------------HHhhhcccccHHHHh-cCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH-Hc
Q 015406 227 ------------------------KISEKKVSTSIEALC-RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI-RE 280 (407)
Q Consensus 227 ------------------------~i~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~-~~ 280 (407)
.+...........+. ..++.++.+|+.+||+.||++||++.++. .+.|. ..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell---~h~~~~~~ 305 (333)
T cd06650 229 PRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLM---VHAFIKRS 305 (333)
T ss_pred cccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHh---hCHHHhcC
Confidence 000000000000011 13578899999999999999999977774 33333 33
Q ss_pred CCCCCCccccc
Q 015406 281 GFQFDYVFDWT 291 (407)
Q Consensus 281 ~~~~~~~~dw~ 291 (407)
..+..+...|.
T Consensus 306 ~~~~~~~~~~~ 316 (333)
T cd06650 306 EAEEVDFAGWL 316 (333)
T ss_pred ccccccHHHHH
Confidence 33444455664
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=325.51 Aligned_cols=253 Identities=19% Similarity=0.251 Sum_probs=197.8
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC----cchHHHHHHHHHHHc--CCCCCCeeEEeee-----eCc
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQ--GGTGIPNVRWFGV-----EGD 76 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~----~~~~~~E~~~l~~l~--~~~~i~~~~~~~~-----~~~ 76 (407)
+|++.+.||+|+||.||+|++..+++.||+|.+..... .....+|+.+++.+. .|+++..+..++. ...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 58999999999999999999999999999998765432 234667888888775 3466666554433 235
Q ss_pred eeEEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceee
Q 015406 77 YNVLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (407)
Q Consensus 77 ~~~lvme~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~ 155 (407)
..+++|||+.++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGQVKLADFGLARI 157 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccCcccc
Confidence 679999999889999987543 358999999999999999999999999999999999999 5788999999999986
Q ss_pred eccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhh----
Q 015406 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK---- 231 (407)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~---- 231 (407)
...... .....||..|+|||++.+..++.++|||||||++|+|++|..||...........+......
T Consensus 158 ~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07863 158 YSCQMA--------LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 229 (288)
T ss_pred ccCccc--------CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChh
Confidence 643221 23456899999999999989999999999999999999999999764432222222111100
Q ss_pred ---------------cccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 232 ---------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 232 ---------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
........+.+.++.++.+++.+||+.||++||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0011223344567889999999999999999999887763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=348.23 Aligned_cols=261 Identities=20% Similarity=0.265 Sum_probs=202.8
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC--cchHHHHHHHHHHHcCCCCCCeeEE-eee-----e-Cce
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRW-FGV-----E-GDY 77 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~-~~~-----~-~~~ 77 (407)
.+++|.+.|.+|||+.||+|++...+.+||+|.+-...+ ...+.+|+++|+.|++|++|+.+.+ ... . .-.
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 467899999999999999999988889999997654422 2347899999999998888888766 221 1 235
Q ss_pred eEEEEecc-CCCHHHHHH-HcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcccccCCCCCceEEEEeccce
Q 015406 78 NVLVMDLL-GPSLEDLFN-FCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~-~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--ivHrDLKp~NILl~~~~~~~~~kL~DFGla 153 (407)
++|.|||| |++|-|+++ +....|++.++++|+.|+++|+.+||... |||||||-+|||| ..++.+||||||.|
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLl---s~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLL---SADGNYKLCDFGSA 193 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEE---cCCCCEEeCccccc
Confidence 68999999 799999997 34556999999999999999999999987 9999999999999 58889999999998
Q ss_pred eeeccCC-CCcccCc-cCCCCcccccccccccccc---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHH
Q 015406 154 KKYRDTS-THQHIPY-RENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228 (407)
Q Consensus 154 ~~~~~~~-~~~~~~~-~~~~~~~gt~~Y~aPE~~~---~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i 228 (407)
....... ....+.+ ...-....|+.|+|||++. +.+.+.|+|||+|||+||.|+....||.+... ..|
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-------laI 266 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-------LAI 266 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-------eeE
Confidence 7432221 1111000 0111234689999999874 78899999999999999999999999987422 123
Q ss_pred hhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHc
Q 015406 229 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (407)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~ 280 (407)
.......+. .+.++..|.+||..||+.||++||++-++...+..+....
T Consensus 267 lng~Y~~P~---~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 267 LNGNYSFPP---FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred EeccccCCC---CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 333332221 1458899999999999999999999777777776665543
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=351.00 Aligned_cols=255 Identities=17% Similarity=0.218 Sum_probs=191.4
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-CcchHHHHHHHHHHHcCCC-----CCCeeEEee-eeCcee
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGT-----GIPNVRWFG-VEGDYN 78 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~E~~~l~~l~~~~-----~i~~~~~~~-~~~~~~ 78 (407)
.++|++.++||+|+||.||+|.+..+++.||||+++... .......|+.+++.+.+.+ ++..+..++ ......
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~ 207 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence 478999999999999999999999999999999986432 2334667888888887643 234444443 345678
Q ss_pred EEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcccccCCC-------------CCce
Q 015406 79 VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGR-------------RANQ 144 (407)
Q Consensus 79 ~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~ivHrDLKp~NILl~~~~-------------~~~~ 144 (407)
|+|||++|++|.+++.. .+.+++..+..|+.||+.||+|||+ .|||||||||+|||++.++ +...
T Consensus 208 ~iv~~~~g~~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~ 286 (467)
T PTZ00284 208 CIVMPKYGPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCR 286 (467)
T ss_pred EEEEeccCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCce
Confidence 99999999999998875 3579999999999999999999998 5999999999999995321 1125
Q ss_pred EEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHH
Q 015406 145 VYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK 224 (407)
Q Consensus 145 ~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~ 224 (407)
+||+|||++...... ....+||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+.......
T Consensus 287 vkl~DfG~~~~~~~~----------~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 287 VRICDLGGCCDERHS----------RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred EEECCCCccccCccc----------cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 999999988643221 2356899999999999999999999999999999999999999987543222222
Q ss_pred HHHHhhhccc---------------------------ccHHHHh-------cCCcHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015406 225 YEKISEKKVS---------------------------TSIEALC-------RGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 225 ~~~i~~~~~~---------------------------~~~~~~~-------~~~~~~l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
+.++...... .....+. ....+.+.+||.+||.+||++||++++++
T Consensus 357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L 436 (467)
T PTZ00284 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT 436 (467)
T ss_pred HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence 2221110000 0000000 00135678999999999999999987765
Q ss_pred H
Q 015406 271 R 271 (407)
Q Consensus 271 ~ 271 (407)
+
T Consensus 437 ~ 437 (467)
T PTZ00284 437 T 437 (467)
T ss_pred c
Confidence 3
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=328.84 Aligned_cols=255 Identities=18% Similarity=0.261 Sum_probs=202.5
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
.++|.+.++||+|+||.||+|++..+++.||+|.++.... ...+.+|+.+++.++| +++..+..+....+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKH-ANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCC-CCcceEEEEEeeCCeEEEEE
Confidence 3679999999999999999999999999999998764332 2357789999999986 66667777777788899999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 83 e~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
||+.++|.+++...+..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 84 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~- 159 (309)
T cd07872 84 EYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSVPTK- 159 (309)
T ss_pred eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECccccceecCCCcc-
Confidence 999889999988766678999999999999999999999999999999999999 5788999999999976543221
Q ss_pred cccCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcc--------
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-------- 233 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-------- 233 (407)
......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.+......
T Consensus 160 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07872 160 ------TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS 233 (309)
T ss_pred ------ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhc
Confidence 1224467899999999875 4579999999999999999999999987544332222222111000
Q ss_pred --------------cccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 234 --------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 234 --------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
..........+++++.++|.+||..||.+|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred chhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00111222457889999999999999999999877754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=337.95 Aligned_cols=258 Identities=22% Similarity=0.315 Sum_probs=206.1
Q ss_pred eccccccCceEEEEEEEc---CCCeEEEEEEecCCC----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEec
Q 015406 12 GRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (407)
Q Consensus 12 ~~~iG~G~~g~Vy~~~~~---~~~~~vAvK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~ 84 (407)
++.||+|+||.||++++. .+++.||+|++.... ....+..|+++++.++| ++++.+..++...+..|+||||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNH-PFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCC-CCcccEEEEEEcCCEEEEEEcC
Confidence 367999999999999863 578999999886432 22346779999999986 6666677777788899999999
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCc
Q 015406 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (407)
Q Consensus 85 ~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~ 163 (407)
+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 ~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~-- 153 (318)
T cd05582 80 LRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEK-- 153 (318)
T ss_pred CCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEE---CCCCcEEEeeccCCcccCCCCC--
Confidence 9 8999999875 4569999999999999999999999999999999999999 5788999999999986543211
Q ss_pred ccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcC
Q 015406 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243 (407)
Q Consensus 164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (407)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.+..+...... +...
T Consensus 154 -----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~---~~~~~~~i~~~~~~-----~p~~ 220 (318)
T cd05582 154 -----KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD---RKETMTMILKAKLG-----MPQF 220 (318)
T ss_pred -----ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC---HHHHHHHHHcCCCC-----CCCC
Confidence 1234679999999999999889999999999999999999999997643 34444444433322 2345
Q ss_pred CcHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHHHHcCCCCCCccccccchhh
Q 015406 244 YPTEFASYFHYCRSLRFDDKPDYAY--LKRIFRDLFIREGFQFDYVFDWTILKYQ 296 (407)
Q Consensus 244 ~~~~l~~li~~cl~~~p~~RPt~~~--l~~~l~~l~~~~~~~~~~~~dw~~~~~~ 296 (407)
+++++.+++.+||+.||++||++.+ +.+++. +.+...++|......
T Consensus 221 ~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~-------~~~~~~~~~~~~~~~ 268 (318)
T cd05582 221 LSPEAQSLLRALFKRNPANRLGAGPDGVEEIKR-------HPFFSTIDWNKLYRR 268 (318)
T ss_pred CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhC-------CCCcCCCCHHHHHhc
Confidence 7899999999999999999999766 444443 345556778765443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=340.49 Aligned_cols=250 Identities=22% Similarity=0.280 Sum_probs=201.6
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+..|+.+++.+.| ++++.+..++......|+
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h-~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANS-EWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCC-CCcceEEEEEecCCEEEE
Confidence 467999999999999999999999999999999886421 22336678999988876 667777777788889999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 81 vme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
||||+ |++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 121 v~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 121 VMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---cCCCCEEEEeccceeeccCC
Confidence 99999 9999999874 468999999999999999999999999999999999999 68899999999999876433
Q ss_pred CCCcccCccCCCCccccccccccccccCC----CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccc
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLGI----EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (407)
.. .......||+.|+|||++.+. .++.++|||||||++|||++|..||.+... ...+.++.......
T Consensus 196 ~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~~~~~~i~~~~~~~ 266 (370)
T cd05596 196 GM------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL---VGTYSKIMDHKNSL 266 (370)
T ss_pred Cc------ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH---HHHHHHHHcCCCcC
Confidence 21 112356799999999998754 378999999999999999999999986433 34455554332111
Q ss_pred cHHHHhcCCcHHHHHHHHHHhCCCCCC--CCCHHHHHH
Q 015406 236 SIEALCRGYPTEFASYFHYCRSLRFDD--KPDYAYLKR 271 (407)
Q Consensus 236 ~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~~l~~ 271 (407)
..+ ....++.++.++|.+||..+|++ |++++++++
T Consensus 267 ~~~-~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 267 TFP-DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred CCC-CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 111 11247899999999999999987 999776643
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=331.63 Aligned_cols=253 Identities=20% Similarity=0.279 Sum_probs=200.4
Q ss_pred eccccccCceEEEEEEEc---CCCeEEEEEEecCCC------CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 12 GRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKT------KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 12 ~~~iG~G~~g~Vy~~~~~---~~~~~vAvK~~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
+++||+|+||.||++++. .+++.||||++.... ....+..|+.+++.++| +++..+...+..++..|+||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~h-p~iv~~~~~~~~~~~~~lv~ 79 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKH-PFIVDLIYAFQTGGKLYLIL 79 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCC-CchhceeeEEecCCeEEEEE
Confidence 368999999999999864 468899999876421 12346789999999987 55666666667778899999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCC
Q 015406 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 83 e~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~ 161 (407)
||+ +++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 80 EYLSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL---DAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred eCCCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEeeCcCCeecccCCC
Confidence 999 8999999875 4568999999999999999999999999999999999999 6788999999999975433221
Q ss_pred CcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHh
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (407)
......||+.|+|||++.+..++.++|||||||++|||++|..||..... .+.+..+..... .+.
T Consensus 156 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~---~~~~~~~~~~~~-----~~~ 220 (323)
T cd05584 156 -------VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR---KKTIDKILKGKL-----NLP 220 (323)
T ss_pred -------cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCCC-----CCC
Confidence 12345799999999999998899999999999999999999999976433 334444443322 233
Q ss_pred cCCcHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCccccccch
Q 015406 242 RGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRIFRDLFIREGFQFDYVFDWTILK 294 (407)
Q Consensus 242 ~~~~~~l~~li~~cl~~~p~~RP-----t~~~l~~~l~~l~~~~~~~~~~~~dw~~~~ 294 (407)
..+++++.++|.+||..+|++|| ++.++.+ ++|....+|....
T Consensus 221 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~----------h~~~~~~~~~~~~ 268 (323)
T cd05584 221 PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS----------HPFFRHVNWDDLL 268 (323)
T ss_pred CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc----------CCCcCCCCHHHHh
Confidence 55789999999999999999999 6555543 2445555665443
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=348.79 Aligned_cols=253 Identities=22% Similarity=0.244 Sum_probs=200.8
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc----chHHHHHHHHHHHcCCCCCCeeEEeeee-----
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVE----- 74 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~----- 74 (407)
...++|++.+.||+|+||.||+|++..+++.||||++...... ..+.+|+.++..+.|++.+.....+...
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3568999999999999999999999999999999998654332 2366788888777765444333222211
Q ss_pred --CceeEEEEecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEE
Q 015406 75 --GDYNVLVMDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 148 (407)
Q Consensus 75 --~~~~~lvme~~-g~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~ 148 (407)
....++||||+ +++|.+++... ...+++..+..++.|++.||.|||+++|+||||||+|||+ +.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl---~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILL---CSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---eCCCCEEEE
Confidence 12468999999 99999998642 2468999999999999999999999999999999999999 578899999
Q ss_pred eccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHH
Q 015406 149 DFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228 (407)
Q Consensus 149 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i 228 (407)
|||+++.+...... .......||+.|+|||++.+..++.++|||||||+||||++|+.||.+.. ....+..+
T Consensus 186 DFGls~~~~~~~~~-----~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~---~~~~~~~~ 257 (496)
T PTZ00283 186 DFGFSKMYAATVSD-----DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN---MEEVMHKT 257 (496)
T ss_pred ecccCeeccccccc-----cccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC---HHHHHHHH
Confidence 99999876543211 11235679999999999999999999999999999999999999997643 23344444
Q ss_pred hhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 229 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
...... .+...+++++.+++.+||+.||++||++.++++
T Consensus 258 ~~~~~~----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 258 LAGRYD----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred hcCCCC----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 333222 234568999999999999999999999998864
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=342.58 Aligned_cols=273 Identities=19% Similarity=0.267 Sum_probs=210.0
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCC-----CCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
++|++.+.||+|+||.||+|++..+++.||||++... .....+..|+.++..++| ++++.+...+...+..|+|
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~iv~~~~~~~~~~~~~lv 79 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG-AWVVKMFYSFQDKRNLYLI 79 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCC-CCEeeEEEEEEcCCEEEEE
Confidence 4799999999999999999999999999999988642 122346778999998876 6666666777788889999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 82 me~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
|||+ |++|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||+ +.++.++|+|||+++.+....
T Consensus 80 ~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli---~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 80 MEFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLL---DAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred EeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEeeccCCccccccc
Confidence 9999 9999999975 4579999999999999999999999999999999999999 578999999999987553221
Q ss_pred CCcc----------------------------cCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCC
Q 015406 161 THQH----------------------------IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212 (407)
Q Consensus 161 ~~~~----------------------------~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~P 212 (407)
.... .........+||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 1000 000011245799999999999999999999999999999999999999
Q ss_pred CCCCCcCchHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccccc
Q 015406 213 WQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTI 292 (407)
Q Consensus 213 f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~dw~~ 292 (407)
|.+... ...+.++.........+. ...+++++.++|.+|+ .||.+|++...+.+++ .++|...++|..
T Consensus 236 f~~~~~---~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~-------~hp~f~~~~~~~ 303 (360)
T cd05627 236 FCSETP---QETYRKVMNWKETLVFPP-EVPISEKAKDLILRFC-TDSENRIGSNGVEEIK-------SHPFFEGVDWGH 303 (360)
T ss_pred CCCCCH---HHHHHHHHcCCCceecCC-CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHh-------cCCCCCCCCHHH
Confidence 976443 334444433211111110 1236789999999977 4999999754343333 347788899987
Q ss_pred chhh
Q 015406 293 LKYQ 296 (407)
Q Consensus 293 ~~~~ 296 (407)
+...
T Consensus 304 ~~~~ 307 (360)
T cd05627 304 IRER 307 (360)
T ss_pred HhcC
Confidence 6543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=340.66 Aligned_cols=242 Identities=23% Similarity=0.301 Sum_probs=200.1
Q ss_pred cccccCceEEEEEEEcCCCeEEEEEEecCCC--CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-CCCHH
Q 015406 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLE 90 (407)
Q Consensus 14 ~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~-g~sL~ 90 (407)
+||+|.||+||-|++..+...+|||-+..+. ..+-+..|+.+.+.|+|.+++ .+.+...+++++-|+||-+ ||||.
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIV-rYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIV-RYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHH-HHhhccCCCCeEEEEeecCCCCcHH
Confidence 6899999999999999999999999775443 345588999999999985544 4445566677889999999 99999
Q ss_pred HHHHHcCCCC--CHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcccCcc
Q 015406 91 DLFNFCSRKL--SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYR 168 (407)
Q Consensus 91 ~~l~~~~~~l--~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 168 (407)
+++...-+++ ++.++-.+..||++||.|||++.|||||||-+|||+. .-.|.+||+|||.++.+..-+.
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvN--TySGvlKISDFGTsKRLAginP------- 731 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVN--TYSGVLKISDFGTSKRLAGINP------- 731 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEe--eccceEEecccccchhhccCCc-------
Confidence 9998766677 8899999999999999999999999999999999996 5679999999999987654332
Q ss_pred CCCCccccccccccccccCC--CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcH
Q 015406 169 ENKNLTGTARYASMNTHLGI--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 246 (407)
Q Consensus 169 ~~~~~~gt~~Y~aPE~~~~~--~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 246 (407)
...++.||..|||||++..+ .|+.++|||||||++.||.||++||..+... ...+.++..-+..+++ +..++.
T Consensus 732 ~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp--qAAMFkVGmyKvHP~i---Peelsa 806 (1226)
T KOG4279|consen 732 CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP--QAAMFKVGMYKVHPPI---PEELSA 806 (1226)
T ss_pred cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh--hHhhhhhcceecCCCC---cHHHHH
Confidence 24688999999999999864 4899999999999999999999999876543 3334444433333333 344778
Q ss_pred HHHHHHHHHhCCCCCCCCCHHHHH
Q 015406 247 EFASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 247 ~l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
+.+.+|.+|+..+|.+||++.+|+
T Consensus 807 eak~FilrcFepd~~~R~sA~~LL 830 (1226)
T KOG4279|consen 807 EAKNFILRCFEPDPCDRPSAKDLL 830 (1226)
T ss_pred HHHHHHHHHcCCCcccCccHHHhc
Confidence 999999999999999999977654
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=341.74 Aligned_cols=271 Identities=22% Similarity=0.245 Sum_probs=205.6
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
..|+++++||+|+||.||+|++..+++.||+|++.... ....+..|+.+++.+.| ++++.+...+.+.+..|+|
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h-~~iv~~~~~~~~~~~~~lv 79 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADN-EWVVRLYYSFQDKDNLYFV 79 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCC-CcCCeEEEEEEeCCEEEEE
Confidence 36999999999999999999999999999999876432 22357789999999976 6677777777888899999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 82 me~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
|||+ +++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++..+....
T Consensus 80 ~E~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl---~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 80 MDYIPGGDMMSLLIR-MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEeECCCCccccccc
Confidence 9999 8999999975 3568999999999999999999999999999999999999 678999999999986432110
Q ss_pred CCcc----------------------------------------cCccCCCCccccccccccccccCCCCChhhHHHHHH
Q 015406 161 THQH----------------------------------------IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLG 200 (407)
Q Consensus 161 ~~~~----------------------------------------~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG 200 (407)
.... .........+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0000 000011245799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHc
Q 015406 201 YVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (407)
Q Consensus 201 ~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~ 280 (407)
|+||||++|..||.+... .+...++.........+ ....+++++.++|.+|+ .+|++|++...+.++++
T Consensus 236 vil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~~p-~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~------ 304 (382)
T cd05625 236 VILYEMLVGQPPFLAQTP---LETQMKVINWQTSLHIP-PQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA------ 304 (382)
T ss_pred HHHHHHHhCCCCCCCCCH---HHHHHHHHccCCCcCCC-CcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc------
Confidence 999999999999986433 23333332211111111 11347889999999976 59999997322222222
Q ss_pred CCCCCCccccccch
Q 015406 281 GFQFDYVFDWTILK 294 (407)
Q Consensus 281 ~~~~~~~~dw~~~~ 294 (407)
++|...++|....
T Consensus 305 -hp~f~~~~~~~~~ 317 (382)
T cd05625 305 -HPFFKTIDFSSDL 317 (382)
T ss_pred -CCCcCCcChHHHH
Confidence 3566677887543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=325.43 Aligned_cols=254 Identities=22% Similarity=0.319 Sum_probs=205.5
Q ss_pred CCceeEeccccccCceEEEEEEEcCCC-----eEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCce
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTN-----EEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~-----~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 77 (407)
.++|++.+.||+|+||.||+|.+...+ ..||+|.+..... ...+.+|+.++..++| +++..+..+......
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h-~~i~~~~~~~~~~~~ 82 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQH-PNIVCLLGVCTKEQP 82 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCC-cccceEEEEEcCCCc
Confidence 457999999999999999999976554 6899998764432 2347889999999987 556666666667778
Q ss_pred eEEEEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCC
Q 015406 78 NVLVMDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 141 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~ 141 (407)
.+++|||+ +++|.+++.... ..+++..++.++.||+.||.|||++|++||||||+||++ ++
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~---~~ 159 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV---GE 159 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEE---cC
Confidence 89999999 899999997531 458889999999999999999999999999999999999 57
Q ss_pred CceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCc
Q 015406 142 ANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGT 220 (407)
Q Consensus 142 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~ 220 (407)
++.++|+|||+++....... +.......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+...
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~-- 232 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADY-----YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN-- 232 (283)
T ss_pred CCcEEECCCcceeecccccc-----ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH--
Confidence 78999999999986543322 111234467889999999998899999999999999999998 9999987543
Q ss_pred hHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 015406 221 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 275 (407)
Q Consensus 221 ~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~ 275 (407)
.+....+...... .....+|+++.+|+.+||+.||++||++.+|.+.|+.
T Consensus 233 -~~~~~~i~~~~~~----~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 233 -QEVIEMIRSRQLL----PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred -HHHHHHHHcCCcC----CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 3334444333222 2335689999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=363.50 Aligned_cols=282 Identities=24% Similarity=0.312 Sum_probs=230.1
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCC-----CCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
.++|.|+++||+|+||.|.+++++.+++.||+|++++- ....-|..|..+|..-. ..=|..+++.+++..+.|+
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~n-s~Wiv~LhyAFQD~~~LYl 152 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGN-SEWIVQLHYAFQDERYLYL 152 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCC-cHHHHHHHHHhcCccceEE
Confidence 46899999999999999999999999999999998752 22334677777776544 4667778888999999999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 81 vme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
||||+ ||+|..++.+.. +++++.+++|+..|+.||.-||+.|+|||||||+|||| |..|++||+|||.|-.+...
T Consensus 153 VMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLl---d~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 153 VMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLL---DKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred EEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEe---cccCcEeeccchhHHhcCCC
Confidence 99999 999999999766 89999999999999999999999999999999999999 79999999999999888765
Q ss_pred CCCcccCccCCCCcccccccccccccc----C-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhccc
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHL----G-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~----~-~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (407)
+... ....+|||.|.|||++. + ..|++.+|+||+||++|||+.|..||+. +...+.|.+|...+-.
T Consensus 229 G~V~------s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa---dslveTY~KIm~hk~~ 299 (1317)
T KOG0612|consen 229 GTVR------SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA---DSLVETYGKIMNHKES 299 (1317)
T ss_pred CcEE------eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH---HHHHHHHHHHhchhhh
Confidence 5432 35679999999999986 2 5689999999999999999999999976 5567788888776433
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHHHHcCCCCCCccccccchhhcccccCCCCccCCCC
Q 015406 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPD---YAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATPPARALVPG 311 (407)
Q Consensus 235 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~~~~~~~~~~~~~~~~~ 311 (407)
...+.. ..+|++.++||.+.+. +|+.|.. +++++. ++|+...||+.++.. .+|..|.+..+
T Consensus 300 l~FP~~-~~VSeeakdLI~~ll~-~~e~RLgrngiedik~----------HpFF~g~~W~~iR~~----~pP~vPevssd 363 (1317)
T KOG0612|consen 300 LSFPDE-TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN----------HPFFEGIDWDNIRES----VPPVVPEVSSD 363 (1317)
T ss_pred cCCCcc-cccCHHHHHHHHHHhc-ChhhhcccccHHHHHh----------CccccCCChhhhhhc----CCCCCCcCCCC
Confidence 222211 2389999999999886 5788877 555543 589999999766553 33444555556
Q ss_pred CCCCCC
Q 015406 312 AGTSGA 317 (407)
Q Consensus 312 ~~~~~~ 317 (407)
.+++.+
T Consensus 364 ~DTsnF 369 (1317)
T KOG0612|consen 364 DDTSNF 369 (1317)
T ss_pred Cccccc
Confidence 666665
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=337.53 Aligned_cols=251 Identities=21% Similarity=0.256 Sum_probs=193.9
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC----CcchHHHHHHHHHHHcCCCCCCeeEEeeee-----
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVE----- 74 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~----- 74 (407)
.+.++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+|+.+++.++|++.+..+..+...
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 35689999999999999999999999999999999886432 233577899999999875555544443322
Q ss_pred CceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEecccee
Q 015406 75 GDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (407)
Q Consensus 75 ~~~~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~ 154 (407)
....|+||||++++|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 98 ~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~---~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 98 FQDVYLVMELMDANLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 171 (359)
T ss_pred cceeEEEEeCCCcCHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEecCCCcc
Confidence 23579999999888888775 358999999999999999999999999999999999999 578999999999997
Q ss_pred eeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhccc
Q 015406 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (407)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (407)
....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+... .+..+......
T Consensus 172 ~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~---~~~~~~~~~~~ 240 (359)
T cd07876 172 TACTNFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID---QWNKVIEQLGT 240 (359)
T ss_pred ccccCcc--------CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCC
Confidence 5433211 234578999999999999999999999999999999999999998754321 11111100000
Q ss_pred -------------------------ccHHH------------HhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 235 -------------------------TSIEA------------LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 235 -------------------------~~~~~------------~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
..... .....++++.+||.+||..||++||++.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 241 PSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred CcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000 11123578999999999999999999877754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=335.81 Aligned_cols=258 Identities=20% Similarity=0.254 Sum_probs=200.2
Q ss_pred ccccCceEEEEEEEcCCCeEEEEEEecCCC-----CcchHHHHHHHHHHHc--CCCCCCeeEEeeeeCceeEEEEecc-C
Q 015406 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQ--GGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (407)
Q Consensus 15 iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~~l~~l~--~~~~i~~~~~~~~~~~~~~lvme~~-g 86 (407)
||+|+||.||+|++..+++.||||++.... .......|..++..+. ++++++.+...+......|+||||+ +
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999999999999999876432 1122445666666654 6788888888888889999999999 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcccC
Q 015406 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166 (407)
Q Consensus 87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~ 166 (407)
++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~~----- 151 (330)
T cd05586 81 GELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILL---DATGHIALCDFGLSKANLTDNK----- 151 (330)
T ss_pred ChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEecCCcCcCCCCCCC-----
Confidence 999998875 4579999999999999999999999999999999999999 5788999999999875332211
Q ss_pred ccCCCCccccccccccccccCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCc
Q 015406 167 YRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 245 (407)
Q Consensus 167 ~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 245 (407)
......||..|+|||++.+. .++.++|||||||++|+|++|..||.... ..+.+..+.......+ ...++
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~~~----~~~~~ 222 (330)
T cd05586 152 --TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED---TQQMYRNIAFGKVRFP----KNVLS 222 (330)
T ss_pred --CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC---HHHHHHHHHcCCCCCC----CccCC
Confidence 12356799999999999764 47999999999999999999999997643 3444444443332211 12368
Q ss_pred HHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHHHHcCCCCCCccccccchhhc
Q 015406 246 TEFASYFHYCRSLRFDDKPDYAY-LKRIFRDLFIREGFQFDYVFDWTILKYQQ 297 (407)
Q Consensus 246 ~~l~~li~~cl~~~p~~RPt~~~-l~~~l~~l~~~~~~~~~~~~dw~~~~~~~ 297 (407)
+++.+++.+||..||++||++.. +.++++ +++....+|.......
T Consensus 223 ~~~~~li~~~L~~~P~~R~~~~~~~~~ll~-------h~~~~~~~~~~~~~~~ 268 (330)
T cd05586 223 DEGRQFVKGLLNRNPQHRLGAHRDAVELKE-------HPFFADIDWDLLSKKQ 268 (330)
T ss_pred HHHHHHHHHHcCCCHHHCCCCCCCHHHHhc-------CccccCCCHHHHHhCC
Confidence 89999999999999999995432 223332 3455567787655433
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=324.81 Aligned_cols=244 Identities=20% Similarity=0.273 Sum_probs=196.0
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
.|++.+.||+|+||+||+|.+..+++.||+|.+..... ...+.+|+++++.++| +++..+...+..++..+++|
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~-~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNS-QFVVNLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCC-cCceeEEEEEecCCEEEEEE
Confidence 47889999999999999999999999999998764321 2236789999999987 55556666667778899999
Q ss_pred ecc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 83 DLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 83 e~~-g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
||+ +++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||++ ++++.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILL---DDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---CCCCCEEEecCCcceecCCCC
Confidence 999 889998886533 469999999999999999999999999999999999999 577899999999997654322
Q ss_pred CCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHH
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (407)
. .....|+..|+|||.+.+..++.++|||||||++|||++|..||.........+. +.... .......
T Consensus 157 ~--------~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~---~~~~~-~~~~~~~ 224 (285)
T cd05632 157 S--------IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE---VDRRV-LETEEVY 224 (285)
T ss_pred c--------ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhh-hcccccc
Confidence 1 1245789999999999998999999999999999999999999976433221112 21111 1111223
Q ss_pred hcCCcHHHHHHHHHHhCCCCCCCCCHH
Q 015406 241 CRGYPTEFASYFHYCRSLRFDDKPDYA 267 (407)
Q Consensus 241 ~~~~~~~l~~li~~cl~~~p~~RPt~~ 267 (407)
...+++++.+|+..||+.||++||+..
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 225 SAKFSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred CccCCHHHHHHHHHHccCCHhHcCCCc
Confidence 456889999999999999999999943
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=339.36 Aligned_cols=258 Identities=22% Similarity=0.290 Sum_probs=207.2
Q ss_pred CCceeEeccccccCceEEEEEEEcCC-----CeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCce
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQT-----NEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~-----~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 77 (407)
.++|+++++||+|+||.||+|++... +..||||++..... .+.+.+|+++++.+..|++++.+..++.....
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 46788999999999999999987433 35799998865432 24578899999999866888888888888889
Q ss_pred eEEEEecc-CCCHHHHHHHcC-----------------------------------------------------------
Q 015406 78 NVLVMDLL-GPSLEDLFNFCS----------------------------------------------------------- 97 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~~~~----------------------------------------------------------- 97 (407)
.||||||| +++|.+++....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 99999999 999999886421
Q ss_pred ------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCC
Q 015406 98 ------------------------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 141 (407)
Q Consensus 98 ------------------------------------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~ 141 (407)
..+++..++.++.||+.||.|||+++|+||||||+|||+ +.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill---~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL---AQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE---eC
Confidence 237788899999999999999999999999999999999 57
Q ss_pred CceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCc
Q 015406 142 ANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGT 220 (407)
Q Consensus 142 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~ 220 (407)
++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~ 347 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNY-----VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS 347 (400)
T ss_pred CCEEEEEeCCcceeccccccc-----cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence 789999999999876443221 11234457788999999999899999999999999999997 999997643321
Q ss_pred hHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHH
Q 015406 221 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (407)
Q Consensus 221 ~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~ 277 (407)
..+..+...... .....++.++.+++.+||+.+|++||++.+|.+.|++++
T Consensus 348 --~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 348 --TFYNKIKSGYRM----AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred --HHHHHHhcCCCC----CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 222222222111 123457899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=333.24 Aligned_cols=259 Identities=20% Similarity=0.310 Sum_probs=203.3
Q ss_pred CCceeEeccccccCceEEEEEEEcC-----CCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEe-eeeCc
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWF-GVEGD 76 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~-----~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~-~~~~~ 76 (407)
.++|++.+.||+|+||.||+|++.. +++.||+|++..... .+.+..|+.++..+.+|+++..+..+ ...+.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 5689999999999999999997543 457899998864332 23467899999999655666666544 44566
Q ss_pred eeEEEEecc-CCCHHHHHHHcC----------------------------------------------------------
Q 015406 77 YNVLVMDLL-GPSLEDLFNFCS---------------------------------------------------------- 97 (407)
Q Consensus 77 ~~~lvme~~-g~sL~~~l~~~~---------------------------------------------------------- 97 (407)
..+++|||+ +++|.+++....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 789999999 999999986421
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcccCccCCCCccc
Q 015406 98 --RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175 (407)
Q Consensus 98 --~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~g 175 (407)
..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.++|+|||+++.+...... .......+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill---~~~~~vkL~DfG~a~~~~~~~~~-----~~~~~~~~ 237 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDY-----VRKGDARL 237 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE---eCCCcEEEeccccchhcccCcch-----hhccCCCC
Confidence 257899999999999999999999999999999999999 57789999999999876432221 11234456
Q ss_pred cccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHH
Q 015406 176 TARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHY 254 (407)
Q Consensus 176 t~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~ 254 (407)
+..|+|||++.+..++.++|||||||+||||++ |..||.+..... .....+...... .....+++++.+++.+
T Consensus 238 ~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~~~~~~~~~~~----~~~~~~~~~~~~l~~~ 311 (337)
T cd05054 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFCRRLKEGTRM----RAPEYATPEIYSIMLD 311 (337)
T ss_pred CccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HHHHHHhccCCC----CCCccCCHHHHHHHHH
Confidence 778999999999999999999999999999998 999997643321 111122111111 1124568899999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHHHHH
Q 015406 255 CRSLRFDDKPDYAYLKRIFRDLFI 278 (407)
Q Consensus 255 cl~~~p~~RPt~~~l~~~l~~l~~ 278 (407)
||+.+|++||++.+|.+.|++++.
T Consensus 312 cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 312 CWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=324.36 Aligned_cols=242 Identities=21% Similarity=0.267 Sum_probs=194.6
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
.|++.+.||+|+||.||++.+..+++.||+|.+..... ...+..|+.+++.++| +++..+...+...+..+++|
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~-~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNS-RFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCC-CCeeeeeEEEecCCEEEEEE
Confidence 47889999999999999999999999999998764321 1236679999999987 45555566666777899999
Q ss_pred ecc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 83 DLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 83 e~~-g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
||+ +++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||++ +..+.++|+|||++.......
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeccceeecCCCc
Confidence 999 899999886433 358999999999999999999999999999999999999 577889999999997654322
Q ss_pred CCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHH
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (407)
. .....|+..|+|||++.+..++.++|||||||++|+|++|..||.................. .....
T Consensus 157 ~--------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~----~~~~~ 224 (285)
T cd05630 157 T--------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE----VQEEY 224 (285)
T ss_pred c--------ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh----hhhhc
Confidence 1 12347899999999999999999999999999999999999999864432222222222111 11123
Q ss_pred hcCCcHHHHHHHHHHhCCCCCCCCC
Q 015406 241 CRGYPTEFASYFHYCRSLRFDDKPD 265 (407)
Q Consensus 241 ~~~~~~~l~~li~~cl~~~p~~RPt 265 (407)
...+++++.+|+.+||+.||++||+
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~R~s 249 (285)
T cd05630 225 SEKFSPDARSLCKMLLCKDPKERLG 249 (285)
T ss_pred CccCCHHHHHHHHHHhhcCHHHccC
Confidence 4568899999999999999999999
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=322.73 Aligned_cols=252 Identities=22% Similarity=0.288 Sum_probs=200.4
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeC----ceeEEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEG----DYNVLVM 82 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~----~~~~lvm 82 (407)
-.|+-.+++|+|+||.||+|....+++.||||..-.+.. --.+|.++|+.+.|+|.+..++.|.... -+..+||
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r--~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR--YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC--cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 358889999999999999999999999999997654433 3357999999888855555555554422 2456999
Q ss_pred eccCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 83 DLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 83 e~~g~sL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
||+..+|.++++. .+.+++...+.-+..||.+||.|||+.||+||||||+|+|++ .+.+.+||||||.|+.+...
T Consensus 102 eymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD--~~tg~LKicDFGSAK~L~~~ 179 (364)
T KOG0658|consen 102 EYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVD--PDTGVLKICDFGSAKVLVKG 179 (364)
T ss_pred HhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEc--CCCCeEEeccCCcceeeccC
Confidence 9999999999984 256799999999999999999999999999999999999995 45699999999999988765
Q ss_pred CCCcccCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccH-
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI- 237 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~- 237 (407)
.. ..+...|..|.|||.+.| ..|+.+.||||.|||+.||+-|++-|.+.+..+....+-++....-...+
T Consensus 180 ep--------niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 180 EP--------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIK 251 (364)
T ss_pred CC--------ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence 54 346678999999999987 46899999999999999999999999986554333333222211100000
Q ss_pred --------------------HHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015406 238 --------------------EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 238 --------------------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
.-+....+++..+|+.++|..+|.+|.++.++.
T Consensus 252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l 304 (364)
T KOG0658|consen 252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEAL 304 (364)
T ss_pred hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHh
Confidence 113355789999999999999999999987765
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=320.18 Aligned_cols=255 Identities=20% Similarity=0.350 Sum_probs=207.2
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEec
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~ 84 (407)
..+|.+.++||+|+||.||+|.+..+++.||+|.+..... ...+.+|+++++.++| +++..+..++......+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH-PNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCC-CChhheEEEEcCCCCcEEEEEe
Confidence 4569999999999999999999999999999998764432 2457889999999987 5566666666677788999999
Q ss_pred c-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 85 L-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 85 ~-g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
+ +++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+|||+ ++++.+||+|||++.........
T Consensus 84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCcEEeCCCccccccccceee
Confidence 9 899999997533 458999999999999999999999999999999999999 57889999999999876543221
Q ss_pred cccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHHh
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (407)
......++..|+|||.+.+..++.++|||||||++|||++ |..||.+... .+....+..... ....
T Consensus 161 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~---~~~~~~~~~~~~----~~~~ 227 (263)
T cd05052 161 ------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYELLEKGYR----MERP 227 (263)
T ss_pred ------ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHCCCC----CCCC
Confidence 1122334678999999999899999999999999999998 9999976433 233333322111 1234
Q ss_pred cCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHH
Q 015406 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (407)
Q Consensus 242 ~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~ 277 (407)
..+|.++.+++.+||..+|++||++.++.+.|+.++
T Consensus 228 ~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 263 (263)
T cd05052 228 EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF 263 (263)
T ss_pred CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence 568899999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=330.87 Aligned_cols=250 Identities=19% Similarity=0.279 Sum_probs=219.1
Q ss_pred CccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc----chHHHHHHHHHHHcCCCCCCeeEEeeeeCcee
Q 015406 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (407)
Q Consensus 3 ~~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 78 (407)
-.|.+-|.+.+.||+|.|..|-+|++.-+|+.||||++.+.... ..+..|++.|+.++| ++|+.++.+.......
T Consensus 14 gkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQH-pNiVRLYEViDTQTKl 92 (864)
T KOG4717|consen 14 GKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQH-PNIVRLYEVIDTQTKL 92 (864)
T ss_pred cceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcC-cCeeeeeehhcccceE
Confidence 35778899999999999999999999999999999998765432 358899999999987 7777787887888889
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeec
Q 015406 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~ 157 (407)
||++|+- +|+|.+||-++...+.++.+.+++.||+.|+.|+|...+|||||||+||.+- .+-|.+||+|||++..+.
T Consensus 93 yLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF--EKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 93 YLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF--EKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred EEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe--eecCceEeeeccccccCC
Confidence 9999999 8899999998888899999999999999999999999999999999999885 678999999999998876
Q ss_pred cCCCCcccCccCCCCccccccccccccccCCCCC-hhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhccccc
Q 015406 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQS-RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (407)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (407)
.... ..+.+|+..|-|||++.|..|+ +++||||||||||-|++|++||+..++ .+.+..|...+...
T Consensus 171 PG~k--------L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND---SETLTmImDCKYtv- 238 (864)
T KOG4717|consen 171 PGKK--------LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND---SETLTMIMDCKYTV- 238 (864)
T ss_pred Ccch--------hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc---hhhhhhhhcccccC-
Confidence 6543 5688999999999999999995 788999999999999999999987554 45566666666542
Q ss_pred HHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 237 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
+..++.++++||..||..||.+|.+.++|..
T Consensus 239 ----PshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 239 ----PSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred ----chhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 3457899999999999999999999888753
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=336.28 Aligned_cols=252 Identities=21% Similarity=0.298 Sum_probs=202.1
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc----chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
+..|+++++||+||.+.||++.. ...+.||+|.+...... ..+..|+.+|.+|+++..|..+++|...+++.|||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 56799999999999999999996 44456677754433222 34889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCC
Q 015406 82 MDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 82 me~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~ 161 (407)
|||-..+|.++|+.....++.-.++.+..||+.|+.++|.+||||.||||.|+|| -.|.+||+|||+|..+..+.+
T Consensus 439 mE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl----VkG~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 439 MECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL----VKGRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred eecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE----EeeeEEeeeechhcccCcccc
Confidence 9999999999999755556655899999999999999999999999999999999 789999999999998877665
Q ss_pred CcccCccCCCCccccccccccccccCCC-----------CChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhh
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHLGIE-----------QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-----------~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~ 230 (407)
... ....+||+.||+||.+.... .++++||||||||||+|+.|+.||.... ....++..|..
T Consensus 515 sI~-----kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~aI~~ 587 (677)
T KOG0596|consen 515 SIV-----KDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLHAITD 587 (677)
T ss_pred cee-----eccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHHhhcC
Confidence 432 34678999999999987533 4578999999999999999999997532 12344444444
Q ss_pred hcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 231 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.......+.+.. +.++.+++..||.+||++||+..+|++
T Consensus 588 P~~~Iefp~~~~--~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 588 PNHEIEFPDIPE--NDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred CCccccccCCCC--chHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 322222222221 234999999999999999999776653
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=323.53 Aligned_cols=242 Identities=22% Similarity=0.215 Sum_probs=197.1
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEecCCCCc-----chHHHHHHHHHHHcCCCCCCeeEEeeee----CceeEEEEe
Q 015406 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKLYRILQGGTGIPNVRWFGVE----GDYNVLVMD 83 (407)
Q Consensus 13 ~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~~~~~~~~----~~~~~lvme 83 (407)
..||+|++|.||+|.+ +|+.||||.+...... +.+.+|+.++++++|+ +++.+.+++.+ ....+++||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSN-NILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCC-CEEEEeeeEEecccCCCceEEEEE
Confidence 5789999999999995 7899999988654322 3466999999999985 66666555544 457899999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCC
Q 015406 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 84 ~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~ 161 (407)
|+ +++|.+++.. .+.+++...+.++.|++.||.|||+ .+++||||||+|||+ ++++.+||+|||+++......
T Consensus 103 y~~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill---~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 103 YCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV---TENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred eCCCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEE---CCCCcEEEcccchHhhhcccc-
Confidence 99 9999999986 4579999999999999999999998 499999999999999 578899999999998654322
Q ss_pred CcccCccCCCCccccccccccccccC--CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHH
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (407)
....|+..|+|||++.+ ..++.++|||||||++|||++|..||.+.+. .+.+..+........
T Consensus 178 ---------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~---~~~~~~i~~~~~~~~--- 242 (283)
T PHA02988 178 ---------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT---KEIYDLIINKNNSLK--- 242 (283)
T ss_pred ---------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhcCCCCC---
Confidence 23468899999999976 6789999999999999999999999987543 344444433222211
Q ss_pred HhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHH
Q 015406 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (407)
Q Consensus 240 ~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~ 277 (407)
+...+|+++.+++.+||+.||++||++.++.+.|+.+.
T Consensus 243 ~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 243 LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 22357899999999999999999999999999998763
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=303.30 Aligned_cols=245 Identities=22% Similarity=0.290 Sum_probs=211.5
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCC-----CCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeE
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 79 (407)
-.++|++++.||+|-||.||+|+.+.++-.||+|++.++ ....++.+|++|...|+| +||..++.++.+....|
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~h-pnilrlY~~fhd~~riy 98 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRH-PNILRLYGYFHDSKRIY 98 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCC-ccHHhhhhheeccceeE
Confidence 357899999999999999999999999999999986543 234568899999999987 67777888888889999
Q ss_pred EEEecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeec
Q 015406 80 LVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (407)
Q Consensus 80 lvme~~-g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~ 157 (407)
|++||. +|+|...+... ..++++..+..++.|++.||.|+|.+++|||||||+|+|+ +..+.+||+|||.+....
T Consensus 99 LilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLl---g~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhcc---CCCCCeeccCCCceeecC
Confidence 999999 88988888732 3569999999999999999999999999999999999999 588999999999997654
Q ss_pred cCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccH
Q 015406 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (407)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (407)
.. ...+.+||..|.+||+..+..++..+|+|++|++.||++.|..||.... ..+.|.+|.......
T Consensus 176 ~~---------kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~---~~etYkrI~k~~~~~-- 241 (281)
T KOG0580|consen 176 SN---------KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS---HSETYKRIRKVDLKF-- 241 (281)
T ss_pred CC---------CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh---hHHHHHHHHHccccC--
Confidence 22 2458899999999999999999999999999999999999999998754 466777776655442
Q ss_pred HHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015406 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 238 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
+..++.+.+++|.+|+..+|.+|....++.
T Consensus 242 ---p~~is~~a~dlI~~ll~~~p~~r~~l~~v~ 271 (281)
T KOG0580|consen 242 ---PSTISGGAADLISRLLVKNPIERLALTEVM 271 (281)
T ss_pred ---CcccChhHHHHHHHHhccCccccccHHHHh
Confidence 256899999999999999999999955543
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=335.90 Aligned_cols=246 Identities=21% Similarity=0.263 Sum_probs=194.9
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
.++|+++++||+|+||.||+|++..+++.||||++..... ...+.+|+++++.++| +++..+..++...+..++||
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~ 151 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNH-PNVVKCHDMFDHNGEIQVLL 151 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCC-CCcceeeeEeccCCeEEEEE
Confidence 3578999999999999999999999999999998854332 2357889999999986 66666777777888899999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCC
Q 015406 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 83 e~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~ 161 (407)
||+ +++|.+. ...++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.+.....
T Consensus 152 e~~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 152 EFMDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLI---NSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred ecCCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEcccccceecccccc
Confidence 999 8888643 245778889999999999999999999999999999999 5788999999999987654321
Q ss_pred CcccCccCCCCccccccccccccccC-----CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhccccc
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHLG-----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (407)
......||..|+|||++.. ...+.++|||||||++|||++|+.||......+.......+.....
T Consensus 224 -------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--- 293 (353)
T PLN00034 224 -------PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP--- 293 (353)
T ss_pred -------cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCC---
Confidence 1234579999999998743 2345789999999999999999999975433333333332222111
Q ss_pred HHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 237 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
......++.++.+||.+||..||++||++.++++
T Consensus 294 -~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 294 -PEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred -CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1223457899999999999999999999887764
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=323.95 Aligned_cols=257 Identities=19% Similarity=0.263 Sum_probs=206.3
Q ss_pred CceeEeccccccCceEEEEEEEcCCCe--EEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNE--EVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~--~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
++|++.+.||+|+||.||+|.+..++. .+++|.++.... ...+..|+.++.++.+|+++..+..++......+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 579999999999999999999877664 478887653221 235788999999997678888888888888889999
Q ss_pred Eecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceE
Q 015406 82 MDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 145 (407)
Q Consensus 82 me~~-g~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~ 145 (407)
|||+ +++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV---GENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEE---CCCCeE
Confidence 9999 899999997532 248899999999999999999999999999999999999 578899
Q ss_pred EEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHH
Q 015406 146 YIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQK 224 (407)
Q Consensus 146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~ 224 (407)
||+|||++........ ......+..|+|||++.+..++.++|||||||++|||++ |..||..... .+.
T Consensus 159 kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~---~~~ 227 (297)
T cd05089 159 KIADFGLSRGEEVYVK--------KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC---AEL 227 (297)
T ss_pred EECCcCCCccccceec--------cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHH
Confidence 9999999864322111 112233567999999999889999999999999999997 9999976443 333
Q ss_pred HHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcC
Q 015406 225 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREG 281 (407)
Q Consensus 225 ~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~ 281 (407)
+..+...... .....++.++.+++.+||..+|.+||+++++.+.|..++....
T Consensus 228 ~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 228 YEKLPQGYRM----EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred HHHHhcCCCC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 3333322111 1224578999999999999999999999999999998887554
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=342.87 Aligned_cols=248 Identities=19% Similarity=0.210 Sum_probs=203.3
Q ss_pred CceeEeccccccCceEEEEEEEcCC-CeEEEEEEecCCCCc--chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQT-NEEVAIKLENVKTKH--PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~-~~~vAvK~~~~~~~~--~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
..|.+.+.||+|+||.||+|.+..+ ++.||+|.+...... ..+..|+.+++.++| ++++.+..++...+..|||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~H-pniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDH-FGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCC-CCEeEEEEEEEECCEEEEEEE
Confidence 4499999999999999999998877 788999976543322 236679999999876 667777777888889999999
Q ss_pred cc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 84 LL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 84 ~~-g~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
|+ +++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+...
T Consensus 146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll---~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL---MPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEE---CCCCcEEEEeCcCceecCCc
Confidence 99 99999988532 3458999999999999999999999999999999999999 57889999999999876543
Q ss_pred CCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHH
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (407)
... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ..+.+..+...... .
T Consensus 223 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~---~~~~~~~~~~~~~~----~ 290 (478)
T PTZ00267 223 VSL-----DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS---QREIMQQVLYGKYD----P 290 (478)
T ss_pred ccc-----ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCC----C
Confidence 221 11345679999999999999999999999999999999999999997643 23444444433322 1
Q ss_pred HhcCCcHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015406 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 240 ~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
+...++.++.++|.+||..+|++||++.++.
T Consensus 291 ~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l 321 (478)
T PTZ00267 291 FPCPVSSGMKALLDPLLSKNPALRPTTQQLL 321 (478)
T ss_pred CCccCCHHHHHHHHHHhccChhhCcCHHHHH
Confidence 2345789999999999999999999998875
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=336.23 Aligned_cols=251 Identities=21% Similarity=0.273 Sum_probs=198.5
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeE
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 79 (407)
..++|++.+.||+|+||.||+|++..+++.||+|++.... ....+..|+.+++.+.| +++..+..++..+...|
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~h-p~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS-PWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCC-CCEeeEEEEEEcCCEEE
Confidence 3578999999999999999999999999999999875421 22346678888888776 66777777778888999
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 80 lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
+||||+ +++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|.....
T Consensus 120 lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl---~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 120 MVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEEecccceeccc
Confidence 999999 9999999974 468999999999999999999999999999999999999 6889999999999987643
Q ss_pred CCCCcccCccCCCCccccccccccccccCCC----CChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhccc
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIE----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (407)
... .......||+.|+|||++.+.. ++.++|||||||+||||++|..||.... ....+..+......
T Consensus 195 ~~~------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~---~~~~~~~i~~~~~~ 265 (370)
T cd05621 195 TGM------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS---LVGTYSKIMDHKNS 265 (370)
T ss_pred CCc------eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCcc
Confidence 321 1123567999999999997643 7889999999999999999999997643 34445555432211
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhCCCCCC--CCCHHHHHH
Q 015406 235 TSIEALCRGYPTEFASYFHYCRSLRFDD--KPDYAYLKR 271 (407)
Q Consensus 235 ~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~~l~~ 271 (407)
...+. ...++..+.+++..||..++.. |+++.++++
T Consensus 266 ~~~p~-~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~ 303 (370)
T cd05621 266 LNFPE-DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ 303 (370)
T ss_pred cCCCC-cccCCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence 11110 1246889999999999855443 778666544
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=349.58 Aligned_cols=258 Identities=23% Similarity=0.339 Sum_probs=219.5
Q ss_pred CceeEeccccccCceEEEEEEEcC-----CCeEEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeeeCcee
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~-----~~~~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 78 (407)
.+.++.+.||+|.||+||+|+... ....||||.++.+... .+|.+|++++..|+| ++|+.+.+.+.+++..
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H-~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQH-PNIVRLLGVCREGDPL 564 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccC-CCeEEEEEEEccCCee
Confidence 456778999999999999998542 3457999988766543 569999999999997 7888888999999999
Q ss_pred EEEEecc-CCCHHHHHHHcC---------CC----CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCce
Q 015406 79 VLVMDLL-GPSLEDLFNFCS---------RK----LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ 144 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~~~---------~~----l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~ 144 (407)
|||+||+ .|+|.++|.... .. |+..+.+.|+.|||.|++||-++.+|||||-.+|+|| .++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV---ge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV---GENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee---ccceE
Confidence 9999999 999999997542 12 8889999999999999999999999999999999999 58899
Q ss_pred EEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHH
Q 015406 145 VYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQ 223 (407)
Q Consensus 145 ~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~ 223 (407)
|||+|||+++..-..++ |+-.....-..+||+||.+....++.+||||||||+|||+++ |+.||.+... .+
T Consensus 642 VKIsDfGLsRdiYssDY-----Yk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn---~E 713 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDY-----YKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN---QE 713 (774)
T ss_pred EEecccccchhhhhhhh-----hcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch---HH
Confidence 99999999997766555 222334445789999999999999999999999999999999 9999999766 45
Q ss_pred HHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHc
Q 015406 224 KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (407)
Q Consensus 224 ~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~ 280 (407)
.++.+..+... ..+.++|.++++||..||+.+|.+||+|.+|...|++.....
T Consensus 714 VIe~i~~g~lL----~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 714 VIECIRAGQLL----SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred HHHHHHcCCcc----cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 66666665542 234679999999999999999999999999999999876543
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=333.42 Aligned_cols=250 Identities=20% Similarity=0.258 Sum_probs=194.8
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC----CcchHHHHHHHHHHHcCCCCCCeeEEeee-----eC
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGV-----EG 75 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~-----~~ 75 (407)
+.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.++|++.+..+..+.. ..
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 5689999999999999999999999999999999886432 22357789999999987655555444322 23
Q ss_pred ceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceee
Q 015406 76 DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (407)
Q Consensus 76 ~~~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~ 155 (407)
...|+||||++++|.+++.. .+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 102 ~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 102 QDVYIVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLART 175 (364)
T ss_pred CeEEEEEeCCCCCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEE---CCCCcEEEEeCCCccc
Confidence 45799999998899888763 58899999999999999999999999999999999999 5788999999999986
Q ss_pred eccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccc
Q 015406 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (407)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (407)
...... .....||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+. ...+.++......+
T Consensus 176 ~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~~~~~~~~~ 244 (364)
T cd07875 176 AGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH---IDQWNKVIEQLGTP 244 (364)
T ss_pred cCCCCc--------ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCC
Confidence 543221 2345789999999999999999999999999999999999999976443 22222221110000
Q ss_pred c-------------------------HH------------HHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 236 S-------------------------IE------------ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 236 ~-------------------------~~------------~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
. .. ......+.++.++|.+||..||++|||+.++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 245 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred CHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0 00 001112467899999999999999999877653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=317.73 Aligned_cols=247 Identities=20% Similarity=0.317 Sum_probs=201.6
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~- 85 (407)
.+|++.+.||+|+||.||++.. .+..||+|..........+..|+.+++.++|.+.+..+..+.......+++|||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence 5799999999999999999984 4788999998766555678899999999988655555544555667789999999
Q ss_pred CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcc
Q 015406 86 GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164 (407)
Q Consensus 86 g~sL~~~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~ 164 (407)
+++|.+++..... .+++..++.++.||+.||+|||++||+||||||+||++ ++++.+||+|||+++......
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~---- 156 (256)
T cd05082 84 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQ---- 156 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEE---cCCCcEEecCCccceeccccC----
Confidence 8899999975433 48899999999999999999999999999999999999 578899999999998654322
Q ss_pred cCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcC
Q 015406 165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243 (407)
Q Consensus 165 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (407)
....++..|+|||++.+..++.++|||||||++|||++ |+.||..... .+....+..... ......
T Consensus 157 ------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~~~~~~----~~~~~~ 223 (256)
T cd05082 157 ------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRVEKGYK----MDAPDG 223 (256)
T ss_pred ------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHhcCCC----CCCCCC
Confidence 12344678999999999889999999999999999998 9999975432 233333322211 122356
Q ss_pred CcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 015406 244 YPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 275 (407)
Q Consensus 244 ~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~ 275 (407)
+|+.+.+++.+||..+|++||++.++.+.|++
T Consensus 224 ~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 224 CPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 88999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=328.32 Aligned_cols=286 Identities=21% Similarity=0.237 Sum_probs=232.4
Q ss_pred CCccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCC-----CCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCc
Q 015406 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGD 76 (407)
Q Consensus 2 ~~~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 76 (407)
+|.--+.|+.-++||+||||+||-++.+.||+-||+|.+.++ ....-.+.|..++.+++. +.|+.+.+.++..+
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s-~FiVslaYAfeTkd 258 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSS-PFIVSLAYAFETKD 258 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhcc-CcEEEEeeeecCCC
Confidence 466678899999999999999999999999999999966543 233347789999999886 58888888899999
Q ss_pred eeEEEEecc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEecccee
Q 015406 77 YNVLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (407)
Q Consensus 77 ~~~lvme~~-g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~ 154 (407)
..++||..| ||+|.-.|.+.+ ..|++..++.++.+|+.||++||+.+||+|||||+|||+ |+.|+++|+|+|+|.
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILL---Dd~GhvRISDLGLAv 335 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILL---DDHGHVRISDLGLAV 335 (591)
T ss_pred ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheee---ccCCCeEeeccceEE
Confidence 999999999 999988886544 359999999999999999999999999999999999999 799999999999999
Q ss_pred eeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhccc
Q 015406 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (407)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (407)
.+..... ....+||.+|||||++.+..|+...|+|||||+||||+.|+.||......... +.+.... .
T Consensus 336 ei~~g~~--------~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~---eEvdrr~-~ 403 (591)
T KOG0986|consen 336 EIPEGKP--------IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR---EEVDRRT-L 403 (591)
T ss_pred ecCCCCc--------cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH---HHHHHHH-h
Confidence 8877554 23558999999999999999999999999999999999999999764443222 2222222 2
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchhhcccccCCCCccC
Q 015406 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATPPARAL 308 (407)
Q Consensus 235 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~~~~~~~~~~~~~~ 308 (407)
.....+...++++.++|.+..|..||.+|.....- ..-.-..++++..++|..+......++..|.+..
T Consensus 404 ~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~-----ga~evk~HpfFk~lnw~rleagml~PPfiPdp~a 472 (591)
T KOG0986|consen 404 EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGE-----GAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDPGA 472 (591)
T ss_pred cchhhcccccCHHHHHHHHHHHccCHHHhccCCCc-----CcchhhhCcccccCCHhHHhccCCCCCCCCCccc
Confidence 33445667899999999999999999999763211 1111223578888999988887766665555443
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=332.60 Aligned_cols=250 Identities=20% Similarity=0.239 Sum_probs=194.1
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC----cchHHHHHHHHHHHcCCCCCCeeEEeee-----eC
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGV-----EG 75 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~-----~~ 75 (407)
+.++|++.+.||+|+||.||+|.+..+++.||||.+..... ...+.+|+.+++.++|++.+..+..+.. ..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 56899999999999999999999999999999998764322 2346789999999987555555444432 22
Q ss_pred ceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceee
Q 015406 76 DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (407)
Q Consensus 76 ~~~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~ 155 (407)
...|++|||++++|.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 95 ~~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill---~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 95 QDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLART 168 (355)
T ss_pred ceeEEEhhhhcccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---CCCCCEEEeeCccccc
Confidence 35799999998888887763 58999999999999999999999999999999999999 5788999999999986
Q ss_pred eccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccc
Q 015406 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (407)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (407)
...... .....||..|+|||++.+..++.++|||||||++|+|++|+.||.+.... ..+..+.......
T Consensus 169 ~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~~~~~~~~~ 237 (355)
T cd07874 169 AGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI---DQWNKVIEQLGTP 237 (355)
T ss_pred CCCccc--------cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCC
Confidence 543221 23457899999999999999999999999999999999999999764321 1111111100000
Q ss_pred -------------------------------------cHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 236 -------------------------------------SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 236 -------------------------------------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.........+.++.++|.+||..||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~ 310 (355)
T cd07874 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310 (355)
T ss_pred CHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence 000011123567899999999999999999877764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=334.47 Aligned_cols=248 Identities=21% Similarity=0.290 Sum_probs=197.0
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+..|+.+++.+.| ++++.+...+..+...|+
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~h-p~iv~~~~~~~~~~~~~l 120 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS-PWVVQLFYAFQDDRYLYM 120 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCC-CCCCeEEEEEEcCCEEEE
Confidence 578999999999999999999999999999999875421 12236678888887765 667777777788889999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 81 vme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
||||+ +++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 121 v~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll---~~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 121 VMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred EEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE---CCCCCEEEEeCCceeEcCcC
Confidence 99999 8999999974 468999999999999999999999999999999999999 57889999999999876533
Q ss_pred CCCcccCccCCCCccccccccccccccCCC----CChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccc
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLGIE----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (407)
.. .......||+.|+|||++.+.. ++.++|||||||+||||++|..||...+ ....+.++.......
T Consensus 196 ~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~---~~~~~~~i~~~~~~~ 266 (371)
T cd05622 196 GM------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS---LVGTYSKIMNHKNSL 266 (371)
T ss_pred Cc------ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCcc
Confidence 21 1123567999999999997643 7899999999999999999999997633 344555554432111
Q ss_pred cHHHHhcCCcHHHHHHHHHHhCCCCCC---CCCHHHHH
Q 015406 236 SIEALCRGYPTEFASYFHYCRSLRFDD---KPDYAYLK 270 (407)
Q Consensus 236 ~~~~~~~~~~~~l~~li~~cl~~~p~~---RPt~~~l~ 270 (407)
..+ ....++.++.++|..||. +|.. |+++++++
T Consensus 267 ~~~-~~~~~s~~~~~li~~~L~-~~~~r~~r~~~~ei~ 302 (371)
T cd05622 267 TFP-DDNDISKEAKNLICAFLT-DREVRLGRNGVEEIK 302 (371)
T ss_pred cCC-CcCCCCHHHHHHHHHHcC-ChhhhcCCCCHHHHh
Confidence 111 123578999999999998 5555 55655444
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=327.17 Aligned_cols=257 Identities=21% Similarity=0.281 Sum_probs=201.9
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCe----EEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCce
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNE----EVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~----~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 77 (407)
-..+|++.+.||+|+||.||+|++..+++ .||+|+++.... ...+..|+.+++.+.|+ ++..+.+++... .
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~-niv~~~g~~~~~-~ 82 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP-HVCRLLGICLTS-T 82 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCC-CCCeEEEEEcCC-C
Confidence 35689999999999999999999766655 489998764332 24577899999999875 455555555443 4
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeee
Q 015406 78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~ 156 (407)
.++++||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.+
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill---~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLV---KTPQHVKITDFGLAKLL 159 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEe---cCCCcEEEccccccccc
Confidence 57899999 999999998766678999999999999999999999999999999999999 57789999999999876
Q ss_pred ccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccc
Q 015406 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVST 235 (407)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (407)
....... ......++..|+|||++.+..++.++|||||||++|||++ |..||.+.... +.. .+.......
T Consensus 160 ~~~~~~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~---~~~-~~~~~~~~~ 230 (316)
T cd05108 160 GADEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EIS-SILEKGERL 230 (316)
T ss_pred cCCCcce-----eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHH-HHHhCCCCC
Confidence 5433211 1122334678999999999999999999999999999998 99999764332 222 222221111
Q ss_pred cHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Q 015406 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (407)
Q Consensus 236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~ 278 (407)
. ....++.++.+++.+||..+|++||++.++...|.++..
T Consensus 231 ~---~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 231 P---QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred C---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 1 124478899999999999999999999999999888754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=319.02 Aligned_cols=261 Identities=20% Similarity=0.269 Sum_probs=204.9
Q ss_pred CCCccCCceeEeccccccCceEEEEEEEcCCCe----EEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeee
Q 015406 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNE----EVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGV 73 (407)
Q Consensus 1 m~~~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~----~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~ 73 (407)
|+-...++|++.++||+|+||.||+|++..+++ .||+|++..... ...+..|+.++..+.| +++..+..++.
T Consensus 1 ~~~l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~ 79 (279)
T cd05109 1 MRILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS-PYVCRLLGICL 79 (279)
T ss_pred CcccchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCC-CCCceEEEEEc
Confidence 566678899999999999999999999877766 489998765432 2346778888888876 55555555554
Q ss_pred eCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccc
Q 015406 74 EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 152 (407)
Q Consensus 74 ~~~~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGl 152 (407)
. ...+++|||+ +++|.+++......+++..++.++.||+.||.|||+++|+||||||+|||+ ++++.+||+|||+
T Consensus 80 ~-~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~---~~~~~~kL~dfG~ 155 (279)
T cd05109 80 T-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLV---KSPNHVKITDFGL 155 (279)
T ss_pred C-CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE---cCCCcEEECCCCc
Confidence 3 3467899999 899999998655679999999999999999999999999999999999999 5778899999999
Q ss_pred eeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhh
Q 015406 153 AKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEK 231 (407)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~ 231 (407)
++.......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||...... .....+...
T Consensus 156 ~~~~~~~~~~~~-----~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~~~ 227 (279)
T cd05109 156 ARLLDIDETEYH-----ADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR---EIPDLLEKG 227 (279)
T ss_pred eeecccccceee-----cCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHHCC
Confidence 987654322110 112345678999999998899999999999999999998 99999764432 222222222
Q ss_pred cccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Q 015406 232 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (407)
Q Consensus 232 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~ 278 (407)
.... ....++.++.+++.+||..||++||++.++.+.|+++..
T Consensus 228 ~~~~----~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 228 ERLP----QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred CcCC----CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1111 124578999999999999999999999999988877643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=321.11 Aligned_cols=253 Identities=23% Similarity=0.344 Sum_probs=204.7
Q ss_pred CCceeEeccccccCceEEEEEEEcC-----CCeEEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeeeCce
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~-----~~~~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 77 (407)
.++|.+.+.||+|+||.||+|.+.. +++.||||.+...... ..+.+|+++++.+.| +++..+..++.....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~ 82 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQH-ENIVKFYGVCTEGDP 82 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCC-CCchheeeEEecCCC
Confidence 4679999999999999999998743 3578999988654433 468899999999987 566667777777788
Q ss_pred eEEEEecc-CCCHHHHHHHcC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCc
Q 015406 78 NVLVMDLL-GPSLEDLFNFCS-------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN 143 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~~~~-------------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~ 143 (407)
.+++|||+ +++|.+++...+ ..+++..+..++.|++.||.|||++|++||||||+||++ +.++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili---~~~~ 159 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLV---GYDL 159 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEE---cCCC
Confidence 99999999 999999997532 347889999999999999999999999999999999999 5789
Q ss_pred eEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchH
Q 015406 144 QVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKK 222 (407)
Q Consensus 144 ~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~ 222 (407)
.++|+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||..... .
T Consensus 160 ~~kl~d~g~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~---~ 231 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYY-----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN---E 231 (280)
T ss_pred eEEECCcccceecccCcce-----ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH---H
Confidence 9999999999865432211 11223456788999999999999999999999999999998 9999976543 3
Q ss_pred HHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015406 223 QKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 274 (407)
Q Consensus 223 ~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~ 274 (407)
.....+....... ....++.++.+++.+||..||++||++.++++.|+
T Consensus 232 ~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 232 EVIECITQGRLLQ----RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHHHHcCCcCC----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 3334333332221 22457899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=332.36 Aligned_cols=253 Identities=20% Similarity=0.312 Sum_probs=196.3
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC----cchHHHHHHHHHHHcCCCCCCeeEEeee-----e
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGV-----E 74 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~-----~ 74 (407)
.+.++|++.+.||+|+||.||+|.+..+++.||||.+..... ...+.+|+.+++.++|++.+..+..+.. .
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 467899999999999999999999999999999998764321 2346789999999988555444433321 2
Q ss_pred CceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEecccee
Q 015406 75 GDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (407)
Q Consensus 75 ~~~~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~ 154 (407)
....|++|++++++|.+++. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 92 ~~~~~~~~~~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~~~ 166 (343)
T cd07878 92 FNEVYLVTNLMGADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAV---NEDCELRILDFGLAR 166 (343)
T ss_pred cCcEEEEeecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEE---CCCCCEEEcCCccce
Confidence 24569999999999999886 3579999999999999999999999999999999999999 578899999999998
Q ss_pred eeccCCCCcccCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhc-
Q 015406 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK- 232 (407)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~- 232 (407)
...... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.......
T Consensus 167 ~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (343)
T cd07878 167 QADDEM----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPS 236 (343)
T ss_pred ecCCCc----------CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 654321 24578999999999987 568999999999999999999999997643321111111110000
Q ss_pred ----------------------ccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 233 ----------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 233 ----------------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
..........+.++.+.+|+.+||..||++||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 237 PEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 001111223456778899999999999999999877764
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=334.40 Aligned_cols=254 Identities=16% Similarity=0.186 Sum_probs=200.8
Q ss_pred cCCceeEeccccccCceEEEEEEEc--CCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNI--QTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~--~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
+..+|++++.||+|+||.||+|... .+++.||+|.+... ....+|+++++.++| ++++.+..++......|++|
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~---~~~~~E~~il~~l~h-~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---KTPGREIDILKTISH-RAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc---ccHHHHHHHHHhcCC-CCccceeeeEeeCCEEEEEe
Confidence 4567999999999999999999754 35678999987543 346789999999987 55556666666778889999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 83 e~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
|+++++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||+ +..+.++|+|||+++........
T Consensus 166 e~~~~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill---~~~~~~~l~DfG~a~~~~~~~~~ 241 (392)
T PHA03207 166 PKYKCDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFL---DEPENAVLGDFGAACKLDAHPDT 241 (392)
T ss_pred hhcCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---cCCCCEEEccCccccccCccccc
Confidence 9998899999854 5679999999999999999999999999999999999999 67889999999999866543321
Q ss_pred cccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhccc--------
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS-------- 234 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-------- 234 (407)
.......||+.|+|||++.+..++.++|||||||+||||++|..||.+.........+..+......
T Consensus 242 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~ 316 (392)
T PHA03207 242 -----PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN 316 (392)
T ss_pred -----ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence 1123567999999999999999999999999999999999999999876544333333332221100
Q ss_pred -------------------ccHHHH--hcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 235 -------------------TSIEAL--CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 235 -------------------~~~~~~--~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
...+.. ...++.++.++|.+||..||++||++.+++.
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374 (392)
T ss_pred cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence 000000 1245778999999999999999999888765
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=335.85 Aligned_cols=242 Identities=23% Similarity=0.319 Sum_probs=206.7
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
.|.-++.||.|+||.||.|++..+.+.||||.++.... ..+++.|+..|+.|.| ++...+.+++......||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~H-PntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRH-PNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccC-CCcccccceeeccchHHHHH
Confidence 36667899999999999999999999999998876543 3568999999999998 66667778888888889999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 83 e~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
|||-||-.|++.-+++++.+.++..|..+.+.||.|||+++.||||||..|||+ .+.+.|||+|||.|.....
T Consensus 106 EYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILL---se~g~VKLaDFGSAsi~~P---- 178 (948)
T KOG0577|consen 106 EYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILL---SEPGLVKLADFGSASIMAP---- 178 (948)
T ss_pred HHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEe---cCCCeeeeccccchhhcCc----
Confidence 999999999998878899999999999999999999999999999999999999 5899999999999976543
Q ss_pred cccCccCCCCcccccccccccccc---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHH
Q 015406 163 QHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (407)
..+++|||.|||||++. .+.|+-++||||||++..||..+++|+..+++.+ .+..|.....++..
T Consensus 179 -------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS---ALYHIAQNesPtLq-- 246 (948)
T KOG0577|consen 179 -------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALYHIAQNESPTLQ-- 246 (948)
T ss_pred -------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH---HHHHHHhcCCCCCC--
Confidence 45789999999999986 4579999999999999999999999998877643 23334333333222
Q ss_pred HhcCCcHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015406 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 240 ~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
....+..|..++..||.+-|.+|||.+++.
T Consensus 247 -s~eWS~~F~~Fvd~CLqKipqeRptse~ll 276 (948)
T KOG0577|consen 247 -SNEWSDYFRNFVDSCLQKIPQERPTSEELL 276 (948)
T ss_pred -CchhHHHHHHHHHHHHhhCcccCCcHHHHh
Confidence 234688999999999999999999988765
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=336.50 Aligned_cols=237 Identities=21% Similarity=0.335 Sum_probs=196.8
Q ss_pred eccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-CCCHH
Q 015406 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLE 90 (407)
Q Consensus 12 ~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~-g~sL~ 90 (407)
++-||+|+.|.||+|+ -.++.||||.++. .-..+++-|++|+| ++|..+.+++.....+||+|||| .|-|.
T Consensus 129 LeWlGSGaQGAVF~Gr--l~netVAVKKV~e-----lkETdIKHLRkLkH-~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGR--LHNETVAVKKVRE-----LKETDIKHLRKLKH-PNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhccCcccceeeee--ccCceehhHHHhh-----hhhhhHHHHHhccC-cceeeEeeeecCCceeEEeeeccccccHH
Confidence 5679999999999999 5688999996432 22456788899997 56666777778888899999999 99999
Q ss_pred HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcccCccCC
Q 015406 91 DLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170 (407)
Q Consensus 91 ~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~ 170 (407)
.+|+. ++.+.......|..+||.|+.|||.+.|||||||.-||||+ .+..|||+|||.++...+..+ .
T Consensus 201 ~VLka-~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs---~~d~VKIsDFGTS~e~~~~ST--------k 268 (904)
T KOG4721|consen 201 EVLKA-GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILIS---YDDVVKISDFGTSKELSDKST--------K 268 (904)
T ss_pred HHHhc-cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEee---ccceEEeccccchHhhhhhhh--------h
Confidence 99985 56799999999999999999999999999999999999994 677899999999997766543 3
Q ss_pred CCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcHHHHH
Q 015406 171 KNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFAS 250 (407)
Q Consensus 171 ~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~ 250 (407)
-.++||..|||||++.+.+.+.|+|||||||||||||||..||.+.+.. .++--+....+.- ..+..+|+.|+=
T Consensus 269 MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss---AIIwGVGsNsL~L---pvPstcP~Gfkl 342 (904)
T KOG4721|consen 269 MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS---AIIWGVGSNSLHL---PVPSTCPDGFKL 342 (904)
T ss_pred hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh---eeEEeccCCcccc---cCcccCchHHHH
Confidence 4789999999999999999999999999999999999999999875432 1111111111111 233568999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHH
Q 015406 251 YFHYCRSLRFDDKPDYAYLKRIFR 274 (407)
Q Consensus 251 li~~cl~~~p~~RPt~~~l~~~l~ 274 (407)
||++||...|..||+|.+|+..|.
T Consensus 343 L~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 343 LLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred HHHHHHhcCCCCCccHHHHHHHHh
Confidence 999999999999999999987663
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=317.08 Aligned_cols=252 Identities=20% Similarity=0.367 Sum_probs=203.9
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEec
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~ 84 (407)
.++|++.++||+|+||.||+|.+ ..+..||+|.+.... ..+.+..|+.+++.++| +++..+..........+++|||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQH-DKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCchhHHHHHHHHHHHHhCCC-CCeeeEEEEEcCCCCcEEEEec
Confidence 46899999999999999999996 456779999876533 23467889999999987 5566666666777888999999
Q ss_pred c-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 85 L-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 85 ~-g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
+ +++|.+++... ...+++..++.++.|++.||+|||+++++||||||+||++ +.++.++|+|||++.........
T Consensus 83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLV---SESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEe---cCCCcEEECCCccceecCCCcee
Confidence 9 89999999753 3568999999999999999999999999999999999999 57889999999999876543211
Q ss_pred cccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHHh
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (407)
......++..|+|||.+.+..++.++|||||||++|+|++ |..||..... ......+...... ...
T Consensus 160 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~~~~~~~~~~----~~~ 226 (261)
T cd05072 160 ------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN---SDVMSALQRGYRM----PRM 226 (261)
T ss_pred ------ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH---HHHHHHHHcCCCC----CCC
Confidence 1123346778999999998889999999999999999998 9999976433 2333333322111 122
Q ss_pred cCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 015406 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 275 (407)
Q Consensus 242 ~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~ 275 (407)
..+|.++.+++.+||..+|++||+++++.+.|++
T Consensus 227 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 227 ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 4578999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=333.38 Aligned_cols=252 Identities=19% Similarity=0.223 Sum_probs=193.9
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCc-----ee
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGD-----YN 78 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~-----~~ 78 (407)
+|++.++||+|+||.||+|.+..+++.||||.+.... ....+.+|+++++.++|++ +..+..+....+ ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDN-VLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCC-cCCHhheecCCCccccceE
Confidence 4889999999999999999999999999999875432 1235788999999998755 444444444333 68
Q ss_pred EEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 79 VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 79 ~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
|+||||++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 80 ~lv~e~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 80 YVVTELMQSDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLV---NSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEEeeccccCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEE---CCCCCEEeccccceeeccc
Confidence 99999998899888864 4579999999999999999999999999999999999999 5788999999999986543
Q ss_pred CCCCcccCccCCCCccccccccccccccCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhh-------
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE------- 230 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~------- 230 (407)
.... ......+|..|+|||++.+. .++.++|||||||++|||++|+.||.+.+.......+.....
T Consensus 156 ~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 229 (372)
T cd07853 156 DESK------HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAM 229 (372)
T ss_pred Cccc------cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 3211 12344678999999999874 479999999999999999999999987543222221111100
Q ss_pred -------------hcc-cccHH---HHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015406 231 -------------KKV-STSIE---ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 231 -------------~~~-~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
... ..... .+....++++.++|.+||+.||++||++.+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l 286 (372)
T cd07853 230 RSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADAL 286 (372)
T ss_pred HHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHh
Confidence 000 00011 12234678999999999999999999987664
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=314.35 Aligned_cols=249 Identities=19% Similarity=0.267 Sum_probs=201.5
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~ 85 (407)
++|++.+.||+|+||.||++++. .+..+|+|.+.... ....+..|+.+++.++| +++..+.+++......+++|||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSH-PKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCCC-CCceeEEEEEccCCCEEEEEEcC
Confidence 57999999999999999999874 45679999876433 23568889999999987 56666677777788899999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcc
Q 015406 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164 (407)
Q Consensus 86 -g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~ 164 (407)
+++|.+++......+++..++.++.|++.||+|||++||+||||||+||++ +.++.+||+|||+++.......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~d~g~~~~~~~~~~--- 155 (256)
T cd05114 82 ENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLV---SSTGVVKVSDFGMTRYVLDDEY--- 155 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEE---cCCCeEEECCCCCccccCCCce---
Confidence 899999997655578999999999999999999999999999999999999 5788999999999986543221
Q ss_pred cCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcC
Q 015406 165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243 (407)
Q Consensus 165 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (407)
.......++..|+|||++.+..++.++||||||+++|||++ |+.||..... .+.+..+....... ....
T Consensus 156 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~~~~~~i~~~~~~~----~~~~ 225 (256)
T cd05114 156 ---TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVVEMISRGFRLY----RPKL 225 (256)
T ss_pred ---eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHCCCCCC----CCCC
Confidence 11123345678999999998899999999999999999999 9999976433 33444443322111 1233
Q ss_pred CcHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 015406 244 YPTEFASYFHYCRSLRFDDKPDYAYLKRIF 273 (407)
Q Consensus 244 ~~~~l~~li~~cl~~~p~~RPt~~~l~~~l 273 (407)
.+.++.+++.+||..+|++||+++++.+.|
T Consensus 226 ~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 226 ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 678899999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=314.20 Aligned_cols=255 Identities=24% Similarity=0.349 Sum_probs=205.4
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
++|++.+.||+|+||.||+|++..+++.||||.+..... ...+..|+++++.++| +++..+..++...+..+++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNH-PNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCC-cceeeeeeeEEECCeEEEE
Confidence 689999999999999999999999999999997654221 2346789999999987 5566666666777888999
Q ss_pred Eecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeec
Q 015406 82 MDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (407)
Q Consensus 82 me~~-g~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~ 157 (407)
|||+ +++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+||++ +.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~---~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEE---cCCCCEEECccccceecc
Confidence 9999 88999988632 3458999999999999999999999999999999999999 577889999999998765
Q ss_pred cCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccH
Q 015406 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (407)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (407)
..... .....|+..|+|||.+.+..++.++||||||+++|||++|..||..... ........+.....+..
T Consensus 158 ~~~~~-------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~- 228 (267)
T cd08228 158 SKTTA-------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLFSLCQKIEQCDYPPL- 228 (267)
T ss_pred chhHH-------HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc-cHHHHHHHHhcCCCCCC-
Confidence 43211 1245688999999999988899999999999999999999999975432 22233333332222111
Q ss_pred HHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 015406 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (407)
Q Consensus 238 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l 276 (407)
....++..+.+++.+||..+|++||++.++++.|+.+
T Consensus 229 --~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 229 --PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred --ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1234678999999999999999999999999998865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=319.12 Aligned_cols=258 Identities=23% Similarity=0.321 Sum_probs=209.0
Q ss_pred CCceeEeccccccCceEEEEEEEc-----CCCeEEEEEEecCCCC--cchHHHHHHHHHHHcCCCCCCeeEEeeeeCcee
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~-----~~~~~vAvK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 78 (407)
.++|.+.+.||+|+||.||++.+. .++..+|+|.+..... ...+.+|+.+++.++| +++..+..++...+..
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQH-EHIVKFYGVCVEGDPL 82 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCC-CCcceEEEEEecCCcc
Confidence 357999999999999999999853 3456799998765432 3358889999999987 6777777777888899
Q ss_pred EEEEecc-CCCHHHHHHHcC------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceE
Q 015406 79 VLVMDLL-GPSLEDLFNFCS------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 145 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~~~------------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~ 145 (407)
+++|||+ +++|.+++.... ..+++..++.++.||+.||+|||++|++||||||+|||+ ++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili---~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---ccCCcE
Confidence 9999999 899999997432 248999999999999999999999999999999999999 578899
Q ss_pred EEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHH
Q 015406 146 YIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQK 224 (407)
Q Consensus 146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~ 224 (407)
+|+|||+++........ .......++..|+|||++.+..++.++|||||||++|+|++ |..||..... ...
T Consensus 160 kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~---~~~ 231 (288)
T cd05093 160 KIGDFGMSRDVYSTDYY-----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEV 231 (288)
T ss_pred EeccCCccccccCCcee-----ecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHH
Confidence 99999999865432211 11223446788999999999889999999999999999998 9999976443 333
Q ss_pred HHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHH
Q 015406 225 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (407)
Q Consensus 225 ~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~ 279 (407)
...+...... .....++.++.+++.+||+.||.+||++.++.+.|+++...
T Consensus 232 ~~~i~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 232 IECITQGRVL----QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHHHcCCcC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 4444433322 12345789999999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=320.08 Aligned_cols=260 Identities=22% Similarity=0.297 Sum_probs=209.9
Q ss_pred CCceeEeccccccCceEEEEEEEc-----CCCeEEEEEEecCCCCc--chHHHHHHHHHHHcCCCCCCeeEEeeeeCcee
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTKH--PQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~-----~~~~~vAvK~~~~~~~~--~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 78 (407)
.++|.+.+.||+|+||.||+|++. .++..+++|.+...... ..+.+|+.+++.+.| +++..+..++......
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQH-EHIVKFYGVCGDGDPL 82 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCC-CCcceEEEEEccCCce
Confidence 457999999999999999999854 34567999987654432 457889999999986 6677777777788889
Q ss_pred EEEEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCC
Q 015406 79 VLVMDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 142 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~ 142 (407)
++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~---~~~ 159 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV---GAN 159 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---ccC
Confidence 9999999 999999997532 348999999999999999999999999999999999999 578
Q ss_pred ceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCch
Q 015406 143 NQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTK 221 (407)
Q Consensus 143 ~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~ 221 (407)
+.++|+|||++......... .......++..|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--- 231 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYY-----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN--- 231 (291)
T ss_pred CcEEECCCCcccccCCCcee-----ecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---
Confidence 89999999999765433211 11234456889999999999899999999999999999999 9999976443
Q ss_pred HHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcC
Q 015406 222 KQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREG 281 (407)
Q Consensus 222 ~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~ 281 (407)
...+..+...... .....+|.++.+++.+||+.+|++||++.++.+.|+++.....
T Consensus 232 ~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~ 287 (291)
T cd05094 232 TEVIECITQGRVL----ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATP 287 (291)
T ss_pred HHHHHHHhCCCCC----CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhcC
Confidence 2333333332222 1234578999999999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=305.51 Aligned_cols=260 Identities=20% Similarity=0.232 Sum_probs=219.0
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc----------chHHHHHHHHHHHcCCCCCCeeEEeeeeC
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----------PQLLYESKLYRILQGGTGIPNVRWFGVEG 75 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----------~~~~~E~~~l~~l~~~~~i~~~~~~~~~~ 75 (407)
-+.|.-.+.||.|..+.|-++.++.++.++|+|++...... +.-..|+.||+++.+|++|..+.++.+..
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 35678889999999999999999999999999987643211 12467899999999999999999999999
Q ss_pred ceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEecccee
Q 015406 76 DYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (407)
Q Consensus 76 ~~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~ 154 (407)
.+.++|+|+| .|.|.|++.. .-.++++..+.|+.|+..|++|||.++||||||||+|||+ +++.++||+|||+|.
T Consensus 96 sF~FlVFdl~prGELFDyLts-~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILl---ddn~~i~isDFGFa~ 171 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTS-KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILL---DDNMNIKISDFGFAC 171 (411)
T ss_pred chhhhhhhhcccchHHHHhhh-heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheee---ccccceEEeccceee
Confidence 9999999999 9999999985 4579999999999999999999999999999999999999 789999999999999
Q ss_pred eeccCCCCcccCccCCCCccccccccccccccC------CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHH
Q 015406 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLG------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228 (407)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i 228 (407)
.+..... ....+|||+|+|||.+.. ..|+...|+||+|||||-|+.|.+||.. ......+..|
T Consensus 172 ~l~~Gek--------LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH---RkQmlMLR~I 240 (411)
T KOG0599|consen 172 QLEPGEK--------LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH---RKQMLMLRMI 240 (411)
T ss_pred ccCCchh--------HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH---HHHHHHHHHH
Confidence 8876654 347899999999999864 2478899999999999999999999965 2334456667
Q ss_pred hhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHHHHHcC
Q 015406 229 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR--IFRDLFIREG 281 (407)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~--~l~~l~~~~~ 281 (407)
.+++..... .-+.+++.+.++||.+||+.||.+|.|+++.+. .+.++.....
T Consensus 241 meGkyqF~s-peWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~ 294 (411)
T KOG0599|consen 241 MEGKYQFRS-PEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQA 294 (411)
T ss_pred HhcccccCC-cchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhcc
Confidence 777664333 345778999999999999999999999887753 3444444443
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=317.27 Aligned_cols=256 Identities=19% Similarity=0.266 Sum_probs=201.1
Q ss_pred CCccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC--cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeE
Q 015406 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 2 ~~~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 79 (407)
+....++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+|+.+++.++|+ ++..+...+...+..+
T Consensus 4 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~-~ii~~~~~~~~~~~~~ 82 (267)
T cd06646 4 RRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHC-NIVAYFGSYLSREKLW 82 (267)
T ss_pred ccCchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCC-CeeeeeEEEEeCCEEE
Confidence 34456789999999999999999999999999999998865432 23467899999998874 5556666667778899
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 80 lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
+||||+ +++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||++ +.++.++|+|||++.....
T Consensus 83 iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06646 83 ICMEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILL---TDNGDVKLADFGVAAKITA 158 (267)
T ss_pred EEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEECcCccceeecc
Confidence 999999 8899999875 4578999999999999999999999999999999999999 5778899999999987643
Q ss_pred CCCCcccCccCCCCcccccccccccccc---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccc
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (407)
... ......|+..|+|||.+. ...++.++|||||||++|||++|..||...... .....+.......
T Consensus 159 ~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~---~~~~~~~~~~~~~ 228 (267)
T cd06646 159 TIA-------KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPM---RALFLMSKSNFQP 228 (267)
T ss_pred ccc-------ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchh---hhheeeecCCCCC
Confidence 221 123456889999999885 344788999999999999999999999654321 1111111111111
Q ss_pred cHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015406 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRI 272 (407)
Q Consensus 236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~ 272 (407)
........++.++.+++.+||..+|++||++++|++.
T Consensus 229 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 229 PKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred CCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 1111123478899999999999999999999887653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=321.73 Aligned_cols=261 Identities=18% Similarity=0.315 Sum_probs=208.3
Q ss_pred CCceeEeccccccCceEEEEEEEcC-------CCeEEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeeeC
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQ-------TNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEG 75 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~-------~~~~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~ 75 (407)
.++|.+.+.||+|+||.||+|++.. +...+|+|++...... ..+..|+.+++.+..|+++..+..++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3789999999999999999998643 2357999988754322 34778999999996668888888888888
Q ss_pred ceeEEEEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCC
Q 015406 76 DYNVLVMDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 139 (407)
Q Consensus 76 ~~~~lvme~~-g~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~ 139 (407)
+..|+||||+ +++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill--- 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV--- 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEE---
Confidence 8899999999 889999997532 248899999999999999999999999999999999999
Q ss_pred CCCceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015406 140 RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 218 (407)
Q Consensus 140 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~ 218 (407)
+.++.+||+|||+++......... ......++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYK-----KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred cCCCcEEECCCcccccccccchhh-----ccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 577899999999997654322110 0112234578999999999889999999999999999998 8999976432
Q ss_pred CchHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcC
Q 015406 219 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREG 281 (407)
Q Consensus 219 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~ 281 (407)
.+....+...... .....++.++.+++.+||..+|++||++.++.+.|++++....
T Consensus 249 ---~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 249 ---EELFKLLKEGHRM----DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred ---HHHHHHHHcCCCC----CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 3333333322211 2234578999999999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=314.18 Aligned_cols=253 Identities=21% Similarity=0.357 Sum_probs=202.1
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEec
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~ 84 (407)
.++|++.++||+|+||.||+|++..+ ..||+|.+..... ...+.+|+.+++.++| +++..+..+.. ....+++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~-~~i~~~~~~~~-~~~~~lv~e~ 81 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRH-EKLVQLYAVVS-EEPIYIVTEY 81 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCC-CCcceEEEEEC-CCCcEEEEEc
Confidence 57899999999999999999998655 4599998875433 3458889999999987 45555554443 4557999999
Q ss_pred c-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 85 L-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 85 ~-g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
+ +++|.+++... ...+++..++.++.|++.||+|||+++|+||||||+||++ ++++.++|+|||.++.+......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill---~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEE---cCCCcEEeccCCceeeccccccc
Confidence 9 88999999753 3458999999999999999999999999999999999999 57889999999999876543221
Q ss_pred cccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHHh
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (407)
......++..|+|||+..+..++.++||||||+++|||++ |..||.+... .+.+..+...... ...
T Consensus 159 ------~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~---~~~~~~~~~~~~~----~~~ 225 (262)
T cd05071 159 ------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQVERGYRM----PCP 225 (262)
T ss_pred ------cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh---HHHHHHHhcCCCC----CCc
Confidence 1123456778999999998899999999999999999999 8889976433 2333333222111 112
Q ss_pred cCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHH
Q 015406 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (407)
Q Consensus 242 ~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~ 277 (407)
..++..+.+++.+||+.+|++||++.++.+.|++.|
T Consensus 226 ~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 226 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred cccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 457899999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=320.64 Aligned_cols=254 Identities=20% Similarity=0.293 Sum_probs=211.5
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-C
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~-g 86 (407)
-|.++++||+|+||.||+|.++.+|+.+|||.+..+...+++.+|+.+++++.. +.++.+++........||||||| .
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S-~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKS-KYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCC-chhhhhhhhhccCCceEeehhhcCC
Confidence 478899999999999999999999999999999998889999999999999987 55555544444555679999999 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcccC
Q 015406 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166 (407)
Q Consensus 87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~ 166 (407)
|++.+++...++.|++.++..++...+.||+|||...-||||||..|||+ +.+|..||+|||.|..+.+...
T Consensus 113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILL---NT~G~AKLADFGVAGQLTDTMA----- 184 (502)
T KOG0574|consen 113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILL---NTDGIAKLADFGVAGQLTDTMA----- 184 (502)
T ss_pred CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEE---cccchhhhhhccccchhhhhHH-----
Confidence 99999999878899999999999999999999999999999999999999 6889999999999987766543
Q ss_pred ccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcH
Q 015406 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 246 (407)
Q Consensus 167 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 246 (407)
...+..||+.|||||++....|+.++||||||++..||..|++||.+..+. ..+..|..+..++.. .+...+.
T Consensus 185 --KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM---RAIFMIPT~PPPTF~--KPE~WS~ 257 (502)
T KOG0574|consen 185 --KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM---RAIFMIPTKPPPTFK--KPEEWSS 257 (502)
T ss_pred --hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc---ceeEeccCCCCCCCC--ChHhhhh
Confidence 245789999999999999999999999999999999999999999886552 122222222222221 1234678
Q ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHc
Q 015406 247 EFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (407)
Q Consensus 247 ~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~ 280 (407)
+|.+++..||.++|++|-|+-+| +++-|.+.
T Consensus 258 ~F~DFi~~CLiK~PE~R~TA~~L---~~H~Fikn 288 (502)
T KOG0574|consen 258 EFNDFIRSCLIKKPEERKTALRL---CEHTFIKN 288 (502)
T ss_pred HHHHHHHHHhcCCHHHHHHHHHH---hhhhhhcC
Confidence 99999999999999999986554 44444433
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=317.67 Aligned_cols=256 Identities=20% Similarity=0.326 Sum_probs=202.2
Q ss_pred CCceeEeccccccCceEEEEEEEcC-----CCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCce
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~-----~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 77 (407)
.++|.+.+.||+|+||.||+|.+.. ++..||+|....... ...+..|+.+++.++| +++..+..++.+...
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~ 83 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNH-QNIVRLIGVSFERLP 83 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEccCCC
Confidence 5789999999999999999999876 778999998764332 2347889999999987 566666666677778
Q ss_pred eEEEEecc-CCCHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEec
Q 015406 78 NVLVMDLL-GPSLEDLFNFCS------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 150 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DF 150 (407)
.+++|||+ +++|.+++.... ..+++..++.++.||+.||+|||+++++||||||+|||++.+.....+||+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~df 163 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADF 163 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccC
Confidence 89999999 999999997543 24899999999999999999999999999999999999953333457999999
Q ss_pred cceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHh
Q 015406 151 GLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKIS 229 (407)
Q Consensus 151 Gla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~ 229 (407)
|+++........ ........+..|+|||++.+..++.++|||||||++|||++ |..||.+... ......+.
T Consensus 164 g~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~---~~~~~~~~ 235 (277)
T cd05036 164 GMARDIYRASYY-----RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN---QEVMEFVT 235 (277)
T ss_pred ccccccCCccce-----ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHH
Confidence 999876332210 11122234568999999999899999999999999999997 9999976443 22233222
Q ss_pred hhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015406 230 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 274 (407)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~ 274 (407)
.... ......+|.++.+++.+||+.+|++||++.+|.+.|+
T Consensus 236 ~~~~----~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 GGGR----LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred cCCc----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 2111 1123567899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=319.91 Aligned_cols=255 Identities=18% Similarity=0.261 Sum_probs=201.8
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
.++|++.++||+|+||.||+|++..+++.||+|.+..... ...+.+|+.+++.++| +++..+..++......++||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKH-ANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCC-CCcceEEEEEecCCeEEEEE
Confidence 4679999999999999999999999999999998764332 2347789999999987 56667777777888899999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 83 e~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
||++++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.++|+|||++........
T Consensus 84 e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~- 159 (301)
T cd07873 84 EYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPTK- 159 (301)
T ss_pred eccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEE---CCCCcEEECcCcchhccCCCCC-
Confidence 999889999998766679999999999999999999999999999999999999 5788999999999975433221
Q ss_pred cccCccCCCCccccccccccccccCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcc--------
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-------- 233 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-------- 233 (407)
......+++.|+|||++.+. .++.++|||||||++|||++|+.||...+.......+..+.....
T Consensus 160 ------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (301)
T cd07873 160 ------TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL 233 (301)
T ss_pred ------cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhh
Confidence 12234678999999998764 478999999999999999999999987543222111111110000
Q ss_pred --------------cccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 234 --------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 234 --------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
..........+++++.+||.+||..||.+|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00112233457889999999999999999999877754
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=326.81 Aligned_cols=260 Identities=20% Similarity=0.311 Sum_probs=203.8
Q ss_pred CCceeEeccccccCceEEEEEEE-----cCCCeEEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEe-eeeCc
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTN-----IQTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWF-GVEGD 76 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~-----~~~~~~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~-~~~~~ 76 (407)
.++|++.+.||+|+||.||+|.+ ..+++.||||++...... ..+.+|+.++..+.+|++++.+..+ ...+.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 46899999999999999999984 346789999998754322 3477899999999777777666554 44566
Q ss_pred eeEEEEecc-CCCHHHHHHHcC----------------------------------------------------------
Q 015406 77 YNVLVMDLL-GPSLEDLFNFCS---------------------------------------------------------- 97 (407)
Q Consensus 77 ~~~lvme~~-g~sL~~~l~~~~---------------------------------------------------------- 97 (407)
..+++|||+ +++|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 789999999 999999986421
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcccCccC
Q 015406 98 --------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRE 169 (407)
Q Consensus 98 --------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 169 (407)
..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....... +..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~---~~~~~~kl~dfg~~~~~~~~~~-----~~~ 237 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPD-----YVR 237 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEE---cCCCcEEEEecccccccccCcc-----hhh
Confidence 236788889999999999999999999999999999999 5788999999999986533221 111
Q ss_pred CCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcHHH
Q 015406 170 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEF 248 (407)
Q Consensus 170 ~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l 248 (407)
.....++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ......+...... .....+++++
T Consensus 238 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~~~----~~~~~~~~~~ 311 (343)
T cd05103 238 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFCRRLKEGTRM----RAPDYTTPEM 311 (343)
T ss_pred cCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--HHHHHHHhccCCC----CCCCCCCHHH
Confidence 223446678999999999899999999999999999997 99999764332 1222222221111 1123467899
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHHHH
Q 015406 249 ASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (407)
Q Consensus 249 ~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~ 279 (407)
.+++.+||..+|++||++.+|.+.|+.+++.
T Consensus 312 ~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 312 YQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=322.17 Aligned_cols=258 Identities=19% Similarity=0.252 Sum_probs=205.6
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeE--EEEEEecCCC---CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEE--VAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~--vAvK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
-++|++.+.||+|+||.||+|++..++.. +|+|.+.... ....+.+|+.++.++.+|++++.+..++...+..|+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 36899999999999999999998777754 5777654322 123477899999999767888888888888889999
Q ss_pred EEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCce
Q 015406 81 VMDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ 144 (407)
Q Consensus 81 vme~~-g~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~ 144 (407)
+|||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili---~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEe---cCCCc
Confidence 99999 899999997532 247899999999999999999999999999999999999 57889
Q ss_pred EEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHH
Q 015406 145 VYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQ 223 (407)
Q Consensus 145 ~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~ 223 (407)
+||+|||+++...... ......++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+
T Consensus 163 ~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~ 231 (303)
T cd05088 163 AKIADFGLSRGQEVYV--------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AE 231 (303)
T ss_pred EEeCccccCcccchhh--------hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh---HH
Confidence 9999999986432111 0112234678999999988889999999999999999998 9999976543 23
Q ss_pred HHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcC
Q 015406 224 KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREG 281 (407)
Q Consensus 224 ~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~ 281 (407)
.+..+..... ......+++++.+++.+||+.+|++||+++++++.|..++....
T Consensus 232 ~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 232 LYEKLPQGYR----LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred HHHHHhcCCc----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 3333322111 11223478899999999999999999999999999988876553
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=312.26 Aligned_cols=246 Identities=20% Similarity=0.308 Sum_probs=195.7
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-CCC
Q 015406 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPS 88 (407)
Q Consensus 13 ~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~-g~s 88 (407)
+.||+|+||.||+|++..+++.||+|....... ...+.+|+++++.++| +++..+..++......++||||+ +++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSH-PNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCC-CCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 479999999999999999999999998654322 2357889999999976 66666777777778899999999 899
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcccCcc
Q 015406 89 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYR 168 (407)
Q Consensus 89 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 168 (407)
|.+++......+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++..........
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~----- 151 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLV---TEKNVLKISDFGMSREEEDGVYAS----- 151 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEE---cCCCcEEECccccCcccccccccc-----
Confidence 999997655568999999999999999999999999999999999999 577889999999987644321100
Q ss_pred CCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcHH
Q 015406 169 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTE 247 (407)
Q Consensus 169 ~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 247 (407)
......++..|+|||.+.+..++.++||||||+++|||++ |..||...... .....+..... . .....++.+
T Consensus 152 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~---~~~~~~~~~~~-~---~~~~~~~~~ 224 (252)
T cd05084 152 TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ---QTREAIEQGVR-L---PCPELCPDA 224 (252)
T ss_pred cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH---HHHHHHHcCCC-C---CCcccCCHH
Confidence 0111123467999999999889999999999999999998 99999764432 22222222111 1 123457899
Q ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015406 248 FASYFHYCRSLRFDDKPDYAYLKRIFR 274 (407)
Q Consensus 248 l~~li~~cl~~~p~~RPt~~~l~~~l~ 274 (407)
+.+++.+||..+|++||++.++.+.|+
T Consensus 225 ~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 225 VYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=318.21 Aligned_cols=253 Identities=20% Similarity=0.286 Sum_probs=201.6
Q ss_pred CceeEeccccccCceEEEEEEEc----CCCeEEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNI----QTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~----~~~~~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 79 (407)
..|++.+.||+|+||.||+|.+. .++..||+|.+...... ..+.+|+.+++.++| +++..+..+...+...|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHH-PNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCC-CCeeeEEEEEecCCceE
Confidence 57999999999999999999853 45678999987643322 347789999999976 56666666777778889
Q ss_pred EEEecc-CCCHHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCC
Q 015406 80 LVMDLL-GPSLEDLFNFCS----------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 142 (407)
Q Consensus 80 lvme~~-g~sL~~~l~~~~----------------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~ 142 (407)
++|||+ +++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||+ +.+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili---~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI---GEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEE---cCC
Confidence 999999 889999985321 247889999999999999999999999999999999999 577
Q ss_pred ceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCch
Q 015406 143 NQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTK 221 (407)
Q Consensus 143 ~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~ 221 (407)
+.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--- 232 (283)
T cd05090 161 LHVKISDLGLSREIYSADYY-----RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--- 232 (283)
T ss_pred CcEEeccccccccccCCcce-----ecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---
Confidence 88999999999865433211 11234456778999999998889999999999999999998 9999976433
Q ss_pred HHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 015406 222 KQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 275 (407)
Q Consensus 222 ~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~ 275 (407)
......+...... .....+++++.+++.+||..||++||++.+|.+.|+.
T Consensus 233 ~~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 233 QEVIEMVRKRQLL----PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHHHcCCcC----CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 2223333222221 2335688999999999999999999999999888763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=348.30 Aligned_cols=254 Identities=21% Similarity=0.304 Sum_probs=199.2
Q ss_pred CccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC----cchHHHHHHHHHHHcCCCCCCeeEEee-eeCce
Q 015406 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFG-VEGDY 77 (407)
Q Consensus 3 ~~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~-~~~~~ 77 (407)
+...++|+++++||+|+||.||+|++..+++.||+|++..... ...+..|+.+++.|+|++++..+..+. .....
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 3456799999999999999999999999999999998865432 235788999999999866555554443 34567
Q ss_pred eEEEEecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC-------CceeccCCCCcccccCC-------
Q 015406 78 NVLVMDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK-------SFLHRDIKPDNFLMGLG------- 139 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~-------~ivHrDLKp~NILl~~~------- 139 (407)
+||||||+ +++|.++|... ...+++..++.|+.||+.||.|||+. +||||||||+||||+.+
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 89999999 89999998743 24699999999999999999999984 59999999999999531
Q ss_pred -------CCCceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccC--CCCChhhHHHHHHHHHHHHHhCC
Q 015406 140 -------RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGS 210 (407)
Q Consensus 140 -------~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~sDIwSlG~il~elltG~ 210 (407)
+....+||+|||++..+..... .....||+.|+|||++.+ ..++.++||||||||||||++|.
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~--------~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk 240 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIESM--------AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccccc--------ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCC
Confidence 1234589999999986643321 234579999999999864 45789999999999999999999
Q ss_pred CCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 211 LPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 211 ~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.||..... ..+.+..+..... . ....++.++.+||..||..+|++||++.+++.
T Consensus 241 ~PF~~~~~--~~qli~~lk~~p~-l----pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 241 TPFHKANN--FSQLISELKRGPD-L----PIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCCCcCCc--HHHHHHHHhcCCC-C----CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 99975432 2233333322211 1 11346899999999999999999999887763
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=331.89 Aligned_cols=257 Identities=24% Similarity=0.330 Sum_probs=204.8
Q ss_pred CceeEeccccccCceEEEEEEEc-----CCCeEEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeeeCcee
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~-----~~~~~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 78 (407)
++|.+.++||+|+||.||+|++. .+++.||||+++..... ..+.+|++++..+..|++++.+..++......
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 46888899999999999999864 34578999998754332 35788999999998567888888888888889
Q ss_pred EEEEecc-CCCHHHHHHHcC------------------------------------------------------------
Q 015406 79 VLVMDLL-GPSLEDLFNFCS------------------------------------------------------------ 97 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~~~------------------------------------------------------------ 97 (407)
++||||+ +|+|.+++....
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 9999999 999999996432
Q ss_pred -------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCC
Q 015406 98 -------------------------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 140 (407)
Q Consensus 98 -------------------------------------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~ 140 (407)
..+++..++.|+.||+.||+|||+++|+||||||+|||+ +
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl---~ 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI---C 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE---e
Confidence 125777889999999999999999999999999999999 5
Q ss_pred CCceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcC
Q 015406 141 RANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAG 219 (407)
Q Consensus 141 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~ 219 (407)
+.+.+||+|||+++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNY-----ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred CCCEEEEEecCcceeccccccc-----ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 7889999999999865432211 11223457889999999999889999999999999999998 89999764332
Q ss_pred chHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHH
Q 015406 220 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (407)
Q Consensus 220 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~ 277 (407)
......+... ... .....++.++.+|+.+||..+|++||++++|.+.|++++
T Consensus 349 --~~~~~~~~~~-~~~---~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 349 --EQFYNAIKRG-YRM---AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred --HHHHHHHHcC-CCC---CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1122222221 111 123457899999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=319.72 Aligned_cols=256 Identities=18% Similarity=0.215 Sum_probs=190.7
Q ss_pred eccccccCceEEEEEEEc--CCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeee-eCceeEEEEeccCCC
Q 015406 12 GRKIGSGSFGEIYLGTNI--QTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGV-EGDYNVLVMDLLGPS 88 (407)
Q Consensus 12 ~~~iG~G~~g~Vy~~~~~--~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~-~~~~~~lvme~~g~s 88 (407)
.++||+|+||.||+|+++ .+++.||+|.+........+.+|+.+++.++|++.+..+..+.. .....|++|||++++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~ 85 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHD 85 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCCC
Confidence 568999999999999965 46789999998766556678899999999998655555444432 455789999999989
Q ss_pred HHHHHHHcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCC-CCCceEEEEeccceeeeccC
Q 015406 89 LEDLFNFCS--------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG-RRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 89 L~~~l~~~~--------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~-~~~~~~kL~DFGla~~~~~~ 159 (407)
|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+... +..+.+||+|||+++.+...
T Consensus 86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~ 165 (317)
T cd07868 86 LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165 (317)
T ss_pred HHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCC
Confidence 999886421 248999999999999999999999999999999999999432 35578999999999876543
Q ss_pred CCCcccCccCCCCccccccccccccccCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCc------hHHHHHHHhhhc
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT------KKQKYEKISEKK 232 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~------~~~~~~~i~~~~ 232 (407)
... ........||+.|+|||++.+. .++.++|||||||++|||++|..||....... ....+..+....
T Consensus 166 ~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07868 166 LKP----LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241 (317)
T ss_pred Ccc----ccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence 211 1123456789999999999874 58999999999999999999999997533211 011111111100
Q ss_pred -------------cc--------------------ccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 233 -------------VS--------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 233 -------------~~--------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.. ...+......+.++.++|.+||..||++|||++++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 0000001123567889999999999999999888764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=314.41 Aligned_cols=255 Identities=15% Similarity=0.270 Sum_probs=206.0
Q ss_pred CCceeEeccccccCceEEEEEEEcCC---CeEEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~---~~~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 79 (407)
.++|++.+.||+|+||.||+|++..+ ...||||.+...... ..+..|+.+++.++| +++..+..+....+..+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDH-PNIIRLEGVVTKSRPVM 81 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCC-CCcceEeEEEecCCceE
Confidence 36799999999999999999998644 458999987654322 347789999999986 56666777777788899
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 80 lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
++|||+ +++|.+++......+++..++.++.|++.||.|||+++|+||||||+|||+ +.++.++|+|||+++....
T Consensus 82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCCEEECccchhhcccc
Confidence 999999 889999998766679999999999999999999999999999999999999 5788999999999987752
Q ss_pred CCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccH
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (407)
..... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||..... .+....+.......
T Consensus 159 ~~~~~-----~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~~-- 228 (266)
T cd05033 159 SEATY-----TTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN---QDVIKAVEDGYRLP-- 228 (266)
T ss_pred cccce-----eccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH---HHHHHHHHcCCCCC--
Confidence 22110 0112345678999999998899999999999999999998 9999976432 23333333221111
Q ss_pred HHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 015406 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (407)
Q Consensus 238 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l 276 (407)
....+++.+.+++.+||+.+|++||++.+|.+.|.++
T Consensus 229 --~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 229 --PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred --CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1245789999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=336.77 Aligned_cols=253 Identities=20% Similarity=0.239 Sum_probs=198.6
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEec
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~ 84 (407)
.+..|.+.+.||+|+||.||+|++..+++.||||... ...+.+|+++++.|+| ++|+.+..++..++..+++||+
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~----~~~~~~E~~iL~~L~H-pnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW----YASSVHEARLLRRLSH-PAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc----ccCHHHHHHHHHHCCC-CCCCcEEEEEEECCEEEEEEEc
Confidence 4568999999999999999999999999999999532 3356789999999987 5666677777788889999999
Q ss_pred cCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcc
Q 015406 85 LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164 (407)
Q Consensus 85 ~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~ 164 (407)
+.++|.+++......+++..++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+++........
T Consensus 242 ~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl---~~~~~vkL~DFGla~~~~~~~~~-- 316 (461)
T PHA03211 242 YRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV---NGPEDICLGDFGAACFARGSWST-- 316 (461)
T ss_pred cCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEE---CCCCCEEEcccCCceeccccccc--
Confidence 9889999987655679999999999999999999999999999999999999 57788999999999876432211
Q ss_pred cCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcC-----chHHHHHHHhhhcc-----c
Q 015406 165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-----TKKQKYEKISEKKV-----S 234 (407)
Q Consensus 165 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~-----~~~~~~~~i~~~~~-----~ 234 (407)
.......||..|+|||++.+..++.++|||||||+||||++|..|+...... ...+....+..... .
T Consensus 317 ---~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~ 393 (461)
T PHA03211 317 ---PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP 393 (461)
T ss_pred ---ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence 1122457999999999999999999999999999999999987765432211 11122222211110 0
Q ss_pred c-------------------------cHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 235 T-------------------------SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 235 ~-------------------------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
. .... ...++.++.+||.+||+.||.+||++.++++
T Consensus 394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTR-YYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred CCcchHHHHHHHhhhhcccCCccCCcchhh-hccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 0 0000 0134568999999999999999999888765
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=317.35 Aligned_cols=266 Identities=19% Similarity=0.297 Sum_probs=207.0
Q ss_pred cCCceeEeccccccCceEEEEEEEcC-----CCeEEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeeeCc
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGD 76 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~-----~~~~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 76 (407)
..++|++.++||+|+||.||+|.++. .+..||+|.++..... ..+..|+.+++.+.| +++..+..+.....
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~ 82 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC-HHVVRLLGVVSKGQ 82 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCC-CCeeeEEEEEcCCC
Confidence 35789999999999999999997642 3458999987644322 236678889998876 56777777777778
Q ss_pred eeEEEEecc-CCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEE
Q 015406 77 YNVLVMDLL-GPSLEDLFNFCS---------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY 146 (407)
Q Consensus 77 ~~~lvme~~-g~sL~~~l~~~~---------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~k 146 (407)
..|++|||+ +++|.+++.... ..++...++.++.||+.||.|||+++|+||||||+|||+ +.++.++
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili---~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMV---AHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEE---cCCCcEE
Confidence 899999999 999999997532 234677899999999999999999999999999999999 5788999
Q ss_pred EEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHH
Q 015406 147 IIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKY 225 (407)
Q Consensus 147 L~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~ 225 (407)
|+|||+++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||.+... .+.+
T Consensus 160 L~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~---~~~~ 231 (288)
T cd05061 160 IGDFGMTRDIYETDYY-----RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN---EQVL 231 (288)
T ss_pred ECcCCccccccccccc-----cccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHH
Confidence 9999999865432221 11223345778999999998899999999999999999998 7899976433 2333
Q ss_pred HHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccc
Q 015406 226 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDW 290 (407)
Q Consensus 226 ~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~dw 290 (407)
..+...... .....+++++.+++.+||+.+|++||++.++.+.|++.+ .++..++||
T Consensus 232 ~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~----~~~~~~~~~ 288 (288)
T cd05061 232 KFVMDGGYL----DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL----HPSFPEVSF 288 (288)
T ss_pred HHHHcCCCC----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc----CCCCCCCCC
Confidence 333222211 123457899999999999999999999999988887764 345556666
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=312.94 Aligned_cols=248 Identities=20% Similarity=0.318 Sum_probs=194.3
Q ss_pred cccccCceEEEEEEEc--CCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-CC
Q 015406 14 KIGSGSFGEIYLGTNI--QTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GP 87 (407)
Q Consensus 14 ~iG~G~~g~Vy~~~~~--~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~-g~ 87 (407)
.||+|+||.||+|.+. ..+..||+|++..... .+.+.+|+.+++.++|.+.+.. ..+.. ....++||||+ ++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~-~~~~~-~~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRM-IGVCE-AEALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEE-EEEEc-CCCeEEEEEeCCCC
Confidence 4899999999999765 4456799998865432 2347889999999987554444 44443 45679999999 89
Q ss_pred CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcccCc
Q 015406 88 SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPY 167 (407)
Q Consensus 88 sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~~ 167 (407)
+|.+++......+++..++.++.||+.||.|||++|++||||||+|||+ +.++.+||+|||+++.........
T Consensus 80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~~~---- 152 (257)
T cd05115 80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLL---VNQHYAKISDFGLSKALGADDSYY---- 152 (257)
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEE---cCCCcEEeccCCccccccCCccce----
Confidence 9999997656679999999999999999999999999999999999999 577899999999998654332210
Q ss_pred cCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcH
Q 015406 168 RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 246 (407)
Q Consensus 168 ~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 246 (407)
.......++..|+|||.+.+..++.++|||||||++|||++ |..||.+.... .....+..... ......+++
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~~~~----~~~~~~~~~ 225 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP---EVMSFIEQGKR----LDCPAECPP 225 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHHHCCCC----CCCCCCCCH
Confidence 11112234678999999998889999999999999999996 99999875442 22222222221 112345789
Q ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHH
Q 015406 247 EFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (407)
Q Consensus 247 ~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~ 277 (407)
++.+++.+||..+|++||++.+|.+.|+..+
T Consensus 226 ~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 226 EMYALMKDCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence 9999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=320.12 Aligned_cols=257 Identities=19% Similarity=0.290 Sum_probs=201.4
Q ss_pred CCceeEeccccccCceEEEEEEEcCCC----------------eEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCC
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTN----------------EEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIP 66 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~----------------~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~ 66 (407)
.++|++.+.||+|+||.||+|.+...+ ..||+|.+..... ...+.+|+++++.++| +++.
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSD-PNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCC-CCEe
Confidence 468999999999999999999876543 5689998775432 2357789999999987 5566
Q ss_pred eeEEeeeeCceeEEEEecc-CCCHHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCccc
Q 015406 67 NVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS----------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 135 (407)
Q Consensus 67 ~~~~~~~~~~~~~lvme~~-g~sL~~~l~~~~----------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NIL 135 (407)
.+..++...+..+++|||+ +++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nil 162 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL 162 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhcee
Confidence 6666667778899999999 899999997543 25899999999999999999999999999999999999
Q ss_pred ccCCCCCceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh--CCCCC
Q 015406 136 MGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR--GSLPW 213 (407)
Q Consensus 136 l~~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt--G~~Pf 213 (407)
+ +.++.++|+|||+++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||
T Consensus 163 i---~~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~ 234 (296)
T cd05051 163 V---GKNYTIKIADFGMSRNLYSSDYY-----RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPY 234 (296)
T ss_pred e---cCCCceEEccccceeecccCcce-----eecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCC
Confidence 9 57799999999999865443221 11234456788999999998889999999999999999998 78888
Q ss_pred CCCCcCchHHHHHHHhhh---cccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015406 214 QGLKAGTKKQKYEKISEK---KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 274 (407)
Q Consensus 214 ~~~~~~~~~~~~~~i~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~ 274 (407)
..... .+.+...... ............+|.++.+++.+||+.||++||++.+|.+.|+
T Consensus 235 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 235 EHLTD---QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred CCcCh---HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 76443 2222222211 0001111122456889999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=316.45 Aligned_cols=255 Identities=20% Similarity=0.310 Sum_probs=201.3
Q ss_pred ccCCceeEeccccccCceEEEEEEEcC-----CCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeC
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEG 75 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~-----~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~ 75 (407)
...++|++.+.||+|+||.||+|.+.. ++..||||.+..... ...+.+|+.+++.++| +++..+..++..+
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~-~~iv~~~~~~~~~ 81 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC-HHVVRLLGVVSQG 81 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CCeeeEEEEEcCC
Confidence 356889999999999999999998642 356899998754322 2347789999999876 5666677777777
Q ss_pred ceeEEEEecc-CCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceE
Q 015406 76 DYNVLVMDLL-GPSLEDLFNFCS---------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 145 (407)
Q Consensus 76 ~~~~lvme~~-g~sL~~~l~~~~---------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~ 145 (407)
...++||||+ +++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||++ +.++.+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~---~~~~~~ 158 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTV 158 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEE---cCCCCE
Confidence 8899999999 899999987532 135778899999999999999999999999999999999 578899
Q ss_pred EEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHH
Q 015406 146 YIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQK 224 (407)
Q Consensus 146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~ 224 (407)
+|+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||.+... ...
T Consensus 159 ~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~---~~~ 230 (277)
T cd05062 159 KIGDFGMTRDIYETDYY-----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN---EQV 230 (277)
T ss_pred EECCCCCccccCCccee-----ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHH
Confidence 99999999765433221 11123355788999999999889999999999999999999 7899976443 233
Q ss_pred HHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015406 225 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 274 (407)
Q Consensus 225 ~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~ 274 (407)
+..+...... .....++.++.+++.+||+.+|++||++.++.+.|+
T Consensus 231 ~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 231 LRFVMEGGLL----DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHHHcCCcC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 3333332221 123557899999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=311.46 Aligned_cols=252 Identities=21% Similarity=0.345 Sum_probs=204.1
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEec
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~ 84 (407)
.++|++.+.||+|+||.||+|.+. .++.||+|.+..... ...+.+|+.+++.++| +++..+..++...+..+++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRH-PKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCC-CCccceeEEEecCCCeeeeeec
Confidence 478999999999999999999974 557899998865432 3468889999999986 5666677777778888999999
Q ss_pred c-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 85 L-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 85 ~-g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
+ +++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||++ +.++.++|+|||+++........
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLV---GENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEE---cCCCCEEECCcceEEEccCCccc
Confidence 9 999999997533 468999999999999999999999999999999999999 57889999999999877533211
Q ss_pred cccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHHh
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (407)
.......+..|+|||.+.+..++.++||||||+++|||++ |+.||.+... ...+..+...... ...
T Consensus 160 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~~~~~~----~~~ 226 (261)
T cd05068 160 ------AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN---AEVLQQVDQGYRM----PCP 226 (261)
T ss_pred ------ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCCCC----CCC
Confidence 0112233467999999999899999999999999999999 9999976443 2333333322111 122
Q ss_pred cCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 015406 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 275 (407)
Q Consensus 242 ~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~ 275 (407)
..++..+.+++.+||+.+|++||++.+|.+.|++
T Consensus 227 ~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 227 PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 4578999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=319.41 Aligned_cols=259 Identities=19% Similarity=0.294 Sum_probs=198.8
Q ss_pred CceeEeccccccCceEEEEEEEcCC--------------CeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQT--------------NEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVR 69 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~--------------~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~ 69 (407)
++|++.++||+|+||.||+|++..+ ...||+|.+..... ...+.+|+++++.++| +++..+.
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h-~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKN-PNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCC-CCcCeEE
Confidence 5899999999999999999987543 23589998765422 2347789999999987 5666777
Q ss_pred EeeeeCceeEEEEecc-CCCHHHHHHHcC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCccccc
Q 015406 70 WFGVEGDYNVLVMDLL-GPSLEDLFNFCS-----------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 137 (407)
Q Consensus 70 ~~~~~~~~~~lvme~~-g~sL~~~l~~~~-----------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~ 137 (407)
.++......++||||+ +++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+|||+
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill- 162 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV- 162 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEE-
Confidence 7777778889999999 899999986432 136888999999999999999999999999999999999
Q ss_pred CCCCCceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh--CCCCCCC
Q 015406 138 LGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR--GSLPWQG 215 (407)
Q Consensus 138 ~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt--G~~Pf~~ 215 (407)
++++.+||+|||++........ ........++..|+|||.+.+..++.++|||||||++|+|++ |..||..
T Consensus 163 --~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 163 --GNHYTIKIADFGMSRNLYSGDY-----YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred --cCCCcEEecccccccccccCcc-----eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 5778899999999986543221 111223455778999999998889999999999999999988 6788876
Q ss_pred CCcCchHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015406 216 LKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 274 (407)
Q Consensus 216 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~ 274 (407)
.......+....................+|+.+.+|+.+||+.+|++||++++|.+.|+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 236 LSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred cChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 54422222211111111011111123447899999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=318.83 Aligned_cols=260 Identities=17% Similarity=0.307 Sum_probs=208.7
Q ss_pred cCCceeEeccccccCceEEEEEEEc-------CCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeee
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNI-------QTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVE 74 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~-------~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~ 74 (407)
..++|.+.+.||+|+||.||+|++. ..+..||+|....... ...+.+|+.+++.+.+|+++..+..++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3578999999999999999999753 2345799998764322 24578899999999666788888888888
Q ss_pred CceeEEEEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccC
Q 015406 75 GDYNVLVMDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 138 (407)
Q Consensus 75 ~~~~~lvme~~-g~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~ 138 (407)
....+++|||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili-- 170 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV-- 170 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEE--
Confidence 88899999999 889999997532 247888999999999999999999999999999999999
Q ss_pred CCCCceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCC
Q 015406 139 GRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLK 217 (407)
Q Consensus 139 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~ 217 (407)
+.++.+||+|||+++........ .......++..|+|||++.+..++.++||||||+++|+|++ |..||.+..
T Consensus 171 -~~~~~~kl~D~g~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 171 -TENNVMKIADFGLARDVNNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred -cCCCcEEECCCccceeccccccc-----ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 57789999999999876543221 11223345678999999999889999999999999999998 888987643
Q ss_pred cCchHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHH
Q 015406 218 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (407)
Q Consensus 218 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~ 279 (407)
. .+....+...... .....++.++.+++.+||..+|++||++.++.+.|++++.-
T Consensus 245 ~---~~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 245 V---EELFKLLKEGHRM----DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred H---HHHHHHHHcCCcC----CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 2 3344444332211 12245789999999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=332.75 Aligned_cols=296 Identities=19% Similarity=0.272 Sum_probs=239.1
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
.+++++..||-|+||.|-++........+|+|++++... .+.+..|.++|..+. .+.|+.++-.+.+..+.|+.
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~-s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECR-SDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcC-chHHHHHHHHhccchhhhhh
Confidence 467788899999999999999766555689998775432 223677889988887 58888888888899999999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 82 me~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
||-| ||.|..++.. ++.|+..++.+++..+++|++|||++|||+|||||+|.|+ +..|-+||.|||+|+.+....
T Consensus 499 mEaClGGElWTiLrd-Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllL---d~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 499 MEACLGGELWTILRD-RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLL---DNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred HHhhcCchhhhhhhh-cCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheee---ccCCceEEeehhhHHHhccCC
Confidence 9999 9999999986 5689999999999999999999999999999999999999 789999999999999988765
Q ss_pred CCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHH
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (407)
. .-+++||+.|.|||++.++..+.++|.||||+++|||++|.+||.+.+. ...|..|..+.-. -.+
T Consensus 575 K--------TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp---mktYn~ILkGid~---i~~ 640 (732)
T KOG0614|consen 575 K--------TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP---MKTYNLILKGIDK---IEF 640 (732)
T ss_pred c--------eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch---HHHHHHHHhhhhh---hhc
Confidence 4 3478999999999999999999999999999999999999999988655 4555555544321 124
Q ss_pred hcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchhhcccccCCCCccCCCCCCCCCCCCC
Q 015406 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATPPARALVPGAGTSGAPPA 320 (407)
Q Consensus 241 ~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (407)
++.++....+||.+++..+|.+|..+ ...-+.++ ..+.|+..|||+.++.+. .++|..+++..+.+.+.+.+.
T Consensus 641 Pr~I~k~a~~Lik~LCr~~P~ERLG~--~~~gI~DI---kkH~Wf~gfdweglr~~~--L~pPi~~~va~ptD~s~Fd~~ 713 (732)
T KOG0614|consen 641 PRRITKTATDLIKKLCRDNPTERLGY--QKGGINDI---KKHRWFEGFDWEGLRSRT--LPPPIIPSVANPTDVSNFDNF 713 (732)
T ss_pred ccccchhHHHHHHHHHhcCcHhhhcc--ccCChHHH---HhhhhhhcCChhhhhhcc--CCCCccccCCCcccchhccCC
Confidence 46688999999999999999999762 11122222 234788899999998876 455555666777777776666
Q ss_pred CCCCCCcC
Q 015406 321 IASGDRQT 328 (407)
Q Consensus 321 ~~~~~~~~ 328 (407)
+...+..+
T Consensus 714 p~dnd~pp 721 (732)
T KOG0614|consen 714 PPDNDEPP 721 (732)
T ss_pred CcccCCCC
Confidence 65544433
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=314.65 Aligned_cols=256 Identities=18% Similarity=0.219 Sum_probs=198.7
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCe----EEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeeeCcee
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNE----EVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~----~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 78 (407)
.++|++.+.||+|+||.||+|.+..+++ .|++|.+...... ..+..|+.++..+.| +++..+..+.. +...
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h-~~iv~~~~~~~-~~~~ 83 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDH-AYIVRLLGICP-GASL 83 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCC-CCcceEEEEEC-CCcc
Confidence 4689999999999999999999877776 4777776533222 235556667777776 45555555544 3456
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeec
Q 015406 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~ 157 (407)
+++|||+ +++|.+++......+++..++.|+.||+.||.|||++|++||||||+|||+ +.++.+||+|||+++...
T Consensus 84 ~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili---~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILL---KSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEEcCCccceecc
Confidence 7889998 999999998766679999999999999999999999999999999999999 578899999999998664
Q ss_pred cCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhccccc
Q 015406 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (407)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (407)
...... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+..... ...+........
T Consensus 161 ~~~~~~-----~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~----~~~~~~~~~~~~ 231 (279)
T cd05111 161 PDDKKY-----FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE----VPDLLEKGERLA 231 (279)
T ss_pred CCCccc-----ccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHHHCCCcCC
Confidence 332211 1224457788999999998899999999999999999998 999997754321 222222111111
Q ss_pred HHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Q 015406 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (407)
Q Consensus 237 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~ 278 (407)
....++.++.+++.+||..+|++||++.++.+.|..+..
T Consensus 232 ---~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 232 ---QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred ---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 123467889999999999999999999999998888764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=312.66 Aligned_cols=250 Identities=17% Similarity=0.268 Sum_probs=202.0
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEec
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~ 84 (407)
.++|++.+.||+|+||.||+|.+. .+..||+|.+..... ...+.+|+.+++.++| ++++.+.+++......+++|||
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSH-EKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcccHHHHHHHHHHHhcCCC-CCeeeEEEEEccCCCcEEEEEc
Confidence 357999999999999999999864 345699998765432 3468899999999986 6777777777777888999999
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCc
Q 015406 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (407)
Q Consensus 85 ~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~ 163 (407)
+ +++|.+++......+++..++.++.||+.||.|||++|++|+||||+||++ +.++.+||+|||+++.......
T Consensus 81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~d~g~~~~~~~~~~-- 155 (256)
T cd05113 81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLV---DDQGCVKVSDFGLSRYVLDDEY-- 155 (256)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCCEEECCCccceecCCCce--
Confidence 9 889999998655579999999999999999999999999999999999999 5778999999999986543321
Q ss_pred ccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHHhc
Q 015406 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (407)
Q Consensus 164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (407)
.......++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ......+....... ...
T Consensus 156 ----~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~~----~~~ 224 (256)
T cd05113 156 ----TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN---SETVEKVSQGLRLY----RPH 224 (256)
T ss_pred ----eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HHHHHHHhcCCCCC----CCC
Confidence 11123345678999999998889999999999999999998 9999976443 23333333322211 123
Q ss_pred CCcHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 015406 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRIF 273 (407)
Q Consensus 243 ~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l 273 (407)
..+.++.+++.+||+.+|++||++.+|.+.|
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 225 LASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred CCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 4688999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=318.50 Aligned_cols=257 Identities=21% Similarity=0.312 Sum_probs=204.9
Q ss_pred CCceeEeccccccCceEEEEEEEc-----CCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCce
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~-----~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 77 (407)
.++|.+.+.||+|+||.||+|.+. .++..||+|.++.... .+.+..|+.+++++.+|+++..+..++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 458999999999999999999752 3456899998765432 23477899999999656788888778888888
Q ss_pred eEEEEecc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceee
Q 015406 78 NVLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~ 155 (407)
.+++|||+ +++|.+++.... ..+++..++.++.|++.||+|||+++|+|+||||+|||+ +.++.++|+|||+++.
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLL---THGKIVKICDFGLARD 190 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEE---cCCCeEEECCCccccc
Confidence 99999999 899999997533 238999999999999999999999999999999999999 5778999999999986
Q ss_pred eccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhccc
Q 015406 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVS 234 (407)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (407)
....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||....... .+.+.......
T Consensus 191 ~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~---~~~~~~~~~~~ 262 (302)
T cd05055 191 IMNDSNY-----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS---KFYKLIKEGYR 262 (302)
T ss_pred ccCCCce-----eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH---HHHHHHHcCCc
Confidence 5443211 11223456788999999999899999999999999999998 999997654321 12222111111
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 015406 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (407)
Q Consensus 235 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l 276 (407)
. ......++++.+++.+||+.+|++||++.++.+.|+++
T Consensus 263 ~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 263 M---AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred C---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1 12234688999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=317.18 Aligned_cols=256 Identities=17% Similarity=0.317 Sum_probs=202.2
Q ss_pred ceeEeccccccCceEEEEEEEcC-----CCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeE
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~-----~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 79 (407)
+|++.+.||+|+||.||+|++.. ....+|+|.+..... ...+..|+.+++.++| +++..+...+...+..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNH-PHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCC-CCEeeEEEEEecCCCcE
Confidence 58899999999999999998753 235799998765432 2357789999999987 55556666667777889
Q ss_pred EEEecc-CCCHHHHHHHcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCccc
Q 015406 80 LVMDLL-GPSLEDLFNFCS-----------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 135 (407)
Q Consensus 80 lvme~~-g~sL~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NIL 135 (407)
++|||+ +++|.+++.... ..+++..++.++.|++.||.|||+++|+||||||+|||
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil 159 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL 159 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence 999999 899999986421 24788999999999999999999999999999999999
Q ss_pred ccCCCCCceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCC
Q 015406 136 MGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQ 214 (407)
Q Consensus 136 l~~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~ 214 (407)
+ ++++.+||+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||.
T Consensus 160 l---~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 231 (290)
T cd05045 160 V---AEGRKMKISDFGLSRDVYEEDSY-----VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 231 (290)
T ss_pred E---cCCCcEEeccccccccccCccch-----hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCC
Confidence 9 57789999999999865433221 11223345678999999998889999999999999999998 999997
Q ss_pred CCCcCchHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHH
Q 015406 215 GLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (407)
Q Consensus 215 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~ 279 (407)
+... .+....+... ... .....++.++.+++..||+.+|++||++.++.+.|++++.+
T Consensus 232 ~~~~---~~~~~~~~~~-~~~---~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 232 GIAP---ERLFNLLKTG-YRM---ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred CCCH---HHHHHHHhCC-CCC---CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 6433 2222222221 111 12345789999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=326.96 Aligned_cols=258 Identities=22% Similarity=0.338 Sum_probs=201.2
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC--cchHHHHHHHHHHHcCCCCCCeeEEeeeeCc-eeEEEEe
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGD-YNVLVMD 83 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~-~~~lvme 83 (407)
++|.-...||+|+||.||+|.. .++..||||.+..... ..+|..|+.++.+++| +|++.+.+|+.+.+ ..+||+|
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H-~Nlv~LlGyC~e~~~~~~LVYE 152 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRH-PNLVKLLGYCLEGGEHRLLVYE 152 (361)
T ss_pred hCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCC-cCcccEEEEEecCCceEEEEEE
Confidence 5677778999999999999996 5558999998776554 4669999999999995 77778888888777 5999999
Q ss_pred cc-CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 84 LL-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 84 ~~-g~sL~~~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~---~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
|+ +|+|.+.+..... .++|...++|+.++|.||+|||+. .||||||||+|||| |.+..+||+|||+|+....
T Consensus 153 ym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL---D~~~~aKlsDFGLa~~~~~ 229 (361)
T KOG1187|consen 153 YMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL---DEDFNAKLSDFGLAKLGPE 229 (361)
T ss_pred ccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE---CCCCCEEccCccCcccCCc
Confidence 99 8999999986555 899999999999999999999984 49999999999999 7899999999999975543
Q ss_pred -CCCCcccCccCCCCc-cccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCch---HH-HHHHHhhhc
Q 015406 159 -TSTHQHIPYRENKNL-TGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK---KQ-KYEKISEKK 232 (407)
Q Consensus 159 -~~~~~~~~~~~~~~~-~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~---~~-~~~~i~~~~ 232 (407)
... .... .||..|+|||++.....+.|+|||||||+|+||++|+.+......... .+ ....+....
T Consensus 230 ~~~~--------~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~ 301 (361)
T KOG1187|consen 230 GDTS--------VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGK 301 (361)
T ss_pred cccc--------eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcc
Confidence 211 1122 799999999999988999999999999999999999988875331111 11 111111111
Q ss_pred ccccHH-HHh-cCCc-----HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHH
Q 015406 233 VSTSIE-ALC-RGYP-----TEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (407)
Q Consensus 233 ~~~~~~-~~~-~~~~-----~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~ 277 (407)
....++ .+. ..++ ..+..+..+|++.+|.+||++.++.+.|+.+.
T Consensus 302 ~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 302 LREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred hhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 111111 111 2233 23678888999999999999999988885543
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=313.48 Aligned_cols=252 Identities=18% Similarity=0.365 Sum_probs=198.5
Q ss_pred eeEeccccccCceEEEEEEEcCC---CeEEEEEEecCCCCc----chHHHHHHHHHHHcCCCCCCeeEEeeeeC------
Q 015406 9 FRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEG------ 75 (407)
Q Consensus 9 y~i~~~iG~G~~g~Vy~~~~~~~---~~~vAvK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~------ 75 (407)
|++.+.||+|+||.||+|....+ +..||+|.+..+... ..+..|++.++.++|+ ++..+..+....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHP-NVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCC-CeeeEEeeeccCCccccC
Confidence 67899999999999999987643 478999988754322 3577899999999875 454454443322
Q ss_pred ceeEEEEecc-CCCHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEe
Q 015406 76 DYNVLVMDLL-GPSLEDLFNFC-----SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID 149 (407)
Q Consensus 76 ~~~~lvme~~-g~sL~~~l~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~D 149 (407)
...+++|||+ +++|.+++... ...+++..++.++.|++.||.|||+++|+||||||+||++ ++++.+||+|
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~d 156 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCML---REDMTVCVAD 156 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEE---CCCCeEEECC
Confidence 2479999999 99999998542 1358999999999999999999999999999999999999 5788999999
Q ss_pred ccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHH
Q 015406 150 FGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKI 228 (407)
Q Consensus 150 FGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i 228 (407)
||+++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||.+... .+.+..+
T Consensus 157 fg~~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---~~~~~~~ 228 (273)
T cd05035 157 FGLSKKIYSGDYY-----RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---HEIYDYL 228 (273)
T ss_pred ccceeeccccccc-----cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH
Confidence 9999876543321 11222345678999999998889999999999999999999 9999976443 3333333
Q ss_pred hhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 015406 229 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (407)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l 276 (407)
...... .....++.++.+++.+||+.||++||++.++.+.|+++
T Consensus 229 ~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 229 RHGNRL----KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HcCCCC----CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 332221 23356889999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=313.39 Aligned_cols=253 Identities=19% Similarity=0.333 Sum_probs=196.7
Q ss_pred eeEeccccccCceEEEEEEEcCCCe--EEEEEEecCCCC----cchHHHHHHHHHHHcCCCCCCeeEEeee-----eCce
Q 015406 9 FRLGRKIGSGSFGEIYLGTNIQTNE--EVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGV-----EGDY 77 (407)
Q Consensus 9 y~i~~~iG~G~~g~Vy~~~~~~~~~--~vAvK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~-----~~~~ 77 (407)
|.+.+.||+|+||.||+|++..++. .||+|.++.... ...+..|..+++.++|.+.+..+..+.. ....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4678999999999999999877765 699998765421 2347789999999987554444433322 1235
Q ss_pred eEEEEecc-CCCHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEecc
Q 015406 78 NVLVMDLL-GPSLEDLFNFC-----SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 151 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFG 151 (407)
.+++|||+ +++|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||+ +.++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCML---NENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEE---cCCCCEEECCCC
Confidence 68999999 89999887432 2348999999999999999999999999999999999999 578899999999
Q ss_pred ceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhh
Q 015406 152 LAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISE 230 (407)
Q Consensus 152 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~ 230 (407)
+++.+..... ........+++.|+|||.+.+..++.++||||||+++|||++ |..||..... .+.+..+..
T Consensus 158 ~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~ 229 (272)
T cd05075 158 LSKKIYNGDY-----YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---SEIYDYLRQ 229 (272)
T ss_pred cccccCcccc-----eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHc
Confidence 9987644321 111223346778999999999899999999999999999999 8999976433 333444433
Q ss_pred hcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 015406 231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (407)
Q Consensus 231 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l 276 (407)
.... .....++..+.+++.+||..||++||++.+|.+.|+++
T Consensus 230 ~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 230 GNRL----KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCC----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 2211 12346789999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=318.15 Aligned_cols=253 Identities=20% Similarity=0.241 Sum_probs=202.8
Q ss_pred CceeEeccccccCceEEEEEEEcCC-----CeEEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeeeCcee
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQT-----NEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~-----~~~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 78 (407)
.+|++.+.||+|+||.||+|.+..+ +..||||+++..... ..+..|+.++..++| +++..+..+.......
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h-~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQH-PNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCC-CCcCeEEEEEcCCCce
Confidence 4688999999999999999987543 578999998754432 346778888888886 5666666777777788
Q ss_pred EEEEecc-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCC
Q 015406 79 VLVMDLL-GPSLEDLFNFC---------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 142 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~~---------------~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~ 142 (407)
++++||+ +++|.+++... +..+++..++.++.|++.||.|||++||+||||||+|||+ +++
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~---~~~ 160 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV---FDK 160 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEe---cCC
Confidence 9999999 89999998531 1347889999999999999999999999999999999999 577
Q ss_pred ceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCch
Q 015406 143 NQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTK 221 (407)
Q Consensus 143 ~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~ 221 (407)
+.+||+|||+++........ .......+++.|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--- 232 (283)
T cd05091 161 LNVKISDLGLFREVYAADYY-----KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--- 232 (283)
T ss_pred CceEecccccccccccchhe-----eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---
Confidence 88999999998865433211 11233456789999999998889999999999999999998 8889976433
Q ss_pred HHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 015406 222 KQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 275 (407)
Q Consensus 222 ~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~ 275 (407)
.+.+..+...... .....+|.++.+++.+||+.+|++||++.+|...|+.
T Consensus 233 ~~~~~~i~~~~~~----~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 233 QDVIEMIRNRQVL----PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHHHcCCcC----CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 3444444443322 2335689999999999999999999999999988863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=311.60 Aligned_cols=249 Identities=20% Similarity=0.292 Sum_probs=201.2
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~ 85 (407)
.+|++.+.||+|+||.||+|.+. ++..+|+|++..... ...+..|+.+++.++| +++..+..++...+..+++|||+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSH-PNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCC-CCEEEEEEEEcCCCceEEEEecC
Confidence 56899999999999999999875 566899998765432 3467889999999986 56666777777788899999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcc
Q 015406 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164 (407)
Q Consensus 86 -g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~ 164 (407)
+++|.+++......+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||+++...+....
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~dfg~~~~~~~~~~~-- 156 (256)
T cd05059 82 ANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLV---GEDNVVKVSDFGLARYVLDDQYT-- 156 (256)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEE---CCCCcEEECCcccceeccccccc--
Confidence 899999997655678999999999999999999999999999999999999 57889999999999865432211
Q ss_pred cCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcC
Q 015406 165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243 (407)
Q Consensus 165 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (407)
......++..|+|||.+.+..++.++||||||+++|+|++ |..||..... .+....+...... .....
T Consensus 157 ----~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~----~~~~~ 225 (256)
T cd05059 157 ----SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN---SEVVESVSAGYRL----YRPKL 225 (256)
T ss_pred ----ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH---HHHHHHHHcCCcC----CCCCC
Confidence 1112234567999999999899999999999999999999 8999976433 3333333322111 12245
Q ss_pred CcHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 015406 244 YPTEFASYFHYCRSLRFDDKPDYAYLKRIF 273 (407)
Q Consensus 244 ~~~~l~~li~~cl~~~p~~RPt~~~l~~~l 273 (407)
+|.++.+++.+||..+|++||++.++.+.|
T Consensus 226 ~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 226 APTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 789999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=325.93 Aligned_cols=250 Identities=18% Similarity=0.234 Sum_probs=193.6
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~ 85 (407)
...|++.+.||+|+||.||+|++..+++.||+|+... .....|+.+++.++| ++++.+..++......++|||++
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~----~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK----GTTLIEAMLLQNVNH-PSVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc----cccHHHHHHHHhCCC-CCCcChhheEEeCCeeEEEEEcc
Confidence 3569999999999999999999999999999997433 234679999999987 56667777777888899999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCccc
Q 015406 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165 (407)
Q Consensus 86 g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~ 165 (407)
.++|.+++......+++..++.|+.||+.||.|||++|||||||||+|||+ +..+.+||+|||+++.......
T Consensus 140 ~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~---- 212 (357)
T PHA03209 140 SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI---NDVDQVCIGDLGAAQFPVVAPA---- 212 (357)
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEecCccccccccCcc----
Confidence 889999987666779999999999999999999999999999999999999 6788999999999975332211
Q ss_pred CccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchH-------HHHHHHhhh-c-----
Q 015406 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK-------QKYEKISEK-K----- 232 (407)
Q Consensus 166 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~-------~~~~~i~~~-~----- 232 (407)
.....||..|+|||++.+..++.++|||||||++|||+++..|+......... ..+..+... .
T Consensus 213 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 288 (357)
T PHA03209 213 ----FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEE 288 (357)
T ss_pred ----cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhh
Confidence 23457899999999999999999999999999999999855554332221100 011111100 0
Q ss_pred cc-----ccHH------------------HHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 233 VS-----TSIE------------------ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 233 ~~-----~~~~------------------~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.. .... .-...++.++..+|.+||+.||.+|||+.++++
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~ 350 (357)
T PHA03209 289 FPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN 350 (357)
T ss_pred cCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence 00 0000 001245777888999999999999999887654
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=347.77 Aligned_cols=264 Identities=25% Similarity=0.339 Sum_probs=205.1
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
++|++.++||+|+||.||+|++..+++.||||++..... ...+.+|++++..++| ++++.+..++.+++..|++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~H-PNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIH-PGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCC-cCcCeEEEEEeeCCEEEEE
Confidence 689999999999999999999999999999998865322 2357889999999987 6666667777788899999
Q ss_pred Eecc-CCCHHHHHHHc----------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEec
Q 015406 82 MDLL-GPSLEDLFNFC----------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 150 (407)
Q Consensus 82 me~~-g~sL~~~l~~~----------~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DF 150 (407)
|||+ |++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.++|+||
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILL---d~dg~vKLiDF 157 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILL---GLFGEVVILDW 157 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEE---cCCCCEEEEec
Confidence 9999 99999998642 1235677889999999999999999999999999999999 57889999999
Q ss_pred cceeeeccCCCCc-----------ccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcC
Q 015406 151 GLAKKYRDTSTHQ-----------HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 219 (407)
Q Consensus 151 Gla~~~~~~~~~~-----------~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~ 219 (407)
|+++......... ..........+||+.|+|||++.+..++.++|||||||++|||++|..||......
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 9998762211100 00011123457999999999999999999999999999999999999999763321
Q ss_pred chHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHHHH
Q 015406 220 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP-DYAYLKRIFRDLFIR 279 (407)
Q Consensus 220 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~~l~~~l~~l~~~ 279 (407)
.. ....... .+........+|+.+.+++.+||+.||++|| +++++.+.|+..+..
T Consensus 238 ki--~~~~~i~---~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 238 KI--SYRDVIL---SPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hh--hhhhhcc---ChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 11 1111000 0000011246889999999999999999996 567777877777653
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=317.88 Aligned_cols=257 Identities=19% Similarity=0.325 Sum_probs=206.0
Q ss_pred CCceeEeccccccCceEEEEEEEcCC-----CeEEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeeeCce
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQT-----NEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~-----~~~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 77 (407)
.++|++.+.||+|+||.||++.+... ...+|+|.+...... ..+.+|+.+++.+..|+++..+..++.....
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 47899999999999999999997643 378999987654322 3477899999999656777777777777888
Q ss_pred eEEEEecc-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCC
Q 015406 78 NVLVMDLL-GPSLEDLFNFC---------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 141 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~~~---------------~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~ 141 (407)
.+++|||+ +++|.+++... ...+++..++.++.|++.||+|||+++|+||||||+|||+ +.
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~---~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV---TE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE---cC
Confidence 99999999 89999999642 2458999999999999999999999999999999999999 57
Q ss_pred CceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCc
Q 015406 142 ANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGT 220 (407)
Q Consensus 142 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~ 220 (407)
++.+||+|||+++.+...... .......++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-- 240 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYY-----RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-- 240 (293)
T ss_pred CCeEEeCccccccccccccce-----eccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH--
Confidence 889999999999876543221 11122345678999999998889999999999999999998 9999976433
Q ss_pred hHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHH
Q 015406 221 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (407)
Q Consensus 221 ~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~ 277 (407)
.+.+..+...... .....++.++.+++.+||..+|++||++.++.+.|+.++
T Consensus 241 -~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 241 -EELFKLLKEGYRM----EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -HHHHHHHHcCCcC----CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 2333333322211 122457889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=310.72 Aligned_cols=247 Identities=20% Similarity=0.335 Sum_probs=194.6
Q ss_pred ccccccCceEEEEEEE--cCCCeEEEEEEecCCCCc----chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-
Q 015406 13 RKIGSGSFGEIYLGTN--IQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (407)
Q Consensus 13 ~~iG~G~~g~Vy~~~~--~~~~~~vAvK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~- 85 (407)
+.||+|+||.||+|.+ ..++..+|+|+++..... ..+..|+.+++.+.|. ++..+.++.. .+..+++|||+
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~-~~~~~lv~e~~~ 78 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNP-YIVRMIGICE-AESWMLVMELAE 78 (257)
T ss_pred CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCC-CcceEEEEEc-CCCcEEEEecCC
Confidence 3689999999999964 456789999988654432 3477889999999874 5555555443 45668999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCccc
Q 015406 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165 (407)
Q Consensus 86 g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~ 165 (407)
+++|.+++.. ...+++..++.++.|++.||+|||++||+||||||.|||+ +.++.+||+|||+++.........
T Consensus 79 ~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill---~~~~~~kl~Dfg~~~~~~~~~~~~-- 152 (257)
T cd05116 79 LGPLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLL---VTQHYAKISDFGLSKALGADENYY-- 152 (257)
T ss_pred CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEE---cCCCeEEECCCccccccCCCCCee--
Confidence 7899999975 4579999999999999999999999999999999999999 577899999999998764432210
Q ss_pred CccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCC
Q 015406 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 244 (407)
Q Consensus 166 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (407)
.......++..|+|||.+.+..++.++|||||||++|||++ |..||..... ......+...... ..+..+
T Consensus 153 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~i~~~~~~----~~~~~~ 223 (257)
T cd05116 153 --KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG---NEVTQMIESGERM----ECPQRC 223 (257)
T ss_pred --eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHCCCCC----CCCCCC
Confidence 11122344678999999988889999999999999999998 9999976443 2333333332221 133568
Q ss_pred cHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 015406 245 PTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (407)
Q Consensus 245 ~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l 276 (407)
++++.++|.+||+.||++||++++|.+.|+..
T Consensus 224 ~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 224 PPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 99999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=312.52 Aligned_cols=256 Identities=16% Similarity=0.267 Sum_probs=205.6
Q ss_pred CCceeEeccccccCceEEEEEEEcCCC---eEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTN---EEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~---~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 79 (407)
.++|++.+.||+|+||.||+|++..++ ..+|+|.++.... ...+..|+.+++.++| +++..+..++...+..+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~ 81 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDH-PNIIHLEGVVTKSKPVM 81 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCC-CCcceEEEEEecCCccE
Confidence 468999999999999999999976544 3799998765332 2357889999999976 66777777777888899
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 80 lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
++|||+ +++|.+++......+++..++.++.|++.||+|||++|++||||||+|||+ +.++.++|+|||++.....
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili---~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILV---NSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEE---CCCCeEEeCCCCccccccc
Confidence 999999 899999998755678999999999999999999999999999999999999 5788999999999987654
Q ss_pred CCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccH
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (407)
..... .......++..|+|||.+.+..++.++||||||+++||+++ |..||.+... .+....+......
T Consensus 159 ~~~~~----~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~---~~~~~~~~~~~~~--- 228 (267)
T cd05066 159 DPEAA----YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN---QDVIKAIEEGYRL--- 228 (267)
T ss_pred cccee----eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH---HHHHHHHhCCCcC---
Confidence 32211 11122334568999999998889999999999999999886 9999976543 2333333332111
Q ss_pred HHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 015406 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (407)
Q Consensus 238 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l 276 (407)
.....+|+.+.+++.+||+.+|++||++.++.+.|.++
T Consensus 229 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 -PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 12245789999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=311.67 Aligned_cols=255 Identities=24% Similarity=0.343 Sum_probs=205.4
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
++|++.+.||+|+||.||+|++..+++.||||.+.... ....+..|+.+++.+.| +++..+..++...+..+++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH-PNVIKYYASFIEDNELNIV 80 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccC-CchhhhhheeEeCCeEEEE
Confidence 57999999999999999999998999999999765422 12357789999999976 5666666667777889999
Q ss_pred Eecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeec
Q 015406 82 MDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (407)
Q Consensus 82 me~~-g~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~ 157 (407)
|||+ +++|.+++... ...+++..++.++.||+.||.|||++|++|+||||+||++ +.++.++|+|||++..+.
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEECcchhhhccc
Confidence 9999 88999998642 3458999999999999999999999999999999999999 577899999999987664
Q ss_pred cCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccH
Q 015406 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (407)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (407)
..... .....|+..|+|||.+.+..++.++||||||+++|+|++|..||.+... ........+........
T Consensus 158 ~~~~~-------~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~- 228 (267)
T cd08229 158 SKTTA-------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKKIEQCDYPPL- 228 (267)
T ss_pred cCCcc-------cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc-hHHHHhhhhhcCCCCCC-
Confidence 43221 1245688999999999998899999999999999999999999976432 12222222222211111
Q ss_pred HHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 015406 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (407)
Q Consensus 238 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l 276 (407)
....+++++.+++.+||..+|++|||+.+|.+.++++
T Consensus 229 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 229 --PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred --CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 1134788999999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=312.61 Aligned_cols=253 Identities=20% Similarity=0.245 Sum_probs=198.1
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
+|++.+.||+|++|.||+|++..+++.||||.+..... ...+..|+.+++.+.| +++..+..+...+...|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQH-PNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCC-CCEeeeEEEEeeCCeEEEEEe
Confidence 58999999999999999999999999999998764322 2457889999999986 667777777778888999999
Q ss_pred ccCCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCC
Q 015406 84 LLGPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 84 ~~g~sL~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~ 161 (407)
|+.++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++........
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 80 FLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLI---DNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred cCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---cCCCcEEECcccceeecCCCcc
Confidence 99889999886533 468999999999999999999999999999999999999 5788999999999976543221
Q ss_pred CcccCccCCCCccccccccccccccCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHh-----------
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS----------- 229 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~----------- 229 (407)
......+++.|+|||.+.+. .++.++|||||||++|+|++|+.||.+..............
T Consensus 157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (285)
T cd07861 157 -------VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGV 229 (285)
T ss_pred -------cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcc
Confidence 12234678899999998764 46899999999999999999999997643211111100000
Q ss_pred ----------hhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 230 ----------EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 230 ----------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
..............+++++.++|.+||..||++||++.+|.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 230 TSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000011112223457899999999999999999999887764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=317.35 Aligned_cols=260 Identities=17% Similarity=0.264 Sum_probs=199.1
Q ss_pred CCceeEeccccccCceEEEEEEEcC----------------CCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCC
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQ----------------TNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIP 66 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~----------------~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~ 66 (407)
.++|++.++||+|+||.||++++.. ++..||+|++..... ...+.+|+.+++.++| +++.
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~-~~i~ 82 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKD-PNII 82 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CCcc
Confidence 4679999999999999999986432 345799998865432 2357889999999976 6666
Q ss_pred eeEEeeeeCceeEEEEecc-CCCHHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCccc
Q 015406 67 NVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS----------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 135 (407)
Q Consensus 67 ~~~~~~~~~~~~~lvme~~-g~sL~~~l~~~~----------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NIL 135 (407)
.+..++...+..+++|||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil 162 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL 162 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence 7777777788899999999 899999987532 23678899999999999999999999999999999999
Q ss_pred ccCCCCCceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh--CCCCC
Q 015406 136 MGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR--GSLPW 213 (407)
Q Consensus 136 l~~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt--G~~Pf 213 (407)
+ +.++.++|+|||+++.+...... .......++..|++||...+..++.++|||||||++|||++ |..||
T Consensus 163 i---~~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~ 234 (296)
T cd05095 163 V---GKNYTIKIADFGMSRNLYSGDYY-----RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPY 234 (296)
T ss_pred E---cCCCCEEeccCcccccccCCcce-----eccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCc
Confidence 9 57889999999999865433211 11123345678999999888889999999999999999998 78999
Q ss_pred CCCCcCchHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015406 214 QGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 274 (407)
Q Consensus 214 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~ 274 (407)
..............................+++.+.+++.+||..||++||++.+|.+.|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 235 SQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred cccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 7644322221111111110000001112457899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=309.64 Aligned_cols=251 Identities=22% Similarity=0.395 Sum_probs=199.6
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEec
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~ 84 (407)
.++|++.++||+|+||.||+|.+..+ ..+|+|.+..... ...+.+|+.+++.+.|++.++.+. +. ..+..+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~-~~-~~~~~~~v~e~ 81 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYA-VV-SEEPIYIVTEF 81 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEE-EE-cCCCcEEEEEc
Confidence 47899999999999999999997554 4699998765432 345788999999999866555443 33 34557899999
Q ss_pred c-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 85 L-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 85 ~-g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
+ +++|.+++.... ..+++..+..++.|++.||.|||+.||+||||||+||++ ++++.++|+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill---~~~~~~~l~dfg~~~~~~~~~~- 157 (260)
T cd05069 82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILV---GDNLVCKIADFGLARLIEDNEY- 157 (260)
T ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCeEEECCCccceEccCCcc-
Confidence 9 789999997533 348999999999999999999999999999999999999 6788999999999987643321
Q ss_pred cccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHHh
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (407)
.......++..|+|||.+.+..++.++||||||+++|||++ |..||.+... ......+...... ...
T Consensus 158 -----~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~~~~~~----~~~ 225 (260)
T cd05069 158 -----TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN---REVLEQVERGYRM----PCP 225 (260)
T ss_pred -----cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC----CCC
Confidence 11223346778999999998889999999999999999999 9999987443 2333333222111 123
Q ss_pred cCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 015406 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 275 (407)
Q Consensus 242 ~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~ 275 (407)
..++..+.+++.+||..||++||+++++.+.|++
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 226 QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 4578999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=317.95 Aligned_cols=260 Identities=18% Similarity=0.314 Sum_probs=207.5
Q ss_pred CCceeEeccccccCceEEEEEEEcC-------CCeEEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeeeC
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQ-------TNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEG 75 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~-------~~~~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~ 75 (407)
.++|.+.++||+|+||.||+|++.. ....||+|++...... ..+..|+.+++.+.+|+++..+..++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 4689999999999999999998632 3457999987654322 24678999999997668888888777778
Q ss_pred ceeEEEEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCC
Q 015406 76 DYNVLVMDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 139 (407)
Q Consensus 76 ~~~~lvme~~-g~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~ 139 (407)
...+++|||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill--- 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV--- 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE---
Confidence 8899999999 899999997532 348899999999999999999999999999999999999
Q ss_pred CCCceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015406 140 RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 218 (407)
Q Consensus 140 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~ 218 (407)
+.++.+||+|||+++......... ......++..|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYK-----KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred cCCCcEEEcccccccccccccccc-----ccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 577899999999998664322111 0112234568999999999889999999999999999999 8999976433
Q ss_pred CchHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHc
Q 015406 219 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (407)
Q Consensus 219 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~ 280 (407)
.+.+..+...... .....++.++.+++.+||..+|++||++.++.+.|.++....
T Consensus 243 ---~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 243 ---EELFKLLREGHRM----DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred ---HHHHHHHHcCCCC----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 3333333332211 123457889999999999999999999999999999887644
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=310.73 Aligned_cols=252 Identities=21% Similarity=0.373 Sum_probs=201.9
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
..++|++.++||+|+||.||+|.. .+++.||+|.+..... ...+.+|+.+++.++|. ++..+..+. ..+..+++||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~-~i~~~~~~~-~~~~~~~v~e 80 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHP-RLVRLYAVV-TQEPIYIITE 80 (260)
T ss_pred chHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCc-CeeeEEEEE-ccCCcEEEEE
Confidence 457899999999999999999986 4677899998775433 34688999999999874 555555544 3456799999
Q ss_pred cc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCC
Q 015406 84 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 84 ~~-g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~ 161 (407)
|+ +++|.+++... +..+++..++.++.|++.||+|||+.|++||||||+||++ ++++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILV---SETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEE---cCCCCEEEccCcceeecCCCCc
Confidence 99 89999998653 3468999999999999999999999999999999999999 5788999999999987653221
Q ss_pred CcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHH
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (407)
. ......++..|+|||++.+..++.++||||||+++|||++ |..||.+.... +....+...... ..
T Consensus 158 ~------~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~~~~~----~~ 224 (260)
T cd05067 158 T------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP---EVIQNLERGYRM----PR 224 (260)
T ss_pred c------cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH---HHHHHHHcCCCC----CC
Confidence 1 1223456778999999998889999999999999999999 99999865432 233333222111 12
Q ss_pred hcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 015406 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 275 (407)
Q Consensus 241 ~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~ 275 (407)
...+|.++.+++.+||..+|++||++++|.+.|++
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 225 PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 34578899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=313.70 Aligned_cols=248 Identities=25% Similarity=0.421 Sum_probs=196.1
Q ss_pred eEeccccccCceEEEEEEEc----CCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 10 RLGRKIGSGSFGEIYLGTNI----QTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 10 ~i~~~iG~G~~g~Vy~~~~~----~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
.+.+.||.|.||.||+|.+. ..+..|+||.++.... ...+..|++.++.++| +++..+.++.......++||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRH-PNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSB-TTBE-EEEEEESSSSEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccc-cccccccccccccccccccc
Confidence 57889999999999999987 4467899999965433 2468899999999955 77777777777777789999
Q ss_pred ecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 83 DLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 83 e~~-g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
||+ +++|.+++... ...+++..++.|+.||+.||.|||+++|+|+||+++|||+ +.++.+||+|||++.......
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill---~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILL---DSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE---ETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccc
Confidence 999 78999999875 4679999999999999999999999999999999999999 578899999999998763222
Q ss_pred CCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHH
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (407)
.. .......+...|+|||.+.+..++.++||||||+++|||++ |+.||.+... .+....+...... .
T Consensus 158 ~~-----~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~---~~~~~~~~~~~~~----~ 225 (259)
T PF07714_consen 158 KY-----KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN---EEIIEKLKQGQRL----P 225 (259)
T ss_dssp SE-----EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH---HHHHHHHHTTEET----T
T ss_pred cc-----cccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccc----e
Confidence 11 11234457789999999998889999999999999999999 7899977533 4444444333321 1
Q ss_pred HhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 015406 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIF 273 (407)
Q Consensus 240 ~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l 273 (407)
....+|..+.++|.+||+.+|++||++.+|.+.|
T Consensus 226 ~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 2345899999999999999999999999998765
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=309.05 Aligned_cols=246 Identities=21% Similarity=0.257 Sum_probs=202.6
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC---CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEec
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~ 84 (407)
+|++.+.||.|+||.||++.+..+++.||+|.++... ..+.+..|+.+++.++| +++..+...+...+..|++|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKH-PNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCC-CCcceEEEEEEECCEEEEEEee
Confidence 5899999999999999999999999999999875432 23457788899998887 5667777777888899999999
Q ss_pred c-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 85 L-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 85 ~-g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
+ +++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+||++ ++++.++|+|||++........
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFL---TQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE---CCCCcEEEcccCcceeeccccc-
Confidence 9 89999988643 3458999999999999999999999999999999999999 5788999999999987654322
Q ss_pred cccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhc
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (407)
......|++.|+|||++.+..++.++|+||||+++|+|++|..||...+. ......+...... .+..
T Consensus 156 ------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~---~~~~~~~~~~~~~----~~~~ 222 (255)
T cd08219 156 ------YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW---KNLILKVCQGSYK----PLPS 222 (255)
T ss_pred ------ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH---HHHHHHHhcCCCC----CCCc
Confidence 12345789999999999998899999999999999999999999976332 3333333332221 1234
Q ss_pred CCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 243 ~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.++.++.+++.+||+.||++||++.+|..
T Consensus 223 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 223 HYSYELRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred ccCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence 57889999999999999999999988865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=310.56 Aligned_cols=250 Identities=28% Similarity=0.463 Sum_probs=201.5
Q ss_pred eeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcch----HHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEec
Q 015406 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ----LLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (407)
Q Consensus 9 y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~----~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~ 84 (407)
|++++.||+|+||.||++++..+++.||+|++........ ...|+.+++.+. ++++..+..+.......+++||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLR-HPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHT-BTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccc-ccccccccccccccccccccccc
Confidence 8999999999999999999999999999999887654332 345899999995 47777788888888999999999
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCc
Q 015406 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (407)
Q Consensus 85 ~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~ 163 (407)
+ +++|.+++.. ...+++..++.++.||+.||.+||++||+|+||||+||++ +.++.++|+|||.+........
T Consensus 80 ~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~---~~~~~~~l~Dfg~~~~~~~~~~-- 153 (260)
T PF00069_consen 80 CPGGSLQDYLQK-NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILL---DENGEVKLIDFGSSVKLSENNE-- 153 (260)
T ss_dssp ETTEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEE---STTSEEEESSGTTTEESTSTTS--
T ss_pred cccccccccccc-cccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccc--
Confidence 9 5599999983 4579999999999999999999999999999999999999 6889999999999986522111
Q ss_pred ccCccCCCCcccccccccccccc-CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhc
Q 015406 164 HIPYRENKNLTGTARYASMNTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (407)
Q Consensus 164 ~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (407)
......++..|+|||++. +..++.++||||||+++|+|++|..||......+....+.+........... ...
T Consensus 154 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 227 (260)
T PF00069_consen 154 -----NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ-QSR 227 (260)
T ss_dssp -----EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT-SHT
T ss_pred -----ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc-ccc
Confidence 134567899999999998 7889999999999999999999999998753323333333333221111100 011
Q ss_pred CCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 243 ~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
..+.++.+++.+||+.||++||++.++++
T Consensus 228 ~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 228 EKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred hhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 12489999999999999999999888764
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=306.98 Aligned_cols=255 Identities=23% Similarity=0.336 Sum_probs=206.1
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
++|++.+.||+|+||.||+|.+..+++.||+|.++... ....+.+|+++++.++| +++..+..++...+..+++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~-~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH-PNVIKYLASFIENNELNIV 80 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCC-CCeeeeeeeeecCCeEEEE
Confidence 68999999999999999999998899999999775321 23457889999999976 5566666666677888999
Q ss_pred Eecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeec
Q 015406 82 MDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (407)
Q Consensus 82 me~~-g~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~ 157 (407)
|||+ +++|.+++... ...+++..++.++.|++.||.|||+.||+||||||+||++ +.++.++|+|||++..+.
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~---~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFI---TATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEE---CCCCcEEEeccceeeecc
Confidence 9999 88999998642 3458999999999999999999999999999999999999 578899999999998654
Q ss_pred cCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccH
Q 015406 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (407)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (407)
..... .....++..|+|||.+.+..++.++||||||+++|+|++|..||..... ...+....+.........
T Consensus 158 ~~~~~-------~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~ 229 (267)
T cd08224 158 SKTTA-------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKKIEKCDYPPLP 229 (267)
T ss_pred CCCcc-------cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc-cHHHHHhhhhcCCCCCCC
Confidence 43211 2244688899999999998899999999999999999999999965332 222333333332222111
Q ss_pred HHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 015406 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (407)
Q Consensus 238 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l 276 (407)
...++.++.++|.+||..+|++||++.+|.+.|+++
T Consensus 230 ---~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 230 ---ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred ---hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 125788999999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=309.21 Aligned_cols=250 Identities=24% Similarity=0.344 Sum_probs=201.6
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-------cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-------HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 79 (407)
+.|++.+.||+|++|.||+|.+..+++.||+|.+..... ...+.+|+++++.++| +++..+..+....+..+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~ 80 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH-ERIVQYYGCLRDDETLS 80 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCC-CCeeeeEEEEccCCeEE
Confidence 579999999999999999999999999999998754321 1346779999999976 56667777777778999
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 80 lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
++|||+ +++|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+||++ +.++.++|+|||+++....
T Consensus 81 ~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv---~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 81 IFMEYMPGGSVKDQLKA-YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEEECCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceeccc
Confidence 999999 8999999975 3468999999999999999999999999999999999999 5778999999999986543
Q ss_pred CCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHH
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (407)
..... .......|+..|+|||++.+..++.++||||||+++|||++|+.||..... ......+..... ..
T Consensus 157 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~---~~ 226 (263)
T cd06625 157 ICSSG----TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA---MAAIFKIATQPT---NP 226 (263)
T ss_pred ccccc----ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch---HHHHHHHhccCC---CC
Confidence 22110 001245678899999999998999999999999999999999999976432 222222222111 12
Q ss_pred HHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 239 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.+...++.++.+++.+||..+|++||++.++.+
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 227 QLPSHVSPDARNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence 234568899999999999999999999888765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=311.85 Aligned_cols=261 Identities=18% Similarity=0.262 Sum_probs=207.1
Q ss_pred CCCccCCceeEeccccccCceEEEEEEEcCCCe----EEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeee
Q 015406 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNE----EVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGV 73 (407)
Q Consensus 1 m~~~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~----~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~ 73 (407)
|.....++|++.+.||+|+||.||+|.++.+++ .||+|........ ..+.+|+.+++.++|. ++..+..++.
T Consensus 1 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~ 79 (279)
T cd05057 1 LRILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHP-HVVRLLGICL 79 (279)
T ss_pred CcccCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCC-CcceEEEEEe
Confidence 345567899999999999999999999876654 6899987654432 3577899999999875 5555544444
Q ss_pred eCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccc
Q 015406 74 EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 152 (407)
Q Consensus 74 ~~~~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGl 152 (407)
. ...+++|||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 80 ~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~---~~~~~~kL~dfg~ 155 (279)
T cd05057 80 S-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV---KTPQHVKITDFGL 155 (279)
T ss_pred c-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEE---cCCCeEEECCCcc
Confidence 4 6789999999 999999998766679999999999999999999999999999999999999 5788999999999
Q ss_pred eeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhh
Q 015406 153 AKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEK 231 (407)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~ 231 (407)
++......... ......++..|+|||.+.+..++.++||||||+++||+++ |..||.+.... +....+...
T Consensus 156 ~~~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~~ 227 (279)
T cd05057 156 AKLLDVDEKEY-----HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV---EIPDLLEKG 227 (279)
T ss_pred cccccCcccce-----ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH---HHHHHHhCC
Confidence 98765332211 0112234678999999988889999999999999999998 99999875432 222333222
Q ss_pred cccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Q 015406 232 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (407)
Q Consensus 232 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~ 278 (407)
... .....++.++.+++.+||..+|++||++.++.+.|+++..
T Consensus 228 ~~~----~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 228 ERL----PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CCC----CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 111 1123467899999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=311.54 Aligned_cols=251 Identities=20% Similarity=0.280 Sum_probs=199.0
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc--chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~--~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
.++|++.+.||+|+||.||+|++..+++.||+|+++..... ..+.+|+.+++.++| +++..+.......+..+++||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h-~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKH-SNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCC-CCeeeEEEEEEeCCEEEEEEe
Confidence 36899999999999999999999999999999988654322 346778899998876 566666666777888999999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 84 ~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
|+ +++|.+++.. .+.+++..++.++.|++.||.|||++||+|+||||+||++ +..+.++|+|||++........
T Consensus 87 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06645 87 FCGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILL---TDNGHVKLADFGVSAQITATIA- 161 (267)
T ss_pred ccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECcceeeeEccCccc-
Confidence 99 8899999875 4579999999999999999999999999999999999999 5788999999999986643221
Q ss_pred cccCccCCCCcccccccccccccc---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHH
Q 015406 163 QHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (407)
......|+..|+|||++. ...++.++|||||||++|+|++|..||....... ................
T Consensus 162 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~ 232 (267)
T cd06645 162 ------KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR---ALFLMTKSNFQPPKLK 232 (267)
T ss_pred ------ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh---hHHhhhccCCCCCccc
Confidence 123557899999999974 4568899999999999999999999997643321 1111111111111111
Q ss_pred HhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 240 ~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
....++..+.+++.+||..+|++||++++|++
T Consensus 233 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 233 DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 11246789999999999999999999887754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=347.26 Aligned_cols=258 Identities=20% Similarity=0.298 Sum_probs=208.5
Q ss_pred CceeEeccccccCceEEEEEEEcCCC-----eEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCcee
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTN-----EEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~-----~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 78 (407)
...++.+.||+|.||.||.|...... ..||||.++.... ..+|++|..+|..+.| +||+.+.+...+....
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~H-pNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDH-PNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCC-cceeeEEEeecCCCCc
Confidence 46778999999999999999876432 3489997765433 3458999999999998 5555555555558888
Q ss_pred EEEEecc-CCCHHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEecc
Q 015406 79 VLVMDLL-GPSLEDLFNFC------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 151 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~~------~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFG 151 (407)
+|++||| ||+|..+|++. ...++..+.+.++.|||+|++||+++++|||||..+|+|| +....+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL---~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLL---DERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheee---cccCcEEEcccc
Confidence 9999999 99999999987 5669999999999999999999999999999999999999 577999999999
Q ss_pred ceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhh
Q 015406 152 LAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISE 230 (407)
Q Consensus 152 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~ 230 (407)
+|+.+..... |+......-...|||||.+....++.|+|||||||+|||++| |..||.+.+.. +.+.....
T Consensus 848 lArDiy~~~y-----yr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~---~v~~~~~~ 919 (1025)
T KOG1095|consen 848 LARDIYDKDY-----YRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF---EVLLDVLE 919 (1025)
T ss_pred hhHhhhhchh-----eeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH---HHHHHHHh
Confidence 9995544333 232233234578999999999999999999999999999999 99999886553 33332222
Q ss_pred hcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHc
Q 015406 231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (407)
Q Consensus 231 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~ 280 (407)
... -..+..||+.++++|.+||..+|++||+|..|.+.+..++...
T Consensus 920 ggR----L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 920 GGR----LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred CCc----cCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 221 1123679999999999999999999999999999888776543
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=312.73 Aligned_cols=260 Identities=20% Similarity=0.314 Sum_probs=205.2
Q ss_pred cCCceeEeccccccCceEEEEEEEcC----CCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCce
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQ----TNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~----~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 77 (407)
-.++|++.+.||+|+||.||+|.+.. ++..|++|.+..... ...+.+|+.+++.++|.+.+..+..+...+..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 36789999999999999999999865 367899998764322 23477899999999775555555444555678
Q ss_pred eEEEEecc-CCCHHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEe
Q 015406 78 NVLVMDLL-GPSLEDLFNFCS-------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID 149 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~~~~-------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~D 149 (407)
.+++++|+ +++|.+++.... ..+++..++.++.||+.||+|||+++++||||||+||++ ++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~---~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVI---DEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEE---cCCCcEEECC
Confidence 89999999 899999997532 358999999999999999999999999999999999999 5779999999
Q ss_pred ccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHH
Q 015406 150 FGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKI 228 (407)
Q Consensus 150 FGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i 228 (407)
||+++.+....... ......++..|+|||++.+..++.++||||||+++||+++ |+.||..... .+....+
T Consensus 161 ~g~~~~~~~~~~~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~ 232 (280)
T cd05043 161 NALSRDLFPMDYHC-----LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAAYL 232 (280)
T ss_pred CCCcccccCCceEE-----eCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHHHH
Confidence 99998664332211 0123346778999999999889999999999999999999 9999976433 2223222
Q ss_pred hhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHH
Q 015406 229 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (407)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~ 279 (407)
...... .....+|+++.+++.+||..+|++||++.++.+.|.++.++
T Consensus 233 ~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 233 KDGYRL----AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred HcCCCC----CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 222111 11234789999999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=311.43 Aligned_cols=258 Identities=15% Similarity=0.255 Sum_probs=203.9
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCe---EEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNE---EVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~---~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 79 (407)
.+.|++.+.||+|+||.||+|++..+++ .||||++..... ...+..|+.+++.+.| +++..+..+...+...+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~~~~~~~~~~~~~ 81 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH-PNIIHLEGVVTKSRPVM 81 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCC-cCcceEEEEECCCCceE
Confidence 3569999999999999999999876664 699998765422 2357889999999976 56666777777778889
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 80 lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
+||||+ +++|.+++....+.+++..++.++.|++.||+|||++|++||||||+||++ +.++.++|+|||++.....
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEE---cCCCcEEECCCcccccccc
Confidence 999999 889999998656679999999999999999999999999999999999999 5788999999999876544
Q ss_pred CCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccH
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (407)
...... +........+..|+|||.+.+..++.++|||||||++|||++ |..||..... ......+......
T Consensus 159 ~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~---~~~~~~i~~~~~~--- 230 (269)
T cd05065 159 DTSDPT--YTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---QDVINAIEQDYRL--- 230 (269)
T ss_pred Cccccc--cccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH---HHHHHHHHcCCcC---
Confidence 322110 000111122457999999999899999999999999999886 9999976443 2333333221111
Q ss_pred HHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 015406 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (407)
Q Consensus 238 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l 276 (407)
.....+|..+.+++.+||..+|++||++.+|...|+.+
T Consensus 231 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 231 -PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11245789999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=312.30 Aligned_cols=252 Identities=20% Similarity=0.325 Sum_probs=206.5
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC--cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
-..+|++.++||.|+||.||+|.+.. ++.+|+|++..... ...+..|+.+++.++| +++..+..++......+++|
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~ 81 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRH-KHLISLFAVCSVGEPVYIIT 81 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCC-cchhheeeeEecCCCeEEEE
Confidence 34679999999999999999999876 88999998875543 4568889999999986 66666667777788899999
Q ss_pred ecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 83 DLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 83 e~~-g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv---~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILV---GEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEE---cCCceEEEccccchhhcCCcc
Confidence 999 88999999753 3468999999999999999999999999999999999999 578899999999998664432
Q ss_pred CCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHH
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (407)
.. .....++..|+|||.+.+..++.++||||||+++|+|++ |..||..... .+.+..+...... .
T Consensus 159 ~~-------~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~----~ 224 (261)
T cd05148 159 YL-------SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN---HEVYDQITAGYRM----P 224 (261)
T ss_pred cc-------ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHHHhCCcC----C
Confidence 11 123346778999999998889999999999999999998 8999976443 3334433322111 1
Q ss_pred HhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 015406 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 275 (407)
Q Consensus 240 ~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~ 275 (407)
....+++++.+++.+||..+|++||++.+|.+.|+.
T Consensus 225 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 225 CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 234578999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=305.93 Aligned_cols=246 Identities=24% Similarity=0.317 Sum_probs=202.5
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
+|.+.+.||+|++|.||+|.+..+++.|++|.+.... ....+..|+++++.++| +++..+..++...+..+++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDS-SYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCC-CCeehheeeeccCCEEEEEEE
Confidence 5889999999999999999999999999999876432 23457789999999986 555566666677788999999
Q ss_pred cc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCC
Q 015406 84 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 84 ~~-g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~ 161 (407)
|+ +++|.+++... ...+++..++.++.|++.||.|||++||+|+||||+||++ +.++.++|+|||+++.+.....
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili---~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFL---DAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---eCCCCEEEcccccceeccCccc
Confidence 99 99999999764 4568999999999999999999999999999999999999 5778999999999987654322
Q ss_pred CcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHh
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (407)
. .....|++.|+|||++.+..++.++||||||+++|+|++|..||.... .......+....... +.
T Consensus 157 ~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~----~~ 222 (256)
T cd08529 157 F-------ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN---QGALILKIIRGVFPP----VS 222 (256)
T ss_pred h-------hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCCC----Cc
Confidence 1 234568899999999999899999999999999999999999997644 233333333332221 22
Q ss_pred cCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 242 ~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
..++.++.+++.+||+.+|++||++.++.+
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 223 QMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 357899999999999999999999888764
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=313.93 Aligned_cols=251 Identities=20% Similarity=0.254 Sum_probs=198.2
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
+|++.+.||+|+||.||+|++..+|+.||+|.+..... ...+.+|+.+++.++| +++..+..+..+....+++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH-KNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCC-CCeeeHHHHhccCCceEEEEe
Confidence 58999999999999999999999999999998765322 2357789999999987 566666666677788999999
Q ss_pred ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCc
Q 015406 84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (407)
Q Consensus 84 ~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~ 163 (407)
|++++|.+++......+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||+++.+.....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~-- 154 (284)
T cd07839 80 YCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVR-- 154 (284)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---cCCCcEEECccchhhccCCCCC--
Confidence 99889999887656679999999999999999999999999999999999999 5788999999999986543221
Q ss_pred ccCccCCCCccccccccccccccCCC-CChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhccc--------
Q 015406 164 HIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS-------- 234 (407)
Q Consensus 164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-------- 234 (407)
......++..|+|||++.+.. ++.++|||||||++|+|++|..||..... ..+.+..+......
T Consensus 155 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd07839 155 -----CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEESWPG 227 (284)
T ss_pred -----CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCC--HHHHHHHHHHHhCCCChHHhHH
Confidence 122446788999999987754 68999999999999999999988644222 22222222111000
Q ss_pred ----------------ccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 235 ----------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 235 ----------------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.........+++++.++|.+||..||.+|||++++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 228 VSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0001223457889999999999999999999888754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=310.11 Aligned_cols=252 Identities=21% Similarity=0.358 Sum_probs=200.0
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
..++|++.++||+|+||.||+|.+. .+..||+|.+..... ...+.+|+.+++.++|.+.+.. ..+.. ....+++||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~-~~~~~-~~~~~lv~e 80 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQL-YAVVS-EEPIYIVTE 80 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEE-EeEEC-CCCcEEEEE
Confidence 4578999999999999999999864 566799998765433 3468899999999987554444 44433 345789999
Q ss_pred cc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCC
Q 015406 84 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 84 ~~-g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~ 161 (407)
|+ +++|.+++... ...+++..++.++.|++.||.|||++||+||||||+||++ ++++.++|+|||++..+.....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili---~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 81 YMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILV---GDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE---eCCceEEeCCceeeeeccCccc
Confidence 99 88999999753 3458999999999999999999999999999999999999 5778999999999987644321
Q ss_pred CcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHH
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (407)
. ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+... .+....+..... . ..
T Consensus 158 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~~~~-~---~~ 224 (260)
T cd05070 158 T------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---REVLEQVERGYR-M---PC 224 (260)
T ss_pred c------cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCCC-C---CC
Confidence 1 1123345678999999998889999999999999999999 9999976443 233333322211 1 12
Q ss_pred hcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 015406 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 275 (407)
Q Consensus 241 ~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~ 275 (407)
....+.++.+++.+||..+|++||+++++.+.|++
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 225 PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 34578999999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=311.23 Aligned_cols=251 Identities=20% Similarity=0.336 Sum_probs=198.9
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-cchHHHHHHHHHHHcCCCCCCeeEEeeee------Cce
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVE------GDY 77 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~------~~~ 77 (407)
..+.|++.+.||+|+||.||+|.+..+++.||+|++..... ...+..|+.+++.+.+|+++..+..++.. ...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 35779999999999999999999999999999998865432 34578899999999766777776665543 346
Q ss_pred eEEEEecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceee
Q 015406 78 NVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~ 155 (407)
.|++|||+ +++|.+++... ...+++..+..++.|++.||.|||+++|+||||||+||++ +.++.++|+|||++..
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili---~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQ 160 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEE---CCCCCEEEccCCCcee
Confidence 89999999 88999998863 3468999999999999999999999999999999999999 5778999999999986
Q ss_pred eccCCCCcccCccCCCCcccccccccccccc-----CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhh
Q 015406 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230 (407)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~ 230 (407)
...... ......|+..|+|||++. +..++.++|||||||++|||++|..||...... .....+..
T Consensus 161 ~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~---~~~~~~~~ 230 (272)
T cd06637 161 LDRTVG-------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM---RALFLIPR 230 (272)
T ss_pred cccccc-------cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH---HHHHHHhc
Confidence 543221 123567899999999986 345788999999999999999999999754321 22221111
Q ss_pred hcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 231 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
... .......++.++.+++.+||..+|.+||++.++.+
T Consensus 231 ~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 NPA---PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCC---CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 111 11112357889999999999999999999887754
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=307.59 Aligned_cols=252 Identities=21% Similarity=0.303 Sum_probs=203.7
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC--CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
.++|++.+.||.|+||.||+|.+..+++.+++|++.... ....+.+|+.+++.++| +++..+..+.......|++||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRH-PNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCC-CChhceEEEEEeCCEEEEEEe
Confidence 368999999999999999999998899999999876543 23458889999999987 556666677778888999999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 84 ~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
|+ +++|.+++......+++..+..++.|++.||.|||++||+|+||||+||++ +.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~- 156 (262)
T cd06613 81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL---TEDGDVKLADFGVSAQLTATIA- 156 (262)
T ss_pred CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEE---CCCCCEEECccccchhhhhhhh-
Confidence 99 889999998655689999999999999999999999999999999999999 5788999999999976543221
Q ss_pred cccCccCCCCccccccccccccccCC---CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHH
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGI---EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~---~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (407)
......++..|+|||.+.+. .++.++||||||+++|+|++|..||..... .+....+...........
T Consensus 157 ------~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~ 227 (262)
T cd06613 157 ------KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP---MRALFLISKSNFPPPKLK 227 (262)
T ss_pred ------ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhccCCCcccc
Confidence 12345788899999999877 789999999999999999999999976443 222222222211111111
Q ss_pred HhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 240 ~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
....++.++.+++.+||..+|.+||++.+|+.
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 228 DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 22346788999999999999999999988764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=309.93 Aligned_cols=256 Identities=15% Similarity=0.241 Sum_probs=204.8
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCe---EEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNE---EVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~---~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 79 (407)
.++|+..+.||+|+||.||+|++..++. .+|+|.+..... ...+..|+++++.++| +++..+..++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSH-HNIIRLEGVVTKFKPAM 82 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCC-CCeeEEEEEEccCCCcE
Confidence 4689999999999999999999876554 799998765432 2357789999999977 56666777777788889
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 80 lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
++|||+ +++|.+++......+++..+..++.|++.||+|||++|++||||||+||++ +.++.+||+|||++.....
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 83 IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILV---NSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEE---cCCCcEEECCCccceeccc
Confidence 999999 889999998656679999999999999999999999999999999999999 5788999999999986644
Q ss_pred CCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccH
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (407)
...... .......+..|+|||++.+..++.++|||||||++|||++ |..||..... ......+......+
T Consensus 160 ~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~---~~~~~~i~~~~~~~-- 230 (268)
T cd05063 160 DPEGTY----TTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---HEVMKAINDGFRLP-- 230 (268)
T ss_pred ccccce----eccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---HHHHHHHhcCCCCC--
Confidence 322110 0111223567999999998889999999999999999997 9999976433 33333333221111
Q ss_pred HHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 015406 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (407)
Q Consensus 238 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l 276 (407)
....++.++.+++.+||..+|++||++.++.+.|+++
T Consensus 231 --~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 231 --APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred --CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1234789999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=298.72 Aligned_cols=265 Identities=19% Similarity=0.214 Sum_probs=201.3
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC--CcchHHHHHHHHHHHcCCCCCCeeEEe----eeeCceeE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKLYRILQGGTGIPNVRWF----GVEGDYNV 79 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~----~~~~~~~~ 79 (407)
+++|+|.++||+|||+-||++++..+++.||+|.+.... ..+..++|++..+++++++.+..+... .......|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 679999999999999999999999999999999765443 344588999999999995555444222 22345689
Q ss_pred EEEecc-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcccccCCCCCceEEEEeccce
Q 015406 80 LVMDLL-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (407)
Q Consensus 80 lvme~~-g~sL~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~--ivHrDLKp~NILl~~~~~~~~~kL~DFGla 153 (407)
|+++|+ .|||.+.++... ..+++.+++.|+.+|++||++||+.. +.||||||.|||++ +.+.++|.|||.+
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls---~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLS---DSGLPVLMDLGSA 176 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEec---CCCceEEEeccCc
Confidence 999999 999999987543 35899999999999999999999998 99999999999994 6899999999998
Q ss_pred eeeccCCCC--cccCccCCCCccccccccccccccC---CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHH
Q 015406 154 KKYRDTSTH--QHIPYRENKNLTGTARYASMNTHLG---IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228 (407)
Q Consensus 154 ~~~~~~~~~--~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i 228 (407)
....-.... ......+......|..|.|||.+.- ...+.++|||||||+||.|+.|..||...-..- ......+
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G-gSlaLAv 255 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG-GSLALAV 255 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC-CeEEEee
Confidence 754322111 1111222334457899999999874 346899999999999999999999995321100 0000001
Q ss_pred hhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHH
Q 015406 229 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (407)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~ 277 (407)
.......+. ...+++.+.++|..|++.||.+||+..+|...+.++.
T Consensus 256 ~n~q~s~P~---~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 256 QNAQISIPN---SSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred eccccccCC---CCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 111111111 1238999999999999999999999999998887763
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=317.78 Aligned_cols=261 Identities=18% Similarity=0.304 Sum_probs=207.8
Q ss_pred CCceeEeccccccCceEEEEEEEcCC-------CeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeC
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQT-------NEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEG 75 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~-------~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~ 75 (407)
..+|++++.||+|+||.||+|++... ...||+|++..... ...+.+|+.+++.+.+|+++..+..++...
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 45799999999999999999986432 23799998765432 235788999999996667888888777788
Q ss_pred ceeEEEEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCC
Q 015406 76 DYNVLVMDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 139 (407)
Q Consensus 76 ~~~~lvme~~-g~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~ 139 (407)
+..+++|||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill--- 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV--- 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE---
Confidence 8899999999 889999987521 247889999999999999999999999999999999999
Q ss_pred CCCceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015406 140 RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 218 (407)
Q Consensus 140 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~ 218 (407)
+.++.+||+|||+++........ .......++..|+|||++.+..++.++||||||+++|||++ |..||.+...
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred cCCCcEEECCcccceeccccccc-----ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 57789999999999876543211 11122344578999999999999999999999999999998 8999976433
Q ss_pred CchHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcC
Q 015406 219 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREG 281 (407)
Q Consensus 219 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~ 281 (407)
.+.+..+...... .....++.++.+++.+||+.+|++||++.++++.|+.++....
T Consensus 243 ---~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 243 ---EELFKLLKEGHRM----DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred ---HHHHHHHHcCCCC----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 3333333332211 1234578899999999999999999999999999999876554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=312.46 Aligned_cols=244 Identities=20% Similarity=0.312 Sum_probs=194.7
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
++|++.+.||+|+||.||+|++..+++.||+|++..... ...+..|+++++.+.| +++..+..++...+..++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDS-PYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCC-CCeeeEEEEEEECCEEEEEEe
Confidence 478999999999999999999999999999998765422 2347789999999976 666666667777788899999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 84 ~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
|+ +++|..+ ..+++..+..++.|++.||.|||++||+|+||||+|||+ +.++.++|+|||++..+....
T Consensus 80 ~~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill---~~~~~~~l~dfg~~~~~~~~~-- 149 (279)
T cd06619 80 FMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLV---NTRGQVKLCDFGVSTQLVNSI-- 149 (279)
T ss_pred cCCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEE---CCCCCEEEeeCCcceeccccc--
Confidence 99 8888644 257899999999999999999999999999999999999 578899999999998664322
Q ss_pred cccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCch----HHHHHHHhhhcccccHH
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK----KQKYEKISEKKVSTSIE 238 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~----~~~~~~i~~~~~~~~~~ 238 (407)
.....||..|+|||++.+..++.++||||||+++|+|++|..||........ ......+.......
T Consensus 150 -------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--- 219 (279)
T cd06619 150 -------AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPV--- 219 (279)
T ss_pred -------ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCC---
Confidence 2345789999999999998999999999999999999999999975332211 11111111111111
Q ss_pred HHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 239 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.....+++++.+++.+||..+|++||+++++.+
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~ 252 (279)
T cd06619 220 LPVGQFSEKFVHFITQCMRKQPKERPAPENLMD 252 (279)
T ss_pred CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 012346789999999999999999999877654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=331.24 Aligned_cols=257 Identities=25% Similarity=0.354 Sum_probs=209.7
Q ss_pred CceeEeccccccCceEEEEEEEcCCC----eEEEEEEecCCC-----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCce
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTN----EEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~----~~vAvK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 77 (407)
++-.+.++||+|+||+||+|+.+..+ ..||||..+.+. ...+++.|+++++.++| ++|+.++++......
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H-~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNH-PNVVRFYGVAVLEEP 235 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCC-CCEEEEEEEEcCCCc
Confidence 44556789999999999999976542 238999876422 22458999999999987 788888888899999
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeee
Q 015406 78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~ 156 (407)
++||||+| ||+|.++++..+..++..+...++.+.+.||+|||++++|||||-.+|+|+ ..++.+||+|||+++.-
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~---~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLY---SKKGVVKISDFGLSRAG 312 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHhee---cCCCeEEeCccccccCC
Confidence 99999999 999999999866679999999999999999999999999999999999999 46677899999998754
Q ss_pred ccCCCCcccCccCCC-CccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhccc
Q 015406 157 RDTSTHQHIPYRENK-NLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVS 234 (407)
Q Consensus 157 ~~~~~~~~~~~~~~~-~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (407)
..-. ... ...-..+|+|||.+....|+.++|||||||++||+++ |..||.+.... +...++......
T Consensus 313 ~~~~--------~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~---~v~~kI~~~~~r 381 (474)
T KOG0194|consen 313 SQYV--------MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY---EVKAKIVKNGYR 381 (474)
T ss_pred ccee--------eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH---HHHHHHHhcCcc
Confidence 3111 111 1234578999999999999999999999999999999 89999987663 444444232222
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcC
Q 015406 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREG 281 (407)
Q Consensus 235 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~ 281 (407)
-. .....|.++..++.+||..+|++||++.++.+.|+.+.....
T Consensus 382 ~~---~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 382 MP---IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred CC---CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 11 223578999999999999999999999999999998876543
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=314.84 Aligned_cols=251 Identities=18% Similarity=0.285 Sum_probs=200.2
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC--cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
..+.|++.++||.|+||.||+|++..+++.||+|.+..... ...+.+|+.+++.++| +++..+...+......++||
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNH-PYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCC-CcEeeeEEEEEeCCeEEEEE
Confidence 35779999999999999999999999999999999865432 2347789999999986 55666666666777899999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCC
Q 015406 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 83 e~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~ 161 (407)
||+ +++|..++......+++..++.++.|++.||.|||++||+||||||+||++ +.++.++|+|||++........
T Consensus 89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLL---TLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEE---cCCCCEEEccCccceecccccc
Confidence 999 889988887656679999999999999999999999999999999999999 5788999999999875433211
Q ss_pred CcccCccCCCCcccccccccccccc-----CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhccccc
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (407)
......++..|+|||++. ...++.++|||||||++|||++|..||..... ...+.++......
T Consensus 166 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~~-- 233 (292)
T cd06644 166 -------RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP---MRVLLKIAKSEPP-- 233 (292)
T ss_pred -------ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH---HHHHHHHhcCCCc--
Confidence 123456889999999985 34568899999999999999999999976432 2333333222111
Q ss_pred HHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 237 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.......++.++.+++.+||..+|++||+++++++
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 234 TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11123457789999999999999999999887754
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=313.46 Aligned_cols=257 Identities=22% Similarity=0.278 Sum_probs=196.6
Q ss_pred Cce-eEeccccccCceEEEEEEE----cCCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeee--eCc
Q 015406 7 NKF-RLGRKIGSGSFGEIYLGTN----IQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGV--EGD 76 (407)
Q Consensus 7 ~~y-~i~~~iG~G~~g~Vy~~~~----~~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~--~~~ 76 (407)
++| ++.+.||+|+||.||++.. ..+++.||+|++..... ...+.+|+++++.++|+ ++..+..++. ...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~-~i~~~~~~~~~~~~~ 81 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHE-NIVKYKGCCSEQGGK 81 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCC-CEeeEEEEEecCCCc
Confidence 455 9999999999999988653 35678999998865432 34577899999999874 5555544433 245
Q ss_pred eeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceee
Q 015406 77 YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (407)
Q Consensus 77 ~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~ 155 (407)
..+++|||+ +++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||+ +.++.++|+|||+++.
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLL---DNDRLVKIGDFGLAKA 156 (283)
T ss_pred eEEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEE---cCCCcEEEeecccccc
Confidence 689999999 8999999974 469999999999999999999999999999999999999 5778999999999987
Q ss_pred eccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchH-----------HH
Q 015406 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK-----------QK 224 (407)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~-----------~~ 224 (407)
........ .......++..|+|||.+.+..++.++||||||+++|||++|..||......... ..
T Consensus 157 ~~~~~~~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05080 157 VPEGHEYY----RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVR 232 (283)
T ss_pred cCCcchhh----ccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhh
Confidence 65432211 1112234567799999999888999999999999999999999998653321000 00
Q ss_pred HHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 015406 225 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (407)
Q Consensus 225 ~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l 276 (407)
.......... ......+|.++.+++.+||+.+|++||+++++.+.|+++
T Consensus 233 ~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 233 LIELLERGMR---LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhhhhhcCCC---CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 0000000000 011345789999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=312.61 Aligned_cols=253 Identities=22% Similarity=0.319 Sum_probs=201.7
Q ss_pred CCceeEeccccccCceEEEEEEEc-----CCCeEEEEEEecCCCC--cchHHHHHHHHHHHcCCCCCCeeEEeeeeCcee
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~-----~~~~~vAvK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 78 (407)
..+|++.++||+|+||.||+|... .++..+|+|.+..... ...+.+|+++++.++| +++..+..++......
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQH-QHIVRFYGVCTEGRPL 82 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCC-CCCceEEEEEecCCce
Confidence 457899999999999999999743 3466899998654332 2458889999999976 5666677777778889
Q ss_pred EEEEecc-CCCHHHHHHHcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCc
Q 015406 79 VLVMDLL-GPSLEDLFNFCS--------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN 143 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~~~--------------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~ 143 (407)
+++|||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+ ++++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~---~~~~ 159 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV---GQGL 159 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEE---cCCC
Confidence 9999999 899999997542 248899999999999999999999999999999999999 5788
Q ss_pred eEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchH
Q 015406 144 QVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKK 222 (407)
Q Consensus 144 ~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~ 222 (407)
.+||+|||+++....... +.......+++.|+|||.+.+..++.++|||||||++|||++ |..||..... .
T Consensus 160 ~~kL~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~ 231 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDY-----YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN---T 231 (280)
T ss_pred CEEECCCCceeEcCCCce-----eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH---H
Confidence 999999999986543221 111233456788999999999899999999999999999998 9999976433 2
Q ss_pred HHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015406 223 QKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 274 (407)
Q Consensus 223 ~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~ 274 (407)
..+..+...... .....+|+.+.+++.+||..||++||++.+|.+.|+
T Consensus 232 ~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 232 EAIECITQGREL----ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHHHHcCccC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 233333222111 122458899999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=312.14 Aligned_cols=257 Identities=23% Similarity=0.325 Sum_probs=210.6
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
++|++.+.||+|+||.||++.+..+++.||+|++.... ....+.+|+++++.+.| +++..+..++..+...|++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v 79 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH-PFLVNLYGSFQDDSNLYLV 79 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC-CCccceeeEEEcCCeEEEE
Confidence 47999999999999999999999999999999875432 23457789999999985 6677777777888889999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 82 me~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
|||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+|+||+|+|||+ +.++.+||+|||+++.....
T Consensus 80 ~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 80 MEYVPGGELFSHLRK-SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred EecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEeeCCCccccCCC-
Confidence 9999 9999999976 3579999999999999999999999999999999999999 57889999999999876443
Q ss_pred CCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHH
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (407)
.....|++.|+|||.+.+..++.++||||||+++|+|++|..||.... ..+....+..... .+
T Consensus 155 ---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~-----~~ 217 (290)
T cd05580 155 ---------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN---PIQIYEKILEGKV-----RF 217 (290)
T ss_pred ---------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhcCCc-----cC
Confidence 124568999999999998888999999999999999999999997644 2333444332221 13
Q ss_pred hcCCcHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCccccccchhh
Q 015406 241 CRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRIFRDLFIREGFQFDYVFDWTILKYQ 296 (407)
Q Consensus 241 ~~~~~~~l~~li~~cl~~~p~~RP-----t~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~~ 296 (407)
...++..+.+++.+||..+|++|+ +++++. .+++...++|..+...
T Consensus 218 ~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~----------~~~~~~~~~~~~~~~~ 268 (290)
T cd05580 218 PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK----------NHPWFAGIDWIALLQR 268 (290)
T ss_pred CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH----------cCcccccCCHHHHhhc
Confidence 345789999999999999999998 433332 2366677888876543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=322.85 Aligned_cols=255 Identities=23% Similarity=0.328 Sum_probs=210.8
Q ss_pred eEeccccccCceEEEEEEEcCC--C--eEEEEEEecCCC---CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 10 RLGRKIGSGSFGEIYLGTNIQT--N--EEVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 10 ~i~~~iG~G~~g~Vy~~~~~~~--~--~~vAvK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
.+.++||.|.||.||.|.+... | --||||..+.+. ..+.|+.|..+++.++| ++|..+.+.+.+. ..||||
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdH-phIikLIGv~~e~-P~Wivm 469 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDH-PHIIKLIGVCVEQ-PMWIVM 469 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCC-cchhheeeeeecc-ceeEEE
Confidence 3456899999999999987543 2 368899776543 34569999999999998 4555555555443 469999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCC
Q 015406 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 83 e~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~ 161 (407)
|++ -|.|..+++..+..++......++.||+.||.|||++++|||||..+|||++ ....+||+|||+++.+.+...
T Consensus 470 EL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVs---Sp~CVKLaDFGLSR~~ed~~y 546 (974)
T KOG4257|consen 470 ELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVS---SPQCVKLADFGLSRYLEDDAY 546 (974)
T ss_pred ecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeec---Ccceeeecccchhhhccccch
Confidence 999 8999999998778899999999999999999999999999999999999994 788999999999998887664
Q ss_pred CcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHH
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (407)
. ..+...-...|||||.+.-..++.++|||-|||++||++. |..||++....+....+++... ...
T Consensus 547 Y------kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeR-------lP~ 613 (974)
T KOG4257|consen 547 Y------KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGER-------LPC 613 (974)
T ss_pred h------hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCC-------CCC
Confidence 2 2333444678999999999999999999999999999997 9999999877654444433221 224
Q ss_pred hcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCC
Q 015406 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGF 282 (407)
Q Consensus 241 ~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~ 282 (407)
+++||+.+..|+.+||+++|.+||++.+|+..|.++++.+..
T Consensus 614 P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~ 655 (974)
T KOG4257|consen 614 PPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKI 655 (974)
T ss_pred CCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhh
Confidence 477999999999999999999999999999999999986543
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=304.13 Aligned_cols=247 Identities=21% Similarity=0.281 Sum_probs=199.2
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
.|++.+.||+|++|.||++.+..+++.||+|.+..+.. ...+..|+++++.++|.+.+..+..+.......|++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 58999999999999999999999999999998765432 23477889999999875544444444345557899999
Q ss_pred cc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCC
Q 015406 84 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 84 ~~-g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~ 161 (407)
|+ +++|.+++... ...+++.+++.++.|++.||+|||++||+||||||+||++ +.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~---~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFL---TRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEE---ecCCcEEEecccceEEecccCC
Confidence 99 89999998753 3458999999999999999999999999999999999999 5788999999999987644322
Q ss_pred CcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHh
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (407)
......|++.|+|||++.+..++.++||||||+++|+|++|..||...+. ......+...... ...
T Consensus 158 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~---~~~~~~~~~~~~~----~~~ 223 (257)
T cd08223 158 -------MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM---NSLVYRIIEGKLP----PMP 223 (257)
T ss_pred -------ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHhcCCC----CCc
Confidence 12345689999999999999999999999999999999999999975332 2223333332221 123
Q ss_pred cCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 242 ~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
..+++++.+++.+||+.+|++||++.++.+
T Consensus 224 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 224 KDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred cccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 457899999999999999999999887764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=310.82 Aligned_cols=247 Identities=19% Similarity=0.263 Sum_probs=197.2
Q ss_pred ccccccCceEEEEEEEcCCCe--EEEEEEecCCC---CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-C
Q 015406 13 RKIGSGSFGEIYLGTNIQTNE--EVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (407)
Q Consensus 13 ~~iG~G~~g~Vy~~~~~~~~~--~vAvK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~-g 86 (407)
+.||+|+||.||+|++..++. .+|+|...... ....+..|++++.++.+|+++..+.+++......+++|||+ +
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999999887775 46888776322 22357789999999977788888888888888899999999 8
Q ss_pred CCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEecc
Q 015406 87 PSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 151 (407)
Q Consensus 87 ~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFG 151 (407)
++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+|||+ +.++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili---~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEE---cCCCeEEECCCC
Confidence 99999997432 247899999999999999999999999999999999999 578899999999
Q ss_pred ceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhh
Q 015406 152 LAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISE 230 (407)
Q Consensus 152 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~ 230 (407)
++........ ......+..|+|||++.+..++.++|||||||++|||++ |..||.+... ...+..+..
T Consensus 158 l~~~~~~~~~--------~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~---~~~~~~~~~ 226 (270)
T cd05047 158 LSRGQEVYVK--------KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYEKLPQ 226 (270)
T ss_pred Cccccchhhh--------ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH---HHHHHHHhC
Confidence 9863221110 112234567999999998889999999999999999997 9999976433 233333322
Q ss_pred hcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHH
Q 015406 231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (407)
Q Consensus 231 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~ 277 (407)
.... .....++.++.+++.+||..+|.+||++.++.+.|++++
T Consensus 227 ~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 227 GYRL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCCC----CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 2111 122347889999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=316.36 Aligned_cols=277 Identities=21% Similarity=0.256 Sum_probs=232.0
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
..+|.++.+||+|+||.|.+|..+.+.+.||||+++++- ..+--+.|.++|.....++.+..++.+++.-+..|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 457899999999999999999999999999999877643 222356788888888888999999999999999999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 81 vme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
||||+ ||+|--.+++. +++.+..+..++.+|+-||-+||++|||.||||.+|||| +.+|++||+|||+++.---.
T Consensus 428 VMEyvnGGDLMyhiQQ~-GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmL---d~eGHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQV-GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIFD 503 (683)
T ss_pred EEEEecCchhhhHHHHh-cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEe---ccCCceEeeecccccccccC
Confidence 99999 99998888764 579999999999999999999999999999999999999 79999999999999853222
Q ss_pred CCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHH
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (407)
. ....+++||+.|+|||++...+|+..+|+|||||+||||+.|+.||.+. +..+.+..|.+....
T Consensus 504 ~-------~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe---DE~elF~aI~ehnvs----- 568 (683)
T KOG0696|consen 504 G-------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE---DEDELFQAIMEHNVS----- 568 (683)
T ss_pred C-------cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHHccCc-----
Confidence 1 2356899999999999999999999999999999999999999999884 456777777776654
Q ss_pred HhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchhhcccccCCCCc
Q 015406 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATPPAR 306 (407)
Q Consensus 240 ~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~~~~~~~~~~~~ 306 (407)
.++.++.+..+++...|.+.|.+|....---+ ++ -..+.|+.-+||+.++..+.+++..|..
T Consensus 569 yPKslSkEAv~ickg~ltK~P~kRLGcg~~ge--~d---i~~H~FFR~iDWek~E~~eiqPPfkPk~ 630 (683)
T KOG0696|consen 569 YPKSLSKEAVAICKGLLTKHPGKRLGCGPEGE--RD---IREHPFFRRIDWEKLERREIQPPFKPKI 630 (683)
T ss_pred CcccccHHHHHHHHHHhhcCCccccCCCCccc--cc---hhhCcchhhccHHHHhhccCCCCCCCcc
Confidence 34668999999999999999999965311000 11 1224677789999999998877776544
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=310.90 Aligned_cols=253 Identities=20% Similarity=0.256 Sum_probs=198.0
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCce-----
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDY----- 77 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~----- 77 (407)
++|++.+.||+|+||.||+|++..+++.||||....... ...+.+|+.+++.+.++++++.+..+....+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 479999999999999999999999999999998765432 24578899999999887888877776665444
Q ss_pred eEEEEeccCCCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccce
Q 015406 78 NVLVMDLLGPSLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (407)
Q Consensus 78 ~~lvme~~g~sL~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla 153 (407)
.|++|||+.++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++ ..++.+||+|||++
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~--~~~~~~kl~dfg~~ 158 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVD--KQKGLLKIADLGLG 158 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEe--cCCCeEEEeecccc
Confidence 79999999779999886432 3589999999999999999999999999999999999994 22789999999999
Q ss_pred eeeccCCCCcccCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhc
Q 015406 154 KKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (407)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (407)
+.+..... ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.... ..+.++....
T Consensus 159 ~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~ 228 (295)
T cd07837 159 RAFSIPVK-------SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL---QQLLHIFKLL 228 (295)
T ss_pred eecCCCcc-------ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHHHh
Confidence 86543211 1123356889999998865 45799999999999999999999999764332 2222211110
Q ss_pred -----------------------ccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 233 -----------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 233 -----------------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.........+.+++++.++|.+||..||++||++.++..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 229 GTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 011112223467899999999999999999999877753
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=311.63 Aligned_cols=254 Identities=20% Similarity=0.327 Sum_probs=203.2
Q ss_pred cCCceeEeccccccCceEEEEEEEcCC-----CeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCc
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQT-----NEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGD 76 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~-----~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 76 (407)
..++|++.+.||+|+||.||+|.+... +..||+|....... ...+.+|+.+++.+.| +++..+..++....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~ 82 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNC-HHVVRLLGVVSTGQ 82 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCC-CceeEEEEEEcCCC
Confidence 357899999999999999999997644 37899998764432 2347788999998876 56777777777788
Q ss_pred eeEEEEecc-CCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEE
Q 015406 77 YNVLVMDLL-GPSLEDLFNFCS---------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY 146 (407)
Q Consensus 77 ~~~lvme~~-g~sL~~~l~~~~---------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~k 146 (407)
..+++|||+ +++|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+|||+ +.++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill---~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV---AEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEE---cCCCCEE
Confidence 899999999 899999986422 236888999999999999999999999999999999999 5789999
Q ss_pred EEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHH
Q 015406 147 IIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKY 225 (407)
Q Consensus 147 L~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~ 225 (407)
|+|||+++....... +.......++..|+|||.+.+..++.++|||||||++||+++ |..||.+... .+..
T Consensus 160 l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~ 231 (277)
T cd05032 160 IGDFGMTRDIYETDY-----YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN---EEVL 231 (277)
T ss_pred ECCcccchhhccCcc-----cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH---HHHH
Confidence 999999986544322 111234456889999999998889999999999999999998 9999976433 3333
Q ss_pred HHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015406 226 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 274 (407)
Q Consensus 226 ~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~ 274 (407)
..+...... .....++.++.+++.+||..+|++|||+.+|.+.|+
T Consensus 232 ~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 232 KFVIDGGHL----DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHHhcCCCC----CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 333322211 123457899999999999999999999999988774
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=310.99 Aligned_cols=249 Identities=19% Similarity=0.332 Sum_probs=197.2
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
++|++.+.||+|+||.||+|++..+|+.||||.++.... ...+..|..++.+..+++++..+..+.......|++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 479999999999999999999999999999998865432 23456677766666667888887777778888999999
Q ss_pred ccCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 84 LLGPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 84 ~~g~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~-~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
|+.++|.+++... +..+++..++.++.||+.||+|||++ +++||||||+|||+ +.++.+||+|||++..+...
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLI---NRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeecccccccccc
Confidence 9998999888642 34589999999999999999999997 99999999999999 67889999999999865432
Q ss_pred CCCcccCccCCCCccccccccccccccC----CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccc
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLG----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~----~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (407)
.. .....|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||..... ..+.+..+.......
T Consensus 158 ~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~ 227 (283)
T cd06617 158 VA--------KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT--PFQQLKQVVEEPSPQ 227 (283)
T ss_pred cc--------cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc--CHHHHHHHHhcCCCC
Confidence 21 123468889999999865 4568899999999999999999999965322 122222222211111
Q ss_pred cHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
. ....+|.++.++|.+||..+|++||++.++.+
T Consensus 228 ~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 228 L---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred C---CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 11347899999999999999999999877754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=308.43 Aligned_cols=251 Identities=21% Similarity=0.236 Sum_probs=196.6
Q ss_pred eeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeC--ceeEEEEe
Q 015406 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEG--DYNVLVMD 83 (407)
Q Consensus 9 y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~--~~~~lvme 83 (407)
|++.++||+|+||.||+|.+..+++.||+|.+..... ......|+.++.++.+|+++..+..++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 7889999999999999999999999999998765322 223457888888887667777777777666 78899999
Q ss_pred ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCc
Q 015406 84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (407)
Q Consensus 84 ~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~ 163 (407)
|++++|.+.+......+++..++.++.|++.||+|||++|++||||||+||++ +. +.+||+|||+++.......
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l---~~-~~~kl~dfg~~~~~~~~~~-- 154 (282)
T cd07831 81 LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILI---KD-DILKLADFGSCRGIYSKPP-- 154 (282)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEE---cC-CCeEEEecccccccccCCC--
Confidence 99889998887655679999999999999999999999999999999999999 45 9999999999986643322
Q ss_pred ccCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhh-----------
Q 015406 164 HIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK----------- 231 (407)
Q Consensus 164 ~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~----------- 231 (407)
.....++..|+|||.+.+ ..++.++|||||||++|||++|..||.+.+..+...........
T Consensus 155 ------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 155 ------YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred ------cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcc
Confidence 123467899999997654 45689999999999999999999999764432211111111000
Q ss_pred ----------cccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 232 ----------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 232 ----------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.....+..+...++.++.++|.+||+.+|++||++.++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0001122333467899999999999999999999887764
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=308.66 Aligned_cols=252 Identities=23% Similarity=0.314 Sum_probs=193.9
Q ss_pred cccccCceEEEEEEEcCCCeEEEEEEecCCCCc-----chHHHHHHHHHHHc--CCCCCCeeEEeeeeCceeEEEEecc-
Q 015406 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKLYRILQ--GGTGIPNVRWFGVEGDYNVLVMDLL- 85 (407)
Q Consensus 14 ~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~~l~~l~--~~~~i~~~~~~~~~~~~~~lvme~~- 85 (407)
.||+|+||.||++.+..+++.||+|.+...... .....|..+++.+. +++++..+...+...+..++||||+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999999999999999987643221 12344555555443 4567777777777788899999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCccc
Q 015406 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165 (407)
Q Consensus 86 g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~ 165 (407)
+++|.+++.. .+.+++..+..++.|++.||+|||+++|+||||||+|||+ +.++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~---~~~~~~~l~dfg~~~~~~~~~----- 151 (279)
T cd05633 81 GGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKK----- 151 (279)
T ss_pred CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEE---CCCCCEEEccCCcceeccccC-----
Confidence 8999998875 4569999999999999999999999999999999999999 678899999999997654322
Q ss_pred CccCCCCcccccccccccccc-CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCC
Q 015406 166 PYRENKNLTGTARYASMNTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 244 (407)
Q Consensus 166 ~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (407)
.....|+..|+|||.+. +..++.++|||||||++|+|++|..||.......... ....... ....+...+
T Consensus 152 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~----~~~~~~~~~ 222 (279)
T cd05633 152 ----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLT----VNVELPDSF 222 (279)
T ss_pred ----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH-HHHHhhc----CCcCCcccc
Confidence 12346899999999986 4568999999999999999999999997654433222 2221111 111234568
Q ss_pred cHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCccccccc
Q 015406 245 PTEFASYFHYCRSLRFDDKP-----DYAYLKRIFRDLFIREGFQFDYVFDWTIL 293 (407)
Q Consensus 245 ~~~l~~li~~cl~~~p~~RP-----t~~~l~~~l~~l~~~~~~~~~~~~dw~~~ 293 (407)
++++.++|.+||..||++|| ++.++++ ++|+...+|...
T Consensus 223 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~----------h~~~~~~~~~~~ 266 (279)
T cd05633 223 SPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE----------HVFFKGIDWQQV 266 (279)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh----------CccccCCCHhHH
Confidence 89999999999999999999 4555533 345556677654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=306.75 Aligned_cols=254 Identities=22% Similarity=0.369 Sum_probs=205.7
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
...++|++.++||+|+||.||+|.+. .++.||||.+..... ...+..|+.+++.++| +++..+..++......+++|
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRH-DKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCC-CCEeeeeeeeecCCceEEEE
Confidence 45689999999999999999999974 557899998875433 3568899999999986 56666667777778889999
Q ss_pred ecc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 83 DLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 83 e~~-g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
||+ +++|.+++.... ..+++..+..++.||+.||.|||++|++|+||||+||++ +.++.++|+|||+++.+....
T Consensus 81 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 81 EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILV---GENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred eccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEE---cCCCCEEECccccceeccchh
Confidence 999 899999997533 468999999999999999999999999999999999999 578999999999998765422
Q ss_pred CCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHH
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (407)
. .......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.+... ...+..+...... .
T Consensus 158 ~------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~~~~~~~~~----~ 224 (261)
T cd05034 158 Y------TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN---REVLEQVERGYRM----P 224 (261)
T ss_pred h------hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC----C
Confidence 1 11123335678999999999889999999999999999998 9999976433 3334443322111 1
Q ss_pred HhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 015406 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 275 (407)
Q Consensus 240 ~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~ 275 (407)
.....|.++.+++.+||..+|++||+++++.+.|+.
T Consensus 225 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 225 RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 123468899999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=307.38 Aligned_cols=246 Identities=20% Similarity=0.288 Sum_probs=198.1
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~ 85 (407)
.++|++.+.||+|+||.||++. .+++.||+|..........+.+|+.+++.++|++.+.. ..+.... ..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~-~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRL-LGVILHN-GLYIVMELM 80 (254)
T ss_pred HHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeE-EEEEcCC-CcEEEEECC
Confidence 3679999999999999999997 57889999988765555678899999999987555554 4444433 468999999
Q ss_pred -CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCc
Q 015406 86 -GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (407)
Q Consensus 86 -g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~ 163 (407)
+++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||++ +.++.+||+|||++.......
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili---~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILV---SEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCcEEECCCccceeccccC---
Confidence 899999997543 358999999999999999999999999999999999999 577899999999997643321
Q ss_pred ccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHHhc
Q 015406 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (407)
Q Consensus 164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (407)
.....+..|+|||.+.+..++.++||||||+++|||++ |..||..... ......+...... ....
T Consensus 155 -------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~~~~~----~~~~ 220 (254)
T cd05083 155 -------DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL---KEVKECVEKGYRM----EPPE 220 (254)
T ss_pred -------CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH---HHHHHHHhCCCCC----CCCC
Confidence 12234568999999998899999999999999999998 9999976543 2223333222111 1234
Q ss_pred CCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 015406 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 275 (407)
Q Consensus 243 ~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~ 275 (407)
.+|.++.+++.+||+.+|++||++++|.+.|++
T Consensus 221 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 221 GCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 678999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=328.57 Aligned_cols=248 Identities=19% Similarity=0.317 Sum_probs=206.5
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC--cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEec
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~ 84 (407)
+.|.|+..||.|+||.||+|.++.++-..|.|++..+.. ...++-|++||..+.| ++++.+...+...+..+|..||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdH-P~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDH-PVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCC-hHHHHHHHHHhccCceEEEEee
Confidence 468899999999999999999999999999998876543 3568899999999996 5555555555555667999999
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCc
Q 015406 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (407)
Q Consensus 85 ~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~ 163 (407)
| ||-.+.++-..++.|.+..+..+++|++.||.|||+++|||||||..|||+ .-+|.++|+|||.+........
T Consensus 111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~---TldGdirLADFGVSAKn~~t~q-- 185 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILL---TLDGDIRLADFGVSAKNKSTRQ-- 185 (1187)
T ss_pred cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEE---EecCcEeeecccccccchhHHh--
Confidence 9 788888888888899999999999999999999999999999999999999 5889999999998865433221
Q ss_pred ccCccCCCCcccccccccccccc-----CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHH
Q 015406 164 HIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (407)
Q Consensus 164 ~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (407)
....+.|||.|||||+.. ..+|+.++||||||++|.||..+.+|....+. ...+.+|.....++..
T Consensus 186 -----kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp---MRVllKiaKSePPTLl- 256 (1187)
T KOG0579|consen 186 -----KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP---MRVLLKIAKSEPPTLL- 256 (1187)
T ss_pred -----hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch---HHHHHHHhhcCCCccc-
Confidence 245789999999999865 56899999999999999999999999987655 4445555554444333
Q ss_pred HHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015406 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 239 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
-+...+..|.+++.+||.+||..||++++|.
T Consensus 257 -qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll 287 (1187)
T KOG0579|consen 257 -QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLL 287 (1187)
T ss_pred -CcchhhhHHHHHHHHHHhcCCccCCCHHHHh
Confidence 2355788999999999999999999998875
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=306.10 Aligned_cols=253 Identities=19% Similarity=0.278 Sum_probs=193.8
Q ss_pred ccccccCceEEEEEEEcC---CCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-
Q 015406 13 RKIGSGSFGEIYLGTNIQ---TNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (407)
Q Consensus 13 ~~iG~G~~g~Vy~~~~~~---~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~- 85 (407)
+.||+|+||.||+|.+.. .+..||+|.+..... ...+..|+.+++.++|++.+..+..+...+...+++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998653 345799998754322 2357789999999887555555544444566789999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCccc
Q 015406 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165 (407)
Q Consensus 86 g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~ 165 (407)
+++|.+++......+++..++.++.||+.||.|||+.+|+||||||+|||+ +.++.+||+|||+++.........
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili---~~~~~~kl~dfg~~~~~~~~~~~~-- 155 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCML---DESFTVKVADFGLARDIYDKEYYS-- 155 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCccccccccCCccee--
Confidence 899999998655567888899999999999999999999999999999999 577899999999998654322110
Q ss_pred CccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCC
Q 015406 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 244 (407)
Q Consensus 166 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (407)
........++..|+|||.+.+..++.++|||||||++|||++ |.+||...+. ......+...... .....+
T Consensus 156 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~~~~~~----~~~~~~ 227 (262)
T cd05058 156 -VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---FDITVYLLQGRRL----LQPEYC 227 (262)
T ss_pred -ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHhcCCCC----CCCCcC
Confidence 011223456778999999998899999999999999999999 4666755332 2223333222111 112346
Q ss_pred cHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Q 015406 245 PTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (407)
Q Consensus 245 ~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~ 278 (407)
|+.+.+++.+||..+|++||++.+|.+.|++++.
T Consensus 228 ~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 228 PDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 8899999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=305.90 Aligned_cols=245 Identities=26% Similarity=0.383 Sum_probs=202.6
Q ss_pred ccccccCceEEEEEEEcCC---CeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-
Q 015406 13 RKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (407)
Q Consensus 13 ~~iG~G~~g~Vy~~~~~~~---~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~- 85 (407)
+.||+|+||.||+|.+... +..||+|++..... ...+..|+++++.++| +++..+..+.......+++|||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGH-PNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCC-CChheeeeeecCCCceEEEEEecc
Confidence 4799999999999998766 88999999876544 3467889999999984 66667766666788899999999
Q ss_pred CCCHHHHHHHc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeec
Q 015406 86 GPSLEDLFNFC--------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (407)
Q Consensus 86 g~sL~~~l~~~--------~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~ 157 (407)
+++|.+++... ...+++..++.++.|++.||.|||++||+||||||+||++ +.++.++|+|||.+....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLV---GEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEE---CCCCcEEEcccccccccc
Confidence 99999999865 3679999999999999999999999999999999999999 577999999999998765
Q ss_pred cCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhccccc
Q 015406 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (407)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (407)
.... +.......++..|+|||.+.+..++.++||||||+++|+|++ |..||..... .+....+.....
T Consensus 157 ~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~--- 225 (262)
T cd00192 157 DDDY-----YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---EEVLEYLRKGYR--- 225 (262)
T ss_pred cccc-----cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCCC---
Confidence 5432 112335567889999999998889999999999999999999 6999987533 333444433211
Q ss_pred HHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 015406 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIF 273 (407)
Q Consensus 237 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l 273 (407)
......+|.++.+++.+||..+|++||++.++.+.|
T Consensus 226 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 226 -LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred -CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 122345789999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=305.12 Aligned_cols=247 Identities=23% Similarity=0.318 Sum_probs=196.2
Q ss_pred ccccccCceEEEEEEEcCCC---eEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-
Q 015406 13 RKIGSGSFGEIYLGTNIQTN---EEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (407)
Q Consensus 13 ~~iG~G~~g~Vy~~~~~~~~---~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~- 85 (407)
++||+|+||.||+|.+..++ ..||+|.+..... ...+..|+.+++.+.| ++++.+..+.. ....+++|||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDH-PCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCC-CCeeeEEEEEc-CCceEEEEEeCC
Confidence 57999999999999876555 7899998775543 3457889999999987 45555555443 44579999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCccc
Q 015406 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165 (407)
Q Consensus 86 g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~ 165 (407)
+++|.+++... ..+++..++.++.|++.||+|||+++++||||||+|||+ +.++.+||+|||+++........
T Consensus 79 ~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili---~~~~~~kl~df~~~~~~~~~~~~--- 151 (257)
T cd05060 79 LGPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLL---VNRHQAKISDFGMSRALGAGSDY--- 151 (257)
T ss_pred CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEE---cCCCcEEeccccccceeecCCcc---
Confidence 88999999863 379999999999999999999999999999999999999 57889999999999876543321
Q ss_pred CccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCC
Q 015406 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 244 (407)
Q Consensus 166 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (407)
+.......++..|+|||.+.+..++.++||||||+++|+|++ |..||..... .+....+...... .....+
T Consensus 152 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~~~~~~----~~~~~~ 223 (257)
T cd05060 152 -YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLESGERL----PRPEEC 223 (257)
T ss_pred -cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHcCCcC----CCCCCC
Confidence 111122334568999999999899999999999999999998 9999976543 2333333322211 123457
Q ss_pred cHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 015406 245 PTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (407)
Q Consensus 245 ~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l 276 (407)
+..+.+++.+||..+|++||++.+|.+.|++.
T Consensus 224 ~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 224 PQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 89999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=315.34 Aligned_cols=256 Identities=18% Similarity=0.217 Sum_probs=188.5
Q ss_pred eccccccCceEEEEEEEcC--CCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEee-eeCceeEEEEeccCCC
Q 015406 12 GRKIGSGSFGEIYLGTNIQ--TNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFG-VEGDYNVLVMDLLGPS 88 (407)
Q Consensus 12 ~~~iG~G~~g~Vy~~~~~~--~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~-~~~~~~~lvme~~g~s 88 (407)
..+||+|+||.||+|++.. ++..||+|.+........+.+|+.+++.++|++.+..+..+. ......+++|||++++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~ 85 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHD 85 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCCc
Confidence 4689999999999999654 568999998876655567889999999999865555444443 3456789999999889
Q ss_pred HHHHHHHc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCC-CCCceEEEEeccceeeeccC
Q 015406 89 LEDLFNFC--------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG-RRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 89 L~~~l~~~--------~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~-~~~~~~kL~DFGla~~~~~~ 159 (407)
|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+... +..+.+||+|||+++.....
T Consensus 86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~ 165 (317)
T cd07867 86 LWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165 (317)
T ss_pred HHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCC
Confidence 99887532 1248899999999999999999999999999999999999432 35678999999999876543
Q ss_pred CCCcccCccCCCCccccccccccccccCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCch------HHHHHHHhhhc
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK------KQKYEKISEKK 232 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~------~~~~~~i~~~~ 232 (407)
... ........||+.|+|||++.+. .++.++|||||||++|||++|..||........ ...+..+....
T Consensus 166 ~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07867 166 LKP----LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM 241 (317)
T ss_pred ccc----ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhc
Confidence 221 1123456789999999999874 579999999999999999999999975332100 00011100000
Q ss_pred c----------------c-----------------ccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 233 V----------------S-----------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 233 ~----------------~-----------------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
. . ..........+..+.+|+.+||..||.+|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred CCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 0 0 0000011123567889999999999999999887764
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=306.25 Aligned_cols=251 Identities=25% Similarity=0.367 Sum_probs=202.1
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc-----------chHHHHHHHHHHHcCCCCCCeeEEeeeeCc
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----------PQLLYESKLYRILQGGTGIPNVRWFGVEGD 76 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~-----------~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 76 (407)
+|.+.+.||.|+||.||+|.+..+++.||+|.+...... ..+.+|+.+++.++| +++..+..++...+
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~ 79 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH-ENIVQYLGSSLDAD 79 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCC-CCeeeEEEEEEeCC
Confidence 588999999999999999999889999999987643221 236788999999976 66667777778888
Q ss_pred eeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceee
Q 015406 77 YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (407)
Q Consensus 77 ~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~ 155 (407)
..+++|||+ +++|.+++.. .+.+++..+..++.|++.||+|||++|++||||||+||++ ++++.++|+|||+++.
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~---~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNN-YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILV---DNKGGIKISDFGISKK 155 (267)
T ss_pred ccEEEEEecCCCCHHHHHHh-ccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEE---cCCCCEEecccCCCcc
Confidence 999999999 8899999986 3578999999999999999999999999999999999999 5788999999999987
Q ss_pred eccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccc
Q 015406 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (407)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (407)
......... .........|+..|+|||.+.+..++.++|||||||++|+|++|..||..... ...+..+....
T Consensus 156 ~~~~~~~~~-~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~--- 228 (267)
T cd06628 156 LEANSLSTK-TNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ---LQAIFKIGENA--- 228 (267)
T ss_pred cccccccCC-ccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH---HHHHHHHhccC---
Confidence 653221110 01112245688999999999998899999999999999999999999976432 22233322211
Q ss_pred cHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
...+...++.++.++|.+||+.||++||++.++++
T Consensus 229 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 229 -SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 12233557899999999999999999999888764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=309.55 Aligned_cols=253 Identities=19% Similarity=0.303 Sum_probs=198.4
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-cchHHHHHHHHHHHcCCCCCCeeEEee-----eeCce
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFG-----VEGDY 77 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~-----~~~~~ 77 (407)
...++|++.+.||+|+||.||+|.+..+++.+|+|+...... ...+..|+.+++.+..|+++..+..++ ..+..
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 94 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQ 94 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCe
Confidence 356899999999999999999999999999999998764332 345778999999996556676665554 24567
Q ss_pred eEEEEecc-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccce
Q 015406 78 NVLVMDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla 153 (407)
.+++|||+ +++|.+++.. ....+++..+..++.|++.||.|||+++|+||||||+||++ +.++.++|+|||++
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili---~~~~~~kl~dfg~~ 171 (286)
T cd06638 95 LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILL---TTEGGVKLVDFGVS 171 (286)
T ss_pred EEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEE---CCCCCEEEccCCce
Confidence 89999999 9999998753 23468999999999999999999999999999999999999 57788999999999
Q ss_pred eeeccCCCCcccCccCCCCccccccccccccccC-----CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHH
Q 015406 154 KKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228 (407)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i 228 (407)
+....... ......|+..|+|||++.+ ..++.++|||||||++|||++|..||...... ..+..+
T Consensus 172 ~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~---~~~~~~ 241 (286)
T cd06638 172 AQLTSTRL-------RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM---RALFKI 241 (286)
T ss_pred eecccCCC-------ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh---HHHhhc
Confidence 87643221 1234568999999999853 44788999999999999999999999764331 222222
Q ss_pred hhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 229 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
...... .......++.++.+++.+||+.+|++||++.+|++
T Consensus 242 ~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 282 (286)
T cd06638 242 PRNPPP--TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282 (286)
T ss_pred cccCCC--cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 111111 11122346788999999999999999999888765
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=306.07 Aligned_cols=250 Identities=21% Similarity=0.336 Sum_probs=204.9
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~ 85 (407)
.++|++.+.||+|+||.||+|.+..+++.|++|.+........+.+|+++++.++| +++..+..++......|++|||+
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDS-PYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCC-CcEeeeeeeeecCCcEEEEEecC
Confidence 36899999999999999999999888999999998765556678999999999965 66666777777778899999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcc
Q 015406 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164 (407)
Q Consensus 86 -g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~ 164 (407)
+++|.+++......+++..++.++.|++.||.|||+.+++|+||+|+||++ +.++.++|+|||++........
T Consensus 81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~---~~~~~~~l~dfg~~~~~~~~~~--- 154 (256)
T cd06612 81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILL---NEEGQAKLADFGVSGQLTDTMA--- 154 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---CCCCcEEEcccccchhcccCcc---
Confidence 889999998666789999999999999999999999999999999999999 5788999999999987654321
Q ss_pred cCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCC
Q 015406 165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 244 (407)
Q Consensus 165 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (407)
......|+..|+|||++.+..++.++||||||+++|+|++|+.||...... +....+..... ........+
T Consensus 155 ----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~--~~~~~~~~~ 225 (256)
T cd06612 155 ----KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM---RAIFMIPNKPP--PTLSDPEKW 225 (256)
T ss_pred ----ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchh---hhhhhhccCCC--CCCCchhhc
Confidence 123445788999999999989999999999999999999999999764332 11111111111 111112346
Q ss_pred cHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 245 PTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 245 ~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
+.++.+++.+||+.+|++||++.++++
T Consensus 226 ~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 226 SPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 789999999999999999999887764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=310.06 Aligned_cols=260 Identities=22% Similarity=0.240 Sum_probs=197.7
Q ss_pred CCceeEeccccccCceEEEEEEE----cCCCeEEEEEEecCCCC--cchHHHHHHHHHHHcCCCCCCeeEEee--eeCce
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTN----IQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFG--VEGDY 77 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~----~~~~~~vAvK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~--~~~~~ 77 (407)
.++|++.+.||+|+||.||+|.. ..+++.||+|.+..... ...+.+|+++++.++|+ +++.+..++ .....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHD-NIVKYKGVCYSAGRRN 81 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCC-CeeEEEEEEccCCCCc
Confidence 46899999999999999999973 45788999998765432 23578899999999875 455554433 34456
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeee
Q 015406 78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~ 156 (407)
.++||||+ +++|.+++......+++..++.++.|++.||+|||++||+||||||+||++ +.++.+||+|||+++..
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILV---ESENRVKIGDFGLTKVL 158 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEE---CCCCeEEECCCcccccc
Confidence 89999999 999999998655679999999999999999999999999999999999999 57889999999999876
Q ss_pred ccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCch------------HHH
Q 015406 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK------------KQK 224 (407)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~------------~~~ 224 (407)
....... .......++..|+|||++.+..++.++||||||+++|||++|..|+........ ...
T Consensus 159 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05081 159 PQDKEYY----KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYH 234 (284)
T ss_pred cCCCcce----eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHH
Confidence 5432210 001122345569999999998999999999999999999998877643221100 000
Q ss_pred HHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 015406 225 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (407)
Q Consensus 225 ~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l 276 (407)
+........ .......++.++.+++.+||..+|++|||+.+|.+.|+.+
T Consensus 235 ~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 235 LIELLKNNG---RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHhcCC---cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 000111000 0012245788999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=305.66 Aligned_cols=247 Identities=21% Similarity=0.337 Sum_probs=201.6
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEec
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~ 84 (407)
.++|++.+.||.|+||.||+|.. .++.||+|.+..... ...+..|+.+++.++| +++..+..+.......++||||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRH-PNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhcCC-cceeeeEEEEcCCCCeEEEEEe
Confidence 56899999999999999999985 488999998876544 4568889999999987 4555555556667888999999
Q ss_pred c-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 85 L-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 85 ~-g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
+ +++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||++ +.++.++|+|||.++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili---~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLV---SEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEE---eCCCCEEEcccccccccccccc-
Confidence 9 789999997543 268999999999999999999999999999999999999 5788999999999986633221
Q ss_pred cccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHHh
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (407)
...++..|+|||.+.+..++.++||||||+++|||++ |..||..... ......+...... ...
T Consensus 158 ---------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~----~~~ 221 (256)
T cd05039 158 ---------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPHVEKGYRM----EAP 221 (256)
T ss_pred ---------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHhcCCCC----CCc
Confidence 2234667999999998889999999999999999997 9999976432 2333333222111 123
Q ss_pred cCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 015406 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 275 (407)
Q Consensus 242 ~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~ 275 (407)
..+|+++.+++.+||..+|++||++.++.+.|+.
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 222 EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred cCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 4578999999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=310.86 Aligned_cols=248 Identities=18% Similarity=0.284 Sum_probs=199.0
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... ...+.+|+.+++.++| +++..+...+...+..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVS-PYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCC-CcHHhhhhheecCCeEEEEEe
Confidence 479999999999999999999988999999998765422 2457889999999976 566666666777888999999
Q ss_pred cc-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 84 ~~-g~sL~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~-~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
|+ +++|.+++... ...+++..+..++.||+.||.|||+ .+|+||||||+||++ +.++.++|+|||++..+...
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLV---NGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEE---CCCCCEEEeecCCcccccCC
Confidence 99 88999988753 2368999999999999999999997 599999999999999 56889999999999765432
Q ss_pred CCCcccCccCCCCccccccccccccccCC------CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcc
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLGI------EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~------~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (407)
. .....++..|+|||.+.+. .++.++|||||||++|+|++|..||...........+..+.....
T Consensus 157 ~---------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd06622 157 L---------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP 227 (286)
T ss_pred c---------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC
Confidence 2 1234678899999998654 358899999999999999999999976443332233333333222
Q ss_pred cccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 234 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
. .+...+++++.++|.+||..+|++||++.++.+
T Consensus 228 ~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 228 P----TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred C----CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 1 233457899999999999999999999887765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=311.49 Aligned_cols=249 Identities=22% Similarity=0.332 Sum_probs=200.4
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC--cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
...+|++.+.||+|+||.||+|.+..+++.||+|.+..... ...+.+|+.+++.+.| +++..+...+..+...|+||
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h-~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN-PNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCC-CCEeeEEEEEEeCCEEEEee
Confidence 35789999999999999999999999999999998765432 3457789999998876 55666666666778899999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCC
Q 015406 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 83 e~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~ 161 (407)
||+ +++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||+ +.++.++|+|||++........
T Consensus 97 e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill---~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 97 EYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred cccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCEEECccccchhcccccc
Confidence 999 8999999873 468999999999999999999999999999999999999 5778999999999876543221
Q ss_pred CcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHh
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (407)
......|++.|+|||.+.+..++.++|||||||++|+|++|+.||...... ...+. +...... .....
T Consensus 172 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~--~~~~~-~~~~~~~--~~~~~ 239 (296)
T cd06654 172 -------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--RALYL-IATNGTP--ELQNP 239 (296)
T ss_pred -------ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH--HhHHH-HhcCCCC--CCCCc
Confidence 112456889999999999888999999999999999999999999764331 11121 1111111 11122
Q ss_pred cCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 242 ~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
..++..+.+++.+||..+|++||++.++++
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred cccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 457889999999999999999999888765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=311.30 Aligned_cols=250 Identities=20% Similarity=0.340 Sum_probs=199.5
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-CcchHHHHHHHHHHHcCCCCCCeeEEeee------eCcee
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGV------EGDYN 78 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~------~~~~~ 78 (407)
.+.|++.+.||.|+||.||+|++..+++.||+|++.... ....+..|+.+++.+.+|+++..+..++. .....
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 94 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL 94 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence 478999999999999999999999999999999876543 33457788999999977788877766653 35678
Q ss_pred EEEEecc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeee
Q 015406 79 VLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~ 156 (407)
|++|||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+||++ +.++.++|+|||++...
T Consensus 95 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili---~~~~~~~l~dfg~~~~~ 171 (282)
T cd06636 95 WLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQL 171 (282)
T ss_pred EEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCcchhhh
Confidence 9999999 789999997533 458899999999999999999999999999999999999 57788999999998765
Q ss_pred ccCCCCcccCccCCCCcccccccccccccc-----CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhh
Q 015406 157 RDTSTHQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 231 (407)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~ 231 (407)
..... ......|+..|+|||++. +..++.++|||||||++|||++|..||..... ......+...
T Consensus 172 ~~~~~-------~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~---~~~~~~~~~~ 241 (282)
T cd06636 172 DRTVG-------RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP---MRALFLIPRN 241 (282)
T ss_pred hcccc-------CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH---HhhhhhHhhC
Confidence 43221 123457899999999986 34578899999999999999999999976432 1222222221
Q ss_pred cccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 232 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 232 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.. .......++.++.++|.+||..||.+||++.+|.+
T Consensus 242 ~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 242 PP---PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred CC---CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 11 11122457899999999999999999999888753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=311.33 Aligned_cols=251 Identities=19% Similarity=0.281 Sum_probs=197.7
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
++|++.+.||+|+||.||++.+..++..+|+|.+..+.. ...+.+|+++++.++| +++..+..++..++..+++||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNS-PYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEeeCCEEEEEee
Confidence 479999999999999999999999999999998765432 2347789999999976 567677777778889999999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCC
Q 015406 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 84 ~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~ 161 (407)
|+ +++|.+++... +.+++..+..++.||+.||.|||+ .+++||||||+|||+ +.++.++|+|||++.......
T Consensus 80 y~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~- 154 (308)
T cd06615 80 HMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSM- 154 (308)
T ss_pred ccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEE---ecCCcEEEccCCCcccccccc-
Confidence 99 89999999863 578999999999999999999997 699999999999999 577889999999987553321
Q ss_pred CcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHh------------
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS------------ 229 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~------------ 229 (407)
.....|+..|+|||.+.+..++.++||||||+++|+|++|..||...........+....
T Consensus 155 --------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (308)
T cd06615 155 --------ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPV 226 (308)
T ss_pred --------cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccc
Confidence 234578999999999998889999999999999999999999996533211111110000
Q ss_pred -----------------hhcccccHHHHh-cCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 230 -----------------EKKVSTSIEALC-RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 230 -----------------~~~~~~~~~~~~-~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
..........++ ..++.++.+++.+||..+|++||++.++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 286 (308)
T cd06615 227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTK 286 (308)
T ss_pred cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000000000 136788999999999999999999776654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=310.03 Aligned_cols=248 Identities=19% Similarity=0.293 Sum_probs=198.2
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC--cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~ 85 (407)
.|++.+.||+|+||.||+|.+..++..+++|.+..... ...+.+|+++++.+.| +++..+..++......++||||+
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h-~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDH-PNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCC-CCeeeEEEEEeeCCEEEEEEEec
Confidence 47899999999999999999999999999998765432 2347789999999986 55666666667778899999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcc
Q 015406 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164 (407)
Q Consensus 86 -g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~ 164 (407)
+++|..++......+++..+..++.|++.||.|||+.||+||||||+|||+ +.++.+||+|||++........
T Consensus 85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~~--- 158 (282)
T cd06643 85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTIQ--- 158 (282)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---ccCCCEEEcccccccccccccc---
Confidence 889988887555679999999999999999999999999999999999999 5788999999999876533211
Q ss_pred cCccCCCCcccccccccccccc-----CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHH
Q 015406 165 IPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (407)
Q Consensus 165 ~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (407)
......|+..|+|||++. +..++.++|||||||++|||++|..||..... .+....+....... ..
T Consensus 159 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~~~~~~~~~~--~~ 229 (282)
T cd06643 159 ----RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP---MRVLLKIAKSEPPT--LA 229 (282)
T ss_pred ----ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH---HHHHHHHhhcCCCC--CC
Confidence 123457899999999984 44578899999999999999999999976432 23333332221111 11
Q ss_pred HhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 240 ~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
....++.++.++|.+||+.+|++||++.++.+
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 230 QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 22457899999999999999999999877653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=316.76 Aligned_cols=255 Identities=16% Similarity=0.209 Sum_probs=192.3
Q ss_pred eEecccccc--CceEEEEEEEcCCCeEEEEEEecCCCC----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 10 RLGRKIGSG--SFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 10 ~i~~~iG~G--~~g~Vy~~~~~~~~~~vAvK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
+++++||+| +|++||++++..+|+.||+|.++.... ...+..|+.+++.++| ++++.+..++..++..++|||
T Consensus 1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h-pniv~~~~~~~~~~~~~lv~e 79 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNH-PNIVPYRATFIADNELWVVTS 79 (327)
T ss_pred ChhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCC-CCeeeEEEEEEECCEEEEEEe
Confidence 357899999 789999999999999999998875432 2346678899998876 666667777788889999999
Q ss_pred cc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCC
Q 015406 84 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 84 ~~-g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~ 161 (407)
|+ +++|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||+ +.++.++++||+.+........
T Consensus 80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~---~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEE---ecCCcEEEcccchhhccccccc
Confidence 99 89999999753 3458999999999999999999999999999999999999 5778999999987654332211
Q ss_pred CcccCccCCCCccccccccccccccC--CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhccc-----
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS----- 234 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~----- 234 (407)
.............++..|+|||++.+ ..++.++|||||||++|||++|..||....... ...........
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~ 233 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ---MLLEKLNGTVPCLLDT 233 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH---HHHHHhcCCccccccc
Confidence 11000001123456788999999976 458999999999999999999999997643321 11111110000
Q ss_pred ------------------------------------ccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 235 ------------------------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 235 ------------------------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.........+++++.+++.+||+.||++|||++++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0000112345778999999999999999999887764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=306.24 Aligned_cols=253 Identities=21% Similarity=0.290 Sum_probs=198.0
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
++|++.+.||+|+||.||+|++..+++.||+|.+..... ...+..|+.+++.++| +++..+..++......+++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKH-PNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCC-CCEeeeeeEEeeCCEEEEEE
Confidence 579999999999999999999998999999998754321 2346789999999987 56666667777788899999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCC
Q 015406 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 83 e~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~ 161 (407)
||+ +++|..++.. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.++|+|||++........
T Consensus 80 e~~~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 80 EYCDHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILI---TKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred eccCccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEE---cCCCcEEECccccceecCCCcc
Confidence 999 6666665543 4579999999999999999999999999999999999999 5778999999999987654331
Q ss_pred CcccCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhh---------
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK--------- 231 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~--------- 231 (407)
. .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+....+...........
T Consensus 156 ~-------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07847 156 D-------YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIF 228 (286)
T ss_pred c-------ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 1 124467889999999876 45789999999999999999999999875442222211111100
Q ss_pred --------------cccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 232 --------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 232 --------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
............++..+.+++.+||..+|++||++.++..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0001112233567899999999999999999999887753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=296.22 Aligned_cols=250 Identities=18% Similarity=0.314 Sum_probs=209.9
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
++.+++..||+|+.|.||+++.+.+|...|||.+...... .++++.+.++..-..++.|+...+++..+...+|.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 4566788999999999999999999999999988765443 3456666666665668999999999999989999999
Q ss_pred ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 84 ~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
.++.-++.++.+..+.+++..+-++...++.||.||-+ +||||||+||+|||+ |..|.+||||||++-.+.++..
T Consensus 172 lMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl---De~GniKlCDFGIsGrlvdSkA- 247 (391)
T KOG0983|consen 172 LMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGNIKLCDFGISGRLVDSKA- 247 (391)
T ss_pred HHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE---ccCCCEEeecccccceeecccc-
Confidence 99888999999888899999999999999999999985 699999999999999 7999999999999988776554
Q ss_pred cccCccCCCCccccccccccccccC---CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHH
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLG---IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (407)
.+...|-+.|||||.+.- ..|+.++||||||++|+||.||..||.+.+. ..+.+.++.....+ .++
T Consensus 248 -------htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t--dFe~ltkvln~ePP-~L~- 316 (391)
T KOG0983|consen 248 -------HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT--DFEVLTKVLNEEPP-LLP- 316 (391)
T ss_pred -------cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc--cHHHHHHHHhcCCC-CCC-
Confidence 345678999999999874 3589999999999999999999999988644 35566666664332 222
Q ss_pred HhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 240 ~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
--.++++.|.+++..||.+|+.+||.+.+|.+
T Consensus 317 ~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 317 GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred cccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 12348999999999999999999999887753
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=312.10 Aligned_cols=249 Identities=21% Similarity=0.290 Sum_probs=199.1
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc-----chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
++|++.+.||+|+||.||+|.+..+++.||+|.+...... ..+..|+++++.++| ++++.+...+......|++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv 79 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH-PFLPTLYASFQTETYLCLV 79 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCC-CCchhheeeeecCCEEEEE
Confidence 4799999999999999999999989999999988654322 347789999999986 6677777777788889999
Q ss_pred Eecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 82 MDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 82 me~~-g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
|||+ +++|.+++... ...+++..++.++.||+.||.|||+.|++|+||||+||++ +.++.++|+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILL---HESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEE---cCCCCEEEeecchhhccccc
Confidence 9999 89999998753 3569999999999999999999999999999999999999 57789999999998765332
Q ss_pred CCCccc----------------------CccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC
Q 015406 160 STHQHI----------------------PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 217 (407)
Q Consensus 160 ~~~~~~----------------------~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~ 217 (407)
...... .........||..|+|||++.+..++.++||||||+++|+|++|..||.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 211000 0011224578999999999999889999999999999999999999997643
Q ss_pred cCchHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCC
Q 015406 218 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD 265 (407)
Q Consensus 218 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt 265 (407)
. ...+..+........ ....++.++.+++.+||..+|++||+
T Consensus 237 ~---~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~R~s 278 (316)
T cd05574 237 R---DETFSNILKKEVTFP---GSPPVSSSARDLIRKLLVKDPSKRLG 278 (316)
T ss_pred h---HHHHHHHhcCCccCC---CccccCHHHHHHHHHHccCCHhHCCC
Confidence 3 333333333222111 11226899999999999999999999
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=311.49 Aligned_cols=271 Identities=19% Similarity=0.267 Sum_probs=210.3
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
++|++.+.||+|+||.||++.+..+++.||+|.+..... ...+..|+++++.++| ++++.+...+..++..+++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv 79 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN-PFVVSMFCSFETKRHLCMV 79 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCC-CCeeeeEEEEecCCEEEEE
Confidence 479999999999999999999999999999998765431 2346788999998876 5666777777788889999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 82 me~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
|||+ |++|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+||++ +..+.++|+|||+++......
T Consensus 80 ~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll---~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 80 MEYVEGGDCATLLKN-IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred EecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEE---CCCCCEEEeeCCCccccCcCc
Confidence 9999 8999999975 3578999999999999999999999999999999999999 578899999999987421111
Q ss_pred CCc--------ccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhc
Q 015406 161 THQ--------HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (407)
Q Consensus 161 ~~~--------~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (407)
... ...........|+..|+|||.+.+..++.++||||||+++|||++|..||.+... .+.+..+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~---~~~~~~~~~~~ 232 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP---EELFGQVISDD 232 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcc
Confidence 000 0000011234678899999999988899999999999999999999999976432 33344333322
Q ss_pred ccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccch
Q 015406 233 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILK 294 (407)
Q Consensus 233 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~dw~~~~ 294 (407)
...+. ....+|.++.++|.+||+.+|++||+...+.++|++ ++....+|....
T Consensus 233 ~~~~~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~-------~~~~~~~~~~~~ 285 (305)
T cd05609 233 IEWPE--GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH-------RFFLGLDWNGLL 285 (305)
T ss_pred cCCCC--ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC-------ccccCCCHHHHh
Confidence 11111 112578999999999999999999998777776665 444556776543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=310.02 Aligned_cols=253 Identities=21% Similarity=0.339 Sum_probs=202.2
Q ss_pred CCceeEeccccccCceEEEEEEEcC-----CCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCce
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~-----~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 77 (407)
.++|++.+.||+|+||.||+|.+.. ++..||+|++..... ...+.+|+.++..+.| +++..+..++..+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h-~~iv~~~~~~~~~~~ 82 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDH-PNIVKLLGVCAVGKP 82 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCC-CchheEEEEEcCCCc
Confidence 4679999999999999999998743 678999998765432 2347789999999987 667777777777788
Q ss_pred eEEEEecc-CCCHHHHHHHcC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCccc
Q 015406 78 NVLVMDLL-GPSLEDLFNFCS---------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 135 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~~~~---------------------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NIL 135 (407)
.+++|||+ +++|.+++.... ..+++..++.++.|++.||.|||+++++||||||+|||
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil 162 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCL 162 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheE
Confidence 89999999 889999997421 24788899999999999999999999999999999999
Q ss_pred ccCCCCCceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCC
Q 015406 136 MGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQ 214 (407)
Q Consensus 136 l~~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~ 214 (407)
+ +.++.++|+|||++........ +.......++..|+|||.+.+..++.++|||||||++|||++ |..||.
T Consensus 163 ~---~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 163 V---GENMVVKIADFGLSRNIYSADY-----YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred e---cCCCceEECccccceecccCcc-----ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 9 5788999999999986543321 111223345678999999998899999999999999999998 888997
Q ss_pred CCCcCchHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015406 215 GLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 274 (407)
Q Consensus 215 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~ 274 (407)
+... .+....+...... .....++.++.+++.+||..+|++||++.++.+.|+
T Consensus 235 ~~~~---~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 235 GMAH---EEVIYYVRDGNVL----SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred CCCH---HHHHHHHhcCCCC----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 6443 2333333332221 123457899999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=310.96 Aligned_cols=258 Identities=22% Similarity=0.266 Sum_probs=197.7
Q ss_pred CceeEeccccccCceEEEEEEE----cCCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeee--Cce
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTN----IQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVE--GDY 77 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~----~~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~--~~~ 77 (407)
.-|++.+.||+|+||.||+++. ..++..||+|.+..... ...+.+|+.+++.+.|++ +..+..++.. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~ 82 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN-IVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCC-eeeeeeEEecCCCCc
Confidence 3479999999999999999974 45688999998764432 235788999999998754 4445444443 367
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeee
Q 015406 78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~ 156 (407)
.++||||+ |++|.+++......+++..++.++.||+.||+|||++||+||||||+||++ +.++.++|+|||+++.+
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~---~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLTKAI 159 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEE---cCCCCEEECCCcccccc
Confidence 89999999 999999997655568999999999999999999999999999999999999 57788999999999876
Q ss_pred ccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCc-----------C-chHHH
Q 015406 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA-----------G-TKKQK 224 (407)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~-----------~-~~~~~ 224 (407)
....... .......++..|+|||++.+..++.++||||||+++|||+++..|+..... . .....
T Consensus 160 ~~~~~~~----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05079 160 ETDKEYY----TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL 235 (284)
T ss_pred ccCccce----eecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence 4432211 112345677889999999988899999999999999999998766532110 0 00011
Q ss_pred HHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 015406 225 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (407)
Q Consensus 225 ~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l 276 (407)
...+..... ......++.++.+|+.+||+.+|++||++.++.+.|+++
T Consensus 236 ~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 236 VRVLEEGKR----LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHcCcc----CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111111111 112345789999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=306.23 Aligned_cols=251 Identities=21% Similarity=0.281 Sum_probs=201.9
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
+|++.+.||+|+||.||+|.+..+++.||+|.+..... ...+.+|+.+++.++| +++..+..+...+...++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQH-PYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCC-CCCcceeeEEecCCeeEEEec
Confidence 58999999999999999999999999999998765432 3457889999999985 666677777777888999999
Q ss_pred ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCc
Q 015406 84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (407)
Q Consensus 84 ~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~ 163 (407)
|++++|.+++......+++..++.++.||+.||.|||++|++|+||||+||++ +.++.++|+|||++........
T Consensus 80 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~-- 154 (286)
T cd07832 80 YMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLI---SADGVLKIADFGLARLFSEEEP-- 154 (286)
T ss_pred ccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEE---cCCCcEEEeeeeecccccCCCC--
Confidence 99999999998666779999999999999999999999999999999999999 5788999999999987654321
Q ss_pred ccCccCCCCccccccccccccccCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhc----------
Q 015406 164 HIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK---------- 232 (407)
Q Consensus 164 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~---------- 232 (407)
+......|+..|+|||++.+. .++.++||||||+++|||++|..||.+... ...+..+....
T Consensus 155 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07832 155 ----RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND---IEQLAIVFRTLGTPNEETWPG 227 (286)
T ss_pred ----CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH---HHHHHHHHHHcCCCChHHHhh
Confidence 112345689999999998764 468999999999999999999888865432 12222211110
Q ss_pred ---------------ccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 233 ---------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 233 ---------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
............+.++.+++.+||..+|++||+++++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 228 LTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred ccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 001122334567899999999999999999999887754
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=317.51 Aligned_cols=257 Identities=20% Similarity=0.332 Sum_probs=217.4
Q ss_pred eeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-C
Q 015406 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (407)
Q Consensus 9 y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~-g 86 (407)
..+..+||-|.||.||.|.+++-.-.||||.++.+.. ..+|+.|+.+|+.++| ++++.+.+++.....+||+.||| .
T Consensus 269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikH-pNLVqLLGVCT~EpPFYIiTEfM~y 347 (1157)
T KOG4278|consen 269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH-PNLVQLLGVCTHEPPFYIITEFMCY 347 (1157)
T ss_pred eeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcC-ccHHHHhhhhccCCCeEEEEecccC
Confidence 4456799999999999999999999999998876654 4679999999999987 66667777777777889999999 9
Q ss_pred CCHHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCccc
Q 015406 87 PSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165 (407)
Q Consensus 87 ~sL~~~l~~~~~~-l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~ 165 (407)
|+|.+|+.++++. ++.-..+.++.||..|++||..+++|||||...|+|+ .++..+|++|||+++.+..+....|
T Consensus 348 GNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLV---gEnhiVKvADFGLsRlMtgDTYTAH- 423 (1157)
T KOG4278|consen 348 GNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHIVKVADFGLSRLMTGDTYTAH- 423 (1157)
T ss_pred ccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccc---cccceEEeeccchhhhhcCCceecc-
Confidence 9999999988754 6777788999999999999999999999999999999 4889999999999999877654322
Q ss_pred CccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCC
Q 015406 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 244 (407)
Q Consensus 166 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (407)
....-...|.|||.+.-..++.|+|||+|||+|||+.| |..||.+.+.......+++-.... -+.+|
T Consensus 424 -----AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~-------~PeGC 491 (1157)
T KOG4278|consen 424 -----AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMD-------GPEGC 491 (1157)
T ss_pred -----cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcccccc-------CCCCC
Confidence 22233578999999999899999999999999999999 999999876554444444433322 23689
Q ss_pred cHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCC
Q 015406 245 PTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGF 282 (407)
Q Consensus 245 ~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~ 282 (407)
|+.+++||..||+++|.+||+|+++.+.|+.+|.....
T Consensus 492 PpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSi 529 (1157)
T KOG4278|consen 492 PPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSI 529 (1157)
T ss_pred CHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccccc
Confidence 99999999999999999999999999999999876543
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=307.69 Aligned_cols=253 Identities=21% Similarity=0.263 Sum_probs=198.3
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
.++|++.+.||+|+||.||+|.+..+++.||||.+..... ...+.+|+++++.++| +++..+..++...+..++||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKH-ANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCC-cceeeEEEEEecCCeEEEEE
Confidence 4789999999999999999999988999999998764332 2346789999999976 66777777788888999999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 83 e~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
||++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 83 e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~- 158 (291)
T cd07844 83 EYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLI---SERGELKLADFGLARAKSVPSK- 158 (291)
T ss_pred ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEE---cCCCCEEECccccccccCCCCc-
Confidence 999779999998766678999999999999999999999999999999999999 5788999999999875432111
Q ss_pred cccCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhc---------
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK--------- 232 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~--------- 232 (407)
......++..|+|||++.+ ..++.++||||||+++|+|++|..||.+.... .+....+....
T Consensus 159 ------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07844 159 ------TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV--EDQLHKIFRVLGTPTEETWP 230 (291)
T ss_pred ------cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHhcCCCChhhhh
Confidence 1123356889999999876 45799999999999999999999999764321 11111111000
Q ss_pred ----------------ccccHHHHhcCCc--HHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 233 ----------------VSTSIEALCRGYP--TEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 233 ----------------~~~~~~~~~~~~~--~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
...........++ .++.+++.+||+.+|++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 231 GVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0011111122344 78899999999999999999887754
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=305.13 Aligned_cols=256 Identities=23% Similarity=0.336 Sum_probs=202.9
Q ss_pred CCceeEeccccccCceEEEEEEEcCC---CeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~---~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 79 (407)
.++|.+.+.||+|+||.||+|.+... ...||||....... ...+..|+.+++.+.|.+ +..+..++.. ...+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~-i~~~~~~~~~-~~~~ 82 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPH-IVKLIGVITE-NPVW 82 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCc-hhceeEEEcC-CCcE
Confidence 46799999999999999999987544 34789998765432 235788999999998754 5555444443 4568
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 80 lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
++|||+ +++|.+++......+++..++.++.|++.||+|||++|++||||||+|||+ +..+.++|+|||+++....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLV---SSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEE---ecCCCeEEccCceeeeccc
Confidence 999999 899999998655568999999999999999999999999999999999999 5778999999999987654
Q ss_pred CCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccH
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (407)
.... ......++..|+|||.+.+..++.++||||||+++|||++ |..||..... .+....+......
T Consensus 160 ~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~---~~~~~~~~~~~~~--- 227 (270)
T cd05056 160 ESYY------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN---NDVIGRIENGERL--- 227 (270)
T ss_pred ccce------ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHcCCcC---
Confidence 3221 1122334568999999998889999999999999999996 9999976543 2333333332211
Q ss_pred HHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHH
Q 015406 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (407)
Q Consensus 238 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~ 279 (407)
.....+|.++.+++.+||..+|++||++.++.+.|+++...
T Consensus 228 -~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 228 -PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred -CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 12356889999999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=311.00 Aligned_cols=252 Identities=17% Similarity=0.273 Sum_probs=198.0
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
++|+..+.||+|+||.||++.+..+++.||+|.+..... ...+.+|+.++.++..+++++.+..+.......+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 467788999999999999999999999999998765432 23577899999998756777777777777788899999
Q ss_pred ccCCCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 84 LLGPSLEDLFNF----CSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 84 ~~g~sL~~~l~~----~~~~l~~~~~~~i~~qi~~aL~yLH~-~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
|++.+|.++... ....+++..+..++.|++.||+|||+ .+|+||||||+||++ +.++.++|+|||+++.+..
T Consensus 84 ~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILL---DRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEE---ccCCcEEEeecchhHHhcc
Confidence 998887776532 23569999999999999999999997 499999999999999 5778999999999976543
Q ss_pred CCCCcccCccCCCCccccccccccccccCC---CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccc
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHLGI---EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~---~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (407)
... .....|+..|+|||++.+. .++.++|||||||++|+|++|+.||.... ...+...++.....+.
T Consensus 161 ~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~ 230 (288)
T cd06616 161 SIA--------KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGDPPI 230 (288)
T ss_pred CCc--------cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcCCCCCc
Confidence 221 1234688999999999876 68999999999999999999999997643 1222222222221111
Q ss_pred cHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
........++.++.+|+.+||+.+|++||++++|.+
T Consensus 231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 231 LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111122347899999999999999999999887764
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=310.63 Aligned_cols=258 Identities=19% Similarity=0.275 Sum_probs=201.2
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCe----EEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeeeCce
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNE----EVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~----~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 77 (407)
-.++|++.+.||+|+||.||+|.+..+++ .||+|.+...... ..+..|+.+++.+.| +++..+.+++... .
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h-~niv~~~~~~~~~-~ 82 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDH-PHLVRLLGVCLSP-T 82 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CCcccEEEEEcCC-C
Confidence 35789999999999999999999877776 5788987654332 246788999999976 5555554444433 4
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeee
Q 015406 78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~ 156 (407)
.++++||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill---~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLV---KSPNHVKITDFGLARLL 159 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeee---cCCCceEEccccccccc
Confidence 57899999 899999998656678999999999999999999999999999999999999 56788999999999876
Q ss_pred ccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccc
Q 015406 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVST 235 (407)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (407)
....... ......++..|+|||.+.+..++.++||||||+++|||++ |..||.+..... +..+.......
T Consensus 160 ~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~----~~~~~~~~~~~ 230 (303)
T cd05110 160 EGDEKEY-----NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE----IPDLLEKGERL 230 (303)
T ss_pred cCccccc-----ccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHHCCCCC
Confidence 4332210 1123345778999999999899999999999999999997 999997643221 22222211111
Q ss_pred cHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHH
Q 015406 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (407)
Q Consensus 236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~ 279 (407)
. ....++..+.+++.+||..+|++||+++++.+.|+++...
T Consensus 231 ~---~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 231 P---QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred C---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 1 1244678999999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=300.38 Aligned_cols=244 Identities=19% Similarity=0.305 Sum_probs=194.5
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-CCC
Q 015406 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPS 88 (407)
Q Consensus 13 ~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~-g~s 88 (407)
+.||+|+||.||+|.. .++..||+|++...... ..+.+|+++++.+.| +++..+..++...+..++||||+ +++
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDH-PNIVKLIGVCTQRQPIYIVMELVPGGD 78 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCC-CCcCeEEEEEecCCccEEEEECCCCCc
Confidence 4789999999999986 56889999987654322 247789999999876 56666666677777889999999 999
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcccCcc
Q 015406 89 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYR 168 (407)
Q Consensus 89 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 168 (407)
|.+++......+++..++.++.|++.||.|||++|++||||||+||++ +.++.+||+|||++.........
T Consensus 79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~------ 149 (250)
T cd05085 79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSRQEDDGIYS------ 149 (250)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEE---cCCCeEEECCCccceeccccccc------
Confidence 999987655668999999999999999999999999999999999999 57889999999999754332211
Q ss_pred CCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcHH
Q 015406 169 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTE 247 (407)
Q Consensus 169 ~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 247 (407)
......++..|+|||++.+..++.++||||||+++|++++ |..||...... .....+..... ......++.+
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~---~~~~~~~~~~~----~~~~~~~~~~ 222 (250)
T cd05085 150 SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ---QAREQVEKGYR----MSCPQKCPDD 222 (250)
T ss_pred cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH---HHHHHHHcCCC----CCCCCCCCHH
Confidence 1122344678999999998889999999999999999998 99999765432 22222222211 1123457899
Q ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015406 248 FASYFHYCRSLRFDDKPDYAYLKRIFR 274 (407)
Q Consensus 248 l~~li~~cl~~~p~~RPt~~~l~~~l~ 274 (407)
+.+++.+||..+|++||++.++.+.|.
T Consensus 223 ~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 223 VYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=303.71 Aligned_cols=253 Identities=19% Similarity=0.365 Sum_probs=200.5
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
...++|++.++||+|+||.||+|.+ ..+..+|+|.+..... ...+.+|+.+++.++|. ++..+..+... ...+++|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~-~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHD-KLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEe-cCCccEEEEecCCChhHHHHHHHHHHHHHhcCCC-CcceEEEEEcC-CCeEEEE
Confidence 3568999999999999999999986 4556799998765432 34578899999999875 45555444444 6679999
Q ss_pred ecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 83 DLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 83 e~~-g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
||+ +++|.+++... ...+++..++.++.|++.||.|||++|++||||||+||++ +..+.+||+|||++..+....
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 80 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCCcceeeccCCC
Confidence 999 88999999753 3457899999999999999999999999999999999999 578899999999998664332
Q ss_pred CCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHH
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (407)
.. ......++..|+|||++.+..++.++|||||||++|++++ |..||...... .....+...... .
T Consensus 157 ~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~~~~~~~----~ 223 (260)
T cd05073 157 YT------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRALERGYRM----P 223 (260)
T ss_pred cc------cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHhCCCCC----C
Confidence 11 1223345678999999998889999999999999999999 99999764432 223332222111 1
Q ss_pred HhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 015406 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 275 (407)
Q Consensus 240 ~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~ 275 (407)
.....+.++.+++.+||..+|++||++.++.+.|+.
T Consensus 224 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 224578999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=316.14 Aligned_cols=257 Identities=21% Similarity=0.221 Sum_probs=195.9
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC---CcchHHHHHHHHHHHcCCCCCCeeEEeee-----eCc
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGV-----EGD 76 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~-----~~~ 76 (407)
++++|++.++||+|+||.||+|++..+++.||||.+.... ....+..|+.+++.++|.+ +..+..+.. ...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN-IIGILDIIRPPSFESFN 81 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCC-cCchhheeecccccccc
Confidence 6789999999999999999999999999999999876422 2234778999999998755 444433322 224
Q ss_pred eeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeee
Q 015406 77 YNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (407)
Q Consensus 77 ~~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~ 156 (407)
..|++|||++++|.+++. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 82 ~~~lv~e~~~~~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 82 DVYIVQELMETDLYKLIK--TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTNCDLKICDFGLARIA 156 (336)
T ss_pred eEEEEehhcccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEECcccceeec
Confidence 579999999889998886 4579999999999999999999999999999999999999 67889999999999876
Q ss_pred ccCCCCcccCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHH--------
Q 015406 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK-------- 227 (407)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~-------- 227 (407)
....... .......||..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 157 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~ 232 (336)
T cd07849 157 DPEHDHT----GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQE 232 (336)
T ss_pred ccccccc----CCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence 4432211 11234578999999998765 4689999999999999999999999976432111111100
Q ss_pred ----Hhh-----------hcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 228 ----ISE-----------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 228 ----i~~-----------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
+.. ...........+.+++++.+++.+||+.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~ 291 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALA 291 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000 00011112233456888999999999999999999877764
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=310.43 Aligned_cols=250 Identities=20% Similarity=0.319 Sum_probs=202.7
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC--cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
.++|++.+.||.|+||.||+|.+..++..||+|++..... ...+..|+++++.++| +++..+...+..+...|+|||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKH-PNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCC-CceeEEEEEEecCCeEEEEee
Confidence 4679999999999999999999988999999998765432 2357789999999985 677777777778889999999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 84 ~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
|+ +++|.+++......+++..++.++.|++.||.|||++||+|+||||+||++ +.++.++|+|||++........
T Consensus 83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~- 158 (280)
T cd06611 83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILL---TLDGDVKLADFGVSAKNKSTLQ- 158 (280)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---CCCCCEEEccCccchhhccccc-
Confidence 99 889999998766679999999999999999999999999999999999999 5789999999999875533221
Q ss_pred cccCccCCCCcccccccccccccc-----CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccH
Q 015406 163 QHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (407)
......|++.|+|||.+. +..++.++||||||+++|+|++|..||..... .+.+..+.......
T Consensus 159 ------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~-- 227 (280)
T cd06611 159 ------KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP---MRVLLKILKSEPPT-- 227 (280)
T ss_pred ------ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH---HHHHHHHhcCCCCC--
Confidence 123456899999999975 34567899999999999999999999976433 23333333322111
Q ss_pred HHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 238 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
......++.++.+++.+||..+|++||++.++++
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 228 LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 1112357889999999999999999999877753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=309.60 Aligned_cols=253 Identities=19% Similarity=0.220 Sum_probs=197.4
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc----chHHHHHHHHHHHcCCCCCCeeEEeee--eCcee
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGV--EGDYN 78 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~--~~~~~ 78 (407)
..++|++.+.||+|+||.||+|.+..+++.||+|.+...... ....+|+.+++.++|.+.+ .+..+.. ..+..
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~-~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIV-ELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCc-ceEEEEecCCCCeE
Confidence 357899999999999999999999999999999987644322 2356899999999985544 4444433 33568
Q ss_pred EEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 79 VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 79 ~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
++||||++++|.+++......+++..++.++.||+.||.|||++|++||||||+||++ +.++.+||+|||++.....
T Consensus 84 ~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 84 FLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLL---TDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccceeeecCC
Confidence 9999999889999998766779999999999999999999999999999999999999 5788999999999987654
Q ss_pred CCCCcccCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhccc---
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS--- 234 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~--- 234 (407)
.... .....++..|+|||.+.+ ..++.++|||||||++|||++|..||.+.+.. +.+..+......
T Consensus 161 ~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~---~~~~~~~~~~~~~~~ 230 (309)
T cd07845 161 PAKP-------MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI---EQLDLIIQLLGTPNE 230 (309)
T ss_pred ccCC-------CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCCh
Confidence 3211 123345788999999876 45799999999999999999999999865432 222222221000
Q ss_pred ----------------------ccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 235 ----------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 235 ----------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.........+++++.++|.+||..||++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 231 SIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0011112235788999999999999999999877764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=305.30 Aligned_cols=245 Identities=22% Similarity=0.345 Sum_probs=201.9
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
++|++.+.||.|+||.||+|++..+++.||+|++..... ...+.+|+.+++.++| +++..+..++..+...++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRS-PYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCC-CCeeeeeEEEEECCeEEEEEE
Confidence 579999999999999999999999999999998865432 2347789999999986 556666667777789999999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 84 ~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
|+ +++|.+++.. ..+++..++.++.|++.||.|||+++++||||+|+||++ ++++.++|+|||+++.......
T Consensus 80 ~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~- 153 (274)
T cd06609 80 YCGGGSCLDLLKP--GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILL---SEEGDVKLADFGVSGQLTSTMS- 153 (274)
T ss_pred eeCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEcccccceeeccccc-
Confidence 99 8899999985 379999999999999999999999999999999999999 5788999999999987765321
Q ss_pred cccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhc
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (407)
......|+..|+|||.+.+..++.++||||||+++|+|++|..||..... ......+....... +..
T Consensus 154 ------~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~---~~~~~~~~~~~~~~----~~~ 220 (274)
T cd06609 154 ------KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP---MRVLFLIPKNNPPS----LEG 220 (274)
T ss_pred ------ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch---HHHHHHhhhcCCCC----Ccc
Confidence 12345788999999999998899999999999999999999999976442 22233232222111 112
Q ss_pred C-CcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 243 G-YPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 243 ~-~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
. ++.++.+++.+||..+|++||+++++.+
T Consensus 221 ~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 221 NKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred cccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 2 7889999999999999999999877754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=299.30 Aligned_cols=247 Identities=22% Similarity=0.271 Sum_probs=205.3
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
+|++.+.||.|+||.||.+++..+++.+++|.+..... ...+.+|+.+++.++| +++..+..++.+.+..+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQH-PNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCC-CCeeEEEeEEecCCeEEEEEE
Confidence 59999999999999999999999999999998764432 2357889999999976 667777777777889999999
Q ss_pred cc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCC
Q 015406 84 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 84 ~~-g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~ 161 (407)
|+ +++|.+++... ...+++..+..++.|++.||.|||+.|++|+||||+||++ +.++.+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~---~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFL---TKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEE---eCCCCEEECcCcceEEcccccc
Confidence 99 89999999754 3468999999999999999999999999999999999999 5778899999999987654332
Q ss_pred CcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHh
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (407)
......|++.|+|||.+.+..++.++||||||+++|||++|..||.... ..+....+....... ..
T Consensus 157 -------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~---~~~~~~~~~~~~~~~----~~ 222 (256)
T cd08221 157 -------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN---PLNLVVKIVQGNYTP----VV 222 (256)
T ss_pred -------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHcCCCCC----Cc
Confidence 1234568999999999998889999999999999999999999997633 334444444433322 12
Q ss_pred cCCcHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015406 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRI 272 (407)
Q Consensus 242 ~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~ 272 (407)
..++.++.+++.+||..+|++||++.++.+.
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 223 SVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred cccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 5578999999999999999999998887653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=304.69 Aligned_cols=254 Identities=20% Similarity=0.306 Sum_probs=200.7
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC--------CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeE
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--------KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 79 (407)
+|+..+.||+|+||.||+|.+..+++.||+|++.... ....+..|+++++.++| ++++.+..++.+.+..+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~ 79 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNH-PHIIRMLGATCEDSHFN 79 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCC-CceehhhceeccCCeEE
Confidence 5889999999999999999999999999999886433 12457889999999987 55566666667778889
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 80 lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
+||||+ +++|.+++.. ...+++..++.++.||+.||.|||++|++|+||||+||+++ .....++|+|||++.....
T Consensus 80 ~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~--~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 80 LFVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLID--STGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--CCCCEEEEccccccccccc
Confidence 999999 8999999975 45789999999999999999999999999999999999994 2334699999999987654
Q ss_pred CCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHH
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (407)
...... .......|+..|+|||.+.+..++.++||||||+++|+|++|..||..............+..... ..
T Consensus 157 ~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~ 230 (268)
T cd06630 157 KGTGAG---EFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATT---AP 230 (268)
T ss_pred ccccCC---ccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCC---CC
Confidence 322111 012345688999999999988899999999999999999999999975443322222222221111 11
Q ss_pred HHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 239 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.+...+++++.+++.+||..+|++||++.++.+
T Consensus 231 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 231 SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 233457889999999999999999999888764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=308.51 Aligned_cols=248 Identities=22% Similarity=0.333 Sum_probs=200.5
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC--CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
..+|++.+.||.|+||.||+|.+..+++.||+|.+.... ....+..|+.+++.++| +++..+..+....+..++|||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKN-PNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCC-CceeeeeeeEecCceEEEEEE
Confidence 457999999999999999999999999999999876543 23457789999999987 555566666677888999999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 84 ~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
|+ +++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||++ +.++.++|+|||++........
T Consensus 97 ~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili---~~~~~~kl~dfg~~~~~~~~~~- 170 (296)
T cd06655 97 YLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLL---GMDGSVKLTDFGFCAQITPEQS- 170 (296)
T ss_pred ecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccchhcccccc-
Confidence 99 9999999874 468999999999999999999999999999999999999 5788999999999886543321
Q ss_pred cccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhc
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (407)
......|+..|+|||.+.+..++.++|||||||++|+|++|..||..... ......+...... ......
T Consensus 171 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~---~~~~~~~~~~~~~--~~~~~~ 239 (296)
T cd06655 171 ------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP---LRALYLIATNGTP--ELQNPE 239 (296)
T ss_pred ------cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCCc--ccCCcc
Confidence 11245688999999999988899999999999999999999999976433 2222222211111 111234
Q ss_pred CCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 243 ~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.+++.+.++|.+||..||++||++.+|..
T Consensus 240 ~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 240 KLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred cCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 57899999999999999999999887763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=299.97 Aligned_cols=246 Identities=22% Similarity=0.280 Sum_probs=201.1
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
+|++.+.||+|+||.||+|.+..+++.+|+|.+..... ...+..|+++++.++| +++..+.......+..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSH-PNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCC-CchhheeeeEecCCEEEEEEe
Confidence 58999999999999999999999999999998765432 2357789999999986 556666666677788999999
Q ss_pred cc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCC
Q 015406 84 LL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 84 ~~-g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~ 161 (407)
|+ +++|.+++.... ..+++..++.++.|++.||.|||++||+|+||||+||+++ ++++.++|+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~--~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLD--KHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--CCCCEEEEccCCCceecCCCcc
Confidence 99 889999997543 4589999999999999999999999999999999999994 3456789999999987654322
Q ss_pred CcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHh
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (407)
.....|+..|+|||.+.+..++.++||||||+++|+|++|..||...+. ......+...... .+.
T Consensus 158 --------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~---~~~~~~~~~~~~~----~~~ 222 (256)
T cd08220 158 --------AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL---PALVLKIMSGTFA----PIS 222 (256)
T ss_pred --------ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch---HHHHHHHHhcCCC----CCC
Confidence 2245688999999999988889999999999999999999999976433 2333333322221 233
Q ss_pred cCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 242 ~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
..+++++.+++.+||..+|++||++.++.+
T Consensus 223 ~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 223 DRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 457899999999999999999999888764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=308.48 Aligned_cols=249 Identities=18% Similarity=0.299 Sum_probs=200.2
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
.++|++.+.||+|+||.||++.+..+++.||+|++..... ...+.+|+++++.++| +++..+..++......++||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRS-PYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCC-CCcceEeeeEecCCEEEEEE
Confidence 3679999999999999999999999999999998764432 2457889999999975 66767777777778899999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 83 e~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
||+ +++|.+++.. .+.+++..+..++.|++.||.|||+ ++++||||||+||++ ++++.++|+|||++.......
T Consensus 83 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~---~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 83 EFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILV---NSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred ecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEE---CCCCcEEEccCCcccchhhhc
Confidence 999 8899999875 4568999999999999999999997 699999999999999 578899999999987543321
Q ss_pred CCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCc-----h---HHHHHHHhhhc
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT-----K---KQKYEKISEKK 232 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~-----~---~~~~~~i~~~~ 232 (407)
.....|+..|+|||++.+..++.++|||||||++|+|++|..||....... . ......+....
T Consensus 159 ---------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd06620 159 ---------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP 229 (284)
T ss_pred ---------cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc
Confidence 124578999999999988889999999999999999999999998644320 0 11111111111
Q ss_pred ccccHHHHh-cCCcHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015406 233 VSTSIEALC-RGYPTEFASYFHYCRSLRFDDKPDYAYLKRI 272 (407)
Q Consensus 233 ~~~~~~~~~-~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~ 272 (407)
...+. ..++.++.+++.+||..||++||++.++.+.
T Consensus 230 ----~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 230 ----PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred ----CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11111 1278899999999999999999999888754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=307.05 Aligned_cols=250 Identities=20% Similarity=0.247 Sum_probs=197.9
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc-------chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-------PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~-------~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
+|++.+.||+|+||.||+|.+..+++.||||.+...... ..+..|+++++.++| +++..+..++...+..++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~l 79 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH-PNIIGLLDVFGHKSNINL 79 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCC-CCChhhhheeecCCEEEE
Confidence 589999999999999999999889999999988654322 235678999999986 556666666666888999
Q ss_pred EEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 81 VMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 81 vme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
||||++++|.+++......+++..++.++.||+.||.|||++||+|+||||+|||+ +.++.++|+|||+++......
T Consensus 80 v~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 80 VFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLI---ASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred EEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEE---cCCCCEEEccceeeeeccCCC
Confidence 99999999999998543469999999999999999999999999999999999999 578899999999998765432
Q ss_pred CCcccCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhc-------
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK------- 232 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~------- 232 (407)
.. .....++..|+|||.+.+ ..++.++|||||||++|||++|..||.+.... ..+.++....
T Consensus 157 ~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 226 (298)
T cd07841 157 RK-------MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI---DQLGKIFEALGTPTEEN 226 (298)
T ss_pred cc-------ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH---HHHHHHHHHcCCCchhh
Confidence 11 123456788999999865 45789999999999999999998888764432 2222221110
Q ss_pred ----------------ccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 233 ----------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 233 ----------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
............+.++.++|.+||..+|++||++.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 227 WPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred hhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 011112233456789999999999999999999887765
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=303.01 Aligned_cols=302 Identities=18% Similarity=0.247 Sum_probs=238.6
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
.++|+++++||+|+|..|.+++.+++.+.||+|+++++. .-.....|..+.....+++.++-++.+++.....++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 478999999999999999999999999999999876542 233477888999999989999999999999999999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 81 vme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
|.||+ ||+|--.+++ +++++++.++.+..+|+.||.|||++|||.||||.+|||| +..+++||+|+|+++.--.+
T Consensus 329 vieyv~ggdlmfhmqr-qrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvll---daeghikltdygmcke~l~~ 404 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGLGP 404 (593)
T ss_pred EEEEecCcceeeehhh-hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEE---ccCCceeecccchhhcCCCC
Confidence 99999 9999877775 5689999999999999999999999999999999999999 79999999999999854333
Q ss_pred CCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCc-----CchHHHHHHHhhhccc
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA-----GTKKQKYEKISEKKVS 234 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~-----~~~~~~~~~i~~~~~~ 234 (407)
.. ..++++||+.|.|||++.|..|+..+|+|+|||+|+||+.|+.||.-... .+..-.+..|.++...
T Consensus 405 gd-------~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir 477 (593)
T KOG0695|consen 405 GD-------TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR 477 (593)
T ss_pred Cc-------ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc
Confidence 22 25689999999999999999999999999999999999999999964321 1223344445555443
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchhhcccccCCCCccCCCCCCC
Q 015406 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATPPARALVPGAGT 314 (407)
Q Consensus 235 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~~~~~~~~~~~~~~~~~~~~ 314 (407)
+++.++-....++..-|++||.+|..-. ...-|++ -.+++|+..+||+.+++.+. .+|..|......+.
T Consensus 478 -----iprslsvkas~vlkgflnkdp~erlgc~-~~~g~~d---ik~h~ffr~idwd~leqk~v--~ppf~p~i~~d~~l 546 (593)
T KOG0695|consen 478 -----IPRSLSVKASHVLKGFLNKDPKERLGCR-PQTGFSD---IKSHAFFRSIDWDLLEQKQV--LPPFQPQITDDYGL 546 (593)
T ss_pred -----ccceeehhhHHHHHHhhcCCcHHhcCCC-cccchhh---hhcchhhhhCCHHHHhhccc--CCCCCCccccccCc
Confidence 3355777888999999999999996521 1112333 34567777899999988764 44444555555555
Q ss_pred CCCCCCCCCCCCcCC
Q 015406 315 SGAPPAIASGDRQTG 329 (407)
Q Consensus 315 ~~~~~~~~~~~~~~~ 329 (407)
.......++...+-+
T Consensus 547 ~~fd~qft~e~~qlt 561 (593)
T KOG0695|consen 547 DNFDTQFTSEPVQLT 561 (593)
T ss_pred cccccccccCCcccC
Confidence 555444444444333
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=304.87 Aligned_cols=252 Identities=20% Similarity=0.266 Sum_probs=196.9
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
.++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+|+.+++.++| +++..+..++..++..|++|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH-ANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCC-CCEeEEEEEEecCCeEEEEE
Confidence 46899999999999999999999999999999987654322 246789999999986 56667777778888899999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 83 e~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
||++++|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||+++.......
T Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~- 158 (291)
T cd07870 83 EYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI---SYLGELKLADFGLARAKSIPSQ- 158 (291)
T ss_pred ecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---cCCCcEEEeccccccccCCCCC-
Confidence 999888888876545568899999999999999999999999999999999999 5788999999999975433221
Q ss_pred cccCccCCCCccccccccccccccCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhc---------
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK--------- 232 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~--------- 232 (407)
......++..|+|||.+.+. .++.++||||||+++|+|++|..||..... ..+.+.++....
T Consensus 159 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07870 159 ------TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD--VFEQLEKIWTVLGVPTEDTWP 230 (291)
T ss_pred ------CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh--HHHHHHHHHHHcCCCChhhhh
Confidence 12234578999999998764 578999999999999999999999976432 122222221100
Q ss_pred ----------------ccccHHHHhc--CCcHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015406 233 ----------------VSTSIEALCR--GYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 233 ----------------~~~~~~~~~~--~~~~~l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
.......... ..+.++.+++.+|+..||.+|||+.++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l 286 (291)
T cd07870 231 GVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDAL 286 (291)
T ss_pred hhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHh
Confidence 0000111111 1357899999999999999999987765
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=299.48 Aligned_cols=249 Identities=20% Similarity=0.285 Sum_probs=200.0
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~ 85 (407)
.+|++.+.||+|+||.||+|.+. .+..+|+|.+..... ...+..|+++++.+.| +++..+..++......+++|||+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSH-PKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCC-CCeeeEEEEEccCCceEEEEEcC
Confidence 57999999999999999999874 467899998765432 3568899999999987 55666666677777889999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcc
Q 015406 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164 (407)
Q Consensus 86 -g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~ 164 (407)
+++|.+++......+++..++.++.|++.||+|||+++++||||||+||++ +.++.++|+|||++........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~--- 155 (256)
T cd05112 82 EHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLV---GENQVVKVSDFGMTRFVLDDQY--- 155 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEE---cCCCeEEECCCcceeecccCcc---
Confidence 899999998655678999999999999999999999999999999999999 5778999999999986543221
Q ss_pred cCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcC
Q 015406 165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243 (407)
Q Consensus 165 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (407)
.......++..|+|||.+.+..++.++||||||+++|||++ |..||..... ......+...... .....
T Consensus 156 ---~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~~~~~----~~~~~ 225 (256)
T cd05112 156 ---TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN---SEVVETINAGFRL----YKPRL 225 (256)
T ss_pred ---cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHHhCCCCC----CCCCC
Confidence 11123345678999999998889999999999999999998 9999976332 3333333222111 01233
Q ss_pred CcHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 015406 244 YPTEFASYFHYCRSLRFDDKPDYAYLKRIF 273 (407)
Q Consensus 244 ~~~~l~~li~~cl~~~p~~RPt~~~l~~~l 273 (407)
.+.++.+++.+||..+|++||++.++.+.|
T Consensus 226 ~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 226 ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 688999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=315.62 Aligned_cols=251 Identities=22% Similarity=0.284 Sum_probs=195.0
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC----CcchHHHHHHHHHHHcCCCCCCeeEEeee-----e
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGV-----E 74 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~-----~ 74 (407)
.+.++|++.+.||+|+||.||+|.+..+++.||||.+.... ....+.+|+.+++.++|.+.+..+..+.. +
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 35788999999999999999999999999999999875432 12346789999999987555554444332 2
Q ss_pred CceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEecccee
Q 015406 75 GDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (407)
Q Consensus 75 ~~~~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~ 154 (407)
....|+||||++++|.+.+.. .++...+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 93 ~~~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~---~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 93 FQDVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 166 (353)
T ss_pred cCcEEEEEeccCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEccCccce
Confidence 235799999998899998864 38999999999999999999999999999999999999 578899999999998
Q ss_pred eeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhccc
Q 015406 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (407)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (407)
....... .....++..|+|||++.+..++.++|||||||++|+|++|+.||...+. ...+..+......
T Consensus 167 ~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~~ 235 (353)
T cd07850 167 TAGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH---IDQWNKIIEQLGT 235 (353)
T ss_pred eCCCCCC--------CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHhcCC
Confidence 7544221 2245688999999999999999999999999999999999999976432 1222221110000
Q ss_pred -------------------------ccHHHH-------------hcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 235 -------------------------TSIEAL-------------CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 235 -------------------------~~~~~~-------------~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.....+ ....++++.++|.+||..||++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 236 PSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred CCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000000 1134667899999999999999999877754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=303.77 Aligned_cols=253 Identities=21% Similarity=0.341 Sum_probs=200.7
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-cchHHHHHHHHHHHcCCCCCCeeEEeeee------Cc
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVE------GD 76 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~------~~ 76 (407)
.-.++|++.+.||+|+||.||+|.+..+++.|++|++..... ...+..|+.+++.+.+|+++..+..++.. +.
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 346899999999999999999999988999999998775443 34578899999999766777777666643 44
Q ss_pred eeEEEEecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccc
Q 015406 77 YNVLVMDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 152 (407)
Q Consensus 77 ~~~lvme~~-g~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGl 152 (407)
..+++|||+ +++|.+++... +..+++..++.++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~---~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILL---TKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---ccCCeEEECCCcc
Confidence 589999999 88999998753 3579999999999999999999999999999999999999 5788999999999
Q ss_pred eeeeccCCCCcccCccCCCCccccccccccccccC-----CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHH
Q 015406 153 AKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK 227 (407)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~ 227 (407)
+......... .....|+..|+|||++.. ..++.++||||||++||+|++|..||..... ......
T Consensus 160 ~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~ 229 (275)
T cd06608 160 SAQLDSTLGR-------RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP---MRALFK 229 (275)
T ss_pred ceecccchhh-------hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch---HHHHHH
Confidence 9865433211 234568999999998864 3467899999999999999999999975432 222223
Q ss_pred HhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 228 ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 228 i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
+......... ....++.++.+++.+||..||++||++.++.+
T Consensus 230 ~~~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 230 IPRNPPPTLK--SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hhccCCCCCC--chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 3222211111 11236789999999999999999999888764
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=307.56 Aligned_cols=260 Identities=22% Similarity=0.305 Sum_probs=202.5
Q ss_pred CCceeEeccccccCceEEEEEEEc----CCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeee--Cc
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNI----QTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVE--GD 76 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~----~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~--~~ 76 (407)
...|++.+.||+|+||.||+|+.. .++..||||++..... ...+..|+++++.+.| +++..+..++.. ..
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~-~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDH-ENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCC-CChheEEeeeecCCCC
Confidence 357889999999999999999864 3478999999876544 3468899999999977 455555555554 56
Q ss_pred eeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceee
Q 015406 77 YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (407)
Q Consensus 77 ~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~ 155 (407)
..+++|||+ +++|.+++......+++..++.++.|++.||+|||++||+||||||+||++ +.++.++|+|||++..
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV---ESEDLVKISDFGLAKV 158 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEcccccccc
Confidence 789999999 899999998655569999999999999999999999999999999999999 5779999999999987
Q ss_pred eccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCch-----------HHH
Q 015406 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-----------KQK 224 (407)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~-----------~~~ 224 (407)
....... +.......++..|+|||.+.+..++.++||||||+++|||++|..||........ ...
T Consensus 159 ~~~~~~~----~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05038 159 LPEDKDY----YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTR 234 (284)
T ss_pred cccCCcc----eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHH
Confidence 6533221 1111223456679999999988899999999999999999999999865332210 111
Q ss_pred HHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 015406 225 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (407)
Q Consensus 225 ~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l 276 (407)
........... .....++.++.+++.+||..+|++||++.+|.+.|+.+
T Consensus 235 ~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 235 LLELLKEGERL---PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHcCCcC---CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11111111111 11234688999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=303.51 Aligned_cols=250 Identities=21% Similarity=0.296 Sum_probs=188.5
Q ss_pred ccccccCceEEEEEEEc--CCCeEEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-C
Q 015406 13 RKIGSGSFGEIYLGTNI--QTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (407)
Q Consensus 13 ~~iG~G~~g~Vy~~~~~--~~~~~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~-g 86 (407)
+.||+|+||.||+|... .++..+|+|.+...... ..+.+|+.+++.++| +++..+..++.+....++||||+ +
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQH-SNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCC-CCEeeEEEEEcCCCCcEEEEECCCC
Confidence 46899999999999854 34568999987654322 357789999999987 45556666666777889999999 8
Q ss_pred CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 87 PSLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 87 ~sL~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
++|.+++.... ...++..++.++.|++.||+|||+++++||||||+||++ +.++.+||+|||+++.......
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~---~~~~~~kL~dfg~~~~~~~~~~- 155 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLL---TADLTVKIGDYGLSHNKYKEDY- 155 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEECCccccccccCcce-
Confidence 99999987432 235777888999999999999999999999999999999 5778999999999975433221
Q ss_pred cccCccCCCCccccccccccccccCC-------CCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhccc
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGI-------EQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVS 234 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-------~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (407)
+.......++..|+|||++.+. .++.++||||||+++|||++ |..||........ ....+......
T Consensus 156 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~--~~~~~~~~~~~ 229 (269)
T cd05087 156 ----YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV--LTYTVREQQLK 229 (269)
T ss_pred ----eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH--HHHHhhcccCC
Confidence 1112345678899999998642 35789999999999999996 9999976543221 11112222222
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015406 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 274 (407)
Q Consensus 235 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~ 274 (407)
...+.+....++.+.+++.+|| .+|++||++++|...|.
T Consensus 230 ~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 2222333457889999999999 68999999999987763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=301.26 Aligned_cols=247 Identities=23% Similarity=0.326 Sum_probs=195.4
Q ss_pred ccccccCceEEEEEEEcC-CC--eEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-
Q 015406 13 RKIGSGSFGEIYLGTNIQ-TN--EEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (407)
Q Consensus 13 ~~iG~G~~g~Vy~~~~~~-~~--~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~- 85 (407)
+.||+|++|.||+|.+.. .+ ..||||.+..... ...+..|+.+++.++|++ +..+...... ...+++|||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHEN-LIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCC-ccceeEEEcC-CeEEEEEEecC
Confidence 478999999999999765 33 3699998876544 345788999999998754 5555544444 7889999999
Q ss_pred CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcc
Q 015406 86 GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164 (407)
Q Consensus 86 g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~ 164 (407)
+++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||++ +.++.+||+|||+++.+......
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~-- 153 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILL---ASDDKVKIGDFGLMRALPQNEDH-- 153 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEE---ecCCEEEeccccccccccccccc--
Confidence 899999997644 468999999999999999999999999999999999999 57799999999999876543221
Q ss_pred cCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcC
Q 015406 165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243 (407)
Q Consensus 165 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (407)
+.......++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+....+...... ......
T Consensus 154 --~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~~~~~~---~~~~~~ 225 (257)
T cd05040 154 --YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG---SQILKKIDKEGER---LERPEA 225 (257)
T ss_pred --eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHhcCCc---CCCCcc
Confidence 111224557789999999999899999999999999999998 9999976443 2333333221111 112245
Q ss_pred CcHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015406 244 YPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 274 (407)
Q Consensus 244 ~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~ 274 (407)
+|..+.+++.+||..+|++||++.++.+.|.
T Consensus 226 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 226 CPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 7899999999999999999999999988774
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=297.96 Aligned_cols=261 Identities=21% Similarity=0.280 Sum_probs=215.6
Q ss_pred eeE-eccccccCceEEEEEEEcCCCeEEEEEEecCCCCc--chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc
Q 015406 9 FRL-GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (407)
Q Consensus 9 y~i-~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~--~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~ 85 (407)
|++ .+.||+|+|+.|--+.+..++.+||||++.+...+ .++.+|++++...++|.+|..+..++++...+|||||-+
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm 158 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKM 158 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecc
Confidence 444 35799999999999999999999999998876544 458999999999999999999999999999999999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcc
Q 015406 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164 (407)
Q Consensus 86 -g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~ 164 (407)
||+|...|.+ .+.|++.++..+..+|+.||.|||.+||.||||||+|||-...+.-.-+|||||.+...+........
T Consensus 159 ~GGplLshI~~-~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 159 RGGPLLSHIQK-RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred cCchHHHHHHH-hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 9999999986 45699999999999999999999999999999999999996444555689999999875443332221
Q ss_pred cCccCCCCcccccccccccccc-----CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCc------------hHHHHHH
Q 015406 165 IPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT------------KKQKYEK 227 (407)
Q Consensus 165 ~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~------------~~~~~~~ 227 (407)
..-....+.+|+..|||||+.. ..-|+.++|.||||||||-|+.|.+||.+.-..+ ....++.
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes 317 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES 317 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence 1122345678999999999764 2358999999999999999999999998754432 3456778
Q ss_pred HhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 228 ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 228 i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
|+++....+. .-+..++.+.++++..++..++.+|.++.++.+
T Consensus 318 IQEGkYeFPd-kdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 318 IQEGKYEFPD-KDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HhccCCcCCh-hhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 8888775444 445779999999999999999999988766654
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=308.43 Aligned_cols=248 Identities=23% Similarity=0.337 Sum_probs=199.7
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC--cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
.++|++.+.||+|+||.||+|.+..+++.||+|.+..... ...+..|+.+++.+.| +++..+..++..++..++|||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKN-PNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCC-CCEeeEEEEEecCCEEEEeec
Confidence 4789999999999999999999999999999998765432 2346778888888876 566666667777888999999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 84 ~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
|+ +++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+|||+ +.++.++|+|||++.........
T Consensus 97 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili---~~~~~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 97 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred ccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEECcCccceEccCCccC
Confidence 99 9999999874 468999999999999999999999999999999999999 57889999999999865433211
Q ss_pred cccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhc
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (407)
.....+++.|+|||.+.+..++.++|||||||++|+|++|..||....... ..+ .+.... ........
T Consensus 172 -------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~--~~~-~~~~~~--~~~~~~~~ 239 (297)
T cd06656 172 -------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--ALY-LIATNG--TPELQNPE 239 (297)
T ss_pred -------cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch--hee-eeccCC--CCCCCCcc
Confidence 124468899999999999889999999999999999999999997643311 111 111111 11111224
Q ss_pred CCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 243 ~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.++..+.+++.+||..+|++||++.++++
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 240 RLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 57889999999999999999999887765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=298.91 Aligned_cols=245 Identities=21% Similarity=0.324 Sum_probs=196.2
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-CCC
Q 015406 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPS 88 (407)
Q Consensus 13 ~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~-g~s 88 (407)
++||+|+||.||+|.+.. ++.||+|.+..... ...+..|+++++.+.| +++..+..++......+++|||+ +++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDH-PNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 479999999999999877 99999998765433 2357889999999986 56667777777888899999999 899
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcccCcc
Q 015406 89 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYR 168 (407)
Q Consensus 89 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 168 (407)
|.+++......+++..++.++.|++.||.|||+++++||||||+|||+ +.++.++|+|||++..........
T Consensus 79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~----- 150 (251)
T cd05041 79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSREEEGGIYTV----- 150 (251)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEE---cCCCcEEEeeccccccccCCccee-----
Confidence 999997655678999999999999999999999999999999999999 578899999999998654322110
Q ss_pred CCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcHH
Q 015406 169 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTE 247 (407)
Q Consensus 169 ~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 247 (407)
......++..|+|||.+.+..++.++||||||+++|||++ |..||....... ....+... ... .....+|.+
T Consensus 151 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~---~~~~~~~~-~~~---~~~~~~~~~ 223 (251)
T cd05041 151 SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ---TRERIESG-YRM---PAPQLCPEE 223 (251)
T ss_pred ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH---HHHHHhcC-CCC---CCCccCCHH
Confidence 0112234667999999998889999999999999999999 899997654322 22222211 111 122457899
Q ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015406 248 FASYFHYCRSLRFDDKPDYAYLKRIFR 274 (407)
Q Consensus 248 l~~li~~cl~~~p~~RPt~~~l~~~l~ 274 (407)
+.+++.+||..+|++||++.++.+.|+
T Consensus 224 ~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 224 IYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=302.55 Aligned_cols=246 Identities=24% Similarity=0.346 Sum_probs=197.4
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEecCCCC-----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-C
Q 015406 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (407)
Q Consensus 13 ~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~-g 86 (407)
+.||+|+||.||+|.+..+++.||+|++..... ...+..|..++....+++++..+..++...+..|++|||+ +
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 579999999999999989999999998764321 1124445555555545678888888888888999999999 9
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcccC
Q 015406 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166 (407)
Q Consensus 87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~ 166 (407)
++|.+++.. ...+++..+..++.||+.||.|||+.+++||||+|+||++ +.++.++|+|||+++....
T Consensus 82 ~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~-------- 149 (260)
T cd05611 82 GDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI---DQTGHLKLTDFGLSRNGLE-------- 149 (260)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEeecccceeccc--------
Confidence 999999985 3468999999999999999999999999999999999999 5778999999999875433
Q ss_pred ccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcH
Q 015406 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 246 (407)
Q Consensus 167 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 246 (407)
.....|+..|+|||.+.+..++.++||||||+++|+|++|..||..... .+.+..+....... .......+++
T Consensus 150 ---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~-~~~~~~~~~~ 222 (260)
T cd05611 150 ---NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP---DAVFDNILSRRINW-PEEVKEFCSP 222 (260)
T ss_pred ---cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhcccCC-CCcccccCCH
Confidence 1244688899999999988899999999999999999999999976433 33344333322211 1122345789
Q ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHH
Q 015406 247 EFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (407)
Q Consensus 247 ~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~ 277 (407)
++.+++.+||+.+|++||++.++.++|.+-+
T Consensus 223 ~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~ 253 (260)
T cd05611 223 EAVDLINRLLCMDPAKRLGANGYQEIKSHPF 253 (260)
T ss_pred HHHHHHHHHccCCHHHccCCCcHHHHHcChH
Confidence 9999999999999999999877877776643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=305.04 Aligned_cols=252 Identities=19% Similarity=0.305 Sum_probs=198.6
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-cchHHHHHHHHHHHcCCCCCCeeEEeeee-----Ccee
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVE-----GDYN 78 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~-----~~~~ 78 (407)
..++|.+.+.||+|+||.||+|.+..+++.+|+|++..... ...+..|+.+++.+.+|+++..+..++.. ....
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~ 99 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL 99 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence 35789999999999999999999999999999998865432 34577899999999666777777665543 2468
Q ss_pred EEEEecc-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEecccee
Q 015406 79 VLVMDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~ 154 (407)
++||||+ +++|.++++. ....+++..++.++.|++.||+|||++||+||||||+||++ +.++.+||+|||++.
T Consensus 100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili---~~~~~~kl~dfg~~~ 176 (291)
T cd06639 100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILL---TTEGGVKLVDFGVSA 176 (291)
T ss_pred EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEEeecccch
Confidence 9999999 8899998863 24568999999999999999999999999999999999999 577889999999998
Q ss_pred eeccCCCCcccCccCCCCccccccccccccccCC-----CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHh
Q 015406 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-----EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 229 (407)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~ 229 (407)
........ .....|+..|+|||.+... .++.++|||||||++|||++|+.||..... ...+..+.
T Consensus 177 ~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~---~~~~~~~~ 246 (291)
T cd06639 177 QLTSTRLR-------RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP---VKTLFKIP 246 (291)
T ss_pred hccccccc-------ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH---HHHHHHHh
Confidence 65432211 1234688999999998643 368899999999999999999999976433 22333332
Q ss_pred hhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 230 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
....... .....++..+.++|.+||+.+|++||++.+|.+
T Consensus 247 ~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 247 RNPPPTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred cCCCCCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 2211111 112346678999999999999999999888764
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=319.47 Aligned_cols=247 Identities=23% Similarity=0.296 Sum_probs=210.3
Q ss_pred CccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc----chHHHHHHHHHHHcCCCCCCeeEEeeeeCcee
Q 015406 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (407)
Q Consensus 3 ~~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 78 (407)
+...+.|.+.+.||+|.|+.|.+|++..++..||||++.+.... ..+.+|+++++.|.| ++|+.++.+-......
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~H-PnIvkl~~v~~t~~~l 130 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNH-PNIVKLFSVIETEATL 130 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCC-cceeeeeeeeeeccee
Confidence 34457799999999999999999999999999999998765433 337899999999997 7777777777888889
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeec
Q 015406 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~ 157 (407)
|+||||+ ++.+.+++...+ ...+..+..++.|++.|++|||+++|||||||.+|||| +.+..+||+|||++..+.
T Consensus 131 ylV~eya~~ge~~~yl~~~g-r~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL---~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLVKHG-RMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILL---DENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEEEEeccCchhHHHHHhcc-cchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccc---ccccceeeeccccceeec
Confidence 9999999 999999998754 56779999999999999999999999999999999999 688889999999999887
Q ss_pred cCCCCcccCccCCCCccccccccccccccCCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhccccc
Q 015406 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (407)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (407)
.... ..+++|++.|+|||++.|..| ++.+|+||+|++||-|+.|.+||.+..- ...-.+....++..
T Consensus 207 ~~~~--------lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l---k~Lr~rvl~gk~rI- 274 (596)
T KOG0586|consen 207 YGLM--------LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL---KELRPRVLRGKYRI- 274 (596)
T ss_pred cccc--------ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc---ccccchheeeeecc-
Confidence 5544 357899999999999999988 6999999999999999999999987433 33333333433332
Q ss_pred HHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015406 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 237 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
.--++.++.++|.++|.++|.+|++.+++.
T Consensus 275 ----p~~ms~dce~lLrk~lvl~Pskr~~~dqim 304 (596)
T KOG0586|consen 275 ----PFYMSCDCEDLLRKFLVLNPSKRGPCDQIM 304 (596)
T ss_pred ----cceeechhHHHHHHhhccCccccCCHHHhh
Confidence 223678999999999999999999988774
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=304.20 Aligned_cols=246 Identities=21% Similarity=0.335 Sum_probs=201.0
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
...|+..+.||.|+||.||+|.+..++..||+|++..... ...+.+|+.+++.+.| ++++.+..++......++||
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEECCEEEEEE
Confidence 3568899999999999999999988999999998765432 2347788999998876 67777777778888999999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCC
Q 015406 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 83 e~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~ 161 (407)
||+ +++|.+++. ...+++..+..++.|++.||+|||+++++|+||+|+||++ +.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~i~--~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 82 EYLGGGSALDLLR--AGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLL---SEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred ecCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEE---cCCCCEEEcccccceeccCCcc
Confidence 999 889999987 3578999999999999999999999999999999999999 5778999999999987644321
Q ss_pred CcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHh
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (407)
......++..|+|||++.+..++.++|+|||||++|||++|..||...... .....+..... +.+.
T Consensus 157 -------~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~---~~~~~~~~~~~----~~~~ 222 (277)
T cd06640 157 -------KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM---RVLFLIPKNNP----PTLT 222 (277)
T ss_pred -------ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH---hHhhhhhcCCC----CCCc
Confidence 122346788999999999888999999999999999999999999765432 22222211111 1223
Q ss_pred cCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 242 ~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
..++.++.+++.+||..+|++||++.++.+
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06640 223 GEFSKPFKEFIDACLNKDPSFRPTAKELLK 252 (277)
T ss_pred hhhhHHHHHHHHHHcccCcccCcCHHHHHh
Confidence 447889999999999999999999988854
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=300.90 Aligned_cols=252 Identities=19% Similarity=0.317 Sum_probs=199.2
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC--------cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeE
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--------HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 79 (407)
+|++.+.||+|+||.||+|.+ .+++.+|+|.+..+.. ...+.+|+++++.++| +++..+..++.+.+..+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~ 78 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH-VNIVQYLGTCLDDNTIS 78 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCC-CCEeeEeeEeecCCeEE
Confidence 588999999999999999986 5788999998764432 1347789999999986 56667777777788999
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 80 lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
++|||+ +++|.+++.. ...+++..+..++.|++.||+|||+.+|+|+||||+||++ +.++.++|+|||++.....
T Consensus 79 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 79 IFMEFVPGGSISSILNR-FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVML---MPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEE---CCCCeEEeccchhhHhhhh
Confidence 999999 9999999975 3468999999999999999999999999999999999999 6788999999999876532
Q ss_pred CCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHH
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (407)
....... ........|+..|+|||++.+..++.++||||||+++|+|++|..||...... .....+... ....+
T Consensus 155 ~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~~~~~~~--~~~~~ 228 (265)
T cd06631 155 VGLHGTH-SNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL---AAMFYIGAH--RGLMP 228 (265)
T ss_pred ccccccc-cccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH---HHHHHhhhc--cCCCC
Confidence 2111000 01123456899999999999988999999999999999999999999764321 111122111 01122
Q ss_pred HHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 239 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.+...++.++.+++.+||..+|++||++.++++
T Consensus 229 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 229 RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 244568899999999999999999999887754
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=302.73 Aligned_cols=253 Identities=20% Similarity=0.238 Sum_probs=197.4
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
+|++.+.||.|++|.||+|++..+++.||||.+..+.. ...+..|+++++.++| +++..+..+....+..+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH-PNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCC-CCCcchhhhcccCCcEEEEee
Confidence 48999999999999999999999999999998765432 2357889999999987 566666666777888999999
Q ss_pred ccCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 84 LLGPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 84 ~~g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
|+.++|.+++... ...+++..++.++.|++.||+|||+++++||||+|+||++ +.++.+||+|||++........
T Consensus 80 ~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill---~~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 80 FLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred ccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEeeccchhhcccCcc-
Confidence 9987899988753 3568999999999999999999999999999999999999 6788999999999876543221
Q ss_pred cccCccCCCCccccccccccccccCCC-CChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhh----------
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK---------- 231 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~---------- 231 (407)
......++..|+|||.+.+.. ++.++||||||+++|||+||+.||..................
T Consensus 156 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07860 156 ------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 229 (284)
T ss_pred ------ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhh
Confidence 122345688999999987654 588999999999999999999999764322111111100000
Q ss_pred -----------cccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 232 -----------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 232 -----------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
............+++++.++|.+||+.||++||+++++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 230 SLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0011122233457889999999999999999999887763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=303.27 Aligned_cols=255 Identities=21% Similarity=0.278 Sum_probs=198.2
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
++|++.+.||+|+||.||+|.+..+++.||+|.++... ....+.+|+++++.++| +++..+..++...+..+++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRH-ENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCC-CCeeehhheEEECCEEEEEE
Confidence 47999999999999999999999999999999876432 23468899999999996 56666666777788899999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 83 e~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
||+++++.+.+......+++..++.++.||+.||.|||+++++|+||+|+||++ ++++.+||+|||++.........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~---~~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILV---SESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEEeeecccccCCCccc
Confidence 999555555544445669999999999999999999999999999999999999 57899999999999876544321
Q ss_pred cccCccCCCCccccccccccccccCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhh----------
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK---------- 231 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~---------- 231 (407)
......++..|+|||++.+. .++.++||||||+++|+|++|..||.+....+.......+...
T Consensus 157 ------~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07833 157 ------PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS 230 (288)
T ss_pred ------cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcc
Confidence 12345678999999999988 7899999999999999999999999764332111111111000
Q ss_pred --------c-----ccccHH-HHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 232 --------K-----VSTSIE-ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 232 --------~-----~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
. ...... .....++.++.++|.+||..+|++||+++++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0 000011 112235889999999999999999999887754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=301.67 Aligned_cols=249 Identities=18% Similarity=0.266 Sum_probs=187.0
Q ss_pred ccccccCceEEEEEEEcC--CCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-C
Q 015406 13 RKIGSGSFGEIYLGTNIQ--TNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (407)
Q Consensus 13 ~~iG~G~~g~Vy~~~~~~--~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~-g 86 (407)
+.||+|+||.||+|.... ....+|+|.+..... ...+.+|+.+++.++| +++..+...+......++||||+ +
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h-~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNH-PNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCC-CCcceEEEEECCCCceEEEEEeCCC
Confidence 469999999999997533 345788997654322 2346789999988876 55666666667778889999999 8
Q ss_pred CCHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 87 PSLEDLFNFCSR----KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 87 ~sL~~~l~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
++|.+++..... .+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQL---TADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEe---cCCCcEEEeccccccccccchhe
Confidence 999999975332 24678889999999999999999999999999999999 67889999999998754322110
Q ss_pred cccCccCCCCccccccccccccccC-------CCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHH-Hhhhcc
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLG-------IEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEK-ISEKKV 233 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~-------~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~-i~~~~~ 233 (407)
.......++..|+|||++.. ..++.++|||||||++|||++ |..||..... .+.+.. +.....
T Consensus 157 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~~~~~~~~~~~~~ 228 (269)
T cd05042 157 -----ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD---EQVLKQVVREQDI 228 (269)
T ss_pred -----eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH---HHHHHHHhhccCc
Confidence 11123356778999998743 356889999999999999999 8889976433 222222 222222
Q ss_pred cccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015406 234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 274 (407)
Q Consensus 234 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~ 274 (407)
....+.+...+++.+.+++..|| .||++||++++|.+.|.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 229 KLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred cCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 22223344568899999999999 59999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=302.96 Aligned_cols=248 Identities=19% Similarity=0.332 Sum_probs=201.4
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... ...+.+|+++++.+.| +++..+...+......+++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNS-PYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCC-CchhhhheeeecCCEEEEEEE
Confidence 478999999999999999999999999999998765432 2457889999999985 666666666677788999999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCC
Q 015406 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 84 ~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~ 161 (407)
|+ +++|.+++......+++..+..++.|++.||.|||+ .|++|+||||+||++ +.++.++|+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~---~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILV---NSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEE---CCCCCEEEeecccchhhHHHHh
Confidence 99 799999998755689999999999999999999999 999999999999999 5788999999999876543221
Q ss_pred CcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCc--CchHHHHHHHhhhcccccHHH
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA--GTKKQKYEKISEKKVSTSIEA 239 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~--~~~~~~~~~i~~~~~~~~~~~ 239 (407)
....++..|+|||.+.+..++.++||||||+++|+|++|..||..... ....+....+.......
T Consensus 157 ---------~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 223 (265)
T cd06605 157 ---------KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPR---- 223 (265)
T ss_pred ---------hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCC----
Confidence 125688999999999999999999999999999999999999976421 12222233332222111
Q ss_pred HhcC-CcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 240 LCRG-YPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 240 ~~~~-~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
+... ++.++.++|.+||..+|++||++.++..
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 224 LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 1122 7889999999999999999999887753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=307.24 Aligned_cols=264 Identities=22% Similarity=0.240 Sum_probs=198.4
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC----cchHHHHHHHHHHHcCCCCCCeeEEeee-------
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGV------- 73 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~------- 73 (407)
..++|++.++||+|+||.||+|++..+++.||||.+..... ...+.+|+++++.++|++.+..+..+..
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 35799999999999999999999999999999998754332 2346789999999988555544433322
Q ss_pred eCceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccce
Q 015406 74 EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (407)
Q Consensus 74 ~~~~~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla 153 (407)
.....+++|||++++|.+.+......+++..+..++.||+.||.|||++||+||||||+|||+ ++++.++|+|||++
T Consensus 86 ~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~ 162 (311)
T cd07866 86 KRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILI---DNQGILKIADFGLA 162 (311)
T ss_pred cCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECcCccc
Confidence 234579999999888988887655679999999999999999999999999999999999999 67899999999999
Q ss_pred eeeccCCCCccc----CccCCCCccccccccccccccCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHH
Q 015406 154 KKYRDTSTHQHI----PYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228 (407)
Q Consensus 154 ~~~~~~~~~~~~----~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i 228 (407)
+........... .........+++.|+|||.+.+. .++.++|||||||++|||++|..||.+.......+.+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~ 242 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL 242 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 865443221110 01112345678899999988754 5789999999999999999999999765443222222111
Q ss_pred hhh----------------------cccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 229 SEK----------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 229 ~~~----------------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
... ............+++++.+++.+||..||++||++.+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 110 0011111222345678999999999999999999877653
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=301.70 Aligned_cols=254 Identities=22% Similarity=0.282 Sum_probs=196.7
Q ss_pred cccccCceEEEEEEEcCCCeEEEEEEecCCCCc-----chHHHHHHHHHHHc--CCCCCCeeEEeeeeCceeEEEEecc-
Q 015406 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKLYRILQ--GGTGIPNVRWFGVEGDYNVLVMDLL- 85 (407)
Q Consensus 14 ~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~~l~~l~--~~~~i~~~~~~~~~~~~~~lvme~~- 85 (407)
.||+|+||.||+|++..+++.||+|.+..+... .....|..+++.+. +++++..+..++...+..++||||+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999999999999999987653211 12344555554443 4577777777778888999999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCccc
Q 015406 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165 (407)
Q Consensus 86 g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~ 165 (407)
|++|.+++.. ...+++..++.++.|++.||.|||+++|+||||||+||++ +.++.++|+|||++..+....
T Consensus 81 g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili---~~~~~~kl~dfg~~~~~~~~~----- 151 (278)
T cd05606 81 GGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKK----- 151 (278)
T ss_pred CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEE---CCCCCEEEccCcCccccCccC-----
Confidence 9999998875 4579999999999999999999999999999999999999 577899999999987553321
Q ss_pred CccCCCCccccccccccccccCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCC
Q 015406 166 PYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 244 (407)
Q Consensus 166 ~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (407)
.....|+..|+|||++.+. .++.++||||||+++|||++|..||................... ..+...+
T Consensus 152 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~~ 222 (278)
T cd05606 152 ----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA-----VELPDSF 222 (278)
T ss_pred ----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccC-----CCCCCcC
Confidence 1245789999999999754 68999999999999999999999998754333222222221111 1233457
Q ss_pred cHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCccccccchh
Q 015406 245 PTEFASYFHYCRSLRFDDKP-----DYAYLKRIFRDLFIREGFQFDYVFDWTILKY 295 (407)
Q Consensus 245 ~~~l~~li~~cl~~~p~~RP-----t~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~ 295 (407)
+.++.+++.+||..+|.+|| ++.++++ +++...++|.....
T Consensus 223 s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~----------~~~~~~~~~~~~~~ 268 (278)
T cd05606 223 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE----------HPFFRSLDWQMVFL 268 (278)
T ss_pred CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh----------CccccCCCchHhhh
Confidence 89999999999999999999 7776653 35566677765543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=303.84 Aligned_cols=253 Identities=22% Similarity=0.276 Sum_probs=196.7
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
++|++.++||+|+||.||+|.+..+++.||+|.+..... ...+..|+++++.++| +++..+..++..+...++||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRH-ENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCC-cchhhHHHhcccCCeEEEEE
Confidence 579999999999999999999988999999998654332 2347789999999976 56666666677788899999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCC
Q 015406 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 83 e~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~ 161 (407)
||+ +++|.++... ...+++..++.++.||+.||.|||+.||+|+||+|+||++ ++++.++|+|||++........
T Consensus 80 e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 80 EFVDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred ecCCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCcEEEEeeeeeeeccCCcc
Confidence 999 6777776653 4469999999999999999999999999999999999999 5788999999999987644321
Q ss_pred CcccCccCCCCccccccccccccccCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhh---------
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK--------- 231 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~--------- 231 (407)
. .....++..|+|||++.+. .++.++||||||+++|||++|..||..............+...
T Consensus 156 ~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07846 156 V-------YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIF 228 (286)
T ss_pred c-------cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHh
Confidence 1 2245678999999998763 4688999999999999999999999754321111111110000
Q ss_pred --------------cccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 232 --------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 232 --------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
..........++++..+.+++.+||..+|++||++.++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0001112234567899999999999999999999887764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=306.59 Aligned_cols=253 Identities=21% Similarity=0.246 Sum_probs=198.8
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcc----hHHHHHHHHHHHcCCCCCCeeEEeeeeC--cee
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKLYRILQGGTGIPNVRWFGVEG--DYN 78 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~----~~~~E~~~l~~l~~~~~i~~~~~~~~~~--~~~ 78 (407)
..++|++.+.||.|+||.||+|.+..+++.+|+|.++...... .+.+|+.+++.++| +++..+..+.... ...
T Consensus 3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~~~~~~~~~~~~~~ 81 (293)
T cd07843 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQH-PNIVTVKEVVVGSNLDKI 81 (293)
T ss_pred chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCC-CCEEEEEEEEEecCCCcE
Confidence 3468999999999999999999999899999999886543322 35679999999986 5666666555544 789
Q ss_pred EEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 79 VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 79 ~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
|++|||++++|.+++......+++..++.++.||+.||+|||++||+|+||||+|||+ +.++.++|+|||++.....
T Consensus 82 ~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 82 YMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL---NNRGILKICDFGLAREYGS 158 (293)
T ss_pred EEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCcEEEeecCceeeccC
Confidence 9999999889999998655569999999999999999999999999999999999999 5778999999999987655
Q ss_pred CCCCcccCccCCCCccccccccccccccCCC-CChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcc----
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV---- 233 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~---- 233 (407)
... ......++..|+|||.+.+.. ++.++||||||+++|+|++|..||...... ..+.++.....
T Consensus 159 ~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~---~~~~~~~~~~~~~~~ 228 (293)
T cd07843 159 PLK-------PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI---DQLNKIFKLLGTPTE 228 (293)
T ss_pred Ccc-------ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCch
Confidence 321 122346788999999987644 689999999999999999999999865432 22222211100
Q ss_pred ---------------------cccHHHHhcC--CcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 234 ---------------------STSIEALCRG--YPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 234 ---------------------~~~~~~~~~~--~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
........+. +++.+.++|.+||+.+|++||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 229 KIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred HHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000011112 4788999999999999999999888764
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=305.84 Aligned_cols=240 Identities=18% Similarity=0.235 Sum_probs=184.4
Q ss_pred ccccccCceEEEEEEEcCCCe-------EEEEEEecCCCC--cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 13 RKIGSGSFGEIYLGTNIQTNE-------EVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 13 ~~iG~G~~g~Vy~~~~~~~~~-------~vAvK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
+.||+|+||.||+|.+...+. .||+|.+..... .+.+..|..+++.+.| +++..+..++..+...++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h-~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSH-KHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCC-CChhheeeEEEeCCCcEEEEe
Confidence 479999999999999765443 488887654322 2356778888888876 666677767777778899999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCC-----CceEEEEeccceeeec
Q 015406 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR-----ANQVYIIDFGLAKKYR 157 (407)
Q Consensus 84 ~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~-----~~~~kL~DFGla~~~~ 157 (407)
|+ +++|.+++...+..+++..++.++.||+.||+|||++||+||||||+|||++.++. .+.++|+|||++....
T Consensus 80 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~ 159 (258)
T cd05078 80 YVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL 159 (258)
T ss_pred cCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccC
Confidence 99 88999999865557899999999999999999999999999999999999953211 1237999999986543
Q ss_pred cCCCCcccCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhCC-CCCCCCCcCchHHHHHHHhhhcccc
Q 015406 158 DTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGS-LPWQGLKAGTKKQKYEKISEKKVST 235 (407)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG~-~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (407)
. .....++..|+|||++.+ ..++.++||||||+++|||++|. .||........ . ......
T Consensus 160 ~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~---~-~~~~~~--- 221 (258)
T cd05078 160 P-----------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK---L-QFYEDR--- 221 (258)
T ss_pred C-----------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH---H-HHHHcc---
Confidence 2 123567889999999987 45799999999999999999984 66654332111 1 111111
Q ss_pred cHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 015406 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIF 273 (407)
Q Consensus 236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l 273 (407)
..++...+.++.+++.+||+.+|++||++++|.+.|
T Consensus 222 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 222 --HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred --ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 112234567899999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=302.35 Aligned_cols=252 Identities=20% Similarity=0.250 Sum_probs=197.6
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
++|++.+.||+|++|.||+|++..+++.||+|.+..... ...+..|+++++.++| +++..+..++......|+||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH-GNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccC-CCEeeEEEEEecCCeEEEEE
Confidence 579999999999999999999999999999998754322 2357789999999976 66777777777888999999
Q ss_pred eccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCC
Q 015406 83 DLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 83 e~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~ 161 (407)
||++++|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+||+++ ..++.+||+|||++........
T Consensus 81 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~--~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 81 EYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLID--RRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred ecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEE--CCCCEEEEcccccccccCCCcc
Confidence 999888988886433 2368889999999999999999999999999999999994 2456799999999976543211
Q ss_pred CcccCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhh---c-----
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK---K----- 232 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~---~----- 232 (407)
......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...... ..+.++... .
T Consensus 159 -------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~---~~~~~~~~~~~~~~~~~~ 228 (294)
T PLN00009 159 -------TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI---DELFKIFRILGTPNEETW 228 (294)
T ss_pred -------ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCChhhc
Confidence 1223467889999999876 45789999999999999999999999764332 112111110 0
Q ss_pred ----------------ccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 233 ----------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 233 ----------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.........+.+++++.+++.+||+.+|++||++.++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 229 PGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011111223457889999999999999999999888764
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=305.20 Aligned_cols=259 Identities=21% Similarity=0.237 Sum_probs=196.1
Q ss_pred ceeEeccccccCceEEEEEEEcC--CCeEEEEEEecCC-----CCcchHHHHHHHHHHHcCCCCCCeeEEeeeeC--cee
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQ--TNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEG--DYN 78 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~--~~~~vAvK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~--~~~ 78 (407)
+|++.++||+|+||.||+|.+.. +++.||+|.+... .....+.+|+.+++.++| +++..+..++... ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH-ENVVSLVEVFLEHADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCC-CCccceEEEEeCCCCceE
Confidence 58999999999999999999988 8999999988762 234557889999999987 5555555555555 789
Q ss_pred EEEEeccCCCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccC-CCCCceEEEEeccce
Q 015406 79 VLVMDLLGPSLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL-GRRANQVYIIDFGLA 153 (407)
Q Consensus 79 ~lvme~~g~sL~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~-~~~~~~~kL~DFGla 153 (407)
++||||++++|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+|||++. ++..+.+||+|||++
T Consensus 80 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 80 YLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 9999999888888876432 25899999999999999999999999999999999999942 112789999999999
Q ss_pred eeeccCCCCcccCccCCCCccccccccccccccCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCc------hHHHHH
Q 015406 154 KKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT------KKQKYE 226 (407)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~------~~~~~~ 226 (407)
+........ ........++..|+|||++.+. .++.++|||||||++|+|++|..||.+..... ....+.
T Consensus 160 ~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (316)
T cd07842 160 RLFNAPLKP----LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235 (316)
T ss_pred cccCCCccc----ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence 876443221 1123455788999999988764 57999999999999999999999998654332 000111
Q ss_pred HHhhh----------------------------ccc-ccHH-HHh--cCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 227 KISEK----------------------------KVS-TSIE-ALC--RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 227 ~i~~~----------------------------~~~-~~~~-~~~--~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.+... ... .... ... ...+.++.+++.+||+.||++||++.++.+
T Consensus 236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11000 000 0000 011 146778999999999999999999888764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=300.20 Aligned_cols=249 Identities=24% Similarity=0.338 Sum_probs=193.6
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-------cchHHHHHHHHHHHcCCCCCCeeEEeee--eCce
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-------HPQLLYESKLYRILQGGTGIPNVRWFGV--EGDY 77 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-------~~~~~~E~~~l~~l~~~~~i~~~~~~~~--~~~~ 77 (407)
.+|++.+.||+|+||.||+|.+..++..||+|.+..... ...+.+|+.+++.++|++ +..+..+.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~ 80 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHER-IVQYYGCLRDRAEKT 80 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCC-eeeEEEEEEcCCCCE
Confidence 479999999999999999999999999999998754321 124677999999998744 444444433 2467
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeee
Q 015406 78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~ 156 (407)
.+++|||+ +++|.+++.. ...+++..++.++.|++.||.|||+++|+||||||+||++ +.++.++|+|||+++..
T Consensus 81 ~~l~~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~---~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 81 LTIFMEYMPGGSVKDQLKA-YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEccCCCcccc
Confidence 89999999 8899999975 3468999999999999999999999999999999999999 57789999999999865
Q ss_pred ccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhccccc
Q 015406 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (407)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (407)
....... .......++..|+|||.+.+..++.++|||||||++|||++|..||..... .+......... .
T Consensus 157 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~---~~~~~~~~~~~---~ 226 (266)
T cd06651 157 QTICMSG----TGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA---MAAIFKIATQP---T 226 (266)
T ss_pred ccccccC----CccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch---HHHHHHHhcCC---C
Confidence 4321100 011234688999999999998899999999999999999999999976432 22222222111 1
Q ss_pred HHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 237 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
...+...+++.+.+++ +||..+|++||++++|++
T Consensus 227 ~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 227 NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 1222344678889998 688899999999888754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=299.77 Aligned_cols=249 Identities=24% Similarity=0.330 Sum_probs=194.4
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-------cchHHHHHHHHHHHcCCCCCCeeEEeeee--Cce
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-------HPQLLYESKLYRILQGGTGIPNVRWFGVE--GDY 77 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~--~~~ 77 (407)
.+|++.+.||+|+||.||+|.+..+++.||||.+..... ...+.+|+.+++.+.|+ ++..+..++.+ ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHE-RIVQYYGCLRDPMERT 80 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCC-CeeeEEeEeccCCCce
Confidence 579999999999999999999999999999998754321 12467799999999774 45455554443 457
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeee
Q 015406 78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~ 156 (407)
.+++|||+ +++|.+++... ..+++..++.++.|++.||+|||+++|+|+||||+||++ +.++.++|+|||+++..
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILR---DSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEe---cCCCCEEECcCcccccc
Confidence 78999999 89999998753 468999999999999999999999999999999999999 57889999999999865
Q ss_pred ccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhccccc
Q 015406 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (407)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (407)
....... .......|+..|+|||++.+..++.++|||||||++|||++|..||..... ...+..+......
T Consensus 157 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~~-- 227 (265)
T cd06652 157 QTICLSG----TGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA---MAAIFKIATQPTN-- 227 (265)
T ss_pred ccccccc----cccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch---HHHHHHHhcCCCC--
Confidence 4321110 112345688999999999988899999999999999999999999976422 2222222221111
Q ss_pred HHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 237 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
......++..+.+++.+||. +|++||++++|++
T Consensus 228 -~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 228 -PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred -CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 11234467889999999995 9999999888764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=300.38 Aligned_cols=255 Identities=22% Similarity=0.289 Sum_probs=202.7
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
++|++.+.||.|+||.||+|.+..++..+|+|++..... ...+.+|+++++.++| +++..+..........+++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNH-PNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCC-CCEEEEEEEEeeCCEEEEEEe
Confidence 579999999999999999999988999999998865432 3457889999999876 556666666777888999999
Q ss_pred cc-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 84 ~~-g~sL~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
++ +++|.+++... ...+++..+..++.|++.||.|||++||+||||||+||++ ++++.++|+|||++..+....
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~---~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILL---GEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEcccchHHHhccCc
Confidence 99 89999999753 2468999999999999999999999999999999999999 577889999999998665443
Q ss_pred CCcccCccCCCCccccccccccccccCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHH-
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE- 238 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~- 238 (407)
... ........|+..|+|||++... .++.++|+||||+++|+|++|..||...... +.+.+...........
T Consensus 157 ~~~---~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~ 230 (267)
T cd06610 157 DRT---RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM---KVLMLTLQNDPPSLETG 230 (267)
T ss_pred ccc---ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh---hhHHHHhcCCCCCcCCc
Confidence 211 0112345789999999998876 7899999999999999999999999765432 2233322221111110
Q ss_pred HHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 239 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.....+++++.+++.+||..||++||++.+|++
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 231 ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 011357899999999999999999999887764
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=302.14 Aligned_cols=240 Identities=16% Similarity=0.197 Sum_probs=183.4
Q ss_pred ccccccCceEEEEEEEcC------------CCeEEEEEEecCCCC--cchHHHHHHHHHHHcCCCCCCeeEEeeeeCcee
Q 015406 13 RKIGSGSFGEIYLGTNIQ------------TNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (407)
Q Consensus 13 ~~iG~G~~g~Vy~~~~~~------------~~~~vAvK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 78 (407)
+.||+|+||.||+|+... ....|++|++..... ...+..|+.++..++| +++..+..++......
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~h-p~iv~~~~~~~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSH-KHIVLLYGVCVRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCC-CCEeeEEEEEecCCCC
Confidence 468999999999998532 233689998765432 2346677888888876 6677777777777788
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCC----CCceEEEEeccce
Q 015406 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR----RANQVYIIDFGLA 153 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~----~~~~~kL~DFGla 153 (407)
+++|||+ +++|..++......+++..++.++.||+.||+|||++||+||||||+|||++.+. ....++++|||++
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~ 159 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP 159 (262)
T ss_pred EEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCC
Confidence 9999999 8899988876556799999999999999999999999999999999999995211 1123899999998
Q ss_pred eeeccCCCCcccCccCCCCcccccccccccccc-CCCCChhhHHHHHHHHHHHHH-hCCCCCCCCCcCchHHHHHHHhhh
Q 015406 154 KKYRDTSTHQHIPYRENKNLTGTARYASMNTHL-GIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEK 231 (407)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~sDIwSlG~il~ell-tG~~Pf~~~~~~~~~~~~~~i~~~ 231 (407)
...... ....++..|+|||.+. +..++.++|||||||++|||+ +|..||........ ......
T Consensus 160 ~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~----~~~~~~ 224 (262)
T cd05077 160 ITVLSR-----------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK----ERFYEG 224 (262)
T ss_pred ccccCc-----------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH----HHHHhc
Confidence 654321 2346788999999887 466899999999999999998 58899876432211 111111
Q ss_pred cccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 015406 232 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIF 273 (407)
Q Consensus 232 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l 273 (407)
... .....++++.+||.+||+.||++||++.+|.+.|
T Consensus 225 ~~~-----~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 225 QCM-----LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred Ccc-----CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 111 1123467899999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=297.56 Aligned_cols=248 Identities=27% Similarity=0.399 Sum_probs=201.3
Q ss_pred eeEeccccccCceEEEEEEEcCCC----eEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 9 FRLGRKIGSGSFGEIYLGTNIQTN----EEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 9 y~i~~~iG~G~~g~Vy~~~~~~~~----~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
+++.+.||.|+||.||++.+...+ ..||+|.+..... ...+..|+.+++.+.| +++..+..++...+..+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDH-PNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCC-CchheEEEEEcCCCeeEEE
Confidence 467899999999999999988766 8999999865543 3467889999999954 6777777777777889999
Q ss_pred Eecc-CCCHHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 82 MDLL-GPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 82 me~~-g~sL~~~l~~~~~~-l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
|||+ +++|.+++...... +++..+..++.|++.||.|||++|++|+||||+||++ +.++.++|+|||+++.....
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV---GENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEE---ccCCeEEEcccCCceecccc
Confidence 9999 89999999754433 9999999999999999999999999999999999999 57789999999999876554
Q ss_pred CCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHH
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (407)
.... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ...+..+.......
T Consensus 157 ~~~~------~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~~--- 224 (258)
T smart00219 157 DYYK------KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEVLEYLKKGYRLP--- 224 (258)
T ss_pred cccc------cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHhcCCCCC---
Confidence 2211 112236789999999988889999999999999999998 8899876332 33344443333221
Q ss_pred HHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 015406 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIF 273 (407)
Q Consensus 239 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l 273 (407)
....++.++.+++.+||..+|++||++.++.+.|
T Consensus 225 -~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 -KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 2244789999999999999999999999887653
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=302.34 Aligned_cols=260 Identities=20% Similarity=0.236 Sum_probs=200.5
Q ss_pred ccccCceEEEEEEEcCCCeEEEEEEecCCC-----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-CCC
Q 015406 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPS 88 (407)
Q Consensus 15 iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~-g~s 88 (407)
||+|+||.||+|.+..+++.||+|++.... ....+..|+++++.++| +++..+...+...+..|+||||+ +++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSS-RFIVSLAYAFETKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCC-CCEeeeeeEEecCCeEEEEEecCCCCc
Confidence 699999999999999999999999875432 12345789999999985 66777776777778899999999 899
Q ss_pred HHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcccCc
Q 015406 89 LEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPY 167 (407)
Q Consensus 89 L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~~ 167 (407)
|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||++ +.++.++|+|||++........
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~------ 150 (277)
T cd05577 80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL---DDHGNVRISDLGLAVELKGGKK------ 150 (277)
T ss_pred HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEccCcchhhhccCCc------
Confidence 999987533 369999999999999999999999999999999999999 5788999999999876543211
Q ss_pred cCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcHH
Q 015406 168 RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTE 247 (407)
Q Consensus 168 ~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 247 (407)
.....++..|+|||++.+..++.++||||||+++|+|++|+.||...........+... .. .........++++
T Consensus 151 --~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~-~~~~~~~~~~~~~ 224 (277)
T cd05577 151 --IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR---TL-EMAVEYPDKFSPE 224 (277)
T ss_pred --cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhc---cc-cccccCCccCCHH
Confidence 23456788999999999888999999999999999999999999765432222222111 11 1111233557899
Q ss_pred HHHHHHHHhCCCCCCCCCHHH-HH-HHHHHHHHHcCCCCCCccccccchhhc
Q 015406 248 FASYFHYCRSLRFDDKPDYAY-LK-RIFRDLFIREGFQFDYVFDWTILKYQQ 297 (407)
Q Consensus 248 l~~li~~cl~~~p~~RPt~~~-l~-~~l~~l~~~~~~~~~~~~dw~~~~~~~ 297 (407)
+.++|.+||+.+|++||++.+ .. +++. ++|...++|...+...
T Consensus 225 ~~~li~~~l~~~p~~R~~~~~~~~~~ll~-------h~~~~~~~~~~~~~~~ 269 (277)
T cd05577 225 AKDLCEALLQKDPEKRLGCRGGSADEVRE-------HPLFKDLNWRRLEAGM 269 (277)
T ss_pred HHHHHHHHccCChhHccCCCcccHHHHHh-------ChhhhcCChhhhhcCC
Confidence 999999999999999995443 22 1222 3555567887665433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=303.61 Aligned_cols=249 Identities=20% Similarity=0.325 Sum_probs=193.0
Q ss_pred ccccccCceEEEEEEEcCCC------eEEEEEEecCCC---CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 13 RKIGSGSFGEIYLGTNIQTN------EEVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 13 ~~iG~G~~g~Vy~~~~~~~~------~~vAvK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
+.||+|+||.||+|++.... +.+|||.+.... ....+.+|+.+++.++| +++..+..++......+++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNH-PNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCC-CCeeeEeeeecCCCCeEEEEe
Confidence 46899999999999976543 689999775432 23457889999999987 555566666677778899999
Q ss_pred cc-CCCHHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCC--CCceEEEEecccee
Q 015406 84 LL-GPSLEDLFNFC------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR--RANQVYIIDFGLAK 154 (407)
Q Consensus 84 ~~-g~sL~~~l~~~------~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~--~~~~~kL~DFGla~ 154 (407)
|+ +++|.+++... ...+++..++.++.||+.||+|||+++++|+||||+||+++.++ ....++|+|||+++
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~ 159 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence 99 89999998642 13478899999999999999999999999999999999995221 12389999999998
Q ss_pred eeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcc
Q 015406 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKV 233 (407)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (407)
........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+....+.....
T Consensus 160 ~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~~~~~~~~~~~ 231 (269)
T cd05044 160 DIYKSDYY-----RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QEVLQHVTAGGR 231 (269)
T ss_pred cccccccc-----ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HHHHHHHhcCCc
Confidence 65433211 11223456788999999999899999999999999999998 9999976433 233333322111
Q ss_pred cccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015406 234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 274 (407)
Q Consensus 234 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~ 274 (407)
. .....+|..+.+++.+||..+|++||+++++.+.|+
T Consensus 232 ~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 232 L----QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred c----CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1 123457899999999999999999999999998875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=300.34 Aligned_cols=253 Identities=21% Similarity=0.290 Sum_probs=199.0
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEec
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~ 84 (407)
+|++.++||.|++|.||+|++..+++.||||.+..... ...+..|+.+++.++| +++..+..++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKH-ENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcC-CCEeeeeeeEeeCCcEEEEEec
Confidence 58999999999999999999999999999998765432 3456789999999976 6777777777888889999999
Q ss_pred cCCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 85 LGPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 85 ~g~sL~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
+.++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||++ ++++.++|+|||++........
T Consensus 80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~---~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 80 MDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLI---NKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred CCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCcEEEeecchhhhhcCCcc-
Confidence 9779999887543 458999999999999999999999999999999999999 5788999999999975543211
Q ss_pred cccCccCCCCccccccccccccccCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcc--------
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-------- 233 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-------- 233 (407)
......++..|++||++.+. .++.++||||||+++|+|++|..||.+..................
T Consensus 156 ------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07836 156 ------TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS 229 (284)
T ss_pred ------ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh
Confidence 12234578899999998764 468999999999999999999999987543222111111100000
Q ss_pred -------------cccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 234 -------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 234 -------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
......+.+.++.++.+++.+||+.||++||++.++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00111223356888999999999999999999887764
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=301.78 Aligned_cols=252 Identities=18% Similarity=0.310 Sum_probs=202.1
Q ss_pred CceeEeccccccCceEEEEEEEcC-----CCeEEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeeeCcee
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~-----~~~~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 78 (407)
++|++.+.||.|+||.||+|+.+. ..+.|++|........ ..+..|+++++.++| +++..+..++.+....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSH-KNVVRLLGLCREAEPH 83 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCC-cceeeeEEEECCCCcc
Confidence 679999999999999999999754 3467999987654332 458889999999976 5666777777777888
Q ss_pred EEEEecc-CCCHHHHHHHcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEe
Q 015406 79 VLVMDLL-GPSLEDLFNFCS--------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID 149 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~~~--------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~D 149 (407)
++||||+ +++|.+++.... ..+++..+..++.||+.||.|||+++|+||||||+|||+ +.++.++|+|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLV---SSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEE---eCCCcEEEcc
Confidence 9999999 899999997533 158999999999999999999999999999999999999 5788999999
Q ss_pred ccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHH
Q 015406 150 FGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKI 228 (407)
Q Consensus 150 FGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i 228 (407)
||+++....... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ...+..+
T Consensus 161 ~~~~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~~~~~ 231 (275)
T cd05046 161 LSLSKDVYNSEY------YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEVLNRL 231 (275)
T ss_pred cccccccCcccc------cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHHHHHH
Confidence 999875432211 11234466788999999998889999999999999999998 8899976433 2333333
Q ss_pred hhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015406 229 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 274 (407)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~ 274 (407)
........ ....+|..+.+++.+||..+|++||++.++.+.|.
T Consensus 232 ~~~~~~~~---~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 232 QAGKLELP---VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HcCCcCCC---CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 32222211 12457899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=305.17 Aligned_cols=246 Identities=24% Similarity=0.339 Sum_probs=200.0
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
.+.|++.+.||+|+||.||+|.+..+++.||+|.+...... ..+..|+.+++.+.| ++++.+..++..+...|+||
T Consensus 3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCC-CccHhhhcccccCCceEEEE
Confidence 35688899999999999999999889999999987644322 347789999999876 66666666777788899999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCC
Q 015406 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 83 e~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~ 161 (407)
||+ +++|.+++. ...+++..++.++.||+.||.|||++|++|+||+|+||++ +.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 82 EYLGGGSALDLLK--PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLL---SEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EccCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEE---eCCCCEEEccccccccccCcch
Confidence 999 889999886 4578999999999999999999999999999999999999 5778999999999986543321
Q ss_pred CcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHh
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (407)
......|+..|+|||.+.+..++.++|||||||++|||++|..||....... ....+..... ..+.
T Consensus 157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~----~~~~ 222 (277)
T cd06642 157 -------KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR---VLFLIPKNSP----PTLE 222 (277)
T ss_pred -------hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh---HHhhhhcCCC----CCCC
Confidence 1223468899999999999899999999999999999999999997644322 1111211111 1223
Q ss_pred cCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 242 ~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
..++.++.+++.+||..+|++||++.++.+
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 223 GQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 457889999999999999999999988875
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=298.37 Aligned_cols=245 Identities=25% Similarity=0.357 Sum_probs=199.9
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-------CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-------KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
+|+..+.||+|+||.||+|.+..+++.|++|.+.... ....+..|+.+++.++| +++..+..+.......++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~l 79 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQH-PNIVQYLGTEREEDNLYI 79 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCC-CCchheeeeEecCCeEEE
Confidence 5888999999999999999998899999999876543 22357889999999976 666667777778888999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 81 vme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
+|||+ +++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+||++ +.++.+||+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~---~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 80 FLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILV---DTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccceecccc
Confidence 99999 88999999753 468999999999999999999999999999999999999 57889999999999875443
Q ss_pred CCCcccCccCCCCccccccccccccccCCC-CChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHH
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (407)
.. .....|+..|+|||.+.... ++.++|+||||+++|+|++|..||..... .+....+.... ...
T Consensus 156 ~~--------~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~~---~~~ 221 (258)
T cd06632 156 SF--------AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG---VAAVFKIGRSK---ELP 221 (258)
T ss_pred cc--------ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH---HHHHHHHHhcc---cCC
Confidence 21 23456889999999998766 89999999999999999999999976442 22222222211 112
Q ss_pred HHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 239 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.+...+++++.+++.+||..+|++||++.++..
T Consensus 222 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 222 PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 233557899999999999999999999888764
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=296.73 Aligned_cols=254 Identities=17% Similarity=0.184 Sum_probs=210.1
Q ss_pred ccCCceeEec-cccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeee----eCcee
Q 015406 4 RVGNKFRLGR-KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGV----EGDYN 78 (407)
Q Consensus 4 ~~~~~y~i~~-~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~----~~~~~ 78 (407)
.|.++|.+-. +||-|-.|.|..+.++.+++.+|+|++. ..+...+|+++.-....|++|+.+..... .....
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~---Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL---DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHh---cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 4667888754 6999999999999999999999999874 34567889999998888888888765543 34567
Q ss_pred EEEEecc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeee
Q 015406 79 VLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~ 156 (407)
.+|||++ ||.|.+.|+..+ ..|++.++..|+.||..|+.|||+.+|.||||||+|+|......+..+||+|||+|+..
T Consensus 135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t 214 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET 214 (400)
T ss_pred EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccccccc
Confidence 8999999 999999998643 45999999999999999999999999999999999999987778889999999999976
Q ss_pred ccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCc-hHHHHHHHhhhcccc
Q 015406 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT-KKQKYEKISEKKVST 235 (407)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~-~~~~~~~i~~~~~~~ 235 (407)
..... ..+.+-|+.|.|||++....|+..+|+||+||++|-|++|.+||+...... ......+|..+....
T Consensus 215 ~~~~~--------L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~F 286 (400)
T KOG0604|consen 215 QEPGD--------LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEF 286 (400)
T ss_pred CCCcc--------ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccC
Confidence 64333 245678999999999999999999999999999999999999998754422 123344455554433
Q ss_pred cHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHH
Q 015406 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 269 (407)
Q Consensus 236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l 269 (407)
+- .-+..+++..+++|+.+|..+|.+|.|+.++
T Consensus 287 P~-pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~ 319 (400)
T KOG0604|consen 287 PE-PEWSCVSEAAKDLIRKLLKTEPTERLTIEEV 319 (400)
T ss_pred CC-hhHhHHHHHHHHHHHHHhcCCchhheeHHHh
Confidence 33 3356689999999999999999999995544
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=304.07 Aligned_cols=266 Identities=18% Similarity=0.264 Sum_probs=209.6
Q ss_pred ceeEeccccccCceEEEEEEEc---CCCeEEEEEEecCCC------CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCcee
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKT------KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~---~~~~~vAvK~~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 78 (407)
+|++.+.||+|+||.||++++. .+++.||||++.... ....+..|+.++..+.++++++.+...+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4899999999999999999864 467899999876422 1234678999999998888888888878888889
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeec
Q 015406 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~ 157 (407)
++||||+ +++|.+++.. ...+++..++.++.|++.||.|||+.+++||||||+||++ +.++.++|+|||+++.+.
T Consensus 81 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL---DSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEEECccccccc
Confidence 9999999 8899999875 3568999999999999999999999999999999999999 577899999999987654
Q ss_pred cCCCCcccCccCCCCccccccccccccccCCC--CChhhHHHHHHHHHHHHHhCCCCCCCCCcCchH-HHHHHHhhhccc
Q 015406 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK-QKYEKISEKKVS 234 (407)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~-~~~~~i~~~~~~ 234 (407)
.... .......|+..|+|||.+.+.. .+.++||||||+++|||++|..||......... .....+....
T Consensus 157 ~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-- 228 (288)
T cd05583 157 AEEE------ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK-- 228 (288)
T ss_pred cccc------cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccC--
Confidence 4322 1123456889999999987755 688999999999999999999999643222111 1112221111
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchh
Q 015406 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKY 295 (407)
Q Consensus 235 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~ 295 (407)
......++.++.+++.+||+.+|++|||+.++.+.|++ .+....+|..+..
T Consensus 229 ---~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~-------~~~~~~~~~~~~~ 279 (288)
T cd05583 229 ---PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH-------PFFQGIDWDDLAA 279 (288)
T ss_pred ---CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC-------cccccCCHHHHhh
Confidence 11234578899999999999999999999988887766 4455667865433
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=303.59 Aligned_cols=239 Identities=17% Similarity=0.235 Sum_probs=184.2
Q ss_pred cccccCceEEEEEEEcCC------------------------CeEEEEEEecCCCC--cchHHHHHHHHHHHcCCCCCCe
Q 015406 14 KIGSGSFGEIYLGTNIQT------------------------NEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPN 67 (407)
Q Consensus 14 ~iG~G~~g~Vy~~~~~~~------------------------~~~vAvK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~ 67 (407)
.||+|+||.||+|....+ ...||+|++..... ...+..|+.+++.++| ++++.
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h-~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSH-IHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCC-CCeee
Confidence 699999999999974321 23588998754322 2346678888888876 77777
Q ss_pred eEEeeeeCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCC----CCC
Q 015406 68 VRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG----RRA 142 (407)
Q Consensus 68 ~~~~~~~~~~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~----~~~ 142 (407)
+..++......++||||+ +++|.+++....+.+++..+..++.||+.||+|||++||+||||||+|||++.. ...
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~ 160 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTS 160 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCcc
Confidence 878888888999999999 899999987656679999999999999999999999999999999999999521 122
Q ss_pred ceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHH-hCCCCCCCCCcCc
Q 015406 143 NQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGT 220 (407)
Q Consensus 143 ~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~ell-tG~~Pf~~~~~~~ 220 (407)
..+||+|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||.......
T Consensus 161 ~~~kl~d~g~~~~~~~~-----------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 161 PFIKLSDPGVSFTALSR-----------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred ceeeecCCccccccccc-----------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 35899999988643221 12357788999998875 56899999999999999995 6999997654322
Q ss_pred hHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 015406 221 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIF 273 (407)
Q Consensus 221 ~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l 273 (407)
....+. .... +....++++.++|.+||+.+|++||++.+|++.|
T Consensus 230 ~~~~~~----~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 230 KERFYE----KKHR-----LPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHHH----hccC-----CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 222111 1111 1123457899999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=302.27 Aligned_cols=288 Identities=43% Similarity=0.695 Sum_probs=239.6
Q ss_pred cCC-ceeEeccccccCceEEEEEEEcCCC-eEEEEEEecCCCCc--chHHHHHHHHHHHc---CCCCCCeeEEee-eeCc
Q 015406 5 VGN-KFRLGRKIGSGSFGEIYLGTNIQTN-EEVAIKLENVKTKH--PQLLYESKLYRILQ---GGTGIPNVRWFG-VEGD 76 (407)
Q Consensus 5 ~~~-~y~i~~~iG~G~~g~Vy~~~~~~~~-~~vAvK~~~~~~~~--~~~~~E~~~l~~l~---~~~~i~~~~~~~-~~~~ 76 (407)
... +|++.++||+|+||.||+|.+..++ ..+|+|+....... ..+..|..++..+. +..+++.+...+ ....
T Consensus 15 ~~~~~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~ 94 (322)
T KOG1164|consen 15 KVNTRYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTED 94 (322)
T ss_pred ccccceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCc
Confidence 345 8999999999999999999987764 68999987764332 37889999999998 467899999999 5888
Q ss_pred eeEEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCC--CCceEEEEeccce
Q 015406 77 YNVLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR--RANQVYIIDFGLA 153 (407)
Q Consensus 77 ~~~lvme~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~--~~~~~kL~DFGla 153 (407)
+.||||+++|.+|.++..... +.++..+++.|+.|++.+|++||+.|++||||||+|++++... ....++|.|||+|
T Consensus 95 ~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 95 FNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 999999999999999997555 7899999999999999999999999999999999999997543 1267999999999
Q ss_pred e--eeccCCCCcccCccC-CCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhh
Q 015406 154 K--KYRDTSTHQHIPYRE-NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230 (407)
Q Consensus 154 ~--~~~~~~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~ 230 (407)
+ .+.........+.+. ...+.||..|++++++.+.+.+++.|+|||++++.|++.|.+||...........+.....
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 9 433333221233444 3467799999999999999999999999999999999999999988776555555555554
Q ss_pred hcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchh
Q 015406 231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKY 295 (407)
Q Consensus 231 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~ 295 (407)
...... .+...|.++.++...+-..++.++|++..+...|++.+...+...+.++||+....
T Consensus 255 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~dw~~~~~ 316 (322)
T KOG1164|consen 255 KLLTDR---FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPFDWEVKLR 316 (322)
T ss_pred hhcccc---ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCCccccccc
Confidence 443322 34456789999999999999999999999999999999999999999999986443
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=306.65 Aligned_cols=252 Identities=19% Similarity=0.327 Sum_probs=201.2
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
-.++|++.+.||+|+||.||+|.+..+++.||||.+..... ...+..|+.++..+..|++++.+..++......|++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 35789999999999999999999988899999999865432 233566777777776678888888888888899999
Q ss_pred EeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 82 MDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 82 me~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
|||++++|.+++......+++..+..++.||+.||.|||+ .||+||||+|+||++ +.++.+||+|||++..+....
T Consensus 93 ~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill---~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 93 MELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILL---DASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred eeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEE---cCCCCEEECccccchhccCCC
Confidence 9999889999888766689999999999999999999997 699999999999999 578899999999997654332
Q ss_pred CCcccCccCCCCccccccccccccccCCC----CChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhccccc
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHLGIE----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (407)
. .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||..... ..+.+..+........
T Consensus 170 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~ 239 (296)
T cd06618 170 A--------KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT--EFEVLTKILQEEPPSL 239 (296)
T ss_pred c--------ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh--HHHHHHHHhcCCCCCC
Confidence 2 12335788999999997654 78999999999999999999999965322 1223333322221111
Q ss_pred HHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 237 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
+ ....++.++.+++.+||..||++||++.++.+
T Consensus 240 -~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 272 (296)
T cd06618 240 -P-PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ 272 (296)
T ss_pred -C-CCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 11247889999999999999999999887764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=310.30 Aligned_cols=264 Identities=18% Similarity=0.248 Sum_probs=202.3
Q ss_pred CCCccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCC----CCcchHHHHHHHHHHHcCCCCCCeeEEeee--e
Q 015406 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQLLYESKLYRILQGGTGIPNVRWFGV--E 74 (407)
Q Consensus 1 m~~~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~--~ 74 (407)
.++.+.++|++.+.||+|+||.||+|.+..+++.||+|.+... .....+.+|+.+++.+.+|+++..+..++. .
T Consensus 1 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~ 80 (337)
T cd07852 1 IDKHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEN 80 (337)
T ss_pred CCchhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCC
Confidence 3678899999999999999999999999889999999976432 223346789999999944466666655543 3
Q ss_pred CceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEecccee
Q 015406 75 GDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (407)
Q Consensus 75 ~~~~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~ 154 (407)
....|+||||++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||+++
T Consensus 81 ~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill---~~~~~~kl~d~g~~~ 155 (337)
T cd07852 81 DKDIYLVFEYMETDLHAVIRA--NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL---NSDCRVKLADFGLAR 155 (337)
T ss_pred CceEEEEecccccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccchh
Confidence 446899999998899999874 378999999999999999999999999999999999999 688999999999998
Q ss_pred eeccCCCCcccCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHh----
Q 015406 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS---- 229 (407)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~---- 229 (407)
.......... ........|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.........+....
T Consensus 156 ~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07852 156 SLSELEENPE--NPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPS 233 (337)
T ss_pred cccccccccc--CcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 6654332110 011234578999999998865 457899999999999999999999997644322111111110
Q ss_pred -------------------hhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 230 -------------------EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 230 -------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
............+.++.++.++|.+||+.+|++||++.++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~ 294 (337)
T cd07852 234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294 (337)
T ss_pred HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence 000111223344557899999999999999999999887764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=297.59 Aligned_cols=247 Identities=23% Similarity=0.300 Sum_probs=200.1
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC----cchHHHHHHHHHHHcCCCCCCeeEEee-eeCceeEEEE
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFG-VEGDYNVLVM 82 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~-~~~~~~~lvm 82 (407)
+|++.+.||.|+||.||+|.+..+++.||+|.+..... ...+..|+++++.++|++.+..+..+. ..+...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 58999999999999999999999999999998765432 234777999999998855444443333 2456789999
Q ss_pred ecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHH-----hCCceeccCCCCcccccCCCCCceEEEEeccce
Q 015406 83 DLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVH-----SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (407)
Q Consensus 83 e~~-g~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH-----~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla 153 (407)
||+ +++|.+++... ...+++..++.++.||+.||.||| +.+|+|+||||+||++ +.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili---~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFL---DANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEE---ecCCCEEEeccccc
Confidence 999 89999999754 457999999999999999999999 9999999999999999 57899999999999
Q ss_pred eeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcc
Q 015406 154 KKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (407)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (407)
......... .....|++.|+|||++.+..++.++|+||||+++|+|++|..||.... .......+.....
T Consensus 158 ~~~~~~~~~-------~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~ 227 (265)
T cd08217 158 KILGHDSSF-------AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQLASKIKEGKF 227 (265)
T ss_pred ccccCCccc-------ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC---HHHHHHHHhcCCC
Confidence 876543210 124568999999999999889999999999999999999999997644 2333333333322
Q ss_pred cccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 234 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
..+...++.++.+++.+||+.+|++||++.+|++
T Consensus 228 ----~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 228 ----RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred ----CCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 1233567899999999999999999999888865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=304.70 Aligned_cols=261 Identities=19% Similarity=0.223 Sum_probs=195.2
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc----chHHHHHHHHHHHcCCCCCCeeEEeee-------
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGV------- 73 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~------- 73 (407)
..++|++.++||+|+||.||+|++..+++.||||.+...... ..+.+|+.+++.++|++.+..+..+..
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 356799999999999999999999999999999987543222 235679999999987655554443322
Q ss_pred eCceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccce
Q 015406 74 EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (407)
Q Consensus 74 ~~~~~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla 153 (407)
.....++||||++++|.+++......+++..++.++.||+.||+|||++|++|+||||+||++ +.++.+||+|||++
T Consensus 90 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~ 166 (310)
T cd07865 90 YKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILI---TKDGILKLADFGLA 166 (310)
T ss_pred CCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---CCCCcEEECcCCCc
Confidence 124569999999889999987655579999999999999999999999999999999999999 57889999999999
Q ss_pred eeeccCCCCcccCccCCCCccccccccccccccCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhc
Q 015406 154 KKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (407)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (407)
..+........ .......++..|+|||.+.+. .++.++||||||+++|||++|..||.+.........+..+....
T Consensus 167 ~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 167 RAFSLSKNSKP---NRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred ccccCCcccCC---CCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 87654322110 112344678899999988764 36899999999999999999999997654322222222221100
Q ss_pred cc------------------cc-----HHHHh-cCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 233 VS------------------TS-----IEALC-RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 233 ~~------------------~~-----~~~~~-~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.. .. ...+. ...+..+.++|.+||..||++||+++++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00 00 00000 112567889999999999999999887763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=299.26 Aligned_cols=236 Identities=18% Similarity=0.248 Sum_probs=185.5
Q ss_pred ccccccCceEEEEEEEcCCC----------eEEEEEEecCCCC-cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 13 RKIGSGSFGEIYLGTNIQTN----------EEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 13 ~~iG~G~~g~Vy~~~~~~~~----------~~vAvK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
+.||+|+||.||+|.+..++ ..|++|+...... ...+.+|+.+++.++| +++..+..++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSH-KHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCC-cchhheeeEEec-CCcEEE
Confidence 47999999999999987766 4588887665433 4568889999999986 555555555554 667999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCc-------eEEEEeccce
Q 015406 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-------QVYIIDFGLA 153 (407)
Q Consensus 82 me~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~-------~~kL~DFGla 153 (407)
|||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ ..+ .+||+|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~---~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVA---RYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEe---cCccccCCceeEEeCCCCcc
Confidence 9999 8999999986555799999999999999999999999999999999999995 444 7999999999
Q ss_pred eeeccCCCCcccCccCCCCccccccccccccccCC--CCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhh
Q 015406 154 KKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI--EQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISE 230 (407)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~ 230 (407)
...... ....++..|+|||++.+. .++.++||||||+++|||++ |..||...........+. .
T Consensus 156 ~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~---~ 221 (259)
T cd05037 156 ITVLSR-----------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ---D 221 (259)
T ss_pred cccccc-----------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh---c
Confidence 865431 234567789999999876 78999999999999999999 688887654322222221 1
Q ss_pred hcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 015406 231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIF 273 (407)
Q Consensus 231 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l 273 (407)
... ........+.+++.+||..+|++||++.++.+.|
T Consensus 222 ~~~------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 222 QHR------LPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred CCC------CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 110 0111237899999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=299.76 Aligned_cols=251 Identities=24% Similarity=0.391 Sum_probs=199.1
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC------------cchHHHHHHHHHHHcCCCCCCeeEEeeeeC
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK------------HPQLLYESKLYRILQGGTGIPNVRWFGVEG 75 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~------------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~ 75 (407)
+|.+.+.||.|+||.||+|.+..+++.||+|.+..... .+.+..|+.+++.++| ++++.+..++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~ 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH-LNIVQYLGFETTE 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCC-CCcceEEEEeccC
Confidence 68999999999999999999988999999997653211 1236678899999986 6666777777888
Q ss_pred ceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEecccee
Q 015406 76 DYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (407)
Q Consensus 76 ~~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~ 154 (407)
+..++||||+ +++|.+++... ..+++..+..++.||+.||.|||+++++||||||+||++ +.++.++|+|||+++
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~---~~~~~~~l~d~~~~~ 156 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLV---DADGICKISDFGISK 156 (272)
T ss_pred CceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEE---cCCCeEEEeeccccc
Confidence 8999999999 99999999864 579999999999999999999999999999999999999 578999999999997
Q ss_pred eeccCCCCcccCccCCCCccccccccccccccCCC--CChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhh-
Q 015406 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK- 231 (407)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~- 231 (407)
........ .......|+..|+|||.+.+.. ++.++|+||||+++|+|++|..||..... ...+..+...
T Consensus 157 ~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~ 228 (272)
T cd06629 157 KSDDIYDN-----DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA---IAAMFKLGNKR 228 (272)
T ss_pred cccccccc-----cccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch---HHHHHHhhccc
Confidence 65432111 1123456889999999988755 78999999999999999999999965322 2222222211
Q ss_pred cccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 232 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 232 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
............++.++.+++.+||..+|++||+++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 229 SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 1112222334567899999999999999999999888764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=298.52 Aligned_cols=242 Identities=19% Similarity=0.256 Sum_probs=192.9
Q ss_pred CCceeEeccc--cccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 6 GNKFRLGRKI--GSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 6 ~~~y~i~~~i--G~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
.++|++.+.+ |+|+||.||+++++.+++.+|+|+....... ..|......+.+++++..+...+...+..|+|||
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e 89 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN---AIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMD 89 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc---hhhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEE
Confidence 3567787777 9999999999999999999999987654221 1234444445567888888888888889999999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCc-eEEEEeccceeeeccCCC
Q 015406 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 84 ~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~-~~kL~DFGla~~~~~~~~ 161 (407)
|+ +++|.+++... ..+++..++.++.||+.||.|||+.|++||||||+||+++ .++ .++|+|||+++.....
T Consensus 90 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~~~l~dfg~~~~~~~~-- 163 (267)
T PHA03390 90 YIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD---RAKDRIYLCDYGLCKIIGTP-- 163 (267)
T ss_pred cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEe---CCCCeEEEecCccceecCCC--
Confidence 99 89999999863 4799999999999999999999999999999999999994 555 8999999999865432
Q ss_pred CcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCch-HHHHHHHhhhcccccHHHH
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYEKISEKKVSTSIEAL 240 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~-~~~~~~i~~~~~~~~~~~~ 240 (407)
....|+..|+|||++.+..++.++||||||+++|+|++|..||........ ...+...... ....
T Consensus 164 ---------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----~~~~ 229 (267)
T PHA03390 164 ---------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK-----KLPF 229 (267)
T ss_pred ---------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcc-----cCCc
Confidence 234688999999999998999999999999999999999999985433211 1111111111 1123
Q ss_pred hcCCcHHHHHHHHHHhCCCCCCCCC-HHHHH
Q 015406 241 CRGYPTEFASYFHYCRSLRFDDKPD-YAYLK 270 (407)
Q Consensus 241 ~~~~~~~l~~li~~cl~~~p~~RPt-~~~l~ 270 (407)
.+.+++.+.++|.+||+.+|.+||+ +++++
T Consensus 230 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l 260 (267)
T PHA03390 230 IKNVSKNANDFVQSMLKYNINYRLTNYNEII 260 (267)
T ss_pred ccccCHHHHHHHHHHhccChhhCCchHHHHh
Confidence 3468999999999999999999996 46665
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=304.42 Aligned_cols=246 Identities=22% Similarity=0.323 Sum_probs=198.7
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc-----chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeE
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 79 (407)
..+.|++.+.||+|+||.||+|.+..+++.||+|.+...... ..+.+|+.+++.++| +++..+..++...+..|
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h-~niv~~~~~~~~~~~~~ 91 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH-PNTIEYKGCYLREHTAW 91 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCC-CCEEEEEEEEEeCCeEE
Confidence 346799999999999999999999889999999987643221 347789999999986 66767777777888899
Q ss_pred EEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 80 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 80 lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
+||||+.++|.+++......+++..+..++.||+.||.|||++||+||||+|+||++ ++++.++|+|||++......
T Consensus 92 lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~---~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 92 LVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILL---TEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred EEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE---CCCCCEEEeecCcceecCCC
Confidence 999999889988887666679999999999999999999999999999999999999 57889999999998754322
Q ss_pred CCCcccCccCCCCcccccccccccccc---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhccccc
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (407)
....++..|+|||++. ...++.++||||||+++|||++|..||..... ......+........
T Consensus 169 -----------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~---~~~~~~~~~~~~~~~ 234 (307)
T cd06607 169 -----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQNDSPTL 234 (307)
T ss_pred -----------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH---HHHHHHHhcCCCCCC
Confidence 2456788999999885 35678999999999999999999999976432 122222222111111
Q ss_pred HHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 237 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
....++.++.+++.+||..+|++||++.+|..
T Consensus 235 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 235 ---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred ---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 11236789999999999999999999888764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=296.50 Aligned_cols=246 Identities=21% Similarity=0.238 Sum_probs=202.7
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
+|++.+.||+|+||.||++++..+++.||+|.+.... ....+.+|+.+++.++| +++..+..+....+..++|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKH-PNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCC-CCeeeeEeeecCCCeEEEEEe
Confidence 5999999999999999999999999999999876432 22357889999999987 566677777778889999999
Q ss_pred cc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCC
Q 015406 84 LL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 84 ~~-g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~ 161 (407)
|+ +++|.+++.... ..+++..++.++.|++.||.|||++|++|+||+|+|||+ +.++.++|+|||++........
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~---~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEEeeccceeecCcchh
Confidence 99 899999987533 358999999999999999999999999999999999999 5778899999999987644321
Q ss_pred CcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHh
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (407)
. .....|++.|+|||++.+..++.++|+|||||++|+|++|..||... ........+...... ...
T Consensus 157 ~-------~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~---~~~~~~~~~~~~~~~----~~~ 222 (256)
T cd08218 157 L-------ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG---NMKNLVLKIIRGSYP----PVS 222 (256)
T ss_pred h-------hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC---CHHHHHHHHhcCCCC----CCc
Confidence 1 12346888999999999988999999999999999999999999753 233344444333322 123
Q ss_pred cCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 242 ~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
..++.++.++|.+||+.+|++||++.++.+
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 223 SHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred ccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 457899999999999999999999888765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=327.89 Aligned_cols=257 Identities=20% Similarity=0.236 Sum_probs=186.7
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCC-eEEEEE------------------EecC-CCCcchHHHHHHHHHHHcCCCC
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTN-EEVAIK------------------LENV-KTKHPQLLYESKLYRILQGGTG 64 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~-~~vAvK------------------~~~~-~~~~~~~~~E~~~l~~l~~~~~ 64 (407)
+.++|+++++||+|+||.||+|..+... +.+++| .+.. ......+.+|+.+++.++| ++
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~H-pn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNH-EN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCC-CC
Confidence 4578999999999999999998764332 122222 1111 1112346789999999987 66
Q ss_pred CCeeEEeeeeCceeEEEEeccCCCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCC
Q 015406 65 IPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 140 (407)
Q Consensus 65 i~~~~~~~~~~~~~~lvme~~g~sL~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~ 140 (407)
|+.+..++...+..|++|++++++|.+++.... .......++.|+.||+.||.|||++|||||||||+|||+ +
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl---~ 301 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL---N 301 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---C
Confidence 777777778888899999999888888875321 224467788999999999999999999999999999999 5
Q ss_pred CCceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCc
Q 015406 141 RANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 220 (407)
Q Consensus 141 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~ 220 (407)
.++.+||+|||+++.+...... ......||..|+|||++.+..++.++|||||||+||||++|..++.......
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~ 375 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREA------FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGK 375 (501)
T ss_pred CCCCEEEEeCCCceecCccccc------ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCC
Confidence 7889999999999876543221 1234679999999999999999999999999999999999876443322222
Q ss_pred hHHHHHHHhhhc------cc-------------------ccHHHHh--cCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 221 KKQKYEKISEKK------VS-------------------TSIEALC--RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 221 ~~~~~~~i~~~~------~~-------------------~~~~~~~--~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
....+.++.... ++ .....+. ..++.++.++|.+||..||++||++.++++
T Consensus 376 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 376 PGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 222222211100 00 0011111 236778889999999999999999888754
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=323.73 Aligned_cols=269 Identities=23% Similarity=0.314 Sum_probs=207.4
Q ss_pred CccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCC---CCcchHHHHHHHHHHHcCCCCCCeeEEeeee-----
Q 015406 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK---TKHPQLLYESKLYRILQGGTGIPNVRWFGVE----- 74 (407)
Q Consensus 3 ~~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~----- 74 (407)
.....-|...+.||+|+||.||+|+++.+|+.||||.++.. ...+...+|++++++|+| +||+.+.+...+
T Consensus 9 ~~~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh-~NIVk~f~iee~~~~~~ 87 (732)
T KOG4250|consen 9 SGENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNH-PNIVKLFDIEETKFLGL 87 (732)
T ss_pred cCCCcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCc-hhhhhhcccCCccccCc
Confidence 34456788899999999999999999999999999988763 344568899999999995 666666555443
Q ss_pred -CceeEEEEecc-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCC-CCceEEEEe
Q 015406 75 -GDYNVLVMDLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR-RANQVYIID 149 (407)
Q Consensus 75 -~~~~~lvme~~-g~sL~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~-~~~~~kL~D 149 (407)
....++||||| ||||..+++... ..|++.+++.++.+++.||.|||++||+||||||.||++-.+. .....||+|
T Consensus 88 ~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtD 167 (732)
T KOG4250|consen 88 VTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTD 167 (732)
T ss_pred ccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeec
Confidence 34568999999 999999998533 3599999999999999999999999999999999999985443 334579999
Q ss_pred ccceeeeccCCCCcccCccCCCCcccccccccccccc-CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCc-hHHHHHH
Q 015406 150 FGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT-KKQKYEK 227 (407)
Q Consensus 150 FGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~-~~~~~~~ 227 (407)
||.|+.+++... ...++||..|.+||++. ...|+..+|.|||||++|+++||..||-...... ..+....
T Consensus 168 fG~Arel~d~s~--------~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~ 239 (732)
T KOG4250|consen 168 FGAARELDDNSL--------FTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWH 239 (732)
T ss_pred ccccccCCCCCe--------eeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhh
Confidence 999999887654 45789999999999999 4789999999999999999999999996543321 1222222
Q ss_pred Hhhhccc--------------------ccHHHHhcCCcHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHHHHHHc
Q 015406 228 ISEKKVS--------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKP--DYAYLKRIFRDLFIRE 280 (407)
Q Consensus 228 i~~~~~~--------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~RP--t~~~l~~~l~~l~~~~ 280 (407)
+..++.. +....+.+.+-..+..++..+|..+|.+|- .+.+.-..+.+++...
T Consensus 240 ~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~ 314 (732)
T KOG4250|consen 240 IITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLK 314 (732)
T ss_pred hhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhh
Confidence 2222110 001112222334466778888899999998 6677777777776654
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=299.19 Aligned_cols=249 Identities=22% Similarity=0.287 Sum_probs=196.7
Q ss_pred eeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc----chHHHHHHHHHHHc--CCCCCCeeEEeeeeCce-----
Q 015406 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQ--GGTGIPNVRWFGVEGDY----- 77 (407)
Q Consensus 9 y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----~~~~~E~~~l~~l~--~~~~i~~~~~~~~~~~~----- 77 (407)
|++.+.||+|+||.||+|++..+++.||+|.+...... ..+..|+.+++.+. .|+++..+..++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 78999999999999999999888999999988644322 24667888888775 35677777666665555
Q ss_pred eEEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeee
Q 015406 78 NVLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (407)
Q Consensus 78 ~~lvme~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~ 156 (407)
.+++|||++++|.+++.... ..+++..++.++.|++.||.|||+++++|+||||+||++ +.++.++|+|||++..+
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili---~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILV---TSDGQVKIADFGLARIY 157 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEE---ccCCCEEEeccCcceec
Confidence 89999999889999887643 358999999999999999999999999999999999999 57799999999999876
Q ss_pred ccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhh-----
Q 015406 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK----- 231 (407)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~----- 231 (407)
..... .....++..|+|||.+.+..++.++|||||||++|||++|..||.+.... +.+.++...
T Consensus 158 ~~~~~--------~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 226 (287)
T cd07838 158 SFEMA--------LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA---DQLDKIFDVIGLPS 226 (287)
T ss_pred cCCcc--------cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH---HHHHHHHHHcCCCC
Confidence 44322 12345788999999999989999999999999999999999999764432 222222211
Q ss_pred -----------------cccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 232 -----------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 232 -----------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
............+++++.+++.+||+.||++||++.++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 227 EEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred hHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0011112223346788999999999999999999887753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=310.39 Aligned_cols=259 Identities=19% Similarity=0.259 Sum_probs=199.5
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC----CcchHHHHHHHHHHHcCCCCCCeeEEeee----eCc
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGV----EGD 76 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~----~~~ 76 (407)
++++|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+.+|+.+++.++| ++++.+..++. ...
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKH-DNIIAIRDILRPPGADFK 81 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCC-CCccCHHHhccccCCCCc
Confidence 5689999999999999999999999999999999876542 22346789999999986 55555443332 345
Q ss_pred eeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeee
Q 015406 77 YNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (407)
Q Consensus 77 ~~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~ 156 (407)
..++||||++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++...
T Consensus 82 ~~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 82 DVYVVMDLMESDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLV---NEDCELRIGDFGMARGL 157 (334)
T ss_pred eEEEEEehhhhhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEecccccceee
Confidence 7899999998899999874 4569999999999999999999999999999999999999 57899999999999876
Q ss_pred ccCCCCcccCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHH-------
Q 015406 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI------- 228 (407)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i------- 228 (407)
....... ........|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.+.............
T Consensus 158 ~~~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~ 234 (334)
T cd07855 158 SSSPTEH---KYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEE 234 (334)
T ss_pred cccCcCC---CcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhH
Confidence 4432211 011234578999999999866 45799999999999999999999999765432111111110
Q ss_pred ----------------hhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 229 ----------------SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 229 ----------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
...........+.+..++++.++|.+||+.+|++||+++++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0011111223344567899999999999999999999876654
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=295.71 Aligned_cols=249 Identities=24% Similarity=0.343 Sum_probs=208.0
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
++|++.+.||+|++|.||+|++..+++.||+|.+..... ...+..|+..+..++| +++..+..+.......+++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCES-PYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCC-CCeeeEEEEEccCCeEEEEEE
Confidence 479999999999999999999999999999998876543 4568889999999985 667777777777889999999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCC
Q 015406 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 84 ~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~ 161 (407)
|+ +++|.+++... ..+++..++.++.|++.||+|||+ ++++||||+|+||++ +.++.++|+|||++........
T Consensus 80 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~---~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 80 YMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLI---NSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred ecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEE---CCCCCEEEccCccceecccCCC
Confidence 99 79999999863 679999999999999999999999 999999999999999 6789999999999987654332
Q ss_pred CcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHh
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (407)
. .....++..|+|||.+.+..++.++||||||+++|+|++|..||.........+....+..... ..+.
T Consensus 156 ~-------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~ 224 (264)
T cd06623 156 Q-------CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP----PSLP 224 (264)
T ss_pred c-------ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCC----CCCC
Confidence 1 1245678999999999998899999999999999999999999977643334444444443222 1223
Q ss_pred cC-CcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 242 RG-YPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 242 ~~-~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.. ++..+.+++.+||..+|++||++.++.+
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 225 AEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 44 7899999999999999999999887765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=309.86 Aligned_cols=259 Identities=20% Similarity=0.242 Sum_probs=196.3
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC--cchHHHHHHHHHHHcCCCCCCeeEEeee---------
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGV--------- 73 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~--------- 73 (407)
++++|++.+.||.|+||.||+|++..+++.||+|.+..... ...+.+|+++++.++|++.+..+..+..
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 57899999999999999999999999999999998765433 2357889999999987554444333222
Q ss_pred ----eCceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEe
Q 015406 74 ----EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID 149 (407)
Q Consensus 74 ----~~~~~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~D 149 (407)
+....|++|||++++|.+++. ...+++..++.++.||+.||.|||++||+||||||+||+++ ..++.++|+|
T Consensus 83 ~~~~~~~~~~lv~e~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~--~~~~~~kl~d 158 (342)
T cd07854 83 GSLTELNSVYIVQEYMETDLANVLE--QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFIN--TEDLVLKIGD 158 (342)
T ss_pred ccccccceEEEEeecccccHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc--CCCceEEECC
Confidence 124578999999889998886 34699999999999999999999999999999999999995 3556899999
Q ss_pred ccceeeeccCCCCcccCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHH
Q 015406 150 FGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228 (407)
Q Consensus 150 FGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i 228 (407)
||+++......... .......++..|+|||.+.+ ..++.++|||||||++|+|++|..||...............
T Consensus 159 fg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 159 FGLARIVDPHYSHK----GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred cccceecCCccccc----cccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99998654322111 01123467889999998754 56789999999999999999999999765432111111000
Q ss_pred ----------------------hhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 229 ----------------------SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 229 ----------------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.......+...+...++.++.+++.+||..||++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0001112222334567889999999999999999999887754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=300.71 Aligned_cols=242 Identities=26% Similarity=0.308 Sum_probs=199.9
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
+|++.+.||.|+||.||+|.+..+++.||+|++.... ....+..|+++++.++| +++..+..++..+...+++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 79 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNH-PFLVNLWYSFQDEENMYLVV 79 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCC-CChHHHHHhhcCCCeEEEEE
Confidence 5899999999999999999998899999999886532 23457889999999987 56666666677788899999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCC
Q 015406 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 83 e~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~ 161 (407)
||+ +++|.+++... ..+++..+..++.||+.||.|||++|++|+||||+||++ ++++.++|+|||++........
T Consensus 80 e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~ 155 (258)
T cd05578 80 DLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTL 155 (258)
T ss_pred eCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---cCCCCEEEeecccccccCCCcc
Confidence 999 99999999863 579999999999999999999999999999999999999 5788999999999986644321
Q ss_pred CcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHh
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (407)
.....|+..|+|||.+.+..++.++|+||||+++|+|++|..||.........+....... ......
T Consensus 156 --------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~ 222 (258)
T cd05578 156 --------TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-----ADVLYP 222 (258)
T ss_pred --------ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-----ccccCc
Confidence 2345688899999999988899999999999999999999999987554322222222221 112233
Q ss_pred cCCcHHHHHHHHHHhCCCCCCCCCHH
Q 015406 242 RGYPTEFASYFHYCRSLRFDDKPDYA 267 (407)
Q Consensus 242 ~~~~~~l~~li~~cl~~~p~~RPt~~ 267 (407)
..+|.++.++|.+||..||++||++.
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~R~~~~ 248 (258)
T cd05578 223 ATWSTEAIDAINKLLERDPQKRLGDN 248 (258)
T ss_pred ccCcHHHHHHHHHHccCChhHcCCcc
Confidence 45789999999999999999999983
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=297.27 Aligned_cols=250 Identities=22% Similarity=0.318 Sum_probs=199.3
Q ss_pred ceeEeccccccCceEEEEEEEcC-CCeEEEEEEecCCCC------------cchHHHHHHHHHHHcCCCCCCeeEEeeee
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQ-TNEEVAIKLENVKTK------------HPQLLYESKLYRILQGGTGIPNVRWFGVE 74 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~-~~~~vAvK~~~~~~~------------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~ 74 (407)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+..... ...+..|+.++.....|+++..+..++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999877 678999997653211 12256677777664455777777777788
Q ss_pred CceeEEEEecc-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcccccCCCCCceEEEEe
Q 015406 75 GDYNVLVMDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIID 149 (407)
Q Consensus 75 ~~~~~lvme~~-g~sL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~-~~ivHrDLKp~NILl~~~~~~~~~kL~D 149 (407)
.+..+++|||+ +++|.+++.. ....+++..++.++.|++.||.|||+ .+++|+||||+||++ +.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~---~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIML---GEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEE---CCCCcEEEec
Confidence 88999999999 8899998853 24468999999999999999999996 789999999999999 5788999999
Q ss_pred ccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHh
Q 015406 150 FGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 229 (407)
Q Consensus 150 FGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~ 229 (407)
||++........ .....|+..|+|||.+.+..++.++||||||+++|+|++|..||..... ......+.
T Consensus 158 fg~~~~~~~~~~--------~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~---~~~~~~~~ 226 (269)
T cd08528 158 FGLAKQKQPESK--------LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM---LSLATKIV 226 (269)
T ss_pred ccceeecccccc--------cccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH---HHHHHHHh
Confidence 999987544321 2345688999999999998899999999999999999999999975432 22233333
Q ss_pred hhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015406 230 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 274 (407)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~ 274 (407)
.....+. ....+++++.+++.+||+.||++||++.++...+.
T Consensus 227 ~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 227 EAVYEPL---PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred hccCCcC---CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 3222211 11247889999999999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=306.29 Aligned_cols=256 Identities=20% Similarity=0.262 Sum_probs=196.6
Q ss_pred ceeEeccccccCceEEEEEEEcCC--CeEEEEEEecCCC----CcchHHHHHHHHHHHcCCCCCCeeEEeee----eCce
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQT--NEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGV----EGDY 77 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~--~~~vAvK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~----~~~~ 77 (407)
+|++.+.||+|+||.||++++..+ +..||+|.+.... ....+.+|+.+++.+.+|++++.+..+.. ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 589999999999999999999887 8899999876432 13357789999999976677777655432 2345
Q ss_pred eEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeec
Q 015406 78 NVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (407)
Q Consensus 78 ~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~ 157 (407)
.|++|+|++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.+.
T Consensus 81 ~~~~~e~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili---~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 81 LYLYEELMEADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV---NADCELKICDFGLARGFS 156 (332)
T ss_pred EEEEEecccCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEE---cCCCCEEeCcCCCceecc
Confidence 789999998899999874 4579999999999999999999999999999999999999 578899999999998765
Q ss_pred cCCCCcccCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHH------------
Q 015406 158 DTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK------------ 224 (407)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~------------ 224 (407)
...... ........||..|+|||.+.+ ..++.++||||||+++|+|++|..||...+.......
T Consensus 157 ~~~~~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 157 ENPGEN---AGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred cccccc---cccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 432211 011234578999999998876 4689999999999999999999999976432111111
Q ss_pred HHHHhh-----------hcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015406 225 YEKISE-----------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 225 ~~~i~~-----------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
+..+.. .............++.++.+++.+||+.||++||++.+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll 290 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 000000 0011122233445688999999999999999999988764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=306.67 Aligned_cols=251 Identities=21% Similarity=0.239 Sum_probs=196.7
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
+.++|++.+.||.|+||.||+|.+..+++.||||.+.... ....+..|+.+++.++|++.+..+..+.......++
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 5789999999999999999999999999999999765322 234577899999999875555444444444667899
Q ss_pred EEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 81 VMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 81 vme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
+|||++++|.+++. ...+++..+..++.||+.||.|||++||+||||||+|||+ +..+.++|+|||++......
T Consensus 88 v~e~~~~~L~~~~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili---~~~~~~~l~dfg~~~~~~~~- 161 (328)
T cd07856 88 VTELLGTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLARIQDPQ- 161 (328)
T ss_pred EeehhccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeE---CCCCCEEeCccccccccCCC-
Confidence 99999989999887 3468999999999999999999999999999999999999 57889999999999754321
Q ss_pred CCcccCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHh----------
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS---------- 229 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~---------- 229 (407)
.....++..|+|||.+.+ ..++.++||||||+++|+|++|..||.............+..
T Consensus 162 ---------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 162 ---------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred ---------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 124467889999998866 568999999999999999999999997643311111111110
Q ss_pred -------------hhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015406 230 -------------EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 230 -------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
......+.....+.+++++.++|.+||+.+|++||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell 286 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEAL 286 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 00111222334456789999999999999999999987764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=306.74 Aligned_cols=248 Identities=18% Similarity=0.295 Sum_probs=200.3
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC--CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
...|.....||+|+||.||+|.+..+++.||+|.+.... ....+.+|+.+++.+.| +++..+..++..++..+++||
T Consensus 20 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h-p~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 20 RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH-QNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred hhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCC-CchhhhhhheeeCCeEEEEEe
Confidence 345677789999999999999998899999999876433 23457789999998876 666666666777888999999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 84 ~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
|+ +++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||++ +.++.++|+|||++..+.....
T Consensus 99 ~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill---~~~~~~kL~dfg~~~~~~~~~~- 172 (297)
T cd06659 99 FLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVP- 172 (297)
T ss_pred cCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEE---ccCCcEEEeechhHhhcccccc-
Confidence 99 8899998863 468999999999999999999999999999999999999 6789999999999875543221
Q ss_pred cccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhc
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (407)
......|+..|+|||++.+..++.++|||||||++|||++|..||..... ...+..+...... ......
T Consensus 173 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~~--~~~~~~ 241 (297)
T cd06659 173 ------KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP---VQAMKRLRDSPPP--KLKNAH 241 (297)
T ss_pred ------cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhccCCC--CccccC
Confidence 12345789999999999998999999999999999999999999975332 3333333222111 111234
Q ss_pred CCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 243 ~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.++.++.+++.+||..+|++||++.++++
T Consensus 242 ~~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 242 KISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred CCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 57889999999999999999999887765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=307.40 Aligned_cols=247 Identities=19% Similarity=0.312 Sum_probs=196.5
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC--CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEec
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~ 84 (407)
+.|.....||+|+||.||++.+..++..||||.+.... ....+.+|+.+++.++| +++..+...+..++..+++|||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~ii~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHH-ENVVDMYNSYLVGDELWVVMEF 100 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCC-CcHHHHHHheecCCeEEEEEeC
Confidence 45666788999999999999998899999999875432 22347789999999876 5555555556677889999999
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCc
Q 015406 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (407)
Q Consensus 85 ~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~ 163 (407)
+ +++|.+++. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.++|+|||++........
T Consensus 101 ~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kL~dfg~~~~~~~~~~-- 173 (292)
T cd06658 101 LEGGALTDIVT--HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILL---TSDGRIKLSDFGFCAQVSKEVP-- 173 (292)
T ss_pred CCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEccCcchhhcccccc--
Confidence 9 889999886 3468999999999999999999999999999999999999 5778999999999875533221
Q ss_pred ccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcC
Q 015406 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243 (407)
Q Consensus 164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (407)
......|+..|+|||.+.+..++.++||||||+++|||++|..||..... .+.+..+.... .... .....
T Consensus 174 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~~~~~~~-~~~~-~~~~~ 243 (292)
T cd06658 174 -----KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP---LQAMRRIRDNL-PPRV-KDSHK 243 (292)
T ss_pred -----cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcC-CCcc-ccccc
Confidence 12345689999999999988899999999999999999999999976433 22222222211 1111 11234
Q ss_pred CcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 244 YPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 244 ~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
++..+.+++.+||..||.+||+++++++
T Consensus 244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~ 271 (292)
T cd06658 244 VSSVLRGFLDLMLVREPSQRATAQELLQ 271 (292)
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 6889999999999999999999887764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=296.69 Aligned_cols=248 Identities=21% Similarity=0.286 Sum_probs=193.9
Q ss_pred eeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC--cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-
Q 015406 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (407)
Q Consensus 9 y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~- 85 (407)
+.....||+|+||.||+|++..++..||+|.+..... ...+.+|+.+++.++| +++..+..++..++..+++|||+
T Consensus 10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~ 88 (268)
T cd06624 10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKH-RNIVQYLGSDSENGFFKIFMEQVP 88 (268)
T ss_pred CCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCC-CCeeeeeeeeccCCEEEEEEecCC
Confidence 3345689999999999999989999999998765432 2357889999999987 55666777777888999999999
Q ss_pred CCCHHHHHHHcCCCC--CHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCc
Q 015406 86 GPSLEDLFNFCSRKL--SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (407)
Q Consensus 86 g~sL~~~l~~~~~~l--~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~ 163 (407)
+++|.+++......+ ++..+..++.||+.||.|||++||+||||||+||+++ ...+.++|+|||++.........
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~--~~~~~~~l~dfg~~~~~~~~~~~- 165 (268)
T cd06624 89 GGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVN--TYSGVVKISDFGTSKRLAGINPC- 165 (268)
T ss_pred CCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc--CCCCeEEEecchhheecccCCCc-
Confidence 899999997544445 8889999999999999999999999999999999994 23678999999999765432211
Q ss_pred ccCccCCCCccccccccccccccCCC--CChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHh
Q 015406 164 HIPYRENKNLTGTARYASMNTHLGIE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (407)
Q Consensus 164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~--~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (407)
.....|+..|+|||.+.+.. ++.++||||||+++|+|++|..||....... .... ..... .....+.
T Consensus 166 ------~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~-~~~~-~~~~~---~~~~~~~ 234 (268)
T cd06624 166 ------TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ-AAMF-KVGMF---KIHPEIP 234 (268)
T ss_pred ------cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh-hhHh-hhhhh---ccCCCCC
Confidence 12346789999999987644 7899999999999999999999997643211 1111 11110 1111233
Q ss_pred cCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 242 ~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
..+++++.+++.+||+.+|++||++.++.+
T Consensus 235 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 235 ESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred cccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 557889999999999999999999888764
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=309.85 Aligned_cols=255 Identities=21% Similarity=0.234 Sum_probs=196.5
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeC-----
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEG----- 75 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~----- 75 (407)
+.++|.+.+.||+|+||.||+|++..+++.||||.+.... ....+..|+.+++.++|. ++..+..+....
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~-ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHE-NVIAIKDIMPPPHREAF 81 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCC-CccchHHheeccccccc
Confidence 6789999999999999999999999999999999875421 223467899999999875 444443333221
Q ss_pred ceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceee
Q 015406 76 DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (407)
Q Consensus 76 ~~~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~ 155 (407)
...|++|||++++|.+++.. ...+++..+..++.||+.||.|||+++++||||||+||++ +.++.+||+|||+++.
T Consensus 82 ~~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 82 NDVYIVYELMDTDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLART 157 (337)
T ss_pred CcEEEEEeCCCCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECcCccccc
Confidence 35799999999899999875 4579999999999999999999999999999999999999 5778999999999986
Q ss_pred eccCCCCcccCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhh----
Q 015406 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE---- 230 (407)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~---- 230 (407)
...... ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+.............
T Consensus 158 ~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 230 (337)
T cd07858 158 TSEKGD-------FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSE 230 (337)
T ss_pred cCCCcc-------cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 644321 1234567889999998875 4688999999999999999999999976432111111111000
Q ss_pred -------------------hcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 231 -------------------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 231 -------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
...........+.+++++.++|.+||+.+|++||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~ 290 (337)
T cd07858 231 EDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALA 290 (337)
T ss_pred HHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHc
Confidence 00011122334568899999999999999999999777764
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=315.85 Aligned_cols=242 Identities=21% Similarity=0.322 Sum_probs=205.8
Q ss_pred eccccccCceEEEEEEEcCCCeEEEEEEecCC----CCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEeccCC
Q 015406 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGP 87 (407)
Q Consensus 12 ~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~g~ 87 (407)
.+.||+|.||+||-|.++++|+.||||++.+. ....++..|+.||+.+.| +.|+.+...++..+..++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~H-PGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHH-PGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCC-CCeeEEEEeecCCceEEEEehhhcc
Confidence 47899999999999999999999999988653 234568889999999876 8999999999999999999999977
Q ss_pred CHHHHH-HHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcccC
Q 015406 88 SLEDLF-NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166 (407)
Q Consensus 88 sL~~~l-~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~ 166 (407)
++.++| ....++|++....+++.||+.||.|||.++|+|+||||+|||+...+.-.++||||||+|+.+.+...
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF----- 722 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF----- 722 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh-----
Confidence 766665 45567899999999999999999999999999999999999998777778999999999999887654
Q ss_pred ccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcH
Q 015406 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 246 (407)
Q Consensus 167 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 246 (407)
....+||+.|+|||+++++.|++.-|+||.|||+|--+.|..||... .+.-++|+...+-.+. .-++.+++
T Consensus 723 ---RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd-----EdIndQIQNAaFMyPp-~PW~eis~ 793 (888)
T KOG4236|consen 723 ---RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED-----EDINDQIQNAAFMYPP-NPWSEISP 793 (888)
T ss_pred ---hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc-----cchhHHhhccccccCC-CchhhcCH
Confidence 34779999999999999999999999999999999999999999753 2233444444333222 22466899
Q ss_pred HHHHHHHHHhCCCCCCCCCHHH
Q 015406 247 EFASYFHYCRSLRFDDKPDYAY 268 (407)
Q Consensus 247 ~l~~li~~cl~~~p~~RPt~~~ 268 (407)
+..+||..+|+..-.+|-+.+.
T Consensus 794 ~AidlIn~LLqVkm~kRysvdk 815 (888)
T KOG4236|consen 794 EAIDLINNLLQVKMRKRYSVDK 815 (888)
T ss_pred HHHHHHHHHHHHHHHHhcchHh
Confidence 9999999999999999988543
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=299.00 Aligned_cols=252 Identities=20% Similarity=0.255 Sum_probs=195.3
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeee--eCceeEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGV--EGDYNVLV 81 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~--~~~~~~lv 81 (407)
++|++.+.||.|++|.||+|.+..+++.||+|.+..... ...+.+|+++++.++|+ ++..+..++. .....++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSP-YIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCC-CeeeeeeEEEccCCCeEEEE
Confidence 479999999999999999999999999999998765432 24588899999999875 4555444332 34578999
Q ss_pred Eecc-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeec
Q 015406 82 MDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (407)
Q Consensus 82 me~~-g~sL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~ 157 (407)
|||+ +++|.+++.. ....+++..+..++.||+.||.|||+.|++|+||+|+||++ +.++.++|+|||++....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILL---TRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---ecCCeEEEeecccccccc
Confidence 9999 8999998753 23458999999999999999999999999999999999999 577889999999987554
Q ss_pred cCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCc--CchHHHHHHHhhhcccc
Q 015406 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA--GTKKQKYEKISEKKVST 235 (407)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~--~~~~~~~~~i~~~~~~~ 235 (407)
... .....++..|+|||.+.+..++.++||||||+++|+|++|..||..... ....+....+.......
T Consensus 157 ~~~---------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd06621 157 NSL---------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPE 227 (287)
T ss_pred ccc---------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchh
Confidence 322 1234578899999999998999999999999999999999999976522 12222232222211111
Q ss_pred cHHHHh--cCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 236 SIEALC--RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 236 ~~~~~~--~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
...... ..+++++.+++.+||..+|++||++.++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 228 LKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred hccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 000000 124678999999999999999999877754
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=298.38 Aligned_cols=245 Identities=21% Similarity=0.339 Sum_probs=197.9
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC---cchHHHHHHHHHHHc--CCCCCCeeEEeeeeCceeEEEE
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQ--GGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~--~~~~i~~~~~~~~~~~~~~lvm 82 (407)
.|++.+.||+|+||.||+|.+..+++.||+|.++.... ...+.+|+.+++.+. .++++..+..++..+...+++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 58899999999999999999999999999998765422 245778999999997 3566666667777888899999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCC
Q 015406 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 83 e~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~ 161 (407)
||+ +++|.+++.. ..+++..++.++.|++.||.|||+.||+|+||+|+||++ +..+.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 82 EYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILV---TNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred ecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEE---cCCCCEEEccCCceeecCCCcc
Confidence 999 8999999874 479999999999999999999999999999999999999 5688999999999987654332
Q ss_pred CcccCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHH
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (407)
. .....|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+... ......+..... ..+
T Consensus 157 ~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~---~~~~~~~~~~~~----~~~ 222 (277)
T cd06917 157 K-------RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA---FRAMMLIPKSKP----PRL 222 (277)
T ss_pred c-------cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh---hhhhhccccCCC----CCC
Confidence 1 234568999999999875 4568999999999999999999999976432 111211111111 112
Q ss_pred hc-CCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 241 CR-GYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 241 ~~-~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.. .++.++.+++.+||..||++||++.++.+
T Consensus 223 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 223 EDNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 22 37889999999999999999999888764
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=299.72 Aligned_cols=243 Identities=16% Similarity=0.271 Sum_probs=194.6
Q ss_pred ceeEeccccccCceEEEEEEEc---CCCeEEEEEEecCCC------CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCcee
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKT------KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~---~~~~~vAvK~~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 78 (407)
+|++.+.||+|+||.||+|++. .+|+.||+|++.... ....+..|+.++..+.++++++.+..++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4899999999999999999874 478999999876432 1234678999999998889999998888888899
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeec
Q 015406 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~ 157 (407)
|+||||+ +++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||+ +.++.+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQ-RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---CCCCCEEEeeCccceecc
Confidence 9999999 8999999875 4568999999999999999999999999999999999999 578899999999998764
Q ss_pred cCCCCcccCccCCCCccccccccccccccCC--CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCch-HHHHHHHhhhccc
Q 015406 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGI--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYEKISEKKVS 234 (407)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~-~~~~~~i~~~~~~ 234 (407)
..... ......|+..|+|||.+.+. .++.++||||||+++|+|++|..||........ ......+.....
T Consensus 157 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~- 229 (290)
T cd05613 157 EDEVE------RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP- 229 (290)
T ss_pred ccccc------ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCC-
Confidence 43211 12245689999999998753 467899999999999999999999965332211 122222211111
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhCCCCCCCCC
Q 015406 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPD 265 (407)
Q Consensus 235 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt 265 (407)
.....+++.+.+++.+||+.+|++||+
T Consensus 230 ----~~~~~~~~~~~~ll~~~l~~~p~~R~~ 256 (290)
T cd05613 230 ----PYPQEMSALAKDIIQRLLMKDPKKRLG 256 (290)
T ss_pred ----CCCccCCHHHHHHHHHHhcCCHHHhcC
Confidence 123457889999999999999999983
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=299.20 Aligned_cols=249 Identities=19% Similarity=0.246 Sum_probs=196.5
Q ss_pred eeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEec
Q 015406 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (407)
Q Consensus 9 y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~ 84 (407)
|++.+.||.|++|.||+|.+..+|..||+|++..... ...+..|+++++.++| ++++.+..++..++..|++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~-~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNH-PNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCC-CCccCHhheeccCCeEEEEEec
Confidence 6788999999999999999999999999998765432 2357789999999986 5666666666777899999999
Q ss_pred cCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCc
Q 015406 85 LGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (407)
Q Consensus 85 ~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~ 163 (407)
++++|.+++.... ..+++..++.++.|++.||+|||+++++||||+|+||++ +.++.++|+|||++........
T Consensus 80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~---~~~~~~~l~df~~~~~~~~~~~-- 154 (283)
T cd07835 80 LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLI---DREGALKLADFGLARAFGVPVR-- 154 (283)
T ss_pred cCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE---cCCCcEEEeecccccccCCCcc--
Confidence 9889999987533 368999999999999999999999999999999999999 5688999999999975533211
Q ss_pred ccCccCCCCccccccccccccccCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhh-----------
Q 015406 164 HIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK----------- 231 (407)
Q Consensus 164 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~----------- 231 (407)
......++..|+|||++.+. .++.++||||||+++|+|++|..||...... ..+.++...
T Consensus 155 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~ 226 (283)
T cd07835 155 -----TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI---DQLFRIFRTLGTPDEDVWPG 226 (283)
T ss_pred -----ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCChHHhhh
Confidence 11233568899999988764 5689999999999999999999999764331 111111110
Q ss_pred -------------cccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 232 -------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 232 -------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
............++.++.+++.+||+.+|++||++.++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 227 VTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0011222334567889999999999999999999887763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=305.81 Aligned_cols=263 Identities=21% Similarity=0.281 Sum_probs=202.8
Q ss_pred CCCccCCceeE-eccccccCceEEEEEEEcCCCeEEEEEEecCCCCcc----------------hHHHHHHHHHHHcCCC
Q 015406 1 MEPRVGNKFRL-GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----------------QLLYESKLYRILQGGT 63 (407)
Q Consensus 1 m~~~~~~~y~i-~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~----------------~~~~E~~~l~~l~~~~ 63 (407)
|...+.++|.. .+.||+|+||.||+|.+..+++.||||.+....... .+.+|+++++.++| +
T Consensus 2 ~~~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~ 80 (335)
T PTZ00024 2 MSFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKH-E 80 (335)
T ss_pred CccccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCC-c
Confidence 66778899975 567999999999999999999999999875432221 46789999999987 5
Q ss_pred CCCeeEEeeeeCceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCc
Q 015406 64 GIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN 143 (407)
Q Consensus 64 ~i~~~~~~~~~~~~~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~ 143 (407)
++..+..++...+..+++|||+.++|.+++.. ...+++..+..++.||+.||+|||++||+|+||||+||++ +.++
T Consensus 81 ~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill---~~~~ 156 (335)
T PTZ00024 81 NIMGLVDVYVEGDFINLVMDIMASDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFI---NSKG 156 (335)
T ss_pred ceeeeeEEEecCCcEEEEEeccccCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEE---CCCC
Confidence 66666667777889999999998899999875 4569999999999999999999999999999999999999 5778
Q ss_pred eEEEEeccceeeeccCCCCcc-------cCccCCCCccccccccccccccCC-CCChhhHHHHHHHHHHHHHhCCCCCCC
Q 015406 144 QVYIIDFGLAKKYRDTSTHQH-------IPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQG 215 (407)
Q Consensus 144 ~~kL~DFGla~~~~~~~~~~~-------~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDIwSlG~il~elltG~~Pf~~ 215 (407)
.++|+|||++........... ..........++..|+|||.+.+. .++.++|||||||++|||++|..||.+
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~ 236 (335)
T PTZ00024 157 ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG 236 (335)
T ss_pred CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999987652211000 000111234568899999998764 468999999999999999999999986
Q ss_pred CCcCchHHHHHHHhhhc-----------------------ccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 216 LKAGTKKQKYEKISEKK-----------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 216 ~~~~~~~~~~~~i~~~~-----------------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.... +.+..+.... ............+.++.+++.+||+.+|++||++++++.
T Consensus 237 ~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 237 ENEI---DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred CCHH---HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 5432 2222221110 011112223456888999999999999999999877764
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=303.00 Aligned_cols=258 Identities=22% Similarity=0.274 Sum_probs=197.8
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC----cchHHHHHHHHHHHcCCCCCCeeEEeeee-----
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVE----- 74 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~----- 74 (407)
+..++|++.+.||+|+||.||+|.+..+++.||+|.++.... ...+..|+.+++.++|+ ++..+..++.+
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~-~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHR-NIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCC-CeeeeeheecCcchhh
Confidence 345789999999999999999999998999999998865432 23467899999999875 45444444333
Q ss_pred -----CceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEe
Q 015406 75 -----GDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID 149 (407)
Q Consensus 75 -----~~~~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~D 149 (407)
....+++|||++++|.+++......+++..++.++.||+.||.|||+.||+||||||+||++ ++++.+||+|
T Consensus 83 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~kl~d 159 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILL---NNKGQIKLAD 159 (302)
T ss_pred hccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCcEEeCc
Confidence 23789999999778888887545579999999999999999999999999999999999999 6788999999
Q ss_pred ccceeeeccCCCCcccCccCCCCccccccccccccccCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHH
Q 015406 150 FGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228 (407)
Q Consensus 150 FGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i 228 (407)
||++......... ......++..|+|||.+.+. .++.++|||||||++|||++|+.||...........+...
T Consensus 160 fg~~~~~~~~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~ 233 (302)
T cd07864 160 FGLARLYNSEESR------PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRL 233 (302)
T ss_pred ccccccccCCccc------ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 9999876543211 11233567889999988754 4689999999999999999999999764432222222222
Q ss_pred hhhccc----------------------ccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 229 SEKKVS----------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 229 ~~~~~~----------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
...... .........+|.++.+++.+||..+|++||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111100 0111223457899999999999999999999887764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=296.26 Aligned_cols=250 Identities=19% Similarity=0.270 Sum_probs=199.0
Q ss_pred ccccCceEEEEEEEcCCCeEEEEEEecCCCC-----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-CCC
Q 015406 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPS 88 (407)
Q Consensus 15 iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~-g~s 88 (407)
||.|+||.||+|++..+++.||+|++..... ...+..|+.+++.++| +++..+.....++...+++|||+ +++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNH-PFIVKLYRTFKDKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCC-CCEeeeeeeEEcCCccEEEEecCCCCc
Confidence 7999999999999988899999998764322 2357889999999976 56666666677788899999999 899
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcccCcc
Q 015406 89 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYR 168 (407)
Q Consensus 89 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 168 (407)
|.+++.. ...+++..+..++.||+.||.|||+++++|+||||+||++ +.++.++|+|||++........
T Consensus 80 L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv---~~~~~~~l~df~~~~~~~~~~~------- 148 (262)
T cd05572 80 LWTILRD-RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLL---DSNGYVKLVDFGFAKKLKSGQK------- 148 (262)
T ss_pred HHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE---cCCCCEEEeeCCcccccCcccc-------
Confidence 9999975 3468999999999999999999999999999999999999 5788999999999987654321
Q ss_pred CCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcHHH
Q 015406 169 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEF 248 (407)
Q Consensus 169 ~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l 248 (407)
.....|+..|++||.+.+..++.++|+||||+++|+|++|..||..... +..+.+..+....... ......++++
T Consensus 149 -~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~---~~~~~~~~~~ 223 (262)
T cd05572 149 -TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE-DPMEIYNDILKGNGKL---EFPNYIDKAA 223 (262)
T ss_pred -cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC-CHHHHHHHHhccCCCC---CCCcccCHHH
Confidence 1234688999999999988899999999999999999999999987543 2233444433211111 1223357899
Q ss_pred HHHHHHHhCCCCCCCCC-----HHHHHHHHHHHHHHcCCCCCCccccc
Q 015406 249 ASYFHYCRSLRFDDKPD-----YAYLKRIFRDLFIREGFQFDYVFDWT 291 (407)
Q Consensus 249 ~~li~~cl~~~p~~RPt-----~~~l~~~l~~l~~~~~~~~~~~~dw~ 291 (407)
.++|.+||..+|++||+ +.++++ ++|+..++|+
T Consensus 224 ~~~i~~~l~~~p~~R~~~~~~~~~~l~~----------~~~~~~~~~~ 261 (262)
T cd05572 224 KDLIKQLLRRNPEERLGNLKGGIKDIKK----------HKWFNGFDWE 261 (262)
T ss_pred HHHHHHHccCChhhCcCCcccCHHHHhc----------ChhhhCCCCC
Confidence 99999999999999999 444443 3455567775
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=298.19 Aligned_cols=245 Identities=22% Similarity=0.335 Sum_probs=200.3
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
+-|++.+.||+|+||.||+|.+..+++.||||+...... ...+.+|+.++..+.| +++..+..++..+...++|||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCC-CCEeEEEEEEEeCCeEEEEEE
Confidence 347889999999999999999988999999998764332 2357788999999886 566677777778888999999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 84 ~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
|+ +++|.+++. ...+++..+..++.|++.||.|||++|++|+||||+||++ +.++.++|+|||++..+......
T Consensus 83 ~~~~~~l~~~i~--~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i---~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06641 83 YLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred eCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEE---CCCCCEEEeecccceecccchhh
Confidence 99 889999987 3568999999999999999999999999999999999999 57788999999999866442211
Q ss_pred cccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhc
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (407)
.....++..|+|||.+.+..++.++|+|||||++|+|++|..||..... ......+..... ..+..
T Consensus 158 -------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~----~~~~~ 223 (277)
T cd06641 158 -------RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP---MKVLFLIPKNNP----PTLEG 223 (277)
T ss_pred -------hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch---HHHHHHHhcCCC----CCCCc
Confidence 1234678899999999988899999999999999999999999976433 222222222211 12334
Q ss_pred CCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 243 ~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.++.++.+++.+||..+|++||++.++++
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 224 NYSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 57899999999999999999999988876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=311.52 Aligned_cols=249 Identities=20% Similarity=0.258 Sum_probs=204.2
Q ss_pred CceeEeccccccCceEEEEEEEcCCC---eEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTN---EEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~---~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
++.++.++||+|.||.|++|.+...+ ..||||.+..... ..+|++|+.+|.+|+| +++..+++...+ ....|
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H-~hliRLyGvVl~-qp~mM 187 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQH-PHLIRLYGVVLD-QPAMM 187 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccC-cceeEEeeeecc-chhhH
Confidence 45677899999999999999986432 4799999876543 3579999999999998 555566555544 66789
Q ss_pred EEecc-CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 81 VMDLL-GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 81 vme~~-g~sL~~~l~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
|||++ .|||.+.|.. .+..|.......|+.||+.||.||.++++|||||-..|+|+ -....|||+|||+.+.+..
T Consensus 188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlll---asprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLL---ASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhhee---cccceeeeecccceeccCC
Confidence 99999 9999999986 44568889999999999999999999999999999999999 4688999999999998876
Q ss_pred CCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccH
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (407)
....- .......-...|.|||.+....++.++|||+|||+||||++ |..||.+... .+.++++..+...+
T Consensus 265 ned~Y----vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g---~qIL~~iD~~erLp-- 335 (1039)
T KOG0199|consen 265 NEDMY----VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG---IQILKNIDAGERLP-- 335 (1039)
T ss_pred CCcce----EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH---HHHHHhccccccCC--
Confidence 65432 11223334567999999999999999999999999999999 9999999766 45555554333221
Q ss_pred HHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 238 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
..+.||+++++++..||..+|++||+|..|++
T Consensus 336 --RPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 336 --RPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred --CCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 23568999999999999999999999999973
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=295.11 Aligned_cols=247 Identities=23% Similarity=0.295 Sum_probs=199.3
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCC----CCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
+|.+.+.||+|+||.||+|.+..++..||+|.+... .....+.+|+.+++.++| +++..+...+......++++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h-~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKH-PNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCC-CChhhhhheeccCCeEEEEEe
Confidence 589999999999999999999999999999987653 233457789999999987 556666666677888999999
Q ss_pred cc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCC
Q 015406 84 LL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 84 ~~-g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~ 161 (407)
|+ +++|.+++.... ..+++..++.++.|++.||.|||+++++|+||||+||+++ ++...++|+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~--~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLS--KNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEc--CCCCeEEecccccchhccCCcc
Confidence 99 899999987533 3589999999999999999999999999999999999994 2335679999999986644321
Q ss_pred CcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHh
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (407)
. .....|+..|+|||++.+..++.++|+||||+++|||++|..||..... .+....+...... ...
T Consensus 158 ~-------~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~----~~~ 223 (257)
T cd08225 158 L-------AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL---HQLVLKICQGYFA----PIS 223 (257)
T ss_pred c-------ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHHHHhcccCC----CCC
Confidence 1 1234688999999999988899999999999999999999999975432 2333333322221 223
Q ss_pred cCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 242 ~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
..++.++.+++.+||..+|++||++.++.+
T Consensus 224 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 224 PNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 457889999999999999999999888764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=293.95 Aligned_cols=249 Identities=24% Similarity=0.342 Sum_probs=195.7
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-------CcchHHHHHHHHHHHcCCCCCCeeEEeeee--Cce
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-------KHPQLLYESKLYRILQGGTGIPNVRWFGVE--GDY 77 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~--~~~ 77 (407)
.+|++.+.||+|+||.||+|++..+++.||+|.+.... ....+.+|+++++.++|.+ +..+..+... ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~-i~~~~~~~~~~~~~~ 80 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDR-IVQYYGCLRDPEEKK 80 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCC-cceEEEEEEcCCCCE
Confidence 57999999999999999999999999999999865321 1124778999999998755 4454444433 456
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeee
Q 015406 78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~ 156 (407)
.+++|||+ +++|.+++.. ...+++..++.++.||+.||.|||++|++|+||||+||++ +.++.++|+|||+++..
T Consensus 81 ~~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKA-YGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEEeCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECcccccccc
Confidence 88999999 8899999875 3468999999999999999999999999999999999999 57788999999999865
Q ss_pred ccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhccccc
Q 015406 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (407)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (407)
....... .......|+..|+|||.+.+..++.++|||||||++|+|++|..||..... .....++.. ...
T Consensus 157 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~---~~~ 226 (264)
T cd06653 157 QTICMSG----TGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA---MAAIFKIAT---QPT 226 (264)
T ss_pred ccccccC----ccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH---HHHHHHHHc---CCC
Confidence 4321100 112245689999999999998899999999999999999999999976432 222222221 122
Q ss_pred HHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 237 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
...++..+++++.+++.+||. ++..||++.++.+
T Consensus 227 ~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 227 KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 233456688999999999999 5799999886653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=302.11 Aligned_cols=246 Identities=23% Similarity=0.326 Sum_probs=198.5
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
...|...+.||+|+||.||+|++..++..||+|.+..... ...+..|+++++.++| +++..+..++......++
T Consensus 24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~l 102 (317)
T cd06635 24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH-PNSIEYKGCYLREHTAWL 102 (317)
T ss_pred hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCC-CCEEEEEEEEeeCCeEEE
Confidence 3558899999999999999999989999999998764322 1247789999999976 566667777777888899
Q ss_pred EEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 81 VMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 81 vme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
||||+.++|.+++......+++..+..++.||+.||.|||++||+||||+|+||++ +.++.++|+|||++.....
T Consensus 103 v~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~---~~~~~~kl~dfg~~~~~~~-- 177 (317)
T cd06635 103 VMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASIASP-- 177 (317)
T ss_pred EEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEE---CCCCCEEEecCCCccccCC--
Confidence 99999778988887666779999999999999999999999999999999999999 5788999999999875432
Q ss_pred CCcccCccCCCCcccccccccccccc---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccH
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (407)
.....|+..|+|||.+. +..++.++|||||||++|||++|..||..... ......+........
T Consensus 178 ---------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~~~~~~~~~~~- 244 (317)
T cd06635 178 ---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQNESPTL- 244 (317)
T ss_pred ---------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH---HHHHHHHHhccCCCC-
Confidence 12446888999999974 45688999999999999999999999976432 222333322221111
Q ss_pred HHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015406 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRI 272 (407)
Q Consensus 238 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~ 272 (407)
....+++.+.+++.+||+.+|.+||++.++.+.
T Consensus 245 --~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 277 (317)
T cd06635 245 --QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKH 277 (317)
T ss_pred --CCccccHHHHHHHHHHccCCcccCcCHHHHHhC
Confidence 123467889999999999999999998887654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=304.80 Aligned_cols=249 Identities=21% Similarity=0.302 Sum_probs=195.1
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC----cchHHHHHHHHHHHcCCCCCCeeEEeeeeC-----
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEG----- 75 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~----- 75 (407)
+.++|++.+.||+|+||.||+|.+..+++.||||.+..... ...+..|+.+++.++|++.+..+..+....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 67899999999999999999999999999999998754322 234778999999998755544444333222
Q ss_pred ceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceee
Q 015406 76 DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (407)
Q Consensus 76 ~~~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~ 155 (407)
...++||||++++|.+++. ...+++..++.++.||+.||+|||++||+||||||+||++ +.++.++|+|||++..
T Consensus 93 ~~~~lv~e~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill---~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 93 HDFYLVMPFMGTDLGKLMK--HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQ 167 (343)
T ss_pred ceEEEEEecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccccc
Confidence 2468999999999999887 3579999999999999999999999999999999999999 5778999999999976
Q ss_pred eccCCCCcccCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhc--
Q 015406 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK-- 232 (407)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~-- 232 (407)
..... ....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.... ..+..+....
T Consensus 168 ~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~---~~~~~~~~~~~~ 234 (343)
T cd07880 168 TDSEM----------TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL---DQLMEIMKVTGT 234 (343)
T ss_pred cccCc----------cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCC
Confidence 53321 24467889999999876 45789999999999999999999999764332 1111111100
Q ss_pred ------------------------ccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 233 ------------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 233 ------------------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.......+...+++++.++|.+|+..||++||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 235 PSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred CCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 001122334567889999999999999999999877653
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=297.90 Aligned_cols=249 Identities=22% Similarity=0.256 Sum_probs=200.8
Q ss_pred eeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc----chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEec
Q 015406 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (407)
Q Consensus 9 y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~ 84 (407)
|++.+.||+|++|.||+|.+..+++.+++|.+...... ..+..|+.+++.++| +++..+..+...+...+++|||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNH-PNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcC-CCcchHHHhhccCCCEEEEEec
Confidence 67889999999999999999889999999987654332 357789999999985 6676777667777889999999
Q ss_pred cCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcc
Q 015406 85 LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164 (407)
Q Consensus 85 ~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~ 164 (407)
+.++|.+++......+++..++.++.||+.||.|||+++|+|+||||+||++ +.++.++|+|||.+........
T Consensus 80 ~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~df~~~~~~~~~~~--- 153 (283)
T cd05118 80 MDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI---NTEGVLKLADFGLARSFGSPVR--- 153 (283)
T ss_pred cCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEE---CCCCcEEEeeeeeeEecCCCcc---
Confidence 9889999988655689999999999999999999999999999999999999 5778999999999987655431
Q ss_pred cCccCCCCccccccccccccccCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhh------------
Q 015406 165 IPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK------------ 231 (407)
Q Consensus 165 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~------------ 231 (407)
......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+.. +.+.++...
T Consensus 154 ----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 226 (283)
T cd05118 154 ----PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI---DQLFKIFRTLGTPDPEVWPKF 226 (283)
T ss_pred ----cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCchHhcccc
Confidence 11234578899999999876 7899999999999999999999999764432 222111111
Q ss_pred -------------cccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 232 -------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 232 -------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
........+.+.++.++.++|.+||..||.+||++.++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 227 TSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0011122334567899999999999999999999888764
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=317.72 Aligned_cols=243 Identities=19% Similarity=0.319 Sum_probs=203.1
Q ss_pred eeEeccccccCceEEEEEEEcCCCeEEE---EEE---ecCCCCcchHHHHHHHHHHHcCCCCCCeeEEee-eeCceeEEE
Q 015406 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVA---IKL---ENVKTKHPQLLYESKLYRILQGGTGIPNVRWFG-VEGDYNVLV 81 (407)
Q Consensus 9 y~i~~~iG~G~~g~Vy~~~~~~~~~~vA---vK~---~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~-~~~~~~~lv 81 (407)
.+....||+|+|-+||+|.|..+|.+|| ||+ .+.....+.|..|+.+|+.|+|.+++..+..+. .......+|
T Consensus 42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 4567789999999999999999999988 442 222223356889999999999966666554333 345567899
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC--CceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK--SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 82 me~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~--~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
.|++ .|+|..|+++. ++++...+..|++||+.||.|||++ .|||||||.+||+|+ ...|.|||+|+|||+....
T Consensus 122 TEL~TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin--G~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN--GNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred eecccCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc--CCcCceeecchhHHHHhhc
Confidence 9999 99999999975 4799999999999999999999987 599999999999996 6779999999999998776
Q ss_pred CCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHH
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (407)
... ....|||.|||||++. ..|+..+||||||++|+||+|+.+||..... ..+.|.++..+..+..+.
T Consensus 199 s~a---------ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n--~AQIYKKV~SGiKP~sl~ 266 (632)
T KOG0584|consen 199 SHA---------KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN--PAQIYKKVTSGIKPAALS 266 (632)
T ss_pred ccc---------ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC--HHHHHHHHHcCCCHHHhh
Confidence 543 4578999999999998 5899999999999999999999999988754 578888888877654443
Q ss_pred HHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015406 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 239 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
+--.+++++||.+|+.. ..+||++.+|+
T Consensus 267 ---kV~dPevr~fIekCl~~-~~~R~sa~eLL 294 (632)
T KOG0584|consen 267 ---KVKDPEVREFIEKCLAT-KSERLSAKELL 294 (632)
T ss_pred ---ccCCHHHHHHHHHHhcC-chhccCHHHHh
Confidence 33478999999999999 99999976664
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=296.45 Aligned_cols=252 Identities=17% Similarity=0.321 Sum_probs=194.4
Q ss_pred eeEeccccccCceEEEEEEEc---CCCeEEEEEEecCCCCc----chHHHHHHHHHHHcCCCCCCeeEEeeeeC------
Q 015406 9 FRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEG------ 75 (407)
Q Consensus 9 y~i~~~iG~G~~g~Vy~~~~~---~~~~~vAvK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~------ 75 (407)
|++.+.||+|+||.||+|.+. .+++.||||++..+... ..+.+|+++++.++| +++..+..++...
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH-PNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCC-CCcceEEEEEccCCCCCcc
Confidence 678899999999999999864 35789999988654322 247789999999987 5555555544321
Q ss_pred ceeEEEEecc-CCCHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEe
Q 015406 76 DYNVLVMDLL-GPSLEDLFNFCS-----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID 149 (407)
Q Consensus 76 ~~~~lvme~~-g~sL~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~D 149 (407)
...+++++|+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||++ +.++.+||+|
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili---~~~~~~kl~d 156 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCML---NENMTVCVAD 156 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEE---cCCCCEEECc
Confidence 2347889999 899998875321 247899999999999999999999999999999999999 5788999999
Q ss_pred ccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHH
Q 015406 150 FGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKI 228 (407)
Q Consensus 150 FGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i 228 (407)
||+++....... +.......++..|++||.+.+..++.++|||||||++|||++ |..||..... ...+..+
T Consensus 157 fg~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~~ 228 (273)
T cd05074 157 FGLSKKIYSGDY-----YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNYL 228 (273)
T ss_pred ccccccccCCcc-----eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHHH
Confidence 999986543221 111223455678999999998889999999999999999999 8999976433 2223333
Q ss_pred hhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 015406 229 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (407)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l 276 (407)
...... .....++..+.+++.+||+.+|++||++.++.+.|+.+
T Consensus 229 ~~~~~~----~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 229 IKGNRL----KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HcCCcC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 222111 11235788999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=295.83 Aligned_cols=253 Identities=20% Similarity=0.282 Sum_probs=195.7
Q ss_pred eeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeC--ceeEEEE
Q 015406 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEG--DYNVLVM 82 (407)
Q Consensus 9 y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~--~~~~lvm 82 (407)
|++.++||+|+||.||+|.+..+++.+|+|.+.... ....+..|+++++.+.| +++..+..+.... ...++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRH-PNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccC-CCeeeheeeEecCCCCcEEEEe
Confidence 788999999999999999999899999999887653 22347789999999986 4555555555554 7899999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 83 e~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
||++++|.+++......+++..++.++.||+.||+|||++|++|+||||+||++ ++++.++|+|||++.........
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~---~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 80 EYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILI---NNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred ccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---cCCCCEEEccccceeeccCCCcc
Confidence 999889999987654579999999999999999999999999999999999999 57899999999999876554320
Q ss_pred cccCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhc---------
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK--------- 232 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~--------- 232 (407)
......++..|+|||.+.+ ..++.++||||||+++|||++|..||...................
T Consensus 157 ------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07840 157 ------DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVS 230 (287)
T ss_pred ------cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccc
Confidence 1123456788999998775 457899999999999999999999997654322111111110000
Q ss_pred -------------ccccHHHHhcC-CcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 233 -------------VSTSIEALCRG-YPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 233 -------------~~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
........... +++++.+++.+||..+|++||++.++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00011112223 3889999999999999999999887764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=300.99 Aligned_cols=248 Identities=23% Similarity=0.322 Sum_probs=199.2
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC--CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
.++|++.+.||+|+||.||++.+..++..||+|.+.... ....+..|+.+++.++| +++..+..++...+..|+|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h-p~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKH-PNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCC-CCeeehhheeeeCCcEEEEEe
Confidence 578999999999999999999998899999999875432 22457789999999876 666677777777888999999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 84 ~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
|+ +++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||++ +.++.++|+|||++.........
T Consensus 97 ~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili---~~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 97 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred cCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEE---cCCCCEEEccCcceecccccccc
Confidence 99 9999999874 468999999999999999999999999999999999999 57789999999998765443221
Q ss_pred cccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhc
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (407)
.....|++.|+|||.+.+..++.++||||||+++|++++|..||...... .....+...... ......
T Consensus 172 -------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~---~~~~~~~~~~~~--~~~~~~ 239 (293)
T cd06647 172 -------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL---RALYLIATNGTP--ELQNPE 239 (293)
T ss_pred -------cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh---hheeehhcCCCC--CCCCcc
Confidence 23456889999999999888999999999999999999999999764331 111111111111 111123
Q ss_pred CCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 243 ~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.++..+.+++.+||..+|++||++.++..
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 268 (293)
T cd06647 240 KLSAIFRDFLNRCLEMDVEKRGSAKELLQ 268 (293)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 46788999999999999999999887753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=291.64 Aligned_cols=252 Identities=25% Similarity=0.411 Sum_probs=200.3
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
+|++.+.||+|+||.||+|.+..+++.||+|.+..... ...+..|+.+++.++| +++..+..+....+..++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKH-PNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCC-CChhheeeeEecCCEEEEEEe
Confidence 68999999999999999999988999999998875543 2357889999999987 566666667778888999999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 84 ~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
|+ +++|.+++.. ...+++..+..++.|++.||.|||++||+|+||||+||++ +..+.+||+|||++.........
T Consensus 80 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~---~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 80 YCSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFL---DHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred cCCCCcHHHHHhh-cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEcccccccccCCCCCc
Confidence 99 8999999985 3458999999999999999999999999999999999999 57889999999999876543321
Q ss_pred cccCccCCCCccccccccccccccCCC---CChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHH
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGIE---QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (407)
.. .......++..|+|||++.+.. ++.++||||||+++|+|++|..||...... ......+...... ..+
T Consensus 156 ~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~-~~~- 228 (264)
T cd06626 156 MG---EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE--FQIMFHVGAGHKP-PIP- 228 (264)
T ss_pred cc---ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch--HHHHHHHhcCCCC-CCC-
Confidence 10 0012356789999999998766 789999999999999999999999764321 1222222221111 111
Q ss_pred HhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 240 ~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
....+++.+.+++.+||+.+|++||++.++..
T Consensus 229 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 229 DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11235889999999999999999999888753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=305.03 Aligned_cols=253 Identities=21% Similarity=0.293 Sum_probs=193.2
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC----cchHHHHHHHHHHHcCCCCCCeeEEeee-----e
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGV-----E 74 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~-----~ 74 (407)
.+.++|.+.+.||+|+||.||+|.+..+++.||+|.+..... ...+.+|+.+++.++|.+.+..+..+.. .
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence 356899999999999999999999999999999998764321 2346789999999987554444433322 2
Q ss_pred CceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEecccee
Q 015406 75 GDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (407)
Q Consensus 75 ~~~~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~ 154 (407)
....|+++++++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||+++
T Consensus 94 ~~~~~lv~~~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~dfg~~~ 168 (345)
T cd07877 94 FNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLAR 168 (345)
T ss_pred cccEEEEehhcccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEE---cCCCCEEEecccccc
Confidence 244789999999999998873 469999999999999999999999999999999999999 578899999999987
Q ss_pred eeccCCCCcccCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhh---
Q 015406 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE--- 230 (407)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~--- 230 (407)
..... .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||...........+.....
T Consensus 169 ~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (345)
T cd07877 169 HTDDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 238 (345)
T ss_pred ccccc----------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 64332 124567899999999876 4678999999999999999999999976433211111111000
Q ss_pred --------------------hcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 231 --------------------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 231 --------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
..............++++.++|.+||..||++||++.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 239 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred HHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 00000111112246788999999999999999999776653
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=289.83 Aligned_cols=247 Identities=25% Similarity=0.417 Sum_probs=202.1
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC--CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~ 85 (407)
.|++.+.||+|++|.||++.+..+++.+++|++.... ....+.+|+++++.+.| +++..+..++......+++|||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKH-PNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCC-CCEeEEEEEEecCCeEEEEEecC
Confidence 4889999999999999999998899999999887654 44568899999999985 66767777777778899999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcc
Q 015406 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164 (407)
Q Consensus 86 -g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~ 164 (407)
+++|.+++......+++..+..++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||.+........
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~--- 153 (253)
T cd05122 80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILL---TSDGEVKLIDFGLSAQLSDTKA--- 153 (253)
T ss_pred CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEE---ccCCeEEEeecccccccccccc---
Confidence 799999998654679999999999999999999999999999999999999 5788999999999987654321
Q ss_pred cCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCC
Q 015406 165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 244 (407)
Q Consensus 165 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (407)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||..... ................ ....+
T Consensus 154 -----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~--~~~~~ 223 (253)
T cd05122 154 -----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP---MKALFKIATNGPPGLR--NPEKW 223 (253)
T ss_pred -----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch---HHHHHHHHhcCCCCcC--ccccc
Confidence 1345688999999999988899999999999999999999999976432 2222222221111111 11124
Q ss_pred cHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 245 PTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 245 ~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
+.++.+++.+||..||++||++.++.+
T Consensus 224 ~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 224 SDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 789999999999999999999888764
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=303.47 Aligned_cols=252 Identities=20% Similarity=0.250 Sum_probs=199.3
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeC-----cee
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEG-----DYN 78 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~-----~~~ 78 (407)
+|++.+.||+|+||.||+|++..+++.||||.+.... ....+.+|+.+++.++| +++..+..+.... ...
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRH-ENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCC-cchhhhhhhhcccCcccccce
Confidence 6899999999999999999998889999999876532 33468889999999986 5555555544443 377
Q ss_pred EEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 79 VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 79 ~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
|++|||++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.++|+|||++.....
T Consensus 80 ~lv~e~~~~~l~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili---~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 80 YIVTELMETDLHKVIKS-PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV---NSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEEecchhhhHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccCceEeecc
Confidence 99999998899999875 3479999999999999999999999999999999999999 5779999999999997655
Q ss_pred CCCCcccCccCCCCccccccccccccccCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhc-----
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK----- 232 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~----- 232 (407)
..... .......++..|+|||++.+. .++.++||||||+++|+|++|..||.+.... +.+..+....
T Consensus 156 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~~~ 228 (330)
T cd07834 156 DEDEK----GFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI---DQLNLIVEVLGTPSE 228 (330)
T ss_pred ccccc----ccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH---HHHHHHHHhcCCCCh
Confidence 43110 112345678999999999987 7899999999999999999999999775432 2222221110
Q ss_pred ---------------------ccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 233 ---------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 233 ---------------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
...........++.++.++|.+||+.+|++||++.++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 288 (330)
T cd07834 229 EDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288 (330)
T ss_pred hHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 011112233457889999999999999999999887764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=342.37 Aligned_cols=252 Identities=22% Similarity=0.338 Sum_probs=208.9
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCC----CCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
+.-+|.-..+||.|.||.||-|.+..+|+..|+|-++.. ...+....|..++..+.| ++++.+++...+.+..+|
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnH-pNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNH-PNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccC-ccccccCceeecHHHHHH
Confidence 456788899999999999999999999999999965432 233457889999999987 778888888889999999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 81 vme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
.|||| ||+|.+++.. ++..++.....+..|++.||.|||++|||||||||+||+| +.+|.+|++|||.|..+...
T Consensus 1312 FMEyC~~GsLa~ll~~-gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~L---d~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILL---DFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHHHhccCcHHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceee---ecCCcEEeecccceeEecCc
Confidence 99999 9999999985 5567888888999999999999999999999999999999 68899999999999988765
Q ss_pred CCCcccCccCCCCccccccccccccccCCC---CChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhccccc
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLGIE---QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (407)
.. .++ .+.....||+.|||||++.+.. ...++||||||||+.||+||+.||...+.. .+.+-++..+..+..
T Consensus 1388 ~~--~~~-~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne--~aIMy~V~~gh~Pq~ 1462 (1509)
T KOG4645|consen 1388 AQ--TMP-GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE--WAIMYHVAAGHKPQI 1462 (1509)
T ss_pred hh--cCC-HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch--hHHHhHHhccCCCCC
Confidence 31 122 3345678999999999998643 578899999999999999999999887653 344444444443332
Q ss_pred HHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015406 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 237 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
+..++.+-.++|.+||..||..|-++.||+
T Consensus 1463 ----P~~ls~~g~dFle~Cl~~dP~~Rw~~~qll 1492 (1509)
T KOG4645|consen 1463 ----PERLSSEGRDFLEHCLEQDPKMRWTASQLL 1492 (1509)
T ss_pred ----chhhhHhHHHHHHHHHhcCchhhhHHHHHH
Confidence 334889999999999999999998766544
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=295.71 Aligned_cols=252 Identities=23% Similarity=0.291 Sum_probs=196.9
Q ss_pred eeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc
Q 015406 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (407)
Q Consensus 9 y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~ 85 (407)
|++.+.||+|+||.||+|++..+++.||||.+..... .....+|+..++.+.+|+++..+..++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 7889999999999999999988999999998765432 1234568888888884577777777777788899999999
Q ss_pred CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcc
Q 015406 86 GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164 (407)
Q Consensus 86 g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~ 164 (407)
+++|.+++.... ..+++..++.++.|++.+|.|||++|++|+||||+||++ +..+.++|+|||++........
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i---~~~~~~~l~d~~~~~~~~~~~~--- 154 (283)
T cd07830 81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLV---SGPEVVKIADFGLAREIRSRPP--- 154 (283)
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCCEEEeecccceeccCCCC---
Confidence 999999887543 468999999999999999999999999999999999999 5789999999999986654322
Q ss_pred cCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhc-----------
Q 015406 165 IPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK----------- 232 (407)
Q Consensus 165 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~----------- 232 (407)
.....++..|+|||++.+ ..++.++||||||+++|||++|..||......+............
T Consensus 155 -----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07830 155 -----YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229 (283)
T ss_pred -----cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhh
Confidence 224568889999998854 457899999999999999999999997654322221111110000
Q ss_pred -----------ccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 233 -----------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 233 -----------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
............+.++.+++.+||..+|++||++.++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 230 ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred hccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 001112222334788999999999999999999887754
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=296.14 Aligned_cols=252 Identities=25% Similarity=0.391 Sum_probs=204.8
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
++|.+.+.||+|+||.||+|.+..+++.||+|++.... ....+..|..+++.+..++++..+..++...+..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999876532 2245778899999998567777777777788889999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 82 me~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
||++ +++|.+++.. ...+++..++.++.|++.||.|||++|++|+||||+||++ +.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i---~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 81 LEYAPNGELLQYIRK-YGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILL---DKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEecCCccccccCCcc
Confidence 9999 9999999986 3479999999999999999999999999999999999999 578899999999998765433
Q ss_pred CCccc-------------CccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHH
Q 015406 161 THQHI-------------PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK 227 (407)
Q Consensus 161 ~~~~~-------------~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~ 227 (407)
..... .........++..|+|||++.+..++.++||||||+++|++++|..||..... .+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~ 233 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE---YLTFQK 233 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH---HHHHHH
Confidence 21100 01223455788999999999988899999999999999999999999976432 333333
Q ss_pred HhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCH----HHHH
Q 015406 228 ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY----AYLK 270 (407)
Q Consensus 228 i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~----~~l~ 270 (407)
+..... .+...+++.+.+++.+||+.+|++||++ .+++
T Consensus 234 ~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll 275 (280)
T cd05581 234 ILKLEY-----SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK 275 (280)
T ss_pred HHhcCC-----CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHh
Confidence 332211 1234578999999999999999999998 5554
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=303.45 Aligned_cols=249 Identities=21% Similarity=0.287 Sum_probs=192.4
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC----cchHHHHHHHHHHHcCCCCCCeeEEeeee-----
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVE----- 74 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~----- 74 (407)
++.++|.+.+.||+|+||.||+|++..+++.||||.+..... ...+.+|+.+++.+.|.+.+..+..+...
T Consensus 12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence 456899999999999999999999989999999998764321 23477899999999875544443333221
Q ss_pred CceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEecccee
Q 015406 75 GDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (407)
Q Consensus 75 ~~~~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~ 154 (407)
....++||||+..+|.+++. ..+++..+..++.|++.||+|||++||+||||||+|||+ +.++.++|+|||+++
T Consensus 92 ~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll---~~~~~~kL~dfg~~~ 165 (342)
T cd07879 92 FQDFYLVMPYMQTDLQKIMG---HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAV---NEDCELKILDFGLAR 165 (342)
T ss_pred CceEEEEecccccCHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCCCCc
Confidence 23469999999878877653 468999999999999999999999999999999999999 578899999999987
Q ss_pred eeccCCCCcccCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhh--
Q 015406 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK-- 231 (407)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~-- 231 (407)
..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||.+.... ..+..+...
T Consensus 166 ~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~---~~~~~~~~~~~ 232 (342)
T cd07879 166 HADAE----------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKVTG 232 (342)
T ss_pred CCCCC----------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcC
Confidence 54321 124567889999999876 46899999999999999999999999864321 112111110
Q ss_pred ------------------------cccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 232 ------------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 232 ------------------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
..........+..+.++.++|.+||+.||++||++++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~ 296 (342)
T cd07879 233 VPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296 (342)
T ss_pred CCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0011112223456788999999999999999999888764
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=293.31 Aligned_cols=248 Identities=19% Similarity=0.278 Sum_probs=184.2
Q ss_pred ccccccCceEEEEEEEcCC--CeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-C
Q 015406 13 RKIGSGSFGEIYLGTNIQT--NEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (407)
Q Consensus 13 ~~iG~G~~g~Vy~~~~~~~--~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~-g 86 (407)
+.||+|+||.||+|+.... ...+++|.+..... ...+.+|+.+++.++| +++..+...+......|+||||+ +
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQH-PNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCC-cchhheEEEecCCCccEEEEecCCC
Confidence 3699999999999975433 34567776654332 2458888889998876 55666666666777889999999 8
Q ss_pred CCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCc
Q 015406 87 PSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (407)
Q Consensus 87 ~sL~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~ 163 (407)
++|.+++.... ..+++..++.++.||+.||+|||+++++||||||+|||+ +.++.++|+|||++........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~---~~~~~~~l~Dfg~~~~~~~~~~-- 154 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFL---TSDLTVKVGDYGIGPSRYKEDY-- 154 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEE---cCCccEEecccccccccCcchh--
Confidence 99999997532 346777889999999999999999999999999999999 5788999999999864322111
Q ss_pred ccCccCCCCccccccccccccccC-------CCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhh-ccc
Q 015406 164 HIPYRENKNLTGTARYASMNTHLG-------IEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEK-KVS 234 (407)
Q Consensus 164 ~~~~~~~~~~~gt~~Y~aPE~~~~-------~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~-~~~ 234 (407)
........++..|+|||++.. ..++.++||||||+++|||++ |..||..... .+.+..+... ...
T Consensus 155 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~~~~~~~~~~~~~~ 228 (268)
T cd05086 155 ---IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD---REVLNHVIKDQQVK 228 (268)
T ss_pred ---hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHhhcccc
Confidence 011234568899999999753 245789999999999999997 6778865433 2333332222 111
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 015406 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIF 273 (407)
Q Consensus 235 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l 273 (407)
...+.+...+++.+.+++..|| .+|++||++++|.+.|
T Consensus 229 ~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 229 LFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred cCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 1222333457889999999999 6799999999998776
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=299.39 Aligned_cols=245 Identities=25% Similarity=0.354 Sum_probs=197.2
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc-----chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
.+.|...++||+|+||.||+|++..+++.||+|.+...... ..+..|+++++.++| ++++.+..++.+....|+
T Consensus 20 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~l 98 (313)
T cd06633 20 EEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKH-PNTIEYKGCYLKEHTAWL 98 (313)
T ss_pred HHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCC-CCCccEEEEEEeCCEEEE
Confidence 34577778899999999999999999999999987643221 346789999999986 667777777788888999
Q ss_pred EEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 81 VMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 81 vme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
+|||+.++|.+++......+++..++.++.||+.||.|||++||+|+||||+||++ +.++.++|+|||++.....
T Consensus 99 v~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili---~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 99 VMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEE---CCCCCEEEeecCCCcccCC--
Confidence 99999889999887666679999999999999999999999999999999999999 5778999999999864321
Q ss_pred CCcccCccCCCCcccccccccccccc---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccH
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (407)
.....|+..|+|||++. +..++.++|||||||++|+|++|..||..... ......+.......
T Consensus 174 ---------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~---~~~~~~~~~~~~~~-- 239 (313)
T cd06633 174 ---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQNDSPT-- 239 (313)
T ss_pred ---------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcCCCC--
Confidence 23457889999999984 35688999999999999999999999976433 22222222221111
Q ss_pred HHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 238 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.....++..+.+++.+||+.+|.+||++.++..
T Consensus 240 -~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 240 -LQSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred -CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 112346788999999999999999999887763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=296.46 Aligned_cols=251 Identities=22% Similarity=0.340 Sum_probs=204.2
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
..+.|++.+.||+|+||.||+|.+..++..|++|++..... ...+..|+++++.++| +++..+...+......++++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKH-PNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCC-CCeeEEEEEEEECCEEEEEEe
Confidence 45679999999999999999999988899999998875543 4567889999999986 677777777777889999999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 84 ~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
|+ +++|.+++......+++..++.++.|++.||.|||+.||+|+||||+||++ +.++.++|+|||++........
T Consensus 96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~- 171 (286)
T cd06614 96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILL---SKDGSVKLADFGFAAQLTKEKS- 171 (286)
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEE---cCCCCEEECccchhhhhccchh-
Confidence 99 799999998654479999999999999999999999999999999999999 5788999999999875543221
Q ss_pred cccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhc
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (407)
......++..|+|||.+.+..++.++||||||+++|+|++|..||..... ......+......... ...
T Consensus 172 ------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~--~~~ 240 (286)
T cd06614 172 ------KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP---LRALFLITTKGIPPLK--NPE 240 (286)
T ss_pred ------hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCCCCCc--chh
Confidence 11234578899999999988899999999999999999999999976433 2222222222211111 123
Q ss_pred CCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 243 ~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.++.++.++|.+||+.+|.+||++.++.+
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 241 KWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred hCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 37899999999999999999999887753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=305.93 Aligned_cols=250 Identities=21% Similarity=0.308 Sum_probs=195.3
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC----CcchHHHHHHHHHHHcCCCCCCeeEEeeee-----
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVE----- 74 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~----- 74 (407)
.+.++|++.+.||+|+||.||+|++..+++.||||.+.... ....+.+|+.+++.+.|++.+..+..+...
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 36789999999999999999999999999999999876432 123467899999999875554443333222
Q ss_pred CceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEecccee
Q 015406 75 GDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (407)
Q Consensus 75 ~~~~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~ 154 (407)
....++|+||++++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||++ +.++.++|+|||++.
T Consensus 92 ~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill---~~~~~~kL~dfg~~~ 166 (343)
T cd07851 92 FQDVYLVTHLMGADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV---NEDCELKILDFGLAR 166 (343)
T ss_pred cccEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEccccccc
Confidence 224799999999999999974 579999999999999999999999999999999999999 578899999999998
Q ss_pred eeccCCCCcccCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcc
Q 015406 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (407)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (407)
..... .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+... ...+..+.....
T Consensus 167 ~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~---~~~~~~i~~~~~ 233 (343)
T cd07851 167 HTDDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH---IDQLKRIMNLVG 233 (343)
T ss_pred ccccc----------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcC
Confidence 65432 124467889999999865 3678999999999999999999999976433 222222211100
Q ss_pred --------------------------cccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 234 --------------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 234 --------------------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
..........+++++.++|.+||+.+|++|||+.+|++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 234 TPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred CCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 01112223456889999999999999999999887753
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=295.69 Aligned_cols=246 Identities=21% Similarity=0.313 Sum_probs=198.4
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC--CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~ 85 (407)
.|...+.||+|++|.||++.+..+++.+++|.+.... ....+.+|+.+++.+.| +++..+..++...+..++++||+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h-~~vv~~~~~~~~~~~~~~v~e~~ 98 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQH-PNIVEMYSSYLVGDELWVVMEFL 98 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCC-CChheEEEEEEcCCeEEEEEecc
Confidence 5666789999999999999998899999999875433 22347789999998876 56666766777788899999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcc
Q 015406 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164 (407)
Q Consensus 86 -g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~ 164 (407)
+++|.+++.. .++++..+..++.|++.||+|||++||+||||||+||++ +.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~d~g~~~~~~~~~~--- 170 (285)
T cd06648 99 EGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILL---TSDGRVKLSDFGFCAQVSKEVP--- 170 (285)
T ss_pred CCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEE---cCCCcEEEcccccchhhccCCc---
Confidence 9999999985 578999999999999999999999999999999999999 5788999999998875543221
Q ss_pred cCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCC
Q 015406 165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 244 (407)
Q Consensus 165 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (407)
......|+..|+|||.+.+..++.++||||||+++|+|++|..||..... ...+..+....... . .....+
T Consensus 171 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~---~~~~~~~~~~~~~~-~-~~~~~~ 241 (285)
T cd06648 171 ----RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP---LQAMKRIRDNLPPK-L-KNLHKV 241 (285)
T ss_pred ----ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH---HHHHHHHHhcCCCC-C-cccccC
Confidence 11235689999999999988899999999999999999999999976332 33333333322111 1 111337
Q ss_pred cHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 245 PTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 245 ~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
+.++.+++.+||..+|++||++.++.+
T Consensus 242 ~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 242 SPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 889999999999999999999877764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=307.48 Aligned_cols=261 Identities=17% Similarity=0.269 Sum_probs=218.0
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
.+...+.++||+|-||+|.+++- ..+..||||.++.... ..+|.+|+++|.+|+| ++|..+.+.+..++.++++|
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkh-PNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRLKH-PNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred hhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhccCC-CCeeEEEeeeecCCchHHHH
Confidence 45678899999999999999994 4468999999876532 3569999999999965 78888888888888999999
Q ss_pred ecc-CCCHHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 83 DLL-GPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 83 e~~-g~sL~~~l~~~~~~-l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
||+ .|+|.+++..+.-. +.......|+.||+.||+||.+.++|||||.+.|+|+ +.+.++||+|||+++.+-...
T Consensus 615 EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv---~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLV---DGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceee---cCcccEEecCcccccccccCC
Confidence 999 99999999875433 3556677899999999999999999999999999999 699999999999999766655
Q ss_pred CCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh--CCCCCCCCCcCchHHHHHHHhhhcccccHH
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR--GSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt--G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (407)
. |+.....+-..+|||+|.+...+++.++|+|+||++|||+++ ...||....++...+...............
T Consensus 692 y-----y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l 766 (807)
T KOG1094|consen 692 Y-----YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVL 766 (807)
T ss_pred c-----eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceec
Confidence 4 333456677899999999999999999999999999999875 899998877755555544444444444444
Q ss_pred HHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 015406 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (407)
Q Consensus 239 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l 276 (407)
..+.-+|.++.++|.+||..+-.+||+|++|...|.+.
T Consensus 767 ~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 767 SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 45567899999999999999999999999999888764
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=292.68 Aligned_cols=258 Identities=24% Similarity=0.334 Sum_probs=201.2
Q ss_pred ccccCceEEEEEEEcCCCeEEEEEEecCCCC-----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-CCC
Q 015406 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPS 88 (407)
Q Consensus 15 iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~-g~s 88 (407)
||.|+||.||++++..+++.||+|++..... ...+..|+++++.+.| +++..+......+...|++|||+ +++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQS-PYVVKLYYSFQGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCC-cchhHHHHheecCcEEEEEEecCCCCc
Confidence 6899999999999988999999998765432 2357788899999986 56666666677788899999999 889
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCc-ccCc
Q 015406 89 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ-HIPY 167 (407)
Q Consensus 89 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~-~~~~ 167 (407)
|.+++.... .+++..++.++.||+.||.|||++|++|+||+|+||++ +.++.++|+|||++.......... ....
T Consensus 80 L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 80 LASLLENVG-SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILI---DSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEE---cCCCCEEEEecccchhcccCccccccccc
Confidence 999998644 79999999999999999999999999999999999999 578899999999987543321100 0000
Q ss_pred cCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcHH
Q 015406 168 RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTE 247 (407)
Q Consensus 168 ~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 247 (407)
.......++..|+|||.+.+..++.++||||||+++|+|++|..||..... .+.+..+......... ...++..
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~---~~~~~~~ 229 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP---EEIFQNILNGKIEWPE---DVEVSDE 229 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhcCCcCCCc---cccCCHH
Confidence 112345678899999999988899999999999999999999999976432 3344444332222111 1124899
Q ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccc
Q 015406 248 FASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDW 290 (407)
Q Consensus 248 l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~dw 290 (407)
+.+++.+||+.+|++||++..+.++|++ +|...++|
T Consensus 230 ~~~~i~~~l~~~p~~Rpt~~~~~~~l~~-------~~~~~~~~ 265 (265)
T cd05579 230 AIDLISKLLVPDPEKRLGAKSIEEIKNH-------PFFKGIDW 265 (265)
T ss_pred HHHHHHHHhcCCHhhcCCCccHHHHhcC-------ccccCCCC
Confidence 9999999999999999999777777664 44445555
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=288.78 Aligned_cols=246 Identities=23% Similarity=0.304 Sum_probs=202.9
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
+|++.+.||.|+||.||++.+..+++.||+|.+..... ...+..|+++++.++| +++..+..........+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNH-PNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCC-CChhheEEEEecCCEEEEEEE
Confidence 58999999999999999999988999999998875432 3457889999999986 556566656666688999999
Q ss_pred cc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 84 LL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 84 ~~-g~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
++ +++|.+++... ...+++..+..++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||++......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFL---TSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEE---cCCCcEEECCccceeecccC
Confidence 99 88999999864 2679999999999999999999999999999999999999 57789999999999876543
Q ss_pred CCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHH
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (407)
.. ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.... ..+.......... ..
T Consensus 157 ~~-------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~---~~~~~~~~~~~~~----~~ 222 (258)
T cd08215 157 VD-------LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN---LLELALKILKGQY----PP 222 (258)
T ss_pred cc-------eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc---HHHHHHHHhcCCC----CC
Confidence 21 1234578999999999999889999999999999999999999996643 2333333333222 22
Q ss_pred HhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 240 ~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
+...++.++.+++.+||..+|++||++.++.+
T Consensus 223 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 223 IPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 33468899999999999999999999888764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=298.45 Aligned_cols=246 Identities=22% Similarity=0.307 Sum_probs=196.4
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
...|+..+.||+|+||.||+|++..+++.||+|.+..... ...+..|+++++.++| +++..+..+.......++
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH-PNTIQYRGCYLREHTAWL 92 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCC-CCcccEEEEEEcCCeeEE
Confidence 4568889999999999999999999999999998754211 2346789999999976 555556666667788899
Q ss_pred EEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 81 VMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 81 vme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
||||+.++|.+++......+++..+..++.|++.||.|||+++++||||||+||++ +.++.++|+|||++......
T Consensus 93 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 93 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred EEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEE---CCCCcEEECCcccceeecCc-
Confidence 99999888988887656679999999999999999999999999999999999999 57789999999998765432
Q ss_pred CCcccCccCCCCcccccccccccccc---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccH
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (407)
....|+..|+|||.+. ...++.++|||||||++|+|++|..||...... .....+........
T Consensus 169 ----------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~~~~~~- 234 (308)
T cd06634 169 ----------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALYHIAQNESPAL- 234 (308)
T ss_pred ----------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH---HHHHHHhhcCCCCc-
Confidence 2446889999999985 345788999999999999999999999764332 22222222211111
Q ss_pred HHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015406 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRI 272 (407)
Q Consensus 238 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~ 272 (407)
....++..+.++|.+||..+|++||++.++.+.
T Consensus 235 --~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 235 --QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred --CcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 123578899999999999999999998877643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=286.45 Aligned_cols=249 Identities=24% Similarity=0.352 Sum_probs=202.9
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC----cchHHHHHHHHHHHcCCCCCCeeEEeeeeC--ceeEEE
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEG--DYNVLV 81 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~--~~~~lv 81 (407)
+|++.+.||+|++|.||+|.+..+++.|++|++..... ...+.+|+.+++++.| +++..+....... ...+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQH-PNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCC-CCEeeEEEEEecCCCCeEEEE
Confidence 58899999999999999999988999999998876543 4458889999999996 5555555555555 788999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 82 me~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
|||+ +++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 80 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 80 LEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILV---DSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---cCCCCEEEcccccEEeccccc
Confidence 9999 999999998644 89999999999999999999999999999999999999 568899999999998776543
Q ss_pred CCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHH
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (407)
.. .......++..|+|||.+.+...+.++||||||+++|+|++|..||.... ........+... .....+
T Consensus 156 ~~-----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~---~~~~~~ 225 (260)
T cd06606 156 TG-----EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG--NPMAALYKIGSS---GEPPEI 225 (260)
T ss_pred cc-----ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--chHHHHHhcccc---CCCcCC
Confidence 21 01234568899999999998889999999999999999999999998754 122222222211 111223
Q ss_pred hcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 241 ~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
...++.++.+++.+||..+|++||++.++.+
T Consensus 226 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 226 PEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 3456899999999999999999999887764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=319.65 Aligned_cols=259 Identities=15% Similarity=0.241 Sum_probs=217.7
Q ss_pred CceeEeccccccCceEEEEEEEcCCC---eEEEEEEecCCC---CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTN---EEVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~---~~vAvK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
....|.++||.|.||+|++|+.+..+ ..||||.++... ...+|+.|+.||-+++| +||..+.+.........|
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdH-PNIIrLEGVVTks~PvMI 707 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDH-PNIIRLEGVVTKSKPVMI 707 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCC-CcEEEEEEEEecCceeEE
Confidence 44678899999999999999987666 479999987643 33469999999999997 777788888888899999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 81 vme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
+.||| +|+|+.+|+...+.|+..+...+++.|+.|+.||-+.|+|||||...|||+ +.+-.+|++|||+++.+.++
T Consensus 708 iTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILV---NsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 708 ITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred EhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheee---ccceEEEeccccceeecccC
Confidence 99999 999999999888899999999999999999999999999999999999999 68899999999999987665
Q ss_pred CCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHH
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (407)
... +.....-.-..+|.|||.+.-..++.+|||||||++|||.++ |..||-++...+. +..|.+.-..++
T Consensus 785 ~~~----~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV---IkaIe~gyRLPp-- 855 (996)
T KOG0196|consen 785 PEA----AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV---IKAIEQGYRLPP-- 855 (996)
T ss_pred CCc----cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH---HHHHHhccCCCC--
Confidence 421 111222223578999999999999999999999999999987 9999988776443 333333222111
Q ss_pred HHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHc
Q 015406 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (407)
Q Consensus 239 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~ 280 (407)
+-+||..+..||..||++|-.+||.|.+|+..|.+++.+.
T Consensus 856 --PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 856 --PMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred --CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 2459999999999999999999999999999999987643
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=299.16 Aligned_cols=252 Identities=14% Similarity=0.199 Sum_probs=187.8
Q ss_pred ecccccc--CceEEEEEEEcCCCeEEEEEEecCCCCc----chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc
Q 015406 12 GRKIGSG--SFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (407)
Q Consensus 12 ~~~iG~G--~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~ 85 (407)
...||.| +||+||++++..+++.||+|+....... +.+.+|+.+++.++| +++..+..++..++..+++|||+
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h-~niv~~~~~~~~~~~~~~v~e~~ 81 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRH-PNIMTSWTVFTTGSWLWVISPFM 81 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CCcceEeeeEecCCceEEEEecc
Confidence 3567777 9999999999999999999998754322 346778888887776 67777777888888899999999
Q ss_pred -CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCc
Q 015406 86 -GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (407)
Q Consensus 86 -g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~ 163 (407)
+++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.++++||+.+..........
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill---~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILI---SGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---eCCCcEEEechHHHhhhhccCccc
Confidence 88999998753 2358999999999999999999999999999999999999 577899999998654332221111
Q ss_pred ccCccCCCCccccccccccccccCC--CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhccc-------
Q 015406 164 HIPYRENKNLTGTARYASMNTHLGI--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS------- 234 (407)
Q Consensus 164 ~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~------- 234 (407)
...+.......++..|+|||++.+. .++.++|||||||++|||++|..||...... +.+.........
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~ 235 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT---QMLLQKLKGPPYSPLDITT 235 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH---HHHHHHhcCCCCCCccccc
Confidence 1111111223456789999999764 4789999999999999999999999764321 111111100000
Q ss_pred -----------------------------------ccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015406 235 -----------------------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 235 -----------------------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
.........+++.+.+|+.+||..||++|||+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l 306 (328)
T cd08226 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLL 306 (328)
T ss_pred cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHh
Confidence 000011223567899999999999999999988875
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=286.22 Aligned_cols=245 Identities=24% Similarity=0.363 Sum_probs=202.1
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
+|++.+.||+|++|.||++++..+++.|++|.+..... ...+.+|++++..+.| +++..+..+.......+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKH-PNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCC-CCccEEEEEEEeCCEEEEEEe
Confidence 58999999999999999999988999999998766542 2357889999999986 556666666777788999999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 84 ~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
|+ +++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||++ +.++.++|+|||++.........
T Consensus 80 ~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 80 YAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILT---TKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred cCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE---CCCCCEEEeccccceecCCCccc
Confidence 99 88999999864 579999999999999999999999999999999999999 46789999999999876553321
Q ss_pred cccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhc
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (407)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||..... ............ ..+..
T Consensus 156 -------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~----~~~~~ 221 (254)
T cd06627 156 -------DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP---MAALFRIVQDDH----PPLPE 221 (254)
T ss_pred -------ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH---HHHHHHHhccCC----CCCCC
Confidence 2345688999999999888889999999999999999999999976442 222222222211 12345
Q ss_pred CCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 243 ~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.+++++.+++.+||..+|++||++.++..
T Consensus 222 ~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 222 GISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 67899999999999999999999887763
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=297.67 Aligned_cols=257 Identities=19% Similarity=0.242 Sum_probs=203.7
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-CcchHHHHHHHHHHHcCC-----CCCCeeEEeeeeCce
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGG-----TGIPNVRWFGVEGDY 77 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~E~~~l~~l~~~-----~~i~~~~~~~~~~~~ 77 (407)
.+.++|.+.+.+|+|.||.|-.+.+..++..||||+++.-. ..+..+-|+++++++.+. .-++.+..++...+.
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 35789999999999999999999999999999999887543 445577899999999542 234445666778888
Q ss_pred eEEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCC----------------
Q 015406 78 NVLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR---------------- 140 (407)
Q Consensus 78 ~~lvme~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~---------------- 140 (407)
.|||+|.+|.|+.+++...+ .+++...++.++.|++.+++|||+.+++|-||||+|||+...+
T Consensus 166 iCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~ 245 (415)
T KOG0671|consen 166 ICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRP 245 (415)
T ss_pred eEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceecc
Confidence 99999999999999998532 4699999999999999999999999999999999999995321
Q ss_pred -CCceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcC
Q 015406 141 -RANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 219 (407)
Q Consensus 141 -~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~ 219 (407)
....|+|+|||.|+...+.. ...+.|..|.|||++++..++.++||||+||||+|+.+|...|+...+.
T Consensus 246 ~ks~~I~vIDFGsAtf~~e~h----------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 246 LKSTAIKVIDFGSATFDHEHH----------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred CCCcceEEEecCCcceeccCc----------ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence 13468999999998765543 3668899999999999999999999999999999999999999886654
Q ss_pred chHHHHHHHhhhcccccHHHH-----------------------------------hcCC---cHHHHHHHHHHhCCCCC
Q 015406 220 TKKQKYEKISEKKVSTSIEAL-----------------------------------CRGY---PTEFASYFHYCRSLRFD 261 (407)
Q Consensus 220 ~~~~~~~~i~~~~~~~~~~~~-----------------------------------~~~~---~~~l~~li~~cl~~~p~ 261 (407)
.....+++|........+..- ...- -.++.+|+++||..||.
T Consensus 316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~ 395 (415)
T KOG0671|consen 316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA 395 (415)
T ss_pred HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence 444455554432111111000 0001 23588999999999999
Q ss_pred CCCCHHHHH
Q 015406 262 DKPDYAYLK 270 (407)
Q Consensus 262 ~RPt~~~l~ 270 (407)
+|+|+.|++
T Consensus 396 ~RiTl~EAL 404 (415)
T KOG0671|consen 396 RRITLREAL 404 (415)
T ss_pred ccccHHHHh
Confidence 999966554
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=288.14 Aligned_cols=244 Identities=19% Similarity=0.295 Sum_probs=200.6
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
+|++.++||+|+||.||++.+..+++.+|+|.+.... ....+..|+++++.++| ++++.+..++......++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNH-PNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCC-CCchhhhhhhccCCEEEEEeh
Confidence 5899999999999999999999999999999876532 22346788999999985 667777777777788999999
Q ss_pred cc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 84 LL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 84 ~~-g~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
|+ +++|.+++... ...+++..++.++.|++.||.|||+.|++|+||+|+||++ +.++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~---~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILL---VANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE---ecCCcEEEeeccchhhhccC
Confidence 99 89999998652 2468999999999999999999999999999999999999 46788999999999876543
Q ss_pred CCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHH
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (407)
. .....++..|++||.+.+..++.++|+||||+++|+|++|+.||...+. ......+...... .
T Consensus 157 ~---------~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~~~~~~----~ 220 (256)
T cd08530 157 M---------AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM---QDLRYKVQRGKYP----P 220 (256)
T ss_pred C---------cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhcCCCC----C
Confidence 1 1234578899999999998999999999999999999999999976443 2223333332222 2
Q ss_pred HhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 240 ~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
+...++.++.+++.+||..+|++||++.++.+
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 221 IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 22357899999999999999999999888764
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=321.37 Aligned_cols=144 Identities=23% Similarity=0.417 Sum_probs=126.5
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
.++|.+.++||+|+||.||+|++..+++.||||++..... ...+..|+.++..++| ++++.+..++......||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~h-p~Iv~~~~~~~~~~~~~l 81 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS-PFIVHLYYSLQSANNVYL 81 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCC-CCcCeEEEEEEECCEEEE
Confidence 4789999999999999999999999999999999865332 1457788888888876 666667777778889999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEecccee
Q 015406 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (407)
Q Consensus 81 vme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~ 154 (407)
||||+ |++|.+++.. .+.+++..++.|+.||+.||.|||+++||||||||+|||| +.++.+||+|||+++
T Consensus 82 VmEy~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl---~~~g~vkL~DFGls~ 152 (669)
T cd05610 82 VMEYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLI---SNEGHIKLTDFGLSK 152 (669)
T ss_pred EEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEE---cCCCCEEEEeCCCCc
Confidence 99999 9999999975 3468999999999999999999999999999999999999 577899999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=303.35 Aligned_cols=263 Identities=21% Similarity=0.312 Sum_probs=212.1
Q ss_pred CccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCC---------CCcchHHHHHHHHHHHcCCCCCCeeEEeee
Q 015406 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK---------TKHPQLLYESKLYRILQGGTGIPNVRWFGV 73 (407)
Q Consensus 3 ~~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---------~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~ 73 (407)
|.+.++|-++..||+|||++||+|.+....+.||||+-... ..+....+|.+|.+.|.|+.++..++++..
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 56788999999999999999999999999999999974332 223347789999999999888887888888
Q ss_pred eCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC--CceeccCCCCcccccCCCCCceEEEEec
Q 015406 74 EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK--SFLHRDIKPDNFLMGLGRRANQVYIIDF 150 (407)
Q Consensus 74 ~~~~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~--~ivHrDLKp~NILl~~~~~~~~~kL~DF 150 (407)
+.+.+|-|+||| |.+|+-+++. .+-+++.+++.|+.||+.||.||.+. .|||-||||.||||-.+...|.+||+||
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQ-hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQ-HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred ccccceeeeeecCCCchhHHHHh-hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeec
Confidence 999999999999 8899999986 45699999999999999999999975 6999999999999987788899999999
Q ss_pred cceeeeccCCCCcccCccCCCCccccccccccccccCC----CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHH
Q 015406 151 GLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI----EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE 226 (407)
Q Consensus 151 Gla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~ 226 (407)
|+++.+++..........-.....||..|++||.+.-. ..+.|+||||.|||+|+++.|+.||.........-.+.
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN 697 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN 697 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh
Confidence 99999988766544444445678999999999988633 35889999999999999999999997643322221222
Q ss_pred HHhhhc-ccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHH
Q 015406 227 KISEKK-VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 269 (407)
Q Consensus 227 ~i~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l 269 (407)
.|.... +..+ ..+-++.+.+.+|.+||++.-++|.+..+|
T Consensus 698 TIlkAtEVqFP---~KPvVsseAkaFIRRCLaYRKeDR~DV~qL 738 (775)
T KOG1151|consen 698 TILKATEVQFP---PKPVVSSEAKAFIRRCLAYRKEDRIDVQQL 738 (775)
T ss_pred chhcceeccCC---CCCccCHHHHHHHHHHHHhhhhhhhhHHHH
Confidence 222211 1111 123478999999999999999999885554
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=293.31 Aligned_cols=244 Identities=19% Similarity=0.292 Sum_probs=195.2
Q ss_pred eEeccccccCceEEEEEEEcCCCeEEEEEEecCCC--CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-C
Q 015406 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (407)
Q Consensus 10 ~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~-g 86 (407)
+...+||+|+||.||++.+..+++.||||.+.... ....+.+|+.+++.+.| ++++.+..++..++..+++|||+ +
T Consensus 23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH-ENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCC-cchhheeeEEEeCCEEEEEEecCCC
Confidence 33468999999999999999999999999875433 23347789999999886 66667777777888999999999 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcccC
Q 015406 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166 (407)
Q Consensus 87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~ 166 (407)
++|.+++. ...+++..++.++.|++.||+|||++|++|+||||+||++ +.++.++|+|||++........
T Consensus 102 ~~L~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv---~~~~~~~l~dfg~~~~~~~~~~----- 171 (292)
T cd06657 102 GALTDIVT--HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVP----- 171 (292)
T ss_pred CcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEcccccceecccccc-----
Confidence 89999876 3468999999999999999999999999999999999999 5778999999999876543221
Q ss_pred ccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcH
Q 015406 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 246 (407)
Q Consensus 167 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 246 (407)
......|+..|+|||.+.+..++.++|+||||+++|+|++|..||..... ......+... ...... ....+++
T Consensus 172 --~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~---~~~~~~~~~~-~~~~~~-~~~~~~~ 244 (292)
T cd06657 172 --RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMKMIRDN-LPPKLK-NLHKVSP 244 (292)
T ss_pred --cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhh-CCcccC-CcccCCH
Confidence 12345688999999999888899999999999999999999999976433 2222222221 111111 1234788
Q ss_pred HHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 247 EFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 247 ~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
++.+++.+||..+|.+||++.++.+
T Consensus 245 ~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 245 SLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHHhCCcccCcCHHHHhc
Confidence 9999999999999999999887754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=290.95 Aligned_cols=249 Identities=20% Similarity=0.237 Sum_probs=198.4
Q ss_pred eeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEec
Q 015406 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (407)
Q Consensus 9 y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~ 84 (407)
|++.+.||+|+||.||+|++..+++.||+|++.... ....+..|+.+++.++| +++..+..+.......++||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKH-PNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCC-CCHHHHHhhhhcCCceEEEecC
Confidence 678899999999999999999999999999887643 22457789999999985 6666666666677889999999
Q ss_pred cCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcc
Q 015406 85 LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164 (407)
Q Consensus 85 ~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~ 164 (407)
++++|.+++......+++..++.++.|++.||.|||++||+||||+|+||++ ++++.++|+|||+++.......
T Consensus 80 ~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~---~~~~~~~l~d~g~~~~~~~~~~--- 153 (282)
T cd07829 80 CDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI---NRDGVLKLADFGLARAFGIPLR--- 153 (282)
T ss_pred cCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEE---cCCCCEEEecCCcccccCCCcc---
Confidence 9889999998754579999999999999999999999999999999999999 5789999999999986644321
Q ss_pred cCccCCCCccccccccccccccCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhh------------
Q 015406 165 IPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK------------ 231 (407)
Q Consensus 165 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~------------ 231 (407)
......++..|+|||.+.+. .++.++||||||+++|||++|..||...... ..+.++...
T Consensus 154 ----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07829 154 ----TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI---DQLFKIFQILGTPTEESWPGV 226 (282)
T ss_pred ----ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH---HHHHHHHHHhCCCcHHHHHhh
Confidence 12234567889999998876 7899999999999999999999999764332 222221110
Q ss_pred ------------cccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 232 ------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 232 ------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
..........+.++.++.+++.+||..+|++||++.++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 227 TKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0001111223446789999999999999999999888764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=307.71 Aligned_cols=243 Identities=19% Similarity=0.230 Sum_probs=206.3
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
...+.|.+...+|.|+|+.|-.+.+..+++..++|++... ..+..+|+.++....+|+++..+.....++...|+|||
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~--~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR--ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheecccc--ccccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 3567899999999999999999999999999999998765 34556788888889999999999999999999999999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 84 ~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
++ |+-|.+.+.. . +.....+..|+.+|+.|+.|||++|+|||||||+|||+. +..++++|+|||.++.....-
T Consensus 397 ~l~g~ell~ri~~-~-~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~--~~~g~lrltyFG~a~~~~~~~-- 470 (612)
T KOG0603|consen 397 LLDGGELLRRIRS-K-PEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD--GSAGHLRLTYFGFWSELERSC-- 470 (612)
T ss_pred hccccHHHHHHHh-c-chhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec--CCCCcEEEEEechhhhCchhh--
Confidence 99 6666655553 2 333378889999999999999999999999999999994 478899999999998766541
Q ss_pred cccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhc
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (407)
.+.+-|..|.|||++...+|++++||||||++||+||+|+.||.....+ .+.+.++...... .
T Consensus 471 --------~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~~i~~~~~s-------~ 533 (612)
T KOG0603|consen 471 --------DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHTRIQMPKFS-------E 533 (612)
T ss_pred --------cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHHhhcCCccc-------c
Confidence 2335688999999999999999999999999999999999999875443 4566666554443 4
Q ss_pred CCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 243 ~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.++++.++|+++||+.||.+||+++++..
T Consensus 534 ~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 534 CVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 58999999999999999999999988764
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=292.01 Aligned_cols=266 Identities=22% Similarity=0.308 Sum_probs=210.6
Q ss_pred CCccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHH--HcCCCCCCeeEEeeee---Cc
Q 015406 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRI--LQGGTGIPNVRWFGVE---GD 76 (407)
Q Consensus 2 ~~~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~--l~~~~~i~~~~~~~~~---~~ 76 (407)
|..|+++..+.+.||+|.||+||+|. ..|+.||||++.. .+...+.+|.+|++. |+|.|++-.+..-..+ -.
T Consensus 206 QRTiarqI~L~e~IGkGRyGEVwrG~--wrGe~VAVKiF~s-rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 206 QRTIARQIVLQEIIGKGRFGEVWRGR--WRGEDVAVKIFSS-RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred HHhhhheeEEEEEecCccccceeecc--ccCCceEEEEecc-cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 45788999999999999999999999 6799999999975 455678889999876 5665444443222222 23
Q ss_pred eeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh--------CCceeccCCCCcccccCCCCCceEEE
Q 015406 77 YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS--------KSFLHRDIKPDNFLMGLGRRANQVYI 147 (407)
Q Consensus 77 ~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~--------~~ivHrDLKp~NILl~~~~~~~~~kL 147 (407)
..+||.+|. .|||.|++.+ ..++.+..++++..++.||++||. -.|.|||||..|||+ .+++...|
T Consensus 283 QLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV---Kkn~~C~I 357 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCI 357 (513)
T ss_pred EEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE---ccCCcEEE
Confidence 579999999 9999999995 579999999999999999999995 249999999999999 79999999
Q ss_pred EeccceeeeccCCCCcccCccCCCCccccccccccccccCCC------CChhhHHHHHHHHHHHHHhC----------CC
Q 015406 148 IDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE------QSRRDDLESLGYVLMYFLRG----------SL 211 (407)
Q Consensus 148 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~------~~~~sDIwSlG~il~elltG----------~~ 211 (407)
+|+|||....+......++ .+..+||.+|||||++...- .-..+||||||.|+||++.+ ++
T Consensus 358 ADLGLAv~h~~~t~~idi~---~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~ 434 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTDTIDIP---PNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQL 434 (513)
T ss_pred eeceeeEEecccCCcccCC---CCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcC
Confidence 9999999877765444333 45779999999999997532 12468999999999999863 68
Q ss_pred CCCCCCcC--chHHHHHHHhhhcccccHHHHhcCCc--HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Q 015406 212 PWQGLKAG--TKKQKYEKISEKKVSTSIEALCRGYP--TEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (407)
Q Consensus 212 Pf~~~~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~--~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~ 278 (407)
||.+.-+. +..+..+.+...+..+.++..+...| ..+.++|+.||..||.-|-|+-.|++.|.++.+
T Consensus 435 Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 435 PYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 88876443 33444444445555566665555554 468899999999999999999999999998864
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=304.25 Aligned_cols=294 Identities=21% Similarity=0.252 Sum_probs=222.8
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
-|..++.||-|+||+|.+++...+...||+|.+.+... ...+..|..||..... +-++.+++.+++.+.+|+||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn-~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADN-EWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCC-cceEEEEEEeccCCceEEEE
Confidence 37889999999999999999999999999997765432 1235678888887765 67788888899999999999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC--
Q 015406 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT-- 159 (407)
Q Consensus 83 e~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~-- 159 (407)
||+ ||++-.+|-+. +-|.+..+++++.++.+|+++.|+.|+|||||||+|||| |.+|++||+|||||.-+.=.
T Consensus 709 dYIPGGDmMSLLIrm-gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILI---DrdGHIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRM-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred eccCCccHHHHHHHh-ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEE---ccCCceeeeeccccccceeccc
Confidence 999 99999998764 479999999999999999999999999999999999999 79999999999999754211
Q ss_pred ------CCCccc----C---c--------------------cCCCCccccccccccccccCCCCChhhHHHHHHHHHHHH
Q 015406 160 ------STHQHI----P---Y--------------------RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYF 206 (407)
Q Consensus 160 ------~~~~~~----~---~--------------------~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~el 206 (407)
..+... + + ...-..+||+.|+|||++....|+..+|+||.|||||||
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence 111000 0 0 012356899999999999999999999999999999999
Q ss_pred HhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCC
Q 015406 207 LRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDY 286 (407)
Q Consensus 207 ltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~ 286 (407)
+.|+.||..........++..+....- -..+.+++.+..++|.+++. ++++|..-. ..+ .-..++|+.
T Consensus 865 ~~g~~pf~~~tp~~tq~kv~nw~~~l~----~~~~~~ls~e~~~li~kLc~-sad~RLGkn-g~d------~vKaHpfFk 932 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGETQYKVINWRNFLH----IPYQGNLSKEALDLIQKLCC-SADSRLGKN-GAD------QVKAHPFFK 932 (1034)
T ss_pred hhCCCCccCCCCCcceeeeeehhhccc----cccccccCHHHHHHHHHHhc-Chhhhhccc-chh------hhhcCcccc
Confidence 999999987666443333322221111 11345688999998887654 567775421 011 123568999
Q ss_pred ccccccchhhcccccCCCCccCCCCCCCCCCCCCCC
Q 015406 287 VFDWTILKYQQSQLATPPARALVPGAGTSGAPPAIA 322 (407)
Q Consensus 287 ~~dw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (407)
.+||..+..+. ++..+.+.-+.+++.+.+...
T Consensus 933 gIDfsslRkq~----ApYIP~ItHptDTSNFdpvdp 964 (1034)
T KOG0608|consen 933 GIDFSSLRKQR----APYIPRITHPTDTSNFDPVDP 964 (1034)
T ss_pred ccchHhhhhcc----CCcCccccCCCccccCCcCCc
Confidence 99999866554 234455666677777777654
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=287.91 Aligned_cols=245 Identities=22% Similarity=0.284 Sum_probs=193.5
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-------CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-------KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
+|.+.+.||+|+||.||++++..++..+++|+.+... ....+..|+.+++.++| +++..+..+..+....++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~l 79 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH-PAIVKFHASFLERDAFCI 79 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCC-CcHHHHHHHHhcCCceEE
Confidence 6899999999999999999998877777777654311 12235678888888876 555556566666777899
Q ss_pred EEecc-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeee
Q 015406 81 VMDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (407)
Q Consensus 81 vme~~-g~sL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~ 156 (407)
+|||+ +++|.+++.. ....+++..++.++.|++.||.|||++|++|+||||+||+++ ++.++|+|||+++..
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~----~~~~~l~d~g~~~~~ 155 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK----NNLLKIGDFGVSRLL 155 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee----cCCEeecccCceeec
Confidence 99999 8899998864 235699999999999999999999999999999999999993 356999999999876
Q ss_pred ccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhccccc
Q 015406 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (407)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (407)
..... ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.... .......+.....+
T Consensus 156 ~~~~~-------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~---~~~~~~~~~~~~~~-- 223 (260)
T cd08222 156 MGSCD-------LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN---FLSVVLRIVEGPTP-- 223 (260)
T ss_pred CCCcc-------cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHHHHHcCCCC--
Confidence 44322 1234568889999999988889999999999999999999999996532 23333333332221
Q ss_pred HHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 237 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.+...++.++.++|.+||..+|++||++.++.+
T Consensus 224 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 224 --SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred --CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 223457889999999999999999999888764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=292.02 Aligned_cols=253 Identities=19% Similarity=0.236 Sum_probs=185.0
Q ss_pred EeccccccCceEEEEEEEcCCCeEEEEEEecCCC----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-
Q 015406 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (407)
Q Consensus 11 i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~- 85 (407)
+++.+|. +|.||.+++..+++.||||+++... ....+..|+++++.++| +++..+..++...+..+++|||+
T Consensus 6 i~~~~~~--~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h-~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 6 IGKCFED--LMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQH-PNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred hhHhhcC--CceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCC-cchhhhhheeecCCeEEEEEeccC
Confidence 3444444 4556666666799999999886542 22357889999999987 55555666667778889999999
Q ss_pred CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcc
Q 015406 86 GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164 (407)
Q Consensus 86 g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~ 164 (407)
+++|.+++... ...+++..+..++.|++.||+|||+++|+||||||+||++ +.++.+||+|||.+...........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili---~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILL---SGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEE---ecCCceEEecCccceeecccccccc
Confidence 89999999753 3468999999999999999999999999999999999999 5778999999999876643322111
Q ss_pred cCccCCCCccccccccccccccC--CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcc---------
Q 015406 165 IPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV--------- 233 (407)
Q Consensus 165 ~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~--------- 233 (407)
..........++..|+|||++.+ ..++.++|||||||++|||++|..||...... .....++.....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 237 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKVRGTVPCLLDKSTYP 237 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccCccccccCchh
Confidence 11112234567889999999876 35789999999999999999999999864321 112222110000
Q ss_pred -------------------cccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 234 -------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 234 -------------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
..........++.++.+++.+||..||++||+++++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 00000111234578999999999999999999877754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=284.04 Aligned_cols=252 Identities=19% Similarity=0.281 Sum_probs=202.9
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
++.+-+..||.|+||.|++-.++.+|+..|||.++.... ..+++.|.+...+-..+++|+.+++..-..+..||.||
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 344556789999999999999999999999998875543 44588888888888888888887777666667799999
Q ss_pred ccCCCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 84 LLGPSLEDLFNF----CSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 84 ~~g~sL~~~l~~----~~~~l~~~~~~~i~~qi~~aL~yLH~-~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
+|..||+.+.+. .+..+++..+-.|....+.||+||-. ..|||||+||+|||+ +..|.+||||||++-.+.+
T Consensus 144 LMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILl---dr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 144 LMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILL---DRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred HHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEE---ecCCCEeeecccchHhHHH
Confidence 999999887653 24569999999999999999999985 689999999999999 7999999999999987655
Q ss_pred CCCCcccCccCCCCccccccccccccccC--CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhccccc
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (407)
+.. .+.-.|-..|||||.+.. ..|+-+||+||||++|||+.||+.||.+-+. ..+.+..+..+..+..
T Consensus 221 SiA--------kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~l 290 (361)
T KOG1006|consen 221 SIA--------KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPIL 290 (361)
T ss_pred HHH--------hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCee
Confidence 432 234578889999999874 4589999999999999999999999987533 3444444444433322
Q ss_pred HH-HHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 237 IE-ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 237 ~~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.. .-+-.++..+..+|..|+.+|-.+||.+.+|++
T Consensus 291 ~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 291 LFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred cCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 21 122347889999999999999999999998875
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=306.97 Aligned_cols=252 Identities=20% Similarity=0.344 Sum_probs=211.8
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-cchHHHHHHHHHHHcCCCCCCeeEEeee-----eCce
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGV-----EGDY 77 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~-----~~~~ 77 (407)
.-.+.|+|.+.||.|.+|.||+++++.+++.+|+|+...... .+++..|.++++.+.+|+|++.+++++. .++.
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence 346789999999999999999999999999999999876544 4568889999999999999999888765 4678
Q ss_pred eEEEEecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceee
Q 015406 78 NVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~ 155 (407)
.||||||| |||.-|+++.. +.++.|..+..|++.++.||.+||.+.++|||||-.|||+ ..++.|||+|||.+..
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLL---T~e~~VKLvDFGvSaQ 172 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQ 172 (953)
T ss_pred EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEE---eccCcEEEeeeeeeee
Confidence 99999999 99999999854 4679999999999999999999999999999999999999 6899999999999988
Q ss_pred eccCCCCcccCccCCCCccccccccccccccCC-----CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhh
Q 015406 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-----EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230 (407)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~ 230 (407)
+..... ...+++||+.|||||++... .|+.++|+||||++..||..|.+|+.++.+. ..+..|..
T Consensus 173 ldsT~g-------rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm---raLF~IpR 242 (953)
T KOG0587|consen 173 LDSTVG-------RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM---RALFLIPR 242 (953)
T ss_pred eecccc-------cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh---hhhccCCC
Confidence 766432 34678999999999999753 3688999999999999999999999887652 22333333
Q ss_pred hcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015406 231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 231 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
...+.. ..++..+.+|.++|..||.+|.++||+..+++
T Consensus 243 NPPPkL--krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll 280 (953)
T KOG0587|consen 243 NPPPKL--KRPKKWSKKFNDFISTCLVKDYEQRPSTEELL 280 (953)
T ss_pred CCCccc--cchhhHHHHHHHHHHHHHhhccccCcchhhhc
Confidence 222211 22355788999999999999999999976654
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=319.52 Aligned_cols=256 Identities=22% Similarity=0.265 Sum_probs=189.9
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC---CcchHHHHHHHHHHHcCCCCCCeeEEe----------
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWF---------- 71 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~---------- 71 (407)
...+|+.++.||+||||.||+++++-+|+.||||.+.... ....+.+|+..+.+|.|++.+.++..+
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 4567899999999999999999999999999999887653 223478899999999986555432100
Q ss_pred -----------------------------------------------e--e------------------e----------
Q 015406 72 -----------------------------------------------G--V------------------E---------- 74 (407)
Q Consensus 72 -----------------------------------------------~--~------------------~---------- 74 (407)
. . +
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence 0 0 0
Q ss_pred -----------------------C--------ceeEEEEecc-CCCHHHHHHHcCCCC-CHHHHHHHHHHHHHHHHHHHh
Q 015406 75 -----------------------G--------DYNVLVMDLL-GPSLEDLFNFCSRKL-SLKTVLMLADQMINRVEFVHS 121 (407)
Q Consensus 75 -----------------------~--------~~~~lvme~~-g~sL~~~l~~~~~~l-~~~~~~~i~~qi~~aL~yLH~ 121 (407)
. ...||-|||| ..+|.+++++ +... ....++++++||++||.|+|+
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~-N~~~~~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRR-NHFNSQRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHh-cccchhhHHHHHHHHHHHHHHHHHHh
Confidence 0 3458999999 5566666664 3222 478999999999999999999
Q ss_pred CCceeccCCCCcccccCCCCCceEEEEeccceeeec----c--C----CCCcc-cCccCCCCccccccccccccccCCC-
Q 015406 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR----D--T----STHQH-IPYRENKNLTGTARYASMNTHLGIE- 189 (407)
Q Consensus 122 ~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~----~--~----~~~~~-~~~~~~~~~~gt~~Y~aPE~~~~~~- 189 (407)
+|||||||||.||+| +..+.|||+|||+|+... . . ..... .+....+..+||.-|+|||++.+..
T Consensus 716 ~giIHRDLKP~NIFL---d~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 716 QGIIHRDLKPRNIFL---DSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred CceeeccCCcceeEE---cCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 999999999999999 688999999999998722 0 0 00000 0111345679999999999998765
Q ss_pred --CChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHH
Q 015406 190 --QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA 267 (407)
Q Consensus 190 --~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ 267 (407)
|+.|+|+|||||||+||+ +||.. ..+....+..+....++.+ +.+...--+.-.++|+.|++.||.+|||+.
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~---yPF~T--sMERa~iL~~LR~g~iP~~-~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~ 866 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEML---YPFGT--SMERASILTNLRKGSIPEP-ADFFDPEHPEEASLIRWLLSHDPSKRPTAT 866 (1351)
T ss_pred ccccchhhhHHHHHHHHHHh---ccCCc--hHHHHHHHHhcccCCCCCC-cccccccchHHHHHHHHHhcCCCccCCCHH
Confidence 999999999999999998 45642 2333444444444444433 223333335567999999999999999998
Q ss_pred HHH
Q 015406 268 YLK 270 (407)
Q Consensus 268 ~l~ 270 (407)
+|+
T Consensus 867 eLL 869 (1351)
T KOG1035|consen 867 ELL 869 (1351)
T ss_pred HHh
Confidence 876
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=254.94 Aligned_cols=253 Identities=21% Similarity=0.272 Sum_probs=204.5
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc----chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
++|.-.++||+|.||+||+|++..+++.||+|....+... ...++|+-+++.|+| .+|+.++.........-+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkh-knivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH-KNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhh-cceeehhhhhccCceeEEeH
Confidence 4678889999999999999999999999999987765433 358899999999998 56666666666777789999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 83 e~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
|||..+|..++...++.++.+.++.++.|+++||.|+|+++++||||||+|.|| +.+|.+||+|||+++.+.-+
T Consensus 81 e~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnlli---n~ngelkladfglarafgip--- 154 (292)
T KOG0662|consen 81 EFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLI---NRNGELKLADFGLARAFGIP--- 154 (292)
T ss_pred HHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEe---ccCCcEEecccchhhhcCCc---
Confidence 999999999999999999999999999999999999999999999999999999 68999999999999977543
Q ss_pred cccCccCCCCccccccccccccccCCC-CChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcc-------
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKV------- 233 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~------- 233 (407)
.+..+..+-|..|.+|.++.|.. |+...|+||-|||+.|+.. |.+.|.+.+..+....+.+......
T Consensus 155 ----vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~ 230 (292)
T KOG0662|consen 155 ----VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSM 230 (292)
T ss_pred ----eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcc
Confidence 33345567799999999998855 7899999999999999987 8888887555443333333221110
Q ss_pred --------------cccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015406 234 --------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 234 --------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
......+.+.+...=++++++.+.-+|.+|.+++...
T Consensus 231 t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaal 281 (292)
T KOG0662|consen 231 TKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAAL 281 (292)
T ss_pred ccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHh
Confidence 0111222233445567899999999999999976543
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=277.26 Aligned_cols=261 Identities=21% Similarity=0.236 Sum_probs=200.3
Q ss_pred CCceeEeccccccCceEEEEEEEcCCC----eEEEEEEecCC----CCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCce
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTN----EEVAIKLENVK----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~----~~vAvK~~~~~----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 77 (407)
...|++++.||+|.||.||+|....++ ..+|||.++.+ .......+|+.+++.|+|++.+..+..+-.....
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 457999999999999999999655543 37899988765 3345689999999999997777777766666888
Q ss_pred eEEEEeccCCCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccC-CCCCceEEEEeccc
Q 015406 78 NVLVMDLLGPSLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL-GRRANQVYIIDFGL 152 (407)
Q Consensus 78 ~~lvme~~g~sL~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~-~~~~~~~kL~DFGl 152 (407)
.++++||..-+|.++|+.+. +.++...+..|+.||+.|+.|||++=|+||||||.|||+.. +...|.|||+|||+
T Consensus 103 v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGl 182 (438)
T KOG0666|consen 103 VWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGL 182 (438)
T ss_pred EEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccH
Confidence 99999999999999997543 35899999999999999999999999999999999999942 12349999999999
Q ss_pred eeeeccCCCCcccCccCCCCccccccccccccccCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcC------chHHHH
Q 015406 153 AKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAG------TKKQKY 225 (407)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDIwSlG~il~elltG~~Pf~~~~~~------~~~~~~ 225 (407)
++.+.+.-. |.......+-|..|.|||.+.|. .|+.+.||||.|||+.||+|-.+-|.+.... -....+
T Consensus 183 aR~~~~plk----pl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 183 ARLFNNPLK----PLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred HHHhhcccc----ccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 998876543 34445677889999999999984 5899999999999999999988888653221 111122
Q ss_pred HHHhhhc-------------ccc---cHHH----------------HhcCCcHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015406 226 EKISEKK-------------VST---SIEA----------------LCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 226 ~~i~~~~-------------~~~---~~~~----------------~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
.+|.+.. .+. .+.. ..+.-++...+|+.++|..||-+|.|+++..
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAl 335 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQAL 335 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHh
Confidence 2222110 000 0000 0111245588999999999999999966543
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=274.76 Aligned_cols=234 Identities=23% Similarity=0.300 Sum_probs=192.2
Q ss_pred ccccCceEEEEEEEcCCCeEEEEEEecCCCC-----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-CCC
Q 015406 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPS 88 (407)
Q Consensus 15 iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~-g~s 88 (407)
||.|+||.||++.+..+++.||+|++..... ...+..|+.+++.+.| +++..+...+..+...+++|||+ +++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINH-PFIVKLHYAFQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCC-CcHHHHHHHeecCCeeEEEEecCCCCc
Confidence 6999999999999988899999998765432 2357889999999986 56666666677888899999999 999
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcccCcc
Q 015406 89 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYR 168 (407)
Q Consensus 89 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 168 (407)
|.+++... ..+++..+..++.|++.||.|||+.+++|+||||+||++ +..+.++|+|||++........
T Consensus 80 L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~---~~~~~~~l~d~~~~~~~~~~~~------- 148 (250)
T cd05123 80 LFSHLSKE-GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILL---DADGHIKLTDFGLAKELSSEGS------- 148 (250)
T ss_pred HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEE---cCCCcEEEeecCcceecccCCC-------
Confidence 99999853 468999999999999999999999999999999999999 5778999999999987654321
Q ss_pred CCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcHHH
Q 015406 169 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEF 248 (407)
Q Consensus 169 ~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l 248 (407)
......++..|+|||.+.+...+.++|+||||+++|+|++|..||..... .+.+..+..... .+...++.++
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~~~~~-----~~~~~~~~~l 220 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKILKDPL-----RFPEFLSPEA 220 (250)
T ss_pred cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHhcCCC-----CCCCCCCHHH
Confidence 12345688899999999988889999999999999999999999965432 333333333221 2334568999
Q ss_pred HHHHHHHhCCCCCCCCCHHH
Q 015406 249 ASYFHYCRSLRFDDKPDYAY 268 (407)
Q Consensus 249 ~~li~~cl~~~p~~RPt~~~ 268 (407)
.+++.+||..||++||++.+
T Consensus 221 ~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 221 RDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHhcCCHhhCCCccc
Confidence 99999999999999999854
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=308.73 Aligned_cols=257 Identities=20% Similarity=0.336 Sum_probs=209.3
Q ss_pred ceeEeccccccCceEEEEEEEcC-------CCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCce
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQ-------TNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~-------~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 77 (407)
+..+.+.||+|.||.|++|.-.. ....||||..+.... ...+..|+++++.+.+|+++..+.+++.....
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~ 376 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP 376 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence 34667799999999999997431 146899998765433 35689999999999999999999888888889
Q ss_pred eEEEEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCC
Q 015406 78 NVLVMDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 141 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~ 141 (407)
.++|+||+ .|+|.+++...+ ..++..+.+.++.||+.|++||++.++|||||-.+|||+ ..
T Consensus 377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi---~~ 453 (609)
T KOG0200|consen 377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLI---TK 453 (609)
T ss_pred eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEe---cC
Confidence 99999999 999999998655 238999999999999999999999999999999999999 57
Q ss_pred CceEEEEeccceeeeccCCCCcccCccCCCCccc--cccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015406 142 ANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG--TARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 218 (407)
Q Consensus 142 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~g--t~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~ 218 (407)
+..+||+|||+|+....... |+ .....| ...|||||.+....|+.++|||||||+|||+++ |..||.+...
T Consensus 454 ~~~~kIaDFGlar~~~~~~~-----y~-~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~ 527 (609)
T KOG0200|consen 454 NKVIKIADFGLARDHYNKDY-----YR-TKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP 527 (609)
T ss_pred CCEEEEccccceeccCCCCc-----eE-ecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence 78999999999996544332 11 112222 345999999999999999999999999999999 9999987442
Q ss_pred CchHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHH
Q 015406 219 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (407)
Q Consensus 219 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~ 279 (407)
. ...++.+..+... ..+..+++++.++|..||+.+|++||++.++.+.|...+..
T Consensus 528 ~--~~l~~~l~~G~r~----~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~~ 582 (609)
T KOG0200|consen 528 T--EELLEFLKEGNRM----EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQD 582 (609)
T ss_pred H--HHHHHHHhcCCCC----CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHHH
Confidence 2 2234444433322 23356799999999999999999999999999999987654
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=275.53 Aligned_cols=219 Identities=16% Similarity=0.146 Sum_probs=175.4
Q ss_pred cCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-CCCHHHHHHHc
Q 015406 18 GSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC 96 (407)
Q Consensus 18 G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~-g~sL~~~l~~~ 96 (407)
|.||.||++++..+++.||+|.+.... ....|...+.... ++++..+..++...+..+++|||+ +++|.+++...
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~---~~~~~~~~~~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS---EYSRERLTIIPHC-VPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh---hhhhHHHHHHhcC-CCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence 899999999999999999999886543 2333444433333 467777777778888999999999 89999998753
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcccCccCCCCcccc
Q 015406 97 SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGT 176 (407)
Q Consensus 97 ~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt 176 (407)
..+++..+..++.|++.||+|||++||+||||||+||++ +.++.++|+|||++....... ....++
T Consensus 80 -~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~df~~~~~~~~~~----------~~~~~~ 145 (237)
T cd05576 80 -LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL---DDRGHIQLTYFSRWSEVEDSC----------DGEAVE 145 (237)
T ss_pred -cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEEecccchhcccccc----------ccCCcC
Confidence 469999999999999999999999999999999999999 578889999999887654322 133457
Q ss_pred ccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHh
Q 015406 177 ARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCR 256 (407)
Q Consensus 177 ~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl 256 (407)
..|+|||.+.+..++.++||||||+++|||++|..||...... +... . ...+...+++.+.++|.+||
T Consensus 146 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~--------~~~~-~---~~~~~~~~~~~~~~li~~~l 213 (237)
T cd05576 146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG--------INTH-T---TLNIPEWVSEEARSLLQQLL 213 (237)
T ss_pred ccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh--------cccc-c---ccCCcccCCHHHHHHHHHHc
Confidence 7899999998888999999999999999999999887542211 0000 0 00123457889999999999
Q ss_pred CCCCCCCCCH
Q 015406 257 SLRFDDKPDY 266 (407)
Q Consensus 257 ~~~p~~RPt~ 266 (407)
+.||++||++
T Consensus 214 ~~dp~~R~~~ 223 (237)
T cd05576 214 QFNPTERLGA 223 (237)
T ss_pred cCCHHHhcCC
Confidence 9999999986
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=305.13 Aligned_cols=249 Identities=18% Similarity=0.181 Sum_probs=168.0
Q ss_pred CCceeEeccccccCceEEEEEEEcCC----CeEEEEEEecCCCCcchHHHHHHHHHHHcC---CCCCCeeEE----e-ee
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQT----NEEVAIKLENVKTKHPQLLYESKLYRILQG---GTGIPNVRW----F-GV 73 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~----~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~---~~~i~~~~~----~-~~ 73 (407)
.++|++.++||+|+||.||+|++..+ +..||||.+...... |..+...+.+ ......+.. . ..
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMNERVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHHHHHHhhchhhHHHHHHhhhcccccc
Confidence 57899999999999999999999888 899999987543222 2222222221 111111111 1 24
Q ss_pred eCceeEEEEecc-CCCHHHHHHHcCCC-------------------CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCc
Q 015406 74 EGDYNVLVMDLL-GPSLEDLFNFCSRK-------------------LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 133 (407)
Q Consensus 74 ~~~~~~lvme~~-g~sL~~~l~~~~~~-------------------l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~N 133 (407)
.....++||||+ +++|.+++...... .....+..++.||+.||.|||+++|+||||||+|
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~N 285 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQN 285 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHH
Confidence 566789999999 88999998743211 1234567899999999999999999999999999
Q ss_pred ccccCCCCCceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCC----------------------CC
Q 015406 134 FLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE----------------------QS 191 (407)
Q Consensus 134 ILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----------------------~~ 191 (407)
||++ ++++.+||+|||+|+.+...... ......+|+.|||||.+.... ++
T Consensus 286 ILl~--~~~~~~KL~DFGlA~~l~~~~~~------~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~ 357 (566)
T PLN03225 286 IIFS--EGSGSFKIIDLGAAADLRVGINY------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP 357 (566)
T ss_pred EEEe--CCCCcEEEEeCCCcccccccccc------CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCC
Confidence 9994 34578999999999865443221 134568899999999764322 34
Q ss_pred hhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhc-------------ccccHH---HHhcCCcHHHHHHHHHH
Q 015406 192 RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK-------------VSTSIE---ALCRGYPTEFASYFHYC 255 (407)
Q Consensus 192 ~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~-------------~~~~~~---~~~~~~~~~l~~li~~c 255 (407)
.++|||||||+||||+++..|+... ..+....+.... ...... .+........++||.+|
T Consensus 358 ~k~DVwSlGviL~el~~~~~~~~~~----~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~m 433 (566)
T PLN03225 358 DRFDIYSAGLIFLQMAFPNLRSDSN----LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSM 433 (566)
T ss_pred CCcccHHHHHHHHHHHhCcCCCchH----HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHH
Confidence 5679999999999999987765321 111111111100 000000 01111233456899999
Q ss_pred hCCCCCCCCCHHHHHH
Q 015406 256 RSLRFDDKPDYAYLKR 271 (407)
Q Consensus 256 l~~~p~~RPt~~~l~~ 271 (407)
|..||++|||+.++++
T Consensus 434 L~~dP~kR~ta~e~L~ 449 (566)
T PLN03225 434 MRFKGRQRISAKAALA 449 (566)
T ss_pred ccCCcccCCCHHHHhC
Confidence 9999999999777654
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=271.41 Aligned_cols=260 Identities=20% Similarity=0.238 Sum_probs=199.0
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC----CcchHHHHHHHHHHHcCCCCCCeeEEee-------ee
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFG-------VE 74 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~-------~~ 74 (407)
.+.|+-..+||+|.||+||+|+.+.+|+.||+|..-.+. .....++|++++..|+|.+.+..+..+. .+
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 467888899999999999999999999999999533222 2234789999999999866554443221 13
Q ss_pred CceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEecccee
Q 015406 75 GDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (407)
Q Consensus 75 ~~~~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~ 154 (407)
...+|+||++|..+|.-++.....+++..++..++.+++.||.|+|...|+|||+||+|+|| +.++.+||+|||+++
T Consensus 96 r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLI---t~dgilklADFGlar 172 (376)
T KOG0669|consen 96 RATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLI---TKDGILKLADFGLAR 172 (376)
T ss_pred cceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEE---cCCceEEeecccccc
Confidence 44689999999999999998766789999999999999999999999999999999999999 688999999999998
Q ss_pred eeccCCCCcccCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhc-
Q 015406 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK- 232 (407)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~- 232 (407)
.+.......... .+..+-|..|.+||.+.| .+|+++.|||+-||||.||++|.+-+++.........+..+....
T Consensus 173 ~fs~~~n~~kpr---ytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 173 AFSTSKNVVKPR---YTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT 249 (376)
T ss_pred ceecccccCCCC---cccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence 876654433211 345566999999999987 568999999999999999999999998754432222222211110
Q ss_pred --------------------cccc----HHHHhc--CCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 233 --------------------VSTS----IEALCR--GYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 233 --------------------~~~~----~~~~~~--~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
++.. ++...+ .-.++..+|+.+++..||.+|+++++..+
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 0000 000000 01457889999999999999999887654
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=280.26 Aligned_cols=258 Identities=21% Similarity=0.286 Sum_probs=196.3
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHc-CCCCCCeeEEeeeeCc----eeEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ-GGTGIPNVRWFGVEGD----YNVLV 81 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~-~~~~i~~~~~~~~~~~----~~~lv 81 (407)
...++.+.||+|.||.||+|. -+++.||||++.. ...+.+..|.+|+.... .|++|..+......+. .++||
T Consensus 210 ~pl~l~eli~~Grfg~V~Kaq--L~~~~VAVKifp~-~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQ--LDNRLVAVKIFPE-QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred CchhhHHHhhcCccceeehhh--ccCceeEEEecCH-HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 346778899999999999999 5679999999875 34567899999988642 3466666555544333 78999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---------CCceeccCCCCcccccCCCCCceEEEEecc
Q 015406 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS---------KSFLHRDIKPDNFLMGLGRRANQVYIIDFG 151 (407)
Q Consensus 82 me~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~---------~~ivHrDLKp~NILl~~~~~~~~~kL~DFG 151 (407)
++|. .|||.++++. ..++|....+++..|++||+|||+ ..|+|||||..|||+ ..+.+..|+|||
T Consensus 287 t~fh~kGsL~dyL~~--ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv---K~DlTccIaDFG 361 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKA--NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV---KNDLTCCIADFG 361 (534)
T ss_pred eeeccCCcHHHHHHh--ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE---ccCCcEEeeccc
Confidence 9999 9999999994 579999999999999999999996 369999999999999 789999999999
Q ss_pred ceeeeccCCCCcccCccCCCCccccccccccccccCCC-CC-----hhhHHHHHHHHHHHHHhCC------------CCC
Q 015406 152 LAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE-QS-----RRDDLESLGYVLMYFLRGS------------LPW 213 (407)
Q Consensus 152 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~-----~~sDIwSlG~il~elltG~------------~Pf 213 (407)
+|..+..... ....-..+||.+|||||++.|.- +. .+.||||+|.+||||+++- +||
T Consensus 362 LAl~~~p~~~-----~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpf 436 (534)
T KOG3653|consen 362 LALRLEPGKP-----QGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPF 436 (534)
T ss_pred eeEEecCCCC-----CcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCch
Confidence 9998874332 12234579999999999998742 22 4689999999999999853 233
Q ss_pred CCC--CcCchHHHHHHHhhhcccccHHHHhcC--CcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHH
Q 015406 214 QGL--KAGTKKQKYEKISEKKVSTSIEALCRG--YPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (407)
Q Consensus 214 ~~~--~~~~~~~~~~~i~~~~~~~~~~~~~~~--~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~ 277 (407)
+.. ......+....+..++..+.++..+.. -..-+.+.++.||+.|++.|.|+.-+.+.+.++.
T Consensus 437 e~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 437 EAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred hHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 310 111223333334444444433333322 3456899999999999999999999888887763
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=289.72 Aligned_cols=255 Identities=21% Similarity=0.272 Sum_probs=209.3
Q ss_pred eeEeccccccCceEEEEEEEcCCCe----EEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 9 FRLGRKIGSGSFGEIYLGTNIQTNE----EVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 9 y~i~~~iG~G~~g~Vy~~~~~~~~~----~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
.+..++||+|+||+||+|.+...|+ +||||++..... ..+++.|+-+|..|.|++.+ .+.++..... .-||
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~-RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLL-RLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHH-HHhhhcccch-HHHH
Confidence 4557899999999999999876554 789998765433 45689999999999985544 4444444333 6799
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 82 me~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
.+|+ .|+|.++++.++.++..+..+.|..||++||.|||++++|||||-.+|||+ ....++||.|||+++.+....
T Consensus 776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLV---ksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLV---KSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheee---cCCCeEEEEecchhhccCccc
Confidence 9999 999999999988899999999999999999999999999999999999999 788999999999999887655
Q ss_pred CCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHH
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (407)
..-+. ....-.+.|||-|.+....|+.++|||||||++||++| |..||.+....+....+++-.+ ++
T Consensus 853 ~ey~~-----~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR--Ls----- 920 (1177)
T KOG1025|consen 853 KEYSA-----PGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER--LS----- 920 (1177)
T ss_pred ccccc-----cccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc--CC-----
Confidence 43221 22233578999999999999999999999999999999 9999999877655555543322 11
Q ss_pred HhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHc
Q 015406 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (407)
Q Consensus 240 ~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~ 280 (407)
.++.++-+++-++.+||..|++.||+|+++...|..+....
T Consensus 921 qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 921 QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP 961 (1177)
T ss_pred CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence 22458899999999999999999999999999998877543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=318.05 Aligned_cols=249 Identities=14% Similarity=0.187 Sum_probs=188.1
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-C
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~-g 86 (407)
.|...+.||+|+||.||+|++..++..||||.+..... ....|++++++++| ++++.+.+++.+.+..|+||||+ +
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~l~~l~H-pnIv~~~~~~~~~~~~~lv~Ey~~~ 767 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS--IPSSEIADMGKLQH-PNIVKLIGLCRSEKGAYLIHEYIEG 767 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc--ccHHHHHHHhhCCC-CCcceEEEEEEcCCCCEEEEeCCCC
Confidence 45667789999999999999989999999998764332 23457888888876 67777777778888899999999 9
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCc
Q 015406 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (407)
Q Consensus 87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~ 163 (407)
++|.++++ .+++..+..|+.||+.||+||| +.+|+||||||+||++ +.++..++. ||.+.....
T Consensus 768 g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~---~~~~~~~~~-~~~~~~~~~----- 834 (968)
T PLN00113 768 KNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII---DGKDEPHLR-LSLPGLLCT----- 834 (968)
T ss_pred CcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEE---CCCCceEEE-ecccccccc-----
Confidence 99999996 4899999999999999999999 6799999999999999 455666664 665543221
Q ss_pred ccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCc-hHHHHHHHhh-h-c----cccc
Q 015406 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT-KKQKYEKISE-K-K----VSTS 236 (407)
Q Consensus 164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~-~~~~~~~i~~-~-~----~~~~ 236 (407)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+.+... . . ..+.
T Consensus 835 ------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (968)
T PLN00113 835 ------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPS 908 (968)
T ss_pred ------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCcc
Confidence 123368899999999999999999999999999999999999995432111 0111111000 0 0 0000
Q ss_pred HH---HHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Q 015406 237 IE---ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (407)
Q Consensus 237 ~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~ 278 (407)
.. ........++.+++.+||+.+|++||++.++.+.|+++..
T Consensus 909 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred ccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 00 0001123467889999999999999999999999988754
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=271.65 Aligned_cols=133 Identities=26% Similarity=0.463 Sum_probs=113.5
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-cchHHHHHHHHHHHcCCC-------CCCeeEEee----
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGGT-------GIPNVRWFG---- 72 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~E~~~l~~l~~~~-------~i~~~~~~~---- 72 (407)
-+++|.+.++||.|.|++||+|.+..+.+.||+|+.+.... .+..+.|+++|+.++.+. +|+.+...+
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 35899999999999999999999999999999999876543 345788999999987533 444444333
Q ss_pred eeCceeEEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCccccc
Q 015406 73 VEGDYNVLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMG 137 (407)
Q Consensus 73 ~~~~~~~lvme~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~-~~ivHrDLKp~NILl~ 137 (407)
..+...|||+|++|.+|..+|.+.. +.++...+..|+.||+.||.|||. .||||-||||+||||.
T Consensus 156 pNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 156 PNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred CCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 3677899999999999999998765 459999999999999999999996 6999999999999994
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=293.83 Aligned_cols=245 Identities=20% Similarity=0.231 Sum_probs=192.5
Q ss_pred eccccccCceE-EEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEeccCCCHH
Q 015406 12 GRKIGSGSFGE-IYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLE 90 (407)
Q Consensus 12 ~~~iG~G~~g~-Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~g~sL~ 90 (407)
.+.+|.|+.|+ ||+|. -.|+.||||.+-. .......+|+..++.-..|+|+..+++...+..+.||+.|+|..+|.
T Consensus 514 ~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~-e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~sL~ 590 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGV--YEGREVAVKRLLE-EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCACSLQ 590 (903)
T ss_pred HHHcccCCCCcEEEEEe--eCCceehHHHHhh-HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhhhHH
Confidence 45688998884 79999 5688999996533 23445789999999999999998888888899999999999999999
Q ss_pred HHHHHcCCC---CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCC--CCCceEEEEeccceeeeccCCCCccc
Q 015406 91 DLFNFCSRK---LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG--RRANQVYIIDFGLAKKYRDTSTHQHI 165 (407)
Q Consensus 91 ~~l~~~~~~---l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~--~~~~~~kL~DFGla~~~~~~~~~~~~ 165 (407)
++++..... ......+.++.|++.||++||+.+||||||||+||||+.. +...+++|+|||+++++......
T Consensus 591 dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS--- 667 (903)
T KOG1027|consen 591 DLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSS--- 667 (903)
T ss_pred HHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcch---
Confidence 999863111 1224568899999999999999999999999999999743 23468899999999988765543
Q ss_pred CccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCC
Q 015406 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 244 (407)
Q Consensus 166 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (407)
++...+..||.+|+|||++.....+.++|||||||++|+.++ |.+||.+.. +.-..|...... ...+....
T Consensus 668 -~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~-----~R~~NIl~~~~~--L~~L~~~~ 739 (903)
T KOG1027|consen 668 -FSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL-----ERQANILTGNYT--LVHLEPLP 739 (903)
T ss_pred -hhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchH-----HhhhhhhcCccc--eeeeccCc
Confidence 344678899999999999999888899999999999999999 599996532 222333332211 11111111
Q ss_pred cHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015406 245 PTEFASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 245 ~~~l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
..+..+||.+|++.+|..||++.++.
T Consensus 740 d~eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 740 DCEAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred hHHHHHHHHHhcCCCcccCCCHHHHh
Confidence 22889999999999999999988875
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=246.33 Aligned_cols=212 Identities=22% Similarity=0.284 Sum_probs=172.4
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEec
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~ 84 (407)
...-+..||+|+||.|-+-++..+|...|+|.+...-. ..++++|+.+..+...++.++.+++........+|.||.
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~ 126 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL 126 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence 34456789999999999999999999999998765433 334777888777777777777766655566678999999
Q ss_pred cCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 85 LGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 85 ~g~sL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~-~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
+..||..+..+ .++.+++..+-+|+..++.||.|||++ .+||||+||+|||| +.+|++|+||||.+-.+.++.
T Consensus 127 M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLI---n~~GqVKiCDFGIsG~L~dSi 203 (282)
T KOG0984|consen 127 MDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILI---NYDGQVKICDFGISGYLVDSI 203 (282)
T ss_pred hhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEE---ccCCcEEEcccccceeehhhh
Confidence 99999887653 356799999999999999999999985 89999999999999 799999999999998877654
Q ss_pred CCcccCccCCCCccccccccccccccC----CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhc
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHLG----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~----~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (407)
. .+.-.|-..|||||.+.. ..|+-++||||||+++.||.+++.||..- .+..+.+.++.+..
T Consensus 204 A--------kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w--~tpF~qLkqvVeep 269 (282)
T KOG0984|consen 204 A--------KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW--GTPFQQLKQVVEEP 269 (282)
T ss_pred H--------HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc--CCHHHHHHHHhcCC
Confidence 3 123468889999998863 36899999999999999999999999753 34456666655543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=255.28 Aligned_cols=236 Identities=25% Similarity=0.345 Sum_probs=190.0
Q ss_pred CceEEEEEEEcCCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-CCCHHHHHH
Q 015406 19 SFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFN 94 (407)
Q Consensus 19 ~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~-g~sL~~~l~ 94 (407)
+||.||+|.+..+++.+|+|++..... ...+..|++.++.++| +++..+..+.......+++|||+ +++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKH-PNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCC-CcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 589999999988899999999876554 4578899999999955 66767767777778899999999 669999998
Q ss_pred HcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcccCccCCCCcc
Q 015406 95 FCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174 (407)
Q Consensus 95 ~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~ 174 (407)
... .+++..++.++.+++.+|.|||+.+++|+||+|.||++ +.++.++|+|||.+........ .....
T Consensus 80 ~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~---~~~~~~~l~d~~~~~~~~~~~~--------~~~~~ 147 (244)
T smart00220 80 KRG-RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILL---DEDGHVKLADFGLARQLDPGGL--------LTTFV 147 (244)
T ss_pred hcc-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEE---CCCCcEEEccccceeeeccccc--------ccccc
Confidence 533 38999999999999999999999999999999999999 5678999999999987765421 23456
Q ss_pred ccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHH
Q 015406 175 GTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHY 254 (407)
Q Consensus 175 gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~ 254 (407)
++..|++||.+.+..++.++||||||+++|+|++|..||..... .......+....... ......++.++.+++.+
T Consensus 148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~i~~ 223 (244)
T smart00220 148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLELFKKIGKPKPPF--PPPEWKISPEAKDLIRK 223 (244)
T ss_pred CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHhccCCCC--ccccccCCHHHHHHHHH
Confidence 78899999999988899999999999999999999999976322 222233222222111 11111178899999999
Q ss_pred HhCCCCCCCCCHHHHHH
Q 015406 255 CRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 255 cl~~~p~~RPt~~~l~~ 271 (407)
||..+|++||++.++.+
T Consensus 224 ~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 224 LLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HccCCchhccCHHHHhh
Confidence 99999999999888765
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=273.39 Aligned_cols=209 Identities=22% Similarity=0.278 Sum_probs=177.0
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCC-CCcchHHHHHHHHHHHcCC-----CCCCeeEEeeeeCce
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-TKHPQLLYESKLYRILQGG-----TGIPNVRWFGVEGDY 77 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-~~~~~~~~E~~~l~~l~~~-----~~i~~~~~~~~~~~~ 77 (407)
.+..+|.+....|+|-|++|.+|.+...|..||||++... ..+..=+.|+++|++|... .++..+.-.+...+.
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 4578999999999999999999999999999999998754 4566678999999999743 234444455667788
Q ss_pred eEEEEeccCCCHHHHHHHcCCC--CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceee
Q 015406 78 NVLVMDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (407)
Q Consensus 78 ~~lvme~~g~sL~~~l~~~~~~--l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~ 155 (407)
+|||+|-+.-+|.++++..+.. |....+..++.|+..||..|-..||+|.||||+|||+. ...+.+||||||.|..
T Consensus 509 LClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVN--E~k~iLKLCDfGSA~~ 586 (752)
T KOG0670|consen 509 LCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVN--ESKNILKLCDFGSASF 586 (752)
T ss_pred eEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEec--cCcceeeeccCccccc
Confidence 9999999999999999876543 78899999999999999999999999999999999996 5678899999999987
Q ss_pred eccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHH
Q 015406 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ 223 (407)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~ 223 (407)
..+... +.+.-+..|.|||++.|.+|+...|+||.||+||||.||+..|.+........
T Consensus 587 ~~enei---------tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLr 645 (752)
T KOG0670|consen 587 ASENEI---------TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLR 645 (752)
T ss_pred cccccc---------cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHH
Confidence 655432 23344678999999999999999999999999999999999999876654433
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=246.44 Aligned_cols=250 Identities=19% Similarity=0.300 Sum_probs=193.3
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeee--eCceeEEEEe
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGV--EGDYNVLVMD 83 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~--~~~~~~lvme 83 (407)
.++|++.+++|+|-|++||.|.+..+++.++||+++.- ....+.+|+.+|+.|.++++|..+..... ......|++|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE 115 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE 115 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence 46899999999999999999999999999999998753 45678999999999998888888766654 3456689999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 84 ~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
|. +.+...+.. .++..+++.++.|++.||.|+|++||+|||+||.|++|+ .....++|+|+|+|..+.....
T Consensus 116 ~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmId--h~~rkLrlIDWGLAEFYHp~~e- 188 (338)
T KOG0668|consen 116 YVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKE- 188 (338)
T ss_pred hhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeec--hhhceeeeeecchHhhcCCCce-
Confidence 99 777776665 588899999999999999999999999999999999995 4456799999999987654332
Q ss_pred cccCccCCCCccccccccccccccCC-CCChhhHHHHHHHHHHHHHhCCCCCCCC-CcCchHHHHHHHhhh---------
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGL-KAGTKKQKYEKISEK--------- 231 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDIwSlG~il~elltG~~Pf~~~-~~~~~~~~~~~i~~~--------- 231 (407)
.+..+.+..|--||.+..- .|+..-|+|||||+|..|+..+.||..- +..+..-++.++...
T Consensus 189 -------YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 189 -------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNK 261 (338)
T ss_pred -------eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHH
Confidence 2344667778899998864 4789999999999999999999998542 222222222211110
Q ss_pred ---cccccHHH------------Hh----c-CCcHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015406 232 ---KVSTSIEA------------LC----R-GYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 232 ---~~~~~~~~------------~~----~-~~~~~l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
.+.+.... +. . -.+++..+++.++|..|-.+|+|+.|..
T Consensus 262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam 320 (338)
T KOG0668|consen 262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAM 320 (338)
T ss_pred HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHh
Confidence 01111111 00 1 1368999999999999999999987654
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=275.29 Aligned_cols=255 Identities=18% Similarity=0.184 Sum_probs=176.2
Q ss_pred cCCceeEeccccccCceEEEEEEEc----------------CCCeEEEEEEecCCCC----------------cchHHHH
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNI----------------QTNEEVAIKLENVKTK----------------HPQLLYE 52 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~----------------~~~~~vAvK~~~~~~~----------------~~~~~~E 52 (407)
-.++|++.++||+|+||.||+|... ..++.||||.+..... ......|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 3578999999999999999999752 2356799998764321 1223456
Q ss_pred HHHHHHHcCCCCCC----eeEEeee--------eCceeEEEEecc-CCCHHHHHHHcC----------------------
Q 015406 53 SKLYRILQGGTGIP----NVRWFGV--------EGDYNVLVMDLL-GPSLEDLFNFCS---------------------- 97 (407)
Q Consensus 53 ~~~l~~l~~~~~i~----~~~~~~~--------~~~~~~lvme~~-g~sL~~~l~~~~---------------------- 97 (407)
+.++.+++|++.+. .+..++. ..+..+|||||+ +++|.++++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 67777777655422 2222221 235679999999 999999886421
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcccCccCCCCcccc
Q 015406 98 -RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGT 176 (407)
Q Consensus 98 -~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt 176 (407)
..+++..++.++.|++.||.|||+++|+||||||+|||+ +.++.+||+|||+++........ ......+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl---~~~~~~kL~DFGla~~~~~~~~~------~~~~g~~t 373 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLV---TVDGQVKIIDFGAAVDMCTGINF------NPLYGMLD 373 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEE---CCCCcEEEEeCcCccccccCCcc------CccccCCC
Confidence 124677889999999999999999999999999999999 57789999999999765432210 01123457
Q ss_pred ccccccccccCCCC----------------------ChhhHHHHHHHHHHHHHhCCC-CCCCCCcCch--------HHHH
Q 015406 177 ARYASMNTHLGIEQ----------------------SRRDDLESLGYVLMYFLRGSL-PWQGLKAGTK--------KQKY 225 (407)
Q Consensus 177 ~~Y~aPE~~~~~~~----------------------~~~sDIwSlG~il~elltG~~-Pf~~~~~~~~--------~~~~ 225 (407)
+.|+|||.+..... ..+.||||+||++|+|++|.+ ||.+...... ...+
T Consensus 374 p~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~ 453 (507)
T PLN03224 374 PRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRW 453 (507)
T ss_pred cceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHH
Confidence 89999999864321 124699999999999999876 7754321110 1111
Q ss_pred HHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCC---CCCCCHHHHHH
Q 015406 226 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRF---DDKPDYAYLKR 271 (407)
Q Consensus 226 ~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p---~~RPt~~~l~~ 271 (407)
..+...... .......++..++|+.+||..+| .+|++++++++
T Consensus 454 r~~~~~~~~---~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 454 RMYKGQKYD---FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred HhhcccCCC---cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 111111111 11235578999999999999876 68999776653
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=251.50 Aligned_cols=264 Identities=20% Similarity=0.299 Sum_probs=205.0
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCC-CCcchHHHHHHHHHHHcCCCCCCe-eEEeeeeCceeEEE
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-TKHPQLLYESKLYRILQGGTGIPN-VRWFGVEGDYNVLV 81 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-~~~~~~~~E~~~l~~l~~~~~i~~-~~~~~~~~~~~~lv 81 (407)
.+.+.|.|.+.||+|-||.+-+++++.++..+++|.+... ....+|.+|...--.|.+|.+|.. +...++..+.++++
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 3567899999999999999999999999999999976543 344568888887777776665544 55667788899999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 82 me~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
|||+ .|+|..-+.. ..+.+.....++.|+++||.|||++++||||||.+||||-. .+..++||||||+.+..+...
T Consensus 101 qE~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~-~df~rvKlcDFG~t~k~g~tV 177 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFD-ADFYRVKLCDFGLTRKVGTTV 177 (378)
T ss_pred eccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEec-CCccEEEeeecccccccCcee
Confidence 9999 8999887763 45889999999999999999999999999999999999953 345699999999998654332
Q ss_pred CCcccCccCCCCccccccccccccccCCC-----CChhhHHHHHHHHHHHHHhCCCCCCCCCcC-chHHHHHHHhhhccc
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHLGIE-----QSRRDDLESLGYVLMYFLRGSLPWQGLKAG-TKKQKYEKISEKKVS 234 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-----~~~~sDIwSlG~il~elltG~~Pf~~~~~~-~~~~~~~~i~~~~~~ 234 (407)
. ...-+..|-+||...... ..+.+|||.||+++|.++||.+||+..... .....+.+....+..
T Consensus 178 ~----------~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~ 247 (378)
T KOG1345|consen 178 K----------YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP 247 (378)
T ss_pred h----------hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc
Confidence 1 223356789999875432 367899999999999999999999853222 223344444444433
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcC
Q 015406 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREG 281 (407)
Q Consensus 235 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~ 281 (407)
..+.....+++.+..+..+-+..+|++|--.-+.++.....+.+.-
T Consensus 248 -~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~ 293 (378)
T KOG1345|consen 248 -ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKL 293 (378)
T ss_pred -cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhh
Confidence 4445556789999999999999999999766667766666665443
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=257.30 Aligned_cols=259 Identities=19% Similarity=0.260 Sum_probs=202.5
Q ss_pred CceeEeccccccCceEEEEEEEcCC-----CeEEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeeeCcee
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQT-----NEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~-----~~~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 78 (407)
.++++...+-+|.||.||.|.++.. .+.|-+|.++..... ..++.|.-++..+.|++....+....++....
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P 363 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATP 363 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcc
Confidence 4678888899999999999976543 234556654432222 23667777777777766666666666778888
Q ss_pred EEEEecc-CCCHHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEec
Q 015406 79 VLVMDLL-GPSLEDLFNFCS-------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 150 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~~~-------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DF 150 (407)
++.+.+. -|+|..++..++ +.++..+...++.|++.|++|||++|+||.||..+|.+| ++.-++||+|=
T Consensus 364 ~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvI---dd~LqVkltDs 440 (563)
T KOG1024|consen 364 FVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVI---DDQLQVKLTDS 440 (563)
T ss_pred eEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhccee---hhheeEEeccc
Confidence 9999999 789999998553 237778889999999999999999999999999999999 68899999999
Q ss_pred cceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHh
Q 015406 151 GLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKIS 229 (407)
Q Consensus 151 Gla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~ 229 (407)
.+++.+-....+. -..+......|||||.+.+..|+.++|+||||++||||+| |+.||.+.++. +....+.
T Consensus 441 aLSRDLFP~DYhc-----LGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf---Em~~ylk 512 (563)
T KOG1024|consen 441 ALSRDLFPGDYHC-----LGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF---EMEHYLK 512 (563)
T ss_pred hhccccCcccccc-----cCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH---HHHHHHh
Confidence 9999765544321 1223344678999999999999999999999999999999 99999886653 3333333
Q ss_pred hhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHc
Q 015406 230 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (407)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~ 280 (407)
.+... ..+-+||+++..+|..||...|++||+++++...|.+.-...
T Consensus 513 dGyRl----aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 513 DGYRL----AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred cccee----cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 32211 122469999999999999999999999999999999876544
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=268.53 Aligned_cols=195 Identities=23% Similarity=0.365 Sum_probs=172.9
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC----------CcchHHHHHHHHHHHc--CCCCCCeeEEeeeeC
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----------KHPQLLYESKLYRILQ--GGTGIPNVRWFGVEG 75 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~----------~~~~~~~E~~~l~~l~--~~~~i~~~~~~~~~~ 75 (407)
.|..++.+|+|+||.|++|.++.+...|+||.+.++. .-..+-.|+.||..|+ .|+||..+..+++++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 4999999999999999999999999999999876543 1223678999999998 347777888899999
Q ss_pred ceeEEEEecc--CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccce
Q 015406 76 DYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (407)
Q Consensus 76 ~~~~lvme~~--g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla 153 (407)
+++||+||-. |-+|.++|.. +..+++.++..|+.||+.|+++||++||||||||-+||.+ +.+|.+||+|||.|
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~-kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenviv---d~~g~~klidfgsa 717 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEF-KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIV---DSNGFVKLIDFGSA 717 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhc-cCccchHHHHHHHHHHHhccccccccCceecccccccEEE---ecCCeEEEeeccch
Confidence 9999999998 6689999986 5579999999999999999999999999999999999999 79999999999999
Q ss_pred eeeccCCCCcccCccCCCCccccccccccccccCCCC-ChhhHHHHHHHHHHHHHhCCCCCCC
Q 015406 154 KKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQG 215 (407)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~sDIwSlG~il~elltG~~Pf~~ 215 (407)
....... ...++||..|+|||++.|..| +..-|||+||++||-++....||+.
T Consensus 718 a~~ksgp---------fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 718 AYTKSGP---------FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhcCCC---------cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 7665543 357899999999999999988 7778999999999999999999864
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=253.63 Aligned_cols=254 Identities=19% Similarity=0.273 Sum_probs=190.0
Q ss_pred CccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCC----CCcchHHHHHHHHHHHcCCCCCCeeEEeeee----
Q 015406 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQLLYESKLYRILQGGTGIPNVRWFGVE---- 74 (407)
Q Consensus 3 ~~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~---- 74 (407)
|....+.+-.+.||-|+||.||.+++..+|+.||+|.+..- .....+.+|.+++..++|.+.+..++.....
T Consensus 49 Pqqq~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~df 128 (449)
T KOG0664|consen 49 PQQQQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSF 128 (449)
T ss_pred ccccccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchH
Confidence 34455667788999999999999999999999999965321 1234578999999999986665554433221
Q ss_pred CceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEecccee
Q 015406 75 GDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (407)
Q Consensus 75 ~~~~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~ 154 (407)
-...|++.|++..+|..+|-. ...++.+.+.-+++||++||.|||+.+|+||||||.|.|+ +.+..+||||||+|+
T Consensus 129 FqEiYV~TELmQSDLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLV---NSNCvLKICDFGLAR 204 (449)
T KOG0664|consen 129 FQELYVLTELMQSDLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLV---NSNCILKICDFGLAR 204 (449)
T ss_pred HHHHHHHHHHHHhhhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEe---ccCceEEeccccccc
Confidence 123578999999999988874 5579999999999999999999999999999999999999 688899999999999
Q ss_pred eeccCCCCcccCccCCCCccccccccccccccCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcc
Q 015406 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (407)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (407)
..+.... .+ .+..+-|..|.|||.+.|. .|+.+.||||.|||+.||+.++..|+..++- +.++.|.+..-
T Consensus 205 vee~d~~-~h-----MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Pi---qQL~lItdLLG 275 (449)
T KOG0664|consen 205 TWDQRDR-LN-----MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPI---EQLQMIIDLLG 275 (449)
T ss_pred ccchhhh-hh-----hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChH---HHHHHHHHHhC
Confidence 6554332 11 2344668899999999985 5899999999999999999999999875543 33333222111
Q ss_pred cccHHH------------------------Hhc-----CCcHHHHHHHHHHhCCCCCCCCCHHHH
Q 015406 234 STSIEA------------------------LCR-----GYPTEFASYFHYCRSLRFDDKPDYAYL 269 (407)
Q Consensus 234 ~~~~~~------------------------~~~-----~~~~~l~~li~~cl~~~p~~RPt~~~l 269 (407)
.+..+. +.. .-..+...++..++..||++|.+..+.
T Consensus 276 TPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A 340 (449)
T KOG0664|consen 276 TPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEA 340 (449)
T ss_pred CCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhh
Confidence 111111 100 112456778888999999999875443
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=231.83 Aligned_cols=208 Identities=28% Similarity=0.433 Sum_probs=180.7
Q ss_pred ccccCceEEEEEEEcCCCeEEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-CCCHH
Q 015406 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLE 90 (407)
Q Consensus 15 iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~-g~sL~ 90 (407)
||+|++|.||++.+..+++.+++|+....... ..+.+|++.++.+++ +++..+..+.......+++||++ +++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNH-PNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCC-CCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 68999999999998878999999998876553 678999999999987 77777777777778899999999 69999
Q ss_pred HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCC-CceEEEEeccceeeeccCCCCcccCccC
Q 015406 91 DLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR-ANQVYIIDFGLAKKYRDTSTHQHIPYRE 169 (407)
Q Consensus 91 ~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~ 169 (407)
+++......++...++.++.+++.+|.+||++|++|+||+|.||++ +. .+.++|+|||.+........ .
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~---~~~~~~~~l~d~~~~~~~~~~~~-------~ 149 (215)
T cd00180 80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILL---DSDNGKVKLADFGLSKLLTSDKS-------L 149 (215)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEE---eCCCCcEEEecCCceEEccCCcc-------h
Confidence 9998643568999999999999999999999999999999999999 45 68999999999987655421 1
Q ss_pred CCCccccccccccccccCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcHHH
Q 015406 170 NKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEF 248 (407)
Q Consensus 170 ~~~~~gt~~Y~aPE~~~~~-~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l 248 (407)
.....+...|++||.+... .++.++|+|+||+++++| ..+
T Consensus 150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------~~~ 190 (215)
T cd00180 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------PEL 190 (215)
T ss_pred hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------HHH
Confidence 1235678899999999887 788999999999999999 578
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHH
Q 015406 249 ASYFHYCRSLRFDDKPDYAYLKRI 272 (407)
Q Consensus 249 ~~li~~cl~~~p~~RPt~~~l~~~ 272 (407)
.+++..|+..+|++||++.++.+.
T Consensus 191 ~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 191 KDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHhhCCcccCcCHHHHhhC
Confidence 999999999999999998887653
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-32 Score=252.40 Aligned_cols=262 Identities=24% Similarity=0.396 Sum_probs=202.4
Q ss_pred CccCCceeEeccccccCceEEEEEEEcC---CCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeE
Q 015406 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQ---TNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 3 ~~~~~~y~i~~~iG~G~~g~Vy~~~~~~---~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 79 (407)
|.+.+.|.++++||+|+|+.||++.+.. ..+.||+|.+........+..|+++|..+.+..++..+..+...++...
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 4567889999999999999999999877 7889999998887777889999999999999999999999999999999
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 80 lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
+||||+ .....++.. .++...+..+++.++.||.++|.+|||||||||.|+|.+ ...+.-.|+|||+|.....
T Consensus 112 ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n--~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYN--RRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred EEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccc--cccCCceEEechhHHHHHh
Confidence 999999 777777776 578999999999999999999999999999999999996 5667789999999972211
Q ss_pred CC------C----------Cccc------------Cc---------cCCCCccccccccccccccCCC-CChhhHHHHHH
Q 015406 159 TS------T----------HQHI------------PY---------RENKNLTGTARYASMNTHLGIE-QSRRDDLESLG 200 (407)
Q Consensus 159 ~~------~----------~~~~------------~~---------~~~~~~~gt~~Y~aPE~~~~~~-~~~~sDIwSlG 200 (407)
.. . .... .+ .......||++|.|||++...+ .+.++||||.|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 00 0 0000 00 1123457999999999998654 68999999999
Q ss_pred HHHHHHHhCCCCCCCCCcCch--HHH--------HHH---Hhhh-----------------cccc--------------c
Q 015406 201 YVLMYFLRGSLPWQGLKAGTK--KQK--------YEK---ISEK-----------------KVST--------------S 236 (407)
Q Consensus 201 ~il~elltG~~Pf~~~~~~~~--~~~--------~~~---i~~~-----------------~~~~--------------~ 236 (407)
+|+.-++++.+||....++.. .+. +.+ .... .+.. .
T Consensus 266 VI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~ 345 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE 345 (418)
T ss_pred ceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence 999999999999965333210 000 000 0000 0000 0
Q ss_pred HHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015406 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 237 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
.......+|..+.+++.+|++.||.+|.++++.+
T Consensus 346 ~~~~~d~~~~~~~dlLdk~le~np~kRitAEeAL 379 (418)
T KOG1167|consen 346 REIGSDVFPALLLDLLDKCLELNPQKRITAEDAL 379 (418)
T ss_pred eccccccccHHHHHHHHHHccCChhhcccHHHHh
Confidence 0111122456899999999999999999987764
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-32 Score=243.05 Aligned_cols=247 Identities=21% Similarity=0.243 Sum_probs=191.8
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCC----CCcchHHHHHHHHHHHcCCCCCCeeEEeee-----eC
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQLLYESKLYRILQGGTGIPNVRWFGV-----EG 75 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~-----~~ 75 (407)
+..+|.-++.+|.|.- .|..+.+...+++||+|..... ...++..+|..++..+.|.+.+..+..+.. +-
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 3467888899999998 8888999899999999965432 234557889999999999777776665543 23
Q ss_pred ceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceee
Q 015406 76 DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (407)
Q Consensus 76 ~~~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~ 155 (407)
...|+|||++..+|.+.+.. .++-.++..|+.|+++|++|||+.||+||||||+||++ ..+..+||.|||+|+.
T Consensus 94 ~e~y~v~e~m~~nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv---~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 94 QEVYLVMELMDANLCQVILM---ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVV---NSDCTLKILDFGLART 167 (369)
T ss_pred HhHHHHHHhhhhHHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhcceeecccCccccee---cchhheeeccchhhcc
Confidence 45699999999999999873 57889999999999999999999999999999999999 6889999999999986
Q ss_pred eccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcc--
Q 015406 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-- 233 (407)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-- 233 (407)
-.... ..+..+.|..|.|||++.+..|...+||||+||++.||++|...|.+.+. ...+.++.+..-
T Consensus 168 e~~~~--------~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~---idQ~~ki~~~lgtp 236 (369)
T KOG0665|consen 168 EDTDF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDH---IDQWNKIIEQLGTP 236 (369)
T ss_pred cCccc--------ccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchH---HHHHHHHHHHhcCC
Confidence 54431 13466889999999999999999999999999999999999999986432 222222211100
Q ss_pred -----------------------cccHHHHhc------------CCcHHHHHHHHHHhCCCCCCCCCHHHH
Q 015406 234 -----------------------STSIEALCR------------GYPTEFASYFHYCRSLRFDDKPDYAYL 269 (407)
Q Consensus 234 -----------------------~~~~~~~~~------------~~~~~l~~li~~cl~~~p~~RPt~~~l 269 (407)
......+.+ .-..-+.+++.+||..||++|-+++++
T Consensus 237 d~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~da 307 (369)
T KOG0665|consen 237 DPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDA 307 (369)
T ss_pred CHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHH
Confidence 000111111 113447899999999999999995544
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-32 Score=264.55 Aligned_cols=250 Identities=18% Similarity=0.277 Sum_probs=199.5
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC--CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
.++|+++..+|+|+||.||+++++.+++..|+|+++... ....+..|+-+++..+|++++..+..| ...+..+++||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsy-lr~dklwicME 92 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSY-LRRDKLWICME 92 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhh-hhhcCcEEEEE
Confidence 578999999999999999999999999999999887643 344577888899988886655554443 45566799999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 84 ~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
|| ||+|.+..+- .+.+++.++....+..+.||+|||++|-+|||||-.|||+ .+.+.+||.|||.+..+.....
T Consensus 93 ycgggslQdiy~~-TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanill---td~gDvklaDfgvsaqitati~- 167 (829)
T KOG0576|consen 93 YCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILL---TDEGDVKLADFGVSAQITATIA- 167 (829)
T ss_pred ecCCCcccceeee-cccchhHHHHHHHhhhhccchhhhcCCcccccccccceee---cccCceeecccCchhhhhhhhh-
Confidence 99 8899988763 5689999999999999999999999999999999999999 5889999999999876654332
Q ss_pred cccCccCCCCcccccccccccccc---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHH
Q 015406 163 QHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (407)
....+.||+.|||||+.. ...|...+|||++|++..|+-.-+.|-.+.... +.+.-.....+.++..+
T Consensus 168 ------KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm---r~l~LmTkS~~qpp~lk 238 (829)
T KOG0576|consen 168 ------KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM---RALFLMTKSGFQPPTLK 238 (829)
T ss_pred ------hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH---HHHHHhhccCCCCCccc
Confidence 245789999999999864 457899999999999999998888887654432 22222222222222222
Q ss_pred HhcCCcHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015406 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 240 ~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
-....++.|.+|++.|+.++|.+||+++.++
T Consensus 239 Dk~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred CCccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 2345678899999999999999999987664
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-29 Score=224.73 Aligned_cols=197 Identities=29% Similarity=0.443 Sum_probs=166.4
Q ss_pred eeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC---CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc
Q 015406 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (407)
Q Consensus 9 y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~ 85 (407)
|.+.+.||+|++|.||++.+..+++.+|+|.+.... ....+.+|++.++.+++ +++..+..+.......++++|++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~-~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKH-PNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCC-CChhhheeeeecCCceEEEEecc
Confidence 678899999999999999998889999999987654 34567889999999976 56666666666778889999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcc
Q 015406 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164 (407)
Q Consensus 86 -g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~ 164 (407)
+++|.+++......+++..+..++.+++.+|.+||+++++|+||+|.||++ +..+.++|+|||++.........
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v---~~~~~~~l~d~g~~~~~~~~~~~-- 154 (225)
T smart00221 80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILL---GMDGLVKLADFGLARFIHRDLAA-- 154 (225)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeeCceeeEecCcccc--
Confidence 669999998643338999999999999999999999999999999999999 56689999999999877554210
Q ss_pred cCccCCCCccccccccccccc-cCCCCChhhHHHHHHHHHHHHHhCCCCCCC
Q 015406 165 IPYRENKNLTGTARYASMNTH-LGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215 (407)
Q Consensus 165 ~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~~sDIwSlG~il~elltG~~Pf~~ 215 (407)
......++..|++||.+ ....++.++|||+||+++|+|++|+.||..
T Consensus 155 ----~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 ----LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ----cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 12345678899999998 666778899999999999999999999955
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=219.70 Aligned_cols=166 Identities=17% Similarity=0.185 Sum_probs=128.8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcccC
Q 015406 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166 (407)
Q Consensus 87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~ 166 (407)
|+|.+++...+..+++..++.|+.||+.||.|||+++ ||+|||+ +.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~---~~~~~~~~--fG~~~~~~~~------- 62 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILL---TWDGLLKL--DGSVAFKTPE------- 62 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeE---cCccceee--ccceEeeccc-------
Confidence 6899999865667999999999999999999999998 9999999 57888998 9999876432
Q ss_pred ccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHH--HHhcCC
Q 015406 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE--ALCRGY 244 (407)
Q Consensus 167 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~~~ 244 (407)
...||+.|||||++.+..++.++|||||||++|||++|..||...... ...+..+.......... .....+
T Consensus 63 -----~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 135 (176)
T smart00750 63 -----QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL--SAILEILLNGMPADDPRDRSNLESV 135 (176)
T ss_pred -----cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--cHHHHHHHHHhccCCccccccHHHH
Confidence 225889999999999999999999999999999999999999754321 12222222211111000 011123
Q ss_pred cH--HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHH
Q 015406 245 PT--EFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (407)
Q Consensus 245 ~~--~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~ 277 (407)
+. ++.+++.+||..+|++||++.++.+.+..+.
T Consensus 136 ~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 136 SAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 33 6999999999999999999999988776554
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-30 Score=272.70 Aligned_cols=187 Identities=14% Similarity=0.168 Sum_probs=134.4
Q ss_pred CceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccC----------------
Q 015406 75 GDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL---------------- 138 (407)
Q Consensus 75 ~~~~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~---------------- 138 (407)
...++++||+++++|.+++......+++..++.|+.||+.||+|||++|||||||||+||||+.
T Consensus 52 ~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~ 131 (793)
T PLN00181 52 DDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSG 131 (793)
T ss_pred cchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCccc
Confidence 3457888999999999999865566999999999999999999999999999999999999942
Q ss_pred CCCCceEEEEeccceeeeccCCCC--------cccCc-cCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhC
Q 015406 139 GRRANQVYIIDFGLAKKYRDTSTH--------QHIPY-RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRG 209 (407)
Q Consensus 139 ~~~~~~~kL~DFGla~~~~~~~~~--------~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG 209 (407)
.+.++.+||+|||+++........ ...+. .......||+.|||||++.+..++.++|||||||+||||++|
T Consensus 132 ~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~ 211 (793)
T PLN00181 132 SDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCP 211 (793)
T ss_pred ccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhC
Confidence 123445667777776543211000 00000 001124689999999999999999999999999999999999
Q ss_pred CCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015406 210 SLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 210 ~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
..|+... ...+..+.....+. .... ..++...++.+||..+|.+||++.+++
T Consensus 212 ~~~~~~~-----~~~~~~~~~~~~~~---~~~~-~~~~~~~~~~~~L~~~P~~Rps~~eil 263 (793)
T PLN00181 212 VSSREEK-----SRTMSSLRHRVLPP---QILL-NWPKEASFCLWLLHPEPSCRPSMSELL 263 (793)
T ss_pred CCchhhH-----HHHHHHHHHhhcCh---hhhh-cCHHHHHHHHHhCCCChhhCcChHHHh
Confidence 8887532 11222222211111 1111 234567899999999999999999885
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-27 Score=226.41 Aligned_cols=180 Identities=18% Similarity=0.192 Sum_probs=136.9
Q ss_pred CccCCceeEeccccccCceEEEEEEEcC-CCeEEEEEEecCCC-------CcchHHHHHHHHHHHcCCCCCCeeEEeeee
Q 015406 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQ-TNEEVAIKLENVKT-------KHPQLLYESKLYRILQGGTGIPNVRWFGVE 74 (407)
Q Consensus 3 ~~~~~~y~i~~~iG~G~~g~Vy~~~~~~-~~~~vAvK~~~~~~-------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~ 74 (407)
+.+.++|.+.+.||+|+||+||+|++.. +++.||||.+.... ....+.+|+++++.++|++.++.+..+
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 4567889999999999999999999876 67888999764321 123478999999999998877766553
Q ss_pred CceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccC-CCCcccccCCCCCceEEEEeccc
Q 015406 75 GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI-KPDNFLMGLGRRANQVYIIDFGL 152 (407)
Q Consensus 75 ~~~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDL-Kp~NILl~~~~~~~~~kL~DFGl 152 (407)
+..||||||+ |++|.. +. ... ...++.|++.||.|||++||+|||| ||+|||+ +.++.+||+|||+
T Consensus 91 -~~~~LVmE~~~G~~L~~-~~----~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv---~~~~~ikLiDFGl 158 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHL-AR----PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLM---GPDGEAAVIDFQL 158 (365)
T ss_pred -CCcEEEEEccCCCCHHH-hC----ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEE---cCCCCEEEEECcc
Confidence 3469999999 888863 21 111 1467899999999999999999999 9999999 4678899999999
Q ss_pred eeeeccCCCCccc-CccCCCCccccccccccccccCCCC------ChhhHHH
Q 015406 153 AKKYRDTSTHQHI-PYRENKNLTGTARYASMNTHLGIEQ------SRRDDLE 197 (407)
Q Consensus 153 a~~~~~~~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~------~~~sDIw 197 (407)
|+.+........+ .+.......+++.|+|||.+..... +..+|-|
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 9987665432221 1122246778999999999875432 3446666
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.8e-25 Score=206.96 Aligned_cols=257 Identities=30% Similarity=0.411 Sum_probs=194.7
Q ss_pred eeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc-----chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 9 y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
|.+.+.||.|+||.||++.+. ..+++|.+...... ..+.+|..++..+.+++++..+..++......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 788999999999999999976 78899987655433 3488899999999988667676666676666899999
Q ss_pred cc-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCc-eEEEEeccceeeeccC
Q 015406 84 LL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKYRDT 159 (407)
Q Consensus 84 ~~-g~sL~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~-~~kL~DFGla~~~~~~ 159 (407)
++ +++|.+++.... ..++...+..++.|++.+|.|+|+.+++||||||+||++ +..+ .++++|||.++.+...
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~---~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILL---DRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeee---cCCCCeEEEeccCcceecCCC
Confidence 99 899997777533 268999999999999999999999999999999999999 4555 7999999999865544
Q ss_pred CCCcccCccCCCCccccccccccccccC---CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcC-chHHHHHHHhhhcccc
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLG---IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-TKKQKYEKISEKKVST 235 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~-~~~~~~~~i~~~~~~~ 235 (407)
....... .......||..|+|||.+.+ ..++...|+||+|++++++++|..||...... ...+....+.......
T Consensus 156 ~~~~~~~-~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 234 (384)
T COG0515 156 GSTSSIP-ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234 (384)
T ss_pred Ccccccc-ccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcc
Confidence 3211000 12356789999999999998 57899999999999999999999998664431 1222233222222110
Q ss_pred cHHHHhcCC----cHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015406 236 SIEALCRGY----PTEFASYFHYCRSLRFDDKPDYAYLKRI 272 (407)
Q Consensus 236 ~~~~~~~~~----~~~l~~li~~cl~~~p~~RPt~~~l~~~ 272 (407)
......... ...+.+++..|+..+|..|.+.......
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 111111111 2578999999999999999987665543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.8e-26 Score=221.95 Aligned_cols=254 Identities=19% Similarity=0.245 Sum_probs=200.7
Q ss_pred cccccCceEEEEEEE---cCCCeEEEEEEecCCCCc----chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-
Q 015406 14 KIGSGSFGEIYLGTN---IQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (407)
Q Consensus 14 ~iG~G~~g~Vy~~~~---~~~~~~vAvK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~- 85 (407)
.+|+|.||.|++++. ...+.-+|+|+.++.... .....|..++..++.++.++.+...++.....++++++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999998763 245678899987654321 234568888888888899999999999999999999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCccc
Q 015406 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165 (407)
Q Consensus 86 g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~ 165 (407)
|+.|...+.. ...+.+.....+...++.|++++|+.+|+|||+|++||++ +.+|++++.|||+++..-...
T Consensus 81 gg~lft~l~~-~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enill---d~~Ghi~~tdfglske~v~~~----- 151 (612)
T KOG0603|consen 81 GGDLFTRLSK-EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLL---LLEGHIKLTDFGLSKEAVKEK----- 151 (612)
T ss_pred cchhhhcccc-CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceee---cccCccccCCchhhhHhHhhh-----
Confidence 8888777764 4468888999999999999999999999999999999999 799999999999998765433
Q ss_pred CccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCc
Q 015406 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 245 (407)
Q Consensus 166 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 245 (407)
..+||..|||||++. .....+|.||||++++||++|..||.. +....|....... +..+.
T Consensus 152 ------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------~~~~~Il~~~~~~-----p~~l~ 211 (612)
T KOG0603|consen 152 ------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------DTMKRILKAELEM-----PRELS 211 (612)
T ss_pred ------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------HHHHHHhhhccCC-----chhhh
Confidence 228999999999998 467889999999999999999999976 3444454433332 23356
Q ss_pred HHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHHHHcCCCCCCccccccchhhcccccCC
Q 015406 246 TEFASYFHYCRSLRFDDKPDY--AYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATP 303 (407)
Q Consensus 246 ~~l~~li~~cl~~~p~~RPt~--~~l~~~l~~l~~~~~~~~~~~~dw~~~~~~~~~~~~~ 303 (407)
....+++.+++..+|..|... ..+.+.. .+.+....||..+..++..++..
T Consensus 212 ~~a~~~~~~l~~r~p~nrLg~~~~~~~eik-------~h~f~~~i~~~~l~~r~~~~~fk 264 (612)
T KOG0603|consen 212 AEARSLFRQLFKRNPENRLGAGPDGVDEIK-------QHEFFQSIDWNELEARSRPPPFK 264 (612)
T ss_pred HHHHHHHHHHHhhCHHHHhccCcchhHHHh-------ccchheeeeHhhHhhcCCCCCCC
Confidence 788999999999999999654 2333333 33566788999888777555443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-25 Score=229.16 Aligned_cols=254 Identities=20% Similarity=0.244 Sum_probs=183.6
Q ss_pred eEeccccccCceEEEEEEEcCCCeEEEEEEecCC---CC-cc----hHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK---TK-HP----QLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 10 ~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---~~-~~----~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
...+.+|.|++|.|+.+......+.++.|..... .. .. .+..|.-+-..|.|.+.+..+..+..... .+-+
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~-~~~~ 399 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG-ILQS 399 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc-chhh
Confidence 4567899999999998887766666666644321 11 11 13334444455566554444433333222 2333
Q ss_pred EeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCC
Q 015406 82 MDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 82 me~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~ 161 (407)
||||.++|..++.. ...+...++..++.|++.|++|||+.||.|||||++|+++ ...+.+||+|||.+..+.....
T Consensus 400 mE~~~~Dlf~~~~~-~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~---~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 400 MEYCPYDLFSLVMS-NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLV---TENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hhcccHHHHHHHhc-ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEE---ecCCceEEeecCcceeeccCcc
Confidence 99994499999884 3479999999999999999999999999999999999999 5788999999999987655433
Q ss_pred CcccCccCCCCccccccccccccccCCCCCh-hhHHHHHHHHHHHHHhCCCCCCCCCcCchHH-HHHHHhhhcccccHHH
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSR-RDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ-KYEKISEKKVSTSIEA 239 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~-~sDIwSlG~il~elltG~~Pf~~~~~~~~~~-~~~~i~~~~~~~~~~~ 239 (407)
.. .......+|+..|+|||++.+.+|++ ..||||.|++++.|++|+.||......+... ................
T Consensus 476 ~~---~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~ 552 (601)
T KOG0590|consen 476 KN---IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNR 552 (601)
T ss_pred hh---hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHH
Confidence 21 12246789999999999999999965 5799999999999999999997644432211 1111112222334455
Q ss_pred HhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 240 ~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
+...+|.+.+.+|.+||+.+|.+|.|+++|.+
T Consensus 553 ~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 553 LLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred HHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 66778999999999999999999999776653
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.2e-24 Score=195.26 Aligned_cols=231 Identities=23% Similarity=0.256 Sum_probs=147.8
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcc-----hHHHHHHHHHHHcC----------CCCCCeeEEe-
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-----QLLYESKLYRILQG----------GTGIPNVRWF- 71 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~-----~~~~E~~~l~~l~~----------~~~i~~~~~~- 71 (407)
.+...+.||.|+++.||.+++..+++.+|+|+........ ++.+|.-....+.+ ...+.-++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 4567889999999999999999999999999865544221 23333222211111 0111111111
Q ss_pred -------ee---eCc-----eeEEEEeccCCCHHHHHHHc---CCC---CCHHHHHHHHHHHHHHHHHHHhCCceeccCC
Q 015406 72 -------GV---EGD-----YNVLVMDLLGPSLEDLFNFC---SRK---LSLKTVLMLADQMINRVEFVHSKSFLHRDIK 130 (407)
Q Consensus 72 -------~~---~~~-----~~~lvme~~g~sL~~~l~~~---~~~---l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLK 130 (407)
.. ... ..+++|+-+.++|.+++... ... +.....+.+..|+++.+++||++|+||+|||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 11 111 23688888899999986531 211 2334445667899999999999999999999
Q ss_pred CCcccccCCCCCceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccC--------CCCChhhHHHHHHHH
Q 015406 131 PDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG--------IEQSRRDDLESLGYV 202 (407)
Q Consensus 131 p~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~~~~sDIwSlG~i 202 (407)
|+|+++ +.+|.++|+||+.......... ....+..|.+||.... ..++.+.|.|+||++
T Consensus 173 ~~nfll---~~~G~v~Lg~F~~~~r~g~~~~----------~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ 239 (288)
T PF14531_consen 173 PENFLL---DQDGGVFLGDFSSLVRAGTRYR----------CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGIT 239 (288)
T ss_dssp GGGEEE----TTS-EEE--GGGEEETTEEEE----------GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHH
T ss_pred eeeEEE---cCCCCEEEcChHHHeecCceee----------ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHH
Confidence 999999 6899999999998876543211 0233577999997643 247899999999999
Q ss_pred HHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCC
Q 015406 203 LMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDK 263 (407)
Q Consensus 203 l~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 263 (407)
+|.|++|..||........... .-..|.++|+.++.||..+|+.||++|
T Consensus 240 ly~lWC~~lPf~~~~~~~~~~~------------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 240 LYSLWCGRLPFGLSSPEADPEW------------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHSS-STCCCGGGSTSGG------------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHccCCCCCCCccccccc------------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 9999999999986543221110 122455799999999999999999987
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=185.52 Aligned_cols=137 Identities=22% Similarity=0.216 Sum_probs=103.8
Q ss_pred eccccccCceEEEEEEEcCCCeEEEEEEecCCCC-----------cch-----------------HHHHHHHHHHHcCCC
Q 015406 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----------HPQ-----------------LLYESKLYRILQGGT 63 (407)
Q Consensus 12 ~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-----------~~~-----------------~~~E~~~l~~l~~~~ 63 (407)
.+.||+|+||.||+|.+. +|+.||||+++.... ... ...|.+++..+.+..
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 578999999999999986 899999998865421 011 134889999997633
Q ss_pred CCCeeEEeeeeCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH-HhCCceeccCCCCcccccCCCC
Q 015406 64 GIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV-HSKSFLHRDIKPDNFLMGLGRR 141 (407)
Q Consensus 64 ~i~~~~~~~~~~~~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yL-H~~~ivHrDLKp~NILl~~~~~ 141 (407)
++....+.. ...+|||||+ |+++...+.. ...++...+..++.|++.+|.|| |+.||+||||||+|||++
T Consensus 81 -v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~---- 152 (190)
T cd05147 81 -IPCPEPILL--KSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH---- 152 (190)
T ss_pred -CCCCcEEEe--cCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE----
Confidence 222222221 2238999999 5555544322 45799999999999999999999 799999999999999993
Q ss_pred CceEEEEeccceeeec
Q 015406 142 ANQVYIIDFGLAKKYR 157 (407)
Q Consensus 142 ~~~~kL~DFGla~~~~ 157 (407)
++.++|+|||+|....
T Consensus 153 ~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 DGKLYIIDVSQSVEHD 168 (190)
T ss_pred CCcEEEEEccccccCC
Confidence 4689999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6e-23 Score=213.26 Aligned_cols=253 Identities=23% Similarity=0.333 Sum_probs=185.7
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHc--CCCCCCeeEEeeeeCceeEEEEe
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ--GGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~--~~~~i~~~~~~~~~~~~~~lvme 83 (407)
++.|.|.+.||+|+||.||+|.... |+.||+|+.+.....+- .-=.+++.+|+ -.+.+-.+.......+.-+||+|
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEf-YI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~e 774 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEF-YICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSE 774 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceee-eehHHHHHhhchhhhcchHHHHHHHccCCcceeeee
Confidence 6789999999999999999999855 99999999876654432 22234444554 11222233333445566689999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccC----CCCCceEEEEeccceeeecc
Q 015406 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL----GRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 84 ~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~----~~~~~~~kL~DFGla~~~~~ 158 (407)
|. .|+|.++++ ..+.+++..+..+..|++.-++.||..+|||+||||+|+||.. +.+...++|+|||.+..+.-
T Consensus 775 y~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~l 853 (974)
T KOG1166|consen 775 YSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKL 853 (974)
T ss_pred ccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeE
Confidence 99 999999999 4667999999999999999999999999999999999999953 12345789999999976543
Q ss_pred CCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHH
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (407)
-... ......++|-.+-.+|+..|.+++...|.|.|..+++-||.|++-= ...+. .....+...
T Consensus 854 fp~~-----~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q--~~~g~---------~~~~~~~~~ 917 (974)
T KOG1166|consen 854 FPDG-----TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME--VKNGS---------SWMVKTNFP 917 (974)
T ss_pred cCCC-----cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH--hcCCc---------ceeccccch
Confidence 3322 1245678899999999999999999999999999999999986421 00000 000001111
Q ss_pred HHhcCCc-HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHc
Q 015406 239 ALCRGYP-TEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (407)
Q Consensus 239 ~~~~~~~-~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~ 280 (407)
.+ .- +-..+++..+|..|-+.-|...+|+..|+..+.+.
T Consensus 918 Ry---~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~ 957 (974)
T KOG1166|consen 918 RY---WKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEH 957 (974)
T ss_pred hh---hhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHH
Confidence 11 11 22457888888866677788899999988887655
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.5e-24 Score=217.15 Aligned_cols=241 Identities=23% Similarity=0.338 Sum_probs=166.9
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~ 85 (407)
..+|..++.|..|+||.||+++++.+.+.+|+|+-+. + -+++. +. ..-+..+.|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq-~---------lilRn-----il-------t~a~npfvv---- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ-N---------LILRN-----IL-------TFAGNPFVV---- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhccccc-c---------hhhhc-----cc-------cccCCccee----
Confidence 4679999999999999999999999999999975322 1 11111 00 000111222
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCc--
Q 015406 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ-- 163 (407)
Q Consensus 86 g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~-- 163 (407)
|+-..+++. -+.++.+ ++.+++|||+.||+|||+||+|.+| ..-|++|++|||+++.........
T Consensus 136 -gDc~tllk~-~g~lPvd--------mvla~Eylh~ygivhrdlkpdnllI---T~mGhiKlTDfgLsk~GLms~atnl~ 202 (1205)
T KOG0606|consen 136 -GDCATLLKN-IGPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKKGLMSLATNLK 202 (1205)
T ss_pred -chhhhhccc-CCCCcch--------hhHHhHhhccCCeecCCCCCCccee---eecccccccchhhhhhhhhhccchhh
Confidence 444555553 2344433 3789999999999999999999999 688999999999998543221110
Q ss_pred --ccC----ccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccH
Q 015406 164 --HIP----YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (407)
Q Consensus 164 --~~~----~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (407)
++. -...+..+||+.|.|||++....|+..+|+|++|+|+||++.|..||.+... .+.+..+.......+.
T Consensus 203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp---eelfg~visd~i~wpE 279 (1205)
T KOG0606|consen 203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP---EELFGQVISDDIEWPE 279 (1205)
T ss_pred hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH---HHHHhhhhhhhccccc
Confidence 000 0123567999999999999999999999999999999999999999988544 4444444333222111
Q ss_pred HHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchhhc
Q 015406 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQ 297 (407)
Q Consensus 238 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~~~ 297 (407)
. -..++++.++++.++|..+|..|-.... .+.-..+.++..+||..+-.|+
T Consensus 280 ~--dea~p~Ea~dli~~LL~qnp~~Rlgt~g-------a~evk~h~ff~~LDw~~llRqk 330 (1205)
T KOG0606|consen 280 E--DEALPPEAQDLIEQLLRQNPLCRLGTGG-------ALEVKQHGFFQLLDWKSLLRQK 330 (1205)
T ss_pred c--CcCCCHHHHHHHHHHHHhChHhhcccch-------hhhhhhccceeecccchhhhhh
Confidence 1 2447899999999999999999954221 1222234566678888554444
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.3e-24 Score=188.88 Aligned_cols=170 Identities=14% Similarity=0.201 Sum_probs=127.8
Q ss_pred CccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcch-----------HHHHHHHHHHHcCCCCCCeeEEe
Q 015406 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-----------LLYESKLYRILQGGTGIPNVRWF 71 (407)
Q Consensus 3 ~~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~-----------~~~E~~~l~~l~~~~~i~~~~~~ 71 (407)
..+.++|++.+.||.|+||.||++.. ++..+|||++..+....+ +.+|++.+.++.| ++++.+..+
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~-~GI~~~~d~ 103 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRS-EGLASLNDF 103 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHH-CCCCcceEe
Confidence 45689999999999999999999764 466899999875432221 4688889999976 566666655
Q ss_pred eee--------CceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCC
Q 015406 72 GVE--------GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 142 (407)
Q Consensus 72 ~~~--------~~~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~ 142 (407)
+.. ....+|+|||+ |.+|.++.. +++ ....+++.+|..||+.|++|||+||+||++ +.+
T Consensus 104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili---~~~ 171 (232)
T PRK10359 104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIV---SKN 171 (232)
T ss_pred eeecccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEE---eCC
Confidence 432 23578999999 789988742 333 245699999999999999999999999999 455
Q ss_pred ceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHH
Q 015406 143 NQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL 207 (407)
Q Consensus 143 ~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ell 207 (407)
+ ++|+|||..+........ -..+....|+.++||||||+++..+.
T Consensus 172 g-i~liDfg~~~~~~e~~a~-------------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRKAK-------------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred C-EEEEECCCcccccchhhH-------------------HHHHHHhHhcccccccceeEeehHHH
Confidence 6 999999988755332110 11344455777899999999987653
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.5e-23 Score=179.42 Aligned_cols=192 Identities=16% Similarity=0.107 Sum_probs=139.9
Q ss_pred eeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcc------hHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP------QLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 9 y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~------~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
+.+...|++|+||+||++. ..+.+++.+.+....... .+.+|++++++|.++++++.+..+ +..+++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~--~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVR--GGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEee--cCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 4567889999999999887 477888877655443311 367899999999988889888765 3359999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccC-CCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI-KPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 83 e~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDL-Kp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
||+ |.+|.+.+.. ....++.|++.+|.++|++||+|||| ||+|||+ +.++.++|+|||+|.......
T Consensus 78 eyI~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv---~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 78 SYLAGAAMYQRPPR--------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLV---QEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred eeecCccHHhhhhh--------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEE---cCCCCEEEEECCCceecCCcc
Confidence 999 8888654321 12357889999999999999999999 7999999 567889999999998554322
Q ss_pred CCcc-cCccC-----CCCccccccccccccccCC-CCC-hhhHHHHHHHHHHHHHhCCCCCCCCC
Q 015406 161 THQH-IPYRE-----NKNLTGTARYASMNTHLGI-EQS-RRDDLESLGYVLMYFLRGSLPWQGLK 217 (407)
Q Consensus 161 ~~~~-~~~~~-----~~~~~gt~~Y~aPE~~~~~-~~~-~~sDIwSlG~il~elltG~~Pf~~~~ 217 (407)
.... ...+. ......++.|++|+...-. ..+ .+.+.++.|+-+|.++||..++.+..
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 1000 00000 0011257788888765432 233 56788899999999999998876543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=178.65 Aligned_cols=138 Identities=20% Similarity=0.250 Sum_probs=105.8
Q ss_pred EeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc----------------------------chHHHHHHHHHHHcCC
Q 015406 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----------------------------PQLLYESKLYRILQGG 62 (407)
Q Consensus 11 i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----------------------------~~~~~E~~~l~~l~~~ 62 (407)
+.+.||+|+||.||+|++. +|+.||||+++..... ..+..|.+.+.++.+.
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999986 8999999987754211 0124678888888864
Q ss_pred CCCCeeEEeeeeCceeEEEEecc-CCCHHH-HHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcccccCC
Q 015406 63 TGIPNVRWFGVEGDYNVLVMDLL-GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLG 139 (407)
Q Consensus 63 ~~i~~~~~~~~~~~~~~lvme~~-g~sL~~-~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~ivHrDLKp~NILl~~~ 139 (407)
. +.....+... ..+|||||+ |+++.. .+. ...++...+..++.|++.+|.+||+ +||+||||||+|||+
T Consensus 80 ~-i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~--~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll--- 151 (190)
T cd05145 80 G-VPVPEPILLK--KNVLVMEFIGDDGSPAPRLK--DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILY--- 151 (190)
T ss_pred C-CCCceEEEec--CCEEEEEEecCCCchhhhhh--hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEE---
Confidence 3 3322222222 248999999 554433 343 3468889999999999999999999 999999999999999
Q ss_pred CCCceEEEEeccceeeecc
Q 015406 140 RRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 140 ~~~~~~kL~DFGla~~~~~ 158 (407)
+ ++.++|+|||+|+....
T Consensus 152 ~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 152 H-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred E-CCCEEEEEcccceecCC
Confidence 3 67899999999986643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-22 Score=179.54 Aligned_cols=244 Identities=14% Similarity=0.177 Sum_probs=183.5
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
.+..+..+|.+...|+.|+|++ .|..+++|+++... ....|..|.-.++.+.|++.++.+..+. ......++.
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacn-sppnlv~is 266 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRW--QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACN-SPPNLVIIS 266 (448)
T ss_pred hhhhhhhhhccCCCcccccccc--cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhcc-CCCCceEee
Confidence 3456677899999999999994 56678888877654 3345788888899999877666665554 445668888
Q ss_pred ecc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcccccCCCCCceEEE--Eeccceeee
Q 015406 83 DLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYI--IDFGLAKKY 156 (407)
Q Consensus 83 e~~-g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~--ivHrDLKp~NILl~~~~~~~~~kL--~DFGla~~~ 156 (407)
.|+ .+||..+++... -.++..++.+++.+|++|+.|||+.. |.---|....++| |++.+.+| +|--++..
T Consensus 267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmi---dedltarismad~kfsfq- 342 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMI---DEDLTARISMADTKFSFQ- 342 (448)
T ss_pred eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEe---cchhhhheecccceeeee-
Confidence 999 999999998533 23678899999999999999999853 3344688889999 56665554 44333321
Q ss_pred ccCCCCcccCccCCCCccccccccccccccCCCCC---hhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcc
Q 015406 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQS---RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (407)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~---~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (407)
. ....-.+.||+||.++.++-+ +++|+|||.++||||.|+..||.+..+.+...+ +. +
T Consensus 343 -e------------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk---ia---l 403 (448)
T KOG0195|consen 343 -E------------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK---IA---L 403 (448)
T ss_pred -c------------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh---hh---h
Confidence 1 122346899999999987653 578999999999999999999998766432222 21 1
Q ss_pred cccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 015406 234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (407)
Q Consensus 234 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l 276 (407)
......++++++..+.+|+.-|+..||.+||.++.|.-+|+++
T Consensus 404 eglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 404 EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 1223345678899999999999999999999999999988875
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.4e-23 Score=208.45 Aligned_cols=250 Identities=16% Similarity=0.129 Sum_probs=174.0
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc------chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH------PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~------~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
+|...+.||++.|=+|.+|++ ..|. |+||++-+.... .+.+.|++ .. +..++|+..+....+.....|||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~-~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~-l~~~pn~lPfqk~~~t~kAAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKD-REGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FA-LMKAPNCLPFQKVLVTDKAAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccC-CCce-EEEEEEeccCCCCCchHHHHHHHHHH-HH-hhcCCcccchHHHHHhhHHHHHH
Confidence 688999999999999999996 4454 999987654422 22334444 23 33345555554446667778999
Q ss_pred EeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCC
Q 015406 82 MDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 82 me~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~ 161 (407)
-+|...+|.|.+.. +.-+..-+...|+.|++.||..+|+.||+|+|||.+|||| ..=+-+.|+||..-+..--+.+
T Consensus 100 RqyvkhnLyDRlST-RPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILi---TSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 100 RQYVKHNLYDRLST-RPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILI---TSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHHHhhhhhhhhcc-chHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEE---eeechhhhhcccccCCccCCCC
Confidence 99999999999873 2347888999999999999999999999999999999999 4777889999987664322221
Q ss_pred Ccc-cCccCCCCccccccccccccccCC----------C-CChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHH
Q 015406 162 HQH-IPYRENKNLTGTARYASMNTHLGI----------E-QSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKI 228 (407)
Q Consensus 162 ~~~-~~~~~~~~~~gt~~Y~aPE~~~~~----------~-~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i 228 (407)
... ..|. ..+...-..|.|||.+... . .+++-||||+||++.||++ |++||.- .+.+. .
T Consensus 176 NPadf~fF-FDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L------SQL~a-Y 247 (1431)
T KOG1240|consen 176 NPADFTFF-FDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL------SQLLA-Y 247 (1431)
T ss_pred CcccceEE-EecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH------HHHHh-H
Confidence 110 0010 1112223469999988642 1 4678999999999999998 8888842 11111 1
Q ss_pred hhhcccccHHHHhcCC-cHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015406 229 SEKKVSTSIEALCRGY-PTEFASYFHYCRSLRFDDKPDYAYLKRIFR 274 (407)
Q Consensus 229 ~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~~p~~RPt~~~l~~~l~ 274 (407)
.... ....+.+...+ +..++++|..|++.||++|.++++.++.-+
T Consensus 248 r~~~-~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 248 RSGN-ADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred hccC-ccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 1111 11222222222 347999999999999999999988876644
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.2e-22 Score=182.26 Aligned_cols=189 Identities=19% Similarity=0.255 Sum_probs=142.9
Q ss_pred CceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCC-CceEEEEeccce
Q 015406 75 GDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR-ANQVYIIDFGLA 153 (407)
Q Consensus 75 ~~~~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~-~~~~kL~DFGla 153 (407)
+...|+||.-+..+|.+++. .+..+......++.|+++|+.|||.+||.|||||.+|||+..+++ -..+.|+|||++
T Consensus 315 ~~tlylvMkrY~~tLr~yl~--~~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCc 392 (598)
T KOG4158|consen 315 PKTLYLVMKRYRQTLREYLW--TRHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCC 392 (598)
T ss_pred CceEEEehhcchhhHHHHHh--cCCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEccccee
Confidence 44679999999999999997 456788899999999999999999999999999999999976533 356789999998
Q ss_pred eeeccCCCCcccCccCC-CCccccccccccccccCCC------CChhhHHHHHHHHHHHHHhCCCCCCCCCcCch-HHHH
Q 015406 154 KKYRDTSTHQHIPYREN-KNLTGTARYASMNTHLGIE------QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKY 225 (407)
Q Consensus 154 ~~~~~~~~~~~~~~~~~-~~~~gt~~Y~aPE~~~~~~------~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~-~~~~ 225 (407)
-.-+.. ....||... -...|....||||+....+ --.|+|.|+.|.+.||++....||+....... ...|
T Consensus 393 LAd~~h--Glqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Y 470 (598)
T KOG4158|consen 393 LADDNH--GLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTY 470 (598)
T ss_pred eecccc--ccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhh
Confidence 643322 222333322 2345788899999987543 13589999999999999999999987322110 1112
Q ss_pred HHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015406 226 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 274 (407)
Q Consensus 226 ~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~ 274 (407)
. + ..++.++..+|+.+++++...|..||.+|++..-..+.|.
T Consensus 471 q---e----~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 471 Q---E----SQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred h---h----hhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 1 2 2234456779999999999999999999999776656554
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-20 Score=171.89 Aligned_cols=140 Identities=20% Similarity=0.217 Sum_probs=108.5
Q ss_pred ceeEeccccccCceEEEEEE-EcCCCeEEEEEEecCCCCc--------------------------chHHHHHHHHHHHc
Q 015406 8 KFRLGRKIGSGSFGEIYLGT-NIQTNEEVAIKLENVKTKH--------------------------PQLLYESKLYRILQ 60 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~-~~~~~~~vAvK~~~~~~~~--------------------------~~~~~E~~~l~~l~ 60 (407)
-|++.+.||+|+||.||+|. +..+|+.||||++...... ..+..|..++..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 58899999999999999999 6689999999987643210 12457999999997
Q ss_pred CC-CCCCeeEEeeeeCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeccCCCCccccc
Q 015406 61 GG-TGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS-FLHRDIKPDNFLMG 137 (407)
Q Consensus 61 ~~-~~i~~~~~~~~~~~~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-ivHrDLKp~NILl~ 137 (407)
+. ..++.+..+ ...++||||+ |.+|..+... ...+....+..++.||+.+|.+||++| |+||||||+||++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli- 182 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV- 182 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE-
Confidence 52 223333322 2348999999 6567665422 335667778899999999999999999 9999999999999
Q ss_pred CCCCCceEEEEeccceeee
Q 015406 138 LGRRANQVYIIDFGLAKKY 156 (407)
Q Consensus 138 ~~~~~~~~kL~DFGla~~~ 156 (407)
+ ++.++|+|||.|...
T Consensus 183 --~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 183 --H-DGKVVIIDVSQSVEL 198 (237)
T ss_pred --E-CCCEEEEEChhhhcc
Confidence 3 678999999998754
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.2e-19 Score=161.58 Aligned_cols=136 Identities=15% Similarity=0.192 Sum_probs=103.9
Q ss_pred EeccccccCceEEEEEEEcCCCeEEEEEEecCCC--CcchHHHHHHHHHHHcC----CCCCCeeEEeeeeC---ce-eEE
Q 015406 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKLYRILQG----GTGIPNVRWFGVEG---DY-NVL 80 (407)
Q Consensus 11 i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~E~~~l~~l~~----~~~i~~~~~~~~~~---~~-~~l 80 (407)
-.+.||+|+||.||. +..++.. +||++.... ....+.+|+.+++.+.| +++|+.++++..++ +. +.+
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 357899999999995 6667666 699876532 33468999999999964 57787777776654 24 347
Q ss_pred EEecc---CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHH-HHHHhCCceeccCCCCcccccCCC-CCceEEEEeccce
Q 015406 81 VMDLL---GPSLEDLFNFCSRKLSLKTVLMLADQMINRV-EFVHSKSFLHRDIKPDNFLMGLGR-RANQVYIIDFGLA 153 (407)
Q Consensus 81 vme~~---g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL-~yLH~~~ivHrDLKp~NILl~~~~-~~~~~kL~DFGla 153 (407)
||||+ +++|.+++.+ ..+++. ..++.|++.++ +|||+++||||||||+|||++..+ ....++|+||+.+
T Consensus 83 I~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 89995 4899999975 346665 36688888888 999999999999999999995322 3458999995544
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.4e-21 Score=184.80 Aligned_cols=242 Identities=20% Similarity=0.229 Sum_probs=161.1
Q ss_pred CceeEeccccccCceEEEEEEEcCC---CeEEEEEEecCCC--CcchHHHHHHHHHHHcCCCCCCeeE-----E-ee---
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKT--KHPQLLYESKLYRILQGGTGIPNVR-----W-FG--- 72 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~---~~~vAvK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~-----~-~~--- 72 (407)
..+.+.+..+..+++.++......+ .+.++-|...... ......+++..+....|++...... . ..
T Consensus 244 ~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~ 323 (516)
T KOG1033|consen 244 GSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRN 323 (516)
T ss_pred ccccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcccc
Confidence 3455556666666666666553322 2334444332222 1112334444444444554443322 0 00
Q ss_pred --eeCceeEEEEecc-CCCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEE
Q 015406 73 --VEGDYNVLVMDLL-GPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI 147 (407)
Q Consensus 73 --~~~~~~~lvme~~-g~sL~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL 147 (407)
....+.||.|++| -.+|.+++.. .....++...+.++.|++.|++| ++.+|||+||.||++ ..+..+||
T Consensus 324 ~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~---~~d~q~kI 397 (516)
T KOG1033|consen 324 KVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFF---SDDDQLKI 397 (516)
T ss_pred ccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhcccccccc---ccchhhhh
Confidence 1134679999999 8999999963 23457888999999999999999 999999999999999 46678999
Q ss_pred EeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHH
Q 015406 148 IDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYE 226 (407)
Q Consensus 148 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~ 226 (407)
.|||+........+ ...++...+..+||..||+||.+.+..|+.++||||||+||+|++. =..+|.. ...+.
T Consensus 398 gDFgl~ts~~~~~~-~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er------~~t~~ 470 (516)
T KOG1033|consen 398 GDFGLVTSQDKDET-VAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER------IATLT 470 (516)
T ss_pred hhhhheeecccCCc-ccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH------HHhhh
Confidence 99999987766541 1112233456789999999999999999999999999999999997 3333322 22233
Q ss_pred HHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCC
Q 015406 227 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD 265 (407)
Q Consensus 227 ~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt 265 (407)
.+....++ +.+..++|. -..|+++++..+|.+||+
T Consensus 471 d~r~g~ip---~~~~~d~p~-e~~ll~~lls~~p~~RP~ 505 (516)
T KOG1033|consen 471 DIRDGIIP---PEFLQDYPE-EYTLLQQLLSPSPEERPS 505 (516)
T ss_pred hhhcCCCC---hHHhhcCcH-HHHHHHHhcCCCcccCch
Confidence 33333332 122333443 468999999999999994
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.4e-20 Score=180.25 Aligned_cols=213 Identities=16% Similarity=0.214 Sum_probs=162.5
Q ss_pred HHcCCCCCCeeEEeeeeCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCc-eeccCCCCccc
Q 015406 58 ILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF-LHRDIKPDNFL 135 (407)
Q Consensus 58 ~l~~~~~i~~~~~~~~~~~~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~i-vHrDLKp~NIL 135 (407)
.+.| .++..+.+...++...++|.+|| .|+|.|.+.....++++--...++++|+.||.|||+..| .|+.|+..|.+
T Consensus 3 ~l~h-~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nCl 81 (484)
T KOG1023|consen 3 QLDH-DNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCL 81 (484)
T ss_pred ccch-hhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccce
Confidence 3444 66777777777778899999999 999999998767788999999999999999999998766 99999999999
Q ss_pred ccCCCCCceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCC-------CChhhHHHHHHHHHHHHHh
Q 015406 136 MGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE-------QSRRDDLESLGYVLMYFLR 208 (407)
Q Consensus 136 l~~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-------~~~~sDIwSlG~il~ellt 208 (407)
+ +....+||+|||+......... +.......-...|.|||.+.+.. .+.+.||||||++++|+++
T Consensus 82 v---d~~w~lklt~~Gl~~~~~~~~~-----~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~ 153 (484)
T KOG1023|consen 82 V---DSRWVLKLTDFGLNSLLEETAE-----PEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILF 153 (484)
T ss_pred e---eeeEEEEechhhhccccccccc-----ccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHh
Confidence 9 7999999999999876643110 00111223456799999998742 3667999999999999999
Q ss_pred CCCCCCCCCcCc-hHHHHHHHhhhc---ccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHc
Q 015406 209 GSLPWQGLKAGT-KKQKYEKISEKK---VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (407)
Q Consensus 209 G~~Pf~~~~~~~-~~~~~~~i~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~ 280 (407)
...||....... ..+....+.... ..+.+.... ..++++..++..||..+|++||+++++...++.+....
T Consensus 154 r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 154 RSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred ccCccccccccCChHHHHHHHHhcCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 999997633222 133343333312 222222222 56778999999999999999999999999888876643
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.4e-19 Score=159.90 Aligned_cols=131 Identities=27% Similarity=0.419 Sum_probs=104.8
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEecCCCCc----------chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----------PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 13 ~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----------~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
+.||+|++|.||+|.+ .+..|++|+....... ..+.+|+.++..+.+. +++....++......+++|
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~-~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKA-GVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHC-CCCCCeEEEEeCCCCEEEE
Confidence 6799999999999985 7788999976543211 2366788899888864 3444344444556678999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceee
Q 015406 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (407)
Q Consensus 83 e~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~ 155 (407)
||+ |++|.+++.... . ....++.+++.+|.+||+.|++|+|++|.|||+ + ++.++|+|||++..
T Consensus 79 e~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~---~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMIL---S-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEE---E-CCCEEEEECCcccC
Confidence 999 889999987422 2 888999999999999999999999999999999 3 67899999999864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.7e-19 Score=155.47 Aligned_cols=127 Identities=26% Similarity=0.397 Sum_probs=100.0
Q ss_pred cccccCceEEEEEEEcCCCeEEEEEEecCCCC-c---------chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-H---------PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 14 ~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~---------~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
.||+|+||.||+|. .++..|++|....... . ..+.+|++++..+.+.. ++....+.......+++||
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~-i~~p~~~~~~~~~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAG-VNTPVVYDVDPDNKTIVME 77 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCC-CCCCEEEEEECCCCEEEEE
Confidence 48999999999998 5678899997543221 1 23567999999998743 3333334445566789999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceee
Q 015406 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (407)
Q Consensus 84 ~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~ 155 (407)
|+ |++|.+++.... . .++.|++.+|.+||+.|++|+|++|.||++ + ++.++|+|||++..
T Consensus 78 ~~~g~~l~~~~~~~~--~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~---~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 78 YIEGKPLKDVIEEGN--D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIV---R-DDKLYLIDFGLGKY 138 (199)
T ss_pred EECCccHHHHHhhcH--H------HHHHHHHHHHHHHHHCCeecCCCCcceEEE---E-CCcEEEEECCCCcC
Confidence 99 899999876421 1 789999999999999999999999999999 3 68899999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.2e-18 Score=154.84 Aligned_cols=136 Identities=19% Similarity=0.281 Sum_probs=104.6
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC------------------------cchHHHHHHHHHHHcCCC
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK------------------------HPQLLYESKLYRILQGGT 63 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~------------------------~~~~~~E~~~l~~l~~~~ 63 (407)
.|.+.+.||+|+||.||++.+ .+|+.||||++..... ......|..++..+.+..
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 488899999999999999986 4799999998654320 012456788888886642
Q ss_pred -CCCeeEEeeeeCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCC
Q 015406 64 -GIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 141 (407)
Q Consensus 64 -~i~~~~~~~~~~~~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~ 141 (407)
.++.... ....+++|||+ |++|.++... .....++.+++.++.++|+.||+||||||+||++ +.
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill---~~ 160 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILV---DD 160 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEE---cC
Confidence 2232222 23458999999 8788765431 3456788999999999999999999999999999 56
Q ss_pred CceEEEEeccceeeecc
Q 015406 142 ANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 142 ~~~~kL~DFGla~~~~~ 158 (407)
++.++|+|||++.....
T Consensus 161 ~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 161 DEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCcEEEEECCccccCCC
Confidence 88999999999975544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.75 E-value=7e-18 Score=172.03 Aligned_cols=133 Identities=24% Similarity=0.414 Sum_probs=103.0
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-C---------cchHHHHHHHHHHHcCCCCCCeeEEeeeeCc
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-K---------HPQLLYESKLYRILQGGTGIPNVRWFGVEGD 76 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-~---------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 76 (407)
..|...+.||+|+||.||+|.+. +..+++|....+. . ...+.+|+++++.++++. ++....+.....
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~-i~~p~~~~~~~~ 409 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAG-VPTPVIYDVDPE 409 (535)
T ss_pred cccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccC-CCeeEEEEEeCC
Confidence 34566789999999999999864 3344544322111 1 134678999999998754 545445555566
Q ss_pred eeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceee
Q 015406 77 YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (407)
Q Consensus 77 ~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~ 155 (407)
..++||||+ |++|.+++. ....++.|++.+|.|||++||+||||||+|||+ .++.++|+|||+++.
T Consensus 410 ~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl----~~~~~~liDFGla~~ 476 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV----RDDRLYLIDFGLGKY 476 (535)
T ss_pred CCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE----ECCcEEEEeCccccc
Confidence 678999999 999999886 346789999999999999999999999999999 456899999999974
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.5e-17 Score=143.91 Aligned_cols=136 Identities=24% Similarity=0.330 Sum_probs=95.6
Q ss_pred EeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc----chH----------------------HHHHHHHHHHcCCC-
Q 015406 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQL----------------------LYESKLYRILQGGT- 63 (407)
Q Consensus 11 i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----~~~----------------------~~E~~~l~~l~~~~- 63 (407)
+.+.||+|+||.||+|.+. +++.||||++...... ... ..|...+..+.+..
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 3578999999999999975 8999999987643211 001 24555566665432
Q ss_pred CCCeeEEeeeeCceeEEEEecc-CCCHH-HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcccccCCC
Q 015406 64 GIPNVRWFGVEGDYNVLVMDLL-GPSLE-DLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGR 140 (407)
Q Consensus 64 ~i~~~~~~~~~~~~~~lvme~~-g~sL~-~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~ivHrDLKp~NILl~~~~ 140 (407)
.++....+ ...+++|||+ ++++. ..+.... .. ..+..++.+++.++.++|. +||+||||||+||++ +
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili---~ 149 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILV---D 149 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEE---E
Confidence 23333322 2358999999 53322 1222111 11 6788999999999999999 999999999999999 4
Q ss_pred CCceEEEEeccceeeecc
Q 015406 141 RANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 141 ~~~~~kL~DFGla~~~~~ 158 (407)
++.++|+|||.+.....
T Consensus 150 -~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 -DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred -CCcEEEEECcccccccC
Confidence 78899999999975544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.69 E-value=9.4e-19 Score=178.37 Aligned_cols=254 Identities=23% Similarity=0.297 Sum_probs=191.1
Q ss_pred CCceeEeccccccCceEEEEEEEcC-CCeEEEEEEecCCCC-cc---hHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQ-TNEEVAIKLENVKTK-HP---QLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~-~~~~vAvK~~~~~~~-~~---~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
...|.+.+.||+|+|+.|-+..+.. +...+|+|.+..... .. ....|..+-+.+..|.++..+..........++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 4578999999999999999888643 344677776554431 11 233466676777757788888888888889999
Q ss_pred EEecc-CCCHHHHH-HHcCCCCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCCCcccccCCCCCc-eEEEEeccceeee
Q 015406 81 VMDLL-GPSLEDLF-NFCSRKLSLKTVLMLADQMINRVEFVH-SKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKY 156 (407)
Q Consensus 81 vme~~-g~sL~~~l-~~~~~~l~~~~~~~i~~qi~~aL~yLH-~~~ivHrDLKp~NILl~~~~~~~-~~kL~DFGla~~~ 156 (407)
+++|. |+++.+.+ .......+...+-.++.|+..+|.|+| ..++.||||||+|.++ +..+ .+++.|||+|..+
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l---~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLL---DESGSALKIADFGLATAY 175 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchh---ccCCCcccCCCchhhccc
Confidence 99999 88988888 432225778889999999999999999 9999999999999999 4566 8999999999987
Q ss_pred cc-CCCCcccCccCCCCccc-cccccccccccCCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcc
Q 015406 157 RD-TSTHQHIPYRENKNLTG-TARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (407)
Q Consensus 157 ~~-~~~~~~~~~~~~~~~~g-t~~Y~aPE~~~~~~~-~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (407)
.. .... +.....+| ++.|+|||...+..+ .+..|+||.|+++.-+++|..||....... ..+........
T Consensus 176 ~~~~g~~-----~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~--~~~~~~~~~~~ 248 (601)
T KOG0590|consen 176 RNKNGAE-----RSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD--GRYSSWKSNKG 248 (601)
T ss_pred cccCCcc-----eeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc--ccceeeccccc
Confidence 66 3221 22334567 999999999998544 788999999999999999999997643322 22222222211
Q ss_pred cccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015406 234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 234 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
......+..++....+++.+++..+|+.|.+.+++.
T Consensus 249 -~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 249 -RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred -ccccCccccCChhhhhcccccccCCchhcccccccc
Confidence 111223456788899999999999999999977664
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.2e-16 Score=132.87 Aligned_cols=132 Identities=21% Similarity=0.327 Sum_probs=108.0
Q ss_pred EeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCC-CCCCeeEEeeeeCceeEEEEecc-CCC
Q 015406 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGG-TGIPNVRWFGVEGDYNVLVMDLL-GPS 88 (407)
Q Consensus 11 i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~-~~i~~~~~~~~~~~~~~lvme~~-g~s 88 (407)
+.+.||+|.++.||++... +..+++|..........+..|..+++.+.++ ..++.+..+....+..+++|||+ |..
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 4678999999999999963 3789999876544345688999999999876 56677766666667889999999 666
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCCCcccccCCCCCceEEEEeccceee
Q 015406 89 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (407)
Q Consensus 89 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~ 155 (407)
+..+ +......++.+++.+|.+||.. +++|+||+|.||++ +..+.++++|||.+..
T Consensus 80 ~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~---~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 80 LDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILV---DDGKILGIIDWEYAGY 138 (155)
T ss_pred cccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEE---ECCcEEEEEecccccC
Confidence 6543 5566778899999999999984 79999999999999 4578899999998863
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.68 E-value=4.2e-16 Score=142.22 Aligned_cols=132 Identities=16% Similarity=0.221 Sum_probs=97.2
Q ss_pred cccc-ccCceEEEEEEEcCCCeEEEEEEecCC---------------CCcchHHHHHHHHHHHcCCCC-CCeeEEeee-e
Q 015406 13 RKIG-SGSFGEIYLGTNIQTNEEVAIKLENVK---------------TKHPQLLYESKLYRILQGGTG-IPNVRWFGV-E 74 (407)
Q Consensus 13 ~~iG-~G~~g~Vy~~~~~~~~~~vAvK~~~~~---------------~~~~~~~~E~~~l~~l~~~~~-i~~~~~~~~-~ 74 (407)
..|| .||.|+||.+.. .+..++||..... .....+.+|++++..|.+... ++....+.. .
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 3577 888999999884 4778999976421 112347789999999987442 343333322 2
Q ss_pred Cce---eEEEEecc-C-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEe
Q 015406 75 GDY---NVLVMDLL-G-PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID 149 (407)
Q Consensus 75 ~~~---~~lvme~~-g-~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~D 149 (407)
... .++|||++ | .+|.+++.. ..++... +.||+.+|.+||++||+||||||.|||+ +.++.++|+|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv---~~~~~v~LID 185 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE--APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILL---DPDGKFWLID 185 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc--CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEE---cCCCCEEEEE
Confidence 222 35999999 5 599998863 3556543 5789999999999999999999999999 4567899999
Q ss_pred ccceee
Q 015406 150 FGLAKK 155 (407)
Q Consensus 150 FGla~~ 155 (407)
||.+..
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 998864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.4e-16 Score=155.91 Aligned_cols=254 Identities=18% Similarity=0.171 Sum_probs=193.3
Q ss_pred cCCceeEeccccc--cCceEEEEEEE--cCCCeEEEEEEecCC----CCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCc
Q 015406 5 VGNKFRLGRKIGS--GSFGEIYLGTN--IQTNEEVAIKLENVK----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGD 76 (407)
Q Consensus 5 ~~~~y~i~~~iG~--G~~g~Vy~~~~--~~~~~~vAvK~~~~~----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 76 (407)
+.+.+.+.+.+|. |.+|.||.+.. ..++..+|+|.-+.. .....-.+|....+.+..+.+.+.........+
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC
Confidence 4556778889999 99999999998 788999999963222 122234566666667766666666566667888
Q ss_pred eeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHH----HHHHHHhCCceeccCCCCcccccCCCCC-ceEEEEecc
Q 015406 77 YNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN----RVEFVHSKSFLHRDIKPDNFLMGLGRRA-NQVYIIDFG 151 (407)
Q Consensus 77 ~~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~----aL~yLH~~~ivHrDLKp~NILl~~~~~~-~~~kL~DFG 151 (407)
..++-.|+|+.+|.++......-++...++.++.+... ||.++|+.+++|-|+||+||++. .+ ...+++|||
T Consensus 192 ~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~---~~~~s~~~~df~ 268 (524)
T KOG0601|consen 192 ILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTT---SDWTSCKLTDFG 268 (524)
T ss_pred cceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecc---cccceeecCCcc
Confidence 89999999999999998865556888999999999999 99999999999999999999994 55 889999999
Q ss_pred ceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhh
Q 015406 152 LAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 231 (407)
Q Consensus 152 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~ 231 (407)
+...+......... .......|...|++||...+ -++..+||||||.++.+..++..++..-..... . +.
T Consensus 269 ~v~~i~~~~~~~~~--~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W----~---~~ 338 (524)
T KOG0601|consen 269 LVSKISDGNFSSVF--KVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSW----S---QL 338 (524)
T ss_pred eeEEccCCccccce--eeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCc----c---cc
Confidence 99988776543221 11123357788999999887 578899999999999999998766543211111 1 11
Q ss_pred cccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 232 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 232 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.......+++.+.+.++...+..|++.++-.|++.+.+..
T Consensus 339 r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 1111234566677888888999999999999998876653
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.8e-14 Score=140.32 Aligned_cols=138 Identities=20% Similarity=0.296 Sum_probs=97.4
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEecCCCCc------------------------------------------chHH
Q 015406 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH------------------------------------------PQLL 50 (407)
Q Consensus 13 ~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~------------------------------------------~~~~ 50 (407)
+.||+|++|.||+|+. .+|+.||||+....... -++.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 5799999999999996 58999999986543100 0234
Q ss_pred HHHHHHHHHc----CCCCCCeeEEeeeeCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHH-HHHHHHhCCc
Q 015406 51 YESKLYRILQ----GGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMIN-RVEFVHSKSF 124 (407)
Q Consensus 51 ~E~~~l~~l~----~~~~i~~~~~~~~~~~~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~-aL~yLH~~~i 124 (407)
+|.+.+.++. +.+.+..-..+.......+|||||+ |.+|.++.......++ ...++.+++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence 4555555553 3333333333333344569999999 8899888753222232 3456666665 4788999999
Q ss_pred eeccCCCCcccccCCCCCceEEEEeccceeeec
Q 015406 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (407)
Q Consensus 125 vHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~ 157 (407)
+|+|+||.||++ +.++.++|+|||++..+.
T Consensus 279 ~H~D~hPgNilv---~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 279 FHADLHPGNIFV---LKDGKIIALDFGIVGRLS 308 (437)
T ss_pred eeCCCCcccEEE---CCCCcEEEEeCCCeeECC
Confidence 999999999999 577899999999997654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.54 E-value=8.6e-13 Score=132.42 Aligned_cols=140 Identities=18% Similarity=0.271 Sum_probs=94.3
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc-----------------------------------------
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----------------------------------------- 46 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----------------------------------------- 46 (407)
.|+. +.||+|++|.||+|+.+.+|+.||||+.......
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4665 7899999999999999877999999987643100
Q ss_pred -chHHHHHHHHHHHc----CCCCCCeeEEeeeeCceeEEEEecc-CCCHHHHH--HHcCC---CCCHHHHHHHHHHHHHH
Q 015406 47 -PQLLYESKLYRILQ----GGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLF--NFCSR---KLSLKTVLMLADQMINR 115 (407)
Q Consensus 47 -~~~~~E~~~l~~l~----~~~~i~~~~~~~~~~~~~~lvme~~-g~sL~~~l--~~~~~---~l~~~~~~~i~~qi~~a 115 (407)
-++.+|...+.++. +.+.+..-..+.......+|||||+ |+.+.++- ...+. .+....+..++.|+
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--- 276 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--- 276 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH---
Confidence 12445555555554 2232222233333345678999999 88998753 22111 13333444444444
Q ss_pred HHHHHhCCceeccCCCCcccccCCCCCc----eEEEEeccceeeecc
Q 015406 116 VEFVHSKSFLHRDIKPDNFLMGLGRRAN----QVYIIDFGLAKKYRD 158 (407)
Q Consensus 116 L~yLH~~~ivHrDLKp~NILl~~~~~~~----~~kL~DFGla~~~~~ 158 (407)
+..|++|+|+||.||+++ .++ .++++|||++..+..
T Consensus 277 ----f~~GffHaDpHPGNIlv~---~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 ----FRDGFFHADMHPGNIFVS---YDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ----HhCCeeeCCCChHHeEEe---cCCCCCCeEEEEecceEEECCH
Confidence 458999999999999994 444 999999999987643
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.52 E-value=6.7e-14 Score=120.87 Aligned_cols=126 Identities=17% Similarity=0.267 Sum_probs=96.9
Q ss_pred eccccccCceEEEEEEEcCCCeEEEEEEecCCC-CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-CCCH
Q 015406 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSL 89 (407)
Q Consensus 12 ~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~-g~sL 89 (407)
++.|+.|.++.||+++. .+..|++|+..... ....+..|+.+++.+.+...++.+..+.. ...++|||++ |.++
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence 46789999999999985 47889999875543 23457889999999987666777665543 2347999999 7666
Q ss_pred HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----eeccCCCCcccccCCCCCceEEEEecccee
Q 015406 90 EDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF-----LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (407)
Q Consensus 90 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~i-----vHrDLKp~NILl~~~~~~~~~kL~DFGla~ 154 (407)
.+. . .....++.+++.+|..||+.++ +|+|++|.||++ + ++.++|+|||.+.
T Consensus 79 ~~~-~--------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~---~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTE-D--------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLL---D-DGRLWLIDWEYAG 135 (170)
T ss_pred ccc-c--------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEE---E-CCeEEEEeccccc
Confidence 543 0 1123456899999999999885 999999999999 3 5679999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.52 E-value=5.5e-15 Score=151.98 Aligned_cols=272 Identities=20% Similarity=0.180 Sum_probs=194.3
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-----cchHHHHHHHHHHHcCCCCCCeeEEe---eeeCce
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWF---GVEGDY 77 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~---~~~~~~ 77 (407)
.+.+.+.+-+-+|+++.++.+.-..++...++|+...... .+....+..+ ..++..+.+..+ +.....
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~----~i~p~~P~v~~~~~s~~~rsP 878 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNI----LITPRSPAVVRSFPSFPCRSP 878 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCc----cccCCCCceecccCCCCCCCC
Confidence 4668888899999999999998777777677775332211 1111111111 111222333222 335667
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeee
Q 015406 78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~ 156 (407)
.+|+|+|+ +++|...++... ..+.+-++.++..+..+++|||+..++|||++|.|+|+ ...++.++.|||+....
T Consensus 879 ~~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~---~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLI---AYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred cchhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccchhhcccccccchhh---cccCCcccCcccccccc
Confidence 79999999 889998888643 57778888899999999999999999999999999999 58899999999844322
Q ss_pred ccC---CCC------------------ccc---CccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCC
Q 015406 157 RDT---STH------------------QHI---PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212 (407)
Q Consensus 157 ~~~---~~~------------------~~~---~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~P 212 (407)
... ... ... ..+......||+.|.+||.+.+......+|+|++|++++|.++|..|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 110 000 000 11234567899999999999999999999999999999999999999
Q ss_pred CCCCCcCchHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccccc
Q 015406 213 WQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTI 292 (407)
Q Consensus 213 f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~dw~~ 292 (407)
|... ...+.++.+.....+.+.- ....+.+..+++...+..++.+|-.+.-- -...++.++...+|+.
T Consensus 1035 ~na~---tpq~~f~ni~~~~~~~p~g--~~~~s~~aq~~~~~ll~~~~~qr~~a~~~-------~e~k~~~~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1035 FNAE---TPQQIFENILNRDIPWPEG--PEEGSYEAQDLINRLLTEEPTQRLGAKGA-------AEVKGHPFFQDVDWEN 1102 (1205)
T ss_pred CCCc---chhhhhhccccCCCCCCCC--ccccChhhhhhhhhhhccCchhccCcccc-------cccccCCccCCCCccc
Confidence 9764 4456666666554433221 23367889999999999999999875421 1245678889999998
Q ss_pred chhhc
Q 015406 293 LKYQQ 297 (407)
Q Consensus 293 ~~~~~ 297 (407)
+..+.
T Consensus 1103 l~~q~ 1107 (1205)
T KOG0606|consen 1103 LALQK 1107 (1205)
T ss_pred ccccc
Confidence 87765
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.5e-13 Score=120.28 Aligned_cols=137 Identities=18% Similarity=0.207 Sum_probs=98.9
Q ss_pred eccccccCceEEEEEEEcC------CCeEEEEEEecCCC------------C------------cch----HHHHHHHHH
Q 015406 12 GRKIGSGSFGEIYLGTNIQ------TNEEVAIKLENVKT------------K------------HPQ----LLYESKLYR 57 (407)
Q Consensus 12 ~~~iG~G~~g~Vy~~~~~~------~~~~vAvK~~~~~~------------~------------~~~----~~~E~~~l~ 57 (407)
...||.|--+.||.|.... .+..+|||+.+... . ... ..+|.+.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4579999999999998543 35799999743210 0 001 237899999
Q ss_pred HHcCC-CCCCeeEEeeeeCceeEEEEeccCCC-H-HHHHHHcCCCCCHHHHHHHHHHHHHHHHHH-HhCCceeccCCCCc
Q 015406 58 ILQGG-TGIPNVRWFGVEGDYNVLVMDLLGPS-L-EDLFNFCSRKLSLKTVLMLADQMINRVEFV-HSKSFLHRDIKPDN 133 (407)
Q Consensus 58 ~l~~~-~~i~~~~~~~~~~~~~~lvme~~g~s-L-~~~l~~~~~~l~~~~~~~i~~qi~~aL~yL-H~~~ivHrDLKp~N 133 (407)
++... -.+|....+ ...+|||||++++ + ...++ ...++...+..+..+++.+|..| |+.||||+||++.|
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk--d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N 155 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK--DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN 155 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh--ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 88753 345555543 4568999999553 2 12233 22456667788899999999999 89999999999999
Q ss_pred ccccCCCCCceEEEEeccceeeecc
Q 015406 134 FLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 134 ILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
||+ .++.++|+|||.|.....
T Consensus 156 IL~----~~~~v~iIDF~qav~~~h 176 (197)
T cd05146 156 MLW----HDGKVWFIDVSQSVEPTH 176 (197)
T ss_pred EEE----ECCcEEEEECCCceeCCC
Confidence 999 346799999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.3e-12 Score=110.33 Aligned_cols=142 Identities=20% Similarity=0.259 Sum_probs=106.7
Q ss_pred EeccccccCceEEEEEEEcCCCeEEEEEE-ecCCCCcc---------hHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHP---------QLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 11 i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~-~~~~~~~~---------~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
....|-+|+-+.|+++. ..|+.+.||. +.+.-.++ +..+|++++.++... .|+.-..++.+.....|
T Consensus 11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~-GI~~P~l~~~D~~~~~i 87 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRAL-GIPAPRLIFIDTYGGQI 87 (229)
T ss_pred cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHh-CCCCceEEEEecCCCeE
Confidence 56788899999999998 6799989994 33333333 356788888887653 45444555556666689
Q ss_pred EEeccCC--CHHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceee
Q 015406 81 VMDLLGP--SLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (407)
Q Consensus 81 vme~~g~--sL~~~l~~~~~~-l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~ 155 (407)
+|||..| ++.+++...-.. ........++.+|-..+.-||..+|||+||..+||++..++....+.|+|||++..
T Consensus 88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 9999955 889988754333 33333378889999999999999999999999999997555556679999999864
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.1e-12 Score=108.54 Aligned_cols=128 Identities=23% Similarity=0.379 Sum_probs=97.0
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEE-ecCCCCcc---------hHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 13 RKIGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHP---------QLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 13 ~~iG~G~~g~Vy~~~~~~~~~~vAvK~-~~~~~~~~---------~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
..|++|+-+.||.+.. -|..+++|. +.+.-.++ .-.+|++++..+.. ..++.-..+..+.+...|+|
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~-~GV~~P~v~dvD~~~~~I~m 78 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKARE-AGVPVPIVYDVDPDNGLIVM 78 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHH-cCCCCCeEEEEcCCCCEEEE
Confidence 4688999999999974 455678884 22222222 24678888888875 46666666777777789999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceee
Q 015406 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (407)
Q Consensus 83 e~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~ 155 (407)
||. |..|.+++... ...++..+-.-+.-||..||||+||.++||++ .++.+.++|||++..
T Consensus 79 e~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl----~~~~i~~IDfGLg~~ 140 (204)
T COG3642 79 EYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIIL----SGGRIYFIDFGLGEF 140 (204)
T ss_pred EEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEE----eCCcEEEEECCcccc
Confidence 999 77888888753 24556666677778999999999999999999 344599999999973
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.34 E-value=5.3e-13 Score=131.01 Aligned_cols=240 Identities=19% Similarity=0.125 Sum_probs=167.5
Q ss_pred CCceeEeccccccCceEEEEEEEc-CCCeEEEEEEecCCC----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNI-QTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~-~~~~~vAvK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
..+|..+..||.|.|+.|+.+... .++..|++|-..... ....-+.|+.+...+.-+.+++.+..........|+
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 457889999999999999998755 677889999543322 112245677777777655666554444444455569
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 81 vme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
-.||| ++++...+ .....+++...+.+..|++.++.++|++.++|+|+||+||++.. .++..++.|||.++.+.-.
T Consensus 344 p~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~--~~~~~~~~~~~~~t~~~~~ 420 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISN--DGFFSKLGDFGCWTRLAFS 420 (524)
T ss_pred chhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeecc--chhhhhcccccccccccee
Confidence 99999 77766555 33456889999999999999999999999999999999999952 2277899999998753221
Q ss_pred CCCcccCccCCCCcccccccc--ccccccCCCCChhhHHHHHHHHHHHHHhCCCC-CCCCCcCchHHHHHHHhhhccccc
Q 015406 160 STHQHIPYRENKNLTGTARYA--SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP-WQGLKAGTKKQKYEKISEKKVSTS 236 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~--aPE~~~~~~~~~~sDIwSlG~il~elltG~~P-f~~~~~~~~~~~~~~i~~~~~~~~ 236 (407)
. ..+.+..+++ +++......+..+.|++|||..+.+.+++..- +.+.. ...+.....+
T Consensus 421 ~----------~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~-------~~~i~~~~~p-- 481 (524)
T KOG0601|consen 421 S----------GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ-------SLTIRSGDTP-- 481 (524)
T ss_pred c----------ccccccccccccchhhccccccccccccccccccccccccCcccCccccc-------ceeeeccccc--
Confidence 1 1222333444 55566667789999999999999999997542 22211 1112221111
Q ss_pred HHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015406 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 237 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
...+...++..+...+...++..||.+.++.
T Consensus 482 ---~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~ 512 (524)
T KOG0601|consen 482 ---NLPGLKLQLQVLLKVMINPDRKRRPSAVELS 512 (524)
T ss_pred ---CCCchHHhhhhhhhhhcCCccccchhhhhhc
Confidence 1123447788888999999999999876554
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.24 E-value=6.8e-11 Score=106.46 Aligned_cols=138 Identities=22% Similarity=0.278 Sum_probs=101.7
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEecCCC---CcchHHHHHHHHHHHcCCC-CCCeeEEeeeeC---ceeEEEEecc
Q 015406 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKLYRILQGGT-GIPNVRWFGVEG---DYNVLVMDLL 85 (407)
Q Consensus 13 ~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~E~~~l~~l~~~~-~i~~~~~~~~~~---~~~~lvme~~ 85 (407)
+.|+.|.++.||+++.. +|+.+++|+..... ....+..|.++++.+.+.. .++.+..+.... +..+++|||+
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 57899999999999863 36889999876543 2456899999999998743 356565555443 3568999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 015406 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS------------------------------------------- 121 (407)
Q Consensus 86 -g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~------------------------------------------- 121 (407)
|.++.+.+.. ..++......++.+++.+|..||+
T Consensus 83 ~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 83 DGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 7777665431 346777777777788888877773
Q ss_pred -------------CCceeccCCCCcccccCCCCCceEEEEecccee
Q 015406 122 -------------KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (407)
Q Consensus 122 -------------~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~ 154 (407)
..++|+|+.|.||+++.+ .++.+.|+||+.+.
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~~~iID~e~~~ 205 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPD-EPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCC-CCcEEEEEeccccc
Confidence 236999999999999411 14678999999875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.19 E-value=3e-11 Score=110.26 Aligned_cols=196 Identities=13% Similarity=0.155 Sum_probs=126.2
Q ss_pred HHcCCCCCCeeEEeee-----eCceeEEEEecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC--Ccee
Q 015406 58 ILQGGTGIPNVRWFGV-----EGDYNVLVMDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK--SFLH 126 (407)
Q Consensus 58 ~l~~~~~i~~~~~~~~-----~~~~~~lvme~~-g~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~--~ivH 126 (407)
.+-|.+ ++.++.|.. +.....++.||+ .++|.++|++. ...+....-.+|+.||+.||.|||+. -|+|
T Consensus 123 qlvHsn-lvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppiih 201 (458)
T KOG1266|consen 123 QLVHSN-LVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIH 201 (458)
T ss_pred HHHHHH-HHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcccc
Confidence 344544 444444433 334568899999 99999999753 44588888999999999999999985 5999
Q ss_pred ccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHH
Q 015406 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYF 206 (407)
Q Consensus 127 rDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~el 206 (407)
+++..+-|++ ..++.+|+.--..... .. .. ....-.+.....+-++|.|||.-.....+.++|||+||++..||
T Consensus 202 gnlTc~tifi---q~ngLIkig~~ap~s~-h~-s~-~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 202 GNLTCDTIFI---QHNGLIKIGSVAPDST-HP-SV-NSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CCcchhheee---cCCceEEecccCcccc-ch-hh-hhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 9999999999 5677666532111100 00 00 00000112234567889999987766778899999999999999
Q ss_pred HhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015406 207 LRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 207 ltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
..+..--.. .......-..+....+. +. ..--+.++..|++..|..||++.++.
T Consensus 276 ailEiq~tn--seS~~~~ee~ia~~i~~-----le---n~lqr~~i~kcl~~eP~~rp~ar~ll 329 (458)
T KOG1266|consen 276 AILEIQSTN--SESKVEVEENIANVIIG-----LE---NGLQRGSITKCLEGEPNGRPDARLLL 329 (458)
T ss_pred HHheeccCC--Ccceeehhhhhhhheee-----cc---CccccCcCcccccCCCCCCcchhhhh
Confidence 887653211 11111111222221111 00 11235678899999999999987764
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.2e-09 Score=101.01 Aligned_cols=132 Identities=19% Similarity=0.138 Sum_probs=93.9
Q ss_pred eEEEEEEEcCCCeEEEEEEecCCCC-----------cc--hHHHHHHHHHHHcCC-CCCCeeEEeeee-----CceeEEE
Q 015406 21 GEIYLGTNIQTNEEVAIKLENVKTK-----------HP--QLLYESKLYRILQGG-TGIPNVRWFGVE-----GDYNVLV 81 (407)
Q Consensus 21 g~Vy~~~~~~~~~~vAvK~~~~~~~-----------~~--~~~~E~~~l~~l~~~-~~i~~~~~~~~~-----~~~~~lv 81 (407)
..|+++. ..|+.|.||....... .+ ...+|...+..|... -..+....+++. ....+||
T Consensus 36 rrvvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 36 RRTLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred ceEEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 3466655 4678899996533220 11 377899999888642 222233334432 2356899
Q ss_pred EeccCC--CHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccC----CCCCceEEEEecccee
Q 015406 82 MDLLGP--SLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL----GRRANQVYIIDFGLAK 154 (407)
Q Consensus 82 me~~g~--sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~----~~~~~~~kL~DFGla~ 154 (407)
||++++ +|.+++... ....+......++.+++..+.-||+.||+|+||++.|||+.. ++....+.|+||+.+.
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 999944 799998642 234667788899999999999999999999999999999952 1235789999999885
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.15 E-value=6.6e-10 Score=110.63 Aligned_cols=183 Identities=15% Similarity=0.115 Sum_probs=128.7
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC--cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~ 85 (407)
-|++ ...+-++.+..-.|..+.++.+|.|...+.... .....+-++.++.++|++++..+..+ +..+..|||.|-+
T Consensus 14 pY~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~-e~~~~~ylvTErV 91 (690)
T KOG1243|consen 14 PYDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTT-EEEGTLYLVTERV 91 (690)
T ss_pred Cccc-ccccCCCcccccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhh-cccCceEEEeecc
Confidence 3555 444444444332466678888999988776555 34466778888999986555555544 4455789999998
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcc
Q 015406 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH-SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164 (407)
Q Consensus 86 g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH-~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~ 164 (407)
.. |..++++ +....+...+.||+.||.||| +.+++|++|.-+.|++ +..|..||++|-++.........
T Consensus 92 ~P-l~~~lk~----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfV---n~~GeWkLggle~v~~~~~~~~~-- 161 (690)
T KOG1243|consen 92 RP-LETVLKE----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFV---NESGEWKLGGLELVSKASGFNAP-- 161 (690)
T ss_pred cc-HHHHHHH----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEE---cCCCcEEEeeeEEEeccccCCcc--
Confidence 43 5666664 346778888999999999998 6789999999999999 68999999999998765443310
Q ss_pred cCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhC
Q 015406 165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRG 209 (407)
Q Consensus 165 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG 209 (407)
.....---.|..|+.+.... -..|.|-|||+++|++.|
T Consensus 162 -----~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 162 -----AKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -----cccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 01111122355666544322 346999999999999999
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.09 E-value=3e-09 Score=100.66 Aligned_cols=256 Identities=13% Similarity=0.192 Sum_probs=158.7
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCe-eEE-----eee-eCceeEE
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPN-VRW-----FGV-EGDYNVL 80 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~-~~~-----~~~-~~~~~~l 80 (407)
-....+.||+|+-+.+|-.- .-+. .+.|+........ -..-+..|...-.++.+.. +.| ++- .+....+
T Consensus 12 ~i~~gr~LgqGgea~ly~l~--e~~d-~VAKIYh~Pppa~-~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 12 PIPPGRPLGQGGEADLYTLG--EVRD-QVAKIYHAPPPAA-QAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred ccCCCccccCCccceeeecc--hhhc-hhheeecCCCchH-HHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 34567889999999999654 2222 3446543322111 1111222222222222222 111 222 3334678
Q ss_pred EEecc-CC-CHHHHHHHc--C---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccce
Q 015406 81 VMDLL-GP-SLEDLFNFC--S---RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (407)
Q Consensus 81 vme~~-g~-sL~~~l~~~--~---~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla 153 (407)
.|..+ |. .+..++.-. . ....|.-.++.++.++.+..-||+.|.+-+|+.++|+|++ +++.+.|.|=..-
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVs---d~~~V~LVdsDsf 164 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVS---DDSKVVLVDSDSF 164 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeee---cCceEEEEcccce
Confidence 88888 43 334443211 1 1378999999999999999999999999999999999994 7788999885543
Q ss_pred eeeccCCCCcccCccCCCCcccccccccccccc-----CCCCChhhHHHHHHHHHHHHHhC-CCCCCCCCcC----chHH
Q 015406 154 KKYRDTSTHQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRG-SLPWQGLKAG----TKKQ 223 (407)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~sDIwSlG~il~elltG-~~Pf~~~~~~----~~~~ 223 (407)
..-.+... ....+|.+.|.+||.-. +..-+...|.|.||+++++++.| ++||.+.... ...+
T Consensus 165 qi~~ng~~--------~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E 236 (637)
T COG4248 165 QINANGTL--------HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE 236 (637)
T ss_pred eeccCCce--------EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch
Confidence 32222211 23457899999999754 44557789999999999999985 9999875331 1111
Q ss_pred -HHH--------HHhhhcccccHHHHhcCCcHHHHHHHHHHhCC--CCCCCCCHHHHHHHHHHHHH
Q 015406 224 -KYE--------KISEKKVSTSIEALCRGYPTEFASYFHYCRSL--RFDDKPDYAYLKRIFRDLFI 278 (407)
Q Consensus 224 -~~~--------~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~--~p~~RPt~~~l~~~l~~l~~ 278 (407)
.+. +-.....+.+...-+.-+|+.+..++.+|+.. ++.-||+++.-...|..+-.
T Consensus 237 ~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~ 302 (637)
T COG4248 237 TDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ 302 (637)
T ss_pred hhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence 000 00111112222222345789999999999864 35689999877666655543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.09 E-value=4.8e-10 Score=97.90 Aligned_cols=125 Identities=24% Similarity=0.345 Sum_probs=80.6
Q ss_pred EEEEEEEcCCCeEEEEEEecCCC--------------C--------------cchHHHHHHHHHHHcCCC-CCCeeEEee
Q 015406 22 EIYLGTNIQTNEEVAIKLENVKT--------------K--------------HPQLLYESKLYRILQGGT-GIPNVRWFG 72 (407)
Q Consensus 22 ~Vy~~~~~~~~~~vAvK~~~~~~--------------~--------------~~~~~~E~~~l~~l~~~~-~i~~~~~~~ 72 (407)
.||.|.. ..|..+|||+-.... . .....+|.+.|.++.... .+|.+..+.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 4899986 678899999743210 0 012567999999988653 466655442
Q ss_pred eeCceeEEEEeccC--CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHH-HHhCCceeccCCCCcccccCCCCCceEEEEe
Q 015406 73 VEGDYNVLVMDLLG--PSLEDLFNFCSRKLSLKTVLMLADQMINRVEF-VHSKSFLHRDIKPDNFLMGLGRRANQVYIID 149 (407)
Q Consensus 73 ~~~~~~~lvme~~g--~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~y-LH~~~ivHrDLKp~NILl~~~~~~~~~kL~D 149 (407)
..+|||||++ |.....+... .++......++.+++..+.. +|+.||||+||.+.|||++ ++.+.|+|
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~----~~~~~iID 149 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVD----DGKVYIID 149 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEE----TTCEEE--
T ss_pred ----CCEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEee----cceEEEEe
Confidence 3479999996 6433334321 22245667788888886655 5799999999999999993 34899999
Q ss_pred ccceeeec
Q 015406 150 FGLAKKYR 157 (407)
Q Consensus 150 FGla~~~~ 157 (407)
||.+....
T Consensus 150 f~qav~~~ 157 (188)
T PF01163_consen 150 FGQAVDSS 157 (188)
T ss_dssp GTTEEETT
T ss_pred cCcceecC
Confidence 99997644
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.1e-10 Score=114.47 Aligned_cols=154 Identities=12% Similarity=0.194 Sum_probs=106.7
Q ss_pred HHHHHHHHHHHh-CCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcccCccCC--CCcccccccccccccc
Q 015406 110 DQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN--KNLTGTARYASMNTHL 186 (407)
Q Consensus 110 ~qi~~aL~yLH~-~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~--~~~~gt~~Y~aPE~~~ 186 (407)
.+++.||.|+|. .++||++|.|++|.+ +..+.+||+.|+++.............|... ....-...|.|||++.
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~---na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVV---NANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hcccchhhhhccCcceeecccchhheee---ccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 345599999996 589999999999999 6889999999999876554322111111111 1123456799999999
Q ss_pred CCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCC
Q 015406 187 GIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD 265 (407)
Q Consensus 187 ~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt 265 (407)
+...+.++|+||||+++|.+.. |+.-+..... ....... .....-.......++|+++.+-+.+++..+...||+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~-~~~~~~~---~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~ 258 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGG-LLSYSFS---RNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPT 258 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCC-cchhhhh---hcccccccccccccCcHHHHHHHHHHhcCCcccCcc
Confidence 9888999999999999999984 5544443222 1111111 111111111223678999999999999999999997
Q ss_pred HHHHH
Q 015406 266 YAYLK 270 (407)
Q Consensus 266 ~~~l~ 270 (407)
+..+.
T Consensus 259 ~~~l~ 263 (700)
T KOG2137|consen 259 LDLLL 263 (700)
T ss_pred hhhhh
Confidence 66654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.88 E-value=4.3e-08 Score=87.50 Aligned_cols=110 Identities=19% Similarity=0.272 Sum_probs=82.9
Q ss_pred cchHHHHHHHHHHHcCC-CCCCeeEEeeeeC----ceeEEEEecc-C-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHH
Q 015406 46 HPQLLYESKLYRILQGG-TGIPNVRWFGVEG----DYNVLVMDLL-G-PSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 118 (407)
Q Consensus 46 ~~~~~~E~~~l~~l~~~-~~i~~~~~~~~~~----~~~~lvme~~-g-~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~y 118 (407)
.....+|...+..|... -.++....++... ...+|++|++ + .+|.+++.... ..+......++.+++..+.-
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-~~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-QLDPSQRRELLRALARLIAK 133 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-ccchhhHHHHHHHHHHHHHH
Confidence 34578899988888642 2233344444431 2458999999 4 37999998533 26777889999999999999
Q ss_pred HHhCCceeccCCCCcccccCCCCCceEEEEeccceeee
Q 015406 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (407)
Q Consensus 119 LH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~ 156 (407)
||++||+|+|+++.|||+..++....+.|+||+.++..
T Consensus 134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999999999999999954333458999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.81 E-value=6.2e-07 Score=87.28 Aligned_cols=211 Identities=17% Similarity=0.194 Sum_probs=144.5
Q ss_pred ceEEEEEEEcCCCeEEEEEEecCCCC--cchHHHHHHHHHHHcCCCCCCeeEEee---eeCceeEEEEecc--CCCHHHH
Q 015406 20 FGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFG---VEGDYNVLVMDLL--GPSLEDL 92 (407)
Q Consensus 20 ~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~---~~~~~~~lvme~~--g~sL~~~ 92 (407)
-.+.|++....+|..|++|.+.-... ...-..-++.++++.|.+.|+.-..+. -.....++|++|+ .++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 45789999999999999998832221 112344578889999866555433322 1345678999999 6688887
Q ss_pred HHHc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 93 FNFC--------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 93 l~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
.-.. +.++++..+|.++.|+..||.++|+.|+.-+-|.|.+||+ ..+.+++|+..|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv---~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILV---TGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEe---eCcceEEEecccceeeecC
Confidence 5211 2247889999999999999999999999999999999999 4666899988887765543
Q ss_pred CCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHH
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (407)
+.. |.+. .-.+-|.=.||.+++.|.||..--.. .+..+.. ...
T Consensus 446 d~~---------------------~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~---~d~~~~s----------~~~ 488 (655)
T KOG3741|consen 446 DPT---------------------EPLE---SQQQNDLRDLGLLLLALATGTENSNR---TDSTQSS----------HLT 488 (655)
T ss_pred CCC---------------------cchh---HHhhhhHHHHHHHHHHHhhccccccc---ccchHHH----------HHH
Confidence 321 1111 12356999999999999998543111 1111111 012
Q ss_pred HHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 239 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.+...++.++++++......++++ -+..++..
T Consensus 489 ~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp 520 (655)
T KOG3741|consen 489 RITTTYSTDLRNVVEYLESLNFRE-KSIQDLLP 520 (655)
T ss_pred HhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHH
Confidence 233457888899999998888886 45555543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.2e-07 Score=83.53 Aligned_cols=137 Identities=10% Similarity=0.078 Sum_probs=99.3
Q ss_pred ccccCceEEEEEEEcCCCeEEEEEEecC--------CCCcchHHHHHHHHHHHcCCCC-CCeeEEeeee----CceeEEE
Q 015406 15 IGSGSFGEIYLGTNIQTNEEVAIKLENV--------KTKHPQLLYESKLYRILQGGTG-IPNVRWFGVE----GDYNVLV 81 (407)
Q Consensus 15 iG~G~~g~Vy~~~~~~~~~~vAvK~~~~--------~~~~~~~~~E~~~l~~l~~~~~-i~~~~~~~~~----~~~~~lv 81 (407)
-|+||.+-|+.... .|..+=+|.... ....+.+.+|...+..|..... ++.+.++... .-..+||
T Consensus 26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence 36799999999873 344688885431 2234569999999999975322 3334433322 2346899
Q ss_pred EeccC--CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEecccee
Q 015406 82 MDLLG--PSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (407)
Q Consensus 82 me~~g--~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~ 154 (407)
+|-++ .+|.+++.... .+.+......++.+++..|.-||+.|+.|+|+-+.|||+... ....++++||--++
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~-g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTE-GKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCC-CCeeEEEEEhhccc
Confidence 99886 69999886422 245777888999999999999999999999999999999421 12349999997665
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.78 E-value=2.9e-08 Score=89.50 Aligned_cols=133 Identities=21% Similarity=0.348 Sum_probs=95.7
Q ss_pred eeEeccccccCceEEEEEEEcCCCeEEEEEEecCC----------------CCc--------chHHHHHHHHHHHcCC-C
Q 015406 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----------------TKH--------PQLLYESKLYRILQGG-T 63 (407)
Q Consensus 9 y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----------------~~~--------~~~~~E~~~l~~l~~~-~ 63 (407)
+.++.+||-|--+.||.|.+ ..|.++|||.=+.. ..+ ....+|.++|..|... -
T Consensus 93 e~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 45778999999999999996 57899999952210 011 1256788999988753 2
Q ss_pred CCCeeEEeeeeCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCC
Q 015406 64 GIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 142 (407)
Q Consensus 64 ~i~~~~~~~~~~~~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~ 142 (407)
.+|... ..+...+||||. |.-|..+ +++.+..-.++..|+.-+.-+-..||||+|+.+=||++ +++
T Consensus 172 ~VP~P~----~~nRHaVvMe~ieG~eL~~~------r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV---~~d 238 (304)
T COG0478 172 KVPKPI----AWNRHAVVMEYIEGVELYRL------RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILV---TED 238 (304)
T ss_pred CCCCcc----ccccceeeeehcccceeecc------cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEE---ecC
Confidence 343332 235668999999 5444432 22455566666777777766668999999999999999 688
Q ss_pred ceEEEEeccceee
Q 015406 143 NQVYIIDFGLAKK 155 (407)
Q Consensus 143 ~~~kL~DFGla~~ 155 (407)
+.++++||=-+..
T Consensus 239 g~~~vIDwPQ~v~ 251 (304)
T COG0478 239 GDIVVIDWPQAVP 251 (304)
T ss_pred CCEEEEeCccccc
Confidence 8999999976653
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.77 E-value=5.7e-08 Score=82.18 Aligned_cols=128 Identities=27% Similarity=0.402 Sum_probs=98.6
Q ss_pred eEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-CCC
Q 015406 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPS 88 (407)
Q Consensus 10 ~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~-g~s 88 (407)
+..+.|++|.+|.||+|. ..|..+|+|+-..+.....+..|++++..+......+.++.|+.+. +.|||. |..
T Consensus 25 ~v~~~L~KG~~s~Vyl~~--~~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~~----i~me~i~G~~ 98 (201)
T COG2112 25 RVEKELAKGTTSVVYLGE--WRGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGEDF----IRMEYIDGRP 98 (201)
T ss_pred hhhhhhhcccccEEEEee--ccCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEechhh----hhhhhhcCcc
Confidence 446789999999999999 5677999999988888889999999999999989999998887654 459999 778
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCC-CC-cccccCCCCCceEEEEeccceee
Q 015406 89 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK-PD-NFLMGLGRRANQVYIIDFGLAKK 155 (407)
Q Consensus 89 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLK-p~-NILl~~~~~~~~~kL~DFGla~~ 155 (407)
|.+.... .+...+ ..++++---|-..||-|..|. |. ||++ .++.+.|+||..|+.
T Consensus 99 L~~~~~~----~~rk~l----~~vlE~a~~LD~~GI~H~El~~~~k~vlv----~~~~~~iIDFd~At~ 155 (201)
T COG2112 99 LGKLEIG----GDRKHL----LRVLEKAYKLDRLGIEHGELSRPWKNVLV----NDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhc----ccHHHH----HHHHHHHHHHHHhccchhhhcCCceeEEe----cCCcEEEEEccchhh
Confidence 8877652 123333 334444344556799998886 44 5555 455899999998873
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.74 E-value=6.2e-08 Score=85.61 Aligned_cols=136 Identities=18% Similarity=0.249 Sum_probs=90.4
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcch-----------HHHHHHHHHHHcC--CCCCCeeEE
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-----------LLYESKLYRILQG--GTGIPNVRW 70 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~-----------~~~E~~~l~~l~~--~~~i~~~~~ 70 (407)
.+.++|.+.+.+-......|.+.. -.|..+++|....+....+ ..+++..+..+.. ......+..
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 456788888888888877777776 6778899997655432211 2233333444432 122222112
Q ss_pred eee-----eCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCce
Q 015406 71 FGV-----EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ 144 (407)
Q Consensus 71 ~~~-----~~~~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~ 144 (407)
... .....+|+|||+ |..|.++.. +++ .+...++.+|.-||+.|+.|+|..|.|+++ .++.
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv----~~~~ 172 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLV----SNNG 172 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEE----ECCc
Confidence 111 223457999999 777776543 232 245667788999999999999999999999 3556
Q ss_pred EEEEecccee
Q 015406 145 VYIIDFGLAK 154 (407)
Q Consensus 145 ~kL~DFGla~ 154 (407)
++++||+..+
T Consensus 173 i~iID~~~k~ 182 (229)
T PF06176_consen 173 IRIIDTQGKR 182 (229)
T ss_pred EEEEECcccc
Confidence 9999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.69 E-value=2.8e-07 Score=83.38 Aligned_cols=71 Identities=21% Similarity=0.176 Sum_probs=56.0
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCC-CCeeEEeeeeCceeEEEEecc-CC
Q 015406 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTG-IPNVRWFGVEGDYNVLVMDLL-GP 87 (407)
Q Consensus 13 ~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~-i~~~~~~~~~~~~~~lvme~~-g~ 87 (407)
..||+|..+.||+. .+..+++|+...........+|.++++.+..... ++.+..++...+...++||++ |.
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 57899999999984 2556889987665555668899999999986554 677888887777788999999 54
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.65 E-value=1.4e-07 Score=94.58 Aligned_cols=140 Identities=19% Similarity=0.297 Sum_probs=92.7
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEecCCCCc------------------------------------------chHH
Q 015406 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH------------------------------------------PQLL 50 (407)
Q Consensus 13 ~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~------------------------------------------~~~~ 50 (407)
+.|+.++-|.||+|+. .+|+.||||+....-.. -++.
T Consensus 131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 5688999999999996 56999999975431100 0134
Q ss_pred HHHHHHHHHc----CCCCCCeeEEeeeeCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 015406 51 YESKLYRILQ----GGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 125 (407)
Q Consensus 51 ~E~~~l~~l~----~~~~i~~~~~~~~~~~~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iv 125 (407)
+|...+..+. +.+.+..-..|.+-....+|+|||+ |..+.++.......++.+.+...+.++. +..+-..|+.
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgff 287 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGFF 287 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCcc
Confidence 5555555543 2333333334444445568999999 7788887532234456444333332222 3334458999
Q ss_pred eccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 126 HrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
|.|..|.||++ +.++.+.+.|||+...+..
T Consensus 288 HaDpHpGNi~v---~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 288 HADPHPGNILV---RSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ccCCCccceEE---ecCCcEEEEcCcceecCCH
Confidence 99999999999 6789999999999976654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.56 E-value=6.9e-07 Score=79.93 Aligned_cols=135 Identities=21% Similarity=0.278 Sum_probs=92.0
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEecCCCCc---------------------c-----hHHHHHHHHHHHcCC-CCC
Q 015406 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---------------------P-----QLLYESKLYRILQGG-TGI 65 (407)
Q Consensus 13 ~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~---------------------~-----~~~~E~~~l~~l~~~-~~i 65 (407)
..|.+|--+.||+|.. ..+..+|+|+....... . ...+|...|+++... -.+
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 3667777889999984 67889999986542210 0 134677777776542 112
Q ss_pred CeeEEeeeeCceeEEEEeccCCCH--HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcccccCCCCC
Q 015406 66 PNVRWFGVEGDYNVLVMDLLGPSL--EDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRA 142 (407)
Q Consensus 66 ~~~~~~~~~~~~~~lvme~~g~sL--~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~ivHrDLKp~NILl~~~~~~ 142 (407)
|.-..+ ....|||||+|... .-.|+ .-.+...++..+..++++.+.-|-. .++||+||..=|||+ .+
T Consensus 133 P~Pi~~----~~nVLvMEfIg~~g~pAP~Lk--Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~----~~ 202 (268)
T COG1718 133 PEPIAF----RNNVLVMEFIGDDGLPAPRLK--DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILV----HD 202 (268)
T ss_pred CCceee----cCCeEEEEeccCCCCCCCCcc--cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEE----EC
Confidence 221111 23479999996541 11222 1223444788889999999998877 899999999999999 47
Q ss_pred ceEEEEeccceeeecc
Q 015406 143 NQVYIIDFGLAKKYRD 158 (407)
Q Consensus 143 ~~~kL~DFGla~~~~~ 158 (407)
+.+.|+|||-|.....
T Consensus 203 ~~p~iID~~QaV~~~h 218 (268)
T COG1718 203 GEPYIIDVSQAVTIDH 218 (268)
T ss_pred CeEEEEECccccccCC
Confidence 8999999999876543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.8e-06 Score=79.15 Aligned_cols=76 Identities=20% Similarity=0.278 Sum_probs=55.5
Q ss_pred cccccCc-eEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-CCCHHH
Q 015406 14 KIGSGSF-GEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLED 91 (407)
Q Consensus 14 ~iG~G~~-g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~-g~sL~~ 91 (407)
.|..|.+ ..||+... .+..+.||+..... ...+.+|+++++.+...-.++.+..+....+..++|||++ |.+|.+
T Consensus 5 ~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~-~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 5 RVTEGQSGATVYRLDG--KNPGLYLKIAPSGP-TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred ecCCCCCcCeEEEEcC--CCCcEEEEecCCCc-ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 3445555 78999974 34688999865443 4467899999999986666677777776666789999999 766654
Q ss_pred H
Q 015406 92 L 92 (407)
Q Consensus 92 ~ 92 (407)
.
T Consensus 82 ~ 82 (244)
T cd05150 82 L 82 (244)
T ss_pred h
Confidence 3
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.48 E-value=1e-06 Score=79.69 Aligned_cols=139 Identities=19% Similarity=0.261 Sum_probs=81.8
Q ss_pred eccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCC-CCeeEEee---eeCceeEEEEecc-C
Q 015406 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTG-IPNVRWFG---VEGDYNVLVMDLL-G 86 (407)
Q Consensus 12 ~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~-i~~~~~~~---~~~~~~~lvme~~-g 86 (407)
++.|+.|..+.||++.... ..+++|+.........+..|..+++.|..... ++.+..+. ......+++|+++ |
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 4678999999999999643 58999986554234567889999999876544 55665533 3444578999999 7
Q ss_pred CCHHH----------------HHH---HcC---CCCCHHH---------HHHH------------HHHHHH-HHHHHH--
Q 015406 87 PSLED----------------LFN---FCS---RKLSLKT---------VLML------------ADQMIN-RVEFVH-- 120 (407)
Q Consensus 87 ~sL~~----------------~l~---~~~---~~l~~~~---------~~~i------------~~qi~~-aL~yLH-- 120 (407)
..+.. .+. ... ..+.... .... ...+.. .++.++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 66666 111 110 0001000 0000 111222 233333
Q ss_pred -----hCCceeccCCCCcccccCCCCCceEEEEecccee
Q 015406 121 -----SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (407)
Q Consensus 121 -----~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~ 154 (407)
...++|+|+.|.|||++ +.++.+.|+||+.+.
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~--~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVD--PSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEE--SSTTEEEE--GTT-E
T ss_pred hccCCCcEEEEeccccccceee--eccceeEEEecccce
Confidence 24699999999999994 256777899998875
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.39 E-value=3.2e-08 Score=98.22 Aligned_cols=186 Identities=13% Similarity=0.028 Sum_probs=134.7
Q ss_pred eeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-CC
Q 015406 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GP 87 (407)
Q Consensus 9 y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~-g~ 87 (407)
|.....+++|+++.+++.+...+...+ .+++... ....-++++|.++++++-......-.+.+++.+++|+++ ++
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~---l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~ 319 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT---LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTG 319 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc---hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCC
Confidence 445566789999999999865554443 5654432 345567889999998773333333344567889999999 43
Q ss_pred -CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcccC
Q 015406 88 -SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166 (407)
Q Consensus 88 -sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~ 166 (407)
+-..........+..-....+.+.-.++|++||+.--+||| ||+. ..+..++.||+....+....
T Consensus 320 rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~----s~~~~~~~~~~v~~~L~~~~------ 385 (829)
T KOG0576|consen 320 RSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILG----SEEEVKLLDFAVPPQLTRTM------ 385 (829)
T ss_pred ccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccc----cccccccccccCCcccCccc------
Confidence 33333222222345556666777788899999998779999 8887 55788999999987765543
Q ss_pred ccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCC
Q 015406 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ 214 (407)
Q Consensus 167 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~ 214 (407)
......+|+.++|||+..+..+....|.|++|.--.+|.-|.+|-.
T Consensus 386 --~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 386 --KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred --ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 2457789999999999999999999999999987778877777654
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.26 E-value=4.8e-06 Score=83.38 Aligned_cols=141 Identities=21% Similarity=0.266 Sum_probs=91.5
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEecCCCC---------------------------------------cchHHHHH
Q 015406 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---------------------------------------HPQLLYES 53 (407)
Q Consensus 13 ~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---------------------------------------~~~~~~E~ 53 (407)
+.||.-+.|.||+|+- .+|+.||||+....-. +-+|..|+
T Consensus 167 ~piaaASlaQVhrA~L-~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARL-KNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEe-cCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 5789999999999996 4599999997443110 01245555
Q ss_pred HHHHHHc----CCC-----CCCeeEEeeeeCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 015406 54 KLYRILQ----GGT-----GIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123 (407)
Q Consensus 54 ~~l~~l~----~~~-----~i~~~~~~~~~~~~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 123 (407)
+...+++ +-. .+|.++ .......+|+|||+ |..+.|+-.-....++...+..-+.+... +-|-..|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~qIf~~G 321 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--EQIFKTG 321 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--HHHHhcC
Confidence 5544443 222 133333 33344568999999 77666554322446777755555444432 3334578
Q ss_pred ceeccCCCCcccccCC-CCCceEEEEeccceeeecc
Q 015406 124 FLHRDIKPDNFLMGLG-RRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 124 ivHrDLKp~NILl~~~-~~~~~~kL~DFGla~~~~~ 158 (407)
++|+|=.|.||++..+ ..+..+.+.|||+...+..
T Consensus 322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 9999999999999522 2478899999999986654
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.16 E-value=3.5e-05 Score=67.50 Aligned_cols=124 Identities=19% Similarity=0.296 Sum_probs=84.4
Q ss_pred CceeEeccccccCc-eEEEEEEEcCCCeEEEEEEecC---C--------------------CCcchHHHHHHHHHHHcCC
Q 015406 7 NKFRLGRKIGSGSF-GEIYLGTNIQTNEEVAIKLENV---K--------------------TKHPQLLYESKLYRILQGG 62 (407)
Q Consensus 7 ~~y~i~~~iG~G~~-g~Vy~~~~~~~~~~vAvK~~~~---~--------------------~~~~~~~~E~~~l~~l~~~ 62 (407)
.+++.++.||.|.- |.||+++ -.|+.||+|++.. . .....|..|.+.+.+|++.
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 68999999999999 9999999 5788999998321 0 0112377899998888754
Q ss_pred CC--C--CeeEEeee-e-----------------CceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Q 015406 63 TG--I--PNVRWFGV-E-----------------GDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120 (407)
Q Consensus 63 ~~--i--~~~~~~~~-~-----------------~~~~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH 120 (407)
.. + +..+++.. . .....||.||....- .+... =+.+|.+-|..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~----~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIR----DIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchh----HHHHHHHHHHHHH
Confidence 33 2 33333321 1 112356777662211 12222 3456777788999
Q ss_pred hCCceeccCCCCcccccCCCCCceEEEEeccce
Q 015406 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (407)
Q Consensus 121 ~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla 153 (407)
..||+-+|+|+.|..=+ +|+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~~G--------~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYRGG--------KLVDFSSS 206 (207)
T ss_pred HCCeeeccCccccccCC--------EEEecccC
Confidence 99999999999998732 89999864
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.12 E-value=1.3e-05 Score=73.11 Aligned_cols=73 Identities=16% Similarity=0.170 Sum_probs=47.4
Q ss_pred eccccccCce-EEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCC--CCCCeeEEeeeeC---ceeEEEEecc
Q 015406 12 GRKIGSGSFG-EIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGG--TGIPNVRWFGVEG---DYNVLVMDLL 85 (407)
Q Consensus 12 ~~~iG~G~~g-~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~--~~i~~~~~~~~~~---~~~~lvme~~ 85 (407)
++.|+.|+.. .||+.. ..+++|+.........+.+|.+++..|... --++.+...+... ...+++|+++
T Consensus 2 ~~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 2 IEPVDSGGTDNATFRLG-----DDMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred ceeccCCCcccceEEcC-----CceEEEcCCccchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 3567777777 499762 357889765533445788999999998753 2344444444332 2458899998
Q ss_pred -CCCH
Q 015406 86 -GPSL 89 (407)
Q Consensus 86 -g~sL 89 (407)
|.++
T Consensus 77 ~G~~l 81 (235)
T cd05155 77 EGETA 81 (235)
T ss_pred cCCCC
Confidence 6555
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.11 E-value=8.8e-05 Score=65.42 Aligned_cols=132 Identities=21% Similarity=0.295 Sum_probs=93.5
Q ss_pred eccccccCceEEEEEEEcCCCeEEEEEEecCCC------------------CcchHHHHHHHHHHHc-C----CCCCCee
Q 015406 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT------------------KHPQLLYESKLYRILQ-G----GTGIPNV 68 (407)
Q Consensus 12 ~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~------------------~~~~~~~E~~~l~~l~-~----~~~i~~~ 68 (407)
...||+|+.-.||.- .......||+..... ...+..+|+..+..+. . ..+++.+
T Consensus 6 ~~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 457899999999974 334456889876654 2455778888887776 3 3566777
Q ss_pred EEeeeeCceeEEEEecc-------CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCC
Q 015406 69 RWFGVEGDYNVLVMDLL-------GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 141 (407)
Q Consensus 69 ~~~~~~~~~~~lvme~~-------g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~ 141 (407)
+++.+++.-..+|+|.. ..+|.+++. .+.++. .....+. .-.+||-+.+|+.+||+|.||++...++
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~--~~~~~~-~~~~~L~---~f~~~l~~~~Iv~~dl~~~NIv~~~~~~ 156 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLK--EGGLTE-ELRQALD---EFKRYLLDHHIVIRDLNPHNIVVQRRDS 156 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHH--cCCccH-HHHHHHH---HHHHHHHHcCCeecCCCcccEEEEecCC
Confidence 77777777778888875 237888886 344665 3333333 3456788899999999999999976555
Q ss_pred Cc-eEEEEe-ccc
Q 015406 142 AN-QVYIID-FGL 152 (407)
Q Consensus 142 ~~-~~kL~D-FGl 152 (407)
.. .+.|+| ||.
T Consensus 157 ~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 157 GEFRLVLIDGLGE 169 (199)
T ss_pred CceEEEEEeCCCC
Confidence 55 788888 453
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.02 E-value=7.1e-05 Score=80.57 Aligned_cols=76 Identities=16% Similarity=0.215 Sum_probs=51.7
Q ss_pred eccccccCceEEEEEEEcCCC--eEEEEEEecCCC---CcchHHHHHHHHHHHcCCCCC--CeeEEeeeeC---ceeEEE
Q 015406 12 GRKIGSGSFGEIYLGTNIQTN--EEVAIKLENVKT---KHPQLLYESKLYRILQGGTGI--PNVRWFGVEG---DYNVLV 81 (407)
Q Consensus 12 ~~~iG~G~~g~Vy~~~~~~~~--~~vAvK~~~~~~---~~~~~~~E~~~l~~l~~~~~i--~~~~~~~~~~---~~~~lv 81 (407)
.++|+.|.++.+|+......+ ..+++|+..... ....+.+|.++++.+..+..+ +.+..++.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 577899999999998764332 467888754322 223588999999999743434 5555554432 457899
Q ss_pred Eecc-CC
Q 015406 82 MDLL-GP 87 (407)
Q Consensus 82 me~~-g~ 87 (407)
|||+ |.
T Consensus 123 ME~v~G~ 129 (822)
T PLN02876 123 MEYLEGR 129 (822)
T ss_pred EEecCCc
Confidence 9999 54
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.94 E-value=4.5e-05 Score=72.03 Aligned_cols=138 Identities=23% Similarity=0.296 Sum_probs=97.5
Q ss_pred eEeccccccCceEEEEEEEcCCCeEEEEEEecCCC----------------------Ccc------hHHHHHHHHHHHcC
Q 015406 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----------------------KHP------QLLYESKLYRILQG 61 (407)
Q Consensus 10 ~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~----------------------~~~------~~~~E~~~l~~l~~ 61 (407)
.|-..|..|--+.||.|.. .+|..+|||+.+... ..+ ....|++.|+++..
T Consensus 147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 4556788899999999985 778889999744210 001 14568888888875
Q ss_pred CCCCCeeEEeeeeCceeEEEEeccCCCHH--HHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCCCcccccC
Q 015406 62 GTGIPNVRWFGVEGDYNVLVMDLLGPSLE--DLFNFCSRKLSLKTVLMLADQMINRVEFVH-SKSFLHRDIKPDNFLMGL 138 (407)
Q Consensus 62 ~~~i~~~~~~~~~~~~~~lvme~~g~sL~--~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH-~~~ivHrDLKp~NILl~~ 138 (407)
. .|+.-.-... ...+|||+|+|.+-. -.|+ ...++...+..+-.|++.-+.-|- ..++||.||.-=|+|+
T Consensus 226 a-GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLK--d~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-- 298 (520)
T KOG2270|consen 226 A-GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLK--DASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-- 298 (520)
T ss_pred c-CCCCCCceee--ecceEeeeeccCCCCcCcccc--cccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE--
Confidence 3 2332211111 234899999965322 2233 345788889999899988888774 6799999999999999
Q ss_pred CCCCceEEEEeccceeeec
Q 015406 139 GRRANQVYIIDFGLAKKYR 157 (407)
Q Consensus 139 ~~~~~~~kL~DFGla~~~~ 157 (407)
.+|.++|+|-+-+....
T Consensus 299 --hdG~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 299 --HDGKLYIIDVSQSVEHD 315 (520)
T ss_pred --ECCEEEEEEccccccCC
Confidence 78999999998876443
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.93 E-value=0.0013 Score=63.09 Aligned_cols=78 Identities=15% Similarity=0.152 Sum_probs=50.1
Q ss_pred cccccCceEEEEEEEcCCCeEEEEEEec----C-----CCCcchHHHHHHHHHHHcC--CCCCCeeEEeeeeCceeEEEE
Q 015406 14 KIGSGSFGEIYLGTNIQTNEEVAIKLEN----V-----KTKHPQLLYESKLYRILQG--GTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 14 ~iG~G~~g~Vy~~~~~~~~~~vAvK~~~----~-----~~~~~~~~~E~~~l~~l~~--~~~i~~~~~~~~~~~~~~lvm 82 (407)
.||.|....||++.+...++.|+||.-. . .....+...|...|+.... +..+|.++.+. .....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D--~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD--TEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc--cccceehH
Confidence 5799999999999975444689999522 1 1122345678888877653 23566665554 44567999
Q ss_pred ecc--CCCHHHHH
Q 015406 83 DLL--GPSLEDLF 93 (407)
Q Consensus 83 e~~--g~sL~~~l 93 (407)
|++ ...|.+.+
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 998 33444443
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.0002 Score=65.11 Aligned_cols=74 Identities=16% Similarity=0.179 Sum_probs=50.6
Q ss_pred eccccccCceEEEEEEEcC-CCeEEEEEEecCCCCc-chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-CCC
Q 015406 12 GRKIGSGSFGEIYLGTNIQ-TNEEVAIKLENVKTKH-PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPS 88 (407)
Q Consensus 12 ~~~iG~G~~g~Vy~~~~~~-~~~~vAvK~~~~~~~~-~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~-g~s 88 (407)
++.|..|-...+|++.... .++.|++|+....... ....+|..+++.+......+.+..... ..++|||+ |.+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 4567788888999997432 3578999976543221 234579999999976666777754432 24899999 655
Q ss_pred H
Q 015406 89 L 89 (407)
Q Consensus 89 L 89 (407)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 4
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.87 E-value=8.4e-05 Score=68.60 Aligned_cols=131 Identities=18% Similarity=0.161 Sum_probs=78.7
Q ss_pred cccccCceEEEEEEEcCCCeEEEEEEecCCCCc--chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-CCCHH
Q 015406 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLE 90 (407)
Q Consensus 14 ~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~--~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~-g~sL~ 90 (407)
.+..|-.+.+|+.. .+++.+++|+....... -....|..+++.+......|.+.+... .++||||+ |..+.
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~ 76 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT 76 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence 35668888999987 56778999975443222 246789999999987655666655542 36899999 65442
Q ss_pred H--------------HHHHc-C-----CCCCHH-HHHHHHHHH---------HHHHHHHHh--------CCceeccCCCC
Q 015406 91 D--------------LFNFC-S-----RKLSLK-TVLMLADQM---------INRVEFVHS--------KSFLHRDIKPD 132 (407)
Q Consensus 91 ~--------------~l~~~-~-----~~l~~~-~~~~i~~qi---------~~aL~yLH~--------~~ivHrDLKp~ 132 (407)
. .+.+. . ..++.. .+..+..++ ...+..+-. ..++|+|+.|.
T Consensus 77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 1 11111 1 112211 122222121 111222211 25899999999
Q ss_pred cccccCCCCCceEEEEecccee
Q 015406 133 NFLMGLGRRANQVYIIDFGLAK 154 (407)
Q Consensus 133 NILl~~~~~~~~~kL~DFGla~ 154 (407)
||+++ .++ ++|+||..|.
T Consensus 157 Nil~~---~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 157 NLVVT---PQG-LKLIDWEYAS 174 (256)
T ss_pred cEEEe---CCC-CEEEeccccC
Confidence 99994 434 7899998875
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00051 Score=67.08 Aligned_cols=72 Identities=19% Similarity=0.278 Sum_probs=51.4
Q ss_pred eccccccCceEEEEEEEcCCCeEEEEEEecCC---------CCcchHHHHHHHHHHHcC--CCCCCeeEEeeeeCceeEE
Q 015406 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK---------TKHPQLLYESKLYRILQG--GTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 12 ~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---------~~~~~~~~E~~~l~~l~~--~~~i~~~~~~~~~~~~~~l 80 (407)
.+.||.|.+..||++.+...++.|+||..... ........|.+.|+.+.. +..+|.+..+.. +..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEE
Confidence 46789999999999997544468999974311 122346778888888753 345777777754 44689
Q ss_pred EEecc
Q 015406 81 VMDLL 85 (407)
Q Consensus 81 vme~~ 85 (407)
|||++
T Consensus 109 VME~L 113 (401)
T PRK09550 109 VMEDL 113 (401)
T ss_pred EEecC
Confidence 99998
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00077 Score=64.30 Aligned_cols=73 Identities=16% Similarity=0.172 Sum_probs=45.8
Q ss_pred eccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCC-CCCeeEE------eeeeCceeEEEEec
Q 015406 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGT-GIPNVRW------FGVEGDYNVLVMDL 84 (407)
Q Consensus 12 ~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~-~i~~~~~------~~~~~~~~~lvme~ 84 (407)
.+.|+.|....+|+... . +..+++|+.. ......+..|..++..|.... .++.+.. +....+..+++|++
T Consensus 27 ~~~l~~G~~n~~y~v~t-~-~g~~vLK~~~-~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 27 LKGIAEGIENSNFFLTT-T-QGEYVLTLFE-RLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred cchhccccccceEEEEe-C-CCcEEEEEec-cCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 45677788789999874 3 3368999876 333445667778888776422 1233221 12234567899999
Q ss_pred c-CC
Q 015406 85 L-GP 87 (407)
Q Consensus 85 ~-g~ 87 (407)
+ |.
T Consensus 104 l~G~ 107 (319)
T PRK05231 104 LEGK 107 (319)
T ss_pred cCCC
Confidence 8 54
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00045 Score=65.11 Aligned_cols=137 Identities=15% Similarity=0.165 Sum_probs=81.1
Q ss_pred eccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCC-CCCeeEE------eeeeCceeEEEEec
Q 015406 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGT-GIPNVRW------FGVEGDYNVLVMDL 84 (407)
Q Consensus 12 ~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~-~i~~~~~------~~~~~~~~~lvme~ 84 (407)
.+.|..|....+|+... .+..+++|+... .....+..|.+++..|.+.. .++.+.. +....+..++++++
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~-~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK-VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCC-CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 56777888889999873 445789998764 33456778899998886532 1333221 11234556899999
Q ss_pred c-CCCHHH-----------HH---HHcCCCC----------CHHHH----------HHHHHHHHHHHHHHHh-------C
Q 015406 85 L-GPSLED-----------LF---NFCSRKL----------SLKTV----------LMLADQMINRVEFVHS-------K 122 (407)
Q Consensus 85 ~-g~sL~~-----------~l---~~~~~~l----------~~~~~----------~~i~~qi~~aL~yLH~-------~ 122 (407)
+ |..+.. .+ +.....+ .+... ......+..++.++.+ .
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 9 554321 11 1100000 11000 0011112334444443 4
Q ss_pred CceeccCCCCcccccCCCCCceEEEEecccee
Q 015406 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (407)
Q Consensus 123 ~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~ 154 (407)
+++|+|+.|.|||+ +.++.+.|+||+.+.
T Consensus 176 ~l~HgD~~~~Nil~---~~~~~~~iIDfe~a~ 204 (296)
T cd05153 176 GVIHADLFRDNVLF---DGDELSGVIDFYFAC 204 (296)
T ss_pred cCCccCcCcccEEE---eCCceEEEeehhhhc
Confidence 79999999999999 455566899998874
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00035 Score=66.30 Aligned_cols=140 Identities=17% Similarity=0.239 Sum_probs=80.7
Q ss_pred eEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCC-CCeeEEe------eeeCceeEEEE
Q 015406 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTG-IPNVRWF------GVEGDYNVLVM 82 (407)
Q Consensus 10 ~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~-i~~~~~~------~~~~~~~~lvm 82 (407)
..++.++.|....+|++.. . +..+++|+.........+..|.+++..|..... ++.+... ....+..+++|
T Consensus 25 ~~i~~~~~G~~n~~y~v~t-~-~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~ 102 (307)
T TIGR00938 25 LSLKGIAEGVENSNYLLTT-D-VGRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV 102 (307)
T ss_pred eeccccCCccccceEEEEe-C-CCcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence 3356777887789999873 3 446888986553334556778888888864221 3332221 12245678999
Q ss_pred ecc-CCCH-----H------HHH---HHcCCCCC-----------HHHHH------------HHHHHHHHHHHHHHh---
Q 015406 83 DLL-GPSL-----E------DLF---NFCSRKLS-----------LKTVL------------MLADQMINRVEFVHS--- 121 (407)
Q Consensus 83 e~~-g~sL-----~------~~l---~~~~~~l~-----------~~~~~------------~i~~qi~~aL~yLH~--- 121 (407)
+|+ |..+ . ..+ +.....++ +.... .....+...++++..
T Consensus 103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~ 182 (307)
T TIGR00938 103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP 182 (307)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence 998 5332 1 111 11011110 00000 001123344555542
Q ss_pred ----CCceeccCCCCcccccCCCCCceEEEEecccee
Q 015406 122 ----KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (407)
Q Consensus 122 ----~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~ 154 (407)
.+++|+|+.+.||+++ .++.+.|+||+.+.
T Consensus 183 ~~~~~~l~HgD~~~~Nvl~~---~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 183 RDLPRGVIHADLFPDNVLFD---GDSVKGVIDFYFAC 216 (307)
T ss_pred hcCCCccCCCCCCcCcEEEE---CCceEEEeeccccc
Confidence 6899999999999993 55566899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00075 Score=72.25 Aligned_cols=196 Identities=14% Similarity=0.099 Sum_probs=126.0
Q ss_pred HHHHHHHHHHHcCCCCCCeeEEeeeeCcee----EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 015406 49 LLYESKLYRILQGGTGIPNVRWFGVEGDYN----VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123 (407)
Q Consensus 49 ~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~----~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 123 (407)
...|...+..+.| .++..+..+..+.... .+..++| ..++...+.. -..++..+.+.+..++.+||.|+|+..
T Consensus 229 ~E~e~~~l~k~~~-~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~-v~~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 229 TEIELESLSKIAH-DNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS-VGSIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHHhhcc-ccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh-ccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 3445566666776 4555555554433222 2344677 6778877775 457899999999999999999999987
Q ss_pred ceeccCCCCcccccCCCCCceEEEE--eccceeeeccCCCCcccCccCCCCccccccccccccccCCCCCh--hhHHHHH
Q 015406 124 FLHRDIKPDNFLMGLGRRANQVYII--DFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSR--RDDLESL 199 (407)
Q Consensus 124 ivHrDLKp~NILl~~~~~~~~~kL~--DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~--~sDIwSl 199 (407)
..|.-|...-..-...+..+.+.++ ||+.++.+.+.... ....-+..|-++|......+.. ..|+|.+
T Consensus 307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~--------~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS--------FSDLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred cceeEEecccccccccCccceeecchhhhcccccCCCcccc--------hhhcCccccccccccccccchhhhhhHHHHH
Confidence 6666655552222222455666666 99988876554331 1223455678888887766544 4799999
Q ss_pred HHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 200 GYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 200 G~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
|..+..+..|..+-... .... .-+......+......+|+..+.++|++..++..
T Consensus 379 gll~~~~~~~~~i~~~~------~~~~-----------~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~ 433 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKS------AVPV-----------SLLDVLSTSELLDALPKCLDEDSEERLSALELLT 433 (1351)
T ss_pred HHHHhhhhhcCcccccc------cchh-----------hhhccccchhhhhhhhhhcchhhhhccchhhhhh
Confidence 99999998876542110 0000 0111112236778888999999999999766653
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00048 Score=65.20 Aligned_cols=74 Identities=12% Similarity=0.056 Sum_probs=51.0
Q ss_pred eccccccCceEEEEEEEcC------CCeEEEEEEecCCCC-cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEec
Q 015406 12 GRKIGSGSFGEIYLGTNIQ------TNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (407)
Q Consensus 12 ~~~iG~G~~g~Vy~~~~~~------~~~~vAvK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~ 84 (407)
++.|..|-...||++.... .++.+++|+...... .....+|.+++..+......+.+..+... .+||||
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 3456667777999988533 257899999765432 24578899999999876666776666542 357888
Q ss_pred c-CCCH
Q 015406 85 L-GPSL 89 (407)
Q Consensus 85 ~-g~sL 89 (407)
+ |..+
T Consensus 79 i~G~~l 84 (302)
T cd05156 79 IPSRTL 84 (302)
T ss_pred eCCCcC
Confidence 8 5554
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.58 E-value=5.1e-05 Score=70.55 Aligned_cols=134 Identities=19% Similarity=0.328 Sum_probs=92.9
Q ss_pred eeEeccccccCceEEEEEEEcCCCeEEEEEEecC----------CC------C--------cchHHHHHHHHHHHcCCC-
Q 015406 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV----------KT------K--------HPQLLYESKLYRILQGGT- 63 (407)
Q Consensus 9 y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~----------~~------~--------~~~~~~E~~~l~~l~~~~- 63 (407)
+.++++||-|--+.||.+-+ ..|++.++|+-.. +. . .-...+|...|+.|..+.
T Consensus 94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 56789999999999999996 6788899994111 10 0 012457888888887532
Q ss_pred CCCeeEEeeeeCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCC
Q 015406 64 GIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 142 (407)
Q Consensus 64 ~i~~~~~~~~~~~~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~ 142 (407)
-+|... +....++|||++ |-.|.+.-+ -.+. ..+...+..-+.-|-.+|+||+|..-=||++ +++
T Consensus 173 pVPkpi----D~~RH~Vvmelv~g~Pl~~v~~----v~d~---~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv---~dd 238 (465)
T KOG2268|consen 173 PVPKPI----DHNRHCVVMELVDGYPLRQVRH----VEDP---PTLYDDLMGLIVRLANHGLIHGDFNEFNIMV---KDD 238 (465)
T ss_pred CCCCcc----cccceeeHHHhhcccceeeeee----cCCh---HHHHHHHHHHHHHHHHcCceecccchheeEE---ecC
Confidence 222221 345679999999 777766543 1222 3344445555667888999999999999999 578
Q ss_pred ceEEEEeccceeeec
Q 015406 143 NQVYIIDFGLAKKYR 157 (407)
Q Consensus 143 ~~~kL~DFGla~~~~ 157 (407)
..++++||=-+....
T Consensus 239 ~~i~vIDFPQmvS~s 253 (465)
T KOG2268|consen 239 DKIVVIDFPQMVSTS 253 (465)
T ss_pred CCEEEeechHhhccC
Confidence 899999997665433
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00029 Score=61.71 Aligned_cols=98 Identities=22% Similarity=0.279 Sum_probs=74.4
Q ss_pred HHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEeccC-CCHHHH---HHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CC
Q 015406 51 YESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLG-PSLEDL---FNFCSRKLSLKTVLMLADQMINRVEFVHS---KS 123 (407)
Q Consensus 51 ~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~g-~sL~~~---l~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~~ 123 (407)
.|.-+++.+++..+++.+.+++ +. +++.||.+ +++... +.. -...+|..+.+|+.++++.+++|+. ..
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~C--G~--~~v~E~~~~~~~~~~~~~l~~-~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSC--GR--FYVVEYVGAGSLYGIYRPLSQ-FLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeEC--CC--EEEEEeecCcccccccccccc-ccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 4778889998877777766654 32 67889984 555321 110 1236899999999999999999997 45
Q ss_pred ceeccCCCCcccccCCCCCceEEEEeccceeee
Q 015406 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (407)
Q Consensus 124 ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~ 156 (407)
+.-.|++++|+-+ ++++.+|++|...+...
T Consensus 83 ~~lcDv~~~nfgv---~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGV---NDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEE---eCCCcEEEEechhcchh
Confidence 7789999999999 57789999999877643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.011 Score=57.46 Aligned_cols=72 Identities=22% Similarity=0.299 Sum_probs=49.3
Q ss_pred eccccccCceEEEEEEEcCCCeEEEEEEe----cCC----CCcchHHHHHHHHHHHcC--CCCCCeeEEeeeeCceeEEE
Q 015406 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLE----NVK----TKHPQLLYESKLYRILQG--GTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 12 ~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~----~~~----~~~~~~~~E~~~l~~l~~--~~~i~~~~~~~~~~~~~~lv 81 (407)
.+.||.|.-.-||++.+...++.|+||.- +.. ....+...|.+.|+.+.. +..+|.++.+.. ....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~--e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDS--VMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECc--HHhhHH
Confidence 56889999999999997433567999952 211 122346678888887653 346777766644 445788
Q ss_pred Eecc
Q 015406 82 MDLL 85 (407)
Q Consensus 82 me~~ 85 (407)
||++
T Consensus 112 MEdL 115 (409)
T PRK12396 112 MEDL 115 (409)
T ss_pred HHhC
Confidence 9988
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.00069 Score=66.74 Aligned_cols=164 Identities=19% Similarity=0.185 Sum_probs=95.2
Q ss_pred CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 015406 45 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124 (407)
Q Consensus 45 ~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~i 124 (407)
...+++....+++.++|.+....+..........++|||+++.||++++.... +-.... + .+++
T Consensus 25 ~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~Sled~~~~~~--l~~~s~----------~----~~~~ 88 (725)
T KOG1093|consen 25 NSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTMSLEDILKTGN--LKDESL----------L----AHGV 88 (725)
T ss_pred cHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhccchHHHHHhcc--cchhhh----------c----cccc
Confidence 34456677788888888665555555555556689999999999999988532 211111 0 2222
Q ss_pred eeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHH
Q 015406 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 204 (407)
Q Consensus 125 vHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ 204 (407)
.| .|+ .+.+| -++... .. +..+|+||||+|.++.
T Consensus 89 ~~-----~~~----------~~~td-~~~t~~--------------~~----------------~~~pKsdVwsl~~i~~ 122 (725)
T KOG1093|consen 89 LH-----LNI----------IYITD-HFLTKY--------------PS----------------PIGPKSDVWSLGFIIL 122 (725)
T ss_pred ce-----ehh----------hhccc-cccccC--------------CC----------------CCCcchhhhhHHHHHH
Confidence 22 222 23334 111000 01 1124999999999999
Q ss_pred HHHhCCCCCCCCCcCchHHHHHHHhhhccc---ccH-HHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015406 205 YFLRGSLPWQGLKAGTKKQKYEKISEKKVS---TSI-EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 205 elltG~~Pf~~~~~~~~~~~~~~i~~~~~~---~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
|+.-|..-|...........+.+....... ... ..+.-.++..+..+...|+...|..||...++.
T Consensus 123 el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~ 192 (725)
T KOG1093|consen 123 ELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELS 192 (725)
T ss_pred HHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHh
Confidence 999998777654332222222221111100 000 011234677889999999999999999766553
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.35 E-value=3.4e-05 Score=83.94 Aligned_cols=130 Identities=12% Similarity=-0.021 Sum_probs=98.0
Q ss_pred eCceeEEEEecc-CCCHHHHHHHcCCC---CCHHHHHHHHHHHHHHHHHHHhC-----CceeccCCCCcccccCCCCCce
Q 015406 74 EGDYNVLVMDLL-GPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHSK-----SFLHRDIKPDNFLMGLGRRANQ 144 (407)
Q Consensus 74 ~~~~~~lvme~~-g~sL~~~l~~~~~~---l~~~~~~~i~~qi~~aL~yLH~~-----~ivHrDLKp~NILl~~~~~~~~ 144 (407)
+....+.+|+|+ +|.+.+.+-+...+ +...-+.....+.+.+..-+|+. --+|++||+-|.+| ..+..
T Consensus 1302 ~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmI---Vtny~ 1378 (2724)
T KOG1826|consen 1302 ESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMI---VTNYN 1378 (2724)
T ss_pred CChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccce---ecCCc
Confidence 455668999999 99999988643222 33333333333337777777753 27899999999999 67888
Q ss_pred EEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCC
Q 015406 145 VYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213 (407)
Q Consensus 145 ~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf 213 (407)
+|+.++|+.+...... ...+...+++.|++++......++.++|+|..|+-+|+...|..+|
T Consensus 1379 v~~gk~gLdKIknp~~-------sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1379 VKLGKGGLDKIKNPVL-------SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred ccccccccccccCchH-------hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 9999999998332221 1234667889999999999889999999999999999999888877
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0014 Score=61.27 Aligned_cols=46 Identities=7% Similarity=0.042 Sum_probs=30.4
Q ss_pred cccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCC
Q 015406 16 GSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGG 62 (407)
Q Consensus 16 G~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~ 62 (407)
++|-...||... ...|+.+++|.-........+.+|.+++..|..+
T Consensus 20 ~~g~~~~v~~i~-~~~g~~~VlR~p~~~~~~~~l~rE~~vL~~L~~~ 65 (276)
T cd05152 20 ESGLDFQVVFAK-DTDGVPWVLRIPRRPDVSERAAAEKRVLALVRKH 65 (276)
T ss_pred CCcceeEEEEEE-cCCCCeEEEEecCCHHHHHHHHHHHHHHHHHHhc
Confidence 344444556553 2457789999765433445689999999999754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0042 Score=58.67 Aligned_cols=107 Identities=15% Similarity=0.103 Sum_probs=74.9
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCC--CCCeeEEeeee---CceeEEEE
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGT--GIPNVRWFGVE---GDYNVLVM 82 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~--~i~~~~~~~~~---~~~~~lvm 82 (407)
.-.-.+.||.|..+.||+... .+..+.+|+.+.......+..|...++.|.... .+|.+...+.. .+..+|||
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~--~~~~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYD--SQGNPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred hhheeeecCCccceeEEEEEc--CCCCEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 334467899999999999873 233577887543223457899999999998643 46666655432 46689999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 015406 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122 (407)
Q Consensus 83 e~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~ 122 (407)
|++ |.++.+. ..+......+..+++.+|.-||+.
T Consensus 93 E~i~G~~~~~~------~~~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 93 ERLRGVSVEAP------ARTPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred eccCCEecCCC------CCCHHHHHHHHHHHHHHHHHHhCC
Confidence 999 7676651 123445566777888999999974
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0054 Score=58.83 Aligned_cols=136 Identities=13% Similarity=0.167 Sum_probs=79.4
Q ss_pred ccccccCceEEEEEEEcCC---CeEEEEEEecCCCC-cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-CC
Q 015406 13 RKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GP 87 (407)
Q Consensus 13 ~~iG~G~~g~Vy~~~~~~~---~~~vAvK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~-g~ 87 (407)
+.|..|-...+|++..... +..|++|+...... .-....|..+++.+.....-+.+.+++..+ ++.+|+ |.
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g~ 95 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINAR 95 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcCC
Confidence 3444577788999875432 34899998754332 123467999999998877777776665322 478887 54
Q ss_pred CHHH--------------HHHHc-CCC------C-CHHHHHHHHHHH----------------------HHHHHH---HH
Q 015406 88 SLED--------------LFNFC-SRK------L-SLKTVLMLADQM----------------------INRVEF---VH 120 (407)
Q Consensus 88 sL~~--------------~l~~~-~~~------l-~~~~~~~i~~qi----------------------~~aL~y---LH 120 (407)
.|.. .+.+. ... . -+..+..+..++ ..-+.. +.
T Consensus 96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~ 175 (330)
T PLN02421 96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT 175 (330)
T ss_pred CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence 4311 11111 111 1 122333333222 111111 11
Q ss_pred -hC----CceeccCCCCcccccCCCCCceEEEEecccee
Q 015406 121 -SK----SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (407)
Q Consensus 121 -~~----~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~ 154 (407)
+. -+.|.|+-+.|||++ ++++.++++||..|.
T Consensus 176 ~~~~~~~v~CHnDl~~~NiL~~--~~~~~l~lID~EYag 212 (330)
T PLN02421 176 DSLKAPVVFAHNDLLSGNLMLN--EDEGKLYFIDFEYGS 212 (330)
T ss_pred ccCCCCeEEEECCCCcccEEEe--CCCCcEEEEcccccC
Confidence 11 278999999999994 345789999998874
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.011 Score=57.09 Aligned_cols=137 Identities=12% Similarity=0.136 Sum_probs=81.9
Q ss_pred eccccccCceEEEEEEEcC----CCeEEEEEEecCCCC-cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-
Q 015406 12 GRKIGSGSFGEIYLGTNIQ----TNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (407)
Q Consensus 12 ~~~iG~G~~g~Vy~~~~~~----~~~~vAvK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~- 85 (407)
.+.|-.|-...+|++.... .++.|++|+...... .-....|..+++.+.....-+.+.+++..+ .+++|+
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 3455558888999987432 346899998754321 123467999999998877777776665433 578888
Q ss_pred CCCHHH-----------H---HHH-cCCC------C-CHHHHHHHHHHH-----------------HHHHHHH----H--
Q 015406 86 GPSLED-----------L---FNF-CSRK------L-SLKTVLMLADQM-----------------INRVEFV----H-- 120 (407)
Q Consensus 86 g~sL~~-----------~---l~~-~~~~------l-~~~~~~~i~~qi-----------------~~aL~yL----H-- 120 (407)
+.+|.. + +.+ +... . .+..+..++.++ ...+..| .
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 555431 1 111 0101 1 122333333221 1111122 1
Q ss_pred --hCCceeccCCCCcccccCCCCCceEEEEecccee
Q 015406 121 --SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (407)
Q Consensus 121 --~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~ 154 (407)
...++|+|+++.|||++ +.++.++|+||..|.
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~--~~~~~~~lID~Eya~ 230 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMID--EETRAITIIDYEYAS 230 (344)
T ss_pred CCCceEEeCCCCcCcEEEe--CCCCcEEEEeehhcc
Confidence 23589999999999994 234689999998874
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.02 Score=55.94 Aligned_cols=72 Identities=17% Similarity=0.284 Sum_probs=48.5
Q ss_pred EeccccccCceEEEEEEEcCCCeEEEEEEec-----CCC----CcchHHHHHHHHHHHcC--CCCCCeeEEeeeeCceeE
Q 015406 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN-----VKT----KHPQLLYESKLYRILQG--GTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 11 i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~-----~~~----~~~~~~~E~~~l~~l~~--~~~i~~~~~~~~~~~~~~ 79 (407)
..+.||.|....||+..+ .+..|+||.-. ... ...+...|...|+.+.. +..+|.++.++. +..+
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 367889999999999986 34569999643 111 22334556677766543 246777777766 4467
Q ss_pred EEEeccC
Q 015406 80 LVMDLLG 86 (407)
Q Consensus 80 lvme~~g 86 (407)
++||++.
T Consensus 112 lvME~L~ 118 (418)
T PLN02756 112 IGMRYLE 118 (418)
T ss_pred EEEeecC
Confidence 8999993
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.016 Score=54.30 Aligned_cols=73 Identities=16% Similarity=0.227 Sum_probs=52.1
Q ss_pred eEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHc--CCCCCCeeEEeeeeCceeEEEEecc
Q 015406 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ--GGTGIPNVRWFGVEGDYNVLVMDLL 85 (407)
Q Consensus 10 ~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~--~~~~i~~~~~~~~~~~~~~lvme~~ 85 (407)
+-.+.|+.|....+|+.. .+++.+.||+-. ......+..|.+-|+.|. ..-.+|.+..++...+..+|+|||+
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~-~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNS-ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEE-GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecC-hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 345678889999999988 788899999876 344567899999999994 4566788888888777789999998
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.012 Score=55.56 Aligned_cols=30 Identities=23% Similarity=0.522 Sum_probs=25.3
Q ss_pred CceeccCCCCcccccCCCCCceEEEEeccceee
Q 015406 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (407)
Q Consensus 123 ~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~ 155 (407)
.++|+|+.+.||++. ...-+=++||+++..
T Consensus 199 ~lvHGD~~~gNlii~---~~~~~gVlDwe~~~l 228 (321)
T COG3173 199 VLVHGDYRPGNLIID---PGRPTGVLDWELATL 228 (321)
T ss_pred eeeeCCcccCCEEEe---CCCeeEEEecccccc
Confidence 489999999999994 555588999999864
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.06 Score=50.96 Aligned_cols=29 Identities=38% Similarity=0.729 Sum_probs=24.4
Q ss_pred CCceeccCCCCcccccCCCCCceEEEEecccee
Q 015406 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (407)
Q Consensus 122 ~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~ 154 (407)
.+++|+|+.+.||+++ . +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~---~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLK---D-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEe---C-CcEEEEECcccc
Confidence 5799999999999993 3 568999998764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.011 Score=56.21 Aligned_cols=74 Identities=24% Similarity=0.295 Sum_probs=59.5
Q ss_pred eeCceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcccccCCCCCceEEEEecc
Q 015406 73 VEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFG 151 (407)
Q Consensus 73 ~~~~~~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~ivHrDLKp~NILl~~~~~~~~~kL~DFG 151 (407)
.++.+.|++|++-|++|.-.- ...++++..|+.+.+.-|.-+..+ .+-|||+.-.|||| + .|.|.|+||-
T Consensus 296 de~~y~yl~~kdhgt~is~ik-----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI---d-~GnvtLIDfk 366 (488)
T COG5072 296 DETLYLYLHFKDHGTPISIIK-----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI---D-EGNVTLIDFK 366 (488)
T ss_pred CCceEEEEEEecCCceeeeee-----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee---e-cCceEEEEee
Confidence 456788999999988875321 246778888988888777666643 68899999999999 4 8999999999
Q ss_pred ceee
Q 015406 152 LAKK 155 (407)
Q Consensus 152 la~~ 155 (407)
+++.
T Consensus 367 lsRl 370 (488)
T COG5072 367 LSRL 370 (488)
T ss_pred eeec
Confidence 9984
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.00 E-value=0.016 Score=51.65 Aligned_cols=118 Identities=20% Similarity=0.305 Sum_probs=59.4
Q ss_pred CeEEEEEEecCCC-CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-CCCHHH-------HH-------HH
Q 015406 32 NEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLED-------LF-------NF 95 (407)
Q Consensus 32 ~~~vAvK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~-g~sL~~-------~l-------~~ 95 (407)
++.|+||+....+ ..-....|..+++.+.....-+.+.+++..+ +|.+|+ |..|.. .+ .+
T Consensus 2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~~ 77 (211)
T PF01633_consen 2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTLSPEDFRNPEILKRIAKLLAK 77 (211)
T ss_dssp TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE--CGGGGSHHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEecccccChhhccChHHHHHHHHHHHH
Confidence 4578899876542 2345677999999998777777776665332 455777 434311 11 00
Q ss_pred c-C--C-----CC-CHHHHHHH----------------------HHHHHHHHHHHHh--------CCceeccCCCCcccc
Q 015406 96 C-S--R-----KL-SLKTVLML----------------------ADQMINRVEFVHS--------KSFLHRDIKPDNFLM 136 (407)
Q Consensus 96 ~-~--~-----~l-~~~~~~~i----------------------~~qi~~aL~yLH~--------~~ivHrDLKp~NILl 136 (407)
. . . .. -+..+..+ +..+..-+..+.+ ..+.|.||.|.|||+
T Consensus 78 lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil~ 157 (211)
T PF01633_consen 78 LHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNILI 157 (211)
T ss_dssp HHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEEE
T ss_pred HhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEEe
Confidence 0 0 0 00 11222222 1111222222221 347899999999999
Q ss_pred cCCCCCceEEEEeccceee
Q 015406 137 GLGRRANQVYIIDFGLAKK 155 (407)
Q Consensus 137 ~~~~~~~~~kL~DFGla~~ 155 (407)
. +.++.++|+||..|..
T Consensus 158 ~--~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 158 N--NKDGEVKLIDFEYAGY 174 (211)
T ss_dssp T--SSSSCEEE--GTT-EE
T ss_pred c--cCCCeEEEecHHHHhh
Confidence 3 4678999999988853
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.96 E-value=0.27 Score=47.09 Aligned_cols=65 Identities=14% Similarity=0.122 Sum_probs=40.1
Q ss_pred CceEEEEEEEcCCCeEEEEEEecCCC-CcchHHHHHHHHHHHcCCCCCCe---eE--E--eeeeCceeEEEEecc
Q 015406 19 SFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPN---VR--W--FGVEGDYNVLVMDLL 85 (407)
Q Consensus 19 ~~g~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~---~~--~--~~~~~~~~~lvme~~ 85 (407)
.-..||+... .++..+++|+.+... ....+..|.+.+..|... .++. +. + +...++..+.+++++
T Consensus 37 ~eN~vy~v~~-~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~-gipv~~p~~~~G~~~~~~~g~~~~l~~~~ 109 (325)
T PRK11768 37 YENRVYQFGD-EDGRRVVAKFYRPERWSDAQILEEHAFALELAEA-EIPVVAPLAFNGQTLHEHQGFRFALFPRR 109 (325)
T ss_pred ccceEEEEec-CCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHC-CCCCCCCccCCCCEEEEECCEEEEEEeee
Confidence 4457898874 456789999876433 334577888888888642 2221 11 1 122345677888888
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.93 E-value=0.042 Score=52.49 Aligned_cols=134 Identities=16% Similarity=0.198 Sum_probs=77.9
Q ss_pred ccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCee-----EE--eeeeCc--eeEEEEecc
Q 015406 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNV-----RW--FGVEGD--YNVLVMDLL 85 (407)
Q Consensus 15 iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~-----~~--~~~~~~--~~~lvme~~ 85 (407)
|.+ .-..||+... ..| .+++|+........++..|...+..|......+.. .+ ...-.. +.+-+.+|+
T Consensus 34 l~s-~eN~~f~~~~-~~g-~~iLki~~~~~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l 110 (331)
T COG2334 34 LNS-EENSNFRVQT-EDG-RYILKIYRPGWTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYL 110 (331)
T ss_pred ccc-ccCceEEEEe-cCC-CeEEEEecCCCCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEec
Confidence 444 4557888884 333 44999987765556688888888888653322221 11 112233 778888998
Q ss_pred -CCCHHH------------HH---HHcCCC-----------CCHH----H---------HHHHHHHHHHHHHHHHh----
Q 015406 86 -GPSLED------------LF---NFCSRK-----------LSLK----T---------VLMLADQMINRVEFVHS---- 121 (407)
Q Consensus 86 -g~sL~~------------~l---~~~~~~-----------l~~~----~---------~~~i~~qi~~aL~yLH~---- 121 (407)
|..+.. ++ +...+. ..|. . -.....++...+..+.+
T Consensus 111 ~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~ 190 (331)
T COG2334 111 PGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPA 190 (331)
T ss_pred CCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchh
Confidence 655552 11 110111 1221 0 01123344445555553
Q ss_pred ----CC--ceeccCCCCcccccCCCCCc-eEEEEecccee
Q 015406 122 ----KS--FLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAK 154 (407)
Q Consensus 122 ----~~--ivHrDLKp~NILl~~~~~~~-~~kL~DFGla~ 154 (407)
-+ +||+|+.|.||++ +.+. .+.++||+-+.
T Consensus 191 ~lp~~~~~iIH~D~~~~NVl~---d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 191 HLPALGDQIIHGDLHPDNVLF---DDDTDVSGFIDFDDAG 227 (331)
T ss_pred hCCcccceeeecCCCccceeE---cCCCCeeeEEEccccc
Confidence 23 9999999999999 4444 48899999874
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.87 E-value=0.11 Score=57.27 Aligned_cols=77 Identities=13% Similarity=0.174 Sum_probs=45.9
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCC-CCC--CeeEE---------eee-eCc-ee
Q 015406 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGG-TGI--PNVRW---------FGV-EGD-YN 78 (407)
Q Consensus 13 ~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~-~~i--~~~~~---------~~~-~~~-~~ 78 (407)
+.|+ |..-.+|+... .++..+++|+.+.......+..|..++..|... +.+ +.+.- ... ++. ..
T Consensus 31 ~~L~-s~~d~nf~v~~-~~g~~yVLKi~~~~~~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~ 108 (1013)
T PRK06148 31 TPLD-GERDLNFRLTT-DDGADYILKIVNPSEPRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRL 108 (1013)
T ss_pred eecC-CcCCceEEEEe-CCCCeEEEEEcCCccchhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEE
Confidence 4564 34577888874 567789999988655444566677777766542 222 22211 011 111 45
Q ss_pred EEEEecc-CCCHHH
Q 015406 79 VLVMDLL-GPSLED 91 (407)
Q Consensus 79 ~lvme~~-g~sL~~ 91 (407)
+-+++|+ |..|.+
T Consensus 109 vrLl~~l~G~~l~~ 122 (1013)
T PRK06148 109 LRLLSWLPGTPLAE 122 (1013)
T ss_pred EEEEeccCCCcHHh
Confidence 7789999 666654
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.86 E-value=0.2 Score=48.98 Aligned_cols=75 Identities=13% Similarity=0.142 Sum_probs=48.2
Q ss_pred EeccccccCceEEEEEEEcCC-Ce-----EEEEEEecCC-CCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 11 LGRKIGSGSFGEIYLGTNIQT-NE-----EVAIKLENVK-TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 11 i~~~iG~G~~g~Vy~~~~~~~-~~-----~vAvK~~~~~-~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
..+.|..|-...+|++..... +. .|++++.... ...-...+|.++++.+.....-+.+.+.+.. +++.|
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~e 129 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQE 129 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEE
Confidence 344565688889999975332 12 2555542111 1112346799999999988888888777643 58889
Q ss_pred cc-CCCH
Q 015406 84 LL-GPSL 89 (407)
Q Consensus 84 ~~-g~sL 89 (407)
|+ |.+|
T Consensus 130 fIeGr~l 136 (383)
T PTZ00384 130 WVEGNTM 136 (383)
T ss_pred EeccccC
Confidence 98 5544
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.42 E-value=0.044 Score=53.01 Aligned_cols=58 Identities=24% Similarity=0.303 Sum_probs=43.7
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH-HhCCceeccCCCCccccc
Q 015406 78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV-HSKSFLHRDIKPDNFLMG 137 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yL-H~~~ivHrDLKp~NILl~ 137 (407)
..|+.+|. |-++..+++. ...+++....++.-.++||--+ --.+++|.|+.|.||++.
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~--~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKW--KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR 379 (565)
T ss_pred ceeeeeccccccHHhhhhc--ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence 36777788 8899999984 3456666677777667776544 357899999999999994
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.18 E-value=0.26 Score=46.73 Aligned_cols=29 Identities=24% Similarity=0.457 Sum_probs=25.7
Q ss_pred CceeccCCCCcccccCCCCCceEEEEecccee
Q 015406 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (407)
Q Consensus 123 ~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~ 154 (407)
+++|+|+.+.|||+ +.++.+.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~---~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLY---DETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEE---cCCCCEEEEEhhhcc
Confidence 79999999999999 566789999998775
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.56 E-value=0.52 Score=47.05 Aligned_cols=73 Identities=12% Similarity=0.063 Sum_probs=48.8
Q ss_pred EeccccccCceEEEEEEEcCC--------CeEEEEEEecCCCC-cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 11 LGRKIGSGSFGEIYLGTNIQT--------NEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 11 i~~~iG~G~~g~Vy~~~~~~~--------~~~vAvK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
-++.|..|-.-.+|++..... ++.|.+|+...... .-....|..+++.+.....-+.+.+.+. .+.+
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I 184 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFS----GGRI 184 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeC----CCEE
Confidence 455676777788999875421 56899998654322 2245679999999988777777765432 2457
Q ss_pred Eecc-CC
Q 015406 82 MDLL-GP 87 (407)
Q Consensus 82 me~~-g~ 87 (407)
.+|+ |.
T Consensus 185 ~efi~g~ 191 (442)
T PTZ00296 185 EEWLYGD 191 (442)
T ss_pred EEeeCCc
Confidence 8888 55
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=94.41 E-value=0.26 Score=44.21 Aligned_cols=70 Identities=17% Similarity=0.295 Sum_probs=47.1
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCC--CCCeeEEeeeeCceeEEEEecc
Q 015406 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGT--GIPNVRWFGVEGDYNVLVMDLL 85 (407)
Q Consensus 13 ~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~--~i~~~~~~~~~~~~~~lvme~~ 85 (407)
+.+.-|-.-.-|... ....++-||+-. ......+..|+.-|..+...+ .++.+...+...+..|+||||+
T Consensus 22 ~~v~gG~inea~~v~--dg~~~~FvK~n~-~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L 93 (286)
T COG3001 22 EEVSGGDINEAWRLR--DGTDPFFVKCNQ-REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYL 93 (286)
T ss_pred cccCCccccceeEee--cCCcceEEEecc-hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeec
Confidence 344444444445444 234578888632 233455788888888776544 6778888899999999999998
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 407 | ||||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 0.0 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 1e-136 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 1e-136 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 1e-135 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 2e-95 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 5e-95 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 1e-94 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 2e-94 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 7e-93 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 2e-92 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 2e-92 | ||
| 2v62_A | 345 | Structure Of Vaccinia-Related Kinase 2 Length = 345 | 1e-26 | ||
| 2lav_A | 361 | Nmr Solution Structure Of Human Vaccinia-Related Ki | 6e-26 | ||
| 2kty_A | 368 | Solution Structure Of Human Vaccinia Related Kinase | 7e-26 | ||
| 3op5_A | 364 | Human Vaccinia-Related Kinase 1 Length = 364 | 8e-26 | ||
| 2jii_A | 352 | Structure Of Vaccinia Related Kinase 3 Length = 352 | 4e-17 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-14 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 7e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-12 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-11 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-10 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-10 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-10 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-10 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-10 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-10 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-10 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 8e-10 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 9e-10 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 9e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-09 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 6e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 6e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 7e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 9e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 9e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-08 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-08 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-08 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-08 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-08 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-08 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-08 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-08 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-08 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-08 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-08 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-08 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-08 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-08 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-08 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-08 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-08 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-08 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-08 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-08 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 8e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 8e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 8e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 8e-08 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 9e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 9e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-07 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-07 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-07 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-07 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-07 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-07 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-07 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-07 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-07 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-07 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-07 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-07 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-07 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-07 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-07 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-07 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-07 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-07 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-07 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-07 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-07 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-07 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 7e-07 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 7e-07 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-07 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 7e-07 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-07 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-07 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 7e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-07 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 8e-07 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-07 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 9e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-06 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-06 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-06 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-06 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-06 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-06 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-06 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-06 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-06 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-06 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-06 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-06 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-06 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-06 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-06 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-06 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-06 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-06 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-06 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-06 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-06 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-06 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-06 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-06 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-06 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-06 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-06 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-06 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-06 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-06 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-06 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-06 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-06 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-06 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-06 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-06 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-06 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-06 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-06 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-06 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-06 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-06 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-06 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-06 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-06 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-06 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-06 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-06 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 6e-06 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 7e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 7e-06 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-06 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-06 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 8e-06 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 8e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 8e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 8e-06 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 8e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-06 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-06 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-06 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 9e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 9e-06 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-05 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-05 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-05 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-05 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-05 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-05 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-05 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-05 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-05 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-05 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-05 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-05 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-05 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-05 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-05 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-05 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-05 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-05 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-05 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-05 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-05 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-05 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-05 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-05 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-05 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-05 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-05 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-05 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-05 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-05 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-05 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-05 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-05 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-05 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-05 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-05 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-05 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-05 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-05 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 3e-05 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 3e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-05 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-05 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-05 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 4e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-05 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-05 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-05 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-05 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-05 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-05 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-05 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 5e-05 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-05 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-05 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 6e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 7e-05 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 7e-05 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 7e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-05 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 8e-05 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 8e-05 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 8e-05 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 9e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-05 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 9e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 9e-05 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 1e-04 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-04 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-04 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-04 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-04 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-04 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-04 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 1e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-04 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-04 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-04 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-04 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-04 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 1e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-04 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-04 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-04 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-04 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-04 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-04 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-04 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-04 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-04 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-04 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-04 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-04 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-04 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-04 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-04 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-04 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-04 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-04 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-04 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-04 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-04 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-04 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-04 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-04 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-04 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-04 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-04 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-04 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-04 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-04 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-04 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-04 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-04 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-04 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-04 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-04 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-04 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-04 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-04 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-04 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-04 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-04 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-04 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-04 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-04 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-04 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-04 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-04 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-04 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-04 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-04 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-04 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 5e-04 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-04 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-04 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 5e-04 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 5e-04 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 6e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 6e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 6e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-04 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-04 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 6e-04 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-04 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-04 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-04 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-04 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 6e-04 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-04 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-04 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 7e-04 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 7e-04 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-04 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-04 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 7e-04 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-04 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 8e-04 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 8e-04 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 8e-04 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-04 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 8e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 9e-04 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 9e-04 |
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|2V62|A Chain A, Structure Of Vaccinia-Related Kinase 2 Length = 345 | Back alignment and structure |
|
| >pdb|2LAV|A Chain A, Nmr Solution Structure Of Human Vaccinia-Related Kinase 1 Length = 361 | Back alignment and structure |
|
| >pdb|2KTY|A Chain A, Solution Structure Of Human Vaccinia Related Kinase-1 Length = 368 | Back alignment and structure |
|
| >pdb|3OP5|A Chain A, Human Vaccinia-Related Kinase 1 Length = 364 | Back alignment and structure |
|
| >pdb|2JII|A Chain A, Structure Of Vaccinia Related Kinase 3 Length = 352 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 407 | |||
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 0.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 0.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 0.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 0.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 0.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 1e-177 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 1e-173 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 2e-27 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 3e-27 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 8e-27 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 9e-27 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-26 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 3e-26 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 2e-25 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 1e-24 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 3e-24 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 3e-24 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 5e-24 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 5e-23 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 9e-23 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 9e-23 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 5e-22 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 9e-22 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 2e-21 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 2e-21 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-21 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 3e-21 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 4e-21 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 5e-21 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 9e-21 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 9e-21 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 1e-20 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 1e-20 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 2e-20 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 4e-20 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 6e-20 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 7e-20 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 8e-20 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 1e-19 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 1e-19 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 1e-19 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 1e-19 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 2e-19 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 2e-19 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 2e-19 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 3e-19 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 3e-19 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 3e-19 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 3e-19 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 4e-19 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 5e-19 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 6e-19 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 6e-19 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 6e-19 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 8e-19 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 8e-19 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 9e-19 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 1e-18 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 1e-18 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 2e-18 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 2e-18 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 2e-18 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 2e-18 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 3e-18 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 3e-18 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 4e-18 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 4e-18 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 5e-18 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 5e-18 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 5e-18 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 6e-18 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 7e-18 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 9e-18 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 9e-18 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 9e-18 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 1e-17 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 1e-17 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 1e-17 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 2e-17 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 2e-17 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 2e-17 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 3e-17 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 4e-17 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 1e-16 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 1e-16 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 2e-16 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 2e-16 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 2e-16 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 2e-16 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 2e-16 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 2e-16 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 3e-16 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 3e-16 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 4e-16 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 6e-16 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 6e-16 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 7e-16 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 1e-15 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 1e-15 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 1e-15 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 1e-15 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 1e-15 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 2e-15 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 2e-15 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 2e-15 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 2e-15 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 2e-15 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 3e-15 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 4e-15 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 5e-15 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 5e-15 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 7e-15 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 7e-15 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 8e-15 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 1e-14 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 1e-14 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 1e-14 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 2e-14 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 2e-14 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 2e-14 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 5e-14 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 7e-14 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 8e-14 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 9e-14 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 9e-14 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 1e-13 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 1e-13 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 2e-13 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 2e-13 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 2e-13 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 4e-13 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 5e-13 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 6e-13 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 1e-12 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 2e-12 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 2e-12 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 2e-12 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 3e-12 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 4e-12 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 4e-12 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 6e-12 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 8e-12 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 2e-11 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 3e-11 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 4e-11 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 4e-11 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 4e-11 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 6e-11 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 7e-11 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 1e-04 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 1e-10 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 1e-10 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 2e-10 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 2e-10 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 2e-10 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 2e-10 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 2e-10 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 2e-10 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 3e-10 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 3e-10 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 3e-10 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 4e-10 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 4e-10 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 4e-10 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 4e-10 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 5e-10 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 8e-10 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 8e-10 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 1e-09 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 1e-09 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 2e-09 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 2e-09 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 3e-09 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 3e-09 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 3e-09 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 3e-09 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 3e-09 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 5e-09 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 6e-09 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 7e-09 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 2e-08 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 3e-08 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 3e-08 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 3e-08 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 4e-08 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 5e-08 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 7e-08 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 8e-08 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 9e-08 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 1e-07 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 2e-07 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 2e-07 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 3e-07 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 3e-07 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 3e-07 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 3e-07 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 3e-07 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 4e-07 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 5e-07 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 5e-07 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 5e-07 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 5e-07 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 6e-07 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 6e-07 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 7e-07 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 1e-05 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 9e-07 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 1e-06 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-06 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 1e-06 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 1e-06 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 1e-06 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 1e-06 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 1e-06 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 1e-06 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 2e-06 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 3e-06 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 3e-06 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 3e-06 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 3e-06 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 3e-06 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 5e-06 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 6e-06 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 6e-06 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 6e-06 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 7e-06 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 1e-05 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 1e-05 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 1e-05 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 2e-05 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 3e-05 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 4e-05 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 4e-05 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 5e-05 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-04 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 1e-04 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 2e-04 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 2e-04 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 7e-04 |
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 608 bits (1568), Expect = 0.0
Identities = 330/381 (86%), Positives = 352/381 (92%), Gaps = 3/381 (0%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESK+YRILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
S+NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV+TSIEAL
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
CRGYPTEFASYFHYCRSLRFDDKPDY+YLKR+FRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 241 CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQI 300
Query: 301 ATPPARALVPGAGTSGAPPAIASGDRQTGGGEEGRPAGLSSMDSSRRRMSGPVINSGSFS 360
A+ P RA+ GAG SG P DRQ+ G +EGR +G SSMD RRR P+ + G+ +
Sbjct: 301 ASAPPRAVGHGAGPSGLAPPALQNDRQS-GVDEGRTSGWSSMD--RRRAPPPIASVGTLA 357
Query: 361 KQKSPVVNEPTMTKDTMVSNS 381
KQK+PV N+ + +K+ ++S S
Sbjct: 358 KQKAPVGNDASFSKEPVISAS 378
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 573 bits (1479), Expect = 0.0
Identities = 174/326 (53%), Positives = 227/326 (69%), Gaps = 3/326 (0%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGT 63
VG FR+G+KIG G+FGE+ LG N+ TNE VAIKLE +K++ PQL E + Y+ L G
Sbjct: 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGD 65
Query: 64 GIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
GIP V +FG G YN +V++LLGPSLEDLF+ C R SLKTVLM+A Q+I+R+E+VHSK+
Sbjct: 66 GIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN 125
Query: 124 FLHRDIKPDNFLMGLG--RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181
++RD+KP+NFL+G + ++IIDF LAK+Y D T +HIPYRE+K+LTGTARY S
Sbjct: 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMS 185
Query: 182 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241
+NTHLG EQSRRDDLE+LG++ MYFLRGSLPWQGLKA T K++Y+KI + K +T IE LC
Sbjct: 186 INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLC 245
Query: 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLA 301
+P E A+Y Y R L F +KPDY YL+++F DLF R+G+ FDY +DW + A
Sbjct: 246 ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIGKQLPTPVGA 304
Query: 302 TPPARALVPGAGTSGAPPAIASGDRQ 327
AL + Q
Sbjct: 305 VQQDPALSSNREAHQHRDKMQQSKNQ 330
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 567 bits (1463), Expect = 0.0
Identities = 231/294 (78%), Positives = 269/294 (91%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
ME RVGN++RLGRKIGSGSFG+IYLGT+I EEVAIKLE VKTKHPQL ESK+Y+++Q
Sbjct: 3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 62
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GG GIP +RW G EGDYNV+VM+LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 63 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 122
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAKKYRD THQHIPYRENKNLTGTARYA
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
S+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 183 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILK 294
C+GYP+EFA+Y ++CRSLRFDDKPDY+YL+++FR+LF R+GF +DYVFDW +LK
Sbjct: 243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK 296
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 562 bits (1451), Expect = 0.0
Identities = 173/295 (58%), Positives = 214/295 (72%), Gaps = 2/295 (0%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
VG +++GR+IG GSFG I+ GTN+ N++VAIK E ++ PQL E + Y++L
Sbjct: 4 QNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLA 63
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
G TGIPNV +FG EG +NVLV+DLLGPSLEDL + C RK S+KTV M A QM+ RV+ +H
Sbjct: 64 GCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 123
Query: 121 SKSFLHRDIKPDNFLMGL--GRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 178
KS ++RDIKPDNFL+G + AN +Y++DFG+ K YRD T QHIPYRE KNL+GTAR
Sbjct: 124 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 183
Query: 179 YASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238
Y S+NTHLG EQSRRDDLE+LG+V MYFLRGSLPWQGLKA T KQKYE+I EKK ST +
Sbjct: 184 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 243
Query: 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTIL 293
LC G+P EF Y HY R+L FD PDY YL+ +F + R D FDW +L
Sbjct: 244 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL 298
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 520 bits (1342), Expect = 0.0
Identities = 84/332 (25%), Positives = 148/332 (44%), Gaps = 29/332 (8%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLG-----TNIQTNEEVAIKLENVKTKHPQLLYESKL 55
+ +++G IG G FG IYL ++ ++ +K+E + + L E K
Sbjct: 29 ITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVE--PSDNGPLFTELKF 86
Query: 56 YRILQ--------------GGTGIPNVRWFGVEG----DYNVLVMDLLGPSLEDLFNFCS 97
Y+ G+P G+ Y ++MD G L+ ++ +
Sbjct: 87 YQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA 146
Query: 98 RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157
++ S KTVL L+ ++++ +E++H ++H DIK N L+ +QVY++D+GLA +Y
Sbjct: 147 KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKN-PDQVYLVDYGLAYRYC 205
Query: 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 217
H+ + GT + S++ H G+ SRR DLE LGY ++ +L G LPW+
Sbjct: 206 PEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265
Query: 218 AGTKKQKYEKISEKKVSTSIEALC---RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 274
K + KI ++ S+ C P E A Y + L + +KP Y L+ I
Sbjct: 266 KDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILL 325
Query: 275 DLFIREGFQFDYVFDWTILKYQQSQLATPPAR 306
G + D D ++++ + T +
Sbjct: 326 QGLKAIGSKDDGKLDLSVVENGGLKAKTITKK 357
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 496 bits (1280), Expect = e-177
Identities = 90/314 (28%), Positives = 141/314 (44%), Gaps = 29/314 (9%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-TKHPQLLYESKLYRIL 59
++ GN++ LG+KIGSG FG IYL E+ A + V+ ++ L E K Y+ +
Sbjct: 31 LDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRV 90
Query: 60 QGGT--------------GIPNVRWFGV----EGDYNVLVMDLLGPSLEDLFNFCSRKLS 101
GIP G+ Y +VM+ LG L+ + +
Sbjct: 91 AKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISG-QNGTFK 149
Query: 102 LKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161
TVL L +M++ +E++H ++H DIK N L+G +QVY+ D+GL+ +Y
Sbjct: 150 KSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKN-PDQVYLADYGLSYRYCPNGN 208
Query: 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL---KA 218
H+ K GT + S++ H G+ SRR D+E LGY ++ +L G LPW+
Sbjct: 209 HKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268
Query: 219 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278
+ K + E S A E A + SL +D+KP+Y LK+I I
Sbjct: 269 AVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328
Query: 279 REGFQFDYVFDWTI 292
G D++
Sbjct: 329 PLGP-----LDFST 337
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 485 bits (1251), Expect = e-173
Identities = 72/316 (22%), Positives = 126/316 (39%), Gaps = 33/316 (10%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQT--------NEEVAIKLENVKT------------ 44
G +++L + G +Y T ++ ++KL+
Sbjct: 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRA 99
Query: 45 -KHPQLLYESKLYRILQGGTGIPNVRWFGV-EGDYNVLVMDLLGPSLEDLFNFCSRK-LS 101
K Q+ KLY IP FGV + Y LV+ LG SL+ + + LS
Sbjct: 100 AKPLQVNKWKKLYST--PLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLS 157
Query: 102 LKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161
++VL +A ++++ +EF+H ++H ++ +N + + +QV + +G A +Y +
Sbjct: 158 ERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQ-SQVTLAGYGFAFRYCPS-- 214
Query: 162 HQHIPYRENKN--LTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 219
+H+ Y E G + SM+ H G SRR DL+SLGY ++ +L G LPW
Sbjct: 215 GKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN 274
Query: 220 TKKQKYEKISEKKVSTSIEALCRGY---PTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276
T+ +K C + Y +L +++KP YA L+ L
Sbjct: 275 TEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL 334
Query: 277 FIREGFQFDYVFDWTI 292
+
Sbjct: 335 LQDLRVSPYDPIGLPM 350
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 54/257 (21%), Positives = 93/257 (36%), Gaps = 47/257 (18%)
Query: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKH-PQLLYESKLYRILQG 61
G + + ++IGSG +++ N + + AIK LE + E LQ
Sbjct: 8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 66
Query: 62 GTGIPN---VRWFGVEGDYN--VLVMDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMIN 114
+ +R + E +VM+ DL ++ +K + M+
Sbjct: 67 ----HSDKIIRLYDYEITDQYIYMVMECGN---IDLNSWLKKKKSIDPWERKSYWKNMLE 119
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174
V +H +H D+KP NFL+ G + +IDFG+A + + +T +
Sbjct: 120 AVHTIHQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVK-----DSQV 170
Query: 175 GTARYAS-----------MNTHLGIEQSRRDDLESLG---YVLMYFLRGSLPWQGLKAGT 220
GT Y N + S + D+ SLG Y + Y G P+Q +
Sbjct: 171 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY---GKTPFQQII--N 225
Query: 221 KKQKYEKISEKKVSTSI 237
+ K I +
Sbjct: 226 QISKLHAIIDPNHEIEF 242
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-27
Identities = 53/255 (20%), Positives = 93/255 (36%), Gaps = 43/255 (16%)
Query: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKH-PQLLYESKLYRILQG 61
G + + ++IGSG +++ N + + AIK LE + E LQ
Sbjct: 27 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 85
Query: 62 GTGIPN---VRWFGVEGDYN--VLVMDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMIN 114
+ +R + E +VM+ DL ++ +K + M+
Sbjct: 86 ----HSDKIIRLYDYEITDQYIYMVMECGNI---DLNSWLKKKKSIDPWERKSYWKNMLE 138
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174
V +H +H D+KP NFL+ G + +IDFG+A + + +T +
Sbjct: 139 AVHTIHQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVK-----DSQV 189
Query: 175 GTARYAS-----------MNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKK 222
GT Y N + S + D+ SLG ++Y G P+Q + +
Sbjct: 190 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG-CILYYMTYGKTPFQQII--NQI 246
Query: 223 QKYEKISEKKVSTSI 237
K I +
Sbjct: 247 SKLHAIIDPNHEIEF 261
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 8e-27
Identities = 38/247 (15%), Positives = 73/247 (29%), Gaps = 53/247 (21%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-----QLLYESKLYRILQG- 61
K +L + G ++L +++ E+ A+K+ + ++ +L + L G
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 62 -------------------GTGIPNV-RWFGVEGDYNV----LVMDLLGPSLEDLFNFCS 97
P + + DY V L+M LE LF+
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 98 R------KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 151
+ + +L Q+I + SK +H PDN + ++ + D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIM---PDGRLMLGDVS 239
Query: 152 LAKKYRDTSTHQHIPYRENKNLTGTARYAS--MNTHLGIEQSRRDDLESLGYVLMY-FLR 208
K + YA + + LG + +Y
Sbjct: 240 ALWKVGTRGP----------ASSVPVTYAPREFLNASTATFTHALNAWQLG-LSIYRVWC 288
Query: 209 GSLPWQG 215
LP+
Sbjct: 289 LFLPFGL 295
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 9e-27
Identities = 53/254 (20%), Positives = 92/254 (36%), Gaps = 41/254 (16%)
Query: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKH-PQLLYESKLYRILQG 61
G + + ++IGSG +++ N + + AIK LE + E LQ
Sbjct: 55 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 113
Query: 62 GTGIPN---VRWFGVEGDYN--VLVMDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMIN 114
+ +R + E +VM+ DL ++ +K + M+
Sbjct: 114 ----HSDKIIRLYDYEITDQYIYMVMECGN---IDLNSWLKKKKSIDPWERKSYWKNMLE 166
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174
V +H +H D+KP NFL+ G + +IDFG+A + + +T +
Sbjct: 167 AVHTIHQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVK-----DSQV 217
Query: 175 GTARYAS-----------MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ 223
G Y N + S + D+ SLG +L Y G P+Q + +
Sbjct: 218 GAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII--NQIS 275
Query: 224 KYEKISEKKVSTSI 237
K I +
Sbjct: 276 KLHAIIDPNHEIEF 289
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-26
Identities = 62/315 (19%), Positives = 110/315 (34%), Gaps = 55/315 (17%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLLYESKLYRILQGGT 63
+ + L +G G+ ++ G + +T + AIK+ + + E ++ + L
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH-- 66
Query: 64 GIPN-VRWFGVEGDYN----VLVMDLL--GPSLEDLFNFCSRK-----LSLKTVLMLADQ 111
N V+ F +E + VL+M+ G L+ L L++
Sbjct: 67 --KNIVKLFAIEEETTTRHKVLIMEFCPCG----SLYTVLEEPSNAYGLPESEFLIVLRD 120
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY-IIDFGLAKKYRDTSTHQHIPYREN 170
++ + + +HR+IKP N + +G VY + DFG A++ D
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF-------- 172
Query: 171 KNLTGTARYAS--------MNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAG-T 220
+L GT Y + + DL S+G V Y GSLP++ +
Sbjct: 173 VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIG-VTFYHAATGSLPFRPFEGPRR 231
Query: 221 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL---F 277
K+ KI K S +I + + D P L R + L
Sbjct: 232 NKEVMYKIITGKPSGAISGVQKAENGPIDWSG---------DMPVSCSLSRGLQVLLTPV 282
Query: 278 IREGFQFDYVFDWTI 292
+ + D W
Sbjct: 283 LANILEADQEKCWGF 297
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 3e-26
Identities = 62/315 (19%), Positives = 110/315 (34%), Gaps = 55/315 (17%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLLYESKLYRILQGGT 63
+ + L +G G+ ++ G + +T + AIK+ + + E ++ + L
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH-- 66
Query: 64 GIPN-VRWFGVEGDYN----VLVMDLL--GPSLEDLFNFCSRK-----LSLKTVLMLADQ 111
N V+ F +E + VL+M+ G L+ L L++
Sbjct: 67 --KNIVKLFAIEEETTTRHKVLIMEFCPCG----SLYTVLEEPSNAYGLPESEFLIVLRD 120
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY-IIDFGLAKKYRDTSTHQHIPYREN 170
++ + + +HR+IKP N + +G VY + DFG A++ D
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF-------- 172
Query: 171 KNLTGTARYAS--------MNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAG-T 220
+L GT Y + + DL S+G V Y GSLP++ +
Sbjct: 173 VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIG-VTFYHAATGSLPFRPFEGPRR 231
Query: 221 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL---F 277
K+ KI K S +I + + D P L R + L
Sbjct: 232 NKEVMYKIITGKPSGAISGVQKAENGPIDWSG---------DMPVSCSLSRGLQVLLTPV 282
Query: 278 IREGFQFDYVFDWTI 292
+ + D W
Sbjct: 283 LANILEADQEKCWGF 297
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 40/276 (14%), Positives = 75/276 (27%), Gaps = 47/276 (17%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-----ENVKTKHPQLLYESKLYRILQGG 62
G +G T+ +T E + + Q+ E R+L+G
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 63 ---------------------TGIPNV-RWFGVEGDYN----VLVMDLLGPSLEDLFNF- 95
+ R E D + + +L+
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 96 -----CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 150
+ L L L Q+I + +H +H ++P + ++ + V++ F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD---QRGGVFLTGF 250
Query: 151 GLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRG 209
+ E L S + + D +LG +++Y
Sbjct: 251 EHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALG-LVIYWIWCA 309
Query: 210 SLPWQGLKAGTKKQKYEKI--SEKKVSTSIEALCRG 243
LP E I S K + + AL G
Sbjct: 310 DLPITK---DAALGGSEWIFRSCKNIPQPVRALLEG 342
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 47/235 (20%), Positives = 84/235 (35%), Gaps = 44/235 (18%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--------LENVKT--------KHP 47
R + F +G G+FG++ N + AIK L + + H
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQ 62
Query: 48 QLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVL 106
Y + Y + + M+ +L DL + +
Sbjct: 63 ---YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119
Query: 107 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT----STH 162
L Q++ + ++HS+ +HRD+KP N + + V I DFGLAK +
Sbjct: 120 RLFRQILEALSYIHSQGIIHRDLKPMNIFID---ESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 163 QHIPYRENKNLT---GTARYAS--MNTHLGIEQSRRDDLE----SLG---YVLMY 205
+ NLT GTA Y + + ++ + + + SLG + ++Y
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEV-----LDGTGHYNEKIDMYSLGIIFFEMIY 226
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-24
Identities = 54/332 (16%), Positives = 107/332 (32%), Gaps = 73/332 (21%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----------LENVKT------ 44
+ + + + ++G+G FG + + T E+VAIK E
Sbjct: 8 LPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMK 67
Query: 45 --KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK--- 99
HP ++ + G + D +L M+ DL + ++
Sbjct: 68 KLNHPNVV---SAREVPDGLQKLA-------PNDLPLLAMEYC--EGGDLRKYLNQFENC 115
Query: 100 --LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157
L + L + + + ++H +HRD+KP+N ++ G + IID G AK+
Sbjct: 116 CGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD 175
Query: 158 DTSTHQHIPYRENKNLTGTARYAS--MNTHLGIEQSRRD---DLESLGYVLMYFL-RGSL 211
GT +Y + + +EQ + D S G L + G
Sbjct: 176 QGEL--------CTEFVGTLQYLAPEL-----LEQKKYTVTVDYWSFG-TLAFECITGFR 221
Query: 212 PWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRF-DDKPDYAYLK 270
P+ + ++ +K + I Y +++F P +L
Sbjct: 222 PFLP---NWQPVQWHGKVREKSNEHIVV-----------YDDLTGAVKFSSVLPTPNHLS 267
Query: 271 RIFRDL---FIREGFQFDYVFDWTILKYQQSQ 299
I +++ + T +
Sbjct: 268 GILAGKLERWLQCMLMWHQRQRGTDPQNPNVG 299
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-24
Identities = 54/239 (22%), Positives = 93/239 (38%), Gaps = 49/239 (20%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRI--- 58
E +RLG +G G FG ++ G + +VAIK+ + + S
Sbjct: 27 EAFEAE-YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIP-RNRVLGWSPLSDSVTCPLE 84
Query: 59 ------LQGGTGIPNV----RWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVL-- 106
+ G G P V WF + + +LV++ P+ +DLF++ + K L
Sbjct: 85 VALLWKVGAGGGHPGVIRLLDWFETQEGF-MLVLERPLPA-QDLFDYITEKGPLGEGPSR 142
Query: 107 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166
Q++ ++ HS+ +HRDIK +N L + R +IDFG D
Sbjct: 143 CFFGQVVAAIQHCHSRGVVHRDIKDENIL--IDLRRGCAKLIDFGSGALLHDEPYT---- 196
Query: 167 YRENKNLT--GTARYA-----SMNTHLGIEQSRRDDLESLG---YVLMYFLRGSLPWQG 215
GT Y+ S + + + + SLG Y ++ G +P++
Sbjct: 197 -------DFDGTRVYSPPEWISRHQYHALPA----TVWSLGILLYDMVC---GDIPFER 241
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 102 bits (254), Expect = 5e-24
Identities = 39/281 (13%), Positives = 75/281 (26%), Gaps = 60/281 (21%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-----ENVKTKHPQLLYESKLYRILQG-- 61
G +G T+ +T E + + Q+ E R+L+G
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 62 -------------------GTGIPNV-RWFGVEGDYNV----LVMDLLGPSLEDLFNFCS 97
+ R E D V + + +L+
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 98 RK------LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 151
L L L Q+I + +H +H ++P + ++ + V++ F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD---QRGGVFLTGFE 256
Query: 152 LAKKY-RDTSTHQHIPYRENKNLTGTARYAS-----MNTHLGIEQSRRDDLESLGYVLMY 205
+ + + + H + D +LG + +Y
Sbjct: 257 HLVRDGASAVSPIGRGF-------APPETTAERMLPFGQHHPTLMTFAFDTWTLG-LAIY 308
Query: 206 F-LRGSLPWQGLKAGTKKQKYEKI--SEKKVSTSIEALCRG 243
+ LP E I S K + + AL G
Sbjct: 309 WIWCADLPNTD---DAALGGSEWIFRSCKNIPQPVRALLEG 346
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 5e-23
Identities = 54/239 (22%), Positives = 88/239 (36%), Gaps = 37/239 (15%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQG 61
E + N + +G GS G + VA+K L E K +L
Sbjct: 10 EQSLKNLVVSEKILGYGSSGTVVF-QGSFQGRPVAVKRML-IDFCDIALMEIK---LLTE 64
Query: 62 GTGIPN-VRWFGVEGDYNV--LVMDLLGPSLEDL------FNFCSRKLSLKTVLMLADQM 112
PN +R++ E + ++L +L+DL + + + L Q+
Sbjct: 65 SDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124
Query: 113 INRVEFVHSKSFLHRDIKPDNFL----------MGLGRRANQVYIIDFGLAKKYRDTSTH 162
+ V +HS +HRD+KP N L G ++ I DFGL KK
Sbjct: 125 ASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG--- 181
Query: 163 QHIPYRENKNLTGTARYA-------SMNTHLGIEQSRRDDLESLGYVLMYFL--RGSLP 212
Q N +GT+ + S N +R D+ S+G + Y++ +G P
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMG-CVFYYILSKGKHP 239
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 9e-23
Identities = 42/222 (18%), Positives = 81/222 (36%), Gaps = 28/222 (12%)
Query: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKLYRILQGGT 63
+ +K+G G F + L + A+K + + E+ ++R+
Sbjct: 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNH-- 85
Query: 64 GIPN-VRWFGV-----EGDYNV-LVMDL-LGPSLEDLFNFCSRK---LSLKTVLMLADQM 112
PN +R + L++ +L + K L+ +L L +
Sbjct: 86 --PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGI 143
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT--STHQHIPYREN 170
+E +H+K + HRD+KP N L+G Q ++D G + + Q + ++
Sbjct: 144 CRGLEAIHAKGYAHRDLKPTNILLG---DEGQPVLMDLGSMNQACIHVEGSRQALTLQDW 200
Query: 171 KNLTGTARYAS---MNTHLGIEQSRRDDLESLG---YVLMYF 206
T Y + + R D+ SLG Y +M+
Sbjct: 201 AAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFG 242
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 9e-23
Identities = 57/237 (24%), Positives = 98/237 (41%), Gaps = 47/237 (19%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYR- 57
EP +++G +GSG FG +Y G + N VAIK K + +L +++
Sbjct: 39 EPLESQ-YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE-KDRISDWGELPNGTRVPME 96
Query: 58 --ILQG-GTGIPNV----RWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK--LSLKTVLML 108
+L+ +G V WF + VL+++ P +DLF+F + + L +
Sbjct: 97 VVLLKKVSSGFSGVIRLLDWFERPDSF-VLILERPEPV-QDLFDFITERGALQEELARSF 154
Query: 109 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYR 168
Q++ V H+ LHRDIK +N L + ++ +IDFG +DT
Sbjct: 155 FWQVLEAVRHCHNCGVLHRDIKDENIL--IDLNRGELKLIDFGSGALLKDTVYT------ 206
Query: 169 ENKNLT--GTARYA-----SMNTHLGIEQSRRDDLESLG---YVLMYFLRGSLPWQG 215
GT Y+ + + G + SLG Y ++ G +P++
Sbjct: 207 -----DFDGTRVYSPPEWIRYHRYHGRSA----AVWSLGILLYDMVC---GDIPFEH 251
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 5e-22
Identities = 49/223 (21%), Positives = 85/223 (38%), Gaps = 21/223 (9%)
Query: 4 RVGN-KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGG 62
VG F +G G+ G I + N +VA+K E + +L+
Sbjct: 20 IVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRIL-PECFSFADREVQ---LLRES 74
Query: 63 TGIPN-VRWFGVEGDYNV--LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
PN +R+F E D + ++L +L++ + L Q + + +
Sbjct: 75 DEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHL 134
Query: 120 HSKSFLHRDIKPDNFL--MGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTA 177
HS + +HRD+KP N L M + I DFGL KK + + GT
Sbjct: 135 HSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS----FSRRSGVPGTE 190
Query: 178 RYAS---MNTHLGIEQSRRDDLESLGYVLMYFL--RGSLPWQG 215
+ + ++ + D+ S G + Y++ GS P+
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAG-CVFYYVISEGSHPFGK 232
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 9e-22
Identities = 61/248 (24%), Positives = 110/248 (44%), Gaps = 40/248 (16%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYR---IL 59
++++ R +G GSFGE+ L + T +E A+K+ + K + Q + L R +L
Sbjct: 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS-KRQVKQKTDKESLLREVQLL 80
Query: 60 QGGTGIPN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFN-FCSRK-LSLKTVLMLADQM 112
+ PN ++ + E LV ++ G +LF+ SRK S + Q+
Sbjct: 81 K-QLDHPNIMKLYEFFEDKGYFYLVGEVYTGG----ELFDEIISRKRFSEVDAARIIRQV 135
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN 172
++ + ++H +HRD+KP+N L+ + + IIDFGL+ + + K+
Sbjct: 136 LSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM--------KD 187
Query: 173 LTGTARYASMNTHLGIEQSRRD-----DLESLGYVLMYF-LRGSLPWQGLKAGTKKQKYE 226
GTA Y + E D+ S G V++Y L G P+ G + +
Sbjct: 188 KIGTAYYIAP------EVLHGTYDEKCDVWSTG-VILYILLSGCPPFNG---ANEYDILK 237
Query: 227 KISEKKVS 234
K+ + K +
Sbjct: 238 KVEKGKYT 245
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-21
Identities = 37/170 (21%), Positives = 61/170 (35%), Gaps = 13/170 (7%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKH-PQLLYESKLY 56
E F+ ++G GS+GE++ + + A+K K + L E
Sbjct: 51 PESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEV--- 107
Query: 57 RILQGGTGIPN-VRWFG--VEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 113
+ P VR EG L +L GPSL+ L V +
Sbjct: 108 GSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTL 167
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163
+ +HS+ +H D+KP N +G + + DFGL + +
Sbjct: 168 LALAHLHSQGLVHLDVKPANIFLG---PRGRCKLGDFGLLVELGTAGAGE 214
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 61/248 (24%), Positives = 113/248 (45%), Gaps = 43/248 (17%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLLY-ESKLYRIL 59
+ ++ +K+GSG++GE+ L + T+ E AIK +V T L E + ++L
Sbjct: 34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL 93
Query: 60 QGGTGIPN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFN-FCSRK-LSLKTVLMLADQM 112
PN ++ + E N LVM+ G +LF+ R + ++ Q+
Sbjct: 94 DH----PNIMKLYDFFEDKRNYYLVMECYKGG----ELFDEIIHRMKFNEVDAAVIIKQV 145
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN 172
++ V ++H + +HRD+KP+N L+ + + I+DFGL+ + + K
Sbjct: 146 LSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM--------KE 197
Query: 173 LTGTARYASMNTHLGIEQSRRD-----DLESLGYVLMYF-LRGSLPWQGLKAGTKKQKYE 226
GTA Y + E R+ D+ S+G V+++ L G P+ G T ++
Sbjct: 198 RLGTAYYIAP------EVLRKKYDEKCDVWSIG-VILFILLAGYPPFGG---QTDQEILR 247
Query: 227 KISEKKVS 234
K+ + K +
Sbjct: 248 KVEKGKYT 255
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 59/250 (23%), Positives = 109/250 (43%), Gaps = 43/250 (17%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLLY-ESKLYR 57
+ ++ + +G GSFGE+ + T +E A+K + K K + E +L +
Sbjct: 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76
Query: 58 ILQGGTGIPN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFN-FCSRK-LSLKTVLMLAD 110
L PN ++ F + E + +V +L G +LF+ RK S +
Sbjct: 77 KLDH----PNIMKLFEILEDSSSFYIVGELYTGG----ELFDEIIKRKRFSEHDAARIIK 128
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170
Q+ + + ++H + +HRD+KP+N L+ + + IIDFGL+ ++ +
Sbjct: 129 QVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM-------- 180
Query: 171 KNLTGTARYASMNTHLGIEQSRRD-----DLESLGYVLMYF-LRGSLPWQGLKAGTKKQK 224
K+ GTA Y + E R D+ S G V++Y L G+ P+ G +
Sbjct: 181 KDRIGTAYYIAP------EVLRGTYDEKCDVWSAG-VILYILLSGTPPFYG---KNEYDI 230
Query: 225 YEKISEKKVS 234
+++ K +
Sbjct: 231 LKRVETGKYA 240
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 3e-21
Identities = 56/228 (24%), Positives = 98/228 (42%), Gaps = 39/228 (17%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLL----YESKLYRILQ 60
+ ++++ K+G G +YL + N +VAIK + R +
Sbjct: 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKA-----IFIPPREKEETLKRFEREVH 63
Query: 61 GGT-----GIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
+ I ++ E D LVM+ + GP+L + LS+ T + +Q+++
Sbjct: 64 NSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIE-SHGPLSVDTAINFTNQILD 122
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174
++ H +HRDIKP N L+ + I DFG+AK +TS Q ++
Sbjct: 123 GIKHAHDMRIVHRDIKPQNILID---SNKTLKIFDFGIAKALSETSLTQ------TNHVL 173
Query: 175 GTARYASMNTHLGIEQSR------RDDLESLGYVLMY-FLRGSLPWQG 215
GT +Y S EQ++ D+ S+G +++Y L G P+ G
Sbjct: 174 GTVQYFSP------EQAKGEATDECTDIYSIG-IVLYEMLVGEPPFNG 214
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 4e-21
Identities = 72/245 (29%), Positives = 110/245 (44%), Gaps = 45/245 (18%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLLYESKLYRILQ 60
F +GR +G G FG +YL Q+ +A+K LE +H QL E ++ L+
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLR 67
Query: 61 GGTGIPN-VRWFGV-EGDYNV-LVMDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINR 115
PN +R +G V L+++ L ++ + K + ++ N
Sbjct: 68 H----PNILRLYGYFHDATRVYLILEYA--PLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175
+ + HSK +HRDIKP+N L+G A ++ I DFG + H P +L G
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSV---------HAPSSRRTDLCG 169
Query: 176 TARYAS--MNTHLGIEQSRRD---DLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYEKIS 229
T Y M IE D DL SLG VL Y FL G P++ A T ++ Y++IS
Sbjct: 170 TLDYLPPEM-----IEGRMHDEKVDLWSLG-VLCYEFLVGKPPFE---ANTYQETYKRIS 220
Query: 230 EKKVS 234
+ +
Sbjct: 221 RVEFT 225
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 5e-21
Identities = 43/198 (21%), Positives = 69/198 (34%), Gaps = 30/198 (15%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKT----------KHP 47
++ R G F+ IGSG FG+++ + + IK N K H
Sbjct: 5 VDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHV 64
Query: 48 QL--LYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLK 103
+ + + + + M+ +LE KL
Sbjct: 65 NIVHYNGC--WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 104 TVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163
L L +Q+ V+++HSK ++RD+KP N + QV I DFGL ++
Sbjct: 123 LALELFEQITKGVDYIHSKKLINRDLKPSNIFLV---DTKQVKIGDFGLVTSLKNDGKRT 179
Query: 164 HIPYRENKNLTGTARYAS 181
GT RY S
Sbjct: 180 RS--------KGTLRYMS 189
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 9e-21
Identities = 66/248 (26%), Positives = 114/248 (45%), Gaps = 42/248 (16%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLLYESKLYRILQG 61
+ + F RK+GSG+FG+++L + E IK + + Q+ E ++ + L
Sbjct: 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDH 79
Query: 62 GTGIPN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLF------NFCSRKLSLKTVLMLAD 110
PN ++ F V E +N+ +VM+ G +L + LS V L
Sbjct: 80 ----PNIIKIFEVFEDYHNMYIVMETCEGG----ELLERIVSAQARGKALSEGYVAELMK 131
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170
QM+N + + HS+ +H+D+KP+N L + + IIDFGLA+ ++
Sbjct: 132 QMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS-------- 183
Query: 171 KNLTGTARYAS---MNTHLGIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTKKQKYE 226
N GTA Y + + + D+ S G V+MYF L G LP+ G + ++ +
Sbjct: 184 TNAAGTALYMAPEVFKRDVTFKC----DIWSAG-VVMYFLLTGCLPFTG---TSLEEVQQ 235
Query: 227 KISEKKVS 234
K + K+ +
Sbjct: 236 KATYKEPN 243
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 9e-21
Identities = 57/234 (24%), Positives = 92/234 (39%), Gaps = 30/234 (12%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLLYESKLYRILQ 60
F++G +G GSF +Y +I T EVAIK + ++ E K++ L+
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQ-RVQNEVKIHCQLK 69
Query: 61 GGTGIPN-VRWFGV-EGDYNV-LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116
P+ + + E V LV+++ + + S Q+I +
Sbjct: 70 H----PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGM 125
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGT 176
++HS LHRD+ N L+ R + I DFGL +T +P+ ++ L GT
Sbjct: 126 LYLHSHGILHRDLTLSNLLLT---RNMNIKIADFGL-------ATQLKMPHEKHYTLCGT 175
Query: 177 ARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYEKIS 229
Y S D+ SLG + Y L G P+ T K K+
Sbjct: 176 PNYISPEIATRSAHGLESDVWSLG-CMFYTLLIGRPPFD---TDTVKNTLNKVV 225
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-20
Identities = 33/187 (17%), Positives = 73/187 (39%), Gaps = 26/187 (13%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGG 62
+ K+ + +G G FG ++ + + K VK + E + I +
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH- 60
Query: 63 TGIPN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFNFCSRK---LSLKTVLMLADQMIN 114
N + E + ++ + + D+F + L+ + ++ Q+
Sbjct: 61 ---RNILHLHESFESMEELVMIFEFISGL----DIFERINTSAFELNEREIVSYVHQVCE 113
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174
++F+HS + H DI+P+N + RR++ + II+FG A++ + + L
Sbjct: 114 ALQFLHSHNIGHFDIRPENIIY-QTRRSSTIKIIEFGQARQLKPGDNF--------RLLF 164
Query: 175 GTARYAS 181
Y +
Sbjct: 165 TAPEYYA 171
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 1e-20
Identities = 53/242 (21%), Positives = 94/242 (38%), Gaps = 53/242 (21%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKLYRILQ 60
+ +GSG+FG ++ + + N+EV +K ++ K + + KL ++
Sbjct: 20 GEYSQK-YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL 78
Query: 61 GGTGI--------PN-VRWFGV---EGDYNVLVMDLLGPSLEDLFNFCSRK--LSLKTVL 106
I N ++ + +G + LVM+ G L+ LF F R L
Sbjct: 79 ---EIAILSRVEHANIIKVLDIFENQGFF-QLVMEKHGSGLD-LFAFIDRHPRLDEPLAS 133
Query: 107 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166
+ Q+++ V ++ K +HRDIK +N + + + +IDFG A
Sbjct: 134 YIFRQLVSAVGYLRLKDIIHRDIKDENIV--IAEDFT-IKLIDFGSAAYLER-------- 182
Query: 167 YRENKNLT---GTARYA-----SMNTHLGIEQSRRDDLESLG---YVLMYFLRGSLPWQG 215
K GT Y N + G E ++ SLG Y L++ P+
Sbjct: 183 ---GKLFYTFCGTIEYCAPEVLMGNPYRGPEL----EMWSLGVTLYTLVF---EENPFCE 232
Query: 216 LK 217
L+
Sbjct: 233 LE 234
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 2e-20
Identities = 57/246 (23%), Positives = 96/246 (39%), Gaps = 43/246 (17%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLLYESKL 55
+PR ++ GR +G G F + + ++ T E A K L + ++ E +
Sbjct: 10 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE-KMSMEISI 68
Query: 56 YRILQGGTGIPN-VRWFGV-EGDYNV-LVMDLLGPSLEDLFNFCSRK--LSLKTVLMLAD 110
+R L + V + G E + V +V++L L R+ L+
Sbjct: 69 HRSLAH----QHVVGFHGFFEDNDFVFVVLELC--RRRSLLELHKRRKALTEPEARYYLR 122
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170
Q++ +++H +HRD+K N + +V I DFGL +T
Sbjct: 123 QIVLGCQYLHRNRVIHRDLKLGNLFLN---EDLEVKIGDFGL-------ATKVEYDGERK 172
Query: 171 KNLTGTARYA-----SMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQK 224
K L GT Y S H S D+ S+G +MY L G P++ K+
Sbjct: 173 KVLCGTPNYIAPEVLSKKGH-----SFEVDVWSIG-CIMYTLLVGKPPFE---TSCLKET 223
Query: 225 YEKISE 230
Y +I +
Sbjct: 224 YLRIKK 229
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 4e-20
Identities = 35/181 (19%), Positives = 74/181 (40%), Gaps = 26/181 (14%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYR---ILQGGTGIPN 67
+++G G F + + T +E A K +K + +++ +L+ P
Sbjct: 33 TSKELGRGKFAVVRQCISKSTGQEYAAKF--LKKRRRGQDCRAEILHEIAVLELAKSCPR 90
Query: 68 -VRWFGV--EGDYNVLVMDLL--GPSLEDLFNFCSRK----LSLKTVLMLADQMINRVEF 118
+ V +L+++ G ++F+ C + +S V+ L Q++ V +
Sbjct: 91 VINLHEVYENTSEIILILEYAAGG----EIFSLCLPELAEMVSENDVIRLIKQILEGVYY 146
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 178
+H + +H D+KP N L+ + I+DFG+++K + + GT
Sbjct: 147 LHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL--------REIMGTPE 198
Query: 179 Y 179
Y
Sbjct: 199 Y 199
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 6e-20
Identities = 56/244 (22%), Positives = 89/244 (36%), Gaps = 62/244 (25%)
Query: 2 EPRVGNKF---RLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--------ENVKTK----- 45
E R G +F RL R +G G G++Y + VA+KL +T+
Sbjct: 26 ESREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREA 85
Query: 46 -------HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS 97
P + + FG + M L+ G L +
Sbjct: 86 RTAGRLQEP----------------HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG 129
Query: 98 RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157
L+ + + Q+ + ++ H+ HRD+KP+N L+ + Y++DFG+A
Sbjct: 130 P-LAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVS---ADDFAYLVDFGIASATT 185
Query: 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSR------RDDLESLGYVLMYFLRGSL 211
D Q N GT Y + E+ R D+ +L VL L GS
Sbjct: 186 DEKLTQ------LGNTVGTLYYMAP------ERFSESHATYRADIYALTCVLYECLTGSP 233
Query: 212 PWQG 215
P+QG
Sbjct: 234 PYQG 237
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 7e-20
Identities = 58/246 (23%), Positives = 94/246 (38%), Gaps = 43/246 (17%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLLYESKL 55
+PR ++ GR +G G F + + ++ T E A K L + ++ E +
Sbjct: 36 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE-KMSMEISI 94
Query: 56 YRILQGGTGIPN-VRWFGV-EGDYNV-LVMDLLGPSLEDLFNFCSR--KLSLKTVLMLAD 110
+R L + V + G E + V +V++L L R L+
Sbjct: 95 HRSLAH----QHVVGFHGFFEDNDFVFVVLELC--RRRSLLELHKRRKALTEPEARYYLR 148
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170
Q++ +++H +HRD+K N L V I DFGL +T
Sbjct: 149 QIVLGCQYLHRNRVIHRDLKLGNLF--LNEDLE-VKIGDFGL-------ATKVEYDGERK 198
Query: 171 KNLTGTARYA-----SMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQK 224
K L GT Y S H S D+ S+G +MY L G P++ K+
Sbjct: 199 KVLCGTPNYIAPEVLSKKGH-----SFEVDVWSIG-CIMYTLLVGKPPFE---TSCLKET 249
Query: 225 YEKISE 230
Y +I +
Sbjct: 250 YLRIKK 255
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 8e-20
Identities = 46/232 (19%), Positives = 85/232 (36%), Gaps = 35/232 (15%)
Query: 4 RVGN-KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKLYRILQ 60
+G + R+ R + G F +Y ++ + E A+K + ++ E + L
Sbjct: 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLS 83
Query: 61 GGTGIPN-VRWFGV---------EGDYNVLV-MDLLGPSLEDLFNFCSRK--LSLKTVLM 107
G PN V++ G L+ +L L + + LS TVL
Sbjct: 84 GH---PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK 140
Query: 108 LADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD-----TS 160
+ Q V+ +H + +HRD+K +N L+ + + DFG A S
Sbjct: 141 IFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS---NQGTIKLCDFGSATTISHYPDYSWS 197
Query: 161 THQHIPYRENKNLTGTARYAS---MNTHLGIEQSRRDDLESLG---YVLMYF 206
+ E T Y + ++ + + D+ +LG Y+L +
Sbjct: 198 AQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFR 249
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 1e-19
Identities = 40/188 (21%), Positives = 81/188 (43%), Gaps = 27/188 (14%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQG 61
V + + + ++G+G+FG ++ T T A K + + E + +L+
Sbjct: 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH 213
Query: 62 GTGIPN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFNFCSRK---LSLKTVLMLADQMI 113
P V E D + ++ + + G +LF + + +S + Q+
Sbjct: 214 ----PTLVNLHDAFEDDNEMVMIYEFMSGG----ELFEKVADEHNKMSEDEAVEYMRQVC 265
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNL 173
+ +H +++H D+KP+N + +R+N++ +IDFGL P + K
Sbjct: 266 KGLCHMHENNYVHLDLKPENIMF-TTKRSNELKLIDFGLTAHLD--------PKQSVKVT 316
Query: 174 TGTARYAS 181
TGTA +A+
Sbjct: 317 TGTAEFAA 324
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 1e-19
Identities = 42/174 (24%), Positives = 71/174 (40%), Gaps = 16/174 (9%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIP 66
+ ++G GSFGE++ + QT + A+K ++ + E L P
Sbjct: 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE---ELVACAGLSS----P 110
Query: 67 N-VRWFGVE--GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
V +G G + + M+LL G SL L L L Q + +E++H++
Sbjct: 111 RIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTR 169
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGT 176
LH D+K DN L L ++ + DFG A + + + + GT
Sbjct: 170 RILHGDVKADNVL--LSSDGSRAALCDFGHALCLQPDGLGKSLLTG--DYIPGT 219
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 1e-19
Identities = 60/258 (23%), Positives = 105/258 (40%), Gaps = 48/258 (18%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---------LENVKTKHPQLLYE 52
E ++G + RK+GSG++GE+ L + E AIK +
Sbjct: 31 EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFH 90
Query: 53 SKLYR---ILQGGTGIPN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFN-FCSR-KLSL 102
++Y +L+ PN ++ F V E LV + G +LF +R K
Sbjct: 91 EEIYNEISLLK-SLDHPNIIKLFDVFEDKKYFYLVTEFYEGG----ELFEQIINRHKFDE 145
Query: 103 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162
+ Q+++ + ++H + +HRDIKP+N L+ + I+DFGL+ +
Sbjct: 146 CDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL 205
Query: 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRD-----DLESLGYVLMYF-LRGSLPWQGL 216
++ GTA Y + E ++ D+ S G V+MY L G P+ G
Sbjct: 206 --------RDRLGTAYYIAP------EVLKKKYNEKCDVWSCG-VIMYILLCGYPPFGG- 249
Query: 217 KAGTKKQKYEKISEKKVS 234
+ +K+ + K
Sbjct: 250 --QNDQDIIKKVEKGKYY 265
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 88.5 bits (219), Expect = 1e-19
Identities = 36/171 (21%), Positives = 67/171 (39%), Gaps = 19/171 (11%)
Query: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYES----KLYRILQG 61
+ +G G+F ++Y T N+ + +K + P +E +L L+
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 62 GT--GIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFN----FCSRKLSLKTVLMLADQMIN 114
+ + +VLV +L +L + N + + V+ A +M+
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQ--------VYIIDFGLAKKYR 157
+E VH +H DIKPDNF++G G + +ID G + +
Sbjct: 184 MIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 38/168 (22%), Positives = 79/168 (47%), Gaps = 16/168 (9%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTG 64
+ +++ + + +GSG+ GE+ L +T ++VAI++ + + E+ ++
Sbjct: 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIE 192
Query: 65 I------PN-VRWFGVEGDYNV-LVMDLL--GPSLEDLFNF-CSR-KLSLKTVLMLADQM 112
I P ++ + +V++L+ G +LF+ +L T + QM
Sbjct: 193 ILKKLNHPCIIKIKNFFDAEDYYIVLELMEGG----ELFDKVVGNKRLKEATCKLYFYQM 248
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160
+ V+++H +HRD+KP+N L+ + I DFG +K +TS
Sbjct: 249 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS 296
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-19
Identities = 65/281 (23%), Positives = 118/281 (41%), Gaps = 29/281 (10%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY----ESKLYRILQGG 62
+ +G++IGSGSFG +Y G + +VA+K+ NV PQ L E + R +
Sbjct: 24 GQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH- 79
Query: 63 TGIPN-VRWFGV--EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 118
N + + G +V G SL + K +K ++ +A Q +++
Sbjct: 80 ---VNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDY 135
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 178
+H+KS +HRD+K +N + N V I DFGLA + S + + L+G+
Sbjct: 136 LHAKSIIHRDLKSNNIFLH---EDNTVKIGDFGLATEKSRWSG-----SHQFEQLSGSIL 187
Query: 179 YAS---MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235
+ + + S + D+ + G VL + G LP+ + + Q E + +S
Sbjct: 188 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIEMVGRGSLSP 245
Query: 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276
+ + P C + D++P + + +L
Sbjct: 246 DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 42/247 (17%), Positives = 78/247 (31%), Gaps = 72/247 (29%)
Query: 1 MEP--RVGNKFRLGRKIGSGSFGEIYLGTNIQTNE-EVAIKL------ENVKT------- 44
+ P V ++ + I G G IYL + N V +K +
Sbjct: 72 LNPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQ 131
Query: 45 -----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV-----LVMDLL-GPSLEDLF 93
HP I + F D + +VM+ + G SL+
Sbjct: 132 FLAEVVHP----------------SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK 175
Query: 94 NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
+KL + + +++ + ++HS ++ D+KP+N ++ Q+ +ID G
Sbjct: 176 G---QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIML----TEEQLKLIDLGAV 228
Query: 154 KKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSR-----RDDLESLGYVLMYFLR 208
+ L GT + + E R D+ ++G L
Sbjct: 229 SRINSFGY-----------LYGTPGFQAP------EIVRTGPTVATDIYTVGRTLAALTL 271
Query: 209 GSLPWQG 215
G
Sbjct: 272 DLPTRNG 278
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 3e-19
Identities = 61/247 (24%), Positives = 102/247 (41%), Gaps = 49/247 (19%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLLYESKLYRILQ 60
+ F +GR +G G FG +YL Q +A+K LE +H QL E ++ L+
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEH-QLRREIEIQSHLR 72
Query: 61 GGTGIPN-VRWFGVEGDYN--VLVMDLL--GPSLEDLFNFCSR--KLSLKTVLMLADQMI 113
PN +R + D L+++ G +L+ + + + +++
Sbjct: 73 H----PNILRMYNYFHDRKRIYLMLEFAPRG----ELYKELQKHGRFDEQRSATFMEELA 124
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNL 173
+ + + H + +HRDIKP+N LMG ++ I DFG + H P + +
Sbjct: 125 DALHYCHERKVIHRDIKPENLLMG---YKGELKIADFGWSV---------HAPSLRRRTM 172
Query: 174 TGTARYAS--MNTHLGIEQSRRD---DLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYEK 227
GT Y M IE D DL G VL Y FL G P+ + + + + +
Sbjct: 173 CGTLDYLPPEM-----IEGKTHDEKVDLWCAG-VLCYEFLVGMPPFD---SPSHTETHRR 223
Query: 228 ISEKKVS 234
I +
Sbjct: 224 IVNVDLK 230
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 3e-19
Identities = 46/189 (24%), Positives = 87/189 (46%), Gaps = 27/189 (14%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLLY-ESKLYR 57
+ ++ + +G GSFGE+ + T +E A+K+ + K K + E +L +
Sbjct: 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76
Query: 58 ILQGGTGIPN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFN-FCSR-KLSLKTVLMLAD 110
L PN ++ F + E + +V +L G +LF+ R + S +
Sbjct: 77 KLDH----PNIMKLFEILEDSSSFYIVGELYTGG----ELFDEIIKRKRFSEHDAARIIK 128
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170
Q+ + + ++H + +HRD+KP+N L+ + + IIDFGL+ ++ +
Sbjct: 129 QVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM-------- 180
Query: 171 KNLTGTARY 179
K+ GTA Y
Sbjct: 181 KDRIGTAYY 189
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 3e-19
Identities = 49/218 (22%), Positives = 97/218 (44%), Gaps = 28/218 (12%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTG 64
+ +++ + + +GSG+ GE+ L +T ++VAIK+ + + E+ ++
Sbjct: 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 65 I------PN-VRWFGVEGDYNV-LVMDLL--GPSLEDLFNF-CSR-KLSLKTVLMLADQM 112
I P ++ + +V++L+ G +LF+ +L T + QM
Sbjct: 68 ILKKLNHPCIIKIKNFFDAEDYYIVLELMEGG----ELFDKVVGNKRLKEATCKLYFYQM 123
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN 172
+ V+++H +HRD+KP+N L+ + I DFG +K +TS +
Sbjct: 124 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--------RT 175
Query: 173 LTGTARYAS---MNTHLGIEQSRRDDLESLGYVLMYFL 207
L GT Y + + + +R D SLG V+++
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG-VILFIC 212
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 3e-19
Identities = 52/220 (23%), Positives = 90/220 (40%), Gaps = 40/220 (18%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ----LLYESKLYRIL 59
V + + + ++GSG+FG ++ T K + T +P + E + L
Sbjct: 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKF--INTPYPLDKYTVKNEISIMNQL 105
Query: 60 QGGTGIPN-VRWFGV--EGDYNVLVMDLL--GPSLEDLFNFCSRK---LSLKTVLMLADQ 111
P + + VL+++ L G +LF+ + + +S V+ Q
Sbjct: 106 HH----PKLINLHDAFEDKYEMVLILEFLSGG----ELFDRIAAEDYKMSEAEVINYMRQ 157
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENK 171
++ +H S +H DIKP+N + ++A+ V IIDFGLA K K
Sbjct: 158 ACEGLKHMHEHSIVHLDIKPENIMC-ETKKASSVKIIDFGLATKLNPDEIV--------K 208
Query: 172 NLTGTARYAS----MNTHLGIEQSRRDDLESLGYVLMYFL 207
T TA +A+ +G D+ ++G VL Y L
Sbjct: 209 VTTATAEFAAPEIVDREPVGFYT----DMWAIG-VLGYVL 243
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 4e-19
Identities = 48/226 (21%), Positives = 87/226 (38%), Gaps = 37/226 (16%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYR----- 57
+ +G G + + T +E A+K+ +V E + R
Sbjct: 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 72
Query: 58 ---ILQGGTGIPN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFNF-CSR-KLSLKTVLM 107
IL+ +G PN ++ E + LV DL+ G +LF++ + LS K
Sbjct: 73 EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKG----ELFDYLTEKVTLSEKETRK 128
Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPY 167
+ ++ + +H + +HRD+KP+N L L N + + DFG + +
Sbjct: 129 IMRALLEVICALHKLNIVHRDLKPENIL--LDDDMN-IKLTDFGFSCQLDPGEKL----- 180
Query: 168 RENKNLTGTARYAS---MNTHLGIEQSRRD---DLESLGYVLMYFL 207
+ + GT Y + + + D+ S G V+MY L
Sbjct: 181 ---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTG-VIMYTL 222
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 5e-19
Identities = 47/257 (18%), Positives = 95/257 (36%), Gaps = 64/257 (24%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-------------LENVKT------ 44
+G K+ +G +G GS+G++ + +T A+K NVK
Sbjct: 3 LIG-KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLR 61
Query: 45 --KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNF-CSRKLS 101
+H ++ +L +L +VM+ ++++ + ++
Sbjct: 62 RLRHKNVI---QLVDVLYNEE-----------KQKMYMVMEYCVCGMQEMLDSVPEKRFP 107
Query: 102 LKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161
+ Q+I+ +E++HS+ +H+DIKP N L L + I G+A+
Sbjct: 108 VCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLL--LTTGGT-LKISALGVAEALH---- 160
Query: 162 HQHIPYRENKNLT---GTARYAS------MNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
P+ + G+ + ++T G + D+ S G L G P
Sbjct: 161 ----PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKV----DIWSAGVTLYNITTGLYP 212
Query: 213 WQGLKAGTKKQKYEKIS 229
++G + +E I
Sbjct: 213 FEG---DNIYKLFENIG 226
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 6e-19
Identities = 34/188 (18%), Positives = 72/188 (38%), Gaps = 29/188 (15%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY---------ESKLYR 57
N+ ++IG G FG ++ G ++ VAIK + + E +
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 58 ILQGGTGIPN-VRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
L PN V+ +G+ + +VM+ + L + + L L +
Sbjct: 79 NLNH----PNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 116 VEFVHSKS--FLHRDIKPDNFLMGLGRRANQVY--IIDFGLAKKYRDTSTHQHIPYRENK 171
+E++ +++ +HRD++ N + V + DFGL+++ + +
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVS---------- 184
Query: 172 NLTGTARY 179
L G ++
Sbjct: 185 GLLGNFQW 192
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 6e-19
Identities = 46/228 (20%), Positives = 86/228 (37%), Gaps = 32/228 (14%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLL----YESKLYRILQGG 62
+ +G IG G FG++Y G + EVAI+L +++ + L E YR +
Sbjct: 33 EQLEIGELIGKGRFGQVYHGR---WHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRH- 88
Query: 63 TGIPN-VRWFGV--EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 118
N V + G + ++ L G +L + L + +A +++ + +
Sbjct: 89 ---ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGY 145
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK-KYRDTSTHQHIPYRENKNLTGTA 177
+H+K LH+D+K N G+ V I DFGL + + R G
Sbjct: 146 LHAKGILHKDLKSKNVFYDNGK----VVITDFGLFSISGVLQAGRREDKLRIQ---NGWL 198
Query: 178 RY---------ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL 216
+ + + S+ D+ +LG + P++
Sbjct: 199 CHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 6e-19
Identities = 43/180 (23%), Positives = 77/180 (42%), Gaps = 47/180 (26%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---------------- 45
+ +G + + +G GSFG++ L T+ +T ++VA+K + +
Sbjct: 5 KRHIGP-YIIRETLGEGSFGKVKLATHYKTQQKVALKFIS-RQLLKKSDMHMRVEREISY 62
Query: 46 -----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK- 99
HP ++ KLY ++ T I V+V++ G +LF++ K
Sbjct: 63 LKLLRHPHII---KLYDVITTPTDI-------------VMVIEYAG---GELFDYIVEKK 103
Query: 100 -LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158
++ Q+I +E+ H +HRD+KP+N L+ V I DFGL+ D
Sbjct: 104 RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLD---DNLNVKIADFGLSNIMTD 160
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 8e-19
Identities = 64/250 (25%), Positives = 99/250 (39%), Gaps = 40/250 (16%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY----ESKLYR 57
P V + L + +G G++GE+ L N T E VA+K+ + + E + +
Sbjct: 3 VPFVE-DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD-MKRAVDCPENIKKEICINK 60
Query: 58 ILQGGTGIPN-VRWFGV--EGDYNVLVMDLL--GPSLEDLFNFCSRK--LSLKTVLMLAD 110
+L N V+++G EG+ L ++ G +LF+ +
Sbjct: 61 MLNH----ENVVKFYGHRREGNIQYLFLEYCSGG----ELFDRIEPDIGMPEPDAQRFFH 112
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170
Q++ V ++H HRDIKP+N L L R N + I DFGLA +R + + +
Sbjct: 113 QLMAGVVYLHGIGITHRDIKPENLL--LDERDN-LKISDFGLATVFRYNNRERLL----- 164
Query: 171 KNLTGTARYA-----SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY 225
+ GT Y D+ S G VL L G LPW Q+Y
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQ--PSDSCQEY 218
Query: 226 EKISEKKVST 235
EKK
Sbjct: 219 SDWKEKKTYL 228
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 8e-19
Identities = 49/204 (24%), Positives = 72/204 (35%), Gaps = 33/204 (16%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLLYESKLYRILQ 60
R F + +G G FG ++ N + AIK L N + +++ E K L+
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 61 GGTGIPN-VRWFGVEGDYNV--------------LVMDLL-GPSLEDLFNFCSRKLSL-- 102
P VR+F + N + M L +L+D N
Sbjct: 62 H----PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117
Query: 103 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162
L + Q+ VEF+HSK +HRD+KP N + V + DFGL
Sbjct: 118 SVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT---MDDVVKVGDFGLVTAMDQDEEE 174
Query: 163 QHIPYRENKNLT-----GTARYAS 181
Q + GT Y S
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMS 198
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 9e-19
Identities = 51/197 (25%), Positives = 89/197 (45%), Gaps = 32/197 (16%)
Query: 1 MEP----RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESK-- 54
MEP +V + + +G ++GSG F + T E A K + S+
Sbjct: 2 MEPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE 61
Query: 55 LYR---ILQGGTGIPN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFNFCSRKLSL--KT 104
+ R IL+ N + V E +V L+++L+ G +LF+F ++K SL +
Sbjct: 62 IEREVSILRQVLH-HNVITLHDVYENRTDVVLILELVSGG----ELFDFLAQKESLSEEE 116
Query: 105 VLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN--QVYIIDFGLAKKYRDTSTH 162
Q+++ V ++H+K H D+KP+N ++ L + + +IDFGLA + D
Sbjct: 117 ATSFIKQILDGVNYLHTKKIAHFDLKPENIML-LDKNIPIPHIKLIDFGLAHEIEDGVEF 175
Query: 163 QHIPYRENKNLTGTARY 179
KN+ GT +
Sbjct: 176 --------KNIFGTPEF 184
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-18
Identities = 40/173 (23%), Positives = 75/173 (43%), Gaps = 21/173 (12%)
Query: 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKLYRILQGGTGIPN-V 68
+G G++G +Y G ++ +AIK + L E L++ L+ N V
Sbjct: 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKH----KNIV 82
Query: 69 RWFGVEGDYNVL--VMDLL-GPSLEDL--FNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
++ G + + M+ + G SL L + K + +T+ Q++ ++++H
Sbjct: 83 QYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ 142
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGT 176
+HRDIK DN L + + + I DFG +K+ + + TGT
Sbjct: 143 IVHRDIKGDNVL--INTYSGVLKISDFGTSKRLAGINPC-------TETFTGT 186
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 2e-18
Identities = 61/247 (24%), Positives = 99/247 (40%), Gaps = 45/247 (18%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLLYESKLYRI 58
+ + L IG GS+GE+ + T A K +E+V + E ++ +
Sbjct: 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVD----RFKQEIEIMKS 62
Query: 59 LQGGTGIPN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFNFCSRK--LSLKTVLMLADQ 111
L PN +R + E + ++ LVM+L G +LF K +
Sbjct: 63 LDH----PNIIRLYETFEDNTDIYLVMELCTGG----ELFERVVHKRVFRESDAARIMKD 114
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENK 171
+++ V + H + HRD+KP+NFL + + +IDFGLA +++ +
Sbjct: 115 VLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--------R 166
Query: 172 NLTGTARYAS---MNTHLGIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTKKQKYEK 227
GT Y S + G E D S G V+MY L G P+ T + K
Sbjct: 167 TKVGTPYYVSPQVLEGLYGPEC----DEWSAG-VMMYVLLCGYPPFSA---PTDSEVMLK 218
Query: 228 ISEKKVS 234
I E +
Sbjct: 219 IREGTFT 225
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 60/255 (23%), Positives = 106/255 (41%), Gaps = 61/255 (23%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----------LENVKT----- 44
+P +GN +RL + IG G+F ++ L +I T EVAIK L+ +
Sbjct: 10 EQPHIGN-YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIM 68
Query: 45 ---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSR--K 99
HP ++ KL+ +++ + L+M+ S ++F++ +
Sbjct: 69 KILNHPNIV---KLFEVIETEKTL-------------YLIMEYA--SGGEVFDYLVAHGR 110
Query: 100 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
+ K Q+++ V++ H K +HRD+K +N L L N + I DFG + ++
Sbjct: 111 MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLL--LDADMN-IKIADFGFSNEFTV- 166
Query: 160 STHQHIPYRENKNLT---GTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQG 215
L G YA+ G + D+ SLG +L + GSLP+ G
Sbjct: 167 ----------GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 216
Query: 216 LKAGTKKQKYEKISE 230
K+ E++
Sbjct: 217 ---QNLKELRERVLR 228
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-18
Identities = 39/170 (22%), Positives = 66/170 (38%), Gaps = 21/170 (12%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQLLYESKLYR--- 57
K+ IG G + + T E A+K+ V + R
Sbjct: 92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETH 151
Query: 58 ILQGGTGIPN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFNF-CSR-KLSLKTVLMLAD 110
IL+ G P+ + E + LV DL+ G +LF++ + LS K +
Sbjct: 152 ILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKG----ELFDYLTEKVALSEKETRSIMR 207
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160
++ V F+H+ + +HRD+KP+N L L + + DFG +
Sbjct: 208 SLLEAVSFLHANNIVHRDLKPENIL--LDDNMQ-IRLSDFGFSCHLEPGE 254
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-18
Identities = 64/253 (25%), Positives = 98/253 (38%), Gaps = 46/253 (18%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY----ESKLYR 57
P V + L + +G G++GE+ L N T E VA+K+ + + E + +
Sbjct: 3 VPFVE-DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD-MKRAVDCPENIKKEICINK 60
Query: 58 ILQGGTGIPN-VRWFGV--EGDYNVLVMDLLGPSLE-----DLFNFCSRK--LSLKTVLM 107
+L N V+++G EG+ L + E +LF+ +
Sbjct: 61 MLNH----ENVVKFYGHRREGNIQYLFL-------EYCSGGELFDRIEPDIGMPEPDAQR 109
Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPY 167
Q++ V ++H HRDIKP+N L L R N + I DFGLA +R + + +
Sbjct: 110 FFHQLMAGVVYLHGIGITHRDIKPENLL--LDERDN-LKISDFGLATVFRYNNRERLL-- 164
Query: 168 RENKNLTGTARYA-----SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK 222
+ GT Y D+ S G VL L G LPW
Sbjct: 165 ---NKMCGTLPYVAPELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQ--PSDSC 215
Query: 223 QKYEKISEKKVST 235
Q+Y EKK
Sbjct: 216 QEYSDWKEKKTYL 228
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 3e-18
Identities = 53/233 (22%), Positives = 99/233 (42%), Gaps = 41/233 (17%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLL----YESKLYRIL 59
+ +++ LG +G G E++L +++ + +VA+K+ L + + R
Sbjct: 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKV-----LRADLARDPSFYLRFRREA 63
Query: 60 QGGTGI--PNV-------RWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 109
Q + P + G +VM+ + G +L D+ + ++ K + +
Sbjct: 64 QNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVI 122
Query: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRE 169
+ F H +HRD+KP N ++ N V ++DFG+A+ D+ +
Sbjct: 123 ADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGN----SVTQ 175
Query: 170 NKNLTGTARYASMNTHLGIEQSR------RDDLESLGYVLMY-FLRGSLPWQG 215
+ GTA+Y S EQ+R R D+ SLG ++Y L G P+ G
Sbjct: 176 TAAVIGTAQYLSP------EQARGDSVDARSDVYSLG-CVLYEVLTGEPPFTG 221
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 3e-18
Identities = 45/189 (23%), Positives = 82/189 (43%), Gaps = 28/189 (14%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTG 64
V + + +G ++GSG F + T +E A K +K + ++
Sbjct: 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKF--IKKRRLSSSRRGVSREEIEREVN 60
Query: 65 I------PN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFNFCSRKLSL--KTVLMLADQ 111
I PN + + E +V L+++L+ G +LF+F + K SL Q
Sbjct: 61 ILREIRHPNIITLHDIFENKTDVVLILELVSGG----ELFDFLAEKESLTEDEATQFLKQ 116
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLM-GLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170
+++ V ++HSK H D+KP+N ++ ++ +IDFG+A K +
Sbjct: 117 ILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF-------- 168
Query: 171 KNLTGTARY 179
KN+ GT +
Sbjct: 169 KNIFGTPEF 177
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 4e-18
Identities = 46/190 (24%), Positives = 80/190 (42%), Gaps = 27/190 (14%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLLY-ESKLYRI 58
+ + + + ++G G+F + + T E A K+ + + + Q L E+++ R
Sbjct: 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 61
Query: 59 LQGGTGIPN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFNF-CSR-KLSLKTVLMLADQ 111
LQ PN VR + + LV DL+ G +LF +R S Q
Sbjct: 62 LQH----PNIVRLHDSIQEESFHYLVFDLVTGG----ELFEDIVAREFYSEADASHCIQQ 113
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENK 171
++ + + HS +HR++KP+N L+ + V + DFGLA + D+
Sbjct: 114 ILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--------H 165
Query: 172 NLTGTARYAS 181
GT Y S
Sbjct: 166 GFAGTPGYLS 175
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 4e-18
Identities = 43/209 (20%), Positives = 68/209 (32%), Gaps = 43/209 (20%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLLYESKL 55
M+ R +F KIGSG FG ++ AIK L + L
Sbjct: 5 MKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAH 64
Query: 56 YRILQGGTGIPN-VRWFG--VEGDYNVLVMDLL-GPSLEDLFNFCSRKLSL---KTVLML 108
+ Q + VR+F E D+ ++ + G SL D + R +S + L
Sbjct: 65 AVLGQ----HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL 120
Query: 109 ADQMINRVEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYII---------------DFGL 152
Q+ + ++HS S +H DIKP N F+ D G
Sbjct: 121 LLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180
Query: 153 AKKYRDTSTHQHIPYRENKNLTGTARYAS 181
+ G +R+ +
Sbjct: 181 VTRISSPQV-----------EEGDSRFLA 198
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 5e-18
Identities = 43/170 (25%), Positives = 76/170 (44%), Gaps = 23/170 (13%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLLYESKLYRILQ 60
FR+ +KIG G F E+Y + VA+K L + K + + E L + L
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARA-DCIKEIDLLKQLN 90
Query: 61 GGTGIPN-VRWFG--VEGDYNVLVMDLL-GPSLEDLFNFCSRKLSL---KTVLMLADQMI 113
PN ++++ +E + +V++L L + ++ L +TV Q+
Sbjct: 91 H----PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLC 146
Query: 114 NRVEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKKYRDTSTH 162
+ +E +HS+ +HRDIKP N F+ V + D GL + + +T
Sbjct: 147 SALEHMHSRRVMHRDIKPANVFIT----ATGVVKLGDLGLGRFFSSKTTA 192
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 5e-18
Identities = 51/280 (18%), Positives = 100/280 (35%), Gaps = 57/280 (20%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--------------LENVKT----- 44
+ K+ L IG GS+G + + QT AIK +E +KT
Sbjct: 23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLM 82
Query: 45 ---KHPQLL-----YESK---------------LYRILQGGTGIPNVRWFGVEGDYNVLV 81
HP + YE + L ++ V
Sbjct: 83 KKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142
Query: 82 MDLLGPSLEDLFNFCSRK----LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 137
+ ++ + K + + Q+ + + ++H++ HRDIKP+NFL
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLF- 201
Query: 138 LGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS--MNTHLGIEQSRRDD 195
++ ++ ++DFGL+K++ + ++ GT + + + + D
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTT---KAGTPYFVAPEVLNTTNESYGPKCD 258
Query: 196 LESLGYVLMYF-LRGSLPWQGLKAGTKKQKYEKISEKKVS 234
S G VL++ L G++P+ G ++ KK+
Sbjct: 259 AWSAG-VLLHLLLMGAVPFPG---VNDADTISQVLNKKLC 294
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 5e-18
Identities = 40/173 (23%), Positives = 71/173 (41%), Gaps = 38/173 (21%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--------ENVK--------TKHP 47
++ + IGSG+FG L + T E VA+K ENV+ +HP
Sbjct: 18 DSD-RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHP 76
Query: 48 QLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNF-CSR-KLSLKTV 105
++ + ++ T + ++M+ S +L+ C+ + S
Sbjct: 77 NIV---RFKEVILTPTHL-------------AIIMEYA--SGGELYERICNAGRFSEDEA 118
Query: 106 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158
Q+++ V + HS HRD+K +N L+ G A ++ I DFG +K
Sbjct: 119 RFFFQQLLSGVSYCHSMQICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVL 170
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 6e-18
Identities = 51/248 (20%), Positives = 90/248 (36%), Gaps = 43/248 (17%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-KTKHPQLLYESKLYR---ILQGGT 63
+ L IG G F + N +T ++ A+K+ +V K L L R I
Sbjct: 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICH-ML 83
Query: 64 GIPN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFNFCSRKLSLKTVLMLAD------QM 112
P+ V D + +V + + DL ++ V A Q+
Sbjct: 84 KHPHIVELLETYSSDGMLYMVFEFMDGA----DLCFEIVKRADAGFVYSEAVASHYMRQI 139
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN 172
+ + + H + +HRD+KP L+ + V + FG+A + +
Sbjct: 140 LEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE-------SGLVAGG 192
Query: 173 LTGTARYAS----MNTHLGIEQSRRDDLESLGYVLMYF-LRGSLP-WQGLKAGTKKQKYE 226
GT + + G D+ G V+++ L G LP + GTK++ +E
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPV----DVWGCG-VILFILLSGCLPFY-----GTKERLFE 242
Query: 227 KISEKKVS 234
I + K
Sbjct: 243 GIIKGKYK 250
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 7e-18
Identities = 44/189 (23%), Positives = 79/189 (41%), Gaps = 34/189 (17%)
Query: 4 RVGNKFRLGR-----KIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKLYR 57
G ++ R K+G G F ++L ++ N VA+K + K E KL +
Sbjct: 11 FKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQ 70
Query: 58 IL-------QGGTGIPNV----RWF---GVEGDYNVLVMDLLGPSLEDL---FNFCSRKL 100
+ + G ++ F G G + V+V ++LG +L L + R +
Sbjct: 71 RVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEH--RGI 128
Query: 101 SLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRR---ANQVYIIDFGLAKKY 156
L V ++ Q++ ++++H + +H DIKP+N LM + Q+ I D G A
Sbjct: 129 PLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--- 185
Query: 157 RDTSTHQHI 165
+H
Sbjct: 186 --CWYDEHY 192
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 9e-18
Identities = 49/226 (21%), Positives = 89/226 (39%), Gaps = 35/226 (15%)
Query: 3 PRVGNKFRLGRK-IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYR---I 58
R + ++L +G G+ + N+ T++E A+K+ K S+++R +
Sbjct: 8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIE-KQP---GHIRSRVFREVEM 63
Query: 59 LQGGTGIPN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLF-------NFCSRKLSLKTVL 106
L G N + E + LV + + G + +F + S
Sbjct: 64 LYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGG----SILSHIHKRRHFNELEAS----- 114
Query: 107 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166
++ + + ++F+H+K HRD+KP+N L + + V I DF L + I
Sbjct: 115 VVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174
Query: 167 YRENKNLTGTARYASMNTHLGIEQSRRD-----DLESLGYVLMYFL 207
E G+A Y + + DL SLG V++Y L
Sbjct: 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLG-VILYIL 219
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 9e-18
Identities = 47/189 (24%), Positives = 81/189 (42%), Gaps = 28/189 (14%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTG 64
V + + G ++GSG F + T + A K +K + + ++
Sbjct: 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKF--IKKRRTKSSRRGVSREDIEREVS 66
Query: 65 I------PN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFNFCSRKLSL--KTVLMLADQ 111
I PN + V E +V L+++L+ G +LF+F + K SL + Q
Sbjct: 67 ILKEIQHPNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQ 122
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMG-LGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170
++N V ++HS H D+KP+N ++ ++ IIDFGLA K +
Sbjct: 123 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF-------- 174
Query: 171 KNLTGTARY 179
KN+ GT +
Sbjct: 175 KNIFGTPEF 183
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 9e-18
Identities = 46/194 (23%), Positives = 83/194 (42%), Gaps = 36/194 (18%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESK--------- 54
+V + + +G ++GSG F + T E A K + +
Sbjct: 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSI 68
Query: 55 LYRILQGGTGIPN-VRWFGV--EGDYNVLVMDLL--GPSLEDLFNFCSRKLSL--KTVLM 107
L ++L PN + V VL+++L+ G +LF+F ++K SL +
Sbjct: 69 LRQVLH-----PNIITLHDVYENRTDVVLILELVSGG----ELFDFLAQKESLSEEEATS 119
Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN--QVYIIDFGLAKKYRDTSTHQHI 165
Q+++ V ++H+K H D+KP+N ++ L + + +IDFGLA + D
Sbjct: 120 FIKQILDGVNYLHTKKIAHFDLKPENIML-LDKNIPIPHIKLIDFGLAHEIEDGVEF--- 175
Query: 166 PYRENKNLTGTARY 179
KN+ GT +
Sbjct: 176 -----KNIFGTPEF 184
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-17
Identities = 41/180 (22%), Positives = 72/180 (40%), Gaps = 25/180 (13%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIP 66
+ + +G G+FG + ++VAIK +++ + E + + P
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAK--WRAKDVAIKQIESESERKAFIVELRQLSRVNH----P 61
Query: 67 N-VRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHS- 121
N V+ +G + LVM+ G SL ++ + + + Q V ++HS
Sbjct: 62 NIVKLYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 122 --KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
K+ +HRD+KP N L L + I DFG A + T N G+A +
Sbjct: 122 QPKALIHRDLKPPNLL--LVAGGTVLKICDFGTACDIQTHMT----------NNKGSAAW 169
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-17
Identities = 41/167 (24%), Positives = 69/167 (41%), Gaps = 24/167 (14%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKH-PQLLYESKLYRILQGG 62
K+ +KIG GSFG+ L + + + IK + + +K + E + ++
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH- 82
Query: 63 TGIPN-VRWFG--VEGDYNVLVMDLL--GPSLEDLFNFCSRK----LSLKTVLMLADQMI 113
PN V++ E +VMD G DLF + + +L Q+
Sbjct: 83 ---PNIVQYRESFEENGSLYIVMDYCEGG----DLFKRINAQKGVLFQEDQILDWFVQIC 135
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160
++ VH + LHRDIK N + + V + DFG+A+ T
Sbjct: 136 LALKHVHDRKILHRDIKSQNIFLT---KDGTVQLGDFGIARVLNSTV 179
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-17
Identities = 43/179 (24%), Positives = 80/179 (44%), Gaps = 44/179 (24%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT----- 44
++G+ + LG +G G+FG++ +G + T +VA+K + +K
Sbjct: 7 RVKIGH-YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNL 65
Query: 45 ---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK-- 99
+HP ++ KLY+++ T +VM+ + S +LF++ +
Sbjct: 66 KLFRHPHII---KLYQVISTPTDF-------------FMVMEYV--SGGELFDYICKHGR 107
Query: 100 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158
+ L Q+++ V++ H +HRD+KP+N L L N I DFGL+ D
Sbjct: 108 VEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVL--LDAHMN-AKIADFGLSNMMSD 163
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-17
Identities = 56/267 (20%), Positives = 98/267 (36%), Gaps = 41/267 (15%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKH-PQLLYESKLY 56
M R + + IG+GS+G + + K ++ L+ E L
Sbjct: 1 MPSRA-EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLL 59
Query: 57 RILQGGTGIPNV-----RWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRK---LSLKTVLM 107
R L+ PN+ R +VM+ G L + +++ L + VL
Sbjct: 60 RELKH----PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLR 115
Query: 108 LADQMINRVEFVHSKSF-----LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162
+ Q+ ++ H +S LHRD+KP N + V + DFGLA+ ++
Sbjct: 116 VMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD---GKQNVKLGDFGLARILNHDTSF 172
Query: 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQG-----L 216
K GT Y S + + + D+ SLG L+Y L P+ L
Sbjct: 173 -------AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLG-CLLYELCALMPPFTAFSQKEL 224
Query: 217 KAGTKKQKYEKISEKKVSTSIEALCRG 243
++ K+ +I + S + +
Sbjct: 225 AGKIREGKFRRIPY-RYSDELNEIITR 250
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 40/166 (24%), Positives = 68/166 (40%), Gaps = 17/166 (10%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYR---IL 59
R +++L ++G G+F + + +E A + + TK KL R I
Sbjct: 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMI--INTKKLSARDHQKLEREARIC 64
Query: 60 QGGTGIPN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFNF-CSR-KLSLKTVLMLADQM 112
+ PN VR + + L+ DL+ G +LF +R S Q+
Sbjct: 65 R-LLKHPNIVRLHDSISEEGHHYLIFDLVTGG----ELFEDIVAREYYSEADASHCIQQI 119
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158
+ V H +HR++KP+N L+ + V + DFGLA +
Sbjct: 120 LEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-17
Identities = 43/171 (25%), Positives = 75/171 (43%), Gaps = 19/171 (11%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQLLYESKLYR 57
+ + + + ++G G+F + + T E A K+ N K +L E+++ R
Sbjct: 24 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 83
Query: 58 ILQGGTGIPN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFNF-CSR-KLSLKTVLMLAD 110
LQ PN VR + + LV DL+ G +LF +R S
Sbjct: 84 KLQH----PNIVRLHDSIQEESFHYLVFDLVTGG----ELFEDIVAREFYSEADASHCIQ 135
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161
Q++ + + HS +HR++KP+N L+ + V + DFGLA + D+
Sbjct: 136 QILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 186
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 3e-17
Identities = 42/166 (25%), Positives = 76/166 (45%), Gaps = 19/166 (11%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYR---IL 59
+ F +GSG+F E++L T + A+K +K +S L +L
Sbjct: 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKC--IKKS--PAFRDSSLENEIAVL 60
Query: 60 QGGTGIPN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFNF-CSR-KLSLKTVLMLADQM 112
+ N V + E + LVM L+ G +LF+ R + K ++ Q+
Sbjct: 61 KKIKH-ENIVTLEDIYESTTHYYLVMQLVSGG----ELFDRILERGVYTEKDASLVIQQV 115
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158
++ V+++H +HRD+KP+N L +++ I DFGL+K ++
Sbjct: 116 LSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 4e-17
Identities = 51/212 (24%), Positives = 87/212 (41%), Gaps = 39/212 (18%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPN-VR 69
+ +G GSF + ++N+ A+K+ + K E ++ +G PN V+
Sbjct: 15 KDKPLGEGSFSICRKCVHKKSNQAFAVKIIS-KRMEANTQKEITALKLCEGH---PNIVK 70
Query: 70 WFGV-EGDYNV-LVMDLL--GPSLEDLF-------NFCSRKLSLKTVLMLADQMINRVEF 118
V + LVM+LL G +LF +F + S + ++++ V
Sbjct: 71 LHEVFHDQLHTFLVMELLNGG----ELFERIKKKKHFSETEAS-----YIMRKLVSAVSH 121
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT---G 175
+H +HRD+KP+N L ++ IIDFG A+ +N+ L
Sbjct: 122 MHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP----------DNQPLKTPCF 171
Query: 176 TARYASMNTHLGIEQSRRDDLESLGYVLMYFL 207
T YA+ DL SLG V++Y +
Sbjct: 172 TLHYAAPELLNQNGYDESCDLWSLG-VILYTM 202
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 57/248 (22%), Positives = 94/248 (37%), Gaps = 40/248 (16%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGG 62
+ + + + IG GS+ + TN E A+K+ + E + IL
Sbjct: 18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKI--IDKSKRDPTEEIE---ILLRY 72
Query: 63 TGIPN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFN--FCSRKLSLKTVLMLADQMINR 115
PN + V + V +V +L+ G +L + + S + + +
Sbjct: 73 GQHPNIITLKDVYDDGKYVYVVTELMKGG----ELLDKILRQKFFSEREASAVLFTITKT 128
Query: 116 VEFVHSKSFLHRDIKPDNFLM-GLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174
VE++H++ +HRD+KP N L + I DFG AK+ R EN L
Sbjct: 129 VEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA----------ENGLLM 178
Query: 175 ---GTARYAS----MNTHLGIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTKKQKYE 226
TA + + D+ SLG VL+Y L G P+ T ++
Sbjct: 179 TPCYTANFVAPEVLERQGYDAAC----DIWSLG-VLLYTMLTGYTPFANGPDDTPEEILA 233
Query: 227 KISEKKVS 234
+I K S
Sbjct: 234 RIGSGKFS 241
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 44/179 (24%), Positives = 82/179 (45%), Gaps = 44/179 (24%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT----- 44
++G+ + LG +G G+FG++ +G + T +VA+K + ++
Sbjct: 12 RVKIGH-YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNL 70
Query: 45 ---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK-- 99
+HP ++ KLY+++ + I +VM+ + S +LF++ +
Sbjct: 71 KLFRHPHII---KLYQVISTPSDI-------------FMVMEYV--SGGELFDYICKNGR 112
Query: 100 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158
L K L Q+++ V++ H +HRD+KP+N L L N I DFGL+ D
Sbjct: 113 LDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVL--LDAHMN-AKIADFGLSNMMSD 168
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-16
Identities = 52/264 (19%), Positives = 92/264 (34%), Gaps = 54/264 (20%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIP 66
N++ L +IG GS+G + L N N A+K+ + K K L+ ++ R P
Sbjct: 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLS-KKK---LIRQAGFPRRPPPRGTRP 68
Query: 67 NVRWFGVEGDY-----------------NVL----VMDLLGPS-----LE-----DLFNF 95
NV+ V+D E +
Sbjct: 69 APGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV 128
Query: 96 CSR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+ LS +I +E++H + +HRDIKP N L+G + I DFG++
Sbjct: 129 PTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG---EDGHIKIADFGVSN 185
Query: 155 KYRDTSTHQHIPYRENKNLTGTARYAS----MNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
+++ + N GT + + T + D+ ++G L F+ G
Sbjct: 186 EFKGSDALLS-------NTVGTPAFMAPESLSETRKIFS-GKALDVWAMGVTLYCFVFGQ 237
Query: 211 LPWQGLKAGTKKQKYEKISEKKVS 234
P+ + KI + +
Sbjct: 238 CPFMD---ERIMCLHSKIKSQALE 258
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-16
Identities = 40/187 (21%), Positives = 74/187 (39%), Gaps = 22/187 (11%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHP-QLLYESKLYRILQGGTG 64
+ G +G G FG+ T+ +T E + +K L + L E K+ R L+
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEH--- 66
Query: 65 IPN-VRWFGV---EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
PN +++ GV + N + + + G +L + + + A + + + ++
Sbjct: 67 -PNVLKFIGVLYKDKRLN-FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL 124
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN------- 172
HS + +HRD+ N L+ V + DFGLA+ D T K
Sbjct: 125 HSMNIIHRDLNSHNCLVR---ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181
Query: 173 LTGTARY 179
+ G +
Sbjct: 182 VVGNPYW 188
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 47/200 (23%), Positives = 80/200 (40%), Gaps = 53/200 (26%)
Query: 4 RVGNKFRLGRK--IGSGSFGEIYLGTNIQTNEEVAIKL---------ENVKT-------- 44
V + + + + +G G FG+++ T ++A K+ E VK
Sbjct: 84 AVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL 143
Query: 45 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRK--- 99
H L+ +LY + I VLVM+ + G +LF+ +
Sbjct: 144 DHANLI---QLYDAFESKNDI-------------VLVMEYVDGG----ELFDRIIDESYN 183
Query: 100 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
L+ ++ Q+ + +H LH D+KP+N L + R A Q+ IIDFGLA++Y+
Sbjct: 184 LTELDTILFMKQICEGIRHMHQMYILHLDLKPENILC-VNRDAKQIKIIDFGLARRYKPR 242
Query: 160 STHQHIPYRENKNLTGTARY 179
K GT +
Sbjct: 243 EKL--------KVNFGTPEF 254
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-16
Identities = 39/194 (20%), Positives = 64/194 (32%), Gaps = 47/194 (24%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKL----------------ENVKTKHPQLLYESK 54
L +G G +GE++ G+ E VA+K+ V +H +L
Sbjct: 12 LLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENIL---G 66
Query: 55 LYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMI 113
W L+ SL D L + L + +
Sbjct: 67 FIASDMTSRHSSTQLW---------LITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIA 115
Query: 114 NRVEFVHSKSF--------LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165
+ + +H + F HRD+K N L+ ++ Q I D GLA + ++ +
Sbjct: 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQCCIADLGLAVMHSQSTNQLDV 172
Query: 166 PYRENKNLTGTARY 179
N GT RY
Sbjct: 173 G---NNPRVGTKRY 183
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 3e-16
Identities = 47/194 (24%), Positives = 76/194 (39%), Gaps = 47/194 (24%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKL----------------ENVKTKHPQLLYESK 54
+ ++IG G +GE+++G E+VA+K+ + V +H +L
Sbjct: 41 MVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENIL---G 95
Query: 55 LYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMI 113
GTG + L+ D SL D S L K++L LA +
Sbjct: 96 FIAADIKGTGSWTQLY---------LITDYHENGSLYDYLK--STTLDAKSMLKLAYSSV 144
Query: 114 NRVEFVHSKSF--------LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165
+ + +H++ F HRD+K N L+ ++ I D GLA K+ + I
Sbjct: 145 SGLCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVKFISDTNEVDI 201
Query: 166 PYRENKNLTGTARY 179
P GT RY
Sbjct: 202 P---PNTRVGTKRY 212
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 3e-16
Identities = 39/164 (23%), Positives = 80/164 (48%), Gaps = 12/164 (7%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKLYRILQGGT 63
+ ++L RK+G G + E++ NI NE+V +K L+ VK K ++ E K+ L+GG
Sbjct: 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK--KIKREIKILENLRGGP 91
Query: 64 ---GIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
+ ++ V ++ + + L+ + L+ + +++ +++ H
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH 147
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164
S +HRD+KP N ++ R ++ +ID+GLA+ Y +
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFYHPGQEYNV 189
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 4e-16
Identities = 39/167 (23%), Positives = 73/167 (43%), Gaps = 30/167 (17%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKLYRILQGGT 63
V ++ + + IG GSFG++ + + ++ VA+K + N K H Q E ++ L+
Sbjct: 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRK-- 152
Query: 64 GIPNVRWFGVEGDYNV--------------LVMDLLGPSLEDLF---NFCSRKLSLKTVL 106
+ NV + +LL +L +L F + SL V
Sbjct: 153 -------QDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKF--QGFSLPLVR 203
Query: 107 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
A ++ ++ +H +H D+KP+N L+ R + + +IDFG +
Sbjct: 204 KFAHSILQCLDALHKNRIIHCDLKPENILLKQQGR-SGIKVIDFGSS 249
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 6e-16
Identities = 42/151 (27%), Positives = 68/151 (45%), Gaps = 9/151 (5%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYES--KLYRILQGGTGI 65
F R+IG GSFG +Y +++ +E VAIK + K ++ K R LQ
Sbjct: 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH- 113
Query: 66 PN-VRWFG--VEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
PN +++ G + LVM+ S DL + L + + + + ++HS
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 173
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
+ +HRD+K N L+ V + DFG A
Sbjct: 174 NMIHRDVKAGNILLSE---PGLVKLGDFGSA 201
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 6e-16
Identities = 43/185 (23%), Positives = 77/185 (41%), Gaps = 29/185 (15%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPN-VR 69
L IG G FGE++ G EEVA+K+ + + + E+++Y+ + N +
Sbjct: 46 LQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER-SWFREAEIYQTVMLRH--ENILG 100
Query: 70 WFGVEGDYNV------LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
+ + N LV D SL D N ++++ ++ LA + + +H +
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLHME 158
Query: 123 --------SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174
+ HRD+K N L+ ++ I D GLA ++ + I +
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIA---PNHRV 212
Query: 175 GTARY 179
GT RY
Sbjct: 213 GTKRY 217
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 7e-16
Identities = 38/231 (16%), Positives = 74/231 (32%), Gaps = 52/231 (22%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----------------ENVKTKHPQLL 50
+ +L IG G +G +Y G+ VA+K+ +H +
Sbjct: 13 DNLKLLELIGRGRYGAVYKGS--LDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIA 70
Query: 51 YESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 109
+ + T + + LVM+ SL + + LA
Sbjct: 71 ---RFIVGDERVTADGRMEYL--------LVMEYYPNGSLXKYLS--LHTSDWVSSCRLA 117
Query: 110 DQMINRVEFVHS---------KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160
+ + ++H+ + HRD+ N L+ + I DFGL+ +
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTCVISDFGLSMRLTGNR 174
Query: 161 THQHIPY-RENKNLTGTARY-------ASMNTHLGIEQSRRDDLESLGYVL 203
+ + GT RY ++N ++ D+ +LG +
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIY 225
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 42/260 (16%), Positives = 93/260 (35%), Gaps = 51/260 (19%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKLYRILQGGTGI 65
N +R+ R + G F +I L N+ A+K E + + +S +I
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 66 --------------PN-VRWFGVEGDYN--VLVMDLLGPSLEDLFNF----------CSR 98
+ G+ +Y+ ++ + + + + F +
Sbjct: 89 DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYM--ENDSILKFDEYFFVLDKNYTC 146
Query: 99 KLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157
+ ++ + + ++N ++H+ K+ HRD+KP N LM + +V + DFG ++
Sbjct: 147 FIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD---KNGRVKLSDFGESEYMV 203
Query: 158 DTSTHQHIPYRENKNLTGTARYAS--MNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQ 214
D GT + ++ + D+ SLG + +Y +P+
Sbjct: 204 DKKIK---------GSRGTYEFMPPEFFSNESSYNGAKVDIWSLG-ICLYVMFYNVVPFS 253
Query: 215 GLKAGTKKQKYEKISEKKVS 234
+ + + I K +
Sbjct: 254 L--KISLVELFNNIRTKNIE 271
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 1e-15
Identities = 40/167 (23%), Positives = 69/167 (41%), Gaps = 17/167 (10%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQL-LYESKLYRILQGG 62
K+ KIG GS+G ++ N T + VAIK ++ L E ++ + L+
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH- 61
Query: 63 TGIPN-VRWFGVEGDYN--VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
PN V V LV + ++ + R + V + Q + V F
Sbjct: 62 ---PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFC 118
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR---DTSTHQ 163
H + +HRD+KP+N L+ + + + + DFG A+ D +
Sbjct: 119 HKHNCIHRDVKPENILIT---KHSVIKLCDFGFARLLTGPSDYYDDE 162
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-15
Identities = 42/192 (21%), Positives = 79/192 (41%), Gaps = 37/192 (19%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT-NIQTNEEVAIKL------ENVKTKHPQLLYESKLYRIL 59
+ L IG G FG++Y +EVA+K E++ + E+KL+ +L
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFWI---GDEVAVKAARHDPDEDISQTIENVRQEAKLFAML 63
Query: 60 QGGTGIPN-VRWFGV--EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
+ PN + GV + LVM+ G L + + +++ ++ A Q+
Sbjct: 64 KH----PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARG 117
Query: 116 VEFVHSK---SFLHRDIKPDNFLMGLGRRANQVY-----IIDFGLAKKYRDTSTHQHIPY 167
+ ++H + +HRD+K N L+ + I DFGLA+++ T+
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK------ 171
Query: 168 RENKNLTGTARY 179
+ G +
Sbjct: 172 ---MSAAGAYAW 180
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-15
Identities = 39/156 (25%), Positives = 75/156 (48%), Gaps = 11/156 (7%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPN 67
F + K+G GS+G +Y + +T + VAIK V++ +++ E I+Q P+
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKE---ISIMQQCDS-PH 85
Query: 68 -VRWFG--VEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
V+++G + +VM+ S+ D+ ++ L+ + + + +E++H
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR 145
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
+HRDIK N L+ + DFG+A + DT
Sbjct: 146 KIHRDIKAGNILLN---TEGHAKLADFGVAGQLTDT 178
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 39/184 (21%), Positives = 72/184 (39%), Gaps = 23/184 (12%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGG 62
+ + F + ++G G+ +Y T + A+K+ + E + L
Sbjct: 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSH- 107
Query: 63 TGIPN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFNF-CSR-KLSLKTVLMLADQMINR 115
PN ++ + E + LV++L+ G +LF+ + S + Q++
Sbjct: 108 ---PNIIKLKEIFETPTEISLVLELVTGG----ELFDRIVEKGYYSERDAADAVKQILEA 160
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175
V ++H +HRD+KP+N L + I DFGL+K K + G
Sbjct: 161 VAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM--------KTVCG 212
Query: 176 TARY 179
T Y
Sbjct: 213 TPGY 216
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 75.2 bits (186), Expect = 2e-15
Identities = 44/176 (25%), Positives = 77/176 (43%), Gaps = 35/176 (19%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHP-------QLLYESK-- 54
K+ KIG G++G ++ N +T+E VA+K L++ P LL E K
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 55 ----LYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLAD 110
L+ +L + LV + L+ F+ C+ L + V
Sbjct: 62 NIVRLHDVLHSDKKL-------------TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLF 108
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD---TSTHQ 163
Q++ + F HS++ LHRD+KP N L+ R ++ + +FGLA+ + + +
Sbjct: 109 QLLKGLGFCHSRNVLHRDLKPQNLLIN---RNGELKLANFGLARAFGIPVRCYSAE 161
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-15
Identities = 35/153 (22%), Positives = 66/153 (43%), Gaps = 15/153 (9%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPN-VR 69
+ +G G G++ N +T E+ A+K + P+ E +L+ P+ VR
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALK---MLQDCPKARREVELHWRASQC---PHIVR 75
Query: 70 WFGV-----EGDYNV-LVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
V G + +VM+ L G + + + + + + + ++++HS
Sbjct: 76 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 135
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+ HRD+KP+N L R + + DFG AK
Sbjct: 136 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-15
Identities = 48/241 (19%), Positives = 76/241 (31%), Gaps = 56/241 (23%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-----------EN-----VKTKHPQLL 50
+L G FG ++ NE VA+K+ E KH +L
Sbjct: 24 MPLQLLEVKARGRFGCVWKAQ--LLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENIL 81
Query: 51 YESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 109
+ + GT + W L+ SL D + +S + +A
Sbjct: 82 ---QFIGAEKRGTSVDVDLW---------LITAFHEKGSLSDFLK--ANVVSWNELCHIA 127
Query: 110 DQMINRVEFVHSKSF----------LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
+ M + ++H HRDIK N L+ + I DFGLA K+
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL---KNNLTACIADFGLALKFEAG 184
Query: 160 STHQHIPYRENKNLTGTARY-----ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ 214
+ + GT RY + + R D+ ++G VL
Sbjct: 185 KSAG-----DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239
Query: 215 G 215
G
Sbjct: 240 G 240
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-15
Identities = 47/180 (26%), Positives = 72/180 (40%), Gaps = 21/180 (11%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLLYESKLYRIL 59
+ + L IGSG+ + E+VAIK LE +T +LL E +
Sbjct: 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC 70
Query: 60 QGGTGIPNV-RWFG--VEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQM--I 113
PN+ ++ V D LVM LL G S+ D+ K K+ ++ + I
Sbjct: 71 HH----PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126
Query: 114 NR-----VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYR 168
R +E++H +HRD+K N L+G V I DFG++ R
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVSAFLATGGDITRNKVR 183
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 2e-15
Identities = 39/179 (21%), Positives = 66/179 (36%), Gaps = 41/179 (22%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LEN------------VKT----KHP 47
K+ +G GS+G + N T VAIK + +K +H
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 48 QLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLM 107
L+ L + + LV + + ++ D L + V
Sbjct: 85 NLV---NLLEVCKKKKRW-------------YLVFEFVDHTILDDLELFPNGLDYQVVQK 128
Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR---DTSTHQ 163
Q+IN + F HS + +HRDIKP+N L+ ++ V + DFG A+ + +
Sbjct: 129 YLFQIINGIGFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTLAAPGEVYDDE 184
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 3e-15
Identities = 43/188 (22%), Positives = 67/188 (35%), Gaps = 48/188 (25%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKT--------------- 44
++ +G G F +Y + TN+ VAIK L +
Sbjct: 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKL 65
Query: 45 ----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKL 100
HP ++ L + I LV D + LE + S L
Sbjct: 66 LQELSHPNII---GLLDAFGHKSNI-------------SLVFDFMETDLEVIIKDNSLVL 109
Query: 101 SLKTV--LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158
+ + ML + +E++H LHRD+KP+N L+ + + DFGLAK +
Sbjct: 110 TPSHIKAYML--MTLQGLEYLHQHWILHRDLKPNNLLLD---ENGVLKLADFGLAKSFGS 164
Query: 159 ---TSTHQ 163
THQ
Sbjct: 165 PNRAYTHQ 172
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 4e-15
Identities = 38/178 (21%), Positives = 72/178 (40%), Gaps = 40/178 (22%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVA---IKLEN-----------VKT----KHPQ 48
+ K+G G++ +Y G + T+ VA I+LE+ V KH
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 49 LLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLML 108
++ L+ I+ + LV + L L+ + C +++ V +
Sbjct: 62 IV---TLHDIIHTEKSL-------------TLVFEYLDKDLKQYLDDCGNIINMHNVKLF 105
Query: 109 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD---TSTHQ 163
Q++ + + H + LHRD+KP N L+ ++ + DFGLA+ T ++
Sbjct: 106 LFQLLRGLAYCHRQKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPTKTYDNE 160
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 5e-15
Identities = 33/165 (20%), Positives = 71/165 (43%), Gaps = 16/165 (9%)
Query: 4 RVGNKFRLGRK-IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGG 62
V + ++L ++ +G G G++ + +T ++ A+K + P+ E + GG
Sbjct: 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALK---LLYDSPKARQEVDHHWQASGG 81
Query: 63 TGIPN-VRWFGV-----EGDYNV-LVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMI 113
P+ V V G + ++M+ + G + + + + + +
Sbjct: 82 ---PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIG 138
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158
++F+HS + HRD+KP+N L + + + DFG AK+
Sbjct: 139 TAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ 183
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 5e-15
Identities = 40/186 (21%), Positives = 81/186 (43%), Gaps = 30/186 (16%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT-NIQTNEEVAIKLENVKTKHPQLL----YESKLYRILQG 61
+ KIG+GSFG ++ + +VA+K+ + H + + E + + L+
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEWH---GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH 93
Query: 62 GTGIPN-VRWFGV--EGDYNVLVMDLL-GPSLEDLF--NFCSRKLSLKTVLMLADQMINR 115
PN V + G + +V + L SL L + +L + L +A +
Sbjct: 94 ----PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 149
Query: 116 VEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNL 173
+ ++H+++ +HR++K N L+ + V + DFGL++ T + +K+
Sbjct: 150 MNYLHNRNPPIVHRNLKSPNLLVD---KKYTVKVCDFGLSRLKAST-------FLSSKSA 199
Query: 174 TGTARY 179
GT +
Sbjct: 200 AGTPEW 205
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 7e-15
Identities = 37/156 (23%), Positives = 71/156 (45%), Gaps = 9/156 (5%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPN 67
+ + ++G G+FG++Y N +T A K+ K++ +L IL P
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE-EELEDYIVEIEILATCDH-PY 77
Query: 68 -VRWFG--VEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
V+ G ++++ G +++ + R L+ + ++ QM+ + F+HSK
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR 137
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
+HRD+K N LM + + DFG++ K T
Sbjct: 138 IIHRDLKAGNVLMT---LEGDIRLADFGVSAKNLKT 170
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 7e-15
Identities = 35/157 (22%), Positives = 67/157 (42%), Gaps = 15/157 (9%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPN-VR 69
+ +G G G++ N +T E+ A+K + P+ E +L+ P+ VR
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALK---MLQDCPKARREVELHWRASQC---PHIVR 119
Query: 70 WFGV-----EGDYNV-LVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
V G + +VM+ L G + + + + + + + ++++HS
Sbjct: 120 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 179
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158
+ HRD+KP+N L R + + DFG AK+
Sbjct: 180 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 8e-15
Identities = 44/173 (25%), Positives = 70/173 (40%), Gaps = 30/173 (17%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLLYESKLYRIL 59
+ + + IG+GSFG +Y + E VAIK L++ + K E ++ R L
Sbjct: 49 DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK----NRELQIMRKL 104
Query: 60 QGGTGIPNV----RWFGVEGD-----YNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLAD 110
N+ +F G+ Y LV+D + E ++ K L +
Sbjct: 105 DH----CNIVRLRYFFYSSGEKKDEVYLNLVLDYVP---ETVYRVARHYSRAKQTLPVIY 157
Query: 111 ------QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157
Q+ + ++HS HRDIKP N L L + + DFG AK+
Sbjct: 158 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQLV 208
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 36/165 (21%), Positives = 74/165 (44%), Gaps = 16/165 (9%)
Query: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGI 65
F L +G+G++G++Y G +++T + AIK+ +V + + + +L+ +
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEI--KQEINMLKKYSHH 80
Query: 66 PN-VRWFG--------VEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMIN 114
N ++G D LVM+ S+ DL L + + + +++
Sbjct: 81 RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILR 140
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
+ +H +HRDIK N L+ +V ++DFG++ + T
Sbjct: 141 GLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRT 182
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 1e-14
Identities = 38/206 (18%), Positives = 81/206 (39%), Gaps = 14/206 (6%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKLYRILQGG--- 62
++ + RK+G G F ++L +IQ + VA+K +++ + L E +L + ++
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPN 96
Query: 63 -TGIPNVR----WF---GVEGDYNVLVMDLLGPSLEDL-FNFCSRKLSLKTVLMLADQMI 113
V F GV G + +V ++LG L + L L V + Q++
Sbjct: 97 DPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVL 156
Query: 114 NRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN 172
++++H+K +H DIKP+N L+ + + + + ++
Sbjct: 157 QGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216
Query: 173 LTGTARYASMNTHLGIEQSRRDDLES 198
+ + + DL +
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGN 242
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 1e-14
Identities = 45/180 (25%), Positives = 75/180 (41%), Gaps = 30/180 (16%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVK----------------TKHP 47
+K+ KIG G+FGE++ + +T ++VA+K +EN K KH
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 76
Query: 48 QLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLM 107
++ L I + N + Y LV D L L + K +L +
Sbjct: 77 NVV---NLIEICRTKASPYNRCKGSI---Y--LVFDFCEHDLAGLLSNVLVKFTLSEIKR 128
Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPY 167
+ ++N + ++H LHRD+K N L+ R + + DFGLA+ + Q Y
Sbjct: 129 VMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNSQPNRY 185
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-14
Identities = 41/157 (26%), Positives = 78/157 (49%), Gaps = 10/157 (6%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPN- 67
F KIG GSFGE++ G + +T + VAIK+ +++ ++ + +L P
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYV 82
Query: 68 VRWFG--VEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
+++G ++ ++M+ L G S DL L + + +++ ++++HS+
Sbjct: 83 TKYYGSYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKK 140
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161
+HRDIK N L+ +V + DFG+A + DT
Sbjct: 141 IHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQI 174
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 2e-14
Identities = 44/177 (24%), Positives = 69/177 (38%), Gaps = 36/177 (20%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHP-------QLLYESK-- 54
F+ KIG G++G +Y N T E VA+K L+ P LL E
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 55 ----LYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLA 109
L ++ + LV + L L+ + + + L +
Sbjct: 63 NIVKLLDVIHTENKL-------------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 109
Query: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD---TSTHQ 163
Q++ + F HS LHRD+KP N L+ + + DFGLA+ + T TH+
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHE 163
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 45/181 (24%), Positives = 79/181 (43%), Gaps = 41/181 (22%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LEN------------VKT----KHP 47
+++R K+G G++GE+Y + TNE VAIK LE+ V +H
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHR 93
Query: 48 QLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLM 107
++ +L ++ + L+ + L+ + +S++ +
Sbjct: 94 NII---ELKSVIHHNHRL-------------HLIFEYAENDLKKYMDKN-PDVSMRVIKS 136
Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN--QVYIIDFGLAKKYRD---TSTH 162
Q+IN V F HS+ LHRD+KP N L+ + + + I DFGLA+ + TH
Sbjct: 137 FLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH 196
Query: 163 Q 163
+
Sbjct: 197 E 197
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 71.4 bits (176), Expect = 5e-14
Identities = 43/168 (25%), Positives = 72/168 (42%), Gaps = 22/168 (13%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTKHPQL----LYESKLYRILQGGTGIP 66
+IG G++G +Y + + VA +++ N L + E L R L+ P
Sbjct: 16 EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEH-P 74
Query: 67 N-VRWFGV------EGDYNV-LVMDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVE 117
N VR V + + V LV + + L + L +T+ L Q + ++
Sbjct: 75 NVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLD 134
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD--TSTHQ 163
F+H+ +HRD+KP+N L+ V + DFGLA+ Y T
Sbjct: 135 FLHANCIVHRDLKPENILVT---SGGTVKLADFGLARIYSYQMALTPV 179
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 70.6 bits (174), Expect = 7e-14
Identities = 48/179 (26%), Positives = 73/179 (40%), Gaps = 42/179 (23%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVK-----T-----------KHP 47
K+ KIG G++G +Y N E A+K LE T KH
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 48 QLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLM 107
++ KLY ++ + VLV + L L+ L + C L T
Sbjct: 61 NIV---KLYDVIHTKKRL-------------VLVFEHLDQDLKKLLDVCEGGLESVTAKS 104
Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD---TSTHQ 163
Q++N + + H + LHRD+KP N L+ R ++ I DFGLA+ + TH+
Sbjct: 105 FLLQLLNGIAYCHDRRVLHRDLKPQNLLIN---REGELKIADFGLARAFGIPVRKYTHE 160
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 8e-14
Identities = 45/164 (27%), Positives = 75/164 (45%), Gaps = 22/164 (13%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKLYRILQGGT 63
+++ + IG GSFG++ + E VAIK ++N K Q E +L ++
Sbjct: 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHD 111
Query: 64 G------IPNVRWFGVEGDYN---VLVMDLLGPSLEDL---FNFCSRKLSLKTVLMLADQ 111
+ R F + LV ++L +L DL NF R +SL A Q
Sbjct: 112 TEMKYYIVHLKRHF----MFRNHLCLVFEMLSYNLYDLLRNTNF--RGVSLNLTRKFAQQ 165
Query: 112 MINRVEFVHSK--SFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
M + F+ + S +H D+KP+N L+ +R + + I+DFG +
Sbjct: 166 MCTALLFLATPELSIIHCDLKPENILLCNPKR-SAIKIVDFGSS 208
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 9e-14
Identities = 57/262 (21%), Positives = 96/262 (36%), Gaps = 74/262 (28%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT--------KH 46
+ F + R IG GSFG++ + T + A+K + NV +H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 47 P---QLLY----ESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCS 97
P L Y E ++ +V+DLL G DL
Sbjct: 75 PFLVNLWYSFQDEEDMF-----------------------MVVDLLLGG----DLRYHLQ 107
Query: 98 R--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155
+ +TV + +++ ++++ ++ +HRD+KPDN L+ V+I DF +A
Sbjct: 108 QNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLD---EHGHVHITDFNIAAM 164
Query: 156 YRDTSTHQHIPYRENKNLTGTARYAS---MNTHLGIEQSRRDDLESLGYVLMY-FLRGSL 211
+ + GT Y + ++ G S D SLG V Y LRG
Sbjct: 165 LPRETQI--------TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLG-VTAYELLRGRR 215
Query: 212 PWQGLKAGTKKQKYEKISEKKV 233
P+ + + K+ V
Sbjct: 216 PYHIRSSTSSKEIVHTFETTVV 237
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 9e-14
Identities = 37/176 (21%), Positives = 66/176 (37%), Gaps = 36/176 (20%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTKHP-------QLLYESK-- 54
K++ K+G G++G +Y + VA I+L+ P LL E
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHP 79
Query: 55 ----LYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLAD 110
L ++ + LV + + L+ + + L + +
Sbjct: 80 NIVSLIDVIHSERCL-------------TLVFEFMEKDLKKVLDENKTGLQDSQIKIYLY 126
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD---TSTHQ 163
Q++ V H LHRD+KP N L+ + + DFGLA+ + + TH+
Sbjct: 127 QLLRGVAHCHQHRILHRDLKPQNLLIN---SDGALKLADFGLARAFGIPVRSYTHE 179
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 43/169 (25%), Positives = 78/169 (46%), Gaps = 23/169 (13%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----LENVKTKHPQLLYESKLYRILQGGTG 64
+ +IG GSF +Y G + +T EVA + K++ + E+++ + LQ
Sbjct: 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH--- 84
Query: 65 IPN-VRWFGVEGDYN------VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116
PN VR++ VLV +L+ +L+ + + +K + Q++ +
Sbjct: 85 -PNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGL 142
Query: 117 EFVHSKS--FLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKKYRDTSTH 162
+F+H+++ +HRD+K DN F+ G V I D GLA R +
Sbjct: 143 QFLHTRTPPIIHRDLKCDNIFITG---PTGSVKIGDLGLATLKRASFAK 188
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 1e-13
Identities = 45/158 (28%), Positives = 74/158 (46%), Gaps = 15/158 (9%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLLYESKLYRILQGGTGI 65
K+ KIG G+ G +Y ++ T +EVAI+ N++ K ++ E + R +
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN---- 76
Query: 66 PN-VRWFG--VEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
PN V + + GD +VM+ L G SL D+ + + + + + +EF+HS
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHS 134
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
+HRDIK DN L+G V + DFG +
Sbjct: 135 NQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQITPE 169
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 2e-13
Identities = 41/183 (22%), Positives = 74/183 (40%), Gaps = 45/183 (24%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVA---IKLEN-----------VKT----KHPQ 48
++F+ K+G+G++ +Y G N T VA +KL++ + KH
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHEN 64
Query: 49 LLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDL-----FNFCSRKLSLK 103
++ +LY ++ + LV + + L+ R L L
Sbjct: 65 IV---RLYDVIHTENKL-------------TLVFEFMDNDLKKYMDSRTVGNTPRGLELN 108
Query: 104 TVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD---TS 160
V Q++ + F H LHRD+KP N L+ + Q+ + DFGLA+ + T
Sbjct: 109 LVKYFQWQLLQGLAFCHENKILHRDLKPQNLLIN---KRGQLKLGDFGLARAFGIPVNTF 165
Query: 161 THQ 163
+ +
Sbjct: 166 SSE 168
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 42/179 (23%), Positives = 79/179 (44%), Gaps = 35/179 (19%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLLYESKLYRILQG 61
+ + + IG+GSFG ++ ++++E VAIK L++ + K E ++ RI++
Sbjct: 37 QREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFK----NRELQIMRIVKH 91
Query: 62 GTGIPNV----------RWFGVEGDYNVLVMDLLGPSLEDL------FNFCSRKLSLKTV 105
PNV E N LV++ + E + + + + + +
Sbjct: 92 ----PNVVDLKAFFYSNGDKKDEVFLN-LVLEYVP---ETVYRASRHYAKLKQTMPMLLI 143
Query: 106 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR--DTSTH 162
+ Q++ + ++HS HRDIKP N L L + + +IDFG AK + +
Sbjct: 144 KLYMYQLLRSLAYIHSIGICHRDIKPQNLL--LDPPSGVLKLIDFGSAKILIAGEPNVS 200
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-13
Identities = 33/156 (21%), Positives = 76/156 (48%), Gaps = 11/156 (7%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPN 67
KIG GS G + L + +VA+K+ +++ + + L +++ I++ N
Sbjct: 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEV-VIMRDYQH-FN 103
Query: 68 -VRWFG--VEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
V + + G+ ++M+ L G +L D+ + +L+ + + + + ++ + ++H++
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLHAQG 161
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
+HRDIK D+ L+ +V + DFG +
Sbjct: 162 VIHRDIKSDSILLT---LDGRVKLSDFGFCAQISKD 194
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 4e-13
Identities = 21/187 (11%), Positives = 50/187 (26%), Gaps = 36/187 (19%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT-NIQTNEEVAIKLENVKTKHPQLL----YESKLYRILQG 61
+ K+ GE++ G ++ +K+ V+ + E RI
Sbjct: 10 KQLNFLTKLNENHSGELWKGRWQ---GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 62 GTGIPN-VRWFGV----EGDYNVLVMDLL-GPSLED-LFNFCSRKLSLKTVLMLADQMIN 114
PN + G + L+ + SL + L + + + A M
Sbjct: 67 ----PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMAR 122
Query: 115 RVEFVHSKSF--LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN 172
+ F+H+ + + ++ I + ++
Sbjct: 123 GMAFLHTLEPLIPRHALNSRSVMIDEDMT---ARISMADVKFSFQSPGR----------- 168
Query: 173 LTGTARY 179
+
Sbjct: 169 -MYAPAW 174
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 5e-13
Identities = 54/257 (21%), Positives = 94/257 (36%), Gaps = 71/257 (27%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT--------KHP- 47
F+ G+ +G GSF + L + T+ E AIK + V HP
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 48 --QLLY----ESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSR- 98
+L + + KLY + G +L + +
Sbjct: 92 FVKLYFTFQDDEKLY-----------------------FGLSYAKNG----ELLKYIRKI 124
Query: 99 -KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157
++++ +E++H K +HRD+KP+N L+ + I DFG AK
Sbjct: 125 GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLS 181
Query: 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGL 216
S + GTA+Y S + DL +LG ++Y + G P+
Sbjct: 182 PESKQA-----RANSFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGLPPF--- 232
Query: 217 KAGTKKQKYEKISEKKV 233
+AG + ++KI + +
Sbjct: 233 RAGNEYLIFQKIIKLEY 249
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 6e-13
Identities = 40/179 (22%), Positives = 66/179 (36%), Gaps = 38/179 (21%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTK-------------- 45
+ ++F++ R G G+FG + LG T VAIK +++ + +
Sbjct: 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLH 77
Query: 46 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTV 105
HP ++ +L R Y +VM+ + + L C +
Sbjct: 78 HPNIV---QLQSYFY----TLGERDR--RDIYLNVVMEYVP---DTLHRCCRNYYRRQVA 125
Query: 106 LMLAD------QMINRVEFVHSKSF--LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
Q+I + +H S HRDIKP N L + + + DFG AKK
Sbjct: 126 PPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVL--VNEADGTLKLCDFGSAKKL 182
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 45/171 (26%), Positives = 72/171 (42%), Gaps = 21/171 (12%)
Query: 3 PRVGNKF-RLGRKIGSGSFGEIYLGTN--IQTNEEVAIKLENVKTKHPQLLYESKLYRIL 59
RV + F G K+G G++G +Y + +++ A+K E L R L
Sbjct: 16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLREL 75
Query: 60 QGGTGIPNV----RWFGVEGDYNV-LVMD--------LLGPSLEDLFNFCSRKLSLKTVL 106
+ PNV + F D V L+ D ++ N +L V
Sbjct: 76 KH----PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK 131
Query: 107 MLADQMINRVEFVHSKSFLHRDIKPDNFL-MGLGRRANQVYIIDFGLAKKY 156
L Q+++ + ++H+ LHRD+KP N L MG G +V I D G A+ +
Sbjct: 132 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 27/181 (14%), Positives = 61/181 (33%), Gaps = 18/181 (9%)
Query: 7 NKFRLGRKIGSG--SFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLLY-ESKLYRILQ 60
+ L IG G + L T E V ++ LE + L E + ++
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN 84
Query: 61 GGTGIPNV-RWFG--VEGDYNVLVMDLL-GPSLEDLF-NFCSRKLSLKTVLMLADQMINR 115
PN+ + + + +V + S +DL ++ + + ++
Sbjct: 85 H----PNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKA 140
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175
++++H ++HR +K + L+ +VY+ Q + + K
Sbjct: 141 LDYIHHMGYVHRSVKASHILIS---VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197
Query: 176 T 176
Sbjct: 198 V 198
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 39/196 (19%), Positives = 74/196 (37%), Gaps = 46/196 (23%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTK-----------HP- 47
K+ LG+ +G+GSFG + +I++ + A+K L++ + K H
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVN 61
Query: 48 --QLLY------ESKLYRILQGGTGIPNVRWFGVEGDYNV-------------LVMDLLG 86
+L+ + + +++ ++M+ +
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 87 PSLEDL------FNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 140
+ L F R + + + + Q+ V F+HS HRDIKP N L +
Sbjct: 122 ---DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLL--VNS 176
Query: 141 RANQVYIIDFGLAKKY 156
+ N + + DFG AKK
Sbjct: 177 KDNTLKLCDFGSAKKL 192
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 44/174 (25%), Positives = 75/174 (43%), Gaps = 19/174 (10%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLLYESKLYRILQGGT 63
LG +IG G+FGE++ G N VA+K + L E+++ +
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSH-- 171
Query: 64 GIPN-VRWFGV--EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
PN VR GV + +VM+L+ G +L +KT+L + +E++
Sbjct: 172 --PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL 229
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH-----IPYR 168
SK +HRD+ N L+ N + I DFG++++ D +P +
Sbjct: 230 ESKCCIHRDLAARNCLVT---EKNVLKISDFGMSREEADGVYAASGGLRQVPVK 280
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 38/183 (20%), Positives = 75/183 (40%), Gaps = 44/183 (24%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKLYRILQ--- 60
+ N F + RK+G G+FG + L +I + A+K + N+K E+ + + +Q
Sbjct: 33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDD 92
Query: 61 -GGTGIPNVR---WFGVEGDYN---VLVMDLLGPSLEDL---FNFCSRKLSLKTVLMLAD 110
I V+ F Y L+ + LGPSL ++ N+ ++ + +
Sbjct: 93 INNNNI--VKYHGKF----MYYDHMCLIFEPLGPSLYEIITRNNY--NGFHIEDIKLYCI 144
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLM----------------------GLGRRANQVYII 148
+++ + ++ S H D+KP+N L+ ++ + +I
Sbjct: 145 EILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204
Query: 149 DFG 151
DFG
Sbjct: 205 DFG 207
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 4e-12
Identities = 31/167 (18%), Positives = 71/167 (42%), Gaps = 38/167 (22%)
Query: 14 KIGSGSFGEIYLGTNIQ-TNEEVA---IKLENVK-------------------TKHPQLL 50
+IG G++G+++ +++ VA ++++ + +HP ++
Sbjct: 18 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 51 YESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK-LSLKTVLMLA 109
+L+ + + LV + + L + + +T+ +
Sbjct: 78 ---RLFDVCTVSRTDRETKLT--------LVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 126
Query: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
Q++ ++F+HS +HRD+KP N L+ + Q+ + DFGLA+ Y
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLADFGLARIY 170
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 4e-12
Identities = 25/221 (11%), Positives = 51/221 (23%), Gaps = 55/221 (24%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY-ESKLYRILQ--- 60
++RL G + + + + +VA+ PQ + + L L
Sbjct: 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTF-----VDPQGVLPDDVLQETLSRTL 83
Query: 61 -----GGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
G+ V ++V + + G SL+++ S + +
Sbjct: 84 RLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGAIRAMQSLAA 140
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174
+ H P + V +
Sbjct: 141 AADAAHRAGVALSIDHPSRVRVS---IDGDVVLAYPA----------------------- 174
Query: 175 GTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
+DD+ +G L L P
Sbjct: 175 ----TMPDANP-------QDDIRGIGASLYALLVNRWPLPE 204
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 6e-12
Identities = 33/161 (20%), Positives = 70/161 (43%), Gaps = 15/161 (9%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLLYESKLYRILQGGT 63
N ++GSG+ G+++ +T +A+K K ++ ++L + ++
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMD---LDVVLKSH 81
Query: 64 GIPN-VRWFG---VEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
P V+ FG D + M+L+G E L + + + + ++ + ++
Sbjct: 82 DCPYIVQCFGTFITNTDV-FIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYL 140
Query: 120 HSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
K +HRD+KP N L+ Q+ + DFG++ + D
Sbjct: 141 KEKHGVIHRDVKPSNILLD---ERGQIKLCDFGISGRLVDD 178
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 8e-12
Identities = 38/177 (21%), Positives = 70/177 (39%), Gaps = 37/177 (20%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKT--------------K 45
+ + +GSG++G + + ++ E+VAIK ++ +
Sbjct: 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ 81
Query: 46 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTV 105
H ++ L + P Y LVM + DL K S + +
Sbjct: 82 HENVI---GLLDVF-----TPASSLRNFYDFY--LVMPFMQ---TDLQKIMGLKFSEEKI 128
Query: 106 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKYRDTST 161
L QM+ ++++HS +HRD+KP N + + ++ I+DFGLA+ T
Sbjct: 129 QYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV----NEDCELKILDFGLARHADAEMT 181
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 59/261 (22%), Positives = 92/261 (35%), Gaps = 75/261 (28%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN--------------------VKTKHP- 47
+ + + IG G+FGE+ L + T + A+KL + P
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 48 --QLLY----ESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSR- 98
QL Y + LY +VM+ + G DL N S
Sbjct: 131 VVQLFYAFQDDRYLY-----------------------MVMEYMPGG----DLVNLMSNY 163
Query: 99 KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158
+ K +++ ++ +HS F+HRD+KPDN L+ ++ + + DFG K
Sbjct: 164 DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD---KSGHLKLADFGTCMKMNK 220
Query: 159 TSTHQHIPYRENKNLTGTARYAS----MNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPW 213
+ GT Y S + R D S+G V +Y L G P+
Sbjct: 221 EGMVR------CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG-VFLYEMLVGDTPF 273
Query: 214 QGLKAGTKKQKYEKISEKKVS 234
A + Y KI K S
Sbjct: 274 ---YADSLVGTYSKIMNHKNS 291
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 3e-11
Identities = 39/195 (20%), Positives = 75/195 (38%), Gaps = 46/195 (23%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV--KTKHPQLLY-ESKLYRILQG 61
+ + F+L +G G++G + T+ T E VAIK K E K+ + +
Sbjct: 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKH 68
Query: 62 GTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLAD----------- 110
N+ + + ++ P + FN ++ + LM D
Sbjct: 69 ----ENI----------ITIFNIQRPDSFENFN----EVYIIQELMQTDLHRVISTQMLS 110
Query: 111 ---------QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKYRDTS 160
Q + V+ +H + +HRD+KP N L+ +N + + DFGLA+ +++
Sbjct: 111 DDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI----NSNCDLKVCDFGLARIIDESA 166
Query: 161 THQHIPYRENKNLTG 175
P + +
Sbjct: 167 ADNSEPTGQQSGMVE 181
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 4e-11
Identities = 34/177 (19%), Positives = 74/177 (41%), Gaps = 25/177 (14%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKT--------------KHP 47
+G+++ + +G G G ++ + ++ VAIK L + ++ H
Sbjct: 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHD 68
Query: 48 QLLYESKLYRILQGGTGIPNVRWFGVEGDYNV-LVMDLLGPSLEDLFNFCSRKLSLKTVL 106
++ K++ IL + +V +V + + L ++ L +
Sbjct: 69 NIV---KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLE--QGPLLEEHAR 123
Query: 107 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163
+ Q++ ++++HS + LHRD+KP N + + I DFGLA+ +H+
Sbjct: 124 LFMYQLLRGLKYIHSANVLHRDLKPANLF--INTEDLVLKIGDFGLARIMDPHYSHK 178
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 61/297 (20%), Positives = 116/297 (39%), Gaps = 53/297 (17%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKLYRILQGGTGI 65
+ K+G G +GE+Y G + + VA+K L+ + + L E+ + + ++
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH---- 275
Query: 66 PN-VRWFGV--EGDYNVLVMDLL-GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFVH 120
PN V+ GV ++ + + +L D L +++S +L +A Q+ + +E++
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 335
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD----TSTHQHIPYRENKNLTGT 176
K+F+HR++ N L+G + V + DFGL++ P + T
Sbjct: 336 KKNFIHRNLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW------T 386
Query: 177 ARYASMNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKISEKKVS 234
A + S + D+ + G VL++ G P Y I +V
Sbjct: 387 APESLAYNKF----SIKSDVWAFG-VLLWEIATYGMSP------------YPGIDLSQV- 428
Query: 235 TSIEALCRGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQ 283
E L + Y P + C D+P +A + + F +F
Sbjct: 429 --YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS 483
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 36/177 (20%), Positives = 65/177 (36%), Gaps = 36/177 (20%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTN-EEVAIK-LENVKTKHPQLLYESKLYRIL--Q 60
+ ++ + +G G+FG++ + + VA+K ++NV E ++ L
Sbjct: 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTT 71
Query: 61 GGTGIPNV----RWFGVEGDYN---VLVMDLLGPSLEDL---FNFCSRKLSLKTVLMLAD 110
WF +++ +V +LLG S D F L + +A
Sbjct: 72 DPNSTFRCVQMLEWF----EHHGHICIVFELLGLSTYDFIKENGF--LPFRLDHIRKMAY 125
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLM----------------GLGRRANQVYIIDFG 151
Q+ V F+HS H D+KP+N L + ++DFG
Sbjct: 126 QICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 6e-11
Identities = 32/182 (17%), Positives = 65/182 (35%), Gaps = 46/182 (25%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGT-NIQTNEEVAIK-LENVKTKHPQLLYESKLYRILQGG 62
+ ++ + +G G+FG++ + + +VA+K + NV E +L+
Sbjct: 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE---INVLK-- 71
Query: 63 TGIPNVRWFGVEGDYNV--------------LVMDLLGPSLEDL---FNFCSRKLSLKTV 105
++ E + + +LLG + + NF + L V
Sbjct: 72 ----KIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNF--QPYPLPHV 125
Query: 106 LMLADQMINRVEFVHSKSFLHRDIKPDNFLM----------------GLGRRANQVYIID 149
+A Q+ + + F+H H D+KP+N L + + + D
Sbjct: 126 RHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVAD 185
Query: 150 FG 151
FG
Sbjct: 186 FG 187
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 7e-11
Identities = 31/110 (28%), Positives = 41/110 (37%), Gaps = 13/110 (11%)
Query: 81 VMDLL-GPSLEDLFNFCSRKLSL--KTVLMLADQMINRVEFVHSKSFLHRDIKPDN-FLM 136
M L +L+D N L + Q+ VEF+HSK +HRD+KP N F
Sbjct: 139 QMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT 198
Query: 137 GLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT-----GTARYAS 181
+ V + DFGL Q + T GT Y S
Sbjct: 199 ----MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 1e-04
Identities = 10/46 (21%), Positives = 17/46 (36%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL 49
R F + +G G FG ++ N + AIK + +
Sbjct: 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR 48
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 40/177 (22%), Positives = 69/177 (38%), Gaps = 52/177 (29%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENV--KTKHPQLLY-ESKLYRILQ 60
+ +++ + IG+GS+G + + VAIK + V + + E + L
Sbjct: 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLN 110
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLAD---------- 110
+V V V+D++ P + F+ +L + + +D
Sbjct: 111 H----DHV----------VKVLDIVIPKDVEKFD----ELYVVLEIADSDFKKLFRTPVY 152
Query: 111 -----------QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ---VYIIDFGLA 153
++ V++VHS LHRD+KP N L NQ V + DFGLA
Sbjct: 153 LTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCL------VNQDCSVKVCDFGLA 203
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 63/279 (22%), Positives = 93/279 (33%), Gaps = 82/279 (29%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----------------------LENVKT 44
N F + R IG G FGE+Y T + A+K L V T
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 45 -KHP---QLLY----ESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFN 94
P + Y KL ++DL+ G DL
Sbjct: 249 GDCPFIVCMSYAFHTPDKLS-----------------------FILDLMNGG----DLHY 281
Query: 95 FCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 152
S+ S + A ++I +E +H++ ++RD+KP N L+ V I D GL
Sbjct: 282 HLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLGL 338
Query: 153 AKKYRDTSTHQHIPYRENKNLTGTARY-ASMNTHLGIEQSRRDDLESLGYVLMY-FLRGS 210
A + H GT Y A G+ D SLG +++ LRG
Sbjct: 339 ACDFSKKKPH---------ASVGTHGYMAPEVLQKGVAYDSSADWFSLG-CMLFKLLRGH 388
Query: 211 LPWQGLKAGTKKQKYEKISEKKV------STSIEALCRG 243
P++ K K + V S + +L G
Sbjct: 389 SPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEG 427
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 2e-10
Identities = 38/162 (23%), Positives = 70/162 (43%), Gaps = 18/162 (11%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLLYESKLYRILQGGTGI 65
++G G++G + ++ + + +A+K + +LL + I
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMD---LDISMRTVDC 65
Query: 66 PN-VRWFG---VEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLA---DQMINRVEF 118
P V ++G EGD + M+L+ SL+ + K +L ++ +E
Sbjct: 66 PFTVTFYGALFREGDV-WICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 119 VHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
+HSK S +HRD+KP N L+ QV + DFG++ D
Sbjct: 125 LHSKLSVIHRDVKPSNVLIN---ALGQVKMCDFGISGYLVDD 163
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 40/177 (22%), Positives = 72/177 (40%), Gaps = 36/177 (20%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKT--------------K 45
V +R + +GSG++G + + +T +VAIK ++ +
Sbjct: 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR 82
Query: 46 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTV 105
H ++ L + P+ Y LVM +G L L KL +
Sbjct: 83 HENVI---GLLDVF-----TPDETLDDFTDFY--LVMPFMGTDLGKLMK--HEKLGEDRI 130
Query: 106 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKYRDTST 161
L QM+ + ++H+ +HRD+KP N + + ++ I+DFGLA++ T
Sbjct: 131 QFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV----NEDCELKILDFGLARQADSEMT 183
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 42/161 (26%), Positives = 73/161 (45%), Gaps = 22/161 (13%)
Query: 7 NKFRLGRKIGSGSFGEIYLG----TNIQTNEEVAIKL--ENVKTKHPQ-LLYESKLYRIL 59
+ R +G G FG++ L TN T E VA+K + +H E + R L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 60 QGGTGIPN-VRWFGV---EGDYNV-LVMDLLGPSLEDLFNF-CSRKLSLKTVLMLADQMI 113
+ +++ G G ++ LVM+ + L L ++ + L +L+ A Q+
Sbjct: 91 YH----EHIIKYKGCCEDAGAASLQLVMEYV--PLGSLRDYLPRHSIGLAQLLLFAQQIC 144
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+ ++H++ ++HRD+ N L+ V I DFGLAK
Sbjct: 145 EGMAYLHAQHYIHRDLAARNVLLD---NDRLVKIGDFGLAK 182
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 41/161 (25%), Positives = 73/161 (45%), Gaps = 21/161 (13%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENV--KTKHPQLLY-ESKLYRILQ 60
V +++ + IGSG+ G + + VAIK L H + Y E L + +
Sbjct: 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 82
Query: 61 --GGTGIPNVRWFGVEGDYNV-----LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 113
G+ NV F + +VM+L+ +L +L + + L QM+
Sbjct: 83 HKNIIGLLNV--FTPQKSLEEFQDVYIVMELMD---ANLCQVIQMELDHERMSYLLYQML 137
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLA 153
++ +HS +HRD+KP N ++ +++ + I+DFGLA
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKILDFGLA 174
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 64/290 (22%), Positives = 117/290 (40%), Gaps = 53/290 (18%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKLYRILQGGTGI 65
RL K+G G FGE+++GT VAIK L+ L E+++ + L+
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRH---- 238
Query: 66 PN-VRWFGV-EGDYNVLVMDLL-GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
V+ + V + +V + + SL D L + L L ++ +A Q+ + + +V
Sbjct: 239 EKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD----TSTHQHIPYRENKNLTGTA 177
+++HRD++ N L+G + DFGLA+ D P + TA
Sbjct: 299 MNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFPIK------WTA 349
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKISEKKVST 235
A++ + + D+ S G +L+ +G +P Y + ++V
Sbjct: 350 PEAALYGRF----TIKSDVWSFG-ILLTELTTKGRVP------------YPGMVNREV-- 390
Query: 236 SIEALCRGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277
++ + RGY P C +++P + YL+ D F
Sbjct: 391 -LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 40/177 (22%), Positives = 75/177 (42%), Gaps = 36/177 (20%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKT--------------K 45
V +++ +GSG++G + + +T VA+K +++ K
Sbjct: 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 86
Query: 46 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTV 105
H ++ L + P Y LV L+G L ++ +KL+ V
Sbjct: 87 HENVI---GLLDVF-----TPARSLEEFNDVY--LVTHLMGADLNNIVK--CQKLTDDHV 134
Query: 106 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKYRDTST 161
L Q++ ++++HS +HRD+KP N + + ++ I+DFGLA+ D T
Sbjct: 135 QFLIYQILRGLKYIHSADIIHRDLKPSNLAV----NEDCELKILDFGLARHTADEMT 187
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 31/158 (19%), Positives = 71/158 (44%), Gaps = 19/158 (12%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLLYESKLYRILQGGTGIPN-VR 69
+IG G++G + + + + +A+K + + QLL + ++ + P V+
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMD---LDVVMRSSDCPYIVQ 85
Query: 70 WFG---VEGDYNVLVMDLLGPSLEDL----FNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
++G EGD + M+L+ S + ++ + + + + + + +
Sbjct: 86 FYGALFREGDC-WICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN 144
Query: 123 -SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
+HRDIKP N L+ R+ + + DFG++ + D+
Sbjct: 145 LKIIHRDIKPSNILLD---RSGNIKLCDFGISGQLVDS 179
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 63/264 (23%), Positives = 92/264 (34%), Gaps = 78/264 (29%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN--------------------VKTKHP- 47
F + + IG G+FGE+ + ++ A+K+ N V
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 48 --QLLY----ESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSR- 98
L Y ++ LY LVMD G DL S+
Sbjct: 136 ITTLHYAFQDDNNLY-----------------------LVMDYYVGG----DLLTLLSKF 168
Query: 99 --KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
+L + +M+ ++ VH ++HRDIKPDN LM + + DFG K
Sbjct: 169 EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD---MNGHIRLADFGSCLKL 225
Query: 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRD-----DLESLGYVLMY-FLRGS 210
+ T Q + GT Y S +E + D SLG V MY L G
Sbjct: 226 MEDGTVQ------SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLG-VCMYEMLYGE 278
Query: 211 LPWQGLKAGTKKQKYEKISEKKVS 234
P+ A + + Y KI K
Sbjct: 279 TPFY---AESLVETYGKIMNHKER 299
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 3e-10
Identities = 64/290 (22%), Positives = 117/290 (40%), Gaps = 53/290 (18%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKLYRILQGGTGI 65
RL K+G G FGE+++GT VAIK L+ L E+++ + L+
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRH---- 321
Query: 66 PN-VRWFGV-EGDYNVLVMDLL-GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
V+ + V + +V + + SL D L + L L ++ +A Q+ + + +V
Sbjct: 322 EKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 381
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD----TSTHQHIPYRENKNLTGTA 177
+++HRD++ N L+G + DFGLA+ D P + TA
Sbjct: 382 MNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFPIK------WTA 432
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKISEKKVST 235
A++ + + D+ S G +L+ +G +P Y + ++V
Sbjct: 433 PEAALYGRF----TIKSDVWSFG-ILLTELTTKGRVP------------YPGMVNREV-- 473
Query: 236 SIEALCRGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277
++ + RGY P C +++P + YL+ D F
Sbjct: 474 -LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 4e-10
Identities = 58/266 (21%), Positives = 89/266 (33%), Gaps = 80/266 (30%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN--------------------VKTKHP- 47
F + + IG G+F E+ + QT + A+K+ N V
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 48 --QLLY----ESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSR- 98
QL + E+ LY LVM+ G DL S+
Sbjct: 123 ITQLHFAFQDENYLY-----------------------LVMEYYVGG----DLLTLLSKF 155
Query: 99 --KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
++ + +++ ++ VH ++HRDIKPDN L+ R + + DFG K
Sbjct: 156 GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLD---RCGHIRLADFGSCLKL 212
Query: 157 RDTSTHQHIPYRENKNLTGTARY-------ASMNTHLGIEQSRRDDLESLGYVLMY-FLR 208
R T + + GT Y A D +LG V Y
Sbjct: 213 RADGTVR------SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALG-VFAYEMFY 265
Query: 209 GSLPWQGLKAGTKKQKYEKISEKKVS 234
G P+ A + + Y KI K
Sbjct: 266 GQTPFY---ADSTAETYGKIVHYKEH 288
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 4e-10
Identities = 39/166 (23%), Positives = 73/166 (43%), Gaps = 25/166 (15%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENV--KTKHPQLLY-ESKLYRILQ 60
V +++ + IGSG+ G + + + VAIK L H + Y E L + +
Sbjct: 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 119
Query: 61 GGTGIPNV-------RWFGVEGDYN--VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 111
N+ ++ LVM+L+ +L +L + + L Q
Sbjct: 120 H----KNIISLLNVFTPQKTLEEFQDVYLVMELMD---ANLCQVIQMELDHERMSYLLYQ 172
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKY 156
M+ ++ +HS +HRD+KP N ++ +++ + I+DFGLA+
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKILDFGLARTA 214
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 4e-10
Identities = 43/161 (26%), Positives = 75/161 (46%), Gaps = 17/161 (10%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENV--KTKHPQLLY-ESKLYR 57
+ V K+ L +K+G G++G ++ + +T E VA+K + + + Q + E +
Sbjct: 4 DRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILT 63
Query: 58 ILQGG---TGIPNVRWFGVEGDYNV-LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 113
L G + NV + D +V LV D + L + + L + Q+I
Sbjct: 64 ELSGHENIVNLLNV--LRADNDRDVYLVFDYMETDLHAVIR--ANILEPVHKQYVVYQLI 119
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLA 153
++++HS LHRD+KP N L+ A V + DFGL+
Sbjct: 120 KVIKYLHSGGLLHRDMKPSNILL----NAECHVKVADFGLS 156
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 5e-10
Identities = 44/163 (26%), Positives = 73/163 (44%), Gaps = 24/163 (14%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKL--ENVKTKHPQ-LLYESKLYRIL 59
+ R +G G FG++ L T E+VA+K H L E ++ R L
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 60 QGGTGIPN-VRWFGV---EGDYNV-LVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQ 111
N V++ G+ +G + L+M+ L L + K++LK L A Q
Sbjct: 81 YH----ENIVKYKGICTEDGGNGIKLIMEFL--PSGSLKEYLPKNKNKINLKQQLKYAVQ 134
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+ ++++ S+ ++HRD+ N L+ +QV I DFGL K
Sbjct: 135 ICKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGLTK 174
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 8e-10
Identities = 45/214 (21%), Positives = 93/214 (43%), Gaps = 27/214 (12%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLLYESKLYRILQGGTGI 65
F ++G+G+ G ++ ++ + +A K LE Q++ E ++L
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRE---LQVLHECNS- 90
Query: 66 PN-VRWFG---VEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
P V ++G +G+ + M+ + G SL+ + R + + + ++ +I + ++
Sbjct: 91 PYIVGFYGAFYSDGEI-SICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLR 148
Query: 121 SK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
K +HRD+KP N L+ ++ + DFG++ + D+ + + GT Y
Sbjct: 149 EKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLIDSMANSFV---------GTRSY 196
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
S G S + D+ S+G L+ G P
Sbjct: 197 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 8e-10
Identities = 40/162 (24%), Positives = 70/162 (43%), Gaps = 23/162 (14%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIK-LENVKTKHPQ-LLYESKLYRILQ 60
+ ++G G+FG + L T VA+K L++ + E ++ + L
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 61 GGTGIPN-VRWFGV---EGDYNV-LVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQM 112
V++ GV G ++ LVM+ L L +F +L +L+ + Q+
Sbjct: 83 S----DFIVKYRGVSYGPGRQSLRLVMEYL--PSGCLRDFLQRHRARLDASRLLLYSSQI 136
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+E++ S+ +HRD+ N L+ V I DFGLAK
Sbjct: 137 CKGMEYLGSRRCVHRDLAARNILVE---SEAHVKIADFGLAK 175
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 38/177 (21%), Positives = 66/177 (37%), Gaps = 52/177 (29%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENV--KTKHPQLLY-ESKLYRILQ 60
V + + + IG GS+G +YL + T + VAIK + + + + E + L+
Sbjct: 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLK 83
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLAD---------- 110
+ + + DL+ P F+ +L + + +D
Sbjct: 84 S----DYI----------IRLYDLIIPDDLLKFD----ELYIVLEIADSDLKKLFKTPIF 125
Query: 111 -----------QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ---VYIIDFGLA 153
++ F+H +HRD+KP N L NQ V + DFGLA
Sbjct: 126 LTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCL------LNQDCSVKVCDFGLA 176
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 1e-09
Identities = 39/158 (24%), Positives = 76/158 (48%), Gaps = 13/158 (8%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LLYESKLYRILQGGTGI 65
+ K+G G +GE+Y G + + VA+K T + L E+ + + ++
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH---- 68
Query: 66 PN-VRWFGV--EGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
PN V+ GV ++ + + G L+ L +++S +L +A Q+ + +E++
Sbjct: 69 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158
K+F+HRD+ N L+G + V + DFGL++
Sbjct: 129 KKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTG 163
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 2e-09
Identities = 37/173 (21%), Positives = 72/173 (41%), Gaps = 21/173 (12%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LLYESKLYRILQGGTGI 65
+++G+G FG + G + +VAIK+ + + E+K+ L
Sbjct: 24 KDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSH---- 78
Query: 66 PN-VRWFGV--EGDYNVLVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFV 119
V+ +GV + ++ + + + L N+ + + +L + + +E++
Sbjct: 79 EKLVQLYGVCTKQRPIFIITEYM--ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 136
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD----TSTHQHIPYR 168
SK FLHRD+ N L+ V + DFGL++ D +S P R
Sbjct: 137 ESKQFLHRDLAARNCLVN---DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR 186
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 39/162 (24%), Positives = 72/162 (44%), Gaps = 23/162 (14%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKL--ENVKTKHPQLLYESKLYRILQ 60
+ +++G G+FG + + T E VA+K + + E ++ + LQ
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 61 GGTGIPN-VRWFGV---EGDYNV-LVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQM 112
N V++ GV G N+ L+M+ L L ++ ++ +L Q+
Sbjct: 101 H----DNIVKYKGVCYSAGRRNLKLIMEYL--PYGSLRDYLQKHKERIDHIKLLQYTSQI 154
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+E++ +K ++HRD+ N L+ N+V I DFGL K
Sbjct: 155 CKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLTK 193
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 3e-09
Identities = 37/160 (23%), Positives = 69/160 (43%), Gaps = 17/160 (10%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LLYESKLYRILQGGTGI 65
+ L +++GSG FG + LG + +VA+K+ + E++ L
Sbjct: 8 EEITLLKELGSGQFGVVKLGK-WKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSH---- 62
Query: 66 PN-VRWFGV--EGDYNVLVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFV 119
P V+++GV + +V + + S L N+ + L +L + + + F+
Sbjct: 63 PKLVKFYGVCSKEYPIYIVTEYI--SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL 120
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
S F+HRD+ N L+ R V + DFG+ + D
Sbjct: 121 ESHQFIHRDLAARNCLVD---RDLCVKVSDFGMTRYVLDD 157
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 57.2 bits (137), Expect = 3e-09
Identities = 35/206 (16%), Positives = 62/206 (30%), Gaps = 59/206 (28%)
Query: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-------------------------- 39
K + KIG G FGE++ + VAIK+
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 40 ------------------------ENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEG 75
V+ +P LL ++ + G+ +F +
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 76 DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNF 134
+ VL + G LE ++ SL T + Q+ + + F HRD+ N
Sbjct: 137 LFIVLEFEFGGIDLE---QMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNV 193
Query: 135 LMGLGRRANQVYIIDFGLAKKYRDTS 160
L+ ++ + + K S
Sbjct: 194 LL---KKTSLKKLHYTLNGKSSTIPS 216
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 3e-09
Identities = 39/168 (23%), Positives = 69/168 (41%), Gaps = 36/168 (21%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----LENVKT--------------KH 46
VG ++ IG G++G + + VAIK E+ +H
Sbjct: 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 84
Query: 47 PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVL 106
++ + I++ P + + Y +V DL+ L L ++ LS +
Sbjct: 85 ENII---GINDIIR----APTIEQM--KDVY--IVQDLMETDLYKLLK--TQHLSNDHIC 131
Query: 107 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLA 153
Q++ ++++HS + LHRD+KP N L+ + I DFGLA
Sbjct: 132 YFLYQILRGLKYIHSANVLHRDLKPSNLLL----NTTCDLKICDFGLA 175
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 3e-09
Identities = 37/173 (21%), Positives = 73/173 (42%), Gaps = 21/173 (12%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LLYESKLYRILQGGTGI 65
++ ++IGSG FG ++LG ++VAIK + + E+++ L
Sbjct: 8 SELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH---- 62
Query: 66 PN-VRWFGV--EGDYNVLVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFV 119
P V+ +GV E LV + + L ++ + +T+L + + + ++
Sbjct: 63 PKLVQLYGVCLEQAPICLVTEFM--EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 120
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD----TSTHQHIPYR 168
+HRD+ N L+G + + DFG+ + D +ST P +
Sbjct: 121 EEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK 170
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 3e-09
Identities = 39/162 (24%), Positives = 72/162 (44%), Gaps = 23/162 (14%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKL--ENVKTKHPQLLYESKLYRILQ 60
+ +++G G+FG + + T E VA+K + + E ++ + LQ
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 61 GGTGIPN-VRWFGV---EGDYNV-LVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQM 112
N V++ GV G N+ L+M+ L L ++ ++ +L Q+
Sbjct: 70 H----DNIVKYKGVCYSAGRRNLKLIMEYL--PYGSLRDYLQKHKERIDHIKLLQYTSQI 123
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+E++ +K ++HRD+ N L+ N+V I DFGL K
Sbjct: 124 CKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLTK 162
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 5e-09
Identities = 42/169 (24%), Positives = 71/169 (42%), Gaps = 17/169 (10%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIP 66
+ +L + IG G FG++ LG +VA+K L E+ + L+
Sbjct: 193 KELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQAFLAEASVMTQLRH----S 246
Query: 67 N-VRWFGV---EGDYNVLVMDLL--GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFV 119
N V+ GV E +V + + G SL D L + L +L + + +E++
Sbjct: 247 NLVQLLGVIVEEKGGLYIVTEYMAKG-SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 305
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYR 168
+F+HRD+ N L+ N + DFGL K+ T +P +
Sbjct: 306 EGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKLPVK 351
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 6e-09
Identities = 39/168 (23%), Positives = 70/168 (41%), Gaps = 15/168 (8%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIP 66
+ +L + IG G FG++ LG +VA+K L E+ + L+
Sbjct: 21 KELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQAFLAEASVMTQLRH----S 74
Query: 67 N-VRWFGV---EGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
N V+ GV E +V + + G ++ L + L +L + + +E++
Sbjct: 75 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 134
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYR 168
+F+HRD+ N L+ N + DFGL K+ T +P +
Sbjct: 135 GNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKLPVK 179
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 7e-09
Identities = 44/173 (25%), Positives = 78/173 (45%), Gaps = 21/173 (12%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LLYESKLYRILQGGTGI 65
+L ++G+G FGE+++G + +VA+K + P L E+ L + LQ
Sbjct: 13 ETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQH---- 67
Query: 66 PN-VRWFGV---EGDYNVLVMDLL-GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFV 119
VR + V E Y ++ + + SL D L KL++ +L +A Q+ + F+
Sbjct: 68 QRLVRLYAVVTQEPIY--IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD----TSTHQHIPYR 168
++++HRD++ N L+ I DFGLA+ D P +
Sbjct: 126 EERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEYTAREGAKFPIK 175
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 2e-08
Identities = 55/275 (20%), Positives = 99/275 (36%), Gaps = 99/275 (36%)
Query: 3 PRVG-NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT----- 44
P+ F++ R +G+GSFG ++L + A+K +E+
Sbjct: 1 PKYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLML 60
Query: 45 ---KHP---QLLY----ESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDL 92
HP ++ +++ ++MD + G +L
Sbjct: 61 SIVTHPFIIRMWGTFQDAQQIF-----------------------MIMDYIEGG----EL 93
Query: 93 FNFCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 150
F+ + + A ++ +E++HSK ++RD+KP+N L L + + + I DF
Sbjct: 94 FSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENIL--LDKNGH-IKITDF 150
Query: 151 GLAKKYRD-TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGY-------- 201
G AK D T T L GT Y + E + + Y
Sbjct: 151 GFAKYVPDVTYT-----------LCGTPDY------IAPEV-----VSTKPYNKSIDWWS 188
Query: 202 --VLMY-FLRGSLPWQGLKAGTKKQKYEKISEKKV 233
+L+Y L G P+ + YEKI ++
Sbjct: 189 FGILIYEMLAGYTPFY---DSNTMKTYEKILNAEL 220
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 3e-08
Identities = 58/258 (22%), Positives = 97/258 (37%), Gaps = 78/258 (30%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT--------KHP- 47
F + +G+GSFG + L + ++ A+K +E+ P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 48 --QLLY----ESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNF--CS 97
+L + S LY +VM+ + G ++F+
Sbjct: 103 LVKLEFSFKDNSNLY-----------------------MVMEYVAGG----EMFSHLRRI 135
Query: 98 RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157
+ S A Q++ E++HS ++RD+KP+N L+ + + + DFG AK+ +
Sbjct: 136 GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVK 192
Query: 158 D-TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQG 215
T T L GT + L ++ D +LG VL+Y G P+
Sbjct: 193 GRTWT-----------LCGTPEALAPEIILSKGYNKAVDWWALG-VLIYEMAAGYPPF-- 238
Query: 216 LKAGTKKQKYEKISEKKV 233
A Q YEKI KV
Sbjct: 239 -FADQPIQIYEKIVSGKV 255
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 3e-08
Identities = 35/167 (20%), Positives = 65/167 (38%), Gaps = 23/167 (13%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQL------------LY 51
+ + + + R I SGS+G + G + VAIK + N + + L
Sbjct: 20 MQSPYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR 78
Query: 52 ESKLYRILQGG--TGIPNVRWFGVEGDYN--VLVMDLLGPSLEDLFNFCSRKLSLKTVLM 107
E +L G+ ++ E + LV +L+ L + + +S + +
Sbjct: 79 EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQY 138
Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLA 153
++ + +H +HRD+ P N L+ N + I DF LA
Sbjct: 139 FMYHILLGLHVLHEAGVVHRDLHPGNILL----ADNNDITICDFNLA 181
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 3e-08
Identities = 46/177 (25%), Positives = 79/177 (44%), Gaps = 24/177 (13%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE---VAIKLENVKTKHPQ---LLYESKLYRILQ 60
+ LGR IG G FG+++ G + VAIK T L E+ R
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 61 GGTGIPN-VRWFGV-EGDYNVLVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINR 115
P+ V+ GV + ++M+L +L +L +F L L ++++ A Q+
Sbjct: 450 H----PHIVKLIGVITENPVWIIMELC--TLGELRSFLQVRKFSLDLASLILYAYQLSTA 503
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD----TSTHQHIPYR 168
+ ++ SK F+HRDI N L+ + V + DFGL++ D ++ +P +
Sbjct: 504 LAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 557
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 4e-08
Identities = 59/283 (20%), Positives = 90/283 (31%), Gaps = 90/283 (31%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----------------------LENVKT 44
N FR R +G G FGE+ T + A K LE V
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN- 242
Query: 45 KHP---QLLY----ESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLF-- 93
L Y + L LV+ L+ G DL
Sbjct: 243 -SRFVVSLAYAYETKDALC-----------------------LVLTLMNGG----DLKFH 274
Query: 94 --NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYII 148
+ + A ++ +E +H + ++RD+KP+N L+ G + I
Sbjct: 275 IYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHG------HIRIS 328
Query: 149 DFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FL 207
D GLA + T K GT Y + + D +LG L+Y +
Sbjct: 329 DLGLAVHVPEGQT--------IKGRVGTVGYMAPEVVKNERYTFSPDWWALG-CLLYEMI 379
Query: 208 RGSLPWQGLKAGTKKQK-YEKISEKKV----STSIEA--LCRG 243
G P+Q K K+++ + E S +A LC
Sbjct: 380 AGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQ 422
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 5e-08
Identities = 51/284 (17%), Positives = 93/284 (32%), Gaps = 89/284 (31%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----------------------LENVKT 44
+ F R +G G FGE++ T + A K L K
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA--KV 242
Query: 45 KHP---QLLY----ESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLF-- 93
L Y ++ L LVM ++ G D+
Sbjct: 243 HSRFIVSLAYAFETKTDLC-----------------------LVMTIMNGG----DIRYH 275
Query: 94 ----NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID 149
+ + + Q+++ +E +H ++ ++RD+KP+N L+ V I D
Sbjct: 276 IYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLD---DDGNVRISD 332
Query: 150 FGLAKKYRDTSTHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY-F 206
GLA + + K GT + + LG E D +LG V +Y
Sbjct: 333 LGLAV---------ELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALG-VTLYEM 382
Query: 207 LRGSLPWQGLKAGTKKQK-YEKISEKKV----STSIEA--LCRG 243
+ P++ + ++ +++ E+ V S + C
Sbjct: 383 IAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEA 426
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 7e-08
Identities = 38/171 (22%), Positives = 76/171 (44%), Gaps = 17/171 (9%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKLYRILQGGTGI 65
+L +K+G+G FGE+++ T + +VA+K ++ L E+ + + LQ
Sbjct: 188 ESLKLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQH---- 242
Query: 66 PN-VRWFGV-EGDYNVLVMDLL-GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
V+ V + ++ + + SL D L + K L ++ + Q+ + F+
Sbjct: 243 DKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD----TSTHQHIPYR 168
++++HRD++ N L+ + I DFGLA+ D P +
Sbjct: 303 RNYIHRDLRAANILVS---ASLVCKIADFGLARVIEDNEYTAREGAKFPIK 350
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 8e-08
Identities = 45/164 (27%), Positives = 75/164 (45%), Gaps = 20/164 (12%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE---VAIKLENVKTKHPQL---LYESKLYRILQ 60
+ LGR IG G FG+++ G + VAIK T L E+ R
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 61 GGTGIPN-VRWFGV-EGDYNVLVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINR 115
P+ V+ GV + ++M+L +L +L +F L L ++++ A Q+
Sbjct: 75 H----PHIVKLIGVITENPVWIIMELC--TLGELRSFLQVRKYSLDLASLILYAYQLSTA 128
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
+ ++ SK F+HRDI N L+ + V + DFGL++ D+
Sbjct: 129 LAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDS 169
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 9e-08
Identities = 38/160 (23%), Positives = 66/160 (41%), Gaps = 21/160 (13%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE----VAIKLENVKTKHPQ---LLYESKLYRIL 59
+F+ + +GSG+FG +Y G I E+ VAIK T +L E+ + +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 60 QGGTGIPN-VRWFGV-EGDYNVLVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMIN 114
P+ R G+ L+ L+ L ++ + + +L Q+
Sbjct: 75 DN----PHVCRLLGICLTSTVQLITQLM--PFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+ ++ + +HRD+ N L+ V I DFGLAK
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAK 165
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 32/165 (19%), Positives = 66/165 (40%), Gaps = 22/165 (13%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKLENVKTKHPQ---LLYESKLYRIL 59
+ + IG+G FGE+Y G + + VAIK Q L E+ +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 60 QGGTGIPN-VRWFGV--EGDYNVLVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMI 113
N +R GV + +++ + + L F + S+ ++ + +
Sbjct: 104 SH----HNIIRLEGVISKYKPMMIITEYM--ENGALDKFLREKDGEFSVLQLVGMLRGIA 157
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158
++++ + +++HRD+ N L+ + DFGL++ D
Sbjct: 158 AGMKYLANMNYVHRDLAARNILVN---SNLVCKVSDFGLSRVLED 199
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 39/180 (21%), Positives = 70/180 (38%), Gaps = 27/180 (15%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT---NIQTNEEVAIKLENVKTKHPQ---LLYESKLYRILQ 60
++ + + IGSG GE+ G Q + VAIK Q L E+ +
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108
Query: 61 GGTGIPN-VRWFGV--EGDYNVLVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMIN 114
PN +R GV G ++V + + L F + ++ ++ + +
Sbjct: 109 H----PNIIRLEGVVTRGRLAMIVTEYM--ENGSLDTFLRTHDGQFTIMQLVGMLRGVGA 162
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD------TSTHQHIPYR 168
+ ++ ++HRD+ N L+ + DFGL++ D T+T IP R
Sbjct: 163 GMRYLSDLGYVHRDLAARNVLVD---SNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIR 219
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 28/174 (16%), Positives = 59/174 (33%), Gaps = 26/174 (14%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT-------NIQTNEEVAIK-LENVKTKHPQ-LLYESKLYR 57
+G G+F +I+ G EV +K L+ + + + +
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 58 ILQGGTGIPN-VRWFGV--EGDYNVLVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQ 111
L + V +GV GD N+LV + + L + +++ L +A Q
Sbjct: 68 KLSH----KHLVLNYGVCVCGDENILVQEFV--KFGSLDTYLKKNKNCINILWKLEVAKQ 121
Query: 112 MINRVEFVHSKSFLHRDIKPDNFL-----MGLGRRANQVYIIDFGLAKKYRDTS 160
+ + F+ + +H ++ N L + + D G++
Sbjct: 122 LAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 51.5 bits (123), Expect = 3e-07
Identities = 37/152 (24%), Positives = 70/152 (46%), Gaps = 15/152 (9%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEE--VAIKL---ENVKTKHPQLLYESKLYRILQGGTGI 65
++G G+FG + G ++ VAIK+ K +++ E+++ L
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN---- 395
Query: 66 PN-VRWFGV-EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
P VR GV + + +LVM++ G L ++ + V L Q+ ++++ K
Sbjct: 396 PYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK 455
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+F+HR++ N L+ + I DFGL+K
Sbjct: 456 NFVHRNLAARNVLLV---NRHYAKISDFGLSK 484
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 3e-07
Identities = 40/170 (23%), Positives = 66/170 (38%), Gaps = 22/170 (12%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEE---VAIKL--ENVKTKHPQ-LLYESKLY 56
P R IG G FG +Y G I + AIK + + + L E L
Sbjct: 17 PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLM 76
Query: 57 RILQGGTGIPN-VRWFGV---EGDYNVLVMDLLGPSLEDLFNF---CSRKLSLKTVLMLA 109
R L PN + G+ +++ + DL F R ++K ++
Sbjct: 77 RGLNH----PNVLALIGIMLPPEGLPHVLLPYM--CHGDLLQFIRSPQRNPTVKDLISFG 130
Query: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
Q+ +E++ + F+HRD+ N ++ V + DFGLA+ D
Sbjct: 131 LQVARGMEYLAEQKFVHRDLAARNCMLDES---FTVKVADFGLARDILDR 177
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 37/178 (20%), Positives = 73/178 (41%), Gaps = 23/178 (12%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT-NIQTNEE--VAIKLENVKTKHPQ---LLYESKLYRILQ 60
+ + +G+G FGE+ G + + +E VAIK V Q L E+ +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 61 GGTGIPN-VRWFGV--EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116
PN +R GV + ++V + + SL+ + ++ ++ + + + +
Sbjct: 105 H----PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD------TSTHQHIPYR 168
+++ ++HRD+ N L+ + DFGL + D T+ IP R
Sbjct: 161 KYLSDMGYVHRDLAARNILIN---SNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR 215
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 34/160 (21%), Positives = 59/160 (36%), Gaps = 21/160 (13%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKL--ENVKTKHPQ-LLYESKLYRIL 59
+ R + +GSG FG ++ G V IK+ + + Q + L
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 60 QGGTGIPN-VRWFGV-EGDYNVLVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMIN 114
+ VR G+ G LV L L L + L + +L Q+
Sbjct: 73 DH----AHIVRLLGLCPGSSLQLVTQYL--PLGSLLDHVRQHRGALGPQLLLNWGVQIAK 126
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+ ++ +HR++ N L+ +QV + DFG+A
Sbjct: 127 GMYYLEEHGMVHRNLAARNVLLK---SPSQVQVADFGVAD 163
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 40/176 (22%), Positives = 74/176 (42%), Gaps = 34/176 (19%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKL--ENVKTKHPQ-LLYESK 54
R K + R++G GSFG +Y G + VAIK E + L E+
Sbjct: 23 AR--EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 80
Query: 55 LYRILQGGTGIPN-VRWFGV--EGDYNVLVM------DLL------GPSLEDLFNFCSRK 99
+ + + VR GV +G +++M DL P++ + N
Sbjct: 81 VMKEFNC----HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMAN--NPVLAP 134
Query: 100 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155
SL ++ +A ++ + + ++++ F+HRD+ N ++ V I DFG+ +
Sbjct: 135 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF---TVKIGDFGMTRD 187
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 4e-07
Identities = 40/154 (25%), Positives = 74/154 (48%), Gaps = 19/154 (12%)
Query: 11 LGRKIGSGSFGEIYLGT--NIQTNEEVAIKL----ENVKTKHPQLLYESKLYRILQGGTG 64
+++GSG+FG + G + + VA+K+ N +LL E+ + + L
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN--- 77
Query: 65 IPN-VRWFGV-EGDYNVLVMDLLGPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVH 120
P VR G+ E + +LVM++ L L + +R + K ++ L Q+ ++++
Sbjct: 78 -PYIVRMIGICEAESWMLVMEMA--ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE 134
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+F+HRD+ N L+ + I DFGL+K
Sbjct: 135 ESNFVHRDLAARNVLLV---TQHYAKISDFGLSK 165
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 5e-07
Identities = 44/185 (23%), Positives = 75/185 (40%), Gaps = 40/185 (21%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE---VAIKL--ENVKTKHPQ-LLYESK 54
PR N+ G+ +G+G+FG++ T + ++ VA+K+ + + L+ E K
Sbjct: 21 PR--NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 78
Query: 55 LYRILQGGTGIPN-VRWFGV--EGDYNVLVM------DLL------------GPSLEDLF 93
+L N V G G +++ DLL + +
Sbjct: 79 ---VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 94 NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
L L+ +L + Q+ + F+ SK+ +HRD+ N L+ G I DFGLA
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG---RITKICDFGLA 192
Query: 154 KKYRD 158
RD
Sbjct: 193 ---RD 194
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 5e-07
Identities = 44/175 (25%), Positives = 71/175 (40%), Gaps = 32/175 (18%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKL--ENVKTKHPQ-LLYESK 54
PR L R +G G+FGE+Y G N + +VA+K E + L E+
Sbjct: 28 PR--KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 85
Query: 55 LYRILQGGTGIPN-VRWFGV--EGDYNVLVMDLL--GPSLEDLFNF---------CSRKL 100
+ N VR GV + ++M+L+ G DL +F L
Sbjct: 86 IISKFNH----QNIVRCIGVSLQSLPRFILMELMAGG----DLKSFLRETRPRPSQPSSL 137
Query: 101 SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155
++ +L +A + +++ F+HRDI N L+ I DFG+A+
Sbjct: 138 AMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 192
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 5e-07
Identities = 38/160 (23%), Positives = 66/160 (41%), Gaps = 21/160 (13%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE----VAIKLENVKTKHPQ---LLYESKLYRIL 59
+F+ + +GSG+FG +Y G I E+ VAIK T +L E+ + +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 60 QGGTGIPN-VRWFGV-EGDYNVLVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMIN 114
P+ R G+ L+ L+ L ++ + + +L Q+
Sbjct: 75 DN----PHVCRLLGICLTSTVQLITQLM--PFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+ ++ + +HRD+ N L+ V I DFGLAK
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAK 165
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 5e-07
Identities = 45/181 (24%), Positives = 74/181 (40%), Gaps = 36/181 (19%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEE-----VAIKLENVKTKHPQ---LLYESK 54
PR N + G+ +G+G+FG++ T +E VA+K+ + L+ E K
Sbjct: 44 PR--NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 55 LYRILQGGTGIPN-VRWFGV--EGDYNVLVM------DLL--------GPSLEDLFNFCS 97
I+ N V G G +++ DLL + F +
Sbjct: 102 ---IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158
Query: 98 RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157
S + +L + Q+ + F+ SK+ +HRD+ N L+ G + I DFGLA R
Sbjct: 159 STASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG---HVAKIGDFGLA---R 212
Query: 158 D 158
D
Sbjct: 213 D 213
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 6e-07
Identities = 37/163 (22%), Positives = 67/163 (41%), Gaps = 16/163 (9%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT---NIQTNEEVAIKLENVKTKHPQL---LYESKLYRILQ 60
L R +G G FGE+Y G + VA+K + E+ + + L
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 61 GGTGIPN-VRWFGV-EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
P+ V+ G+ E + ++M+L L L + T+++ + Q+ +
Sbjct: 72 H----PHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160
++ S + +HRDI N L+ V + DFGL++ D
Sbjct: 128 YLESINCVHRDIAVRNILVA---SPECVKLGDFGLSRYIEDED 167
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 6e-07
Identities = 45/158 (28%), Positives = 68/158 (43%), Gaps = 20/158 (12%)
Query: 9 FRLGRKIGSGSFGEIYLGT-NIQTNEE--VAIK-LENVKTKHPQL----LYESKLYRILQ 60
RL K+G GSFG + G + + + VA+K L+ P+ + E L
Sbjct: 20 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 79
Query: 61 GGTGIPN-VRWFGV-EGDYNVLVMDL--LGPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116
N +R +GV +V +L LG SL D L T+ A Q+ +
Sbjct: 80 H----RNLIRLYGVVLTPPMKMVTELAPLG-SLLDRLRKHQGHFLLGTLSRYAVQVAEGM 134
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
++ SK F+HRD+ N L+ + V I DFGL +
Sbjct: 135 GYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMR 169
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.6 bits (120), Expect = 7e-07
Identities = 51/295 (17%), Positives = 88/295 (29%), Gaps = 90/295 (30%)
Query: 24 YLGTNIQTNEEVAIKL-ENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGD------ 76
YL Q L V T +P+ L S + ++ G + W V D
Sbjct: 310 YLDCRPQ-------DLPREVLTTNPRRL--SIIAESIRDGLATWD-NWKHVNCDKLTTII 359
Query: 77 ---YNVLVMDLLGPSLEDLFNF-CSRKLSLKTVLMLADQMINR-----VEFVHSKSFLHR 127
NVL + L F S + + ++ +I V +H S + +
Sbjct: 360 ESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEK 419
Query: 128 DIK------PDNFLMGLGRRANQVY----IID----------FGLAKKYRDTSTHQHIPY 167
K P +L + N+ I+D L Y D + HI +
Sbjct: 420 QPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGH 479
Query: 168 RENKNLTGTARYASMNTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE 226
HL IE R L + ++ FL +K +++
Sbjct: 480 -----------------HLKNIEHPERMTLFRMVFLDFRFLE------------QKIRHD 510
Query: 227 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL--FIR 279
+ + + L + Y Y D+ P Y +R+ + F+
Sbjct: 511 STAWNASGSILNTL-----QQLKFYKPYI----CDNDPKY---ERLVNAILDFLP 553
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.8 bits (110), Expect = 1e-05
Identities = 40/379 (10%), Positives = 102/379 (26%), Gaps = 122/379 (32%)
Query: 28 NIQTNEEVAIKLENVKTKHPQLLYESKLYRI----LQGGTGIPNVRWFGVEG----DYNV 79
+I + EE+ + +K S R+ L + V+ F VE +Y
Sbjct: 44 SILSKEEID---HIIMSKDA----VSGTLRLFWTLLSKQEEM--VQKF-VEEVLRINYKF 93
Query: 80 LVMDL----LGPSLE-DLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDN 133
L+ + PS+ ++ +L + A ++R++ + L ++P
Sbjct: 94 LMSPIKTEQRQPSMMTRMYIEQRDRLY-NDNQVFAKYNVSRLQPYLKLRQALLE-LRPAK 151
Query: 134 FL----M-GLG----------------RRANQVYIIDFGLAKKYRDTSTH-QHIPYRENK 171
+ + G G + +++ ++ Q + Y+ +
Sbjct: 152 NVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDP 211
Query: 172 NLTGTARYAS---MNTHLGIEQSRR--------------DDLESLGYVLMYF-------- 206
N T + ++S + H + RR ++++ F
Sbjct: 212 NWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAK-AWNAFNLSCKILL 270
Query: 207 --------------LRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL----CRGYP--- 245
+ + + + K + + L P
Sbjct: 271 TTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRL 330
Query: 246 -------TEFASYFHYCRSLRFD----------DKPDYAYLKRIFRDLFIREGFQFD--- 285
+ + + + + D + + A +++F L + F
Sbjct: 331 SIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSV---FPPSAHI 387
Query: 286 ----YVFDWTILKYQQSQL 300
W + +
Sbjct: 388 PTILLSLIWFDVIKSDVMV 406
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 9e-07
Identities = 37/181 (20%), Positives = 67/181 (37%), Gaps = 68/181 (37%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT---------KHP 47
F L R IG GS+ ++ L +T+ A+K ++ V+T HP
Sbjct: 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 48 ---QLLY----ESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSR 98
L ES+L+ V++ + G DL R
Sbjct: 71 FLVGLHSCFQTESRLF-----------------------FVIEYVNGG----DLMFHMQR 103
Query: 99 --KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLA 153
KL + + ++ + ++H + ++RD+K DN L+ G + + D+G+
Sbjct: 104 QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG------HIKLTDYGMC 157
Query: 154 K 154
K
Sbjct: 158 K 158
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 1e-06
Identities = 61/281 (21%), Positives = 96/281 (34%), Gaps = 94/281 (33%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT---------KHP 47
F +G GSFG++ L T+E A+K +E K P
Sbjct: 22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 81
Query: 48 ---QLLY----ESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSR 98
QL +LY VM+ + G DL +
Sbjct: 82 FLTQLHSCFQTMDRLY-----------------------FVMEYVNGG----DLMYHIQQ 114
Query: 99 --KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLA 153
+ + A ++ + F+ SK ++RD+K DN ++ G + I DFG+
Sbjct: 115 VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG------HIKIADFGMC 168
Query: 154 K---KYRD-TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLR 208
K T T GT Y + + D + G VL+Y L
Sbjct: 169 KENIWDGVTTKT-----------FCGTPDYIAPEIIAYQPYGKSVDWWAFG-VLLYEMLA 216
Query: 209 GSLPWQGLKAGTKKQKYEKISEKKV----STSIEA--LCRG 243
G P++G + + ++ I E V S S EA +C+G
Sbjct: 217 GQAPFEG---EDEDELFQSIMEHNVAYPKSMSKEAVAICKG 254
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 1e-06
Identities = 39/171 (22%), Positives = 73/171 (42%), Gaps = 28/171 (16%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYE----SKLYRILQ 60
N F IG G FG++Y G ++ +VA+K ++ + E S
Sbjct: 39 NNFDHKFLIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIEEFETEIETLSFCRH--- 94
Query: 61 GGTGIPN-VRWFG--VEGDYNVLVMDLL--GPSLED-LF--NFCSRKLSLKTVLMLADQM 112
P+ V G E + +L+ + G +L+ L+ + + +S + L +
Sbjct: 95 -----PHLVSLIGFCDERNEMILIYKYMENG-NLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS-TH 162
+ ++H+++ +HRD+K N L+ I DFG++KK + TH
Sbjct: 149 ARGLHYLHTRAIIHRDVKSINILLDENFVPK---ITDFGISKKGTELDQTH 196
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 45/178 (25%), Positives = 72/178 (40%), Gaps = 35/178 (19%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKL--ENVKTKHPQ-LLYESK 54
PR L R +G G+FGE+Y G N + +VA+K E + L E+
Sbjct: 69 PR--KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 126
Query: 55 LYRILQGGTGIPN-VRWFGV--EGDYNVLVMDLL--GPSLEDLFNF---------CSRKL 100
+ N VR GV + ++++L+ G DL +F L
Sbjct: 127 IISKFNH----QNIVRCIGVSLQSLPRFILLELMAGG----DLKSFLRETRPRPSQPSSL 178
Query: 101 SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158
++ +L +A + +++ F+HRDI N L+ I DFG+A RD
Sbjct: 179 AMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---RD 233
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 43/181 (23%), Positives = 74/181 (40%), Gaps = 36/181 (19%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE---VAIKLENVKTKHPQ---LLYESK 54
PR ++ +LG+ +G G+FG++ I VA+K+ H + L+ E K
Sbjct: 25 PR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 82
Query: 55 LYRILQGGTGIPN-VRWFGV---EGDYNVLVM------DLL----------GPSLEDLFN 94
IL N V G G ++++ +L P +
Sbjct: 83 ---ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 95 FCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
L+L+ ++ + Q+ +EF+ S+ +HRD+ N L+ N V I DFGLA+
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK---NVVKICDFGLAR 196
Query: 155 K 155
Sbjct: 197 D 197
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 36/181 (19%), Positives = 67/181 (37%), Gaps = 68/181 (37%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT---------KHP 47
F L R IG GS+ ++ L +T+ A++ ++ V+T HP
Sbjct: 54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 48 ---QLLY----ESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSR 98
L ES+L+ V++ + G DL R
Sbjct: 114 FLVGLHSCFQTESRLF-----------------------FVIEYVNGG----DLMFHMQR 146
Query: 99 --KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLA 153
KL + + ++ + ++H + ++RD+K DN L+ G + + D+G+
Sbjct: 147 QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG------HIKLTDYGMC 200
Query: 154 K 154
K
Sbjct: 201 K 201
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 46/181 (25%), Positives = 78/181 (43%), Gaps = 37/181 (20%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE---VAIKLENVKTKHPQ--LLYESKL 55
R L ++G G+FG+++L N+ ++ VA+K ++ + E++L
Sbjct: 39 KR--RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAEL 96
Query: 56 YRILQGGTGIPN-VRWFGV--EGDYNVLVM------DLL---------GPSLEDLFNFCS 97
+LQ + VR+FGV EG ++V DL L +
Sbjct: 97 LTMLQH----QHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAP 152
Query: 98 RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157
L L +L +A Q+ + ++ F+HRD+ N L+G G V I DFG++ R
Sbjct: 153 GPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL---VVKIGDFGMS---R 206
Query: 158 D 158
D
Sbjct: 207 D 207
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 1e-06
Identities = 49/182 (26%), Positives = 84/182 (46%), Gaps = 38/182 (20%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE---VAIKLENVKTKHPQ--LLYESKL 55
R L R++G G+FG+++L N+ ++ VA+K T + E++L
Sbjct: 13 KR--RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 70
Query: 56 YRILQGGTGIPN-VRWFGV--EGDYNVLVM------DLL------GPSLEDLFNFCSR-- 98
LQ + V+++GV +GD ++V DL GP L + R
Sbjct: 71 LTNLQH----EHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQA 126
Query: 99 --KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
+L L +L +A Q+ + + ++ S+ F+HRD+ N L+G V I DFG++
Sbjct: 127 KGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN---LLVKIGDFGMS--- 180
Query: 157 RD 158
RD
Sbjct: 181 RD 182
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 62/281 (22%), Positives = 97/281 (34%), Gaps = 94/281 (33%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT---------KHP 47
F L + +G GSFG+++L +TN+ AIK +E +HP
Sbjct: 19 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 78
Query: 48 ---QLLY----ESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSR 98
+ + L+ VM+ L G DL
Sbjct: 79 FLTHMFCTFQTKENLF-----------------------FVMEYLNGG----DLMYHIQS 111
Query: 99 --KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLA 153
K L A ++I ++F+HSK ++RD+K DN L+ G + I DFG+
Sbjct: 112 CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG------HIKIADFGMC 165
Query: 154 K---KYRD-TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLR 208
K T+T GT Y + LG + + D S G VL+Y L
Sbjct: 166 KENMLGDAKTNT-----------FCGTPDYIAPEILLGQKYNHSVDWWSFG-VLLYEMLI 213
Query: 209 GSLPWQGLKAGTKKQKYEKISEKKV------STSIEALCRG 243
G P+ G +++ + I + L
Sbjct: 214 GQSPFHG---QDEEELFHSIRMDNPFYPRWLEKEAKDLLVK 251
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 59/281 (20%), Positives = 94/281 (33%), Gaps = 94/281 (33%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT---------KHP 47
F +G GSFG++ L T+E A+K +E K P
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402
Query: 48 ---QLLY----ESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSR 98
QL +LY VM+ + G DL +
Sbjct: 403 FLTQLHSCFQTMDRLY-----------------------FVMEYVNGG----DLMYHIQQ 435
Query: 99 --KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLA 153
+ + A ++ + F+ SK ++RD+K DN ++ G + I DFG+
Sbjct: 436 VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG------HIKIADFGMC 489
Query: 154 K---KYRD-TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLR 208
K T T GT Y + + D + G VL+Y L
Sbjct: 490 KENIWDGVTTKT-----------FCGTPDYIAPEIIAYQPYGKSVDWWAFG-VLLYEMLA 537
Query: 209 GSLPWQGLKAGTKKQKYEKISEKKV------STSIEALCRG 243
G P++G + + ++ I E V S A+C+G
Sbjct: 538 GQAPFEG---EDEDELFQSIMEHNVAYPKSMSKEAVAICKG 575
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 3e-06
Identities = 37/157 (23%), Positives = 75/157 (47%), Gaps = 16/157 (10%)
Query: 7 NKFRLGR-KIGSGSFGEIYLGT-NIQTNE-EVAIKL--ENVKTKHPQ-LLYESKLYRILQ 60
+ + ++G G+FG + G ++ + +VAIK+ + + + ++ E+++ L
Sbjct: 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD 68
Query: 61 GGTGIPN-VRWFGV-EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
P VR GV + + +LVM++ G L ++ + V L Q+ ++
Sbjct: 69 N----PYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMK 124
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
++ K+F+HRD+ N L+ + I DFGL+K
Sbjct: 125 YLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSK 158
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 3e-06
Identities = 41/193 (21%), Positives = 66/193 (34%), Gaps = 36/193 (18%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEEVAIKL--ENVKTKHPQ-LLYESKLYR 57
N + IG G+FG++ + AIK E + E
Sbjct: 23 DW--NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGE---LE 77
Query: 58 ILQGGTGIPN-VRWFGV--EGDYNVLVM------DLL----------GPSLEDLFNFCSR 98
+L PN + G Y L + +LL + N +
Sbjct: 78 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 137
Query: 99 KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK--- 155
LS + +L A + ++++ K F+HRD+ N L+G I DFGL++
Sbjct: 138 TLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN---YVAKIADFGLSRGQEV 194
Query: 156 YRDTSTHQHIPYR 168
Y T +P R
Sbjct: 195 YV-KKTMGRLPVR 206
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 3e-06
Identities = 53/262 (20%), Positives = 93/262 (35%), Gaps = 81/262 (30%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-----------------EN---VKTKHP- 47
F + +G G+FG++ L T A+K+ E+ T+HP
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 48 --QLLY----ESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSR- 98
L Y +L VM+ G +LF SR
Sbjct: 67 LTALKYAFQTHDRLC-----------------------FVMEYANGG----ELFFHLSRE 99
Query: 99 -KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK--- 154
+ + ++++ +E++HS+ ++RDIK +N ++ + + I DFGL K
Sbjct: 100 RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD---KDGHIKITDFGLCKEGI 156
Query: 155 KYRD-TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLP 212
T GT Y + + R D LG V+MY + G LP
Sbjct: 157 SDGATMKT-----------FCGTPEYLAPEVLEDNDYGRAVDWWGLG-VVMYEMMCGRLP 204
Query: 213 WQGLKAGTKKQKYEKISEKKVS 234
+ ++ +E I +++
Sbjct: 205 FYN---QDHERLFELILMEEIR 223
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 3e-06
Identities = 55/281 (19%), Positives = 92/281 (32%), Gaps = 94/281 (33%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT---------KHP 47
F R +G GSFG++ L +T + A+K +E T HP
Sbjct: 25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP 84
Query: 48 ---QLLY----ESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSR 98
QL +L+ VM+ + G DL +
Sbjct: 85 FLTQLFCCFQTPDRLF-----------------------FVMEFVNGG----DLMFHIQK 117
Query: 99 --KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLA 153
+ A ++I+ + F+H K ++RD+K DN L+ G + DFG+
Sbjct: 118 SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEG------HCKLADFGMC 171
Query: 154 K---KYRD-TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLR 208
K T+T GT Y + + D ++G VL+Y L
Sbjct: 172 KEGICNGVTTAT-----------FCGTPDYIAPEILQEMLYGPAVDWWAMG-VLLYEMLC 219
Query: 209 GSLPWQGLKAGTKKQKYEKISEKKV------STSIEALCRG 243
G P++ + +E I +V + +
Sbjct: 220 GHAPFEA---ENEDDLFEAILNDEVVYPTWLHEDATGILKS 257
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 3e-06
Identities = 44/189 (23%), Positives = 77/189 (40%), Gaps = 44/189 (23%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEE---VAIK---LENVKTKHPQ-LLYESKL 55
R N LG+ +G G FG + G Q + VA+K L+N + + L E+
Sbjct: 32 DR--NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAAC 89
Query: 56 YRILQGGTGIPN-VRWFGV-------EGDYNVLVMDLL--GPSLEDLFNF--------CS 97
+ PN +R GV ++++ + G DL +
Sbjct: 90 MKDFSH----PNVIRLLGVCIEMSSQGIPKPMVILPFMKYG----DLHTYLLYSRLETGP 141
Query: 98 RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK-- 155
+ + L+T+L + +E++ +++FLHRD+ N ++ V + DFGL+KK
Sbjct: 142 KHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDD---MTVCVADFGLSKKIY 198
Query: 156 ----YRDTS 160
YR
Sbjct: 199 SGDYYRQGR 207
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 5e-06
Identities = 37/177 (20%), Positives = 71/177 (40%), Gaps = 35/177 (19%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEE---VAIKL--ENVKTK--HPQLLYESKL 55
P +F LGR +G G FG + Q + VA+K+ ++ + L E+
Sbjct: 21 PE--QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAAC 78
Query: 56 YRILQGGTGIPN-VRWFGV--------EGDYNVLVMDLLGPSLEDLFNF--------CSR 98
+ P+ + GV ++++ + DL F
Sbjct: 79 MKEFDH----PHVAKLVGVSLRSRAKGRLPIPMVILPFM--KHGDLHAFLLASRIGENPF 132
Query: 99 KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155
L L+T++ + +E++ S++F+HRD+ N ++ V + DFGL++K
Sbjct: 133 NLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED---MTVCVADFGLSRK 186
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 6e-06
Identities = 37/182 (20%), Positives = 75/182 (41%), Gaps = 37/182 (20%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE-----VAIKLENVKTKHPQ---LLYE 52
PR ++ LG+ +G G+FG++ L + ++ VA+K+ L+ E
Sbjct: 67 PR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 124
Query: 53 SKLYRILQGGTGIPN-VRWFGV--EGDYNVLVM------DLL----------GPSLEDLF 93
++ +++ N + G + +++ +L +
Sbjct: 125 MEMMKMIGKH---KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 181
Query: 94 NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
+ +LS K ++ A Q+ +E++ SK +HRD+ N L+ N + I DFGLA
Sbjct: 182 HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED---NVMKIADFGLA 238
Query: 154 KK 155
+
Sbjct: 239 RD 240
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 6e-06
Identities = 36/182 (19%), Positives = 76/182 (41%), Gaps = 37/182 (20%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE-----VAIKL--ENVKTKHPQ-LLYE 52
PR +K LG+ +G G+FG++ + I ++ VA+K+ ++ K L+ E
Sbjct: 33 PR--DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 53 SKLYRILQGGTGIPN-VRWFGV--EGDYNVLVM------DLL----------GPSLEDLF 93
+ +++ N + G + +++ +L D+
Sbjct: 91 ME---MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 147
Query: 94 NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
+++ K ++ Q+ +E++ S+ +HRD+ N L+ N + I DFGLA
Sbjct: 148 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN---NVMKIADFGLA 204
Query: 154 KK 155
+
Sbjct: 205 RD 206
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 6e-06
Identities = 58/281 (20%), Positives = 95/281 (33%), Gaps = 94/281 (33%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT---------KHP 47
F + IG GSFG++ L + A+K +++ + KHP
Sbjct: 40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 48 ---QLLY----ESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSR 98
L + KLY V+D + G +LF R
Sbjct: 100 FLVGLHFSFQTADKLY-----------------------FVLDYINGG----ELFYHLQR 132
Query: 99 --KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLA 153
A ++ + + ++HS + ++RD+KP+N L+ G + + DFGL
Sbjct: 133 ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG------HIVLTDFGLC 186
Query: 154 K---KYRD-TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLR 208
K ++ TST GT Y + R D LG ++Y L
Sbjct: 187 KENIEHNSTTST-----------FCGTPEYLAPEVLHKQPYDRTVDWWCLG-AVLYEMLY 234
Query: 209 GSLPWQGLKAGTKKQKYEKISEKKV------STSIEALCRG 243
G P+ + Y+ I K + + S L G
Sbjct: 235 GLPPFYS---RNTAEMYDNILNKPLQLKPNITNSARHLLEG 272
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 7e-06
Identities = 53/261 (20%), Positives = 94/261 (36%), Gaps = 78/261 (29%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT--------KHP- 47
F + +G G+FG++ L T A+K + + T +HP
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 209
Query: 48 --QLLY----ESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSR- 98
L Y +L VM+ G +LF SR
Sbjct: 210 LTALKYSFQTHDRLC-----------------------FVMEYANGG----ELFFHLSRE 242
Query: 99 -KLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
S ++++ ++++HS K+ ++RD+K +N ++ + + I DFGL K
Sbjct: 243 RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD---KDGHIKITDFGLCK-- 297
Query: 157 RDTSTHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPW 213
+ I T GT Y + + R D LG V+MY + G LP+
Sbjct: 298 ------EGIKD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG-VVMYEMMCGRLPF 349
Query: 214 QGLKAGTKKQKYEKISEKKVS 234
++ +E I +++
Sbjct: 350 YN---QDHEKLFELILMEEIR 367
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 1e-05
Identities = 40/179 (22%), Positives = 71/179 (39%), Gaps = 27/179 (15%)
Query: 10 RLGRKIGSGSFGEIYLGTNIQTNEE---VAIKLENVKTKHPQ---LLYESKLYRILQGGT 63
IG G FG +Y GT + + + A+K N T + L E + +
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH-- 85
Query: 64 GIPN-VRWFGV--EGDYNVL-VMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRV 116
PN + G+ + + L V+ + DL NF + ++K ++ Q+ +
Sbjct: 86 --PNVLSLLGICLRSEGSPLVVLPYM--KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM 141
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175
+++ SK F+HRD+ N ++ V + DFGLA+ D Y +
Sbjct: 142 KYLASKKFVHRDLAARNCMLDEK---FTVKVADFGLARDMYDKE-----YYSVHNKTGA 192
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 36/182 (19%), Positives = 75/182 (41%), Gaps = 37/182 (20%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE-----VAIKL--ENVKTKHPQ-LLYE 52
PR +K LG+ +G G FG++ + I ++ VA+K+ ++ K L+ E
Sbjct: 79 PR--DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 136
Query: 53 SKLYRILQGGTGIPN-VRWFGV--EGDYNVLVM------DLL----------GPSLEDLF 93
+ +++ N + G + +++ +L D+
Sbjct: 137 ME---MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 193
Query: 94 NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
+++ K ++ Q+ +E++ S+ +HRD+ N L+ N + I DFGLA
Sbjct: 194 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN---NVMKIADFGLA 250
Query: 154 KK 155
+
Sbjct: 251 RD 252
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 45.6 bits (109), Expect = 1e-05
Identities = 61/267 (22%), Positives = 104/267 (38%), Gaps = 89/267 (33%)
Query: 9 FRLGRKIGSGSFGEIYL-------GTN------------IQTNEEVAIKLEN---VKTKH 46
F L + +G GSFG+++L ++ + V K+E V+ H
Sbjct: 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 85
Query: 47 P---QLLY----ESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCS 97
P +L Y E KLY L++D L G DLF S
Sbjct: 86 PFIVKLHYAFQTEGKLY-----------------------LILDFLRGG----DLFTRLS 118
Query: 98 R--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGL 152
+ + + V ++ ++ +HS ++RD+KP+N L+ G + + DFGL
Sbjct: 119 KEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG------HIKLTDFGL 172
Query: 153 AKK--YRDTSTHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY-FL 207
+K+ + + + GT Y + ++ D S G VLM+ L
Sbjct: 173 SKESIDHEKKAY-----------SFCGTVEYMAPEVVNRRGHTQSADWWSFG-VLMFEML 220
Query: 208 RGSLPWQGLKAGTKKQKYEKISEKKVS 234
G+LP+QG +K+ I + K+
Sbjct: 221 TGTLPFQG---KDRKETMTMILKAKLG 244
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 42/172 (24%), Positives = 70/172 (40%), Gaps = 25/172 (14%)
Query: 10 RLGRKIGSGSFGEIYLGTNIQTNEE---VAIKLENVKTKHPQ---LLYESKLYRILQGGT 63
IG G FG +Y GT + + + A+K N T + L E + +
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH-- 149
Query: 64 GIPNV-RWFGV--EGDYNVL-VMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRV 116
PNV G+ + + L V+ + DL NF + ++K ++ Q+ +
Sbjct: 150 --PNVLSLLGICLRSEGSPLVVLPYM--KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM 205
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYR 168
+F+ SK F+HRD+ N ++ V + DFGLA RD +
Sbjct: 206 KFLASKKFVHRDLAARNCMLDEK---FTVKVADFGLA---RDMYDKEFDSVH 251
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 3e-05
Identities = 40/183 (21%), Positives = 62/183 (33%), Gaps = 39/183 (21%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE---VAIKLENVKTKHPQ---LLYESK 54
+ R ++G FG++Y G E+ VAIK K + P +E+
Sbjct: 7 SL--SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAM 64
Query: 55 LYRILQGGTGIPN-VRWFGV--EGDYNVLVM------DLL----------GPSLEDLFNF 95
L LQ PN V GV + ++ DL D
Sbjct: 65 LRARLQH----PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 96 CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155
L + L Q+ +E++ S +H+D+ N L+ V I D GL
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDK---LNVKISDLGLF-- 175
Query: 156 YRD 158
R+
Sbjct: 176 -RE 177
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 4e-05
Identities = 37/194 (19%), Positives = 74/194 (38%), Gaps = 56/194 (28%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE---VAIKLENVKTKHPQ-----LLYE 52
PR LG+ +G G FG++ T +++ VA+K+ +K LL E
Sbjct: 21 PR--KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM--LKENASPSELRDLLSE 76
Query: 53 SKLYRILQGGTGIPN-VRWFGV--EGDYNVLVM------DLL------------------ 85
+ + + P+ ++ +G + +L++ L
Sbjct: 77 FNVLKQVNH----PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGG 132
Query: 86 GPSLEDLFNFCSRKLSLKTVLMLADQ----MINRVEFVHSKSFLHRDIKPDNFLMGLGRR 141
+ L + R L++ ++ A Q M +++ +HRD+ N L+ G
Sbjct: 133 SRNSSSLDHPDERALTMGDLISFAWQISQGM----QYLAEMKLVHRDLAARNILVAEG-- 186
Query: 142 ANQVYIIDFGLAKK 155
++ I DFGL++
Sbjct: 187 -RKMKISDFGLSRD 199
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 4e-05
Identities = 63/269 (23%), Positives = 100/269 (37%), Gaps = 91/269 (33%)
Query: 9 FRLGRKIGSGSFGEIYL---GTNIQTNEEVAIK-------------LENVKT-------- 44
F L R +G G +G+++ T T + A+K + K
Sbjct: 19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 45 KHP---QLLY----ESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNF 95
KHP L+Y KLY L+++ L G +LF
Sbjct: 79 KHPFIVDLIYAFQTGGKLY-----------------------LILEYLSGG----ELFMQ 111
Query: 96 CSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDF 150
R T ++ + +H K ++RD+KP+N ++ G V + DF
Sbjct: 112 LEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQG------HVKLTDF 165
Query: 151 GLAKK--YRDTSTHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY- 205
GL K+ + T TH T GT Y + + +R D SLG LMY
Sbjct: 166 GLCKESIHDGTVTH-----------TFCGTIEYMAPEILMRSGHNRAVDWWSLG-ALMYD 213
Query: 206 FLRGSLPWQGLKAGTKKQKYEKISEKKVS 234
L G+ P+ G +K+ +KI + K++
Sbjct: 214 MLTGAPPFTG---ENRKKTIDKILKCKLN 239
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 5e-05
Identities = 44/193 (22%), Positives = 69/193 (35%), Gaps = 51/193 (26%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE---VAIKLENVKTKHPQ-----LLYE 52
PR N R IG G+FG ++ + E VA+K+ +K + E
Sbjct: 45 PR--NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKM--LKEEASADMQADFQRE 100
Query: 53 SKLYRILQGGTGIPN-VRWFGV--EGDYNVLVM------DLL------------------ 85
+ L PN V+ GV G L+ DL
Sbjct: 101 AALMAEFDN----PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 156
Query: 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 145
+ + + LS L +A Q+ + ++ + F+HRD+ N L+G V
Sbjct: 157 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM---VV 213
Query: 146 YIIDFGLAKKYRD 158
I DFGL+ R+
Sbjct: 214 KIADFGLS---RN 223
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 43/185 (23%), Positives = 65/185 (35%), Gaps = 53/185 (28%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTG-- 64
+ F +G G FG++Y G + VA+K +L E QGG
Sbjct: 30 DNFSNKNILGRGGFGKVYKGR-LADGTLVAVK---------RLKEERT-----QGGELQF 74
Query: 65 ------I-----PN-VRWFG--VEGDYNVLVMDLL--GPSLED-LFNFCSRKLSL----- 102
I N +R G + +LV + G S+ L + L
Sbjct: 75 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG-SVASCLRERPESQPPLDWPKR 133
Query: 103 -KTVLMLADQMINR-VEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157
+ L A R + ++H +HRD+K N L+ + + DFGLAK
Sbjct: 134 QRIALGSA-----RGLAYLHDHCDPKIIHRDVKAANILLD---EEFEAVVGDFGLAKLMD 185
Query: 158 DTSTH 162
TH
Sbjct: 186 YKDTH 190
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 45/187 (24%), Positives = 68/187 (36%), Gaps = 42/187 (22%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE---VAIKL--ENVKTKHPQ-LLYESK 54
PR G+ +GSG+FG++ T I VA+K+ E + + L+ E K
Sbjct: 43 PR--ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 100
Query: 55 LYRILQGGTGIPN-VRWFGV--EGDYNVLVM------DLL-----------------GPS 88
++ N V G L+ DLL
Sbjct: 101 ---MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQ 157
Query: 89 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 148
L+ + +L A Q+ +EF+ KS +HRD+ N L+ G V I
Sbjct: 158 KRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG---KVVKIC 214
Query: 149 DFGLAKK 155
DFGLA+
Sbjct: 215 DFGLARD 221
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 55/274 (20%), Positives = 106/274 (38%), Gaps = 93/274 (33%)
Query: 9 FRLGRKIGSGSFGEIYL---GTNIQTNEEVAIK-----------------------LENV 42
F L + +G+G++G+++L + T + A+K LE++
Sbjct: 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115
Query: 43 KTKHP---QLLY----ESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLF 93
+ + P L Y E+KL+ L++D + G +LF
Sbjct: 116 R-QSPFLVTLHYAFQTETKLH-----------------------LILDYINGG----ELF 147
Query: 94 NFCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYII 148
S+ + + V + +++ +E +H ++RDIK +N L+ G V +
Sbjct: 148 THLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG------HVVLT 201
Query: 149 DFGLAKKYRDTSTHQHIPYRENKNLT--GTARYAS----MNTHLGIEQSRRDDLESLGYV 202
DFGL+K + + + GT Y + G +++ D SLG V
Sbjct: 202 DFGLSK--------EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAV--DWWSLG-V 250
Query: 203 LMY-FLRGSLPWQGLKAG-TKKQKYEKISEKKVS 234
LMY L G+ P+ ++ + +I + +
Sbjct: 251 LMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 284
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 2e-04
Identities = 20/86 (23%), Positives = 35/86 (40%), Gaps = 8/86 (9%)
Query: 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY 146
E + L+L+ ++ + Q+ +EF+ S+ +HRD+ N L+ V
Sbjct: 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN---VVK 233
Query: 147 IIDFGLAKKYRDTSTHQHIPYRENKN 172
I DFGLA+ Y +
Sbjct: 234 ICDFGLARDIYKDPD-----YVRKGD 254
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 40.3 bits (94), Expect = 7e-04
Identities = 26/161 (16%), Positives = 60/161 (37%), Gaps = 31/161 (19%)
Query: 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKL------------ENVKTKHPQLLYESKL-- 55
+G+ +G G ++ + + E +K E +
Sbjct: 93 AIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 151
Query: 56 ---YRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQM 112
+R LQ G+ + + EG N ++M+L+ ++L ++ ++ + D +
Sbjct: 152 RNEFRALQKLQGLAVPKVYAWEG--NAVLMELID--AKEL-----YRVRVENPDEVLDMI 202
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
+ V + + +H D+ N L+ ++IIDF +
Sbjct: 203 LEEVAKFYHRGIVHGDLSQYNVLVSEE----GIWIIDFPQS 239
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 407 | |||
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.88 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.77 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.48 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.35 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.2 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.13 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.89 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.73 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.6 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.52 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.46 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.45 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.37 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.26 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.9 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.85 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.81 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.81 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.78 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.78 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.72 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.25 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.23 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.22 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.17 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.1 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.62 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.35 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.22 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.65 |
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-65 Score=514.54 Aligned_cols=389 Identities=85% Similarity=1.331 Sum_probs=277.6
Q ss_pred CCCccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 1 m~~~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
|+++++++|++.++||+|+||.||+|++..+++.||||++........+.+|+++++.|.|+++++.+..++...+..+|
T Consensus 1 m~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp -CCEETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred CCCCcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 89999999999999999999999999999999999999998888888899999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 81 VMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 81 vme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
||||++++|.+++......+++..++.|+.||+.||.|||++|||||||||+||||+.++.++.+||+|||+++.+....
T Consensus 81 vme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 81 VMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (483)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence 99999999999999877889999999999999999999999999999999999999655578899999999999888776
Q ss_pred CCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHH
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (407)
.....+++......||+.|+|||++.+..++.++|||||||+||||++|..||.+.......+.+.++...........+
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL 240 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHH
T ss_pred cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHH
Confidence 66666667777889999999999999999999999999999999999999999998888888889988888888888889
Q ss_pred hcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchhhcccccCCCCccCCCCCCCCCCCCC
Q 015406 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATPPARALVPGAGTSGAPPA 320 (407)
Q Consensus 241 ~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (407)
+..+|+++.+||.+||+.+|++||++.+|++.|++++.+.+++++..+||+.++.++.+.+.+|.++..++...+..+++
T Consensus 241 ~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~~~~~~~~~~~~p~~~~~~~~~~s~~~~~ 320 (483)
T 3sv0_A 241 CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQIASAPPRAVGHGAGPSGLAPP 320 (483)
T ss_dssp HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHHHTC-------------------------
T ss_pred hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCchhhccccccccCCCCCCCCCCCCCCCCCCc
Confidence 99999999999999999999999999999999999999999999999999999888877766666655555555544444
Q ss_pred CCCCCCcCCCCCCCCCCCcccCCccccCCCCCCCCCCCccccCCCCCCCCCCccceeeecCcccccCCC-Cce
Q 015406 321 IASGDRQTGGGEEGRPAGLSSMDSSRRRMSGPVINSGSFSKQKSPVVNEPTMTKDTMVSNSYYLFCPFS-PRS 392 (407)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 392 (407)
+....++++ .++.+..+..++ .+|+.++++..+|+++++++|+.++++.+++.+++++.++..+.+ +|+
T Consensus 321 ~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (483)
T 3sv0_A 321 ALQNDRQSG-VDEGRTSGWSSM--DRRRAPPPIASVGTLAKQKAPVGNDASFSKEPVISASNFLGRSSGSSRR 390 (483)
T ss_dssp -------------------------------------------------------------------------
T ss_pred cccccccCc-cccccccCCccc--ccccCCcccccccccccccCCCCCCccccccccccccccccccCCcccc
Confidence 444444444 455555555544 477888899999999999999999999999999999998865555 444
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-60 Score=448.15 Aligned_cols=269 Identities=20% Similarity=0.309 Sum_probs=228.6
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCC-----CCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
.++|++++.||+|+||+||+|+++.+++.||||+++.. .....+.+|+++++.|+| ++|+.++.++.+.+..||
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~~~~yi 109 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH-PFFVKLYFTFQDDEKLYF 109 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEEeCCEEEE
Confidence 35799999999999999999999999999999998642 334568899999999986 777788888888999999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 81 vme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
||||| ||+|.+++.. .+.+++..++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.+...
T Consensus 110 vmEy~~gG~L~~~i~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl---~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp EECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECCTT
T ss_pred EEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEE---cCCCCEEEEEcCCceecCCC
Confidence 99999 9999999986 3579999999999999999999999999999999999999 68899999999999987543
Q ss_pred CCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHH
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (407)
... ....+.+||+.|||||++.+..|+.++|||||||+||||++|..||.+. +..+.+.++......
T Consensus 186 ~~~-----~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~---~~~~~~~~i~~~~~~----- 252 (311)
T 4aw0_A 186 SKQ-----ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG---NEGLIFAKIIKLEYD----- 252 (311)
T ss_dssp TTC-----CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHTCCC-----
T ss_pred CCc-----ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHcCCCC-----
Confidence 321 1235679999999999999999999999999999999999999999763 446667777665543
Q ss_pred HhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchhh
Q 015406 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQ 296 (407)
Q Consensus 240 ~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~~ 296 (407)
++..+++++++||.+||..||++||+++++... ..+ ..++|+..+||+.+.++
T Consensus 253 ~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~-~~i---~~Hp~F~~idw~~l~~~ 305 (311)
T 4aw0_A 253 FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY-GPL---KAHPFFESVTWENLHQQ 305 (311)
T ss_dssp CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH-HHH---HTSGGGTTCCCTTGGGS
T ss_pred CCcccCHHHHHHHHHHccCCHhHCcChHHHcCC-HHH---HCCCCcCCCCHHHhcCC
Confidence 235689999999999999999999998876421 111 24578889999988654
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-58 Score=440.37 Aligned_cols=260 Identities=21% Similarity=0.244 Sum_probs=216.3
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~- 85 (407)
+.|++.++||+|+||.||+|+++.+|+.||||+++.+.. ..+|+.+++.|+| ++|+.++.++.+.+..|||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~---~~~E~~il~~l~H-pnIV~l~~~~~~~~~~~ivmEy~~ 133 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF---RVEELVACAGLSS-PRIVPLYGAVREGPWVNIFMELLE 133 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CTHHHHTTTTCCC-TTBCCEEEEEEETTEEEEEECCCT
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh---HHHHHHHHHhCCC-CCCCcEEEEEEECCEEEEEEeccC
Confidence 568999999999999999999999999999999876433 3579999999986 77778888888899999999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCc-eEEEEeccceeeeccCCCCcc
Q 015406 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKYRDTSTHQH 164 (407)
Q Consensus 86 g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~-~~kL~DFGla~~~~~~~~~~~ 164 (407)
||+|.++++.. +.+++..++.|+.||+.||+|||++|||||||||+|||| +.++ .+||+|||+|+.+........
T Consensus 134 gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~~vKl~DFGla~~~~~~~~~~~ 209 (336)
T 4g3f_A 134 GGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLL---SSDGSRAALCDFGHALCLQPDGLGKS 209 (336)
T ss_dssp TCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEE---CTTSCCEEECCCTTCEEC--------
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEE---eCCCCEEEEeeCCCCeEccCCCcccc
Confidence 99999999864 579999999999999999999999999999999999999 4555 699999999998765432111
Q ss_pred cCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCC
Q 015406 165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 244 (407)
Q Consensus 165 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (407)
.......+||+.|||||++.+..|+.++|||||||+||||++|+.||.+...... +.++.... .....+++.+
T Consensus 210 --~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~i~~~~--~~~~~~~~~~ 282 (336)
T 4g3f_A 210 --LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL---CLKIASEP--PPIREIPPSC 282 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC---HHHHHHSC--CGGGGSCTTS
T ss_pred --eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH---HHHHHcCC--CCchhcCccC
Confidence 1123456899999999999999999999999999999999999999987655433 33333332 2233456789
Q ss_pred cHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcC
Q 015406 245 PTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREG 281 (407)
Q Consensus 245 ~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~ 281 (407)
++++.++|.+||+.||++|||+.||++.|...+...+
T Consensus 283 s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 283 APLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 9999999999999999999999999999988877654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-59 Score=445.48 Aligned_cols=247 Identities=22% Similarity=0.234 Sum_probs=207.0
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc----chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
++|+++++||+|+||+||+|+++.+|+.||||+++..... ..+.+|+++++.|+| ++|+.++.++.+.+..||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~H-pnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH-PNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCC-CCCCcEEEEEEECCEEEEEE
Confidence 6899999999999999999999999999999998765432 358899999999986 77778888888999999999
Q ss_pred ecc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 83 DLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 83 e~~-g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
||| ||+|.+++...+ ..+++..++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.+....
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEE---CTTCCEEECSTTEESCCCHHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCCEEEcccccceeecCCc
Confidence 999 999999997543 457999999999999999999999999999999999999 688999999999998764322
Q ss_pred CCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHH
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (407)
. .....+||+.|||||++.+..|+.++|||||||+||||++|+.||.+. +..+.+.++.....+. +
T Consensus 180 ~-------~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~---~~~~~~~~i~~~~~~~----~ 245 (350)
T 4b9d_A 180 E-------LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG---SMKNLVLKIISGSFPP----V 245 (350)
T ss_dssp H-------HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHTCCCC----C
T ss_pred c-------cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc---CHHHHHHHHHcCCCCC----C
Confidence 1 123568999999999999999999999999999999999999999874 4456666666655432 3
Q ss_pred hcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 241 ~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
...+|+++.+||.+||+.||++|||++++++
T Consensus 246 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 246 SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 3568999999999999999999999887653
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-58 Score=438.64 Aligned_cols=247 Identities=19% Similarity=0.270 Sum_probs=211.9
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCC--CCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEec
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~ 84 (407)
+.|++.++||+|+||.||+|+++.+|+.||||+++.. ...+.+.+|+.+++.++| ++|+.++.++.+.+..||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~H-pnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH-ENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEEECC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCC-CCCCcEEEEEEECCEEEEEEeC
Confidence 5699999999999999999999999999999998643 334568899999999986 7788888888889999999999
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCc
Q 015406 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (407)
Q Consensus 85 ~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~ 163 (407)
| ||+|.+++.. +.+++..++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.+.....
T Consensus 153 ~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~~~-- 225 (346)
T 4fih_A 153 LEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVP-- 225 (346)
T ss_dssp CTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSC--
T ss_pred CCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE---CCCCCEEEecCcCceecCCCCC--
Confidence 9 9999999985 469999999999999999999999999999999999999 6889999999999998755432
Q ss_pred ccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcC
Q 015406 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243 (407)
Q Consensus 164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (407)
...+.+||+.|||||++.+..|+.++|||||||+||||++|..||.+.+ ..+.+..+....... ......
T Consensus 226 -----~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~~~~~i~~~~~~~--~~~~~~ 295 (346)
T 4fih_A 226 -----RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP---PLKAMKMIRDNLPPR--LKNLHK 295 (346)
T ss_dssp -----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHSSCCC--CSCGGG
T ss_pred -----cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHHHHHHHHcCCCCC--CCcccc
Confidence 1346799999999999999999999999999999999999999998743 345555554432211 112346
Q ss_pred CcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 244 YPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 244 ~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
+++++.+||.+||..||++|||++++++
T Consensus 296 ~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 296 VSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 8999999999999999999999877653
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-58 Score=425.83 Aligned_cols=245 Identities=24% Similarity=0.307 Sum_probs=197.9
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
.++|++.+.||+|+||+||+|+++.+|+.||||+++... ....+.+|+++++.++| ++|+.+..++.+.+..||
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~~~~~~~~~~~~~i 90 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRH-PHIIKLYDVIKSKDEIIM 90 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCC-CCCCeEEEEEEECCEEEE
Confidence 368999999999999999999999999999999986542 22358899999999986 777788888888899999
Q ss_pred EEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 81 VMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 81 vme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
|||||+|+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||| +.++.+||+|||+|+......
T Consensus 91 vmEy~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 91 VIEYAGNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp EEECCCEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTCCEEECCSSCC-------
T ss_pred EEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEE---CCCCCEEEeecCCCeecCCCC
Confidence 999999999999986 5679999999999999999999999999999999999999 678999999999998765433
Q ss_pred CCcccCccCCCCccccccccccccccCCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHH
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (407)
. ..+.+||+.|||||++.+..| +.++|||||||+||||++|+.||.+. +..+.+..+......
T Consensus 167 ~--------~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~---~~~~~~~~i~~~~~~----- 230 (275)
T 3hyh_A 167 F--------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE---SIPVLFKNISNGVYT----- 230 (275)
T ss_dssp ----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHTCCC-----
T ss_pred c--------cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHcCCCC-----
Confidence 2 346789999999999999886 68999999999999999999999763 345566666655433
Q ss_pred HhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 240 ~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
++..+++++.+||.+||+.||++|||++++++
T Consensus 231 ~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 231 LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 23568999999999999999999999776643
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-59 Score=437.71 Aligned_cols=268 Identities=21% Similarity=0.309 Sum_probs=215.9
Q ss_pred CCceeEeccccccCceEEEEEEEc---CCCeEEEEEEecCCC----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCcee
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~---~~~~~vAvK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 78 (407)
.++|++++.||+|+||+||+|++. .+++.||||+++... ....+.+|+++++.++| ++|+.++.++.+.+..
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH-PFIVKLHYAFQTEGKL 101 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCC-TTEECEEEEEEETTEE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCC-CCCCeEEEEEEECCEE
Confidence 367999999999999999999974 467899999886532 22357889999999976 7777788888889999
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeec
Q 015406 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~ 157 (407)
||||||| ||+|.+++.+ .+.+++..++.|+.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+...
T Consensus 102 ~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EEEECCCTTCEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTSCEEEESSEEEEC--
T ss_pred EEEEEcCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEE---cCCCCEEecccccceecc
Confidence 9999999 9999999986 3579999999999999999999999999999999999999 688999999999998654
Q ss_pred cCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccH
Q 015406 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (407)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (407)
.... ...+.+||+.|||||++.+..|+.++|||||||+||||++|+.||.+. +..+.+..+......
T Consensus 178 ~~~~-------~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~---~~~~~~~~i~~~~~~--- 244 (304)
T 3ubd_A 178 DHEK-------KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK---DRKETMTMILKAKLG--- 244 (304)
T ss_dssp ---C-------CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCC---
T ss_pred CCCc-------cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc---CHHHHHHHHHcCCCC---
Confidence 4322 134678999999999999999999999999999999999999999874 345666666655443
Q ss_pred HHHhcCCcHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHHHHcCCCCCCccccccchhhcccc
Q 015406 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYA--YLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300 (407)
Q Consensus 238 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~--~l~~~l~~l~~~~~~~~~~~~dw~~~~~~~~~~ 300 (407)
++..+|+++.+||.+||+.||++||++. .+.+++ .++|...+||+.+..++.++
T Consensus 245 --~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil-------~Hp~f~~idw~~l~~~~~~p 300 (304)
T 3ubd_A 245 --MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIK-------RHSFFSTIDWNKLYRREIHP 300 (304)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHH-------TSGGGTTCCHHHHHTTCSCC
T ss_pred --CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHH-------cCccccCCCHHHHHhCCCCc
Confidence 2356899999999999999999999863 123333 24677789999887765433
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-58 Score=429.77 Aligned_cols=259 Identities=23% Similarity=0.334 Sum_probs=215.8
Q ss_pred CCceeEeccccccCceEEEEEEEc-----CCCeEEEEEEecCCCC--cchHHHHHHHHHHHcCCCCCCeeEEeeeeCcee
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~-----~~~~~vAvK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 78 (407)
.++|.+.++||+|+||.||+|++. .++..||||+++.... .+.+.+|++++++|+| +||+.+.+++.+.+..
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H-pnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQH-EHIVKFYGVCVEGDPL 90 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEECSSSSE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCC-CCCccEEEEEeeCCEE
Confidence 468999999999999999999875 3578999999875432 2458899999999976 7777888888888889
Q ss_pred EEEEecc-CCCHHHHHHHcC------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceE
Q 015406 79 VLVMDLL-GPSLEDLFNFCS------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 145 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~~~------------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~ 145 (407)
||||||| +|+|.+++...+ ..+++..++.|+.||+.||+|||+++||||||||+|||| +.++.+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl---~~~~~~ 167 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GENLLV 167 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEE---CCCCcE
Confidence 9999999 999999997532 469999999999999999999999999999999999999 688999
Q ss_pred EEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHH
Q 015406 146 YIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQK 224 (407)
Q Consensus 146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~ 224 (407)
||+|||+|+....... ........||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+. .+.
T Consensus 168 Ki~DFGla~~~~~~~~-----~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~---~~~ 239 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEV 239 (299)
T ss_dssp EECCCSCHHHHTGGGC-----EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHH
T ss_pred EECCcccceecCCCCc-----eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHH
Confidence 9999999986544322 112345679999999999999999999999999999999999 9999987543 455
Q ss_pred HHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHc
Q 015406 225 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (407)
Q Consensus 225 ~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~ 280 (407)
+..+....... .+..+|+++.+||.+||+.||++|||+++|.+.|+++....
T Consensus 240 ~~~i~~~~~~~----~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~ 291 (299)
T 4asz_A 240 IECITQGRVLQ----RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS 291 (299)
T ss_dssp HHHHHHTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred HHHHHcCCCCC----CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 55555544322 33568999999999999999999999999999999876543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-57 Score=427.50 Aligned_cols=256 Identities=23% Similarity=0.322 Sum_probs=204.2
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc----chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
.+++++.++||+|+||+||+|++. ..||||+++..... ..+.+|+.+++.++| +||+.+.+++.+ +..|||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~H-pNIV~l~g~~~~-~~~~iV 109 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRH-VNILLFMGYMTK-DNLAIV 109 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEECS-SSCEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEC-CeEEEE
Confidence 367889999999999999999853 35999998754332 348899999999987 555556566544 457999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 82 me~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
|||| ||+|.+++...+..+++..++.|+.||+.||+|||+++||||||||+|||| ++++.+||+|||+|+......
T Consensus 110 mEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl---~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFL---HEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp EECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEE---ETTEEEEECCCSSCBC-----
T ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEE---CCCCcEEEeeccCceecccCC
Confidence 9999 999999998766789999999999999999999999999999999999999 588999999999998765432
Q ss_pred CCcccCccCCCCccccccccccccccC---CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccH
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHLG---IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (407)
.. ......+||+.|||||++.+ ..|+.++|||||||+||||+||+.||.+.+.. ......+......+..
T Consensus 187 ~~-----~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~--~~~~~~~~~~~~~p~~ 259 (307)
T 3omv_A 187 GS-----QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR--DQIIFMVGRGYASPDL 259 (307)
T ss_dssp ------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHHHHHHHTTCCCCCS
T ss_pred cc-----eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH--HHHHHHHhcCCCCCCc
Confidence 21 11345689999999999974 35899999999999999999999999875432 2333333333333444
Q ss_pred HHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 015406 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (407)
Q Consensus 238 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l 276 (407)
..+...+|+++.+||.+||+.||++|||+.+|.+.|+.+
T Consensus 260 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 260 SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 455677999999999999999999999999999988765
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-56 Score=418.38 Aligned_cols=293 Identities=78% Similarity=1.357 Sum_probs=258.2
Q ss_pred CCCccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 1 m~~~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
|+..++++|++.+.||+|+||.||+|++..+++.||||++........+..|+.+++.++|+++++.+..+....+..++
T Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp --------CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred cccccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 56788999999999999999999999999999999999988777778899999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 81 VMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 81 vme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
||||++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.++.+||+|||+++......
T Consensus 83 v~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 83 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 99999999999998777789999999999999999999999999999999999999544577899999999999887766
Q ss_pred CCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHH
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (407)
.....++.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.......+.+..+...........+
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH
T ss_pred cCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhh
Confidence 55555555666788999999999999999999999999999999999999999987766666667777776666777777
Q ss_pred hcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccc
Q 015406 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTIL 293 (407)
Q Consensus 241 ~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~dw~~~ 293 (407)
...+|+++.+++.+||+.||++||++.+|.+.|++++.+.+..+++.+||+.+
T Consensus 243 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~~~ 295 (296)
T 4hgt_A 243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNML 295 (296)
T ss_dssp TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGGGC
T ss_pred hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchhhc
Confidence 78899999999999999999999999999999999999999999999999865
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-57 Score=440.60 Aligned_cols=247 Identities=19% Similarity=0.270 Sum_probs=212.0
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC--CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEec
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~ 84 (407)
+.|++.++||+|+||.||+|+++.+|+.||||+++... ..+.+.+|+.+++.|+| ++|+.++.++.+.+..||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~H-pnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH-ENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEEEEC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCC-CCCCceEEEEEECCEEEEEEeC
Confidence 56999999999999999999999999999999987543 33458899999999986 7788888888888999999999
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCc
Q 015406 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (407)
Q Consensus 85 ~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~ 163 (407)
| ||+|.+++.. +.+++..+..|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.+.....
T Consensus 230 ~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl---~~~g~vKl~DFGla~~~~~~~~-- 302 (423)
T 4fie_A 230 LEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVP-- 302 (423)
T ss_dssp CTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEE---CTTCCEEECCCTTCEECCSSCC--
T ss_pred CCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEecCccceECCCCCc--
Confidence 9 9999999974 469999999999999999999999999999999999999 6889999999999998755432
Q ss_pred ccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcC
Q 015406 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243 (407)
Q Consensus 164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (407)
...+.+||+.|||||++.+..|+.++|||||||+||||++|..||.+.+ ..+.+..+....... ......
T Consensus 303 -----~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~~~~~i~~~~~~~--~~~~~~ 372 (423)
T 4fie_A 303 -----RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP---PLKAMKMIRDNLPPR--LKNLHK 372 (423)
T ss_dssp -----CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHSCCCC--CSCTTS
T ss_pred -----cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHHHHHHHHcCCCCC--Cccccc
Confidence 1346799999999999999999999999999999999999999997743 345555554432211 122356
Q ss_pred CcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 244 YPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 244 ~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
+++++.+||.+||..||++|||++++++
T Consensus 373 ~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 373 VSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 8999999999999999999999877643
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-56 Score=416.10 Aligned_cols=293 Identities=78% Similarity=1.357 Sum_probs=264.2
Q ss_pred CCCccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 1 m~~~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
|+..++++|++.+.||+|+||.||+|++..+++.||||++........+.+|+.+++.+.|+++++.+..+.......++
T Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp --CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred ccceeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 67788999999999999999999999999999999999988877778899999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 81 VMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 81 vme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
||||++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.++.+||+|||+++......
T Consensus 83 v~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 83 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 99999999999998767789999999999999999999999999999999999999544477899999999999887765
Q ss_pred CCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHH
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (407)
.....++.......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.......+.+..+...........+
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH
T ss_pred cccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHH
Confidence 55444555566788999999999999999999999999999999999999999887665555666666666666677777
Q ss_pred hcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccc
Q 015406 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTIL 293 (407)
Q Consensus 241 ~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~dw~~~ 293 (407)
+..+|+++.+++.+||+.||++||++.+|.+.|++++.+.+...+..+||+.+
T Consensus 243 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~~~ 295 (296)
T 3uzp_A 243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNML 295 (296)
T ss_dssp TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGGGC
T ss_pred HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccccccccccc
Confidence 88899999999999999999999999999999999999999999999999864
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-57 Score=429.50 Aligned_cols=256 Identities=21% Similarity=0.293 Sum_probs=207.3
Q ss_pred CceeEeccccccCceEEEEEEEc-----CCCeEEEEEEecCCCC--cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~-----~~~~~vAvK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 79 (407)
++|.+.++||+|+||+||+|++. .+++.||||+++.... .+.|.+|+++++.|+| +||+.+.+++.+.+..|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H-pnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQH-QHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCC-TTBCCEEEEECSSSSEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEEECCEEE
Confidence 57899999999999999999865 3688999999875432 2458899999999976 77777888888888899
Q ss_pred EEEecc-CCCHHHHHHHcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCce
Q 015406 80 LVMDLL-GPSLEDLFNFCS--------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ 144 (407)
Q Consensus 80 lvme~~-g~sL~~~l~~~~--------------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~ 144 (407)
|||||| +|+|.+++.... ..+++..++.|+.||+.||+|||+++||||||||+|||| +.++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl---~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV---GQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE---CCCCc
Confidence 999999 999999997532 358999999999999999999999999999999999999 58899
Q ss_pred EEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHH
Q 015406 145 VYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQ 223 (407)
Q Consensus 145 ~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~ 223 (407)
+||+|||+|+........ .......||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+. .+
T Consensus 197 ~Ki~DFGla~~~~~~~~~-----~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~---~~ 268 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYY-----RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN---TE 268 (329)
T ss_dssp EEECCCC---------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH---HH
T ss_pred EEEcccccceeccCCCcc-----eecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH---HH
Confidence 999999999876543321 12345679999999999999999999999999999999999 9999987543 44
Q ss_pred HHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Q 015406 224 KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (407)
Q Consensus 224 ~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~ 278 (407)
.+..+....... .+..+|+++.+||.+||+.||++|||+.+|.+.|+.+.+
T Consensus 269 ~~~~i~~g~~~~----~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 269 AIDCITQGRELE----RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HHHHHHHTCCCC----CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCC----CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 555555443221 335689999999999999999999999999999998765
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-55 Score=420.54 Aligned_cols=284 Identities=60% Similarity=1.068 Sum_probs=258.7
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
.++++|++.+.||+|+||.||+|++..+++.||||++........+.+|+.+++.+.+|++++.+..++......++|||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46889999999999999999999999999999999998777777899999999999777999999999999999999999
Q ss_pred ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCce-----EEEEeccceeeecc
Q 015406 84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ-----VYIIDFGLAKKYRD 158 (407)
Q Consensus 84 ~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~-----~kL~DFGla~~~~~ 158 (407)
|++++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++. +||+|||+++.+..
T Consensus 86 ~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill---~~~~~~~~~~~kl~DFg~a~~~~~ 162 (330)
T 2izr_A 86 LLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLI---GRPGNKTQQVIHIIDFALAKEYID 162 (330)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CCGGGTCTTSEEECCCTTCEESBC
T ss_pred eCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeee---ccCCCCCCceEEEEEcccceeeec
Confidence 99999999999766789999999999999999999999999999999999999 45555 99999999998776
Q ss_pred CCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHH
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (407)
.......+++......||+.|+|||++.+..++.++|||||||++|||++|..||.+.......+.+..+..........
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 242 (330)
T 2izr_A 163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIE 242 (330)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred CCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHH
Confidence 66555555566678899999999999999999999999999999999999999999887777778888887777777777
Q ss_pred HHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccc
Q 015406 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWT 291 (407)
Q Consensus 239 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~dw~ 291 (407)
.++..+| ++.+++..||+.||.+||++++|.+.|++++.+.+...+..+||+
T Consensus 243 ~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~ 294 (330)
T 2izr_A 243 VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWI 294 (330)
T ss_dssp HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTT
T ss_pred HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCC
Confidence 7777788 999999999999999999999999999999999999999999998
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-56 Score=417.19 Aligned_cols=246 Identities=20% Similarity=0.296 Sum_probs=200.9
Q ss_pred Cce-eEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC----cchHHHHHHHHHHHcCCCCCCeeEEeeee----Cce
Q 015406 7 NKF-RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVE----GDY 77 (407)
Q Consensus 7 ~~y-~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~----~~~ 77 (407)
++| ++.++||+|+||.||+|+++.+++.||+|++..... ...+.+|+++++.|+| ++|+.++.++.. ...
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~H-pnIV~~~~~~~~~~~~~~~ 103 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH-PNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEEEEEETTEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEeeccCCCcE
Confidence 455 888899999999999999999999999998865432 2348899999999987 555555554432 456
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcccccCCCCCceEEEEecccee
Q 015406 78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--ivHrDLKp~NILl~~~~~~~~~kL~DFGla~ 154 (407)
.||||||| ||+|.+++.+ .+.+++..++.|+.||+.||+|||++| ||||||||+||||+ +.++.+||+|||+|+
T Consensus 104 ~~lvmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~--~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEES--STTSCEEECCTTGGG
T ss_pred EEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEE--CCCCCEEEEeCcCCE
Confidence 89999999 9999999986 457999999999999999999999998 99999999999994 246899999999997
Q ss_pred eeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhccc
Q 015406 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (407)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (407)
...... ..+.+||+.|||||++.+ .|+.++|||||||+||||+||+.||.+... ..+.+..+.....+
T Consensus 181 ~~~~~~---------~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~--~~~~~~~i~~~~~~ 248 (290)
T 3fpq_A 181 LKRASF---------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVTSGVKP 248 (290)
T ss_dssp GCCTTS---------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHHHHHTTTCCC
T ss_pred eCCCCc---------cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc--HHHHHHHHHcCCCC
Confidence 543321 245689999999999976 699999999999999999999999976432 34445555444332
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 235 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
..+...+++++.+||.+||..||++|||++++++
T Consensus 249 ---~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 249 ---ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ---GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2234567899999999999999999999887753
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-56 Score=421.17 Aligned_cols=254 Identities=19% Similarity=0.243 Sum_probs=211.9
Q ss_pred CCceeEeccccccCceEEEEEEEc-----CCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCce
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~-----~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 77 (407)
..++++.++||+|+||+||+|+.. .+++.||||+++.... .+.|.+|+.++.+|+| +||+.+.+++.+.+.
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~H-pNIV~l~g~~~~~~~ 103 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH-PNVVCLLGVVTKDQP 103 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCC-TTBCCEEEEECSSSS
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCC-CCCCCcceEEEECCE
Confidence 357899999999999999999863 4678999999865432 3468999999999986 677777777777888
Q ss_pred eEEEEecc-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCC
Q 015406 78 NVLVMDLL-GPSLEDLFNFC---------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 141 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~~~---------------~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~ 141 (407)
.+|||||| +|+|.+++... ...+++..++.|+.||+.||+|||+++||||||||+|||| ++
T Consensus 104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl---~~ 180 (308)
T 4gt4_A 104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV---YD 180 (308)
T ss_dssp CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CG
T ss_pred EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE---CC
Confidence 89999999 99999999642 1358999999999999999999999999999999999999 68
Q ss_pred CceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCc
Q 015406 142 ANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGT 220 (407)
Q Consensus 142 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~ 220 (407)
++.+||+|||+|+....... ........||+.|||||++.+..|+.++|||||||+||||+| |..||.+.+.
T Consensus 181 ~~~~Ki~DFGlar~~~~~~~-----~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~-- 253 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAADY-----YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-- 253 (308)
T ss_dssp GGCEEECCSCCBCGGGGGGC-----BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH--
T ss_pred CCCEEECCcccceeccCCCc-----eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH--
Confidence 89999999999987654332 122346689999999999999999999999999999999998 8999987544
Q ss_pred hHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 015406 221 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 275 (407)
Q Consensus 221 ~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~ 275 (407)
.+.+..+......+ .+..+|+++.+|+.+||+.||++||++.+|.+.|+.
T Consensus 254 -~~~~~~i~~~~~~~----~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 254 -QDVVEMIRNRQVLP----CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp -HHHHHHHHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred -HHHHHHHHcCCCCC----CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 45555555543322 345789999999999999999999999999998864
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-56 Score=426.31 Aligned_cols=260 Identities=20% Similarity=0.305 Sum_probs=216.5
Q ss_pred CceeEeccccccCceEEEEEEEcCC-----CeEEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeee-Cce
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQT-----NEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVE-GDY 77 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~-----~~~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~-~~~ 77 (407)
++|++.++||+|+||+||+|++..+ ++.||||.+...... ..+.+|++++..+.||++|+.+.+++.+ ++.
T Consensus 64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~ 143 (353)
T 4ase_A 64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 143 (353)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCE
Confidence 6799999999999999999997654 368999998765432 3588999999999999988888776654 567
Q ss_pred eEEEEecc-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCC
Q 015406 78 NVLVMDLL-GPSLEDLFNFC---------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 141 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~~~---------------~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~ 141 (407)
.||||||| +|+|.++++.. ...+++..++.|+.||+.||+|||+++||||||||+|||+ ++
T Consensus 144 ~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl---~~ 220 (353)
T 4ase_A 144 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SE 220 (353)
T ss_dssp CEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CG
T ss_pred EEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceee---CC
Confidence 89999999 99999999753 2348999999999999999999999999999999999999 68
Q ss_pred CceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCc
Q 015406 142 ANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGT 220 (407)
Q Consensus 142 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~ 220 (407)
++.+||+|||+|+.+..... +......+||+.|||||++.+..|+.++|||||||+||||+| |..||.+....
T Consensus 221 ~~~vKi~DFGlar~~~~~~~-----~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~- 294 (353)
T 4ase_A 221 KNVVKICDFGLARDIYKDPD-----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID- 294 (353)
T ss_dssp GGCEEECCCGGGSCTTTCTT-----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-
T ss_pred CCCEEECcchhhhhcccCCC-----ceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH-
Confidence 89999999999987654432 122346789999999999999999999999999999999998 99999876543
Q ss_pred hHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHc
Q 015406 221 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (407)
Q Consensus 221 ~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~ 280 (407)
......+...... ..+..+|+++.++|.+||+.||++|||+.+|.+.|+.+++..
T Consensus 295 -~~~~~~i~~g~~~----~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 295 -EEFCRRLKEGTRM----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp -HHHHHHHHHTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred -HHHHHHHHcCCCC----CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 2233333332221 123568999999999999999999999999999999988654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-54 Score=407.34 Aligned_cols=290 Identities=59% Similarity=1.007 Sum_probs=260.6
Q ss_pred CccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 3 ~~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
..++++|++.+.||+|+||.||+|++..+++.||||++........+.+|+.+++.+.++++++.+..++......++||
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 35789999999999999999999999999999999998877777789999999999988899999999999999999999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCC--CCCceEEEEeccceeeeccCC
Q 015406 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG--RRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 83 e~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~--~~~~~~kL~DFGla~~~~~~~ 160 (407)
||++++|.+++...+..+++..++.++.||+.||.|||++||+||||||+|||++.+ +....+||+|||+++......
T Consensus 86 e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~ 165 (298)
T 1csn_A 86 DLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 165 (298)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred EecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccc
Confidence 999999999999766679999999999999999999999999999999999999522 122349999999999887665
Q ss_pred CCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHH
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (407)
.....++.......||+.|+|||++.+..++.++||||||+++|||++|..||.+.......+.+..+...........+
T Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (298)
T 1csn_A 166 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 245 (298)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH
T ss_pred ccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHH
Confidence 54444455566788999999999999999999999999999999999999999987777777777777777766777778
Q ss_pred hcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccccc
Q 015406 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTI 292 (407)
Q Consensus 241 ~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~dw~~ 292 (407)
...+|+++.+++.+||+.||++||++++|.+.|++++.+.+...+..+||+.
T Consensus 246 ~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~ 297 (298)
T 1csn_A 246 CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNL 297 (298)
T ss_dssp TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGC
T ss_pred HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccccCC
Confidence 8889999999999999999999999999999999999999999999999974
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-54 Score=438.72 Aligned_cols=273 Identities=23% Similarity=0.300 Sum_probs=227.8
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCC-----CCcchHHHHHHHHHHHc--CCCCCCeeEEeeeeCc
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQ--GGTGIPNVRWFGVEGD 76 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~~~E~~~l~~l~--~~~~i~~~~~~~~~~~ 76 (407)
.-.++|++++.||+|+||.||+|+++.+|+.||||+++.. ........|..++..+. +|++|+.++.++.+.+
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~ 265 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 265 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence 3457899999999999999999999999999999998642 22334566766666664 4688999999999999
Q ss_pred eeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceee
Q 015406 77 YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (407)
Q Consensus 77 ~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~ 155 (407)
..||||||| ||+|.+++... +.+++..++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.
T Consensus 266 ~lylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILl---d~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTSCEEECCCTTCEE
T ss_pred EEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEE---eCCCCEEecccceeee
Confidence 999999999 99999999864 579999999999999999999999999999999999999 6889999999999997
Q ss_pred eccCCCCcccCccCCCCcccccccccccccc-CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhccc
Q 015406 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (407)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (407)
+.... ..+.+||+.|||||++. +..|+.++|||||||+||||++|..||.+....+..+.+..+......
T Consensus 342 ~~~~~---------~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~ 412 (689)
T 3v5w_A 342 FSKKK---------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 412 (689)
T ss_dssp CSSCC---------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCC
T ss_pred cCCCC---------CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCC
Confidence 75433 24679999999999997 467999999999999999999999999876555555555555444332
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHHHHcCCCCCCccccccchhhcccccCCC
Q 015406 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPD-----YAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATPP 304 (407)
Q Consensus 235 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~~~~~~~~~~ 304 (407)
++..+++++.+||.+||..||.+|++ +++|+ .++|+..+||+.+..++..++..|
T Consensus 413 -----~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~----------~HpfF~~idW~~l~~~~~~pP~~P 472 (689)
T 3v5w_A 413 -----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK----------ESPFFRSLDWQMVFLQKYPPPLIP 472 (689)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT----------TSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred -----CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh----------cCccccCCCHHHHHcCCCCcCccC
Confidence 33568999999999999999999998 45443 458888999999887775554443
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-54 Score=419.69 Aligned_cols=255 Identities=21% Similarity=0.268 Sum_probs=204.7
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc----chHHHHHHHHHHHcCCCCCCeeEEeee------e
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGV------E 74 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~------~ 74 (407)
++++|++++.||+|+||+||+|+++.+|+.||||+++..... ..+.+|+++|+.|+| ++|+.+..++. +
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~~ 130 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKH-DNIIAIKDILRPTVPYGE 130 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCC-TTBCCEEEECCCSSCTTT
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCC-CCcceEeeeeeccccccc
Confidence 578999999999999999999999999999999998755432 347789999999987 55555555433 3
Q ss_pred CceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEecccee
Q 015406 75 GDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (407)
Q Consensus 75 ~~~~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~ 154 (407)
.+..|||||||+|+|.+++.. .+.+++..+..|+.||+.||.|||++|||||||||+|||+ +.++.+||+|||+|+
T Consensus 131 ~~~~~ivmE~~~g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~---~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 131 FKSVYVVLDLMESDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLV---NENCELKIGDFGMAR 206 (398)
T ss_dssp CCCEEEEEECCSEEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCCTTCB
T ss_pred CCEEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCcccccc---CCCCCEEEeecceee
Confidence 467899999998899999975 5679999999999999999999999999999999999999 688999999999998
Q ss_pred eeccCCCCcccCccCCCCccccccccccccccCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhc-
Q 015406 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK- 232 (407)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~- 232 (407)
.+....... .....+.+||+.|||||++.+. .++.++||||||||||||++|+.||.+.+. .+.+..|....
T Consensus 207 ~~~~~~~~~---~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~---~~~l~~I~~~~g 280 (398)
T 4b99_A 207 GLCTSPAEH---QYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY---VHQLQLIMMVLG 280 (398)
T ss_dssp CC----------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH---HHHHHHHHHHHC
T ss_pred ecccCcccc---ccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH---HHHHHHHHHhcC
Confidence 764432211 1123567999999999999875 469999999999999999999999987544 33333332211
Q ss_pred -------------------------ccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015406 233 -------------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 233 -------------------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
.......+.+++++++.+||.+||..||++|||+.+++
T Consensus 281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L 343 (398)
T 4b99_A 281 TPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAAL 343 (398)
T ss_dssp CCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred CCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence 11223344567889999999999999999999977654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-54 Score=409.30 Aligned_cols=266 Identities=22% Similarity=0.281 Sum_probs=197.9
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHH--HHHcCCCCCCeeEEeeeeC----cee
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLY--RILQGGTGIPNVRWFGVEG----DYN 78 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l--~~l~~~~~i~~~~~~~~~~----~~~ 78 (407)
|.++|.+.++||+|+||.||+|++ +|+.||||+++... ...+..|.++. ..++| +||+.+.+++.+. ...
T Consensus 1 Iar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~H-pNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRH-ENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCC-TTBCCEEEEEEEECSSSEEE
T ss_pred CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-hhhHHHHHHHHHHhcCCC-CCCCcEEEEEEecCCCceEE
Confidence 467899999999999999999985 68999999986543 33444555444 45665 5566655555432 367
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeccCCCCcccccCCCCCceEEEEe
Q 015406 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK--------SFLHRDIKPDNFLMGLGRRANQVYIID 149 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~--------~ivHrDLKp~NILl~~~~~~~~~kL~D 149 (407)
||||||| +|+|.++++. ..+++..++.++.|++.||+|||++ +||||||||+|||| +.++.+||+|
T Consensus 77 ~lV~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl---~~~~~~Ki~D 151 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIAD 151 (303)
T ss_dssp EEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEECC
T ss_pred EEEecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEE---CCCCCEEEEe
Confidence 9999999 9999999985 4699999999999999999999987 99999999999999 6889999999
Q ss_pred ccceeeeccCCCCcccCccCCCCccccccccccccccCC------CCChhhHHHHHHHHHHHHHhCCCCCCC--------
Q 015406 150 FGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI------EQSRRDDLESLGYVLMYFLRGSLPWQG-------- 215 (407)
Q Consensus 150 FGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~------~~~~~sDIwSlG~il~elltG~~Pf~~-------- 215 (407)
||+|+.......... ......+||+.|||||++.+. .++.++|||||||+||||+||..||..
T Consensus 152 FGla~~~~~~~~~~~---~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~ 228 (303)
T 3hmm_A 152 LGLAVRHDSATDTID---IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228 (303)
T ss_dssp CTTCEEEETTTTEES---CC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred CCCCccccCCCCcee---eecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccc
Confidence 999998765443211 112356899999999999865 367899999999999999999776532
Q ss_pred --CCc--CchHHHHHHHhhhcccccHHHHhc--CCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCC
Q 015406 216 --LKA--GTKKQKYEKISEKKVSTSIEALCR--GYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGF 282 (407)
Q Consensus 216 --~~~--~~~~~~~~~i~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~ 282 (407)
... ....+....+......+.++.... .+++.+.+|+.+||+.||++|||+.+|.+.|+++.++.+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~i 301 (303)
T 3hmm_A 229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 301 (303)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred hhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcCC
Confidence 211 112233333333333222222222 2346799999999999999999999999999998776654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-54 Score=403.43 Aligned_cols=253 Identities=23% Similarity=0.281 Sum_probs=185.5
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeee-eC------
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGV-EG------ 75 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~-~~------ 75 (407)
.++|++++.||+|+||+||+|+++.+|+.||||+++..... +.+.+|+++++.|+| ++|+.++.++. .+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~H-pnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEH-PGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCC-TTBCCEEEEEEEEC------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEEecCcccccc
Confidence 35799999999999999999999999999999998754432 357899999999987 45555544433 22
Q ss_pred -----ceeEEEEecc-CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEE
Q 015406 76 -----DYNVLVMDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI 147 (407)
Q Consensus 76 -----~~~~lvme~~-g~sL~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL 147 (407)
.+.||||||| |++|.+++..... ..++..++.|+.||+.||+|||++|||||||||+|||| +.++.+||
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl---~~~~~vKl 159 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKV 159 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEE
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEE---CCCCcEEE
Confidence 2479999999 9999999985321 24567789999999999999999999999999999999 57889999
Q ss_pred EeccceeeeccCCCCccc-----CccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchH
Q 015406 148 IDFGLAKKYRDTSTHQHI-----PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK 222 (407)
Q Consensus 148 ~DFGla~~~~~~~~~~~~-----~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~ 222 (407)
+|||+|+.+......... ......+.+||+.|||||++.+..|+.++|||||||+||||++ ||... ....
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~--~~~~ 234 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ--MERV 234 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH--HHHH
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc--cHHH
Confidence 999999977654321110 1112345689999999999999999999999999999999996 78542 1122
Q ss_pred HHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 223 QKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 223 ~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
..+..+.....+. .....++++.+||.+||+.||++|||+.++++
T Consensus 235 ~~~~~~~~~~~p~----~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 235 RTLTDVRNLKFPP----LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHHHTTCCCH----HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHhcCCCCC----CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 3333333333322 22334667889999999999999999887754
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-53 Score=408.76 Aligned_cols=260 Identities=22% Similarity=0.311 Sum_probs=206.0
Q ss_pred CccCCceeEeccccccCceEEEEEEEc---CCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeE
Q 015406 3 PRVGNKFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 3 ~~~~~~y~i~~~iG~G~~g~Vy~~~~~---~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 79 (407)
|.+.++|++.++||+|+||+||+|+++ .+++.||||.+........+.+|+++++.+.+|++|+.+..++.+.+..|
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 567889999999999999999999875 46789999998776666678999999999988899999999999999999
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 80 lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
|||||+ |++|.++++ .+++..++.++.||+.||+|||++|||||||||+|||++ .+.+.+||+|||+|+....
T Consensus 97 lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~--~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYN--RRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp EEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEECTT
T ss_pred EEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEe--CCCCeEEECcCCCCcccCC
Confidence 999999 899999985 599999999999999999999999999999999999995 3447999999999987654
Q ss_pred CCCCccc---------------------CccCCCCccccccccccccccCC-CCChhhHHHHHHHHHHHHHhCCCCCCCC
Q 015406 159 TSTHQHI---------------------PYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGL 216 (407)
Q Consensus 159 ~~~~~~~---------------------~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDIwSlG~il~elltG~~Pf~~~ 216 (407)
....... ........+||+.|||||++.+. .|+.++||||+|||+|||++|+.||...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 3211000 00112356899999999999876 4899999999999999999999999653
Q ss_pred CcCchHHHHHHHhhhcc----------------------------------------c---------ccHHHHhcCCcHH
Q 015406 217 KAGTKKQKYEKISEKKV----------------------------------------S---------TSIEALCRGYPTE 247 (407)
Q Consensus 217 ~~~~~~~~~~~i~~~~~----------------------------------------~---------~~~~~~~~~~~~~ 247 (407)
.. ..+.+..+....- + ......+..++++
T Consensus 251 ~~--~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~ 328 (361)
T 4f9c_A 251 SD--DLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDE 328 (361)
T ss_dssp SS--HHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHH
T ss_pred CC--HHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHH
Confidence 32 2222222211000 0 0001123457899
Q ss_pred HHHHHHHHhCCCCCCCCCHHHHH
Q 015406 248 FASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 248 l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
+.+||.+||..||++|||+++++
T Consensus 329 a~DLl~~lL~~dP~~R~ta~eaL 351 (361)
T 4f9c_A 329 AYDLLDKLLDLNPASRITAEEAL 351 (361)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHH
T ss_pred HHHHHHHHCcCChhHCcCHHHHh
Confidence 99999999999999999987765
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-52 Score=401.51 Aligned_cols=287 Identities=29% Similarity=0.539 Sum_probs=224.8
Q ss_pred cCCceeEeccccccCceEEEEEEEcCC-----CeEEEEEEecCCCCcchHHHHHHHHHHHcC--------------CCCC
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQT-----NEEVAIKLENVKTKHPQLLYESKLYRILQG--------------GTGI 65 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~-----~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~--------------~~~i 65 (407)
..++|++.+.||+|+||.||+|.+..+ ++.||||++... ...+..|+++++.+.+ |+++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~i 110 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSD--NGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGV 110 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETT--CHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCS
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeecc--chhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCC
Confidence 456999999999999999999998764 588999998654 3456677777776655 6777
Q ss_pred CeeEEeeeeC----ceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCC
Q 015406 66 PNVRWFGVEG----DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 141 (407)
Q Consensus 66 ~~~~~~~~~~----~~~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~ 141 (407)
+.+..++... .+.||||||+|++|.+++......+++..++.|+.||+.||+|||++||+||||||+|||++.+ .
T Consensus 111 v~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~-~ 189 (364)
T 3op5_A 111 PKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYK-N 189 (364)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESS-C
T ss_pred CeEEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecC-C
Confidence 7777766543 5689999999999999998766789999999999999999999999999999999999999421 6
Q ss_pred CceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCch
Q 015406 142 ANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 221 (407)
Q Consensus 142 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~ 221 (407)
++.+||+|||+++.+..................||+.|+|||++.+..++.++|||||||+||||++|..||.+......
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~ 269 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence 78999999999988765433222222223456799999999999999999999999999999999999999986433222
Q ss_pred HHHHHHHhhhcccccHHHHh------cCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchh
Q 015406 222 KQKYEKISEKKVSTSIEALC------RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKY 295 (407)
Q Consensus 222 ~~~~~~i~~~~~~~~~~~~~------~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~ 295 (407)
....... .....+..+. ..+|+++.+++..||+.||++||++.+|.+.|++++...+.+.+..+||+....
T Consensus 270 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~ 346 (364)
T 3op5_A 270 YVRDSKI---RYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSVVEN 346 (364)
T ss_dssp HHHHHHH---HHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC-----
T ss_pred HHHHHHH---HhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccceEeccC
Confidence 1111111 1111122221 568999999999999999999999999999999999999999999999997665
Q ss_pred hc
Q 015406 296 QQ 297 (407)
Q Consensus 296 ~~ 297 (407)
..
T Consensus 347 ~~ 348 (364)
T 3op5_A 347 GG 348 (364)
T ss_dssp --
T ss_pred Cc
Confidence 43
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-52 Score=422.29 Aligned_cols=253 Identities=18% Similarity=0.264 Sum_probs=215.3
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC--cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
+.++|++++.||+|+||.||+|+++.+|+.||||++..... ...+.+|+.+|+.|+| ++|+.++.++.+....||||
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~iv~ 233 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH-PTLVNLHDAFEDDNEMVMIY 233 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCC-TTBCCEEEEEECSSEEEEEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCC-CCCCeEEEEEEECCEEEEEE
Confidence 34689999999999999999999999999999998875432 2457889999999986 67778888888899999999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCC
Q 015406 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 83 e~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~ 161 (407)
||| ||+|.+++....+.+++..+..|+.||+.||+|||++||+||||||+|||++. +..+.+||+|||+|+.+.....
T Consensus 234 E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~-~~~~~vKl~DFG~a~~~~~~~~ 312 (573)
T 3uto_A 234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQS 312 (573)
T ss_dssp ECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCSSCEECCTTSE
T ss_pred eecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccC-CCCCCEEEeeccceeEccCCCc
Confidence 999 99999999755567999999999999999999999999999999999999942 1347899999999998765432
Q ss_pred CcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHh
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (407)
....+||+.|||||++.+..|+.++|||||||+||||++|..||.+.+ ..+.+..+....... .....
T Consensus 313 --------~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~---~~~~~~~i~~~~~~~-~~~~~ 380 (573)
T 3uto_A 313 --------VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN---DDETLRNVKSCDWNM-DDSAF 380 (573)
T ss_dssp --------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHTTCCCC-CSGGG
T ss_pred --------eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHHHHHHHHhCCCCC-Ccccc
Confidence 235689999999999999999999999999999999999999998743 355666665554332 22345
Q ss_pred cCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 242 ~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
..+++++.+||.+||..||++||++.++++
T Consensus 381 ~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 381 SGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 678999999999999999999999877643
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=385.90 Aligned_cols=274 Identities=18% Similarity=0.242 Sum_probs=224.9
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
.++|+++++||+|+||.||+|+++.+++.||||+++... ....+..|..++..+.+|++|+.+..++.+....|+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 468999999999999999999999999999999986532 234478899999998777999999999999999999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 81 vme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
||||+ |++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||| +.++.+||+|||+|+.....
T Consensus 131 V~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCT
T ss_pred EEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---CCCCCEEEeecceeeecccC
Confidence 99999 89999999863 579999999999999999999999999999999999999 68899999999999853322
Q ss_pred CCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcC------chHHHHHHHhhhcc
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG------TKKQKYEKISEKKV 233 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~------~~~~~~~~i~~~~~ 233 (407)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|..||...... .....+..+.....
T Consensus 207 ~~-------~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~ 279 (396)
T 4dc2_A 207 GD-------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 279 (396)
T ss_dssp TC-------CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC
T ss_pred CC-------ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc
Confidence 21 134678999999999999999999999999999999999999999753221 12233444444333
Q ss_pred cccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHHHHcCCCCCCccccccchhhcccccC
Q 015406 234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA---YLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLAT 302 (407)
Q Consensus 234 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~---~l~~~l~~l~~~~~~~~~~~~dw~~~~~~~~~~~~ 302 (407)
. ++..+++++.+||.+||..||++||++. .+.++++ ++|+..+||+.+..++..++.
T Consensus 280 ~-----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~-------Hpff~~i~w~~l~~~~~~pp~ 339 (396)
T 4dc2_A 280 R-----IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG-------HPFFRNVDWDMMEQKQVVPPF 339 (396)
T ss_dssp C-----CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH-------STTTTTCCHHHHHTTCSCCSC
T ss_pred C-----CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc-------CccccCCCHHHHHcCCCCCCC
Confidence 2 3356899999999999999999999962 2333333 477888999988776644333
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=383.94 Aligned_cols=268 Identities=19% Similarity=0.247 Sum_probs=221.2
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCC-----CCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
.++|++.+.||+|+||.||+|+++.+++.||||++... .....+..|..++..+.+|++++.+..++...+..|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 57899999999999999999999999999999988643 2334577899999998778999999999999999999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 81 vme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
||||+ |++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||| +.++.+||+|||+|+.....
T Consensus 102 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl---~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCC-
T ss_pred EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEE---CCCCCEEEccccceeecccC
Confidence 99999 89999999863 579999999999999999999999999999999999999 68899999999999854322
Q ss_pred CCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHH
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (407)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+ ..+.+..+.......
T Consensus 178 ~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~---~~~~~~~i~~~~~~~---- 243 (353)
T 3txo_A 178 GV-------TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN---EDDLFEAILNDEVVY---- 243 (353)
T ss_dssp ---------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCC----
T ss_pred Cc-------cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCCC----
Confidence 21 1346689999999999999899999999999999999999999998743 455666666554332
Q ss_pred HhcCCcHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHHHHHcCCCCCCccccccchhhcccccC
Q 015406 240 LCRGYPTEFASYFHYCRSLRFDDKPDY------AYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLAT 302 (407)
Q Consensus 240 ~~~~~~~~l~~li~~cl~~~p~~RPt~------~~l~~~l~~l~~~~~~~~~~~~dw~~~~~~~~~~~~ 302 (407)
...+++++.++|.+||..||++||++ .+++ .++|...+||..+..++..++.
T Consensus 244 -p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il----------~hp~f~~~~w~~l~~~~~~~p~ 301 (353)
T 3txo_A 244 -PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAIL----------RHPFFKEIDWAQLNHRQIEPPF 301 (353)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHH----------TSGGGTTCCHHHHHTTCSCCSC
T ss_pred -CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHh----------hCCcccCCCHHHHhcCcCCCCc
Confidence 24588999999999999999999997 3333 2467778899988776644433
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=375.38 Aligned_cols=263 Identities=20% Similarity=0.286 Sum_probs=220.4
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCC-----CCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
.++|++++.||+|+||.||+|+++.+++.||||+++.. .....+.+|+.+++.++| ++++.+..++...+..|+
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH-PFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCC-TTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCC-CcCcceEEEEEeCCEEEE
Confidence 47899999999999999999999999999999998642 234457889999998875 778888888888889999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 81 vme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
||||+ |++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 83 v~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 83 VMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCCT
T ss_pred EEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEE---CCCCCEEEeeccchhhcccC
Confidence 99999 8999999986 3579999999999999999999999999999999999999 68899999999999864332
Q ss_pred CCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHH
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (407)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+ ....+..+......
T Consensus 159 ~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~i~~~~~~----- 223 (337)
T 1o6l_A 159 GA-------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HERLFELILMEEIR----- 223 (337)
T ss_dssp TC-------CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCC-----
T ss_pred CC-------cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC---HHHHHHHHHcCCCC-----
Confidence 21 1346789999999999999999999999999999999999999997643 34455555444332
Q ss_pred HhcCCcHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCccccccchhhcc
Q 015406 240 LCRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQS 298 (407)
Q Consensus 240 ~~~~~~~~l~~li~~cl~~~p~~RP-----t~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~~~~ 298 (407)
++..+++++.++|.+||..||++|| ++++|++ ++|+..+||..+..++.
T Consensus 224 ~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~----------h~~f~~~~~~~~~~~~~ 277 (337)
T 1o6l_A 224 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME----------HRFFLSINWQDVVQKKL 277 (337)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT----------SGGGTTCCHHHHHTTCS
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc----------CCCcCCCCHHHHHhCCC
Confidence 2346899999999999999999999 7666643 36777889988766553
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=375.69 Aligned_cols=280 Identities=23% Similarity=0.416 Sum_probs=221.9
Q ss_pred CCceeEeccccccCceEEEEEEEcC--------CCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCC-------------
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQ--------TNEEVAIKLENVKTKHPQLLYESKLYRILQGGTG------------- 64 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~--------~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~------------- 64 (407)
+++|++.+.||+|+||.||+|++.. .++.||||++... ..+.+|+++++.++|++.
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL 117 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence 6899999999999999999999987 4889999998754 568899999999987332
Q ss_pred -CCeeEEeeee-CceeEEEEeccCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCC
Q 015406 65 -IPNVRWFGVE-GDYNVLVMDLLGPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 141 (407)
Q Consensus 65 -i~~~~~~~~~-~~~~~lvme~~g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~ 141 (407)
++.+..++.. ....|+||||++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++ .
T Consensus 118 ~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~---~ 194 (352)
T 2jii_A 118 AIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVD---P 194 (352)
T ss_dssp SCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEE---T
T ss_pred CccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEc---C
Confidence 3334455554 7889999999999999999864 35799999999999999999999999999999999999994 5
Q ss_pred Cc--eEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcC
Q 015406 142 AN--QVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 219 (407)
Q Consensus 142 ~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~ 219 (407)
++ .+||+|||+++.+..................||+.|+|||++.+..++.++|||||||+||||++|..||......
T Consensus 195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 274 (352)
T 2jii_A 195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN 274 (352)
T ss_dssp TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcC
Confidence 55 8999999999876543322111112234568999999999999999999999999999999999999999875422
Q ss_pred chHHHHHHHh--hhcccccHH--HHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccccc
Q 015406 220 TKKQKYEKIS--EKKVSTSIE--ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTI 292 (407)
Q Consensus 220 ~~~~~~~~i~--~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~dw~~ 292 (407)
. ........ ......... .....+++++.+++.+||+.||++||++.+|.+.|++++.+.+...+..+||+.
T Consensus 275 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~dw~~ 350 (352)
T 2jii_A 275 T-EDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDPIGLPM 350 (352)
T ss_dssp H-HHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSCCCCCC
T ss_pred H-HHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCccccCcC
Confidence 1 11111111 111111100 011357899999999999999999999999999999999999999999999974
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-49 Score=378.81 Aligned_cols=272 Identities=19% Similarity=0.241 Sum_probs=225.4
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCC-----CCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeE
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 79 (407)
..++|++.+.||+|+||.||+|++..+++.||||+++.. .....+..|..++..+.+|++++.+..++...+..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 457899999999999999999999999999999988643 233457788999888878899999999999999999
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 80 lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
+||||+ |++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 98 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCC
T ss_pred EEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---cCCCcEEEEeCCccccccc
Confidence 999999 89999999863 479999999999999999999999999999999999999 6889999999999986432
Q ss_pred CCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHH
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (407)
... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+ ..+.+..+......
T Consensus 174 ~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~---~~~~~~~i~~~~~~---- 239 (353)
T 2i0e_A 174 DGV-------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED---EDELFQSIMEHNVA---- 239 (353)
T ss_dssp TTC-------CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCC----
T ss_pred CCc-------ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC---HHHHHHHHHhCCCC----
Confidence 221 1346789999999999999999999999999999999999999997643 35556666554433
Q ss_pred HHhcCCcHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHHHHcCCCCCCccccccchhhcccccC
Q 015406 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYA--YLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLAT 302 (407)
Q Consensus 239 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~--~l~~~l~~l~~~~~~~~~~~~dw~~~~~~~~~~~~ 302 (407)
++..+++++.+||.+||..||++||+.. .+.+++ .++|+..+||+.+..++..++.
T Consensus 240 -~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~-------~h~~f~~~~w~~l~~~~~~~p~ 297 (353)
T 2i0e_A 240 -YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIK-------EHAFFRYIDWEKLERKEIQPPY 297 (353)
T ss_dssp -CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHH-------TSGGGTTCCHHHHHTTCSCCSC
T ss_pred -CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh-------cCccccCCCHHHHHhCCCCCCc
Confidence 2356899999999999999999999742 122222 2466778999988766644443
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=375.09 Aligned_cols=276 Identities=19% Similarity=0.268 Sum_probs=224.7
Q ss_pred CCCccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc-----chHHHHHHHHHHHcCCCCCCeeEEeeeeC
Q 015406 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKLYRILQGGTGIPNVRWFGVEG 75 (407)
Q Consensus 1 m~~~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~ 75 (407)
|++.-.++|++.+.||+|+||.||+|+++.+++.||||++...... ..+.+|..++..+.+|++++.+..++...
T Consensus 3 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~ 82 (345)
T 3a8x_A 3 MDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE 82 (345)
T ss_dssp CCCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred CCCCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC
Confidence 4566678999999999999999999999999999999998754321 23678999999886778899998888889
Q ss_pred ceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEecccee
Q 015406 76 DYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (407)
Q Consensus 76 ~~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~ 154 (407)
...|+||||+ |++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 83 ~~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFG~a~ 158 (345)
T 3a8x_A 83 SRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCK 158 (345)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCGGGCB
T ss_pred CEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEEeccccc
Confidence 9999999999 89999999863 579999999999999999999999999999999999999 688999999999998
Q ss_pred eeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCc------CchHHHHHHH
Q 015406 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA------GTKKQKYEKI 228 (407)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~------~~~~~~~~~i 228 (407)
....... .....+||+.|+|||++.+..++.++|||||||++|||++|..||..... ......+..+
T Consensus 159 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i 231 (345)
T 3a8x_A 159 EGLRPGD-------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 231 (345)
T ss_dssp CSCCTTC-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHH
T ss_pred cccCCCC-------cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHH
Confidence 6432221 13466899999999999999999999999999999999999999975322 1222334444
Q ss_pred hhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHHHHcCCCCCCccccccchhhccc
Q 015406 229 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA---YLKRIFRDLFIREGFQFDYVFDWTILKYQQSQ 299 (407)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~---~l~~~l~~l~~~~~~~~~~~~dw~~~~~~~~~ 299 (407)
...... ++..+++++.++|.+||..||++||++. .+.+++ .++|+..+||+.+..++..
T Consensus 232 ~~~~~~-----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~-------~hp~f~~~~w~~~~~~~~~ 293 (345)
T 3a8x_A 232 LEKQIR-----IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQ-------GHPFFRNVDWDMMEQKQVV 293 (345)
T ss_dssp HHCCCC-----CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHH-------TSGGGTTCCHHHHHTTCSC
T ss_pred HcCCCC-----CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHh-------cCCccCCCCHHHHHhCCCC
Confidence 443322 2356899999999999999999999962 223322 3467778999887665533
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=385.90 Aligned_cols=267 Identities=22% Similarity=0.280 Sum_probs=221.6
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecC-----CCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-----KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~-----~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
.++|++.++||+|+||.||+|+++.+++.||+|+++. ......+..|..++..+.| ++++.+..++.+.+..||
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~h-p~Iv~l~~~~~~~~~~~l 151 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS-KWITTLHYAFQDDNNLYL 151 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCT-TTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCC-CCEEEEEEEEeeCCEEEE
Confidence 4789999999999999999999999999999998764 2334458899999998865 778888888888899999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 81 vme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
||||+ |++|.+++......+++..++.++.||+.||.|||++|||||||||+|||| +.++.+||+|||+|+.....
T Consensus 152 V~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---~~~g~vkL~DFGla~~~~~~ 228 (437)
T 4aw2_A 152 VMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMED 228 (437)
T ss_dssp EECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCTT
T ss_pred EEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeE---cCCCCEEEcchhhhhhcccC
Confidence 99999 999999998656789999999999999999999999999999999999999 68899999999999876544
Q ss_pred CCCcccCccCCCCcccccccccccccc-----CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhccc
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (407)
... .....+||+.|+|||++. +..++.++|||||||+||||++|..||.+.+ ..+.+.++......
T Consensus 229 ~~~------~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~ 299 (437)
T 4aw2_A 229 GTV------QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES---LVETYGKIMNHKER 299 (437)
T ss_dssp SCE------ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHTHHHH
T ss_pred CCc------ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC---hhHHHHhhhhcccc
Confidence 321 123568999999999997 5568999999999999999999999998743 34555555443221
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhCCCCCC--CCCHHHHHHHHHHHHHHcCCCCCCccccccchh
Q 015406 235 TSIEALCRGYPTEFASYFHYCRSLRFDD--KPDYAYLKRIFRDLFIREGFQFDYVFDWTILKY 295 (407)
Q Consensus 235 ~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~ 295 (407)
...+.....+++++.+||.+||..+|++ ||+++++++ ++|...+||+.+..
T Consensus 300 ~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~----------Hpff~~i~w~~l~~ 352 (437)
T 4aw2_A 300 FQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK----------HPFFSGIDWDNIRN 352 (437)
T ss_dssp CCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT----------SGGGTTCCTTTGGG
T ss_pred ccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC----------CCccCCCCHHHHhh
Confidence 1222223458999999999999988888 899877654 47788899998843
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-49 Score=377.90 Aligned_cols=267 Identities=21% Similarity=0.297 Sum_probs=223.8
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCC-----CCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeE
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 79 (407)
..++|++.+.||+|+||.||+|+++.+++.||||+++.. .....+..|..++..+.+|++++.+..++.+.+..|
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 457899999999999999999999999999999988642 334457889999998867789999988889999999
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 80 lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
+||||+ |++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 95 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENML 170 (345)
T ss_dssp EEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCC
T ss_pred EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEE---CCCCCEEEeEChhhhhccc
Confidence 999999 99999999863 479999999999999999999999999999999999999 6788999999999986432
Q ss_pred CCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHH
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (407)
... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+ ..+.+..+......
T Consensus 171 ~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~i~~~~~~---- 236 (345)
T 1xjd_A 171 GDA-------KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD---EEELFHSIRMDNPF---- 236 (345)
T ss_dssp TTC-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCC----
T ss_pred CCC-------cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHHhCCCC----
Confidence 221 1346789999999999999999999999999999999999999998643 34555555544322
Q ss_pred HHhcCCcHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHHHHcCCCCCCccccccchhhcccc
Q 015406 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYA-YLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300 (407)
Q Consensus 239 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~-~l~~~l~~l~~~~~~~~~~~~dw~~~~~~~~~~ 300 (407)
+...+++++.++|.+||..||++||++. +|+ .++|...+||+.+...+..+
T Consensus 237 -~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~----------~hp~f~~~~w~~l~~~~~~~ 288 (345)
T 1xjd_A 237 -YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR----------QHPLFREINWEELERKEIDP 288 (345)
T ss_dssp -CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG----------GSGGGTTCCHHHHHTTCSCC
T ss_pred -CCcccCHHHHHHHHHHhcCCHhHcCCChHHHH----------cCccccCCCHHHHhhCCCCC
Confidence 2345889999999999999999999975 433 24677789999877655333
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=381.88 Aligned_cols=267 Identities=22% Similarity=0.299 Sum_probs=218.4
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCC-----CCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeE
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 79 (407)
..++|++.+.||+|+||.||+|+++.+++.||||+++.. .....+..|..++..+.| ++++.+..++.+.+..|
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~h-p~Iv~l~~~~~~~~~~~ 137 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR-RWITQLHFAFQDENYLY 137 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCT-TTBCCEEEEEECSSEEE
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCC-CCeeeEEEEEeeCCEEE
Confidence 357899999999999999999999999999999998642 223457889999988865 78888888888899999
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 80 lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
|||||+ |++|.+++...+..+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+++....
T Consensus 138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---d~~g~vkL~DFGla~~~~~ 214 (412)
T 2vd5_A 138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL---DRCGHIRLADFGSCLKLRA 214 (412)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCT
T ss_pred EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeee---cCCCCEEEeechhheeccC
Confidence 999999 999999998766689999999999999999999999999999999999999 6889999999999987654
Q ss_pred CCCCcccCccCCCCcccccccccccccc-------CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhh
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHL-------GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 231 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-------~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~ 231 (407)
.... .....+||+.|+|||++. +..++.++|||||||++|||++|..||.+.+ ..+.+.++...
T Consensus 215 ~~~~------~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~---~~~~~~~i~~~ 285 (412)
T 2vd5_A 215 DGTV------RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS---TAETYGKIVHY 285 (412)
T ss_dssp TSCE------ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHTH
T ss_pred CCcc------ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC---HHHHHHHHHhc
Confidence 3321 123568999999999997 4568999999999999999999999997743 34555555543
Q ss_pred cccccHHHHhcCCcHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHHHHHHcCCCCCCccccccchh
Q 015406 232 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP---DYAYLKRIFRDLFIREGFQFDYVFDWTILKY 295 (407)
Q Consensus 232 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP---t~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~ 295 (407)
......+.....+++++.+||.+||. +|++|+ ++++|+ .++|+..+||+.+..
T Consensus 286 ~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~----------~Hpff~~i~w~~l~~ 341 (412)
T 2vd5_A 286 KEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFR----------THPFFFGLDWDGLRD 341 (412)
T ss_dssp HHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHH----------TSGGGTTCCSTTSTT
T ss_pred ccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHh----------cCCCcCCCCHHHHhh
Confidence 22112222345689999999999999 999984 666654 347778899998753
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=369.63 Aligned_cols=262 Identities=21% Similarity=0.284 Sum_probs=220.8
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCC-----CCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
.++|++.+.||+|+||.||+|++..+|+.||+|+++.. .....+.+|..+++.+.| ++++.+..++.+....|+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH-PFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCB-TTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCC-CCCceEeEEEEeCCEEEE
Confidence 47899999999999999999999999999999988643 233457789999988865 777778888888889999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 81 vme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
||||+ |++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 84 v~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 84 IMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp EECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECSSC
T ss_pred EEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEE---cCCCCEEEeecCcceecCCc
Confidence 99999 8999999986 4579999999999999999999999999999999999999 68899999999999876432
Q ss_pred CCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHH
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (407)
....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+ ....+..+......
T Consensus 160 ----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~----- 221 (318)
T 1fot_A 160 ----------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN---TMKTYEKILNAELR----- 221 (318)
T ss_dssp ----------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHCCCC-----
T ss_pred ----------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCC-----
Confidence 235689999999999999999999999999999999999999997643 34555555554332
Q ss_pred HhcCCcHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCccccccchhhcccc
Q 015406 240 LCRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300 (407)
Q Consensus 240 ~~~~~~~~l~~li~~cl~~~p~~RP-----t~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~~~~~~ 300 (407)
+...+++++.++|.+||..||++|| +++++++ ++|...++|..+..+...+
T Consensus 222 ~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~----------hp~f~~~~~~~~~~~~~~~ 277 (318)
T 1fot_A 222 FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN----------HPWFKEVVWEKLLSRNIET 277 (318)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT----------SGGGSSCCHHHHHTTCSCC
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc----------CccccCCCHHHHHhCCCCC
Confidence 2345889999999999999999999 6665543 4677789999877665433
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=373.97 Aligned_cols=264 Identities=19% Similarity=0.301 Sum_probs=222.8
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCC-----CCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCcee
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 78 (407)
...++|++++.||+|+||.||+|++..+++.||||++... .....+.+|+.+++.+.| ++++.+..++.+....
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~ 116 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVKLEFSFKDNSNL 116 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEEcCCEE
Confidence 3457899999999999999999999999999999987542 233457889999998865 7777788888888899
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeec
Q 015406 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~ 157 (407)
|+||||+ |++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 117 ~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECS
T ss_pred EEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEE---CCCCCEEEcccccceecc
Confidence 9999999 99999999864 469999999999999999999999999999999999999 688999999999998764
Q ss_pred cCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccH
Q 015406 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (407)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (407)
.. ....+||+.|+|||++.+..++.++|||||||++|||++|..||.+. ...+.+..+......
T Consensus 193 ~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~---~~~~~~~~i~~~~~~--- 256 (350)
T 1rdq_E 193 GR----------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD---QPIQIYEKIVSGKVR--- 256 (350)
T ss_dssp SC----------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCC---
T ss_pred CC----------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC---CHHHHHHHHHcCCCC---
Confidence 42 23568999999999999999999999999999999999999999764 345566666555432
Q ss_pred HHHhcCCcHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHHHHcCCCCCCccccccchhhcccc
Q 015406 238 EALCRGYPTEFASYFHYCRSLRFDDKPD-----YAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300 (407)
Q Consensus 238 ~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~~~~~~ 300 (407)
++..+++++.++|.+||..||++||+ +++|++ ++|...+||..+..++..+
T Consensus 257 --~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~----------h~~f~~~~w~~~~~~~~~~ 312 (350)
T 1rdq_E 257 --FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN----------HKWFATTDWIAIYQRKVEA 312 (350)
T ss_dssp --CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT----------SGGGTTCCHHHHHTTCSCC
T ss_pred --CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh----------CcCcCCCCHHHHhhccCCC
Confidence 23568999999999999999999998 555543 4677789998877655433
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=365.92 Aligned_cols=262 Identities=23% Similarity=0.362 Sum_probs=214.0
Q ss_pred CccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc-----chHHHHHHHHHHHcCCCCCCeeEEeeeeCce
Q 015406 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (407)
Q Consensus 3 ~~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 77 (407)
..+.++|++.+.||+|+||.||+|++..+++.||+|++...... ..+.+|+.+++.++| ++++.+..++...+.
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-p~iv~~~~~~~~~~~ 85 (294)
T 4eqm_A 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH-QNIVSMIDVDEEDDC 85 (294)
T ss_dssp SCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCB-TTBCCEEEEEECSSE
T ss_pred hHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCC-CCCceEEEeeeeCCe
Confidence 45678999999999999999999999999999999987543322 347789999998876 677777788888889
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeee
Q 015406 78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~ 156 (407)
.|+||||+ |++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 86 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~ 161 (294)
T 4eqm_A 86 YYLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILI---DSNKTLKIFDFGIAKAL 161 (294)
T ss_dssp EEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCSSSTTC
T ss_pred EEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEEeCCCcccc
Confidence 99999999 88999999864 479999999999999999999999999999999999999 67889999999999865
Q ss_pred ccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhccccc
Q 015406 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (407)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (407)
..... .......||+.|+|||++.+..++.++||||||+++|+|++|..||.+... .....+.........
T Consensus 162 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~---~~~~~~~~~~~~~~~ 232 (294)
T 4eqm_A 162 SETSL------TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA---VSIAIKHIQDSVPNV 232 (294)
T ss_dssp -------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH---HHHHHHHHSSCCCCH
T ss_pred ccccc------cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHhhccCCCc
Confidence 44322 113356799999999999999999999999999999999999999977433 333333444444444
Q ss_pred HHHHhcCCcHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHHH
Q 015406 237 IEALCRGYPTEFASYFHYCRSLRFDDKP-DYAYLKRIFRDLFI 278 (407)
Q Consensus 237 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~~l~~~l~~l~~ 278 (407)
.......+|+.+.++|.+||+.||++|| +++++.+.|+.++.
T Consensus 233 ~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 233 TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 4556678999999999999999999998 88888888876543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-48 Score=376.04 Aligned_cols=270 Identities=20% Similarity=0.294 Sum_probs=224.8
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCC-----CCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeE
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 79 (407)
..++|++.+.||+|+||.||+|++..+++.||+|++... .....+.+|+.+++.++| ++++.+..++.+....|
T Consensus 13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~~~~~~ 91 (384)
T 4fr4_A 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH-PFLVNLWYSFQDEEDMF 91 (384)
T ss_dssp CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEEeCCEEE
Confidence 357899999999999999999999999999999987542 233467889999999975 77777888888888999
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 80 lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
+||||+ |++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++....
T Consensus 92 lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 92 MVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILL---DEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp EEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCT
T ss_pred EEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---CCCCCEEEeccceeeeccC
Confidence 999999 9999999985 4579999999999999999999999999999999999999 6889999999999987654
Q ss_pred CCCCcccCccCCCCccccccccccccccC---CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccc
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHLG---IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (407)
... ....+||+.|+|||++.+ ..++.++|||||||++|||++|..||.........+.+..+......
T Consensus 168 ~~~--------~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~- 238 (384)
T 4fr4_A 168 ETQ--------ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVT- 238 (384)
T ss_dssp TCC--------BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCC-
T ss_pred CCc--------eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccC-
Confidence 332 346789999999999974 45899999999999999999999999876665555555555443332
Q ss_pred cHHHHhcCCcHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHHHHcCCCCCCccccccchhhcccccC
Q 015406 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPD-YAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLAT 302 (407)
Q Consensus 236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~~~~~~~~ 302 (407)
....+++++.+||.+||+.||++||+ +++|+ .++|...++|..+...+..++.
T Consensus 239 ----~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~----------~hp~f~~~~w~~~~~~~~~p~~ 292 (384)
T 4fr4_A 239 ----YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ----------NFPYMNDINWDAVFQKRLIPGF 292 (384)
T ss_dssp ----CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHH----------TSGGGTTCCHHHHHTTCSCCCC
T ss_pred ----CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHH----------cChhhhcCCHHHHHhCCCCCCC
Confidence 23458899999999999999999998 44433 3467778999987766544433
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-48 Score=371.92 Aligned_cols=255 Identities=20% Similarity=0.274 Sum_probs=214.1
Q ss_pred CccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC--------cchHHHHHHHHHHHcCCCCCCeeEEeeee
Q 015406 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--------HPQLLYESKLYRILQGGTGIPNVRWFGVE 74 (407)
Q Consensus 3 ~~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~ 74 (407)
..+.++|++.+.||+|+||.||+|++..+|+.||+|++..... ...+.+|+.+++.+.| ++++.+..++.+
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~ 86 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH-PNIITLHDVYEN 86 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCC-TTBCCEEEEEEC
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCC-cCCCcEEEEEEe
Confidence 4567889999999999999999999999999999999875432 2357899999999985 677777778888
Q ss_pred CceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCC-CCceEEEEeccc
Q 015406 75 GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR-RANQVYIIDFGL 152 (407)
Q Consensus 75 ~~~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~-~~~~~kL~DFGl 152 (407)
....|+||||+ |++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+..+. ....+||+|||+
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 87 RTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred CCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 88999999999 9999999975 45799999999999999999999999999999999999994211 112799999999
Q ss_pred eeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhc
Q 015406 153 AKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (407)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (407)
++....... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+ ..+.+..+....
T Consensus 166 a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~---~~~~~~~i~~~~ 234 (361)
T 2yab_A 166 AHEIEDGVE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANITAVS 234 (361)
T ss_dssp CEECCTTCC--------CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHTTC
T ss_pred ceEcCCCCc--------cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhcC
Confidence 987755322 235679999999999999999999999999999999999999997743 345556665544
Q ss_pred ccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 233 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 233 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
... ....+..+++++.+||.+||..||++||++.++++
T Consensus 235 ~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 235 YDF-DEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CCC-CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCC-CchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 432 23455778999999999999999999999877653
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=377.27 Aligned_cols=269 Identities=21% Similarity=0.285 Sum_probs=221.9
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecC-----CCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-----KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~-----~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
.++|++.++||+|+||.||+|+++.+++.||+|++.. ......+..|+.+++.++| ++++.+..++.+....||
T Consensus 68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~~~~~~l 146 (410)
T 3v8s_A 68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS-PWVVQLFYAFQDDRYLYM 146 (410)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCC-TTBCCEEEEEECSSEEEE
T ss_pred ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCC-CCCCeEEEEEEECCEEEE
Confidence 5789999999999999999999999999999998754 2334558899999998875 777788888888999999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 81 vme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
||||+ |++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||| +.++.+||+|||+|+.....
T Consensus 147 V~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFG~a~~~~~~ 221 (410)
T 3v8s_A 147 VMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKE 221 (410)
T ss_dssp EECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCTT
T ss_pred EEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeE---CCCCCEEEeccceeEeeccC
Confidence 99999 9999999974 469999999999999999999999999999999999999 68899999999999876543
Q ss_pred CCCcccCccCCCCccccccccccccccCCC----CChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccc
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLGIE----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (407)
.. ......+||+.|+|||++.+.. ++.++|||||||+||||++|..||.+.+ ....+.++.......
T Consensus 222 ~~------~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~---~~~~~~~i~~~~~~~ 292 (410)
T 3v8s_A 222 GM------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS---LVGTYSKIMNHKNSL 292 (410)
T ss_dssp SE------EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHTHHHHC
T ss_pred Cc------ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC---hhhHHHHHHhccccc
Confidence 32 1134678999999999998765 7899999999999999999999998643 345555555432111
Q ss_pred cHHHHhcCCcHHHHHHHHHHhCCCCCC--CCCHHHHHHHHHHHHHHcCCCCCCccccccchhhcccc
Q 015406 236 SIEALCRGYPTEFASYFHYCRSLRFDD--KPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300 (407)
Q Consensus 236 ~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~~~~~~ 300 (407)
..+ ....+++++.+||.+||..+|.+ ||++++|++ ++|+..+||..+..++..+
T Consensus 293 ~~p-~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~----------Hp~f~~~~w~~~~~~~~~~ 348 (410)
T 3v8s_A 293 TFP-DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR----------HLFFKNDQWAWETLRDTVA 348 (410)
T ss_dssp CCC-TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT----------SGGGCCSSCCSTTGGGSCC
T ss_pred cCC-CcccccHHHHHHHHHHccChhhhCCCCCHHHHhc----------CccccCCCHHHHhhcccCC
Confidence 111 12458999999999999999988 999887754 4677788998776665433
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-48 Score=368.04 Aligned_cols=247 Identities=23% Similarity=0.335 Sum_probs=208.7
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc----chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeE
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 79 (407)
...++|++.+.||+|+||.||+|++..+|+.||||++...... ..+.+|+++++.++| ++++.+..+....+..|
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~~~~~ 90 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNH-PNIVKLFEVIETEKTLY 90 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEECCEEE
Confidence 3457899999999999999999999999999999998654322 347789999999986 67777777788888999
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 80 lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
+||||+ +++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 91 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLL---DADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp EEECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTCCGGGSS
T ss_pred EEEECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEE---cCCCCEEEeeccCceecCC
Confidence 999999 99999999764 579999999999999999999999999999999999999 6889999999999976544
Q ss_pred CCCCcccCccCCCCccccccccccccccCCCCC-hhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccH
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQS-RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (407)
... ....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+ ..+....+......
T Consensus 167 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~--- 232 (328)
T 3fe3_A 167 GGK--------LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN---LKELRERVLRGKYR--- 232 (328)
T ss_dssp SCG--------GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCC---
T ss_pred CCc--------cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCC---
Confidence 322 2456899999999999988875 89999999999999999999998743 34445555444332
Q ss_pred HHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 238 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
++..+++++.+++.+||..||.+|||++++++
T Consensus 233 --~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 233 --IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp --CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred --CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 22347899999999999999999999877654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=372.46 Aligned_cols=260 Identities=17% Similarity=0.309 Sum_probs=215.8
Q ss_pred CCceeEeccccccCceEEEEEEEc-------CCCeEEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeeeC
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNI-------QTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEG 75 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~-------~~~~~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~ 75 (407)
.++|++.+.||+|+||.||+|++. .++..||||+++..... ..+.+|+.+++.+.+|++++.+..++...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 468999999999999999999975 34568999998754332 34789999999996668888888888888
Q ss_pred ceeEEEEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCC
Q 015406 76 DYNVLVMDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 139 (407)
Q Consensus 76 ~~~~lvme~~-g~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~ 139 (407)
+..|+||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll--- 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV--- 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE---
Confidence 8899999999 889999998643 348999999999999999999999999999999999999
Q ss_pred CCCceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015406 140 RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 218 (407)
Q Consensus 140 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~ 218 (407)
+.++.+||+|||+++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~ 311 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTT-----CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred CCCCCEEEccccCCcccCcccce-----ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 67899999999999876543321 12334567899999999999999999999999999999999 9999987554
Q ss_pred CchHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHc
Q 015406 219 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (407)
Q Consensus 219 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~ 280 (407)
.. .+..+...... .....+++++.++|.+||+.||++||++.+|.+.|+.++...
T Consensus 312 ~~---~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 312 EE---LFKLLKEGHRM----DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp GG---HHHHHHTTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HH---HHHHHhcCCCC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 32 33333332221 123468899999999999999999999999999999987643
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-48 Score=366.30 Aligned_cols=254 Identities=18% Similarity=0.252 Sum_probs=214.4
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
.+.++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+|+.+++.++| ++++.+..++.+.+..++||
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH-RNILHLHESFESMEELVMIF 80 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCC-TTBCCEEEEEEETTEEEEEE
T ss_pred chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCC-CCCCeEeEEEecCCEEEEEE
Confidence 467899999999999999999999999999999999875432 2347789999999986 67777777788888999999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCC
Q 015406 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 83 e~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~ 161 (407)
||+ |++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.+ .++.+||+|||+++.+.....
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~-~~~~~kl~Dfg~a~~~~~~~~ 159 (321)
T 1tki_A 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCTTCEECCTTCE
T ss_pred EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccC-CCCCEEEEECCCCeECCCCCc
Confidence 999 889999998655679999999999999999999999999999999999999421 268999999999987754332
Q ss_pred CcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHh
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (407)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ..+.+..+........ ...+
T Consensus 160 --------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~-~~~~ 227 (321)
T 1tki_A 160 --------FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET---NQQIIENIMNAEYTFD-EEAF 227 (321)
T ss_dssp --------EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHTCCCCC-HHHH
T ss_pred --------cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC---HHHHHHHHHcCCCCCC-hhhh
Confidence 234578999999999999889999999999999999999999997743 3455555555544333 3345
Q ss_pred cCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 242 ~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
..+++++.++|.+||..||++||++.++++
T Consensus 228 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 228 KEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 678999999999999999999999777654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=362.00 Aligned_cols=249 Identities=22% Similarity=0.328 Sum_probs=207.3
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC--CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
..++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+|+.+++.++| ++++.+..++...+..++||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN-PNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCC-CCCCeEeEEEEECCEEEEEE
Confidence 3568999999999999999999999999999999876433 33457889999999876 67777777778888899999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCC
Q 015406 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 83 e~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~ 161 (407)
||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++........
T Consensus 97 e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 97 EYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp ECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSTTC
T ss_pred ECCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEE---CCCCCEEEeeCCCceecCCccc
Confidence 999 9999999985 369999999999999999999999999999999999999 5788999999999987654332
Q ss_pred CcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHh
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (407)
......||+.|+|||++.+..++.++|||||||++|||++|..||.+... ......+....... ....
T Consensus 172 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~~~~~~~~~--~~~~ 239 (297)
T 3fxz_A 172 -------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---LRALYLIATNGTPE--LQNP 239 (297)
T ss_dssp -------CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHHCSCC--CSCG
T ss_pred -------ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCCC--CCCc
Confidence 12456899999999999999999999999999999999999999976443 22232222222111 1123
Q ss_pred cCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 242 ~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
..+++.+.++|.+||+.||++||++.++++
T Consensus 240 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 240 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 458899999999999999999999877753
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-48 Score=400.11 Aligned_cols=272 Identities=19% Similarity=0.248 Sum_probs=229.5
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecC-----CCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-----KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~-----~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
.++|++++.||+|+||.||+|++..+++.||||+++. ......+..|..++..+.++++++.+..++.+.+..||
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 5789999999999999999999999999999998764 23445578899999988889999999999999999999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 81 vme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
||||+ |++|.+++... +.+++..++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.....
T Consensus 420 V~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl---~~~g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIWD 495 (674)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEE---CSSSCEEECCCTTCEECCCT
T ss_pred EEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEE---cCCCcEEEeecceeeccccC
Confidence 99999 99999999864 579999999999999999999999999999999999999 68899999999999864332
Q ss_pred CCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHH
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (407)
.. .....+||+.|+|||++.+..|+.++|||||||+||||++|..||.+. +..+.+..+......
T Consensus 496 ~~-------~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~---~~~~~~~~i~~~~~~----- 560 (674)
T 3pfq_A 496 GV-------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE---DEDELFQSIMEHNVA----- 560 (674)
T ss_dssp TC-------CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHSSCCC-----
T ss_pred Cc-------ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC---CHHHHHHHHHhCCCC-----
Confidence 22 134678999999999999999999999999999999999999999874 345666666665443
Q ss_pred HhcCCcHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHHHHcCCCCCCccccccchhhcccccCC
Q 015406 240 LCRGYPTEFASYFHYCRSLRFDDKPDYA--YLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATP 303 (407)
Q Consensus 240 ~~~~~~~~l~~li~~cl~~~p~~RPt~~--~l~~~l~~l~~~~~~~~~~~~dw~~~~~~~~~~~~~ 303 (407)
++..+++++.+||.+||..||++||++. ...++ ..++|+..+||+.+..++.+++..
T Consensus 561 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei-------~~h~ff~~i~w~~l~~~~~~pp~~ 619 (674)
T 3pfq_A 561 YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDI-------KEHAFFRYIDWEKLERKEIQPPYK 619 (674)
T ss_dssp CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHH-------HSSGGGSSCCHHHHTTTCSCCSCC
T ss_pred CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHH-------hcCccccCCCHHHHHhCCCCCCCC
Confidence 2356899999999999999999999971 11222 235777889999988776544443
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=374.63 Aligned_cols=271 Identities=19% Similarity=0.259 Sum_probs=214.7
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeE
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 79 (407)
..++|++++.||+|+||.||+|+++.+++.||||++.... ....+..|..++....+|++++.+..++...+..|
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 3468999999999999999999999999999999986532 22335556555333234588888888888899999
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 80 lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
+||||+ |++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 116 lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCBCGGGBC
T ss_pred EEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEeeCcccccccc
Confidence 999999 8999999986 3579999999999999999999999999999999999999 6889999999999985433
Q ss_pred CCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHH
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (407)
... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+. +..+.+..+......
T Consensus 192 ~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~---~~~~~~~~i~~~~~~---- 257 (373)
T 2r5t_A 192 HNS-------TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR---NTAEMYDNILNKPLQ---- 257 (373)
T ss_dssp CCC-------CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS---BHHHHHHHHHHSCCC----
T ss_pred CCC-------ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHhcccC----
Confidence 221 134678999999999999999999999999999999999999999764 345566666554332
Q ss_pred HHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchhhcccc
Q 015406 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300 (407)
Q Consensus 239 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~~~~~~ 300 (407)
+...+++++.+||.+||..||.+||++.+. +.++ ..++|+..+||+.+..++..+
T Consensus 258 -~~~~~~~~~~~li~~lL~~dp~~R~~~~~~---~~~i---~~h~~f~~~~w~~l~~~~~~p 312 (373)
T 2r5t_A 258 -LKPNITNSARHLLEGLLQKDRTKRLGAKDD---FMEI---KSHVFFSLINWDDLINKKITP 312 (373)
T ss_dssp -CCSSSCHHHHHHHHHHTCSSGGGSTTTTTT---HHHH---HTSGGGTTCCHHHHHTTCSCC
T ss_pred -CCCCCCHHHHHHHHHHcccCHHhCCCCCCC---HHHH---hCCccccCCCHHHHHhCCCCC
Confidence 235689999999999999999999997522 2222 234677789999887665433
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=367.90 Aligned_cols=256 Identities=20% Similarity=0.224 Sum_probs=216.0
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
.+.++|++.+.||+|+||.||+|+++.+++.||||++.... ....+|++++..+.+|++++.+..++.+....|+|||
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK--RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT--CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc--CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 34678999999999999999999999999999999987543 3457899999999777899999999999999999999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCC-CCCceEEEEeccceeeeccCCC
Q 015406 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG-RRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 84 ~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~-~~~~~~kL~DFGla~~~~~~~~ 161 (407)
|+ |++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+... +..+.+||+|||+++.......
T Consensus 97 ~~~gg~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~ 175 (342)
T 2qr7_A 97 LMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175 (342)
T ss_dssp CCCSCBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC
T ss_pred CCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC
Confidence 99 8999999975 4579999999999999999999999999999999999998422 2235699999999997655432
Q ss_pred CcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHh
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (407)
. ....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.......+.+..+........ ...+
T Consensus 176 ~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~-~~~~ 247 (342)
T 2qr7_A 176 L-------LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLS-GGYW 247 (342)
T ss_dssp C-------BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCC-STTT
T ss_pred c-------eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccC-cccc
Confidence 1 2356789999999999988899999999999999999999999987655566666776666554322 2234
Q ss_pred cCCcHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015406 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 242 ~~~~~~l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
..+++++.+||.+||..||++||++.+++
T Consensus 248 ~~~s~~~~~li~~~L~~dP~~R~t~~~il 276 (342)
T 2qr7_A 248 NSVSDTAKDLVSKMLHVDPHQRLTAALVL 276 (342)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 56899999999999999999999977664
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-47 Score=357.79 Aligned_cols=256 Identities=18% Similarity=0.260 Sum_probs=208.2
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc----chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeE
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 79 (407)
.+.++|++.++||+|+||.||+|++ .+++.||+|++...... ..+.+|+.+++.++| ++++.+..++......+
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~ 95 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHH-PNIVSLIDVIHSERCLT 95 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEE-TTSCEEEEEEEC------CHHHHHHHHHHHHHHCCC-TTBCCEEEEECCSSCEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEE-CCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCC-CCEeeeeeEEccCCEEE
Confidence 4678999999999999999999998 46899999988654332 357889999999976 67777777777888899
Q ss_pred EEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 80 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 80 lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
+||||+.++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 96 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 96 LVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI---NSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp EEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEETTSC
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEE---CCCCCEEEccCcCceecCCC
Confidence 999999889999998766679999999999999999999999999999999999999 57889999999999876543
Q ss_pred CCCcccCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcc-----
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV----- 233 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~----- 233 (407)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+..+.....
T Consensus 173 ~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 245 (311)
T 3niz_A 173 VR-------SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWP 245 (311)
T ss_dssp CC----------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSG
T ss_pred cc-------cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhh
Confidence 22 1234578999999999986 5689999999999999999999999988766555444443322211
Q ss_pred -----------------cccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 234 -----------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 234 -----------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
......+.+.+++++.+||.+||..||++|||++++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 11223344568899999999999999999999887754
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=368.47 Aligned_cols=253 Identities=21% Similarity=0.276 Sum_probs=212.2
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc----chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
+.++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+|+.+++.++| ++++.+..++.+.+..|+
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH-PNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEEeCCEEEE
Confidence 346899999999999999999999999999999998765432 347789999999976 677777788888889999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 81 vme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
||||+ |++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++.+||+|||+++.....
T Consensus 106 v~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp EECCCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred EEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 99999 8899999875 457999999999999999999999999999999999999964444567999999999876543
Q ss_pred CCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHH
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (407)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+ ....+..+......... .
T Consensus 185 ~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~---~~~~~~~i~~~~~~~~~-~ 252 (362)
T 2bdw_A 185 EA--------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYAQIKAGAYDYPS-P 252 (362)
T ss_dssp CS--------CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCCCT-T
T ss_pred cc--------cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhCCCCCCc-c
Confidence 22 235689999999999999999999999999999999999999997743 34555555554433222 2
Q ss_pred HhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 240 ~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.+..+++++.+||.+||..||++||++.++++
T Consensus 253 ~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 253 EWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 33568999999999999999999999887753
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=363.79 Aligned_cols=256 Identities=24% Similarity=0.338 Sum_probs=209.2
Q ss_pred CCCccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCce
Q 015406 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (407)
Q Consensus 1 m~~~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 77 (407)
|...+.++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+|+.+++.++| ++++.+..++.+.+.
T Consensus 1 m~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~ 79 (323)
T 3tki_A 1 MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-ENVVKFYGHRREGNI 79 (323)
T ss_dssp -CCTTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCC-TTBCCEEEEEECSSE
T ss_pred CCCcHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCC-CCCCeEEEEEecCCe
Confidence 667788999999999999999999999999999999999865432 3568899999999986 677777788888889
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeee
Q 015406 78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~ 156 (407)
.|+||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.+
T Consensus 80 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~ 155 (323)
T 3tki_A 80 QYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVF 155 (323)
T ss_dssp EEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEE---eCCCCEEEEEeecccee
Confidence 99999999 8899999874 4469999999999999999999999999999999999999 67889999999999876
Q ss_pred ccCCCCcccCccCCCCccccccccccccccCCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccc
Q 015406 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (407)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (407)
...... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||....... ..+..........
T Consensus 156 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~~~~~~~~~~ 228 (323)
T 3tki_A 156 RYNNRE-----RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--QEYSDWKEKKTYL 228 (323)
T ss_dssp EETTEE-----CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS--HHHHHHHTTCTTS
T ss_pred ccCCcc-----cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH--HHHHHHhcccccC
Confidence 543321 11245689999999999998776 789999999999999999999998654432 2222222222111
Q ss_pred cHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.....+++++.+||.+||..||++||++.++++
T Consensus 229 ---~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 229 ---NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp ---TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---CccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 113458899999999999999999999877753
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=367.29 Aligned_cols=255 Identities=18% Similarity=0.221 Sum_probs=210.9
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCC-------CCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCc
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-------TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGD 76 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 76 (407)
.+.++|++.+.||+|+||.||+|++..+++.||||++... .....+.+|+.+++.++| ++|+.+..++...+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~ 99 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH-PHIVELLETYSSDG 99 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCC-TTBCCEEEEEEETT
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCC-CCCCcEEEEEEeCC
Confidence 3467899999999999999999999999999999987532 124568899999999976 67777777778888
Q ss_pred eeEEEEecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccc
Q 015406 77 YNVLVMDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 152 (407)
Q Consensus 77 ~~~lvme~~-g~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGl 152 (407)
..|+||||+ |++|.+++... +..+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||+
T Consensus 100 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 100 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999 89998887542 23589999999999999999999999999999999999996444456699999999
Q ss_pred eeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhc
Q 015406 153 AKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (407)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (407)
++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+. ..+.+..+....
T Consensus 180 a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~----~~~~~~~i~~~~ 248 (351)
T 3c0i_A 180 AIQLGESGL-------VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT----KERLFEGIIKGK 248 (351)
T ss_dssp CEECCTTSC-------BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS----HHHHHHHHHHTC
T ss_pred eeEecCCCe-------eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc----HHHHHHHHHcCC
Confidence 987755322 123567999999999999999999999999999999999999999763 234445554444
Q ss_pred ccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 233 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 233 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.... ...+..+++++.+||.+||..||++||++.++++
T Consensus 249 ~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 249 YKMN-PRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CCCC-HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCC-ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 3322 2344678999999999999999999999887753
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=357.46 Aligned_cols=245 Identities=18% Similarity=0.205 Sum_probs=203.5
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc----chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
.++|++.++||+|+||.||+|++..+++.||||++...... .....|+..+..+.+|++++.+..++.+.+..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 36799999999999999999999999999999987654322 23556666677776778899998889999999999
Q ss_pred EeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCC
Q 015406 82 MDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 82 me~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~ 161 (407)
|||++++|.+++...+..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 136 ~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~DFG~a~~~~~~~~ 212 (311)
T 3p1a_A 136 TELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL---GPRGRCKLGDFGLLVELGTAGA 212 (311)
T ss_dssp EECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CGGGCEEECCCTTCEECC----
T ss_pred EeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEccceeeeecccCCC
Confidence 9999999999998777789999999999999999999999999999999999999 6889999999999987654332
Q ss_pred CcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHh
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (407)
.....||+.|+|||++.+ .++.++|||||||++|||++|..||.+. .....+..... ...+.
T Consensus 213 --------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~------~~~~~~~~~~~---~~~~~ 274 (311)
T 3p1a_A 213 --------GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG------EGWQQLRQGYL---PPEFT 274 (311)
T ss_dssp ----------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH------HHHHHHTTTCC---CHHHH
T ss_pred --------CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc------cHHHHHhccCC---Ccccc
Confidence 234579999999999987 7999999999999999999997766541 22333333322 23455
Q ss_pred cCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 242 ~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
..+++++.++|.+||+.||++||++.++++
T Consensus 275 ~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 275 AGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 678999999999999999999999888764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=376.03 Aligned_cols=255 Identities=20% Similarity=0.243 Sum_probs=213.5
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc----chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeE
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 79 (407)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+|+.+++.++| ++|+.+..++.+.+..|
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~~~~ 86 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH-PNIVRLHDSISEEGHHY 86 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCB-TTBCCEEEEEECSSEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCC-cCCCeEEEEEEECCEEE
Confidence 4567899999999999999999999999999999998765432 347899999999976 67777777888889999
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 80 lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
+||||+ |++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+..++.+||+|||+++....
T Consensus 87 lv~E~~~gg~L~~~i~~-~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp EEECCCBCCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred EEEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 999999 8999999986 45799999999999999999999999999999999999996444678999999999987654
Q ss_pred CCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHH
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (407)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ....+..+.........
T Consensus 166 ~~~-------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~---~~~~~~~i~~~~~~~~~- 234 (444)
T 3soa_A 166 EQQ-------AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED---QHRLYQQIKAGAYDFPS- 234 (444)
T ss_dssp TCC-------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHTCCCCCT-
T ss_pred CCc-------eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc---HHHHHHHHHhCCCCCCc-
Confidence 332 1235689999999999999999999999999999999999999997643 35555555555443222
Q ss_pred HHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 239 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
..+..+++++.+||.+||+.||++||++.++++
T Consensus 235 ~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 235 PEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 233568999999999999999999999888764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-47 Score=360.93 Aligned_cols=254 Identities=19% Similarity=0.245 Sum_probs=211.1
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC--------cchHHHHHHHHHHHcCCCCCCeeEEeeeeC
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--------HPQLLYESKLYRILQGGTGIPNVRWFGVEG 75 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~ 75 (407)
.+.++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+|+.+++.++| ++++.+..++...
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~ 86 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH-PNVITLHEVYENK 86 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCC-TTBCCEEEEEECS
T ss_pred CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCC-CCCCcEEEEEEeC
Confidence 456789999999999999999999999999999998865432 2358899999999986 6777777778888
Q ss_pred ceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCC-CCceEEEEeccce
Q 015406 76 DYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR-RANQVYIIDFGLA 153 (407)
Q Consensus 76 ~~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~-~~~~~kL~DFGla 153 (407)
...++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+. ....+||+|||++
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 87 TDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp SEEEEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CEEEEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 8999999999 8999999975 45799999999999999999999999999999999999994211 1238999999999
Q ss_pred eeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcc
Q 015406 154 KKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (407)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (407)
+....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ..+.+..+.....
T Consensus 166 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~~~~~~~ 234 (326)
T 2y0a_A 166 HKIDFGNE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANVSAVNY 234 (326)
T ss_dssp EECCTTSC--------CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHHTCC
T ss_pred eECCCCCc--------cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC---HHHHHHHHHhcCC
Confidence 87754322 235679999999999999999999999999999999999999997643 3444444444333
Q ss_pred cccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 234 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
. ........+++++.++|.+||..||++||++.++++
T Consensus 235 ~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 235 E-FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp C-CCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred C-cCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 2 223455678999999999999999999999887764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=365.43 Aligned_cols=260 Identities=17% Similarity=0.261 Sum_probs=212.9
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCe---EEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeeeCcee
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNE---EVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~---~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 78 (407)
..++|++.+.||+|+||.||+|++..+++ .||||++...... ..+.+|+.+++.++| ++++.+..++......
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~ 125 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDH-PNIIRLEGVVTRGRLA 125 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEECGGGCC
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEEeCCcc
Confidence 45789999999999999999999986554 5999998754332 347889999999975 6777777777888889
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeec
Q 015406 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~ 157 (407)
|+||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCSSCEECC
T ss_pred EEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---CCCCCEEECCCCcccccc
Confidence 9999999 889999998666789999999999999999999999999999999999999 678999999999999775
Q ss_pred cCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhccccc
Q 015406 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (407)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (407)
...... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+... .+....+.......
T Consensus 203 ~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~---~~~~~~~~~~~~~~- 274 (325)
T 3kul_A 203 DDPDAA----YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN---RDVISSVEEGYRLP- 274 (325)
T ss_dssp ----CC----EECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH---HHHHHHHHTTCCCC-
T ss_pred cCccce----eeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHcCCCCC-
Confidence 543211 11234456889999999998899999999999999999999 9999977543 33444443332211
Q ss_pred HHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHH
Q 015406 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (407)
Q Consensus 237 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~ 279 (407)
....+++++.++|.+||..||++||++.+|.+.|+.++..
T Consensus 275 ---~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 275 ---APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ---CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 2346899999999999999999999999999999998754
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=360.60 Aligned_cols=264 Identities=18% Similarity=0.250 Sum_probs=213.7
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC--CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
.++|++.+.||+|+||.||+|++..+++.||+|.+.... ....+.+|+++++.++| ++++.+..++.+....++|||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEH-PNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEEEETTEEEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCC-cCcccEEEEEecCCeeEEEEE
Confidence 478999999999999999999999999999999875432 22357899999999985 777777788888899999999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 84 ~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
|+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++........
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 88 YIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp CCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE---CTTSCEEECCCTTCEECC-----
T ss_pred ecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEE---CCCCCEEEeecccceeccccccc
Confidence 99 889999999767789999999999999999999999999999999999999 67889999999999876543321
Q ss_pred ccc-------CccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHH--HHHHHhhhcc
Q 015406 163 QHI-------PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ--KYEKISEKKV 233 (407)
Q Consensus 163 ~~~-------~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~--~~~~i~~~~~ 233 (407)
... .........||+.|+|||++.+..++.++||||||+++|||++|..||.......... .......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~--- 241 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD--- 241 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH---
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc---
Confidence 100 0011125679999999999999999999999999999999999999997643321110 0111111
Q ss_pred cccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHc
Q 015406 234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (407)
Q Consensus 234 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~ 280 (407)
......+|+++.+++.+||+.||++||++.++.+.|+.+....
T Consensus 242 ----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 242 ----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp ----HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 1123568899999999999999999999999999999886554
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=356.26 Aligned_cols=254 Identities=19% Similarity=0.247 Sum_probs=203.6
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-------CcchHHHHHHHHHHHc--CCCCCCeeEEeeee
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-------KHPQLLYESKLYRILQ--GGTGIPNVRWFGVE 74 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-------~~~~~~~E~~~l~~l~--~~~~i~~~~~~~~~ 74 (407)
.+.++|++.++||+|+||.||+|++..+++.||||++.... ....+.+|+.+++.++ +|++++.+..++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 56789999999999999999999999999999999876432 1235788999988887 35666666665554
Q ss_pred Cc-----eeEEEEeccCCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEE
Q 015406 75 GD-----YNVLVMDLLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 148 (407)
Q Consensus 75 ~~-----~~~lvme~~g~sL~~~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~ 148 (407)
.. ..++||||++++|.+++..... .+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+
T Consensus 86 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~---~~~~~~kl~ 162 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGTVKLA 162 (308)
T ss_dssp CCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEE---CTTSCEEEC
T ss_pred cCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCEEEe
Confidence 33 5799999998899999986432 39999999999999999999999999999999999999 578899999
Q ss_pred eccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHH
Q 015406 149 DFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228 (407)
Q Consensus 149 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i 228 (407)
|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.... ..+..+
T Consensus 163 Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~i 231 (308)
T 3g33_A 163 DFGLARIYSYQMA--------LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA---DQLGKI 231 (308)
T ss_dssp SCSCTTTSTTCCC--------SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH---HHHHHH
T ss_pred eCccccccCCCcc--------cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH
Confidence 9999986543322 23567899999999999999999999999999999999999999875443 333333
Q ss_pred hhhc----------------------ccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 229 SEKK----------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 229 ~~~~----------------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.... .......+.+.+++++.+||.+||+.||++|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 232 FDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 2211 112233455678999999999999999999999887653
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=365.87 Aligned_cols=255 Identities=18% Similarity=0.210 Sum_probs=197.0
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
.+.++|++.+.||+|+||.||+|++..+++.||||++........+.+|+.+++.++| ++++.+..++......++|||
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSH-PNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCC-TTBCCEEEEEECSSEEEEEEC
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCC-CCCcceeeeEecCCeEEEEEE
Confidence 3567799999999999999999999999999999998876666678899999999986 667777777788888999999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 84 ~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
|+ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||+++.......
T Consensus 129 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~- 206 (349)
T 2w4o_A 129 LVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL- 206 (349)
T ss_dssp CCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----------
T ss_pred eCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccc-
Confidence 99 8999999975 45699999999999999999999999999999999999996444588999999999987654321
Q ss_pred cccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhc
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (407)
.....||+.|+|||++.+..++.++|||||||++|||++|..||..... ....+..+...... .......
T Consensus 207 -------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~~i~~~~~~-~~~~~~~ 276 (349)
T 2w4o_A 207 -------MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG--DQFMFRRILNCEYY-FISPWWD 276 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC--HHHHHHHHHTTCCC-CCTTTTT
T ss_pred -------cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc--cHHHHHHHHhCCCc-cCCchhh
Confidence 2356799999999999999999999999999999999999999976433 22344444443322 1223345
Q ss_pred CCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 243 ~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.++.++.+||.+||..||++||++.++++
T Consensus 277 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 277 EVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 68999999999999999999999877654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-47 Score=360.66 Aligned_cols=267 Identities=19% Similarity=0.263 Sum_probs=208.8
Q ss_pred ccCCceeEeccccccCceEEEEEEEc---CCCeEEEEEEecCCC------CcchHHHHHHHHHHHcCCCCCCeeEEeeee
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKT------KHPQLLYESKLYRILQGGTGIPNVRWFGVE 74 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~---~~~~~vAvK~~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~ 74 (407)
...++|++.+.||+|+||.||+|++. .+++.||+|+++... ....+.+|+.+++.++| ++++.+..++..
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~ 92 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKH-PFIVDLIYAFQT 92 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCC-TTBCCEEEEEEC
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCC-CCccceeEEEEc
Confidence 34678999999999999999999985 689999999987542 23347789999999986 677777777788
Q ss_pred CceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccce
Q 015406 75 GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (407)
Q Consensus 75 ~~~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla 153 (407)
.+..|+||||+ |++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML---NHQGHVKLTDFGLC 168 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTSCEEECCCSCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEE---CCCCcEEEEeCCcc
Confidence 88899999999 89999999863 469999999999999999999999999999999999999 57889999999999
Q ss_pred eeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcc
Q 015406 154 KKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (407)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (407)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ..+.+..+.....
T Consensus 169 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~~~~ 238 (327)
T 3a62_A 169 KESIHDGT-------VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN---RKKTIDKILKCKL 238 (327)
T ss_dssp -----------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHTCC
T ss_pred cccccCCc-------cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhCCC
Confidence 86433221 1235679999999999999999999999999999999999999997643 3444555544433
Q ss_pred cccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHHHHcCCCCCCccccccchhhc
Q 015406 234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA--YLKRIFRDLFIREGFQFDYVFDWTILKYQQ 297 (407)
Q Consensus 234 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~--~l~~~l~~l~~~~~~~~~~~~dw~~~~~~~ 297 (407)
. +...+++++.++|.+||..||++||++. .+.+++++ +|...++|+.+....
T Consensus 239 ~-----~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h-------p~f~~~~~~~~~~~~ 292 (327)
T 3a62_A 239 N-----LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH-------PFFRHINWEELLARK 292 (327)
T ss_dssp C-----CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS-------GGGSSCCHHHHHTTC
T ss_pred C-----CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC-------CcccCCCHHHHhhcc
Confidence 2 2345889999999999999999999432 23333332 556678898765544
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=372.49 Aligned_cols=255 Identities=17% Similarity=0.172 Sum_probs=198.9
Q ss_pred cCCceeEe-ccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeeee----CceeE
Q 015406 5 VGNKFRLG-RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVE----GDYNV 79 (407)
Q Consensus 5 ~~~~y~i~-~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~----~~~~~ 79 (407)
+.++|.+. +.||+|+||.||+|++..+++.||||++.. ...+.+|+.++.++.+|++|+.+..++.. ....|
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~---~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC---SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc---chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 45678777 789999999999999999999999999863 35678899998887777888887766553 56789
Q ss_pred EEEecc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeec
Q 015406 80 LVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (407)
Q Consensus 80 lvme~~-g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~ 157 (407)
|||||+ |++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+|||++..+.++.+||+|||+++...
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~ 215 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 215 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccC
Confidence 999999 889999998532 359999999999999999999999999999999999999643337899999999998765
Q ss_pred cCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCch-HHHHHHHhhhccccc
Q 015406 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYEKISEKKVSTS 236 (407)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~-~~~~~~i~~~~~~~~ 236 (407)
.... ....+||+.|+|||++.+..++.++|||||||+||||++|..||.+...... ......+........
T Consensus 216 ~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~ 287 (400)
T 1nxk_A 216 SHNS--------LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 287 (400)
T ss_dssp -------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCC
T ss_pred CCCc--------cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCC
Confidence 4322 2356889999999999999999999999999999999999999987543221 112223333322211
Q ss_pred HHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 237 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
. ..+..+++++.+||.+||..||++||++.++++
T Consensus 288 ~-~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 288 N-PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp T-TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C-cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1 123568999999999999999999999776654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=366.65 Aligned_cols=262 Identities=19% Similarity=0.290 Sum_probs=213.1
Q ss_pred cCCceeEeccccccCceEEEEEE-----EcCCCeEEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeee-C
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVE-G 75 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~-----~~~~~~~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~-~ 75 (407)
..++|++.+.||+|+||.||+|+ +..+++.||||++...... ..+.+|++++..+.+|++++.+..++.. +
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 99 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 99 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC
Confidence 35789999999999999999999 4566789999998765433 3488999999999877888887776654 4
Q ss_pred ceeEEEEecc-CCCHHHHHHHcCC--------------------------------------------------------
Q 015406 76 DYNVLVMDLL-GPSLEDLFNFCSR-------------------------------------------------------- 98 (407)
Q Consensus 76 ~~~~lvme~~-g~sL~~~l~~~~~-------------------------------------------------------- 98 (407)
...++||||+ +++|.+++.....
T Consensus 100 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (359)
T 3vhe_A 100 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179 (359)
T ss_dssp SCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------------
T ss_pred CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhc
Confidence 5589999999 8899999975432
Q ss_pred ---------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcccCccC
Q 015406 99 ---------KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRE 169 (407)
Q Consensus 99 ---------~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 169 (407)
.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++........ ..
T Consensus 180 ~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~-----~~ 251 (359)
T 3vhe_A 180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDY-----VR 251 (359)
T ss_dssp ----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCGGGSCTTSCTTC-----EE
T ss_pred ccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCcEEEEeccceeeecccccc-----hh
Confidence 18999999999999999999999999999999999999 68899999999999866443321 12
Q ss_pred CCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcHHH
Q 015406 170 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEF 248 (407)
Q Consensus 170 ~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l 248 (407)
.....||+.|+|||++.+..++.++|||||||++|||++ |..||.+..... .....+...... .....+++++
T Consensus 252 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~~~~~~~----~~~~~~~~~l 325 (359)
T 3vhe_A 252 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRLKEGTRM----RAPDYTTPEM 325 (359)
T ss_dssp C--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHHHHHHHTCCC----CCCTTCCHHH
T ss_pred ccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--HHHHHHHcCCCC----CCCCCCCHHH
Confidence 345678999999999999999999999999999999998 999998755432 222222222111 1234588999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHc
Q 015406 249 ASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (407)
Q Consensus 249 ~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~ 280 (407)
.+++.+||+.||++||++.++.+.|+.++...
T Consensus 326 ~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 326 YQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 99999999999999999999999999987643
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=366.93 Aligned_cols=268 Identities=31% Similarity=0.519 Sum_probs=199.4
Q ss_pred ccCCceeEeccccccCceEEEEEEEcC---CCeEEEEEEecCCCC-------------cchHHHHHHHHHHHcCCCCCCe
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQ---TNEEVAIKLENVKTK-------------HPQLLYESKLYRILQGGTGIPN 67 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~---~~~~vAvK~~~~~~~-------------~~~~~~E~~~l~~l~~~~~i~~ 67 (407)
..+++|++.+.||+|+||.||+|++.. ++..||||+...... ...+.+|+.++..+.| ++++.
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h-~ni~~ 112 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDY-LGIPL 112 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSC-CCCCC
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccc-cCcce
Confidence 356799999999999999999999987 788999998875432 1124455555555565 66666
Q ss_pred eEEeeee----CceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCc
Q 015406 68 VRWFGVE----GDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN 143 (407)
Q Consensus 68 ~~~~~~~----~~~~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~ 143 (407)
+..++.. ....|+||||++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++ .++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~ 188 (345)
T 2v62_A 113 FYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLG---YKN 188 (345)
T ss_dssp EEEEEEEESSSCEEEEEEEECEEEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---SSS
T ss_pred eecccccccCCCcEEEEEEeccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEc---cCC
Confidence 6666555 78899999999999999997543 799999999999999999999999999999999999994 444
Q ss_pred --eEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCch
Q 015406 144 --QVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 221 (407)
Q Consensus 144 --~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~ 221 (407)
.+||+|||+++.+..................||+.|+|||++.+..++.++|||||||++|||++|..||.+......
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 999999999987754332211111112456899999999999999999999999999999999999999965322211
Q ss_pred -HHHHHHHhhhcccccHHHHhc--CCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 015406 222 -KQKYEKISEKKVSTSIEALCR--GYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (407)
Q Consensus 222 -~~~~~~i~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l 276 (407)
............+........ .+|+++.++|.+||..||++||++.+|.+.|+++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 269 AVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred HHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 111111111122222222222 7899999999999999999999999999988764
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=356.12 Aligned_cols=268 Identities=21% Similarity=0.263 Sum_probs=208.0
Q ss_pred CCccCCceeEe-ccccccCceEEEEEEEcCCCeEEEEEEecCCCC--cchHHHHHHHHHHHcCCCCCCeeEEeeeeCcee
Q 015406 2 EPRVGNKFRLG-RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (407)
Q Consensus 2 ~~~~~~~y~i~-~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 78 (407)
..++.++|++. +.||+|+||.||+|++..+++.||||++..... ...+.+|+.++..+.+|++++.+..++...+..
T Consensus 7 ~~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~ 86 (316)
T 2ac3_A 7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRF 86 (316)
T ss_dssp CCCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred CcccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 34678899995 789999999999999999999999999865432 345889999999987778888888888899999
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeec
Q 015406 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~ 157 (407)
|+||||+ +++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++....+||+|||++....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp EEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 9999999 89999999863 579999999999999999999999999999999999999533333459999999998654
Q ss_pred cCCCCcccCccCCCCccccccccccccccC-----CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCc------------
Q 015406 158 DTSTHQHIPYRENKNLTGTARYASMNTHLG-----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT------------ 220 (407)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~------------ 220 (407)
.................||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.....
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 322111111111234569999999999975 457899999999999999999999998754322
Q ss_pred hHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 221 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 221 ~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
....+..+.......+ ......+++++.+||.+||..||++||++.++++
T Consensus 246 ~~~~~~~i~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 246 QNMLFESIQEGKYEFP-DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHCCCCCC-HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHhccCcccC-chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 2233444444433322 2334568999999999999999999999887764
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=352.82 Aligned_cols=252 Identities=21% Similarity=0.265 Sum_probs=205.6
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc----chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
++|++.++||+|+||.||+|++..+++.||||++...... ..+.+|+.+++.++| ++++.+..++......++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH-KNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCC-TTBCCEEEEEEETTEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCC-CCEeeEEeEEEeCCEEEEEE
Confidence 6899999999999999999999999999999998754432 347789999999986 67777778888889999999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 83 e~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
||++++|.+++....+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~- 156 (292)
T 3o0g_A 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVR- 156 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCSCCS-
T ss_pred ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceecCCccc-
Confidence 999888888888767789999999999999999999999999999999999999 6788999999999987654322
Q ss_pred cccCccCCCCccccccccccccccCCC-CChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhccc-------
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS------- 234 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~------- 234 (407)
......||+.|+|||++.+.. ++.++|||||||++|||++|..||.... .....+..+......
T Consensus 157 ------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~--~~~~~~~~i~~~~~~~~~~~~~ 228 (292)
T 3o0g_A 157 ------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEEQWP 228 (292)
T ss_dssp ------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS--SHHHHHHHHHHHHCCCCTTTCT
T ss_pred ------cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCC--CHHHHHHHHHHHhCCCChhhhh
Confidence 234567899999999998766 7999999999999999999888864322 223333333221110
Q ss_pred -----------------ccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 235 -----------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 235 -----------------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.......+.+++++.+||.+||+.||++|||++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0111222457899999999999999999999887754
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=372.08 Aligned_cols=258 Identities=20% Similarity=0.300 Sum_probs=213.4
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
.++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+|+++++.++| ++++.+..++...+..|+||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSH-PNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCC-TTBCCEEEEECSSSSCEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCC-CCEEEEEEEEecCCCcEEEE
Confidence 4689999999999999999999988999999999875432 2357889999999976 66777777777778889999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCC
Q 015406 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 83 e~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~ 161 (407)
||+ +++|.+++...+..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 192 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~---~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV---TEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCGGGCEECTTSEE
T ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEE---cCCCcEEECcCCCceecCCCce
Confidence 999 899999998766679999999999999999999999999999999999999 5788999999999986543221
Q ss_pred CcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHH
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (407)
. .......++..|+|||++.+..++.++|||||||++|||++ |..||.+... .+....+...... ..
T Consensus 269 ~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~---~~~~~~~~~~~~~----~~ 336 (377)
T 3cbl_A 269 A-----ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN---QQTREFVEKGGRL----PC 336 (377)
T ss_dssp E-----CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH---HHHHHHHHTTCCC----CC
T ss_pred e-----ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC----CC
Confidence 1 01123346788999999998889999999999999999998 9999987543 2333333322211 12
Q ss_pred hcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHH
Q 015406 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (407)
Q Consensus 241 ~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~ 279 (407)
...+|+++.++|.+||+.||++||++.+|.+.|+++..+
T Consensus 337 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 337 PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 345899999999999999999999999999999988654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=369.96 Aligned_cols=263 Identities=18% Similarity=0.282 Sum_probs=212.4
Q ss_pred ccCCceeEeccccccCceEEEEEE-----EcCCCeEEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeeeC
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEG 75 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~-----~~~~~~~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~ 75 (407)
...++|++.+.||+|+||.||+|+ +..+++.||||++...... ..+.+|+.+++.++| ++++.+..++...
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~ 146 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH-QNIVRCIGVSLQS 146 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEECSS
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCC-CCCCeEEEEEecC
Confidence 345789999999999999999999 4457889999998643322 247789999999976 6677777777777
Q ss_pred ceeEEEEecc-CCCHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEE
Q 015406 76 DYNVLVMDLL-GPSLEDLFNFCS------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 148 (407)
Q Consensus 76 ~~~~lvme~~-g~sL~~~l~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~ 148 (407)
...++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.+..+..+||+
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEEC
Confidence 8889999999 889999998643 358999999999999999999999999999999999999544355679999
Q ss_pred eccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHH
Q 015406 149 DFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEK 227 (407)
Q Consensus 149 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~ 227 (407)
|||+++....... ........||+.|+|||++.+..++.++|||||||++|||++ |..||..... .+.+..
T Consensus 227 DFG~a~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~---~~~~~~ 298 (367)
T 3l9p_A 227 DFGMARDIYRAGY-----YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVLEF 298 (367)
T ss_dssp CCHHHHHHHHHSS-----CTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHH
T ss_pred CCccccccccccc-----cccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH
Confidence 9999986543222 112345678999999999999999999999999999999998 9999977443 344444
Q ss_pred HhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHH
Q 015406 228 ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (407)
Q Consensus 228 i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~ 279 (407)
+....... ....+++++.+|+.+||+.||++||++.+|.+.|+.+...
T Consensus 299 i~~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 299 VTSGGRMD----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp HHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHcCCCCC----CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 44433221 2356899999999999999999999999999999887653
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=365.30 Aligned_cols=264 Identities=19% Similarity=0.305 Sum_probs=219.4
Q ss_pred cCCceeEeccccccCceEEEEEEEcCC-------CeEEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeee
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQT-------NEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVE 74 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~-------~~~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~ 74 (407)
..++|++.++||+|+||.||+|++..+ +..||||++...... ..+.+|+++++.+..|++|+.+..++..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 357899999999999999999997543 358999998765433 3478999999999666888888888888
Q ss_pred CceeEEEEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccC
Q 015406 75 GDYNVLVMDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 138 (407)
Q Consensus 75 ~~~~~lvme~~-g~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~ 138 (407)
.+..++||||+ +++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+|||+
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll-- 224 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV-- 224 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE--
Confidence 88899999999 889999998643 359999999999999999999999999999999999999
Q ss_pred CCCCceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCC
Q 015406 139 GRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLK 217 (407)
Q Consensus 139 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~ 217 (407)
+.++.+||+|||+++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus 225 -~~~~~~kL~DFG~a~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 225 -TEDNVMKIADFGLARDIHHIDYY-----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp -CTTCCEEECSCSCCCCSSCCCTT-----CCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred -cCCCcEEEcccCccccccccccc-----ccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 57889999999999876543321 12345567899999999999999999999999999999999 999998754
Q ss_pred cCchHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCC
Q 015406 218 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQ 283 (407)
Q Consensus 218 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~ 283 (407)
. .+....+....... ....+++++.+++.+||+.||++||++.+|.+.|+.++.....+
T Consensus 299 ~---~~~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 357 (382)
T 3tt0_A 299 V---EELFKLLKEGHRMD----KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 357 (382)
T ss_dssp H---HHHHHHHHTTCCCC----CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred H---HHHHHHHHcCCCCC----CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence 3 33444443332211 23568999999999999999999999999999999998776543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=356.87 Aligned_cols=254 Identities=21% Similarity=0.304 Sum_probs=202.2
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc----chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
.++|++.+.||+|+||.||+|++ +++.||||++...... ..+.+|+++++.++| ++++.+..++......++|
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH-PNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCC-TTBCCEEEEECSTTCCEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEECCceEEE
Confidence 57899999999999999999985 6889999998765433 247789999999986 6777777777788889999
Q ss_pred Eecc-CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcccccCCCCCceEEEEeccceeee
Q 015406 82 MDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (407)
Q Consensus 82 me~~-g~sL~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~--ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~ 156 (407)
|||+ +++|.+++..... .+++..++.++.||+.||+|||++| |+||||||+|||+ +.++.+||+|||+++..
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV---DKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEE---CTTCCEEECCCC-----
T ss_pred EecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEE---eCCCcEEECCCCCCccc
Confidence 9999 8899999985321 3999999999999999999999999 9999999999999 67889999999999854
Q ss_pred ccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhccccc
Q 015406 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (407)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (407)
..... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+... .+....+......
T Consensus 190 ~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~---~~~~~~~~~~~~~-- 257 (309)
T 3p86_A 190 ASTFL-------SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP---AQVVAAVGFKCKR-- 257 (309)
T ss_dssp -------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH---HHHHHHHHHSCCC--
T ss_pred ccccc-------ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCCC--
Confidence 43221 12356799999999999999999999999999999999999999987543 3333333222111
Q ss_pred HHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Q 015406 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (407)
Q Consensus 237 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~ 278 (407)
..+...+++++.++|.+||+.||++||++.+|.+.|+.++.
T Consensus 258 -~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 258 -LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred -CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 12345689999999999999999999999999999998864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=368.29 Aligned_cols=262 Identities=21% Similarity=0.250 Sum_probs=196.4
Q ss_pred CCccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC----cchHHHHHHHHHHHcCCCCCCeeEEeeee--C
Q 015406 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVE--G 75 (407)
Q Consensus 2 ~~~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~--~ 75 (407)
+..+.++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.+.+|++++.+..++.. .
T Consensus 4 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 83 (388)
T 3oz6_A 4 DRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND 83 (388)
T ss_dssp CHHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred cCcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence 44567899999999999999999999999999999998754322 23467899999999866777777766653 3
Q ss_pred ceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceee
Q 015406 76 DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (407)
Q Consensus 76 ~~~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~ 155 (407)
...|+||||++++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+.
T Consensus 84 ~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 84 RDVYLVFDYMETDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL---NAECHVKVADFGLSRS 158 (388)
T ss_dssp SCEEEEEECCSEEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred CEEEEEecccCcCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEE---cCCCCEEecCCccccc
Confidence 46899999998899999985 479999999999999999999999999999999999999 6888999999999987
Q ss_pred eccCCCCcc--------------cCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCc
Q 015406 156 YRDTSTHQH--------------IPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 220 (407)
Q Consensus 156 ~~~~~~~~~--------------~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~ 220 (407)
+........ .........+||+.|+|||++.+ ..++.++|||||||+||||++|+.||.+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-- 236 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST-- 236 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH--
Confidence 643211000 00111345689999999999987 6789999999999999999999999987543
Q ss_pred hHHHHHHHhhhcccccHHH------------------------------------------HhcCCcHHHHHHHHHHhCC
Q 015406 221 KKQKYEKISEKKVSTSIEA------------------------------------------LCRGYPTEFASYFHYCRSL 258 (407)
Q Consensus 221 ~~~~~~~i~~~~~~~~~~~------------------------------------------~~~~~~~~l~~li~~cl~~ 258 (407)
...+..+......+.... ....+++++.+||.+||..
T Consensus 237 -~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 315 (388)
T 3oz6_A 237 -MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF 315 (388)
T ss_dssp -HHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred -HHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence 333333322111111000 0126789999999999999
Q ss_pred CCCCCCCHHHHHH
Q 015406 259 RFDDKPDYAYLKR 271 (407)
Q Consensus 259 ~p~~RPt~~~l~~ 271 (407)
||++|||++++++
T Consensus 316 dP~~R~t~~e~l~ 328 (388)
T 3oz6_A 316 NPNKRISANDALK 328 (388)
T ss_dssp SGGGSCCHHHHTT
T ss_pred CcccCCCHHHHhC
Confidence 9999999776653
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=377.39 Aligned_cols=263 Identities=20% Similarity=0.272 Sum_probs=210.6
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCC-----CCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
.++|++.++||+|+||.||+|++..+++.||||++... .....+.+|+.+++.++| ++++.+..++...+..|+
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH-PFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSC-TTSCCEEEEEEETTEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCC-CeEeeEEEEEeeCCEEEE
Confidence 46899999999999999999999999999999987642 223456788888888875 677788888888889999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 81 vme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
||||+ +++|.+++... ..+++..++.++.||+.||+|||+ +||+||||||+|||| +.++.+||+|||+|+....
T Consensus 226 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEE---CSSSCEEECCCCCCCTTCC
T ss_pred EEeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEE---CCCCCEEEccCCCceeccC
Confidence 99999 88999999763 579999999999999999999998 999999999999999 6788999999999975332
Q ss_pred CCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHH
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (407)
... .....+||+.|+|||++.+..++.++|||||||+||||++|..||.+.. ..+.+..+......
T Consensus 302 ~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~i~~~~~~---- 367 (446)
T 4ejn_A 302 DGA-------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEKLFELILMEEIR---- 367 (446)
T ss_dssp ------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCC----
T ss_pred CCc-------ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC---HHHHHHHHHhCCCC----
Confidence 221 1345789999999999999999999999999999999999999997743 34445554443332
Q ss_pred HHhcCCcHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCccccccchhhcc
Q 015406 239 ALCRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQS 298 (407)
Q Consensus 239 ~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~~~~ 298 (407)
+...+++++.+||.+||+.||++|| +++++++ ++|...++|........
T Consensus 368 -~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~----------hp~f~~~~~~~~~~~~~ 421 (446)
T 4ejn_A 368 -FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ----------HRFFAGIVWQHVYEKKL 421 (446)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT----------SGGGTTCCHHHHHTTCS
T ss_pred -CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh----------CccccCCCHHHHhhCcC
Confidence 2355899999999999999999999 8776653 36777889987665543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-47 Score=383.53 Aligned_cols=274 Identities=20% Similarity=0.215 Sum_probs=223.1
Q ss_pred CccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCC-----CCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCce
Q 015406 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (407)
Q Consensus 3 ~~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 77 (407)
+...++|++.+.||+|+||.||+|++..+|+.||||++... .....+.+|+.+++.++| ++++.+..++.+.+.
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~~~~~~~ 258 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS-RFVVSLAYAYETKDA 258 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSE
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCC-CCEeeEEEEEeeCCE
Confidence 34567899999999999999999999999999999987542 233457889999999976 677777788888889
Q ss_pred eEEEEecc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceee
Q 015406 78 NVLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~ 155 (407)
.|+||||+ |++|.+++.... ..+++..++.++.||+.||+|||++|||||||||+|||| +.++.+||+|||+++.
T Consensus 259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILl---d~~g~vKL~DFGla~~ 335 (576)
T 2acx_A 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDLGLAVH 335 (576)
T ss_dssp EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCEE
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEE---eCCCCeEEEeccccee
Confidence 99999999 999999997533 349999999999999999999999999999999999999 6889999999999987
Q ss_pred eccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCch-HHHHHHHhhhccc
Q 015406 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYEKISEKKVS 234 (407)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~-~~~~~~i~~~~~~ 234 (407)
...... ....+||+.|+|||++.+..++.++|||||||++|||++|..||........ ......+......
T Consensus 336 ~~~~~~--------~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~ 407 (576)
T 2acx_A 336 VPEGQT--------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEE 407 (576)
T ss_dssp CCTTCC--------EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCC
T ss_pred cccCcc--------ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccccc
Confidence 654332 2345899999999999999999999999999999999999999987544322 3333333332221
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCccccccchhhcccccCC
Q 015406 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATP 303 (407)
Q Consensus 235 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~~~~~~~~~ 303 (407)
+...+++++.+||.+||..||.+|| +++++++ ++|...+||..+......++..
T Consensus 408 -----~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~----------HpfF~~i~w~~l~~~~~~pp~~ 466 (576)
T 2acx_A 408 -----YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE----------HPLFKKLNFKRLGAGMLEPPFK 466 (576)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT----------SGGGTTCCHHHHHTTCSCCSCC
T ss_pred -----CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh----------ChhhccCCHHHHhcCCCCCCCC
Confidence 2356899999999999999999999 4455443 3677788999887665444433
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=373.26 Aligned_cols=252 Identities=19% Similarity=0.302 Sum_probs=208.6
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~ 85 (407)
.++|++.+.||+|+||.||+|.+ .++.||||+++.......+.+|+.+++.++|++.+..+..+.......|+||||+
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred hHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 46899999999999999999996 4789999999887777789999999999987554444444444455789999999
Q ss_pred -CCCHHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCc
Q 015406 86 -GPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (407)
Q Consensus 86 -g~sL~~~l~~~~~~-l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~ 163 (407)
+++|.+++...+.. +++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 270 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~--- 343 (450)
T 1k9a_A 270 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQ--- 343 (450)
T ss_dssp TTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTSCEEECCCTTCEECC------
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---CCCCCEEEeeCCCcccccccc---
Confidence 88999999865443 7999999999999999999999999999999999999 578899999999998643321
Q ss_pred ccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHHhc
Q 015406 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (407)
Q Consensus 164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (407)
....++..|+|||++.+..++.++|||||||+||||++ |..||.+....... ..+...... ..+.
T Consensus 344 -------~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~---~~i~~~~~~----~~p~ 409 (450)
T 1k9a_A 344 -------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---PRVEKGYKM----DAPD 409 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH---HHHHTTCCC----CCCT
T ss_pred -------cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHcCCCC----CCCC
Confidence 23367889999999999999999999999999999998 99999886654433 333222111 1235
Q ss_pred CCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHH
Q 015406 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (407)
Q Consensus 243 ~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~ 279 (407)
.+|+++.++|.+||+.||++||++.+|.+.|+++...
T Consensus 410 ~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 410 GCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 6899999999999999999999999999999988654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=365.39 Aligned_cols=249 Identities=22% Similarity=0.294 Sum_probs=206.9
Q ss_pred CCccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCC-----CCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCc
Q 015406 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGD 76 (407)
Q Consensus 2 ~~~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 76 (407)
.+...++|++.+.||+|+||.||+|++..+++.||||++... .....+.+|+.+++.++| ++++.+..++....
T Consensus 4 ~~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~~ 82 (336)
T 3h4j_B 4 SKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRH-PHIIKLYDVITTPT 82 (336)
T ss_dssp CCSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCC-TTBCCEEEEEECSS
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCC-CCCCeEEEEEEeCC
Confidence 456678999999999999999999999999999999987532 334568899999999986 67777777788888
Q ss_pred eeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeee
Q 015406 77 YNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (407)
Q Consensus 77 ~~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~ 156 (407)
..++||||++++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 83 ~~~lv~E~~~g~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~DFG~s~~~ 158 (336)
T 3h4j_B 83 DIVMVIEYAGGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLL---DDNLNVKIADFGLSNIM 158 (336)
T ss_dssp EEEEEECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEE---CTTCCEEECCSSCTBTT
T ss_pred EEEEEEECCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEE---cCCCCEEEEEeccceec
Confidence 8999999999999999876 3579999999999999999999999999999999999999 67889999999999865
Q ss_pred ccCCCCcccCccCCCCccccccccccccccCCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccc
Q 015406 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (407)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (407)
..... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+...... +..+..
T Consensus 159 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---~~~i~~----- 222 (336)
T 3h4j_B 159 TDGNF--------LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL---FKKVNS----- 222 (336)
T ss_dssp TTSBT--------TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC---BCCCCS-----
T ss_pred cCCcc--------cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH---HHHHHc-----
Confidence 44322 245679999999999998876 7999999999999999999999976433211 111111
Q ss_pred cHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
....++..+++++.++|.+||..||.+|||++++++
T Consensus 223 ~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 223 CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 111223457899999999999999999999777653
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=360.63 Aligned_cols=256 Identities=21% Similarity=0.259 Sum_probs=194.4
Q ss_pred cCCceeEe---ccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 5 VGNKFRLG---RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 5 ~~~~y~i~---~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
+.++|++. +.||+|+||.||+|++..+++.||||++... ....+.+|+.+++.+.+|++|+.+..++.+....|+|
T Consensus 6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv 84 (325)
T 3kn6_A 6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLV 84 (325)
T ss_dssp HHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred chhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEE
Confidence 34678886 7899999999999999999999999998653 3456788999999999778999999999999999999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 82 me~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
|||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||+++......
T Consensus 85 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 163 (325)
T 3kn6_A 85 MELLNGGELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN 163 (325)
T ss_dssp ECCCCSCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--
T ss_pred EEccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC
Confidence 9999 8899999986 4679999999999999999999999999999999999999643344489999999998765432
Q ss_pred CCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCc----CchHHHHHHHhhhccccc
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA----GTKKQKYEKISEKKVSTS 236 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~----~~~~~~~~~i~~~~~~~~ 236 (407)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|..||..... ....+.+..+.......
T Consensus 164 ~~-------~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~- 235 (325)
T 3kn6_A 164 QP-------LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF- 235 (325)
T ss_dssp ---------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC-
T ss_pred Cc-------ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC-
Confidence 21 2355789999999999999999999999999999999999999976433 22344555555544332
Q ss_pred HHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015406 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 237 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
....+..+++++.+||.+||..||++||++.+++
T Consensus 236 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell 269 (325)
T 3kn6_A 236 EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR 269 (325)
T ss_dssp CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence 2233456899999999999999999999987764
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=355.99 Aligned_cols=264 Identities=19% Similarity=0.230 Sum_probs=204.7
Q ss_pred ccCCceeEeccccccCceEEEEEE----EcCCCeEEEEEEecCCCCc--chHHHHHHHHHHHcCCCCCCeeEEeee--eC
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKLENVKTKH--PQLLYESKLYRILQGGTGIPNVRWFGV--EG 75 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~----~~~~~~~vAvK~~~~~~~~--~~~~~E~~~l~~l~~~~~i~~~~~~~~--~~ 75 (407)
...++|++.++||+|+||.||+|+ +..+++.||||++...... ..+.+|+.+++.++| ++++.+..++. ..
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~ 85 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH-DNIVKYKGVCYSAGR 85 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEECHHHH
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEecCCC
Confidence 457899999999999999999998 5678999999998754322 357899999999987 55555544443 34
Q ss_pred ceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEecccee
Q 015406 76 DYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (407)
Q Consensus 76 ~~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~ 154 (407)
...++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTK 162 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCCCSCC
T ss_pred CceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEE---cCCCeEEEccCcccc
Confidence 5679999999 899999998766669999999999999999999999999999999999999 578899999999998
Q ss_pred eeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcC---------chH---
Q 015406 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG---------TKK--- 222 (407)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~---------~~~--- 222 (407)
......... .......++..|+|||++.+..++.++||||||+++|||++|..||...... ...
T Consensus 163 ~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (295)
T 3ugc_A 163 VLPQDKEFF----KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238 (295)
T ss_dssp -----------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHH
T ss_pred cccCCccee----eeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhH
Confidence 765433211 1123456788899999999999999999999999999999999998642110 000
Q ss_pred -HHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHH
Q 015406 223 -QKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (407)
Q Consensus 223 -~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~ 279 (407)
.....+.... .......+|+++.+++.+||+.||++||++.++.+.|+++..+
T Consensus 239 ~~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 239 FHLIELLKNNG----RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHHHHTTC----CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHhccC----cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 1111111111 1112356899999999999999999999999999999998754
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=378.40 Aligned_cols=275 Identities=19% Similarity=0.227 Sum_probs=223.5
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCC-----CCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCcee
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 78 (407)
...++|++.+.||+|+||.||+|+++.+|+.||||++... .....+..|+.+++.++| ++++.+..++......
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~~~~~~~l 260 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS-RFIVSLAYAFETKTDL 260 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCC-CCEeeEEEEEeeCCEE
Confidence 4457899999999999999999999999999999988643 233457889999999975 7777787888888899
Q ss_pred EEEEecc-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEecccee
Q 015406 79 VLVMDLL-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~ 154 (407)
|+||||+ |++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl---~~~g~vkL~DFGla~ 337 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAV 337 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCE
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEE---eCCCCEEEeecceee
Confidence 9999999 899999987532 359999999999999999999999999999999999999 688999999999998
Q ss_pred eeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcC-chHHHHHHHhhhcc
Q 015406 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-TKKQKYEKISEKKV 233 (407)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~-~~~~~~~~i~~~~~ 233 (407)
.+...... ....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.... ...+....+.....
T Consensus 338 ~~~~~~~~-------~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~ 410 (543)
T 3c4z_A 338 ELKAGQTK-------TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV 410 (543)
T ss_dssp ECCTTCCC-------BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC
T ss_pred eccCCCcc-------cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc
Confidence 76543321 23568999999999999999999999999999999999999999875432 23344444444332
Q ss_pred cccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHHHHcCCCCCCccccccchhhccccc
Q 015406 234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY--LKRIFRDLFIREGFQFDYVFDWTILKYQQSQLA 301 (407)
Q Consensus 234 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~--l~~~l~~l~~~~~~~~~~~~dw~~~~~~~~~~~ 301 (407)
. ++..+++++.+||.+||..||++||++.+ ..+++ .++|...++|..+......++
T Consensus 411 ~-----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~-------~Hpff~~i~w~~l~~~~~~pp 468 (543)
T 3c4z_A 411 T-----YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLR-------THPLFRDISWRQLEAGMLTPP 468 (543)
T ss_dssp C-----CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHH-------TSGGGTTCCHHHHHTTCSCCS
T ss_pred C-----CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHH-------cCccccCCCHHHHHcCCCCCC
Confidence 2 23568999999999999999999997632 12222 346777889988776554333
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=352.63 Aligned_cols=253 Identities=21% Similarity=0.315 Sum_probs=201.3
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
++|++.+.||+|+||.||+|++ .+++.||+|.+..... ...+.+|+.+++.++| ++++.+..++...+..++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKH-SNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCC-TTBCCEEEEEECSSCEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCC-CCEeeeeeEEccCCeEEEEE
Confidence 6899999999999999999998 7889999998865432 2457899999999976 67777777777888899999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 83 e~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
||+.++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~- 155 (288)
T 1ob3_A 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVR- 155 (288)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC----
T ss_pred EecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEeECccccccCcccc-
Confidence 999889999998766789999999999999999999999999999999999999 6788999999999986543221
Q ss_pred cccCccCCCCccccccccccccccCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcc--------
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-------- 233 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-------- 233 (407)
......||+.|+|||++.+. .++.++|||||||++|||++|..||.+.........+........
T Consensus 156 ------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T 1ob3_A 156 ------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229 (288)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred ------ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhh
Confidence 12345789999999999764 589999999999999999999999987543322222222111100
Q ss_pred -------------cccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 234 -------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 234 -------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
..........+++++.++|.+||+.||++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 01112334568999999999999999999999887754
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=361.93 Aligned_cols=258 Identities=20% Similarity=0.276 Sum_probs=206.5
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-CcchHHHHHHHHHHHc----CCCCCCeeEEeeeeCcee
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQ----GGTGIPNVRWFGVEGDYN 78 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~E~~~l~~l~----~~~~i~~~~~~~~~~~~~ 78 (407)
.+.++|++.++||+|+||.||+|++..+++.||||++.... ....+..|+.+++.+. .|++++.+..++...+..
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~ 111 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHM 111 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEE
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCee
Confidence 46789999999999999999999999999999999986432 2344678999999997 367888888888888999
Q ss_pred EEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCC------------------
Q 015406 79 VLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG------------------ 139 (407)
Q Consensus 79 ~lvme~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~------------------ 139 (407)
++||||++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++..
T Consensus 112 ~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~ 191 (360)
T 3llt_A 112 CLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKI 191 (360)
T ss_dssp EEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEE
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccc
Confidence 9999999999999998643 359999999999999999999999999999999999999421
Q ss_pred ----CCCceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCC
Q 015406 140 ----RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215 (407)
Q Consensus 140 ----~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~ 215 (407)
...+.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 192 ~~~~~~~~~~kl~DFG~a~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 192 QIYRTKSTGIKLIDFGCATFKSDYH----------GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp EEEEESCCCEEECCCTTCEETTSCC----------CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccCCCCEEEEeccCceecCCCC----------cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCC
Confidence 127889999999998654322 356789999999999999999999999999999999999999987
Q ss_pred CCcCchHHHHHHHhhhccccc--------------------------------------HHHHhcCCcHHHHHHHHHHhC
Q 015406 216 LKAGTKKQKYEKISEKKVSTS--------------------------------------IEALCRGYPTEFASYFHYCRS 257 (407)
Q Consensus 216 ~~~~~~~~~~~~i~~~~~~~~--------------------------------------~~~~~~~~~~~l~~li~~cl~ 257 (407)
.........+..+........ .+.+....++.+.+||.+||+
T Consensus 262 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 341 (360)
T 3llt_A 262 HEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQ 341 (360)
T ss_dssp SSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCC
T ss_pred CcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhc
Confidence 544332222222211100000 000111234788899999999
Q ss_pred CCCCCCCCHHHHHH
Q 015406 258 LRFDDKPDYAYLKR 271 (407)
Q Consensus 258 ~~p~~RPt~~~l~~ 271 (407)
.||++|||+.++++
T Consensus 342 ~dP~~Rpta~elL~ 355 (360)
T 3llt_A 342 IDPTLRPSPAELLK 355 (360)
T ss_dssp SSGGGSCCHHHHTT
T ss_pred CChhhCCCHHHHhc
Confidence 99999999887753
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=349.15 Aligned_cols=255 Identities=19% Similarity=0.272 Sum_probs=213.4
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEec
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~ 84 (407)
.++|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+|+++++.++| ++++.+..++.+....++||||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH-PKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCC-TTBCCEEEEECSSSSEEEEEEC
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCC-CCEeeEEEEEecCCceEEEEEe
Confidence 468999999999999999999985 67789999987654 34568899999999986 6777777777778889999999
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCc
Q 015406 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (407)
Q Consensus 85 ~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~ 163 (407)
+ +++|.+++......+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~-- 161 (269)
T 4hcu_A 87 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQY-- 161 (269)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CGGGCEEECCTTGGGGBCCHHH--
T ss_pred CCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEE---cCCCCEEecccccccccccccc--
Confidence 9 889999998666679999999999999999999999999999999999999 5788999999999986543221
Q ss_pred ccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHHhc
Q 015406 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (407)
Q Consensus 164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (407)
.......+|+.|+|||++.+..++.++||||||+++|+|++ |..||..... .+....+...... ....
T Consensus 162 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~---~~~~~~~~~~~~~----~~~~ 230 (269)
T 4hcu_A 162 ----TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDISTGFRL----YKPR 230 (269)
T ss_dssp ----HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTTCCC----CCCT
T ss_pred ----ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH---HHHHHHHhcCccC----CCCC
Confidence 11234567889999999998899999999999999999999 9999977433 3444444433221 1224
Q ss_pred CCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Q 015406 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (407)
Q Consensus 243 ~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~ 278 (407)
.+++++.+++.+||+.||++||++.++.+.|+++..
T Consensus 231 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 231 LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 478999999999999999999999999999998864
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-46 Score=345.80 Aligned_cols=254 Identities=21% Similarity=0.276 Sum_probs=212.0
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc----chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeE
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 79 (407)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+|+.+++.++| ++++.+..++......+
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~ 81 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH-PNIVRLHDSIQEESFHY 81 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEEE
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCC-CCcCeEEEEEEcCCEEE
Confidence 5789999999999999999999999999999999998654322 347789999999976 67777777788888899
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 80 lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
+||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++..+.+||+|||++.....
T Consensus 82 ~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 82 LVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp EEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 999999 88999888763 5699999999999999999999999999999999999996544556699999999987654
Q ss_pred CCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHH
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (407)
... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+.. .......+.........
T Consensus 161 ~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~~- 228 (284)
T 3kk8_A 161 SEA--------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYAQIKAGAYDYPS- 228 (284)
T ss_dssp SCB--------CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCCCT-
T ss_pred Ccc--------ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc---hhHHHHHHHhccccCCc-
Confidence 332 235679999999999999999999999999999999999999997743 34444444444332222
Q ss_pred HHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 239 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.....+++++.+++.+||+.||++||++.++++
T Consensus 229 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 229 PEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 223568999999999999999999999877754
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=353.87 Aligned_cols=264 Identities=20% Similarity=0.279 Sum_probs=204.1
Q ss_pred CCCccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHH--HcCCCCCCeeEEeee----e
Q 015406 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRI--LQGGTGIPNVRWFGV----E 74 (407)
Q Consensus 1 m~~~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~--l~~~~~i~~~~~~~~----~ 74 (407)
|+..+.++|++.+.||+|+||.||+|++ +++.||||++... ....+..|.+++.. ++| +++..+..++. .
T Consensus 2 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-~~~~~~~e~~~~~~~~l~h-~niv~~~~~~~~~~~~ 77 (301)
T 3q4u_A 2 MQRTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR-DEKSWFRETELYNTVMLRH-ENILGFIASDMTSRHS 77 (301)
T ss_dssp --CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG-GHHHHHHHHHHHHHTCCCC-TTBCCEEEEEEEEETT
T ss_pred ccccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc-cchhhHHHHHHHHHhhccC-cCeeeEEEeeccccCC
Confidence 6778899999999999999999999986 7899999998653 33456778888877 455 55655554432 2
Q ss_pred CceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceeccCCCCcccccCCCCCceE
Q 015406 75 GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH--------SKSFLHRDIKPDNFLMGLGRRANQV 145 (407)
Q Consensus 75 ~~~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH--------~~~ivHrDLKp~NILl~~~~~~~~~ 145 (407)
....++||||+ +++|.++++ ...+++..++.++.||+.||.||| ++||+||||||+|||+ +.++.+
T Consensus 78 ~~~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill---~~~~~~ 152 (301)
T 3q4u_A 78 STQLWLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQC 152 (301)
T ss_dssp EEEEEEEECCCTTCBHHHHHT--TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE---CTTSCE
T ss_pred CceeEEehhhccCCCHHHHHh--hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEE---cCCCCE
Confidence 45689999999 889999996 457999999999999999999999 9999999999999999 578899
Q ss_pred EEEeccceeeeccCCCCcccCccCCCCccccccccccccccCC------CCChhhHHHHHHHHHHHHHhC----------
Q 015406 146 YIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI------EQSRRDDLESLGYVLMYFLRG---------- 209 (407)
Q Consensus 146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~------~~~~~sDIwSlG~il~elltG---------- 209 (407)
||+|||+++.......... .......||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 153 kl~Dfg~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~ 229 (301)
T 3q4u_A 153 CIADLGLAVMHSQSTNQLD---VGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY 229 (301)
T ss_dssp EECCCTTCEEEETTTTEEE---CCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred EEeeCCCeeeccccccccc---ccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccc
Confidence 9999999987765443211 112345799999999999886 455799999999999999999
Q ss_pred CCCCCCCCcCc-hHHHHHHHh-hhccc--ccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 015406 210 SLPWQGLKAGT-KKQKYEKIS-EKKVS--TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (407)
Q Consensus 210 ~~Pf~~~~~~~-~~~~~~~i~-~~~~~--~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l 276 (407)
..||....... ....+.... ..... .+.......+++++.+++.+||+.||++||++.++.+.|+++
T Consensus 230 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 230 KPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 88987643322 222222222 11111 111112233568899999999999999999999999999875
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=362.48 Aligned_cols=267 Identities=18% Similarity=0.267 Sum_probs=214.6
Q ss_pred CCceeEeccccccCceEEEEEEEc---CCCeEEEEEEecCC------CCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCc
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVK------TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGD 76 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~---~~~~~vAvK~~~~~------~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 76 (407)
.++|++.+.||+|+||.||+|++. .+++.||||+++.. .....+.+|+.+++.+.++++++.+..++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 378999999999999999999984 48899999987642 233457789999999988899999999889999
Q ss_pred eeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceee
Q 015406 77 YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (407)
Q Consensus 77 ~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~ 155 (407)
..++||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEE
T ss_pred eEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCcEEEeeCCCCee
Confidence 999999999 88999999863 479999999999999999999999999999999999999 6788999999999987
Q ss_pred eccCCCCcccCccCCCCccccccccccccccC--CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCch-HHHHHHHhhhc
Q 015406 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYEKISEKK 232 (407)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~-~~~~~~i~~~~ 232 (407)
+...... ......||+.|+|||++.+ ..++.++|||||||+||||++|..||........ ......+....
T Consensus 209 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 282 (355)
T 1vzo_A 209 FVADETE------RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 282 (355)
T ss_dssp CCGGGGG------GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC
T ss_pred cccCCCC------cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccC
Confidence 6443221 1235679999999999986 3478999999999999999999999976543322 22233332222
Q ss_pred ccccHHHHhcCCcHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCccccccchhhc
Q 015406 233 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQ 297 (407)
Q Consensus 233 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~~~ 297 (407)
. .+...++..+.+||.+||..||++|| +++++++ +.|...++|..+..+.
T Consensus 283 ~-----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~----------h~~f~~~~~~~l~~~~ 337 (355)
T 1vzo_A 283 P-----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE----------HLFFQKINWDDLAAKK 337 (355)
T ss_dssp C-----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT----------SGGGTTCCHHHHHTTC
T ss_pred C-----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc----------CcchhcCChhHhhhcc
Confidence 1 12356889999999999999999999 7666543 2455567888766554
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=355.94 Aligned_cols=255 Identities=21% Similarity=0.274 Sum_probs=190.6
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
.++|++.+.||+|+||.||+|++..+++.||||+++.... ...+.+|+.+++.++| ++++.+..++...+..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH-ENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCB-TTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCC-CCcceEEEEEEECCeEEEEE
Confidence 5789999999999999999999999999999998865432 3458899999999976 67777777778888999999
Q ss_pred eccCCCHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeec
Q 015406 83 DLLGPSLEDLFNFCS-----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (407)
Q Consensus 83 e~~g~sL~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~ 157 (407)
||+.++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 83 e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 83 EFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLI---NKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp ECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCSSCEETT
T ss_pred EecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEE---cCCCCEEECcCccceecC
Confidence 999889999987532 358999999999999999999999999999999999999 678899999999998765
Q ss_pred cCCCCcccCccCCCCccccccccccccccCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhccc--
Q 015406 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS-- 234 (407)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-- 234 (407)
.... ......||+.|+|||++.+. .++.++|||||||++|||++|..||.+.........+.........
T Consensus 160 ~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 232 (317)
T 2pmi_A 160 IPVN-------TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESL 232 (317)
T ss_dssp SCCC-------CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTT
T ss_pred CCcc-------cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhH
Confidence 4322 12355789999999999874 6899999999999999999999999875443222222221111000
Q ss_pred -------------------cc-----HHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 235 -------------------TS-----IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 235 -------------------~~-----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.. .......+++++.+||.+||..||++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 233 WPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp CGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00 00112357899999999999999999999877653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=355.10 Aligned_cols=264 Identities=20% Similarity=0.241 Sum_probs=208.0
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC---CcchHHHHHHHHHHHcCCCCCCeeEEeeeeC--cee
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEG--DYN 78 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~--~~~ 78 (407)
.+.++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+|+++++.++| ++++.+..++... ...
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH-KNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCC-TTBCCEEEEEECTTTCCE
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCC-CCcceEEEEeecCCCceE
Confidence 46789999999999999999999999999999999986532 23457899999999986 5565665555443 377
Q ss_pred EEEEecc-CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccC-CCCCceEEEEecccee
Q 015406 79 VLVMDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL-GRRANQVYIIDFGLAK 154 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~-~~~~~~~kL~DFGla~ 154 (407)
++||||+ +++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||+.. ++..+.+||+|||+++
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 9999999 8999999985332 3999999999999999999999999999999999999832 2356789999999998
Q ss_pred eeccCCCCcccCccCCCCcccccccccccccc--------CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCc-CchHHHH
Q 015406 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHL--------GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA-GTKKQKY 225 (407)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--------~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~-~~~~~~~ 225 (407)
....... .....||+.|+|||++. +..++.++|||||||++|||++|..||..... ....+.+
T Consensus 165 ~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 236 (319)
T 4euu_A 165 ELEDDEQ--------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236 (319)
T ss_dssp ECCTTCC--------BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHH
T ss_pred ecCCCCc--------eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHH
Confidence 7755432 23557999999999986 56789999999999999999999999975443 2233444
Q ss_pred HHHhhhccccc--------------------HHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 015406 226 EKISEKKVSTS--------------------IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (407)
Q Consensus 226 ~~i~~~~~~~~--------------------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l 276 (407)
..+........ ...+...+++.+.+++.+||+.||++||+++++.+...+.
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 44443322110 0012233567899999999999999999998888766543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=351.39 Aligned_cols=257 Identities=17% Similarity=0.277 Sum_probs=211.8
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEec
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~ 84 (407)
.++|++.+.||+|+||.||+|.+. ++..||||++.... ....+.+|+++++.++| ++++.+..++......++||||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSH-EKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCC-TTBCCEEEEECSSSSEEEEECC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCC-CCEeeEEEEEecCCCeEEEEec
Confidence 468999999999999999999874 67889999987654 34568899999999986 6677777777788889999999
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCc
Q 015406 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (407)
Q Consensus 85 ~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~ 163 (407)
+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~~-- 175 (283)
T 3gen_A 101 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEY-- 175 (283)
T ss_dssp CTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTSCEEECSTTGGGGBCCHHH--
T ss_pred cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEE---cCCCCEEEcccccccccccccc--
Confidence 9 899999998655679999999999999999999999999999999999999 5788999999999976543221
Q ss_pred ccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHHhc
Q 015406 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (407)
Q Consensus 164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (407)
.......+|+.|+|||++.+..++.++||||||+++|+|++ |..||..... .+....+....... ...
T Consensus 176 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~---~~~~~~~~~~~~~~----~~~ 244 (283)
T 3gen_A 176 ----TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN---SETAEHIAQGLRLY----RPH 244 (283)
T ss_dssp ----HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHHHHHHTTCCCC----CCT
T ss_pred ----ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh---hHHHHHHhcccCCC----CCC
Confidence 11234567889999999998899999999999999999998 9999987543 33444444332211 124
Q ss_pred CCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHc
Q 015406 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (407)
Q Consensus 243 ~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~ 280 (407)
.+++++.+++.+||+.||++||++.++++.|++++.++
T Consensus 245 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 245 LASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 57899999999999999999999999999999998764
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=360.12 Aligned_cols=268 Identities=18% Similarity=0.267 Sum_probs=215.5
Q ss_pred cCCceeEe-ccccccCceEEEEEEEcCCCeEEEEEEecCCCC----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeE
Q 015406 5 VGNKFRLG-RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 5 ~~~~y~i~-~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 79 (407)
+.++|.+. +.||+|+||.||+|++..+++.||||++..... ...+.+|+.+++.+.++++++.+..++......+
T Consensus 26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~ 105 (327)
T 3lm5_A 26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEII 105 (327)
T ss_dssp HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEE
Confidence 45678888 899999999999999999999999998765332 3458899999999999899999999999999999
Q ss_pred EEEecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeec
Q 015406 80 LVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (407)
Q Consensus 80 lvme~~-g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~ 157 (407)
+||||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.....+.+||+|||+++...
T Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 185 (327)
T 3lm5_A 106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185 (327)
T ss_dssp EEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-
T ss_pred EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccC
Confidence 999999 88999988532 3569999999999999999999999999999999999999533337899999999998765
Q ss_pred cCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccH
Q 015406 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (407)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (407)
.... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+... .+.+..+....... .
T Consensus 186 ~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~~-~ 253 (327)
T 3lm5_A 186 HACE--------LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN---QETYLNISQVNVDY-S 253 (327)
T ss_dssp ----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTCCCC-C
T ss_pred Cccc--------cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---hHHHHHHHhccccc-C
Confidence 4332 2346799999999999999999999999999999999999999977443 34444444333222 2
Q ss_pred HHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccch
Q 015406 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILK 294 (407)
Q Consensus 238 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~dw~~~~ 294 (407)
......+++.+.++|.+||..||++||+++++++ ++|...++|....
T Consensus 254 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~----------h~~~~~~~~~~~~ 300 (327)
T 3lm5_A 254 EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS----------HSWLQQWDFENLF 300 (327)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT----------CGGGCCCCTTCC-
T ss_pred chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC----------CHhhccccccccc
Confidence 2334568999999999999999999999877753 3555566776443
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=359.24 Aligned_cols=253 Identities=22% Similarity=0.235 Sum_probs=195.8
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
..++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+|+.+++.++| ++++.+..++......++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCC-CCCCcEEEEEeeCCEEEEEEE
Confidence 3578999999999999999999999999999999887543 34568899999999986 677777778888889999999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 84 ~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
|+ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++. +..+.+||+|||+++.......
T Consensus 97 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~-~~~~~~kl~Dfg~a~~~~~~~~- 173 (361)
T 3uc3_A 97 YASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQ- 173 (361)
T ss_dssp CCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECS-SSSCCEEECCCCCC---------
T ss_pred eCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcC-CCCceEEEeecCccccccccCC-
Confidence 99 9999999976 347999999999999999999999999999999999999941 1223599999999975433221
Q ss_pred cccCccCCCCccccccccccccccCCCCChh-hHHHHHHHHHHHHHhCCCCCCCCCcC-chHHHHHHHhhhcccccHHHH
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRR-DDLESLGYVLMYFLRGSLPWQGLKAG-TKKQKYEKISEKKVSTSIEAL 240 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-sDIwSlG~il~elltG~~Pf~~~~~~-~~~~~~~~i~~~~~~~~~~~~ 240 (407)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.... .....+..+.......+.
T Consensus 174 -------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--- 243 (361)
T 3uc3_A 174 -------PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPD--- 243 (361)
T ss_dssp --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCT---
T ss_pred -------CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCC---
Confidence 235679999999999998888655 89999999999999999999875443 223334444333222111
Q ss_pred hcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 241 ~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
...+++++.+||.+||..||++|||+.++++
T Consensus 244 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 244 DIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred cCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 1347899999999999999999999776643
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=362.80 Aligned_cols=260 Identities=16% Similarity=0.216 Sum_probs=204.9
Q ss_pred cCCceeEecccccc--CceEEEEEEEcCCCeEEEEEEecCCCCc----chHHHHHHHHHHHcCCCCCCeeEEeeeeCcee
Q 015406 5 VGNKFRLGRKIGSG--SFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (407)
Q Consensus 5 ~~~~y~i~~~iG~G--~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 78 (407)
-+++|++.++||+| +||.||+|++..+++.||||++...... ..+.+|+.+++.++| ++|+.+..++...+..
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNH-PNIVPYRATFIADNEL 101 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCC-CCCCcEeEEEEECCEE
Confidence 36789999999999 9999999999999999999998754322 346779999999986 6777777778888899
Q ss_pred EEEEecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeee
Q 015406 79 VLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~ 156 (407)
|+||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll---~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCGGGCEEC
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccccceee
Confidence 9999999 89999999864 2569999999999999999999999999999999999999 67889999999998765
Q ss_pred ccCCCCcccCccCCCCccccccccccccccC--CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcc-
Q 015406 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV- 233 (407)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~- 233 (407)
..................||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.......... .....
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~---~~~~~~ 255 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK---LNGTVP 255 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH---hcCCCC
Confidence 4433222111122344589999999999988 67899999999999999999999999875543222111 00000
Q ss_pred ----------------------------------------cccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 234 ----------------------------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 234 ----------------------------------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
..........+++++.+||.+||+.||++||++.++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 00011234567899999999999999999999887753
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=349.75 Aligned_cols=258 Identities=22% Similarity=0.308 Sum_probs=199.9
Q ss_pred cCCceeEeccccccCceEEEEEEEcCC---CeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCcee
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~---~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 78 (407)
..++|++.+.||+|+||.||+|++..+ +..||+|+...... ...+.+|+.+++.++| ++++.+..+. ..+..
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~-~~~~~ 90 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH-PHIVKLIGVI-TENPV 90 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCC-TTBCCEEEEE-CSSSC
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CccceEEEEE-ccCcc
Confidence 467899999999999999999998654 45799998765432 2347889999999986 5555555554 34567
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeec
Q 015406 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~ 157 (407)
++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECC--------
T ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEE---CCCCCEEECccccccccC
Confidence 8999999 789999998766679999999999999999999999999999999999999 577899999999998765
Q ss_pred cCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhccccc
Q 015406 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (407)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (407)
..... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||.+..... ....+......
T Consensus 168 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~~~~i~~~~~~-- 236 (281)
T 1mp8_A 168 DSTYY------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIENGERL-- 236 (281)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHHHTTCCC--
T ss_pred ccccc------ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---HHHHHHcCCCC--
Confidence 43321 1234467889999999998899999999999999999997 999998765433 33333332221
Q ss_pred HHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHc
Q 015406 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (407)
Q Consensus 237 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~ 280 (407)
.+...+|+++.+++.+||+.||++||++.++.+.|++++...
T Consensus 237 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 237 --PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 133568999999999999999999999999999999987654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=350.32 Aligned_cols=248 Identities=19% Similarity=0.282 Sum_probs=198.8
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC----------------------------cchHHHHHHHH
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----------------------------HPQLLYESKLY 56 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~----------------------------~~~~~~E~~~l 56 (407)
..++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+|++++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 45789999999999999999999999999999998865421 24578999999
Q ss_pred HHHcCCCCCCeeEEeeee--CceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCc
Q 015406 57 RILQGGTGIPNVRWFGVE--GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 133 (407)
Q Consensus 57 ~~l~~~~~i~~~~~~~~~--~~~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~N 133 (407)
+.++| ++++.+..++.. ....|+||||+ +++|.+++. ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 91 ~~l~h-~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 91 KKLDH-PNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp HTCCC-TTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HhCCC-CCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 99986 555555555543 67889999999 889988754 4579999999999999999999999999999999999
Q ss_pred ccccCCCCCceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCC---CChhhHHHHHHHHHHHHHhCC
Q 015406 134 FLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE---QSRRDDLESLGYVLMYFLRGS 210 (407)
Q Consensus 134 ILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~~~~sDIwSlG~il~elltG~ 210 (407)
||+ +.++.+||+|||+++........ .....||+.|+|||++.+.. ++.++|||||||++|+|++|.
T Consensus 168 il~---~~~~~~kl~Dfg~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~ 237 (298)
T 2zv2_A 168 LLV---GEDGHIKIADFGVSNEFKGSDAL-------LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237 (298)
T ss_dssp EEE---CTTSCEEECCCTTCEECSSSSCE-------ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSS
T ss_pred EEE---CCCCCEEEecCCCcccccccccc-------ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCC
Confidence 999 57889999999999876543221 23457999999999998765 378999999999999999999
Q ss_pred CCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 211 LPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 211 ~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.||.+... ......+.......+ ....+++++.++|.+||+.||++||++.++++
T Consensus 238 ~pf~~~~~---~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 238 CPFMDERI---MCLHSKIKSQALEFP---DQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp CSSCCSSH---HHHHHHHHHCCCCCC---SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCCCccH---HHHHHHHhcccCCCC---CccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 99976432 333344433322211 12468899999999999999999999887753
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=358.10 Aligned_cols=252 Identities=20% Similarity=0.286 Sum_probs=200.1
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc----chHHHHHHHHHHHcCC-CCCCeeEEeeeeCcee
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGG-TGIPNVRWFGVEGDYN 78 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----~~~~~E~~~l~~l~~~-~~i~~~~~~~~~~~~~ 78 (407)
..+++|++.+.||+|+||.||+|.+ .+++.||||++...... ..+.+|+.+++.++|+ ++++.+..++......
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 3478899999999999999999997 56889999998765433 3477899999999864 7899999999999999
Q ss_pred EEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 79 VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 79 ~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
|+|||+.+++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||+ .++.+||+|||+++.+..
T Consensus 85 ~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll----~~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 85 YMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EEEECCCSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----ETTEEEECCCSSSCCC--
T ss_pred EEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE----ECCcEEEeecccccccCc
Confidence 99999779999999986 4579999999999999999999999999999999999999 357899999999987654
Q ss_pred CCCCcccCccCCCCccccccccccccccC-----------CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHH
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHLG-----------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK 227 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----------~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~ 227 (407)
.... .......||+.|+|||++.+ ..++.++|||||||++|||++|..||..... ....+..
T Consensus 160 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~~ 232 (343)
T 3dbq_A 160 DTTS-----VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--QISKLHA 232 (343)
T ss_dssp ---------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHHHHH
T ss_pred cccc-----ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh--HHHHHHH
Confidence 3321 11235679999999999865 6789999999999999999999999976432 2223333
Q ss_pred HhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 228 ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 228 i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
+...... ..+....+.++.+++.+||..||++||++.++++
T Consensus 233 ~~~~~~~---~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 233 IIDPNHE---IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp HHCTTSC---CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HhcCCcc---cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 3222111 1123446789999999999999999999777653
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=351.94 Aligned_cols=251 Identities=21% Similarity=0.290 Sum_probs=210.9
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC--------cchHHHHHHHHHHHcCCCCCCeeEEeeeeC
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--------HPQLLYESKLYRILQGGTGIPNVRWFGVEG 75 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~ 75 (407)
.+.++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+|+.+++.+.| ++++.+..++...
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~ 87 (321)
T 2a2a_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH-HNVITLHDVYENR 87 (321)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCC-TTBCCEEEEEECS
T ss_pred hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCC-CCcceEEEEEecC
Confidence 345689999999999999999999999999999998875432 2348899999999986 6677777777888
Q ss_pred ceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCc----eEEEEec
Q 015406 76 DYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN----QVYIIDF 150 (407)
Q Consensus 76 ~~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~----~~kL~DF 150 (407)
...++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++ .+||+||
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~---~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 88 TDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL---DKNIPIPHIKLIDF 163 (321)
T ss_dssp SEEEEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES---CTTSSSCCEEECCC
T ss_pred CEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEe---cCCCCcCCEEEccC
Confidence 8899999999 8999999985 45799999999999999999999999999999999999994 444 7999999
Q ss_pred cceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhh
Q 015406 151 GLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230 (407)
Q Consensus 151 Gla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~ 230 (407)
|+++....... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+.. ..+.+..+..
T Consensus 164 g~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~i~~ 232 (321)
T 2a2a_A 164 GLAHEIEDGVE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANITS 232 (321)
T ss_dssp TTCEECCTTCC--------CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHT
T ss_pred ccceecCcccc--------ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHh
Confidence 99987655332 235579999999999999999999999999999999999999997643 3444444444
Q ss_pred hcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 231 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.... ........+++++.++|.+||..||++||++.++++
T Consensus 233 ~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 233 VSYD-FDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp TCCC-CCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred cccc-cChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 3332 233455678999999999999999999999887764
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=353.70 Aligned_cols=254 Identities=22% Similarity=0.345 Sum_probs=195.9
Q ss_pred CccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc-----chHHHHHHHHHHHcCCCCCCeeEEeeeeCc-
Q 015406 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKLYRILQGGTGIPNVRWFGVEGD- 76 (407)
Q Consensus 3 ~~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~- 76 (407)
..+.++|++.+.||+|+||.||+|++..+++.||||++...... ..+.+|+.+++.++| ++++.+..++....
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~ 86 (311)
T 3ork_A 8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH-PAIVAVYDTGEAETP 86 (311)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCC-TTBCCEEEEEEEEET
T ss_pred ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCC-CCcceEEEeeeccCC
Confidence 34688999999999999999999999999999999998765332 246788888888876 55555555544322
Q ss_pred ---eeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccc
Q 015406 77 ---YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 152 (407)
Q Consensus 77 ---~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGl 152 (407)
..|+||||+ |++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 87 ~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~ 162 (311)
T 3ork_A 87 AGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMDFGI 162 (311)
T ss_dssp TEEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---ETTSCEEECCCSC
T ss_pred CCcccEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEE---cCCCCEEEeeccC
Confidence 459999999 89999999863 479999999999999999999999999999999999999 5778999999999
Q ss_pred eeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhc
Q 015406 153 AKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (407)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (407)
++.+....... .......||+.|+|||++.+..++.++||||||+++|||++|..||.+... ...........
T Consensus 163 a~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~---~~~~~~~~~~~ 235 (311)
T 3ork_A 163 ARAIADSGNSV----TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP---VSVAYQHVRED 235 (311)
T ss_dssp C----------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHCC
T ss_pred ccccccccccc----ccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHhcCC
Confidence 98765432211 123356799999999999999999999999999999999999999977433 23333332222
Q ss_pred ccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHH
Q 015406 233 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 269 (407)
Q Consensus 233 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l 269 (407)
..........+++++.++|.+||+.||++||+..++
T Consensus 236 -~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~ 271 (311)
T 3ork_A 236 -PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAE 271 (311)
T ss_dssp -CCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHH
T ss_pred -CCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHH
Confidence 233344556799999999999999999999975543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=363.62 Aligned_cols=250 Identities=20% Similarity=0.292 Sum_probs=200.3
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc----chHHHHHHHHHHHcC-CCCCCeeEEeeeeCceeEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQG-GTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----~~~~~E~~~l~~l~~-~~~i~~~~~~~~~~~~~~l 80 (407)
+.+|++.+.||+|+||.||+|.+.. ++.||||++...... ..+.+|+.+++.+.| +++++.+..++...+..||
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 4569999999999999999999754 899999998765432 347899999999986 7889999988888899999
Q ss_pred EEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 81 VMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 81 vme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
|||+.+++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||+ .++.+||+|||+++.+....
T Consensus 134 v~E~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll----~~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 134 VMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EEECCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEE----SSSCEEECCCSSSCCC----
T ss_pred EEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE----ECCeEEEEecCccccccCCC
Confidence 999779999999986 4579999999999999999999999999999999999999 34789999999998765432
Q ss_pred CCcccCccCCCCccccccccccccccC-----------CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHh
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHLG-----------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 229 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----------~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~ 229 (407)
.. ......+||+.|+|||++.+ ..++.++|||||||+||||++|..||..... ....+..+.
T Consensus 209 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--~~~~~~~~~ 281 (390)
T 2zmd_A 209 TS-----VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--QISKLHAII 281 (390)
T ss_dssp ----------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC--HHHHHHHHH
T ss_pred cc-----ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH--HHHHHHHHh
Confidence 21 11235679999999999976 3689999999999999999999999976432 223333333
Q ss_pred hhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 230 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
...... .+....+.++.+||.+||..||++||++.++++
T Consensus 282 ~~~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 282 DPNHEI---EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp CTTSCC---CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CccccC---CCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 322211 122345789999999999999999999877653
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=350.68 Aligned_cols=262 Identities=21% Similarity=0.316 Sum_probs=216.2
Q ss_pred CCceeEeccccccCceEEEEEEE-----cCCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCce
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTN-----IQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~-----~~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 77 (407)
.++|++.+.||+|+||.||+|++ ..+++.||||++..... ...+.+|+.+++.+.+|++++.+..++...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 47899999999999999999985 45678999999876543 24578999999999666888888888888888
Q ss_pred eEEEEecc-CCCHHHHHHHcCC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCC
Q 015406 78 NVLVMDLL-GPSLEDLFNFCSR-----------------KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 139 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~~~~~-----------------~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~ 139 (407)
.++||||+ +++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~--- 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL--- 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE---
Confidence 99999999 8899999986432 38999999999999999999999999999999999999
Q ss_pred CCCceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015406 140 RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 218 (407)
Q Consensus 140 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~ 218 (407)
+.++.+||+|||+++........ .......||+.|+|||++.+..++.++||||||+++|+|++ |..||.+...
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNY-----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTS-----EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred cCCCCEEEccccccccccccccc-----eeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 57889999999999876544321 11335567889999999999999999999999999999999 9999987554
Q ss_pred CchHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcC
Q 015406 219 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREG 281 (407)
Q Consensus 219 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~ 281 (407)
... ....+... .... ....+++++.+++.+||+.||++||++.++.+.|++++.+..
T Consensus 254 ~~~--~~~~~~~~-~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 254 DSK--FYKMIKEG-FRML---SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp SHH--HHHHHHHT-CCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred hhH--HHHHhccC-CCCC---CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 322 22222221 1111 124578999999999999999999999999999999987653
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=365.98 Aligned_cols=254 Identities=21% Similarity=0.213 Sum_probs=210.5
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC--cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
.+.++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+|+.+++.++| ++++.+..++.+....++|
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH-PKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCS-TTBCCEEEEEECSSEEEEE
T ss_pred ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCC-cCCCeEEEEEEeCCEEEEE
Confidence 345789999999999999999999999999999999875432 2357889999999976 6777777778888899999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 82 me~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
|||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++. +..+.+||+|||+++......
T Consensus 127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEECCTTS
T ss_pred EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEec-CCCCceEEEecccceecCCCc
Confidence 9999 89999999765557999999999999999999999999999999999999942 135789999999998765432
Q ss_pred CCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHH
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (407)
. .....||+.|+|||++.+..++.++|||||||++|||++|..||.+... .+.+..+....... ....
T Consensus 206 ~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~~i~~~~~~~-~~~~ 273 (387)
T 1kob_A 206 I--------VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---LETLQNVKRCDWEF-DEDA 273 (387)
T ss_dssp C--------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHHHCCCCC-CSST
T ss_pred c--------eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCCC-Cccc
Confidence 2 1244789999999999999999999999999999999999999987433 44444444433221 1223
Q ss_pred hcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 241 ~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
...+++++.++|.+||..||++||++.++++
T Consensus 274 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 274 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 4568999999999999999999999887753
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=346.87 Aligned_cols=255 Identities=16% Similarity=0.224 Sum_probs=212.6
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
..++|++.+.||+|+||.||+|++. ++..||+|++.... ....+.+|+.+++.++| ++++.+..++......++|||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSH-PKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCC-TTBCCEEEEECSSSSEEEEEE
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCC-CCEeeEEEEEccCCceEEEEE
Confidence 3578999999999999999999874 67789999987654 34568899999999986 677777777778888999999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 84 ~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
|+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.........
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 84 YISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV---DRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEE---CTTCCEEECCTTCEEECCTTCEE
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEE---CCCCCEEEccCccceecchhhhh
Confidence 99 899999998766679999999999999999999999999999999999999 67889999999999876554321
Q ss_pred cccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHHh
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (407)
......+|+.|+|||++.+..++.++||||||+++|+|++ |..||..... ......+....... ..
T Consensus 161 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~~----~~ 227 (268)
T 3sxs_A 161 ------SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN---SEVVLKVSQGHRLY----RP 227 (268)
T ss_dssp ------ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHHHHHHTTCCCC----CC
T ss_pred ------cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh---HHHHHHHHcCCCCC----CC
Confidence 1234567788999999999889999999999999999999 9999976443 33333333332211 12
Q ss_pred cCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHH
Q 015406 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (407)
Q Consensus 242 ~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~ 277 (407)
..+++++.+++.+||+.||++||++.++.+.|+.+.
T Consensus 228 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 228 HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 447899999999999999999999999999988763
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=347.84 Aligned_cols=255 Identities=18% Similarity=0.266 Sum_probs=204.2
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc---------chHHHHHHHHHHHcCCCCCCeeEEeeee
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---------PQLLYESKLYRILQGGTGIPNVRWFGVE 74 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~---------~~~~~E~~~l~~l~~~~~i~~~~~~~~~ 74 (407)
...++|++.+.||+|+||.||+|++..+++.||||++...... ..+.+|+.+++.++| +++..+..++..
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~ 94 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH-PNIVKLYGLMHN 94 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCC-TTBCCEEEEETT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCC-CCchhhheeecC
Confidence 4578999999999999999999999999999999987654322 457889999999976 566666555544
Q ss_pred CceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcccccCCC--CCceEEEEe
Q 015406 75 GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGR--RANQVYIID 149 (407)
Q Consensus 75 ~~~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--ivHrDLKp~NILl~~~~--~~~~~kL~D 149 (407)
.. ++||||+ +++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++ ....+||+|
T Consensus 95 ~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 95 PP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp TT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred CC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 43 7999999 89999998765667999999999999999999999999 99999999999994221 112399999
Q ss_pred ccceeeeccCCCCcccCccCCCCcccccccccccccc--CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHH
Q 015406 150 FGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL--GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK 227 (407)
Q Consensus 150 FGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~ 227 (407)
||+++..... .....||+.|+|||++. +..++.++|||||||++|||++|..||....... ......
T Consensus 173 fg~~~~~~~~----------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~ 241 (287)
T 4f0f_A 173 FGLSQQSVHS----------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-IKFINM 241 (287)
T ss_dssp CTTCBCCSSC----------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH-HHHHHH
T ss_pred CCcccccccc----------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH-HHHHHH
Confidence 9999754332 23467999999999994 4557899999999999999999999998755432 222333
Q ss_pred HhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 015406 228 ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 275 (407)
Q Consensus 228 i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~ 275 (407)
+....... .+...+|+++.+++.+||+.||++||++.++.+.|++
T Consensus 242 ~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 242 IREEGLRP---TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HHHSCCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HhccCCCC---CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 33322221 2335689999999999999999999999999998875
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=357.82 Aligned_cols=254 Identities=18% Similarity=0.267 Sum_probs=200.8
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+|+.+++.++| ++++.+..++...+..++|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKH-ANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCC-TTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCC-CCCCeeeeEEeeCCEEEEEec
Confidence 689999999999999999999999999999998865432 2245679999999986 677777777888888999999
Q ss_pred ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCc
Q 015406 84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (407)
Q Consensus 84 ~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~ 163 (407)
|++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~-- 155 (324)
T 3mtl_A 81 YLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPTK-- 155 (324)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEE---CTTCCEEECSSSEEECC-------
T ss_pred ccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEE---CCCCCEEEccCcccccccCCcc--
Confidence 99889999998777779999999999999999999999999999999999999 5788999999999986543322
Q ss_pred ccCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcc---------
Q 015406 164 HIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV--------- 233 (407)
Q Consensus 164 ~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~--------- 233 (407)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+........
T Consensus 156 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (324)
T 3mtl_A 156 -----TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 230 (324)
T ss_dssp ------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred -----ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhc
Confidence 1234578999999999987 5689999999999999999999999987554333333322221111
Q ss_pred -------------cccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 234 -------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 234 -------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
..........+++++.+||.+||+.||++|||++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 01112233467899999999999999999999877754
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=357.16 Aligned_cols=257 Identities=19% Similarity=0.280 Sum_probs=202.6
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeE----EEEEEecCCC---CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCce
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEE----VAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~----vAvK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 77 (407)
..++|++.++||+|+||.||+|++..+++. ||+|.+.... ....+.+|+.+++.++| ++++.+..++....
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~- 90 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN-PHVCRLLGICLTST- 90 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCB-TTBCCEEEEEESSS-
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCC-CCEeEEEEEEecCC-
Confidence 467899999999999999999998877765 5777764332 33458899999999986 66666666666554
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeee
Q 015406 78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~ 156 (407)
.+++|||+ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCTTHHHHH
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEE---CCCCCEEEccCcceeEc
Confidence 57788888 999999998777789999999999999999999999999999999999999 57889999999999876
Q ss_pred ccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccc
Q 015406 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVST 235 (407)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (407)
....... ......||+.|+|||++.+..++.++|||||||++|||++ |..||.+......... +.......
T Consensus 168 ~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~---~~~~~~~~ 239 (327)
T 3poz_A 168 GAEEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---LEKGERLP 239 (327)
T ss_dssp TTTCC------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH---HHTTCCCC
T ss_pred cCCcccc-----cccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHH---HHcCCCCC
Confidence 5443211 1234567889999999999999999999999999999999 9999987655433222 22221111
Q ss_pred cHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Q 015406 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (407)
Q Consensus 236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~ 278 (407)
....++.++.+++.+||+.||++||++.++.+.|+.+..
T Consensus 240 ----~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 240 ----QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp ----CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred ----CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 224578999999999999999999999999999988754
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=352.72 Aligned_cols=258 Identities=16% Similarity=0.298 Sum_probs=212.9
Q ss_pred CCceeEeccccccCceEEEEEEEc-----CCCeEEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeeeCce
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~-----~~~~~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 77 (407)
.++|++.+.||+|+||.||+|++. .+++.||||++...... ..+.+|+.+++.++| ++++.+..++...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNH-PHVIKLYGACSQDGP 100 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEECSSSS
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCC-CceeeEEEEEecCCc
Confidence 578999999999999999999983 45689999998754332 347789999999975 677777777777888
Q ss_pred eEEEEecc-CCCHHHHHHHcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCc
Q 015406 78 NVLVMDLL-GPSLEDLFNFCS-----------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 133 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~N 133 (407)
.++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~N 180 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARN 180 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchhe
Confidence 99999999 899999998643 238999999999999999999999999999999999
Q ss_pred ccccCCCCCceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCC
Q 015406 134 FLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLP 212 (407)
Q Consensus 134 ILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~P 212 (407)
||+ +.++.+||+|||+++........ .......+|+.|+|||++.+..++.++||||||+++|||++ |..|
T Consensus 181 Ili---~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 252 (314)
T 2ivs_A 181 ILV---AEGRKMKISDFGLSRDVYEEDSY-----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252 (314)
T ss_dssp EEE---ETTTEEEECCCTTCEECTTTSCE-----ECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred EEE---cCCCCEEEccccccccccccccc-----eeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence 999 57889999999999876543321 11234567889999999999889999999999999999999 9999
Q ss_pred CCCCCcCchHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHH
Q 015406 213 WQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (407)
Q Consensus 213 f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~ 279 (407)
|.+..... ....+...... .....+++++.+++.+||+.||++||++.+|.+.|++++.+
T Consensus 253 ~~~~~~~~---~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 253 YPGIPPER---LFNLLKTGHRM----ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp STTCCGGG---HHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCHHH---HHHHhhcCCcC----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 98765433 23333332211 12356899999999999999999999999999999998764
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=369.81 Aligned_cols=263 Identities=18% Similarity=0.219 Sum_probs=186.5
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc----chHHHHHHHHHHHcCCCCCCeeEEeee-----e
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGV-----E 74 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~-----~ 74 (407)
.+.++|++++.||+|+||.||+|++..+++.||||++...... ..+.+|+.+++.++| ++|+.+..++. .
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~ 128 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNH-DHVVKVLDIVIPKDVEK 128 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCC-TTBCCEEEECCCSCTTT
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCC-CCCCceEEEEecCCccc
Confidence 4678999999999999999999999999999999988654322 347889999999986 55555555442 2
Q ss_pred CceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEecccee
Q 015406 75 GDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (407)
Q Consensus 75 ~~~~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~ 154 (407)
....|+||||++++|.+++.. ...+++..++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+|+
T Consensus 129 ~~~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl---~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 129 FDELYVVLEIADSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV---NQDCSVKVCDFGLAR 204 (458)
T ss_dssp CCCEEEEECCCSEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCCTTCB
T ss_pred CceEEEEEeccccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEE---CCCCCEeecccccch
Confidence 356899999999999999975 4579999999999999999999999999999999999999 678899999999998
Q ss_pred eeccCCCCccc--------------------CccCCCCccccccccccccc-cCCCCChhhHHHHHHHHHHHHHh-----
Q 015406 155 KYRDTSTHQHI--------------------PYRENKNLTGTARYASMNTH-LGIEQSRRDDLESLGYVLMYFLR----- 208 (407)
Q Consensus 155 ~~~~~~~~~~~--------------------~~~~~~~~~gt~~Y~aPE~~-~~~~~~~~sDIwSlG~il~ellt----- 208 (407)
........... ........+||+.|+|||++ .+..++.++||||||||||||++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~ 284 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence 76533211000 00123456889999999986 45679999999999999999999
Q ss_pred ------CCCCCCCCCcC-----------------chHHHHHHHhhh--------------------------cccccHHH
Q 015406 209 ------GSLPWQGLKAG-----------------TKKQKYEKISEK--------------------------KVSTSIEA 239 (407)
Q Consensus 209 ------G~~Pf~~~~~~-----------------~~~~~~~~i~~~--------------------------~~~~~~~~ 239 (407)
|.++|.+.... .....+..+... ........
T Consensus 285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (458)
T 3rp9_A 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE 364 (458)
T ss_dssp CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence 67777553310 001111111110 01111222
Q ss_pred HhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 240 ~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
..+.+++++.+||.+||..||++|||++++++
T Consensus 365 ~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~ 396 (458)
T 3rp9_A 365 RFPASSADAIHLLKRMLVFNPNKRITINECLA 396 (458)
T ss_dssp GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HCCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 33556899999999999999999999877654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=342.61 Aligned_cols=253 Identities=21% Similarity=0.238 Sum_probs=212.2
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCC--CCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
.+.++|++.+.||+|+||.||+|++..++..||+|.+... .....+.+|+++++.++| ++++.+..++......++|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDH-PNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSEEEEE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCC-CCEeeEEEEEecCCeEEEE
Confidence 3567899999999999999999999999999999987653 334568899999999976 6777777788888899999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 82 me~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
|||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+..++.++.+||+|||++.......
T Consensus 85 ~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 85 MELCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp EECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred EeccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 9999 8899999876 3569999999999999999999999999999999999999655677899999999998765433
Q ss_pred CCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHH
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (407)
. .....||+.|+|||++.+. ++.++||||||+++|+|++|..||..... .+....+........ ...
T Consensus 164 ~--------~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~-~~~ 230 (277)
T 3f3z_A 164 M--------MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD---SEVMLKIREGTFTFP-EKD 230 (277)
T ss_dssp C--------BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCCCC-HHH
T ss_pred c--------hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhCCCCCC-chh
Confidence 2 2355799999999998774 89999999999999999999999977433 444555554443332 233
Q ss_pred hcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 241 ~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
...+++++.++|.+||+.||++||++.++++
T Consensus 231 ~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 231 WLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 4568999999999999999999999877753
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=365.01 Aligned_cols=263 Identities=18% Similarity=0.252 Sum_probs=196.6
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc----chHHHHHHHHHHHcCCCCCCeeEEeeeeC----
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEG---- 75 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~---- 75 (407)
.+.++|++.+.||+|+||.||+|++..+++.||||++...... ..+.+|+.+++.++| ++++.+..++...
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~ 101 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKS-DYIIRLYDLIIPDDLLK 101 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCC-TTBCCEEEECCCSCTTT
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCC-CCcceEEEEEecCCCCc
Confidence 4689999999999999999999999999999999998654322 357899999999987 5555555544433
Q ss_pred -ceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEecccee
Q 015406 76 -DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (407)
Q Consensus 76 -~~~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~ 154 (407)
...|+||||++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+
T Consensus 102 ~~~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl---~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 102 FDELYIVLEIADSDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLL---NQDCSVKVCDFGLAR 177 (432)
T ss_dssp CCCEEEEEECCSEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCE
T ss_pred CCeEEEEEecCCcCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEE---CCCCCEEEccCCCcc
Confidence 56899999998899999985 4569999999999999999999999999999999999999 678899999999999
Q ss_pred eeccCCCCccc---------------CccCCCCccccccccccccc-cCCCCChhhHHHHHHHHHHHHHhCCCCC-----
Q 015406 155 KYRDTSTHQHI---------------PYRENKNLTGTARYASMNTH-LGIEQSRRDDLESLGYVLMYFLRGSLPW----- 213 (407)
Q Consensus 155 ~~~~~~~~~~~---------------~~~~~~~~~gt~~Y~aPE~~-~~~~~~~~sDIwSlG~il~elltG~~Pf----- 213 (407)
........... ........+||+.|+|||++ .+..++.++|||||||+||||++|..||
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~ 257 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGG
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccc
Confidence 76543221000 00113567899999999986 4566999999999999999999854444
Q ss_pred ------CCCCcC--------------chHHHHHHHhh--------------------------hcccccHHHHhcCCcHH
Q 015406 214 ------QGLKAG--------------TKKQKYEKISE--------------------------KKVSTSIEALCRGYPTE 247 (407)
Q Consensus 214 ------~~~~~~--------------~~~~~~~~i~~--------------------------~~~~~~~~~~~~~~~~~ 247 (407)
.+.... .....+..+.. ...........+.++++
T Consensus 258 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 337 (432)
T 3n9x_A 258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDD 337 (432)
T ss_dssp GCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHH
T ss_pred cccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHH
Confidence 332100 00111111111 11112223344678999
Q ss_pred HHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 248 FASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 248 l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
+.+||.+||..||++|||++++++
T Consensus 338 ~~dLl~~mL~~dP~~R~ta~e~L~ 361 (432)
T 3n9x_A 338 GINLLESMLKFNPNKRITIDQALD 361 (432)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHhcCCcccCCCHHHHhc
Confidence 999999999999999999877653
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=346.45 Aligned_cols=254 Identities=25% Similarity=0.352 Sum_probs=203.4
Q ss_pred CccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC---CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeE
Q 015406 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 3 ~~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 79 (407)
..+.++|.+.++||+|+||.||+|++..+++.||+|++.... ....+.+|+++++.++| ++++.+..++......+
T Consensus 18 g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~ 96 (285)
T 3is5_A 18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDH-PNIIKIFEVFEDYHNMY 96 (285)
T ss_dssp SCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSEEE
T ss_pred CChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCC-chHHhHHHheecCCeEE
Confidence 456788999999999999999999999999999999876543 23568899999999986 67777777778888899
Q ss_pred EEEecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceee
Q 015406 80 LVMDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (407)
Q Consensus 80 lvme~~-g~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~ 155 (407)
+||||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+..++.++.+||+|||+++.
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp EEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 999999 88999988542 46799999999999999999999999999999999999996545568899999999986
Q ss_pred eccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccc
Q 015406 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (407)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (407)
...... .....||+.|+|||++.+ .++.++||||||+++|||++|..||.+... .+....+.......
T Consensus 177 ~~~~~~--------~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~---~~~~~~~~~~~~~~ 244 (285)
T 3is5_A 177 FKSDEH--------STNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSL---EEVQQKATYKEPNY 244 (285)
T ss_dssp ------------------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCCC
T ss_pred cCCccc--------CcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCH---HHHHhhhccCCccc
Confidence 654322 235578999999999864 789999999999999999999999987443 23333332222211
Q ss_pred cHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
. .....+++++.+++.+||+.||++||++.++++
T Consensus 245 ~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 245 A--VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp C--C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred c--cccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 122447899999999999999999999887753
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=358.50 Aligned_cols=259 Identities=21% Similarity=0.331 Sum_probs=212.8
Q ss_pred cCCceeEeccccccCceEEEEEEEc-----CCCeEEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeeeCc
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGD 76 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~-----~~~~~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 76 (407)
..++|++.+.||+|+||.||+|++. .+++.||||++...... ..+.+|+.+++.++| ++++.+..++...+
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~ 123 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN-PNIVKLLGVCAVGK 123 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEECSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCC-CCEEEEEEEEccCC
Confidence 3578999999999999999999987 35589999998754432 347889999999975 67777777777788
Q ss_pred eeEEEEecc-CCCHHHHHHHcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCC
Q 015406 77 YNVLVMDLL-GPSLEDLFNFCS-----------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPD 132 (407)
Q Consensus 77 ~~~lvme~~-g~sL~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~ 132 (407)
..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~ 203 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 203 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcc
Confidence 899999999 889999998642 56999999999999999999999999999999999
Q ss_pred cccccCCCCCceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCC
Q 015406 133 NFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSL 211 (407)
Q Consensus 133 NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~ 211 (407)
|||+ +.++.+||+|||+++....... ........||+.|+|||++.+..++.++||||||+++|||++ |..
T Consensus 204 NIl~---~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 204 NCLV---GENMVVKIADFGLSRNIYSADY-----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp GEEE---CGGGCEEECCCSCHHHHTGGGC-----BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred eEEE---CCCCeEEEeecCCCcccccCcc-----ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence 9999 6888999999999986543221 112335578999999999999899999999999999999999 999
Q ss_pred CCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHH
Q 015406 212 PWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (407)
Q Consensus 212 Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~ 279 (407)
||.+... .+....+...... .....+|+++.+++.+||+.||++||++.++.+.|+++..+
T Consensus 276 p~~~~~~---~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 276 PYYGMAH---EEVIYYVRDGNIL----ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp TTTTSCH---HHHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred cCCCCCh---HHHHHHHhCCCcC----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 9987443 3444444443322 12356899999999999999999999999999999987543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=356.10 Aligned_cols=261 Identities=20% Similarity=0.277 Sum_probs=211.4
Q ss_pred CCceeEeccccccCceEEEEEEEc-----CCCeEEEEEEecCCC---CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCce
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~-----~~~~~vAvK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 77 (407)
.++|++.+.||+|+||.||+|++. .+++.||||++.... ....+.+|+.+++.+..|++++.+..++...+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 468999999999999999999973 456789999986532 334688999999999666888888888888888
Q ss_pred eEEEEecc-CCCHHHHHHHcCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcc
Q 015406 78 NVLVMDLL-GPSLEDLFNFCSR----------------------KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNF 134 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~~~~~----------------------~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NI 134 (407)
.++||||+ +++|.+++..... .+++..++.++.||+.||.|||++||+||||||+||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NI 203 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV 203 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGE
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhE
Confidence 99999999 8899999985432 279999999999999999999999999999999999
Q ss_pred cccCCCCCceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCC
Q 015406 135 LMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPW 213 (407)
Q Consensus 135 Ll~~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf 213 (407)
|+ +.++.+||+|||++......... .......||+.|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus 204 ll---~~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 204 LV---THGKVVKICDFGLARDIMSDSNY-----VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp EE---ETTTEEEECCCGGGSCGGGCTTS-----EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred EE---cCCCcEEeCCCccCcccccCccc-----eeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 99 57889999999999876544321 11335567889999999999899999999999999999998 99999
Q ss_pred CCCCcCchHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHc
Q 015406 214 QGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (407)
Q Consensus 214 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~ 280 (407)
.+..... .+.......... .....+++++.+++.+||+.||++||++.+|.+.|+.++...
T Consensus 276 ~~~~~~~---~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 276 PGIPVDA---NFYKLIQNGFKM---DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp TTCCCSH---HHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred ccCCcHH---HHHHHHhcCCCC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 8765432 222222222111 122457899999999999999999999999999999886543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=356.02 Aligned_cols=262 Identities=19% Similarity=0.217 Sum_probs=201.7
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-cchHHHHHHHHHHHcCCCCCCeeEEeeee----CceeEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVE----GDYNVL 80 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~----~~~~~l 80 (407)
.++|++.++||+|+||.||+|++. ++.||||++..... .....+|+.+++.++| ++++.+..++.. ....++
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKH-ENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCC-TTBCCEEEEEEEECSSSEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCC-CCchhhcceeccCCCCCceEEE
Confidence 468999999999999999999864 89999999865432 2235567777888876 555555555443 334799
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC----------CceeccCCCCcccccCCCCCceEEEEe
Q 015406 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK----------SFLHRDIKPDNFLMGLGRRANQVYIID 149 (407)
Q Consensus 81 vme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~----------~ivHrDLKp~NILl~~~~~~~~~kL~D 149 (407)
||||+ +++|.+++.. ..+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|
T Consensus 100 v~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill---~~~~~~kL~D 174 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL---KNNLTACIAD 174 (322)
T ss_dssp EEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEE---CTTCCEEECC
T ss_pred EEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEE---CCCCeEEEcc
Confidence 99999 8899999985 4699999999999999999999999 99999999999999 6788999999
Q ss_pred ccceeeeccCCCCcccCccCCCCccccccccccccccCC-----CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCc----
Q 015406 150 FGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-----EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT---- 220 (407)
Q Consensus 150 FGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~---- 220 (407)
||+++.+...... .......||+.|+|||++.+. .++.++|||||||++|||++|..||.+.....
T Consensus 175 Fg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~ 249 (322)
T 3soc_A 175 FGLALKFEAGKSA-----GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249 (322)
T ss_dssp CTTCEEECTTSCC-----CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTT
T ss_pred CCcccccccccCc-----cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccch
Confidence 9999877654321 123346799999999999873 45678999999999999999999997643321
Q ss_pred ---------hHHHHHHHhhhcccccHHHHh--cCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHc
Q 015406 221 ---------KKQKYEKISEKKVSTSIEALC--RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (407)
Q Consensus 221 ---------~~~~~~~i~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~ 280 (407)
.......+......+...... ...++++.+||.+||+.||++||++.++.+.|+++....
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp HHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred hhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 112222222222222211111 123567999999999999999999999999999987654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=347.74 Aligned_cols=260 Identities=19% Similarity=0.341 Sum_probs=217.3
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
..++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+|+.+++.++| ++++.+..++......++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH-PNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCC-TTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEccCCCEEEEEE
Confidence 45789999999999999999999999999999999876543 3458899999999986 667777777777888899999
Q ss_pred cc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCC
Q 015406 84 LL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 84 ~~-g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~ 161 (407)
|+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++........
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~ 166 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTY 166 (288)
T ss_dssp CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEE---CGGGCEEECCCCGGGTSCSSSS
T ss_pred cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEE---cCCCCEEEccCccceeccCCcc
Confidence 99 799999998643 459999999999999999999999999999999999999 6788999999999986554322
Q ss_pred CcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHH
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (407)
.......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+...... ...+...... ..
T Consensus 167 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~---~~~~~~~~~~----~~ 233 (288)
T 3kfa_A 167 ------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---YELLEKDYRM----ER 233 (288)
T ss_dssp ------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HHHHHTTCCC----CC
T ss_pred ------ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHhccCCC----CC
Confidence 11234567889999999999899999999999999999999 9999987654333 2222222111 12
Q ss_pred hcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcC
Q 015406 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREG 281 (407)
Q Consensus 241 ~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~ 281 (407)
...+|+++.+++.+||..||++||++.++.+.|+.++.+..
T Consensus 234 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~ 274 (288)
T 3kfa_A 234 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 274 (288)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 25689999999999999999999999999999999987654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=350.52 Aligned_cols=246 Identities=18% Similarity=0.293 Sum_probs=205.3
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC--cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~ 85 (407)
.|+..++||+|+||.||+|++..+|+.||||++..... ...+.+|+.+++.++| ++++.+..++...+..++||||+
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~ 124 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH-FNVVEMYKSYLVGEELWVLMEFL 124 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC-TTBCCEEEEEEETTEEEEEECCC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC-CCcceEEEEEEECCEEEEEEecC
Confidence 48889999999999999999988999999999875433 3457899999999976 66777777777888899999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcc
Q 015406 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164 (407)
Q Consensus 86 -g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~ 164 (407)
+++|.+++. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 125 ~~~~L~~~l~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~--- 196 (321)
T 2c30_A 125 QGGALTDIVS--QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVP--- 196 (321)
T ss_dssp CSCBHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSC---
T ss_pred CCCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCcEEEeeeeeeeecccCcc---
Confidence 999999987 4579999999999999999999999999999999999999 5788999999999987654322
Q ss_pred cCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCC
Q 015406 165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 244 (407)
Q Consensus 165 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (407)
......||+.|+|||++.+..++.++||||||+++|||++|..||..... .+.+..+........ .....+
T Consensus 197 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~---~~~~~~~~~~~~~~~--~~~~~~ 267 (321)
T 2c30_A 197 ----KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP---VQAMKRLRDSPPPKL--KNSHKV 267 (321)
T ss_dssp ----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSSCCCC--TTGGGS
T ss_pred ----ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhcCCCCCc--CccccC
Confidence 12356799999999999999999999999999999999999999976433 344444433322211 112457
Q ss_pred cHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 245 PTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 245 ~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
++++.+++.+||..||++||++.++++
T Consensus 268 ~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 268 SPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 899999999999999999999887754
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=364.75 Aligned_cols=255 Identities=20% Similarity=0.250 Sum_probs=204.7
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-cchHHHHHHHHHHHcCC-----CCCCeeEEeeeeCce
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGG-----TGIPNVRWFGVEGDY 77 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~E~~~l~~l~~~-----~~i~~~~~~~~~~~~ 77 (407)
.+.++|++.+.||+|+||.||+|++..+++.||||++..... ...+..|+.+++.+++. +++..+..++.....
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 356789999999999999999999999999999999875432 24577899999998753 467777778888899
Q ss_pred eEEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCce--EEEEecccee
Q 015406 78 NVLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ--VYIIDFGLAK 154 (407)
Q Consensus 78 ~~lvme~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~--~kL~DFGla~ 154 (407)
.++||||++++|.+++.... ..+++..++.|+.||+.||+|||++||+||||||+|||| +.++. +||+|||+++
T Consensus 174 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl---~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 174 ICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILL---KQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEE---SSTTSCCEEECCCTTCE
T ss_pred EEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---ccCCCcceEEeecccce
Confidence 99999999889999998644 359999999999999999999999999999999999999 45555 9999999997
Q ss_pred eeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhccc
Q 015406 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (407)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (407)
..... .....||+.|+|||++.+..++.++|||||||+||||++|..||.+.+.......+.........
T Consensus 251 ~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~ 320 (429)
T 3kvw_A 251 YEHQR----------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ 320 (429)
T ss_dssp ETTCC----------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred ecCCc----------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence 65432 23568999999999999999999999999999999999999999875443222222221110000
Q ss_pred ---------------------------------------------------ccHHHHhcCCcHHHHHHHHHHhCCCCCCC
Q 015406 235 ---------------------------------------------------TSIEALCRGYPTEFASYFHYCRSLRFDDK 263 (407)
Q Consensus 235 ---------------------------------------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~R 263 (407)
.....+....++++.+||.+||..||++|
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~R 400 (429)
T 3kvw_A 321 KLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVR 400 (429)
T ss_dssp HHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTS
T ss_pred HHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhC
Confidence 00011222347889999999999999999
Q ss_pred CCHHHHHH
Q 015406 264 PDYAYLKR 271 (407)
Q Consensus 264 Pt~~~l~~ 271 (407)
||++++++
T Consensus 401 pta~e~L~ 408 (429)
T 3kvw_A 401 MTPGQALR 408 (429)
T ss_dssp CCHHHHHT
T ss_pred CCHHHHhC
Confidence 99887754
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=356.63 Aligned_cols=256 Identities=18% Similarity=0.224 Sum_probs=205.0
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeE----EEEEEecCCC---CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCce
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEE----VAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~----vAvK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 77 (407)
-.++|++.+.||+|+||.||+|++..+++. ||+|.+.... ....+.+|+.+++.++| ++++.+..++. ...
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~-~~~ 88 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDH-AHIVRLLGLCP-GSS 88 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCC-TTBCCEEEEEC-BSS
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCC-CCcCeEEEEEc-CCc
Confidence 367899999999999999999999888775 7788765432 23457889999999976 55666655554 445
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeee
Q 015406 78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~ 156 (407)
.++||||+ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 89 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 89 LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL---KSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEE---SSSSCEEECSCSGGGGS
T ss_pred cEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEE---CCCCeEEECCCCccccc
Confidence 78999999 899999998655679999999999999999999999999999999999999 57889999999999876
Q ss_pred ccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccc
Q 015406 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVST 235 (407)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (407)
....... ......||..|+|||++.+..++.++|||||||++|+|++ |..||.+...... ...+.......
T Consensus 166 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~~~~~~~~~ 237 (325)
T 3kex_A 166 PPDDKQL-----LYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV---PDLLEKGERLA 237 (325)
T ss_dssp CCCTTCC-----C-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH---HHHHHTTCBCC
T ss_pred Ccccccc-----cccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH---HHHHHcCCCCC
Confidence 5443211 1235568889999999998899999999999999999999 9999987554332 22222222111
Q ss_pred cHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHH
Q 015406 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (407)
Q Consensus 236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~ 277 (407)
....++.++.+++.+||..||++||++.++.+.|+.+.
T Consensus 238 ----~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 238 ----QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp ----CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred ----CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 12346788999999999999999999999999998874
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=352.42 Aligned_cols=261 Identities=16% Similarity=0.313 Sum_probs=214.7
Q ss_pred CCceeEeccccccCceEEEEEEEc-------CCCeEEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeeeC
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNI-------QTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEG 75 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~-------~~~~~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~ 75 (407)
.++|++.+.||+|+||.||+|++. .+++.||||++...... ..+.+|+.+++.+.+|++++.+..++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 578999999999999999999976 35678999998755432 34788999999996668888888888888
Q ss_pred ceeEEEEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCC
Q 015406 76 DYNVLVMDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 139 (407)
Q Consensus 76 ~~~~lvme~~-g~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~ 139 (407)
+..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll--- 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV--- 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE---
Confidence 8899999999 889999998532 238999999999999999999999999999999999999
Q ss_pred CCCceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015406 140 RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 218 (407)
Q Consensus 140 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~ 218 (407)
+.++.+||+|||+++........ .......+|+.|+|||++.+..++.++||||||+++|||++ |..||.+...
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 265 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSE-----ECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred cCCCCEEEccccccccccccccc-----cccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence 57889999999999876543321 11234567889999999998889999999999999999999 9999987543
Q ss_pred CchHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcC
Q 015406 219 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREG 281 (407)
Q Consensus 219 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~ 281 (407)
.+....+...... .....+++++.+++.+||+.||++||++.++.+.|+.++....
T Consensus 266 ---~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 266 ---EELFKLLKEGHRM----DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp ---HHHHHHHHHTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred ---HHHHHHHhcCCCC----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 3333333333221 1235689999999999999999999999999999999987553
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=355.87 Aligned_cols=266 Identities=22% Similarity=0.239 Sum_probs=204.4
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeE
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 79 (407)
...++|++.++||+|+||.||+|++..+++.||||++..... ...+.+|+.+++.++| ++++.+..++......+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQH-RNIIELKSVIHHNHRLH 109 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCC-TTBCCEEEEEEETTEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCC-CCcceEEEEEecCCEEE
Confidence 346789999999999999999999999999999999865433 2346789999999975 77777888888889999
Q ss_pred EEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCC--CCCceEEEEeccceeeec
Q 015406 80 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG--RRANQVYIIDFGLAKKYR 157 (407)
Q Consensus 80 lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~--~~~~~~kL~DFGla~~~~ 157 (407)
+||||++++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||++.+ +..+.+||+|||+++...
T Consensus 110 lv~e~~~~~L~~~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 110 LIFEYAENDLKKYMDK-NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp EEEECCSEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred EEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 9999998899999986 4569999999999999999999999999999999999999532 234569999999998664
Q ss_pred cCCCCcccCccCCCCccccccccccccccCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhccc--
Q 015406 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS-- 234 (407)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-- 234 (407)
.... ......||+.|+|||++.+. .++.++|||||||++|||++|..||.+... .+.+..+......
T Consensus 189 ~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~~~~~~~~~~ 258 (329)
T 3gbz_A 189 IPIR-------QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE---IDQLFKIFEVLGLPD 258 (329)
T ss_dssp ------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCC
T ss_pred Cccc-------ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH---HHHHHHHHHHhCCCc
Confidence 3321 12355789999999999875 489999999999999999999999987443 2333333221100
Q ss_pred -----------------------ccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccc
Q 015406 235 -----------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWT 291 (407)
Q Consensus 235 -----------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~dw~ 291 (407)
.....+...+++++.+||.+||+.||++||++.++++ ++|....+|+
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~----------hp~f~~~~~~ 328 (329)
T 3gbz_A 259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE----------HPYFSHNDFD 328 (329)
T ss_dssp TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT----------SGGGSSSCSC
T ss_pred hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC----------CcccCCCCCC
Confidence 0111222337899999999999999999999877754 3555566664
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=346.73 Aligned_cols=254 Identities=21% Similarity=0.264 Sum_probs=199.2
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc----chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
.++|++.++||+|+||.||+|++..+++.||||++...... ..+.+|+.+++.++| ++++.+..++...+..++|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH-PNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCC-CCccchhheeecCCeEEEE
Confidence 57899999999999999999999999999999988655433 346789999999986 6677777778888899999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 82 me~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
|||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 81 ~e~~~~~~l~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 81 FEYCDHTVLHELDRY-QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILI---TKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp EECCSEEHHHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC---
T ss_pred EEeCCCchHHHHHhh-hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEE---cCCCCEEEeeCCCchhccCcc
Confidence 9999 6777777764 5579999999999999999999999999999999999999 578899999999998765433
Q ss_pred CCcccCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcc------
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV------ 233 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~------ 233 (407)
.. .....||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.........+........
T Consensus 157 ~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (311)
T 4agu_A 157 DY-------YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQV 229 (311)
T ss_dssp ----------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred cc-------cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccc
Confidence 21 235578999999999986 5689999999999999999999999987554332222222211100
Q ss_pred -----------------cccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 234 -----------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 234 -----------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
........+.+++++.+++.+||+.||++|||++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp HHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 01122233568899999999999999999999887754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=364.12 Aligned_cols=259 Identities=16% Similarity=0.268 Sum_probs=201.2
Q ss_pred CCceeEeccccccCceEEEEEEEc---CCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~---~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 79 (407)
.++|++.+.||+|+||.||+|++. .++..||||+++.... ...+.+|+.+++.++| ++++.+..++......+
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH-PNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEECSSSSCE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEeeCCceE
Confidence 458999999999999999999976 4677899999875432 2357889999999976 67777777778888899
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 80 lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
+||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 123 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC--------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---cCCCCEEECcCcccccccc
Confidence 999999 999999998766679999999999999999999999999999999999999 6788999999999987654
Q ss_pred CCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccH
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (407)
..... .......++..|+|||++.+..++.++|||||||+||||++ |..||..... .+....+.......
T Consensus 200 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~---~~~~~~i~~~~~~~-- 270 (373)
T 2qol_A 200 DPEAA----YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---QDVIKAVDEGYRLP-- 270 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH---HHHHHHHHTTEECC--
T ss_pred CCccc----eeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCCC--
Confidence 32211 11123345788999999999999999999999999999998 9999977543 33344433332211
Q ss_pred HHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHH
Q 015406 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (407)
Q Consensus 238 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~ 279 (407)
....++.++.+++.+||+.||++||++.+|.+.|+.++..
T Consensus 271 --~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 271 --PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp --CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred --CCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 1245889999999999999999999999999999998764
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=348.13 Aligned_cols=259 Identities=24% Similarity=0.387 Sum_probs=199.3
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc----chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeE
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 79 (407)
...++|++.++||+|+||.||+|++. ..||||+++..... ..+.+|+.+++.++|+ ++..+..+. .....+
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~-~~~~~~ 95 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV-NILLFMGYS-TAPQLA 95 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCT-TBCCEEEEE-CSSSCE
T ss_pred cCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCC-cEEEEEeec-cCCccE
Confidence 45789999999999999999999853 35999998765433 3478899999999875 455555544 445579
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 80 lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
+||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL---HEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp EEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ETTTEEEECCCC-------
T ss_pred EEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE---CCCCCEEEccceecccccc
Confidence 999999 899999997666779999999999999999999999999999999999999 5778999999999986543
Q ss_pred CCCCcccCccCCCCcccccccccccccc---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccc
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (407)
.... .......||+.|+|||++. +..++.++||||||+++|+|++|..||.+... .......+.......
T Consensus 173 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~ 245 (289)
T 3og7_A 173 WSGS-----HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIEMVGRGSLSP 245 (289)
T ss_dssp ----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC--HHHHHHHHHHTSCCC
T ss_pred cccc-----ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch--HHHHHHHhcccccCc
Confidence 2221 1123567999999999987 66789999999999999999999999987543 233444444444444
Q ss_pred cHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHH
Q 015406 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (407)
Q Consensus 236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~ 277 (407)
....+...+|+++.+++.+||+.||++||++.++++.|+++.
T Consensus 246 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 246 DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 455556678999999999999999999999999999998764
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=351.23 Aligned_cols=261 Identities=20% Similarity=0.301 Sum_probs=213.8
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCe-----EEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCce
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNE-----EVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~-----~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 77 (407)
.++|++.+.||+|+||.||+|.+..+++ .||+|++..... ...+.+|+.+++.+.+|++++.+..++...+.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 5789999999999999999999876654 799999876542 23478999999999666888888888888888
Q ss_pred eEEEEecc-CCCHHHHHHHc-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCc
Q 015406 78 NVLVMDLL-GPSLEDLFNFC-------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN 143 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~~~-------------~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~ 143 (407)
.++||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~---~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL---TNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE---EGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE---CCCC
Confidence 99999999 88999999753 2458999999999999999999999999999999999999 5788
Q ss_pred eEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchH
Q 015406 144 QVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKK 222 (407)
Q Consensus 144 ~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~ 222 (407)
.+||+|||+++........ .......||+.|+|||++.+..++.++||||||+++|||++ |..||.+.......
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 276 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNY-----IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTS-----EECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred eEEECccccccccccccce-----eecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence 9999999999876543321 11335567889999999999899999999999999999998 99999875543222
Q ss_pred HHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHc
Q 015406 223 QKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (407)
Q Consensus 223 ~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~ 280 (407)
..+....... .....+|+++.+++.+||+.||++||++.+|.+.|+++....
T Consensus 277 ---~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 277 ---YKLVKDGYQM---AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp ---HHHHHHTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---HHHHhcCCCC---CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 2222221111 122457899999999999999999999999999999887643
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=370.49 Aligned_cols=253 Identities=21% Similarity=0.318 Sum_probs=211.1
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecC----CCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeE
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV----KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~----~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 79 (407)
.+.++|++.++||+|+||.||+|++..+++.||||++.. ......+.+|+.+++.++| ++++.+..++......|
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~ 97 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH-PNIMKLFEILEDSSSFY 97 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCC-CCcCeEEEEEEcCCEEE
Confidence 356789999999999999999999999999999998753 2334568899999999976 67777777888888999
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 80 lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
+||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||+++.+..
T Consensus 98 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp EEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 999999 89999988763 5799999999999999999999999999999999999996555667899999999986544
Q ss_pred CCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHH
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (407)
... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.. ..+.+..+.........+
T Consensus 177 ~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~~ 244 (486)
T 3mwu_A 177 NTK--------MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN---EYDILKRVETGKYAFDLP 244 (486)
T ss_dssp C------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCSCSG
T ss_pred CCc--------cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCCCc
Confidence 322 235679999999999987 59999999999999999999999998743 345555555554433222
Q ss_pred HHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 239 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.+..+++++.++|.+||..||++|||+.++++
T Consensus 245 -~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 245 -QWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp -GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 23568999999999999999999999877654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=369.17 Aligned_cols=250 Identities=20% Similarity=0.237 Sum_probs=191.8
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC----CcchHHHHHHHHHHHcCCCCCCeeEEeeee-----C
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVE-----G 75 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~-----~ 75 (407)
+.++|+++++||+|+||.||+|++..+++.||||++.... ....+.+|+.+++.++|++.+..+..+... .
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 4578999999999999999999999999999999986432 123577899999999875544444444322 2
Q ss_pred ceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceee
Q 015406 76 DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (407)
Q Consensus 76 ~~~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~ 155 (407)
...||||||++++|.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+.
T Consensus 140 ~~~~lv~E~~~~~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll---~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 140 QDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLART 213 (464)
T ss_dssp CEEEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCCC--
T ss_pred CeEEEEEeCCCCCHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEE---eCCCCEEEEEEEeeee
Confidence 4679999999888888775 359999999999999999999999999999999999999 6788999999999987
Q ss_pred eccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccc
Q 015406 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (407)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (407)
...... ....+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+. .+.+..+......+
T Consensus 214 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~---~~~~~~i~~~lg~p 282 (464)
T 3ttj_A 214 AGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY---IDQWNKVIEQLGTP 282 (464)
T ss_dssp ---CCC--------C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCSC
T ss_pred cCCCcc--------cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCC
Confidence 654322 3456899999999999999999999999999999999999999987543 33333332211111
Q ss_pred cH-------------------------HHHhc------------CCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 236 SI-------------------------EALCR------------GYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 236 ~~-------------------------~~~~~------------~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.. ....+ ..++++.+||.+||..||++|||++++++
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 283 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp CHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 01100 01567999999999999999999877653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=353.46 Aligned_cols=261 Identities=16% Similarity=0.300 Sum_probs=193.0
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCe---EEEEEEecCCCC----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCce
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNE---EVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~---~vAvK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 77 (407)
..++|++.+.||+|+||.||+|++..++. .||||++..... ...+.+|+.+++.++| ++++.+..++.....
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDH-PHVAKLVGVSLRSRA 99 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCC-TTBCCCCEEEECC--
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCC-Cceehhhceeecccc
Confidence 46789999999999999999999877665 899999865432 2457889999999976 556665555554443
Q ss_pred e------EEEEecc-CCCHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceE
Q 015406 78 N------VLVMDLL-GPSLEDLFNFCS-----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 145 (407)
Q Consensus 78 ~------~lvme~~-g~sL~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~ 145 (407)
. ++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli---~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML---AEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEE---cCCCCE
Confidence 3 9999999 889999986432 158999999999999999999999999999999999999 578899
Q ss_pred EEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHH
Q 015406 146 YIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQK 224 (407)
Q Consensus 146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~ 224 (407)
||+|||+++........ .......+++.|+|||++.+..++.++|||||||++|||++ |..||.+.... +.
T Consensus 177 kl~Dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~ 248 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYY-----RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA---EI 248 (323)
T ss_dssp EECCCCC----------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GH
T ss_pred EEeeccccccccccccc-----cccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH---HH
Confidence 99999999876543321 12234567889999999999999999999999999999999 99999875543 33
Q ss_pred HHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcC
Q 015406 225 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREG 281 (407)
Q Consensus 225 ~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~ 281 (407)
+..+....... ....+++++.+++.+||+.||++||++.++.+.|++++....
T Consensus 249 ~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 249 YNYLIGGNRLK----QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp HHHHHTTCCCC----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred HHHHhcCCCCC----CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 33333322211 234688999999999999999999999999999999987654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=354.77 Aligned_cols=244 Identities=22% Similarity=0.320 Sum_probs=204.1
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc-----chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
+.|++.+.||+|+||.||+|++..+++.||||++...... ..+.+|+++++.++| ++++.+..++...+..++|
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH-PNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEECCeEEEE
Confidence 4699999999999999999999999999999998754322 347889999999986 6677777778888899999
Q ss_pred EeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCC
Q 015406 82 MDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 82 me~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~ 161 (407)
|||+.++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 133 ~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~--- 206 (348)
T 1u5q_A 133 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAP--- 206 (348)
T ss_dssp EECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE---ETTTEEEECCCTTCBSSSS---
T ss_pred EecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEeeccCceecCC---
Confidence 9999889999987667789999999999999999999999999999999999999 5788999999999976533
Q ss_pred CcccCccCCCCcccccccccccccc---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHH
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (407)
.....||+.|+|||++. +..++.++|||||||++|||++|..||.+... ...+..+........
T Consensus 207 --------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~---~~~~~~~~~~~~~~~-- 273 (348)
T 1u5q_A 207 --------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQNESPAL-- 273 (348)
T ss_dssp --------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSCCCCC--
T ss_pred --------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcCCCCC--
Confidence 23457999999999985 46789999999999999999999999976443 233333333222211
Q ss_pred HHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 239 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
....+++++.++|.+||+.||++||+++++++
T Consensus 274 -~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 274 -QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -CCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 12457899999999999999999999887753
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=374.23 Aligned_cols=255 Identities=19% Similarity=0.351 Sum_probs=213.5
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEec
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~ 84 (407)
.++|++.++||+|+||.||+|++..++..||||+++... ....+.+|+.+++.++| ++++.+..++......||||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH-PNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCC-TTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCC-CCEeeEEEEEecCCcEEEEEEc
Confidence 357999999999999999999999889999999987543 34568899999999986 6677777777777888999999
Q ss_pred c-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 85 L-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 85 ~-g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~- 373 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLV---GENHLVKVADFGLSRLMTGDTY- 373 (495)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGCEEECCTTCEECCTTCCE-
T ss_pred cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEE---CCCCcEEEeecccceeccCCce-
Confidence 9 899999998643 459999999999999999999999999999999999999 6789999999999987654321
Q ss_pred cccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHHh
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (407)
.......++..|+|||++.+..++.++|||||||+||||++ |..||.+...... +..+...... ...
T Consensus 374 -----~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~---~~~~~~~~~~----~~~ 441 (495)
T 1opk_A 374 -----TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---YELLEKDYRM----ERP 441 (495)
T ss_dssp -----ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HHHHHTTCCC----CCC
T ss_pred -----eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHcCCCC----CCC
Confidence 12234556889999999998899999999999999999999 9999988655433 3333222111 123
Q ss_pred cCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHH
Q 015406 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (407)
Q Consensus 242 ~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~ 277 (407)
..+|+++.+||.+||+.||++||++.+|.+.|+.++
T Consensus 442 ~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 442 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 568999999999999999999999999999998765
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=353.00 Aligned_cols=259 Identities=20% Similarity=0.228 Sum_probs=201.7
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC----cchHHHHHHHHHHHcCCCCCCeeEEeeee-------
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVE------- 74 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~------- 74 (407)
.++|++.++||+|+||.||+|++..+++.||||++..... ...+.+|+.+++.++| ++++.+..++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH-ENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCC-TTBCCEEEEEEEC------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccC-CCcccHhheeecccccccc
Confidence 4789999999999999999999999999999998765433 2357899999999987 555555444443
Q ss_pred -CceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccce
Q 015406 75 -GDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (407)
Q Consensus 75 -~~~~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla 153 (407)
.+..++||||++++|.+.+......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 95 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 95 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLA 171 (351)
T ss_dssp --CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTC
T ss_pred CCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE---cCCCCEEEccchhc
Confidence 45689999999889999888666789999999999999999999999999999999999999 67889999999999
Q ss_pred eeeccCCCCcccCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhc
Q 015406 154 KKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (407)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (407)
+.+........ .......||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.........+.......
T Consensus 172 ~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 248 (351)
T 3mi9_A 172 RAFSLAKNSQP---NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248 (351)
T ss_dssp EECCCCSSSSC---CCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccccccc---cccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 87654332211 12345678999999999986 457999999999999999999999998755433333333222211
Q ss_pred ccccHHHHh------------------------cCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 233 VSTSIEALC------------------------RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 233 ~~~~~~~~~------------------------~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
......... ...++++.+||.+||..||++||+++++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 111000000 013678999999999999999999877654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=349.36 Aligned_cols=263 Identities=19% Similarity=0.293 Sum_probs=214.0
Q ss_pred cCCceeEeccccccCceEEEEEEE-----cCCCeEEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeee-C
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTN-----IQTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVE-G 75 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~-----~~~~~~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~-~ 75 (407)
..++|++.+.||+|+||.||+|++ ..+++.||||++...... ..+.+|+.++..+.+|++++.+..++.. +
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 104 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 104 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCC
Confidence 357899999999999999999985 356789999998765432 3478899999999877888777766554 4
Q ss_pred ceeEEEEecc-CCCHHHHHHHcCCC---------------CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCC
Q 015406 76 DYNVLVMDLL-GPSLEDLFNFCSRK---------------LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 139 (407)
Q Consensus 76 ~~~~lvme~~-g~sL~~~l~~~~~~---------------l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~ 139 (407)
...++||||+ +++|.+++...... +++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~--- 181 (316)
T 2xir_A 105 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--- 181 (316)
T ss_dssp SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---
T ss_pred CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE---
Confidence 5689999999 88999999854322 8999999999999999999999999999999999999
Q ss_pred CCCceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015406 140 RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 218 (407)
Q Consensus 140 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~ 218 (407)
+.++.+||+|||+++........ .......||+.|+|||++.+..++.++||||||+++|+|++ |..||.+...
T Consensus 182 ~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 182 SEKNVVKICDFGLARDIYKDPDY-----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTS-----EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred CCCCCEEECCCccccccccCccc-----eeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence 57899999999999866443221 11235578899999999999999999999999999999998 9999987544
Q ss_pred CchHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcC
Q 015406 219 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREG 281 (407)
Q Consensus 219 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~ 281 (407)
.. .....+...... .....+++++.+++.+||+.||++||++.++.+.|+.++....
T Consensus 257 ~~--~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 257 DE--EFCRRLKEGTRM----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp SH--HHHHHHHHTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred hH--HHHHHhccCccC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 32 222222222211 1234578999999999999999999999999999999987654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=349.79 Aligned_cols=260 Identities=22% Similarity=0.259 Sum_probs=206.4
Q ss_pred CCceeEeccccccCceEEEEEE----EcCCCeEEEEEEecCCC---CcchHHHHHHHHHHHcCCCCCCeeEEeeeeC--c
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEG--D 76 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~----~~~~~~~vAvK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~--~ 76 (407)
.++|++.+.||+|+||.||+|+ +..+++.||||++.... ....+.+|+.+++.++| ++++.+..++... .
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYH-ENIVKYKGICTEDGGN 98 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCC-TTBCCEEEEEEC---C
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCC-CCeeeeeeEEecCCCc
Confidence 4569999999999999999999 56789999999987543 22458899999999986 5555555555443 6
Q ss_pred eeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceee
Q 015406 77 YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (407)
Q Consensus 77 ~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~ 155 (407)
..++||||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLTKA 175 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCTTCEE
T ss_pred eEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEE---cCCCCEEECccccccc
Confidence 689999999 889999997767789999999999999999999999999999999999999 5778999999999987
Q ss_pred eccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC-----------cC-chHH
Q 015406 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK-----------AG-TKKQ 223 (407)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~-----------~~-~~~~ 223 (407)
........ .......||..|+|||++.+..++.++||||||+++|+|++|..|+.... .. ....
T Consensus 176 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (302)
T 4e5w_A 176 IETDKEYY----TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251 (302)
T ss_dssp CCTTCCEE----ECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHH
T ss_pred ccCCCcce----eccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHH
Confidence 76543211 12345678899999999999899999999999999999999999874311 00 1111
Q ss_pred HHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHH
Q 015406 224 KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (407)
Q Consensus 224 ~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~ 277 (407)
....+.... .......+++++.+++.+||+.||++||++.++.+.|+.++
T Consensus 252 ~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 252 LVNTLKEGK----RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHTTC----CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhccC----CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 111111111 11123568899999999999999999999999999999875
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=367.97 Aligned_cols=253 Identities=21% Similarity=0.305 Sum_probs=209.8
Q ss_pred CccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC---------------CcchHHHHHHHHHHHcCCCCCCe
Q 015406 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---------------KHPQLLYESKLYRILQGGTGIPN 67 (407)
Q Consensus 3 ~~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---------------~~~~~~~E~~~l~~l~~~~~i~~ 67 (407)
..+.++|+++++||+|+||.||+|++..+++.||||++.... ....+.+|+.+++.++| ++|+.
T Consensus 32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~ 110 (504)
T 3q5i_A 32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDH-PNIIK 110 (504)
T ss_dssp SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCC-TTBCC
T ss_pred CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCC-CCCCe
Confidence 356789999999999999999999999999999999876532 23457889999999976 77778
Q ss_pred eEEeeeeCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEE
Q 015406 68 VRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY 146 (407)
Q Consensus 68 ~~~~~~~~~~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~k 146 (407)
+..++......|+||||| |++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++....+|
T Consensus 111 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 111 LFDVFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred EEEEEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEE
Confidence 888888889999999999 88999998763 5799999999999999999999999999999999999996433334799
Q ss_pred EEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHH
Q 015406 147 IIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE 226 (407)
Q Consensus 147 L~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~ 226 (407)
|+|||+++....... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.. ..+.+.
T Consensus 190 l~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~ 257 (504)
T 3q5i_A 190 IVDFGLSSFFSKDYK--------LRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQN---DQDIIK 257 (504)
T ss_dssp ECCCTTCEECCTTSC--------BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHH
T ss_pred EEECCCCEEcCCCCc--------cccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHH
Confidence 999999987755322 235679999999999875 69999999999999999999999998743 345556
Q ss_pred HHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015406 227 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 227 ~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
.+......... ..+..+++++.+||.+||..||.+|||+.+++
T Consensus 258 ~i~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l 300 (504)
T 3q5i_A 258 KVEKGKYYFDF-NDWKNISDEAKELIKLMLTYDYNKRCTAEEAL 300 (504)
T ss_dssp HHHHCCCCCCH-HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred HHHcCCCCCCc-cccCCCCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence 66555443333 34467899999999999999999999987764
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=356.90 Aligned_cols=249 Identities=19% Similarity=0.280 Sum_probs=195.4
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc----chHHHHHHHHHHHcCCCCCCeeEEeeeeC----
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEG---- 75 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~---- 75 (407)
.+.++|++.+.||+|+||.||+|++..+|+.||||.+...... ..+.+|+++++.++|+ ++..+..++...
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hp-nIv~l~~~~~~~~~~~ 100 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE-NVIGLLDVFTPDETLD 100 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBT-TBCCCSEEECSCSSTT
T ss_pred eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCc-CCCCceeeEecCCccc
Confidence 3568899999999999999999999999999999998654322 3467899999999875 454444443322
Q ss_pred --ceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccce
Q 015406 76 --DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (407)
Q Consensus 76 --~~~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla 153 (407)
...|+||||++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 101 ~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 101 DFTDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLA 175 (367)
T ss_dssp TCCCCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTC
T ss_pred cCceEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEE---cCCCCEEEEeeecc
Confidence 34699999999999999985 579999999999999999999999999999999999999 57889999999999
Q ss_pred eeeccCCCCcccCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhc
Q 015406 154 KKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (407)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (407)
+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+. ...+..+....
T Consensus 176 ~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~l~~i~~~~ 242 (367)
T 1cm8_A 176 RQADSE----------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH---LDQLKEIMKVT 242 (367)
T ss_dssp EECCSS----------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHH
T ss_pred cccccc----------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhc
Confidence 876432 235678999999999987 6799999999999999999999999987543 23333322211
Q ss_pred c--------------------------cccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 233 V--------------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 233 ~--------------------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
. ......+...+++++.+|+.+||..||++|||+.++++
T Consensus 243 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 243 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp CCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 1 11122334567899999999999999999999877654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=353.73 Aligned_cols=258 Identities=19% Similarity=0.213 Sum_probs=204.1
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeee----Cce
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVE----GDY 77 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~----~~~ 77 (407)
++++|++.+.||+|+||.||+|++..+++.||||++...... ..+.+|+++++.++|++.+..+..+... ...
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 468999999999999999999999999999999998754332 3578899999999875544444433322 246
Q ss_pred eEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeec
Q 015406 78 NVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (407)
Q Consensus 78 ~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~ 157 (407)
.|+||||++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 105 ~~iv~e~~~~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 105 VYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVAD 179 (364)
T ss_dssp EEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECC
T ss_pred EEEEEcccCcCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEE---CCCCCEEEEeCcceEecC
Confidence 899999998899999974 469999999999999999999999999999999999999 678899999999998765
Q ss_pred cCCCCcccCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhc----
Q 015406 158 DTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK---- 232 (407)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~---- 232 (407)
...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.......
T Consensus 180 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 180 PDHDHT----GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255 (364)
T ss_dssp GGGCBC----CTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred CCCCcc----ccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 432211 11245689999999998765 458999999999999999999999998865544333332221111
Q ss_pred -------------------ccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 233 -------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 233 -------------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.......+...+++++.+||.+||..||++||++.++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 111223444678899999999999999999999777653
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-46 Score=345.42 Aligned_cols=253 Identities=20% Similarity=0.301 Sum_probs=201.2
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~ 85 (407)
.++|++.+.||+|+||.||+|++ +++.||||++......+.+.+|+.+++.++|++.+..+..+....+..++||||+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 47899999999999999999986 5889999999877666778999999999987555555544455556789999999
Q ss_pred -CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCc
Q 015406 86 -GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (407)
Q Consensus 86 -g~sL~~~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~ 163 (407)
+++|.+++..... .+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 98 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~--- 171 (278)
T 1byg_A 98 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQ--- 171 (278)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEE---eCCCcEEEeeccccccccccc---
Confidence 7799999975432 38999999999999999999999999999999999999 578899999999998654322
Q ss_pred ccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHHhc
Q 015406 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (407)
Q Consensus 164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (407)
....+++.|+|||++.+..++.++||||||+++|+|++ |..||...... +....+..... .....
T Consensus 172 -------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~~~~~~~~----~~~~~ 237 (278)
T 1byg_A 172 -------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRVEKGYK----MDAPD 237 (278)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHHTTTCC----CCCCT
T ss_pred -------cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHhcCCC----CCCcc
Confidence 23467889999999999899999999999999999998 99999875443 23333332211 12235
Q ss_pred CCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHc
Q 015406 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (407)
Q Consensus 243 ~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~ 280 (407)
.+++++.+++.+||+.||++||++.++.+.|+++....
T Consensus 238 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 238 GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred cCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 68999999999999999999999999999999886543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=367.89 Aligned_cols=247 Identities=21% Similarity=0.293 Sum_probs=209.4
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCC-----CCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCcee
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 78 (407)
...++|.+.+.||+|+||.||+|++..+|+.||||++... .....+.+|+.+++.++| +++..+..++......
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~H-pnIv~l~~~~~~~~~~ 91 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRH-PHIIKLYQVISTPSDI 91 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEE
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEEECCEE
Confidence 3467899999999999999999999999999999988643 223468899999999886 6777777777888889
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeec
Q 015406 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~ 157 (407)
|+||||+ |++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 92 ~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll---~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 92 FMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EEEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEE---CTTCCEEECCCSSCEECC
T ss_pred EEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEE---ecCCCeEEEeccchhhcc
Confidence 9999999 9999999975 4579999999999999999999999999999999999999 678899999999998765
Q ss_pred cCCCCcccCccCCCCccccccccccccccCCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhccccc
Q 015406 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (407)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (407)
.... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+... ...+.++......
T Consensus 168 ~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~---~~~~~~i~~~~~~-- 234 (476)
T 2y94_A 168 DGEF--------LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV---PTLFKKICDGIFY-- 234 (476)
T ss_dssp TTCC--------BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS---HHHHHHHHTTCCC--
T ss_pred cccc--------ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH---HHHHHHHhcCCcC--
Confidence 4332 235689999999999998776 7899999999999999999999987443 4455555544332
Q ss_pred HHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 237 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
....+++++.+||.+||..||++|||+.++++
T Consensus 235 ---~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 235 ---TPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---CCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 22457899999999999999999999887754
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=359.43 Aligned_cols=258 Identities=19% Similarity=0.251 Sum_probs=199.6
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-cchHHHHHHHHHHHcC-------CCCCCeeEEeee--
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQG-------GTGIPNVRWFGV-- 73 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~E~~~l~~l~~-------~~~i~~~~~~~~-- 73 (407)
.+.++|++.++||+|+||.||+|++..+++.||||++..... ...+.+|+.+++.+++ ++++..+..++.
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 457899999999999999999999999999999999865422 3457889999999974 344655555544
Q ss_pred --eCceeEEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcccccCCC---------
Q 015406 74 --EGDYNVLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGR--------- 140 (407)
Q Consensus 74 --~~~~~~lvme~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~-~ivHrDLKp~NILl~~~~--------- 140 (407)
.....++||||++++|.+.+.... ..+++..++.|+.||+.||.|||++ ||+||||||+||||+.+.
T Consensus 114 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~ 193 (397)
T 1wak_A 114 GVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAE 193 (397)
T ss_dssp ETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHH
T ss_pred CCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhh
Confidence 456789999999888888776543 5699999999999999999999998 999999999999994211
Q ss_pred -------------------------------------CCceEEEEeccceeeeccCCCCcccCccCCCCccccccccccc
Q 015406 141 -------------------------------------RANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMN 183 (407)
Q Consensus 141 -------------------------------------~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE 183 (407)
....+||+|||+++...... ....||+.|+|||
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~----------~~~~gt~~y~aPE 263 (397)
T 1wak_A 194 ATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF----------TEDIQTRQYRSLE 263 (397)
T ss_dssp HC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS----------CSCCSCGGGCCHH
T ss_pred hHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC----------ccCCCCCcccCCh
Confidence 11379999999998765432 3457899999999
Q ss_pred cccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCc---hHHHHHHHhhhcccccHH----------------------
Q 015406 184 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT---KKQKYEKISEKKVSTSIE---------------------- 238 (407)
Q Consensus 184 ~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~---~~~~~~~i~~~~~~~~~~---------------------- 238 (407)
++.+..++.++|||||||+||||++|..||....... ....+..+.......+..
T Consensus 264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 343 (397)
T 1wak_A 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT 343 (397)
T ss_dssp HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence 9999999999999999999999999999998654332 112222221111000000
Q ss_pred ---------------HHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 239 ---------------ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 239 ---------------~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
......++++.+||.+||+.||++||+++++++
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 001223567899999999999999999887764
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=351.88 Aligned_cols=258 Identities=19% Similarity=0.279 Sum_probs=201.2
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEE----EEEEecCCC---CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCc
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEV----AIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGD 76 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~v----AvK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 76 (407)
...++|++.++||+|+||.||+|++..+++.| |+|.+.... ....+.+|+.+++.++| ++++.+..++....
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~ 90 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN-PHVCRLLGICLTST 90 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCB-TTBCCCCEEEESSS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCC-CCeeEEEEEEecCC
Confidence 34688999999999999999999998888755 666654332 33458889999999986 55555555555544
Q ss_pred eeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceee
Q 015406 77 YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (407)
Q Consensus 77 ~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~ 155 (407)
.+++|+|+ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKL 166 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCTTC---
T ss_pred -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEE---cCCCCEEEccCcceeE
Confidence 67888888 999999998777789999999999999999999999999999999999999 5788999999999987
Q ss_pred eccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhccc
Q 015406 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVS 234 (407)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (407)
........ ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+........ .+......
T Consensus 167 ~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~---~~~~~~~~ 238 (327)
T 3lzb_A 167 LGAEEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS---ILEKGERL 238 (327)
T ss_dssp ------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH---HHHTTCCC
T ss_pred ccCccccc-----cccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH---HHHcCCCC
Confidence 65433211 1234467889999999999999999999999999999999 999998765543322 22222211
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Q 015406 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (407)
Q Consensus 235 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~ 278 (407)
. ....++.++.+++.+||..||++||++.++.+.|+.+..
T Consensus 239 ~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 239 P----QPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp C----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred C----CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1 234578999999999999999999999999999998763
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=349.99 Aligned_cols=249 Identities=20% Similarity=0.247 Sum_probs=209.9
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC----------cchHHHHHHHHHHHcCCCCCCeeEEeeeeCc
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----------HPQLLYESKLYRILQGGTGIPNVRWFGVEGD 76 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~----------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 76 (407)
++|++.+.||+|+||.||+|++..+|+.||||++..... ...+.+|+.+++.+.++++++.+..++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 579999999999999999999988999999999875432 2346789999999966688888888888889
Q ss_pred eeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceee
Q 015406 77 YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (407)
Q Consensus 77 ~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~ 155 (407)
..|+||||+ |++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~---~~~~~ikl~DfG~~~~ 249 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---DDNMQIRLSDFGFSCH 249 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEE
T ss_pred EEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEEecCcccc
Confidence 999999999 8899999985 3579999999999999999999999999999999999999 6789999999999987
Q ss_pred eccCCCCcccCccCCCCccccccccccccccC------CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHh
Q 015406 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLG------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 229 (407)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~ 229 (407)
+..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... ....+..+.
T Consensus 250 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~---~~~~~~~i~ 318 (365)
T 2y7j_A 250 LEPGEK--------LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR---QILMLRMIM 318 (365)
T ss_dssp CCTTCC--------BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHH
T ss_pred cCCCcc--------cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC---HHHHHHHHH
Confidence 754332 235689999999999863 357899999999999999999999997643 344445554
Q ss_pred hhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 230 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
........ ..+..+++++.++|.+||..||++||++.++++
T Consensus 319 ~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 319 EGQYQFSS-PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HTCCCCCH-HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hCCCCCCC-cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 44443332 234678999999999999999999999887764
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=340.37 Aligned_cols=254 Identities=20% Similarity=0.268 Sum_probs=207.8
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC--------cchHHHHHHHHHHHcCCCCCCeeEEeeeeC
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--------HPQLLYESKLYRILQGGTGIPNVRWFGVEG 75 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~ 75 (407)
.+.++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+|+.+++.++| ++++.+..++...
T Consensus 2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~ 80 (283)
T 3bhy_A 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH-PNIITLHDIFENK 80 (283)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCC-TTBCCEEEEEECS
T ss_pred chhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCC-CCeeehhheecCC
Confidence 356789999999999999999999999999999998765431 3458899999999986 6777777777888
Q ss_pred ceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCC-CCceEEEEeccce
Q 015406 76 DYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR-RANQVYIIDFGLA 153 (407)
Q Consensus 76 ~~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~-~~~~~kL~DFGla 153 (407)
...++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.+. ....+||+|||++
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 81 TDVVLILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp SEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CeEEEEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 8899999999 8999999975 35799999999999999999999999999999999999994211 1238999999999
Q ss_pred eeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcc
Q 015406 154 KKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (407)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (407)
........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+... .+.+..+.....
T Consensus 160 ~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~ 228 (283)
T 3bhy_A 160 HKIEAGNE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK---QETLTNISAVNY 228 (283)
T ss_dssp EECC----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHTTCC
T ss_pred eeccCCCc--------ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch---HHHHHHhHhccc
Confidence 87654322 2345789999999999999999999999999999999999999977433 344444444333
Q ss_pred cccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 234 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
. ........+++++.+++.+||..||++||++.++.+
T Consensus 229 ~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 229 D-FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp C-CCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C-CcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 2 223455678999999999999999999999888765
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=339.64 Aligned_cols=251 Identities=22% Similarity=0.363 Sum_probs=196.7
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC------cchHHHHHHHHHHHcCCCCCCeeEEeeeeCcee
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK------HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 78 (407)
-.++|++.+.||+|+||.||+|++ +++.||||++..... ...+.+|+++++.++| ++++.+..++...+..
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH-PNIIALRGVCLKEPNL 81 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCC-TTBCCEEEEECCC--C
T ss_pred chhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCC-CCEeeEEEEEecCCce
Confidence 357899999999999999999996 488999998765322 2457889999999986 6777777777788889
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCCCcccccCCC-----CCceEEEEe
Q 015406 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGR-----RANQVYIID 149 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~---ivHrDLKp~NILl~~~~-----~~~~~kL~D 149 (407)
++||||+ +++|.+++. .+.+++..++.++.||+.||.|||++| |+||||||+|||++... .++.+||+|
T Consensus 82 ~lv~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EEEEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEEEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 9999999 899999986 567999999999999999999999999 99999999999995311 267899999
Q ss_pred ccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHh
Q 015406 150 FGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 229 (407)
Q Consensus 150 FGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~ 229 (407)
||+++....... ....||+.|+|||++.+..++.++||||||+++|+|++|..||.+... ......+.
T Consensus 160 fg~~~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~ 227 (271)
T 3dtc_A 160 FGLAREWHRTTK---------MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG---LAVAYGVA 227 (271)
T ss_dssp CCC----------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH---HHHHHHHH
T ss_pred CCcccccccccc---------cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHhhh
Confidence 999986654322 245789999999999999999999999999999999999999987443 23333333
Q ss_pred hhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 015406 230 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 275 (407)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~ 275 (407)
...... .....+++++.+++.+||+.||++||++.++.+.|++
T Consensus 228 ~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 228 MNKLAL---PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp TSCCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred cCCCCC---CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 222221 1235689999999999999999999999999998875
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=345.03 Aligned_cols=262 Identities=17% Similarity=0.251 Sum_probs=206.9
Q ss_pred CCceeEeccccccCceEEEEEEEcCCC---eEEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTN---EEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~---~~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 79 (407)
..+|++.+.||+|+||.||+|++..++ ..||+|.+...... ..+.+|+.+++.++|++.+..+..+....+..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 457999999999999999999975443 46899988754432 347889999999987655555555566677889
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 80 lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
+||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSCGGGCCCSC
T ss_pred EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---CCCCCEEECcccccccccc
Confidence 999999 889999998656679999999999999999999999999999999999999 6788999999999986644
Q ss_pred CCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccH
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (407)
..... ........||+.|+|||.+.+..++.++||||||+++|+|++ |.+||......... ..+.......
T Consensus 181 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~---~~~~~~~~~~-- 252 (298)
T 3f66_A 181 KEYYS---VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT---VYLLQGRRLL-- 252 (298)
T ss_dssp GGGCB---C-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHH---HHHHTTCCCC--
T ss_pred cchhc---cccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHH---HHHhcCCCCC--
Confidence 32111 122345577899999999999999999999999999999999 66777665443322 2222222111
Q ss_pred HHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHc
Q 015406 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (407)
Q Consensus 238 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~ 280 (407)
....+|+++.+++.+||+.||++||++.++.+.|+.++...
T Consensus 253 --~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 253 --QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp --CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred --CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 12457899999999999999999999999999999998754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=354.18 Aligned_cols=241 Identities=20% Similarity=0.236 Sum_probs=202.6
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC----------CcchHHHHHHHHHHHcCCCCCCeeEEeee
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----------KHPQLLYESKLYRILQGGTGIPNVRWFGV 73 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~----------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~ 73 (407)
.+.++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+|+.+++.++| ++++.+..++.
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~Iv~~~~~~~ 99 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEH-ANIIKVLDIFE 99 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCC-TTBCCEEEEEE
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCC-CCEeeEEEEEe
Confidence 34578999999999999999999999999999999887653 23457889999999975 77777777888
Q ss_pred eCceeEEEEecc-CC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEecc
Q 015406 74 EGDYNVLVMDLL-GP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 151 (407)
Q Consensus 74 ~~~~~~lvme~~-g~-sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFG 151 (407)
..+..++||||+ ++ +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 100 ~~~~~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg 175 (335)
T 3dls_A 100 NQGFFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI---AEDFTIKLIDFG 175 (335)
T ss_dssp CSSEEEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCT
T ss_pred eCCEEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEE---cCCCcEEEeecc
Confidence 888999999998 44 99999985 4579999999999999999999999999999999999999 578899999999
Q ss_pred ceeeeccCCCCcccCccCCCCccccccccccccccCCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhh
Q 015406 152 LAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230 (407)
Q Consensus 152 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~ 230 (407)
+++....... .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||..... ...
T Consensus 176 ~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---------~~~ 238 (335)
T 3dls_A 176 SAAYLERGKL--------FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE---------TVE 238 (335)
T ss_dssp TCEECCTTCC--------BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG---------GTT
T ss_pred cceECCCCCc--------eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH---------HHh
Confidence 9987655432 234679999999999998887 8999999999999999999999975321 011
Q ss_pred hcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 231 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
... .....+++++.+||.+||+.||++||++.++++
T Consensus 239 ~~~-----~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~ 274 (335)
T 3dls_A 239 AAI-----HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVT 274 (335)
T ss_dssp TCC-----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hcc-----CCCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111 112347899999999999999999999776654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=341.13 Aligned_cols=250 Identities=18% Similarity=0.185 Sum_probs=205.5
Q ss_pred CCCccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCc
Q 015406 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEGD 76 (407)
Q Consensus 1 m~~~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 76 (407)
|..++.++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+|+..+..+.+|++++.+..++.+.+
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~ 84 (289)
T 1x8b_A 5 MKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD 84 (289)
T ss_dssp CCCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT
T ss_pred ccccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence 556778899999999999999999999999999999999875432 2347788888888866788888888888999
Q ss_pred eeEEEEecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCC------------
Q 015406 77 YNVLVMDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR------------ 140 (407)
Q Consensus 77 ~~~lvme~~-g~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~------------ 140 (407)
..++||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.+.
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------------
T ss_pred eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 999999999 88999999753 25699999999999999999999999999999999999995322
Q ss_pred ----CCceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCC-CCChhhHHHHHHHHHHHHHhCCCCCCC
Q 015406 141 ----RANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQG 215 (407)
Q Consensus 141 ----~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDIwSlG~il~elltG~~Pf~~ 215 (407)
....+||+|||++....... ...||+.|+|||++.+. .++.++|||||||++|+|++|..|+..
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~~-----------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 233 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSPQ-----------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN 233 (289)
T ss_dssp -----CCCEEECCCTTCEETTCSC-----------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS
T ss_pred cccCCceEEEEcccccccccCCcc-----------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence 44579999999998765422 34589999999999876 567899999999999999999887744
Q ss_pred CCcCchHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 216 LKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 216 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
. .....+...... .+...+++++.+++.+||+.||++||++.++++
T Consensus 234 ~------~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 234 G------DQWHEIRQGRLP----RIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp S------HHHHHHHTTCCC----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred h------hHHHHHHcCCCC----CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 2 223333333322 234568999999999999999999999887754
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=350.51 Aligned_cols=258 Identities=19% Similarity=0.253 Sum_probs=212.7
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEE--EEEEecCC---CCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEV--AIKLENVK---TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~v--AvK~~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
.++|++.+.||+|+||.||+|++..++..+ |+|.+... .....+.+|+.+++.+.+|++++.+..++...+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 378999999999999999999998888865 99987642 2345688999999999667888888888889999999
Q ss_pred EEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCce
Q 015406 81 VMDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ 144 (407)
Q Consensus 81 vme~~-g~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~ 144 (407)
||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEE---cCCCe
Confidence 99999 889999997532 369999999999999999999999999999999999999 67889
Q ss_pred EEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHH
Q 015406 145 VYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQ 223 (407)
Q Consensus 145 ~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~ 223 (407)
+||+|||+++....... .....+++.|+|||++.+..++.++||||||+++|||++ |..||.+... .+
T Consensus 181 ~kL~Dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~~ 249 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYVK--------KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AE 249 (327)
T ss_dssp EEECCTTCEESSCEECC--------C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HH
T ss_pred EEEcccCcCcccccccc--------ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH---HH
Confidence 99999999974332111 234467889999999998889999999999999999998 9999977443 33
Q ss_pred HHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcC
Q 015406 224 KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREG 281 (407)
Q Consensus 224 ~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~ 281 (407)
.+..+...... .....+++++.++|.+||..||++||++.++.+.|+.++....
T Consensus 250 ~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 250 LYEKLPQGYRL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp HHHHGGGTCCC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred HHHHhhcCCCC----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 44443332211 1234578999999999999999999999999999999987654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=340.11 Aligned_cols=255 Identities=19% Similarity=0.269 Sum_probs=212.7
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEec
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~ 84 (407)
.++|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+|+++++.++| +++..+..++...+..++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH-PKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCC-TTBCCEEEEECSSSSCEEEECC
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCC-CCEeeEEEEEccCCCeEEEEeC
Confidence 468999999999999999999985 67899999987654 33568899999999975 6677777777777889999999
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCc
Q 015406 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (407)
Q Consensus 85 ~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~ 163 (407)
+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++........
T Consensus 85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~~~-- 159 (267)
T 3t9t_A 85 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQY-- 159 (267)
T ss_dssp CTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CGGGCEEECCTTGGGGBCCHHH--
T ss_pred CCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE---CCCCCEEEcccccccccccccc--
Confidence 9 889999998766679999999999999999999999999999999999999 6789999999999976533211
Q ss_pred ccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHHhc
Q 015406 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (407)
Q Consensus 164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (407)
.......++..|+|||++.+..++.++||||||+++|+|++ |..||..... .+....+...... ....
T Consensus 160 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~i~~~~~~----~~~~ 228 (267)
T 3t9t_A 160 ----TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDISTGFRL----YKPR 228 (267)
T ss_dssp ----HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTTCCC----CCCT
T ss_pred ----cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH---HHHHHHHhcCCcC----CCCc
Confidence 11234567889999999998899999999999999999999 8999976433 3444444433211 1224
Q ss_pred CCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Q 015406 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (407)
Q Consensus 243 ~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~ 278 (407)
.+++++.+++.+||+.||++||++.++.+.|+++..
T Consensus 229 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 229 LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 578999999999999999999999999999998864
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=353.00 Aligned_cols=204 Identities=25% Similarity=0.340 Sum_probs=175.6
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-cchHHHHHHHHHHHcCCCC-----CCeeEEeeeeCce
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTG-----IPNVRWFGVEGDY 77 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~E~~~l~~l~~~~~-----i~~~~~~~~~~~~ 77 (407)
.+.++|++.+.||+|+||.||+|++..+++.||||++..... ...+..|+.+++.+.++++ ++.+..++...+.
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 346889999999999999999999999999999999864322 2446778999999986664 6777778888899
Q ss_pred eEEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCceeccCCCCcccccCCCCCceEEEEecccee
Q 015406 78 NVLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVH--SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (407)
Q Consensus 78 ~~lvme~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH--~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~ 154 (407)
.++||||++++|.+++.... ..+++..++.++.||+.||.||| +.||+||||||+|||++. +..+.+||+|||+++
T Consensus 131 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~-~~~~~~kL~DFG~a~ 209 (382)
T 2vx3_A 131 LCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN-PKRSAIKIVDFGSSC 209 (382)
T ss_dssp EEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESS-TTSCCEEECCCTTCE
T ss_pred eEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEec-CCCCcEEEEeccCce
Confidence 99999999889999998644 46999999999999999999999 579999999999999942 246789999999998
Q ss_pred eeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015406 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218 (407)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~ 218 (407)
...... ....||+.|+|||++.+..++.++|||||||++|||++|..||.+...
T Consensus 210 ~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 210 QLGQRI----------YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp ETTCCC----------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eccccc----------ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 764422 356789999999999999999999999999999999999999987543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=362.71 Aligned_cols=253 Identities=22% Similarity=0.305 Sum_probs=197.4
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC----------CcchHHHHHHHHHHHcCCCCCCeeEEeeee
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----------KHPQLLYESKLYRILQGGTGIPNVRWFGVE 74 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~----------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~ 74 (407)
+.++|.+.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.++| ++++.+..++.
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~- 210 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH-PCIIKIKNFFD- 210 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCC-TTBCCCCEEEE-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCC-CCEeeEEEEEe-
Confidence 3578999999999999999999999999999999876431 12357899999999987 55555555544
Q ss_pred CceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccce
Q 015406 75 GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (407)
Q Consensus 75 ~~~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla 153 (407)
....|+||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+..+||+|||++
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred cCceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 44579999999 8999998874 457999999999999999999999999999999999999965445667999999999
Q ss_pred eeeccCCCCcccCccCCCCccccccccccccccC---CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhh
Q 015406 154 KKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG---IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230 (407)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~ 230 (407)
+....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ ....+..
T Consensus 290 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~~i~~ 359 (419)
T 3i6u_A 290 KILGETSL--------MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQITS 359 (419)
T ss_dssp TSCC-------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHHHHHT
T ss_pred eecCCCcc--------ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHHHHhc
Confidence 87654322 235689999999999864 5678999999999999999999999986543321 2223333
Q ss_pred hcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 231 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
... .........+++++.++|.+||+.||++||+++++++
T Consensus 360 ~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 360 GKY-NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp TCC-CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCC-CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 322 2334455678999999999999999999999887754
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=367.88 Aligned_cols=252 Identities=22% Similarity=0.333 Sum_probs=207.6
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
+.++|+++++||+|+||.||+|++..+++.||||++.... ....+.+|+.+++.++| ++|+.+..++......|+
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~l 113 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH-PNIMKLYDFFEDKRNYYL 113 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCC-CCCCeEEEEEEeCCEEEE
Confidence 3457999999999999999999999999999999886532 34568899999999976 677777777888889999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 81 vme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||+++.+...
T Consensus 114 v~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 114 VMECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred EEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 99999 89999988753 57999999999999999999999999999999999999965445677999999999877643
Q ss_pred CCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHH
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (407)
.. .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+... .+.+..+........ ..
T Consensus 193 ~~--------~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~~~-~~ 259 (494)
T 3lij_A 193 KK--------MKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTD---QEILRKVEKGKYTFD-SP 259 (494)
T ss_dssp BC--------BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTCCCCC-SG
T ss_pred cc--------ccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCCCC-ch
Confidence 32 235679999999999875 699999999999999999999999987443 455555555443322 22
Q ss_pred HhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 240 ~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.+..+++++.+||.+||..||.+|||+.++++
T Consensus 260 ~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 260 EWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 34678999999999999999999999888763
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=344.78 Aligned_cols=252 Identities=19% Similarity=0.290 Sum_probs=204.7
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
...++|++.+.||+|+||.||+|++..+++.||||++........+.+|+.+++.+.| ++++.+..++......++|||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDS-PHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCC-TTBCCEEEEEEETTEEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCC-CCCccEEEEEEeCCEEEEEee
Confidence 4567899999999999999999999999999999999877777789999999999976 667777777778888999999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 84 ~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
|+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++........
T Consensus 105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~- 180 (314)
T 3com_A 105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILL---NTEGHAKLADFGVAGQLTDTMA- 180 (314)
T ss_dssp CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECBTTBS-
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEE---CCCCCEEEeecccchhhhhhcc-
Confidence 99 779999998667789999999999999999999999999999999999999 5788999999999987654322
Q ss_pred cccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhc
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (407)
......||+.|+|||++.+..++.++||||||+++|+|++|..||..... ......+....... .....
T Consensus 181 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~--~~~~~ 249 (314)
T 3com_A 181 ------KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP---MRAIFMIPTNPPPT--FRKPE 249 (314)
T ss_dssp ------CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSCCCC--CSSGG
T ss_pred ------ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHhcCCCcc--cCCcc
Confidence 12355789999999999999999999999999999999999999976433 22222222221111 11224
Q ss_pred CCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 243 ~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.+++++.++|.+||..||++||++.++++
T Consensus 250 ~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 250 LWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp GSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 47899999999999999999999877754
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=341.56 Aligned_cols=263 Identities=22% Similarity=0.317 Sum_probs=203.2
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCcee
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 78 (407)
...++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+|+.+++.++| +++..+..++...+..
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~ 107 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH-PNVIKYYASFIEDNEL 107 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEEEETTEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEcCCcE
Confidence 345789999999999999999999999999999999875322 2347789999999976 6677777777788899
Q ss_pred EEEEecc-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEecccee
Q 015406 79 VLVMDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~ 154 (407)
++||||+ +++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~---~~~~~~kl~Dfg~~~ 184 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGR 184 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCC----
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEE---cCCCCEEEEecccee
Confidence 9999999 8899999874 24569999999999999999999999999999999999999 578899999999998
Q ss_pred eeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhccc
Q 015406 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (407)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (407)
....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+... ........+......
T Consensus 185 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~ 256 (310)
T 2wqm_A 185 FFSSKTT-------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKKIEQCDYP 256 (310)
T ss_dssp ---------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C-CHHHHHHHHHTTCSC
T ss_pred eecCCCc-------cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch-hHHHHHHHhhcccCC
Confidence 6654322 12345789999999999999999999999999999999999999976432 223333333333222
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcC
Q 015406 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREG 281 (407)
Q Consensus 235 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~ 281 (407)
.. ....+++++.+++.+||+.||++||++.++.+.|+++.....
T Consensus 257 ~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 257 PL---PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp CC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred CC---cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 11 124588999999999999999999999999999999866543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=348.06 Aligned_cols=259 Identities=17% Similarity=0.209 Sum_probs=204.4
Q ss_pred CccCCceeEeccccccCceEEEEEEE-cCCCeEEEEEEecCCCC-cchHHHHHHHHHHHcCCC-----CCCeeEEeeeeC
Q 015406 3 PRVGNKFRLGRKIGSGSFGEIYLGTN-IQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGGT-----GIPNVRWFGVEG 75 (407)
Q Consensus 3 ~~~~~~y~i~~~iG~G~~g~Vy~~~~-~~~~~~vAvK~~~~~~~-~~~~~~E~~~l~~l~~~~-----~i~~~~~~~~~~ 75 (407)
..+.++|++.+.||+|+||.||+|.+ ..+++.||||++..... ...+.+|+.+++.+.|.+ ++..+..++...
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 35678999999999999999999998 56889999999864322 345788999999998644 466677777888
Q ss_pred ceeEEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCC-------------
Q 015406 76 DYNVLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR------------- 141 (407)
Q Consensus 76 ~~~~lvme~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~------------- 141 (407)
+..++||||++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++..+.
T Consensus 90 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~ 169 (339)
T 1z57_A 90 GHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDER 169 (339)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEE
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccc
Confidence 8999999999999999998643 36899999999999999999999999999999999999952211
Q ss_pred ---CceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015406 142 ---ANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218 (407)
Q Consensus 142 ---~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~ 218 (407)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|..||...+.
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 239 (339)
T 1z57_A 170 TLINPDIKVVDFGSATYDDEH----------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239 (339)
T ss_dssp EESCCCEEECCCSSCEETTSC----------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred cccCCCceEeeCcccccCccc----------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 567999999999865432 2356789999999999999999999999999999999999999987554
Q ss_pred CchHHHHHHHhhhcccccHH------------------------------------HHhcCCcHHHHHHHHHHhCCCCCC
Q 015406 219 GTKKQKYEKISEKKVSTSIE------------------------------------ALCRGYPTEFASYFHYCRSLRFDD 262 (407)
Q Consensus 219 ~~~~~~~~~i~~~~~~~~~~------------------------------------~~~~~~~~~l~~li~~cl~~~p~~ 262 (407)
......+..+.......... ......++++.+||.+||..||++
T Consensus 240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 33333333222111000000 000123578999999999999999
Q ss_pred CCCHHHHHH
Q 015406 263 KPDYAYLKR 271 (407)
Q Consensus 263 RPt~~~l~~ 271 (407)
||++.++++
T Consensus 320 Rpt~~ell~ 328 (339)
T 1z57_A 320 RITLREALK 328 (339)
T ss_dssp SCCHHHHTT
T ss_pred ccCHHHHhc
Confidence 999887753
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=349.06 Aligned_cols=262 Identities=16% Similarity=0.227 Sum_probs=206.8
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCC----eEEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeeeCc
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTN----EEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGD 76 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~----~~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 76 (407)
...++|++.+.||+|+||.||+|++..++ ..||||++...... ..+.+|+.+++.++| ++++.+..++...+
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~ 119 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH-HNIIRLEGVISKYK 119 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEECSSS
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEecCC
Confidence 34678999999999999999999976553 46999998754332 247789999999976 66777777777788
Q ss_pred eeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceee
Q 015406 77 YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (407)
Q Consensus 77 ~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~ 155 (407)
..++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 120 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 120 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRV 196 (333)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC---
T ss_pred CcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEE---CCCCcEEECCCCcchh
Confidence 899999999 889999998766789999999999999999999999999999999999999 5788999999999987
Q ss_pred eccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhccc
Q 015406 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVS 234 (407)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (407)
........ .......+|+.|+|||++.+..++.++||||||+++|||++ |..||.+... .+....+......
T Consensus 197 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~~~~~~~~~~~~~ 269 (333)
T 1mqb_A 197 LEDDPEAT----YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---HEVMKAINDGFRL 269 (333)
T ss_dssp ------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTTCCC
T ss_pred hccccccc----cccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHCCCcC
Confidence 65432211 11223456889999999999999999999999999999999 9999976543 3344444333221
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHc
Q 015406 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (407)
Q Consensus 235 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~ 280 (407)
. ....+++++.+++.+||+.||++||++.++.+.|++++...
T Consensus 270 ~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 270 P----TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp C----CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred C----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 1 23468999999999999999999999999999999987643
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=340.18 Aligned_cols=249 Identities=22% Similarity=0.290 Sum_probs=206.1
Q ss_pred CCccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeee--------
Q 015406 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGV-------- 73 (407)
Q Consensus 2 ~~~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~-------- 73 (407)
+..++++|++.+.||+|+||.||+|++..+++.||+|++... ...+.+|+++++.++|++ +..+..+..
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN--NEKAEREVKALAKLDHVN-IVHYNGCWDGFDYDPET 82 (284)
T ss_dssp CHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECC--SGGGHHHHHHHHHCCCTT-BCCEEEEEEEEEEC---
T ss_pred cchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHhCCCCC-EEEEeeeEeccccCccc
Confidence 345678899999999999999999999989999999998754 356889999999998754 544444332
Q ss_pred --------eCceeEEEEecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCc
Q 015406 74 --------EGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN 143 (407)
Q Consensus 74 --------~~~~~~lvme~~-g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~ 143 (407)
.....++||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~ 159 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFL---VDTK 159 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETT
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEE---cCCC
Confidence 245679999999 78999999753 3579999999999999999999999999999999999999 5788
Q ss_pred eEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHH
Q 015406 144 QVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ 223 (407)
Q Consensus 144 ~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~ 223 (407)
.+||+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||.. ...
T Consensus 160 ~~kl~Dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~-----~~~ 226 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDGK--------RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE-----TSK 226 (284)
T ss_dssp EEEECCCTTCEESSCCSC--------CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH-----HHH
T ss_pred CEEECcchhheecccccc--------ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh-----HHH
Confidence 999999999987655332 2345789999999999999999999999999999999999988743 122
Q ss_pred HHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 015406 224 KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (407)
Q Consensus 224 ~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l 276 (407)
....+.... +...+++++.++|.+||+.||++||++.++.+.|..+
T Consensus 227 ~~~~~~~~~-------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 227 FFTDLRDGI-------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp HHHHHHTTC-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhhccc-------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 233332222 1245789999999999999999999999999988765
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=344.12 Aligned_cols=252 Identities=20% Similarity=0.254 Sum_probs=208.3
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC--CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
+.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+|+.+++.++| +++..+..++......++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKH-ENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCC-TTBCCEEEEEECSSEEEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCC-CCeeehhhhcccCCEEEEEE
Confidence 4678999999999999999999999999999999987543 23458899999999976 66777777778888999999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCC
Q 015406 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 83 e~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~ 161 (407)
||+ +++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+...+.++.+||+|||+++......
T Consensus 86 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~- 163 (304)
T 2jam_A 86 QLVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI- 163 (304)
T ss_dssp CCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT-
T ss_pred EcCCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc-
Confidence 999 88999998763 479999999999999999999999999999999999999554577899999999987543221
Q ss_pred CcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHh
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (407)
.....||+.|+|||++.+..++.++||||||+++|+|++|..||.... ....+..+....... .....
T Consensus 164 --------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~i~~~~~~~-~~~~~ 231 (304)
T 2jam_A 164 --------MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET---ESKLFEKIKEGYYEF-ESPFW 231 (304)
T ss_dssp --------THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHCCCCC-CTTTT
T ss_pred --------cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHcCCCCC-Ccccc
Confidence 124568999999999999999999999999999999999999997643 344445554443221 12234
Q ss_pred cCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 242 ~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
..+++++.++|.+||..||++||++.++++
T Consensus 232 ~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 232 DDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp TTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 568999999999999999999999776653
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=355.94 Aligned_cols=251 Identities=20% Similarity=0.225 Sum_probs=203.4
Q ss_pred CceeE--eccccccCceEEEEEEEcCCCeEEEEEEecCCC--CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 7 NKFRL--GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 7 ~~y~i--~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
+.|.+ .+.||+|+||.||+|++..+++.||+|++.... ....+.+|+.+++.++| ++++.+..++...+..+|||
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~lv~ 165 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDH-ANLIQLYDAFESKNDIVLVM 165 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEEEEEE
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCC-CCCCeEEEEEEECCEEEEEE
Confidence 44555 678999999999999999999999999987643 23458899999999976 67777777888888999999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCC
Q 015406 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 83 e~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~ 161 (407)
||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+.. +..+.+||+|||+++.+.....
T Consensus 166 E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~DFG~a~~~~~~~~ 244 (373)
T 2x4f_A 166 EYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN-RDAKQIKIIDFGLARRYKPREK 244 (373)
T ss_dssp ECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEE-TTTTEEEECCCSSCEECCTTCB
T ss_pred eCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEec-CCCCcEEEEeCCCceecCCccc
Confidence 999 89999998765567999999999999999999999999999999999999832 2457899999999997754332
Q ss_pred CcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHh
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (407)
.....||+.|+|||++.+..++.++|||||||++|||++|..||.+... .+.+..+........ ....
T Consensus 245 --------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~~~i~~~~~~~~-~~~~ 312 (373)
T 2x4f_A 245 --------LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND---AETLNNILACRWDLE-DEEF 312 (373)
T ss_dssp --------CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHHTCCCSC-SGGG
T ss_pred --------cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhccCCCC-hhhh
Confidence 2345799999999999998999999999999999999999999987443 444555554433222 2234
Q ss_pred cCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 242 ~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
..+++++.+||.+||..||++||++.++++
T Consensus 313 ~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 313 QDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 568999999999999999999999887764
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=339.95 Aligned_cols=257 Identities=18% Similarity=0.233 Sum_probs=205.5
Q ss_pred cCCceeEeccccccCceEEEEEEEcC---CCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCcee
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQ---TNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~---~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 78 (407)
..++|++.+.||+|+||.||+|++.. ++..||+|++..... ...+.+|+.+++.++| +++..+..+... +..
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~-~~~ 87 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH-PHIVKLIGIIEE-EPT 87 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCC-TTBCCEEEEECS-SSC
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCC-CCcceEEEEEcC-CCC
Confidence 35789999999999999999998754 345699999875432 2457889999999986 555555555443 345
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeec
Q 015406 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~ 157 (407)
++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 88 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILV---ASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---EETTEEEECCCCGGGCC-
T ss_pred EEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE---CCCCcEEeCccCCCcccc
Confidence 8999999 899999998766779999999999999999999999999999999999999 577899999999998665
Q ss_pred cCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhccccc
Q 015406 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (407)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (407)
.... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.......... .+.......
T Consensus 165 ~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~---~~~~~~~~~- 234 (281)
T 3cc6_A 165 DEDY------YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIG---VLEKGDRLP- 234 (281)
T ss_dssp --------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHH---HHHHTCCCC-
T ss_pred cccc------cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHH---HHhcCCCCC-
Confidence 4322 11234567889999999998899999999999999999998 999998755443332 222221111
Q ss_pred HHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHH
Q 015406 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (407)
Q Consensus 237 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~ 279 (407)
....+++++.+++.+||+.||++||++.++.+.|++++..
T Consensus 235 ---~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 235 ---KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 2245789999999999999999999999999999988754
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=355.21 Aligned_cols=253 Identities=22% Similarity=0.293 Sum_probs=197.9
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEee-----------
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFG----------- 72 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~----------- 72 (407)
...++|++.+.||+|+||.||+|++..+++.||||++..... ...+|+.+++.++|++.+..+..+.
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~--~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 81 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR--YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ 81 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT--SCCHHHHHHTTCCCTTBCCEEEEEEEC---------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc--hHHHHHHHHHHcCCCCccchhheeeecCcccccccc
Confidence 346899999999999999999999999999999998765432 3457999999998755444444432
Q ss_pred --------------------------eeCceeEEEEeccCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 015406 73 --------------------------VEGDYNVLVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKS 123 (407)
Q Consensus 73 --------------------------~~~~~~~lvme~~g~sL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 123 (407)
....+.++||||+.++|.+.+.. .+..+++..++.++.||+.||.|||++|
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g 161 (383)
T 3eb0_A 82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG 161 (383)
T ss_dssp ----------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred cccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc
Confidence 23345889999998898888763 3467999999999999999999999999
Q ss_pred ceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCC-CChhhHHHHHHHH
Q 015406 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYV 202 (407)
Q Consensus 124 ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~sDIwSlG~i 202 (407)
|+||||||+|||++ ..++.+||+|||+|+.+..... .....||+.|+|||++.+.. ++.++|||||||+
T Consensus 162 i~H~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 162 ICHRDIKPQNLLVN--SKDNTLKLCDFGSAKKLIPSEP--------SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp EECSCCCGGGEEEE--TTTTEEEECCCTTCEECCTTSC--------CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred CccCccCHHHEEEc--CCCCcEEEEECCCCcccCCCCC--------CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 99999999999994 2578999999999997654432 23557899999999998754 8999999999999
Q ss_pred HHHHHhCCCCCCCCCcCchHHHHHHHhhhccc------------------------ccHHHHhcCCcHHHHHHHHHHhCC
Q 015406 203 LMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS------------------------TSIEALCRGYPTEFASYFHYCRSL 258 (407)
Q Consensus 203 l~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~------------------------~~~~~~~~~~~~~l~~li~~cl~~ 258 (407)
+|||++|..||.+.... +.+..+...... .....+...+++++.+||.+||..
T Consensus 232 l~ell~g~~pf~~~~~~---~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (383)
T 3eb0_A 232 FGELILGKPLFSGETSI---DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY 308 (383)
T ss_dssp HHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred HHHHHhCCCCCCCCChH---HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence 99999999999875443 333332221110 111123345889999999999999
Q ss_pred CCCCCCCHHHHHH
Q 015406 259 RFDDKPDYAYLKR 271 (407)
Q Consensus 259 ~p~~RPt~~~l~~ 271 (407)
||++|||+.++++
T Consensus 309 dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 309 EPDLRINPYEAMA 321 (383)
T ss_dssp SGGGSCCHHHHHT
T ss_pred ChhhCCCHHHHhc
Confidence 9999999888763
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=349.86 Aligned_cols=258 Identities=17% Similarity=0.206 Sum_probs=202.9
Q ss_pred CccCCceeEeccccccCceEEEEEEEcCCC-eEEEEEEecCCCC-cchHHHHHHHHHHHcCCCC-----CCeeEEeeeeC
Q 015406 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTN-EEVAIKLENVKTK-HPQLLYESKLYRILQGGTG-----IPNVRWFGVEG 75 (407)
Q Consensus 3 ~~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~-~~vAvK~~~~~~~-~~~~~~E~~~l~~l~~~~~-----i~~~~~~~~~~ 75 (407)
..+.++|++.+.||+|+||.||+|++..++ +.||||++..... ...+.+|+.+++.+.|.+. +..+..++...
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred ceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 456789999999999999999999998776 7999999865322 3457789999999986543 55666777788
Q ss_pred ceeEEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCC---------------
Q 015406 76 DYNVLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG--------------- 139 (407)
Q Consensus 76 ~~~~lvme~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~--------------- 139 (407)
+..++||||++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+...
T Consensus 95 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~ 174 (355)
T 2eu9_A 95 GHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEK 174 (355)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEE
T ss_pred CeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccccc
Confidence 8999999999888888887543 469999999999999999999999999999999999999432
Q ss_pred -CCCceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015406 140 -RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218 (407)
Q Consensus 140 -~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~ 218 (407)
+..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|..||.....
T Consensus 175 ~~~~~~~kl~Dfg~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (355)
T 2eu9_A 175 SVKNTSIRVADFGSATFDHEH----------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244 (355)
T ss_dssp EESCCCEEECCCTTCEETTSC----------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccCCCcEEEeecCcccccccc----------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 25688999999999864432 2356799999999999999999999999999999999999999987554
Q ss_pred CchHHHHHHHhhhcccccH--------------------------HHH----------hcCCcHHHHHHHHHHhCCCCCC
Q 015406 219 GTKKQKYEKISEKKVSTSI--------------------------EAL----------CRGYPTEFASYFHYCRSLRFDD 262 (407)
Q Consensus 219 ~~~~~~~~~i~~~~~~~~~--------------------------~~~----------~~~~~~~l~~li~~cl~~~p~~ 262 (407)
......+.++......... ... ....+.++.+||.+||+.||++
T Consensus 245 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 324 (355)
T 2eu9_A 245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324 (355)
T ss_dssp HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence 3333333322211100000 000 0112458999999999999999
Q ss_pred CCCHHHHH
Q 015406 263 KPDYAYLK 270 (407)
Q Consensus 263 RPt~~~l~ 270 (407)
||++.+++
T Consensus 325 Rpt~~e~l 332 (355)
T 2eu9_A 325 RITLAEAL 332 (355)
T ss_dssp SCCHHHHT
T ss_pred CcCHHHHh
Confidence 99987775
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=360.13 Aligned_cols=251 Identities=21% Similarity=0.210 Sum_probs=195.5
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeeee-----CceeEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVE-----GDYNVL 80 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~-----~~~~~l 80 (407)
..+|++.+.||+|+||.||+|++..+++.||||.+.... ....+|+++++.++|++.+..+..+... ..+.++
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT--TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc--hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 347999999999999999999999999999999876533 2345799999999875555444443321 234679
Q ss_pred EEeccCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeec
Q 015406 81 VMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (407)
Q Consensus 81 vme~~g~sL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~ 157 (407)
||||+.++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+||||+ .+.+.+||+|||+++.+.
T Consensus 131 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~--~~~~~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 131 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLV 208 (420)
T ss_dssp EEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEECC
T ss_pred ehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEe--CCCCeEEeccchhhhhcc
Confidence 999998888877653 356799999999999999999999999999999999999994 245678999999999765
Q ss_pred cCCCCcccCccCCCCccccccccccccccCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccc-
Q 015406 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST- 235 (407)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~- 235 (407)
.... .....||+.|+|||++.+. .++.++|||||||+||||++|+.||.+... .+.+.++......+
T Consensus 209 ~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~---~~~l~~i~~~lg~p~ 277 (420)
T 1j1b_A 209 RGEP--------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG---VDQLVEIIKVLGTPT 277 (420)
T ss_dssp TTCC--------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCSCC
T ss_pred cCCC--------ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCC
Confidence 4332 2356789999999999875 789999999999999999999999987543 22222222211000
Q ss_pred -----------------------cHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 236 -----------------------SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 236 -----------------------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
....+...+++++.+||.+||..||++||++.++++
T Consensus 278 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 278 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 011123457899999999999999999999877653
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=370.27 Aligned_cols=256 Identities=19% Similarity=0.369 Sum_probs=207.8
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEec
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~ 84 (407)
.++|++.+.||+|+||.||+|.+. .+..||||+++... ....+.+|+.+++.++| ++++.+..+.. ....++||||
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQH-DKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCC-TTBCCEEEEEC-SSSCEEEECC
T ss_pred hHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCC-CCEeeEEEEEe-CCccEEEEee
Confidence 467999999999999999999974 57889999987543 34568899999999987 55555555554 5567999999
Q ss_pred c-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 85 L-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 85 ~-g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 264 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~a~~~~~~~~- 339 (454)
T 1qcf_A 264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLARVIEDNEY- 339 (454)
T ss_dssp CTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTCCEEECSTTGGGGBCCHHH-
T ss_pred cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE---CCCCcEEEeeCCCceEcCCCce-
Confidence 9 89999999743 2368999999999999999999999999999999999999 5788999999999986543211
Q ss_pred cccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHHh
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (407)
.......+|..|+|||++.+..++.++|||||||+||||++ |..||.+... .+....+....... ..
T Consensus 340 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~---~~~~~~i~~~~~~~----~~ 407 (454)
T 1qcf_A 340 -----TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVIRALERGYRMP----RP 407 (454)
T ss_dssp -----HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHHHHTCCCC----CC
T ss_pred -----eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCCC----CC
Confidence 11234456889999999998899999999999999999999 9999987544 33344433322111 23
Q ss_pred cCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHc
Q 015406 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (407)
Q Consensus 242 ~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~ 280 (407)
..+|+++.+||.+||+.||++||++.+|.+.|++++...
T Consensus 408 ~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 408 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 568999999999999999999999999999998875433
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=362.97 Aligned_cols=268 Identities=21% Similarity=0.245 Sum_probs=211.5
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC---CcchHHHHHHHHHHHcCCCCCCeeEEeeeeC--cee
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEG--DYN 78 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~--~~~ 78 (407)
..+++|++.++||+|+||.||+|++..+++.||||++.... ....+.+|+++++.++| ++++.+..++... ...
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH-KNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCC-TTBCCEEEEEECTTTCCE
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCC-CCCCeEEEeeccCCCCee
Confidence 45789999999999999999999999999999999986532 23457799999999987 5565655555443 377
Q ss_pred EEEEecc-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccC-CCCCceEEEEecccee
Q 015406 79 VLVMDLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL-GRRANQVYIIDFGLAK 154 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~-~~~~~~~kL~DFGla~ 154 (407)
++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+.. ++..+.+||+|||+++
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 9999999 899999997532 23999999999999999999999999999999999999832 2356789999999998
Q ss_pred eeccCCCCcccCccCCCCccccccccccccccC--------CCCChhhHHHHHHHHHHHHHhCCCCCCCCCc-CchHHHH
Q 015406 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLG--------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKA-GTKKQKY 225 (407)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~~~~sDIwSlG~il~elltG~~Pf~~~~~-~~~~~~~ 225 (407)
....... .....||+.|+|||++.+ ..++.++|||||||++|||++|..||..... ....+.+
T Consensus 165 ~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~ 236 (396)
T 4eut_A 165 ELEDDEQ--------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236 (396)
T ss_dssp ECCCGGG--------SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHH
T ss_pred EccCCCc--------cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHH
Confidence 7654322 235679999999999875 4678899999999999999999999975433 2233444
Q ss_pred HHHhhhcccccH--------------------HHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHc
Q 015406 226 EKISEKKVSTSI--------------------EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (407)
Q Consensus 226 ~~i~~~~~~~~~--------------------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~ 280 (407)
.++......... ..+...++..+.+++.+||..||++||++.++.+.+++++.+.
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp HHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred HHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 444433221100 0112335678999999999999999999999999999887653
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=370.19 Aligned_cols=253 Identities=23% Similarity=0.344 Sum_probs=212.2
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCcee
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 78 (407)
.+.++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+|+.+++.++| ++|+.+..++......
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~ 101 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH-PNIMKLYEFFEDKGYF 101 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCC-CCCCcEEEEEEeCCEE
Confidence 34578999999999999999999999999999999986542 23458899999999975 7777777888888899
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeec
Q 015406 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~ 157 (407)
|+||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+...+.++.+||+|||+++.+.
T Consensus 102 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 102 YLVGEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp EEEECCCCSCBHHHHHHT-CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 9999999 9999999875 4579999999999999999999999999999999999999655567899999999998765
Q ss_pred cCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccH
Q 015406 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (407)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (407)
.... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.. ..+.+..+.........
T Consensus 181 ~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~ 248 (484)
T 3nyv_A 181 ASKK--------MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN---EYDILKKVEKGKYTFEL 248 (484)
T ss_dssp CCCS--------HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCCS
T ss_pred cccc--------cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHcCCCCCCC
Confidence 4332 224579999999999987 69999999999999999999999998743 34555555555433222
Q ss_pred HHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 238 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
+ .+..+++++.+||.+||..||.+|||+.++++
T Consensus 249 ~-~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 249 P-QWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp G-GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred c-ccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 2 33568999999999999999999999877753
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=345.65 Aligned_cols=249 Identities=18% Similarity=0.292 Sum_probs=201.2
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeeee--CceeEEEEe
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVE--GDYNVLVMD 83 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~--~~~~~lvme 83 (407)
.++|++.+.||+|+||.||+|++..+++.||||++.. .....+.+|+.+++.+.+|+++..+..+... ....++|||
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e 113 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 113 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc-cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence 5789999999999999999999999999999999864 3456789999999999977888888777776 667899999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 84 ~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
|+ +++|.+++. .+++..++.++.||+.||+|||++||+||||||+|||++ .+...+||+|||+++.......
T Consensus 114 ~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~- 186 (330)
T 3nsz_A 114 HVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQE- 186 (330)
T ss_dssp CCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCCTTCEECCTTCC-
T ss_pred ccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEc--CCCCEEEEEeCCCceEcCCCCc-
Confidence 99 899999875 489999999999999999999999999999999999994 2334899999999987654332
Q ss_pred cccCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhccc-------
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS------- 234 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~------- 234 (407)
.....||..|+|||++.+ ..++.++|||||||++|+|++|..||..... ....+..+......
T Consensus 187 -------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~--~~~~l~~~~~~~~~~~~~~~~ 257 (330)
T 3nsz_A 187 -------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD--NYDQLVRIAKVLGTEDLYDYI 257 (330)
T ss_dssp -------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS--HHHHHHHHHHHHCHHHHHHHH
T ss_pred -------cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCc--hHHHHHHHHHhcCCchhhhHH
Confidence 235578999999999987 6789999999999999999999999965332 11222211111000
Q ss_pred --------ccHH-----------------HHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 235 --------TSIE-----------------ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 235 --------~~~~-----------------~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.... .....+++++.+||.+||..||++|||++++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000 011227899999999999999999999887764
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=348.53 Aligned_cols=255 Identities=23% Similarity=0.272 Sum_probs=195.0
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeC-----
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEG----- 75 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~----- 75 (407)
++.++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+|+.+++.++|+ +++.+..++.+.
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp-niv~~~~~~~~~~~~~~ 81 (332)
T 3qd2_B 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP-GIVRYFNAWLETPPEKW 81 (332)
T ss_dssp HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCT-TBCCEEEEEEECCSCHH
T ss_pred hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCC-CEeeEEEEEEEeccchh
Confidence 345789999999999999999999999999999999875432 24588999999999874 455544433221
Q ss_pred ----------------------------------------------------ceeEEEEecc-CCCHHHHHHHcC--CCC
Q 015406 76 ----------------------------------------------------DYNVLVMDLL-GPSLEDLFNFCS--RKL 100 (407)
Q Consensus 76 ----------------------------------------------------~~~~lvme~~-g~sL~~~l~~~~--~~l 100 (407)
.+.++||||+ +++|.+++.... ...
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~ 161 (332)
T 3qd2_B 82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161 (332)
T ss_dssp HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence 2479999999 899999998532 235
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCccc-----CccCCCCccc
Q 015406 101 SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI-----PYRENKNLTG 175 (407)
Q Consensus 101 ~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~-----~~~~~~~~~g 175 (407)
++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++........... .+.......|
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g 238 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred hhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEE---eCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence 677899999999999999999999999999999999 57889999999999987654321110 0122345679
Q ss_pred cccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHH
Q 015406 176 TARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYC 255 (407)
Q Consensus 176 t~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~c 255 (407)
|+.|+|||++.+..++.++|||||||++|||++|..|+.. .......+.....+ ......++++.++|.+|
T Consensus 239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~ 309 (332)
T 3qd2_B 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNLKFP----LLFTQKYPQEHMMVQDM 309 (332)
T ss_dssp CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTTCCC----HHHHHHCHHHHHHHHHH
T ss_pred CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhccCCC----cccccCChhHHHHHHHH
Confidence 9999999999999999999999999999999998776521 22223333332222 22234578899999999
Q ss_pred hCCCCCCCCCHHHHHH
Q 015406 256 RSLRFDDKPDYAYLKR 271 (407)
Q Consensus 256 l~~~p~~RPt~~~l~~ 271 (407)
|+.||++||++.++++
T Consensus 310 l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 310 LSPSPTERPEATDIIE 325 (332)
T ss_dssp HCSSGGGSCCHHHHHH
T ss_pred ccCCCCcCCCHHHHhh
Confidence 9999999999887764
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=351.41 Aligned_cols=253 Identities=19% Similarity=0.211 Sum_probs=201.6
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-------cchHHHHHHHHHHHcCCCCCCeeEEeeeeCce
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-------HPQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 77 (407)
..++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+|+.+++.++| ++++.+..++.....
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH-PNIIGLLDAFGHKSN 86 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCC-TTBCCEEEEECCTTC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCC-CCCCeEEEEEeeCCc
Confidence 45789999999999999999999999999999998764321 2457899999999986 667777777777888
Q ss_pred eEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeec
Q 015406 78 NVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (407)
Q Consensus 78 ~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~ 157 (407)
.++||||+.++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+.
T Consensus 87 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 87 ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFG 163 (346)
T ss_dssp CEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGSTTT
T ss_pred eEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEE---cCCCCEEEEecccceecc
Confidence 99999999779999998655679999999999999999999999999999999999999 578899999999998664
Q ss_pred cCCCCcccCccCCCCccccccccccccccCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcc---
Q 015406 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV--- 233 (407)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~--- 233 (407)
.... ......||+.|+|||++.+. .++.++|||||||++|||++|..||.+... .+.+..+.....
T Consensus 164 ~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~---~~~~~~i~~~~~~~~ 233 (346)
T 1ua2_A 164 SPNR-------AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---LDQLTRIFETLGTPT 233 (346)
T ss_dssp SCCC-------CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCC
T ss_pred CCcc-------cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHHcCCCC
Confidence 4322 12356789999999999764 589999999999999999999999987543 333333332111
Q ss_pred --------------------cccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 234 --------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 234 --------------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
......+...+++++.+||.+||..||++|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 234 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp TTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 11223344667899999999999999999999887654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=356.26 Aligned_cols=262 Identities=17% Similarity=0.251 Sum_probs=199.1
Q ss_pred CceeEeccccccCceEEEEEEEcCCC---eEEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTN---EEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~---~~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
..|++.+.||+|+||.||+|++..++ ..||+|.++..... ..+.+|+.+++.++|++.+..+..+....+..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 35889999999999999999975432 46899987654332 3578899999999875555444444556677899
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 81 vme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC---------
T ss_pred EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEE---CCCCCEEEeecccccccccc
Confidence 99999 889999998656679999999999999999999999999999999999999 67889999999999866443
Q ss_pred CCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHH
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (407)
.... ........+|+.|+|||++.+..++.++|||||||++|||++ |.+||.+........ .+.......
T Consensus 246 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~---~~~~~~~~~--- 316 (373)
T 3c1x_A 246 EFDS---VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV---YLLQGRRLL--- 316 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHH---HHHTTCCCC---
T ss_pred cccc---ccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHH---HHHcCCCCC---
Confidence 2111 011234567889999999999999999999999999999999 788887765543332 222222111
Q ss_pred HHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcC
Q 015406 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREG 281 (407)
Q Consensus 239 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~ 281 (407)
....+|+++.+++.+||+.||++||++.++.+.|+.++....
T Consensus 317 -~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 317 -QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred -CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 124589999999999999999999999999999999987553
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=348.75 Aligned_cols=265 Identities=18% Similarity=0.217 Sum_probs=192.9
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC--cchHHHHHHHHHHHcCCCCCCeeEEee--------eeC
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFG--------VEG 75 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~--------~~~ 75 (407)
..+|++.++||+|+||.||+|++..+++.||||++..... ...+.+|+.+++.+.+|++++.+..++ ...
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 4589999999999999999999999999999998754332 345788999999998567777766555 345
Q ss_pred ceeEEEEeccCCCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcccccCCCCCceEEEEecc
Q 015406 76 DYNVLVMDLLGPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFG 151 (407)
Q Consensus 76 ~~~~lvme~~g~sL~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~--ivHrDLKp~NILl~~~~~~~~~kL~DFG 151 (407)
...+++|||++++|.+++.. ....+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||
T Consensus 107 ~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg 183 (337)
T 3ll6_A 107 AEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL---SNQGTIKLCDFG 183 (337)
T ss_dssp EEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEE---CTTSCEEBCCCT
T ss_pred ceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEE---CCCCCEEEecCc
Confidence 56899999999999999864 3456999999999999999999999999 9999999999999 578899999999
Q ss_pred ceeeeccCCCCccc-----CccCCCCccccccccccccc---cCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHH
Q 015406 152 LAKKYRDTSTHQHI-----PYRENKNLTGTARYASMNTH---LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ 223 (407)
Q Consensus 152 la~~~~~~~~~~~~-----~~~~~~~~~gt~~Y~aPE~~---~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~ 223 (407)
+++........... .........||+.|+|||++ .+..++.++|||||||++|+|++|..||...... .
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~ 260 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL---R 260 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH---H
Confidence 99876543221100 00112245689999999998 5667899999999999999999999999753321 1
Q ss_pred HHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCC
Q 015406 224 KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQ 283 (407)
Q Consensus 224 ~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~ 283 (407)
.. ....... ....++..+.+|+.+||+.||++||++.++.+.|+.+.......
T Consensus 261 ~~----~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~ 313 (337)
T 3ll6_A 261 IV----NGKYSIP---PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVN 313 (337)
T ss_dssp ---------CCCC---TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCC
T ss_pred hh----cCcccCC---cccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCC
Confidence 11 1111111 12446788999999999999999999999999999988766543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=339.45 Aligned_cols=246 Identities=22% Similarity=0.303 Sum_probs=204.2
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCC-----CCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCcee
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 78 (407)
...++|++.+.||+|+||.||+|++..+++.||||++... .....+.+|+.+++.++| ++++.+..++.+....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH-PNILRLYGYFHDATRV 84 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEE
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCC-CCCcchhheEecCCEE
Confidence 4467899999999999999999999999999999987532 233457889999999986 6777777888888899
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeec
Q 015406 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~ 157 (407)
++||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 85 ~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEE---CTTSCEEECSCCEESCC-
T ss_pred EEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEE---cCCCCEEEEeccccccCC
Confidence 9999999 88999999864 469999999999999999999999999999999999999 688899999999986543
Q ss_pred cCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccH
Q 015406 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (407)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (407)
... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.... ..+.+..+......
T Consensus 161 ~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~--- 225 (279)
T 3fdn_A 161 SSR---------RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT---YQETYKRISRVEFT--- 225 (279)
T ss_dssp ----------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHTCCC---
T ss_pred ccc---------ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc---HHHHHHHHHhCCCC---
Confidence 322 235578999999999999999999999999999999999999997643 33444444433322
Q ss_pred HHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 238 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
+...+++++.++|.+||+.||++||++.++++
T Consensus 226 --~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 226 --FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp --CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred --CCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 22457899999999999999999999777764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=341.51 Aligned_cols=261 Identities=20% Similarity=0.306 Sum_probs=211.8
Q ss_pred CCceeEec-cccccCceEEEEEEEc--CCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeE
Q 015406 6 GNKFRLGR-KIGSGSFGEIYLGTNI--QTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 6 ~~~y~i~~-~iG~G~~g~Vy~~~~~--~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 79 (407)
.++|.+.+ .||+|+||.||+|.+. .+++.||||++..... ...+.+|+++++.++| +++..+..++ ..+..+
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~-~~~~~~ 85 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN-PYIVRLIGVC-QAEALM 85 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEE-ESSSEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCC-CCEeEEEEEe-cCCCcE
Confidence 46788877 9999999999999864 4678999999876433 2347889999999976 5555555555 455689
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 80 lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
+||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 86 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL---VNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---EETTEEEECCCTTCEECTT
T ss_pred EEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEE---cCCCCEEECcccceeeecc
Confidence 999999 889999997656679999999999999999999999999999999999999 5778999999999987754
Q ss_pred CCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccH
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (407)
..... .......||+.|+|||++.+..++.++||||||+++|||++ |..||..... .+....+......
T Consensus 163 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~i~~~~~~--- 232 (287)
T 1u59_A 163 DDSYY----TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAFIEQGKRM--- 232 (287)
T ss_dssp CSCEE----CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHHHHHHTTCCC---
T ss_pred Cccee----eccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHhcCCcC---
Confidence 33211 11234467899999999998889999999999999999998 9999987544 3333334333221
Q ss_pred HHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCC
Q 015406 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGF 282 (407)
Q Consensus 238 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~ 282 (407)
.+...+|+++.++|.+||+.||++||++.++.+.|+.++...+.
T Consensus 233 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 276 (287)
T 1u59_A 233 -ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276 (287)
T ss_dssp -CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred -CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 12356899999999999999999999999999999999876643
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=343.17 Aligned_cols=258 Identities=20% Similarity=0.339 Sum_probs=207.1
Q ss_pred CCceeEec-cccccCceEEEEEEE--cCCCeEEEEEEecCCCC----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCcee
Q 015406 6 GNKFRLGR-KIGSGSFGEIYLGTN--IQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (407)
Q Consensus 6 ~~~y~i~~-~iG~G~~g~Vy~~~~--~~~~~~vAvK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 78 (407)
.++|++.+ .||+|+||.||+|.+ ..+++.||||++..... ...+.+|+.+++.++| +++..+..++ ..+..
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN-PYIVRMIGIC-EAESW 92 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCC-TTBCCEEEEE-ESSSE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCC-CCEEEEEEEE-CCCCc
Confidence 46799998 999999999999954 56678999999875433 2357889999999976 5555555555 55667
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeec
Q 015406 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~ 157 (407)
++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 93 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALR 168 (291)
T ss_dssp EEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCTTCEECC
T ss_pred EEEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEE---eCCCcEEEccCCcceeec
Confidence 9999999 8999999986 4569999999999999999999999999999999999999 577899999999998765
Q ss_pred cCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhccccc
Q 015406 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (407)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (407)
...... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+... .+....+......
T Consensus 169 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~-- 239 (291)
T 1xbb_A 169 ADENYY----KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAMLEKGERM-- 239 (291)
T ss_dssp TTCSEE----EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCCC--
T ss_pred cCCCcc----cccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCCCC--
Confidence 443211 11223456789999999998889999999999999999999 9999987543 3333333332221
Q ss_pred HHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHc
Q 015406 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (407)
Q Consensus 237 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~ 280 (407)
.....+++++.+++.+||+.||++||++.++.+.|++++...
T Consensus 240 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 240 --GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 123568999999999999999999999999999999998654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=345.74 Aligned_cols=259 Identities=22% Similarity=0.301 Sum_probs=201.9
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc-----chHHHHHHHHHHHcCCCCCCeeEEeeeeCcee
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 78 (407)
...++|++.+.||+|+||.||+|++..+++.||||++...... ..+.+|+.+++.++| +++..+..++...+..
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-p~iv~~~~~~~~~~~~ 109 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQE-PHVVPIHDFGEIDGQL 109 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCC-TTBCCEEEEEEETTEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCC-CCeeEEEEEEeeCCeE
Confidence 3467899999999999999999999999999999998654321 457789999999976 6777777788888899
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeec
Q 015406 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~ 157 (407)
|+||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 110 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV---SADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSCCC-----
T ss_pred EEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEE---cCCCCEEEecCccCcccc
Confidence 9999999 78999999863 479999999999999999999999999999999999999 577899999999998665
Q ss_pred cCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccH
Q 015406 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (407)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (407)
.... .......||+.|+|||++.+..++.++||||||+++|+|++|..||..... . .+........ ...
T Consensus 186 ~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~-~~~~~~~~~~-~~~ 254 (309)
T 2h34_A 186 DEKL------TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL---S-VMGAHINQAI-PRP 254 (309)
T ss_dssp -----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH---H-HHHHHHHSCC-CCG
T ss_pred cccc------ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH---H-HHHHHhccCC-CCc
Confidence 4321 112355789999999999999999999999999999999999999976432 2 2222222221 223
Q ss_pred HHHhcCCcHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHHH
Q 015406 238 EALCRGYPTEFASYFHYCRSLRFDDKP-DYAYLKRIFRDLFI 278 (407)
Q Consensus 238 ~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~~l~~~l~~l~~ 278 (407)
......+|+++.++|.+||+.||++|| +++++.+.|+.++.
T Consensus 255 ~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 255 STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 344567899999999999999999999 99999999887643
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=349.66 Aligned_cols=263 Identities=19% Similarity=0.273 Sum_probs=208.3
Q ss_pred CccCCceeEeccccccCceEEEEEE-----EcCCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeee
Q 015406 3 PRVGNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVE 74 (407)
Q Consensus 3 ~~~~~~y~i~~~iG~G~~g~Vy~~~-----~~~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~ 74 (407)
....++|++.+.||+|+||.||+|+ +..+++.||||++..... ...+.+|+.+++.++| +++..+..++..
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~ 104 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH-QNIVRCIGVSLQ 104 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEECS
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCC-CCCCeEEEEEcC
Confidence 3557899999999999999999999 556788999999864432 2347889999999965 677777777777
Q ss_pred CceeEEEEecc-CCCHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEE
Q 015406 75 GDYNVLVMDLL-GPSLEDLFNFCS------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI 147 (407)
Q Consensus 75 ~~~~~lvme~~-g~sL~~~l~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL 147 (407)
....|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++....+||
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence 78889999999 899999998643 34899999999999999999999999999999999999964445667999
Q ss_pred EeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHH
Q 015406 148 IDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYE 226 (407)
Q Consensus 148 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~ 226 (407)
+|||+++........ .......||+.|+|||++.+..++.++||||||+++|+|++ |..||..... .+...
T Consensus 185 ~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~ 256 (327)
T 2yfx_A 185 GDFGMARDIYRASYY-----RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVLE 256 (327)
T ss_dssp CCCHHHHHHHC-----------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHH
T ss_pred Ccccccccccccccc-----ccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH---HHHHH
Confidence 999999765433221 11234568999999999998899999999999999999998 9999976433 33444
Q ss_pred HHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Q 015406 227 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (407)
Q Consensus 227 ~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~ 278 (407)
.+....... ....+++++.++|.+||+.||++||++.++.+.|..+..
T Consensus 257 ~~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 257 FVTSGGRMD----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp HHHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhcCCCCC----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 443332221 235689999999999999999999999999999987754
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=340.80 Aligned_cols=261 Identities=17% Similarity=0.249 Sum_probs=205.6
Q ss_pred ceeEeccccccCceEEEEEEEcCCCe---EEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNE---EVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~---~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
.|++.++||+|+||.||+|++..+++ .||+|++...... ..+.+|+.+++.++|++.+..+..+.......+++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 57778999999999999999765544 7999998754432 34778999999998755444444444455556999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 82 me~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
|||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML---DESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECCTTSSCTTTTGG
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCcEEeCcCCCcccccCCc
Confidence 9999 999999998666779999999999999999999999999999999999999 578899999999998654322
Q ss_pred CCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCC-CCCCCcCchHHHHHHHhhhcccccHHH
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP-WQGLKAGTKKQKYEKISEKKVSTSIEA 239 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~P-f~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (407)
.. .........+|+.|+|||.+.+..++.++||||||+++|+|++|..| |...... .....+.......
T Consensus 179 ~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~---~~~~~~~~~~~~~---- 248 (298)
T 3pls_A 179 YY---SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF---DLTHFLAQGRRLP---- 248 (298)
T ss_dssp GG---CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG---GHHHHHHTTCCCC----
T ss_pred cc---ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH---HHHHHhhcCCCCC----
Confidence 11 11223456789999999999999999999999999999999995555 5443332 2222232222111
Q ss_pred HhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcC
Q 015406 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREG 281 (407)
Q Consensus 240 ~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~ 281 (407)
....+++++.+++.+||+.||++||++.++.+.|++++....
T Consensus 249 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 249 QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 234578999999999999999999999999999999988764
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-46 Score=352.26 Aligned_cols=258 Identities=20% Similarity=0.320 Sum_probs=210.7
Q ss_pred cCCceeEeccccccCceEEEEEEEc-----CCCeEEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeeeCc
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGD 76 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~-----~~~~~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 76 (407)
..++|++.+.||+|+||.||+|++. .+++.||||++...... ..+.+|+.+++.++| +++..+..++...+
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~ 101 (322)
T 1p4o_A 23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC-HHVVRLLGVVSQGQ 101 (322)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCC-TTBCCEEEEECSSS
T ss_pred hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCC-CCEeeeEEEEccCC
Confidence 4578999999999999999999876 35789999998754332 247789999999976 56777777777778
Q ss_pred eeEEEEecc-CCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEE
Q 015406 77 YNVLVMDLL-GPSLEDLFNFCS---------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY 146 (407)
Q Consensus 77 ~~~lvme~~-g~sL~~~l~~~~---------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~k 146 (407)
..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+|
T Consensus 102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli---~~~~~~k 178 (322)
T 1p4o_A 102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTVK 178 (322)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---CTTCCEE
T ss_pred ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEE---cCCCeEE
Confidence 889999999 889999997532 357999999999999999999999999999999999999 5788999
Q ss_pred EEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHH
Q 015406 147 IIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKY 225 (407)
Q Consensus 147 L~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~ 225 (407)
|+|||+++....... ........||+.|+|||++.+..++.++||||||+++|+|++ |..||.+... .+..
T Consensus 179 l~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~ 250 (322)
T 1p4o_A 179 IGDFGMTRDIYETDY-----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---EQVL 250 (322)
T ss_dssp ECCTTCCCGGGGGGC-----EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---HHHH
T ss_pred ECcCccccccccccc-----cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH---HHHH
Confidence 999999986544322 112234567899999999999899999999999999999999 8999977433 3444
Q ss_pred HHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Q 015406 226 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (407)
Q Consensus 226 ~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~ 278 (407)
..+....... ....+++++.+++.+||+.||++||++.++.+.|++++.
T Consensus 251 ~~~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 251 RFVMEGGLLD----KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHHHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHcCCcCC----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 4444333221 235689999999999999999999999999998877643
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=353.00 Aligned_cols=257 Identities=16% Similarity=0.212 Sum_probs=204.9
Q ss_pred CCceeEeccccccCceEEEEE-----EEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcC--CCCCCeeEEeeeeCcee
Q 015406 6 GNKFRLGRKIGSGSFGEIYLG-----TNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQG--GTGIPNVRWFGVEGDYN 78 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~-----~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~--~~~i~~~~~~~~~~~~~ 78 (407)
.++|++.++||+|+||.||+| .+..+++.||||++... ....+..|.++++.+.+ ++++..+..++...+..
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~ 142 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGS 142 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCE
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCc
Confidence 577999999999999999999 46678999999998654 45568889999998873 46677777777788888
Q ss_pred EEEEecc-CCCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccC--------CCCCceE
Q 015406 79 VLVMDLL-GPSLEDLFNF----CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL--------GRRANQV 145 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~----~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~--------~~~~~~~ 145 (407)
||||||+ +++|.+++.. ....+++..++.|+.||+.||+|||++|||||||||+||||+. ++..+.+
T Consensus 143 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~ 222 (365)
T 3e7e_A 143 VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGL 222 (365)
T ss_dssp EEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTE
T ss_pred EEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCE
Confidence 9999999 8999999975 2456999999999999999999999999999999999999942 1117899
Q ss_pred EEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHH
Q 015406 146 YIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY 225 (407)
Q Consensus 146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~ 225 (407)
||+|||+|+.+...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 223 kl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---- 293 (365)
T 3e7e_A 223 ALIDLGQSIDMKLFPKG-----TIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC---- 293 (365)
T ss_dssp EECCCTTCEEGGGSCTT-----EEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE----
T ss_pred EEeeCchhhhhhccCCC-----ceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce----
Confidence 99999999876533221 113456799999999999999999999999999999999999999964322110
Q ss_pred HHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHHHHHc
Q 015406 226 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDK-PDYAYLKRIFRDLFIRE 280 (407)
Q Consensus 226 ~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R-Pt~~~l~~~l~~l~~~~ 280 (407)
........ ...++.+.+++..|++.+|.+| |++.++.+.|++.+...
T Consensus 294 ------~~~~~~~~--~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 294 ------KPEGLFRR--LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp ------EECSCCTT--CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ------eechhccc--cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 00011111 1246789999999999999998 67889999999988764
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=343.18 Aligned_cols=250 Identities=20% Similarity=0.294 Sum_probs=198.3
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~ 85 (407)
.++|++.+.||+|+||.||+|++ .++.||||.+........+.+|+++++.++| +++..+..++. +..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNH-PNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTTHHHHHHHHHHHHHHCCC-TTBCCEEEBCT--TTTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChhHHHHHHHHHHHHhcCCC-CCcCeEEEEEc--CCcEEEEEcC
Confidence 57899999999999999999996 4789999998766656678999999999986 55555555544 3479999999
Q ss_pred -CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCCCcccccCCCCCc-eEEEEeccceeeecc
Q 015406 86 -GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKYRD 158 (407)
Q Consensus 86 -g~sL~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~---~~ivHrDLKp~NILl~~~~~~~-~~kL~DFGla~~~~~ 158 (407)
+++|.+++..... .+++..++.++.||+.||.|||+ +||+||||||+|||++ .++ .+||+|||++.....
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~---~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV---AGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEE---TTTTEEEECCCCC------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEe---CCCCEEEEccccccccccc
Confidence 8999999985332 37899999999999999999999 8999999999999994 444 489999999976543
Q ss_pred CCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHH
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (407)
.. ....||+.|+|||++.+..++.++||||||+++|||++|..||....... ......+......
T Consensus 159 ~~----------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~---- 223 (307)
T 2eva_A 159 HM----------TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA-FRIMWAVHNGTRP---- 223 (307)
T ss_dssp ----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH-HHHHHHHHTTCCC----
T ss_pred cc----------ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH-HHHHHHHhcCCCC----
Confidence 22 23468999999999999999999999999999999999999998654322 2222222222221
Q ss_pred HHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Q 015406 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (407)
Q Consensus 239 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~ 278 (407)
.....+|+++.+++.+||+.||++||+++++.+.|+.+..
T Consensus 224 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 224 PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 2335689999999999999999999999999999998753
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=350.68 Aligned_cols=265 Identities=18% Similarity=0.224 Sum_probs=210.4
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC--cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
..++|++.+.||+|+||.||+|++ .+++.||||.+..... ...+.+|+.+++.++| ++++.+..++...+..++||
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~ 114 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRH-PHLVSLIGFCDERNEMILIY 114 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCC-TTBCCEEEECCCTTCCEEEE
T ss_pred HHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCC-CCEeeEEEEEcCCCeEEEEE
Confidence 468899999999999999999996 5789999998765433 2457889999988876 67777777777888899999
Q ss_pred ecc-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 83 DLL-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 83 e~~-g~sL~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 115 KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL---DENFVPKITDFGISKKGTE 191 (321)
T ss_dssp ECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEE---CTTCCEEECCCTTCEECSS
T ss_pred EcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEE---CCCCCEEEeeccccccccc
Confidence 999 899999986432 258999999999999999999999999999999999999 6889999999999987543
Q ss_pred CCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHH----HHhhhccc
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE----KISEKKVS 234 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~----~i~~~~~~ 234 (407)
.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||............. ........
T Consensus 192 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (321)
T 2qkw_B 192 LDQT-----HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266 (321)
T ss_dssp SSCC-----CCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred cccc-----ccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence 3221 11234579999999999998899999999999999999999999997654432221111 11111110
Q ss_pred -----ccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHH
Q 015406 235 -----TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (407)
Q Consensus 235 -----~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~ 279 (407)
.....+...++.++.+++.+||+.||++||++.++.+.|+.++..
T Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 011112233567899999999999999999999999999988753
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=349.89 Aligned_cols=255 Identities=16% Similarity=0.200 Sum_probs=177.0
Q ss_pred ccCCceeEec-cccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeeee----Ccee
Q 015406 4 RVGNKFRLGR-KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVE----GDYN 78 (407)
Q Consensus 4 ~~~~~y~i~~-~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~----~~~~ 78 (407)
.+.++|++.+ .||+|+||.||+|++..+++.||||++... .....|+..+..+..+++++.+..++.. ....
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 4678999965 599999999999999999999999998642 3445555555555555777766665543 4568
Q ss_pred EEEEecc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeee
Q 015406 79 VLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~ 156 (407)
++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++.+||+|||+++..
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~ 181 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence 9999999 889999998543 36999999999999999999999999999999999999965445677999999999876
Q ss_pred ccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHH-HHHHhhhcccc
Q 015406 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK-YEKISEKKVST 235 (407)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~-~~~i~~~~~~~ 235 (407)
.... .....||+.|+|||++.+..++.++||||||+++|+|++|..||........... ...+......
T Consensus 182 ~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~- 251 (336)
T 3fhr_A 182 TQNA---------LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYG- 251 (336)
T ss_dssp -------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------C-
T ss_pred cccc---------cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccc-
Confidence 5432 2345789999999999988899999999999999999999999976543222111 1111111111
Q ss_pred cHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
........+++++.+||.+||..||++||++.++++
T Consensus 252 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 252 FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111223468999999999999999999999877654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=354.89 Aligned_cols=252 Identities=21% Similarity=0.291 Sum_probs=184.0
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC----cchHHHHHHHHHHHcCCCCCCeeEEeee-----eC
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGV-----EG 75 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~-----~~ 75 (407)
+.++|++.+.||+|+||.||+|.+..+|+.||||++..... ...+.+|+.+++.++|++.+..+..+.. ..
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 46899999999999999999999999999999999865432 2347789999999987554444444332 23
Q ss_pred ceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceee
Q 015406 76 DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (407)
Q Consensus 76 ~~~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~ 155 (407)
...|++||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 107 ~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 107 NDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH 181 (367)
T ss_dssp CCCEEEEECCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECC------
T ss_pred CeEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEE---CCCCCEEEeecccccc
Confidence 56799999999999999874 579999999999999999999999999999999999999 5788999999999986
Q ss_pred eccCCCCcccCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhh---
Q 015406 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK--- 231 (407)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~--- 231 (407)
.... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+.+....
T Consensus 182 ~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~ 251 (367)
T 2fst_X 182 TADE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 251 (367)
T ss_dssp -------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred cccc----------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 5432 235679999999999987 67899999999999999999999999875442222222111100
Q ss_pred --------------------cccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 232 --------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 232 --------------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
........+..++++++.+||.+||..||++|||+.++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 0112233445567899999999999999999999776653
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=339.36 Aligned_cols=257 Identities=21% Similarity=0.388 Sum_probs=209.3
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEec
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~ 84 (407)
.++|++.+.||+|+||.||+|++ .++..||||.+.... ....+.+|+++++.++| +++..+..+.. .+..++||||
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~-~~~~~~v~e~ 88 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQH-QRLVRLYAVVT-QEPIYIITEY 88 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCC-TTBCCEEEEEC-SSSCEEEEEC
T ss_pred HHhhhheeeecCCCCeEEEEEEE-cCCcEEEEEEecCCcccHHHHHHHHHHHHhCCC-cCcceEEEEEc-CCCcEEEEec
Confidence 57899999999999999999997 467789999887543 34568899999999987 55555555544 3457999999
Q ss_pred c-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 85 L-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 85 ~-g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~- 164 (279)
T 1qpc_A 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEY- 164 (279)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECSSSCE-
T ss_pred CCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEE---cCCCCEEECCCcccccccCccc-
Confidence 9 899999986422 269999999999999999999999999999999999999 5788999999999987654332
Q ss_pred cccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHHh
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (407)
.......++..|+|||++.+..++.++||||||+++|||++ |..||.+... .+....+...... ...
T Consensus 165 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~~~~~----~~~ 232 (279)
T 1qpc_A 165 -----TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN---PEVIQNLERGYRM----VRP 232 (279)
T ss_dssp -----ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCCC----CCC
T ss_pred -----ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH---HHHHHHHhcccCC----CCc
Confidence 11234567889999999998889999999999999999999 9999987443 3333333332211 123
Q ss_pred cCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcC
Q 015406 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREG 281 (407)
Q Consensus 242 ~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~ 281 (407)
..+++++.+++.+||+.||++||++.++.+.|++++....
T Consensus 233 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred ccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 5689999999999999999999999999999999987653
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=352.77 Aligned_cols=263 Identities=21% Similarity=0.236 Sum_probs=208.5
Q ss_pred CCceeEeccccccCceEEEEEE----EcCCCeEEEEEEecCCCCc--chHHHHHHHHHHHcCCCCCCeeEEeee--eCce
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKLENVKTKH--PQLLYESKLYRILQGGTGIPNVRWFGV--EGDY 77 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~----~~~~~~~vAvK~~~~~~~~--~~~~~E~~~l~~l~~~~~i~~~~~~~~--~~~~ 77 (407)
.++|++.+.||+|+||.||+|+ +..+++.||||++...... ..+.+|+++++.++| ++++.+..+.. ....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHS-DFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCC-CceeEEEEEEecCCCce
Confidence 4789999999999999999999 4678999999998765322 347899999999976 55555554443 5677
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeee
Q 015406 78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~ 156 (407)
.++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV---ESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCGGGCEEC
T ss_pred EEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEE---CCCCCEEEcccccceec
Confidence 89999999 999999998766679999999999999999999999999999999999999 57889999999999977
Q ss_pred ccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcC------------chHHH
Q 015406 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG------------TKKQK 224 (407)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~------------~~~~~ 224 (407)
....... .......||..|+|||++.+..++.++||||||+++|+|++|..||...... .....
T Consensus 178 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 253 (327)
T 3lxl_A 178 PLDKDYY----VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL 253 (327)
T ss_dssp CTTCSEE----ECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH
T ss_pred ccCCccc----eeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH
Confidence 5443211 1233456889999999999988999999999999999999999998652211 00111
Q ss_pred HHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHc
Q 015406 225 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (407)
Q Consensus 225 ~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~ 280 (407)
...+..... ......+++++.+++.+||+.||++||++.++.+.|+.++...
T Consensus 254 ~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 254 LELLEEGQR----LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHHHHTTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred HHHhhcccC----CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 111111111 1123568999999999999999999999999999999876433
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=375.55 Aligned_cols=267 Identities=19% Similarity=0.295 Sum_probs=210.1
Q ss_pred CceeEec-cccccCceEEEEEEEc--CCCeEEEEEEecCCC---CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 7 NKFRLGR-KIGSGSFGEIYLGTNI--QTNEEVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 7 ~~y~i~~-~iG~G~~g~Vy~~~~~--~~~~~vAvK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
+++.+.+ .||+|+||.||+|.+. .++..||||+++... ....+.+|+++++.++| ++++.+..++.. +..++
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~h-pniv~l~~~~~~-~~~~l 412 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN-PYIVRLIGVCQA-EALML 412 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCC-TTBCCEEEEEES-SSEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCC-CCEeeEEEEecc-CCeEE
Confidence 3455555 8999999999999875 356689999987543 23468899999999976 566666666554 45899
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 81 vme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
||||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||| +.++.+||+|||+++.+...
T Consensus 413 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl---~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 413 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLL---VNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp EEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCCSTTTTCC--
T ss_pred EEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEE---cCCCcEEEeeccCcccccCC
Confidence 99999 899999997656679999999999999999999999999999999999999 57889999999999865433
Q ss_pred CCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHH
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (407)
... +.......+|+.|+|||++.+..++.++|||||||+||||++ |..||.+.... +.+..+......
T Consensus 490 ~~~----~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~~~i~~~~~~---- 558 (613)
T 2ozo_A 490 DSY----YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFIEQGKRM---- 558 (613)
T ss_dssp ----------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH---HHHHHHHTTCCC----
T ss_pred Cce----eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHHHHHcCCCC----
Confidence 211 111223346789999999998899999999999999999998 99999886543 344444433221
Q ss_pred HHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccc
Q 015406 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFD 289 (407)
Q Consensus 239 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~d 289 (407)
.....+|+++.+||.+||..||++||++.+|.+.|++++...+.+.+...+
T Consensus 559 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~~~~s~ 609 (613)
T 2ozo_A 559 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGGSA 609 (613)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSCCCSSS
T ss_pred CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccccCCccc
Confidence 123568999999999999999999999999999999999887766544433
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=348.44 Aligned_cols=252 Identities=18% Similarity=0.259 Sum_probs=202.8
Q ss_pred CccCCceeEeccccccCceEEEEEEEcCCC-------eEEEEEEecCCC--CcchHHHHHHHHHHHcCCCCCCeeEEeee
Q 015406 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTN-------EEVAIKLENVKT--KHPQLLYESKLYRILQGGTGIPNVRWFGV 73 (407)
Q Consensus 3 ~~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~-------~~vAvK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~ 73 (407)
....++|++.+.||+|+||.||+|++..++ ..||+|++.... ....+.+|+.+++.++| ++++.+..++.
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~ 82 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH-KHLVLNYGVCV 82 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCC-TTBCCEEEEEC
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCC-CCEeEEEEEEE
Confidence 445789999999999999999999988776 579999886432 23458889999999986 67777777777
Q ss_pred eCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCce--------
Q 015406 74 EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ-------- 144 (407)
Q Consensus 74 ~~~~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~-------- 144 (407)
..+..++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.
T Consensus 83 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~~~~~~~~ 159 (289)
T 4fvq_A 83 CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLI---REEDRKTGNPPF 159 (289)
T ss_dssp CTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE---ECCBGGGTBCCE
T ss_pred eCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEe---cCCcccccccce
Confidence 788889999999 8999999987555599999999999999999999999999999999999995 4443
Q ss_pred EEEEeccceeeeccCCCCcccCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhC-CCCCCCCCcCchH
Q 015406 145 VYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRG-SLPWQGLKAGTKK 222 (407)
Q Consensus 145 ~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG-~~Pf~~~~~~~~~ 222 (407)
+||+|||++..... .....||+.|+|||++.+ ..++.++||||||+++|||++| ..||..... .
T Consensus 160 ~kl~Dfg~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~---~ 225 (289)
T 4fvq_A 160 IKLSDPGISITVLP-----------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS---Q 225 (289)
T ss_dssp EEECCCCSCTTTSC-----------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---H
T ss_pred eeeccCcccccccC-----------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch---H
Confidence 99999999864322 123468899999999988 6789999999999999999995 455544222 2
Q ss_pred HHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Q 015406 223 QKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (407)
Q Consensus 223 ~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~ 278 (407)
........ .. .+...+++++.+++.+||+.||++||++.++.+.|++++.
T Consensus 226 ~~~~~~~~-~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 226 RKLQFYED-RH-----QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HHHHHHHT-TC-----CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred HHHHHhhc-cC-----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 22221111 11 1224467889999999999999999999999999987654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=348.54 Aligned_cols=268 Identities=20% Similarity=0.320 Sum_probs=204.2
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHc-CCCCCCeeEEeeeeC----cee
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ-GGTGIPNVRWFGVEG----DYN 78 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~-~~~~i~~~~~~~~~~----~~~ 78 (407)
.+.++|++.+.||+|+||.||+|++. ++.||||++... .......|.+++..+. +|+++..+..++... ...
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 110 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT-EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc-ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence 45678999999999999999999964 899999998643 2344566666666542 457777776666655 688
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeccCCCCcccccCCCCCceEEEEe
Q 015406 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK--------SFLHRDIKPDNFLMGLGRRANQVYIID 149 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~--------~ivHrDLKp~NILl~~~~~~~~~kL~D 149 (407)
++||||+ +++|.+++.. ..+++..++.++.|++.||.|||++ ||+||||||+|||+ +.++.+||+|
T Consensus 111 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill---~~~~~~kl~D 185 (337)
T 3mdy_A 111 YLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIAD 185 (337)
T ss_dssp EEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEECC
T ss_pred EEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE---CCCCCEEEEe
Confidence 9999999 8899999975 4699999999999999999999998 99999999999999 5788999999
Q ss_pred ccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChh------hHHHHHHHHHHHHHhC----------CCCC
Q 015406 150 FGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRR------DDLESLGYVLMYFLRG----------SLPW 213 (407)
Q Consensus 150 FGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~------sDIwSlG~il~elltG----------~~Pf 213 (407)
||+++.+........ .......||+.|+|||++.+..++.. +|||||||++|||++| ..||
T Consensus 186 fg~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~ 262 (337)
T 3mdy_A 186 LGLAVKFISDTNEVD---IPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262 (337)
T ss_dssp CTTCEECC------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred CCCceeecccccccc---CCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence 999987654433211 11235679999999999988766554 9999999999999999 7788
Q ss_pred CCCCcCc-hHHHHHH-HhhhcccccHH--HHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCC
Q 015406 214 QGLKAGT-KKQKYEK-ISEKKVSTSIE--ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGF 282 (407)
Q Consensus 214 ~~~~~~~-~~~~~~~-i~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~ 282 (407)
....... ....... +.........+ .....+++++.+++.+||+.||++||++.++.+.|+.+......
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 335 (337)
T 3mdy_A 263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQDI 335 (337)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTTC
T ss_pred hhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhccc
Confidence 6643322 1122222 22211111111 11234678899999999999999999999999999999876654
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=342.77 Aligned_cols=254 Identities=19% Similarity=0.273 Sum_probs=205.1
Q ss_pred ccCCceeEeccccccCceEEEEEEEc-CCCeEEEEEEecCCC----CcchHHHHHHHHHHHc--CCCCCCeeEEeee---
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNI-QTNEEVAIKLENVKT----KHPQLLYESKLYRILQ--GGTGIPNVRWFGV--- 73 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~-~~~~~vAvK~~~~~~----~~~~~~~E~~~l~~l~--~~~~i~~~~~~~~--- 73 (407)
...++|++.+.||+|+||.||+|++. .+++.||||++.... ....+.+|+.+++.+. .|+++..+..++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 34688999999999999999999995 678999999876432 2346788999998885 4567777666554
Q ss_pred --eCceeEEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEec
Q 015406 74 --EGDYNVLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 150 (407)
Q Consensus 74 --~~~~~~lvme~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DF 150 (407)
.....++||||++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili---~~~~~~kl~Df 164 (326)
T 1blx_A 88 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADF 164 (326)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECSC
T ss_pred cCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEE---cCCCCEEEecC
Confidence 456789999999889999998643 349999999999999999999999999999999999999 57889999999
Q ss_pred cceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhh
Q 015406 151 GLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230 (407)
Q Consensus 151 Gla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~ 230 (407)
|+++....... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+... ...+..+..
T Consensus 165 g~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~i~~ 233 (326)
T 1blx_A 165 GLARIYSFQMA--------LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---VDQLGKILD 233 (326)
T ss_dssp CSCCCCCGGGG--------GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHH
T ss_pred cccccccCCCC--------ccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHH
Confidence 99986543221 2356789999999999999999999999999999999999999987543 233333322
Q ss_pred hc----------------------ccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 231 KK----------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 231 ~~----------------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.. .......+...+++++.+||.+||+.||++||++.++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 234 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp HHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 10 011223445678999999999999999999999877753
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=337.44 Aligned_cols=252 Identities=18% Similarity=0.204 Sum_probs=210.1
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-----------cchHHHHHHHHHHHcCCCCCCeeEEee
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----------HPQLLYESKLYRILQGGTGIPNVRWFG 72 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-----------~~~~~~E~~~l~~l~~~~~i~~~~~~~ 72 (407)
.+.++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+|+.+++.+.+|++++.+..++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 356899999999999999999999999999999999875431 234678999999998678888888888
Q ss_pred eeCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEecc
Q 015406 73 VEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 151 (407)
Q Consensus 73 ~~~~~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFG 151 (407)
......++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg 169 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFG 169 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCT
T ss_pred ccCCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---cCCCcEEEeccc
Confidence 8889999999999 8899999986 3579999999999999999999999999999999999999 578899999999
Q ss_pred ceeeeccCCCCcccCccCCCCcccccccccccccc------CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHH
Q 015406 152 LAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL------GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY 225 (407)
Q Consensus 152 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~ 225 (407)
++........ .....||+.|+|||++. ...++.++||||||+++|+|++|..||..... ....
T Consensus 170 ~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~ 238 (298)
T 1phk_A 170 FSCQLDPGEK--------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ---MLML 238 (298)
T ss_dssp TCEECCTTCC--------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH
T ss_pred chhhcCCCcc--------cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH---HHHH
Confidence 9987654332 23457899999999985 45688999999999999999999999976433 3444
Q ss_pred HHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 226 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 226 ~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
..+......... .....+++++.+++.+||+.||++||++.++++
T Consensus 239 ~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 239 RMIMSGNYQFGS-PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHHTCCCCCT-TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHhcCCcccCc-ccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 444443332221 223468999999999999999999999887754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=365.03 Aligned_cols=255 Identities=21% Similarity=0.356 Sum_probs=202.5
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEec
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~ 84 (407)
.++|++.++||+|+||.||+|.+.. +..||||+++.... .+.+.+|+.+++.++| ++++.+..+... +..++||||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRH-EKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCC-TTBCCEEEEECS-SSCEEEECC
T ss_pred hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCC-CCEeeEEEEEcC-CceEEEehh
Confidence 4679999999999999999999854 56799999876443 3568999999999987 455555555544 567999999
Q ss_pred c-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 85 L-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 85 ~-g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~- 335 (452)
T 1fmk_A 260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEY- 335 (452)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC--------
T ss_pred hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEE---CCCCCEEECCCccceecCCCce-
Confidence 9 89999999743 3469999999999999999999999999999999999999 5788999999999987654321
Q ss_pred cccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHHh
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (407)
.......++..|+|||++.+..++.++|||||||+||||++ |..||.+... .+....+...... ...
T Consensus 336 -----~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~---~~~~~~i~~~~~~----~~~ 403 (452)
T 1fmk_A 336 -----TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQVERGYRM----PCP 403 (452)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCCC----CCC
T ss_pred -----ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC----CCC
Confidence 11234457889999999998899999999999999999999 9999987543 3344444333211 123
Q ss_pred cCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHH
Q 015406 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (407)
Q Consensus 242 ~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~ 279 (407)
..+|+++.++|.+||+.||++||++++|.+.|++++..
T Consensus 404 ~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 404 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 46899999999999999999999999999999887543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=348.30 Aligned_cols=249 Identities=23% Similarity=0.305 Sum_probs=209.0
Q ss_pred CccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCce
Q 015406 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (407)
Q Consensus 3 ~~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 77 (407)
+...++|.+.+.||+|+||.||+|++..+++.||+|++..... ...+.+|+.+++.+.| ++++.+..++.+.+.
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~ 115 (335)
T 2owb_A 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH-QHVVGFHGFFEDNDF 115 (335)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSE
T ss_pred cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEecCCe
Confidence 4567899999999999999999999999999999998765422 2347789999999976 677777778888889
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeee
Q 015406 78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~ 156 (407)
.|+||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 116 ~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~~ 191 (335)
T 2owb_A 116 VFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKV 191 (335)
T ss_dssp EEEEECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred EEEEEecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEE---cCCCCEEEeeccCceec
Confidence 99999999 8999999876 3579999999999999999999999999999999999999 57889999999999876
Q ss_pred ccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhccccc
Q 015406 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (407)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (407)
...... .....||+.|+|||++.+..++.++||||||+++|+|++|..||..... .+.+..+......
T Consensus 192 ~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~-- 259 (335)
T 2owb_A 192 EYDGER-------KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---KETYLRIKKNEYS-- 259 (335)
T ss_dssp CSTTCC-------BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHHTCCC--
T ss_pred ccCccc-------ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH---HHHHHHHhcCCCC--
Confidence 543221 2356799999999999999999999999999999999999999976432 3344444433322
Q ss_pred HHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 237 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
+...+++++.++|.+||+.||++||++.++++
T Consensus 260 ---~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 260 ---IPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ---CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 23457899999999999999999999877654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=338.92 Aligned_cols=250 Identities=23% Similarity=0.308 Sum_probs=209.7
Q ss_pred CCccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCc
Q 015406 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGD 76 (407)
Q Consensus 2 ~~~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 76 (407)
++...++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+|+.+++.+.| ++++.+..++...+
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~ 88 (294)
T 2rku_A 10 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH-QHVVGFHGFFEDND 88 (294)
T ss_dssp ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCC-TTBCCEEEEEECSS
T ss_pred CCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCC-CCEeeeeeeeccCC
Confidence 35678899999999999999999999999999999998765422 2347789999999975 67777777788888
Q ss_pred eeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceee
Q 015406 77 YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (407)
Q Consensus 77 ~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~ 155 (407)
..++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 89 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~ 164 (294)
T 2rku_A 89 FVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATK 164 (294)
T ss_dssp EEEEEEECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred EEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEE---cCCCCEEEEeccCcee
Confidence 999999999 8999999876 3579999999999999999999999999999999999999 5788999999999987
Q ss_pred eccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccc
Q 015406 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (407)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (407)
....... .....||+.|+|||++.+..++.++||||||+++|+|++|..||..... .+.+..+......
T Consensus 165 ~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~- 233 (294)
T 2rku_A 165 VEYDGER-------KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---KETYLRIKKNEYS- 233 (294)
T ss_dssp CCSTTCC-------BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHTTCCC-
T ss_pred cccCccc-------cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhhccCC-
Confidence 6543221 2345789999999999998999999999999999999999999976433 3444444433322
Q ss_pred cHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
+...+++++.+++.+||+.||++||+++++++
T Consensus 234 ----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 234 ----IPKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ----CccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 23467899999999999999999999877754
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=347.97 Aligned_cols=253 Identities=23% Similarity=0.309 Sum_probs=201.3
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC----------CcchHHHHHHHHHHHcCCCCCCeeEEeeee
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----------KHPQLLYESKLYRILQGGTGIPNVRWFGVE 74 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~----------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~ 74 (407)
+.++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+|+.+++.++| +++..+..+...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~ 86 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH-PCIIKIKNFFDA 86 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCC-TTBCCEEEEEES
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCC-CCCceEeeEEcC
Confidence 4578999999999999999999999999999999876432 12347899999999976 555556555554
Q ss_pred CceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccce
Q 015406 75 GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (407)
Q Consensus 75 ~~~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla 153 (407)
.. .|+||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+..+||+|||++
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred Cc-eEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 44 79999999 8899998874 457999999999999999999999999999999999999964444556999999999
Q ss_pred eeeccCCCCcccCccCCCCcccccccccccccc---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhh
Q 015406 154 KKYRDTSTHQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230 (407)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~ 230 (407)
+....... .....||+.|+|||++. +..++.++|||||||++|+|++|..||........ ....+..
T Consensus 165 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~ 234 (322)
T 2ycf_A 165 KILGETSL--------MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQITS 234 (322)
T ss_dssp EECCCCHH--------HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHHHH
T ss_pred eecccccc--------cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHHHh
Confidence 87644221 12456899999999974 56789999999999999999999999976544321 2222222
Q ss_pred hcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 231 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
... ...+.....+++++.++|.+||..||++||++.++++
T Consensus 235 ~~~-~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 235 GKY-NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp TCC-CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred Ccc-ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 222 2234455678999999999999999999999887753
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=338.79 Aligned_cols=256 Identities=24% Similarity=0.338 Sum_probs=207.5
Q ss_pred CCCccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCce
Q 015406 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (407)
Q Consensus 1 m~~~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 77 (407)
|...+.++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+|+.+++.++| +++..+..++...+.
T Consensus 1 M~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~ 79 (276)
T 2yex_A 1 MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-ENVVKFYGHRREGNI 79 (276)
T ss_dssp -CHHHHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCC-TTBCCEEEEEEETTE
T ss_pred CCCceecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCC-CCceeeeeEEEcCCE
Confidence 444566889999999999999999999999999999999864432 2457889999998876 677777778888889
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeee
Q 015406 78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~ 156 (407)
.++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++..+
T Consensus 80 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~ 155 (276)
T 2yex_A 80 QYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVF 155 (276)
T ss_dssp EEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred EEEEEEecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEE---ccCCCEEEeeCCCcccc
Confidence 99999999 7899999874 4569999999999999999999999999999999999999 57889999999999876
Q ss_pred ccCCCCcccCccCCCCccccccccccccccCCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccc
Q 015406 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (407)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (407)
...... .......||+.|+|||++.+..+ +.++||||||+++|+|++|..||....... ..+..+.......
T Consensus 156 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~ 228 (276)
T 2yex_A 156 RYNNRE-----RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--QEYSDWKEKKTYL 228 (276)
T ss_dssp EETTEE-----CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS--HHHHHHHTTCTTS
T ss_pred CCCcch-----hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH--HHHHHhhhccccc
Confidence 543221 11235678999999999988775 789999999999999999999998754432 2222222221111
Q ss_pred cHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.....+++++.++|.+||+.||++||++.++++
T Consensus 229 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 229 ---NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp ---TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 123458999999999999999999999887754
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=350.52 Aligned_cols=258 Identities=22% Similarity=0.328 Sum_probs=201.9
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCC-------CCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCce
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-------TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 77 (407)
+.++|++.+.||+|+||.||+|++..+++.||+|++... .....+.+|+.+++.++| ++++.+..++.+.+.
T Consensus 24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~ 102 (345)
T 3hko_A 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH-PNIARLYEVYEDEQY 102 (345)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSE
T ss_pred hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCC-CCcceeehhhccCCe
Confidence 357899999999999999999999999999999987532 223458889999999975 777777788888889
Q ss_pred eEEEEecc-CCCHHHHHHHc---------------------------------------CCCCCHHHHHHHHHHHHHHHH
Q 015406 78 NVLVMDLL-GPSLEDLFNFC---------------------------------------SRKLSLKTVLMLADQMINRVE 117 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~~~---------------------------------------~~~l~~~~~~~i~~qi~~aL~ 117 (407)
.++||||+ +++|.+++... ...+++..++.++.||+.||+
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 99999999 99999988411 112467889999999999999
Q ss_pred HHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccC--CCCChhhH
Q 015406 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDD 195 (407)
Q Consensus 118 yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~sD 195 (407)
|||++||+||||||+|||++. +....+||+|||+++.+....... ........||+.|+|||++.+ ..++.++|
T Consensus 183 ~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~Dfg~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 183 YLHNQGICHRDIKPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGE---YYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHTTEECCCCCGGGEEESC-SSSCCEEECCCTTCEEGGGTTCC-----------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHCCccccCCChhhEEEec-CCCceEEEeeccccccccccCccc---cccccccCCCccccCchhhccCCCCCCcHHH
Confidence 999999999999999999941 122389999999999765433211 112345679999999999975 67899999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 196 LESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 196 IwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
||||||++|||++|..||.+... .+....+......... .....+++++.++|.+||+.||++||++.++++
T Consensus 259 iwslG~il~el~~g~~pf~~~~~---~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVND---ADTISQVLNKKLCFEN-PNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCCTTS-GGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred HHHHHHHHHHHHHCCCCCCCCCh---HHHHHHHHhcccccCC-cccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 99999999999999999987543 3444444443332211 223457899999999999999999999777643
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=348.99 Aligned_cols=249 Identities=19% Similarity=0.255 Sum_probs=188.2
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc----chHHHHHHHHHHHcCCCCCCeeEEeeeeC-----
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEG----- 75 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~----- 75 (407)
+.++|++.+.||+|+||.||+|++..+++.||||++...... ..+.+|+.+++.++| ++++.+..++...
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH-KNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCC-TTBCCEEEEECSCCSTTT
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCC-CCccceEEeecccccccc
Confidence 457899999999999999999999999999999998754322 347789999999987 4555554444332
Q ss_pred -ceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEecccee
Q 015406 76 -DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (407)
Q Consensus 76 -~~~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~ 154 (407)
...|+||||++++|.+++. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 102 ~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 102 FQDVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 175 (371)
T ss_dssp CCEEEEEEECCSEEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCCCC--
T ss_pred ccceEEEEEcCCCCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEEEeeccc
Confidence 3789999999889999886 369999999999999999999999999999999999999 578899999999998
Q ss_pred eeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhccc
Q 015406 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (407)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (407)
....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+. .+.+..+......
T Consensus 176 ~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~ 244 (371)
T 2xrw_A 176 TAGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH---IDQWNKVIEQLGT 244 (371)
T ss_dssp ----------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHC-CCC
T ss_pred ccccccc--------cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCC
Confidence 6643321 2356799999999999999999999999999999999999999987443 3333333221111
Q ss_pred ccH-------------------------HHH------------hcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 235 TSI-------------------------EAL------------CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 235 ~~~-------------------------~~~------------~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
+.. ..+ ....++++.+||.+||..||++|||++++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 245 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp CCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 000 000 0112578999999999999999999776643
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=336.07 Aligned_cols=246 Identities=18% Similarity=0.258 Sum_probs=207.1
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCC-----CCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCcee
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 78 (407)
...++|++.+.||+|+||.||+|++..+++.||||++... .....+.+|+.+++.++| ++++.+..++...+..
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~ 89 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH-PNILRMYNYFHDRKRI 89 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSEE
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCC-CCEeeEEEEEEcCCEE
Confidence 3457899999999999999999999999999999987532 233568889999999976 6677777777888899
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeec
Q 015406 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~ 157 (407)
++||||+ +++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 90 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLM---GYKGELKIADFGWSVHAP 165 (284)
T ss_dssp EEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECS
T ss_pred EEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---cCCCCEEEecccccccCc
Confidence 9999999 88999999864 469999999999999999999999999999999999999 578899999999997654
Q ss_pred cCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccH
Q 015406 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (407)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (407)
... .....||+.|+|||++.+..++.++||||||+++|+|++|..||..... ......+......
T Consensus 166 ~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~--- 230 (284)
T 2vgo_A 166 SLR---------RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH---TETHRRIVNVDLK--- 230 (284)
T ss_dssp SSC---------BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHTTCCC---
T ss_pred ccc---------cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH---hHHHHHHhccccC---
Confidence 322 2355789999999999999999999999999999999999999976432 3334444333221
Q ss_pred HHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 238 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
+...+++++.++|.+||..||++||++.++.+
T Consensus 231 --~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 231 --FPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp --CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 23457899999999999999999999877754
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=345.64 Aligned_cols=262 Identities=19% Similarity=0.219 Sum_probs=201.8
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeee-----C
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVE-----G 75 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~-----~ 75 (407)
.+.++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+|+.+++.++| ++++.+..+... .
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKH-ENIITIFNIQRPDSFENF 86 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCC-TTBCCEEEECCCSCSTTC
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcC-CCcCCeeeeecccccCcc
Confidence 467899999999999999999999999999999999864332 2346789999999986 555555544433 3
Q ss_pred ceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceee
Q 015406 76 DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (407)
Q Consensus 76 ~~~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~ 155 (407)
...++||||++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 87 ~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 87 NEVYIIQELMQTDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDFGLARI 161 (353)
T ss_dssp CCEEEEECCCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred ceEEEEEeccCccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---cCCCcEEEEecccccc
Confidence 67899999998899999985 479999999999999999999999999999999999999 5788999999999987
Q ss_pred eccCCCCcccC---ccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhh
Q 015406 156 YRDTSTHQHIP---YRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 231 (407)
Q Consensus 156 ~~~~~~~~~~~---~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~ 231 (407)
..........+ ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence 65432211100 011234578999999998765 67899999999999999999999999875432221111111100
Q ss_pred ------------------------cccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 232 ------------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 232 ------------------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
............+++++.++|.+||..||++||++.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0112233445678999999999999999999999887754
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=342.23 Aligned_cols=259 Identities=19% Similarity=0.329 Sum_probs=197.8
Q ss_pred CCceeEeccccccCceEEEEEEEcC---CCeEEEEEEecCCCCc----chHHHHHHHHHHHcCCCCCCeeEEeeeeCc--
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQ---TNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGD-- 76 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~---~~~~vAvK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~-- 76 (407)
.++|++.+.||+|+||.||+|++.. +++.||||++...... ..+.+|+.+++.++|+ ++..+..++....
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHP-NVIRLLGVCIEMSSQ 111 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCT-TBCCCCEEEEC----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCC-CeeeeeEEEeecccc
Confidence 5789999999999999999998765 5668999998755433 3478899999999875 4545444443322
Q ss_pred ---eeEEEEecc-CCCHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEE
Q 015406 77 ---YNVLVMDLL-GPSLEDLFNFC-----SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI 147 (407)
Q Consensus 77 ---~~~lvme~~-g~sL~~~l~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL 147 (407)
..++||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli---~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML---RDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEE---CTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCcEEE
Confidence 459999999 88999998532 3469999999999999999999999999999999999999 57889999
Q ss_pred EeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHH
Q 015406 148 IDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYE 226 (407)
Q Consensus 148 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~ 226 (407)
+|||+++....... ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+..... ...
T Consensus 189 ~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~ 260 (313)
T 3brb_A 189 ADFGLSKKIYSGDY-----YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---MYD 260 (313)
T ss_dssp CSCSCC---------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHH
T ss_pred eecCcceecccccc-----cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HHH
Confidence 99999987654322 112234567889999999999999999999999999999999 999998755433 333
Q ss_pred HHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHc
Q 015406 227 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (407)
Q Consensus 227 ~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~ 280 (407)
.+...... .....+++++.+++.+||..||++||++.+|.+.|++++...
T Consensus 261 ~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 261 YLLHGHRL----KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp HHHTTCCC----CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHcCCCC----CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 33332221 123568899999999999999999999999999999988654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=345.56 Aligned_cols=267 Identities=20% Similarity=0.229 Sum_probs=206.5
Q ss_pred ccCCce-eEeccccccCceEEEEEEE----cCCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeee-
Q 015406 4 RVGNKF-RLGRKIGSGSFGEIYLGTN----IQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVE- 74 (407)
Q Consensus 4 ~~~~~y-~i~~~iG~G~~g~Vy~~~~----~~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~- 74 (407)
.+.++| +++++||+|+||.||++.. ..+++.||||++..... ...+.+|+++++.++| ++++.+..++..
T Consensus 27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~ 105 (318)
T 3lxp_A 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYH-EHIIKYKGCCEDA 105 (318)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEET
T ss_pred eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCC-cchhhEEEEEecC
Confidence 456666 9999999999999988764 35789999999876543 2347899999999996 556666555554
Q ss_pred -CceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccc
Q 015406 75 -GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 152 (407)
Q Consensus 75 -~~~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGl 152 (407)
....++||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~ 180 (318)
T 3lxp_A 106 GAASLQLVMEYVPLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLL---DNDRLVKIGDFGL 180 (318)
T ss_dssp TTTEEEEEECCCTTCBHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCGGG
T ss_pred CCceEEEEEecccCCcHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---cCCCCEEECCccc
Confidence 46789999999 8899999974 459999999999999999999999999999999999999 5788999999999
Q ss_pred eeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCc--------hHHH
Q 015406 153 AKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT--------KKQK 224 (407)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~--------~~~~ 224 (407)
++......... .......||..|+|||++.+..++.++||||||+++|+|++|..||....... ....
T Consensus 181 a~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 256 (318)
T 3lxp_A 181 AKAVPEGHEYY----RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMT 256 (318)
T ss_dssp CEECCTTCSEE----EC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHH
T ss_pred ccccccccccc----ccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchh
Confidence 99876543211 12334568889999999999899999999999999999999999996521100 0000
Q ss_pred HHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHc
Q 015406 225 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (407)
Q Consensus 225 ~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~ 280 (407)
...+...............+++++.+||.+||+.||++||++.++.+.|+.+..+.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 257 VLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 00111100001111223568999999999999999999999999999999987654
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=339.38 Aligned_cols=247 Identities=22% Similarity=0.332 Sum_probs=207.6
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
..+.|++.+.||+|+||.||+|++..+++.||||++..... ...+.+|+.+++.+.| +++..+..++......++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCC-CCEeEEEEEEecCCeEEEE
Confidence 34679999999999999999999999999999999875432 3458889999999976 6777777777888899999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 82 me~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
|||+ +++|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 99 ~e~~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 99 MEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp EECCTTEEHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECBTTB
T ss_pred EEeCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEE---CCCCCEEEeecccceecCccc
Confidence 9999 789999997 4579999999999999999999999999999999999999 578899999999998765432
Q ss_pred CCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHH
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (407)
. ......||+.|+|||++.+..++.++||||||+++|+|++|..||..... ......+..... ..+
T Consensus 174 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~----~~~ 239 (303)
T 3a7i_A 174 I-------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP---MKVLFLIPKNNP----PTL 239 (303)
T ss_dssp C-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSCC----CCC
T ss_pred c-------ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH---HHHHHHhhcCCC----CCC
Confidence 2 12356789999999999999999999999999999999999999976433 233333332221 123
Q ss_pred hcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 241 ~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
...++.++.+++.+||..||++||++.++++
T Consensus 240 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 240 EGNYSKPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ccccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 4568999999999999999999999888764
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=343.65 Aligned_cols=255 Identities=22% Similarity=0.259 Sum_probs=199.3
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc----chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
..++|++.+.||+|+||.||+|++..+++.||||++...... ..+.+|+.+++.++| ++++.+..++...+..++
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRH-ENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCC-CCEeeEEEEeecCCEEEE
Confidence 357899999999999999999999999999999987654433 236789999999986 677777778888899999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 81 vme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 102 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 102 VFEFVDHTILDDLELF-PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp EEECCSEEHHHHHHHS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCTTC------
T ss_pred EEecCCcchHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEE---cCCCcEEEEeCCCceeecCC
Confidence 99999 6666666553 5579999999999999999999999999999999999999 57889999999999866543
Q ss_pred CCCcccCccCCCCccccccccccccccCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhh-------
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK------- 231 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~------- 231 (407)
... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+................
T Consensus 178 ~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (331)
T 4aaa_A 178 GEV-------YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQE 250 (331)
T ss_dssp -------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccc-------cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Confidence 221 2345789999999999875 6899999999999999999999999875432222111111100
Q ss_pred ----------------cccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 232 ----------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 232 ----------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
..........+.+++++.+||.+||+.||++||++.++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 251 LFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred HhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0112223334568999999999999999999999887754
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=340.66 Aligned_cols=252 Identities=20% Similarity=0.340 Sum_probs=199.2
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-CcchHHHHHHHHHHHcCCCCCCeeEEeeee------Cc
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVE------GD 76 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~------~~ 76 (407)
...++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+|+.+++.+.+|++++.+..++.. ..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 100 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 100 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence 35689999999999999999999999999999999986543 345688999999999767778777766654 56
Q ss_pred eeEEEEecc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEecccee
Q 015406 77 YNVLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (407)
Q Consensus 77 ~~~lvme~~-g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~ 154 (407)
..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~ 177 (326)
T 2x7f_A 101 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSA 177 (326)
T ss_dssp EEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEEECCCTTTC
T ss_pred eEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEE---cCCCCEEEeeCcCce
Confidence 789999999 779999998642 469999999999999999999999999999999999999 578899999999998
Q ss_pred eeccCCCCcccCccCCCCcccccccccccccc-----CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHh
Q 015406 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 229 (407)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~ 229 (407)
....... ......||+.|+|||++. +..++.++|||||||++|+|++|..||.+... ......+.
T Consensus 178 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~ 247 (326)
T 2x7f_A 178 QLDRTVG-------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP---MRALFLIP 247 (326)
T ss_dssp --------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHH
T ss_pred ecCcCcc-------ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH---HHHHHHhh
Confidence 6643221 123457899999999997 56689999999999999999999999976433 23333333
Q ss_pred hhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 230 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
...... .....+++++.++|.+||..||++||++.++++
T Consensus 248 ~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 248 RNPAPR---LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HSCCCC---CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cCcccc---CCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 222211 113457899999999999999999999887754
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=337.68 Aligned_cols=252 Identities=18% Similarity=0.268 Sum_probs=188.6
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcc---hHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP---QLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~---~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
...++|++.+.||+|+||.||+|++..+++.||||++....... ....|...+....+|+++..+..++...+..++
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 34588999999999999999999999999999999987543322 233333333333456788888888888888999
Q ss_pred EEeccCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcccccCCCCCceEEEEeccceeee
Q 015406 81 VMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (407)
Q Consensus 81 vme~~g~sL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~-~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~ 156 (407)
||||++++|.+++.. ....+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||+++..
T Consensus 84 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 84 CMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLI---NALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEE---CTTCCEEBCCC------
T ss_pred EEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeecCCcccc
Confidence 999998899888764 346799999999999999999999998 99999999999999 57889999999999876
Q ss_pred ccCCCCcccCccCCCCccccccccccccc----cCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhc
Q 015406 157 RDTSTHQHIPYRENKNLTGTARYASMNTH----LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (407)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~----~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (407)
..... .....||+.|+|||++ .+..++.++||||||+++|+|++|..||..... ....+.......
T Consensus 161 ~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~ 230 (290)
T 3fme_A 161 VDDVA--------KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT--PFQQLKQVVEEP 230 (290)
T ss_dssp -----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC--HHHHHHHHHHSC
T ss_pred ccccc--------ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc--hHHHHHHHhccC
Confidence 54332 2344789999999996 566789999999999999999999999975332 223333333222
Q ss_pred ccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 233 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 233 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.... ....+++++.+++.+||+.||++||++.++++
T Consensus 231 ~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 231 SPQL---PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CCCC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCc---ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 2111 12458899999999999999999999888764
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=341.07 Aligned_cols=257 Identities=19% Similarity=0.267 Sum_probs=196.5
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC--cchHHHHHHHHHHHcCCCCCCeeEEee---------
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFG--------- 72 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~--------- 72 (407)
.++++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+|+.+++.++|++.+..+..+.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 468899999999999999999999999999999998865432 245788999999998755444444332
Q ss_pred ----eeCceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEE
Q 015406 73 ----VEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 148 (407)
Q Consensus 73 ----~~~~~~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~ 148 (407)
......++||||++++|.+++. .+.+++..++.++.||+.||+|||++||+||||||+|||++ ..++.+||+
T Consensus 88 ~~~~~~~~~~~lv~e~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~~~~kl~ 163 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYMETDLANVLE--QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFIN--TEDLVLKIG 163 (320)
T ss_dssp ---CCSCSEEEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE--TTTTEEEEC
T ss_pred cccccccCceeEEeeccCCCHHHHhh--cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc--CCCCeEEEc
Confidence 3456789999999889999997 45799999999999999999999999999999999999994 356799999
Q ss_pred eccceeeeccCCCCcccCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHH
Q 015406 149 DFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK 227 (407)
Q Consensus 149 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~ 227 (407)
|||+++......... .......+|..|+|||.+.+ ..++.++||||||+++|||++|..||.+... .+.+..
T Consensus 164 Dfg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---~~~~~~ 236 (320)
T 2i6l_A 164 DFGLARIMDPHYSHK----GHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE---LEQMQL 236 (320)
T ss_dssp CCTTCBCC------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHH
T ss_pred cCccccccCCCcccc----cccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH---HHHHHH
Confidence 999998764322111 11234567999999999876 6789999999999999999999999987543 222222
Q ss_pred Hhhhc-------------------------ccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 228 ISEKK-------------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 228 i~~~~-------------------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
+.... .......+...+++++.++|.+||+.||++||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 237 ILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 22211 112233455678999999999999999999999877753
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=338.69 Aligned_cols=248 Identities=23% Similarity=0.313 Sum_probs=184.2
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCC-----CCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeE
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 79 (407)
..++|++.+.||+|+||.||+|++..+++.||||++... .....+.+|+.+++.++| ++++.+..++...+..+
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~ 87 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH-PSILELYNYFEDSNYVY 87 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCC-TTBCCEEEEEECSSEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCC-CCeEeEEEEEccCCeEE
Confidence 346799999999999999999999999999999987543 223567889999999876 67777777778888999
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 80 lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
+||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 88 LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLL---TRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEE---CTTCCEEECCCTTCEECC-
T ss_pred EEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEEeecceeeccC
Confidence 999999 889999998655679999999999999999999999999999999999999 5788999999999987653
Q ss_pred CCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHH
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (407)
.... .....||+.|+|||++.+..++.++||||||+++|+|++|..||...... ..+..+.....
T Consensus 165 ~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~----- 229 (278)
T 3cok_A 165 PHEK-------HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK---NTLNKVVLADY----- 229 (278)
T ss_dssp ----------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------CCSSCC-----
T ss_pred CCCc-------ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHH---HHHHHHhhccc-----
Confidence 3221 23457899999999999989999999999999999999999999765432 12222211111
Q ss_pred HHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 239 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.....++.++.++|.+||..||++||+++++++
T Consensus 230 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 230 EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 123457899999999999999999999887754
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=348.69 Aligned_cols=247 Identities=20% Similarity=0.282 Sum_probs=195.4
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc----chHHHHHHHHHHHcCCCCCCeeEEeeeeCce---
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDY--- 77 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~--- 77 (407)
+.++|.+.+.||+|+||.||+|++..+++.||||++...... ..+.+|+.+++.++|+ +++.+..++.....
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~ 118 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHE-NVIGLLDVFTPASSLRN 118 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCT-TBCCCSEEECSCSSSTT
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCC-CchhhhhheeccCCccc
Confidence 568999999999999999999999999999999998754332 3477899999999875 45554444443332
Q ss_pred ---eEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEecccee
Q 015406 78 ---NVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (407)
Q Consensus 78 ---~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~ 154 (407)
.|+||||++++|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 119 ~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 119 FYDFYLVMPFMQTDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLAR 192 (371)
T ss_dssp CCCCEEEEECCCEEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECSTTCC-
T ss_pred ceeEEEEEccccccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEE---CCCCCEEEEecCccc
Confidence 39999999889888774 459999999999999999999999999999999999999 678899999999998
Q ss_pred eeccCCCCcccCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhc-
Q 015406 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK- 232 (407)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~- 232 (407)
...... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.... +.+..+....
T Consensus 193 ~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~ 259 (371)
T 4exu_A 193 HADAEM----------TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKVTG 259 (371)
T ss_dssp -----------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHC
T ss_pred ccccCc----------CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhC
Confidence 654332 35678999999999987 67899999999999999999999999875432 2222222110
Q ss_pred -------------------------ccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 233 -------------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 233 -------------------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.......+...+++++.+||.+||+.||++||++.++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 260 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp CCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 112223344567999999999999999999999877653
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=350.08 Aligned_cols=251 Identities=19% Similarity=0.276 Sum_probs=202.5
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
...++|++.+.||+|+||.||+|++..+++.||+|++...... ..+.+|+.+++.++| ++++.+..++...+..++
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~l 108 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS-PYIVGFYGAFYSDGEISI 108 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCC-TTBCCEEEEEEETTEEEE
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCC-CCEEEEeEEEEECCEEEE
Confidence 4568899999999999999999999999999999998765332 347889999998875 777777778888889999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 81 vme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
||||+ +++|.+++... ..+++..+..++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||++.....
T Consensus 109 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp EECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHHHH
T ss_pred EEECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEE---CCCCCEEEEECCCCccccc
Confidence 99999 88999999864 4699999999999999999999996 99999999999999 5788999999999976543
Q ss_pred CCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHH-------------
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY------------- 225 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~------------- 225 (407)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+
T Consensus 185 ~~---------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (360)
T 3eqc_A 185 SM---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 255 (360)
T ss_dssp HC-------------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------
T ss_pred cc---------ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCC
Confidence 22 23457899999999999999999999999999999999999999764432211111
Q ss_pred --------------------------HHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 226 --------------------------EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 226 --------------------------~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
..+....... .....++.++.+||.+||..||++|||++++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 256 RPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPK---LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ------------------CCCHHHHHHHHHHSCCCC---CCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CcccCCCcccccccCCCCcccchhhhhHHhccCCCC---CCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 1111111000 011246889999999999999999999887753
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=333.70 Aligned_cols=248 Identities=12% Similarity=0.170 Sum_probs=201.7
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc----chHHHHHHHHHHHcCCCCCCeeEEeeeeC--ceeE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEG--DYNV 79 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~--~~~~ 79 (407)
.++|++.+.||+|+||.||+|++ .++.||||++...... ..+.+|+.+++.++| +++..+..++... ...+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~ 85 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH-PNVLPVLGACQSPPAPHPT 85 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSC-TTEECEEEEECTTTSSSCE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCC-CchhheEEEEccCCCCCeE
Confidence 57899999999999999999996 4889999998765432 347788888888876 5566665655544 7789
Q ss_pred EEEecc-CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcccccCCCCCceEEEEeccceee
Q 015406 80 LVMDLL-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (407)
Q Consensus 80 lvme~~-g~sL~~~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~--ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~ 155 (407)
+||||+ +++|.+++..... .+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.++|+|||++..
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~---~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 86 LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMI---DEDMTARISMADVKFS 162 (271)
T ss_dssp EEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEE---CTTSCEEEEGGGSCCT
T ss_pred eeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEE---cCCcceeEEeccceee
Confidence 999999 8899999985433 4899999999999999999999999 9999999999999 5788999999998754
Q ss_pred eccCCCCcccCccCCCCccccccccccccccCCCCC---hhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhc
Q 015406 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQS---RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (407)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~---~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (407)
.. .....||+.|+|||++.+..++ .++||||||+++|||++|..||.+... ......+....
T Consensus 163 ~~------------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~ 227 (271)
T 3kmu_A 163 FQ------------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN---MEIGMKVALEG 227 (271)
T ss_dssp TS------------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH---HHHHHHHHHSC
T ss_pred ec------------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh---HHHHHHHHhcC
Confidence 22 2245789999999999876554 489999999999999999999987543 33333333222
Q ss_pred ccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHH
Q 015406 233 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (407)
Q Consensus 233 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~ 277 (407)
... .+...+++++.+++.+||+.||++||++.++.+.|+++.
T Consensus 228 ~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 228 LRP---TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 221 233568999999999999999999999999999998863
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=341.52 Aligned_cols=243 Identities=23% Similarity=0.353 Sum_probs=204.5
Q ss_pred CccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC--------CcchHHHHHHHHHHHcC-CCCCCeeEEeee
Q 015406 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--------KHPQLLYESKLYRILQG-GTGIPNVRWFGV 73 (407)
Q Consensus 3 ~~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--------~~~~~~~E~~~l~~l~~-~~~i~~~~~~~~ 73 (407)
..+.++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+|+.+++.+.+ ++++..+..++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 356789999999999999999999999999999999876542 22457889999999985 688888888888
Q ss_pred eCceeEEEEecc-C-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEecc
Q 015406 74 EGDYNVLVMDLL-G-PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 151 (407)
Q Consensus 74 ~~~~~~lvme~~-g-~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFG 151 (407)
..+..++|||++ + ++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++ ..++.+||+|||
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~--~~~~~~kL~Dfg 195 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFG 195 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCCT
T ss_pred cCCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEe--CCCCCEEEeeCc
Confidence 888999999999 4 899999986 45799999999999999999999999999999999999994 267899999999
Q ss_pred ceeeeccCCCCcccCccCCCCccccccccccccccCCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhh
Q 015406 152 LAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230 (407)
Q Consensus 152 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~ 230 (407)
+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|..||.... .+..
T Consensus 196 ~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~---------~~~~ 257 (320)
T 3a99_A 196 SGALLKDTV---------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------EIIR 257 (320)
T ss_dssp TCEECCSSC---------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------HHHH
T ss_pred ccccccccc---------ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh---------hhhc
Confidence 998765432 234579999999999987666 788999999999999999999996521 1111
Q ss_pred hcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 231 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
... .+...+++++.++|.+||+.||++||++++|++
T Consensus 258 ~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 258 GQV-----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp CCC-----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ccc-----cccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111 123568999999999999999999999887754
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=332.16 Aligned_cols=247 Identities=21% Similarity=0.283 Sum_probs=198.2
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCC-----CCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCcee
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 78 (407)
...++|++.+.||+|+||.||+|++..+++.||||++... .....+.+|+.+++.++| +++..+..++...+..
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH-PHIIKLYQVISTPTDF 86 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSEE
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCC-CCEeEEEEEEecCCeE
Confidence 3458899999999999999999999999999999987542 233467889999999986 6677777777888899
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeec
Q 015406 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~ 157 (407)
++||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEE---CTTSCEEECCCCGGGCCC
T ss_pred EEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEE---CCCCCEEEeecccccccC
Confidence 9999999 88999999864 469999999999999999999999999999999999999 578899999999998664
Q ss_pred cCCCCcccCccCCCCccccccccccccccCCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhccccc
Q 015406 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (407)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (407)
.... .....||+.|+|||++.+..+ +.++||||||+++|+|++|..||.... ....+..+......
T Consensus 163 ~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~~-- 229 (276)
T 2h6d_A 163 DGEF--------LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH---VPTLFKKIRGGVFY-- 229 (276)
T ss_dssp C---------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCC--
T ss_pred CCcc--------eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHhhcCccc--
Confidence 4321 234578999999999998776 689999999999999999999997643 33444444433221
Q ss_pred HHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 237 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
+...++.++.+++.+||+.||++||++.++++
T Consensus 230 ---~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 230 ---IPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---CchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 23457899999999999999999999887754
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=336.05 Aligned_cols=253 Identities=21% Similarity=0.316 Sum_probs=208.1
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeE
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 79 (407)
.+.++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+|+++++.++| +++..+..++......+
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH-PNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccC-CCccEEEEEEeCCCeEE
Confidence 34678999999999999999999999999999999875432 33458899999999976 67777777778888999
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 80 lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
+||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+..+||+|||++.....
T Consensus 98 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp EEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred EEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence 999999 89999988753 4799999999999999999999999999999999999996444456899999999986544
Q ss_pred CCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHH
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (407)
... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.+... .+....+.........+
T Consensus 177 ~~~--------~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~ 244 (287)
T 2wei_A 177 NTK--------MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE---YDILKRVETGKYAFDLP 244 (287)
T ss_dssp CSS--------CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCCCCSG
T ss_pred CCc--------cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHcCCCCCCch
Confidence 322 234568999999999887 489999999999999999999999987443 34444444443322221
Q ss_pred HHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 239 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
....+++++.++|.+||..||++||++.++++
T Consensus 245 -~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 245 -QWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp -GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -hhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 23568999999999999999999999888764
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=356.29 Aligned_cols=250 Identities=16% Similarity=0.128 Sum_probs=187.0
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-----cchHHHHHHHHHHHcC-CCCCCe-eEE------eee
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQG-GTGIPN-VRW------FGV 73 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~~l~~l~~-~~~i~~-~~~------~~~ 73 (407)
.+|++.+.||+|+||.||+|++..+++.||||++..... ...+..|+.+++.|++ |+++.. +.. +..
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 359999999999999999999999999999999887543 2236678777777762 344333 211 111
Q ss_pred eC-----------------ceeEEEEeccCCCHHHHHHHcCCCCCHHHH------HHHHHHHHHHHHHHHhCCceeccCC
Q 015406 74 EG-----------------DYNVLVMDLLGPSLEDLFNFCSRKLSLKTV------LMLADQMINRVEFVHSKSFLHRDIK 130 (407)
Q Consensus 74 ~~-----------------~~~~lvme~~g~sL~~~l~~~~~~l~~~~~------~~i~~qi~~aL~yLH~~~ivHrDLK 130 (407)
.. ...||||||++++|.+++...+..+++..+ +.++.||+.||+|||++||+|||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDik 221 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT 221 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCC
Confidence 11 447999999999999999865445565566 7788999999999999999999999
Q ss_pred CCcccccCCCCCceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccC--CCCChhhHHHHHHHHHHHHHh
Q 015406 131 PDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLR 208 (407)
Q Consensus 131 p~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~sDIwSlG~il~ellt 208 (407)
|+|||+ +.++.+||+|||+|+...... ....+|+.|+|||++.+ ..++.++|||||||+||||++
T Consensus 222 p~NIll---~~~~~~kL~DFG~a~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 222 PDNLFI---MPDGRLMLGDVSALWKVGTRG----------PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp GGGEEE---CTTSCEEECCGGGEEETTCEE----------EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred HHHEEE---CCCCCEEEEecceeeecCCCc----------cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 999999 578899999999998664321 13456799999999988 779999999999999999999
Q ss_pred CCCCCCCCCcCchHHHHHHHh--hhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015406 209 GSLPWQGLKAGTKKQKYEKIS--EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 209 G~~Pf~~~~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
|..||.+....... .+.... ...........+..+++++.+||.+||+.||++||++.+++
T Consensus 289 g~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 351 (371)
T 3q60_A 289 LFLPFGLVTPGIKG-SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAM 351 (371)
T ss_dssp SSCSTTBCCTTCTT-CCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHT
T ss_pred CCCCCCCcCccccc-chhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 99999875332110 000000 00000111112356899999999999999999999988875
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=346.29 Aligned_cols=253 Identities=17% Similarity=0.193 Sum_probs=193.2
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc-------------chHHHHHHHHHHHcCCCCCCeeEE
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-------------PQLLYESKLYRILQGGTGIPNVRW 70 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~-------------~~~~~E~~~l~~l~~~~~i~~~~~ 70 (407)
.+.++|++.+.||+|+||.||+|.+. +++.||||++...... ..+.+|+.+++.++|++.+..+..
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 35789999999999999999999974 4899999987543221 457899999999987554444444
Q ss_pred eee----eCceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEE
Q 015406 71 FGV----EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY 146 (407)
Q Consensus 71 ~~~----~~~~~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~k 146 (407)
+.. .....|+||||++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+|
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~---~~~~~~k 174 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL---ADNNDIT 174 (362)
T ss_dssp EEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEE
T ss_pred EEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEE---cCCCCEE
Confidence 332 234689999999889999998656679999999999999999999999999999999999999 5788999
Q ss_pred EEeccceeeeccCCCCcccCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHH
Q 015406 147 IIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY 225 (407)
Q Consensus 147 L~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~ 225 (407)
|+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.... ..+
T Consensus 175 l~Dfg~~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~ 243 (362)
T 3pg1_A 175 ICDFNLAREDTADAN--------KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY---NQL 243 (362)
T ss_dssp ECCTTC-----------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHH
T ss_pred EEecCcccccccccc--------cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH---HHH
Confidence 999999985443322 235578999999999987 67899999999999999999999999875432 223
Q ss_pred HHHhhhc---------------------------ccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 226 EKISEKK---------------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 226 ~~i~~~~---------------------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
..+.... ...........+++.+.+||.+||+.||++||++.++++
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 244 NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 2222111 111223344567899999999999999999999877653
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=338.05 Aligned_cols=251 Identities=20% Similarity=0.284 Sum_probs=198.2
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc----chHHHHHHHHHHHcC-CCCCCeeEEeeeeCceeE
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQG-GTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----~~~~~E~~~l~~l~~-~~~i~~~~~~~~~~~~~~ 79 (407)
.+++|++.+.||+|+||.||+|++. +++.||||++...... ..+.+|+.+++.++| ++++..+..++......+
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 104 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence 4678999999999999999999974 5889999998754432 347889999999986 688888888888889999
Q ss_pred EEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 80 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 80 lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
+|||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.....
T Consensus 105 lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~----~~~~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 105 MVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPD 179 (313)
T ss_dssp EEECCCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSSCC----
T ss_pred EEEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE----CCeEEEeeccccccccCc
Confidence 9999779999999986 45799999999999999999999999999999999999993 488999999999876543
Q ss_pred CCCcccCccCCCCccccccccccccccC-----------CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHH
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLG-----------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----------~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i 228 (407)
... .......||+.|+|||++.+ ..++.++||||||+++|||++|..||..... ....+..+
T Consensus 180 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--~~~~~~~~ 252 (313)
T 3cek_A 180 TTS-----VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--QISKLHAI 252 (313)
T ss_dssp ---------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHHHHHH
T ss_pred ccc-----ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH--HHHHHHHH
Confidence 221 11234578999999999976 4688999999999999999999999976432 12223222
Q ss_pred hhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 229 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
...... ..+...+++++.++|.+||+.||++||++.++++
T Consensus 253 ~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 253 IDPNHE---IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp HCTTSC---CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred Hhcccc---cCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 222111 1123456889999999999999999999777654
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=342.53 Aligned_cols=263 Identities=19% Similarity=0.236 Sum_probs=206.1
Q ss_pred cCCceeEeccccccCceEEEEEE----EcCCCeEEEEEEecCCCCc--chHHHHHHHHHHHcCCCCCCeeEEeee--eCc
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKLENVKTKH--PQLLYESKLYRILQGGTGIPNVRWFGV--EGD 76 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~----~~~~~~~vAvK~~~~~~~~--~~~~~E~~~l~~l~~~~~i~~~~~~~~--~~~ 76 (407)
..++|++.+.||+|+||.||+|+ +..+++.||||++...... ..+.+|+.+++.++| ++++.+..+.. ...
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH-DNIVKYKGVCYSAGRR 117 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCC-TTBCCEEEEECC----
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCC-CCeeeEEEEEEecCCC
Confidence 45679999999999999999998 4568999999998764332 357899999999986 45555544433 334
Q ss_pred eeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceee
Q 015406 77 YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (407)
Q Consensus 77 ~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~ 155 (407)
..++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli---~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKV 194 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---EETTEEEECCCTTCEE
T ss_pred ceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE---cCCCcEEEecCcchhh
Confidence 779999999 889999998766679999999999999999999999999999999999999 5778999999999987
Q ss_pred eccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcC---------chH----
Q 015406 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG---------TKK---- 222 (407)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~---------~~~---- 222 (407)
........ .......++..|+|||++.+..++.++||||||+++|||++|..||...... ...
T Consensus 195 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (326)
T 2w1i_A 195 LPQDKEYY----KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 270 (326)
T ss_dssp CCSSCSEE----ECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHH
T ss_pred cccccccc----ccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHH
Confidence 75543211 1123446788899999999888999999999999999999999998642100 000
Q ss_pred HHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHH
Q 015406 223 QKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (407)
Q Consensus 223 ~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~ 279 (407)
.....+..... ......+|+++.++|.+||+.||++||++.+|.+.|+++..+
T Consensus 271 ~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 271 HLIELLKNNGR----LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHHTTCC----CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHhhcCCC----CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 00111111111 112356899999999999999999999999999999988654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=360.38 Aligned_cols=239 Identities=14% Similarity=0.110 Sum_probs=185.4
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-----CcchHHHHHHHHHHHc--CCCCCCeeE-------Ee
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQ--GGTGIPNVR-------WF 71 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~~l~~l~--~~~~i~~~~-------~~ 71 (407)
.++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+|+.+++.+. .|++++.+. .+
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 578999999999999999999998999999999986432 1245778996666654 345554432 22
Q ss_pred eeeCc-----------------eeEEEEeccCCCHHHHHHHcCCCCC-------HHHHHHHHHHHHHHHHHHHhCCceec
Q 015406 72 GVEGD-----------------YNVLVMDLLGPSLEDLFNFCSRKLS-------LKTVLMLADQMINRVEFVHSKSFLHR 127 (407)
Q Consensus 72 ~~~~~-----------------~~~lvme~~g~sL~~~l~~~~~~l~-------~~~~~~i~~qi~~aL~yLH~~~ivHr 127 (407)
....+ ..||||||++|+|.+++.... .++ +..++.|+.||+.||+|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~-~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL-SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHH-HTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhcc-ccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 22221 378999999999999998532 244 48888999999999999999999999
Q ss_pred cCCCCcccccCCCCCceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCC-----------CCChhhHH
Q 015406 128 DIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-----------EQSRRDDL 196 (407)
Q Consensus 128 DLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----------~~~~~sDI 196 (407)
||||+|||+ +.++.+||+|||+|+..... .....| +.|+|||++.+. .++.++||
T Consensus 231 Dikp~NIll---~~~~~~kL~DFG~a~~~~~~----------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dv 296 (377)
T 3byv_A 231 YLRPVDIVL---DQRGGVFLTGFEHLVRDGAR----------VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDA 296 (377)
T ss_dssp CCCGGGEEE---CTTCCEEECCGGGCEETTCE----------EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHH
T ss_pred CCCHHHEEE---cCCCCEEEEechhheecCCc----------ccCCCC-cCccChhhhcccccccccccccccCChhhhH
Confidence 999999999 57789999999999864321 234567 999999999987 89999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 197 ESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 197 wSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
|||||+||||++|..||.+....... . .....+..+++++.+||.+||+.||++||++.++++
T Consensus 297 wSlG~il~elltg~~Pf~~~~~~~~~---~---------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 297 WALGLVIYWIWCADLPITKDAALGGS---E---------WIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHHHHHHSSCCC------CCS---G---------GGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHHHHHHCCCCCcccccccch---h---------hhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999999999999764322111 0 111122568999999999999999999999988874
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=348.84 Aligned_cols=251 Identities=18% Similarity=0.223 Sum_probs=192.4
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeee-----eCceeE
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGV-----EGDYNV 79 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~-----~~~~~~ 79 (407)
...+|++.+.||+|+||.||+|++..+++ ||+|.+..... ...+|+++++.++|++.+..+..+.. ...+.+
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~--~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR--FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT--SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc--hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 35679999999999999999999876666 88886654332 23479999999987544444444332 233478
Q ss_pred EEEeccCCCHHHHHH---HcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeee
Q 015406 80 LVMDLLGPSLEDLFN---FCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (407)
Q Consensus 80 lvme~~g~sL~~~l~---~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~ 156 (407)
+||||+.+++.+.+. .....+++..++.++.||+.||.|||++||+||||||+|||++ ..++.+||+|||+|+..
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~--~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD--PPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEEC
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEc--CCCCcEEEeeCCCcccc
Confidence 999999777666554 2356799999999999999999999999999999999999994 26789999999999876
Q ss_pred ccCCCCcccCccCCCCccccccccccccccCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhccc-
Q 015406 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS- 234 (407)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~- 234 (407)
..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.. +.+..+......
T Consensus 193 ~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~l~~i~~~~g~p 261 (394)
T 4e7w_A 193 IAGEP--------NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI---DQLVEIIKVLGTP 261 (394)
T ss_dssp CTTCC--------CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCC
T ss_pred cCCCC--------CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCC
Confidence 54332 2356789999999999775 5899999999999999999999999875432 222222221100
Q ss_pred -----------------------ccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 235 -----------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 235 -----------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.....+...+++++.+||.+||..||++||++.++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp CHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 1111223458899999999999999999999877654
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=336.60 Aligned_cols=250 Identities=22% Similarity=0.259 Sum_probs=201.9
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc----chHHHHHHHHHHHcCCCCCCeeEEee--eeCce
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFG--VEGDY 77 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~--~~~~~ 77 (407)
...++|++.+.||+|+||.||+|++..+++.||+|.+...... ..+.+|+.+++.++| +++..+..++ .....
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~ 81 (279)
T 2w5a_A 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH-PNIVRYYDRIIDRTNTT 81 (279)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEEGGGTE
T ss_pred CchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCC-CCCCeEEEEEecCCCce
Confidence 4568999999999999999999999999999999998754422 347889999999986 5555555443 34678
Q ss_pred eEEEEecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeccCCCCcccccCCCCCceEEEE
Q 015406 78 NVLVMDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKS-----FLHRDIKPDNFLMGLGRRANQVYII 148 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~-----ivHrDLKp~NILl~~~~~~~~~kL~ 148 (407)
.++||||+ +++|.+++... ...+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~---~~~~~~kl~ 158 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLG 158 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEE---CSSSCEEEC
T ss_pred EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEE---cCCCCEEEe
Confidence 89999999 78999999753 234999999999999999999999999 9999999999999 678899999
Q ss_pred eccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHH
Q 015406 149 DFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228 (407)
Q Consensus 149 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i 228 (407)
|||+++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||..... .+....+
T Consensus 159 dfg~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~i 228 (279)
T 2w5a_A 159 DFGLARILNHDTSF-------AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELAGKI 228 (279)
T ss_dssp CCCHHHHC---CHH-------HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH
T ss_pred cCchheeecccccc-------ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---HHHHHHH
Confidence 99999865432210 1234689999999999999999999999999999999999999987543 3344444
Q ss_pred hhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 229 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
...... .+...+++++.++|.+||+.||++||++.+|++
T Consensus 229 ~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 267 (279)
T 2w5a_A 229 REGKFR----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267 (279)
T ss_dssp HHTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhcccc----cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 443332 233468999999999999999999999888765
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=335.53 Aligned_cols=251 Identities=17% Similarity=0.275 Sum_probs=199.8
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCC------CCcchHHHHHHHHHHHcCCCCCCeeEEee--eeC
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK------TKHPQLLYESKLYRILQGGTGIPNVRWFG--VEG 75 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~~~E~~~l~~l~~~~~i~~~~~~~--~~~ 75 (407)
++.++|++.+.||+|+||.||+|.+..+++.||+|++... .....+.+|+.+++.++| +++..+..+. ...
T Consensus 2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~ 80 (305)
T 2wtk_C 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH-KNVIQLVDVLYNEEK 80 (305)
T ss_dssp ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCC-TTBCCEEEEEECC--
T ss_pred ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCC-CCeeEEEEEEEcCCC
Confidence 4568999999999999999999999999999999988643 223458899999999986 5555555544 455
Q ss_pred ceeEEEEeccCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEecccee
Q 015406 76 DYNVLVMDLLGPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (407)
Q Consensus 76 ~~~~lvme~~g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~ 154 (407)
...++||||+.++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 81 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~---~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 81 QKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLL---TTGGTLKISALGVAE 157 (305)
T ss_dssp -CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCE
T ss_pred CeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---cCCCcEEeecccccc
Confidence 678999999966688888753 3569999999999999999999999999999999999999 578899999999998
Q ss_pred eeccCCCCcccCccCCCCccccccccccccccCCCC--ChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhc
Q 015406 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ--SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (407)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~--~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (407)
......... ......||+.|+|||++.+... +.++||||||+++|||++|..||.+.. ..+.+..+....
T Consensus 158 ~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~i~~~~ 229 (305)
T 2wtk_C 158 ALHPFAADD-----TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN---IYKLFENIGKGS 229 (305)
T ss_dssp ECCTTCSSC-----EECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHCC
T ss_pred ccCcccccc-----ccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch---HHHHHHHHhcCC
Confidence 765432211 1234578999999999987544 889999999999999999999998643 344444444433
Q ss_pred ccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 233 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 233 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.. +...+++++.++|.+||..||++||++.++++
T Consensus 230 ~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 230 YA-----IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp CC-----CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CC-----CCCccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 22 23568999999999999999999999877754
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=353.76 Aligned_cols=263 Identities=17% Similarity=0.217 Sum_probs=186.6
Q ss_pred ccCCceeE-eccccccCceEEEEEEEc--CCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEee--eeCcee
Q 015406 4 RVGNKFRL-GRKIGSGSFGEIYLGTNI--QTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFG--VEGDYN 78 (407)
Q Consensus 4 ~~~~~y~i-~~~iG~G~~g~Vy~~~~~--~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~--~~~~~~ 78 (407)
++.+.|++ +++||+|+||.||+|+++ .+++.||||++........+.+|+.+++.++|+ +++.+..++ ......
T Consensus 17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hp-niv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHP-NVISLQKVFLSHADRKV 95 (405)
T ss_dssp CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCT-TBCCCCEEEEETTTTEE
T ss_pred hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCC-CeeeEeeEEecCCCCeE
Confidence 45567887 558999999999999976 568899999998776677899999999999875 555554444 346788
Q ss_pred EEEEeccCCCHHHHHHHcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCC-CCCceEEEEe
Q 015406 79 VLVMDLLGPSLEDLFNFCS--------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG-RRANQVYIID 149 (407)
Q Consensus 79 ~lvme~~g~sL~~~l~~~~--------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~-~~~~~~kL~D 149 (407)
|+||||++++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+||||... +..+.+||+|
T Consensus 96 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 96 WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp EEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred EEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 9999999889999886321 249999999999999999999999999999999999999532 3568999999
Q ss_pred ccceeeeccCCCCcccCccCCCCccccccccccccccCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCc------hH
Q 015406 150 FGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT------KK 222 (407)
Q Consensus 150 FGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~------~~ 222 (407)
||+|+.+...... .......+||+.|+|||++.+. .++.++|||||||+||||++|..||.+..... ..
T Consensus 176 fg~a~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~ 251 (405)
T 3rgf_A 176 MGFARLFNSPLKP----LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 251 (405)
T ss_dssp TTCCC--------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred CCCceecCCCCcc----cccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence 9999876543211 1223456899999999999874 58999999999999999999999997643310 11
Q ss_pred HHHHHHhhhccccc---------------------------------HHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHH
Q 015406 223 QKYEKISEKKVSTS---------------------------------IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 269 (407)
Q Consensus 223 ~~~~~i~~~~~~~~---------------------------------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l 269 (407)
..+..+......+. ........++++.+||.+||..||.+|||++++
T Consensus 252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~ 331 (405)
T 3rgf_A 252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA 331 (405)
T ss_dssp HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 22222211100000 000011236789999999999999999998776
Q ss_pred HH
Q 015406 270 KR 271 (407)
Q Consensus 270 ~~ 271 (407)
++
T Consensus 332 L~ 333 (405)
T 3rgf_A 332 MQ 333 (405)
T ss_dssp HT
T ss_pred hc
Confidence 53
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=338.73 Aligned_cols=252 Identities=20% Similarity=0.301 Sum_probs=201.3
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC--CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
...++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+|+.+++.++| ++++.+..++...+..++|
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDH-PYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCC-TTBCCEEEEEECC-CEEEE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCC-CCEeeeeeeeeeCCeEEEE
Confidence 35678999999999999999999999999999999886543 23568889999999976 6677777777777889999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 82 me~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
|||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLM---TLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTSCEEECCCHHHHHHHHHH
T ss_pred EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---CCCCCEEEEECCCCccccccc
Confidence 9999 889999998767789999999999999999999999999999999999999 578899999999986432211
Q ss_pred CCcccCccCCCCccccccccccccc-----cCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccc
Q 015406 161 THQHIPYRENKNLTGTARYASMNTH-----LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~-----~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (407)
.......||+.|+|||++ .+..++.++||||||+++|+|++|..||..... ...+..+.......
T Consensus 172 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~ 241 (302)
T 2j7t_A 172 -------QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP---MRVLLKIAKSDPPT 241 (302)
T ss_dssp -------HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSCCCC
T ss_pred -------cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH---HHHHHHHhccCCcc
Confidence 012345789999999998 366789999999999999999999999987543 33333333322211
Q ss_pred cHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
. .....++.++.++|.+||..||++||++.++++
T Consensus 242 ~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 242 L--LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp C--SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred c--CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1 122457899999999999999999999887754
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=369.22 Aligned_cols=255 Identities=22% Similarity=0.368 Sum_probs=207.2
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEec
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~ 84 (407)
.++|++.++||+|+||.||+|++.. +..||||+++.... .+.+.+|+++++.|+|. +++.+..++.+ ...||||||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp-niv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE-KLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCT-TBCCEEEEECS-SSCEEEECC
T ss_pred hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCC-CEeeEEEEEee-ccceEeeeh
Confidence 4679999999999999999999854 56799999876443 35689999999999874 55555555544 567999999
Q ss_pred c-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 85 L-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 85 ~-g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
+ +++|.+++... ...+++..++.|+.||+.||+|||++||+||||||+|||| +.++.+||+|||+++......
T Consensus 343 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~-- 417 (535)
T 2h8h_A 343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE-- 417 (535)
T ss_dssp CTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCTTSTTTCCCHH--
T ss_pred hcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---cCCCcEEEcccccceecCCCc--
Confidence 9 88999999743 3469999999999999999999999999999999999999 578899999999997654321
Q ss_pred cccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHHh
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (407)
+.......++..|+|||++.+..++.++|||||||+||||++ |..||.+... .+.+..+...... ...
T Consensus 418 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~---~~~~~~i~~~~~~----~~~ 486 (535)
T 2h8h_A 418 ----YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQVERGYRM----PCP 486 (535)
T ss_dssp ----HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH---HHHHHHHHTTCCC----CCC
T ss_pred ----eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC----CCC
Confidence 111234457889999999998899999999999999999999 9999987543 3344444333211 123
Q ss_pred cCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHH
Q 015406 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (407)
Q Consensus 242 ~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~ 279 (407)
..+++++.+||.+||+.||++||++.+|.+.|++++..
T Consensus 487 ~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 487 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 46899999999999999999999999999999876543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=330.83 Aligned_cols=247 Identities=20% Similarity=0.287 Sum_probs=199.5
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc----chHHHHHHHHHHHcCCCCCCeeEEeee----eCce
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGV----EGDY 77 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~----~~~~ 77 (407)
+..|++.+.||+|+||.||+|.+..++..||+|++...... ..+.+|+.+++.++|+ +++.+..++. ....
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP-NIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCT-TBCCEEEEEEEESSSCEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCC-CeeeeeeeeccccCCCce
Confidence 56799999999999999999999999999999987654322 3478899999999875 4544444433 2567
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcccccCCCCCceEEEEecccee
Q 015406 78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--ivHrDLKp~NILl~~~~~~~~~kL~DFGla~ 154 (407)
.++||||+ +++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ ..++.+||+|||++.
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~--~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGGG
T ss_pred EEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEE--CCCCCEEEeeCCCcc
Confidence 89999999 88999999863 57999999999999999999999999 99999999999994 367899999999996
Q ss_pred eeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhccc
Q 015406 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (407)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (407)
...... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||..... ....+..+......
T Consensus 181 ~~~~~~---------~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~ 248 (290)
T 1t4h_A 181 LKRASF---------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVTSGVKP 248 (290)
T ss_dssp GCCTTS---------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHHHHHTTTCCC
T ss_pred cccccc---------cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCc--HHHHHHHHhccCCc
Confidence 543322 234578999999999875 589999999999999999999999976433 33444444333222
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 235 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
..+...+++++.++|.+||+.||++||++.++++
T Consensus 249 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 249 ---ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ---GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 2234567899999999999999999999887764
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=342.04 Aligned_cols=253 Identities=19% Similarity=0.199 Sum_probs=184.3
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-CcchHHHHHHHHHHHcCCCCCCeeEEeeee------Ccee
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVE------GDYN 78 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~------~~~~ 78 (407)
.++|++.+.||+|+||.||+|++..+++.||||++.... .......|++.+..++|++.+..+..+... ..+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 101 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL 101 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence 468999999999999999999999999999999875543 334567778888888775444444443332 2247
Q ss_pred EEEEeccCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHH--hCCceeccCCCCcccccCCCCCceEEEEeccce
Q 015406 79 VLVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVH--SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (407)
Q Consensus 79 ~lvme~~g~sL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH--~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla 153 (407)
++||||+.++|.+.+.. ....+++..++.++.||+.||.||| ++||+||||||+|||++ ..++.+||+|||++
T Consensus 102 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~--~~~~~~kl~Dfg~a 179 (360)
T 3e3p_A 102 NVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVN--EADGTLKLCDFGSA 179 (360)
T ss_dssp EEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEE--TTTTEEEECCCTTC
T ss_pred EEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEe--CCCCcEEEeeCCCc
Confidence 89999997787766542 3456899999999999999999999 99999999999999994 23789999999999
Q ss_pred eeeccCCCCcccCccCCCCccccccccccccccCCC-CChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhc
Q 015406 154 KKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (407)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (407)
+....... .....||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.... ..+..+....
T Consensus 180 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~~~~~~~~~~ 248 (360)
T 3e3p_A 180 KKLSPSEP--------NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA---GQLHEIVRVL 248 (360)
T ss_dssp BCCCTTSC--------CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHH
T ss_pred eecCCCCC--------cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH---HHHHHHHHHc
Confidence 87654332 23557899999999997655 899999999999999999999999875443 3333332211
Q ss_pred cccc-----------------------HHHH----hcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 233 VSTS-----------------------IEAL----CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 233 ~~~~-----------------------~~~~----~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.... .... ...+++++.+||.+||+.||++||++.++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 1110 0111 1125789999999999999999999877653
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=342.95 Aligned_cols=267 Identities=22% Similarity=0.304 Sum_probs=208.3
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHH-cCCCCCCeeEEeeeeCc----eeE
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRIL-QGGTGIPNVRWFGVEGD----YNV 79 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l-~~~~~i~~~~~~~~~~~----~~~ 79 (407)
+.++|++.+.||+|+||.||+|++ +++.||||++... ....+.+|.+++..+ ..|+++..+..++.... ..+
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~ 116 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 116 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG-GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEE
T ss_pred ccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch-hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeE
Confidence 457899999999999999999996 5899999998643 345578899998884 24466666666665544 789
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceeccCCCCcccccCCCCCceEEEEec
Q 015406 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH--------SKSFLHRDIKPDNFLMGLGRRANQVYIIDF 150 (407)
Q Consensus 80 lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH--------~~~ivHrDLKp~NILl~~~~~~~~~kL~DF 150 (407)
+||||+ +++|.+++.. ..+++..++.++.||+.||.||| ++||+||||||+|||+ +.++.+||+||
T Consensus 117 lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll---~~~~~~kL~Df 191 (342)
T 1b6c_B 117 LVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADL 191 (342)
T ss_dssp EEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE---CTTSCEEECCC
T ss_pred EEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE---CCCCCEEEEEC
Confidence 999999 8899999985 46999999999999999999999 8999999999999999 57889999999
Q ss_pred cceeeeccCCCCcccCccCCCCccccccccccccccCCC------CChhhHHHHHHHHHHHHHhC----------CCCCC
Q 015406 151 GLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE------QSRRDDLESLGYVLMYFLRG----------SLPWQ 214 (407)
Q Consensus 151 Gla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~------~~~~sDIwSlG~il~elltG----------~~Pf~ 214 (407)
|+++.......... .......||+.|+|||++.+.. ++.++|||||||++|||++| ..||.
T Consensus 192 g~~~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~ 268 (342)
T 1b6c_B 192 GLAVRHDSATDTID---IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268 (342)
T ss_dssp TTCEEEETTTTEEE---ECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred CCceeccccccccc---cccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcc
Confidence 99987765432111 0124567999999999998753 34789999999999999999 88997
Q ss_pred CCCcC--chHHHHHHHhhhcccccHHH--HhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCC
Q 015406 215 GLKAG--TKKQKYEKISEKKVSTSIEA--LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGF 282 (407)
Q Consensus 215 ~~~~~--~~~~~~~~i~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~ 282 (407)
..... ........+........... ....+++.+.+|+.+||+.||++||++.++.+.|+++..+.+.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~~ 340 (342)
T 1b6c_B 269 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 340 (342)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC-
T ss_pred ccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhcC
Confidence 65432 22233333333222222111 1123457899999999999999999999999999999877654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=345.46 Aligned_cols=260 Identities=17% Similarity=0.222 Sum_probs=202.4
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC---CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
..++|++.+.||+|+||.||+|++ .+++.||||++.... ....+.+|+.+++.+.| ++++.+..++......++|
T Consensus 28 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv 105 (326)
T 3uim_A 28 ASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVH-RNLLRLRGFCMTPTERLLV 105 (326)
T ss_dssp TTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCC-TTBCCCCEEECCSSCCEEE
T ss_pred HhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccC-CCccceEEEEecCCceEEE
Confidence 468899999999999999999985 578999999886543 23368899999999886 6677777777777888999
Q ss_pred Eecc-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCCCcccccCCCCCceEEEEecccee
Q 015406 82 MDLL-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (407)
Q Consensus 82 me~~-g~sL~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~---~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~ 154 (407)
|||+ +++|.+++.... ..+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||+++
T Consensus 106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~~~ 182 (326)
T 3uim_A 106 YPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAK 182 (326)
T ss_dssp EECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE---CTTCCEEECCCSSCE
T ss_pred EEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE---CCCCCEEeccCcccc
Confidence 9999 889999998532 2499999999999999999999999 99999999999999 578899999999998
Q ss_pred eeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCC-----CcCchHHHHHHHh
Q 015406 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL-----KAGTKKQKYEKIS 229 (407)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~-----~~~~~~~~~~~i~ 229 (407)
......... .....||+.|+|||++.+..++.++|||||||++|+|++|..||... .............
T Consensus 183 ~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 183 LMDYKDTHV------TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256 (326)
T ss_dssp ECCSSSSCE------ECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred ccCcccccc------cccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence 765433211 23456999999999999888999999999999999999999999521 1111111111000
Q ss_pred hhc-cc-----ccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 015406 230 EKK-VS-----TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 275 (407)
Q Consensus 230 ~~~-~~-----~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~ 275 (407)
... .. ..........++++.+++.+||+.||++||++.+|++.|+.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 000 00 00001112235789999999999999999999999998875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=370.35 Aligned_cols=250 Identities=20% Similarity=0.357 Sum_probs=199.7
Q ss_pred ccccccCceEEEEEEE--cCCCeEEEEEEecCCCC----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-
Q 015406 13 RKIGSGSFGEIYLGTN--IQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (407)
Q Consensus 13 ~~iG~G~~g~Vy~~~~--~~~~~~vAvK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~- 85 (407)
++||+|+||.||+|.+ ..+++.||||+++.... ...+.+|+++++.++| ++|+.+..++.. +..++||||+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~-~~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN-PYIVRMIGICEA-ESWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCC-TTBCCEEEEEES-SSEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEec-CCEEEEEEccC
Confidence 4799999999999955 45678999999875432 2458899999999986 556666666544 4578999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCccc
Q 015406 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165 (407)
Q Consensus 86 g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~ 165 (407)
+++|.+++.. ...+++..++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+++.+......
T Consensus 453 ~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl---~~~~~~kL~DFGla~~~~~~~~~--- 525 (635)
T 4fl3_A 453 LGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALRADENY--- 525 (635)
T ss_dssp TEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCTTHHHHTTC-------
T ss_pred CCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEE---eCCCCEEEEEcCCccccccCccc---
Confidence 8999999975 5579999999999999999999999999999999999999 57889999999999876543321
Q ss_pred CccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCC
Q 015406 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 244 (407)
Q Consensus 166 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (407)
+.......+|+.|+|||++.+..++.++|||||||+||||++ |..||.+... .+....+...... .....+
T Consensus 526 -~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~---~~~~~~i~~~~~~----~~p~~~ 597 (635)
T 4fl3_A 526 -YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAMLEKGERM----GCPAGC 597 (635)
T ss_dssp ----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCCC----CCCTTC
T ss_pred -cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC----CCCCCC
Confidence 111234457889999999999999999999999999999998 9999987544 3334444333222 123568
Q ss_pred cHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHH
Q 015406 245 PTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (407)
Q Consensus 245 ~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~ 279 (407)
|+++.+||.+||+.||++||++.+|.+.|++++..
T Consensus 598 ~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 598 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999998764
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=347.61 Aligned_cols=258 Identities=22% Similarity=0.282 Sum_probs=196.9
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-CcchHHHHHHHHHHHcC----------CCCCCeeEEee
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQG----------GTGIPNVRWFG 72 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~E~~~l~~l~~----------~~~i~~~~~~~ 72 (407)
...++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+|+.+++.+.+ ++++..+..++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 34679999999999999999999999999999999986432 23457889999999874 34566655554
Q ss_pred eeC----ceeEEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcccccCC---CCCc
Q 015406 73 VEG----DYNVLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLG---RRAN 143 (407)
Q Consensus 73 ~~~----~~~~lvme~~g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~-~ivHrDLKp~NILl~~~---~~~~ 143 (407)
... ...+++|||++++|.+++.... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.+ +..+
T Consensus 96 ~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~ 175 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 175 (373)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred hccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcc
Confidence 432 2789999999999999998643 4599999999999999999999998 99999999999999421 2345
Q ss_pred eEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCc---
Q 015406 144 QVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT--- 220 (407)
Q Consensus 144 ~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~--- 220 (407)
.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus 176 ~~kl~Dfg~a~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 245 (373)
T 1q8y_A 176 QIKIADLGNACWYDEHY----------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245 (373)
T ss_dssp EEEECCCTTCEETTBCC----------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred eEEEcccccccccCCCC----------CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence 89999999998765432 24578999999999999999999999999999999999999998644221
Q ss_pred hHHHHHHHhhhcccccH------------------------------H-------HHhcCCcHHHHHHHHHHhCCCCCCC
Q 015406 221 KKQKYEKISEKKVSTSI------------------------------E-------ALCRGYPTEFASYFHYCRSLRFDDK 263 (407)
Q Consensus 221 ~~~~~~~i~~~~~~~~~------------------------------~-------~~~~~~~~~l~~li~~cl~~~p~~R 263 (407)
....+..+.......+. . .+...+++++.+||.+||+.||++|
T Consensus 246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence 11222222111000000 0 0112346789999999999999999
Q ss_pred CCHHHHHH
Q 015406 264 PDYAYLKR 271 (407)
Q Consensus 264 Pt~~~l~~ 271 (407)
|++.++++
T Consensus 326 pt~~ell~ 333 (373)
T 1q8y_A 326 ADAGGLVN 333 (373)
T ss_dssp BCHHHHHT
T ss_pred CCHHHHhh
Confidence 99887754
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=336.03 Aligned_cols=257 Identities=21% Similarity=0.279 Sum_probs=197.7
Q ss_pred CCceeEeccccccCceEEEEEEEcC-CC--eEEEEEEecCCCC-----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCce
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQ-TN--EEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~-~~--~~vAvK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 77 (407)
.++|++.+.||+|+||.||+|++.. ++ ..||||++..... ...+.+|+++++.++| +++..+..+.....
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH-RNLIRLYGVVLTPP- 94 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCC-TTBCCEEEEECSSS-
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCC-CCcccEEEEEccCC-
Confidence 5689999999999999999998643 33 3699998765321 2457889999999976 55666655555544
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeee
Q 015406 78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~ 156 (407)
.++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL---ATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---EETTEEEECCCTTCEEC
T ss_pred ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE---cCCCCEEEccccccccc
Confidence 78999999 899999998766679999999999999999999999999999999999999 57789999999999876
Q ss_pred ccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccc
Q 015406 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVST 235 (407)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (407)
....... .......+|..|+|||++.+..++.++||||||+++|+|++ |..||.+... .+....+.......
T Consensus 172 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~~ 244 (291)
T 1u46_A 172 PQNDDHY----VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---SQILHKIDKEGERL 244 (291)
T ss_dssp CC-CCEE----EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTSCCCC
T ss_pred cccccch----hhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH---HHHHHHHHccCCCC
Confidence 5443211 11234567889999999998889999999999999999999 9999987543 34444443332211
Q ss_pred cHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHH
Q 015406 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (407)
Q Consensus 236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~ 277 (407)
.....+++++.+++.+||+.||++||++.++.+.|+++.
T Consensus 245 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 245 ---PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ---CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 123568999999999999999999999999999988764
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=342.97 Aligned_cols=266 Identities=17% Similarity=0.236 Sum_probs=192.8
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHH--HcCCCCCCeeEEe-----eeeCce
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRI--LQGGTGIPNVRWF-----GVEGDY 77 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~--l~~~~~i~~~~~~-----~~~~~~ 77 (407)
-.++|++.+.||+|+||.||+|++ +++.||||++.... ...+..|.+++.. +.| +++..+... ......
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~e~~~~~~~~~~h-~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN-RQNFINEKNIYRVPLMEH-DNIARFIVGDERVTADGRME 86 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG-HHHHHHHHHHHTSTTCCC-TTBCCEEEEEEEECTTSCEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc-hhhHHHHHHHHHHHhccC-cchhhheecccccccCCCce
Confidence 468899999999999999999985 78999999986532 3345555555443 555 555554332 223446
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---------CceeccCCCCcccccCCCCCceEEE
Q 015406 78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---------SFLHRDIKPDNFLMGLGRRANQVYI 147 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---------~ivHrDLKp~NILl~~~~~~~~~kL 147 (407)
.++||||+ +++|.+++.. ..+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||
T Consensus 87 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill---~~~~~~kL 161 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSL--HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTCVI 161 (336)
T ss_dssp EEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE---CTTSCEEE
T ss_pred EEEEEecCCCCcHHHHHhh--cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEE---cCCCcEEE
Confidence 78999999 8999999985 3569999999999999999999999 99999999999999 57789999
Q ss_pred EeccceeeeccCCCCcc-cCccCCCCccccccccccccccC-------CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcC
Q 015406 148 IDFGLAKKYRDTSTHQH-IPYRENKNLTGTARYASMNTHLG-------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 219 (407)
Q Consensus 148 ~DFGla~~~~~~~~~~~-~~~~~~~~~~gt~~Y~aPE~~~~-------~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~ 219 (407)
+|||+++.+........ ..........||+.|+|||++.+ ..++.++|||||||++|||++|..||......
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 99999987654322110 00112235579999999999987 35678999999999999999997776432221
Q ss_pred ch---------------HHHHHHHhhhcccccHHHHh---cCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHH
Q 015406 220 TK---------------KQKYEKISEKKVSTSIEALC---RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (407)
Q Consensus 220 ~~---------------~~~~~~i~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~ 279 (407)
.. ......+.........+..+ ..+++++.+||.+||+.||++|||+.++.+.|++++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 10 01111111111111111111 11355899999999999999999999999999999753
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=332.48 Aligned_cols=255 Identities=24% Similarity=0.320 Sum_probs=201.2
Q ss_pred eeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC------cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK------HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 9 y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
|...+.||+|+||.||+|+ .+++.||||++..... ...+.+|+.+++.++| ++++.+..++...+..++||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 109 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGY--VNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH-ENLVELLGFSSDGDDLCLVY 109 (307)
T ss_dssp TTTCCEEEECSSEEEEEEE--SSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC-TTBCCEEEEECSSSSCEEEE
T ss_pred cccCCccccCCCeEEEEEE--ECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC-CCeEEEEEEEecCCceEEEE
Confidence 3445899999999999998 4788999998764321 2357889999999976 67777777777788889999
Q ss_pred ecc-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 83 DLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 83 e~~-g~sL~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILL---DEAFTAKISDFGLARASEKF 186 (307)
T ss_dssp ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECCSC
T ss_pred EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEE---cCCCcEEEeecccccccccc
Confidence 999 99999999743 3459999999999999999999999999999999999999 67889999999999876543
Q ss_pred CCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHH
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (407)
.... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+........ .....
T Consensus 187 ~~~~-----~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~ 259 (307)
T 2nru_A 187 AQTV-----MTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEE-KTIED 259 (307)
T ss_dssp SSCE-----ECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTS-CCHHH
T ss_pred cccc-----cccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhh-hhhhh
Confidence 2211 1234579999999999876 589999999999999999999999987554332222221111110 01111
Q ss_pred --------HhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 015406 240 --------LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (407)
Q Consensus 240 --------~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l 276 (407)
....+++.+.+++.+||+.||.+||++.++.+.|+++
T Consensus 260 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 260 YIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp HSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred hccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 1122467899999999999999999999999999886
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=338.55 Aligned_cols=263 Identities=16% Similarity=0.197 Sum_probs=198.0
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC--CcchHHHHHHHHHHHcCCCCCCeeEEeee---eCceeEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKLYRILQGGTGIPNVRWFGV---EGDYNVL 80 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~---~~~~~~l 80 (407)
.++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+|+.+++.++|++.+..+..+.. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 578999999999999999999999999999999875432 23457889999999987544444444332 2347799
Q ss_pred EEecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeee
Q 015406 81 VMDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (407)
Q Consensus 81 vme~~-g~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~ 156 (407)
||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILL---GDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---cCCCCEEEEecCcchhc
Confidence 99999 88999999752 4569999999999999999999999999999999999999 57889999999998765
Q ss_pred ccCCCCcc--cCccCCCCccccccccccccccCCC---CChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhh
Q 015406 157 RDTSTHQH--IPYRENKNLTGTARYASMNTHLGIE---QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 231 (407)
Q Consensus 157 ~~~~~~~~--~~~~~~~~~~gt~~Y~aPE~~~~~~---~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~ 231 (407)
........ ..........||+.|+|||++.+.. ++.++||||||+++|+|++|..||........ .....+..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~- 262 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVALAVQN- 262 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHHHHHC-
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhHHhhc-
Confidence 32111000 0000012345799999999998654 68999999999999999999999954211100 01111111
Q ss_pred cccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 015406 232 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (407)
Q Consensus 232 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l 276 (407)
.... .....+++++.++|.+||+.||++||++.++.+.|+.+
T Consensus 263 ~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 304 (317)
T 2buj_A 263 QLSI---PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304 (317)
T ss_dssp C--C---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred cCCC---CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence 1111 11245789999999999999999999999999988764
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=340.44 Aligned_cols=271 Identities=18% Similarity=0.256 Sum_probs=200.9
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
..++|++.+.||+|+||.||+|++.. .||+|++.... ....+.+|+.+++.++| +++..+..++......++
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~i 106 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRH-ENVVLFMGACMSPPHLAI 106 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCC-TTBCCCCEEEECSSCEEE
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCC-CCEeEEEEEEecCCceEE
Confidence 45889999999999999999999743 49999876542 23457789999999976 666666677777778999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 81 vme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
+|||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ + ++.+||+|||+++.....
T Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~---~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 107 ITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY---D-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp ECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEE---C---CCEECCCSCCC-----
T ss_pred EeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEE---e-CCCEEEeecCCccccccc
Confidence 99999 899999998655579999999999999999999999999999999999999 3 578999999998765322
Q ss_pred CCCcccCccCCCCccccccccccccccC---------CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhh
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLG---------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---------~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~ 230 (407)
..... ........||+.|+|||++.+ ..++.++||||||+++|||++|..||..... ......+..
T Consensus 183 ~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~ 257 (319)
T 2y4i_B 183 QAGRR--EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA---EAIIWQMGT 257 (319)
T ss_dssp -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH---HHHHHHHHT
T ss_pred ccccc--ccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHhcc
Confidence 11110 111234568999999999875 4579999999999999999999999976433 333333333
Q ss_pred hcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccc
Q 015406 231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWT 291 (407)
Q Consensus 231 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~dw~ 291 (407)
...... ....++.++.+++.+||..||++||++.++.+.|+++..+..........|.
T Consensus 258 ~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~~ 315 (319)
T 2y4i_B 258 GMKPNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWK 315 (319)
T ss_dssp TCCCCC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---------------
T ss_pred CCCCCC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCccccc
Confidence 322211 1235788999999999999999999999999999988776655555555553
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=338.55 Aligned_cols=258 Identities=22% Similarity=0.273 Sum_probs=185.3
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC---CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
..++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+|+.+++.++| ++++.+..++...+..++|
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHH-PNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCC-TTBCCEEEEEESSSCEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCC-CCEeeEEEEEeecCCcEEE
Confidence 4678999999999999999999988899999999876432 23457788888888875 6677777777777889999
Q ss_pred Eecc-CCCHHHHHHH-------cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccce
Q 015406 82 MDLL-GPSLEDLFNF-------CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (407)
Q Consensus 82 me~~-g~sL~~~l~~-------~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla 153 (407)
|||+ +++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILL---GEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEE---cCCCCEEEEeccch
Confidence 9999 8999999974 23459999999999999999999999999999999999999 57889999999999
Q ss_pred eeeccCCCCcccCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhc
Q 015406 154 KKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (407)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (407)
........... ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||........ ........
T Consensus 169 ~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~ 243 (303)
T 2vwi_A 169 AFLATGGDITR--NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV---LMLTLQND 243 (303)
T ss_dssp HHCC-----------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---HHHHHTSS
T ss_pred heeccCCCccc--hhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH---HHHHhccC
Confidence 76543221100 011235579999999999876 5689999999999999999999999987544322 11111111
Q ss_pred ccc-----cHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 233 VST-----SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 233 ~~~-----~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
... ........+++++.+++.+||+.||++||++.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 111 111233568899999999999999999999888764
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=340.48 Aligned_cols=247 Identities=20% Similarity=0.283 Sum_probs=193.8
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc----chHHHHHHHHHHHcCCCCCCeeEEeeeeCc----
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGD---- 76 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~---- 76 (407)
+.++|.+.+.||+|+||.||+|++..+|+.||||++...... ..+.+|+.+++.++|+ ++..+..++....
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~~ 100 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHE-NVIGLLDVFTPASSLRN 100 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCT-TBCCCSEEECSCSSGGG
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCC-CcccHhheEeccccccc
Confidence 457899999999999999999999999999999998654332 3467899999999875 4545444443332
Q ss_pred --eeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEecccee
Q 015406 77 --YNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (407)
Q Consensus 77 --~~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~ 154 (407)
..|+||||++++|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 101 ~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 101 FYDFYLVMPFMQTDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLAR 174 (353)
T ss_dssp CCCCEEEEECCSEEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTCCEEECSTTCTT
T ss_pred ceeEEEEeccccCCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeE---CCCCcEEEeeccccc
Confidence 359999999889888775 369999999999999999999999999999999999999 578899999999997
Q ss_pred eeccCCCCcccCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcc
Q 015406 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (407)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (407)
..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+. .+.+..+.....
T Consensus 175 ~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~ 241 (353)
T 3coi_A 175 HADAE----------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY---LDQLTQILKVTG 241 (353)
T ss_dssp C------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH---HHHHHHHHHHHC
T ss_pred CCCCC----------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhC
Confidence 65432 234578999999999987 6789999999999999999999999987543 222222221100
Q ss_pred --------------------------cccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 234 --------------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 234 --------------------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
......+...+++++.++|.+||..||++||++.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 242 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp BCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 01112233467899999999999999999999877653
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=338.43 Aligned_cols=254 Identities=17% Similarity=0.280 Sum_probs=180.2
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
..++|++.+.||+|+||.||+|.+..+++.||||++...... ..+..|...+....+|+++..+..++...+..++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 357899999999999999999999999999999998765332 23455555444444568888888888888899999
Q ss_pred EeccCCCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcccccCCCCCceEEEEeccceeee
Q 015406 82 MDLLGPSLEDLFNF----CSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (407)
Q Consensus 82 me~~g~sL~~~l~~----~~~~l~~~~~~~i~~qi~~aL~yLH~~-~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~ 156 (407)
|||+.++|.+++.. ....+++..++.++.|++.||.|||++ ||+||||||+|||+ +.++.+||+|||+++..
T Consensus 100 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 100 MELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILL---DRSGNIKLCDFGISGQL 176 (327)
T ss_dssp ECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEE---ETTTEEEECCCSSSCC-
T ss_pred EeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEE---cCCCCEEEccCCCceec
Confidence 99998899988864 246799999999999999999999998 99999999999999 57889999999999866
Q ss_pred ccCCCCcccCccCCCCccccccccccccc----cCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhc
Q 015406 157 RDTSTHQHIPYRENKNLTGTARYASMNTH----LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (407)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~----~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (407)
..... .....||+.|+|||++ .+..++.++||||||+++|+|++|..||...... .+.+..+....
T Consensus 177 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~ 246 (327)
T 3aln_A 177 VDSIA--------KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV--FDQLTQVVKGD 246 (327)
T ss_dssp -------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCCCCSC
T ss_pred ccccc--------cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH--HHHHHHHhcCC
Confidence 54322 2234789999999998 4567899999999999999999999999764321 11111111111
Q ss_pred ccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 233 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 233 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
...........+++++.+++.+||..||++||++.++++
T Consensus 247 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 247 PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 111111122458999999999999999999999888764
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=332.21 Aligned_cols=242 Identities=21% Similarity=0.315 Sum_probs=193.3
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC--------CcchHHHHHHHHHHHc---CCCCCCeeEEee
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--------KHPQLLYESKLYRILQ---GGTGIPNVRWFG 72 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--------~~~~~~~E~~~l~~l~---~~~~i~~~~~~~ 72 (407)
.+.++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+|+.++..+. .|+++..+..++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 45788999999999999999999999999999999986543 2234678999999994 457777777777
Q ss_pred eeCceeEEEEec-c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEec
Q 015406 73 VEGDYNVLVMDL-L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 150 (407)
Q Consensus 73 ~~~~~~~lvme~-~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DF 150 (407)
...+..++|||+ + +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ ..++.+||+||
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~~~~kl~df 184 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILID--LRRGCAKLIDF 184 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEE--TTTTEEEECCC
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEe--CCCCeEEEEEc
Confidence 777888999998 5 8999999986 34699999999999999999999999999999999999994 26789999999
Q ss_pred cceeeeccCCCCcccCccCCCCccccccccccccccCCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHh
Q 015406 151 GLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 229 (407)
Q Consensus 151 Gla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~ 229 (407)
|+++...... .....||..|+|||++.+..+ +.++||||||+++|+|++|+.||... . .+.
T Consensus 185 g~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-----~----~~~ 246 (312)
T 2iwi_A 185 GSGALLHDEP---------YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD-----Q----EIL 246 (312)
T ss_dssp SSCEECCSSC---------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-----H----HHH
T ss_pred chhhhcccCc---------ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh-----H----HHh
Confidence 9998765432 235578999999999987666 45999999999999999999999652 1 111
Q ss_pred hhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 230 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
..... +...+++++.++|.+||+.||++||++.++.+
T Consensus 247 ~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 247 EAELH-----FPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp HTCCC-----CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hhccC-----CcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 21111 23568899999999999999999999887764
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=365.75 Aligned_cols=257 Identities=22% Similarity=0.312 Sum_probs=207.1
Q ss_pred CCceeEeccccccCceEEEEEEEcCC---CeEEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~---~~~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 79 (407)
.++|++.+.||+|+||.||+|++..+ +..||||.+...... ..+.+|+.+++.++| ++++.+..++. .+..|
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDH-PHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEC-SSSCE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEe-cCceE
Confidence 46799999999999999999998643 467999987654322 457889999999987 55555555554 45579
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 80 lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
+||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 467 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl---~~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp EEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCCCCCCSCCC
T ss_pred EEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEE---eCCCCEEEEecCCCeecCC
Confidence 999999 899999998766679999999999999999999999999999999999999 5788999999999987654
Q ss_pred CCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccH
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (407)
... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+... .+.+..+.......
T Consensus 544 ~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~---~~~~~~i~~~~~~~-- 612 (656)
T 2j0j_A 544 STY------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGRIENGERLP-- 612 (656)
T ss_dssp ----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHHTCCCC--
T ss_pred Ccc------eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHcCCCCC--
Confidence 322 11234467889999999998899999999999999999997 9999987543 33444443332221
Q ss_pred HHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHc
Q 015406 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (407)
Q Consensus 238 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~ 280 (407)
+...+|+++.++|.+||+.||++||++.+|.+.|++++...
T Consensus 613 --~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 613 --MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp --CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 33568999999999999999999999999999999988654
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=330.11 Aligned_cols=251 Identities=19% Similarity=0.294 Sum_probs=185.4
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcc---hHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP---QLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~---~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
.++|++.+.||+|+||.||+|++..+++.||||++....... ....|...+....+|+++..+..++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 468999999999999999999999999999999987654332 23334333333334578888888888888999999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcccccCCCCCceEEEEeccceeeeccCCC
Q 015406 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 83 e~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~ 161 (407)
||+++.+..+.......+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||++........
T Consensus 104 e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~ 180 (318)
T 2dyl_A 104 ELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGQIKLCDFGISGRLVDDKA 180 (318)
T ss_dssp CCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEE---CTTSCEEECCCTTC--------
T ss_pred eccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEE---CCCCCEEEEECCCchhccCCcc
Confidence 9998888888876677899999999999999999999995 99999999999999 5788999999999976654322
Q ss_pred CcccCccCCCCcccccccccccccc-----CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhccccc
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (407)
.....||+.|+|||++. +..++.++||||||+++|||++|..||..... ..+.+..+........
T Consensus 181 --------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~ 250 (318)
T 2dyl_A 181 --------KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT--DFEVLTKVLQEEPPLL 250 (318)
T ss_dssp --------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHHHHHHHHSCCCCC
T ss_pred --------ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc--cHHHHHHHhccCCCCC
Confidence 23457899999999995 45688999999999999999999999976432 2333444433322111
Q ss_pred HHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 237 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
. ....+++++.++|.+||+.||.+||++.++++
T Consensus 251 ~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 251 P--GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp C--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred C--ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1 12357899999999999999999999888764
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=328.12 Aligned_cols=246 Identities=22% Similarity=0.276 Sum_probs=195.3
Q ss_pred EeccccccCceEEEEEEEcCCCeEEEEEEecCCCC--cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-CC
Q 015406 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GP 87 (407)
Q Consensus 11 i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~-g~ 87 (407)
....||+|+||.||+|++..+++.||||.+..... ...+.+|+.+++.++| ++++.+..++...+..++||||+ ++
T Consensus 26 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~ 104 (295)
T 2clq_A 26 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKH-KNIVQYLGSFSENGFIKIFMEQVPGG 104 (295)
T ss_dssp SBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCC-TTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred CcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCC-CCEeeEeeEEEeCCcEEEEEEeCCCC
Confidence 34489999999999999999999999998865432 3458889999999976 66777777778888999999999 89
Q ss_pred CHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCccc
Q 015406 88 SLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165 (407)
Q Consensus 88 sL~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~ 165 (407)
+|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++ ..++.+||+|||+++.......
T Consensus 105 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~--~~~~~~kl~Dfg~~~~~~~~~~---- 178 (295)
T 2clq_A 105 SLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLIN--TYSGVLKISDFGTSKRLAGINP---- 178 (295)
T ss_dssp EHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTCCEEECCTTTCEESCC-------
T ss_pred CHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEE--CCCCCEEEeecccccccCCCCC----
Confidence 99999986433 467899999999999999999999999999999999994 2378999999999987654321
Q ss_pred CccCCCCccccccccccccccCCC--CChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcC
Q 015406 166 PYRENKNLTGTARYASMNTHLGIE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243 (407)
Q Consensus 166 ~~~~~~~~~gt~~Y~aPE~~~~~~--~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (407)
......||+.|+|||++.+.. ++.++||||||+++|+|++|..||...... ............ ...+...
T Consensus 179 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~---~~~~~~~ 250 (295)
T 2clq_A 179 ---CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP--QAAMFKVGMFKV---HPEIPES 250 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH--HHHHHHHHHHCC---CCCCCTT
T ss_pred ---cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch--hHHHHhhccccc---ccccccc
Confidence 123557899999999997644 899999999999999999999999754322 111111111111 1123456
Q ss_pred CcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 244 YPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 244 ~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
+++++.++|.+||+.||++||++.++++
T Consensus 251 ~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 251 MSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp SCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 8999999999999999999999877753
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=331.12 Aligned_cols=259 Identities=19% Similarity=0.221 Sum_probs=192.7
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-CcchHHHHHHHHHHHcCCCCCCeeEEeee---------
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGV--------- 73 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~--------- 73 (407)
++.++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+|+.+++.++|++.+..+..+..
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred cccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 45678999999999999999999999999999999885432 22457889999999987544444433322
Q ss_pred ---eCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEe
Q 015406 74 ---EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID 149 (407)
Q Consensus 74 ---~~~~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~D 149 (407)
.....|+||||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~---~~~~~~kl~d 159 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI---DESRNVKIGD 159 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEE---cCCCCEEEee
Confidence 246789999999 889999998766678999999999999999999999999999999999999 5788999999
Q ss_pred ccceeeeccCCCCcc-----c--CccCCCCccccccccccccccCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCch
Q 015406 150 FGLAKKYRDTSTHQH-----I--PYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 221 (407)
Q Consensus 150 FGla~~~~~~~~~~~-----~--~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~ 221 (407)
||+++.......... . .........||+.|+|||++.+. .++.++|||||||++|+|++ ||... ...
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~--~~~ 234 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG--MER 234 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH--HHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc--hhH
Confidence 999986543211000 0 01112356789999999999865 68999999999999999998 55431 122
Q ss_pred HHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 222 KQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 222 ~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
......+..... .....+....++.+.+++.+||+.||++||++.++.+
T Consensus 235 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 235 VNILKKLRSVSI-EFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHHHHHSTTC-CCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcccccc-ccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 233333332221 1222344567888999999999999999999887764
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=349.91 Aligned_cols=239 Identities=15% Similarity=0.127 Sum_probs=186.5
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-----cchHHHHHHHHHHHcCCCCCC----------eeE--
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIP----------NVR-- 69 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~----------~~~-- 69 (407)
..|.+.+.||+|+||.||+|++..+|+.||||++..... ...+.+|+.+++.+.|..+.. .+.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 358899999999999999999999999999999874322 345788998888887633211 110
Q ss_pred ---------Eeee-----eCceeEEEEeccCCCHHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccC
Q 015406 70 ---------WFGV-----EGDYNVLVMDLLGPSLEDLFNFC------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 129 (407)
Q Consensus 70 ---------~~~~-----~~~~~~lvme~~g~sL~~~l~~~------~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDL 129 (407)
.+.. .....+++|++++++|.++++.. +..+++..++.++.||+.||+|||++|||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi 237 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237 (413)
T ss_dssp ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 0111 12346889999999999999532 334788899999999999999999999999999
Q ss_pred CCCcccccCCCCCceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccc----------cCCCCChhhHHHHH
Q 015406 130 KPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTH----------LGIEQSRRDDLESL 199 (407)
Q Consensus 130 Kp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~----------~~~~~~~~sDIwSl 199 (407)
||+|||| +.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||
T Consensus 238 Kp~NILl---~~~~~~kL~DFG~a~~~~~~----------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSl 303 (413)
T 3dzo_A 238 RPVDIVL---DQRGGVFLTGFEHLVRDGAS----------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL 303 (413)
T ss_dssp CGGGEEE---CTTCCEEECCGGGCEETTEE----------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHH
T ss_pred ccceEEE---ecCCeEEEEeccceeecCCc----------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHH
Confidence 9999999 67888999999999865433 134567 999999999 56668999999999
Q ss_pred HHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 200 GYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 200 G~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
||+||||++|+.||........ .. .....+..+|+++.+||.+||+.||++||++.++++
T Consensus 304 Gvil~elltg~~Pf~~~~~~~~---~~---------~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 304 GLAIYWIWCADLPNTDDAALGG---SE---------WIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHHHHSSCCCCTTGGGSC---SG---------GGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHCCCCCCCcchhhh---HH---------HHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999999999999976433211 11 111122468999999999999999999999877753
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=335.78 Aligned_cols=251 Identities=16% Similarity=0.222 Sum_probs=202.9
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc-------------------chHHHHHHHHHHHcCCCC
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-------------------PQLLYESKLYRILQGGTG 64 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~-------------------~~~~~E~~~l~~l~~~~~ 64 (407)
...++|++.+.||+|+||.||+|++ +++.||||++...... ..+.+|+.+++.++| ++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~ 104 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKN-EY 104 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCC-TT
T ss_pred cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCC-CC
Confidence 3457999999999999999999997 8999999987643111 568899999999985 66
Q ss_pred CCeeEEeeeeCceeEEEEecc-CCCHHHH------HHHc-CCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCccc
Q 015406 65 IPNVRWFGVEGDYNVLVMDLL-GPSLEDL------FNFC-SRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFL 135 (407)
Q Consensus 65 i~~~~~~~~~~~~~~lvme~~-g~sL~~~------l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~-~~ivHrDLKp~NIL 135 (407)
+..+..++...+..++||||+ +++|.++ +... ...+++..++.++.||+.||.|||+ +||+||||||+|||
T Consensus 105 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL 184 (348)
T ss_dssp BCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred cceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence 777777777788999999999 7899998 5432 4569999999999999999999999 99999999999999
Q ss_pred ccCCCCCceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCC-CCCh-hhHHHHHHHHHHHHHhCCCCC
Q 015406 136 MGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSR-RDDLESLGYVLMYFLRGSLPW 213 (407)
Q Consensus 136 l~~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~-~sDIwSlG~il~elltG~~Pf 213 (407)
+ +.++.+||+|||++....... .....||+.|+|||++.+. .++. ++||||||+++|||++|..||
T Consensus 185 ~---~~~~~~kl~dfg~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 252 (348)
T 2pml_X 185 M---DKNGRVKLSDFGESEYMVDKK---------IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF 252 (348)
T ss_dssp E---CTTSCEEECCCTTCEECBTTE---------ECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSS
T ss_pred E---cCCCcEEEecccccccccccc---------ccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCC
Confidence 9 678899999999998765431 2356789999999999987 6666 999999999999999999999
Q ss_pred CCCCcCchHHHHHHHhhhcccccH--------------HHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 214 QGLKAGTKKQKYEKISEKKVSTSI--------------EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 214 ~~~~~~~~~~~~~~i~~~~~~~~~--------------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
...... .+....+.......+. ......+++++.++|.+||+.||++||++.++++
T Consensus 253 ~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 253 SLKISL--VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp CCSSCS--HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCCcH--HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 865432 3444444433222110 1112568999999999999999999999887764
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=343.70 Aligned_cols=260 Identities=21% Similarity=0.232 Sum_probs=192.1
Q ss_pred CCccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 2 ~~~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
+..+.+.|.+.+.||+|+||+||.+. ..+|+.||||.+..+ ....+.+|+.+++.+.+|++|+.+..++......|||
T Consensus 10 ~~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~-~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv 87 (434)
T 2rio_A 10 EQSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID-FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA 87 (434)
T ss_dssp SCSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG-GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH-HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence 44567788889999999999998754 478999999987653 2345788999999887678888888888888999999
Q ss_pred EeccCCCHHHHHHHcCCC------CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCC----------CCCceE
Q 015406 82 MDLLGPSLEDLFNFCSRK------LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG----------RRANQV 145 (407)
Q Consensus 82 me~~g~sL~~~l~~~~~~------l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~----------~~~~~~ 145 (407)
|||++++|.+++...... .++..++.++.||+.||+|||++||+||||||+|||++.+ +....+
T Consensus 88 ~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 88 LELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp ECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred EecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence 999988999999853211 1233467899999999999999999999999999999532 234689
Q ss_pred EEEeccceeeeccCCCCcccCccCCCCccccccccccccccC-------CCCChhhHHHHHHHHHHHHHh-CCCCCCCCC
Q 015406 146 YIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-------IEQSRRDDLESLGYVLMYFLR-GSLPWQGLK 217 (407)
Q Consensus 146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-------~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~ 217 (407)
||+|||+++.......... .......||+.|+|||++.+ ..++.++|||||||++|||++ |..||.+..
T Consensus 168 kL~DFG~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFR---TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp EECCCTTCEECCC-----------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred EEcccccceecCCCCccce---eeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 9999999998755332110 11235679999999999976 568999999999999999999 999997643
Q ss_pred cCchHHHHHHHhhhccccc-HHH-HhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 218 AGTKKQKYEKISEKKVSTS-IEA-LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 218 ~~~~~~~~~~i~~~~~~~~-~~~-~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.. . ..+........ ... ....+++++.++|.+||+.||++||++.++++
T Consensus 245 ~~--~---~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 245 SR--E---SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp TH--H---HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hh--H---HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 21 1 12222211110 000 01234688999999999999999999888763
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=343.15 Aligned_cols=254 Identities=17% Similarity=0.185 Sum_probs=190.8
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEeccC
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLG 86 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~g 86 (407)
.+|.+.+.||+|+||.||. ....+++.||||++... ....+.+|+.+++.+.+|++|+.+..++.+....||||||++
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~-~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~ 101 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPE-CFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA 101 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTT-TEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHH-HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC
Confidence 3699999999999999664 33478999999988653 344578999999999767888888888889999999999998
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCC--CCceEEEEeccceeeeccCCCCcc
Q 015406 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR--RANQVYIIDFGLAKKYRDTSTHQH 164 (407)
Q Consensus 87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~--~~~~~kL~DFGla~~~~~~~~~~~ 164 (407)
++|.+++......+.+..++.++.||+.||.|||++||+||||||+|||++.++ ....+||+|||+|+........
T Consensus 102 g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~-- 179 (432)
T 3p23_A 102 ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS-- 179 (432)
T ss_dssp EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--------
T ss_pred CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcc--
Confidence 899999986555566677889999999999999999999999999999995322 2346889999999876543211
Q ss_pred cCccCCCCcccccccccccccc---CCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHH
Q 015406 165 IPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (407)
Q Consensus 165 ~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (407)
........||+.|+|||++. +..++.++|||||||++|||++ |..||..... . ....+....... ....
T Consensus 180 --~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~---~-~~~~~~~~~~~~-~~~~ 252 (432)
T 3p23_A 180 --FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ---R-QANILLGACSLD-CLHP 252 (432)
T ss_dssp --------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT---H-HHHHHTTCCCCT-TSCT
T ss_pred --eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH---H-HHHHHhccCCcc-ccCc
Confidence 11234567999999999998 4567889999999999999999 9999965322 1 111111111100 0000
Q ss_pred hcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 241 ~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
....+..+.+||.+||+.||++||++.++++
T Consensus 253 ~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 253 EKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 1123566899999999999999999888763
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=320.26 Aligned_cols=235 Identities=17% Similarity=0.199 Sum_probs=184.1
Q ss_pred ccCCceeEe-ccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeeee----Ccee
Q 015406 4 RVGNKFRLG-RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVE----GDYN 78 (407)
Q Consensus 4 ~~~~~y~i~-~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~----~~~~ 78 (407)
.+.++|.+. +.||+|+||.||+|++..+++.||||++.. ...+.+|+.++.++.+|++++.+..++.. ....
T Consensus 14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC---SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc---cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 456778887 789999999999999999999999999853 45678899999777777888887776655 6778
Q ss_pred EEEEecc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeee
Q 015406 79 VLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~ 156 (407)
++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++...
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 170 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 170 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccccc
Confidence 9999999 889999998643 36999999999999999999999999999999999999964333789999999998753
Q ss_pred ccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHH-HHHhhhcccc
Q 015406 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY-EKISEKKVST 235 (407)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~-~~i~~~~~~~ 235 (407)
.. ..++.++|||||||++|||++|..||............ ..+..... .
T Consensus 171 ~~-----------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~-~ 220 (299)
T 3m2w_A 171 TG-----------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-E 220 (299)
T ss_dssp TT-----------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCC-S
T ss_pred cc-----------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccc-c
Confidence 21 24678999999999999999999999764321100000 00011111 1
Q ss_pred cHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
........+++++.++|.+||+.||++||++.++++
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 221 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp SCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 122233568999999999999999999999877754
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=319.01 Aligned_cols=231 Identities=11% Similarity=0.080 Sum_probs=188.6
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc-----chHHHHHHHHHHHcCCCCCCeeEEeeeeCcee
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 78 (407)
.++++|++.+.||+|+||.||+|++..+++.||||++...... ..+.+|+.++..+.| ++++.+..++...+..
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-p~iv~~~~~~~~~~~~ 106 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDK-PGVARVLDVVHTRAGG 106 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEEEETTEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCC-CCcceeeEEEEECCcE
Confidence 4678999999999999999999999999999999998765433 457889999988876 6777888888888999
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeec
Q 015406 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~ 157 (407)
|+||||+ |++|.++++. .....++..|+.||+.||+|||++||+||||||+|||+ +.++.+||+++|
T Consensus 107 ~lv~e~~~g~~L~~~l~~---~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll---~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 107 LVVAEWIRGGSLQEVADT---SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRV---SIDGDVVLAYPA------ 174 (286)
T ss_dssp EEEEECCCEEEHHHHHTT---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---ETTSCEEECSCC------
T ss_pred EEEEEecCCCCHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEE---cCCCCEEEEecc------
Confidence 9999999 8999999963 34667889999999999999999999999999999999 577888887443
Q ss_pred cCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccH
Q 015406 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (407)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (407)
|++ .++.++|||||||+||||++|+.||.+...........+... ......
T Consensus 175 ---------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~-~~~~~~ 225 (286)
T 3uqc_A 175 ---------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTA-GQPIEP 225 (286)
T ss_dssp ---------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTT-SCBCCH
T ss_pred ---------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhc-cCCCCh
Confidence 333 378999999999999999999999987554221100000001 112334
Q ss_pred HHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHH
Q 015406 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (407)
Q Consensus 238 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~ 277 (407)
..+...+|+++.++|.+||+.||++| |+.++.+.|+++.
T Consensus 226 ~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 226 ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 45667899999999999999999999 9999999998874
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=350.57 Aligned_cols=266 Identities=18% Similarity=0.244 Sum_probs=197.1
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeee------
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVE------ 74 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~------ 74 (407)
...++|++.++||+|+||.||+|.+..+|+.||||++..... ...+.+|+++++.++| ++++.+..+...
T Consensus 11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~H-pnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNH-PNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCB-TTBCCEEECCTTTCCCCT
T ss_pred CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCC-CCCCceeeeecccccccC
Confidence 345899999999999999999999999999999998765432 2347889999999976 556555555433
Q ss_pred CceeEEEEecc-CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEecc
Q 015406 75 GDYNVLVMDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 151 (407)
Q Consensus 75 ~~~~~lvme~~-g~sL~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFG 151 (407)
.+..++||||+ |++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 66789999999 9999999985332 58999999999999999999999999999999999999644445569999999
Q ss_pred ceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCch------HHHH
Q 015406 152 LAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK------KQKY 225 (407)
Q Consensus 152 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~------~~~~ 225 (407)
++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||........ ....
T Consensus 170 ~a~~~~~~~~--------~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~ 241 (676)
T 3qa8_A 170 YAKELDQGEL--------CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSN 241 (676)
T ss_dssp CCCBTTSCCC--------CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC----
T ss_pred cccccccccc--------cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccc
Confidence 9987654332 2356899999999999999999999999999999999999999965311000 0000
Q ss_pred HHHh-----hh-----cccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHHHHH
Q 015406 226 EKIS-----EK-----KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL-----KRIFRDLFI 278 (407)
Q Consensus 226 ~~i~-----~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l-----~~~l~~l~~ 278 (407)
..+. .. ........+...+++++.++|.+||..||++||++.++ .+.+++++.
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 0000 00 00011112334468899999999999999999999774 355555554
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=347.25 Aligned_cols=241 Identities=15% Similarity=0.188 Sum_probs=189.6
Q ss_pred ccCCceeEeccccccCceEEEEEEEcC-CCeEEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeeeCce--
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQ-TNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDY-- 77 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~-~~~~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~-- 77 (407)
.+.++|++.+.||+|+||.||+|++.. +++.||||++...... ..+.+|+.++..++| ++|+.+..++...+.
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~ 155 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVH-PSIVQIFNFVEHTDRHG 155 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCC-TTBCCEEEEEEEECTTS
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCC-CCcCeEeeeEeecCCCC
Confidence 456899999999999999999999976 7899999988654322 246789999999986 556666555554333
Q ss_pred ---eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccce
Q 015406 78 ---NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (407)
Q Consensus 78 ---~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla 153 (407)
.||||||+ |++|.+++.. .+++..++.|+.||+.||.|||++|||||||||+|||++ . +.+||+|||++
T Consensus 156 ~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~---~-~~~kl~DFG~a 228 (681)
T 2pzi_A 156 DPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT---E-EQLKLIDLGAV 228 (681)
T ss_dssp CEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---S-SCEEECCCTTC
T ss_pred CceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEe---C-CcEEEEecccc
Confidence 69999999 8999987753 799999999999999999999999999999999999993 3 48999999999
Q ss_pred eeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcc
Q 015406 154 KKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (407)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (407)
+..... ....||+.|+|||++.+. ++.++|||||||+||+|++|..||.+......
T Consensus 229 ~~~~~~-----------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~------------ 284 (681)
T 2pzi_A 229 SRINSF-----------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL------------ 284 (681)
T ss_dssp EETTCC-----------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC------------
T ss_pred hhcccC-----------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc------------
Confidence 876442 245799999999999875 49999999999999999999999875322110
Q ss_pred cccHHHHhcCCcHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHHH
Q 015406 234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPD-YAYLKRIFRDLFI 278 (407)
Q Consensus 234 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~~l~~~l~~l~~ 278 (407)
..... ....++.+.++|.+||+.||++||+ ++++...|..++.
T Consensus 285 ~~~~~--~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 285 PEDDP--VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp CTTCH--HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred ccccc--ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 00000 0114678999999999999999995 5667776666543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=316.86 Aligned_cols=238 Identities=18% Similarity=0.197 Sum_probs=180.6
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc----------chHHHHHHHHHHHc--------CCCCCCe
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----------PQLLYESKLYRILQ--------GGTGIPN 67 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----------~~~~~E~~~l~~l~--------~~~~i~~ 67 (407)
.++|++.++||+|+||.||+|++ +++.||||++...... ..+.+|+.+++.++ .|++++.
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 36799999999999999999997 7899999998765321 56889999999997 3455555
Q ss_pred eEEeee------------------------------eCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHH
Q 015406 68 VRWFGV------------------------------EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116 (407)
Q Consensus 68 ~~~~~~------------------------------~~~~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL 116 (407)
+..... .....||||||+ +|++.+.+. ++.+++..++.|+.||+.||
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~--~~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR--TKLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT--TTCCCHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH--hcCCCHHHHHHHHHHHHHHH
Confidence 443321 267889999999 776555553 35689999999999999999
Q ss_pred HHHH-hCCceeccCCCCcccccCCCCCc--------------------eEEEEeccceeeeccCCCCcccCccCCCCccc
Q 015406 117 EFVH-SKSFLHRDIKPDNFLMGLGRRAN--------------------QVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175 (407)
Q Consensus 117 ~yLH-~~~ivHrDLKp~NILl~~~~~~~--------------------~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~g 175 (407)
+||| ++||+||||||+||||+ .++ .+||+|||+|+..... ..+|
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~---~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------------~~~g 239 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLK---KTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------------IVVF 239 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEE---ECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------------EEEC
T ss_pred HHHHHhCCEeECCCCHHHEEEe---ccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------------cEEE
Confidence 9999 99999999999999995 433 8999999999876542 3479
Q ss_pred cccccccccccCCCCChhhHHHHHHHH-HHHHHhCCCCCCCCCcCchHHHHHHHhhh-c-ccccHHHHhcCCcHHHHHHH
Q 015406 176 TARYASMNTHLGIEQSRRDDLESLGYV-LMYFLRGSLPWQGLKAGTKKQKYEKISEK-K-VSTSIEALCRGYPTEFASYF 252 (407)
Q Consensus 176 t~~Y~aPE~~~~~~~~~~sDIwSlG~i-l~elltG~~Pf~~~~~~~~~~~~~~i~~~-~-~~~~~~~~~~~~~~~l~~li 252 (407)
|+.|+|||++.+.. +.++||||||++ .+++++|..||.+.. ........+... . ...........+++++.+||
T Consensus 240 t~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli 316 (336)
T 2vuw_A 240 CDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL--WLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFH 316 (336)
T ss_dssp CCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH--HHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHH
T ss_pred eecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh--hhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHH
Confidence 99999999999876 999999998777 778888999984310 001112222211 1 11112223455789999999
Q ss_pred HHHhCCCCCCCCCHHHHH
Q 015406 253 HYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 253 ~~cl~~~p~~RPt~~~l~ 270 (407)
.+||..| |+++++
T Consensus 317 ~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 317 RTMLNFS-----SATDLL 329 (336)
T ss_dssp HHGGGSS-----SHHHHH
T ss_pred HHHhccC-----CHHHHH
Confidence 9999976 766654
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=291.84 Aligned_cols=184 Identities=16% Similarity=0.134 Sum_probs=132.2
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEecCCCC------------cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK------------HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 13 ~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~------------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
..++.|++|.+..++....|+.||+|++..... ..++.+|+++|+++.++++++.+..++++....||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 346778888888888778899999999865421 13488999999999988999999999999999999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 81 vme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
||||+ |++|.++|.. .+.++.. .|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.....
T Consensus 320 VMEyv~G~~L~d~i~~-~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL---~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAA-GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMV---DARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EEECCCSEEHHHHHHT-TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEE---CTTSCEEECCCTTEESCC--
T ss_pred EEecCCCCcHHHHHHh-CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEE---CCCCCEEEeecccCeeCCCC
Confidence 99999 9999999985 4567764 488999999999999999999999999999 68899999999999876543
Q ss_pred CCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCC
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSL 211 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~ 211 (407)
.. ...+.+||+.|||||++.+ .+..++|+||+|++++++.++..
T Consensus 393 ~~-------~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 393 CS-------WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp -C-------CSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred Cc-------cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 32 1345789999999999987 46778999999999887765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.8e-29 Score=254.59 Aligned_cols=187 Identities=21% Similarity=0.208 Sum_probs=140.8
Q ss_pred EeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc----------chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----------PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 11 i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----------~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
..+.||+|+||.||+|. ..++.+++|....+... +.+.+|+++++.++| ++++.+..++...+..||
T Consensus 340 ~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h-~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKD-FGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp --------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGG-GTCCCCCEEEEETTTTEE
T ss_pred CCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCC-CCcCceEEEEEeCCccEE
Confidence 35689999999999995 67889999976543321 236899999999987 555544445556667799
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 81 vme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
||||+ |++|.+++.. ++.++.||+.||+|||++||+||||||+|||++ . .+||+|||+|+.....
T Consensus 417 VmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~---~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 417 MMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFD---K--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEES---S--SEEECCCTTCEECCCH
T ss_pred EEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEEC---C--eEEEEECccCEECCCc
Confidence 99999 8999999873 678999999999999999999999999999993 4 9999999999987543
Q ss_pred CCCcccCccCCCCccccccccccccccC--CCCChhhHHHHHHHHHHHHHhCCCCCC
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQ 214 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~sDIwSlG~il~elltG~~Pf~ 214 (407)
.......+.......||+.|||||++.+ ..|+..+|+||..+-..+.+.++.+|.
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 2110000001235689999999999987 567888999999999998888877763
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.2e-26 Score=212.08 Aligned_cols=143 Identities=17% Similarity=0.242 Sum_probs=112.3
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC--------------------cchHHHHHHHHHHHcCCCCCC
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--------------------HPQLLYESKLYRILQGGTGIP 66 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--------------------~~~~~~E~~~l~~l~~~~~i~ 66 (407)
..|.+.+.||+|+||.||+|++ .+|+.||||++..... ...+.+|+.+++.+.| +.
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~ 165 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LA 165 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SS
T ss_pred eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CC
Confidence 3455669999999999999999 8899999999864321 2247899999999983 33
Q ss_pred eeEEeeeeCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceE
Q 015406 67 NVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 145 (407)
Q Consensus 67 ~~~~~~~~~~~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~ 145 (407)
....+. .+..|+||||+ |++|.+ +. . .....++.||+.||.|||++||+||||||+|||+ + ++.+
T Consensus 166 v~~~~~--~~~~~lvmE~~~g~~L~~-l~-----~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl---~-~~~v 231 (282)
T 1zar_A 166 VPKVYA--WEGNAVLMELIDAKELYR-VR-----V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV---S-EEGI 231 (282)
T ss_dssp SCCEEE--EETTEEEEECCCCEEGGG-CC-----C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE---E-TTEE
T ss_pred cCeEEe--ccceEEEEEecCCCcHHH-cc-----h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEE---E-CCcE
Confidence 333222 24569999999 889988 42 1 2355799999999999999999999999999999 5 7899
Q ss_pred EEEeccceeeeccCCCCcccCccCCCCccccccccccccccC
Q 015406 146 YIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG 187 (407)
Q Consensus 146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 187 (407)
||+|||+|+. +..|+|||.+..
T Consensus 232 kl~DFG~a~~--------------------~~~~~a~e~l~r 253 (282)
T 1zar_A 232 WIIDFPQSVE--------------------VGEEGWREILER 253 (282)
T ss_dssp EECCCTTCEE--------------------TTSTTHHHHHHH
T ss_pred EEEECCCCeE--------------------CCCCCHHHHHHH
Confidence 9999999963 345788998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=7.2e-23 Score=188.40 Aligned_cols=136 Identities=20% Similarity=0.287 Sum_probs=107.2
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeE--EEEEEecCCCCc--------------------------chHHHHHHHHHHH
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEE--VAIKLENVKTKH--------------------------PQLLYESKLYRIL 59 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~--vAvK~~~~~~~~--------------------------~~~~~E~~~l~~l 59 (407)
-|++.+.||+|+||.||+|.+..+|+. ||||+++..... ..+.+|+.++..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 478999999999999999998778999 999986543111 1477899999999
Q ss_pred cCCC-CCCeeEEeeeeCceeEEEEeccC--C----CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCC
Q 015406 60 QGGT-GIPNVRWFGVEGDYNVLVMDLLG--P----SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH-SKSFLHRDIKP 131 (407)
Q Consensus 60 ~~~~-~i~~~~~~~~~~~~~~lvme~~g--~----sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH-~~~ivHrDLKp 131 (407)
.|+. .++.+..+ ...+|||||++ | +|.++... .++..+..++.||+.||.||| ++||+||||||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 8753 23333332 35689999994 3 67766432 335578899999999999999 99999999999
Q ss_pred CcccccCCCCCceEEEEeccceeee
Q 015406 132 DNFLMGLGRRANQVYIIDFGLAKKY 156 (407)
Q Consensus 132 ~NILl~~~~~~~~~kL~DFGla~~~ 156 (407)
+|||++ . .++|+|||+|...
T Consensus 200 ~NILl~---~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMYI---D--KVYFIDMGQAVTL 219 (258)
T ss_dssp TSEEES---S--SEEECCCTTCEET
T ss_pred HHEEEc---C--cEEEEECcccccC
Confidence 999993 4 8999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.77 E-value=4.4e-19 Score=170.28 Aligned_cols=135 Identities=16% Similarity=0.274 Sum_probs=98.5
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC--------c--------ch--------HHHHHHHHHHHcCCC
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--------H--------PQ--------LLYESKLYRILQGGT 63 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--------~--------~~--------~~~E~~~l~~l~~~~ 63 (407)
-|++.++||+|+||.||+|.+ .+|+.||||+.+.... . .. ..+|...+.++.+ .
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~-~ 173 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYE-E 173 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHH-T
T ss_pred EEEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHh-c
Confidence 389999999999999999997 5799999998653210 0 00 1346777777754 3
Q ss_pred CCCeeEEeeeeCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCC
Q 015406 64 GIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 142 (407)
Q Consensus 64 ~i~~~~~~~~~~~~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~ 142 (407)
+++....+.... .+|||||+ |.+|.++.. ......++.||+.+|.|||++|||||||||.|||++ ++
T Consensus 174 gv~vp~p~~~~~--~~LVME~i~G~~L~~l~~-------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~---~d 241 (397)
T 4gyi_A 174 GFPVPEPIAQSR--HTIVMSLVDALPMRQVSS-------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIR---EE 241 (397)
T ss_dssp TCSCCCEEEEET--TEEEEECCSCEEGGGCCC-------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE---EE
T ss_pred CCCCCeeeeccC--ceEEEEecCCccHhhhcc-------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEe---CC
Confidence 333332232222 37999999 777765432 224567889999999999999999999999999995 33
Q ss_pred c----------eEEEEeccceeee
Q 015406 143 N----------QVYIIDFGLAKKY 156 (407)
Q Consensus 143 ~----------~~kL~DFGla~~~ 156 (407)
+ .+.|+||+-+...
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCcccccccccceEEEEeCCcccC
Confidence 3 4899999988653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=3.8e-13 Score=123.28 Aligned_cols=137 Identities=18% Similarity=0.279 Sum_probs=110.1
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCC--CCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEec
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~ 84 (407)
+.|++...++.|+.+.||++. ..++.+++|+.... .....+.+|..+++.|.++..++.+..++...+..|+|||+
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~--~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred ccceeEeeccCCCCCeEEEEE--CCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 569999999999999999998 34789999987642 23346899999999997766788888888888899999999
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 015406 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS------------------------------------------ 121 (407)
Q Consensus 85 ~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~------------------------------------------ 121 (407)
+ |.+|.+.+. +......++.+++.+|..||+
T Consensus 92 i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T 3tm0_A 92 ADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp CSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred cCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence 9 888876531 122345788899999999998
Q ss_pred -----------------CCceeccCCCCcccccCCCCCceEEEEecccee
Q 015406 122 -----------------KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (407)
Q Consensus 122 -----------------~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~ 154 (407)
..++|+|++|.|||+ +++..+.|+||+.+.
T Consensus 166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~---~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFV---KDGKVSGFIDLGRSG 212 (263)
T ss_dssp SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEE---ETTEEEEECCCTTCE
T ss_pred CHHHHHHHHHhcCCCCCceEECCCCCcCcEEE---ECCcEEEEEEchhcc
Confidence 458999999999999 344556799999875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.35 E-value=8.3e-12 Score=113.73 Aligned_cols=134 Identities=15% Similarity=0.070 Sum_probs=100.0
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCC-CCeeEEeeeeCceeEEEEecc
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTG-IPNVRWFGVEGDYNVLVMDLL 85 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~-i~~~~~~~~~~~~~~lvme~~ 85 (407)
..|.+....+.|..+.||++.. .+|..+++|+.... ....+..|..+++.+.++.. ++.+..+....+..++||||+
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~-~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc-cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 4567665555677799999974 56778999987654 34568899999999987644 676777777777789999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 015406 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS----------------------------------------- 123 (407)
Q Consensus 86 -g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~----------------------------------------- 123 (407)
|.+|. .. ..+ ...++.+++..|..||+..
T Consensus 98 ~G~~l~--~~----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
T 1nd4_A 98 PGQDLL--SS----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 168 (264)
T ss_dssp SSEETT--TS----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred CCcccC--cC----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence 77773 21 122 2356777778888888643
Q ss_pred -----------------ceeccCCCCcccccCCCCCceEEEEecccee
Q 015406 124 -----------------FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (407)
Q Consensus 124 -----------------ivHrDLKp~NILl~~~~~~~~~kL~DFGla~ 154 (407)
++|+|++|.|||+ +.+..+.|+||+.+.
T Consensus 169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~---~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 169 ELFARLKARMPDGEDLVVTHGDACLPNIMV---ENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEE---ETTEEEEECCCTTCE
T ss_pred HHHHHHHHhcCCCCCeEEECCCCCCCcEEE---ECCcEEEEEcchhcc
Confidence 9999999999999 344556799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.20 E-value=7.7e-11 Score=113.02 Aligned_cols=138 Identities=14% Similarity=0.196 Sum_probs=101.7
Q ss_pred eEeccccccCceEEEEEEEcCCCeEEEEEEec--CCC---CcchHHHHHHHHHHHcCCC-CCCeeEEeeeeC---ceeEE
Q 015406 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN--VKT---KHPQLLYESKLYRILQGGT-GIPNVRWFGVEG---DYNVL 80 (407)
Q Consensus 10 ~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~--~~~---~~~~~~~E~~~l~~l~~~~-~i~~~~~~~~~~---~~~~l 80 (407)
...+.|+.|.++.||++.. .+..+++|+.. ... ....+.+|..+++.|.+.. .++.+..++.+. +..|+
T Consensus 41 ~~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp CEEEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred ceEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 3467889999999999984 45688999765 322 2346889999999998633 366666666554 44799
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 015406 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-------------------------------------- 121 (407)
Q Consensus 81 vme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-------------------------------------- 121 (407)
||||+ |..+.+.. -..++......++.+++..|..||+
T Consensus 119 vme~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 119 IMEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 99999 66664311 2347888889999999999999997
Q ss_pred --------------------CCceeccCCCCcccccCCCCC--ceEEEEeccceee
Q 015406 122 --------------------KSFLHRDIKPDNFLMGLGRRA--NQVYIIDFGLAKK 155 (407)
Q Consensus 122 --------------------~~ivHrDLKp~NILl~~~~~~--~~~kL~DFGla~~ 155 (407)
.+++|+|++|.|||++ .+ ..+.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~---~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFH---PTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEEC---SSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEe---CCCCcEEEEECcccccc
Confidence 3689999999999994 33 3468999999874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.13 E-value=1.7e-11 Score=114.89 Aligned_cols=190 Identities=16% Similarity=0.209 Sum_probs=120.9
Q ss_pred eccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCC--CCeeEEeeeeCc---eeEEEEecc-
Q 015406 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTG--IPNVRWFGVEGD---YNVLVMDLL- 85 (407)
Q Consensus 12 ~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~--i~~~~~~~~~~~---~~~lvme~~- 85 (407)
++.++.|....||++. ..+++|+.........+.+|..+++.+..... ++.+...+.... ..|+||+++
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 4568999999999864 46899986543223468899999999855433 444544443333 458999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 015406 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-------------------------------------------- 121 (407)
Q Consensus 86 g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-------------------------------------------- 121 (407)
|.+|.+... ..++..+...++.|++..|..||+
T Consensus 100 G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 176 (304)
T 3sg8_A 100 GVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF 176 (304)
T ss_dssp CEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred CeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence 777765433 257888888888999998888885
Q ss_pred --------------CCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcccCccCC---C-----Cccccccc
Q 015406 122 --------------KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN---K-----NLTGTARY 179 (407)
Q Consensus 122 --------------~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~---~-----~~~gt~~Y 179 (407)
..++|+|++|.||+++.+ ....+.|+||+.+............ .... . .+.....+
T Consensus 177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~-~~~~~~~iD~~~~~~~~~~~Dl~~~-~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTE-KNTICGIIDFGDAAISDPDNDFISL-MEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHTCGGGTCCCCEEECSCCCGGGEEEETT-TTEEEEECCCTTCEEECTTHHHHTT-CCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHhccccccCCceeEeCCCCcccEEEeCC-CCCEEEEEeCCCCccCChHHHHHHH-HhhccccCHHHHHHHHHHcCC
Confidence 137999999999999411 1566889999998754321110000 0000 0 00000001
Q ss_pred cc-cccccCCCCChhhHHHHHHHHHHHHHhCCCCC
Q 015406 180 AS-MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213 (407)
Q Consensus 180 ~a-PE~~~~~~~~~~sDIwSlG~il~elltG~~Pf 213 (407)
.. |+.... .....+.|++|.++|.+.+|..+|
T Consensus 255 ~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 255 KDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp SCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 11 121111 122368999999999999998776
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.73 E-value=5.3e-08 Score=91.11 Aligned_cols=136 Identities=24% Similarity=0.262 Sum_probs=91.8
Q ss_pred eccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCC--CCCeeEEeee-eCceeEEEEecc-CC
Q 015406 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGT--GIPNVRWFGV-EGDYNVLVMDLL-GP 87 (407)
Q Consensus 12 ~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~--~i~~~~~~~~-~~~~~~lvme~~-g~ 87 (407)
.+.++.|....||+. +..+++|+-........+.+|.++++.|.++. .++.+..++. ..+..+++|+++ |.
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 456788888999988 56789998533222346889999999998642 3555555553 455678999999 77
Q ss_pred CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------------
Q 015406 88 SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK--------------------------------------------- 122 (407)
Q Consensus 88 sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~--------------------------------------------- 122 (407)
+|.+..- ..++......++.++...|..||+.
T Consensus 99 ~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 175 (306)
T 3tdw_A 99 ILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR 175 (306)
T ss_dssp ECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred ECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence 7765321 1345555555555555555555532
Q ss_pred ---------------CceeccCCCCcccccCCCCCce-EEEEeccceee
Q 015406 123 ---------------SFLHRDIKPDNFLMGLGRRANQ-VYIIDFGLAKK 155 (407)
Q Consensus 123 ---------------~ivHrDLKp~NILl~~~~~~~~-~kL~DFGla~~ 155 (407)
.++|+|++|.|||++.++.++. +.|+||+.+..
T Consensus 176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3599999999999952112344 58999998864
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.60 E-value=4.3e-07 Score=83.00 Aligned_cols=131 Identities=18% Similarity=0.149 Sum_probs=95.1
Q ss_pred ccccCce-EEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-CCCHHHH
Q 015406 15 IGSGSFG-EIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDL 92 (407)
Q Consensus 15 iG~G~~g-~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~-g~sL~~~ 92 (407)
+..|..| .||+......+..+++|+.... ....+.+|...++.|...--++.+..++.+.+..++|||++ |.++.+.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~ 110 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS-VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQV 110 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH-HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC-CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccccc
Confidence 3445544 6999887667788999986432 23457889999999986655778888888888999999999 7787776
Q ss_pred HHHcCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------------------
Q 015406 93 FNFCSRKLSLKTVLMLADQMINRVEFVHSK-------------------------------------------------- 122 (407)
Q Consensus 93 l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-------------------------------------------------- 122 (407)
.... ......+..+++..|..||+.
T Consensus 111 ~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 185 (272)
T 4gkh_A 111 LEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHK 185 (272)
T ss_dssp HHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHT
T ss_pred ccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHh
Confidence 5431 122334556666666666631
Q ss_pred --------CceeccCCCCcccccCCCCCceEEEEecccee
Q 015406 123 --------SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (407)
Q Consensus 123 --------~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~ 154 (407)
.++|+|+.+.|||+ +..+.+-|+||+.+.
T Consensus 186 ~~~~~~~~~l~HGDl~~~Nil~---~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 186 LLPFSPDSVVTHGDFSLDNLIF---DEGKLIGCIDVGRVG 222 (272)
T ss_dssp TCCCCCCEEEECSCCCTTSEEE---ETTEEEEECCCTTCE
T ss_pred cccccCCcEEEcCCCCCCeEEE---ECCeEEEEEECcccc
Confidence 16899999999999 455566799999875
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.46 E-value=3e-07 Score=87.65 Aligned_cols=81 Identities=17% Similarity=0.287 Sum_probs=55.6
Q ss_pred eeEeccc-cccCceEEEEEEEc--C----CCeEEEEEEecCCC-----CcchHHHHHHHHHHHcCC--CCCCeeEEeeee
Q 015406 9 FRLGRKI-GSGSFGEIYLGTNI--Q----TNEEVAIKLENVKT-----KHPQLLYESKLYRILQGG--TGIPNVRWFGVE 74 (407)
Q Consensus 9 y~i~~~i-G~G~~g~Vy~~~~~--~----~~~~vAvK~~~~~~-----~~~~~~~E~~~l~~l~~~--~~i~~~~~~~~~ 74 (407)
....+.| +.|....+|+.... . +++.+++|+..... ....+.+|..+++.|... -.++.+..+..+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 3445677 88989999998742 0 26789999865432 135688999999998754 346666666544
Q ss_pred C---ceeEEEEecc-CCCH
Q 015406 75 G---DYNVLVMDLL-GPSL 89 (407)
Q Consensus 75 ~---~~~~lvme~~-g~sL 89 (407)
. +..|++||++ |..+
T Consensus 102 ~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp STTTSSCEEEEECCCCBCC
T ss_pred CCccCCceEEEEecCCCCh
Confidence 3 3568999999 5444
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.45 E-value=1.1e-06 Score=85.21 Aligned_cols=75 Identities=17% Similarity=0.162 Sum_probs=50.4
Q ss_pred EeccccccCceEEEEEEEcCCCeEEEEEEecCCC---------CcchHHHHHHHHHHHcCC--CCCCeeEEeeeeCceeE
Q 015406 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---------KHPQLLYESKLYRILQGG--TGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 11 i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---------~~~~~~~E~~~l~~l~~~--~~i~~~~~~~~~~~~~~ 79 (407)
-.+.||.|.++.||++.....++.|+||...... ....+..|.++++.+... ..++.+..+ +.+..+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 3568999999999999765567889999754321 123467899999988653 345565554 344568
Q ss_pred EEEeccCC
Q 015406 80 LVMDLLGP 87 (407)
Q Consensus 80 lvme~~g~ 87 (407)
+|||++.+
T Consensus 112 lvmE~l~g 119 (397)
T 2olc_A 112 TVMEDLSH 119 (397)
T ss_dssp EEECCCTT
T ss_pred EEEEeCCC
Confidence 99999943
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.26 E-value=6.6e-06 Score=77.50 Aligned_cols=136 Identities=15% Similarity=0.219 Sum_probs=78.8
Q ss_pred eccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCC-CCCeeEE------eeeeCceeEEEEec
Q 015406 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGT-GIPNVRW------FGVEGDYNVLVMDL 84 (407)
Q Consensus 12 ~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~-~i~~~~~------~~~~~~~~~lvme~ 84 (407)
.+.|+.|..+.||++.. .+..+++|+... ....+..|..+++.|.... .++.+.. +....+..+++|+|
T Consensus 37 ~~~l~gG~~n~~~~v~~--~~~~~vlk~~~~--~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHT--DSGAVCLKRIHR--PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EEECC----CEEEEEEE--TTEEEEEEEECS--CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeeccccccCcEEEEEe--CCCCEEEEecCC--CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 34566678899999984 344599998765 2344566778777776321 2333322 12346678999999
Q ss_pred c-CCCHH-----------HH---HHHcCCCC-------------CHHH-------------------------------H
Q 015406 85 L-GPSLE-----------DL---FNFCSRKL-------------SLKT-------------------------------V 105 (407)
Q Consensus 85 ~-g~sL~-----------~~---l~~~~~~l-------------~~~~-------------------------------~ 105 (407)
+ |..+. .. ++.....+ .+.. +
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9 54321 11 11111111 1111 1
Q ss_pred HHHHHHHHHHHHHHH-------------hCCceeccCCCCcccccCCCCCceEEEEecccee
Q 015406 106 LMLADQMINRVEFVH-------------SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (407)
Q Consensus 106 ~~i~~qi~~aL~yLH-------------~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~ 154 (407)
..+..++..++.+|+ ..+++|+|+++.|||+ +.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~---~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLL---GENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEE---CGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEE---eCCCcEEEEehhhcc
Confidence 111222344566665 2579999999999999 456789999999875
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.90 E-value=4.4e-05 Score=74.42 Aligned_cols=73 Identities=16% Similarity=0.307 Sum_probs=46.4
Q ss_pred EeccccccCceEEEEEEEcCCCeEEEEEEecC-----CCC----cchHHHHHHHHHHHc--CCCCCCeeEEeeeeCceeE
Q 015406 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-----KTK----HPQLLYESKLYRILQ--GGTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 11 i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~-----~~~----~~~~~~E~~~l~~l~--~~~~i~~~~~~~~~~~~~~ 79 (407)
-.+.||.|..+.||++. .+++.++||.... ... ......|.+++..+. .+..++.+..++ ....+
T Consensus 38 ~i~~l~~G~~n~vyrv~--~~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~ 113 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVV--GSSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMAL 113 (420)
T ss_dssp EEEECCCSSSCEEEEEE--CSSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTE
T ss_pred EEEEccCCCcEEEEEEE--cCCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccE
Confidence 35678999999999996 4567899994221 111 123344555554443 234566666555 45679
Q ss_pred EEEecc-CC
Q 015406 80 LVMDLL-GP 87 (407)
Q Consensus 80 lvme~~-g~ 87 (407)
+|||++ ++
T Consensus 114 lv~e~l~~g 122 (420)
T 2pyw_A 114 IGMRYLEPP 122 (420)
T ss_dssp EEECCCCTT
T ss_pred EEEeecCCc
Confidence 999999 76
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.85 E-value=7.7e-05 Score=69.14 Aligned_cols=71 Identities=13% Similarity=0.095 Sum_probs=49.1
Q ss_pred eeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-C
Q 015406 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (407)
Q Consensus 9 y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~-g 86 (407)
|.-.+.|+.|....+|++ ..+++|+...... ......|..+++.+......+.+..+. .+..++++||+ +
T Consensus 20 ~~~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~ 91 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAG 91 (301)
T ss_dssp CCSCEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTT
T ss_pred ccceeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCC
Confidence 333678889999999998 4689998754321 224578999999888665556666554 33347899999 5
Q ss_pred C
Q 015406 87 P 87 (407)
Q Consensus 87 ~ 87 (407)
|
T Consensus 92 g 92 (301)
T 3dxq_A 92 A 92 (301)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.81 E-value=9.7e-05 Score=69.44 Aligned_cols=141 Identities=16% Similarity=0.114 Sum_probs=74.4
Q ss_pred eccccccCceE-EEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCC-CCeeEEeeeeCceeEEEEecc-CCC
Q 015406 12 GRKIGSGSFGE-IYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTG-IPNVRWFGVEGDYNVLVMDLL-GPS 88 (407)
Q Consensus 12 ~~~iG~G~~g~-Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~-i~~~~~~~~~~~~~~lvme~~-g~s 88 (407)
.+.|+.|.... +|+... .++..+++|...... ...+..|..+++.|..... ++.+..+....+ +++||++ +.+
T Consensus 23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~-~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEE-GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp ECC--------CCEEEEC-TTCCEEEEEECCTTT-TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCC-CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 34566565554 667762 236778888654321 1456788999988875432 555555533333 7899999 556
Q ss_pred HHHHHHHc-------------------C------CCCCHHHHH-------H-HH------------HHHHHHHHHH----
Q 015406 89 LEDLFNFC-------------------S------RKLSLKTVL-------M-LA------------DQMINRVEFV---- 119 (407)
Q Consensus 89 L~~~l~~~-------------------~------~~l~~~~~~-------~-i~------------~qi~~aL~yL---- 119 (407)
+.+.+... . ..++..... . +. ..+...++.+
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 65443210 0 012221110 0 00 0111222233
Q ss_pred --HhCCceeccCCCCcccccCCCC-CceEEEEeccceeee
Q 015406 120 --HSKSFLHRDIKPDNFLMGLGRR-ANQVYIIDFGLAKKY 156 (407)
Q Consensus 120 --H~~~ivHrDLKp~NILl~~~~~-~~~~kL~DFGla~~~ 156 (407)
+...++|+|+.+.|||+..+.. .+.+.|+||+.+..-
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 2357999999999999942110 267899999988643
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.81 E-value=7.9e-05 Score=69.55 Aligned_cols=75 Identities=20% Similarity=0.257 Sum_probs=57.8
Q ss_pred EeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCC--CCCCeeEEeeeeCceeEEEEecc-CC
Q 015406 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGG--TGIPNVRWFGVEGDYNVLVMDLL-GP 87 (407)
Q Consensus 11 i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~--~~i~~~~~~~~~~~~~~lvme~~-g~ 87 (407)
-.+.|+.|....+|+.. ..+..+++|+.... ....+..|...++.|... ..++.+..++...+..++|||++ |.
T Consensus 40 ~~~~l~gG~~n~~y~v~--~~~~~~vlK~~~~~-~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIN--DEVQTVFVKINERS-YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEEECCSSSSEEEEEE--SSSCEEEEEEEEGG-GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eeEEeCCccceeeeEEE--ECCCeEEEEeCCcc-cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 35678999999999998 45778999986543 234578899999998643 55677777777778899999999 55
Q ss_pred C
Q 015406 88 S 88 (407)
Q Consensus 88 s 88 (407)
.
T Consensus 117 ~ 117 (312)
T 3jr1_A 117 K 117 (312)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.78 E-value=0.00029 Score=64.73 Aligned_cols=78 Identities=14% Similarity=0.073 Sum_probs=55.3
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC--cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
.+.+..-++.+|.|..+.||+.+. .+|+.|.+|+...... ...+..|...|+.|.....++.-..+.... .+++|
T Consensus 13 ~G~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~~--~~lv~ 89 (288)
T 3f7w_A 13 TGREVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWDD--RTLAM 89 (288)
T ss_dssp HCCCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEET--TEEEE
T ss_pred cCCCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEeccC--ceEEE
Confidence 356677788999999999999985 6789999998654322 234788999999997543333322333333 37899
Q ss_pred ecc
Q 015406 83 DLL 85 (407)
Q Consensus 83 e~~ 85 (407)
|++
T Consensus 90 e~l 92 (288)
T 3f7w_A 90 EWV 92 (288)
T ss_dssp ECC
T ss_pred Eee
Confidence 998
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.78 E-value=0.00047 Score=60.03 Aligned_cols=123 Identities=13% Similarity=0.111 Sum_probs=77.7
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCccc
Q 015406 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165 (407)
Q Consensus 87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~ 165 (407)
.||.+++...+.+++++++|.++.|.+.+|.-+-. +.-..+=+-|..|+| ..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l---~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRV---WRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEE---ETTSCEEECC-C--------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEE---ecCCceeccc-cccc-----------
Confidence 38999999888999999999999999999877621 111122233566666 3556555443 1110
Q ss_pred CccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCCc
Q 015406 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 245 (407)
Q Consensus 166 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 245 (407)
.....+.+||... ...+.+.=|||||+++|..+-=..|=. ....++
T Consensus 98 --------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~-------------------------eE~eLS 143 (229)
T 2yle_A 98 --------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKEN-------------------------EERELS 143 (229)
T ss_dssp -----------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTT-------------------------EEECCC
T ss_pred --------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcc-------------------------cchhhC
Confidence 1123456788764 345788999999999999986222211 113478
Q ss_pred HHHHHHHHHHhCC
Q 015406 246 TEFASYFHYCRSL 258 (407)
Q Consensus 246 ~~l~~li~~cl~~ 258 (407)
+.+.+||..|..-
T Consensus 144 ~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 144 PPLEQLIDHMANT 156 (229)
T ss_dssp HHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHhc
Confidence 9999999999765
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.72 E-value=0.0003 Score=65.57 Aligned_cols=139 Identities=17% Similarity=0.199 Sum_probs=78.9
Q ss_pred EeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCC-CCeeEEe------eeeCceeEEEEe
Q 015406 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTG-IPNVRWF------GVEGDYNVLVMD 83 (407)
Q Consensus 11 i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~-i~~~~~~------~~~~~~~~lvme 83 (407)
-.+.|+.|....+|++.. ..+ .+++|+.........+..|..+++.|..... ++.+... ....+..+++|+
T Consensus 26 ~~~~i~~G~~n~~~~v~~-~~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~ 103 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHT-TKD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS 103 (322)
T ss_dssp EEEEECC---EEEEEEEE-SSC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred EeeccCCCcccceEEEEe-CCc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence 356678888899999984 333 6889987754344567889999988875322 3333221 123456789999
Q ss_pred cc-CCCHH-----H------H---HHHcCCCC--------C---HHHHHH------------HHHHHHHHHHHHHh----
Q 015406 84 LL-GPSLE-----D------L---FNFCSRKL--------S---LKTVLM------------LADQMINRVEFVHS---- 121 (407)
Q Consensus 84 ~~-g~sL~-----~------~---l~~~~~~l--------~---~~~~~~------------i~~qi~~aL~yLH~---- 121 (407)
++ |..+. . . ++.....+ . +..... +...+...++++++
T Consensus 104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~ 183 (322)
T 2ppq_A 104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 183 (322)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence 99 54321 1 1 11111111 1 111000 00113344555552
Q ss_pred ---CCceeccCCCCcccccCCCCCceEEEEecccee
Q 015406 122 ---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (407)
Q Consensus 122 ---~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~ 154 (407)
.+++|+|+.+.|||+. .+..+.|+||+.+.
T Consensus 184 ~~~~~liHgDl~~~Nil~~---~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 184 DLPAGVIHADLFQDNVFFL---GDELSGLIDFYFAC 216 (322)
T ss_dssp SSCEEEECSCCCGGGEEEE---TTEEEEECCCTTCE
T ss_pred cCCcccCCCCCCccCEEEe---CCceEEEecchhcc
Confidence 4699999999999993 44455799998775
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.25 E-value=0.0015 Score=63.72 Aligned_cols=70 Identities=13% Similarity=0.113 Sum_probs=50.1
Q ss_pred eccccccCceEEEEEEEcC-------CCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEec
Q 015406 12 GRKIGSGSFGEIYLGTNIQ-------TNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (407)
Q Consensus 12 ~~~iG~G~~g~Vy~~~~~~-------~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~ 84 (407)
.+.|+.|....||++.... .++.+++|+.........+..|..+++.|......+.+.+.+. + .+||||
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e~ 153 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEEY 153 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEECC
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEEE
Confidence 5578888889999998642 2578999987432211567789999999987666677655433 2 389999
Q ss_pred c
Q 015406 85 L 85 (407)
Q Consensus 85 ~ 85 (407)
+
T Consensus 154 l 154 (429)
T 1nw1_A 154 I 154 (429)
T ss_dssp C
T ss_pred e
Confidence 8
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.23 E-value=0.00064 Score=65.11 Aligned_cols=139 Identities=17% Similarity=0.187 Sum_probs=81.8
Q ss_pred eccccccCceEEEEEEEcC-------CCeEEEEEEecCCC-CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 12 GRKIGSGSFGEIYLGTNIQ-------TNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 12 ~~~iG~G~~g~Vy~~~~~~-------~~~~vAvK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
.+.|..|-...+|++.... .++.|++|+..... ....+.+|.++++.|......+.+.+++.. .+|||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 3467778888999998532 35789999853321 233467899999999876667777665543 28999
Q ss_pred cc-CCCHH--------------HHHHHc-C------CCCC--HHHHHHHHHHHHH-------------------HHHHHH
Q 015406 84 LL-GPSLE--------------DLFNFC-S------RKLS--LKTVLMLADQMIN-------------------RVEFVH 120 (407)
Q Consensus 84 ~~-g~sL~--------------~~l~~~-~------~~l~--~~~~~~i~~qi~~-------------------aL~yLH 120 (407)
|+ |.+|. +.+.+. . +... +..+..+..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 99 54332 111111 1 1112 3455666554422 233333
Q ss_pred ----h----CCceeccCCCCcccccCC-CCCceEEEEecccee
Q 015406 121 ----S----KSFLHRDIKPDNFLMGLG-RRANQVYIIDFGLAK 154 (407)
Q Consensus 121 ----~----~~ivHrDLKp~NILl~~~-~~~~~~kL~DFGla~ 154 (407)
. ..++|+|+.+.|||+..+ +..+.+.|+||..|.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2 258999999999999522 113689999998875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0017 Score=60.61 Aligned_cols=72 Identities=13% Similarity=0.104 Sum_probs=46.6
Q ss_pred cccccCceEEEEEEEcCCCeEEEEEEecCC-CCcchHHHHHHHHHHHcCCCC-CCeeEEe-----eeeCceeEEEEeccC
Q 015406 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVK-TKHPQLLYESKLYRILQGGTG-IPNVRWF-----GVEGDYNVLVMDLLG 86 (407)
Q Consensus 14 ~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-~~~~~~~~E~~~l~~l~~~~~-i~~~~~~-----~~~~~~~~lvme~~g 86 (407)
.|+ |....||++.. .+|+.+++|+.... .....+..|..+++.|..... ++.+... ....+..+++|+++.
T Consensus 33 ~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 33 PLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred eec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 455 77889998863 45667999998643 234567789999988874322 3333221 123456688999994
Q ss_pred C
Q 015406 87 P 87 (407)
Q Consensus 87 ~ 87 (407)
|
T Consensus 111 G 111 (328)
T 1zyl_A 111 G 111 (328)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.17 E-value=0.00081 Score=64.09 Aligned_cols=72 Identities=13% Similarity=0.081 Sum_probs=44.8
Q ss_pred eccccccCceEEEEEEEcC--------CCeEEEEEEecCCCC-cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 12 GRKIGSGSFGEIYLGTNIQ--------TNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 12 ~~~iG~G~~g~Vy~~~~~~--------~~~~vAvK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
.+.|+.|....+|++.... .++.+++|+...... ......|..+++.|......+.+.... . .+++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 4567888888999998543 136899998654221 113468999999987655566665433 2 36899
Q ss_pred ecc-CC
Q 015406 83 DLL-GP 87 (407)
Q Consensus 83 e~~-g~ 87 (407)
+|+ |.
T Consensus 114 e~i~G~ 119 (369)
T 3c5i_A 114 EWLYGD 119 (369)
T ss_dssp ECCCSE
T ss_pred EEecCC
Confidence 999 53
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0038 Score=61.33 Aligned_cols=70 Identities=16% Similarity=0.074 Sum_probs=48.0
Q ss_pred eccccccCceEEEEEEEcCCCeEEEEEEecCCCC-cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc
Q 015406 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (407)
Q Consensus 12 ~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~ 85 (407)
.+.|+.|-...+|++.....+..+++|+...... .-...+|..+++.|......+.+.+++. + .+||||+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I 183 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFM 183 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEee
Confidence 4578888889999998654458899998643221 1123689999999987666677766552 2 3599998
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.35 E-value=0.032 Score=52.30 Aligned_cols=68 Identities=13% Similarity=0.111 Sum_probs=42.1
Q ss_pred cccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCC--CCeeEEe------eeeCceeEEEEecc-C
Q 015406 16 GSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTG--IPNVRWF------GVEGDYNVLVMDLL-G 86 (407)
Q Consensus 16 G~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~--i~~~~~~------~~~~~~~~lvme~~-g 86 (407)
|.|....||++.. .+| .+++|+..... ...|..+++.|..... ++..... ....+..+++|+|+ |
T Consensus 32 G~g~~N~vy~v~~-~~g-~~vLK~~~~~~----~~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G 105 (339)
T 3i1a_A 32 GADTNAFAYQADS-ESK-SYFIKLKYGYH----DEINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA 105 (339)
T ss_dssp TSCSSCEEEEEEC-SSC-EEEEEEEECSS----CCHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred cCccccceEEEEe-CCC-CEEEEEecCcc----chHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence 3344679999983 345 89999876543 2467778877764311 2332211 23456789999999 5
Q ss_pred CCH
Q 015406 87 PSL 89 (407)
Q Consensus 87 ~sL 89 (407)
..+
T Consensus 106 ~~~ 108 (339)
T 3i1a_A 106 PNG 108 (339)
T ss_dssp CBT
T ss_pred CcC
Confidence 544
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.22 E-value=0.17 Score=48.86 Aligned_cols=73 Identities=12% Similarity=0.132 Sum_probs=50.3
Q ss_pred eccccccCceEEEEEEEcCC-------CeEEEEEEecCCCC-cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 12 GRKIGSGSFGEIYLGTNIQT-------NEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 12 ~~~iG~G~~g~Vy~~~~~~~-------~~~vAvK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
++.|..|-...+|++..... ++.|++|+...... .-...+|..+++.|......+.+...+ . .++||+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~e 150 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEE 150 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEE
Confidence 45677788889999986421 57899998644321 223578999999998766677766432 2 278999
Q ss_pred cc-CCC
Q 015406 84 LL-GPS 88 (407)
Q Consensus 84 ~~-g~s 88 (407)
|+ |.+
T Consensus 151 fI~G~~ 156 (424)
T 3mes_A 151 FIDGEP 156 (424)
T ss_dssp CCCSEE
T ss_pred EeCCcc
Confidence 99 544
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.65 E-value=0.083 Score=50.70 Aligned_cols=32 Identities=28% Similarity=0.500 Sum_probs=25.7
Q ss_pred ceeccCCCCcccccCC---CCCceEEEEeccceee
Q 015406 124 FLHRDIKPDNFLMGLG---RRANQVYIIDFGLAKK 155 (407)
Q Consensus 124 ivHrDLKp~NILl~~~---~~~~~~kL~DFGla~~ 155 (407)
++|+|+.+.|||+..+ ++...++++||-.|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999431 3567899999988753
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 407 | ||||
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-96 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-92 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-32 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-31 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-31 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-30 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-30 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-30 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 9e-30 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-29 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-29 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-28 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-28 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-28 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-28 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-27 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-27 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-27 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-27 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-27 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-27 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-27 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-26 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-26 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-25 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-25 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-25 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-25 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-25 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-24 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-24 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-24 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-24 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-24 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-24 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 9e-24 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-23 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-23 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-23 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-23 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-23 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-23 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-23 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-23 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-22 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-22 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-22 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-22 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-22 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-22 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 9e-22 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-21 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-21 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-21 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-21 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-21 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-20 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-19 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-19 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-18 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-18 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-17 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-17 |
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 288 bits (737), Expect = 3e-96
Identities = 232/299 (77%), Positives = 272/299 (90%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
ME RVGN++RLGRKIGSGSFG+IYLGT+I EEVAIKLE VKTKHPQL ESK+Y+++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GG GIP +RW G EGDYNV+VM+LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAKKYRD THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
S+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQ 299
C+GYP+EFA+Y ++CRSLRFDDKPDY+YL+++FR+LF R+GF +DYVFDW +LK+ S+
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASR 299
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 278 bits (711), Expect = 2e-92
Identities = 173/291 (59%), Positives = 214/291 (73%), Gaps = 2/291 (0%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTG 64
VG +++GR+IG GSFG I+ GTN+ N++VAIK E ++ PQL E + Y++L G TG
Sbjct: 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTG 62
Query: 65 IPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
IPNV +FG EG +NVLV+DLLGPSLEDL + C RK S+KTV M A QM+ RV+ +H KS
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSL 122
Query: 125 LHRDIKPDNFLMGLG--RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASM 182
++RDIKPDNFL+G + AN +Y++DFG+ K YRD T QHIPYRE KNL+GTARY S+
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182
Query: 183 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242
NTHLG EQSRRDDLE+LG+V MYFLRGSLPWQGLKA T KQKYE+I EKK ST + LC
Sbjct: 183 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA 242
Query: 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTIL 293
G+P EF Y HY R+L FD PDY YL+ +F + R D FDW +L
Sbjct: 243 GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL 293
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 5e-32
Identities = 61/280 (21%), Positives = 114/280 (40%), Gaps = 27/280 (9%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ----LLYESKLYRILQGG 62
+ +G++IGSGSFG +Y G + + +VA+K+ NV PQ E + R +
Sbjct: 8 GQITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH- 63
Query: 63 TGIPN-VRWFGVEGDYNV-LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
N + + G + +V G SL + K + ++ +A Q ++++
Sbjct: 64 ---VNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
H+KS +HRD+K +N + V I DFGLA S + L+G+ +
Sbjct: 121 HAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQF-----EQLSGSILW 172
Query: 180 ASMNTHLGIEQ---SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236
+ ++ S + D+ + G VL + G LP+ + + Q + +S
Sbjct: 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN--NRDQIIFMVGRGYLSPD 230
Query: 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276
+ + P C + D++P + + L
Sbjct: 231 LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 119 bits (300), Expect = 3e-31
Identities = 50/312 (16%), Positives = 114/312 (36%), Gaps = 31/312 (9%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLLYESKLYRILQGGTG 64
+ + + ++G+G+FG ++ T T A K + ++ + E + +L+
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR-HPT 84
Query: 65 IPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
+ N+ + + V++ + + G L + K+S + Q+ + +H +
Sbjct: 85 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 144
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMN 183
++H D+KP+N + +R+N++ +IDFGL + + TGTA +A+
Sbjct: 145 YVHLDLKPENIMF-TTKRSNELKLIDFGLTAHLDPKQSVKVT--------TGTAEFAAPE 195
Query: 184 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243
G D+ S+G + L G P+ G + + ++ G
Sbjct: 196 VAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE---NDDETLRNVKSCDW-NMDDSAFSG 251
Query: 244 YPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREG-----------FQFDYVFDWTI 292
+ + + + + + ++ G ++ + D
Sbjct: 252 ISEDGKDFIRKLLLADPNTRMT---IHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIK 308
Query: 293 LKYQQSQLATPP 304
KY PP
Sbjct: 309 TKYDAWPEPLPP 320
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 8e-31
Identities = 48/233 (20%), Positives = 88/233 (37%), Gaps = 19/233 (8%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLLYESKLYRILQGG 62
F+ G+ +G GSF + L + T+ E AIK + K P + E + L
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH- 67
Query: 63 TGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
+ + + + + L ++++ +E++H
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHG 126
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181
K +HRD+KP+N L+ + I DFG AK S + GTA+Y S
Sbjct: 127 KGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARA-----NSFVGTAQYVS 178
Query: 182 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234
+ DL +LG ++ + G P++ G + ++KI + +
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA---GNEYLIFQKIIKLEYD 228
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 1e-30
Identities = 57/332 (17%), Positives = 119/332 (35%), Gaps = 33/332 (9%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY-ESKLYRILQGGTGIP 66
K+ + +G G FG ++ + + K VK L+ E + I + I
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR-HRNIL 64
Query: 67 NVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 125
++ + V++ + + G + + N + +L+ + ++ Q+ ++F+HS +
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124
Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTH 185
H DI+P+N + RR++ + II+FG A++ + + + Y + H
Sbjct: 125 HFDIRPENIIYQ-TRRSSTIKIIEFGQARQLKPGDNFRLLF--------TAPEYYAPEVH 175
Query: 186 LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 245
S D+ SLG ++ L G P+ T +Q E I + T E +
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINPFLA---ETNQQIIENIMNAEY-TFDEEAFKEIS 231
Query: 246 TEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREG--------------FQFDYVFDWT 291
E + + + ++++ ++ +
Sbjct: 232 IEAMDFVDRLLVKERKSRMT---ASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKK 288
Query: 292 ILKYQQSQLATPPARALVPGAGTSGAPPAIAS 323
L S A+ G S A +AS
Sbjct: 289 DLNMVVSAARISCGGAIRSQKGVSVAKVKVAS 320
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 2e-30
Identities = 47/271 (17%), Positives = 101/271 (37%), Gaps = 27/271 (9%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLLYESKLYRILQGGT 63
+ F ++G+G+ G ++ ++ + +A K LE Q++ E ++
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN-SP 64
Query: 64 GIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
I + M+ + G SL+ + + ++ + + ++ +I + ++ K
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 123 -SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181
+HRD+KP N L+ ++ + DFG++ + D+ + + GT Y S
Sbjct: 124 HKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLIDSMANSFV---------GTRSYMS 171
Query: 182 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241
G S + D+ S+G L+ G P A + + E +
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA------- 224
Query: 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRI 272
P + S D +P A + +
Sbjct: 225 -ETPPRPRTPGRPLSSYGMDSRPPMAIFELL 254
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 117 bits (295), Expect = 2e-30
Identities = 51/235 (21%), Positives = 91/235 (38%), Gaps = 20/235 (8%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKLYRILQ 60
V + + + ++GSG+FG ++ T K + T +P + E + L
Sbjct: 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKF--INTPYPLDKYTVKNEISIMNQLH 84
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
+ N+ + VL+++ L G L D K+S V+ Q ++ +
Sbjct: 85 -HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHM 143
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
H S +H DIKP+N + ++A+ V IIDFGLA K + T TA +
Sbjct: 144 HEHSIVHLDIKPENIMC-ETKKASSVKIIDFGLATKLNPDEIVKVT--------TATAEF 194
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234
A+ D+ ++G + L G P+ G + + +
Sbjct: 195 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG---EDDLETLQNVKRCDWE 246
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 9e-30
Identities = 42/235 (17%), Positives = 93/235 (39%), Gaps = 28/235 (11%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKLYRILQGGTGIP 66
+ + ++G G+FG++Y N +T+ A K+ + K++ + E + P
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH----P 69
Query: 67 N-VRWFGV--EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
N V+ + ++++ G +++ + R L+ + ++ Q ++ + ++H
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 129
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASM 182
+HRD+K N L + + DFG++ K T + + GT + +
Sbjct: 130 KIIHRDLKAGNILFT---LDGDIKLADFGVSAKNTRTIQRRD-------SFIGTPYWMAP 179
Query: 183 NTHLGIEQSRRD-----DLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232
+ R D+ SLG L+ P L + KI++ +
Sbjct: 180 EVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL---NPMRVLLKIAKSE 231
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 1e-29
Identities = 54/233 (23%), Positives = 91/233 (39%), Gaps = 21/233 (9%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLLYESKLYRILQG 61
F +GR +G G FG +YL Q+ +A+K QL E ++ L+
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR- 64
Query: 62 GTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
I + + + L+++ K + ++ N + + HS
Sbjct: 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 124
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181
K +HRDIKP+N L+G A ++ I DFG + + GT Y
Sbjct: 125 KRVIHRDIKPENLLLG---SAGELKIADFGWSVHAPSSRRTTLC---------GTLDYLP 172
Query: 182 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234
G + DL SLG + FL G P++ T ++ Y++IS + +
Sbjct: 173 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA---NTYQETYKRISRVEFT 222
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 111 bits (279), Expect = 6e-29
Identities = 53/225 (23%), Positives = 97/225 (43%), Gaps = 25/225 (11%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLLYESKLYRI 58
+ +++ LG +G G E++L +++ + +VA+K L + + + E++
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 59 LQGGTGIPN-VRWFGV------EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLAD 110
L P V + G +VM+ + G +L D+ + ++ K + +
Sbjct: 64 LNH----PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIA 118
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170
+ F H +HRD+KP N ++ N V ++DFG+A+ D+ +
Sbjct: 119 DACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVT----QT 171
Query: 171 KNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
+ GTA+Y S G R D+ SLG VL L G P+ G
Sbjct: 172 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 216
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 2e-28
Identities = 57/248 (22%), Positives = 103/248 (41%), Gaps = 27/248 (10%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--------ENVKTKHPQLLYESKLYRI 58
+++++G +GSG FG +Y G + N VAIK ++ E L +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 59 LQGG-TGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINR 115
+ G +G+ + + D VL+++ P DLF+F + + L + Q++
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEA 122
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175
V H+ LHRDIK +N L + ++ +IDFG +DT G
Sbjct: 123 VRHCHNCGVLHRDIKDENIL--IDLNRGELKLIDFGSGALLKDTVYTDFD---------G 171
Query: 176 TARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234
T Y+ R + SLG +L + G +P++ + + + ++VS
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH---DEEIIRGQVFFRQRVS 228
Query: 235 TSIEALCR 242
+ + L R
Sbjct: 229 SECQHLIR 236
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 2e-28
Identities = 58/250 (23%), Positives = 100/250 (40%), Gaps = 25/250 (10%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLLYESKLYRILQGGT 63
+ L + +G G++GE+ L N T E VA+K ++ + E + ++L
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-- 62
Query: 64 GIPN-VRWFGV--EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
N V+++G EG+ L ++ + Q++ V ++H
Sbjct: 63 --ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
HRDIKP+N L+ + + I DFGLA +R + + + + GT Y
Sbjct: 121 GIGITHRDIKPENLLLD---ERDNLKISDFGLATVFRYNNRERLL-----NKMCGTLPYV 172
Query: 181 SMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQG------LKAGTKKQKYEKISEKKV 233
+ E + D+ S G VL L G LPW + K++K KK+
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 232
Query: 234 STSIEALCRG 243
++ AL
Sbjct: 233 DSAPLALLHK 242
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 2e-28
Identities = 46/235 (19%), Positives = 94/235 (40%), Gaps = 25/235 (10%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLLYESKLYRILQG 61
N F + +G G+FG++ L T A+K + K + + ES++ + +
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 62 GTGIPN-VRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEF 118
P ++ L + + +LF SR+ + + ++++ +E+
Sbjct: 65 ----PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 178
+HS+ ++RDIK +N ++ + + I DFGL K+ GT
Sbjct: 121 LHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMK-------TFCGTPE 170
Query: 179 YASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233
Y + + R D LG V+ + G LP+ ++ +E I +++
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN---QDHERLFELILMEEI 222
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (277), Expect = 4e-28
Identities = 42/211 (19%), Positives = 83/211 (39%), Gaps = 17/211 (8%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNV-- 68
+ +G G G++ N +T E+ A+K + P+ E +L+ I +
Sbjct: 16 TSQVLGLGINGKVLQIFNKRTQEKFALK---MLQDCPKARREVELHWRASQCPHIVRIVD 72
Query: 69 --RWFGVEGDYNVLVMDLL-GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
++VM+ L G L + + + + + + + ++++HS +
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 132
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNT 184
HRD+KP+N L R + + DFG AK+ ++ Y T Y +
Sbjct: 133 AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--------TPYYVAPEV 184
Query: 185 HLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
+ + D+ SLG ++ L G P+
Sbjct: 185 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 215
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 1e-27
Identities = 57/277 (20%), Positives = 114/277 (41%), Gaps = 27/277 (9%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKLYRILQGGTGI 65
+L ++G+G FGE+++G + +VA+K L+ L E+ L + LQ
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQH---- 67
Query: 66 PN-VRWFGVEGDYNV-LVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
VR + V + ++ + + G ++ L KL++ +L +A Q+ + F+
Sbjct: 68 QRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181
++++HRD++ N L+ I DFGLA+ D + ++ +
Sbjct: 128 RNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEYTAR------EGAKFPIKWTA 178
Query: 182 MNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
+ + D+ S G +L + G +P+ G+ T + + + +
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQNLERGYRMVRPD-- 233
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277
P E C R +D+P + YL+ + D F
Sbjct: 234 --NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 108 bits (272), Expect = 1e-27
Identities = 51/251 (20%), Positives = 94/251 (37%), Gaps = 34/251 (13%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLLYESKLYRILQGG 62
F R+IG GSFG +Y +++ +E VAIK + K ++ E + + L+
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH- 74
Query: 63 TGIPN-VRWFGV--EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
PN +++ G LVM+ S DL + L + + + + ++
Sbjct: 75 ---PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 131
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
HS + +HRD+K N L+ V + DFG A ++ GT +
Sbjct: 132 HSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPANSF-----------VGTPYW 177
Query: 180 ASMNTHLGIEQSRRD---DLESLGYVLMYFLRGSLPWQGLKAGT-----KKQKYEKISEK 231
+ L +++ + D D+ SLG + P + A + + + +
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSG 237
Query: 232 KVSTSIEALCR 242
S
Sbjct: 238 HWSEYFRNFVD 248
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 2e-27
Identities = 55/245 (22%), Positives = 97/245 (39%), Gaps = 22/245 (8%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLLYESKLYRILQGGTG 64
K+ KIG G+ G +Y ++ T +EVAI+ N++ K ++ E + R +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK-NPN 78
Query: 65 IPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
I N + GD +VM+ L G SL D+ + + + + + +EF+HS
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDV--VTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMN 183
+HRDIK DN L+ V + DFG + + + + GT + +
Sbjct: 137 VIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRS-------TMVGTPYWMAPE 186
Query: 184 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQG------LKAGTKKQKYEKISEKKVSTSI 237
+ D+ SLG + + + G P+ L E + +K+S
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246
Query: 238 EALCR 242
Sbjct: 247 RDFLN 251
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 108 bits (270), Expect = 2e-27
Identities = 51/235 (21%), Positives = 99/235 (42%), Gaps = 19/235 (8%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLLYESKLYRILQG 61
+ + + +G+G+F E+ L + +T + VAIK + ++ K + E + ++
Sbjct: 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK- 65
Query: 62 GTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFV 119
I + G + L+M L+ S +LF+ K + + L Q+++ V+++
Sbjct: 66 HPNIVALDDIYESGGHLYLIMQLV--SGGELFDRIVEKGFYTERDASRLIFQVLDAVKYL 123
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
H +HRD+KP+N L +++ I DFGL+K S GT Y
Sbjct: 124 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA--------CGTPGY 175
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234
+ S+ D S+G + L G P+ + +E+I + +
Sbjct: 176 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD---ENDAKLFEQILKAEYE 227
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 107 bits (268), Expect = 3e-27
Identities = 43/238 (18%), Positives = 81/238 (34%), Gaps = 21/238 (8%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----------LENVKTKHPQLLYESKLY 56
+ +G G + + T +E A+K E V+ L E +
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 57 RILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
R + G I ++ + LV DL+ L D LS K + ++
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-EKVTLSEKETRKIMRALLEV 122
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175
+ +H + +HRD+KP+N L+ + + DFG + + + + +
Sbjct: 123 ICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 179
Query: 176 TARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233
+ + H G + D+ S G ++ L GS P+ + I
Sbjct: 180 IIECSMNDNHPGY--GKEVDMWSTGVIMYTLLAGSPPFWH---RKQMLMLRMIMSGNY 232
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (269), Expect = 4e-27
Identities = 56/215 (26%), Positives = 88/215 (40%), Gaps = 17/215 (7%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLLYESKLYRILQGGTG 64
F L + +G GSFG+++L +TN+ AIK ++V + R+L
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 65 IPN-VRWFGV--EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
P F + VM+ L G L C K L A ++I ++F+H
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SK ++RD+K DN L+ + + I DFG+ K+ + GT Y
Sbjct: 121 SKGIVYRDLKLDNILLD---KDGHIKIADFGMCKENMLGDAKTN-------TFCGTPDYI 170
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
+ LG + + D S G +L L G P+ G
Sbjct: 171 APEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 205
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 5e-27
Identities = 67/293 (22%), Positives = 108/293 (36%), Gaps = 24/293 (8%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHP-QLLYESKLYRILQG- 61
+K+ KIG G+FGE++ + +T ++VA+K +EN K P L E K+ ++L+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 62 ------GTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
+ LV D L L + K +L + + ++N
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175
+ ++H LHRD+K N L+ R + + DFGLA+ + Q Y N
Sbjct: 130 LYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNSQPNRY---TNRVV 183
Query: 176 TARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234
T Y LG DL G ++ S QG T++ + IS+ S
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG---NTEQHQLALISQLCGS 240
Query: 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR--IFRDLFIREGFQFD 285
+ E E + + K R DL I + D
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDL-IDKLLVLD 292
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 106 bits (266), Expect = 2e-26
Identities = 55/235 (23%), Positives = 87/235 (37%), Gaps = 20/235 (8%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLLYESKLYRILQG 61
N F + R IG G FGE+Y T + A+K +K L E + ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 62 GT--GIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
G I + + D ++DL+ S + A ++I +E +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
H++ ++RD+KP N L+ V I D GLA + H + GT Y
Sbjct: 124 HNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKKKPHASV---------GTHGY 171
Query: 180 ASMNTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233
+ G+ D SLG +L LRG P++ K K + V
Sbjct: 172 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV 226
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 105 bits (263), Expect = 3e-26
Identities = 45/248 (18%), Positives = 97/248 (39%), Gaps = 15/248 (6%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIP 66
+ ++L RK+G G + E++ NI NE+V +K+ K ++ E K+ L+GG I
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-PVKKKKIKREIKILENLRGGPNII 93
Query: 67 NVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 126
+ + + + D + L+ + +++ +++ HS +H
Sbjct: 94 TLADIVKDPVSRTPALVFEHVNNTDFKQLY-QTLTDYDIRFYMYEILKALDYCHSMGIMH 152
Query: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL 186
RD+KP N + + ++ +ID+GLA+ Y + + + +
Sbjct: 153 RDVKPHNVM--IDHEHRKLRLIDWGLAEFYHPGQEYNVR--------VASRYFKGPELLV 202
Query: 187 GIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 245
+ D+ SLG +L + P+ + +I++ + + Y
Sbjct: 203 DYQMYDYSLDMWSLGCMLASMIFRKEPFFH--GHDNYDQLVRIAKVLGTEDLYDYIDKYN 260
Query: 246 TEFASYFH 253
E F+
Sbjct: 261 IELDPRFN 268
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 1e-25
Identities = 55/275 (20%), Positives = 109/275 (39%), Gaps = 27/275 (9%)
Query: 13 RKIGSGSFGEIYLGTNIQTNE--EVAIK---LENVKTKHPQLLYESKLYRILQGGTGIPN 67
++G G+FG + G + +VAIK K +++ E+++ L P
Sbjct: 15 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN----PY 70
Query: 68 -VRWFGV-EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
VR GV + + +LVM++ G L ++ + V L Q+ ++++ K+F
Sbjct: 71 IVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 130
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNT 184
+HRD+ N L+ + I DFGL+K ++ ++ +
Sbjct: 131 VHRDLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTA----RSAGKWPLKWYAPEC 183
Query: 185 HLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243
+ S R D+ S G + L G P++ + + I + K
Sbjct: 184 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM---KGPEVMAFIEQGK----RMECPPE 236
Query: 244 YPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278
P E + C +++D+PD+ +++ R +
Sbjct: 237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 2e-25
Identities = 58/294 (19%), Positives = 101/294 (34%), Gaps = 30/294 (10%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLLYESKLYRILQG 61
VG ++ IG G++G + + VAIK +T + L E K+ +
Sbjct: 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 65
Query: 62 GTGIPN-VRWFGV-------EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 113
N + + + LV L+G L L ++ LS + Q++
Sbjct: 66 ----ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK--TQHLSNDHICYFLYQIL 119
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNL 173
++++HS + LHRD+KP N L+ + I DFGLA+ H
Sbjct: 120 RGLKYIHSANVLHRDLKPSNLLLN---TTCDLKICDFGLARVADPDHDHTGFLTE----Y 172
Query: 174 TGTARYASMN-THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232
T Y + ++ D+ S+G +L L + G + I
Sbjct: 173 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG---KHYLDQLNHILGIL 229
Query: 233 VSTSIEALCRGYPTEFASY-FHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFD 285
S S E L + +Y + + DL + + F+
Sbjct: 230 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDL-LDKMLTFN 282
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 3e-25
Identities = 61/280 (21%), Positives = 98/280 (35%), Gaps = 29/280 (10%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTN---EEVAIK-----LENVKTKHPQLLYESKLYRILQ 60
RL K+G GSFG + G + VA+K + + + E L
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 61 GGTGIPN-VRWFGV-EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
N +R +GV +V +L SL D L T+ A Q+ +
Sbjct: 70 H----RNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTA 177
++ SK F+HRD+ N L+ + V I DFGL + H Y ++
Sbjct: 126 YLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMRALPQNDDH----YVMQEHRKVPF 178
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTS 236
+ + + S D G L G PW GL Q KI ++
Sbjct: 179 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL---NGSQILHKIDKEGERLP 235
Query: 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276
C P + + C + + +D+P + L+ +
Sbjct: 236 RPEDC---PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 4e-25
Identities = 50/249 (20%), Positives = 99/249 (39%), Gaps = 31/249 (12%)
Query: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLLYESKLYRILQG 61
G + +IG GSF +Y G + +T EVA + K++ + E+++ + LQ
Sbjct: 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH 67
Query: 62 GTGIPN-VRWFGV------EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
PN VR++ VLV +L+ + + + +K + Q++
Sbjct: 68 ----PNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILK 123
Query: 115 RVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN 172
++F+H+++ +HRD+K DN + V I D GLA R + K
Sbjct: 124 GLQFLHTRTPPIIHRDLKCDNIF--ITGPTGSVKIGDLGLATLKRASFA---------KA 172
Query: 173 LTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232
+ GT + + + + D+ + G ++ P+ Q Y +++
Sbjct: 173 VIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE--CQNAAQIYRRVTSGV 229
Query: 233 VSTSIEALC 241
S + +
Sbjct: 230 KPASFDKVA 238
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 4e-25
Identities = 50/240 (20%), Positives = 90/240 (37%), Gaps = 27/240 (11%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLLYESKLYRILQGGT 63
+ + IG+GS+G + + K + + L+ E L R L+
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 64 GIPNVRWFGVEGDYNV-LVMDLL-GPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEF 118
+ + + +VM+ G L + +++ L + VL + Q+ ++
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 119 VHSKS-----FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNL 173
H +S LHRD+KP N + V + DFGLA+ ++ K
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTSFA-------KAF 174
Query: 174 TGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233
GT Y S + + + D+ SLG +L P+ ++K+ KI E K
Sbjct: 175 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF---SQKELAGKIREGKF 231
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 1e-24
Identities = 55/295 (18%), Positives = 108/295 (36%), Gaps = 31/295 (10%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQT-NEEVAIKLENVKTKHP----QLLYESKLYRI 58
R ++ +IG G++G+++ +++ VA+K V+T + E + R
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 59 LQGGTGIPNVRWFGV--------EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLAD 110
L+ VR F V E ++ + L + +T+ +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170
Q++ ++F+HS +HRD+KP N L+ + Q+ + DFGLA+ Y +
Sbjct: 124 QLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLADFGLARIYSFQMALTSV----- 175
Query: 171 KNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230
T Y + L + DL S+G + R ++G + + KI +
Sbjct: 176 ---VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG---SSDVDQLGKILD 229
Query: 231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFD 285
E R ++ D + + +DL + + F+
Sbjct: 230 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTD---IDELGKDL-LLKCLTFN 280
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 1e-24
Identities = 62/293 (21%), Positives = 101/293 (34%), Gaps = 40/293 (13%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPN- 67
+ + IG+GSFG +Y + E VAIK V E ++ R L N
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--VLQDKRFKNRELQIMRKLDH----CNI 75
Query: 68 VRWFGV--------EGDYNVLVMDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRV 116
VR + Y LV+D + ++ + SR L + V + Q+ +
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT----STHQHIPYRENKN 172
++HS HRDIKP N L + + DFG AK+ S YR +
Sbjct: 136 AYIHSFGICHRDIKPQNL--LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 193
Query: 173 LTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232
+ G Y + D+ S G VL L G + G + + +I +
Sbjct: 194 IFGATDY-----------TSSIDVWSAGCVLAELLLGQPIFPG---DSGVDQLVEIIKVL 239
Query: 233 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFD 285
+ + E + P F ++ + K L ++
Sbjct: 240 GTPTREQIREMNPNYTEFKFPQIKAHPW-TKVFRPRTPPEAIAL-CSRLLEYT 290
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 100 bits (250), Expect = 2e-24
Identities = 50/232 (21%), Positives = 94/232 (40%), Gaps = 20/232 (8%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKLYRILQGGTGI 65
F++ R +G+GSFG ++L + A+K L+ + + + R++
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 66 PN-VRWFGV--EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
P +R +G + ++MD + S++ A ++ +E++HSK
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASM 182
++RD+KP+N L+ + + I DFG AK D + L GT Y +
Sbjct: 124 DIIYRDLKPENILLD---KNGHIKITDFGFAKYVPDVTY----------TLCGTPDYIAP 170
Query: 183 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234
++ D S G ++ L G P+ + YEKI ++
Sbjct: 171 EVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD---SNTMKTYEKILNAELR 219
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.0 bits (246), Expect = 3e-24
Identities = 55/274 (20%), Positives = 108/274 (39%), Gaps = 21/274 (7%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKLYRILQGGTGI 65
RL K+G G FGE+++GT T VAIK L+ L E+++ + L+ +
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLR-HEKL 74
Query: 66 PNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKL-SLKTVLMLADQMINRVEFVHSKSF 124
+ E ++ + SL D + K L ++ +A Q+ + + +V ++
Sbjct: 75 VQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 134
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNT 184
+HRD++ N L+G + DFGLA+ D + ++ +
Sbjct: 135 VHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTAR------QGAKFPIKWTAPEA 185
Query: 185 HLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243
L + + D+ S G +L +G +P+ G+ ++ +++
Sbjct: 186 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQVERGYRMPCPP----E 238
Query: 244 YPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277
P C +++P + YL+ D F
Sbjct: 239 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.3 bits (244), Expect = 5e-24
Identities = 54/274 (19%), Positives = 118/274 (43%), Gaps = 27/274 (9%)
Query: 13 RKIGSGSFGEIYLGT--NIQTNEEVAIKLENVKTKHP----QLLYESKLYRILQGGTGIP 66
+++GSG+FG + G + + VA+K+ + P +LL E+ + + L P
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN----P 68
Query: 67 N-VRWFGV-EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
VR G+ E + +LVM++ + + +R + K ++ L Q+ ++++ +F
Sbjct: 69 YIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 128
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNT 184
+HRD+ N L+ + I DFGL+K R + Y+ + ++ +
Sbjct: 129 VHRDLAARNVLLV---TQHYAKISDFGLSKALRADENY----YKAQTHGKWPVKWYAPEC 181
Query: 185 HLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243
+ S + D+ S G ++ G P++G+ + + + + G
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM---KGSEVTAMLEKGERMGCPA----G 234
Query: 244 YPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277
P E + C + +++P +A ++ R+ +
Sbjct: 235 CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.9 bits (243), Expect = 7e-24
Identities = 55/280 (19%), Positives = 103/280 (36%), Gaps = 30/280 (10%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE---VAIK---LENVKTKHPQLLYESKLYRILQ 60
+ LGR IG G FG+++ G + VAIK + + L E+ R
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 61 GGTGIPN-VRWFGV--EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
P+ V+ GV E +++ L L L ++++ A Q+ +
Sbjct: 67 H----PHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 122
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTA 177
++ SK F+HRDI N L+ + V + DFGL++ D++ ++
Sbjct: 123 YLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDSTYYKA------SKGKLPI 173
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTS 236
++ + + + D+ G + L G P+QG+ K + + +
Sbjct: 174 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV-------KNNDVIGRIENGE 226
Query: 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276
+ P S C + +P + LK +
Sbjct: 227 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 97.9 bits (243), Expect = 9e-24
Identities = 54/275 (19%), Positives = 115/275 (41%), Gaps = 21/275 (7%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKLYRILQGGTGI 65
+ K+G G +GE+Y G + + VA+K L+ + + L E+ + + ++ +
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNL 75
Query: 66 PNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
+ ++ + + G L+ L +++S +L +A Q+ + +E++ K+
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 135
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMN 183
F+HRD+ N L+G + V + DFGL++ + H + ++ +
Sbjct: 136 FIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAK------FPIKWTAPE 186
Query: 184 THLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242
+ + S + D+ + G +L G P+ G+ Q YE + + E
Sbjct: 187 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI---DLSQVYELLEKDYRMERPE---- 239
Query: 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277
G P + C D+P +A + + F +F
Sbjct: 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.1 bits (241), Expect = 1e-23
Identities = 42/232 (18%), Positives = 92/232 (39%), Gaps = 23/232 (9%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKLYRILQGGTGI 65
+++G+G FG + G + +VAIK ++ + + E+K+ L
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSH---- 58
Query: 66 PN-VRWFGV--EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
V+ +GV + ++ + + L + + + +L + + +E++ S
Sbjct: 59 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181
K FLHRD+ N L+ V + DFGL++ D + R++
Sbjct: 119 KQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYTSSV------GSKFPVRWSP 169
Query: 182 MNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKK 232
+ + S + D+ + G ++ G +P++ T + E I++
Sbjct: 170 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF---TNSETAEHIAQGL 218
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 98.0 bits (243), Expect = 1e-23
Identities = 55/306 (17%), Positives = 102/306 (33%), Gaps = 49/306 (16%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKLENVKTKHPQLLYESKLYR 57
PR N R IG G+FG ++ + VA+K+ + +
Sbjct: 11 PR--NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 68
Query: 58 ILQGGTGIPNVRWFGV--EGDYNVLVMDLL-GPSLEDL---------------------- 92
++ V+ GV G L+ + + L +
Sbjct: 69 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 128
Query: 93 -FNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 151
+ LS L +A Q+ + ++ + F+HRD+ N L+G V I DFG
Sbjct: 129 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKIADFG 185
Query: 152 LAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL-RGS 210
L++ Y+ + N R+ + + D+ + G VL G
Sbjct: 186 LSRNIYSADY-----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 211 LPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270
P+ G+ ++ + + + E P E + C S D+P + +
Sbjct: 241 QPYYGM---AHEEVIYYVRDGNILACPE----NCPLELYNLMRLCWSKLPADRPSFCSIH 293
Query: 271 RIFRDL 276
RI + +
Sbjct: 294 RILQRM 299
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 98.7 bits (245), Expect = 1e-23
Identities = 46/213 (21%), Positives = 90/213 (42%), Gaps = 17/213 (7%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLLYESKLYRILQGGTG 64
++F + +G+GSFG + L + ++ A+K+ + K Q+ + RILQ
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 65 IPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSK 122
V+ D + L M + + ++F+ R + S A Q++ E++HS
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASM 182
++RD+KP+N L+ + + + DFG AK+ + + GT +
Sbjct: 161 DLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTWTLC----------GTPEALAP 207
Query: 183 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
L ++ D +LG ++ G P+
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.0 bits (241), Expect = 1e-23
Identities = 54/277 (19%), Positives = 100/277 (36%), Gaps = 33/277 (11%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIP 66
+ +L + IG G FG++ LG +VA+K L E+ + L+
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRH----S 60
Query: 67 N-VRWFGV---EGDYNVLVMDLL-GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFVH 120
N V+ GV E +V + + SL D L + L +L + + +E++
Sbjct: 61 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
+F+HRD+ N L+ N + DFGL K+ T ++
Sbjct: 121 GNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGK----------LPVKWT 167
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239
+ + S + D+ S G +L G +P+ + K ++ + + +
Sbjct: 168 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI---PLKDVVPRVEKGYKMDAPD- 223
Query: 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276
G P C L +P + L+ +
Sbjct: 224 ---GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.8 bits (240), Expect = 2e-23
Identities = 47/243 (19%), Positives = 89/243 (36%), Gaps = 21/243 (8%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--------ENVKTKHPQLLYESKLY 56
V + + G ++GSG F + T + A K + E +
Sbjct: 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 67
Query: 57 RILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116
+ +Q + + +L+++L+ F L+ + Q++N V
Sbjct: 68 KEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 126
Query: 117 EFVHSKSFLHRDIKPDNFLM-GLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175
++HS H D+KP+N ++ ++ IIDFGLA K + ++I G
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI--------FG 178
Query: 176 TARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235
T + + D+ S+G + L G+ P+ G TK++ +S
Sbjct: 179 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSAVNYEF 235
Query: 236 SIE 238
E
Sbjct: 236 EDE 238
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 96.5 bits (239), Expect = 3e-23
Identities = 52/218 (23%), Positives = 89/218 (40%), Gaps = 25/218 (11%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKLYRILQGG 62
K+ KIG G++G +Y N E A+K ++ + + E + + L+
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKH- 59
Query: 63 TGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
+ I + VLV + L L+ L + C L T Q++N + + H +
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH-----QHIPYRENKNLTGTA 177
LHRD+KP N L+ R ++ I DFGLA+ + + YR L G+
Sbjct: 120 RVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
+Y S D+ S+G + + G+ + G
Sbjct: 177 KY-----------STTIDIWSVGCIFAEMVNGTPLFPG 203
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.8 bits (240), Expect = 4e-23
Identities = 50/267 (18%), Positives = 92/267 (34%), Gaps = 43/267 (16%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNE-----EVAIKL---ENVKTKHPQLLYESKLYRI 58
G+ +GSG+FG++ T ++ +VA+K+ + ++ L+ E K+
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 59 LQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRK------------------ 99
L I N+ L+ + L + K
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 100 ----LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155
L+ + +L A Q+ +EF+ KS +HRD+ N L+ V I DFGLA+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKICDFGLARD 213
Query: 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQ 214
S Y N ++ + + + + D+ S G +L G P+
Sbjct: 214 IMSDSN-----YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268
Query: 215 GLKAGTKKQKYEKISEKKVSTSIEALC 241
G+ + K+ +
Sbjct: 269 GI---PVDANFYKLIQNGFKMDQPFYA 292
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.0 bits (238), Expect = 6e-23
Identities = 43/227 (18%), Positives = 85/227 (37%), Gaps = 17/227 (7%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-------LENVKTKHPQLLYESKLYRILQG 61
F+ + +GSG+FG +Y G I E+V I + ++L E+ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 62 GTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
+ + + ++ + L D + + +L Q+ + ++
Sbjct: 71 -PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181
+ +HRD+ N L+ V I DFGLAK H + ++ +
Sbjct: 130 RRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEEKEYHA-----EGGKVPIKWMA 181
Query: 182 MNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEK 227
+ + L + + D+ S G + + GS P+ G+ A EK
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 228
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.9 bits (235), Expect = 1e-22
Identities = 56/283 (19%), Positives = 98/283 (34%), Gaps = 20/283 (7%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLLYESKLYRILQGGT 63
F+ KIG G++G +Y N T E VA+K + + E L + L
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HP 61
Query: 64 GIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSK 122
I + + LV + L L+ + + L + Q++ + F HS
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASM 182
LHRD+KP N L+ + + DFGLA+ + + A
Sbjct: 122 RVLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYT------HEVVTLWYRAPE 172
Query: 183 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242
S D+ SLG + + + G ++ + +I + + T E +
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG---DSEIDQLFRI-FRTLGTPDEVVWP 228
Query: 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFD 285
G + + + R D L R L + + +D
Sbjct: 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSL-LSQMLHYD 270
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.0 bits (233), Expect = 1e-22
Identities = 53/276 (19%), Positives = 106/276 (38%), Gaps = 27/276 (9%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKLYRILQGGTGI 65
++ ++IGSG FG ++LG + ++VAIK + + E+++ L
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH---- 59
Query: 66 PN-VRWFGV--EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
P V+ +GV E LV + + L D + +T+L + + + ++
Sbjct: 60 PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181
+HRD+ N L+ + + DFG+ + D + ++AS
Sbjct: 120 ACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTK------FPVKWAS 170
Query: 182 MNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
S + D+ S G ++ G +P++ + + E IS
Sbjct: 171 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR---SNSEVVEDISTGFR----LYK 223
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276
R T ++C R +D+P ++ L R ++
Sbjct: 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.0 bits (235), Expect = 2e-22
Identities = 56/296 (18%), Positives = 113/296 (38%), Gaps = 38/296 (12%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKLYRILQ 60
V +++ +GSG++G + + +T VA+K + + + E +L + ++
Sbjct: 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 75
Query: 61 GGTGIPN-VRWFGV--------EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 111
N + V E + LV L+G L ++ +KL+ V L Q
Sbjct: 76 H----ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQ 129
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENK 171
++ ++++HS +HRD+KP N + ++ I+DFGLA+ D T
Sbjct: 130 ILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDDEMTGYVA------ 180
Query: 172 NLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230
T Y + L ++ D+ S+G ++ L G + G + + I
Sbjct: 181 ----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG---TDHIDQLKLILR 233
Query: 231 KKVSTSIEALCRGYPTEFASYFHYCRSL-RFDDKPDYAYLKRIFRDLFIREGFQFD 285
+ E L + +Y + + + + + DL + + D
Sbjct: 234 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDL-LEKMLVLD 288
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.6 bits (234), Expect = 3e-22
Identities = 50/252 (19%), Positives = 102/252 (40%), Gaps = 26/252 (10%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKLYRIL 59
V +++ + IGSG+ G + + + VAIK + ++ + E L + +
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 73
Query: 60 QGGT-----GIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
+ + E LVM+L+ +L + +L + + L QM+
Sbjct: 74 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLC 130
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174
++ +HS +HRD+KP N ++ + + I+DFGLA+ +
Sbjct: 131 GIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPY--------V 179
Query: 175 GTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234
T Y + LG+ D+ S+G ++ +R + + G ++ K+ E+ +
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG---RDYIDQWNKVIEQLGT 236
Query: 235 TSIEALCRGYPT 246
E + + PT
Sbjct: 237 PCPEFMKKLQPT 248
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 93.3 bits (231), Expect = 5e-22
Identities = 35/234 (14%), Positives = 88/234 (37%), Gaps = 17/234 (7%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE---VAIK---LENVKTKHPQLLYESKLYRILQ 60
+ ++ + IG+G FGE+ G + VAIK + + L E+ +
Sbjct: 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 85
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
+ ++ + +++ + + SL+ + ++ ++ + + ++++
Sbjct: 86 H-PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 144
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
+++HRD+ N L+ + DFGL++ D ++ Y R+
Sbjct: 145 ADMNYVHRDLAARNILVN---SNLVCKVSDFGLSRFLEDDTSDPT--YTSALGGKIPIRW 199
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKK 232
+ + + D+ S G V+ + G P+ + T + I +
Sbjct: 200 TAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM---TNQDVINAIEQDY 250
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.7 bits (229), Expect = 8e-22
Identities = 52/215 (24%), Positives = 87/215 (40%), Gaps = 22/215 (10%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLLYESKLYRILQGG 62
K+ KIG G++G ++ N +T+E VA+K ++ + L E L + L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH- 60
Query: 63 TGIPN-VRWFGV--EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
N VR V LV + L+ F+ C+ L + V Q++ + F
Sbjct: 61 ---KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
HS++ LHRD+KP N L+ R ++ + +FGLA+ + T Y
Sbjct: 118 HSRNVLHRDLKPQNLLIN---RNGELKLANFGLARAFGIPVRCYS-------AEVVTLWY 167
Query: 180 ASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPW 213
+ G + S D+ S G + P
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 93.6 bits (231), Expect = 9e-22
Identities = 50/294 (17%), Positives = 109/294 (37%), Gaps = 25/294 (8%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKLYRILQ 60
EP ++ L RK+G G F ++L ++ N VA+K + K E KL + +
Sbjct: 8 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVN 67
Query: 61 ----------GGTGIPNVRWFGVEGDYNVLVMDLLG-----PSLEDLFNFCSRKLSLKTV 105
G I + N + + ++ L + + R + L V
Sbjct: 68 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 127
Query: 106 LMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164
++ Q++ ++++H + +H DIKP+N L + + +I +A +H
Sbjct: 128 KQISKQLLLGLDYMHRRCGIIHTDIKPENVL--MEIVDSPENLIQIKIADLGNACWYDEH 185
Query: 165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK 224
T Y S LG D+ S ++ + G ++ + + +
Sbjct: 186 YTNS-----IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 240
Query: 225 YEKISE-KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277
+ I++ ++ + + ++F+ LR K + L+ + + +
Sbjct: 241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKY 294
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.6 bits (229), Expect = 1e-21
Identities = 43/233 (18%), Positives = 81/233 (34%), Gaps = 34/233 (14%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKL---ENVKTKHPQLLYESKLYRI 58
N+ G+ +G+G+FG++ T VA+K+ T+ L+ E K+
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 59 LQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDL-----------------FNFCSRKL 100
L I N+ G +++ + L + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 101 SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160
L+ +L + Q+ + F+ SK+ +HRD+ N L+ I DFGLA+ ++ S
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIKNDS 199
Query: 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
+ N ++ + + + D+ S G L
Sbjct: 200 NYVV-----KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.2 bits (228), Expect = 1e-21
Identities = 62/283 (21%), Positives = 98/283 (34%), Gaps = 29/283 (10%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK-------LENVKTKHPQLLYESKLYRILQGGTGI 65
+G G F +Y + TN+ VAIK E + L E KL + L I
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNI 62
Query: 66 PNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 125
+ LV D + LE + S L+ + + +E++H L
Sbjct: 63 IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 122
Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTH 185
HRD+KP+N L+ + + DFGLAK + P R + T Y +
Sbjct: 123 HRDLKPNNLLL---DENGVLKLADFGLAKSFGS-------PNRAYTHQVVTRWYRAPELL 172
Query: 186 LGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 244
G D+ ++G +L L G + + +I E + + E
Sbjct: 173 FGARMYGVGVDMWAVGCILAELLLRVPFLPG---DSDLDQLTRIFETLGTPTEEQW---- 225
Query: 245 PTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL--FIREGFQFD 285
+ S Y F P + DL I+ F F+
Sbjct: 226 -PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFN 267
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.2 bits (228), Expect = 2e-21
Identities = 55/296 (18%), Positives = 111/296 (37%), Gaps = 38/296 (12%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLLYESKLYRILQ 60
V +R + +GSG++G + + +T +VAIK + + E +L + ++
Sbjct: 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR 75
Query: 61 GGTGIPN-VRWFGV--------EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 111
N + V + LVM +G L L KL + L Q
Sbjct: 76 H----ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK--HEKLGEDRIQFLVYQ 129
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ--HIPYRE 169
M+ + ++H+ +HRD+KP N + ++ I+DFGLA++ T YR
Sbjct: 130 MLKGLRYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLARQADSEMTGYVVTRWYRA 186
Query: 170 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 229
+ + RY ++ D+ S+G ++ + G ++G + ++ K++
Sbjct: 187 PEVILNWMRY-----------TQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT 235
Query: 230 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFD 285
+ ++ L + F A + +L + + D
Sbjct: 236 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNA--SPLAVNL-LEKMLVLD 288
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.0 bits (225), Expect = 3e-21
Identities = 49/246 (19%), Positives = 87/246 (35%), Gaps = 36/246 (14%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNE--EVAIK---LENVKTKHPQLLYESKLYRILQG 61
N + IG G+FG++ + + AIK K H E ++ L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 62 GTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDL---------------FNFCSRKLSLKTV 105
I N+ Y L ++ +L D N + LS + +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 106 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165
L A + ++++ K F+HRD+ N L+G I DFGL++
Sbjct: 130 LHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLSRGQEVYVKKTMG 186
Query: 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQK 224
R+ ++ + + D+ S G +L + G P+ G+ T +
Sbjct: 187 --------RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM---TCAEL 235
Query: 225 YEKISE 230
YEK+ +
Sbjct: 236 YEKLPQ 241
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.3 bits (223), Expect = 6e-21
Identities = 42/224 (18%), Positives = 90/224 (40%), Gaps = 21/224 (9%)
Query: 4 RVG-NKFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIK------LENVKTKHPQLLYES 53
+VG F L + +G+G++G+++L I T + A+K + E
Sbjct: 20 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 79
Query: 54 KLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 113
++ ++ + + + L++D + + + V + +++
Sbjct: 80 QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIV 139
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNL 173
+E +H ++RDIK +N L+ V + DFGL+K++ T + +
Sbjct: 140 LALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFC----- 191
Query: 174 TGTARYASMNTHLGIEQ--SRRDDLESLGYVLMYFLRGSLPWQG 215
GT Y + + G + + D SLG ++ L G+ P+
Sbjct: 192 -GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV 234
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.2 bits (215), Expect = 6e-20
Identities = 45/253 (17%), Positives = 100/253 (39%), Gaps = 38/253 (15%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE-------VAIK---LENVKTKHPQLLYESKLY 56
++ LG+ +G G+FG++ L I +++ VA+K + + L+ E ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 57 RILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC---------------SRKL 100
+++ I N+ + ++++ +L + +L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 101 SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160
S K ++ A Q+ +E++ SK +HRD+ N L+ N + I DFGLA+
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHID 189
Query: 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAG 219
++ N ++ + + + D+ S G +L G P+ G+
Sbjct: 190 YYKK-----TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--- 241
Query: 220 TKKQKYEKISEKK 232
++ ++ + E
Sbjct: 242 PVEELFKLLKEGH 254
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.4 bits (213), Expect = 1e-19
Identities = 33/233 (14%), Positives = 81/233 (34%), Gaps = 16/233 (6%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE----VAIK---LENVKTKHPQLLYESKLYRIL 59
+ + IG+G FGE+Y G ++ + VAIK + + L E+ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 60 QGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
I ++ + +L+ + S+ ++ + + ++++
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
+ +++HRD+ N L+ + DFGL++ D + R+
Sbjct: 127 ANMNYVHRDLAARNILVN---SNLVCKVSDFGLSRVLEDDPEATYT----TSGGKIPIRW 179
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232
+ + + D+ S G V+ + + + + I++
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW--ELSNHEVMKAINDGF 230
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.1 bits (207), Expect = 7e-19
Identities = 51/245 (20%), Positives = 96/245 (39%), Gaps = 29/245 (11%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTN-----IQTNEEVAIKLENVKTKHPQLLYESKLYRILQG 61
K + R++G GSFG +Y G + VAIK N + + +++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 62 GTGIPNVRWFGV--EGDYNVLVMDLL-GPSLEDLFNFCSR---------KLSLKTVLMLA 109
VR GV +G +++M+L+ L+ SL ++ +A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRE 169
++ + + ++++ F+HRD+ N ++ V I DFG+ + +T YR+
Sbjct: 140 GEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDY-----YRK 191
Query: 170 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKI 228
R+ S + + D+ S G VL P+QGL + +Q +
Sbjct: 192 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL---SNEQVLRFV 248
Query: 229 SEKKV 233
E +
Sbjct: 249 MEGGL 253
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 81.4 bits (200), Expect = 1e-18
Identities = 26/181 (14%), Positives = 65/181 (35%), Gaps = 32/181 (17%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT------------KHPQLLYESKL--- 55
+G+ +G G ++ + + E +K V +
Sbjct: 4 IGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 56 --YRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 113
+R LQ G+ + + EG+ ++M E + ++ ++ + D ++
Sbjct: 63 NEFRALQKLQGLAVPKVYAWEGNA--VLM-------ELIDAKELYRVRVENPDEVLDMIL 113
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNL 173
V + + +H D+ N L+ ++IIDF + + + + + R+ +N+
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVLVS----EEGIWIIDFPQSVEVGEEGWREIL-ERDVRNI 168
Query: 174 T 174
Sbjct: 169 I 169
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.2 bits (202), Expect = 4e-18
Identities = 41/232 (17%), Positives = 82/232 (35%), Gaps = 33/232 (14%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKLENVKTKHPQLLYESKLYRILQG 61
++ +LG+ +G G+FG++ T VA+K+ H + +IL
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 62 GTGIPNVR----WFGVEGDYNVLVMDLL-GPSLEDL---------------FNFCSRKLS 101
NV G +++++ +L + L+
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 102 LKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161
L+ ++ + Q+ +EF+ S+ +HRD+ N L+ N V I DFGLA+
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPD 189
Query: 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
+ + ++ + T + + D+ S G +L
Sbjct: 190 YVR-----KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 236
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.0 bits (199), Expect = 1e-17
Identities = 44/221 (19%), Positives = 86/221 (38%), Gaps = 22/221 (9%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTN---EEVAIKLENVKTKHP---QLLYESKLYRILQG 61
IG G FG +Y GT + + A+K N T Q L E + +
Sbjct: 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 62 GTGIPN-VRWFGV---EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116
PN + G+ ++V+ + L + + ++K ++ Q+ +
Sbjct: 88 ----PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM 143
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGT 176
+F+ SK F+HRD+ N ++ V + DFGLA+ D
Sbjct: 144 KFLASKKFVHRDLAARNCMLD---EKFTVKVADFGLARDMYDKEFDSV---HNKTGAKLP 197
Query: 177 ARYASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGL 216
++ ++ + + + + D+ S G +L + RG+ P+ +
Sbjct: 198 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 238
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.3 bits (192), Expect = 8e-17
Identities = 55/278 (19%), Positives = 89/278 (32%), Gaps = 36/278 (12%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----------------LENVKTKHPQ 48
+ L IG G FGE++ G EEVA+K + V +H
Sbjct: 1 IARTIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERSWFREAEIYQTVMLRHEN 58
Query: 49 LLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLML 108
+L G W + + + D L + + KL+L T L
Sbjct: 59 IL---GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGL 113
Query: 109 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYR 168
A + V + HRD+K N L+ + I D GLA ++ + I
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVK---KNGTCCIADLGLAVRHDSATDTIDIAP- 169
Query: 169 ENKNLTGTARY------ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK 222
+ GT RY E +R D+ ++G V R +
Sbjct: 170 --NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227
Query: 223 QKYEKISEKKVSTSIEALC-RGYPTEFASYFHYCRSLR 259
S+ V + +C + + + C +LR
Sbjct: 228 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALR 265
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 407 | |||
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.64 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.19 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.17 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.36 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.2 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.14 |
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.5e-63 Score=466.21 Aligned_cols=297 Identities=78% Similarity=1.347 Sum_probs=266.6
Q ss_pred CCCccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 1 m~~~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
|+-+++++|+++++||+|+||.||+|++..+|+.||||++..+.....+..|+++++.++|+++++.+..++.+.+..++
T Consensus 1 ~~~~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i 80 (299)
T d1ckia_ 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 80 (299)
T ss_dssp CCCEETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred CCCeECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEE
Confidence 88999999999999999999999999999999999999998887788899999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 81 VMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 81 vme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
||||++++|.+.+....+.+++..++.++.|++.||+|||++|||||||||+|||++..+.+..+||+|||+|+.+....
T Consensus 81 vme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 81 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 99999999999888777889999999999999999999999999999999999998655567789999999999988776
Q ss_pred CCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHH
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (407)
.....+++......||+.|||||++.+..++.++|||||||++|||++|..||...........+.+........+.+.+
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHH
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHh
Confidence 66555566677889999999999999999999999999999999999999999887766666666666666666677778
Q ss_pred hcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchhhc
Q 015406 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQ 297 (407)
Q Consensus 241 ~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~~~ 297 (407)
..++|+++.++|.+||+.+|++||++++|.++|++++.+.++..+..+||+.++...
T Consensus 241 ~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~Dw~~~~~~~ 297 (299)
T d1ckia_ 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGA 297 (299)
T ss_dssp TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCHHHHGGGTC
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCcCchhhcCCC
Confidence 889999999999999999999999999999999999999999999999999877643
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5e-61 Score=449.86 Aligned_cols=290 Identities=60% Similarity=1.013 Sum_probs=265.4
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
.++++|+++++||+|+||+||+|++..+|+.||||+++.......+.+|+++++.|+|+++++.+..++......++|||
T Consensus 2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 57899999999999999999999999999999999988777778899999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCC--CCCceEEEEeccceeeeccCCC
Q 015406 84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG--RRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 84 ~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~--~~~~~~kL~DFGla~~~~~~~~ 161 (407)
|++++|.+++...+..++...+..++.|++.||+|||++|||||||||+|||++.. ...+.+||+|||+|+.+.....
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (293)
T d1csna_ 82 LLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 161 (293)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred ecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCcc
Confidence 99999999998877789999999999999999999999999999999999999632 1357899999999999877665
Q ss_pred CcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHh
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (407)
....+.+.....+||+.|||||++.+..++.++|||||||++|||++|..||.+.........+.++...........++
T Consensus 162 ~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (293)
T d1csna_ 162 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241 (293)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHT
T ss_pred ccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhc
Confidence 55555566677899999999999999999999999999999999999999999887777777777777777677788888
Q ss_pred cCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccc
Q 015406 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTIL 293 (407)
Q Consensus 242 ~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~dw~~~ 293 (407)
+++|+++.+++..||..+|++||+++.+.+.|++++.+.+...++.+||+.+
T Consensus 242 ~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw~~~ 293 (293)
T d1csna_ 242 AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL 293 (293)
T ss_dssp TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGCC
T ss_pred CCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCCCcC
Confidence 9999999999999999999999999999999999999999999999999853
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-57 Score=423.43 Aligned_cols=269 Identities=20% Similarity=0.308 Sum_probs=222.8
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecC-----CCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-----KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~-----~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
.++|++++.||+|+||+||+|+++.+++.||||+++. ......+.+|+++++.++| ++|..+..++.+.+..||
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH-PFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCS-TTBCCEEEEEECSSEEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCC-CCeeEEEEEEEECCEEEE
Confidence 3679999999999999999999999999999998763 2334568899999999986 677778888888899999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 81 vme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
||||| ||+|.+++.. .+.+++..++.++.||+.||+|||++|||||||||+|||+ ++++.+||+|||+|+.+...
T Consensus 86 vmEy~~gg~L~~~~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll---~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp EECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECC--
T ss_pred EEEccCCCCHHHhhhc-cCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcccccc---CCCceEEecccccceecccC
Confidence 99999 8999999886 4579999999999999999999999999999999999999 68889999999999987543
Q ss_pred CCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHH
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (407)
... ......+||+.|||||++.+..|+.++|||||||+||||++|..||.+. +..+.+.++......
T Consensus 162 ~~~-----~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~~~~~~~~i~~~~~~----- 228 (288)
T d1uu3a_ 162 SKQ-----ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG---NEYLIFQKIIKLEYD----- 228 (288)
T ss_dssp -------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHTTCCC-----
T ss_pred Ccc-----cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc---CHHHHHHHHHcCCCC-----
Confidence 321 1134568999999999999999999999999999999999999999864 345566666655432
Q ss_pred HhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchhh
Q 015406 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQ 296 (407)
Q Consensus 240 ~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~~ 296 (407)
++..+++++.+||.+||+.||++|||++|+.+. ..+ ..++|+..+||+.+..+
T Consensus 229 ~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~-~~i---~~Hpff~~i~w~~l~~~ 281 (288)
T d1uu3a_ 229 FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY-GPL---KAHPFFESVTWENLHQQ 281 (288)
T ss_dssp CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH-HHH---HTSGGGTTCCCTTGGGS
T ss_pred CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC-HHH---HcCCccCCCCHHHhhcC
Confidence 235689999999999999999999999887542 111 23577788999987654
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-56 Score=412.38 Aligned_cols=244 Identities=23% Similarity=0.307 Sum_probs=210.9
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecC-----CCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-----KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~-----~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
.++|++++.||+|+||+||+|+++.+++.||||++.. ......+.+|+.+++.++| ++|+.+..++.+.+..||
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~~~~~~~~~~~~~i 83 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH-PNILRLYGYFHDATRVYL 83 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCC-CCCCeEEEEEEECCEEEE
Confidence 4689999999999999999999999999999998753 2334568899999999976 677788888888899999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 81 vme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
||||| +|+|.+++.. .+.+++..++.|+.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+.....
T Consensus 84 vmEy~~~g~L~~~l~~-~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 84 ILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp EEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCSCSCCCCC
T ss_pred EEeecCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeecccccee---cCCCCEeecccceeeecCCC
Confidence 99999 8999999986 3479999999999999999999999999999999999999 57889999999999865543
Q ss_pred CCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHH
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (407)
. .....||+.|||||++.+..++.++|||||||+||||++|+.||.+. +..+.+..+......
T Consensus 160 ~---------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~~~~~i~~~~~~----- 222 (263)
T d2j4za1 160 R---------RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---TYQETYKRISRVEFT----- 222 (263)
T ss_dssp C---------CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHTTCCC-----
T ss_pred c---------ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC---CHHHHHHHHHcCCCC-----
Confidence 2 23567999999999999999999999999999999999999999764 345556666554432
Q ss_pred HhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 240 ~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
++..+|+++.+||.+||+.||++|||++++++
T Consensus 223 ~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 223 FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 23568999999999999999999999887754
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-56 Score=414.78 Aligned_cols=251 Identities=24% Similarity=0.334 Sum_probs=207.5
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC---CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
+.++|+++++||+|+||+||+|+++.+|+.||||+++.+. ..+.+.+|+++++.++| ++|+.+..++.+.+..|||
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~H-pnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-ENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCC-TTBCCEEEEEEETTEEEEE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCC-CCEeeEeeeeccCceeEEE
Confidence 4578999999999999999999999999999999986543 23468899999999986 6777888888889999999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 82 me~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
|||| |++|.+++.. ...+++..++.|+.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+......
T Consensus 82 mEy~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl---~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 82 LEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp EECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECEETT
T ss_pred EeccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEE---CCCCCEEEccchhheeeccCC
Confidence 9999 8899999874 4579999999999999999999999999999999999999 577899999999999775443
Q ss_pred CCcccCccCCCCccccccccccccccCCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHH
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (407)
.. ......+||+.|||||++.+..+ +.++|||||||+||||++|+.||....... ..+..+...... ..
T Consensus 158 ~~-----~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~--~~~~~~~~~~~~---~~ 227 (271)
T d1nvra_ 158 RE-----RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--QEYSDWKEKKTY---LN 227 (271)
T ss_dssp EE-----CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS--HHHHHHHTTCTT---ST
T ss_pred cc-----ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH--HHHHHHhcCCCC---CC
Confidence 21 12346789999999999998886 678999999999999999999997654322 222222222211 11
Q ss_pred HhcCCcHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015406 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 240 ~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
....+++++.+||.+||+.||++|||+++++
T Consensus 228 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil 258 (271)
T d1nvra_ 228 PWKKIDSAPLALLHKILVENPSARITIPDIK 258 (271)
T ss_dssp TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 2356899999999999999999999988774
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-56 Score=414.58 Aligned_cols=247 Identities=22% Similarity=0.332 Sum_probs=208.7
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC--CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
.++|++.++||+|+||+||+|+++.+|+.||||++.... ..+.+.+|+.+++.++| ++|+.+..++.+.+..|||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN-PNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCC-CCEeeEeEEEEECCEEEEEEE
Confidence 358999999999999999999999999999999876543 33458899999999987 677778888888889999999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 84 ~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
|| |++|.+++.. +.+++..++.|+.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+.+......
T Consensus 98 y~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl---~~~~~vkl~DFG~a~~~~~~~~~ 172 (293)
T d1yhwa1 98 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSK 172 (293)
T ss_dssp CCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSTTCC
T ss_pred ecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEE---CCCCcEeeccchhheeecccccc
Confidence 99 9999998874 469999999999999999999999999999999999999 57789999999999987544321
Q ss_pred cccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhc
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (407)
....+||+.|||||++.+..|+.++|||||||+||||++|..||.+.+. .+.+..+........ ....
T Consensus 173 -------~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~~~~~~~~~~~~~--~~~~ 240 (293)
T d1yhwa1 173 -------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---LRALYLIATNGTPEL--QNPE 240 (293)
T ss_dssp -------BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHHCSCCC--SSGG
T ss_pred -------ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH---HHHHHHHHhCCCCCC--CCcc
Confidence 3456899999999999999999999999999999999999999976433 333333333222111 1235
Q ss_pred CCcHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015406 243 GYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 243 ~~~~~l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
.+++++.+||.+||+.||++|||+++++
T Consensus 241 ~~s~~~~~li~~~L~~dP~~R~s~~eil 268 (293)
T d1yhwa1 241 KLSAIFRDFLNRCLDMDVEKRGSAKELL 268 (293)
T ss_dssp GSCHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 6899999999999999999999988774
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.8e-56 Score=417.92 Aligned_cols=254 Identities=20% Similarity=0.248 Sum_probs=201.4
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC---CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
.+.+.|++.+.||+|+||+||+|+++.+++.||||++.... ....+.+|+.+++.++| ++|+.+..++.+.+..||
T Consensus 6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~l 84 (307)
T d1a06a_ 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKH-PNIVALDDIYESGGHLYL 84 (307)
T ss_dssp CGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCC-TTBCCEEEEEECSSEEEE
T ss_pred CCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCC-CCCCcEEEEEEECCEEEE
Confidence 35677999999999999999999999999999999986543 23457789999999976 777788888888899999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 81 vme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
||||| |++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+...+.++.+||+|||+|+.....
T Consensus 85 vmE~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 85 IMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp EECCCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred EEeccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 99999 8999999975 557999999999999999999999999999999999999975566789999999999876543
Q ss_pred CCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHH
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (407)
.. ....+||+.|||||++.+..|+.++|||||||+||||++|..||.+.. ..+.+..+........ ..
T Consensus 164 ~~--------~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~~~~~~~i~~~~~~~~-~~ 231 (307)
T d1a06a_ 164 SV--------LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN---DAKLFEQILKAEYEFD-SP 231 (307)
T ss_dssp -----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHTTCCCCC-TT
T ss_pred Ce--------eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC---HHHHHHHHhccCCCCC-Cc
Confidence 32 235689999999999999999999999999999999999999997743 3455556655443322 22
Q ss_pred HhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 240 ~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
....+|+++.+||.+||+.||++|||++++++
T Consensus 232 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 232 YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 44678999999999999999999999887653
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-55 Score=411.58 Aligned_cols=249 Identities=18% Similarity=0.296 Sum_probs=209.4
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC--cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEec
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~ 84 (407)
+.|+++++||+|+||.||+|+++.+++.||||+++.... .+.+.+|+++++.++| ++|+.+..++.+.+..||||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH-PNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEEEEC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEeeCCeEEEEEec
Confidence 569999999999999999999999999999999875433 3568899999999986 6777788888888999999999
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCc
Q 015406 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (407)
Q Consensus 85 ~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~ 163 (407)
| +++|.+++....+.+++..+..|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+.......
T Consensus 91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll---~~~~~~Kl~DFG~a~~~~~~~~-- 165 (288)
T d2jfla1 91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTIQ-- 165 (288)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECHHHHH--
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeE---CCCCCEEEEechhhhccCCCcc--
Confidence 9 999999987667789999999999999999999999999999999999999 5788999999999986544221
Q ss_pred ccCccCCCCcccccccccccccc-----CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHH
Q 015406 164 HIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (407)
Q Consensus 164 ~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (407)
......||+.|||||++. +..|+.++|||||||+||||++|..||.+.+. .+.+.++........
T Consensus 166 -----~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~---~~~~~~i~~~~~~~~-- 235 (288)
T d2jfla1 166 -----RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP---MRVLLKIAKSEPPTL-- 235 (288)
T ss_dssp -----HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG---GGHHHHHHHSCCCCC--
T ss_pred -----cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH---HHHHHHHHcCCCCCC--
Confidence 123568999999999984 45689999999999999999999999987554 334444444332211
Q ss_pred HHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 239 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.....+++++.+||.+||+.||++|||++++++
T Consensus 236 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 236 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 123468999999999999999999999887743
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-56 Score=410.55 Aligned_cols=258 Identities=22% Similarity=0.348 Sum_probs=207.4
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc----chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
.++|++.++||+|+||.||+|+. +..||||+++..... ..+.+|+.+++.++| ++|+.+.++..+ +..+||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~~~~~~~~-~~~~lv 81 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH-VNILLFMGYSTA-PQLAIV 81 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCC-TTBCCEEEEECS-SSCEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCC-CCEeeeeEEEec-cEEEEE
Confidence 47899999999999999999984 235999998654322 357889999999986 556666666544 457999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 82 me~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
|||| +|+|.+++...+..+++..++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+......
T Consensus 82 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl---~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp EECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ETTSSEEECCCCCSCC-----
T ss_pred EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEE---cCCCCEEEccccceeeccccC
Confidence 9999 899999998766779999999999999999999999999999999999999 578999999999998765433
Q ss_pred CCcccCccCCCCccccccccccccccCC---CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccH
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHLGI---EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~---~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (407)
.. .......||+.|||||++.+. .|+.++|||||||+||||+||+.||.+.... .+....+......+..
T Consensus 159 ~~-----~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~--~~~~~~~~~~~~~p~~ 231 (276)
T d1uwha_ 159 GS-----HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIFMVGRGYLSPDL 231 (276)
T ss_dssp ------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHHHHHHHHTSCCCCG
T ss_pred Cc-----ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH--HHHHHHHhcCCCCCcc
Confidence 21 123456899999999999753 4899999999999999999999999875432 3334444444444555
Q ss_pred HHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Q 015406 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (407)
Q Consensus 238 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~ 278 (407)
......+|+++.+||.+||+.||++|||+++|.+.|+.+.+
T Consensus 232 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 232 SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 56667899999999999999999999999999999987754
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-55 Score=415.11 Aligned_cols=263 Identities=19% Similarity=0.279 Sum_probs=222.8
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCC-----CCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
-++|++++.||+|+||.||+|+++.+|+.||||+++.. .....+.+|+.+++.++| ++|+.+..++.+.+..|+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~~~~~~i 82 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH-PFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCC-TTBCCEEEEEECSSEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCC-CCEEEEEeeecccccccc
Confidence 36899999999999999999999999999999998642 234568899999999985 788888888889999999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 81 vme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
||||| ||+|.+++.. .+.+++..++.++.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.....
T Consensus 83 v~ey~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl---~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 83 VMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCCT
T ss_pred ceeccCCCchhhhhhc-ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEe---cCCCCEEEeecccccccccC
Confidence 99999 9999999986 4579999999999999999999999999999999999999 68899999999999865443
Q ss_pred CCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHH
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (407)
.. .....+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+ ..+.+..+......
T Consensus 159 ~~-------~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~---~~~~~~~i~~~~~~----- 223 (337)
T d1o6la_ 159 GA-------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HERLFELILMEEIR----- 223 (337)
T ss_dssp TC-------CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCC-----
T ss_pred Cc-------ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC---HHHHHHHHhcCCCC-----
Confidence 22 1346789999999999999999999999999999999999999998743 35555555554433
Q ss_pred HhcCCcHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHHHHcCCCCCCccccccchhhcc
Q 015406 240 LCRGYPTEFASYFHYCRSLRFDDKPD-----YAYLKRIFRDLFIREGFQFDYVFDWTILKYQQS 298 (407)
Q Consensus 240 ~~~~~~~~l~~li~~cl~~~p~~RPt-----~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~~~~ 298 (407)
++..+++++.+||.+||+.||++|++ +++++ .++|+..++|..+..++.
T Consensus 224 ~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil----------~Hp~f~~i~~~~l~~~~~ 277 (337)
T d1o6la_ 224 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVM----------EHRFFLSINWQDVVQKKL 277 (337)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHH----------TSGGGTTCCHHHHHTTCS
T ss_pred CCccCCHHHHHHHHhhccCCchhhcccccccHHHHH----------cCcccccCCHHHHHhCCC
Confidence 34568999999999999999999995 44443 246667789987766553
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.4e-55 Score=417.72 Aligned_cols=253 Identities=18% Similarity=0.270 Sum_probs=214.5
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC--cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
+.++|++++.||+|+||.||+|+++.+|+.||||++..... .+.+.+|+.+++.++| ++|+.+..++.+.+..||||
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH-PTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCC-TTBCCEEEEEEETTEEEEEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCC-CCCCcEEEEEEECCEEEEEE
Confidence 44689999999999999999999999999999999865432 2347889999999986 77777778888899999999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCC
Q 015406 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 83 e~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~ 161 (407)
||| ||+|.+++....+.+++..++.|+.||+.||+|||++|||||||||+|||++. +.++.+||+|||+|+.+.....
T Consensus 103 E~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~-~~~~~vkL~DFG~a~~~~~~~~ 181 (350)
T d1koaa2 103 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQS 181 (350)
T ss_dssp CCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTSCCEEECCCTTCEECCTTSC
T ss_pred EcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeecc-CCCCeEEEeecchheecccccc
Confidence 999 99999999755667999999999999999999999999999999999999952 2357899999999998765432
Q ss_pred CcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHh
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (407)
.....||+.|||||++.+..++.++|||||||++|||++|..||.+.+ ..+.+..+........ ....
T Consensus 182 --------~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~---~~~~~~~i~~~~~~~~-~~~~ 249 (350)
T d1koaa2 182 --------VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN---DDETLRNVKSCDWNMD-DSAF 249 (350)
T ss_dssp --------EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCSC-CGGG
T ss_pred --------cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCC-cccc
Confidence 235689999999999999999999999999999999999999997643 3555666655443222 2344
Q ss_pred cCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 242 ~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
..+++++.+||.+||..||++|||++++++
T Consensus 250 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 250 SGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp GGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 668999999999999999999999877654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-55 Score=405.72 Aligned_cols=248 Identities=22% Similarity=0.259 Sum_probs=195.5
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc----chHHHHHHHHHHHcCCCCCCeeEEee--eeCceeE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFG--VEGDYNV 79 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~--~~~~~~~ 79 (407)
.++|++.+.||+|+||.||+|+++.+|+.||||++...... +.+.+|+++++.++| ++|+.+..++ ......|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH-PNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCC-TTBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCC-CCEeeEEEEEEeCCCCEEE
Confidence 47899999999999999999999999999999998765432 237889999999987 5555555444 3456689
Q ss_pred EEEecc-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeccCCCCcccccCCCCCceEEEEec
Q 015406 80 LVMDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKS-----FLHRDIKPDNFLMGLGRRANQVYIIDF 150 (407)
Q Consensus 80 lvme~~-g~sL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~-----ivHrDLKp~NILl~~~~~~~~~kL~DF 150 (407)
|||||| +|+|.+++.. .+..+++..++.++.||+.||+|||++| ||||||||+|||| +.++.+||+||
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll---~~~~~vkl~DF 158 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDF 158 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEE---CTTSCEEECCH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCc---CCCCcEEEeec
Confidence 999999 8999999864 3467999999999999999999999976 9999999999999 67899999999
Q ss_pred cceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhh
Q 015406 151 GLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230 (407)
Q Consensus 151 Gla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~ 230 (407)
|+|+.+..... ......||+.|||||++.+..|+.++|||||||++|||++|..||.+.+ ..+.+.++..
T Consensus 159 G~a~~~~~~~~-------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~---~~~~~~~i~~ 228 (269)
T d2java1 159 GLARILNHDTS-------FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKELAGKIRE 228 (269)
T ss_dssp HHHHHC------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHH
T ss_pred cceeecccCCC-------ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC---HHHHHHHHHc
Confidence 99987654332 1245789999999999999999999999999999999999999997743 3455566655
Q ss_pred hcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 231 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
..... ++..+++++.+||.+||+.||++|||+++|++
T Consensus 229 ~~~~~----~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 229 GKFRR----IPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp TCCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCC----CCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 44332 33568999999999999999999999888753
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-54 Score=400.55 Aligned_cols=255 Identities=19% Similarity=0.266 Sum_probs=204.1
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEec
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~ 84 (407)
.++|++.++||+|+||.||+|++. +++.||||+++... ..+++.+|+++++.++| ++|+.+.+++...+..++||||
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~H-pnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH-PKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCC-TTBCCEEEEECSSSSCEEEEEC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCC-CCcccccceeccCCceEEEEEe
Confidence 368999999999999999999974 67889999987544 34568999999999986 7777887887778889999999
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCc
Q 015406 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (407)
Q Consensus 85 ~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~ 163 (407)
+ +|+|.+++......+++..++.|+.||+.||.|||+++|+||||||+|||+ +.++.+||+|||+|+........
T Consensus 82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~~~~~~~- 157 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYT- 157 (263)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEE---CGGGCEEECSCC------------
T ss_pred cCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheee---cCCCCeEecccchheeccCCCce-
Confidence 9 999999998666779999999999999999999999999999999999999 68899999999999876554321
Q ss_pred ccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhC-CCCCCCCCcCchHHHHHHHhhhcccccHHHHhc
Q 015406 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRG-SLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (407)
Q Consensus 164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG-~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (407)
......||+.|+|||++.+..++.++|||||||+||||+|+ .+||... ...+.+..+....... .+.
T Consensus 158 -----~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~---~~~~~~~~i~~~~~~~----~p~ 225 (263)
T d1sm2a_ 158 -----SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR---SNSEVVEDISTGFRLY----KPR 225 (263)
T ss_dssp ------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC---CHHHHHHHHHHTCCCC----CCT
T ss_pred -----eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC---CHHHHHHHHHhcCCCC----Ccc
Confidence 12346789999999999999999999999999999999994 5556543 3344555554432221 224
Q ss_pred CCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Q 015406 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (407)
Q Consensus 243 ~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~ 278 (407)
.+++++.+|+.+||+.||++||++++|++.|+++.+
T Consensus 226 ~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 578999999999999999999999999999998854
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-54 Score=410.31 Aligned_cols=258 Identities=21% Similarity=0.293 Sum_probs=220.3
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecC-----CCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-----KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~-----~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
++|++++.||+|+||+||+|+++.+|+.||||+++. ......+.+|+.+++.++| ++|+.+..++.+.+..|+|
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH-PFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCB-TTBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccC-cChhheeeeEeeCCeeeeE
Confidence 679999999999999999999999999999999753 2334568899999999976 7777888888889999999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 82 me~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
|||| |++|.+++.. ...+++..++.++.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+......
T Consensus 83 mE~~~gg~l~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl---~~~g~vkL~DFG~a~~~~~~~ 158 (316)
T d1fota_ 83 MDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPDVT 158 (316)
T ss_dssp ECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECSSCB
T ss_pred eeecCCccccccccc-cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeE---cCCCCEEEecCccceEecccc
Confidence 9999 8999998886 5578999999999999999999999999999999999999 678999999999998765432
Q ss_pred CCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHH
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (407)
...+||+.|||||++.+..|+.++|||||||+||||++|+.||.+. +..+.+.++...... +
T Consensus 159 ----------~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~---~~~~~~~~i~~~~~~-----~ 220 (316)
T d1fota_ 159 ----------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS---NTMKTYEKILNAELR-----F 220 (316)
T ss_dssp ----------CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHHCCCC-----C
T ss_pred ----------ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc---CHHHHHHHHHcCCCC-----C
Confidence 3568999999999999999999999999999999999999999874 345556666554432 2
Q ss_pred hcCCcHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCccccccchhhc
Q 015406 241 CRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQ 297 (407)
Q Consensus 241 ~~~~~~~l~~li~~cl~~~p~~RP-----t~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~~~ 297 (407)
+..+++++.+++.+||..||.+|+ ++++|++ ++|...++|+.+..+.
T Consensus 221 p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~----------Hp~f~~i~~~~l~~~~ 272 (316)
T d1fota_ 221 PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN----------HPWFKEVVWEKLLSRN 272 (316)
T ss_dssp CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT----------SGGGSSCCHHHHHTTC
T ss_pred CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc----------CcccccCCHHHHHhCC
Confidence 356899999999999999999996 6666543 4677788998766554
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.3e-54 Score=412.50 Aligned_cols=260 Identities=19% Similarity=0.304 Sum_probs=221.9
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCC-----CCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
.++|++++.||+|+||.||+|+++.+|+.||||++... .....+.+|+++++.++| ++|+.+..++......++
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~~~~~~~~~~~~~~ 118 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCC-CcEeeccccccccccccc
Confidence 37899999999999999999999999999999987532 233457899999999976 677777788888888999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 81 vme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
||||+ |++|.+++... +.+++..++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+|+.+...
T Consensus 119 v~e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl---~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECSSC
T ss_pred ccccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHccc---CCCCCEEeeeceeeeecccc
Confidence 99999 99999999764 479999999999999999999999999999999999999 57889999999999977543
Q ss_pred CCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHH
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (407)
. ....||+.|||||++.+..++.++|||||||+||||++|..||.+. +....+.++.......
T Consensus 195 ~----------~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~---~~~~~~~~i~~~~~~~---- 257 (350)
T d1rdqe_ 195 T----------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD---QPIQIYEKIVSGKVRF---- 257 (350)
T ss_dssp B----------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCCC----
T ss_pred c----------ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc---CHHHHHHHHhcCCCCC----
Confidence 2 3568999999999999999999999999999999999999999764 3455666666554332
Q ss_pred HhcCCcHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCccccccchhhcc
Q 015406 240 LCRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQS 298 (407)
Q Consensus 240 ~~~~~~~~l~~li~~cl~~~p~~RP-----t~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~~~~ 298 (407)
+..+++++.+||.+||..||.+|+ ++++|++ ++|+..+||..+..++.
T Consensus 258 -p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~----------Hp~f~~~~~~~~~~~~~ 310 (350)
T d1rdqe_ 258 -PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN----------HKWFATTDWIAIYQRKV 310 (350)
T ss_dssp -CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT----------SGGGTTCCHHHHHTTCS
T ss_pred -CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc----------CccccCCCHHHHHhcCC
Confidence 356899999999999999999994 7666643 57777889998776553
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-54 Score=404.18 Aligned_cols=254 Identities=19% Similarity=0.242 Sum_probs=214.7
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC--------cchHHHHHHHHHHHcCCCCCCeeEEeeeeC
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--------HPQLLYESKLYRILQGGTGIPNVRWFGVEG 75 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~ 75 (407)
.+.++|++++.||+|+||+||+|+++.+|+.||||+++.... .+.+.+|+.+++.++| ++|+.+..++.+.
T Consensus 7 ~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~ 85 (293)
T d1jksa_ 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH-PNVITLHEVYENK 85 (293)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCC-TTBCCEEEEEECS
T ss_pred CcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCC-CCCCcEEEEEEEC
Confidence 466789999999999999999999999999999998864321 2357899999999986 6777888888889
Q ss_pred ceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCC-CCceEEEEeccce
Q 015406 76 DYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR-RANQVYIIDFGLA 153 (407)
Q Consensus 76 ~~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~-~~~~~kL~DFGla 153 (407)
+..||||||| |++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++ ....+||+|||+|
T Consensus 86 ~~~~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 86 TDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CEEEEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhh
Confidence 9999999999 89999999863 4799999999999999999999999999999999999995322 2236999999999
Q ss_pred eeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcc
Q 015406 154 KKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (407)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (407)
+....... .....||+.|+|||++.+..++.++|||||||+||||++|..||.+.+ ..+.+..+.....
T Consensus 165 ~~~~~~~~--------~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~~~~~~~i~~~~~ 233 (293)
T d1jksa_ 165 HKIDFGNE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANVSAVNY 233 (293)
T ss_dssp EECTTSCB--------CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHTTCC
T ss_pred hhcCCCcc--------ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC---HHHHHHHHHhcCC
Confidence 88755432 345689999999999999999999999999999999999999998743 4555666655544
Q ss_pred cccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 234 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.. .......+|+++.+||.+||+.||++|||++++++
T Consensus 234 ~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 234 EF-EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CC-CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CC-CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 32 23455678999999999999999999999887753
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.9e-55 Score=408.16 Aligned_cols=256 Identities=19% Similarity=0.297 Sum_probs=213.0
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~ 85 (407)
++|++.++||+|+||+||+|++..+++.||||+++.+.. .+++.+|+++++.++| ++|+.+.+++.+++..+||||||
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~~~~~iv~E~~ 95 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH-PNLVQLLGVCTREPPFYIITEFM 95 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCC-TTBCCEEEEECSSSSCEEEEECC
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCC-CCEecCCccEeeCCeeEEEeecc
Confidence 478999999999999999999999999999999875543 3568999999999986 77777777778888899999999
Q ss_pred -CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCc
Q 015406 86 -GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (407)
Q Consensus 86 -g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~ 163 (407)
+|+|.+++... ...+++..++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+........
T Consensus 96 ~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFG~a~~~~~~~~~- 171 (287)
T d1opja_ 96 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYT- 171 (287)
T ss_dssp TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCCTTTCCSSSSE-
T ss_pred cCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEE---CCCCcEEEccccceeecCCCCce-
Confidence 89999999753 3568999999999999999999999999999999999999 68899999999999876543321
Q ss_pred ccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcC
Q 015406 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243 (407)
Q Consensus 164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (407)
......||+.|+|||++.+..|+.++|||||||++|||++|..||.... +..+.+..+...... ..+..
T Consensus 172 -----~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~--~~~~~~~~i~~~~~~----~~~~~ 240 (287)
T d1opja_ 172 -----AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDYRM----ERPEG 240 (287)
T ss_dssp -----EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC--CHHHHHHHHHTTCCC----CCCTT
T ss_pred -----eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc--hHHHHHHHHhcCCCC----CCCcc
Confidence 1234568999999999999999999999999999999999766664422 223333333332211 23356
Q ss_pred CcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Q 015406 244 YPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (407)
Q Consensus 244 ~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~ 278 (407)
+|+++.+||.+||+.||++|||+++|.+.|+.+++
T Consensus 241 ~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 241 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 89999999999999999999999999998887654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.1e-55 Score=409.20 Aligned_cols=261 Identities=14% Similarity=0.248 Sum_probs=203.9
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCe---EEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeE
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNE---EVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~---~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 79 (407)
.++|++.++||+|+||+||+|+++.+++ .||||.+...... ..+.+|+++++.++| ++|+.+.+++...+..+
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~g~~~~~~~~~ 103 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH-PNVIHLEGVVTKSTPVM 103 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEECSSSSCE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC-CCCccEEEEEeeCCEEE
Confidence 4689999999999999999999876664 5889987654332 358899999999976 77777777888888899
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 80 lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
+||||| +|+|.+++....+.+++..++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+|+.+..
T Consensus 104 iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 104 IITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC--------
T ss_pred EEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEE---CCCCcEEECCcccceEccC
Confidence 999999 999999998766679999999999999999999999999999999999999 6889999999999987654
Q ss_pred CCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccH
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (407)
...... ........||+.|||||++.+..++.++|||||||+||||+| |..||.+... .+.+..+......+
T Consensus 181 ~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~---~~~~~~i~~~~~~~-- 253 (299)
T d1jpaa_ 181 DTSDPT--YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN---QDVINAIEQDYRLP-- 253 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTTCCCC--
T ss_pred CCCcce--eeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCCC--
Confidence 332111 111234568999999999999999999999999999999998 8999987543 44445554433222
Q ss_pred HHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHH
Q 015406 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (407)
Q Consensus 238 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~ 279 (407)
....+|+++.+|+.+||+.||++||++.+|.+.|+++++.
T Consensus 254 --~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 254 --PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp --CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 2346899999999999999999999999999999988753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.7e-54 Score=414.25 Aligned_cols=265 Identities=23% Similarity=0.303 Sum_probs=217.8
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCC-----CCcchHHHHHHHHHHHc--CCCCCCeeEEeeeeCcee
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQ--GGTGIPNVRWFGVEGDYN 78 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~~~E~~~l~~l~--~~~~i~~~~~~~~~~~~~ 78 (407)
.++|++.+.||+|+||.||+|+++.+|+.||||++... .....+.+|..+++.++ +|++|+.+..++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 36899999999999999999999999999999987532 22334666766676665 367888888888889999
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeec
Q 015406 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~ 157 (407)
||||||| |++|.+++.. ...+++..++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.+.
T Consensus 83 ~ivmE~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl---~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEEECCCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CSSSCEEECCCTTCEECS
T ss_pred EEEEEecCCCcHHHHHHh-cccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEE---cCCCcEEEeeeceeeecC
Confidence 9999999 9999999986 4579999999999999999999999999999999999999 688999999999999765
Q ss_pred cCCCCcccCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhccccc
Q 015406 158 DTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (407)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (407)
... .....||+.|||||++.+ ..|+.++|||||||+||||++|+.||.+............+.....
T Consensus 159 ~~~---------~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~--- 226 (364)
T d1omwa3 159 KKK---------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV--- 226 (364)
T ss_dssp SSC---------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCC---
T ss_pred CCc---------ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC---
Confidence 433 235689999999999974 5689999999999999999999999987665544443333222221
Q ss_pred HHHHhcCCcHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHHHHcCCCCCCccccccchhhcc
Q 015406 237 IEALCRGYPTEFASYFHYCRSLRFDDKPD-----YAYLKRIFRDLFIREGFQFDYVFDWTILKYQQS 298 (407)
Q Consensus 237 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~~~~ 298 (407)
.++..+++++.+||.+||+.||++||+ ++++++ ++|...+||..+..++.
T Consensus 227 --~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~----------Hp~f~~i~~~~~~~~~~ 281 (364)
T d1omwa3 227 --ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE----------SPFFRSLDWQMVFLQKY 281 (364)
T ss_dssp --CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT----------SGGGTTCCHHHHHTTCS
T ss_pred --CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc----------CccccCCCHHHHhcCCC
Confidence 234568999999999999999999999 344432 46777899988766554
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-54 Score=397.24 Aligned_cols=247 Identities=20% Similarity=0.299 Sum_probs=201.3
Q ss_pred CCce-eEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC----cchHHHHHHHHHHHcCCCCCCeeEEeeee----Cc
Q 015406 6 GNKF-RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVE----GD 76 (407)
Q Consensus 6 ~~~y-~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~----~~ 76 (407)
.++| ++.++||+|+||+||+|++..+++.||+|.+..... .+.+.+|+++++.++| ++|+.++.++.. ..
T Consensus 7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~~~~~~ 85 (270)
T d1t4ha_ 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH-PNIVRFYDSWESTVKGKK 85 (270)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEEEEESSSCE
T ss_pred CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCC-CCeeeEEEEEeeccccCC
Confidence 3455 788899999999999999999999999998765432 2347899999999987 555555544432 46
Q ss_pred eeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcccccCCCCCceEEEEeccce
Q 015406 77 YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (407)
Q Consensus 77 ~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--ivHrDLKp~NILl~~~~~~~~~kL~DFGla 153 (407)
..||||||+ +++|.+++... ..+++..++.|+.||+.||+|||+++ |+||||||+||||+ ++++.+||+|||+|
T Consensus 86 ~~~ivmE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~--~~~~~~Kl~DFGla 162 (270)
T d1t4ha_ 86 CIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLA 162 (270)
T ss_dssp EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGG
T ss_pred EEEEEEeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceee--CCCCCEEEeecCcc
Confidence 789999999 99999999863 57999999999999999999999998 99999999999994 34689999999999
Q ss_pred eeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcc
Q 015406 154 KKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (407)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (407)
+...... ....+||+.|||||++.+ .++.++|||||||+||||++|+.||.+.. ...+.+..+.....
T Consensus 163 ~~~~~~~---------~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~--~~~~~~~~i~~~~~ 230 (270)
T d1t4ha_ 163 TLKRASF---------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ--NAAQIYRRVTSGVK 230 (270)
T ss_dssp GGCCTTS---------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS--SHHHHHHHHTTTCC
T ss_pred eeccCCc---------cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc--cHHHHHHHHHcCCC
Confidence 7543322 235689999999999986 59999999999999999999999997643 33445555554433
Q ss_pred cccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 234 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
+ ..+...+++++.+||.+||+.||++|||++++++
T Consensus 231 ~---~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 231 P---ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp C---GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C---cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 2 2244568899999999999999999999888754
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.1e-54 Score=415.82 Aligned_cols=253 Identities=21% Similarity=0.215 Sum_probs=213.7
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC--cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
+.++|++++.||+|+||.||+|+++.+|+.||||+++.... ...+.+|+.+++.|+| ++|+.+..++.+.+..||||
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~H-pnIv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH-PKLINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCS-TTBCCEEEEEECSSEEEEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCC-CCCCcEEEEEEECCEEEEEE
Confidence 45679999999999999999999999999999999876432 2347789999999976 67777888888889999999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCC
Q 015406 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 83 e~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~ 161 (407)
||| |++|.+++......+++..++.|+.||+.||+|||++|||||||||+||||+. ..++.+||+|||+|+.+.....
T Consensus 106 E~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~-~~~~~vkL~DFGla~~~~~~~~ 184 (352)
T d1koba_ 106 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATKLNPDEI 184 (352)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEECCTTSC
T ss_pred EcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccc-cCCCeEEEeecccceecCCCCc
Confidence 999 99999988765667999999999999999999999999999999999999942 1468999999999998765432
Q ss_pred CcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHh
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (407)
.....||+.|||||++.+..++.++|||||||+||||++|..||.+.+ ..+.+..+...... ......
T Consensus 185 --------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~---~~~~~~~i~~~~~~-~~~~~~ 252 (352)
T d1koba_ 185 --------VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED---DLETLQNVKRCDWE-FDEDAF 252 (352)
T ss_dssp --------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHHCCCC-CCSSTT
T ss_pred --------eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCC-CCcccc
Confidence 235679999999999999999999999999999999999999998743 34555555554432 222344
Q ss_pred cCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 242 ~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
..+++++.+||.+||+.||++|||+.++++
T Consensus 253 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 253 SSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 678999999999999999999999877743
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-54 Score=411.82 Aligned_cols=256 Identities=17% Similarity=0.171 Sum_probs=206.2
Q ss_pred ccCCceeEec-cccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeeee----Ccee
Q 015406 4 RVGNKFRLGR-KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVE----GDYN 78 (407)
Q Consensus 4 ~~~~~y~i~~-~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~----~~~~ 78 (407)
.+.++|++.+ .||+|+||.||+|++..+++.||||+++. ...+.+|+.++.++.+|++++.+..++.+ ....
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~---~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC---SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC---cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 4567899875 59999999999999999999999999853 45678899998888767787777666543 4678
Q ss_pred EEEEecc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeee
Q 015406 79 VLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~ 156 (407)
||||||| ||+|.+++...+ ..+++..++.|+.||+.||+|||++||+||||||+|||++..+..+.+||+|||+|+..
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~ 164 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 164 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeec
Confidence 9999999 899999997543 46999999999999999999999999999999999999975555778999999999977
Q ss_pred ccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHH-HHHHhhhcccc
Q 015406 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK-YEKISEKKVST 235 (407)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~-~~~i~~~~~~~ 235 (407)
..... .....||+.|||||++.+..|+.++|||||||+||+|++|+.||.+......... ...+.......
T Consensus 165 ~~~~~--------~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~ 236 (335)
T d2ozaa1 165 TSHNS--------LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 236 (335)
T ss_dssp CCCCC--------CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSC
T ss_pred cCCCc--------cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCC
Confidence 65433 3456899999999999999999999999999999999999999977544322221 12222222111
Q ss_pred cHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.......+++++.+||.+||..||++||++.++++
T Consensus 237 -~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 237 -PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp -CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11223458999999999999999999999877654
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-55 Score=413.01 Aligned_cols=253 Identities=19% Similarity=0.282 Sum_probs=202.9
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC---cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
..++|+++++||+|+||.||+|+++.+|+.||+|+++.+.. ...+.+|+.+++.++| ++|+.+..++.+.+..|||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS-PYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCC-TTBCCEEEEEECSSEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEEECCEEEEE
Confidence 36789999999999999999999999999999999875432 2357899999999986 6777788888888899999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 82 me~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
|||+ |++|.+++.+. +.+++..++.++.||+.||.|||+ +||+||||||+|||| +.++.+||+|||+|+.+...
T Consensus 83 mEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp EECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHHHHH
T ss_pred EEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeE---CCCCCEEEeeCCCccccCCC
Confidence 9999 89999999864 479999999999999999999997 599999999999999 67899999999999876543
Q ss_pred CCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhc-------
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK------- 232 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~------- 232 (407)
. ..+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+...............
T Consensus 159 ~---------~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (322)
T d1s9ja_ 159 M---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 229 (322)
T ss_dssp T---------C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------
T ss_pred c---------cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcc
Confidence 2 235789999999999999999999999999999999999999997754322111100000000
Q ss_pred ----------------cccc----HH--------HH-hcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 233 ----------------VSTS----IE--------AL-CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 233 ----------------~~~~----~~--------~~-~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.... .. .+ ...++.++.+||.+||..||++|||++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ----------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0000 00 00 0125789999999999999999999887764
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4e-54 Score=404.96 Aligned_cols=242 Identities=21% Similarity=0.318 Sum_probs=203.3
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc-----chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
.|+++++||+|+||.||+|++..+++.||||++...... ..+.+|+++++.++| ++|+.+..++.+.+..||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH-PNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCC-TTBCCEEEEEEETTEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCC-CCEeeEEEEEEECCEEEEEE
Confidence 599999999999999999999999999999998765432 247889999999986 77777778888889999999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCC
Q 015406 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 83 e~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~ 161 (407)
||| +++|..++.. ++.+++..++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl---~~~~~~Kl~DFG~a~~~~~--- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAP--- 167 (309)
T ss_dssp ECCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE---ETTTEEEECCCTTCBSSSS---
T ss_pred EecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE---CCCCCEEEeecccccccCC---
Confidence 999 7777655554 5689999999999999999999999999999999999999 5789999999999986433
Q ss_pred CcccCccCCCCccccccccccccccC---CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHH
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHLG---IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (407)
.....||+.|||||++.+ ..|+.++|||||||++|||++|..||.+... .+.+.++.........
T Consensus 168 --------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~---~~~~~~i~~~~~~~~~- 235 (309)
T d1u5ra_ 168 --------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQNESPALQ- 235 (309)
T ss_dssp --------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSCCCCCS-
T ss_pred --------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhCCCCCCC-
Confidence 235679999999999975 3589999999999999999999999987433 4445555444333221
Q ss_pred HHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 239 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
...+|+++.+||.+||+.||++|||++++++
T Consensus 236 --~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 236 --SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 2458999999999999999999999888754
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-54 Score=407.93 Aligned_cols=263 Identities=21% Similarity=0.300 Sum_probs=220.6
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecC-----CCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-----KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~-----~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
++|++++.||+|+||+||+|+++.+++.||||++.. ......+..|..++....+|++|+.+..++.+++..|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 679999999999999999999999999999999863 233345777888777655568888988899999999999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCC
Q 015406 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (407)
Q Consensus 82 me~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~ 160 (407)
|||+ +|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ ++.+.+||+|||+|+......
T Consensus 82 mEy~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~---~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTT
T ss_pred EeecCCCcHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceee---cCCCceeccccchhhhccccc
Confidence 9999 9999999986 4579999999999999999999999999999999999999 688999999999998655433
Q ss_pred CCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHH
Q 015406 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (407)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (407)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+ ..+.+.++...... +
T Consensus 158 ~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~---~~~~~~~i~~~~~~-----~ 222 (320)
T d1xjda_ 158 A-------KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD---EEELFHSIRMDNPF-----Y 222 (320)
T ss_dssp C-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCC-----C
T ss_pred c-------cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCC-----C
Confidence 2 1345689999999999999999999999999999999999999998743 45556666544332 2
Q ss_pred hcCCcHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHHHHcCCCCCCccccccchhhcc
Q 015406 241 CRGYPTEFASYFHYCRSLRFDDKPDYA-YLKRIFRDLFIREGFQFDYVFDWTILKYQQS 298 (407)
Q Consensus 241 ~~~~~~~l~~li~~cl~~~p~~RPt~~-~l~~~l~~l~~~~~~~~~~~~dw~~~~~~~~ 298 (407)
++.+|+++.+||.+||..||++||++. +|++ ++|...++|+.+..++.
T Consensus 223 p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~----------hpff~~~~~~~l~~~~~ 271 (320)
T d1xjda_ 223 PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ----------HPLFREINWEELERKEI 271 (320)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG----------SGGGTTCCHHHHHTTCS
T ss_pred CccCCHHHHHHHHHhcccCCCCCcCHHHHHHh----------CchhccCCHHHHHhcCC
Confidence 356899999999999999999999974 5532 35666788987765553
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-54 Score=400.61 Aligned_cols=258 Identities=20% Similarity=0.303 Sum_probs=212.4
Q ss_pred CceeEecc-ccccCceEEEEEEEcC--CCeEEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 7 NKFRLGRK-IGSGSFGEIYLGTNIQ--TNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 7 ~~y~i~~~-iG~G~~g~Vy~~~~~~--~~~~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
++|.+.+. ||+|+||.||+|.++. ++..||||+++..... ..+.+|+++++.++| ++|+.+.+++.. +..||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN-PYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEES-SSEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCC-CCEeeEeeeecc-CeEEE
Confidence 56888884 9999999999998754 4558999998754432 358899999999986 566666666654 45789
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 81 vme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
||||+ +|+|.+++...+..+++..++.|+.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+.+...
T Consensus 86 vmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL---VNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---EETTEEEECCCTTCEECTTC
T ss_pred EEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheee---ccCCceeeccchhhhccccc
Confidence 99999 899999987666789999999999999999999999999999999999999 57889999999999987654
Q ss_pred CCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHH
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (407)
.... .......||+.|||||++.+..++.++|||||||++|||+| |..||.+... .+.+..+......
T Consensus 163 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~---~~~~~~i~~~~~~---- 231 (285)
T d1u59a_ 163 DSYY----TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAFIEQGKRM---- 231 (285)
T ss_dssp SCEE----CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHHHHHHTTCCC----
T ss_pred cccc----ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC----
Confidence 3221 12345578999999999999899999999999999999998 9999987654 3444555443322
Q ss_pred HHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHc
Q 015406 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (407)
Q Consensus 239 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~ 280 (407)
..++.+|+++.+||.+||+.||++||++.+|.+.|++.+...
T Consensus 232 ~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 232 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 234568999999999999999999999999999999887654
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-54 Score=407.34 Aligned_cols=254 Identities=21% Similarity=0.295 Sum_probs=209.8
Q ss_pred CceeEeccccccCceEEEEEEEcCCCe-----EEEEEEecCCC---CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCcee
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNE-----EVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~-----~vAvK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 78 (407)
++|+++++||+|+||+||+|++..+++ .||+|.+.... ....+.+|+.++..+.+|++|+.+.+++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 679999999999999999999876543 69999875432 3345889999999997778999998888888899
Q ss_pred EEEEecc-CCCHHHHHHHcC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCccc
Q 015406 79 VLVMDLL-GPSLEDLFNFCS----------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 135 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~~~----------------------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NIL 135 (407)
||||||| +|+|.+++.... ..+++..++.|+.||+.||+|||+++||||||||+|||
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nil 196 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL 196 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEE
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccc
Confidence 9999999 999999997532 24899999999999999999999999999999999999
Q ss_pred ccCCCCCceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCC
Q 015406 136 MGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQ 214 (407)
Q Consensus 136 l~~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~ 214 (407)
+ +.++.+||+|||+|+........ .......||+.|||||++.+..++.++|||||||+||||+| |..||.
T Consensus 197 l---~~~~~~Kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 197 V---THGKVVKICDFGLARDIMSDSNY-----VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp E---ETTTEEEECCCGGGSCGGGCTTS-----EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred c---ccCCeEEEeeccccccccCCCce-----eeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 9 57899999999999876554432 11345678999999999999999999999999999999998 899998
Q ss_pred CCCcCchHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015406 215 GLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 274 (407)
Q Consensus 215 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~ 274 (407)
+.... +.+.++....... ..+..+|+++.+||.+||+.||++|||+++|.+.|.
T Consensus 269 ~~~~~---~~~~~~~~~~~~~---~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 269 GIPVD---ANFYKLIQNGFKM---DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TCCCS---HHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCHH---HHHHHHHhcCCCC---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 75543 2233333332221 123568999999999999999999999999998875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-54 Score=398.02 Aligned_cols=256 Identities=20% Similarity=0.328 Sum_probs=208.5
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEec
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~ 84 (407)
.++|++.++||+|+||.||+|++ .+++.||||+++... ..+.+.+|+.+++.++| ++|+.+.++..+ +..++||||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQH-QRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCC-TTBCCEEEEECS-SSCEEEEEC
T ss_pred HHHeEEeEEEecCCCcEEEEEEE-CCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCC-CCEeEEEeeecc-CCeEEEEEe
Confidence 36899999999999999999997 467899999987543 34468999999999976 556666666544 456899999
Q ss_pred c-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 85 L-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 85 ~-g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
+ +|+|.+++... ..++++..++.|+.||+.||.|||+++|+||||||+|||| +.++.+||+|||+|+.......
T Consensus 89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll---~~~~~~Kl~DFGla~~~~~~~~- 164 (272)
T d1qpca_ 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEY- 164 (272)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECSSSCE-
T ss_pred CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheee---ecccceeeccccceEEccCCcc-
Confidence 9 99999987532 2369999999999999999999999999999999999999 6889999999999998765432
Q ss_pred cccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhc
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (407)
.......||+.|||||++.+..++.++|||||||+||||+||..||... ....+.+..+....... .+.
T Consensus 165 -----~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~--~~~~~~~~~i~~~~~~~----~p~ 233 (272)
T d1qpca_ 165 -----TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG--MTNPEVIQNLERGYRMV----RPD 233 (272)
T ss_dssp -----ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT--CCHHHHHHHHHTTCCCC----CCT
T ss_pred -----ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCC--CCHHHHHHHHHhcCCCC----Ccc
Confidence 1234567899999999999889999999999999999999965554332 22344455554432221 235
Q ss_pred CCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHH
Q 015406 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (407)
Q Consensus 243 ~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~ 279 (407)
.+|+++.+|+.+||+.||++|||+++|.+.|+++|..
T Consensus 234 ~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 6899999999999999999999999999999998864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.3e-53 Score=394.65 Aligned_cols=262 Identities=20% Similarity=0.321 Sum_probs=205.7
Q ss_pred CccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc-----chHHHHHHHHHHHcCCCCCCeeEEeeeeC--
Q 015406 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKLYRILQGGTGIPNVRWFGVEG-- 75 (407)
Q Consensus 3 ~~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~-- 75 (407)
..+.++|++.+.||+|+||.||+|++..+|+.||||+++..... ..+.+|+++++.++|++.+..+..+....
T Consensus 3 ~~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~ 82 (277)
T d1o6ya_ 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 82 (277)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSS
T ss_pred cCccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCC
Confidence 35788999999999999999999999999999999998754332 24788999999998865555554444332
Q ss_pred -ceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccce
Q 015406 76 -DYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (407)
Q Consensus 76 -~~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla 153 (407)
...||||||+ |++|.+++.. .+.+++.+++.|+.||+.||+|||++|||||||||+|||+ +.++.++|+|||.+
T Consensus 83 ~~~~~lvmE~~~g~~L~~~~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll---~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 83 GPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMDFGIA 158 (277)
T ss_dssp SEEEEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---ETTSCEEECCCTTC
T ss_pred CceEEEEEECCCCCEehhhhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCccccc---Cccccceeehhhhh
Confidence 3579999999 8999998876 4579999999999999999999999999999999999999 57889999999999
Q ss_pred eeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcc
Q 015406 154 KKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (407)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (407)
+......... ......+||+.|||||++.+..++.++|||||||+||||+||..||.+.+. .+.+.++.....
T Consensus 159 ~~~~~~~~~~----~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~~~~~~~~~~~~ 231 (277)
T d1o6ya_ 159 RAIADSGNSV----TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP---VSVAYQHVREDP 231 (277)
T ss_dssp EECC--------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHCCC
T ss_pred hhhccccccc----cccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH---HHHHHHHHhcCC
Confidence 8664433211 123466899999999999999999999999999999999999999976433 344444433322
Q ss_pred cccHHHHhcCCcHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHH
Q 015406 234 STSIEALCRGYPTEFASYFHYCRSLRFDDKP-DYAYLKRIFRDL 276 (407)
Q Consensus 234 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~~l~~~l~~l 276 (407)
.........+|+++.++|.+||+.||++|| +++++++.|.++
T Consensus 232 -~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 232 -IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp -CCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -CCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 223334567999999999999999999999 888888777665
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-53 Score=403.62 Aligned_cols=254 Identities=19% Similarity=0.253 Sum_probs=216.7
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc-chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~-~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
.+-++|++.+.||+|+||+||+|+++.+++.||||+++.+... ..+.+|+++++.++| ++|+.+..++.+.+..||||
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~H-pnIv~~~~~~~~~~~~~lvm 80 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH-RNILHLHESFESMEELVMIF 80 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCC-TTBCCEEEEEEETTEEEEEE
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCC-CCCCeEEEEEEECCEEEEEE
Confidence 4678999999999999999999999999999999998765433 347799999999986 67777888888889999999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCC
Q 015406 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 83 e~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~ 161 (407)
||| |++|.+++...+..+++.+++.|+.||+.||+|||++||+||||||+|||++. +....+||+|||+++.......
T Consensus 81 E~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~-~~~~~ikl~DFG~~~~~~~~~~ 159 (321)
T d1tkia_ 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCTTCEECCTTCE
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecC-CCceEEEEcccchhhccccCCc
Confidence 999 89999999865557999999999999999999999999999999999999942 2446899999999987654332
Q ss_pred CcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHh
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (407)
.....||+.|+|||.+.+..++.++|||||||++|+|++|..||.+.+ ..+.+..+....... .....
T Consensus 160 --------~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~---~~~~~~~i~~~~~~~-~~~~~ 227 (321)
T d1tkia_ 160 --------FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET---NQQIIENIMNAEYTF-DEEAF 227 (321)
T ss_dssp --------EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHTCCCC-CHHHH
T ss_pred --------ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCC-Chhhc
Confidence 234578999999999999999999999999999999999999997743 455666666655433 23455
Q ss_pred cCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 242 ~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
+.+++++.+||.+||..||++|||++++++
T Consensus 228 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 228 KEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 678999999999999999999999887754
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4e-53 Score=392.19 Aligned_cols=250 Identities=18% Similarity=0.209 Sum_probs=212.9
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc-----------chHHHHHHHHHHHcCCCCCCeeEEeee
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----------PQLLYESKLYRILQGGTGIPNVRWFGV 73 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~-----------~~~~~E~~~l~~l~~~~~i~~~~~~~~ 73 (407)
+.++|++.+.||+|+||+||+|+++.+++.||||++...... ..+.+|+.+++.++.|++|+.+..++.
T Consensus 1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 80 (277)
T d1phka_ 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 80 (277)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence 468999999999999999999999999999999998754321 247789999999997788989989999
Q ss_pred eCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccc
Q 015406 74 EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 152 (407)
Q Consensus 74 ~~~~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGl 152 (407)
+++..||||||+ +++|.+++.. ++.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 81 ~~~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~ 156 (277)
T d1phka_ 81 TNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGF 156 (277)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTT
T ss_pred cCcceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE---cCCCCeEEccchh
Confidence 999999999999 8999999986 4579999999999999999999999999999999999999 6889999999999
Q ss_pred eeeeccCCCCcccCccCCCCccccccccccccccC------CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHH
Q 015406 153 AKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE 226 (407)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~ 226 (407)
++.+..... .....||+.|+|||.+.+ ..++.++||||+||+||||++|+.||.+.+ ....+.
T Consensus 157 a~~~~~~~~--------~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~---~~~~~~ 225 (277)
T d1phka_ 157 SCQLDPGEK--------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---QMLMLR 225 (277)
T ss_dssp CEECCTTCC--------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHH
T ss_pred eeEccCCCc--------eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC---HHHHHH
Confidence 998765332 245689999999999863 346889999999999999999999998744 344555
Q ss_pred HHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015406 227 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 227 ~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
.+........ .....++|+++.+|+.+||+.||++||++++++
T Consensus 226 ~i~~~~~~~~-~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil 268 (277)
T d1phka_ 226 MIMSGNYQFG-SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEAL 268 (277)
T ss_dssp HHHHTCCCCC-TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred HHHhCCCCCC-CcccccCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 5555443222 223356899999999999999999999988764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-54 Score=393.89 Aligned_cols=251 Identities=17% Similarity=0.286 Sum_probs=213.7
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC-CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~ 85 (407)
++|++.++||+|+||+||+|++ .+++.||||+++... ....+.+|+.++..++| ++|..+.+++.+.+..++||||+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~H-pnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSH-EKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCC-TTBCCEEEEECCSSSEEEEEECC
T ss_pred HHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCC-CceeeEEEEEeeCCceEEEEEcc
Confidence 6899999999999999999998 578899999987654 34569999999999976 66777777777788899999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCcc
Q 015406 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164 (407)
Q Consensus 86 -g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~ 164 (407)
+|+|.+++......+++..++.|+.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.+......
T Consensus 82 ~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill---~~~~~~kl~DfG~a~~~~~~~~~-- 156 (258)
T d1k2pa_ 82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYT-- 156 (258)
T ss_dssp TTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEE---CTTCCEEECCCSSCCBCSSSSCC--
T ss_pred CCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEE---cCCCcEEECcchhheeccCCCce--
Confidence 899999987666789999999999999999999999999999999999999 68899999999999876554321
Q ss_pred cCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcC
Q 015406 165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243 (407)
Q Consensus 165 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (407)
......||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+... .+....+....... .+..
T Consensus 157 ----~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~---~~~~~~i~~~~~~~----~p~~ 225 (258)
T d1k2pa_ 157 ----SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN---SETAEHIAQGLRLY----RPHL 225 (258)
T ss_dssp ----CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH---HHHHHHHHTTCCCC----CCTT
T ss_pred ----eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH---HHHHHHHHhCCCCC----Cccc
Confidence 2345679999999999999999999999999999999998 8999987544 44455554432221 2356
Q ss_pred CcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 015406 244 YPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 275 (407)
Q Consensus 244 ~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~ 275 (407)
+|+++.+||.+||+.||++|||+++|++.|.+
T Consensus 226 ~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 226 ASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 88999999999999999999999999887754
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=395.83 Aligned_cols=249 Identities=20% Similarity=0.347 Sum_probs=201.2
Q ss_pred ccccccCceEEEEEEEc--CCCeEEEEEEecCCCCc----chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEecc-
Q 015406 13 RKIGSGSFGEIYLGTNI--QTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (407)
Q Consensus 13 ~~iG~G~~g~Vy~~~~~--~~~~~vAvK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~~- 85 (407)
++||+|+||.||+|.+. .+++.||||+++..... +.+.+|++++++++| ++|+.+.+++.. +..+|||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN-PYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCC-TTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCC-CCCceEEEEecc-CCEEEEEEcCC
Confidence 47999999999999864 45678999998654332 358899999999986 566666666654 4468999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCccc
Q 015406 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165 (407)
Q Consensus 86 g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~ 165 (407)
+|+|.+++.. ...+++..++.|+.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+.+.......
T Consensus 91 ~g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill---~~~~~~kl~DFGla~~~~~~~~~~-- 164 (277)
T d1xbba_ 91 LGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALRADENYY-- 164 (277)
T ss_dssp TEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCTTCEECCTTCSEE--
T ss_pred CCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcc---cccCcccccchhhhhhcccccccc--
Confidence 9999999986 5579999999999999999999999999999999999999 588999999999999775543321
Q ss_pred CccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHHhcCC
Q 015406 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 244 (407)
Q Consensus 166 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (407)
.......||+.|||||++.+..++.++|||||||++|||++ |..||.+.+. .+....+...... ..+..+
T Consensus 165 --~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~---~~~~~~i~~~~~~----~~p~~~ 235 (277)
T d1xbba_ 165 --KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAMLEKGERM----GCPAGC 235 (277)
T ss_dssp --EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCCC----CCCTTC
T ss_pred --ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH---HHHHHHHHcCCCC----CCCccc
Confidence 12345678999999999999999999999999999999998 8999987543 3444444443322 233568
Q ss_pred cHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Q 015406 245 PTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (407)
Q Consensus 245 ~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~ 278 (407)
|+++.+||.+||+.||++||++++|.+.|++.+.
T Consensus 236 ~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 236 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 9999999999999999999999999999988764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-53 Score=392.66 Aligned_cols=259 Identities=15% Similarity=0.189 Sum_probs=204.9
Q ss_pred CCceeEeccccccCceEEEEEEEcCCC----eEEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeeeCcee
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTN----EEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~----~~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 78 (407)
.+.|++.+.||+|+||.||+|.+..++ ..||||.++..... ..+.+|+.+++.++| ++|+.+.+++.+.+..
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H-~nIv~~~g~~~~~~~~ 84 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH-HNIIRLEGVISKYKPM 84 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEECSSSSE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCC-CCEeeeeEEEecCCce
Confidence 467999999999999999999987654 47999998654332 247899999999986 6777777787888888
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeec
Q 015406 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~ 157 (407)
++||||+ +++|.+++......+++..++.++.||+.||+|||+++|+||||||+|||| +.++.+||+|||+|+...
T Consensus 85 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 85 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC-----
T ss_pred EEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEE---CCCCeEEEcccchhhccc
Confidence 9999999 889999888767789999999999999999999999999999999999999 688999999999998765
Q ss_pred cCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccH
Q 015406 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (407)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (407)
...... .......||+.|||||++.+..++.++|||||||+||||++|..||.... ...+.+..+......+
T Consensus 162 ~~~~~~----~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~--~~~~~~~~i~~~~~~~-- 233 (283)
T d1mqba_ 162 DDPEAT----YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL--SNHEVMKAINDGFRLP-- 233 (283)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHHHTTCCCC--
T ss_pred CCCccc----eEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC--CHHHHHHHHhccCCCC--
Confidence 433211 11234578999999999999999999999999999999999655554322 2344555554443222
Q ss_pred HHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Q 015406 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (407)
Q Consensus 238 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~ 278 (407)
....+|.++.+||.+||+.||++||++.+|.+.|+.+++
T Consensus 234 --~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 234 --TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp --CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 235689999999999999999999999999999998875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-52 Score=393.42 Aligned_cols=261 Identities=19% Similarity=0.277 Sum_probs=204.1
Q ss_pred CCceeEeccccccCceEEEEEEEcC-----CCeEEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeee-eCc
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGV-EGD 76 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~-----~~~~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~-~~~ 76 (407)
.++|+++++||+|+||.||+|++.. +++.||||+++..... ..+..|..++.++.||++++.+..+.. ...
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 3689999999999999999999754 4578999998654332 347788889999988888887766654 456
Q ss_pred eeEEEEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCC
Q 015406 77 YNVLVMDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 140 (407)
Q Consensus 77 ~~~lvme~~-g~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~ 140 (407)
..++||||| +|+|.+++.... ..+++..++.++.||+.||.|||++|||||||||+|||| +
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl---~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---S 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---C
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE---C
Confidence 789999999 999999997432 248999999999999999999999999999999999999 6
Q ss_pred CCceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhC-CCCCCCCCcC
Q 015406 141 RANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRG-SLPWQGLKAG 219 (407)
Q Consensus 141 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG-~~Pf~~~~~~ 219 (407)
.++.+||+|||+|+........ .......||+.|||||++.+..++.++|||||||++|||++| ..||.+....
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~ 243 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDY-----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243 (299)
T ss_dssp GGGCEEECC------CCSCTTS-----CCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred CCCcEEEccCcchhhccccccc-----cccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence 8899999999999876544332 123456899999999999999999999999999999999986 5678765433
Q ss_pred chHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHc
Q 015406 220 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (407)
Q Consensus 220 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~ 280 (407)
......+...... ..+..+++++.++|.+||+.||++|||+++|.+.|+++++..
T Consensus 244 --~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n 298 (299)
T d1ywna1 244 --EEFCRRLKEGTRM----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298 (299)
T ss_dssp --HHHHHHHHHTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --HHHHHHHhcCCCC----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence 2222333332221 233568999999999999999999999999999999987653
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-53 Score=390.23 Aligned_cols=256 Identities=22% Similarity=0.317 Sum_probs=201.1
Q ss_pred CceeEeccccccCceEEEEEEEcCCC---eEEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTN---EEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~---~~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~l 80 (407)
++|++++.||+|+||.||+|++..++ ..||||.++..... ..+.+|+.+++.++| ++|+.+.+++. .+..|+
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH-PHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCC-TTBCCEEEEEC-SSSCEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEe-cCeEEE
Confidence 68999999999999999999986543 56899987654332 348899999999986 55666666554 456799
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 81 vme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
||||+ +++|.+++......+++..++.++.||+.||.|||+++||||||||+|||+ +.++.+||+|||+|+.....
T Consensus 85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll---~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECC----------
T ss_pred EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheee---cCCCcEEEccchhheeccCC
Confidence 99999 899999988767789999999999999999999999999999999999999 57889999999999876543
Q ss_pred CCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHH
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (407)
... ......||+.|+|||++.+..++.++|||||||+||||++ |.+||.+.... +.+..+......
T Consensus 162 ~~~------~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~---~~~~~i~~~~~~---- 228 (273)
T d1mp8a_ 162 TYY------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRIENGERL---- 228 (273)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHHHTTCCC----
T ss_pred cce------eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH---HHHHHHHcCCCC----
Confidence 321 2345578999999999999999999999999999999998 89999876553 344444443322
Q ss_pred HHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHc
Q 015406 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (407)
Q Consensus 239 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~ 280 (407)
.+++++|+++.+||.+||+.||++|||+.+|++.|+.++++.
T Consensus 229 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 229 PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 234678999999999999999999999999999999887653
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=388.94 Aligned_cols=241 Identities=24% Similarity=0.360 Sum_probs=202.8
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC--------CcchHHHHHHHHHHHcC-CCCCCeeEEeeeeC
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--------KHPQLLYESKLYRILQG-GTGIPNVRWFGVEG 75 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--------~~~~~~~E~~~l~~l~~-~~~i~~~~~~~~~~ 75 (407)
+.++|++.+.||+|+||.||+|++..+|+.||||+++... ....+.+|+.+++.+++ |++++.+..++.+.
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 5689999999999999999999999999999999876432 12347799999999984 68888898899999
Q ss_pred ceeEEEEecc-C-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccce
Q 015406 76 DYNVLVMDLL-G-PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (407)
Q Consensus 76 ~~~~lvme~~-g-~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla 153 (407)
+..|+||||+ + +++.+++.. +..+++..++.|+.||+.||+|||++||+||||||+|||++ .+.+.+||+|||+|
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~--~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSG 158 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTC
T ss_pred CeEEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEe--cCCCeEEECccccc
Confidence 9999999999 4 578888875 45799999999999999999999999999999999999994 24579999999999
Q ss_pred eeeccCCCCcccCccCCCCccccccccccccccCCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhc
Q 015406 154 KKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (407)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (407)
+...... .....||+.|+|||++.+..+ +.++|||||||+||||++|+.||... ..+....
T Consensus 159 ~~~~~~~---------~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---------~~i~~~~ 220 (273)
T d1xwsa_ 159 ALLKDTV---------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD---------EEIIRGQ 220 (273)
T ss_dssp EECCSSC---------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---------HHHHHCC
T ss_pred eeccccc---------ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc---------hHHhhcc
Confidence 8754432 245689999999999987765 67899999999999999999999652 1222222
Q ss_pred ccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 233 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 233 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.. +...+|+++.+||.+||+.||++|||++++++
T Consensus 221 ~~-----~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 221 VF-----FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp CC-----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cC-----CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 21 33568999999999999999999999888753
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-52 Score=391.71 Aligned_cols=255 Identities=20% Similarity=0.282 Sum_probs=202.8
Q ss_pred CceeEeccccccCceEEEEEEEcCCCe----EEEEEEecCCC---CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNE----EVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~----~vAvK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 79 (407)
.+|+++++||+|+||+||+|++..+|+ +||+|.++... ....+.+|+.+++.++| ++|+.+.+++.++.. +
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~g~~~~~~~-~ 86 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN-PHVCRLLGICLTSTV-Q 86 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCC-TTBCCEEEEEESSSE-E
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEecCCe-e
Confidence 569999999999999999999988776 58888775432 23468999999999986 667677777766554 5
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeecc
Q 015406 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (407)
Q Consensus 80 lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~ 158 (407)
++|||+ +++|.+++......+++..++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+....
T Consensus 87 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll---~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCCSHHHHTTT
T ss_pred EEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhccee---CCCCCeEeeccccceeccc
Confidence 666666 999999988777789999999999999999999999999999999999999 5788999999999987654
Q ss_pred CCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccH
Q 015406 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (407)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (407)
..... ......||+.|||||++.+..++.++|||||||+||||+| |..||.+.+... ....+.......
T Consensus 164 ~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~~~i~~~~~~~-- 233 (317)
T d1xkka_ 164 EEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEKGERLP-- 233 (317)
T ss_dssp TCC-------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HHHHHHHTCCCC--
T ss_pred ccccc-----cccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HHHHHHcCCCCC--
Confidence 33311 1234578999999999999999999999999999999998 899998765543 333333322211
Q ss_pred HHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Q 015406 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (407)
Q Consensus 238 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~ 278 (407)
.+..+|+++.+|+.+||+.||++|||+.+|.+.|..+..
T Consensus 234 --~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 234 --QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp --CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 234688999999999999999999999999988877653
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-52 Score=383.97 Aligned_cols=250 Identities=20% Similarity=0.302 Sum_probs=202.3
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEee-eeCceeEEEEec
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFG-VEGDYNVLVMDL 84 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~-~~~~~~~lvme~ 84 (407)
.++|+++++||+|+||.||+|++ .|..||||+++.+...+.+.+|++++++++| ++|..+.+++ ...+..|+||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~H-pnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRH-SNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCC-TTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEecCCcEEEEEec
Confidence 35799999999999999999996 5789999999887777889999999999976 6666666655 445667999999
Q ss_pred c-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 85 L-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 85 ~-g~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
+ +|+|.+++.... ..+++..++.|+.||+.||.|||+++|+||||||+|||+ +.++.+||+|||+++......
T Consensus 83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~s~~~~~~~-- 157 (262)
T d1byga_ 83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQ-- 157 (262)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC----------
T ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhhee---cCCCCEeecccccceecCCCC--
Confidence 9 999999996432 358999999999999999999999999999999999999 688999999999998654432
Q ss_pred cccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccccHHHHh
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (407)
....+|..|+|||++.+..++.++|||||||++|||+| |++||..... .+.+..+....... +.
T Consensus 158 --------~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~---~~~~~~i~~~~~~~----~~ 222 (262)
T d1byga_ 158 --------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRVEKGYKMD----AP 222 (262)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHHHHTTTCCCC----CC
T ss_pred --------ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH---HHHHHHHHcCCCCC----CC
Confidence 24568899999999999999999999999999999998 7888877544 34455554433322 33
Q ss_pred cCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Q 015406 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (407)
Q Consensus 242 ~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~ 278 (407)
..+++++.+||.+||+.||++|||+.+|.+.|+++-.
T Consensus 223 ~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 223 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 5688999999999999999999999999999988744
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=386.60 Aligned_cols=258 Identities=19% Similarity=0.323 Sum_probs=212.2
Q ss_pred CCceeEeccccccCceEEEEEEEcCCC-------eEEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeeeC
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTN-------EEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEG 75 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~-------~~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~ 75 (407)
.++|++++.||+|+||.||+|++..++ ..||||+++.+... ..+.+|...+.++.+|++|+.+..++.+.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 478999999999999999999976554 47999998765432 34778999999997789999998888888
Q ss_pred ceeEEEEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCC
Q 015406 76 DYNVLVMDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 139 (407)
Q Consensus 76 ~~~~lvme~~-g~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~ 139 (407)
+..++||||+ +|+|.+++.... ..+++..++.++.||+.||+|||+++||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl--- 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV--- 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee---
Confidence 8999999999 999999997432 358999999999999999999999999999999999999
Q ss_pred CCCceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015406 140 RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 218 (407)
Q Consensus 140 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~ 218 (407)
+.++.+||+|||+++........ .......||+.|+|||.+.+..|+.++|||||||++|||++ |..||.+...
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYY-----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTT-----CCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred cCCCCeEeccchhhccccccccc-----cccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence 68899999999999977654432 12345678999999999999999999999999999999998 7899976443
Q ss_pred CchHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Q 015406 219 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (407)
Q Consensus 219 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~ 278 (407)
.+.+..+...... ..+..+++++.+||.+||+.||++|||+.+|++.|+.++.
T Consensus 244 ---~~~~~~i~~~~~~----~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 244 ---EELFKLLKEGHRM----DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp ---HHHHHHHHTTCCC----CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHHHHHHHcCCCC----CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 3444544443222 2335689999999999999999999999999999998864
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-52 Score=383.06 Aligned_cols=256 Identities=21% Similarity=0.279 Sum_probs=199.7
Q ss_pred CCceeEeccccccCceEEEEEEEcCC---CeEEEEEEecCCCC-----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCce
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~---~~~vAvK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 77 (407)
.++|++.+.||+|+||.||+|++... ...||||+++.... .+.+.+|+.+++.++| ++|..+++++.++ .
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H-~nIv~~~g~~~~~-~ 84 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH-RNLIRLYGVVLTP-P 84 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCC-TTBCCEEEEECSS-S
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCC-CCEEEEEEEEeec-c
Confidence 35699999999999999999986533 24789998764321 2358899999999976 6666666666554 5
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeee
Q 015406 78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~ 156 (407)
.++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 85 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll---~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL---ATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---EETTEEEECCCTTCEEC
T ss_pred hheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcc---ccccceeeccchhhhhc
Confidence 68999999 899999887666779999999999999999999999999999999999999 57889999999999987
Q ss_pred ccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcCchHHHHHHHhhhcccc
Q 015406 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVST 235 (407)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (407)
....... .......|+..|+|||++.+..++.++|||||||++|||+| |..||.+.+. .+.+..+.......
T Consensus 162 ~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~---~~~~~~i~~~~~~~ 234 (273)
T d1u46a_ 162 PQNDDHY----VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---SQILHKIDKEGERL 234 (273)
T ss_dssp CC-CCEE----EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTSCCCC
T ss_pred ccCCCcc----eecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH---HHHHHHHHhCCCCC
Confidence 6544322 11234567889999999999999999999999999999998 8999987543 44555554443222
Q ss_pred cHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 015406 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (407)
Q Consensus 236 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l 276 (407)
.....+|+++.+||.+||+.||++|||+.+|.+.|+++
T Consensus 235 ---~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 235 ---PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 22356899999999999999999999999999888764
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-51 Score=387.08 Aligned_cols=255 Identities=20% Similarity=0.315 Sum_probs=209.6
Q ss_pred CCceeEeccccccCceEEEEEEEc-----CCCeEEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeeeCce
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~-----~~~~~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 77 (407)
.++|++++.||+|+||.||+|+++ .+++.||||+++..... ..+.+|+++++.++| +++..+..++.....
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h-~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN-PNIVKLLGVCAVGKP 90 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEECSSSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCC-CCcccceeeeccCCc
Confidence 367999999999999999999975 35679999998754433 358899999999987 556666666677788
Q ss_pred eEEEEecc-CCCHHHHHHHcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCc
Q 015406 78 NVLVMDLL-GPSLEDLFNFCS-----------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 133 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~N 133 (407)
.+++|||+ +++|.+++.... ..+++..++.|+.||+.||+|||+++||||||||+|
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~N 170 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN 170 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccc
Confidence 89999999 999999997432 238899999999999999999999999999999999
Q ss_pred ccccCCCCCceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCC-CC
Q 015406 134 FLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGS-LP 212 (407)
Q Consensus 134 ILl~~~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~-~P 212 (407)
||| +.++.+||+|||+|+........ .......||+.|+|||.+.+..++.++|||||||+||||++|. .|
T Consensus 171 ILl---d~~~~~Kl~DFGls~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 171 CLV---GENMVVKIADFGLSRNIYSADYY-----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp EEE---CGGGCEEECCCSCHHHHTGGGCB-----C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eEE---CCCCcEEEccchhheeccCCccc-----cccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 999 68899999999999866443321 1234567899999999999999999999999999999999985 67
Q ss_pred CCCCCcCchHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 015406 213 WQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (407)
Q Consensus 213 f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l 276 (407)
|.+.. ..+.+..+...... .....+|+++.+||.+||+.||++|||+.+|.+.|+++
T Consensus 243 ~~~~~---~~e~~~~v~~~~~~----~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 243 YYGMA---HEEVIYYVRDGNIL----ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TTTSC---HHHHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCC---HHHHHHHHHcCCCC----CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 76643 34555555554432 23457899999999999999999999999999999875
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-51 Score=386.31 Aligned_cols=247 Identities=20% Similarity=0.208 Sum_probs=197.8
Q ss_pred EeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-------cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-------HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 11 i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
.+++||+|+||+||+|+++.+|+.||||+++.... ...+.+|+.+++.++| ++|+.+..++...+..|||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH-PNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCC-TTBCCEEEEECCTTCCEEEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCC-CCEeEEEeeeccCCceeehhh
Confidence 46889999999999999999999999998764322 2458899999999986 667777777788888999999
Q ss_pred ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCCc
Q 015406 84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (407)
Q Consensus 84 ~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~~ 163 (407)
|+.+++...+...+..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+.......
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli---~~~~~~KL~DFG~a~~~~~~~~-- 155 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNR-- 155 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGSTTTSCCC--
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEe---cCCCccccccCccccccCCCcc--
Confidence 99555555554446679999999999999999999999999999999999999 6889999999999986654332
Q ss_pred ccCccCCCCccccccccccccccCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhc----------
Q 015406 164 HIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK---------- 232 (407)
Q Consensus 164 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~---------- 232 (407)
.....+||+.|+|||++.+. .|+.++|||||||++|||++|..||.+... .+.+.++....
T Consensus 156 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~---~~~l~~i~~~~~~~~~~~~~~ 227 (299)
T d1ua2a_ 156 -----AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---LDQLTRIFETLGTPTEEQWPD 227 (299)
T ss_dssp -----CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCTTTSSS
T ss_pred -----cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH---HHHHHHHHHhcCCCChhhccc
Confidence 12356899999999998754 579999999999999999999999987544 33333332210
Q ss_pred -------------ccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 233 -------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 233 -------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.......+...+++++.+||.+||..||++|||++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 228 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 012233445678899999999999999999999887753
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-51 Score=384.33 Aligned_cols=253 Identities=19% Similarity=0.268 Sum_probs=200.2
Q ss_pred cCCceeEeccccccCceEEEEEEEcCC-CeEEEEEEecCC----CCcchHHHHHHHHHHHc--CCCCCCeeEEeee----
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQT-NEEVAIKLENVK----TKHPQLLYESKLYRILQ--GGTGIPNVRWFGV---- 73 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~-~~~vAvK~~~~~----~~~~~~~~E~~~l~~l~--~~~~i~~~~~~~~---- 73 (407)
..++|+++++||+|+||+||+|++..+ ++.||||+++.. .....+.+|+.+++.|. +|+++..+..++.
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 457999999999999999999999765 678999987543 23345789999998885 4566666655443
Q ss_pred -eCceeEEEEeccCCCHHH-HHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEecc
Q 015406 74 -EGDYNVLVMDLLGPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 151 (407)
Q Consensus 74 -~~~~~~lvme~~g~sL~~-~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFG 151 (407)
.....+++|||+.+++.. ........+++..++.++.||+.||+|||++|||||||||+|||+ +..+.+||+|||
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi---~~~~~~kl~dfg 161 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFG 161 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEE---cCCCCeeecchh
Confidence 345789999999554444 444445679999999999999999999999999999999999999 688899999999
Q ss_pred ceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhh
Q 015406 152 LAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 231 (407)
Q Consensus 152 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~ 231 (407)
+++....... .....||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+. .+.+..+...
T Consensus 162 ~~~~~~~~~~--------~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~ 230 (305)
T d1blxa_ 162 LARIYSFQMA--------LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---VDQLGKILDV 230 (305)
T ss_dssp SCCCCCGGGG--------GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHH
T ss_pred hhhhhccccc--------CCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH---HHHHHHHHHh
Confidence 9986543322 3467899999999999999999999999999999999999999987543 3333333221
Q ss_pred ----------------------cccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 232 ----------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 232 ----------------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
........+...+++++.+||.+||..||++|||++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 231 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 1112233445668899999999999999999999887643
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-51 Score=382.79 Aligned_cols=251 Identities=21% Similarity=0.255 Sum_probs=204.4
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC----CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
++|+++++||+|+||.||+|++..+|+.||||+++... ....+.+|+++++.++| ++|+.+..++.+.+..|+||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~H-p~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH-PNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCC-TTBCCEEEEEEETTEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCC-CcEEEeccccccccceeEEE
Confidence 68999999999999999999999999999999986543 24568899999999986 67777888888999999999
Q ss_pred eccCCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCC
Q 015406 83 DLLGPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 83 e~~g~sL~~~l~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~ 161 (407)
||+++++.+++.. ....+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+.......
T Consensus 81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~---~~~~~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVR 157 (298)
T ss_dssp ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTHHHHHCCCSB
T ss_pred eecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheee---cccCcceeccCCcceeccCCcc
Confidence 9997777776654 34569999999999999999999999999999999999999 6788999999999987654332
Q ss_pred CcccCccCCCCccccccccccccccCCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhh---------
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK--------- 231 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~--------- 231 (407)
......||+.|+|||++....+ +.++|||||||++|+|++|+.||.+.+. ...+.++...
T Consensus 158 -------~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~ 227 (298)
T d1gz8a_ 158 -------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE---IDQLFRIFRTLGTPDEVVW 227 (298)
T ss_dssp -------CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCTTTS
T ss_pred -------cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH---HHHHHHHHHhcCCCchhhc
Confidence 2345689999999999887664 8999999999999999999999987543 2222222211
Q ss_pred ---------------cccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 232 ---------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 232 ---------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
............+++++.+|+.+||..||++|||++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp TTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 0111223344567899999999999999999999888754
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=383.10 Aligned_cols=254 Identities=20% Similarity=0.296 Sum_probs=199.7
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEec
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~ 84 (407)
.++|++.+.||+|+||.||+|++.. ++.||||+++.... .+.+.+|+.++++++|+ +|+.+.+++.+ +..++||||
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~-nIv~~~g~~~~-~~~~lv~Ey 92 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE-KLVQLYAVVSE-EPIYIVTEY 92 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCT-TBCCEEEEECS-SSCEEEECC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECcccCCHHHHHHHHHHHHhcccC-CEeEEEEEEec-CCeEEEEEe
Confidence 3689999999999999999999854 46799999875543 34699999999999875 55555555544 456899999
Q ss_pred c-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 85 L-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 85 ~-g~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
+ +|+|.+++... ...+++..++.|+.||+.||+|||++||+||||||+|||| ++++.+||+|||+|+........
T Consensus 93 ~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll---~~~~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 93 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC--------
T ss_pred cCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEE---CCCCcEEEcccchhhhccCCCce
Confidence 9 89999888642 3569999999999999999999999999999999999999 68899999999999876543321
Q ss_pred cccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhc
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (407)
......||+.|+|||++.+..++.++|||||||+||||++|..||... ....+.+..+......+ ...
T Consensus 170 ------~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~--~~~~~~~~~i~~~~~~~----~~~ 237 (285)
T d1fmka3 170 ------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG--MVNREVLDQVERGYRMP----CPP 237 (285)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT--CCHHHHHHHHHTTCCCC----CCT
T ss_pred ------eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC--CCHHHHHHHHHhcCCCC----CCc
Confidence 123467899999999999999999999999999999999965555432 22344555554433221 335
Q ss_pred CCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHH
Q 015406 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (407)
Q Consensus 243 ~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~ 277 (407)
.+|+++.++|.+||+.||++||++++|.+.|++.+
T Consensus 238 ~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 238 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred ccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 68999999999999999999999999998887644
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-51 Score=384.69 Aligned_cols=256 Identities=19% Similarity=0.246 Sum_probs=212.2
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeE--EEEEEecCC---CCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE--VAIKLENVK---TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~--vAvK~~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 81 (407)
++|++.++||+|+||.||+|+++.++.. ||||.+... ...+.+.+|++++..+.+|++|+.+.+++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 5899999999999999999999888874 677766432 23456899999999997678899998899999999999
Q ss_pred Eecc-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceE
Q 015406 82 MDLL-GPSLEDLFNFC---------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 145 (407)
Q Consensus 82 me~~-g~sL~~~l~~~---------------~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~ 145 (407)
|||+ +|+|.+++... ...+++..++.++.||+.||.|||+++||||||||+|||+ +.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~---~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEE---cCCCce
Confidence 9999 99999999642 2569999999999999999999999999999999999999 688999
Q ss_pred EEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCC-CCCCCCCcCchHHH
Q 015406 146 YIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGS-LPWQGLKAGTKKQK 224 (407)
Q Consensus 146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~-~Pf~~~~~~~~~~~ 224 (407)
||+|||+|+....... .....||..|+|||.+.+..++.++|||||||++|||++|. +||.+. +..+.
T Consensus 167 kl~DfG~a~~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~---~~~~~ 235 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK--------KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM---TCAEL 235 (309)
T ss_dssp EECCTTCEESSCEECC--------C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHH
T ss_pred EEcccccccccccccc--------ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC---CHHHH
Confidence 9999999986544322 23557899999999999999999999999999999999965 567654 33455
Q ss_pred HHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHc
Q 015406 225 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (407)
Q Consensus 225 ~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~ 280 (407)
+..+...... ..+..+|+++.+||.+||+.||++||++.+|.+.|++++...
T Consensus 236 ~~~i~~~~~~----~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 236 YEKLPQGYRL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp HHHGGGTCCC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHHHHhcCCC----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 5555443222 233568999999999999999999999999999999987643
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=381.74 Aligned_cols=260 Identities=20% Similarity=0.311 Sum_probs=215.1
Q ss_pred CCceeEeccccccCceEEEEEEEc-----CCCeEEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeeeCce
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~-----~~~~~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 77 (407)
.++|+++++||+|+||.||+|++. .+++.||||+++..... ..+.+|+.+++.+.+|++|+.+.+++.+.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 378999999999999999999863 45679999998765432 2478899999999878999999999988888
Q ss_pred eEEEEecc-CCCHHHHHHHcC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCC
Q 015406 78 NVLVMDLL-GPSLEDLFNFCS-----------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 139 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~~~~-----------------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~ 139 (407)
.+|+|||| +++|.+++.... ..+++..++.|+.||+.||+|||+++||||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~--- 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL--- 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc---
Confidence 99999999 999999997532 258999999999999999999999999999999999999
Q ss_pred CCCceEEEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015406 140 RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 218 (407)
Q Consensus 140 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~ellt-G~~Pf~~~~~ 218 (407)
+.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||+| |.+||.....
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNY-----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTS-----EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred cccCcccccccchheeccCCCcc-----eEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 57899999999999876554332 22456789999999999999999999999999999999999 6666665444
Q ss_pred CchHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHH
Q 015406 219 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (407)
Q Consensus 219 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~ 279 (407)
.. .+.++........ ....+|+++.+||.+||+.||++||++++|++.|++.+..
T Consensus 254 ~~---~~~~~i~~~~~~~---~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 254 DS---KFYKMIKEGFRML---SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp SH---HHHHHHHHTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH---HHHHHHhcCCCCC---CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 32 2222222222221 2245789999999999999999999999999999987654
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=383.43 Aligned_cols=270 Identities=17% Similarity=0.246 Sum_probs=220.3
Q ss_pred CCceeEeccccccCceEEEEEEEc---CCCeEEEEEEecCC------CCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCc
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVK------TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGD 76 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~---~~~~~vAvK~~~~~------~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 76 (407)
.++|++++.||+|+||+||+|++. .+|+.||||+++.. .....+.+|++++++++|+++|..+..+..+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 367999999999999999999974 46899999987543 233457899999999999999999999999999
Q ss_pred eeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceee
Q 015406 77 YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (407)
Q Consensus 77 ~~~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~ 155 (407)
..+++|||+ +++|.+++... +.+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+.
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEE
T ss_pred ceeeeeecccccHHHHHHHhc-ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceee---cCCCCEEEeeccchhh
Confidence 999999999 99999999864 468899999999999999999999999999999999999 5788999999999987
Q ss_pred eccCCCCcccCccCCCCccccccccccccccCCC--CChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcc
Q 015406 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (407)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (407)
+...... ......|++.|+|||.+.+.. ++.++|||||||+||||++|..||.+.........+.+......
T Consensus 179 ~~~~~~~------~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~ 252 (322)
T d1vzoa_ 179 FVADETE------RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 252 (322)
T ss_dssp CCGGGGG------GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC
T ss_pred hcccccc------cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCC
Confidence 6543321 134567999999999998654 68899999999999999999999988765554444433322221
Q ss_pred cccHHHHhcCCcHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHHHHcCCCCCCccccccchhhccc
Q 015406 234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPD-----YAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQ 299 (407)
Q Consensus 234 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~~l~~~l~~l~~~~~~~~~~~~dw~~~~~~~~~ 299 (407)
. .++..+++++.+||.+||+.||++||+ ++++ |+ ++|...++|..+..++.+
T Consensus 253 ~----~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~ei---l~-------Hpff~~i~~~~l~~~~~~ 309 (322)
T d1vzoa_ 253 P----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEI---KE-------HLFFQKINWDDLAAKKVP 309 (322)
T ss_dssp C----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHH---HT-------SGGGTTCCHHHHHTTCSC
T ss_pred C----CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHH---Hc-------CHhhcCCCHHHHHhCCCC
Confidence 1 123468999999999999999999995 4444 32 355667889877766544
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=380.74 Aligned_cols=259 Identities=20% Similarity=0.224 Sum_probs=199.5
Q ss_pred ccCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEeeee----Cc
Q 015406 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVE----GD 76 (407)
Q Consensus 4 ~~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~----~~ 76 (407)
.++.+|+++++||+|+||+||+|++..+|+.||||+++..... ..+.+|+.+++.|+|++.+..+..+... ..
T Consensus 5 ~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred CcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence 3678999999999999999999999999999999998754432 3578899999999876555444444322 23
Q ss_pred eeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeee
Q 015406 77 YNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (407)
Q Consensus 77 ~~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~ 156 (407)
..|++|++++++|.+++.. +.+++..++.++.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+..
T Consensus 85 ~~~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl---~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 85 DVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVA 159 (345)
T ss_dssp CEEEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred eEEEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEE---CCCCCEEEcccCceeec
Confidence 4577777669999999974 479999999999999999999999999999999999999 57889999999999876
Q ss_pred ccCCCCcccCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhh-----
Q 015406 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE----- 230 (407)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~----- 230 (407)
....... ......+||+.|+|||++.. ..++.++||||+||++|||++|+.||.+....+..........
T Consensus 160 ~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (345)
T d1pmea_ 160 DPDHDHT----GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 235 (345)
T ss_dssp CGGGCBC----CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred cCCCccc----eeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChh
Confidence 5433221 12345689999999999854 5678999999999999999999999977543222222111110
Q ss_pred ------------------hcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 231 ------------------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 231 ------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.........+...+++++.+|+.+||..||++|||++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01112233455678899999999999999999999887753
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=381.15 Aligned_cols=252 Identities=19% Similarity=0.276 Sum_probs=195.7
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc----chHHHHHHHHHHHcCCCCCCeeEEeeee-----C
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVE-----G 75 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~-----~ 75 (407)
+.++|+++++||+|+||+||+|+++.+|+.||||+++..... +.+.+|+++++.++|++.+..+..+... .
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 678999999999999999999999999999999998754332 3478899999999875544444443322 2
Q ss_pred ceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceee
Q 015406 76 DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (407)
Q Consensus 76 ~~~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~ 155 (407)
...|+||||++.+|..+++. ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+.
T Consensus 96 ~~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~---~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 96 TDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQ 170 (346)
T ss_dssp CCCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred ceEEEEEecccccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhc---ccccccccccccceec
Confidence 25699999999999998874 479999999999999999999999999999999999999 6889999999999987
Q ss_pred eccCCCCcccCccCCCCccccccccccccccCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhh---
Q 015406 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK--- 231 (407)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~--- 231 (407)
..... ....||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+..............
T Consensus 171 ~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (346)
T d1cm8a_ 171 ADSEM----------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 240 (346)
T ss_dssp CCSSC----------CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred cCCcc----------ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcH
Confidence 65432 356899999999999874 4689999999999999999999999875432222222111110
Q ss_pred --------------------cccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 232 --------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 232 --------------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
........+...+++++.+||.+||..||++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 1111222334567899999999999999999999887764
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.4e-50 Score=372.62 Aligned_cols=249 Identities=22% Similarity=0.318 Sum_probs=199.2
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC----cchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
++|+++++||+|+||+||+|++ .+|+.||||+++.... ...+.+|+.+++.++| ++|+.+..++...+..+++|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKH-SNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCC-TTBCCEEEEEECSSCEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEe-CCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCC-CcEEeeeeecccCCceeEEE
Confidence 6899999999999999999998 4889999999865432 3468899999999976 67777778888888899999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 83 e~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
||+++++...+....+.+++..++.|+.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|.........
T Consensus 80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll---~~~~~~kl~DfG~a~~~~~~~~~ 156 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRK 156 (286)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC----
T ss_pred EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeE---cCCCCEEecccccceecccCccc
Confidence 999766666666556789999999999999999999999999999999999999 67899999999999876543321
Q ss_pred cccCccCCCCccccccccccccccCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhc---------
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK--------- 232 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~--------- 232 (407)
.....|++.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+. .+.+.++....
T Consensus 157 -------~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~ 226 (286)
T d1ob3a_ 157 -------YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE---ADQLMRIFRILGTPNSKNWP 226 (286)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCTTTST
T ss_pred -------cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH---HHHHHHHHHhhCCCChhhcc
Confidence 2345789999999999765 469999999999999999999999987543 22333322110
Q ss_pred ---------------ccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015406 233 ---------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 233 ---------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
...........+++++.+||.+||..||++|||++|++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell 279 (286)
T d1ob3a_ 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279 (286)
T ss_dssp TGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred chhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 01111233456789999999999999999999988775
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-50 Score=375.73 Aligned_cols=256 Identities=17% Similarity=0.246 Sum_probs=203.5
Q ss_pred EeccccccCceEEEEEEEcCCC---eEEEEEEecCCCCc---chHHHHHHHHHHHcCCCCCCeeEEee-eeCceeEEEEe
Q 015406 11 LGRKIGSGSFGEIYLGTNIQTN---EEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFG-VEGDYNVLVMD 83 (407)
Q Consensus 11 i~~~iG~G~~g~Vy~~~~~~~~---~~vAvK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~-~~~~~~~lvme 83 (407)
+.++||+|+||+||+|++..++ ..||||.++..... ..+.+|++++.+++| +++..+.++. ......++|||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH-PNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCC-TTBCCCCEEEEETTTEEEEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC-CCEeEEeEEEEecCCceEEEEE
Confidence 4678999999999999986643 36999988643322 358999999999987 5555555544 45668899999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 84 ~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
|| +++|.+++......+++..++.++.|++.||.|||+++|+||||||+|||| ++++.+||+|||+++........
T Consensus 110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl---~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSSGGGCCTTTTTCC
T ss_pred EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeE---CCCCCEEEecccchhhccccccc
Confidence 99 999999998666678899999999999999999999999999999999999 68899999999999876554332
Q ss_pred cccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccccHHHHhc
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (407)
. ........||+.|+|||.+.+..++.++||||||++||||++|..||..... ..+....+....... .+.
T Consensus 187 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~--~~~~~~~i~~g~~~~----~p~ 257 (311)
T d1r0pa_ 187 S---VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN--TFDITVYLLQGRRLL----QPE 257 (311)
T ss_dssp C---TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHTTCCCC----CCT
T ss_pred c---ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC--HHHHHHHHHcCCCCC----Ccc
Confidence 2 1223456789999999999999999999999999999999998777765322 223333333333221 235
Q ss_pred CCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHH
Q 015406 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (407)
Q Consensus 243 ~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~ 279 (407)
.+++++.+||.+||+.||++||++.+|.+.|+.++..
T Consensus 258 ~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 258 YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 6899999999999999999999999999999998753
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-49 Score=377.64 Aligned_cols=249 Identities=21% Similarity=0.213 Sum_probs=193.5
Q ss_pred ceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeee-----eCceeEEEE
Q 015406 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGV-----EGDYNVLVM 82 (407)
Q Consensus 8 ~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~-----~~~~~~lvm 82 (407)
+|+.+++||+|+||+||+|++..+|+.||||++..+. ....+|+++++.++|++.+..+..+.. ...+.||||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 98 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 98 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc--hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEE
Confidence 6999999999999999999999999999999987543 334589999999987555444444322 234678999
Q ss_pred eccCCCHHHHHH---HcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccC
Q 015406 83 DLLGPSLEDLFN---FCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (407)
Q Consensus 83 e~~g~sL~~~l~---~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~ 159 (407)
|||++++.+.+. .....+++..++.|+.||+.||+|||++||+||||||+||||+ .+...+||+|||+++.....
T Consensus 99 Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~--~~~~~~kl~DFG~a~~~~~~ 176 (350)
T d1q5ka_ 99 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRG 176 (350)
T ss_dssp ECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC--TTTCCEEECCCTTCEECCTT
T ss_pred eccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEe--cCCCceeEecccchhhccCC
Confidence 999766655543 2355799999999999999999999999999999999999994 23358999999999877554
Q ss_pred CCCcccCccCCCCccccccccccccccC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhccc----
Q 015406 160 STHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS---- 234 (407)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~---- 234 (407)
.. .....||+.|+|||.+.+ ..++.++|||||||++|||++|..||...... +.+..+......
T Consensus 177 ~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~---~~l~~i~~~~g~~~~~ 245 (350)
T d1q5ka_ 177 EP--------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV---DQLVEIIKVLGTPTRE 245 (350)
T ss_dssp SC--------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH---HHHHHHHHHHCCCCHH
T ss_pred cc--------cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH---HHHHHHHHHhCCChHH
Confidence 32 235689999999998875 46899999999999999999999999875432 333332211000
Q ss_pred --------------------ccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 235 --------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 235 --------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.........+++++.+||.+||..||++|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0011112357889999999999999999999887653
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-49 Score=372.53 Aligned_cols=260 Identities=20% Similarity=0.237 Sum_probs=196.2
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC----cchHHHHHHHHHHHcCCCCCCeeEEeee-------e
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGV-------E 74 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~-------~ 74 (407)
.++|+++++||+|+||+||+|++..+|+.||||++..+.. ...+.+|+.+++.++|++.+..+..+.. .
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 3789999999999999999999999999999998764432 3458899999999998655555544422 2
Q ss_pred CceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEecccee
Q 015406 75 GDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (407)
Q Consensus 75 ~~~~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~ 154 (407)
....|++|||+++.+...+......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl---~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLAR 165 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCE
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheee---cCCCcEEeeecceee
Confidence 45679999999776766666556789999999999999999999999999999999999999 688999999999998
Q ss_pred eeccCCCCcccCccCCCCccccccccccccccCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcc
Q 015406 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (407)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (407)
.+........ ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.........+........
T Consensus 166 ~~~~~~~~~~---~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 242 (318)
T d3blha1 166 AFSLAKNSQP---NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242 (318)
T ss_dssp ECCC-----C---CCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred eccccccccc---ccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 7654332211 123456899999999999865 689999999999999999999999987544333333332221111
Q ss_pred ccc----------------------HHH-H-hcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 234 STS----------------------IEA-L-CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 234 ~~~----------------------~~~-~-~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
... ... + ....++++.+||.+||..||++|||++++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 000 000 0 0113677889999999999999999877653
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.6e-49 Score=375.06 Aligned_cols=259 Identities=18% Similarity=0.279 Sum_probs=204.7
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeee--eCceeEEEEe
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGV--EGDYNVLVMD 83 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~--~~~~~~lvme 83 (407)
.++|+++++||+|+||+||+|+++.+|+.||||+++.. ....+.+|+.+++.+.+|++|+.+..++. .....++|||
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 46799999999999999999999999999999998653 45678899999999987788888877665 3456899999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCCC
Q 015406 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (407)
Q Consensus 84 ~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~~ 162 (407)
|| +++|.++. +.+++..++.++.||+.||+|||++|||||||||+|||++ .+++.+||+|||+|+.......
T Consensus 113 ~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~--~~~~~vkl~DFG~a~~~~~~~~- 185 (328)
T d3bqca1 113 HVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQE- 185 (328)
T ss_dssp CCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCGGGCEECCTTCC-
T ss_pred ecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEc--CCCCeeeecccccceeccCCCc-
Confidence 99 78887653 4699999999999999999999999999999999999995 3455799999999987765432
Q ss_pred cccCccCCCCccccccccccccccCCC-CChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhc---------
Q 015406 163 QHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK--------- 232 (407)
Q Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~--------- 232 (407)
.....||+.|+|||.+.+.. ++.++|||||||++|||++|..||...... ......+....
T Consensus 186 -------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~--~~~~~~i~~~~g~~~~~~~~ 256 (328)
T d3bqca1 186 -------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN--YDQLVRIAKVLGTEDLYDYI 256 (328)
T ss_dssp -------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH--HHHHHHHHHHHCHHHHHHHH
T ss_pred -------ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchh--HHHHHHHHHHHCCchhhhhh
Confidence 34668999999999988754 799999999999999999999999764432 11111111100
Q ss_pred ----cc-------------------ccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccc
Q 015406 233 ----VS-------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFD 289 (407)
Q Consensus 233 ----~~-------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~~~~~~d 289 (407)
.. .........+++++.+||.+||..||++|||++++++ ++|+..+.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~----------Hp~F~~v~ 326 (328)
T d3bqca1 257 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME----------HPYFYTVV 326 (328)
T ss_dssp HHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT----------SGGGTTSC
T ss_pred hhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc----------CcccCCCC
Confidence 00 0000112346889999999999999999999887754 35555566
Q ss_pred cc
Q 015406 290 WT 291 (407)
Q Consensus 290 w~ 291 (407)
|+
T Consensus 327 ~~ 328 (328)
T d3bqca1 327 KD 328 (328)
T ss_dssp CC
T ss_pred CC
Confidence 63
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=374.28 Aligned_cols=255 Identities=20% Similarity=0.306 Sum_probs=209.7
Q ss_pred CCceeEeccccccCceEEEEEEEcC-----CCeEEEEEEecCCCCcc---hHHHHHHHHHHHcCCCCCCeeEEeeeeCce
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTKHP---QLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~-----~~~~vAvK~~~~~~~~~---~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 77 (407)
.++|++.++||+|+||.||+|++.. +++.||||+++...... .+.+|+.+++.++| ++++.+.+++.....
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h-~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC-HHVVRLLGVVSQGQP 97 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCC-TTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCC-CCEeeeeeEEecCCc
Confidence 3789999999999999999998753 35789999987544332 37899999999986 566666677777778
Q ss_pred eEEEEecc-CCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEE
Q 015406 78 NVLVMDLL-GPSLEDLFNFCS---------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI 147 (407)
Q Consensus 78 ~~lvme~~-g~sL~~~l~~~~---------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL 147 (407)
.++||||+ +|+|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+|||| +.++.+||
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl---d~~~~~Kl 174 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTVKI 174 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---CTTCCEEE
T ss_pred eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee---cCCceEEE
Confidence 89999999 999999986432 247899999999999999999999999999999999999 68899999
Q ss_pred EeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhC-CCCCCCCCcCchHHHHH
Q 015406 148 IDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRG-SLPWQGLKAGTKKQKYE 226 (407)
Q Consensus 148 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG-~~Pf~~~~~~~~~~~~~ 226 (407)
+|||+|+........ .......||+.|+|||.+.+..++.++||||||++||||+|| ..||.+.+ ..+.+.
T Consensus 175 ~DFGla~~~~~~~~~-----~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~---~~~~~~ 246 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYY-----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS---NEQVLR 246 (308)
T ss_dssp CCTTCCCGGGGGGCE-----EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC---HHHHHH
T ss_pred eecccceeccCCcce-----eeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC---HHHHHH
Confidence 999999876544321 123455789999999999999999999999999999999997 57786643 345555
Q ss_pred HHhhhcccccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 015406 227 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (407)
Q Consensus 227 ~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l 276 (407)
.+....... ....+|+++.++|.+||+.||++||++.+|++.|++.
T Consensus 247 ~i~~~~~~~----~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 247 FVMEGGLLD----KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp HHHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHHhCCCCC----CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 555544322 2356899999999999999999999999999888764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=372.16 Aligned_cols=267 Identities=21% Similarity=0.269 Sum_probs=201.3
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHH--HHcCCCCCCeeEEeeeeC----cee
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYR--ILQGGTGIPNVRWFGVEG----DYN 78 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~--~l~~~~~i~~~~~~~~~~----~~~ 78 (407)
|..+|.+.++||+|+||.||+|++ +|+.||||+++.+. .....+|.+++. .++| ++|..+.+++.+. ...
T Consensus 1 ~~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~H-pnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRH-ENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCC-TTBCCEEEEEEEECSSSEEE
T ss_pred CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-hhHHHHHHHHHHHhhCCC-CcCcceEEEEEeCCCcceEE
Confidence 457899999999999999999984 68999999986543 334555655553 4454 6666666555432 367
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh--------CCceeccCCCCcccccCCCCCceEEEEe
Q 015406 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS--------KSFLHRDIKPDNFLMGLGRRANQVYIID 149 (407)
Q Consensus 79 ~lvme~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~--------~~ivHrDLKp~NILl~~~~~~~~~kL~D 149 (407)
|+||||+ +++|.+++++ ..+++..++.++.|++.||.|||+ +|||||||||+|||| +.++.+||+|
T Consensus 77 ~lv~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl---~~~~~~Kl~D 151 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIAD 151 (303)
T ss_dssp EEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE---CTTSCEEECC
T ss_pred EEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE---cCCCCeEEEe
Confidence 9999999 9999999985 469999999999999999999996 699999999999999 6889999999
Q ss_pred ccceeeeccCCCCcccCccCCCCccccccccccccccCCC------CChhhHHHHHHHHHHHHHhCCCCCCCCCc-----
Q 015406 150 FGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE------QSRRDDLESLGYVLMYFLRGSLPWQGLKA----- 218 (407)
Q Consensus 150 FGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~------~~~~sDIwSlG~il~elltG~~Pf~~~~~----- 218 (407)
||+++.......... .......||+.|||||++.+.. ++.++|||||||+||||+||..||.....
T Consensus 152 FGl~~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~ 228 (303)
T d1vjya_ 152 LGLAVRHDSATDTID---IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228 (303)
T ss_dssp CTTCEEEETTTTEEC---C----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred cCccccccCCCccee---ccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccch
Confidence 999998765443221 1234568999999999988643 57799999999999999999887743221
Q ss_pred -------CchHHHHHHHhhhcccccHHHH--hcCCcHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHHHcCCC
Q 015406 219 -------GTKKQKYEKISEKKVSTSIEAL--CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQ 283 (407)
Q Consensus 219 -------~~~~~~~~~i~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~~l~~l~~~~~~~ 283 (407)
................+.++.. ....+.++.+|+.+||+.||++|||+.+|.+.|+++..+.+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~~~ 302 (303)
T d1vjya_ 229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIK 302 (303)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHCCC
T ss_pred hhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcCCC
Confidence 1112222222222222221111 1223467999999999999999999999999999998887754
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-48 Score=371.26 Aligned_cols=249 Identities=21% Similarity=0.289 Sum_probs=194.3
Q ss_pred cCCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc----chHHHHHHHHHHHcCCCCCCeeEEeee-----eC
Q 015406 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGV-----EG 75 (407)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~-----~~ 75 (407)
+.++|+++++||+|+||+||+|++..+|+.||||++...... ..+.+|+++++.++|++.+..+..+.. +.
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 357899999999999999999999999999999998755432 247889999999987555544444422 23
Q ss_pred ceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceee
Q 015406 76 DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (407)
Q Consensus 76 ~~~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~ 155 (407)
...+++|+++|++|.+++. .+++++..++.++.||+.||+|||++||+||||||+|||+ +.++.+|++|||++..
T Consensus 96 ~~~~i~~~~~gg~L~~~~~--~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi---~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH 170 (348)
T ss_dssp CCCEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCC----C
T ss_pred ceEEEEEeecCCchhhhcc--cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccc---cccccccccccchhcc
Confidence 3456666555999999996 4579999999999999999999999999999999999999 6889999999999976
Q ss_pred eccCCCCcccCccCCCCccccccccccccccCCC-CChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcc-
Q 015406 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV- 233 (407)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~- 233 (407)
.... .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.. .....+.....
T Consensus 171 ~~~~----------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~---~~~~~i~~~~~~ 237 (348)
T d2gfsa1 171 TDDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI---DQLKLILRLVGT 237 (348)
T ss_dssp CTGG----------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCC
T ss_pred cCcc----------cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCC
Confidence 5432 23568999999999987755 589999999999999999999999875432 22222221111
Q ss_pred -------------------------cccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 234 -------------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 234 -------------------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
.........++++++.+||.+||..||++|||++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 238 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp CCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 11222334568899999999999999999999877753
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=356.85 Aligned_cols=251 Identities=20% Similarity=0.239 Sum_probs=202.3
Q ss_pred CceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCc----chHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEE
Q 015406 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (407)
Q Consensus 7 ~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvm 82 (407)
++|+++++||+|+||+||+|++..+++.||||+++..... ..+.+|+.+++.++| +++..+..++......+++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h-~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH-KNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCc-CCEEeeccccccccceeEEe
Confidence 6899999999999999999999999999999998654432 357899999999887 56777778888888999999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceeeeccCCC
Q 015406 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (407)
Q Consensus 83 e~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~~~~~~~ 161 (407)
+++ +++|..++. ..+.+++..++.++.|++.||+|||++|||||||||+|||+ +.++.+||+|||.|+.......
T Consensus 81 ~~~~~~~l~~~~~-~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli---~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 81 EFCDQDLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp ECCSEEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSCCS
T ss_pred eeccccccccccc-cccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccc---ccCCceeeeecchhhcccCCCc
Confidence 999 666666655 46689999999999999999999999999999999999999 5778999999999998765433
Q ss_pred CcccCccCCCCccccccccccccccCCC-CChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcc-------
Q 015406 162 HQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV------- 233 (407)
Q Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~------- 233 (407)
. .....+++.|+|||.+.+.. ++.++|||||||++|||++|..||.... +..+.+.++.....
T Consensus 157 ~-------~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~ 227 (292)
T d1unla_ 157 C-------YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEEQW 227 (292)
T ss_dssp C-------CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS--SHHHHHHHHHHHHCCCCTTTC
T ss_pred c-------ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCC--CHHHHHHHHHhhcCCCChhhh
Confidence 2 23456788999999988765 6999999999999999999999975432 22333333322111
Q ss_pred -----------------cccHHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015406 234 -----------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (407)
Q Consensus 234 -----------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (407)
..........+++++.+||.+||+.||.+|||++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11112233456889999999999999999999887643
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=368.43 Aligned_cols=247 Identities=19% Similarity=0.224 Sum_probs=185.6
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCCcc----hHHHHHHHHHHHcCCCCCCeeEEeee------eC
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKLYRILQGGTGIPNVRWFGV------EG 75 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~----~~~~E~~~l~~l~~~~~i~~~~~~~~------~~ 75 (407)
.++|+++++||+|+||+||+|+++.+|+.||||++....... .+.+|+.+++.++| ++|+.+..++. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH-KNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCC-TTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCC-CCeeEEEEEEecccccccC
Confidence 478999999999999999999999999999999987654332 47789999999986 55555444432 34
Q ss_pred ceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEEEeccceee
Q 015406 76 DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (407)
Q Consensus 76 ~~~~lvme~~g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~~ 155 (407)
...|+|||||.+++.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+|++|||+++.
T Consensus 95 ~~~~iv~Ey~~~~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~---~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 95 QDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLART 168 (355)
T ss_dssp CEEEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC---
T ss_pred ceeEEEEeccchHHHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccc---ccccceeeechhhhhc
Confidence 6889999999777766654 469999999999999999999999999999999999999 5788999999999987
Q ss_pred eccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCchHHHHHHHhhhcccc
Q 015406 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (407)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (407)
...... .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+.. ....++.......
T Consensus 169 ~~~~~~--------~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~---~~~~~i~~~~~~~ 237 (355)
T d2b1pa1 169 AGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI---DQWNKVIEQLGTP 237 (355)
T ss_dssp --------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCC
T ss_pred cccccc--------cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHH---HHHHHHHHhccCC
Confidence 655332 34567999999999999999999999999999999999999999875432 2222221111000
Q ss_pred c-------------------------------------HHHHhcCCcHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015406 236 S-------------------------------------IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (407)
Q Consensus 236 ~-------------------------------------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~l~ 270 (407)
. ........++++.+||.+||..||++|||+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL 309 (355)
T d2b1pa1 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309 (355)
T ss_dssp CHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence 0 0001112467899999999999999999988875
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.6e-43 Score=337.84 Aligned_cols=255 Identities=22% Similarity=0.259 Sum_probs=184.4
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC-cchHHHHHHHHHHHcCC----------CCCCeeEEeee-
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGG----------TGIPNVRWFGV- 73 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~E~~~l~~l~~~----------~~i~~~~~~~~- 73 (407)
.++|+++++||+|+||+||+|+++.+|+.||||+++.+.. .+.+.+|+.+++.+.|. ++++.+..++.
T Consensus 12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 3579999999999999999999999999999999876432 24578899999988763 34554444433
Q ss_pred -eCceeEEEEecc--CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcccccCCC---CCceE
Q 015406 74 -EGDYNVLVMDLL--GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGR---RANQV 145 (407)
Q Consensus 74 -~~~~~~lvme~~--g~sL~~~l~~-~~~~l~~~~~~~i~~qi~~aL~yLH~-~~ivHrDLKp~NILl~~~~---~~~~~ 145 (407)
.....+++|+++ +++....... ....+++..+..++.||+.||+|||+ +||+||||||+||||+.++ ....+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccccee
Confidence 445666666666 4444444432 34568999999999999999999998 8999999999999994211 11359
Q ss_pred EEEeccceeeeccCCCCcccCccCCCCccccccccccccccCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcCch---H
Q 015406 146 YIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK---K 222 (407)
Q Consensus 146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDIwSlG~il~elltG~~Pf~~~~~~~~---~ 222 (407)
+|+|||.|....... ...+||+.|+|||++.+..++.++||||+||++++|++|+.||........ .
T Consensus 172 kl~dfg~s~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~ 241 (362)
T d1q8ya_ 172 KIADLGNACWYDEHY----------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241 (362)
T ss_dssp EECCCTTCEETTBCC----------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred eEeeccccccccccc----------ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchh
Confidence 999999998654432 356799999999999999999999999999999999999999975432211 1
Q ss_pred HHHHHHhhhccc------------------------------ccHH-------HHhcCCcHHHHHHHHHHhCCCCCCCCC
Q 015406 223 QKYEKISEKKVS------------------------------TSIE-------ALCRGYPTEFASYFHYCRSLRFDDKPD 265 (407)
Q Consensus 223 ~~~~~i~~~~~~------------------------------~~~~-------~~~~~~~~~l~~li~~cl~~~p~~RPt 265 (407)
..+......... .... ......++++.+||.+||..||.+|||
T Consensus 242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt 321 (362)
T d1q8ya_ 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 321 (362)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence 111111000000 0000 001224678999999999999999999
Q ss_pred HHHHH
Q 015406 266 YAYLK 270 (407)
Q Consensus 266 ~~~l~ 270 (407)
+++++
T Consensus 322 a~e~L 326 (362)
T d1q8ya_ 322 AGGLV 326 (362)
T ss_dssp HHHHH
T ss_pred HHHHh
Confidence 87764
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=5.4e-26 Score=197.61 Aligned_cols=161 Identities=19% Similarity=0.282 Sum_probs=112.2
Q ss_pred eeEeccccccCceEEEEEEEcCCCeEEEEEEecCCCC------------c--------chHHHHHHHHHHHcCCCCCCee
Q 015406 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK------------H--------PQLLYESKLYRILQGGTGIPNV 68 (407)
Q Consensus 9 y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~------------~--------~~~~~E~~~l~~l~~~~~i~~~ 68 (407)
+.++++||+|+||+||+|++ .+|+.||||+++.... . .....|...+..+.+.+ ++..
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-v~~~ 79 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLA-VPKV 79 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSS-SCCE
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCC-cceE
Confidence 56899999999999999998 5789999998653211 0 11235667777776643 4433
Q ss_pred EEeeeeCceeEEEEeccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcccccCCCCCceEEE
Q 015406 69 RWFGVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI 147 (407)
Q Consensus 69 ~~~~~~~~~~~lvme~~g~-sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDLKp~NILl~~~~~~~~~kL 147 (407)
..+ .. .+++|||+++ .+. .++...+..++.|++.+|.|||++||+||||||+|||++ +..++|
T Consensus 80 ~~~--~~--~~lvme~~~~~~~~--------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~----~~~~~l 143 (191)
T d1zara2 80 YAW--EG--NAVLMELIDAKELY--------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----EEGIWI 143 (191)
T ss_dssp EEE--ET--TEEEEECCCCEEGG--------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE----TTEEEE
T ss_pred EEe--cC--CEEEEEeecccccc--------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeee----CCCEEE
Confidence 322 22 3799999944 332 245566788999999999999999999999999999993 355899
Q ss_pred EeccceeeeccCCCCcccCccCCCCcccccccccc------ccccCCCCChhhHHHHHHHHH
Q 015406 148 IDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASM------NTHLGIEQSRRDDLESLGYVL 203 (407)
Q Consensus 148 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aP------E~~~~~~~~~~sDIwSlG~il 203 (407)
+|||+|+....... ..|... +.+ .+.|+.++|+||+.--+
T Consensus 144 iDFG~a~~~~~~~~---------------~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 144 IDFPQSVEVGEEGW---------------REILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCCTTCEETTSTTH---------------HHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred EECCCcccCCCCCc---------------HHHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 99999986543321 111111 111 34678889999976443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.64 E-value=1.3e-07 Score=83.77 Aligned_cols=138 Identities=19% Similarity=0.256 Sum_probs=94.9
Q ss_pred CCceeEeccccccCceEEEEEEEcCCCeEEEEEEecCCC--CcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEe
Q 015406 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (407)
Q Consensus 6 ~~~y~i~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme 83 (407)
.+.|++.+..+.++.+.||+.. ..+..+++|+..... ....+.+|...+..+...-.++.+..++..++..++||+
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~ 90 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred hhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEE
Confidence 3567888876666678999987 566778889765432 233578899999998766557888888888888999999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 015406 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS----------------------------------------- 121 (407)
Q Consensus 84 ~~-g~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~----------------------------------------- 121 (407)
++ |.++.+.... ... ...++.+++..|..||+
T Consensus 91 ~l~G~~~~~~~~~---~~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T d1j7la_ 91 EADGVLCSEEYED---EQS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp CCSSEEHHHHTTT---CSC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSC
T ss_pred ecccccccccccc---ccc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccc
Confidence 99 6666543321 111 12233334444444442
Q ss_pred ------------------CCceeccCCCCcccccCCCCCceEEEEecccee
Q 015406 122 ------------------KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (407)
Q Consensus 122 ------------------~~ivHrDLKp~NILl~~~~~~~~~kL~DFGla~ 154 (407)
..++|+|+.|.|||+ ++++.+.|+||+.+.
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~---~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFV---KDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEE---ETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhcCCcCCcEEEEeeccCcceee---cCCceEEEeechhcc
Confidence 127899999999999 455555799999875
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.19 E-value=3.6e-06 Score=73.78 Aligned_cols=73 Identities=15% Similarity=0.048 Sum_probs=52.8
Q ss_pred ccccC-ceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCC-CCeeEEeeeeCceeEEEEecc-CCCH
Q 015406 15 IGSGS-FGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTG-IPNVRWFGVEGDYNVLVMDLL-GPSL 89 (407)
Q Consensus 15 iG~G~-~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~-i~~~~~~~~~~~~~~lvme~~-g~sL 89 (407)
+..|. .+.||+... ..+..+++|..... ....+..|...++.|..... ++.+..+..+++..+++|+++ |.++
T Consensus 18 ~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~-~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CSCTTSSCEEEEEEC-TTSCCEEEEEECSC-TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCcccCCeEEEEEe-CCCCEEEEEeCCcc-CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 34444 468999984 55667889976543 34568899999998876443 566777777778889999999 5554
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.17 E-value=3.5e-06 Score=79.22 Aligned_cols=73 Identities=18% Similarity=0.184 Sum_probs=48.0
Q ss_pred eccccccCceEEEEEEEcCCCeEEEEEEecC------C---CCcchHHHHHHHHHHHcCC--CCCCeeEEeeeeCceeEE
Q 015406 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENV------K---TKHPQLLYESKLYRILQGG--TGIPNVRWFGVEGDYNVL 80 (407)
Q Consensus 12 ~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~------~---~~~~~~~~E~~~l~~l~~~--~~i~~~~~~~~~~~~~~l 80 (407)
.+.||.|....||++.+..+++.|+||.-.. + ....+...|.+.++.+... ..+|.+..+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4578999999999999877788999996321 1 1122356789998887643 345555554 4455689
Q ss_pred EEeccC
Q 015406 81 VMDLLG 86 (407)
Q Consensus 81 vme~~g 86 (407)
+||+++
T Consensus 109 vmE~L~ 114 (392)
T d2pula1 109 VMEDLS 114 (392)
T ss_dssp EECCCT
T ss_pred EEeccC
Confidence 999993
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.36 E-value=0.00022 Score=66.45 Aligned_cols=70 Identities=13% Similarity=0.108 Sum_probs=51.9
Q ss_pred eccccccCceEEEEEEEcC-------CCeEEEEEEecCCCCcchHHHHHHHHHHHcCCCCCCeeEEeeeeCceeEEEEec
Q 015406 12 GRKIGSGSFGEIYLGTNIQ-------TNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (407)
Q Consensus 12 ~~~iG~G~~g~Vy~~~~~~-------~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~lvme~ 84 (407)
++.|+.|-.-.+|++.... ..+.|.+++...........+|..+++.+......+.+.+++.. .+||||
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef 122 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 122 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence 4578888889999998643 24578888865433334567899999999877778888777642 688999
Q ss_pred c
Q 015406 85 L 85 (407)
Q Consensus 85 ~ 85 (407)
+
T Consensus 123 i 123 (395)
T d1nw1a_ 123 I 123 (395)
T ss_dssp C
T ss_pred e
Confidence 8
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.20 E-value=0.00043 Score=62.20 Aligned_cols=48 Identities=15% Similarity=0.172 Sum_probs=30.9
Q ss_pred eccccccCceEEEEEEEcCCCeEEEEEEecCCCCcchHHHHHHHHHHHcC
Q 015406 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQG 61 (407)
Q Consensus 12 ~~~iG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~E~~~l~~l~~ 61 (407)
.+.|..|---+.|+.+. ..| .+++|+.........+..|..++..|..
T Consensus 23 ~~~i~~G~~N~ny~v~t-~~g-~yVLri~~~~~~~~~l~~~~~~l~~L~~ 70 (316)
T d2ppqa1 23 YKGIAEGVENSNFLLHT-TKD-PLILTLYEKRVEKNDLPFFLGLMQHLAA 70 (316)
T ss_dssp EEEECC---EEEEEEEE-SSC-CEEEEEECC---CCHHHHHHHHHHHHHH
T ss_pred eecCCCCcccCeEEEEE-CCC-cEEEEEcCCCCCHHHHHHHHHHHHhhhh
Confidence 44455676678899884 334 5899998665555677888888888875
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.14 E-value=0.0012 Score=59.64 Aligned_cols=64 Identities=14% Similarity=0.204 Sum_probs=43.5
Q ss_pred eEEEEEEEcCCCeEEEEEEecCCC-CcchHHHHHHHHHHHcCCCCCCee-------EEeeeeCceeEEEEeccC
Q 015406 21 GEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNV-------RWFGVEGDYNVLVMDLLG 86 (407)
Q Consensus 21 g~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~-------~~~~~~~~~~~lvme~~g 86 (407)
-.||+++. .+|+.|++|+..... ...++..|...+..|.... ++.. .......+..+.++++++
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~g-ipv~~p~~~~g~~~~~~~~~~~~l~~~~~ 107 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDE-VPVAAPVAFNGQTLLNHQGFYFAVFPSVG 107 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTT-CSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcC-CCCCCceecCCCeeeeeeeEEEEEEeecC
Confidence 47999985 678889999976543 3455788999998887532 2211 112235667788999883
|